data_2ew9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ew9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 108.592 -0.892 . . . . 2.96 108.592 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -91.73 140.73 29.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.665 -0.865 . . . . 4.16 108.665 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.5 t -119.6 132.24 55.67 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.048 -1.093 . . . . 3.17 108.048 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -106.01 102.69 12.1 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.674 1.189 . . . . 3.74 108.533 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.415 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.5 pt? -130.36 171.9 12.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.401 0.62 . . . . 3.53 111.713 174.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.05 153.33 38.77 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.451 -1.315 . . . . 2.02 107.451 172.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.9 mm -97.64 148.05 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 106.541 -1.652 . . . . 2.05 106.541 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -126.43 132.93 51.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.419 -1.697 . . . . 3.64 106.419 159.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.16 -94.45 0.2 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 108.062 -2.015 . . . . 1.29 108.062 -168.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.2 mtt 50.92 75.01 0.2 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.176 1.39 . . . . 2.87 112.552 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -37.87 37.79 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.565 -0.731 . . . . 2.88 111.758 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.1 t 133.6 -74.66 0.0 OUTLIER 'General case' 0 C--N 1.347 0.471 0 C-N-CA 127.104 2.162 . . . . 4.18 109.471 162.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.23 -44.0 89.64 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.053 0.76 . . . . 6.41 113.053 -160.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 m -153.56 0.47 0.24 Allowed 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 114.689 1.366 . . . . 3.3 114.689 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.26 -42.44 68.79 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.985 1.266 . . . . 2.68 110.227 -174.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -53.58 -46.35 60.42 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 108.703 -0.851 . . . . 3.14 108.703 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -60.64 -41.59 95.22 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.387 0.613 . . . . 3.53 111.545 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -61.42 -52.32 65.06 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.625 -0.672 . . . . 2.36 109.81 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.6 mt -47.66 -50.4 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.331 1.052 . . . . 3.06 110.822 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -49.8 -49.13 49.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.117 0.567 . . . . 4.75 112.055 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -65.25 -40.0 93.44 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.918 -0.489 . . . . 10.07 110.214 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -59.4 -53.5 57.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.662 -0.496 . . . . 1.7 109.662 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.49 -41.83 86.19 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.969 -0.457 . . . . 3.72 111.748 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -54.58 -19.49 6.06 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.977 0.732 . . . . 2.07 112.977 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -110.54 3.04 19.13 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 117.865 -1.064 . . . . 4.06 113.069 175.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -60.37 -68.03 0.34 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 120.359 1.436 . . . . 2.98 110.97 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -168.96 -117.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.306 0.642 . . . . 2.36 109.987 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.47 -8.53 76.08 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.557 -0.58 . . . . 1.6 113.341 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.48 122.16 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 118.628 1.214 . . . . 2.4 110.231 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.54 51.93 1.34 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.435 0.636 . . . . 4.27 111.613 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -160.72 132.58 5.89 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.595 -1.631 . . . . 2.39 106.595 161.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.9 m -118.36 132.57 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.771 -1.937 . . . . 3.33 105.771 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -140.0 74.88 1.48 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.052 -1.462 . . . . 3.49 107.052 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -97.39 127.88 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.432 -0.951 . . . . 3.05 108.432 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.78 93.49 5.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.301 -1.74 . . . . 2.49 106.301 166.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.46 -28.13 65.03 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.28 0.632 . . . . 4.36 110.499 176.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 40.9 mtt -59.39 -64.35 0.97 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.448 1.099 . . . . 4.17 110.425 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.0 -26.83 54.33 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.391 -0.822 . . . . 1.85 110.552 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.63 61.23 1.8 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 125.009 1.29 . . . . 1.22 110.545 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -138.52 144.39 39.93 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.412 -1.329 . . . . 6.84 107.412 175.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.38 102.08 9.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.283 1.433 . . . . 2.32 109.35 167.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -96.17 134.67 38.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.301 -2.111 . . . . 4.76 105.301 165.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 pt -140.1 171.27 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.634 -1.247 . . . . 2.73 107.634 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -120.47 108.17 13.77 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.658 0.663 . . . . 5.13 111.952 167.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -97.52 -179.67 4.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.684 2.393 . . . . 3.42 111.907 174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -134.97 98.86 12.74 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.065 1.346 . . . . 4.92 109.322 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.68 -26.87 75.58 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.754 2.969 . . . . 1.94 113.185 -162.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -75.04 -10.5 59.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.939 0.495 . . . . 3.6 111.753 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.3 -49.37 2.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 124.102 0.961 . . . . 4.05 109.954 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.59 147.5 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.71 1.204 . . . . 3.66 107.958 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -124.17 151.89 66.48 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.484 1.114 . . . . 2.83 108.869 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.4 -34.87 97.44 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.747 2.298 . . . . 1.8 112.127 -172.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -71.28 -35.07 71.2 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.567 0.58 . . . . 4.17 112.567 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -58.02 -48.33 80.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.407 0.683 . . . . 3.16 109.22 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -52.47 -53.28 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 106.931 -1.507 . . . . 2.33 106.931 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.33 73.78 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.008 -0.542 . . . . 2.2 109.964 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -45.79 74.84 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.3 0.64 . . . . 2.66 110.645 176.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -47.51 81.57 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.387 0.613 . . . . 3.56 110.119 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.2 mm -67.36 -41.84 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.548 -0.72 . . . . 3.55 111.008 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -44.86 95.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.94 1.296 . . . . 2.32 109.443 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.04 -51.62 68.88 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.067 0.547 . . . . 2.17 109.842 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.3 mt -58.94 -31.1 68.37 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.567 -0.288 . . . . 4.66 111.767 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.89 27.63 2.93 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.145 0.879 . . . . 1.17 111.923 163.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -119.31 167.35 11.97 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.102 1.361 . . . . 3.43 108.274 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -96.82 132.74 42.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.183 -1.414 . . . . 2.52 107.183 164.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.09 119.37 39.28 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.162 -1.792 . . . . 1.72 106.162 163.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.53 122.44 29.23 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.063 -1.088 . . . . 2.5 108.063 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.415 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.9 t -56.89 144.05 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 109.551 -0.537 . . . . 3.3 109.551 171.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.6 mtp . . . . . 0 N--CA 1.448 -0.527 0 CA-C-N 115.361 -0.836 . . . . 4.63 109.245 171.098 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 108.392 -1.883 . . . . 2.26 108.392 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.83 82.53 3.03 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 127.469 2.308 . . . . 4.5 107.572 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.41 172.63 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.665 0.745 . . . . 3.79 109.005 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -142.34 157.39 44.86 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 124.26 1.024 . . . . 4.56 108.402 170.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.6 mt -143.0 147.39 35.05 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.581 1.152 . . . . 3.38 109.138 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.64 119.34 34.94 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.72 -1.585 . . . . 2.92 106.72 165.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.24 116.0 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.712 1.205 . . . . 3.12 108.165 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.7 m -106.58 147.49 29.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.149 1.38 . . . . 3.69 107.986 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.4 -40.29 2.48 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.635 1.112 . . . . 1.21 111.279 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -58.96 141.67 53.13 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.458 0.703 . . . . 3.26 110.648 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.8 t -159.94 37.68 0.18 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.092 0.557 . . . . 3.75 111.328 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 51.8 t -162.71 142.06 9.07 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.257 -0.902 . . . . 3.63 110.732 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.78 -45.31 49.55 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.878 0.871 . . . . 3.46 111.441 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 m -56.21 -39.74 72.96 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.816 -0.553 . . . . 2.9 111.649 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 78.7 m -64.97 -46.81 79.96 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.838 -0.801 . . . . 2.82 108.838 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.1 t -50.91 -55.06 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.167 0.587 . . . . 2.38 110.593 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -59.38 -42.47 91.74 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.865 0.84 . . . . 4.23 109.581 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.59 -49.36 75.53 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.136 1.374 . . . . 2.5 110.906 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -54.75 -50.08 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.233 0.613 . . . . 2.5 109.677 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.86 -41.39 99.36 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.195 0.598 . . . . 2.38 109.507 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.7 t -56.15 -52.88 62.78 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.116 0.566 . . . . 1.76 110.475 171.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -51.98 -45.8 64.61 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.639 -0.663 . . . . 3.5 110.77 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.23 -60.19 3.26 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.732 -1.21 . . . . 2.93 107.732 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -52.92 -23.2 6.68 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.822 0.701 . . . . 2.88 112.429 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -64.89 -25.53 67.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 120.36 -0.536 . . . . 5.52 112.305 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 m -69.69 135.09 49.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.195 1.798 . . . . 2.84 110.384 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.9 p-10 -52.38 -51.22 60.14 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.139 0.975 . . . . 2.47 113.565 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.29 -36.96 43.4 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 122.094 -0.379 . . . . 1.28 113.277 -170.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.38 121.57 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 O-C-N 121.753 -0.851 . . . . 2.81 109.307 -168.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.7 m -102.64 -40.11 6.77 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.665 0.386 . . . . 3.16 111.141 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -141.74 127.69 19.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.291 0.496 . . . . 3.3 110.378 164.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -98.45 155.61 17.17 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.707 -1.22 . . . . 1.75 107.707 162.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.0 m -144.36 106.17 4.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 118.048 -0.977 . . . . 2.95 108.687 165.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.1 p -98.76 126.66 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.216 0.916 . . . . 3.56 112.496 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.87 101.59 7.15 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.844 1.257 . . . . 2.03 109.947 -172.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 pp -75.49 -29.2 59.47 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.367 1.467 . . . . 3.27 113.062 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.32 85.55 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 121.716 0.77 . . . . 2.2 109.171 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.8 -30.9 18.65 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.27 1.828 . . . . 2.73 109.138 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 74.1 m 64.76 50.48 2.03 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.974 1.709 . . . . 2.94 110.261 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -139.71 166.15 25.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.618 -0.719 . . . . 3.54 110.816 158.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -130.38 132.7 45.91 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.073 2.149 . . . . 1.7 107.917 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.49 138.56 34.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.711 -1.218 . . . . 2.99 107.711 172.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.1 t -131.42 128.64 61.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.624 1.17 . . . . 3.49 108.811 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -121.67 94.36 4.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.106 0.963 . . . . 4.31 109.123 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -128.4 -177.94 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.719 0.691 . . . . 4.01 111.528 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -99.65 115.3 65.73 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.0 0.92 . . . . 3.38 109.476 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.28 69.52 7.56 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.256 2.637 . . . . 1.82 112.084 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -163.56 -44.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.694 1.198 . . . . 3.99 109.928 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pt -81.69 -30.71 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 122.275 -0.266 . . . . 2.61 111.318 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.01 171.38 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.76 -1.57 . . . . 2.52 106.76 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.11 160.98 28.76 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.789 -0.924 . . . . 2.16 110.789 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.85 -36.59 90.31 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.93 3.086 . . . . 2.03 112.231 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -35.64 74.74 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 123.01 0.524 . . . . 7.25 110.177 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.36 -43.19 82.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.175 0.898 . . . . 3.3 109.622 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 68.7 mt -57.96 -48.14 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.447 -0.575 . . . . 2.11 109.447 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 60.1 mt -51.41 -60.8 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 108.82 -0.807 . . . . 3.25 108.82 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -44.44 -52.7 7.59 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.633 1.173 . . . . 5.45 112.378 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.4 mm -51.99 -53.64 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 109.253 -0.647 . . . . 3.28 109.253 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.272 2.3 pp -70.34 -26.83 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 114.034 1.124 . . . . 2.32 114.034 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -62.74 -38.16 89.4 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.321 0.964 . . . . 3.35 109.418 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -63.88 -35.87 82.08 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.609 0.764 . . . . 5.06 109.017 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 47.7 mt -68.38 -49.3 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 110.052 -0.351 . . . . 2.14 110.052 170.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.91 30.53 2.31 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.943 1.735 . . . . 1.15 112.488 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -102.06 179.06 4.43 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.944 1.372 . . . . 3.3 109.757 166.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -132.94 118.03 18.38 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 108.007 -1.108 . . . . 5.29 108.007 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.07 100.06 9.57 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.554 1.142 . . . . 1.94 109.755 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.6 m -109.37 112.73 25.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.189 0.995 . . . . 2.94 108.587 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -33.07 105.81 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 126.447 1.899 . . . . 5.35 110.101 168.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.93 -34.76 71.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.345 -0.843 . . . . 3.83 110.314 -171.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.249 1.044 0 C-N-CA 128.156 2.582 . . . . 5.82 114.604 169.187 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 106.478 -1.675 . . . . 2.96 106.478 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -103.23 154.53 19.24 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.747 -1.205 . . . . 4.16 107.747 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 p -142.32 130.34 21.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.316 0.488 . . . . 3.17 112.316 169.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -98.27 103.69 15.66 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.126 2.17 . . . . 3.74 110.271 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.39 176.64 5.77 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.744 0.783 . . . . 3.53 110.199 171.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.87 151.51 43.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.259 -1.386 . . . . 2.02 107.259 168.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.5 mm -95.85 148.04 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.538 -1.653 . . . . 2.05 106.538 171.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -121.64 106.43 11.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.46 -1.311 . . . . 3.64 107.46 163.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.8 -93.65 0.12 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.746 -1.342 . . . . 1.29 109.746 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 mtt 54.25 80.66 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.137 1.375 . . . . 2.87 113.808 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.14 -20.47 17.78 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.847 0.859 . . . . 2.88 112.671 170.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.4 t 74.79 -79.5 0.04 OUTLIER 'General case' 0 C--N 1.342 0.255 0 N-CA-C 107.642 -1.244 . . . . 4.18 107.642 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 4.83 -87.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 128.418 2.687 . . . . 6.41 112.813 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.1 m -138.22 22.49 2.78 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.292 0.637 . . . . 3.3 109.982 160.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.5 m -69.69 -53.49 18.31 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 119.342 -0.943 . . . . 2.68 109.125 -168.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.5 t -50.03 -39.65 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.348 0.594 . . . . 3.14 110.381 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.12 -46.83 87.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.491 0.663 . . . . 3.53 111.221 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -64.57 -46.52 82.39 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.836 -1.165 . . . . 2.36 110.804 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -46.57 -53.7 2.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 C-N-CA 124.868 1.267 . . . . 3.06 108.842 175.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -45.68 -56.26 5.45 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.393 0.616 . . . . 4.75 110.858 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -24.33 61.48 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.151 0.98 . . . . 10.07 110.874 -173.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -69.98 -57.35 5.11 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.683 -0.858 . . . . 1.7 108.683 173.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.03 -42.03 89.22 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 118.522 0.601 . . . . 3.72 110.562 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -22.51 19.93 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.513 0.56 . . . . 2.07 112.513 177.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -124.28 32.16 5.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.944 0.898 . . . . 4.06 111.229 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -74.18 -76.84 0.12 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.021 -1.103 . . . . 2.98 108.021 165.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.74 -118.69 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.276 0.63 . . . . 2.36 110.0 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.82 -13.03 80.89 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 119.522 1.056 . . . . 1.6 113.049 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.08 125.86 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 117.61 0.705 . . . . 2.4 112.215 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.91 57.01 1.41 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.701 1.2 . . . . 4.27 108.093 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.5 t -160.32 154.4 23.12 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 120.535 -1.353 . . . . 2.39 108.141 149.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.4 t -132.94 106.74 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.681 -1.229 . . . . 3.33 107.681 167.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 tt -124.25 73.79 1.26 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.509 -1.293 . . . . 3.49 107.509 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.75 128.0 55.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 109.003 -0.74 . . . . 3.05 109.003 174.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.94 98.07 9.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.654 -1.239 . . . . 2.49 107.654 170.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 tp -61.67 -26.83 68.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.267 1.027 . . . . 4.36 110.258 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -50.75 43.42 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.784 -0.573 . . . . 4.17 110.108 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.5 -7.22 26.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.545 0.738 . . . . 1.85 112.555 -169.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.38 66.98 2.13 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.181 -1.168 . . . . 1.22 110.181 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 131.16 20.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.106 -1.232 . . . . 6.84 108.839 171.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.06 90.2 3.24 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.992 2.117 . . . . 2.32 110.521 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -102.95 130.08 49.91 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.254 -1.388 . . . . 4.76 107.254 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 pt -140.13 -179.6 2.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 O-C-N 121.236 -0.915 . . . . 2.73 108.585 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -132.67 104.71 6.78 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.27 0.628 . . . . 5.13 110.007 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -106.27 172.55 6.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.83 1.252 . . . . 3.42 113.265 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -114.56 101.49 54.32 Favored Pre-proline 0 N--CA 1.444 -0.75 0 C-N-CA 129.212 3.005 . . . . 4.92 109.627 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.11 8.91 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.749 1.633 . . . . 1.94 113.978 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -91.05 -26.83 18.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.533 1.133 . . . . 3.6 112.039 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.69 -63.35 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 105.566 -2.012 . . . . 4.05 105.566 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.46 170.07 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 120.242 -0.583 . . . . 3.66 110.35 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.86 159.54 68.26 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.742 1.217 . . . . 2.83 108.416 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.24 -40.78 30.64 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.46 2.107 . . . . 1.8 111.256 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -58.22 -40.71 82.36 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.993 -0.442 . . . . 4.17 111.184 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -61.16 -44.94 96.53 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.893 0.877 . . . . 3.16 110.656 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -49.66 -57.92 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.368 0 N-CA-C 106.212 -1.773 . . . . 2.33 106.212 170.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.03 -43.51 86.84 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.473 -0.785 . . . . 2.2 110.165 -170.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -50.1 65.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.569 1.548 . . . . 2.66 110.049 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.06 -45.83 86.4 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.574 0.702 . . . . 3.56 109.707 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.6 mm -61.59 -44.03 97.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 116.291 -0.413 . . . . 3.55 110.373 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -64.96 -40.86 95.65 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.234 -0.916 . . . . 2.32 110.012 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -61.1 -50.44 73.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.935 0.894 . . . . 2.17 109.932 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.38 -35.18 80.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.3 -0.56 . . . . 4.66 110.781 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.29 23.4 1.75 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 123.386 0.517 . . . . 1.17 112.708 163.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -112.79 158.71 19.79 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.889 0.845 . . . . 3.43 109.68 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -95.43 133.35 39.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.045 -1.465 . . . . 2.52 107.045 167.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.06 125.31 44.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.111 0.964 . . . . 1.72 108.531 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.19 134.88 44.66 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.408 -0.59 . . . . 2.5 109.408 171.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.15 151.8 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.315 1.046 . . . . 3.3 110.726 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.0 mtp . . . . . 0 N--CA 1.449 -0.494 0 CA-C-N 115.649 -0.705 . . . . 4.63 111.946 173.038 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.771 0 N-CA-C 110.642 -0.983 . . . . 2.26 110.642 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -129.39 119.34 23.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.917 0.887 . . . . 4.5 111.283 169.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.27 157.02 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.547 -1.279 . . . . 3.79 107.547 172.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.94 141.54 32.96 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.813 0.845 . . . . 4.56 109.632 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.6 mt -141.47 143.77 34.03 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 109.099 -0.704 . . . . 3.38 109.099 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.57 130.63 43.72 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 107.726 -1.212 . . . . 2.92 107.726 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 pp -111.4 99.88 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.331 1.052 . . . . 3.12 110.671 -169.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.1 p -97.31 129.51 44.58 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.875 -0.787 . . . . 3.69 108.875 -175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.86 -26.98 6.98 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.349 0.976 . . . . 1.21 111.326 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.0 mtm -63.11 149.03 46.21 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.125 -0.632 . . . . 3.26 112.211 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -169.82 41.92 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.939 1.295 . . . . 3.75 109.287 172.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -166.04 140.63 4.54 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 121.107 -0.996 . . . . 3.63 112.895 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.08 -42.62 81.02 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.447 0.699 . . . . 3.46 110.751 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.3 m -50.48 -45.14 56.15 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.228 0.611 . . . . 2.9 110.807 173.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 75.5 m -64.39 -50.94 65.68 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.017 -0.735 . . . . 2.82 109.017 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 78.7 t -48.32 -51.77 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.08 0.552 . . . . 2.38 110.664 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -59.17 -34.71 72.42 Favored 'General case' 0 C--O 1.227 -0.086 0 CA-C-O 120.722 0.296 . . . . 4.23 110.335 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -63.4 -58.86 5.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.86 0.864 . . . . 2.5 109.393 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.2 mp -52.94 -52.22 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.366 -0.605 . . . . 2.5 109.366 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.28 -49.76 73.32 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.175 -0.676 . . . . 2.38 109.175 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 t -53.73 -46.77 70.94 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 122.047 -0.408 . . . . 1.76 110.529 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -65.18 -38.11 89.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.124 0.57 . . . . 3.5 111.791 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 47.7 mt -70.91 -62.64 1.32 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.373 -0.973 . . . . 2.93 108.373 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.4 m -50.29 -24.36 2.88 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.633 2.373 . . . . 2.88 112.692 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -32.12 62.58 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.288 0.477 . . . . 5.52 112.288 172.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.2 m -59.42 144.54 46.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.573 1.149 . . . . 2.84 111.118 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -66.8 -47.97 70.43 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.968 0.907 . . . . 2.47 111.552 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.74 -30.21 66.45 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 123.527 0.584 . . . . 1.28 113.293 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.9 tt -69.61 130.26 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 122.117 -0.637 . . . . 2.81 110.277 -167.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 37.7 m -99.64 -49.77 4.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.753 -0.203 . . . . 3.16 110.824 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -141.31 122.65 14.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.274 -0.639 . . . . 3.3 109.274 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.88 156.12 16.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.265 -1.013 . . . . 1.75 108.265 161.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.5 t -141.05 122.25 14.77 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 107.276 -1.379 . . . . 2.95 107.276 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.59 117.2 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.691 1.196 . . . . 3.56 108.825 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.26 97.72 5.18 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.131 0.967 . . . . 2.03 111.525 -171.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 pp -59.72 -22.07 61.53 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.412 0.893 . . . . 3.27 113.412 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.53 -38.28 49.12 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.454 0.645 . . . . 2.2 109.471 -176.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.5 p -88.79 -20.08 25.17 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 125.011 1.324 . . . . 2.73 109.353 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.5 m 73.25 21.48 3.05 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.885 2.074 . . . . 2.94 111.096 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -130.24 157.3 42.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.899 0.857 . . . . 3.54 112.083 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.27 122.47 29.7 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.061 2.145 . . . . 1.7 107.366 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mp -99.87 137.86 37.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.542 1.537 . . . . 2.99 107.451 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.73 122.63 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.825 1.25 . . . . 3.49 109.346 -169.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -111.37 87.94 2.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.665 -0.683 . . . . 4.31 109.615 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -117.55 173.33 6.78 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.858 0.863 . . . . 4.01 110.657 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -98.49 112.61 62.78 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 108.397 -0.964 . . . . 3.38 108.397 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.02 73.65 4.81 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.39 2.726 . . . . 1.82 111.991 -165.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -162.1 -43.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.228 1.411 . . . . 3.99 110.153 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 pt -83.77 -31.77 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 123.762 0.825 . . . . 2.61 111.281 -170.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.68 158.96 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.337 -0.986 . . . . 2.52 108.337 171.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -126.71 159.93 20.99 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.099 1.333 . . . . 2.16 109.958 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.7 -36.17 42.77 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.125 2.55 . . . . 2.03 111.356 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.17 -40.71 74.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.748 1.219 . . . . 7.25 110.869 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -66.05 -43.91 86.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.671 -0.492 . . . . 3.3 109.671 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.45 -47.68 89.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.645 -0.872 . . . . 2.11 108.645 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.7 mt -53.05 -56.19 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 123.825 0.85 . . . . 3.25 109.529 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -48.34 64.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.366 0.985 . . . . 5.45 110.824 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.0 mm -54.74 -52.99 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 122.047 -0.408 . . . . 3.28 110.065 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.257 2.5 pp -70.52 -27.85 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.764 -1.21 . . . . 2.32 113.419 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.29 -32.85 73.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.36 0.527 . . . . 3.35 110.646 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -57.31 -42.94 82.78 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.844 -0.798 . . . . 5.06 108.844 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.8 mt -73.8 -40.57 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.771 -0.65 . . . . 2.14 109.517 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.38 37.0 3.41 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.007 1.289 . . . . 1.15 110.92 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -99.49 178.1 4.97 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.262 -1.014 . . . . 3.3 108.262 160.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -140.63 125.87 18.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 107.027 -1.471 . . . . 5.29 107.027 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.59 106.45 14.88 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.498 1.519 . . . . 1.94 108.722 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.9 t -123.6 136.27 54.42 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 118.423 0.556 . . . . 2.94 110.496 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp -32.24 119.91 0.29 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.808 2.043 . . . . 5.35 113.27 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.56 49.03 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.085 0.954 . . . . 3.83 111.211 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.332 0 CA-C-O 116.042 -1.932 . . . . 5.82 107.356 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 108.418 -0.956 . . . . 4.0 108.418 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -90.64 157.08 17.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.99 -1.855 . . . . 4.84 105.99 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.22 121.92 20.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.695 -1.594 . . . . 3.21 106.695 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -102.3 90.59 3.95 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.313 1.845 . . . . 4.98 109.05 -173.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.68 171.26 8.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.576 0.703 . . . . 3.7 111.204 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.48 143.03 46.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.394 -0.965 . . . . 1.92 108.394 166.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.3 mm -99.44 139.29 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 107.276 -1.379 . . . . 2.24 107.276 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -125.97 123.01 37.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.074 -1.454 . . . . 3.83 107.074 168.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.58 -69.66 0.25 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.224 1.392 . . . . 1.74 110.442 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.9 mmt 37.09 71.2 0.15 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.758 2.023 . . . . 2.71 114.254 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -52.56 -60.52 3.15 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.469 -0.769 . . . . 3.5 113.064 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 t -165.87 48.67 0.08 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 119.518 -0.873 . . . . 4.19 111.816 -172.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.05 51.91 15.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.454 1.102 . . . . 6.73 112.243 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.3 m -175.18 -36.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.039 1.335 . . . . 4.09 110.96 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.71 -42.86 77.12 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 120.965 -1.084 . . . . 2.43 110.536 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.0 -43.98 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.348 -0.612 . . . . 3.01 109.348 168.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -62.07 -30.78 71.23 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.459 0.647 . . . . 2.86 111.861 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -71.47 -46.45 59.87 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 120.98 -1.075 . . . . 3.52 110.706 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.8 mt -49.28 -45.98 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.397 0.679 . . . . 2.71 110.823 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -45.19 -48.07 12.48 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.444 0.565 . . . . 4.17 112.216 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.0 mtm105 -66.02 -34.09 77.29 Favored 'General case' 0 C--N 1.339 0.115 0 O-C-N 121.754 -0.591 . . . . 6.9 110.753 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -63.7 -54.55 33.7 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.241 -1.022 . . . . 1.16 108.241 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mp -60.19 -36.44 77.63 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 111.953 0.353 . . . . 3.01 111.953 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -19.45 6.34 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.178 -0.951 . . . . 2.34 113.128 173.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -118.77 21.31 12.54 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.656 -0.688 . . . . 4.46 112.519 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -66.69 -68.36 0.38 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.355 0.98 . . . . 3.09 109.292 168.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.57 -125.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.419 0.687 . . . . 2.09 109.161 -167.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.0 -10.07 61.07 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 121.85 -0.531 . . . . 1.56 113.389 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -74.95 120.59 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 118.739 1.269 . . . . 2.99 110.38 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.86 53.07 1.09 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.068 0.396 . . . . 3.56 112.068 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' A' ' 47' ' ' LYS . 29.1 t -158.16 137.0 11.34 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 106.731 -1.581 . . . . 2.98 106.731 171.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.25 101.79 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.607 -1.627 . . . . 3.83 106.607 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -129.3 76.39 1.72 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.158 -1.793 . . . . 3.27 106.158 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.21 141.55 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.945 -1.131 . . . . 3.28 107.945 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -112.85 101.82 9.87 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.263 -1.754 . . . . 2.13 106.263 164.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 tp -55.65 -33.0 63.67 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.488 1.115 . . . . 4.45 109.037 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -48.97 77.29 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.545 0.738 . . . . 6.66 110.571 -174.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.05 -30.48 16.74 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.499 0.72 . . . . 2.38 110.875 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.35 57.69 1.74 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.984 1.278 . . . . 1.17 110.603 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -140.05 144.56 36.94 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.131 0.966 . . . . 3.93 108.856 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.49 116.24 29.95 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.151 0.98 . . . . 1.92 111.398 164.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -97.78 123.79 41.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.716 -1.216 . . . . 4.33 107.716 157.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mt -114.01 164.87 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 108.136 -1.061 . . . . 4.2 108.136 167.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' CB ' ' HB3' ' A' ' 34' ' ' SER . 10.3 ttmt -124.65 108.93 12.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.739 1.215 . . . . 4.66 110.194 166.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -116.83 177.26 4.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.1 2.16 . . . . 4.05 112.634 175.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.42 107.63 23.81 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.641 1.576 . . . . 3.19 107.559 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.93 6.81 2.28 Favored 'Trans proline' 0 N--CA 1.455 -0.753 1 C-N-CA 125.512 4.142 . . . . 2.64 113.605 -168.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -86.73 -22.16 26.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.46 0.704 . . . . 3.83 111.207 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.73 -56.01 3.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-N 118.566 0.621 . . . . 4.32 109.876 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.31 142.77 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.549 -1.278 . . . . 2.38 107.549 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.26 150.79 54.78 Favored Pre-proline 0 N--CA 1.453 -0.293 0 C-N-CA 124.798 1.239 . . . . 3.21 109.583 -174.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.18 -44.27 35.46 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.758 2.305 . . . . 1.55 111.627 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -39.72 94.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.372 -0.83 . . . . 4.39 111.488 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -58.47 -43.69 89.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.005 0.522 . . . . 4.22 110.352 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.57 -42.39 29.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 N-CA-C 108.727 -0.842 . . . . 2.64 108.727 173.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.32 -38.59 74.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.12 0.486 . . . . 2.67 111.152 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -63.88 -51.48 64.38 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.491 -0.755 . . . . 3.01 110.109 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -54.26 -51.91 63.05 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.91 0.323 . . . . 4.8 111.695 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 pp -61.25 -42.73 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.649 -0.657 . . . . 5.55 111.741 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.41 -35.15 80.06 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.663 -0.648 . . . . 3.22 110.758 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -64.27 -50.75 66.69 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.174 0.59 . . . . 2.59 109.901 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.3 mt -55.08 -35.38 64.5 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.163 0.585 . . . . 2.92 111.129 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.4 39.88 1.44 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.558 1.075 . . . . 1.45 110.589 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -135.43 156.97 48.04 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.528 1.531 . . . . 3.67 107.596 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -104.94 129.75 53.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.695 -1.224 . . . . 3.63 107.695 171.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.62 112.32 17.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.392 -1.707 . . . . 2.05 106.392 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.53 129.45 55.8 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.356 1.035 . . . . 1.83 108.916 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.8 154.29 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.788 0.835 . . . . 3.85 109.153 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.0 mtt . . . . . 0 N--CA 1.454 -0.246 0 CA-C-N 116.19 -0.459 . . . . 4.23 110.525 170.012 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.877 0 N-CA-C 107.913 -2.075 . . . . 2.79 107.913 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.05 110.94 23.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.225 0.61 . . . . 2.45 109.489 175.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.5 pp -129.67 174.96 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.799 0.84 . . . . 4.77 110.874 164.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 148' ' ' ALA . 0.9 OUTLIER -111.3 150.93 28.97 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 128.041 2.536 . . . . 4.41 109.401 174.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.2 mt -142.34 139.58 31.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.563 0.745 . . . . 3.58 110.03 172.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.1 t -97.1 124.45 41.12 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.33 0.968 . . . . 2.43 109.51 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -95.9 106.51 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.185 -0.672 . . . . 2.62 109.185 -171.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.9 m -98.83 133.74 42.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.903 -1.147 . . . . 2.37 107.903 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.62 -44.96 1.32 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.918 1.247 . . . . 1.0 112.013 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.52 150.82 41.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.662 0.731 . . . . 3.6 111.349 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -162.5 44.65 0.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.543 0.687 . . . . 3.76 110.057 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 48.9 t -161.99 136.67 6.98 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.826 -1.171 . . . . 3.34 110.721 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.6 -39.15 49.23 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.055 0.942 . . . . 3.67 111.352 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 m -56.23 -44.2 79.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.611 -0.681 . . . . 2.54 111.394 174.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 64.1 m -68.58 -49.98 55.25 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.222 -0.659 . . . . 2.79 109.222 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 78.8 t -43.49 -60.4 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.775 1.23 . . . . 2.24 109.792 170.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -59.13 -43.31 91.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.239 1.016 . . . . 3.86 111.105 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -62.48 -47.68 82.92 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.578 0.751 . . . . 1.89 110.673 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.7 mt -56.02 -49.42 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.388 -0.967 . . . . 1.8 108.388 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.57 -45.11 92.8 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.679 -0.489 . . . . 2.58 109.679 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.1 m -57.02 -48.82 77.59 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.358 0.663 . . . . 2.74 110.736 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -60.01 -38.64 83.24 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.723 0.809 . . . . 4.87 111.493 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 42.6 mt -67.81 -60.5 2.48 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.693 -1.225 . . . . 2.66 107.693 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.6 p -55.74 -17.37 5.86 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.278 0.631 . . . . 2.82 112.64 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -60.99 -24.49 66.18 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.615 -0.678 . . . . 6.89 112.412 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.1 m -73.86 166.13 23.89 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.407 1.483 . . . . 2.43 111.505 -167.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -76.57 -58.32 3.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.65 1.18 . . . . 3.28 111.722 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.69 -45.73 8.35 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.362 -1.095 . . . . 1.75 110.362 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.44 131.29 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.485 -0.561 . . . . 3.58 109.485 175.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.2 t -131.53 -39.21 1.14 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.217 1.007 . . . . 3.74 110.875 172.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.06 112.18 17.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.704 -1.591 . . . . 3.64 106.704 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.75 166.69 16.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.672 -0.862 . . . . 2.31 108.672 163.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 m -142.59 138.34 30.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.69 -1.226 . . . . 2.56 107.69 163.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.66 105.12 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.207 1.003 . . . . 2.97 108.616 -171.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -112.61 102.47 10.54 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.12 0.968 . . . . 2.05 110.573 -168.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -29.7 68.95 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.079 1.352 . . . . 3.82 113.638 -173.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.32 -44.75 95.77 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.797 0.839 . . . . 2.66 109.964 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.74 -25.63 26.32 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.519 1.127 . . . . 2.2 109.623 170.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.2 m 73.97 24.31 2.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.127 1.771 . . . . 2.41 111.509 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -116.06 150.33 37.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.459 1.027 . . . . 3.84 110.425 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.14 107.57 4.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.82 1.248 . . . . 1.96 112.595 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.82 141.5 28.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.245 1.021 . . . . 3.97 110.794 173.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.8 m -133.94 135.3 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 126.029 1.732 . . . . 3.74 106.475 -173.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.15 104.21 14.11 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 108.292 -1.003 . . . . 4.44 108.292 171.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -113.43 -179.55 3.67 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.782 0.833 . . . . 4.26 111.199 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.79 114.32 37.62 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.165 1.386 . . . . 3.73 108.587 171.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.96 57.83 6.69 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.677 2.918 . . . . 2.42 112.511 -169.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -147.11 -52.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.634 1.573 . . . . 4.59 107.539 172.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 pt -83.94 -25.71 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 123.178 0.591 . . . . 2.9 112.27 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -147.03 169.73 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.075 -0.713 . . . . 2.3 109.075 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.57 165.75 30.09 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 111.145 -0.782 . . . . 1.56 111.145 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.18 -32.99 41.51 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.535 2.823 . . . . 1.71 111.505 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -52.37 -39.62 61.02 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.369 0.604 . . . . 7.47 111.188 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -72.26 -38.28 68.9 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.355 -0.98 . . . . 4.42 108.355 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 81.3 mt -58.03 -54.14 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.648 -0.501 . . . . 2.11 109.648 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 22.2 pt -56.25 -55.01 21.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.404 -0.591 . . . . 4.1 109.404 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -47.52 -46.28 27.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 119.117 0.871 . . . . 5.03 112.931 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 mm -59.07 -42.7 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 O-C-N 121.735 -0.603 . . . . 2.55 111.682 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.3 pt -76.93 -28.99 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 113.785 1.032 . . . . 3.06 113.785 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.38 -28.33 65.06 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.363 -0.836 . . . . 3.06 110.301 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -60.77 -41.0 94.66 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.638 -0.504 . . . . 5.49 109.638 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 27.7 mt -70.79 -40.95 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.887 -0.782 . . . . 2.19 108.887 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.62 31.61 3.39 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.393 1.473 . . . . 1.09 110.729 -176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -108.9 166.82 10.53 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 108.782 -0.822 . . . . 3.33 108.782 169.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -137.59 133.72 34.74 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 106.985 -1.487 . . . . 4.59 106.985 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.45 92.66 3.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.981 1.712 . . . . 2.43 109.239 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.3 p -146.87 105.47 3.82 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 117.021 -1.466 . . . . 3.03 112.581 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.3 -70.56 0.09 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 121.361 1.891 . . . . 9.37 114.031 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.447 ' HA ' ' CB ' ' A' ' 83' ' ' GLU 0.361 . . 40.68 80.09 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.334 2.254 . . . . 5.99 116.891 -163.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.917 0 C-N-CA 128.643 2.777 . . . . 7.06 103.875 172.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 107.84 -1.17 . . . . 4.28 107.84 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.84 154.36 18.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.274 -1.33 . . . . 5.08 107.75 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.6 t -141.71 132.25 25.39 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.674 0.67 . . . . 3.52 109.507 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -107.83 87.35 2.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.983 1.313 . . . . 3.81 108.983 -162.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.19 177.69 4.55 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.51 0.671 . . . . 3.92 110.59 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.86 151.79 49.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.74 -1.578 . . . . 2.88 106.74 172.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.1 mm -99.3 120.57 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.296 -1.372 . . . . 1.67 107.296 171.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -101.47 87.44 3.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.677 -1.972 . . . . 5.29 105.677 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.12 -87.71 0.08 OUTLIER Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.117 -1.193 . . . . 1.31 110.117 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.2 ptp 41.51 69.72 0.33 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.263 1.825 . . . . 2.8 115.636 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -53.33 -13.32 0.53 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.822 1.416 . . . . 3.24 114.822 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.8 t 74.58 -61.76 0.48 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.397 1.879 . . . . 3.39 111.217 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.15 -72.69 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.741 2.416 . . . . 6.7 113.043 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.6 p -157.51 10.88 0.2 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 113.027 0.751 . . . . 4.73 113.027 166.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -50.64 30.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.423 -1.325 . . . . 2.6 107.423 -169.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 p -49.72 -48.71 20.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 109.783 -0.451 . . . . 4.31 109.783 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 m -54.77 -46.98 74.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.667 0.787 . . . . 2.62 112.552 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -63.82 -45.49 89.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.978 -1.076 . . . . 2.88 110.122 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.83 -45.02 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.314 1.046 . . . . 3.22 109.291 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -56.08 -50.52 70.77 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.209 1.403 . . . . 5.31 110.779 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -61.4 -39.53 91.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.084 0.554 . . . . 5.93 109.979 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -63.4 -51.58 65.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.554 -0.536 . . . . 1.53 109.554 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -57.26 9.25 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.487 1.115 . . . . 4.09 111.783 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.8 -18.67 34.24 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.946 1.091 . . . . 3.51 113.946 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -102.79 5.64 38.86 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.039 1.336 . . . . 3.97 114.136 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -57.33 -64.68 0.81 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 121.169 1.804 . . . . 3.77 111.611 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -168.47 -133.99 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.434 -1.691 . . . . 2.43 106.434 -169.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.78 33.13 1.23 Allowed Glycine 0 CA--C 1.534 1.221 0 CA-C-N 119.929 1.241 . . . . 1.64 113.61 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.41 124.22 60.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 N-CA-C 105.559 -2.015 . . . . 2.5 105.559 165.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 49.65 1.68 Allowed 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.073 -0.714 . . . . 3.72 109.073 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.3 t -161.88 148.41 13.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.559 -1.275 . . . . 3.0 107.559 173.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.25 120.59 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.964 -1.865 . . . . 3.89 105.964 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.41 71.46 1.47 Allowed 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.262 -1.014 . . . . 3.44 108.262 168.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.3 m -98.14 160.89 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.511 0.672 . . . . 3.43 110.49 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.24 99.65 5.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.426 -1.694 . . . . 2.46 106.426 170.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.7 -27.35 64.77 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.239 1.415 . . . . 4.5 109.869 171.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -69.14 -43.15 74.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.838 0.855 . . . . 5.4 111.688 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.43 -37.96 9.39 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.234 1.014 . . . . 2.17 110.104 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.4 62.94 0.83 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 126.082 1.801 . . . . 1.08 111.011 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -143.04 144.37 32.25 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.834 -1.172 . . . . 3.59 107.834 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.23 105.83 12.18 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.959 1.304 . . . . 1.66 111.174 171.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.66 136.39 38.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 105.64 -1.985 . . . . 4.31 105.64 166.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.9 pt -136.34 174.13 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.039 -1.097 . . . . 2.86 108.039 169.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -134.64 111.48 10.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.967 1.307 . . . . 5.71 109.488 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -124.38 177.31 5.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.86 1.664 . . . . 4.58 113.526 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -113.43 106.0 54.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.343 1.457 . . . . 4.02 111.128 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.47 -10.78 29.88 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.69 2.26 . . . . 3.43 114.296 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -65.89 -18.38 65.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.859 0.754 . . . . 4.13 112.397 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.87 -45.85 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 123.287 0.635 . . . . 4.1 110.281 -170.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.66 153.59 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 109.255 -0.646 . . . . 2.91 109.255 175.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -130.62 150.08 75.35 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.911 1.685 . . . . 2.82 108.952 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -62.29 -39.27 48.52 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.075 2.516 . . . . 2.03 111.998 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.43 -46.98 87.8 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.495 -0.753 . . . . 5.5 109.91 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -59.79 -37.28 78.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.972 0.509 . . . . 3.05 111.128 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.5 mt -54.16 -56.36 10.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 107.202 -1.407 . . . . 2.43 107.202 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.1 -44.48 74.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.104 -0.498 . . . . 2.89 111.002 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -48.67 -52.2 24.52 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.134 0.974 . . . . 4.6 110.301 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -49.08 73.52 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.087 0.47 . . . . 3.54 109.811 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -62.4 -37.16 78.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 122.099 -0.376 . . . . 3.78 110.928 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -65.81 -45.17 83.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.629 -0.508 . . . . 2.89 109.629 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -59.02 -50.07 75.5 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.89 -0.411 . . . . 2.46 109.89 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.0 mt -53.49 -45.12 69.52 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.31 0.644 . . . . 3.38 111.241 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.87 30.63 0.87 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.807 0.718 . . . . 1.35 112.363 166.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -129.95 163.79 25.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.401 1.48 . . . . 3.36 108.951 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -99.84 122.6 43.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.63 -1.248 . . . . 2.29 107.63 170.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.04 122.54 45.47 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.727 -1.583 . . . . 2.21 106.727 165.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.27 141.62 50.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.772 -1.196 . . . . 2.0 107.772 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 p -67.97 149.09 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.107 -0.701 . . . . 3.95 109.107 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.2 mtt . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 109.99 -0.374 . . . . 5.34 109.99 173.186 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.263 0 N-CA-C 109.715 -1.354 . . . . 3.22 109.715 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -93.1 102.86 15.19 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.574 -2.009 . . . . 2.8 105.574 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.51 143.04 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 108.111 -1.07 . . . . 3.97 108.111 175.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -95.92 146.91 24.21 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.349 -1.723 . . . . 4.41 106.349 170.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.3 mt -137.73 158.96 43.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.172 -1.788 . . . . 3.36 106.172 166.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.75 123.43 42.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.333 -1.729 . . . . 2.37 106.333 170.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.3 pt -97.82 140.18 18.47 Favored 'Isoleucine or valine' 0 C--N 1.336 0.009 0 N-CA-C 108.465 -0.939 . . . . 3.1 108.465 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.4 m -129.03 138.18 51.75 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.814 0.845 . . . . 2.33 109.42 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.51 -35.32 2.7 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 126.032 1.777 . . . . 1.25 112.146 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -30.48 103.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.964 1.706 . . . . 3.85 114.565 172.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.5 m -100.6 -4.81 27.77 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.268 0.627 . . . . 4.0 111.063 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.66 165.52 14.33 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 120.646 -1.284 . . . . 4.14 110.25 177.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.06 -36.79 61.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.54 0.336 . . . . 3.61 110.712 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.3 t -48.46 -45.9 37.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.37 0.668 . . . . 2.82 111.364 173.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 64.2 m -59.77 -53.78 53.98 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 108.759 -0.83 . . . . 2.66 108.759 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.7 t -52.41 -43.6 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.389 0.676 . . . . 2.49 111.027 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -65.21 -42.31 93.61 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.362 -0.977 . . . . 3.33 108.362 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -42.01 97.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.022 -0.362 . . . . 3.85 110.022 176.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.28 -53.66 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.683 -0.858 . . . . 1.89 108.683 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -54.97 -45.19 74.95 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.644 1.178 . . . . 3.24 108.834 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -53.75 -52.85 58.84 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.927 -0.483 . . . . 1.68 111.612 172.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -60.36 -35.2 75.12 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 120.823 -1.173 . . . . 3.14 111.716 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.49 -59.07 3.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.194 -1.039 . . . . 2.8 108.194 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.8 p -57.05 -19.03 16.65 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.077 0.951 . . . . 2.88 112.637 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.93 -31.84 67.2 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.048 -0.407 . . . . 4.88 111.499 171.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 17.4 m -65.45 142.64 58.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.569 1.547 . . . . 2.43 110.923 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -64.83 -48.1 75.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.459 1.103 . . . . 2.58 111.697 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.19 -32.85 57.8 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.97 -0.35 . . . . 1.39 112.741 -171.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.48 134.61 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 117.899 0.85 . . . . 3.2 109.039 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.8 t -107.71 -49.82 3.17 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.08 0.4 . . . . 4.09 112.08 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -136.65 121.64 18.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.482 -0.933 . . . . 3.04 108.482 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.43 133.15 44.16 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.009 -0.737 . . . . 1.76 109.009 166.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.5 m -113.4 102.73 10.6 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 107.901 -1.148 . . . . 2.43 107.901 168.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -108.43 140.33 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.233 -0.654 . . . . 3.98 109.233 175.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.37 95.58 3.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.165 0.983 . . . . 2.31 110.599 -169.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.72 -33.02 72.26 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.993 1.317 . . . . 3.44 112.685 -174.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.78 -33.74 17.36 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.071 0.948 . . . . 2.56 111.308 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.66 -5.93 12.16 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.743 1.617 . . . . 2.68 111.426 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.0 m 63.41 27.87 15.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.056 1.742 . . . . 2.4 111.989 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -99.02 158.08 15.9 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.348 0.659 . . . . 4.73 110.642 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -139.13 101.62 4.32 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.506 1.922 . . . . 2.19 108.455 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.79 103.62 15.26 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.185 0.994 . . . . 2.83 108.319 -176.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.6 m -102.12 127.56 55.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 124.612 1.165 . . . . 3.32 109.688 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.36 103.75 14.2 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.457 1.103 . . . . 5.0 108.619 172.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -121.51 -174.67 2.91 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.149 1.379 . . . . 4.02 110.257 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -111.59 111.9 54.32 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 119.153 0.888 . . . . 3.21 109.424 176.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.35 72.18 6.65 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.973 2.449 . . . . 2.2 111.937 -164.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.33 -43.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.206 1.402 . . . . 3.73 109.669 172.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.1 pt -85.73 -31.81 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 124.149 0.98 . . . . 2.59 110.827 -174.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.29 161.67 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.791 1.236 . . . . 2.37 108.296 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.02 162.95 29.33 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.969 -1.252 . . . . 1.65 109.969 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -59.89 -34.38 95.41 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.602 2.868 . . . . 1.61 111.375 -173.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -36.3 69.01 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 122.991 0.517 . . . . 5.34 111.337 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -69.9 -45.7 67.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.617 -0.882 . . . . 3.22 108.617 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.8 -49.38 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.29 -1.004 . . . . 1.92 108.29 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.5 mt -49.66 -59.99 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 118.369 -0.824 . . . . 2.9 109.05 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -49.65 -50.89 41.45 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.891 1.223 . . . . 4.29 112.713 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.62 -52.31 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.737 -0.602 . . . . 2.91 110.864 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.259 2.4 pp -70.43 -26.11 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 120.777 -1.202 . . . . 2.27 113.716 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -60.77 -39.45 88.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.575 0.625 . . . . 2.61 110.224 169.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.11 -40.37 81.02 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.999 -0.741 . . . . 3.43 108.999 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.7 mt -72.73 -42.16 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.99 -0.55 . . . . 1.96 110.095 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.37 35.12 4.53 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.997 1.284 . . . . 1.07 111.383 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -97.35 176.01 6.05 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.286 -1.005 . . . . 3.14 108.286 163.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -133.42 131.05 39.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.071 -1.455 . . . . 4.55 107.071 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.87 99.0 6.37 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.647 1.579 . . . . 1.95 109.551 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 58.4 m -111.49 114.85 28.23 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.886 0.875 . . . . 2.21 110.701 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -35.88 113.06 0.19 Allowed 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 127.793 2.437 . . . . 4.5 111.216 169.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -103.14 68.45 0.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.706 0.765 . . . . 4.1 110.85 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.291 1.436 . . . . 6.93 110.32 171.972 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 120.619 0.247 . . . . 4.55 110.911 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -96.51 140.15 31.57 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.578 -0.701 . . . . 5.33 109.677 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.9 t -119.39 136.19 54.4 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.338 1.055 . . . . 2.85 110.115 174.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -106.99 90.06 3.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.401 1.881 . . . . 6.13 111.075 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.271 0.3 OUTLIER -118.13 167.39 11.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.249 1.023 . . . . 3.83 113.087 176.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.69 161.05 20.31 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.594 -1.632 . . . . 2.94 106.594 165.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.0 mm -100.16 136.81 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 105.552 -2.018 . . . . 2.09 105.552 167.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -121.85 78.01 1.42 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.06 -1.459 . . . . 6.31 107.06 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.96 -76.73 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.737 -0.945 . . . . 1.38 110.737 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mpt? 57.98 89.18 0.05 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.664 1.586 . . . . 2.81 112.715 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.9 m -59.18 -60.72 3.41 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.583 -0.698 . . . . 3.39 110.961 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.5 t -167.72 88.18 0.27 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.689 -1.226 . . . . 4.33 107.689 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 1.94 65.87 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 129.189 2.996 . . . . 6.81 115.476 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t 173.61 -43.89 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 125.218 1.407 . . . . 3.97 108.537 -168.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 t -66.42 -40.76 89.73 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.833 -1.167 . . . . 3.35 111.32 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.9 -32.02 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 121.799 -0.563 . . . . 2.88 110.464 167.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 t -69.51 -27.2 64.98 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.039 -0.413 . . . . 3.7 111.253 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.59 -47.75 74.65 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.598 -1.314 . . . . 2.86 109.599 171.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.2 mt -42.74 -37.99 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 121.354 -0.841 . . . . 2.6 112.966 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -47.71 -55.37 9.66 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.719 0.691 . . . . 3.7 112.821 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -64.52 -36.01 82.82 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.48 -0.762 . . . . 7.21 109.858 -172.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -61.7 -54.22 45.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.94 -1.133 . . . . 1.34 107.94 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -54.97 -44.58 74.52 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 112.173 0.434 . . . . 3.13 112.173 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.82 -21.1 3.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.907 0.776 . . . . 2.27 112.814 175.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 5.05 13.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 117.843 -1.075 . . . . 6.29 112.61 177.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -64.12 -58.42 6.7 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.678 1.126 . . . . 2.77 110.735 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.5 -135.84 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 O-C-N 122.002 -0.436 . . . . 2.19 110.48 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.79 -15.09 47.1 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.929 1.252 . . . . 1.64 113.465 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.28 125.34 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 117.981 0.891 . . . . 2.95 111.755 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 mt -141.53 44.32 1.74 Allowed 'General case' 0 C--N 1.342 0.257 0 CA-C-O 119.286 -0.387 . . . . 4.35 111.074 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -158.13 149.1 20.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.451 -0.574 . . . . 3.23 109.451 169.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.98 70.26 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 124.902 1.281 . . . . 3.93 109.275 -170.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.304 0.7 OUTLIER -102.32 78.93 1.79 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 119.234 -0.986 . . . . 6.09 110.26 -177.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p -96.91 145.76 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.002 -0.999 . . . . 3.81 108.81 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.59 99.78 6.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.963 -1.495 . . . . 2.58 106.963 163.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.6 mt -56.88 -26.65 59.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.007 0.923 . . . . 4.01 111.441 172.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.1 ttt -56.55 -57.59 11.7 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.226 1.01 . . . . 5.1 110.197 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.29 -27.57 22.81 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.798 0.839 . . . . 2.36 110.898 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.89 57.59 2.25 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.552 1.072 . . . . 1.17 110.567 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.34 132.18 35.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.178 -1.045 . . . . 4.56 108.178 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.9 102.62 11.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.584 2.354 . . . . 2.09 109.273 171.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -96.95 137.91 35.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.326 -1.731 . . . . 3.37 106.326 164.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.3 pt -143.49 171.61 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.178 -1.045 . . . . 2.91 108.178 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -125.74 105.48 9.01 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.828 0.851 . . . . 6.47 109.971 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -97.53 169.79 9.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.052 2.541 . . . . 3.72 113.007 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -117.26 100.7 53.11 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 106.096 -1.816 . . . . 2.96 106.096 171.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.75 -29.62 43.05 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.535 3.49 . . . . 2.87 114.704 -170.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -65.65 -18.82 65.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.7 1.6 . . . . 4.6 112.469 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.3 m -126.8 -38.22 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.343 0.657 . . . . 4.25 111.46 -175.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.93 149.88 17.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-N 118.887 0.767 . . . . 2.55 109.268 173.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -129.6 150.34 75.42 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 124.634 1.173 . . . . 3.48 109.287 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -56.22 -37.24 97.0 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.114 2.542 . . . . 1.84 111.263 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.6 mp -54.64 -41.71 70.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.26 0.624 . . . . 4.13 111.344 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -69.49 -40.97 76.73 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.546 -0.721 . . . . 3.7 109.564 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -45.22 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.06 -1.089 . . . . 2.37 108.06 172.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.53 -42.97 93.51 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.904 -0.589 . . . . 2.43 110.804 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -59.4 -51.63 69.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 121.773 -0.58 . . . . 3.11 110.19 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -56.06 15.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.208 0.528 . . . . 3.47 111.137 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.12 -40.23 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 121.187 -0.946 . . . . 5.09 112.559 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.59 -32.6 74.27 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.492 -0.755 . . . . 3.14 110.85 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.31 -51.29 61.63 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.503 0.592 . . . . 2.65 109.648 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.07 -38.63 68.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.416 -0.514 . . . . 4.53 111.808 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.77 45.47 0.65 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.676 -0.97 . . . . 1.57 110.676 171.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -131.95 157.09 44.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.72 1.208 . . . . 3.99 108.035 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -99.82 129.71 45.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.944 -1.502 . . . . 2.53 106.944 166.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.38 124.71 45.2 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.222 -1.399 . . . . 2.21 107.222 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.53 119.98 27.23 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.155 0.909 . . . . 2.02 109.946 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 p -68.33 141.31 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 125.065 1.346 . . . . 3.7 108.737 166.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.2 ptm . . . . . 0 N--CA 1.455 -0.194 0 O-C-N 124.486 1.117 . . . . 6.98 111.357 -172.63 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 108.107 -1.997 . . . . 2.24 108.107 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.46 107.02 13.3 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.275 1.43 . . . . 2.37 108.467 -166.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.6 148.02 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 120.336 1.425 . . . . 3.55 112.455 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.11 124.0 50.08 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.15 1.78 . . . . 4.47 112.621 -175.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.7 mt -128.76 138.83 52.32 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.315 1.046 . . . . 3.3 109.418 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.96 124.1 47.83 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.808 -1.182 . . . . 2.75 107.808 -177.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.37 105.49 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.713 1.205 . . . . 2.75 109.715 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.8 p -101.77 126.26 48.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.575 -0.898 . . . . 3.5 108.575 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.64 -34.3 3.66 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.128 0.87 . . . . 1.44 111.034 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -63.36 130.94 46.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.083 0.553 . . . . 3.37 109.808 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 p -137.54 22.58 2.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.965 1.306 . . . . 4.28 110.693 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 5.3 t -157.25 141.19 16.1 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 121.298 -0.876 . . . . 3.35 111.881 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.6 -35.13 79.93 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.214 0.606 . . . . 3.31 111.456 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 p -53.4 -47.3 69.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.504 -0.554 . . . . 2.89 109.504 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 59.7 m -59.26 -49.76 76.6 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 119.22 -0.419 . . . . 3.39 110.129 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.4 t -49.36 -50.15 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 118.237 0.471 . . . . 2.83 110.544 175.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -60.63 -40.81 93.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.768 -0.456 . . . . 5.24 109.768 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -42.47 96.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.865 -0.522 . . . . 2.66 110.253 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.8 mt -61.42 -51.47 72.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.111 -1.07 . . . . 2.08 108.111 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -55.67 -45.88 77.64 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.676 1.19 . . . . 2.23 109.61 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.8 t -54.95 -54.82 37.88 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.687 -0.633 . . . . 2.4 110.637 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -51.2 -61.32 2.3 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.194 0.452 . . . . 3.34 110.261 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.85 -39.32 91.45 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.768 -0.373 . . . . 3.52 110.415 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 96.3 m -59.73 -19.24 48.82 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.54 0.609 . . . . 3.0 112.1 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -66.49 -27.02 67.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 119.166 -1.014 . . . . 5.35 111.919 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 81.3 m -63.54 126.58 27.98 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.631 0.773 . . . . 2.94 111.597 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -38.51 -59.63 0.89 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.651 1.98 . . . . 3.49 113.845 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.22 -28.36 68.29 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.231 0.469 . . . . 1.74 113.319 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.78 118.8 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 O-C-N 121.359 -1.083 . . . . 2.6 109.475 -168.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.2 m -102.92 -44.86 5.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.857 0.318 . . . . 3.1 111.857 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -142.12 128.8 20.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.406 -0.961 . . . . 3.09 108.406 166.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.75 162.52 12.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.87 -0.332 . . . . 1.84 110.375 161.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m -145.0 113.05 6.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.45 -0.945 . . . . 2.45 108.45 162.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 p -110.03 128.93 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.75 0.705 . . . . 2.84 110.962 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -125.04 90.4 3.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.145 0.978 . . . . 2.17 110.951 -166.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.09 -32.5 55.01 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.287 1.435 . . . . 3.45 112.964 -174.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.71 -32.12 65.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.259 0.624 . . . . 2.84 111.154 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.53 -14.45 11.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.145 1.378 . . . . 2.83 111.202 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.4 m 65.99 28.29 10.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.101 1.361 . . . . 2.98 111.951 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.403 ' NZ ' ' O ' ' A' ' 149' ' ' GLN . 44.3 mmtt -96.75 152.84 18.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.312 1.445 . . . . 3.49 109.703 173.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.26 106.36 4.35 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.521 1.128 . . . . 1.91 109.383 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.3 mp -95.43 130.19 42.32 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.633 -1.247 . . . . 3.98 107.633 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.1 t -128.28 123.9 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.031 0.932 . . . . 2.72 108.75 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -105.55 92.06 4.03 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.918 0.887 . . . . 3.81 109.136 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -115.35 173.7 6.38 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.761 0.709 . . . . 3.93 111.098 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -100.26 112.68 64.65 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 108.886 -0.783 . . . . 2.74 108.886 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.72 70.03 7.11 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.649 2.899 . . . . 1.99 111.217 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -165.05 -47.95 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.523 1.529 . . . . 3.04 108.836 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.6 pt -84.85 -37.48 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.121 0.969 . . . . 2.94 111.103 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.7 tp -136.86 169.3 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.304 0.642 . . . . 3.72 109.458 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.25 170.77 32.17 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.64 -1.784 . . . . 1.97 108.64 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -58.41 -35.65 98.44 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.27 2.646 . . . . 1.93 111.285 -171.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.9 ptm85 -56.63 -30.55 63.41 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.18 0.807 . . . . 6.33 113.18 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.36 -50.03 67.11 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.231 -1.026 . . . . 3.37 108.231 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 42.5 mt -63.32 -44.17 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.512 -1.222 . . . . 2.0 108.123 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.54 -57.2 5.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 118.476 -0.773 . . . . 2.72 109.366 172.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -49.58 -51.14 39.15 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.302 1.41 . . . . 4.36 112.36 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.6 mm -54.16 -53.72 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.019 0.528 . . . . 2.84 110.377 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 pp -70.36 -29.72 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 120.967 -1.083 . . . . 2.43 113.108 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -59.04 -41.79 88.71 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 119.143 0.883 . . . . 2.8 109.309 168.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -64.82 -37.92 89.23 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.483 -0.562 . . . . 2.99 109.483 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.7 mt -62.83 -44.96 99.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 122.006 -0.434 . . . . 1.98 110.437 170.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.19 28.21 5.02 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.381 1.467 . . . . 1.03 111.941 -174.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -101.67 -179.81 4.12 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.42 1.11 . . . . 3.59 108.929 164.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -139.1 126.55 21.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.635 -1.617 . . . . 5.0 106.635 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.62 91.16 3.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.315 1.846 . . . . 1.93 108.373 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 68.3 m -102.82 131.45 49.69 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.092 -0.707 . . . . 2.45 109.092 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 mt -41.25 109.87 0.14 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.26 1.824 . . . . 4.61 111.37 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.09 -20.93 22.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.742 -0.663 . . . . 4.72 110.741 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.403 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.375 0 C-N-CA 125.91 1.684 . . . . 6.35 112.062 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 107.41 -1.329 . . . . 3.93 107.41 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.56 147.95 41.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.444 -0.947 . . . . 5.76 108.444 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.4 p -141.18 140.38 34.02 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.871 -0.788 . . . . 4.42 108.871 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -120.72 103.52 9.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.693 -1.966 . . . . 4.26 105.693 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -132.66 160.37 36.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.136 -1.061 . . . . 3.14 108.136 175.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.41 171.83 7.34 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.545 -0.909 . . . . 3.6 108.545 173.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.2 mm -99.84 126.74 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.098 -1.815 . . . . 2.16 106.098 162.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -102.36 95.86 6.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.348 -2.093 . . . . 4.57 105.348 166.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.38 -77.26 0.11 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.14 0.876 . . . . 1.28 110.961 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 mtp 35.53 76.22 0.05 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.933 2.093 . . . . 3.33 114.831 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 p -41.04 -54.0 2.89 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.669 0.787 . . . . 3.78 112.448 171.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t 119.13 -62.95 0.0 OUTLIER 'General case' 0 C--N 1.342 0.266 0 C-N-CA 129.355 3.062 . . . . 3.55 107.659 -174.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -22.51 -77.5 0.01 OUTLIER 'General case' 0 C--N 1.344 0.341 0 C-N-CA 127.659 2.384 . . . . 6.53 113.148 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 t -161.82 21.9 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.487 0.661 . . . . 3.06 110.945 165.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -71.89 -41.28 68.17 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 120.91 -1.119 . . . . 2.47 110.256 -163.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.68 -46.89 79.64 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.684 -0.858 . . . . 2.62 108.684 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 t -55.79 -48.63 75.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.294 0.569 . . . . 2.55 110.285 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.25 -49.3 74.67 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.827 -0.434 . . . . 2.56 109.827 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.6 mt -56.06 -49.93 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.886 0.874 . . . . 3.07 109.509 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.5 mm-40 -61.94 -39.08 90.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.892 0.877 . . . . 7.03 112.393 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -44.38 93.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.105 -0.702 . . . . 5.95 109.105 175.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -61.69 -37.12 82.95 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.883 -0.51 . . . . 1.47 110.031 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.79 -52.72 33.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.93 0.892 . . . . 3.0 110.958 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.67 -26.53 56.63 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.784 1.175 . . . . 3.49 112.608 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -74.22 0.63 13.5 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 116.782 -1.58 . . . . 3.9 115.125 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -48.67 -84.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 121.044 1.747 . . . . 3.01 112.581 174.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.84 -90.91 0.0 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.686 0.795 . . . . 3.38 110.095 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.15 -26.18 74.21 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.369 -0.692 . . . . 1.63 111.369 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.1 t -61.06 128.6 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.069 -0.715 . . . . 3.35 109.069 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.19 53.5 1.08 Allowed 'General case' 0 C--N 1.337 0.053 0 C-N-CA 121.099 -0.241 . . . . 4.01 111.207 163.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.1 t -158.1 139.22 13.28 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 120.926 -1.109 . . . . 2.61 110.549 167.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 p -126.53 107.89 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 125.94 1.696 . . . . 3.77 107.432 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -126.22 72.24 1.3 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.503 -1.666 . . . . 3.08 106.503 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.4 t -103.55 141.09 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.843 -0.799 . . . . 2.93 108.843 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.25 95.75 5.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.551 -0.907 . . . . 2.41 108.551 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.97 -18.19 4.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.022 0.529 . . . . 3.91 112.309 169.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.8 mtt -69.13 -50.54 46.97 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.3 0.64 . . . . 4.23 110.116 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.08 -30.69 12.89 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.715 0.806 . . . . 2.34 111.435 -172.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.38 64.08 1.4 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.837 1.208 . . . . 1.2 110.479 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -141.0 138.5 33.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.384 -1.709 . . . . 3.92 106.384 171.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.09 92.74 3.94 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 124.868 1.355 . . . . 2.02 112.301 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.92 119.59 35.67 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.996 -1.113 . . . . 4.67 107.996 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.99 163.35 20.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 126.379 1.872 . . . . 3.71 108.858 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -122.34 106.08 10.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.588 0.755 . . . . 4.47 110.083 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -100.11 173.36 6.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.075 1.75 . . . . 3.43 113.272 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -122.85 102.86 37.66 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.239 1.815 . . . . 4.06 109.27 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -45.8 -36.02 14.38 Favored 'Trans proline' 0 C--N 1.355 0.913 1 C-N-CA 126.076 4.517 . . . . 2.93 113.743 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.39 -29.11 68.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.224 1.409 . . . . 3.36 111.69 -170.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.89 -32.45 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.684 0.794 . . . . 3.69 112.261 -174.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.56 146.2 25.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 107.947 -1.131 . . . . 2.16 107.947 173.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -124.27 146.51 51.97 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.149 1.38 . . . . 2.6 109.394 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.72 -38.5 49.29 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.313 2.676 . . . . 1.78 112.057 -171.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -57.58 -45.62 85.01 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.879 -0.513 . . . . 4.15 111.005 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -61.05 -43.18 99.28 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.002 0.921 . . . . 3.39 109.904 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.37 -53.2 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.251 -1.388 . . . . 2.32 107.251 171.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.17 85.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 110.019 -0.363 . . . . 2.78 110.019 -173.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -55.89 -42.55 76.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.292 0.637 . . . . 3.32 110.86 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.2 -43.25 87.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.394 0.543 . . . . 4.17 110.129 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.1 mm -65.4 -44.03 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.671 -0.643 . . . . 3.42 110.607 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -58.46 -41.96 86.34 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.288 0.635 . . . . 3.38 111.279 174.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -63.76 -48.73 75.78 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.174 0.59 . . . . 2.91 109.984 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.8 mt -56.22 -35.51 67.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.645 0.378 . . . . 2.86 111.323 173.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.82 25.57 3.6 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.216 0.912 . . . . 1.42 112.077 168.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -115.48 168.79 9.68 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.055 1.742 . . . . 3.27 108.643 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -104.06 142.55 34.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.801 -1.185 . . . . 2.4 107.801 165.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.81 112.38 17.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.78 -1.563 . . . . 1.96 106.78 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.85 129.33 48.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.656 -0.868 . . . . 1.91 108.656 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.7 p -47.69 145.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 125.484 1.513 . . . . 3.91 109.702 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.5 ptt? . . . . . 0 N--CA 1.447 -0.625 0 CA-C-N 115.751 -0.659 . . . . 5.87 110.273 -175.16 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.615 0 N-CA-C 107.17 -2.372 . . . . 1.97 107.17 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.15 96.49 10.61 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 105.477 -2.046 . . . . 2.49 105.477 172.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.6 pt -123.06 145.69 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 O-C-N 123.211 0.319 . . . . 4.12 110.213 173.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.98 157.35 15.94 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.491 -1.67 . . . . 3.54 106.491 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 pp -147.51 161.72 40.52 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.091 -0.707 . . . . 3.9 109.091 161.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.6 m -99.73 127.86 45.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.624 1.17 . . . . 2.91 108.815 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 pp -99.57 127.61 52.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 C-N-CA 123.079 0.552 . . . . 2.64 110.311 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.5 m -106.45 142.6 35.84 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.722 0.809 . . . . 2.38 109.188 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.65 -24.26 17.78 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.653 1.121 . . . . 0.97 113.061 172.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.2 ttm -66.28 143.6 57.11 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.063 0.931 . . . . 3.0 111.274 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.6 t -162.0 37.18 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.925 0.49 . . . . 3.24 110.593 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.1 t -164.62 138.35 5.1 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.605 -1.31 . . . . 3.25 111.509 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.27 -40.17 81.15 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.243 0.617 . . . . 3.16 110.895 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -43.23 70.44 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.494 -0.753 . . . . 3.02 109.612 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 91.2 m -67.76 -42.38 81.84 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.157 -0.449 . . . . 2.39 110.796 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.95 -50.35 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 118.864 0.756 . . . . 3.36 110.509 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -59.23 -37.0 76.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.766 -0.457 . . . . 4.12 109.766 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -65.25 -49.11 70.9 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.275 -0.266 . . . . 1.7 110.663 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.07 -48.27 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 109.438 -0.579 . . . . 1.92 109.438 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -58.63 -49.3 78.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.443 -0.947 . . . . 2.46 108.443 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.1 t -52.45 -46.38 66.42 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.1 0.56 . . . . 1.87 110.122 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -63.33 -41.47 98.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.284 0.634 . . . . 3.54 111.723 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.6 mt -67.34 -58.59 4.51 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.538 -1.282 . . . . 2.73 107.538 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.3 p -57.05 -18.74 15.43 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.133 0.973 . . . . 2.92 112.749 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.16 -34.45 66.17 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.943 -0.473 . . . . 7.1 111.65 170.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.5 m -67.44 149.22 50.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.407 1.883 . . . . 2.28 111.458 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -64.47 -52.68 56.71 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.347 1.059 . . . . 2.47 111.891 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.21 -27.41 59.94 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 122.175 -0.328 . . . . 1.15 113.074 -168.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.52 132.02 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 117.647 0.723 . . . . 2.84 109.538 -173.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 49.6 m -103.03 -58.21 1.91 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.249 0.619 . . . . 2.76 111.19 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -134.69 113.7 11.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.2 -0.667 . . . . 4.25 109.2 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.24 149.88 21.54 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 108.102 -1.073 . . . . 1.82 108.102 165.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.7 t -143.03 109.01 5.18 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 108.19 -1.041 . . . . 2.93 108.19 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.44 138.99 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.322 1.449 . . . . 3.05 110.686 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.21 93.64 2.85 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.74 1.216 . . . . 1.9 110.665 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 pp -60.11 -17.62 41.38 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.538 1.135 . . . . 3.29 113.83 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.71 86.75 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.458 0.572 . . . . 2.19 109.574 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.82 -39.91 10.02 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.505 1.122 . . . . 2.33 108.905 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.1 m 88.94 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 127.568 2.347 . . . . 2.14 110.539 -169.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.0 157.95 17.41 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.365 -0.606 . . . . 4.9 109.365 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.57 144.26 34.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.812 -1.09 . . . . 2.26 109.944 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.79 143.31 26.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.462 -0.94 . . . . 4.0 108.462 163.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.74 124.16 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.634 -1.987 . . . . 2.63 105.634 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -108.64 92.44 4.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.086 -1.079 . . . . 4.0 108.086 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -113.33 -178.56 3.41 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 124.014 0.926 . . . . 3.1 108.83 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -113.99 110.75 48.5 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 108.322 -0.992 . . . . 2.98 108.322 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.32 68.47 8.27 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.924 2.416 . . . . 1.74 112.229 -166.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.34 -44.92 0.07 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.617 1.567 . . . . 3.31 109.206 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.6 pt -86.67 -30.73 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 123.365 0.666 . . . . 2.56 111.559 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.2 162.63 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.426 -0.953 . . . . 2.24 108.426 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.79 167.84 31.64 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.837 -0.905 . . . . 1.58 110.837 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.12 -39.01 62.81 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.811 3.008 . . . . 1.61 112.334 -169.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.76 -39.43 52.33 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.471 0.545 . . . . 6.79 112.471 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.51 -45.0 81.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.602 -0.518 . . . . 3.37 109.602 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 88.3 mt -58.67 -49.29 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.815 -0.809 . . . . 1.76 108.815 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.2 mt -49.57 -59.31 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 N-CA-C 108.445 -0.946 . . . . 3.15 108.445 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -50.07 -47.55 53.5 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.105 -0.997 . . . . 5.92 111.365 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 82.4 mt -55.54 -50.12 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.447 -0.783 . . . . 3.61 109.646 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 12.7 pt -70.37 -30.14 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 118.108 -0.949 . . . . 2.34 112.861 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.77 -42.48 79.47 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.829 1.195 . . . . 3.02 109.068 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.71 -34.32 76.91 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.758 1.223 . . . . 3.45 109.232 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.9 mt -75.39 -41.21 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.264 0.626 . . . . 1.99 111.376 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.55 30.44 6.19 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.847 1.689 . . . . 0.99 112.433 -172.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -105.31 171.58 7.25 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.727 1.263 . . . . 3.42 110.304 167.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -129.04 117.63 21.22 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 106.655 -1.609 . . . . 4.84 106.655 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.06 102.54 11.95 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 125.292 1.437 . . . . 1.86 108.616 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.0 p -98.85 112.7 24.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.092 -1.447 . . . . 3.49 107.092 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.2 mt -49.78 105.86 0.1 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.523 -1.288 . . . . 6.82 107.523 166.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.67 -38.48 33.53 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.333 -0.617 . . . . 4.03 109.333 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 126.72 2.008 . . . . 7.01 113.167 -179.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 106.449 -1.686 . . . . 4.28 106.449 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -123.09 152.13 41.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.331 1.052 . . . . 4.23 109.585 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.5 t -140.87 127.98 20.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.774 -0.825 . . . . 3.06 108.774 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -101.01 98.73 9.15 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.986 1.715 . . . . 4.97 109.082 -171.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.456 ' CB ' ' HA ' ' A' ' 71' ' ' VAL 0.273 1.4 pt? -125.44 176.55 6.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.943 0.877 . . . . 3.35 112.383 176.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.36 147.11 47.21 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.186 -1.412 . . . . 2.23 107.186 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.1 mm -99.05 140.07 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 106.264 -1.754 . . . . 2.09 106.264 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -115.41 76.69 1.02 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.293 -1.003 . . . . 3.97 108.293 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.25 -69.96 0.04 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.952 -1.259 . . . . 1.31 109.952 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 31.38 72.1 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.734 2.013 . . . . 2.82 115.646 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -53.08 -16.62 1.18 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.557 1.543 . . . . 3.05 114.053 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.2 t 74.79 -56.68 0.63 Allowed 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 126.28 1.832 . . . . 3.47 111.767 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -23.15 -75.44 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 127.523 2.329 . . . . 6.55 112.917 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.8 m -154.66 17.44 0.45 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.83 0.852 . . . . 3.7 111.541 162.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.83 -51.83 36.48 Favored 'General case' 0 C--O 1.224 -0.242 0 O-C-N 121.051 -1.031 . . . . 2.3 109.618 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -51.67 -47.86 37.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 CA-C-N 118.458 0.572 . . . . 2.46 109.689 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -56.95 -49.66 75.0 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.545 0.688 . . . . 3.5 110.609 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -59.1 -51.7 68.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.612 -0.68 . . . . 2.64 109.677 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.8 mt -51.32 -47.57 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.334 1.454 . . . . 2.52 110.859 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -55.38 -53.19 59.26 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.877 0.762 . . . . 4.06 110.482 174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -65.58 -31.55 72.66 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.395 -0.815 . . . . 5.62 111.438 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -68.66 -51.29 43.61 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.255 1.022 . . . . 1.19 109.697 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.33 -40.35 67.93 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.084 0.954 . . . . 2.95 110.663 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.67 -19.72 2.58 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.66 0.615 . . . . 2.7 112.66 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -126.63 24.06 6.68 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.216 1.406 . . . . 4.72 111.831 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.38 -82.57 0.05 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.091 -1.078 . . . . 3.2 108.091 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.44 -132.74 0.08 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.074 0.95 . . . . 2.21 109.19 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.38 33.17 1.35 Allowed Glycine 0 CA--C 1.531 1.06 0 O-C-N 120.909 -1.12 . . . . 1.49 113.816 -174.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.3 p -104.31 118.79 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.682 1.593 . . . . 2.52 108.923 170.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.1 mp -134.24 53.38 2.0 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.406 -0.961 . . . . 4.54 108.406 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.66 149.42 14.88 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.419 -1.326 . . . . 2.78 107.419 173.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.92 100.84 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 106.404 -1.702 . . . . 3.79 106.404 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.72 71.89 1.05 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.046 -1.094 . . . . 4.07 108.046 176.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.77 133.6 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.432 -0.951 . . . . 2.85 108.432 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.36 83.06 1.71 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.033 -1.099 . . . . 2.17 108.033 173.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.49 -24.03 1.87 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.466 1.506 . . . . 3.9 112.267 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -70.16 -40.06 74.96 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.806 1.242 . . . . 5.85 111.785 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.24 -31.89 11.49 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.513 1.125 . . . . 2.03 110.991 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.79 61.17 1.71 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 125.072 1.32 . . . . 1.04 110.565 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -141.23 136.83 32.1 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.181 -1.414 . . . . 4.42 107.181 171.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.34 102.15 10.82 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.283 1.433 . . . . 1.72 109.683 170.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -98.67 135.88 39.54 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.777 -1.934 . . . . 4.28 105.777 166.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.09 174.34 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.978 -1.119 . . . . 3.55 107.978 168.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.74 103.44 6.83 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.753 0.821 . . . . 6.53 108.797 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -117.6 167.83 10.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.103 1.361 . . . . 4.6 113.755 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -99.26 106.32 38.16 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 127.202 2.201 . . . . 3.17 110.452 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.01 -4.44 13.53 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.103 1.869 . . . . 2.84 114.35 -172.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -88.62 -20.84 24.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.926 0.785 . . . . 4.46 110.907 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.97 -30.48 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.505 1.122 . . . . 3.77 110.091 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.98 155.96 17.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.666 0.746 . . . . 2.44 109.257 173.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -132.31 154.27 81.54 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.416 2.286 . . . . 2.94 108.379 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.28 -40.13 34.03 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.634 2.223 . . . . 1.62 112.194 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -63.76 -40.27 96.3 Favored 'General case' 0 C--O 1.225 -0.227 0 O-C-N 121.763 -0.586 . . . . 3.96 110.868 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -58.36 -45.83 87.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.943 0.897 . . . . 2.95 110.334 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.9 mt -53.98 -56.06 11.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.851 -1.537 . . . . 2.31 106.851 172.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.95 -41.32 70.95 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.787 -0.642 . . . . 2.66 110.578 -173.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -53.84 -50.18 66.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.23 1.412 . . . . 2.77 109.387 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -48.46 72.12 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.379 0.609 . . . . 3.47 109.777 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.7 mm -63.22 -40.33 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.129 -0.357 . . . . 3.64 110.564 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -64.9 -42.19 94.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.735 -0.469 . . . . 2.78 109.735 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -60.46 -47.89 84.15 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.138 0.575 . . . . 2.98 109.562 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.18 -33.52 71.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.209 0.604 . . . . 2.97 111.629 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.9 27.72 3.92 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.172 0.892 . . . . 1.46 111.632 168.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -118.91 162.3 18.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.994 1.717 . . . . 3.53 108.694 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -98.31 129.19 45.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.931 1.293 . . . . 3.69 107.973 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.4 110.61 21.8 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.984 1.314 . . . . 1.78 108.507 174.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.93 122.92 35.96 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.122 0.419 . . . . 2.37 109.977 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.456 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.4 t -58.38 148.23 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 123.24 0.616 . . . . 3.99 110.931 172.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 39.8 mtt . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 119.076 -0.488 . . . . 5.85 111.449 179.659 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.985 0 N-CA-C 110.038 -1.225 . . . . 2.37 110.038 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.32 73.09 2.13 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.847 1.259 . . . . 2.81 109.139 -167.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.28 155.68 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.584 -0.895 . . . . 3.31 108.584 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.84 140.69 50.41 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.636 1.174 . . . . 2.76 107.998 173.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 mp -130.68 149.53 52.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.844 -0.799 . . . . 3.15 108.844 171.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.63 130.77 44.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.311 1.044 . . . . 2.4 108.614 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.8 mt -99.92 115.28 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.635 -0.506 . . . . 4.03 109.635 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.8 p -107.84 89.13 2.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.926 1.29 . . . . 3.57 109.543 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.6 -45.8 0.57 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.798 -0.921 . . . . 1.15 110.798 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -56.41 136.64 53.73 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 110.221 -0.289 . . . . 3.19 110.221 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -158.2 34.71 0.24 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.103 0.561 . . . . 3.42 110.891 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 34.0 t -158.91 144.23 16.22 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.548 -0.72 . . . . 3.63 110.617 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.15 -39.12 42.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.153 0.981 . . . . 3.25 111.995 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.2 p -53.6 -46.27 70.34 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.906 -0.497 . . . . 4.28 110.74 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 65.6 m -67.98 -45.96 72.68 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.909 -0.774 . . . . 2.38 108.909 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -51.91 -49.58 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.042 0.937 . . . . 2.61 109.591 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -64.38 -37.66 88.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.776 -0.824 . . . . 4.03 108.776 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -59.87 -52.61 64.71 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.63 0.772 . . . . 2.71 110.347 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.1 mt -54.17 -54.13 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.654 0.782 . . . . 2.02 109.045 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.6 -45.17 85.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.806 -0.442 . . . . 3.13 109.806 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.8 t -54.69 -49.31 70.98 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.507 0.723 . . . . 2.15 110.583 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -34.8 78.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.412 -0.805 . . . . 3.21 111.274 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.3 mt -71.57 -58.16 3.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.778 -0.823 . . . . 2.7 108.778 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.5 p -56.21 -22.73 31.13 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 111.915 0.339 . . . . 2.52 111.915 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.31 -27.09 69.09 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.457 0.91 . . . . 5.47 113.457 174.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.1 p -69.4 172.71 6.73 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 119.822 1.192 . . . . 3.92 111.246 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -88.62 -47.21 8.45 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.222 -0.899 . . . . 3.98 110.278 173.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.47 -34.09 51.06 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.471 -0.627 . . . . 1.26 113.587 -170.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.97 135.17 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 119.145 1.472 . . . . 3.39 109.251 -176.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -105.27 -44.67 4.68 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 122.407 0.283 . . . . 3.98 111.624 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.413 ' CZ ' ' HG3' ' A' ' 123' ' ' LYS . 27.2 p90 -139.7 122.75 16.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.67 -1.604 . . . . 3.19 106.67 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.85 143.82 45.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.564 -0.854 . . . . 1.88 109.795 164.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.6 m -133.56 119.99 20.19 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.037 -1.468 . . . . 2.55 107.037 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 p -122.55 133.55 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 123.631 0.772 . . . . 2.89 109.079 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -127.92 99.98 5.73 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.961 0.886 . . . . 2.26 109.216 -171.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.416 ' CD1' ' H ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -55.62 -21.43 17.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.756 1.622 . . . . 4.15 113.743 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.76 -41.36 62.57 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.933 -0.765 . . . . 2.28 108.933 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.2 p -88.11 -15.28 36.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.711 1.204 . . . . 3.27 111.191 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.8 t 65.11 25.64 12.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.869 1.268 . . . . 2.77 110.778 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.56 149.28 50.22 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.412 0.685 . . . . 3.65 110.941 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -125.15 115.64 20.78 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.68 2.392 . . . . 1.86 108.199 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.42 116.55 29.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.003 -1.48 . . . . 3.05 107.003 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.3 m -111.58 140.12 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.025 0.93 . . . . 3.17 109.799 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 2.2 mmtp -123.19 95.89 4.78 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-O 118.511 -0.757 . . . . 4.38 110.063 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -121.52 178.52 4.78 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.706 1.002 . . . . 3.04 113.706 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -104.64 110.42 64.33 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.233 1.013 . . . . 3.48 108.687 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.9 62.51 6.59 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.609 2.873 . . . . 1.75 112.788 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -148.25 -52.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.123 1.769 . . . . 3.02 107.72 172.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -86.98 -32.67 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.442 0.697 . . . . 2.55 111.413 -172.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.78 165.82 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.429 -1.693 . . . . 2.55 106.429 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.94 164.46 31.32 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 109.852 -1.299 . . . . 1.9 109.852 -176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.23 -40.86 46.69 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.032 2.488 . . . . 2.05 110.2 -171.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -48.35 -38.47 19.32 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 113.47 0.915 . . . . 8.55 113.47 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.1 -44.92 75.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.681 -0.859 . . . . 3.44 108.681 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.13 -47.59 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.383 -0.969 . . . . 2.26 108.383 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.9 mt -54.12 -60.69 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.004 -0.739 . . . . 3.01 109.004 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -51.61 -45.74 63.34 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 119.59 1.086 . . . . 4.38 111.055 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.6 mt -54.17 -53.49 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 121.664 -0.647 . . . . 3.36 110.076 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.253 2.1 pp -67.83 -30.83 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 121.109 -0.994 . . . . 2.27 112.891 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -55.89 -39.94 72.3 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.798 0.726 . . . . 2.98 110.107 170.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -63.06 -35.86 81.65 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.756 -0.461 . . . . 2.65 109.756 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.5 mt -68.26 -44.33 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.562 -0.533 . . . . 2.06 109.562 172.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.35 32.6 2.51 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.273 1.416 . . . . 0.88 111.182 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -99.28 178.41 4.91 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.116 0.958 . . . . 3.67 108.891 165.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -141.05 124.38 16.59 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.57 -1.641 . . . . 4.93 106.57 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.97 94.78 4.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.307 1.443 . . . . 1.81 108.706 -174.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.3 m -103.0 117.66 35.08 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.997 0.919 . . . . 2.32 110.456 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 mp -45.73 117.89 1.62 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.786 1.634 . . . . 5.14 110.108 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -109.57 13.44 23.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.37 0.668 . . . . 4.43 112.303 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? . . . . . 0 C--O 1.25 1.129 0 C-N-CA 125.486 1.514 . . . . 7.39 109.811 161.214 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 106.291 -1.744 . . . . 2.98 106.291 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.51 166.51 10.49 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 107.758 -1.201 . . . . 4.75 107.758 166.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.97 120.25 11.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.579 1.081 . . . . 3.83 108.933 170.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -98.2 90.23 4.77 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.556 0.742 . . . . 4.04 110.267 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.56 165.72 15.97 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.704 0.764 . . . . 3.75 111.04 175.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.424 HE22 ' CB ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -120.14 156.32 31.3 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.303 -0.999 . . . . 3.12 108.303 174.379 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.1 144.44 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 107.677 -1.231 . . . . 2.04 107.677 172.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -116.54 125.07 51.36 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.678 -1.231 . . . . 6.01 107.678 162.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 147.86 -81.14 0.2 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.188 1.375 . . . . 1.4 109.998 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.9 mtt 57.92 66.64 1.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.825 1.25 . . . . 2.34 113.013 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -46.52 -54.71 8.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.862 1.265 . . . . 3.25 113.303 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.2 p -167.83 44.48 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.516 0.598 . . . . 6.34 111.323 -170.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.67 35.44 8.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.274 1.029 . . . . 5.67 112.681 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 m -152.24 -43.26 0.11 Allowed 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.385 1.474 . . . . 3.12 110.555 -173.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.55 -46.15 87.45 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.347 -0.845 . . . . 3.35 109.937 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.3 t -52.69 -39.64 31.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 O-C-N 122.184 -0.322 . . . . 2.84 110.437 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -59.7 -42.73 93.63 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.085 0.469 . . . . 2.62 110.868 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -66.19 -47.6 73.39 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.31 -0.869 . . . . 2.63 109.631 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.41 -46.98 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 122.211 -0.306 . . . . 3.38 110.418 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -57.6 -41.15 80.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.292 1.037 . . . . 6.96 112.39 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -46.48 89.07 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.355 -0.98 . . . . 6.39 108.355 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -58.0 -45.16 87.27 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.072 -0.49 . . . . 1.65 110.557 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.2 -58.56 6.24 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.533 0.733 . . . . 3.42 111.424 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -19.99 65.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.812 1.187 . . . . 3.98 112.921 -175.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -90.39 -0.92 57.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.713 1.375 . . . . 5.54 114.713 168.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -53.1 -70.63 0.09 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.848 1.658 . . . . 3.09 111.012 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.7 -81.47 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.42 1.088 . . . . 2.5 110.66 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.52 -28.71 73.61 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.889 -0.484 . . . . 1.92 111.889 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 t -61.34 116.16 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.209 1.004 . . . . 3.88 110.284 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.66 54.66 1.67 Allowed 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.861 -1.533 . . . . 4.37 106.861 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.4 t -160.39 161.48 33.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 120.887 -1.133 . . . . 2.99 110.42 155.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.81 109.43 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 127.277 2.231 . . . . 3.9 106.779 172.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tt -135.54 63.05 1.61 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.114 -1.069 . . . . 3.0 108.114 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -96.12 149.09 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.143 -1.058 . . . . 3.74 108.143 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.22 100.0 6.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.113 -1.44 . . . . 2.49 107.113 166.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.41 -15.38 60.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.277 0.631 . . . . 3.78 112.158 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.4 mmt -72.39 -52.81 14.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.533 0.733 . . . . 6.02 110.405 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.33 -34.02 21.93 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.95 0.5 . . . . 1.99 110.974 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.94 62.79 1.28 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.035 1.303 . . . . 1.23 110.899 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -140.14 137.04 34.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.887 -1.523 . . . . 4.75 106.887 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.07 96.35 5.99 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 125.044 1.338 . . . . 2.13 109.791 173.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -98.65 136.5 38.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.481 -2.044 . . . . 3.64 105.481 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.98 177.92 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 N-CA-C 106.079 -1.823 . . . . 2.98 106.079 172.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -129.84 99.92 5.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.785 0.434 . . . . 4.71 110.386 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -94.47 -177.86 4.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.621 1.968 . . . . 3.81 112.857 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -127.67 108.52 20.65 Favored Pre-proline 0 N--CA 1.444 -0.765 0 CA-C-N 114.169 -1.378 . . . . 3.43 108.003 169.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.22 -3.01 10.79 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.581 2.187 . . . . 2.24 112.764 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.67 -39.6 64.31 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.797 1.18 . . . . 3.58 110.708 172.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -110.01 -19.18 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 118.291 0.496 . . . . 4.17 110.335 -166.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 pt -131.7 -176.48 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 107.484 -1.302 . . . . 3.77 107.484 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.64 155.94 59.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 125.418 1.487 . . . . 2.99 108.449 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.39 -35.6 60.54 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.309 2.006 . . . . 1.63 110.192 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.94 -37.99 84.27 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 122.064 -0.397 . . . . 3.95 111.94 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -67.74 -45.54 74.7 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.964 0.905 . . . . 3.08 110.372 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.9 mt -48.5 -56.76 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 106.546 -1.65 . . . . 2.38 106.546 167.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.59 89.31 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.07 -0.514 . . . . 2.69 110.777 -170.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -52.27 -49.78 63.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.81 1.644 . . . . 3.17 109.604 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.74 -50.27 44.9 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.154 0.502 . . . . 4.32 109.797 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -65.99 -38.9 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 121.919 -0.488 . . . . 3.4 110.958 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -64.11 -46.28 84.91 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.567 -0.531 . . . . 2.9 109.567 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -57.8 -52.43 65.51 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.316 0.646 . . . . 2.63 109.817 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.3 mt -58.77 -38.78 79.25 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.27 -0.423 . . . . 3.25 111.576 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.79 33.33 0.65 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 123.367 0.508 . . . . 1.37 112.59 163.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -133.02 163.64 28.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.733 1.213 . . . . 3.79 110.365 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -97.41 128.73 44.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.97 -1.493 . . . . 2.54 106.97 171.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.85 124.33 52.13 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.491 -1.3 . . . . 1.83 107.491 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.424 ' CB ' HE22 ' A' ' 9' ' ' GLN . . . -128.49 138.01 52.06 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.558 -1.275 . . . . 2.41 107.558 168.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -60.64 141.14 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.536 -0.913 . . . . 4.18 108.536 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.6 mtt . . . . . 0 N--CA 1.45 -0.45 0 C-N-CA 124.805 1.242 . . . . 5.51 110.604 176.647 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.7 0 N-CA-C 110.686 -0.965 . . . . 2.38 110.686 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.99 101.84 4.13 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.236 1.414 . . . . 2.86 108.66 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -125.87 155.31 35.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 125.55 1.54 . . . . 4.0 108.123 -167.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -131.38 153.17 49.93 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.121 1.368 . . . . 4.24 107.396 174.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.07 162.71 32.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.151 -1.425 . . . . 3.55 107.151 170.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.42 133.52 41.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.965 -2.235 . . . . 3.04 104.965 170.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.6 pp -106.16 117.59 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 123.54 0.736 . . . . 3.12 109.652 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.6 m -105.6 136.79 44.54 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.577 -1.268 . . . . 2.49 107.577 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.28 -45.24 1.34 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.493 1.044 . . . . 1.43 111.151 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -62.26 132.96 54.42 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.39 -0.476 . . . . 3.42 110.345 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -156.89 42.01 0.35 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.373 0.669 . . . . 4.93 110.303 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.6 t -162.4 144.92 11.1 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 120.711 -1.243 . . . . 3.78 110.523 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.49 -40.37 62.29 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.697 0.799 . . . . 4.08 110.897 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -54.67 -47.1 74.02 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.897 -0.502 . . . . 2.92 110.364 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.8 m -64.6 -44.76 89.58 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.06 0.544 . . . . 2.16 109.596 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.4 t -51.14 -51.17 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 122.589 0.356 . . . . 2.74 110.074 171.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -62.28 -37.84 87.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.208 -0.664 . . . . 3.66 109.208 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -59.95 -55.02 39.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.183 0.993 . . . . 2.66 110.185 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.8 mt -54.91 -56.4 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.301 -0.629 . . . . 2.86 109.301 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.86 -43.32 76.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.19 0.996 . . . . 3.38 108.938 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.3 t -53.82 -47.18 71.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.643 0.656 . . . . 1.95 111.069 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -63.96 -42.74 97.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.63 -1.294 . . . . 3.53 111.54 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -54.89 37.59 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.359 -0.978 . . . . 3.94 108.359 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.0 p -59.11 -25.03 63.48 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.647 0.61 . . . . 2.83 112.647 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -72.52 -16.27 61.78 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.187 0.903 . . . . 4.81 112.357 175.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.5 m -80.55 152.82 28.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.915 0.886 . . . . 2.26 109.528 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -72.41 -49.49 33.36 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.197 0.999 . . . . 2.74 112.555 -175.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.75 -40.26 7.76 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 121.702 0.612 . . . . 1.26 111.71 -167.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.4 mm -53.66 136.11 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.06 -0.719 . . . . 3.37 109.06 168.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 38.6 p -123.25 -25.69 4.43 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.33 0.493 . . . . 3.9 112.33 166.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.07 112.51 6.8 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.258 -1.756 . . . . 3.18 106.258 -169.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -115.55 157.65 23.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.154 -1.054 . . . . 1.87 108.154 163.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 61.8 m -144.72 118.46 9.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.048 -1.464 . . . . 2.55 107.048 170.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.92 134.3 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 108.57 -0.9 . . . . 4.2 108.57 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.2 88.76 2.9 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.678 0.751 . . . . 2.86 109.146 -167.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -54.2 -30.18 48.86 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.315 1.046 . . . . 4.3 112.13 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.59 65.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.101 0.96 . . . . 3.05 111.088 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.74 -9.8 15.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.32 1.448 . . . . 2.97 110.949 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.3 m 66.58 30.58 8.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.574 1.55 . . . . 2.32 111.713 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -105.74 158.15 16.93 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.292 0.637 . . . . 4.96 110.683 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.11 109.4 8.91 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.235 1.814 . . . . 2.41 107.988 174.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.9 mp -98.55 131.06 45.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.722 -1.214 . . . . 3.53 107.722 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.65 133.82 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.371 1.068 . . . . 3.57 108.555 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -117.67 93.75 4.27 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.041 -1.096 . . . . 4.11 108.041 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -122.28 168.76 11.65 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.645 1.178 . . . . 2.91 112.284 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -98.13 113.47 63.95 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 109.266 -0.642 . . . . 2.65 109.266 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.53 67.86 7.71 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.695 2.93 . . . . 1.95 111.474 -172.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -160.49 -46.86 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.159 1.384 . . . . 3.55 108.874 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.1 pt -86.66 -28.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 123.692 0.797 . . . . 2.47 111.876 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.53 165.04 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.159 -1.052 . . . . 2.44 108.159 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.98 162.5 28.94 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 109.874 -1.29 . . . . 1.74 109.874 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -62.57 -35.13 72.48 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.425 2.75 . . . . 1.75 111.516 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -52.71 -42.06 64.5 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 112.759 0.651 . . . . 6.28 112.759 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.57 -39.0 74.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.459 -0.896 . . . . 3.36 109.565 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.1 -47.57 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.967 -0.753 . . . . 2.22 108.967 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 52.2 mt -55.36 -56.48 11.45 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 124.015 0.926 . . . . 3.12 109.573 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -49.89 -50.44 45.92 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 119.461 1.028 . . . . 4.94 110.619 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 50.7 mt -54.88 -55.33 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 122.557 0.343 . . . . 3.42 110.154 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.7 pp -68.21 -29.59 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.774 -1.204 . . . . 2.14 112.951 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.11 -35.86 74.18 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.401 0.546 . . . . 3.08 110.657 171.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.62 -37.76 82.49 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.471 -0.566 . . . . 4.73 109.471 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.0 mt -72.92 -40.5 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 109.212 -0.662 . . . . 2.37 109.212 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.7 33.97 2.95 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.047 1.308 . . . . 1.51 110.961 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -99.19 177.4 5.23 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 108.233 -1.025 . . . . 4.44 108.233 164.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -141.38 120.88 13.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.099 -1.815 . . . . 5.26 106.099 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.0 110.81 22.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.533 1.533 . . . . 1.96 108.727 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.7 m -130.35 134.33 47.09 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.477 0.711 . . . . 3.27 110.935 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -37.97 127.88 1.25 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.063 2.145 . . . . 5.03 110.151 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -103.93 -12.09 17.06 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 116.445 -1.74 . . . . 3.73 113.343 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 . . . . . 0 C--O 1.259 1.597 0 C-N-CA 129.4 3.08 . . . . 6.85 114.554 152.267 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 106.471 -1.677 . . . . 2.99 106.471 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -95.45 157.89 15.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.586 1.555 . . . . 4.93 107.448 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.9 p -140.95 133.79 28.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 122.544 0.337 . . . . 3.52 110.215 168.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -104.01 105.58 15.8 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 125.665 1.586 . . . . 4.27 108.371 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -134.63 169.46 17.27 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.472 -0.491 . . . . 3.02 110.969 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.22 138.95 51.37 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.012 -1.848 . . . . 1.84 106.012 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.8 mm -97.93 134.04 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 106.802 -1.555 . . . . 2.17 106.802 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -104.51 123.29 47.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.533 -1.654 . . . . 4.23 106.533 160.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.84 -27.38 3.06 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.367 0.985 . . . . 3.06 111.472 -175.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.2 ptt? -57.92 167.67 1.14 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.791 -0.829 . . . . 4.1 111.405 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 m 77.11 -8.81 1.63 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.801 1.24 . . . . 10.24 112.016 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.8 m -114.45 136.01 53.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.888 0.875 . . . . 6.49 109.645 -173.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 42.33 -106.15 0.08 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.357 1.463 . . . . 7.04 109.894 -174.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 p -158.95 38.84 0.22 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.918 0.866 . . . . 3.65 109.308 171.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.66 -42.96 63.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.76 -0.655 . . . . 3.01 110.443 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -57.08 -42.01 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 122.252 1.025 . . . . 3.57 109.378 171.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.95 -46.07 82.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.863 -1.062 . . . . 2.8 111.293 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -60.83 -46.41 90.66 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.267 -0.896 . . . . 2.58 110.519 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.0 mt -47.68 -40.29 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 C-N-CA 124.153 0.981 . . . . 2.93 111.637 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -47.31 -60.34 2.57 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.117 0.567 . . . . 5.15 111.974 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -37.29 72.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.327 -0.62 . . . . 6.96 109.327 -173.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -56.61 -54.85 41.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.186 -0.461 . . . . 1.24 110.066 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.404 ' HG ' ' CE2' ' A' ' 61' ' ' PHE . 6.7 mt -58.7 -44.37 90.3 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 118.652 0.66 . . . . 3.39 111.137 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.08 -11.26 1.04 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 114.285 1.217 . . . . 1.97 114.285 171.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.11 3.75 11.4 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.955 -1.091 . . . . 4.58 111.974 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.73 -65.9 0.66 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.851 1.205 . . . . 2.52 110.515 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.28 -131.36 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.122 0.569 . . . . 2.23 109.951 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.42 -0.94 80.47 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 119.501 1.046 . . . . 1.85 113.096 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.91 127.61 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 O-C-N 121.523 -0.986 . . . . 2.66 111.298 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.52 54.01 1.12 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.284 0.846 . . . . 3.49 113.284 173.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 t -157.15 143.68 18.16 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 107.02 -1.474 . . . . 2.7 107.02 165.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.0 92.53 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.04 -1.837 . . . . 3.29 106.04 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -116.53 79.78 1.37 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.351 -1.722 . . . . 4.35 106.351 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.9 p -98.73 128.23 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.453 -0.943 . . . . 3.49 108.453 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.39 74.98 2.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.957 -1.868 . . . . 2.02 105.957 172.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.86 -29.88 3.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.393 1.077 . . . . 4.23 111.87 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.2 ttt -72.65 -36.18 67.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.947 1.299 . . . . 4.83 111.135 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.71 -48.02 5.65 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 124.177 0.991 . . . . 2.03 109.191 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.23 58.24 0.35 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 125.48 1.514 . . . . 1.18 111.599 167.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -142.97 136.91 28.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.12 -1.067 . . . . 3.87 108.12 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.64 110.36 22.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.637 1.575 . . . . 1.84 111.597 168.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -99.51 111.36 23.72 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.081 -1.081 . . . . 4.65 108.081 167.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.9 mt -109.57 167.04 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.684 0.794 . . . . 3.96 109.066 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -123.61 108.23 12.37 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.871 0.868 . . . . 4.73 109.107 162.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -113.81 163.4 15.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.73 1.212 . . . . 4.15 111.336 168.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -105.71 106.37 56.21 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 127.215 2.206 . . . . 4.62 110.075 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.69 2.21 1.77 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.057 2.505 . . . . 2.05 114.015 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -83.14 -22.75 33.22 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.128 1.371 . . . . 4.49 110.408 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.1 t -123.42 -65.44 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.2 -1.037 . . . . 3.68 108.2 -171.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.26 155.14 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.276 -0.638 . . . . 2.37 109.276 174.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -129.27 151.74 78.29 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.692 1.597 . . . . 2.59 108.004 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.91 -38.42 79.21 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.841 2.361 . . . . 1.29 112.149 -172.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -59.51 -41.09 89.14 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.328 -0.857 . . . . 4.09 111.255 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -61.2 -40.54 94.35 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.307 0.643 . . . . 3.03 110.254 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.75 -46.45 74.17 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 N-CA-C 107.746 -1.205 . . . . 2.13 107.746 171.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.4 94.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.064 0.459 . . . . 1.98 111.036 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -57.77 -52.89 63.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.468 -0.77 . . . . 2.58 110.34 173.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.404 ' CE2' ' HG ' ' A' ' 26' ' ' LEU . 8.0 t80 -51.0 -55.5 17.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.429 0.692 . . . . 6.83 111.496 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 pp -61.4 -39.87 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 121.065 -1.022 . . . . 5.45 111.647 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.58 -33.72 76.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.343 0.52 . . . . 3.08 110.816 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.51 -50.3 67.95 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.485 -0.561 . . . . 2.51 109.485 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.1 mt -58.65 -35.73 73.0 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.937 -0.305 . . . . 3.03 111.402 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.08 31.19 2.52 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 123.92 0.771 . . . . 1.33 111.915 169.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -112.16 164.64 12.95 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.625 1.57 . . . . 3.51 109.04 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -102.9 136.05 43.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.02 -1.474 . . . . 2.6 107.02 164.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.3 127.04 38.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.216 -1.772 . . . . 1.82 106.216 169.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.4 138.98 33.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.009 0.818 . . . . 1.88 109.328 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.84 144.46 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 116.138 -0.483 . . . . 3.72 109.734 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.7 mtp . . . . . 0 CA--C 1.532 0.285 0 C-N-CA 124.098 0.959 . . . . 4.77 111.23 -175.518 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 107.366 -2.294 . . . . 2.14 107.366 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -102.65 110.06 21.88 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.381 1.472 . . . . 2.68 109.046 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.96 138.91 53.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 O-C-N 123.332 0.395 . . . . 3.57 110.67 175.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -110.33 141.36 43.45 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.128 1.371 . . . . 4.42 108.326 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.79 156.45 44.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.298 -0.63 . . . . 4.3 109.298 174.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.31 121.75 39.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 105.018 -2.216 . . . . 2.51 105.018 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 pp -100.88 121.07 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.14 -0.689 . . . . 2.6 109.14 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.2 p -106.92 142.79 35.98 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.27 0.628 . . . . 3.46 109.348 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.74 -26.17 10.31 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.741 1.162 . . . . 1.48 112.742 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.0 ttp -67.51 108.62 2.9 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.641 -0.917 . . . . 3.6 112.096 -169.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.7 m -117.86 7.77 12.47 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.044 0.938 . . . . 3.27 111.923 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 23.9 p -163.07 151.21 13.78 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 120.742 -1.224 . . . . 3.65 112.08 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.54 72.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.683 0.793 . . . . 3.83 111.411 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.2 m -53.29 -40.96 65.14 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.284 -0.885 . . . . 3.12 110.785 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.1 m -69.89 -40.93 75.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.615 -0.707 . . . . 2.82 110.04 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.0 t -50.35 -57.21 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 118.636 0.653 . . . . 2.63 109.557 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -58.58 -45.71 88.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.358 0.663 . . . . 4.35 110.205 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -61.21 -50.62 72.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.0 0.52 . . . . 1.77 110.84 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 41.7 mt -56.27 -47.2 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.089 -0.708 . . . . 1.87 109.089 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.28 -49.49 74.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.634 -0.876 . . . . 2.81 108.634 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.3 t -52.52 -50.45 62.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.719 0.808 . . . . 1.99 110.159 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -61.31 -42.37 98.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.753 -0.592 . . . . 3.76 111.31 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.5 mt -67.18 -56.26 10.68 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.932 -1.136 . . . . 2.83 107.932 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.7 p -55.33 -17.78 5.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.484 0.714 . . . . 2.89 112.703 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -13.77 62.59 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.502 -0.749 . . . . 6.83 112.398 171.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -80.83 153.86 27.45 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.389 1.876 . . . . 2.4 109.63 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -67.39 -64.44 0.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.943 0.897 . . . . 3.14 111.353 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.32 -32.41 58.08 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 122.253 -0.279 . . . . 1.27 112.921 -172.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.07 112.52 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.733 0.766 . . . . 2.67 109.616 -172.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.6 m -99.3 -41.32 7.5 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.561 0.344 . . . . 2.71 110.265 -172.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.402 ' CE2' ' HG3' ' A' ' 123' ' ' LYS . 54.2 p90 -140.15 121.22 14.69 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.468 -0.567 . . . . 3.6 109.468 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.18 140.8 37.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.72 -0.844 . . . . 1.7 108.72 165.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -132.69 116.98 17.29 Favored 'General case' 0 C--O 1.228 -0.052 0 N-CA-C 108.29 -1.004 . . . . 2.01 108.29 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 m -112.28 135.23 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.591 1.157 . . . . 3.31 109.087 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.32 89.55 2.57 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.332 0.969 . . . . 1.8 111.211 -173.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -24.51 67.04 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 125.22 1.408 . . . . 4.28 113.718 -170.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.81 70.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.654 0.381 . . . . 2.27 110.397 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.83 -13.12 12.02 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.477 1.511 . . . . 2.12 111.317 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.3 m 69.13 15.8 8.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.319 1.847 . . . . 2.25 114.326 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -95.16 158.0 15.65 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 120.127 1.33 . . . . 4.23 108.464 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.53 125.15 17.98 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.225 1.01 . . . . 1.7 108.652 168.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.26 114.42 26.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.637 -1.616 . . . . 2.46 106.637 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 m -106.75 135.06 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.048 0.84 . . . . 3.43 111.687 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.402 ' HG3' ' CE2' ' A' ' 110' ' ' TYR . 9.2 mmmt -113.01 95.97 5.69 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.13 1.372 . . . . 4.47 109.524 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -122.95 174.16 7.35 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.843 0.747 . . . . 3.96 111.362 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -105.19 110.07 63.99 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 108.564 -0.902 . . . . 3.13 108.564 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.53 69.01 6.83 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.48 2.787 . . . . 2.09 111.305 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -158.45 -48.53 0.06 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.875 1.27 . . . . 3.21 108.917 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pt -82.83 -28.93 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.406 0.682 . . . . 2.86 110.867 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.64 163.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.575 -0.898 . . . . 2.32 108.575 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.71 161.5 28.24 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.444 -1.462 . . . . 1.91 109.444 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.52 -37.62 87.9 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.557 2.838 . . . . 2.1 111.713 -172.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -52.21 -36.65 52.7 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.262 0.838 . . . . 7.93 113.262 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.43 -46.02 67.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.453 -0.573 . . . . 3.42 109.453 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.4 mt -57.46 -45.32 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.631 -0.878 . . . . 2.15 108.631 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.7 mt -53.85 -61.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 118.354 -0.831 . . . . 3.59 109.055 173.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.15 -49.49 32.17 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.913 1.233 . . . . 6.12 111.174 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.5 mt -53.05 -60.11 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.808 -0.812 . . . . 3.11 108.808 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.3 pp -65.9 -30.56 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 119.375 -0.93 . . . . 2.33 113.279 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.43 -40.53 94.78 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.111 0.869 . . . . 2.55 109.758 170.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -64.98 -37.47 87.76 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.079 -0.712 . . . . 2.84 109.079 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.35 -43.29 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.075 -0.391 . . . . 2.21 109.956 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.61 31.56 4.83 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.57 1.557 . . . . 1.12 111.619 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -99.62 174.93 6.01 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.315 1.057 . . . . 3.55 108.652 165.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -139.02 119.15 13.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.055 -1.831 . . . . 4.59 106.055 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.19 109.42 20.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.129 1.771 . . . . 1.77 108.793 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 26.6 m -117.14 113.72 22.66 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.944 0.497 . . . . 2.53 110.274 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -31.34 115.2 0.14 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.391 1.876 . . . . 4.49 112.039 169.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -101.17 15.69 27.93 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.637 1.347 . . . . 3.69 114.637 -161.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.085 -1.436 . . . . 5.64 112.618 -175.76 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 106.564 -1.643 . . . . 3.83 106.564 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -126.2 149.04 49.3 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.546 1.538 . . . . 5.92 106.951 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.1 p -140.53 146.03 37.58 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.829 -0.804 . . . . 4.58 108.829 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.15 109.68 19.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.041 -1.466 . . . . 5.99 107.041 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.458 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 2.3 pt? -133.69 174.72 10.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.071 0.938 . . . . 3.39 111.192 170.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.78 137.75 40.16 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.023 -1.103 . . . . 2.42 108.023 176.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 mm -98.67 126.51 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 106.972 -1.492 . . . . 2.15 106.972 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -102.48 103.55 13.92 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.064 -1.828 . . . . 4.89 106.064 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.23 -89.46 0.1 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.287 -1.525 . . . . 1.26 109.287 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.4 mtt 47.1 73.67 0.18 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.169 1.388 . . . . 3.33 113.497 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -57.56 -11.8 2.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.75 1.22 . . . . 3.32 113.653 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.5 t 73.97 -66.03 0.32 Allowed 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 126.187 1.795 . . . . 3.6 110.878 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -15.4 -74.51 0.01 OUTLIER 'General case' 0 C--N 1.342 0.279 0 C-N-CA 128.368 2.667 . . . . 7.62 113.219 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.8 m -153.37 19.26 0.55 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.498 0.719 . . . . 4.71 111.07 161.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 31.7 m -70.64 -47.5 59.74 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 121.093 -1.004 . . . . 2.82 109.211 -169.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -54.81 -49.83 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.752 -0.462 . . . . 4.38 109.752 175.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -55.55 -48.38 74.82 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.175 0.59 . . . . 2.84 111.433 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -58.75 -47.92 82.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.615 -0.513 . . . . 3.09 109.615 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -46.4 -50.89 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.632 1.173 . . . . 3.01 110.051 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -54.51 -54.54 39.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.472 0.578 . . . . 4.39 111.168 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -59.9 -43.04 95.04 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.166 -0.47 . . . . 6.15 110.3 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -56.52 -57.44 12.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.267 0.627 . . . . 1.48 109.478 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mp -57.68 -44.99 86.17 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 119.014 -0.517 . . . . 3.13 111.679 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -54.85 -20.68 9.24 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.428 1.013 . . . . 2.17 113.481 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -112.05 15.37 20.65 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.712 1.004 . . . . 4.24 113.712 173.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -70.02 -64.54 0.87 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.949 1.25 . . . . 2.77 110.229 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.73 -124.09 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.929 0.492 . . . . 2.45 110.713 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.74 -25.62 69.2 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 118.795 0.725 . . . . 1.65 111.987 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.95 125.73 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 O-C-N 122.446 -0.444 . . . . 2.51 110.036 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 pp -143.12 50.55 1.41 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.71 0.767 . . . . 4.13 109.765 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.8 t -160.64 149.53 16.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.092 -1.077 . . . . 2.58 108.092 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.0 129.7 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.046 -1.094 . . . . 3.69 108.046 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -142.52 74.28 1.44 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.104 -1.073 . . . . 3.63 108.104 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 m -97.33 159.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 121.372 -0.83 . . . . 3.99 108.995 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.88 90.6 2.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.307 -1.368 . . . . 3.38 107.307 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 tp -51.86 -27.44 12.67 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.881 1.672 . . . . 4.74 110.358 172.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.3 mtp -59.16 -38.65 80.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.187 0.995 . . . . 3.84 111.603 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.3 -31.47 7.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.473 0.709 . . . . 3.48 111.449 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.49 61.59 0.96 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.457 1.503 . . . . 2.19 110.403 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -142.08 142.7 32.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.429 -1.323 . . . . 4.2 107.429 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.08 101.34 7.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.968 0.907 . . . . 2.48 110.43 171.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -102.31 131.05 49.15 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.161 -2.162 . . . . 5.69 105.161 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.7 pt -136.74 171.71 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 120.434 -1.416 . . . . 3.42 108.988 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.22 99.77 6.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.422 1.089 . . . . 6.6 108.356 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -100.05 -179.17 4.07 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.686 1.194 . . . . 5.0 110.206 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -128.25 103.3 20.53 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.597 1.159 . . . . 3.98 110.894 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.25 -8.32 18.29 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.796 3.664 . . . . 3.03 114.84 -167.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -92.86 -8.94 42.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.352 0.661 . . . . 4.79 111.598 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.5 -47.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 123.934 0.894 . . . . 4.66 110.21 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.36 143.25 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 108.08 -1.081 . . . . 3.2 108.08 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.89 142.72 26.44 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 124.352 1.061 . . . . 3.3 109.143 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -57.39 -40.39 81.96 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.12 2.546 . . . . 2.05 111.505 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.24 -43.37 98.99 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.319 0.648 . . . . 5.88 110.371 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -63.05 -40.24 97.12 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.902 0.481 . . . . 3.79 110.103 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -53.4 19.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 N-CA-C 106.915 -1.513 . . . . 2.19 106.915 170.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.15 -45.46 79.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.99 -0.55 . . . . 2.2 110.599 -172.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.69 -49.94 56.16 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.486 0.715 . . . . 4.06 110.485 174.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.44 -48.9 65.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.527 0.679 . . . . 3.49 109.858 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -64.01 -39.06 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 122.081 -0.387 . . . . 3.37 111.413 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -65.56 -44.56 86.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.731 -0.47 . . . . 2.57 109.731 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.0 -50.51 73.83 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.714 -0.476 . . . . 2.5 109.714 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.7 mt -55.62 -40.58 72.3 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.387 -0.369 . . . . 2.95 111.629 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.37 33.46 1.03 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 123.516 0.579 . . . . 1.28 112.017 165.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -124.44 162.02 24.79 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.704 1.202 . . . . 3.13 108.86 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.81 130.46 41.37 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.138 -1.43 . . . . 2.58 107.138 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.59 111.38 24.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.836 1.254 . . . . 2.34 108.117 173.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.31 116.28 19.57 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.621 -0.511 . . . . 2.35 109.621 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.458 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.8 t -68.71 155.45 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.187 1.795 . . . . 3.75 111.36 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mtt . . . . . 0 CA--C 1.53 0.176 0 C-N-CA 124.176 0.99 . . . . 5.76 111.267 173.804 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.672 0 N-CA-C 111.208 -0.757 . . . . 2.84 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -129.65 128.33 42.38 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.359 -1.348 . . . . 2.99 107.359 169.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.89 154.11 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 107.096 -1.446 . . . . 4.22 107.096 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.22 141.14 51.55 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 123.477 0.711 . . . . 3.14 110.143 169.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.66 149.28 52.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.37 -2.085 . . . . 3.53 105.37 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.5 127.92 46.71 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 104.87 -2.27 . . . . 2.3 104.87 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.01 136.78 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 O-C-N 123.863 0.727 . . . . 2.84 109.065 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.2 m -128.34 115.2 17.9 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.372 1.069 . . . . 2.45 109.401 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.38 -38.13 1.72 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.174 1.369 . . . . 1.33 111.438 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.6 mtp -45.94 119.55 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.667 1.187 . . . . 3.23 111.763 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.0 m -129.66 17.02 5.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.922 0.889 . . . . 3.72 110.676 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 47.5 t -165.56 141.26 5.15 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 120.827 -1.171 . . . . 3.46 109.993 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.92 -32.51 66.02 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.709 0.686 . . . . 3.67 111.495 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -53.12 -37.92 62.18 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.756 -0.59 . . . . 2.51 110.469 173.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 85.8 m -62.53 -49.74 74.12 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 109.265 -0.643 . . . . 2.17 109.265 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.9 t -49.87 -45.54 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 122.506 0.322 . . . . 2.27 110.712 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -48.67 80.73 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.065 -0.346 . . . . 3.8 110.065 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -38.88 92.59 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 119.812 -0.755 . . . . 3.48 110.484 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.5 mt -64.76 -54.29 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.43 -0.952 . . . . 2.38 108.43 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -49.46 -49.77 43.99 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 126.337 1.855 . . . . 4.39 109.251 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.0 t -50.17 -50.43 49.13 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 119.368 -0.349 . . . . 2.22 111.317 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -50.2 68.52 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.03 0.832 . . . . 3.79 112.3 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.75 -45.13 87.71 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 120.841 -1.162 . . . . 4.04 110.892 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 87.2 m -61.11 -16.93 49.58 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.707 0.803 . . . . 3.72 111.061 173.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -17.71 64.83 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 118.624 -0.703 . . . . 5.78 111.733 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.9 p -72.66 -176.41 1.95 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 120.159 1.345 . . . . 4.23 110.885 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -94.29 -50.35 5.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.541 1.137 . . . . 2.4 111.083 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.47 -41.37 30.31 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 122.245 -0.285 . . . . 1.56 112.768 -168.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.17 126.34 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.751 -0.833 . . . . 3.96 108.751 -173.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.0 m -112.36 -46.32 3.19 Favored 'General case' 0 CA--C 1.522 -0.11 0 N-CA-C 111.824 0.305 . . . . 3.21 111.824 -174.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -136.42 125.15 23.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.718 -1.216 . . . . 4.1 107.718 167.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.17 159.99 21.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.784 -1.191 . . . . 1.8 107.784 161.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.0 m -142.98 105.12 4.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.794 -1.187 . . . . 2.56 107.794 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.1 t -98.36 115.67 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 125.968 1.707 . . . . 3.53 107.596 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -119.0 106.37 12.37 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 118.943 0.792 . . . . 2.14 110.484 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 pp -72.59 -29.92 63.92 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.467 1.107 . . . . 3.15 112.447 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.52 -43.22 89.1 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.395 0.678 . . . . 2.02 110.341 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -28.69 19.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.786 1.234 . . . . 2.34 110.314 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.35 21.91 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.162 1.785 . . . . 3.37 111.155 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -99.08 160.82 13.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.607 1.563 . . . . 3.94 110.216 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.48 130.13 24.25 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.408 -0.96 . . . . 1.86 108.408 166.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -95.54 143.27 26.99 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.24 -1.393 . . . . 2.94 107.24 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.35 128.7 25.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 124.998 1.319 . . . . 3.11 109.027 -173.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -118.54 106.65 12.88 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.006 -0.739 . . . . 4.64 109.006 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -125.44 175.8 7.26 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.802 0.841 . . . . 4.13 110.318 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -97.82 113.58 63.86 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 108.009 -1.108 . . . . 3.75 108.009 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.6 67.96 7.11 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.524 2.816 . . . . 2.45 111.222 -173.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -162.49 -47.64 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.719 1.208 . . . . 3.93 109.026 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 pt -86.39 -32.18 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 122.539 0.335 . . . . 3.12 111.524 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.68 163.05 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 107.939 -1.134 . . . . 2.48 107.939 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.21 160.82 28.37 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.456 -1.458 . . . . 2.15 109.456 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.36 -35.78 89.8 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.511 2.807 . . . . 2.14 111.665 -172.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -32.66 69.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 112.39 0.515 . . . . 7.76 112.39 -175.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.79 -48.45 68.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.976 -0.75 . . . . 3.68 108.976 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 74.9 mt -58.3 -45.18 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.533 -0.914 . . . . 2.34 108.533 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 80.4 mt -52.44 -61.09 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 117.566 -1.207 . . . . 3.41 108.889 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.26 -51.8 17.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.399 1.454 . . . . 6.0 110.996 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.0 mm -52.89 -49.92 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.599 0.636 . . . . 2.86 110.104 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.288 2.5 pp -70.75 -31.53 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 121.173 -0.954 . . . . 2.48 113.31 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.5 -39.76 84.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.74 1.155 . . . . 3.06 109.813 169.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -35.41 77.27 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.196 1.398 . . . . 3.17 108.867 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 78.1 mt -77.27 -41.81 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 122.542 0.337 . . . . 1.97 110.724 172.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.31 30.98 5.45 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.598 1.57 . . . . 1.06 111.583 -173.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -98.33 175.3 6.1 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.422 1.111 . . . . 3.2 108.251 165.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -135.92 126.36 26.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.191 -2.151 . . . . 5.24 105.191 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.6 100.57 7.2 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.648 1.579 . . . . 1.93 107.466 -175.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.1 m -146.8 117.2 7.44 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 117.896 -1.049 . . . . 4.09 111.408 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.99 -102.0 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.217 -0.896 . . . . 8.09 109.588 170.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 41.1 40.21 1.04 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.434 1.493 . . . . 7.85 111.814 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 . . . . . 0 C--O 1.248 0.99 0 N-CA-C 114.726 1.38 . . . . 7.35 114.726 -169.942 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.514 -0.414 0 N-CA-C 109.78 -0.452 . . . . 4.51 109.78 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 152.39 19.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 123.891 0.744 . . . . 4.12 110.547 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.7 t -119.65 137.45 53.88 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.562 -0.903 . . . . 3.07 108.562 168.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -102.33 103.55 14.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.847 1.659 . . . . 4.86 108.973 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.444 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.8 pt? -125.8 176.91 6.6 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.894 0.854 . . . . 3.53 111.236 171.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.82 136.45 34.04 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.225 -1.028 . . . . 2.25 108.225 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.6 mm -93.69 121.25 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 107.004 -1.48 . . . . 1.93 107.004 -169.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.75 102.17 11.75 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.583 -2.377 . . . . 5.02 104.583 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.47 -89.27 0.09 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 109.785 -1.326 . . . . 1.16 109.785 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.2 mmt 46.98 77.32 0.09 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.079 1.752 . . . . 2.62 113.375 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 p -65.62 -58.41 5.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.464 -0.773 . . . . 3.67 111.528 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 49.68 0.07 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 119.976 -0.689 . . . . 4.33 110.784 -172.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 47.66 36.27 5.37 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.822 0.849 . . . . 6.37 111.593 -177.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -129.4 -51.66 1.18 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.698 1.199 . . . . 4.11 109.635 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 23.4 t -68.79 -43.25 76.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 118.434 -1.306 . . . . 3.73 109.811 -174.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -38.65 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 122.125 0.965 . . . . 3.36 109.399 173.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -65.83 -41.55 91.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.084 -0.962 . . . . 2.93 111.26 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.57 -38.17 70.99 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 120.801 -1.187 . . . . 3.11 111.667 172.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.0 mt -49.4 -42.79 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.494 1.118 . . . . 2.2 109.968 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -41.14 -56.46 2.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.635 0.731 . . . . 4.44 112.515 172.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -68.57 -27.51 66.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.873 0.869 . . . . 6.07 110.79 -175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -69.48 -57.4 5.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.436 -0.95 . . . . 1.21 108.436 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.11 -40.6 85.87 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 118.745 0.702 . . . . 3.55 110.261 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -24.56 5.94 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 112.771 0.656 . . . . 2.14 112.771 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -127.31 25.43 6.15 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.273 0.629 . . . . 4.75 111.734 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -76.77 -58.15 3.44 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.995 -0.742 . . . . 2.83 108.995 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -162.56 -131.87 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.015 0.526 . . . . 2.1 109.972 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.49 -2.44 42.69 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.761 0.696 . . . . 1.5 113.767 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -80.22 122.38 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.163 0.981 . . . . 2.5 109.382 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.1 51.36 2.13 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.774 0.797 . . . . 3.53 109.933 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 t -161.6 151.14 16.47 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.246 -1.761 . . . . 2.31 106.246 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -140.72 124.35 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.172 -1.788 . . . . 3.59 106.172 166.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.73 87.89 2.55 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.144 0.973 . . . . 5.5 110.492 169.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.59 139.92 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.249 -1.019 . . . . 3.53 108.249 172.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -109.3 100.97 10.01 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.967 -1.864 . . . . 2.5 105.967 162.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.74 -33.61 70.45 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.258 1.023 . . . . 4.89 109.052 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -53.07 62.41 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.56 1.144 . . . . 5.62 110.78 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.73 -25.39 22.33 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.347 0.659 . . . . 2.5 111.388 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.66 55.68 2.65 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.741 1.162 . . . . 1.46 110.957 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -135.33 139.42 44.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.175 0.988 . . . . 4.14 108.336 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.66 105.3 13.45 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 124.682 1.193 . . . . 1.69 109.765 167.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.31 144.49 28.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.591 -1.633 . . . . 3.72 106.591 163.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.64 172.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.536 -1.283 . . . . 3.3 107.536 166.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -115.4 112.32 22.15 Favored 'General case' 0 C--N 1.34 0.178 0 O-C-N 124.054 0.846 . . . . 4.39 110.206 167.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -105.21 172.33 6.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.598 1.559 . . . . 4.08 110.758 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -117.17 106.34 47.37 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.894 1.278 . . . . 3.42 109.001 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.15 -12.56 30.36 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 124.609 3.539 . . . . 2.65 113.819 -160.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -96.46 0.86 50.97 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.177 0.591 . . . . 3.18 111.3 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.0 t -118.85 -49.03 3.73 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 123.979 0.912 . . . . 3.36 109.478 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.16 149.97 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.833 1.253 . . . . 2.25 108.344 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.23 140.06 27.54 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 106.564 -1.643 . . . . 2.98 106.564 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -56.69 -38.78 94.91 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.022 2.482 . . . . 1.78 112.06 -172.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mp -52.06 -43.83 64.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.681 0.792 . . . . 4.68 111.061 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -39.51 94.08 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.137 -0.69 . . . . 3.35 109.137 -176.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -52.11 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.493 -1.299 . . . . 2.4 107.493 172.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.82 -45.53 86.01 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 123.365 0.415 . . . . 2.34 110.263 -173.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.5 -45.99 69.87 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.068 0.547 . . . . 3.31 110.944 172.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.37 -46.83 87.58 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.379 0.609 . . . . 3.72 109.863 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mm -58.76 -44.21 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.916 -0.49 . . . . 3.53 110.991 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -63.69 -39.77 95.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.348 0.659 . . . . 3.22 111.507 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -62.62 -46.69 87.08 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.977 0.511 . . . . 2.12 109.702 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 mt -58.21 -36.85 73.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.549 0.34 . . . . 2.71 111.742 172.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.88 24.56 3.03 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.268 0.937 . . . . 1.07 112.469 167.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 18' ' ' CYS . 2.1 m-30 -115.12 160.91 19.1 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.188 1.395 . . . . 3.74 109.118 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -98.03 119.21 36.27 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.321 -0.992 . . . . 4.04 108.321 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.31 91.11 5.06 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.087 1.355 . . . . 2.11 107.947 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.71 97.5 8.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.596 -1.631 . . . . 2.17 106.596 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.444 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -60.81 155.67 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.187 -1.37 . . . . 4.77 110.104 169.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.568 -0.901 . . . . 6.08 108.568 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.813 0 CA-C-O 117.674 -1.626 . . . . 3.12 109.899 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.45 70.26 2.65 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.534 1.667 . . . . 2.59 107.739 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.42 161.25 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.521 -0.918 . . . . 3.79 108.521 -178.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.12 148.09 44.06 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.522 0.729 . . . . 2.87 109.611 177.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.02 147.45 52.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.908 1.283 . . . . 3.7 108.505 172.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 m -98.02 126.31 43.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 105.971 -1.863 . . . . 2.98 105.971 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.03 134.69 35.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 109.181 -0.674 . . . . 2.53 109.181 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.5 m -125.74 140.56 52.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.115 -1.439 . . . . 2.72 107.115 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.44 -22.53 5.87 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.912 1.244 . . . . 1.33 111.89 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -51.74 139.49 21.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.061 1.134 . . . . 4.43 114.061 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.2 t -147.0 11.02 1.04 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.384 0.674 . . . . 4.95 111.902 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.04 144.83 1.03 Allowed 'General case' 0 C--N 1.342 0.277 0 O-C-N 120.455 -1.403 . . . . 4.16 110.084 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.69 -34.0 66.98 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.422 0.689 . . . . 3.28 111.782 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.8 m -43.48 -49.01 7.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.753 0.421 . . . . 2.51 110.991 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.52 -36.82 83.78 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.825 0.284 . . . . 3.55 111.059 -177.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.83 -56.59 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.636 -0.876 . . . . 3.06 108.636 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -59.85 -35.73 75.37 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.801 0.81 . . . . 3.39 110.556 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -63.19 -49.41 74.35 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.814 1.646 . . . . 1.74 111.252 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 34.5 mt -58.49 -45.3 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.716 -0.846 . . . . 2.24 108.716 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -55.32 -48.7 73.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.239 0.616 . . . . 3.33 110.194 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.8 t -51.91 -53.43 41.01 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.334 0.97 . . . . 1.74 110.889 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.34 -39.68 73.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.321 -0.862 . . . . 3.64 112.056 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.4 -60.41 2.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.576 -1.268 . . . . 3.16 107.576 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.0 p -54.93 -20.97 10.17 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.855 0.862 . . . . 3.64 112.754 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.1 mtt85 -60.73 -34.1 73.91 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.88 0.696 . . . . 6.86 112.88 171.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.1 m -57.36 150.23 18.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.604 0.762 . . . . 2.48 111.621 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -68.87 -56.0 9.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.155 0.982 . . . . 2.69 112.336 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.89 -28.18 65.32 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.972 -0.451 . . . . 1.11 111.972 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.34 122.62 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.718 -0.871 . . . . 2.77 109.426 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.7 m -104.35 -41.25 5.82 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.163 0.185 . . . . 2.7 111.225 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CZ ' ' HG2' ' A' ' 123' ' ' LYS . 30.3 p90 -138.25 122.39 18.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.017 -0.735 . . . . 4.42 109.017 172.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.73 135.28 46.4 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 107.419 -1.326 . . . . 1.98 107.419 163.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.7 t -127.8 121.94 31.44 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.205 0.457 . . . . 2.56 110.488 164.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.54 114.37 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.014 1.326 . . . . 3.39 111.111 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -106.81 88.75 2.82 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.708 1.603 . . . . 1.97 110.43 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.58 -33.19 69.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.374 1.87 . . . . 2.96 111.683 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.24 -31.51 53.62 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.379 1.072 . . . . 2.31 111.477 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.08 -0.14 12.82 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.01 1.324 . . . . 2.04 110.495 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.0 m 59.85 20.63 9.54 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.039 1.336 . . . . 2.44 113.176 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -97.61 150.63 20.94 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.484 0.714 . . . . 4.65 110.604 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.02 106.14 7.08 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.663 1.985 . . . . 1.97 108.124 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.01 108.93 20.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.469 -2.048 . . . . 2.88 105.469 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.5 p -113.95 127.0 71.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 3.37 108.412 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HG2' ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -114.87 105.6 13.19 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 123.929 0.892 . . . . 5.92 110.044 -176.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -124.01 -177.37 3.74 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.003 0.814 . . . . 2.9 111.804 -174.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -105.38 106.81 57.39 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.2 -1.407 . . . . 3.56 107.2 178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.71 66.11 8.82 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.519 2.813 . . . . 1.73 111.088 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -161.51 -48.34 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.484 1.514 . . . . 3.24 108.623 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.9 pt -86.28 -32.59 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 123.698 0.799 . . . . 2.3 111.23 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.02 163.68 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.287 0.635 . . . . 2.12 109.574 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.39 166.44 26.44 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.452 -1.059 . . . . 1.45 110.452 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.19 -37.11 19.31 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.397 2.731 . . . . 1.56 111.156 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -50.05 -39.06 40.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.237 0.615 . . . . 7.02 111.471 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.25 -38.99 71.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.506 -0.924 . . . . 4.35 108.506 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.15 -49.02 85.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.486 0.714 . . . . 2.06 109.165 172.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 77.1 mt -51.51 -53.04 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.704 -0.85 . . . . 2.75 108.704 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -48.79 75.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.364 -0.835 . . . . 4.38 111.872 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 49.9 mt -49.92 -56.08 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.894 -0.78 . . . . 3.62 108.894 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.256 2.2 pp -67.25 -30.38 49.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 113.194 0.813 . . . . 2.45 113.194 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -60.79 -37.78 83.09 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.511 1.051 . . . . 2.61 110.15 170.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -69.33 -31.39 69.82 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.758 -0.46 . . . . 3.89 109.758 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.2 mt -66.72 -45.14 88.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.898 -0.501 . . . . 2.43 109.765 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.07 31.94 3.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.667 1.603 . . . . 1.29 111.343 -175.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.87 174.46 6.19 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.927 0.864 . . . . 3.78 109.068 171.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -125.96 123.26 38.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.622 -1.622 . . . . 5.11 106.622 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -115.81 100.77 8.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.357 1.463 . . . . 1.94 108.91 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.4 p -98.42 99.25 10.42 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.012 -1.107 . . . . 4.09 108.012 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.91 98.9 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.489 1.915 . . . . 4.58 110.811 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 48.38 42.7 18.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.951 0.901 . . . . 4.72 112.23 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 116.893 -1.527 . . . . 8.44 108.716 -175.267 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 107.032 -1.47 . . . . 4.18 107.032 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HZ1' ' CD ' ' A' ' 45' ' ' GLU . 32.2 ttmt -94.93 151.67 19.0 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 119.645 1.111 . . . . 5.12 109.376 176.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.66 133.63 40.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.441 -1.254 . . . . 3.15 108.531 167.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -103.67 118.49 36.84 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.657 1.583 . . . . 4.69 109.135 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.8 pt? -141.09 179.93 6.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.567 0.747 . . . . 3.05 111.488 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.62 146.38 52.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.327 -0.99 . . . . 1.95 108.327 173.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 mm -100.95 136.19 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 107.442 -1.318 . . . . 2.12 107.442 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -108.98 125.3 51.91 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.157 -1.423 . . . . 3.78 107.157 164.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.02 -79.98 0.17 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.507 1.051 . . . . 1.05 110.957 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.9 mtt 45.26 78.73 0.06 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.22 1.808 . . . . 2.11 114.685 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -54.29 -60.78 2.88 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.75 0.648 . . . . 3.08 112.75 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -169.59 68.27 0.06 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.443 0.565 . . . . 3.34 110.321 -174.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 34.37 41.52 0.05 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.304 2.242 . . . . 6.72 115.78 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -160.14 -41.05 0.05 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.192 1.397 . . . . 3.7 111.27 -171.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.2 t -70.88 -38.53 73.06 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.673 -1.267 . . . . 2.76 111.01 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.8 t -59.4 -34.96 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.434 0.635 . . . . 2.8 109.397 167.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.27 -40.84 96.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.37 -0.831 . . . . 2.61 111.088 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -44.85 83.42 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.752 -1.218 . . . . 2.46 110.451 172.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.3 mt -47.36 -31.24 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 123.249 0.62 . . . . 2.59 111.854 175.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -46.54 -59.22 3.13 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.588 0.631 . . . . 5.25 111.539 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -71.55 -21.43 61.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.424 -0.353 . . . . 5.35 111.834 -173.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -67.59 -57.59 6.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.407 -1.331 . . . . 1.19 107.407 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.27 -41.71 99.05 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 118.39 0.541 . . . . 2.76 111.237 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.54 -17.91 9.97 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.582 -0.699 . . . . 2.29 112.59 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -123.58 27.48 7.37 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.56 0.744 . . . . 4.59 111.406 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -81.2 -61.45 1.95 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.932 0.893 . . . . 2.69 110.04 172.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.16 -138.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.138 0.575 . . . . 2.19 109.927 -172.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.22 -18.09 66.76 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 119.068 0.849 . . . . 1.52 112.541 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.38 121.02 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 O-C-N 121.842 -0.799 . . . . 2.74 110.862 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 pp -142.16 50.05 1.53 Allowed 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 121.86 0.838 . . . . 3.4 110.336 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -157.92 144.51 17.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.713 -1.588 . . . . 2.54 106.713 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.4 t -138.61 112.64 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 104.553 -2.388 . . . . 3.68 104.553 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.94 86.77 2.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 122.219 1.009 . . . . 3.82 109.128 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.18 157.1 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.07 -0.968 . . . . 3.55 109.11 171.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.38 98.42 5.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.116 -1.809 . . . . 2.27 106.116 159.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 mp -62.33 -20.82 64.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.014 0.37 . . . . 4.67 111.242 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 40.4 ttm -73.83 -37.03 64.96 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.368 1.067 . . . . 3.83 110.735 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.57 -23.2 14.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.6 0.76 . . . . 2.08 111.797 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.17 62.29 1.83 Allowed Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.475 1.036 . . . . 1.34 111.322 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -144.0 140.37 29.55 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.487 -1.301 . . . . 4.8 107.487 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.21 108.49 16.67 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.616 1.167 . . . . 2.0 110.104 165.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' CD ' ' HZ1' ' A' ' 5' ' ' LYS . 2.0 pt-20 -104.09 148.7 25.95 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.442 1.019 . . . . 4.01 109.082 158.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.5 pt -137.53 177.76 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.187 -1.412 . . . . 2.78 107.187 176.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.11 110.75 13.87 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 119.137 -0.459 . . . . 4.17 110.644 165.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -115.59 -178.43 3.38 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.232 1.813 . . . . 4.04 111.475 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -122.83 106.58 34.22 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 127.675 2.39 . . . . 4.54 110.095 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.19 10.53 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.614 2.876 . . . . 2.24 113.358 -173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.32 -19.01 18.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.494 0.718 . . . . 3.52 110.724 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.08 -66.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.115 -1.069 . . . . 3.84 108.115 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.07 142.26 13.63 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-O 120.859 0.361 . . . . 2.14 110.299 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.39 149.06 41.52 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.302 1.441 . . . . 2.86 109.939 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.97 -19.97 67.27 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.942 2.428 . . . . 1.51 112.546 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -70.59 -60.35 2.31 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.986 -0.746 . . . . 3.93 108.986 173.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -59.76 -33.57 71.85 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.1 -0.375 . . . . 3.56 111.963 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.87 -47.06 41.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 N-CA-C 107.321 -1.363 . . . . 2.29 107.321 171.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.56 -36.65 81.23 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.697 -0.683 . . . . 2.22 110.686 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -59.57 -45.39 91.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.843 0.747 . . . . 2.62 109.568 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -52.16 63.47 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.185 -0.672 . . . . 3.59 109.185 176.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mm -63.48 -42.77 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 O-C-N 122.007 -0.433 . . . . 3.28 112.123 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -44.45 95.64 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.23 1.012 . . . . 2.33 110.356 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -60.39 -53.94 51.54 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.671 0.788 . . . . 2.16 108.899 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.7 mt -50.36 -39.82 47.58 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.648 0.779 . . . . 2.73 111.775 174.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.56 37.55 1.07 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.637 -0.985 . . . . 1.16 110.637 167.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -130.92 158.79 39.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.41 -1.33 . . . . 3.47 107.41 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -99.24 119.58 38.13 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.243 -1.021 . . . . 2.29 108.243 171.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.66 119.72 36.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.417 -1.327 . . . . 2.29 107.417 168.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.46 124.94 27.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.099 -1.074 . . . . 1.84 108.099 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.465 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 21.8 t -60.78 151.69 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 124.546 1.139 . . . . 3.89 111.261 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.378 0 CA-C-N 115.955 -0.566 . . . . 5.14 110.984 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 109.616 -1.393 . . . . 3.9 109.616 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -95.79 111.12 23.16 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 107.637 -1.246 . . . . 3.36 107.637 164.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.73 161.81 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 125.445 1.716 . . . . 3.94 107.136 173.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.84 154.42 21.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.828 1.251 . . . . 3.17 108.292 165.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -142.42 151.87 42.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.332 0.653 . . . . 4.31 110.518 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 m -99.95 132.1 45.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.831 1.652 . . . . 2.98 107.296 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.5 mt -99.1 124.69 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.965 -0.754 . . . . 3.83 108.965 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.7 m -110.56 100.98 9.69 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.247 0.619 . . . . 2.57 109.342 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.57 -34.35 2.12 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.621 1.105 . . . . 1.24 111.216 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -58.23 141.8 49.58 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.383 0.673 . . . . 3.11 111.811 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 51.8 m -153.57 84.46 1.18 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.858 1.663 . . . . 4.57 106.558 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 63.3 m 51.09 -110.51 0.48 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.017 1.327 . . . . 7.13 111.602 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 48.72 -144.11 0.44 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.164 1.385 . . . . 6.38 110.3 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.5 t -89.15 9.4 25.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 118.849 -0.596 . . . . 4.63 109.97 164.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.54 -56.93 6.66 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 119.506 1.048 . . . . 3.46 110.082 -166.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.5 t -49.6 -46.41 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.321 1.049 . . . . 2.13 109.92 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -63.82 -36.28 83.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.125 -0.489 . . . . 4.68 109.927 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -63.45 -52.79 59.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.556 0.742 . . . . 2.47 109.691 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mt -53.92 -53.99 23.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 109.496 -0.557 . . . . 2.07 109.496 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -56.95 -45.69 82.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.907 -0.568 . . . . 2.16 109.758 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.3 t -54.29 -54.07 45.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.822 0.737 . . . . 1.96 110.857 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -34.54 72.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 121.169 -0.957 . . . . 3.15 111.147 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -71.07 -60.63 2.12 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.429 -0.952 . . . . 2.78 108.429 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.1 p -56.34 -18.78 11.86 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.06 0.763 . . . . 2.98 113.06 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -61.48 -33.23 73.42 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.767 0.712 . . . . 6.37 112.466 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.7 m -62.35 152.4 34.05 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.077 0.951 . . . . 2.7 111.387 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -70.64 -52.96 17.8 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.317 1.047 . . . . 2.3 111.502 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.49 -43.04 20.72 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.572 -0.611 . . . . 1.22 111.572 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.66 134.64 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.855 -0.794 . . . . 2.98 108.855 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.8 t -128.0 -35.95 2.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.756 0.823 . . . . 3.66 110.845 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -110.11 92.0 3.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.951 -1.5 . . . . 4.46 106.951 -173.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.49 135.11 47.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.165 -1.791 . . . . 1.7 106.165 160.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 t -140.23 108.75 5.87 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.477 -1.305 . . . . 2.47 107.477 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.5 t -101.63 107.55 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.521 1.128 . . . . 3.29 109.341 -173.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.97 80.12 2.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.561 1.144 . . . . 2.11 109.818 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 pp -53.56 -26.63 22.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.012 0.925 . . . . 3.14 113.042 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.48 -35.23 65.3 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.342 0.657 . . . . 2.49 111.248 176.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -7.61 18.79 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.264 1.425 . . . . 2.38 110.78 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.4 m 73.51 3.9 4.66 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.003 1.721 . . . . 2.41 112.406 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -98.09 165.33 11.95 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.132 0.973 . . . . 4.05 112.0 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -137.51 136.12 37.38 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.66 1.184 . . . . 1.9 108.651 168.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.96 132.18 43.76 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.959 -1.867 . . . . 3.55 105.959 171.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.0 t -125.44 142.01 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 105.345 -2.094 . . . . 2.8 105.345 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -125.06 99.52 6.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.458 1.103 . . . . 4.36 109.255 169.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -109.68 -178.78 3.63 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.645 1.578 . . . . 3.03 109.106 173.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -114.41 113.12 45.81 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.201 1.4 . . . . 4.16 107.651 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.01 58.72 6.8 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.754 2.303 . . . . 2.2 112.479 -164.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -145.77 -49.89 0.23 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.894 1.677 . . . . 4.74 108.242 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -80.34 -32.03 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 122.34 -0.225 . . . . 2.64 111.205 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.41 162.94 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.942 -1.132 . . . . 2.17 107.942 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.23 163.91 27.71 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.628 -1.389 . . . . 1.49 109.628 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.72 -41.26 39.85 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.101 2.534 . . . . 1.52 110.396 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -40.05 25.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.184 0.809 . . . . 7.09 113.184 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.38 -47.96 79.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.18 -0.674 . . . . 2.71 109.18 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.31 -46.76 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.493 -0.928 . . . . 1.81 108.493 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.2 mt -53.66 -54.24 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 109.121 -0.696 . . . . 2.63 109.121 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -54.65 -47.24 73.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.935 0.789 . . . . 4.53 111.702 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.2 mm -54.17 -56.47 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.863 -0.421 . . . . 3.04 109.863 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 pp -66.57 -30.96 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 120.973 -1.08 . . . . 2.46 113.119 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.31 -38.38 73.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.312 0.645 . . . . 3.39 109.917 170.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -65.99 -36.49 83.45 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.485 -0.561 . . . . 3.01 109.485 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.7 mt -68.38 -40.84 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.395 -0.594 . . . . 2.21 109.395 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.13 33.18 3.52 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.518 1.532 . . . . 1.17 111.007 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -101.35 176.67 5.16 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.279 1.039 . . . . 4.5 108.364 166.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -134.92 125.67 27.15 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.413 -1.328 . . . . 6.07 107.413 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.22 106.15 14.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.983 1.313 . . . . 1.86 109.74 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.57 94.75 6.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.848 1.659 . . . . 2.99 108.572 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.79 103.76 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.663 1.585 . . . . 4.88 110.501 172.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 46.75 43.76 13.33 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.744 0.818 . . . . 5.02 112.397 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.158 -0.925 . . . . 10.4 108.531 177.612 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 121.853 0.835 . . . . 3.85 109.163 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.7 151.35 19.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.86 -1.904 . . . . 4.97 105.86 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.8 t -123.25 141.41 52.01 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 117.837 -1.078 . . . . 2.93 108.333 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -123.85 100.53 6.8 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.752 -0.833 . . . . 4.76 108.752 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.04 168.02 13.93 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.38 1.086 . . . . 3.98 110.736 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.68 146.16 43.9 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.65 -1.611 . . . . 2.24 106.65 169.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.5 mm -102.37 130.54 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.614 -1.254 . . . . 2.18 107.614 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -118.78 117.87 30.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.494 -1.669 . . . . 4.0 106.494 167.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.78 -99.91 0.18 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.127 -1.589 . . . . 1.14 109.127 -174.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 58.5 76.25 0.35 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.172 1.789 . . . . 2.51 113.288 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -48.96 -58.73 4.41 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.893 0.877 . . . . 3.19 112.698 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.56 52.63 0.05 OUTLIER 'General case' 0 C--N 1.346 0.449 0 C-N-CA 119.211 -0.995 . . . . 5.29 111.37 -175.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.46 41.12 20.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.97 0.908 . . . . 5.4 112.399 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -151.82 -43.19 0.11 Allowed 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.494 1.118 . . . . 3.07 110.881 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.36 -46.99 83.96 Favored 'General case' 0 C--O 1.226 -0.167 0 O-C-N 121.052 -1.03 . . . . 3.16 109.132 -176.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.18 -36.98 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.967 0.889 . . . . 3.4 109.996 174.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -65.8 -31.19 72.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.921 -0.581 . . . . 2.08 112.336 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -38.19 71.82 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.93 -1.106 . . . . 3.09 110.171 172.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.0 mt -59.85 -39.96 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.264 1.026 . . . . 2.87 110.256 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.9 -58.26 2.47 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.791 0.836 . . . . 5.73 112.08 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.53 -39.99 88.9 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.924 0.392 . . . . 5.88 110.144 -172.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -54.45 -56.66 16.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.519 -0.764 . . . . 1.47 109.266 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mt -65.67 -36.25 83.12 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 113.313 0.857 . . . . 3.7 113.313 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -21.9 3.65 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 118.283 0.492 . . . . 2.81 112.165 168.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -123.75 30.88 6.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.152 0.581 . . . . 4.35 112.42 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.32 -80.08 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.582 0.628 . . . . 3.54 109.371 167.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.29 -114.28 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.516 0.726 . . . . 2.31 110.469 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.5 -9.58 69.13 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 119.248 0.931 . . . . 1.35 112.984 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.8 t -59.22 119.75 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 118.366 1.083 . . . . 3.5 109.092 167.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.45 49.6 1.71 Allowed 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.496 0.665 . . . . 3.35 110.448 162.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 t -159.66 151.13 19.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.566 -1.272 . . . . 2.46 107.566 161.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.01 120.11 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.399 -2.074 . . . . 3.65 105.399 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 tt -138.75 89.72 2.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.936 -1.876 . . . . 3.52 105.936 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.7 p -106.29 135.63 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.3 -1.0 . . . . 3.53 108.3 172.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -104.76 102.69 12.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.247 -1.76 . . . . 2.27 106.247 164.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tp -57.57 -33.7 68.44 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.054 1.342 . . . . 3.88 109.182 169.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 62.8 mtt -59.29 -47.67 84.49 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.537 0.735 . . . . 5.0 110.901 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.3 -25.86 16.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.915 0.886 . . . . 2.21 111.446 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.4 55.71 2.82 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.615 1.102 . . . . 1.09 110.833 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 128.74 27.86 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.04 -1.096 . . . . 3.7 108.04 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.07 117.32 30.24 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 124.518 1.136 . . . . 2.06 111.071 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -113.63 142.47 45.96 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.609 0.719 . . . . 3.98 110.641 162.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.5 mt -121.25 168.16 13.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 125.595 1.558 . . . . 4.64 106.893 171.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -133.84 105.54 6.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.098 0.559 . . . . 4.6 109.568 170.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -102.69 -176.22 3.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.8 2.04 . . . . 4.22 111.792 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -109.35 129.93 23.34 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.252 1.421 . . . . 4.17 107.7 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.57 41.49 1.15 Allowed 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.46 2.774 . . . . 4.37 112.334 -166.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -163.41 24.42 0.08 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.041 0.936 . . . . 3.49 110.392 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.13 -50.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 107.027 -1.471 . . . . 4.1 107.027 -174.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.35 153.01 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.837 -0.801 . . . . 4.12 108.837 176.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -125.77 158.49 65.12 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 106.373 -1.714 . . . . 3.69 106.373 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.44 -27.9 54.39 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.528 1.485 . . . . 1.7 110.438 -165.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -56.74 -42.17 78.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.123 0.969 . . . . 4.65 111.239 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.6 -52.52 57.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.976 0.807 . . . . 2.85 109.856 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -47.7 -54.16 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.071 -1.085 . . . . 2.81 108.071 168.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.35 -35.05 74.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.158 -0.474 . . . . 3.2 111.308 -172.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -58.2 -47.39 83.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.506 1.122 . . . . 3.42 109.269 -178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -54.11 -53.14 57.34 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.747 -0.464 . . . . 3.84 109.747 174.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.0 mm -59.07 -48.16 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.04 0.448 . . . . 3.64 110.631 -174.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.3 -45.79 90.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.381 0.673 . . . . 2.71 111.164 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.36 -49.81 76.1 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.504 0.593 . . . . 2.56 110.192 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mt -57.97 -28.03 64.0 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.688 0.795 . . . . 3.14 111.793 174.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.43 36.15 3.91 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.11 -1.196 . . . . 1.85 110.11 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -120.13 162.07 19.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.187 1.795 . . . . 3.12 106.445 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -104.1 124.43 49.06 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.598 -0.89 . . . . 2.74 108.598 168.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.35 121.96 45.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.506 -1.294 . . . . 2.68 107.506 162.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.52 156.54 48.72 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.767 -1.198 . . . . 2.41 107.767 169.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.28 153.96 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.841 -1.072 . . . . 4.55 110.004 -164.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.8 mtp . . . . . 0 C--O 1.226 -0.174 0 C-N-CA 123.719 0.808 . . . . 5.16 111.578 172.963 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.288 0 N-CA-C 109.455 -1.458 . . . . 3.72 109.455 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.57 71.79 1.53 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.507 1.523 . . . . 3.5 108.044 -165.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.8 148.3 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.855 -1.535 . . . . 4.46 106.855 -173.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -117.76 145.57 44.4 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 123.46 0.704 . . . . 3.79 109.152 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.94 157.45 43.64 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.128 0.971 . . . . 3.81 109.899 -175.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.46 133.58 41.85 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 106.778 -1.564 . . . . 3.35 106.778 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.08 110.76 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.522 -0.918 . . . . 3.04 108.522 173.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.0 m -98.93 137.81 36.95 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.946 -1.131 . . . . 2.88 107.946 172.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.3 -28.19 14.48 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.487 1.042 . . . . 1.58 112.806 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -75.0 122.91 24.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 117.914 0.857 . . . . 3.84 110.537 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 m -138.88 44.31 2.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.162 0.985 . . . . 3.64 109.748 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 11.0 t -165.73 140.8 4.86 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.268 -0.895 . . . . 5.01 112.167 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.66 75.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.027 0.531 . . . . 3.69 111.361 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.4 m -53.55 -45.69 69.95 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.439 -0.788 . . . . 2.99 110.036 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.0 m -64.85 -44.97 88.02 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.188 -0.91 . . . . 3.49 109.493 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 37.2 t -46.32 -60.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 118.772 0.714 . . . . 3.1 110.749 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -56.7 -45.14 81.99 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.686 0.755 . . . . 4.71 110.357 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.72 -50.76 72.57 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.808 0.843 . . . . 2.24 111.166 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.2 mt -54.6 -50.53 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.041 -1.096 . . . . 2.18 108.041 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.77 -44.32 86.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.697 0.799 . . . . 2.66 110.299 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.8 t -56.07 -55.76 28.98 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.829 -0.434 . . . . 2.46 109.829 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -43.15 77.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.274 0.63 . . . . 4.43 112.572 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.39 -58.91 5.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.756 -0.831 . . . . 3.11 108.756 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.8 m -53.09 -23.65 8.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.673 1.189 . . . . 3.06 111.432 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -4.45 8.88 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.028 1.121 . . . . 6.49 114.028 174.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.3 m -84.74 149.73 25.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.055 1.742 . . . . 2.69 109.646 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -67.0 -53.56 30.15 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.89 0.876 . . . . 3.17 112.004 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.94 -21.03 69.12 Favored Glycine 0 CA--C 1.528 0.871 0 O-C-N 122.157 -0.34 . . . . 1.77 113.202 -170.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.75 129.54 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 121.138 -1.213 . . . . 2.87 109.154 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.9 m -103.98 -51.65 3.11 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 119.403 -0.332 . . . . 3.06 111.867 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 123' ' ' LYS . 43.6 p90 -140.0 114.98 9.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.373 0.533 . . . . 3.25 110.014 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.49 149.69 23.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.988 -0.745 . . . . 1.89 108.988 165.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.9 m -139.34 115.61 10.44 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.347 -1.353 . . . . 2.7 107.347 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.16 119.78 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 118.227 0.467 . . . . 3.58 110.358 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -118.78 87.98 2.84 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.817 0.818 . . . . 3.13 109.612 -168.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.65 -32.1 28.12 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 125.724 1.61 . . . . 3.87 112.025 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.62 -36.28 69.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.525 0.73 . . . . 4.07 111.158 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.99 -20.08 15.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.96 1.304 . . . . 3.62 110.439 177.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 78.79 7.05 2.23 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.656 1.583 . . . . 3.08 111.407 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -96.37 148.86 22.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.66 1.584 . . . . 4.79 110.057 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.41 119.29 25.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.281 2.232 . . . . 2.4 107.605 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.88 122.85 40.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.701 -1.962 . . . . 3.94 105.701 174.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.35 133.95 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.4 -0.963 . . . . 3.95 108.4 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.408 ' HG3' ' CE2' ' A' ' 110' ' ' TYR . 4.8 mmmt -116.12 110.4 18.8 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.363 1.065 . . . . 3.58 109.272 177.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.25 176.71 7.2 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 118.498 0.59 . . . . 3.64 111.933 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -96.73 109.05 46.61 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 107.008 -1.479 . . . . 3.96 107.008 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.36 64.36 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.534 2.823 . . . . 3.8 111.07 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.21 -44.88 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.426 1.49 . . . . 4.71 109.321 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -90.88 -29.81 4.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 118.003 0.365 . . . . 3.8 111.254 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.76 164.81 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.225 1.01 . . . . 3.2 108.53 -175.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -149.68 167.05 29.81 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.011 -0.835 . . . . 3.28 111.011 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -60.82 -34.38 91.54 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.243 3.295 . . . . 3.14 111.953 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -54.17 -37.62 64.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.557 0.743 . . . . 8.52 112.062 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.58 -43.46 84.87 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.05 0.452 . . . . 4.33 109.834 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 14.1 mm -56.07 -48.7 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.712 0.805 . . . . 4.22 109.189 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.9 mt -53.46 -57.89 4.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 123.513 0.725 . . . . 4.13 109.382 172.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.0 tttp -49.36 -48.39 46.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 119.264 0.938 . . . . 5.13 112.74 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.6 mt -51.46 -52.71 19.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.055 -0.721 . . . . 5.52 109.055 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.309 2.2 pp -70.62 -29.15 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 118.892 -1.123 . . . . 2.43 114.021 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -58.11 -45.05 87.93 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.356 0.98 . . . . 3.23 109.019 170.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.88 -37.12 85.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.041 0.536 . . . . 3.7 109.558 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.8 mt -66.37 -41.67 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.99 -0.444 . . . . 2.52 110.483 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.68 30.75 6.34 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.337 1.446 . . . . 1.49 111.8 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -101.16 -179.78 4.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.549 1.175 . . . . 3.16 108.771 163.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -133.79 121.13 21.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.938 -1.504 . . . . 5.84 106.938 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.78 115.38 30.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.177 1.391 . . . . 2.49 108.249 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.8 t -135.28 128.32 31.61 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 117.78 -1.105 . . . . 3.9 108.606 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 pp -25.42 109.74 0.03 OUTLIER 'General case' 0 C--N 1.341 0.214 0 C-N-CA 127.626 2.37 . . . . 7.04 109.705 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.85 -37.62 55.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.745 -0.662 . . . . 6.29 110.782 -173.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 C--O 1.245 0.824 0 CA-C-O 116.149 -1.881 . . . . 9.63 111.079 -179.877 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.514 -0.413 0 N-CA-C 110.256 -0.276 . . . . 3.19 110.256 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.408 ' NZ ' ' O ' ' A' ' 149' ' ' GLN . 2.7 ttpt -93.16 136.45 33.4 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.289 -1.004 . . . . 7.32 108.289 -175.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.3 t -125.07 130.25 51.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.029 -1.441 . . . . 3.3 110.534 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -102.3 96.28 6.85 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 126.615 1.966 . . . . 6.39 111.125 -171.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.468 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.3 pt? -128.46 174.49 9.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.307 1.051 . . . . 3.59 112.839 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.09 155.7 42.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.977 -1.49 . . . . 2.02 106.977 169.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.4 mm -98.72 145.16 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.418 -1.327 . . . . 1.69 107.418 171.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -118.86 128.07 54.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.645 -1.613 . . . . 3.92 106.645 162.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.86 -54.12 0.48 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.933 0.777 . . . . 1.32 112.037 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.0 mtt 11.85 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.946 2.498 . . . . 2.83 115.595 -172.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.3 p -62.36 -61.2 2.62 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.697 -0.627 . . . . 4.95 111.104 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.8 t -162.87 48.18 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.984 0.421 . . . . 3.99 110.205 -173.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 55.52 22.18 4.94 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.275 1.03 . . . . 7.69 113.553 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 m -130.71 -38.96 1.27 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.931 0.892 . . . . 4.12 111.732 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 m -64.41 -48.4 75.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 O-C-N 121.427 -0.796 . . . . 3.88 109.228 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 81.8 t -55.39 -39.92 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.006 -0.739 . . . . 2.88 109.006 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 t -58.99 -42.06 89.15 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.971 -0.559 . . . . 3.56 110.856 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -43.33 69.04 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.251 -1.53 . . . . 3.34 111.242 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.3 mt -52.7 -49.61 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.768 1.227 . . . . 2.74 109.375 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -55.23 -38.22 68.19 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.241 -0.912 . . . . 4.21 111.946 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -68.07 -31.84 71.76 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.1 -1.0 . . . . 9.89 110.366 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -65.82 -49.45 68.18 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.69 -0.856 . . . . 1.69 108.69 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -57.04 -37.54 71.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 112.695 0.628 . . . . 2.66 112.695 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -54.78 -18.58 4.93 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.219 -0.926 . . . . 2.81 112.819 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -116.99 23.86 11.6 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.643 0.777 . . . . 3.79 112.271 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -71.98 -69.17 0.41 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.945 0.793 . . . . 2.79 109.632 167.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.2 -118.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.162 0.985 . . . . 2.05 109.568 -171.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.19 -23.76 68.3 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.829 -0.544 . . . . 1.72 113.106 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.2 p -60.1 111.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.914 0.886 . . . . 2.74 111.556 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.17 52.32 1.37 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.068 -1.086 . . . . 3.62 108.068 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.3 t -162.9 152.88 15.97 Favored 'General case' 0 CA--C 1.521 -0.154 0 O-C-N 119.866 -1.772 . . . . 2.2 108.498 156.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.14 74.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 125.365 1.466 . . . . 3.63 108.981 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.88 68.79 1.02 Allowed 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.473 -0.767 . . . . 6.76 109.18 -177.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.99 157.42 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.561 -0.903 . . . . 4.3 108.561 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.71 103.04 8.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.06 -1.459 . . . . 2.48 107.06 170.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.4 mt -67.31 -15.69 63.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.895 0.878 . . . . 4.57 110.962 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 17.2 ttt -76.25 -47.86 22.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.584 1.154 . . . . 5.49 109.885 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.72 -35.83 12.61 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.595 1.158 . . . . 2.34 111.271 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.73 74.85 1.29 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 124.612 1.101 . . . . 1.53 110.627 -174.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -140.58 141.03 35.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.986 -2.227 . . . . 3.97 104.986 165.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.87 101.63 9.22 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 124.036 0.835 . . . . 1.89 108.82 163.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -96.75 133.87 40.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.2 -1.407 . . . . 4.09 107.2 165.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.67 160.33 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.993 -1.854 . . . . 4.21 105.993 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -121.11 105.58 10.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 123.264 0.353 . . . . 5.67 110.587 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -104.13 -177.09 3.27 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 126.81 2.044 . . . . 4.11 112.757 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -122.15 109.12 33.66 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.809 2.044 . . . . 4.72 109.12 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.71 -11.29 23.11 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.756 2.304 . . . . 2.73 114.722 -175.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -95.21 -4.5 45.78 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.885 0.766 . . . . 6.08 110.938 -170.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.5 p -134.29 -37.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.585 1.154 . . . . 4.6 111.184 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.53 153.02 20.71 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 N-CA-C 109.024 -0.732 . . . . 2.54 109.024 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -138.02 152.81 72.73 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.639 1.176 . . . . 3.43 109.86 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.57 -37.14 39.09 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.711 2.274 . . . . 2.11 111.757 -170.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.1 -40.95 95.67 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.8 -0.563 . . . . 4.55 112.085 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -61.88 -44.58 96.51 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.264 0.625 . . . . 3.74 109.984 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -52.3 -54.97 12.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 N-CA-C 106.986 -1.487 . . . . 2.71 106.986 170.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.01 -45.95 71.65 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.948 -0.569 . . . . 2.86 110.255 -172.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -51.06 -51.15 56.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.966 0.906 . . . . 4.94 110.022 175.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -45.16 75.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.318 0.58 . . . . 4.04 110.183 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.82 -37.7 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 O-C-N 121.939 -0.476 . . . . 3.36 110.515 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -66.28 -41.07 90.36 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.382 -0.599 . . . . 3.35 109.382 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.4 -50.8 72.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.866 0.466 . . . . 3.23 109.998 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.0 mt -57.67 -32.46 67.35 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 111.889 0.329 . . . . 2.78 111.889 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.85 35.11 1.9 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.458 1.028 . . . . 1.78 111.445 166.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -132.18 164.05 27.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.054 1.342 . . . . 3.42 109.149 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -102.72 124.83 48.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.867 -1.16 . . . . 2.44 107.867 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.97 122.3 44.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.829 -1.175 . . . . 1.92 107.829 166.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.98 118.59 24.79 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.555 -0.906 . . . . 2.22 108.555 174.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.468 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 7.1 p -69.07 160.3 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 125.169 1.388 . . . . 4.16 110.247 171.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 121.3 0.572 . . . . 7.02 110.15 168.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.054 0 N-CA-C 112.264 -0.334 . . . . 2.4 112.264 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.65 118.14 10.32 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 104.907 -2.257 . . . . 2.77 104.907 174.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.3 mm -131.6 165.82 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.657 0.783 . . . . 3.59 109.062 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -131.1 149.03 52.78 Favored 'General case' 0 N--CA 1.438 -1.056 0 O-C-N 124.51 1.131 . . . . 4.68 111.551 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.51 151.04 38.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.344 1.027 . . . . 3.64 109.221 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.99 132.87 43.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.27 -2.122 . . . . 2.29 105.27 174.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.5 pt -98.62 139.46 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.191 -1.04 . . . . 3.11 108.191 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.4 m -136.64 140.66 42.93 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.219 -1.4 . . . . 2.7 107.219 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.51 -20.62 15.49 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.5 1.048 . . . . 1.18 112.669 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.42 148.78 26.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.494 1.147 . . . . 3.77 112.073 176.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.6 t -134.89 -9.97 2.34 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.586 1.154 . . . . 4.53 112.521 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 35.4 t -160.03 158.35 30.34 Favored 'General case' 0 C--N 1.341 0.237 0 O-C-N 120.952 -1.092 . . . . 3.42 108.598 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.33 -37.26 35.88 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.375 1.07 . . . . 3.34 112.028 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -45.53 -42.13 10.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.732 0.813 . . . . 2.49 111.721 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 81.5 m -62.51 -53.18 58.57 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 109.134 -0.691 . . . . 2.41 109.134 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -45.33 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.648 -0.657 . . . . 3.23 111.65 176.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -62.43 -35.31 78.85 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.696 -0.483 . . . . 4.12 109.696 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -61.63 -60.84 3.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.535 1.134 . . . . 2.7 109.035 176.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -44.4 -57.12 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 123.733 0.813 . . . . 3.1 110.073 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.57 -45.02 93.09 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 120.173 -0.611 . . . . 2.59 109.794 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.9 t -53.74 -57.57 10.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.48 0.712 . . . . 2.32 110.519 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -55.15 -38.06 67.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.446 0.906 . . . . 7.62 113.446 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.1 mt -71.05 -56.7 5.6 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.681 -1.97 . . . . 3.27 105.681 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 53.7 m -50.08 -21.51 1.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.86 2.064 . . . . 2.68 112.499 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -68.22 -24.61 64.95 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.578 0.751 . . . . 6.05 112.97 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.4 m -62.42 170.18 2.53 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.141 0.576 . . . . 2.9 110.707 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -82.59 -49.91 9.34 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.137 -0.977 . . . . 3.3 110.302 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.46 -30.98 66.07 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.444 1.021 . . . . 1.44 112.425 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -49.77 105.35 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.313 0.645 . . . . 3.92 110.843 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 59.8 m -104.39 -31.31 9.58 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.729 0.412 . . . . 2.91 110.522 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.26 114.07 8.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.345 -1.724 . . . . 4.52 106.345 -175.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -117.85 157.33 26.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.076 -1.453 . . . . 2.08 107.076 155.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.0 t -141.98 136.48 30.37 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.904 -1.517 . . . . 2.69 106.904 166.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.2 133.83 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 123.841 0.857 . . . . 3.33 110.052 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -132.34 116.06 16.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.681 1.192 . . . . 2.01 110.256 -170.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.4 mt -75.43 -46.82 30.4 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 127.251 2.22 . . . . 4.02 110.859 -172.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.59 -35.44 4.01 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.581 1.552 . . . . 2.55 111.705 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.92 -4.37 13.28 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.548 1.939 . . . . 2.37 111.281 -177.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 63.6 m 52.73 31.85 11.09 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.054 1.342 . . . . 2.55 112.508 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -108.2 151.0 26.52 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.484 0.713 . . . . 5.7 110.509 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.86 116.84 10.47 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.269 1.028 . . . . 1.74 108.599 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mp -102.03 128.79 48.33 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 126.607 1.963 . . . . 3.76 106.451 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.82 131.75 50.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.309 -0.626 . . . . 3.87 109.309 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -113.33 83.94 1.92 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.717 0.807 . . . . 4.93 110.651 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -113.97 171.94 7.29 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.65 1.58 . . . . 3.01 109.317 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -96.33 117.75 65.93 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 108.93 -0.767 . . . . 3.13 108.93 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.7 70.85 6.77 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.287 2.658 . . . . 2.04 111.013 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -164.29 -44.95 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.082 1.353 . . . . 4.11 109.709 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 25.7 pt -76.83 -38.73 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 123.377 0.671 . . . . 3.04 110.364 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.18 156.09 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.998 1.319 . . . . 3.26 108.127 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -121.82 158.66 16.52 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.048 -1.221 . . . . 2.49 110.048 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -62.52 -43.39 22.21 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.801 2.334 . . . . 2.16 110.056 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -54.21 -37.68 64.83 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 122.759 0.424 . . . . 6.11 111.907 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.79 -44.19 70.6 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.752 -1.203 . . . . 4.84 107.752 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.51 -48.99 86.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 108.604 -0.887 . . . . 2.55 108.604 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 64.2 mt -50.26 -58.75 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 124.237 1.015 . . . . 2.9 108.958 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -53.09 -45.76 68.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.032 -1.043 . . . . 6.11 112.488 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.2 mm -56.29 -46.08 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 109.965 -0.383 . . . . 4.04 109.965 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 27.4 pt -72.35 -34.77 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 121.112 -0.993 . . . . 2.43 113.109 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -56.05 -36.86 68.51 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.171 0.896 . . . . 2.64 109.279 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.25 -25.52 68.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.061 -0.518 . . . . 3.63 110.057 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.3 mt -86.89 -39.26 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.155 0.582 . . . . 2.46 109.708 172.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.33 27.42 5.3 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.129 1.347 . . . . 1.93 111.342 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -99.28 170.35 8.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.299 1.049 . . . . 3.13 108.954 165.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -135.53 144.87 46.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.835 -1.172 . . . . 6.74 107.835 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.4 103.08 7.99 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.136 1.775 . . . . 2.11 109.31 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.45 112.66 19.25 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.656 0.782 . . . . 3.12 109.932 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -17.71 106.68 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.983 2.513 . . . . 5.08 113.191 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.52 -40.22 23.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.94 -0.573 . . . . 4.33 110.403 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.408 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 14.9 mt-30 . . . . . 0 C--O 1.256 1.441 0 CA-C-O 115.403 -2.236 . . . . 6.92 116.994 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 . . . . . 0 C--O 1.223 -0.32 0 N-CA-C 107.487 -1.301 . . . . 3.95 107.487 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -92.37 159.17 15.7 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.506 1.522 . . . . 6.16 107.348 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 30.8 p -152.14 145.97 25.13 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 118.426 0.557 . . . . 4.05 111.3 166.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.96 102.49 11.49 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.273 1.029 . . . . 5.6 109.001 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.58 168.83 8.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.069 0.938 . . . . 3.75 111.113 172.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.12 156.31 33.9 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.549 -1.278 . . . . 1.98 107.549 167.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.3 mm -99.13 141.06 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 107.608 -1.256 . . . . 2.29 107.608 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -119.55 121.78 40.14 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.236 -1.765 . . . . 3.62 106.236 160.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.57 -83.68 0.15 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.644 1.116 . . . . 1.32 110.396 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.5 mmt 54.07 71.58 0.51 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.708 1.603 . . . . 2.62 113.6 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -55.26 -61.95 1.99 Allowed 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.616 -0.677 . . . . 2.81 112.374 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.0 t -168.59 64.57 0.06 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.757 0.708 . . . . 3.55 110.034 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 38.86 44.65 0.86 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.452 1.501 . . . . 6.59 112.912 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.5 t -160.81 -41.8 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.054 0.542 . . . . 3.46 110.528 -166.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -61.78 -40.3 94.71 Favored 'General case' 0 CA--C 1.527 0.08 0 O-C-N 120.889 -1.132 . . . . 2.9 109.833 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.44 -32.48 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 121.871 -0.518 . . . . 2.52 110.456 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 m -66.85 -37.56 84.7 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.102 -0.639 . . . . 2.71 111.428 176.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.262 0.3 OUTLIER -71.9 -35.14 69.64 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.556 -1.34 . . . . 3.63 112.146 171.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 mt -48.15 -51.41 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.712 -0.617 . . . . 3.2 110.965 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -34.37 -55.13 0.53 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.083 0.953 . . . . 4.35 110.907 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -68.8 -30.46 69.04 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.0 1.32 . . . . 9.26 110.285 -170.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -65.48 -57.94 7.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.513 -0.921 . . . . 2.12 108.513 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.83 -38.8 79.48 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.568 -0.16 . . . . 2.75 110.568 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -49.57 -26.64 3.68 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.949 0.9 . . . . 2.65 112.53 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -123.29 22.55 9.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.176 -0.916 . . . . 5.21 112.858 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -61.93 -68.88 0.28 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.433 1.015 . . . . 3.24 110.756 165.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.8 -130.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.938 0.495 . . . . 2.0 109.828 -163.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.07 -13.26 72.68 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 118.791 0.723 . . . . 1.41 112.959 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.95 127.16 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 118.417 1.108 . . . . 2.21 110.635 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 pp -142.69 51.81 1.43 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.41 0.624 . . . . 3.53 111.032 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 t -156.66 151.61 26.09 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.015 -0.735 . . . . 2.41 109.015 164.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.83 69.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.553 1.541 . . . . 3.71 108.583 -171.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tt -98.05 74.17 2.26 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.14 -1.059 . . . . 3.36 108.14 -173.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.7 t -104.81 136.95 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.849 -0.614 . . . . 3.24 109.435 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -113.74 98.84 7.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.56 -0.904 . . . . 2.46 108.56 173.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.5 -17.49 45.65 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.585 0.754 . . . . 4.08 112.607 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 6.1 mtm -70.05 -55.95 8.2 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.137 0.494 . . . . 5.2 109.781 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.89 -24.88 22.39 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.398 0.679 . . . . 1.95 111.429 -175.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.93 68.32 1.54 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.185 -1.166 . . . . 1.22 110.185 -174.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.24 139.46 41.02 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.574 -2.009 . . . . 3.69 105.574 171.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.91 101.48 9.53 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 124.641 1.213 . . . . 1.76 111.878 169.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -97.97 136.0 38.87 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.799 -1.185 . . . . 5.14 107.799 169.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 pt -141.51 168.57 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.88 -0.785 . . . . 2.61 108.88 171.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -120.6 97.96 5.81 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 119.072 -0.489 . . . . 4.35 110.151 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -102.27 178.97 4.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 124.611 1.194 . . . . 3.32 112.156 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -123.38 104.53 34.42 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 127.96 2.504 . . . . 4.35 110.056 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.66 26.95 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 124.336 3.357 . . . . 2.09 112.717 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -106.1 -20.83 13.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.959 1.303 . . . . 3.19 110.76 165.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 87.9 t -117.6 -72.06 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 N-CA-C 108.246 -1.02 . . . . 3.79 108.246 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.12 140.62 15.5 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.079 0 N-CA-C 108.853 -0.795 . . . . 2.13 108.853 176.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -121.38 153.05 58.61 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.358 1.063 . . . . 2.77 108.421 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.46 -39.57 87.95 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.897 2.398 . . . . 1.28 112.739 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.23 -42.55 98.8 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.491 -0.755 . . . . 3.74 111.477 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -62.07 -39.99 94.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.027 0.531 . . . . 3.7 110.544 175.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.44 -51.04 45.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.359 -1.349 . . . . 2.09 107.359 171.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.37 -39.68 70.4 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 119.238 -0.411 . . . . 2.09 111.152 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -57.64 -47.82 81.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.101 0.864 . . . . 2.49 110.394 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -46.15 82.66 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.053 0.454 . . . . 4.11 110.44 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -67.9 -45.39 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.483 -0.761 . . . . 3.4 111.23 -175.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -33.38 72.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.852 -0.594 . . . . 2.35 110.877 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.96 -50.24 72.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.905 0.775 . . . . 2.18 110.225 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.81 -28.73 67.01 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 118.087 -1.445 . . . . 5.03 111.195 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.55 31.42 2.16 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.178 -0.769 . . . . 1.28 111.178 171.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -109.25 168.36 9.44 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.282 -0.636 . . . . 3.38 109.282 169.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -107.64 129.66 54.98 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.794 -0.817 . . . . 2.57 108.794 168.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.93 123.27 48.7 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.615 0.766 . . . . 1.77 109.074 166.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.81 162.48 31.9 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.891 1.277 . . . . 2.07 107.658 166.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 m -75.9 151.73 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 108.701 -0.851 . . . . 3.97 108.701 -171.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 108.844 -0.799 . . . . 5.2 108.844 171.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.826 0 N-CA-C 111.64 -0.584 . . . . 2.39 111.64 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.75 84.47 2.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.619 1.167 . . . . 3.01 109.082 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -102.52 157.71 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 108.803 -0.814 . . . . 3.75 108.803 -175.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.49 157.1 44.39 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.555 -0.716 . . . . 3.63 111.287 175.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 mt -144.14 155.99 44.15 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.049 0.94 . . . . 3.32 109.845 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.11 122.74 41.62 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 106.659 -1.608 . . . . 2.41 106.659 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.3 pt -97.93 111.65 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-O 122.015 0.912 . . . . 2.96 109.321 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 m -103.72 145.06 30.63 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.496 1.118 . . . . 2.38 108.702 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.29 -33.84 5.87 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.292 0.948 . . . . 1.24 111.436 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.7 151.93 36.96 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.398 0.599 . . . . 3.6 110.948 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 t -163.39 33.83 0.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.597 0.359 . . . . 3.62 111.103 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.0 p -162.15 145.1 11.61 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.381 -0.824 . . . . 4.55 111.658 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.0 -34.92 70.52 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.573 1.149 . . . . 3.53 111.334 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 t -54.2 -50.06 67.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.642 0.377 . . . . 2.75 110.046 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 55.6 m -68.14 -45.96 72.13 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.961 -0.462 . . . . 2.81 110.125 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.4 t -48.75 -57.18 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.937 1.695 . . . . 2.55 109.921 172.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -59.0 -43.96 91.58 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.686 -0.634 . . . . 4.54 111.017 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -60.78 -42.88 98.41 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.347 0.659 . . . . 1.76 110.876 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.0 mt -57.28 -50.41 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 108.321 -0.992 . . . . 1.94 108.321 174.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -53.51 -43.67 68.48 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.029 -0.51 . . . . 2.67 110.425 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.4 t -57.96 -50.4 73.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.544 0.738 . . . . 2.28 111.305 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -37.35 78.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.25 -0.906 . . . . 3.25 110.933 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.4 mt -70.59 -51.34 28.91 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.837 -0.801 . . . . 2.85 108.837 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.6 p -60.05 -17.07 36.53 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.936 0.717 . . . . 2.39 112.936 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -59.82 -33.91 72.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 119.298 -0.961 . . . . 5.7 112.338 168.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.8 m -73.34 142.51 47.07 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.706 0.803 . . . . 2.46 111.162 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -66.0 -42.38 89.83 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.361 0.874 . . . . 3.08 113.361 -173.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.29 -39.29 27.03 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.127 -1.189 . . . . 1.12 110.127 -170.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.33 126.36 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.975 -0.75 . . . . 4.83 108.975 168.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.1 t -124.41 -26.3 3.93 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.676 0.791 . . . . 4.43 111.585 165.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.62 93.97 3.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.694 -1.965 . . . . 3.44 105.694 -172.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.98 151.45 21.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.219 -1.401 . . . . 1.84 107.219 158.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.7 t -142.23 110.83 6.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.213 -1.773 . . . . 2.55 106.213 167.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.4 m -104.89 147.64 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 118.048 0.385 . . . . 3.67 110.774 176.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.73 102.31 4.7 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.305 0.574 . . . . 2.5 110.395 -174.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 pp -61.94 -19.12 62.4 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.345 0.868 . . . . 3.43 113.345 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.14 -40.75 64.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.908 -0.775 . . . . 2.71 108.908 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.1 p -90.14 -25.35 20.74 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.004 0.921 . . . . 3.65 110.344 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 p 77.9 9.68 2.27 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 128.257 2.623 . . . . 3.36 112.894 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -99.71 151.18 21.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.163 0.982 . . . . 4.3 111.767 174.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -117.25 117.48 29.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.855 2.462 . . . . 1.89 107.0 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.5 mp -99.83 131.23 45.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.547 -1.279 . . . . 4.11 107.547 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 83.0 t -140.78 128.94 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.378 1.071 . . . . 3.24 109.682 -170.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -116.45 93.03 4.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.951 -0.759 . . . . 4.39 108.951 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -113.98 169.48 8.97 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.654 1.182 . . . . 2.97 109.777 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -105.28 115.6 61.83 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.289 1.036 . . . . 3.68 109.708 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.86 65.17 7.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.856 3.037 . . . . 1.89 112.83 -170.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -143.29 -51.14 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.671 1.588 . . . . 3.58 108.219 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -34.48 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 122.96 0.504 . . . . 3.77 111.096 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.5 tp -145.79 168.49 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.078 -0.712 . . . . 3.31 109.078 -174.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.96 169.86 31.33 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.181 -1.168 . . . . 1.55 110.181 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -61.22 -35.31 85.88 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.278 2.652 . . . . 1.64 110.801 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -51.93 -39.68 59.56 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 112.458 0.54 . . . . 7.82 112.458 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.05 -44.45 84.54 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.209 -0.663 . . . . 3.17 109.209 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.97 -55.95 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.24 -0.652 . . . . 2.33 109.24 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 pt -54.61 -57.1 7.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-O 118.003 -0.998 . . . . 3.99 109.334 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -47.77 -50.59 25.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.125 1.33 . . . . 5.01 112.839 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.4 mm -52.91 -54.7 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.423 -0.584 . . . . 3.06 109.423 175.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.287 2.6 pp -71.49 -25.0 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 119.077 -1.049 . . . . 2.38 113.538 -176.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -63.86 -32.06 73.45 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.327 1.051 . . . . 3.03 110.32 169.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -62.17 -39.24 92.02 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.214 -0.661 . . . . 2.98 109.214 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.2 mt -66.78 -42.01 88.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.409 -0.589 . . . . 2.43 109.409 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.91 22.61 5.6 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.874 1.702 . . . . 1.48 111.511 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -99.06 -178.71 4.02 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.52 -1.289 . . . . 3.51 107.52 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -140.6 135.65 31.98 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.157 -1.053 . . . . 4.36 108.157 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -122.87 96.67 5.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.236 1.014 . . . . 2.28 109.765 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.1 p -123.43 127.21 48.1 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.425 0.69 . . . . 2.79 110.918 -173.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -14.92 113.13 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.109 2.564 . . . . 4.97 115.086 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -107.29 48.61 0.83 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.698 0.999 . . . . 5.03 113.698 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 . . . . . 0 C--O 1.254 1.319 0 CA-C-O 117.798 -1.096 . . . . 6.72 112.366 177.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 109.393 -0.595 . . . . 4.17 109.393 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -110.3 154.75 23.03 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.409 0.684 . . . . 4.64 110.58 165.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.9 t -125.78 130.18 50.93 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.142 0.977 . . . . 3.22 109.424 170.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.52 106.37 16.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 128.388 2.675 . . . . 4.46 110.027 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 -179.19 5.4 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.458 -0.776 . . . . 4.65 110.617 173.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.16 161.58 28.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.49 -1.3 . . . . 3.08 107.49 173.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mm -97.16 134.84 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.878 -1.897 . . . . 2.19 105.878 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -117.58 67.83 0.75 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.537 -1.283 . . . . 4.51 107.537 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.4 -69.4 0.06 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.152 -0.779 . . . . 1.46 111.152 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.08 93.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.521 2.328 . . . . 2.94 116.883 176.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.44 -22.7 21.6 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.387 1.075 . . . . 3.22 113.589 170.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 89.5 m 75.57 -62.9 0.43 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.938 1.695 . . . . 6.55 110.078 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.98 -75.29 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.495 2.318 . . . . 5.04 112.925 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.3 p -160.02 14.28 0.13 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.432 0.901 . . . . 2.99 113.432 169.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.92 -45.05 64.93 Favored 'General case' 0 N--CA 1.462 0.126 0 O-C-N 121.239 -0.913 . . . . 3.33 110.071 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -53.67 -47.13 61.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.418 -0.956 . . . . 2.48 108.418 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.02 -41.53 64.79 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.353 0.661 . . . . 2.17 112.073 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -67.41 -49.27 64.53 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.969 -0.382 . . . . 2.72 109.969 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.3 mt -48.96 -45.32 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.963 0.905 . . . . 2.65 110.586 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -44.62 -57.38 3.68 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.042 0.837 . . . . 4.7 111.194 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -61.6 -39.17 90.27 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.154 0.982 . . . . 5.84 110.208 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -62.65 -57.38 11.24 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.963 -0.755 . . . . 1.35 108.963 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.12 -31.42 72.61 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.036 -0.415 . . . . 4.42 111.009 -175.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.58 -35.01 3.68 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.445 0.566 . . . . 1.9 112.257 168.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -110.2 24.19 13.33 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.377 0.671 . . . . 5.07 112.135 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.34 -72.24 0.17 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.034 0.534 . . . . 3.55 109.596 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.38 -120.88 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.418 0.687 . . . . 2.24 109.998 -172.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.17 -11.23 63.67 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.782 0.719 . . . . 1.63 113.183 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -75.46 122.56 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.691 -0.888 . . . . 2.48 109.464 173.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.21 49.35 1.93 Allowed 'General case' 0 C--N 1.34 0.164 0 CA-C-O 120.786 0.327 . . . . 3.53 110.577 173.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.6 m -150.53 156.11 40.78 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.291 -1.003 . . . . 3.57 108.291 165.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.0 p -140.29 117.01 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 107.37 -1.345 . . . . 4.01 107.37 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -140.44 79.59 1.71 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 108.172 -1.047 . . . . 3.7 108.172 172.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.1 t -99.4 136.58 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.135 -0.939 . . . . 3.18 108.551 169.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.88 96.58 6.25 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.608 -1.256 . . . . 2.47 107.608 167.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.66 -21.04 24.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.906 0.882 . . . . 3.68 111.669 175.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -59.0 5.12 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.793 1.237 . . . . 3.77 109.547 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.22 20.3 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.99 0.916 . . . . 2.63 111.102 -172.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.71 63.96 1.86 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.154 -1.178 . . . . 1.34 110.154 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.77 137.36 41.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.253 -2.128 . . . . 3.46 105.253 169.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.85 104.51 11.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.784 1.302 . . . . 1.91 109.61 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -111.74 144.65 40.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.244 0.545 . . . . 4.03 109.719 167.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.08 178.78 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 124.444 1.097 . . . . 2.81 109.147 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.74 94.92 4.33 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.033 0.933 . . . . 10.08 110.213 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -99.99 169.51 9.14 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.414 2.285 . . . . 3.89 113.476 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.93 97.43 41.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.849 1.66 . . . . 3.09 108.858 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -53.22 -21.31 16.72 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.663 3.576 . . . . 3.02 114.817 -171.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -77.98 -25.52 48.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.5 1.52 . . . . 4.51 111.285 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 p -121.34 -31.19 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 123.988 0.915 . . . . 4.44 112.522 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.11 135.32 63.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 123.601 0.76 . . . . 2.42 109.189 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -120.46 154.83 56.81 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.505 1.122 . . . . 3.16 111.84 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.23 -30.19 92.35 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.152 1.901 . . . . 1.87 111.607 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -42.25 94.15 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.797 0.726 . . . . 4.92 111.705 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -71.17 -41.08 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.686 0.794 . . . . 3.63 110.745 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.8 -42.34 42.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 108.255 -1.017 . . . . 2.17 108.255 170.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.23 86.59 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.519 -0.764 . . . . 2.41 111.172 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -59.93 -52.96 63.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.278 -0.889 . . . . 3.11 109.655 171.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -54.86 19.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.94 0.4 . . . . 3.91 110.846 -177.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.05 -44.26 98.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.503 0.557 . . . . 5.12 112.503 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.64 -39.35 84.06 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.587 1.085 . . . . 2.49 110.226 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.37 -47.75 72.38 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.648 0.779 . . . . 2.58 109.636 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.7 mt -53.81 -33.07 54.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.184 0.594 . . . . 2.6 111.452 170.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.58 33.09 2.97 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.262 -1.135 . . . . 1.31 110.262 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -124.67 149.56 47.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.763 -1.569 . . . . 3.17 106.763 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.81 129.66 44.2 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.017 -1.475 . . . . 3.22 107.017 170.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.77 120.19 36.63 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.63 -1.619 . . . . 1.89 106.63 175.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.89 128.28 34.28 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.424 -1.262 . . . . 2.01 107.923 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.4 t -49.29 151.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.012 1.325 . . . . 3.99 108.832 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 110.283 -0.266 . . . . 4.25 110.283 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.688 0 N-CA-C 106.757 -2.537 . . . . 2.57 106.757 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -104.23 126.13 51.08 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.719 1.208 . . . . 4.01 109.366 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.71 149.72 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 C-N-CA 124.297 1.039 . . . . 3.24 108.253 175.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -125.37 146.51 49.56 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.35 1.06 . . . . 3.67 110.536 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.46 149.63 39.48 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.269 1.027 . . . . 3.54 108.744 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.32 132.2 42.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.404 -1.702 . . . . 2.57 106.404 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 pp -106.59 113.39 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 O-C-N 123.909 0.756 . . . . 2.64 110.727 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.5 m -104.43 139.33 39.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.177 0.991 . . . . 3.0 108.794 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.1 -27.8 11.3 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.995 1.283 . . . . 1.24 111.984 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 5.3 tmm? -63.8 131.65 48.48 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.845 0.858 . . . . 3.57 109.901 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 m -144.77 34.9 1.14 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.588 1.155 . . . . 3.34 109.331 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 43.3 t -165.82 129.61 2.2 Favored 'General case' 0 C--N 1.341 0.239 0 O-C-N 120.854 -1.154 . . . . 3.29 111.908 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.43 -35.89 63.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.542 0.737 . . . . 3.46 111.785 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 t -53.73 -46.94 70.99 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.134 0.492 . . . . 2.63 110.257 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 35.1 m -62.58 -46.24 89.23 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.112 -0.699 . . . . 2.96 109.112 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.5 t -52.79 -53.03 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.098 0.408 . . . . 2.59 110.783 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -56.85 -44.88 82.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.158 0.504 . . . . 3.86 110.746 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -60.74 -47.68 85.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.891 0.476 . . . . 1.97 110.639 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.3 mt -55.83 -52.64 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.746 -0.835 . . . . 1.96 108.746 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -56.24 -42.06 76.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.837 0.855 . . . . 3.18 110.134 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.2 t -57.94 -55.51 33.96 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.923 0.329 . . . . 2.38 110.815 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -50.82 64.7 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.666 -0.646 . . . . 3.33 110.999 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.8 mt -55.82 -58.0 9.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 119.22 -0.419 . . . . 3.04 110.051 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.8 m -53.67 -25.17 16.92 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.61 1.164 . . . . 2.39 111.549 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -62.39 -28.29 69.67 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.881 -0.512 . . . . 7.45 111.348 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.3 m -68.08 118.31 11.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.448 1.499 . . . . 2.47 111.225 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -33.05 -55.82 0.39 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.637 1.975 . . . . 2.96 114.033 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.55 -29.14 60.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 119.513 -0.604 . . . . 1.72 113.354 -171.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.1 127.94 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.522 -1.288 . . . . 4.31 107.522 -174.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 36.9 p -99.16 -51.4 3.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 118.303 0.501 . . . . 4.4 110.437 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -131.95 128.66 38.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.322 -0.992 . . . . 3.81 108.322 169.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.99 128.26 53.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.879 -1.156 . . . . 1.87 107.879 165.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.2 m -115.45 112.32 22.1 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 117.707 -1.14 . . . . 2.8 109.498 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 t -114.47 131.55 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 120.325 1.421 . . . . 3.52 112.651 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -125.67 106.44 9.73 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.489 1.115 . . . . 2.11 111.226 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -22.92 59.5 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 125.172 1.389 . . . . 3.29 113.266 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.73 80.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.149 0.5 . . . . 2.21 110.073 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.22 -34.82 10.19 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.243 1.417 . . . . 2.32 110.402 177.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.4 m 79.78 38.55 0.11 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.407 1.883 . . . . 2.47 110.875 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.9 144.05 46.64 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 123.539 0.736 . . . . 3.77 109.436 173.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.18 120.65 29.28 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.249 2.62 . . . . 1.99 107.679 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.8 mp -115.07 104.43 11.87 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.623 1.569 . . . . 3.44 110.254 -170.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.3 m -103.82 135.86 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.6 1.16 . . . . 3.36 111.114 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.71 104.52 11.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.858 -1.164 . . . . 5.77 107.858 174.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -123.25 176.47 6.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.667 1.587 . . . . 3.93 112.258 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -98.7 113.55 64.49 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 108.49 -0.93 . . . . 3.18 108.49 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.31 71.52 6.72 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.772 2.981 . . . . 2.03 111.346 -167.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -168.59 -48.43 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.318 1.047 . . . . 4.48 109.337 -173.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.6 pt -83.75 -33.05 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.819 0.847 . . . . 3.01 110.917 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.92 160.59 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.318 1.047 . . . . 2.3 109.144 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.87 169.63 23.81 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.623 1.106 . . . . 1.73 110.45 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.97 -40.44 11.93 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.233 2.622 . . . . 2.04 111.092 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -51.32 -37.21 46.51 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.359 0.664 . . . . 7.18 112.396 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.77 -45.37 78.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.619 -0.882 . . . . 4.27 108.619 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 64.2 mt -60.73 -46.65 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 108.644 -0.872 . . . . 2.39 108.644 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 77.2 mt -51.2 -58.46 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 118.363 -0.827 . . . . 3.23 108.972 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -48.53 -50.25 32.75 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.568 1.076 . . . . 5.46 110.606 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.5 mm -55.6 -50.02 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 109.85 -0.426 . . . . 2.81 109.85 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.283 2.5 pp -70.11 -28.52 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 119.197 -1.001 . . . . 2.68 113.615 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -63.71 -42.26 97.98 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.566 1.076 . . . . 2.29 109.896 170.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -60.0 -39.24 85.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.79 0.836 . . . . 3.36 109.16 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.2 mt -71.01 -39.0 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 O-C-N 122.259 -0.275 . . . . 2.24 110.941 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.03 29.48 8.0 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.499 1.523 . . . . 0.96 112.096 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -99.65 177.11 5.25 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.689 1.245 . . . . 3.67 109.443 165.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -130.78 120.14 23.32 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.045 -1.465 . . . . 5.69 107.045 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.06 113.31 26.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.502 1.521 . . . . 2.3 108.654 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.8 m -123.13 114.23 20.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.101 0.41 . . . . 2.58 111.028 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.6 mt -28.29 114.58 0.08 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 128.222 2.609 . . . . 5.0 111.923 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.86 23.9 5.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.442 0.697 . . . . 4.16 112.68 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.456 -1.259 . . . . 6.08 110.78 168.687 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--O 1.223 -0.322 0 N-CA-C 109.786 -0.45 . . . . 4.94 109.786 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.12 148.9 23.08 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.424 1.09 . . . . 4.67 108.356 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.1 t -135.89 134.77 39.12 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.784 -1.191 . . . . 2.84 107.784 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -103.65 98.01 7.95 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 124.244 0.965 . . . . 4.96 109.02 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.414 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 2.6 pt? -121.67 169.73 10.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.957 0.884 . . . . 3.16 111.364 172.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.02 142.67 49.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.24 -1.022 . . . . 2.27 108.24 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.4 mm -98.18 146.92 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.674 -1.232 . . . . 1.66 107.674 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 68' ' ' GLU . 20.8 mtmt -128.2 96.74 4.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.565 -1.643 . . . . 4.64 106.565 171.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.14 -70.98 0.09 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.952 -1.259 . . . . 1.75 109.952 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 ptm 29.03 70.47 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.48 2.312 . . . . 3.87 116.053 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.69 -14.32 2.17 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.764 1.626 . . . . 3.47 114.16 175.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t 71.66 -63.49 0.42 Allowed 'General case' 0 C--N 1.339 0.128 0 C-N-CA 126.372 1.869 . . . . 3.08 111.373 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -16.17 -73.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 128.177 2.591 . . . . 7.47 113.224 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -157.5 24.11 0.29 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.856 0.862 . . . . 4.33 110.654 159.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.0 m -71.01 -52.98 16.44 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.296 -0.877 . . . . 2.66 109.178 -170.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.7 t -50.24 -46.83 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.019 -0.734 . . . . 2.96 109.019 173.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 t -54.91 -51.9 64.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.46 0.704 . . . . 3.94 110.875 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -40.53 80.19 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 121.331 -0.856 . . . . 2.78 110.386 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mt -55.93 -50.71 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.781 1.232 . . . . 2.61 109.548 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -52.22 -44.44 64.79 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.63 0.65 . . . . 4.19 111.27 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -69.22 -40.46 77.94 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.748 -1.22 . . . . 6.81 111.588 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -61.7 -53.75 51.84 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 122.116 -0.365 . . . . 1.39 110.043 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.54 -39.01 70.03 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.677 0.791 . . . . 4.0 110.361 175.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.17 -23.97 9.66 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.212 0.915 . . . . 2.09 112.902 173.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -106.12 21.13 17.86 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.108 0.963 . . . . 4.63 112.491 176.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -70.34 -72.64 0.19 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.802 -0.814 . . . . 3.56 108.802 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.42 -105.08 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.839 1.256 . . . . 2.88 107.859 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.83 25.33 24.05 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.241 -1.31 . . . . 2.4 113.352 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.5 p -96.0 120.74 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 119.373 1.587 . . . . 2.85 109.308 168.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 mp -139.54 53.72 1.7 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 108.96 -0.756 . . . . 4.08 108.96 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 t -161.64 156.51 23.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.869 -1.9 . . . . 3.66 105.869 165.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.29 110.05 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 106.7 -1.593 . . . . 3.84 106.7 175.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -128.98 76.87 1.75 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.822 -1.177 . . . . 4.16 107.822 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 t -97.84 127.09 50.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 109.541 -0.54 . . . . 3.26 109.541 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.84 88.24 3.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.93 -1.137 . . . . 3.22 107.93 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.5 tp -53.33 -22.98 8.14 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.029 1.332 . . . . 4.56 110.805 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -35.04 68.77 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.388 0.675 . . . . 6.33 111.285 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.49 -39.44 4.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.955 0.902 . . . . 3.52 110.926 -172.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.99 63.41 0.81 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 125.916 1.722 . . . . 1.82 110.47 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -142.35 136.68 29.89 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.127 -1.805 . . . . 5.01 106.127 172.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.43 95.02 4.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.434 1.084 . . . . 2.49 109.272 172.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -101.51 137.43 39.84 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.805 -1.554 . . . . 5.74 106.805 171.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.77 -178.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 107.316 -1.365 . . . . 4.0 107.316 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.58 106.2 6.88 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.753 -1.203 . . . . 6.6 107.753 176.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -117.41 176.23 5.25 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 124.762 1.289 . . . . 4.49 114.459 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -113.37 107.3 53.67 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.895 1.278 . . . . 3.87 111.348 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.48 -11.37 31.33 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.991 2.461 . . . . 3.52 112.929 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.37 -21.33 64.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 120.203 1.365 . . . . 4.18 111.228 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -128.59 -46.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.44 0.696 . . . . 5.06 110.403 -169.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.37 147.61 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 121.913 0.863 . . . . 3.56 109.43 174.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -128.04 150.07 72.7 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 125.69 1.596 . . . . 3.66 108.776 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -58.42 -29.8 89.49 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.261 2.641 . . . . 2.38 111.596 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -49.55 77.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.245 1.418 . . . . 3.34 109.718 172.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -68.11 -38.55 82.39 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.933 -0.479 . . . . 3.03 109.726 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -46.25 89.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 107.486 -1.302 . . . . 2.43 107.486 172.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.48 -44.52 95.84 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 122.973 0.509 . . . . 2.27 110.397 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -60.1 -51.25 70.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.661 -0.649 . . . . 3.32 110.94 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.11 -48.43 73.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.612 0.642 . . . . 5.07 112.176 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.07 -39.63 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 121.261 -0.9 . . . . 5.45 111.658 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.5 -34.9 79.35 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.518 0.599 . . . . 3.42 110.511 177.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.18 -52.02 65.48 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.459 -0.571 . . . . 2.83 109.459 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.6 mt -58.45 -29.95 66.55 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.828 0.307 . . . . 3.02 111.828 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.36 31.54 3.73 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 124.512 1.053 . . . . 1.6 111.336 167.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.59 161.48 19.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.63 1.572 . . . . 3.18 108.405 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' A' ' 11' ' ' LYS . 52.7 mt-10 -98.45 134.58 41.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.77 -1.567 . . . . 2.2 106.77 163.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.49 127.23 46.14 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.919 -1.882 . . . . 1.94 105.919 169.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.48 123.98 23.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.201 -1.037 . . . . 2.13 108.201 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.414 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.5 t -71.1 145.26 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.057 -1.09 . . . . 4.04 108.057 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.4 mtt . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 109.04 -0.726 . . . . 5.21 109.04 173.336 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.341 0 N-CA-C 109.597 -1.401 . . . . 3.66 109.597 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.33 104.63 17.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.594 -1.632 . . . . 2.84 106.594 -176.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.94 157.72 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 106.94 -1.504 . . . . 4.21 106.94 172.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -123.06 160.7 25.81 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.947 -1.024 . . . . 3.91 110.176 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 pp -143.78 159.92 41.66 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.638 -1.164 . . . . 4.4 110.229 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.8 m -109.36 131.67 54.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.374 1.87 . . . . 3.4 107.943 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.53 98.08 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.733 1.613 . . . . 2.89 110.706 -170.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.3 m -95.53 112.52 24.23 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.877 -0.786 . . . . 2.75 108.877 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 135.3 -22.98 3.5 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.486 1.041 . . . . 1.42 111.921 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.1 ttp -70.74 133.59 46.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.021 -0.693 . . . . 3.56 111.719 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.2 m -151.53 39.44 0.65 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.844 0.858 . . . . 3.96 110.239 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.5 t -167.96 138.94 2.82 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.963 -1.086 . . . . 3.1 110.71 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.7 67.2 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.474 0.654 . . . . 3.54 111.856 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.9 m -53.47 -43.93 68.54 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.256 -0.902 . . . . 3.1 110.275 170.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.0 m -64.4 -42.24 96.21 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.888 0.475 . . . . 2.17 109.849 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.7 t -52.23 -55.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.721 0.808 . . . . 2.22 108.826 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.7 m170 -61.66 -36.6 81.29 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 109.737 -0.468 . . . . 4.56 109.737 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -59.01 -60.71 3.44 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.959 -0.756 . . . . 2.63 108.959 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.6 mt -49.59 -49.2 19.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 C-N-CA 124.472 1.109 . . . . 2.41 110.051 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -54.38 -52.93 60.13 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.222 1.009 . . . . 2.47 109.786 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.0 m -66.85 -25.16 66.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.431 0.692 . . . . 2.91 112.186 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -46.87 49.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 120.865 -1.147 . . . . 3.94 111.816 170.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.58 -45.8 64.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.272 0.942 . . . . 4.72 108.888 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.0 p -60.43 -12.45 9.52 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.702 0.63 . . . . 2.28 112.702 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -53.57 -34.29 57.8 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.634 -0.666 . . . . 4.92 111.349 167.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.4 p -78.44 164.88 24.39 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 118.936 0.789 . . . . 3.45 110.907 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -82.89 -44.87 14.9 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.887 0.875 . . . . 2.98 111.188 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.01 -36.58 64.47 Favored Glycine 0 C--N 1.335 0.523 0 O-C-N 122.236 -0.29 . . . . 1.64 112.606 -170.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -66.21 130.19 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.127 -0.694 . . . . 3.19 109.127 -174.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.0 t -109.81 -53.46 2.67 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.422 0.289 . . . . 4.13 111.466 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.41 124.88 31.21 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.694 -1.224 . . . . 4.64 107.694 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.39 161.82 15.27 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.525 -0.546 . . . . 1.6 109.525 153.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.4 m -139.27 110.24 6.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.696 -1.594 . . . . 2.26 106.696 168.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.68 132.74 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.446 1.099 . . . . 2.79 110.115 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.42 119.16 12.45 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.96 0.886 . . . . 2.19 111.545 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -71.36 -31.05 66.87 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.322 1.449 . . . . 3.43 112.778 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.99 81.74 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.522 0.677 . . . . 2.14 109.947 -176.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.67 -36.65 65.37 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.352 -0.84 . . . . 2.4 109.363 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.3 t 85.23 14.78 0.17 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 126.473 1.909 . . . . 3.68 111.462 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.86 164.74 16.2 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.471 0.708 . . . . 5.67 111.029 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.74 143.57 47.22 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.04 1.336 . . . . 2.29 108.567 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -99.46 146.02 26.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.535 1.147 . . . . 3.06 108.122 165.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.4 t -134.93 136.67 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 126.349 1.859 . . . . 3.36 107.869 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -113.22 109.52 18.9 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.276 1.43 . . . . 4.78 108.81 166.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -127.51 -176.1 3.65 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.654 1.115 . . . . 3.26 111.098 173.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -103.0 112.32 65.7 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 108.307 -0.998 . . . . 3.13 108.307 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.99 67.65 8.0 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.874 2.383 . . . . 2.59 111.962 -166.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -165.25 -43.93 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.227 1.411 . . . . 3.84 109.59 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pp -79.68 -40.48 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 122.852 0.461 . . . . 3.74 110.303 -177.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.7 tp -135.42 178.23 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.237 1.015 . . . . 3.5 109.398 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.84 -178.81 34.17 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.031 -2.027 . . . . 2.05 108.031 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.11 -40.19 34.96 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.12 1.88 . . . . 1.78 110.285 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 -50.94 -40.07 56.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.485 1.114 . . . . 6.35 113.511 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.75 -52.66 64.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.56 -0.533 . . . . 4.21 109.56 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.72 -44.79 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.336 -0.987 . . . . 2.69 108.336 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.2 mt -51.9 -61.32 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 123.711 0.804 . . . . 2.88 109.105 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.68 -46.31 67.2 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.269 0.94 . . . . 5.3 110.835 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.5 mm -57.13 -51.68 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 121.974 -0.454 . . . . 2.87 109.856 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.13 -27.2 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 120.701 -1.249 . . . . 2.38 112.925 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -59.68 -35.39 74.35 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.659 -0.65 . . . . 3.01 110.349 170.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.52 -35.56 79.79 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.472 -0.566 . . . . 3.36 109.472 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.4 mt -69.85 -45.63 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.681 -0.488 . . . . 2.29 109.681 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.19 31.33 2.26 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.612 1.577 . . . . 1.01 111.66 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -99.06 -179.52 4.28 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.92 0.86 . . . . 3.41 109.69 171.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -139.33 105.19 5.16 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 107.774 -1.195 . . . . 5.46 107.774 -175.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.88 98.96 9.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.913 1.285 . . . . 2.04 109.267 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 51.8 m -101.44 115.91 31.58 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.618 -1.253 . . . . 2.8 107.618 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.38 101.28 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.772 1.229 . . . . 5.45 109.469 170.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.65 -38.77 77.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.922 -0.581 . . . . 3.96 110.168 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 126.168 1.787 . . . . 7.83 112.804 -175.542 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.419 -0.586 . . . . 3.03 109.419 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.64 161.59 18.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.708 -1.219 . . . . 5.65 107.708 169.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.31 132.72 26.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.492 -0.929 . . . . 3.66 108.492 162.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -109.08 93.72 4.66 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.137 1.375 . . . . 4.93 109.125 -171.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -116.65 173.75 6.45 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.472 1.13 . . . . 3.74 111.22 177.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.38 156.89 42.41 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.804 -1.924 . . . . 2.19 105.804 174.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mm -97.87 134.26 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 106.454 -1.684 . . . . 2.09 106.454 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -106.5 117.53 34.29 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 105.768 -1.938 . . . . 5.12 105.768 158.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.5 -101.49 0.24 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.3 -1.12 . . . . 1.66 110.3 -175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.3 mtt 60.14 89.04 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.886 1.674 . . . . 2.79 114.529 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -30.88 71.13 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.467 -0.771 . . . . 2.91 111.231 166.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.0 t 78.05 -58.35 0.46 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.141 1.376 . . . . 4.29 111.187 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -19.03 -68.46 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.91 2.484 . . . . 6.0 113.139 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.9 m -156.17 24.87 0.36 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.12 0.968 . . . . 2.98 110.509 162.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.1 m -70.99 -51.53 25.03 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.283 -0.886 . . . . 2.51 109.939 -169.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.4 t -47.68 -50.53 8.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 N-CA-C 109.1 -0.704 . . . . 3.24 109.1 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -49.99 -48.85 52.11 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.134 0.574 . . . . 3.17 112.54 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -39.13 74.85 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.464 -0.772 . . . . 3.01 111.212 178.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.3 mt -59.89 -48.84 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.812 1.245 . . . . 2.75 109.063 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.24 -49.73 41.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.458 0.572 . . . . 3.77 110.896 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -63.77 -34.57 78.18 Favored 'General case' 0 N--CA 1.458 -0.029 0 O-C-N 121.596 -0.69 . . . . 6.18 111.056 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.97 -51.8 65.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.641 -0.503 . . . . 1.33 109.641 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.29 -37.54 75.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.975 0.352 . . . . 3.55 111.449 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -23.96 3.02 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.701 -1.25 . . . . 2.98 112.078 173.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -126.08 34.86 4.78 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.231 -0.89 . . . . 4.98 112.941 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -69.46 -70.54 0.27 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.992 1.269 . . . . 4.65 111.96 169.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.29 -132.38 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.524 -0.917 . . . . 2.57 108.524 -164.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.83 15.85 29.65 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-O 118.139 -1.367 . . . . 1.82 113.112 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.26 128.76 53.24 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 119.961 1.88 . . . . 2.81 107.241 163.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 53.46 1.98 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.904 -1.147 . . . . 3.91 107.904 172.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.1 t -156.25 143.85 19.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.307 -1.738 . . . . 2.45 106.307 174.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.6 132.19 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.452 -1.684 . . . . 3.36 106.452 174.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tt -139.05 83.68 1.97 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.785 -0.82 . . . . 3.39 108.785 172.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.32 139.57 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 107.909 -1.145 . . . . 3.1 107.909 171.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.14 99.67 7.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 106.938 -1.504 . . . . 2.52 106.938 165.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.02 -27.15 66.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.897 0.879 . . . . 3.58 110.679 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 36.6 mtt -63.28 -60.52 3.29 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.517 0.727 . . . . 3.99 110.353 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.24 -29.07 47.98 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.795 -0.639 . . . . 2.64 110.91 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.05 61.18 1.77 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.227 -1.149 . . . . 1.26 110.227 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -134.82 144.08 47.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.539 -1.652 . . . . 4.41 106.539 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.57 104.22 9.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.444 1.097 . . . . 1.98 108.265 165.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.61 137.93 50.89 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.77 0.714 . . . . 4.43 109.478 169.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.48 172.2 16.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 O-C-N 121.919 -0.488 . . . . 3.43 110.594 178.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.03 105.33 10.53 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.286 1.034 . . . . 5.28 111.012 173.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -106.15 171.48 7.32 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.077 1.751 . . . . 3.81 112.916 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.96 112.0 38.63 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.822 1.649 . . . . 3.61 107.764 174.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.4 36.38 0.62 Allowed 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.892 3.061 . . . . 2.64 114.286 -155.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -129.27 -15.64 4.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.03 0.932 . . . . 3.93 112.398 170.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.1 t -106.06 -35.21 3.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 C-N-CA 124.379 1.072 . . . . 3.66 109.43 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.83 150.69 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 105.351 -2.092 . . . . 2.55 105.351 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -135.7 155.25 78.27 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.881 1.272 . . . . 3.29 111.416 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.57 -34.07 88.74 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.024 2.483 . . . . 1.73 112.662 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.38 -56.54 19.91 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.211 0.529 . . . . 3.49 110.805 176.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.99 -31.7 69.52 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.77 -0.581 . . . . 4.75 110.964 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.66 -50.68 57.86 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 N-CA-C 107.269 -1.382 . . . . 2.25 107.269 168.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.4 76.15 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.462 -0.335 . . . . 2.18 110.19 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.32 -48.41 79.02 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 119.04 -0.505 . . . . 2.62 111.011 175.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.61 -52.23 62.87 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 109.246 -0.65 . . . . 3.82 109.246 176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.6 mm -62.84 -44.6 99.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 122.27 -0.269 . . . . 3.87 111.059 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.71 -47.7 79.38 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.204 1.001 . . . . 2.02 111.173 173.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.23 -48.83 80.07 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.241 0.473 . . . . 2.35 109.876 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.9 mt -58.27 -32.2 68.17 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.906 -0.588 . . . . 2.98 111.3 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.8 25.08 3.45 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 123.976 0.798 . . . . 1.35 111.604 164.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -119.03 158.21 26.27 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.767 -1.568 . . . . 4.49 106.767 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -97.03 128.15 43.7 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.059 -1.089 . . . . 2.42 108.059 167.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.38 115.18 27.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.344 -1.354 . . . . 2.04 107.344 169.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.43 142.92 39.5 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.559 -1.275 . . . . 2.02 107.559 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 t -59.49 153.4 4.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.19 0.596 . . . . 3.66 110.003 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 mtm . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 112.77 0.656 . . . . 5.98 112.77 171.105 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.45 0 N-CA-C 108.101 -2.0 . . . . 2.8 108.101 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -98.69 59.03 1.23 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.605 1.202 . . . . 3.71 109.668 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.3 mm -92.0 139.74 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.185 -1.413 . . . . 3.7 107.185 -167.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -106.84 149.38 27.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.218 -1.03 . . . . 2.96 108.218 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.8 mt -144.24 152.44 40.83 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 122.899 0.479 . . . . 3.5 110.054 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.01 135.86 38.41 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.878 -1.527 . . . . 3.0 106.878 173.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.37 109.0 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 108.289 -1.004 . . . . 3.08 108.289 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.4 m -96.44 134.16 39.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.283 -1.377 . . . . 2.9 107.283 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.25 -15.71 54.05 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.521 1.058 . . . . 1.79 113.002 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -76.56 124.05 27.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.192 1.496 . . . . 3.84 110.807 -174.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -129.58 9.83 5.56 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.75 0.82 . . . . 5.57 113.1 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 50.2 t -155.23 134.31 12.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.675 1.125 . . . . 5.32 111.546 -173.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.8 -38.95 61.89 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.537 0.735 . . . . 3.9 112.83 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -49.64 -39.25 35.4 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.295 -0.878 . . . . 3.28 111.842 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 74.1 m -61.91 -34.14 75.52 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.986 -0.446 . . . . 2.5 110.597 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.6 t -58.58 -50.78 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.18 -0.674 . . . . 3.29 109.18 174.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -60.63 -41.34 94.71 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.78 -0.822 . . . . 3.69 108.78 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -59.07 -52.34 66.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.0 0.92 . . . . 2.83 110.11 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.1 mt -56.26 -53.15 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.013 0.925 . . . . 1.76 109.867 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.14 -37.77 86.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.685 -0.487 . . . . 2.22 109.685 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -59.57 -53.57 56.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.039 -0.356 . . . . 2.37 110.039 171.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.32 -47.42 66.02 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.285 0.634 . . . . 4.7 111.372 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.3 -59.47 4.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.125 -0.694 . . . . 2.59 109.125 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.6 m -55.3 -19.75 9.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.863 1.265 . . . . 2.88 112.144 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -31.88 63.14 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.324 0.65 . . . . 6.11 111.131 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.1 m -70.47 151.08 45.52 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.991 2.117 . . . . 3.19 111.908 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -72.54 -49.08 35.16 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.814 0.446 . . . . 3.94 111.964 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.98 -34.77 71.18 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 122.193 -0.317 . . . . 1.83 112.56 -172.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.31 124.12 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 O-C-N 121.881 -0.776 . . . . 3.25 110.395 -170.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 59.7 m -99.65 -49.65 4.32 Favored 'General case' 0 CA--C 1.522 -0.114 0 O-C-N 122.978 0.174 . . . . 3.45 111.082 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -140.82 124.23 16.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.437 -0.579 . . . . 3.38 109.437 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -98.52 153.79 18.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.222 -1.029 . . . . 2.25 108.222 161.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.6 t -142.73 109.77 5.57 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.43 -1.322 . . . . 3.03 107.43 169.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.5 p -114.15 121.82 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.669 0.788 . . . . 3.14 111.188 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -122.72 105.13 9.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.05 0.94 . . . . 3.32 110.072 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.28 -22.94 65.31 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.08 0.771 . . . . 3.94 113.08 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.02 -54.51 7.05 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.886 -0.783 . . . . 4.19 108.886 -172.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.4 p -69.73 -25.28 63.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.08 0.952 . . . . 4.36 109.998 172.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.2 m 74.02 19.03 3.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.426 1.891 . . . . 3.14 111.732 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -113.81 149.17 35.35 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.559 0.744 . . . . 4.54 110.531 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.01 115.87 16.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.723 2.009 . . . . 2.63 108.516 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 mt -100.62 130.54 46.69 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.465 -1.309 . . . . 3.8 107.465 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.3 t -131.04 121.19 48.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.65 -0.87 . . . . 3.44 108.65 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -100.62 93.77 5.76 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.754 1.221 . . . . 3.9 109.624 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -111.18 -179.51 3.75 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.444 0.698 . . . . 3.42 110.338 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -108.4 109.97 61.64 Favored Pre-proline 0 C--O 1.236 0.39 0 N-CA-C 107.502 -1.295 . . . . 3.94 107.502 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.27 63.42 8.72 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.29 2.66 . . . . 2.27 112.119 -167.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -147.17 -51.5 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.033 1.733 . . . . 4.05 108.343 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.15 -35.33 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 110.401 -0.222 . . . . 3.82 110.401 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.11 159.52 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 108.17 -1.048 . . . . 2.47 108.17 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.33 164.31 25.93 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.59 -1.404 . . . . 1.91 109.59 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -63.07 -44.18 16.53 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.047 2.498 . . . . 2.06 111.03 -172.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -51.06 -40.86 59.3 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 113.614 0.968 . . . . 7.61 113.614 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -63.08 -47.4 83.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.94 -0.763 . . . . 2.75 108.94 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 97.5 mt -56.86 -50.18 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.878 -0.786 . . . . 1.86 108.878 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.7 mt -48.85 -60.67 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-O 118.399 -0.81 . . . . 3.29 109.004 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.62 -48.17 39.63 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.221 0.919 . . . . 4.05 110.716 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 9.9 mm -54.18 -48.76 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 118.31 -0.852 . . . . 2.65 110.849 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.332 0.0 OUTLIER -72.97 -31.74 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 120.436 1.471 . . . . 3.9 114.154 174.152 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.05 -36.56 70.66 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.113 1.324 . . . . 2.4 110.246 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -70.43 -24.36 62.89 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.1 0.96 . . . . 4.36 110.778 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 30.1 mt -75.36 -43.77 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.481 0.582 . . . . 2.41 109.455 166.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.93 31.94 2.36 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.793 1.663 . . . . 1.14 111.284 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -114.13 160.73 18.62 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.726 -1.212 . . . . 3.73 107.726 165.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -124.46 131.97 53.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.847 -1.168 . . . . 5.79 107.847 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.86 105.9 13.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.2 1.0 . . . . 2.27 109.533 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.0 m -134.21 117.78 16.88 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 117.616 -1.183 . . . . 2.64 111.156 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -5.23 98.93 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.5 2.72 . . . . 6.26 114.964 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.09 65.45 1.5 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.932 0.893 . . . . 6.0 111.872 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 C--O 1.25 1.101 0 C-N-CA 125.253 1.421 . . . . 7.31 107.729 168.182 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 120.747 0.308 . . . . 3.85 110.545 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -92.08 141.76 28.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.558 -0.534 . . . . 4.29 109.558 -176.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.3 p -119.57 154.94 33.14 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.866 -1.161 . . . . 3.92 107.866 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -115.9 105.57 12.82 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.71 -1.218 . . . . 4.41 107.71 173.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mt -114.32 170.59 8.19 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.173 0.987 . . . . 3.81 109.73 172.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.06 146.61 47.02 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.441 -1.689 . . . . 1.79 106.441 168.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 mm -98.04 142.9 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 107.307 -1.368 . . . . 1.82 107.307 172.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -117.2 126.73 53.25 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.217 -1.031 . . . . 4.48 108.217 165.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.28 -57.83 0.39 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.559 1.076 . . . . 1.94 111.089 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.1 mtt 24.91 73.09 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.119 2.167 . . . . 2.53 115.643 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -59.24 -57.54 12.59 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.729 0.64 . . . . 3.24 112.729 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.3 t -166.79 61.81 0.09 Allowed 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.722 0.692 . . . . 4.38 112.031 -171.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 38.52 50.31 1.53 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.59 1.556 . . . . 5.86 112.765 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.7 t -167.63 -45.6 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.812 0.845 . . . . 3.19 109.223 -168.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.8 t -65.42 -45.51 83.63 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.507 -0.746 . . . . 2.12 109.794 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.2 -22.68 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 121.337 -0.852 . . . . 2.94 112.031 170.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -39.49 94.73 Favored 'General case' 0 C--O 1.223 -0.301 0 O-C-N 120.848 -1.157 . . . . 2.14 110.537 167.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -36.16 71.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.081 -1.012 . . . . 3.78 111.089 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -49.15 -32.9 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.122 0.969 . . . . 3.11 111.787 172.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -55.17 -53.0 61.53 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.523 0.729 . . . . 5.11 110.653 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.93 -43.76 67.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.745 -0.661 . . . . 6.12 109.679 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -54.52 -52.56 61.61 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.698 -0.482 . . . . 3.2 109.698 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.9 mt -66.3 -41.06 90.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.901 -0.571 . . . . 3.55 112.111 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -22.84 16.44 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.552 1.069 . . . . 2.07 111.957 172.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -116.1 33.48 5.5 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.935 0.494 . . . . 3.77 112.269 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -75.58 -93.76 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.249 -1.389 . . . . 3.82 107.249 161.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.51 -101.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.249 1.019 . . . . 1.94 110.325 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.92 -23.27 67.39 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 119.248 0.931 . . . . 1.43 113.437 -176.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.4 p -74.82 130.26 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.009 1.404 . . . . 2.44 111.311 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -141.89 54.22 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.828 1.299 . . . . 3.2 110.807 173.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.82 143.25 17.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.991 -1.485 . . . . 2.54 106.991 169.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.9 t -133.92 100.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 106.271 -1.752 . . . . 3.24 106.271 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -119.1 78.39 1.28 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.212 -1.033 . . . . 3.12 108.212 175.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.96 126.98 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 109.306 -0.627 . . . . 2.85 109.306 173.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.94 95.79 7.12 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.997 -1.482 . . . . 2.17 106.997 167.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.43 -22.82 63.86 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.362 0.265 . . . . 4.19 110.707 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 10.8 tpt -65.3 -46.85 78.72 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.389 1.075 . . . . 4.93 110.56 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.62 -30.34 13.33 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.288 1.035 . . . . 1.9 111.061 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.94 66.58 1.27 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 125.016 1.293 . . . . 1.01 111.003 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -142.05 132.69 25.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.244 -1.762 . . . . 4.02 106.244 172.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.24 103.4 12.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 124.368 1.043 . . . . 1.84 109.697 168.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -106.72 146.7 30.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.002 -1.11 . . . . 3.46 108.002 166.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 pp -139.62 166.62 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 106.647 -1.612 . . . . 3.8 106.647 174.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 107.21 15.5 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.138 1.375 . . . . 5.38 108.456 171.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -104.52 -178.8 3.76 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.245 1.018 . . . . 3.18 112.578 171.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.18 104.06 35.44 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.215 1.406 . . . . 3.92 109.335 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.98 -5.07 16.13 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.678 2.252 . . . . 2.31 112.991 -172.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -75.98 -15.35 60.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.703 0.683 . . . . 3.69 111.72 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.5 p -125.68 -41.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 118.772 0.715 . . . . 3.93 109.518 -172.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 pp -113.3 -177.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 121.315 0.579 . . . . 3.97 111.477 170.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -139.45 155.92 71.77 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 104.575 -2.38 . . . . 3.11 104.575 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -59.5 -34.2 97.09 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.739 1.626 . . . . 1.8 110.493 -175.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.79 -43.73 77.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.74 -0.648 . . . . 4.73 111.549 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -65.7 -43.45 89.17 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.745 1.157 . . . . 2.77 110.818 -174.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.0 mt -51.79 -55.78 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.065 -1.457 . . . . 2.85 107.065 169.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.06 -43.59 78.08 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.782 -0.644 . . . . 2.59 111.121 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -54.46 -46.82 73.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.28 1.032 . . . . 3.66 110.021 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.54 -48.03 72.48 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.837 -0.431 . . . . 4.79 109.837 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.8 mm -60.29 -43.28 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 122.228 -0.295 . . . . 3.88 111.182 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -64.48 -44.89 89.58 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.007 -0.368 . . . . 3.33 110.007 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.13 -43.94 98.1 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.848 0.859 . . . . 4.67 109.961 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.93 -47.63 74.18 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 123.922 0.889 . . . . 4.31 108.878 173.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.61 34.12 1.12 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.919 0.771 . . . . 1.88 112.02 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -119.31 165.68 13.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.993 1.317 . . . . 3.59 109.199 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -99.95 139.02 36.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.318 -0.993 . . . . 2.18 108.318 162.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.9 122.89 38.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.736 -1.95 . . . . 2.11 105.736 165.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.02 142.88 46.51 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 108.457 -0.942 . . . . 1.94 108.457 174.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.62 136.03 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 124.127 0.971 . . . . 3.81 109.482 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 C-N-CA 123.911 0.884 . . . . 5.11 109.202 166.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.692 0 N-CA-C 107.936 -2.065 . . . . 2.34 107.936 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.26 79.95 5.03 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.569 -1.641 . . . . 3.49 106.569 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.83 148.71 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 118.514 0.597 . . . . 4.15 111.123 178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.05 154.86 17.77 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.779 -0.823 . . . . 2.82 108.779 174.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.71 142.1 47.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.88 -1.155 . . . . 3.79 107.88 168.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.0 m -96.05 123.96 39.87 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.016 -1.476 . . . . 3.68 107.016 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.67 112.22 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 123.51 0.724 . . . . 2.51 110.111 -172.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.4 m -101.04 135.48 42.43 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.741 -0.837 . . . . 2.43 108.741 176.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.88 -30.31 8.17 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.775 1.179 . . . . 1.41 112.283 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 131.26 50.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.535 1.134 . . . . 3.63 111.009 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.7 m -148.69 46.23 1.02 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.093 0.957 . . . . 3.88 110.254 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.0 t -169.61 139.86 2.1 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 120.987 -1.07 . . . . 3.11 110.857 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.38 -44.77 68.9 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.873 0.469 . . . . 3.11 110.638 174.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.1 m -52.45 -39.54 61.2 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.758 0.823 . . . . 3.06 112.06 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.417 ' SG ' ' CZ ' ' A' ' 143' ' ' PHE . 2.4 t -63.41 -55.42 24.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.129 -0.693 . . . . 3.84 109.129 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.7 t -46.81 -50.34 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.68 -0.691 . . . . 2.23 110.653 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -47.16 84.77 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.317 -0.623 . . . . 4.43 109.317 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -45.92 91.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.789 -0.448 . . . . 3.58 109.789 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.5 mt -58.77 -49.72 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.47 -0.567 . . . . 2.07 109.47 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -56.37 -50.0 72.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.115 0.966 . . . . 2.44 108.539 177.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 66.9 m -60.42 -36.25 77.71 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.845 0.858 . . . . 2.87 112.419 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -66.76 -50.36 62.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.55 -0.719 . . . . 3.4 109.773 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.76 -42.32 70.58 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.023 -0.732 . . . . 3.88 109.023 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.6 p -55.8 -16.05 3.99 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.374 0.879 . . . . 2.82 113.374 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -27.47 69.2 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.104 0.866 . . . . 5.54 111.383 172.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.8 m -60.49 150.7 30.48 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.92 1.688 . . . . 2.39 110.385 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -73.65 -54.73 7.45 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.398 0.679 . . . . 2.26 112.114 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.17 -32.84 68.98 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 121.387 0.437 . . . . 1.68 112.688 -172.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.96 119.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.817 -0.813 . . . . 3.31 109.73 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.7 m -102.79 -49.16 3.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.727 0.411 . . . . 3.19 111.018 -174.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.4 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 36.2 p90 -142.04 117.42 10.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.575 -0.726 . . . . 3.53 109.46 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.85 155.19 17.17 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 118.865 -1.134 . . . . 2.31 110.721 161.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -140.81 114.46 8.86 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.464 -0.569 . . . . 3.13 109.464 160.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 p -109.66 140.65 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.727 0.694 . . . . 3.01 112.764 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.23 104.61 6.56 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-O 121.972 0.891 . . . . 2.27 111.857 -171.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.438 ' CD1' ' H ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -65.9 -20.01 66.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.625 1.57 . . . . 3.9 114.061 -177.305 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.71 70.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.18 0.445 . . . . 2.13 110.757 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.22 -18.02 10.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.605 1.562 . . . . 2.38 111.164 -173.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.4 m 72.43 17.63 4.7 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 126.713 2.005 . . . . 2.04 112.426 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -101.11 135.74 42.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.862 1.265 . . . . 3.96 110.371 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -114.09 110.9 20.74 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 126.049 1.74 . . . . 2.03 109.094 175.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.82 125.16 35.64 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 105.892 -1.892 . . . . 4.0 105.892 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.3 t -130.98 132.1 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.353 1.061 . . . . 3.59 109.463 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.4 ' HG2' ' CE1' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -119.71 88.12 2.87 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.466 0.706 . . . . 4.29 109.65 -174.293 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -108.64 -179.48 3.88 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.558 1.161 . . . . 3.05 111.76 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -107.36 112.78 62.51 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 124.25 1.02 . . . . 4.13 108.324 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.79 67.41 8.62 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.162 2.575 . . . . 2.45 111.115 -171.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -161.52 -46.75 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.03 1.332 . . . . 3.78 109.413 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.5 pt -84.24 -31.25 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 123.021 0.528 . . . . 2.75 110.722 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.88 161.7 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 124.446 1.099 . . . . 2.22 108.156 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.68 162.06 28.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.672 -1.371 . . . . 1.7 109.672 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -57.18 -36.45 99.11 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.655 2.903 . . . . 1.69 111.57 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -49.92 -37.18 30.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.467 0.707 . . . . 7.72 112.616 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.15 -44.66 71.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.2 0.524 . . . . 3.3 109.639 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.53 -45.87 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.27 -1.011 . . . . 1.85 108.27 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.4 mt -53.29 -60.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 118.027 -0.987 . . . . 2.97 108.685 175.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -46.26 -53.17 11.18 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 120.18 1.355 . . . . 4.71 111.012 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 90.0 mt -51.22 -53.12 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.428 0.558 . . . . 3.68 110.068 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.252 2.5 pp -71.08 -28.25 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 114.032 1.123 . . . . 2.68 114.032 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -61.63 -42.9 99.54 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.158 0.89 . . . . 3.11 109.063 170.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -39.81 87.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.891 0.877 . . . . 4.36 108.734 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 74.6 mt -71.22 -41.54 75.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 O-C-N 122.348 -0.22 . . . . 2.5 110.957 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.13 32.65 6.04 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.291 1.424 . . . . 1.68 111.899 -173.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.417 ' CZ ' ' SG ' ' A' ' 94' ' ' CYS . 27.4 m-85 -101.5 -178.77 3.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.325 1.063 . . . . 3.73 109.507 165.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -135.89 114.43 11.79 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 105.798 -1.927 . . . . 6.16 105.798 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.07 108.4 19.89 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.05 1.74 . . . . 1.9 108.73 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 m -104.65 95.29 5.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.115 -1.439 . . . . 2.96 107.115 -174.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.15 84.68 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.865 1.666 . . . . 6.43 111.262 -177.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 47.31 52.94 11.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.722 0.809 . . . . 5.73 109.965 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 116.406 -1.759 . . . . 7.97 108.683 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 . . . . . 0 CA--C 1.528 0.127 0 N-CA-C 109.335 -0.617 . . . . 3.5 109.335 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -93.61 152.03 19.28 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.315 0.646 . . . . 4.04 111.697 177.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 t -140.83 128.05 20.96 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.552 1.141 . . . . 2.52 110.282 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -105.63 101.16 10.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.434 1.893 . . . . 5.34 110.864 -176.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.99 173.38 8.71 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.223 0.92 . . . . 3.8 111.17 175.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -124.8 149.03 47.82 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.31 -0.869 . . . . 3.15 109.163 165.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -96.11 124.82 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.88 -1.526 . . . . 1.81 106.88 177.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -100.47 111.91 24.21 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.707 -1.96 . . . . 3.96 105.707 173.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.65 -78.0 0.16 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.178 0.894 . . . . 1.25 111.306 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.0 mtm 42.24 79.99 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.477 1.911 . . . . 2.9 114.205 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.7 m -53.14 -55.74 21.78 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.492 -0.755 . . . . 2.77 112.232 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t -164.09 56.55 0.16 Allowed 'General case' 0 C--N 1.344 0.343 0 C-N-CA 119.527 -0.869 . . . . 3.65 111.904 -174.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 40.23 44.99 1.68 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.464 1.506 . . . . 7.03 112.832 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.4 t -171.91 -43.03 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.413 0.685 . . . . 4.11 109.682 -166.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.96 -43.06 99.82 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.998 -1.064 . . . . 2.36 110.393 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -51.55 -39.69 23.57 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 O-C-N 122.053 -0.404 . . . . 3.13 110.203 170.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 t -60.58 -33.46 72.74 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.359 0.412 . . . . 2.82 110.737 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.19 -54.95 10.65 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.037 -1.039 . . . . 2.48 109.895 170.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mp -44.33 -56.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 122.893 0.477 . . . . 3.26 110.919 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.61 -35.42 72.42 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.184 -0.947 . . . . 4.59 112.594 -176.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -67.48 -34.58 77.45 Favored 'General case' 0 N--CA 1.458 -0.035 0 O-C-N 121.082 -1.012 . . . . 8.11 109.779 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -65.41 -48.06 74.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.929 -0.767 . . . . 1.78 108.929 173.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.32 -36.6 68.9 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.704 0.684 . . . . 4.62 112.144 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.85 -22.96 6.07 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.822 0.675 . . . . 1.94 112.822 174.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -110.45 21.1 17.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.103 0.961 . . . . 4.28 112.059 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -72.98 -64.82 0.89 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.229 0.612 . . . . 3.51 109.705 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.35 -123.9 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.439 1.096 . . . . 2.53 108.064 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.84 -0.23 54.37 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 119.039 0.836 . . . . 1.66 114.594 -173.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -82.11 102.79 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.055 1.427 . . . . 2.78 109.275 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -120.56 52.35 1.17 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 122.145 0.974 . . . . 3.35 110.688 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.1 m -159.81 143.86 14.6 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.494 -1.298 . . . . 3.93 107.494 172.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.88 116.69 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 105.663 -1.977 . . . . 3.48 105.663 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pp -139.02 90.39 2.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 119.591 -0.844 . . . . 5.78 111.381 166.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -99.5 163.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.426 -0.796 . . . . 3.87 109.951 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.58 101.73 6.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.568 -1.271 . . . . 2.32 107.568 167.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.75 -17.59 64.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.958 0.903 . . . . 4.26 111.325 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 49.4 mtm -68.58 -55.52 11.32 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.87 0.868 . . . . 5.23 109.941 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.71 -26.88 24.03 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.047 0.539 . . . . 2.27 111.494 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.88 65.86 1.67 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.313 -1.115 . . . . 1.12 110.313 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -141.01 140.9 34.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.909 -1.515 . . . . 3.72 106.909 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.74 110.19 18.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.677 1.191 . . . . 1.92 110.236 170.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.32 134.06 42.73 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.572 -1.64 . . . . 4.52 106.572 168.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.51 168.69 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.217 0.917 . . . . 2.75 111.117 167.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.67 109.85 19.26 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 123.911 0.885 . . . . 4.6 110.228 163.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -98.63 -176.75 3.46 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 127.96 2.504 . . . . 3.62 111.022 170.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -138.06 108.67 8.25 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.861 1.264 . . . . 3.81 109.443 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.59 8.47 1.23 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 124.497 3.465 . . . . 2.54 113.997 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -95.82 -13.92 23.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.276 1.398 . . . . 4.0 111.688 167.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.2 m -130.23 -42.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 118.929 0.786 . . . . 3.85 112.853 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.21 137.42 48.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 N-CA-C 107.21 -1.404 . . . . 2.5 107.21 177.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.5 mm100 -119.67 149.91 49.17 Favored Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 108.219 -1.03 . . . . 3.63 108.219 -175.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -61.04 -35.78 85.48 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.449 2.099 . . . . 1.61 111.308 -173.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -58.21 -45.42 87.65 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.839 -0.538 . . . . 4.37 111.439 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -58.48 -44.76 89.47 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.657 0.783 . . . . 3.62 110.008 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.28 -56.41 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.04 -1.837 . . . . 1.91 106.04 172.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.51 -44.81 95.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.916 -0.584 . . . . 1.79 111.142 -170.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -55.96 -44.27 78.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.747 0.819 . . . . 2.85 110.283 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.56 -42.99 95.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.399 -0.593 . . . . 4.34 109.399 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mm -60.18 -43.34 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.859 -0.526 . . . . 3.2 110.141 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -63.42 -42.41 98.72 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.549 0.739 . . . . 2.92 111.683 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.98 -50.66 72.88 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.582 0.628 . . . . 2.61 109.741 175.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.65 -34.65 67.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.515 0.726 . . . . 2.76 111.62 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.93 37.63 1.24 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.161 0.886 . . . . 1.43 111.093 166.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -133.15 169.46 16.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.773 1.629 . . . . 3.52 107.002 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -113.3 129.32 56.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.315 -0.624 . . . . 2.44 109.315 169.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.06 120.44 38.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.551 -1.648 . . . . 1.6 106.551 168.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.03 133.88 46.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.074 -1.454 . . . . 1.92 107.074 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.15 154.36 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.508 -0.923 . . . . 3.52 108.508 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.658 0 CA-C-N 114.97 -1.014 . . . . 5.83 111.892 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.095 0 N-CA-C 108.345 -1.902 . . . . 2.61 108.345 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.4 104.18 14.25 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.196 -1.409 . . . . 2.76 107.196 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.02 170.4 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.152 -1.425 . . . . 3.84 107.152 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.33 151.06 46.09 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.497 0.719 . . . . 2.69 111.948 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.2 mt -136.94 146.16 45.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.901 1.28 . . . . 2.95 107.674 -172.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.04 127.9 55.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.392 -1.336 . . . . 2.6 107.392 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.26 117.41 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.37 -1.715 . . . . 2.9 106.37 -171.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.2 p -98.72 141.91 30.93 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.013 -1.106 . . . . 3.69 108.013 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.52 -17.68 28.52 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 119.348 -0.695 . . . . 2.37 113.257 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -79.92 140.46 36.69 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.199 1.5 . . . . 3.17 111.023 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 t -155.37 85.91 1.07 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.216 -1.031 . . . . 5.39 108.216 176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 77.8 m 59.86 -99.2 0.09 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.017 1.327 . . . . 6.78 111.386 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 43.37 -148.49 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.508 1.923 . . . . 6.24 110.7 -168.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.9 t -79.76 -6.31 57.01 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.346 -0.613 . . . . 4.19 109.346 159.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.4 t -59.76 -49.96 75.67 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.39 -0.818 . . . . 3.61 109.817 -167.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.7 p -46.48 -61.19 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.375 1.07 . . . . 3.84 111.447 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -65.04 -31.01 72.03 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.369 0.668 . . . . 4.94 110.579 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -69.08 -48.95 61.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.225 1.01 . . . . 1.99 110.333 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.5 mt -58.95 -47.9 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.216 -1.031 . . . . 2.03 108.216 175.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -50.69 -54.35 23.89 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.508 -0.553 . . . . 2.57 109.508 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.3 t -52.34 -48.06 65.7 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.471 0.708 . . . . 2.22 111.093 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -60.59 -39.05 86.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.216 -0.928 . . . . 3.19 111.201 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 25.5 mt -71.25 -61.65 1.69 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.196 -1.038 . . . . 2.63 108.196 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 74.0 p -59.31 -19.21 44.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.323 1.049 . . . . 2.82 112.736 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -57.15 -36.24 70.5 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 119.291 -0.385 . . . . 5.22 110.7 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 t -75.33 174.84 9.01 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.649 0.738 . . . . 3.78 111.597 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -85.27 -47.72 9.78 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.11 0.964 . . . . 2.28 111.428 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.72 -35.56 80.56 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-O 119.974 -0.348 . . . . 1.25 112.916 -170.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.67 119.08 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 117.552 0.676 . . . . 4.07 109.339 -172.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.8 m -95.72 -47.13 6.32 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 109.658 -0.497 . . . . 3.04 109.658 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -142.55 92.54 2.42 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 112.859 0.688 . . . . 5.03 112.859 -176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.42 145.13 24.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.665 -1.235 . . . . 2.0 107.665 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 m -141.76 109.31 5.64 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.572 -0.899 . . . . 2.78 108.572 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.3 p -99.91 124.73 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.918 1.287 . . . . 3.32 109.475 -177.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.32 88.27 2.91 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.309 1.443 . . . . 2.15 109.626 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 pp -66.18 -20.84 66.26 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 125.408 1.483 . . . . 3.16 113.295 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.57 97.56 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.382 0.537 . . . . 2.59 109.965 176.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -19.09 20.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.893 1.277 . . . . 2.38 110.41 175.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.5 m 65.83 37.18 5.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.167 1.387 . . . . 2.15 110.647 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.96 157.45 37.76 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.43 0.559 . . . . 3.87 109.499 171.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.42 131.58 26.43 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.128 0.971 . . . . 2.01 109.386 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.92 129.68 45.26 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.942 1.697 . . . . 3.44 107.166 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.15 124.45 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.263 1.425 . . . . 3.62 110.49 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.65 94.74 5.15 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 107.57 -1.27 . . . . 5.13 107.57 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -111.12 -177.71 3.28 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 124.239 0.962 . . . . 2.91 110.397 174.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.86 116.69 60.4 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 108.255 -1.017 . . . . 2.85 108.255 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -81.32 68.55 8.16 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.893 2.396 . . . . 1.96 111.135 -167.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -165.86 -44.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.748 1.219 . . . . 3.33 109.669 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.8 pt -79.72 -38.23 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 123.109 0.564 . . . . 2.67 111.136 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.54 158.28 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 123.576 0.75 . . . . 2.48 109.118 175.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -124.07 168.76 16.17 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.861 1.22 . . . . 1.94 110.452 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.0 -41.88 6.96 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.718 2.279 . . . . 1.76 110.383 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.48 -39.59 57.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.678 0.791 . . . . 7.6 112.487 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.95 -49.58 75.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.667 0.787 . . . . 3.95 109.332 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.21 -47.28 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.563 -0.903 . . . . 2.04 108.563 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 95.2 mt -52.52 -59.25 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.538 -0.912 . . . . 2.83 108.538 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -49.05 -48.86 43.66 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 119.159 0.891 . . . . 5.14 112.431 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 mm -51.59 -53.51 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.82 -0.437 . . . . 3.7 109.82 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.315 2.0 pp -70.75 -26.99 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 114.385 1.254 . . . . 2.57 114.385 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.36 -43.5 96.47 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 119.359 0.981 . . . . 2.65 109.078 169.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -63.97 -38.29 90.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.18 -0.674 . . . . 3.21 109.18 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.44 -44.84 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 122.227 -0.296 . . . . 1.89 110.257 171.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.38 23.85 5.58 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.536 1.541 . . . . 1.35 112.629 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -100.59 178.78 4.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.268 1.534 . . . . 4.04 108.802 164.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -136.93 130.39 31.52 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.146 -1.798 . . . . 5.05 106.146 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.98 97.24 5.18 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.717 1.607 . . . . 2.47 108.073 -171.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.7 p -143.22 134.17 25.52 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.269 -0.641 . . . . 2.84 109.269 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.31 -94.35 0.0 OUTLIER 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.138 1.375 . . . . 9.0 109.12 170.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 37.47 36.38 0.08 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.445 1.898 . . . . 6.97 113.367 -169.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.224 -1.37 . . . . 6.5 110.912 -176.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 106.733 -1.581 . . . . 3.08 106.733 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -104.37 154.48 19.78 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.704 0.802 . . . . 5.24 110.812 179.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 54.1 t -143.19 140.72 30.87 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.42 0.688 . . . . 3.02 110.939 170.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -109.57 92.3 3.99 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.076 2.15 . . . . 4.79 109.698 -173.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.262 1.5 pp -119.07 164.58 15.3 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.068 0.937 . . . . 3.74 112.195 176.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.15 154.72 18.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.487 -1.301 . . . . 2.45 107.487 166.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.4 mm -97.78 145.45 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 106.628 -1.619 . . . . 2.0 106.628 160.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -123.77 123.13 39.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.039 -1.837 . . . . 4.57 106.039 158.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.04 -81.38 0.19 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 108.792 -1.723 . . . . 1.31 108.792 -172.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 28.43 73.15 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.064 2.146 . . . . 2.84 115.335 178.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -16.63 2.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.214 1.406 . . . . 3.42 113.781 174.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.8 t 78.25 -48.67 0.47 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.745 1.618 . . . . 3.95 112.433 173.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.25 -70.29 0.11 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.448 1.499 . . . . 5.74 111.776 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 p -159.96 15.13 0.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.13 0.572 . . . . 3.21 112.43 172.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.7 m -70.69 -48.3 55.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.573 -0.705 . . . . 2.52 109.385 -168.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.0 t -47.96 -51.69 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.365 -0.976 . . . . 3.11 108.365 172.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -59.22 -34.29 72.0 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.906 1.282 . . . . 1.99 113.675 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -45.52 58.77 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.233 -0.292 . . . . 3.01 110.321 172.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.6 mt -56.23 -47.34 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.895 0.878 . . . . 2.34 109.213 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -47.63 -53.45 14.76 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.391 0.676 . . . . 4.48 110.837 175.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.0 mtt85 -67.9 -30.21 69.5 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.629 0.771 . . . . 7.25 112.378 -175.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -69.07 -55.77 9.76 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.75 -0.833 . . . . 1.36 108.75 175.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -61.06 -36.07 78.63 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.067 0.547 . . . . 4.58 110.792 -176.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -24.61 6.2 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.896 0.702 . . . . 3.33 112.896 171.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -119.55 30.22 7.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.748 0.819 . . . . 4.92 111.537 178.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -77.8 -89.27 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 105.686 -1.968 . . . . 3.3 105.686 163.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.54 -91.24 0.06 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.489 0.716 . . . . 2.22 111.044 177.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.27 -15.75 68.44 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.287 -0.729 . . . . 1.84 112.593 -171.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.45 109.71 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 CA-C-N 118.102 0.951 . . . . 3.01 109.168 177.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.3 mt -138.59 50.59 1.86 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.89 -0.782 . . . . 4.85 108.89 177.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 t -159.86 152.68 21.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.217 -1.771 . . . . 3.15 106.217 159.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.17 102.07 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.122 -1.807 . . . . 3.3 106.122 -178.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -127.24 74.2 1.49 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.419 -1.697 . . . . 3.95 106.419 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.13 123.66 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.427 -0.953 . . . . 3.08 108.427 174.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.75 92.65 6.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.692 -1.966 . . . . 2.45 105.692 169.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 tp -54.71 -30.04 54.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.24 1.416 . . . . 4.49 110.192 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 31.7 mtt -66.51 -54.32 25.24 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.418 0.687 . . . . 4.08 110.421 -178.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.11 -23.59 28.4 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.151 0.58 . . . . 2.17 111.484 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.54 63.78 2.28 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.059 1.314 . . . . 1.23 110.9 -176.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.0 pttm -140.98 140.58 34.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.751 -1.203 . . . . 4.05 107.751 170.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.72 104.44 11.36 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 124.435 1.084 . . . . 2.12 112.975 173.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -98.01 125.76 43.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.259 -1.385 . . . . 4.31 107.259 172.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.0 mt -126.06 163.29 28.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 107.027 -1.471 . . . . 3.74 107.027 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -123.98 105.75 9.84 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.435 -0.95 . . . . 4.8 108.435 165.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -117.54 159.8 22.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.397 1.479 . . . . 4.15 110.027 172.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -98.95 111.15 60.05 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.931 0.893 . . . . 3.74 110.297 -179.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.08 -3.84 7.92 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.076 3.184 . . . . 2.2 113.623 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -73.25 -44.99 58.43 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 120.07 1.305 . . . . 4.64 110.741 169.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -108.59 -30.22 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 122.175 -0.328 . . . . 3.84 111.427 -165.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.51 131.96 69.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 108.655 -0.868 . . . . 2.58 108.655 177.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.02 150.7 39.05 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.605 1.562 . . . . 2.91 109.773 -177.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -51.94 -52.58 8.65 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.37 2.713 . . . . 1.51 112.247 179.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -60.4 -43.76 96.35 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.419 -0.8 . . . . 4.17 111.265 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -57.77 -37.62 73.99 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.944 0.498 . . . . 3.94 111.101 174.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.31 -50.11 67.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 107.568 -1.271 . . . . 2.28 107.568 171.175 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.84 -43.87 77.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.988 -0.551 . . . . 2.65 110.203 -175.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -53.12 -46.84 68.94 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.305 0.502 . . . . 2.74 110.75 175.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -48.79 79.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.002 0.43 . . . . 3.83 110.371 177.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -64.53 -44.04 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 121.961 -0.462 . . . . 3.32 111.012 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -42.69 98.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.448 1.099 . . . . 2.71 110.247 176.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.77 -49.15 77.55 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.39 0.541 . . . . 2.6 109.974 177.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 mt -56.24 -37.03 69.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.399 0.279 . . . . 2.77 111.583 174.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.94 26.51 2.75 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.239 0.923 . . . . 1.46 112.242 167.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -118.5 167.72 11.33 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.35 1.46 . . . . 3.21 107.96 176.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -98.55 143.74 28.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.373 -0.973 . . . . 2.59 108.373 163.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.74 135.16 48.13 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.801 0.84 . . . . 2.08 108.79 162.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.63 138.72 30.91 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.912 0.885 . . . . 2.48 109.731 171.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 p -87.19 152.84 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 125.613 1.565 . . . . 3.58 109.499 178.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.7 mtt . . . . . 0 CA--C 1.533 0.294 0 O-C-N 123.371 0.419 . . . . 4.48 111.605 178.275 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.087 0 N-CA-C 112.004 -0.439 . . . . 2.07 112.004 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.01 114.44 8.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.067 -1.457 . . . . 2.37 107.067 173.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -128.01 160.85 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.405 -1.331 . . . . 3.78 107.405 176.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.8 153.83 28.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.23 -1.026 . . . . 3.97 108.23 169.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 mp -133.01 141.21 48.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.705 0.802 . . . . 3.42 109.027 163.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.4 m -94.74 125.97 39.75 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.356 -1.72 . . . . 3.82 106.356 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.8 mt -101.52 123.36 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.241 -0.651 . . . . 4.75 109.241 -174.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.5 m -96.5 124.65 40.56 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.819 -1.178 . . . . 2.66 107.819 172.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 117.22 -34.82 4.41 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.95 1.262 . . . . 1.34 112.161 175.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 55.7 ttp -50.44 120.52 4.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.998 0.899 . . . . 3.32 110.98 177.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.4 6.18 1.27 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.526 0.935 . . . . 4.4 113.526 -170.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.4 t -156.01 142.21 18.32 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.084 1.311 . . . . 3.41 111.243 -178.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.19 64.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.568 1.147 . . . . 4.04 112.271 -175.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.24 -49.5 66.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.124 0.97 . . . . 3.57 110.739 171.33 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 88.4 m -64.17 -46.56 83.48 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.011 -0.737 . . . . 2.21 109.011 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.2 t -47.67 -59.0 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.279 1.032 . . . . 2.62 109.778 175.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -57.68 -44.33 85.73 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 122.997 0.519 . . . . 5.73 111.285 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -62.69 -47.66 82.67 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.836 0.455 . . . . 1.85 110.627 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.35 -48.75 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.744 -0.836 . . . . 1.96 108.744 177.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -59.74 -46.45 89.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.427 -0.582 . . . . 3.1 109.427 178.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.6 t -52.0 -46.64 64.99 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.577 0.626 . . . . 1.77 110.811 174.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -60.18 -50.65 72.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.747 -0.596 . . . . 3.98 110.89 177.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.7 mt -58.0 -56.81 17.15 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 118.378 0.536 . . . . 3.29 109.587 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 33.3 m -50.04 -19.15 0.66 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.144 1.778 . . . . 2.74 112.912 173.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -67.37 -16.46 64.26 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.058 0.845 . . . . 6.13 112.251 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.0 m -72.38 155.0 40.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.169 1.387 . . . . 2.42 110.838 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -74.47 -52.82 10.91 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.962 0.905 . . . . 2.65 111.7 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.36 -37.75 80.13 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.786 -0.525 . . . . 1.53 111.786 -172.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.51 136.94 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.706 -0.85 . . . . 2.83 108.706 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.8 m -137.22 -12.92 1.61 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.482 -0.761 . . . . 4.39 112.394 171.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.91 118.34 10.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.786 -2.301 . . . . 3.53 104.786 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.49 161.04 28.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.314 -1.365 . . . . 1.83 107.314 166.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.0 m -141.07 111.96 7.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 118.915 -0.564 . . . . 2.45 109.505 161.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.71 134.52 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.641 0.776 . . . . 2.86 110.542 171.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.65 108.47 5.67 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.53 1.157 . . . . 2.5 110.967 -171.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.71 -41.18 98.13 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.544 1.937 . . . . 5.37 112.081 -173.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.22 62.45 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.277 0.631 . . . . 3.07 111.094 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 -15.81 15.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.455 1.902 . . . . 2.83 110.199 -177.252 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.1 t 71.56 20.27 4.83 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.517 2.327 . . . . 2.71 112.145 168.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -131.55 172.82 11.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.271 0.558 . . . . 3.48 110.741 177.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.06 134.35 48.07 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.739 1.216 . . . . 2.33 109.377 170.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.39 123.35 35.65 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 104.484 -2.413 . . . . 2.75 104.484 172.429 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.4 t -124.14 129.39 74.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.372 -1.344 . . . . 2.75 107.372 -176.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.12 88.15 2.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.7 -1.222 . . . . 4.37 107.7 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -113.04 164.71 13.13 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.055 0.942 . . . . 2.93 111.311 174.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -99.04 116.63 65.11 Favored Pre-proline 0 C--O 1.237 0.423 0 C-N-CA 123.932 0.893 . . . . 3.01 109.344 177.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -78.22 68.22 7.97 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.236 2.624 . . . . 2.21 111.546 -173.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.54 -47.34 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.245 1.018 . . . . 3.22 109.348 173.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -81.59 -30.88 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 122.922 0.489 . . . . 2.49 110.924 -177.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -135.25 163.39 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.91 -0.774 . . . . 2.31 108.91 176.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.49 163.54 28.18 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.488 -1.445 . . . . 2.1 109.488 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.45 -35.67 81.54 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.857 3.038 . . . . 2.49 112.565 -170.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -40.62 75.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.92 -0.488 . . . . 8.44 111.316 -175.258 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.92 -38.99 72.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 119.148 -1.021 . . . . 3.85 109.969 -177.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 83.4 mt -56.65 -48.68 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.674 -0.862 . . . . 2.42 108.674 173.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.9 mt -50.51 -60.33 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 118.111 -0.947 . . . . 3.95 108.671 173.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -51.47 -44.71 62.51 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.959 1.254 . . . . 5.39 112.469 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.4 mm -56.05 -54.39 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.449 -0.782 . . . . 3.22 109.491 176.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.256 2.5 pp -68.18 -25.53 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 120.861 -1.149 . . . . 3.07 113.392 -178.498 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.34 -39.52 87.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.954 0.797 . . . . 3.51 109.932 168.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.77 -40.59 97.76 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.994 -0.743 . . . . 3.81 108.994 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.8 mt -66.41 -43.09 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 110.02 -0.363 . . . . 2.12 110.02 173.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.01 33.42 4.96 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.647 1.594 . . . . 0.97 111.536 -175.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -103.81 177.3 4.88 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.403 1.102 . . . . 3.68 109.264 166.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -129.79 121.98 27.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.176 -1.787 . . . . 5.13 106.176 172.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.84 113.27 26.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.574 1.15 . . . . 2.11 108.691 179.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.1 m -110.66 98.61 7.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.758 1.623 . . . . 2.65 107.991 -173.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.59 98.71 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.186 1.794 . . . . 6.37 111.003 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 48.53 45.19 21.12 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.74 0.816 . . . . 6.15 111.289 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 . . . . . 0 C--O 1.248 1.006 0 N-CA-C 106.537 -1.653 . . . . 9.85 106.537 -175.587 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 107.544 -1.28 . . . . 5.12 107.544 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -96.79 142.66 28.53 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.697 0.681 . . . . 5.42 111.572 -172.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.0 t -141.1 126.53 18.74 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.077 0.551 . . . . 3.32 111.826 172.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -97.43 101.69 13.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.255 2.222 . . . . 4.76 108.187 175.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.34 167.35 11.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 122.344 1.069 . . . . 4.24 108.616 173.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.63 136.86 33.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.641 -0.874 . . . . 2.1 108.641 175.204 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.02 138.06 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 105.34 -2.096 . . . . 2.18 105.34 -178.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -106.95 125.17 50.65 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.201 -1.037 . . . . 4.15 108.201 170.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.23 -88.23 0.28 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.787 1.66 . . . . 1.76 109.494 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.4 mpt? 66.13 144.32 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.502 1.921 . . . . 2.82 112.416 -169.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -109.34 -19.08 13.41 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.495 1.118 . . . . 3.4 110.702 172.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.4 t 65.73 -65.23 0.18 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.183 1.793 . . . . 3.25 112.001 -170.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.36 -73.25 0.02 OUTLIER 'General case' 0 C--N 1.342 0.264 0 C-N-CA 128.083 2.553 . . . . 6.7 113.413 -175.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.63 13.07 0.09 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.006 0.743 . . . . 3.36 113.006 166.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.3 m -74.85 -41.57 59.59 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 120.169 -1.582 . . . . 3.13 110.768 -171.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.87 -31.86 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.878 -0.786 . . . . 2.96 108.878 176.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -61.06 -52.13 66.24 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.919 -0.488 . . . . 2.21 110.72 170.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -53.15 -45.76 68.55 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.877 -1.139 . . . . 2.96 110.833 175.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -43.88 -38.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.61 1.164 . . . . 2.64 111.613 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -52.24 -58.41 6.7 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.268 0.627 . . . . 4.84 111.469 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -67.11 -37.58 84.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.655 -0.498 . . . . 4.99 109.655 -176.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -55.68 -56.8 16.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.414 -0.587 . . . . 1.37 109.414 178.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 mp -61.18 -42.43 98.56 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.822 0.737 . . . . 3.39 110.969 177.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -22.25 18.84 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.781 0.719 . . . . 2.15 112.537 178.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -113.01 16.53 19.32 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.414 0.894 . . . . 3.91 113.414 175.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.41 -69.5 0.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.265 -1.013 . . . . 3.16 108.265 165.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.13 -134.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.163 1.385 . . . . 3.07 107.951 -176.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.11 35.69 1.28 Allowed Glycine 0 CA--C 1.538 1.499 0 CA-C-N 120.255 1.389 . . . . 2.74 114.847 -172.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.89 77.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 125.306 1.443 . . . . 2.77 109.454 175.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.47 51.55 0.77 Allowed 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 108.602 -0.888 . . . . 4.46 108.602 -172.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -163.79 126.02 2.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.607 -1.257 . . . . 2.59 107.607 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.1 t -128.48 114.52 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.998 -1.482 . . . . 3.73 106.998 176.255 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -123.68 79.57 1.71 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.612 -1.255 . . . . 4.45 107.612 174.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 t -97.76 128.26 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 109.054 -0.721 . . . . 3.31 109.054 173.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.31 86.81 3.99 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.333 -1.358 . . . . 3.23 107.333 176.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.8 mt -57.25 -5.38 0.29 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.958 1.096 . . . . 4.05 113.958 176.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 28.5 mtp -97.66 -42.51 7.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.268 1.427 . . . . 4.19 110.468 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.3 -38.12 12.25 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.644 0.778 . . . . 3.18 110.879 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.89 60.14 1.04 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 126.216 1.865 . . . . 1.82 111.649 173.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -138.19 137.47 37.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 105.412 -2.07 . . . . 4.59 105.412 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.5 92.94 4.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.185 0.928 . . . . 2.03 110.119 169.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.04 111.63 23.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.112 -2.551 . . . . 6.19 104.112 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 pt -117.38 174.94 3.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 O-C-N 120.325 -1.484 . . . . 3.5 108.414 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -131.12 108.61 9.87 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.924 -0.399 . . . . 6.05 109.924 170.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -117.32 164.78 14.32 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.618 1.567 . . . . 4.09 113.288 174.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -99.0 106.12 36.0 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.646 1.978 . . . . 4.2 109.978 177.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.05 9.66 0.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.354 2.703 . . . . 3.61 113.701 -171.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -97.85 -21.32 16.98 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.535 0.734 . . . . 5.1 111.038 173.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.9 t -111.01 -62.45 2.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 N-CA-C 108.34 -0.985 . . . . 4.88 108.34 -175.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.96 144.42 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 N-CA-C 109.115 -0.698 . . . . 3.07 109.115 176.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -113.49 151.78 44.77 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 125.008 1.323 . . . . 3.66 108.328 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.26 -39.38 85.21 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.716 2.277 . . . . 2.22 111.314 -175.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -38.4 69.61 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.461 -0.774 . . . . 4.16 112.505 -178.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -57.3 -43.65 83.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.998 -0.741 . . . . 3.26 108.998 172.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.2 -47.56 55.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 108.51 -0.922 . . . . 2.33 108.51 168.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.49 -38.69 78.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 119.898 -0.721 . . . . 2.43 110.266 -171.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -52.65 -50.85 62.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.047 0.939 . . . . 3.09 109.971 177.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -48.15 70.54 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.501 -0.555 . . . . 3.68 109.501 177.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.5 mm -62.77 -39.85 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 122.164 -0.335 . . . . 3.28 111.08 -178.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -67.38 -42.92 82.59 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.813 -0.439 . . . . 2.64 109.813 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -60.58 -49.9 75.67 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.029 0.532 . . . . 2.32 109.878 176.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.61 -36.42 69.42 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.02 0.528 . . . . 2.85 111.032 175.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.24 41.67 0.95 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.127 -0.789 . . . . 1.47 111.127 165.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -132.59 162.88 30.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.277 1.031 . . . . 4.39 109.168 -174.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -93.17 124.11 36.91 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 106.914 -1.513 . . . . 2.69 106.914 171.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.38 124.63 43.16 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.853 -1.165 . . . . 2.27 107.853 167.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.66 113.46 9.71 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.789 -0.819 . . . . 2.06 108.789 172.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 t -72.83 158.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.836 0.855 . . . . 3.85 110.171 -178.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.4 mtt . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 113.296 0.85 . . . . 5.0 113.296 174.361 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.374 0 N-CA-C 109.592 -1.403 . . . . 3.08 109.592 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -115.21 122.92 47.51 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.682 -2.34 . . . . 3.45 104.682 175.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.71 158.9 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.553 -1.277 . . . . 4.23 107.553 168.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.7 157.32 39.36 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 123.333 0.653 . . . . 3.33 109.471 171.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 pp -147.31 161.6 40.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.585 -0.734 . . . . 3.64 110.333 172.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.9 126.3 44.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.15 -1.426 . . . . 2.2 107.15 173.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.65 127.08 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.57 -0.9 . . . . 2.99 108.57 176.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.6 m -118.02 112.08 19.79 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.034 -1.099 . . . . 2.47 108.034 176.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.96 -25.76 1.15 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.656 1.122 . . . . 1.8 111.386 -172.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.9 tpp -61.25 120.72 10.92 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 121.978 -0.719 . . . . 3.75 111.389 -174.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.7 t -130.49 4.92 4.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.29 0.636 . . . . 3.58 111.463 176.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.27 153.12 6.41 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 120.654 -1.278 . . . . 4.41 111.682 177.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.89 -32.62 66.06 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.319 0.647 . . . . 3.89 111.148 173.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.9 t -51.99 -43.95 63.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.949 0.5 . . . . 3.21 110.525 171.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.5 m -63.91 -53.51 49.22 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 108.41 -0.959 . . . . 2.61 108.41 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 82.1 t -43.39 -54.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.194 0.998 . . . . 2.35 110.71 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -59.05 -40.0 83.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.685 -0.234 . . . . 5.14 110.958 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -66.89 -46.34 75.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.874 -0.516 . . . . 1.84 110.579 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.6 mm -55.65 -50.46 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.616 -0.883 . . . . 3.11 108.616 176.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -59.75 -45.54 91.91 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 118.842 -0.599 . . . . 2.11 110.057 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.3 m -55.44 -39.87 70.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.826 0.739 . . . . 3.49 111.622 175.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.44 -39.27 81.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.016 -0.428 . . . . 3.65 111.193 175.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.92 -58.25 5.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.338 -0.986 . . . . 2.57 108.338 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.9 p -57.27 -15.39 5.96 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.597 1.159 . . . . 2.63 113.13 176.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -35.66 64.26 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.517 -0.739 . . . . 6.99 111.583 167.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.8 m -66.85 144.77 56.08 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.632 1.573 . . . . 2.69 111.1 -175.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -68.17 -47.3 68.35 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.011 0.925 . . . . 2.85 111.432 177.114 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.27 -21.75 74.92 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.62 -0.544 . . . . 1.98 113.139 -168.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.2 156.77 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.596 -0.89 . . . . 3.28 108.596 177.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.9 m -140.0 -39.8 0.45 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.39 -0.819 . . . . 4.35 112.348 168.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.39 95.02 4.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.94 -1.504 . . . . 3.8 106.94 -168.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -96.51 155.32 16.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.984 -1.117 . . . . 2.34 107.984 168.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.3 m -140.22 111.27 7.01 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.005 -0.434 . . . . 2.43 110.276 159.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.19 133.38 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.749 1.219 . . . . 2.95 110.657 -178.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.92 104.92 5.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.594 1.158 . . . . 2.28 110.803 -171.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 pp -70.53 -21.6 62.71 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 124.204 1.002 . . . . 3.84 112.649 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.41 91.39 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.398 -0.593 . . . . 2.74 109.398 -179.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.07 -34.48 16.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.941 0.897 . . . . 2.91 110.049 170.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.96 45.51 0.15 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.312 -0.996 . . . . 3.61 108.312 -168.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.06 167.72 20.43 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.852 -0.613 . . . . 4.8 111.592 165.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.5 141.83 46.85 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.624 1.169 . . . . 2.26 108.695 171.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.53 137.92 36.49 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.127 -1.805 . . . . 3.21 106.127 168.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.16 129.89 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.484 -0.932 . . . . 4.03 108.484 -179.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.83 105.57 13.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.079 -1.082 . . . . 4.4 108.079 -176.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -137.04 168.75 18.99 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.172 0.92 . . . . 3.33 111.714 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -97.29 115.79 65.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.681 -0.488 . . . . 3.79 109.681 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.36 55.06 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.343 2.696 . . . . 2.59 112.552 -166.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -143.76 -51.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.489 1.516 . . . . 3.74 108.012 172.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pt -77.38 -31.75 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 122.438 -0.163 . . . . 3.6 110.987 -176.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.88 163.54 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.985 -0.746 . . . . 2.8 108.985 -178.03 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.75 164.73 31.82 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.256 -1.137 . . . . 2.19 110.256 -176.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -61.55 -38.5 62.07 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.575 2.85 . . . . 2.13 111.817 -168.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -31.83 62.95 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 113.086 0.772 . . . . 7.98 113.086 -176.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.87 -40.63 65.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 118.498 -1.281 . . . . 3.31 110.231 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.3 -48.14 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.543 -0.91 . . . . 2.28 108.543 171.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.18 -60.99 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 108.799 -0.815 . . . . 3.22 108.799 174.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.98 -50.23 19.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.14 0.882 . . . . 5.19 113.147 178.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.8 -53.57 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 121.933 -0.479 . . . . 3.15 109.858 177.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.268 2.5 pp -68.16 -29.24 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.287 -0.883 . . . . 2.53 113.278 -177.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.71 -41.98 78.35 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.158 0.89 . . . . 4.0 109.54 169.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -61.45 -40.26 93.85 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.41 0.684 . . . . 3.76 109.295 -179.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.9 mt -68.91 -38.95 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 122.865 0.466 . . . . 2.25 110.153 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.16 33.49 6.55 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.975 1.274 . . . . 1.07 110.771 -171.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -99.48 175.03 5.98 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 107.914 -1.143 . . . . 4.77 107.914 167.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -135.25 121.7 20.53 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.01 -1.478 . . . . 5.27 107.01 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.03 100.89 10.18 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.613 1.165 . . . . 2.46 109.56 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.6 m -99.13 104.12 16.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.394 -0.965 . . . . 2.39 108.394 174.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 mt -48.03 107.74 0.14 Allowed 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 125.323 1.449 . . . . 7.32 108.346 171.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -84.4 -31.23 24.79 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.606 -0.887 . . . . 4.47 108.606 175.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 127.563 2.345 . . . . 9.53 112.678 165.462 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 119.885 -0.102 . . . . 3.71 110.734 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -123.84 147.09 47.91 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 124.604 1.161 . . . . 5.96 110.292 -179.037 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.17 137.15 51.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.693 -1.225 . . . . 2.86 107.693 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -121.64 96.08 4.93 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.786 -1.19 . . . . 5.54 107.786 -172.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.2 177.4 4.74 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.711 0.767 . . . . 3.93 111.095 -176.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.18 149.42 49.98 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.693 1.597 . . . . 1.96 107.19 166.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mm -103.11 126.35 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 106.859 -1.534 . . . . 2.27 106.859 175.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -107.24 138.11 44.04 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.158 -1.053 . . . . 3.72 108.158 160.328 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 144.84 -88.32 0.17 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.342 1.449 . . . . 1.07 109.685 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt 55.86 73.89 0.41 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.263 1.425 . . . . 2.29 113.554 171.125 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m -50.12 -59.95 3.42 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.072 0.768 . . . . 2.85 113.072 -178.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 t -170.01 63.08 0.05 OUTLIER 'General case' 0 C--N 1.343 0.323 0 CA-C-N 118.522 0.601 . . . . 4.67 110.119 -175.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 41.89 47.97 3.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.887 1.275 . . . . 5.86 112.898 176.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.01 -40.1 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.451 0.7 . . . . 2.67 110.905 -174.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -67.63 -42.59 82.05 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.029 -1.044 . . . . 2.3 109.733 -177.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.38 -32.59 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 O-C-N 121.219 -0.925 . . . . 2.59 109.955 170.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -62.69 -25.8 68.34 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.597 -1.314 . . . . 2.01 112.133 173.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.95 -36.85 70.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.2 -0.937 . . . . 2.78 110.42 173.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 mt -49.51 -42.76 17.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-O 118.91 -0.567 . . . . 3.82 110.496 174.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -46.2 -58.41 3.68 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.377 0.535 . . . . 5.88 111.519 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -66.83 -39.93 87.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.981 0.512 . . . . 5.1 110.053 -173.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -58.42 -58.24 9.41 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.777 -0.647 . . . . 1.19 109.289 178.215 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.77 -39.67 92.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 119.176 -0.44 . . . . 3.54 111.058 -177.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.67 -34.71 3.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.67 0.788 . . . . 2.5 111.604 172.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -121.7 29.58 7.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.296 0.639 . . . . 3.83 111.914 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -72.87 -69.1 0.43 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.888 -0.782 . . . . 3.8 108.888 170.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.78 -143.37 0.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.014 0.926 . . . . 1.93 108.805 -167.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.9 -15.07 40.7 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 119.144 0.884 . . . . 1.55 114.039 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.3 79.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.567 1.147 . . . . 2.52 112.351 -177.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.86 52.52 1.68 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.225 1.012 . . . . 3.59 109.34 -178.344 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 m -160.48 145.05 14.3 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.305 -0.872 . . . . 3.77 109.099 172.422 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.9 t -140.87 112.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.046 -2.205 . . . . 3.61 105.046 171.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -131.57 79.83 1.9 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.496 0.665 . . . . 4.4 110.065 175.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 p -98.98 150.75 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 115.81 -0.632 . . . . 3.56 109.624 173.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.17 113.34 15.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.784 -1.191 . . . . 2.67 107.784 163.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 tp -62.67 -32.78 73.91 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.554 1.542 . . . . 4.27 109.869 176.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 28.7 mtt -57.62 -55.63 32.37 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.383 0.611 . . . . 3.76 110.192 -177.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.28 -21.6 25.67 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.268 -0.878 . . . . 2.62 110.928 -177.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.39 53.28 6.84 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 110.27 -1.132 . . . . 1.37 110.27 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -128.17 130.65 48.37 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.126 -1.435 . . . . 5.06 107.126 178.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.55 107.6 18.52 Favored 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 125.259 1.424 . . . . 2.27 109.194 167.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -99.29 131.87 45.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.751 -1.574 . . . . 4.6 106.751 166.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.73 163.91 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 119.104 0.865 . . . . 3.33 111.338 161.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.38 106.83 15.43 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.274 2.23 . . . . 9.34 107.562 175.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -106.76 -179.48 3.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.338 1.055 . . . . 4.07 113.14 171.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.66 118.88 14.75 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.238 1.415 . . . . 3.25 108.033 175.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.65 -16.43 38.03 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.9 3.067 . . . . 3.16 113.069 -165.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -72.44 -11.82 60.84 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.981 0.363 . . . . 3.56 111.981 -177.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.08 -46.93 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 123.438 0.695 . . . . 3.79 111.227 -170.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.12 152.47 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.141 0.576 . . . . 2.42 109.99 174.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -127.08 156.96 73.6 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 125.316 1.446 . . . . 2.59 109.696 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.19 -9.7 27.01 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.368 2.045 . . . . 1.66 112.276 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mp -73.54 -61.88 1.68 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.59 0.756 . . . . 3.43 110.159 172.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -32.41 73.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.481 -0.327 . . . . 5.05 111.195 -174.2 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.5 tt -58.79 -51.04 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.66 -1.607 . . . . 2.57 106.66 173.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.85 98.1 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.267 -0.424 . . . . 1.97 110.225 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -55.53 -46.41 77.08 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.433 -0.581 . . . . 2.42 109.433 174.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.24 -49.81 74.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.128 -0.693 . . . . 3.69 109.128 -177.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.6 mm -55.57 -47.19 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 121.926 -0.484 . . . . 3.74 111.505 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.47 -47.56 81.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.989 0.516 . . . . 2.47 111.331 176.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.67 -49.82 71.67 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.42 0.688 . . . . 2.38 110.391 -178.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.34 -43.24 53.99 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.761 1.224 . . . . 3.06 110.528 173.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.18 40.36 0.34 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 111.123 -0.791 . . . . 1.47 111.123 162.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -137.81 160.86 38.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.058 -0.719 . . . . 4.24 109.058 -175.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -98.52 117.39 32.83 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.595 -1.261 . . . . 2.77 107.595 170.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.57 111.45 23.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.409 -1.7 . . . . 2.03 106.409 164.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.02 154.59 46.49 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 106.708 -1.59 . . . . 1.83 106.708 169.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.02 148.59 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 115.446 -0.797 . . . . 4.9 109.202 -172.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.4 ptm . . . . . 0 CA--C 1.536 0.412 0 C-N-CA 120.016 -0.673 . . . . 4.83 111.066 177.561 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.804 0 N-CA-C 110.688 -0.965 . . . . 3.16 110.688 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.0 76.95 1.08 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.925 -1.139 . . . . 3.33 107.925 -140.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.8 pt -105.92 158.54 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.689 -0.486 . . . . 4.89 109.689 177.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -106.76 144.09 33.92 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 124.026 0.829 . . . . 4.49 109.989 169.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 mt -131.57 145.46 51.73 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.843 0.857 . . . . 3.53 109.126 175.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.52 124.2 44.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.147 0.979 . . . . 3.77 108.66 179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.34 110.97 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 O-C-N 123.57 0.544 . . . . 3.05 110.124 -176.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.9 p -96.53 164.97 12.38 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.539 -0.912 . . . . 3.14 108.539 177.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.5 -33.89 3.17 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 121.914 -0.491 . . . . 1.98 112.262 -178.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.69 142.17 50.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 117.991 0.896 . . . . 4.03 111.414 178.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 m -155.26 46.74 0.51 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.783 0.833 . . . . 3.95 108.782 172.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.7 t -165.36 143.69 6.19 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.263 -0.898 . . . . 3.88 111.136 174.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.66 -46.5 81.06 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 109.546 -0.538 . . . . 3.59 109.546 175.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.1 m -50.19 -41.44 49.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.753 0.821 . . . . 2.94 112.006 174.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.59 -50.68 62.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.249 -0.649 . . . . 2.51 109.249 -177.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -48.34 -54.77 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.122 0.569 . . . . 2.93 110.506 170.406 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.31 -39.6 83.56 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.842 0.829 . . . . 3.46 111.088 -176.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -63.67 -44.33 94.07 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.912 0.885 . . . . 2.24 110.499 175.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.6 mt -60.26 -46.88 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.593 -0.521 . . . . 2.16 109.593 176.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -55.8 -45.95 78.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.796 -0.446 . . . . 2.19 109.796 174.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.9 m -57.16 -48.19 79.32 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 117.82 0.282 . . . . 2.69 111.519 175.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -55.09 -52.36 63.48 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.825 0.739 . . . . 3.86 110.565 177.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.4 mt -57.93 -59.41 5.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.004 -0.739 . . . . 2.98 109.004 179.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 59.2 m -51.06 -26.06 5.81 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.772 1.629 . . . . 2.42 112.244 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -64.83 -19.77 66.04 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.77 -0.581 . . . . 4.8 112.359 177.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.5 m -68.87 139.12 55.15 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.731 1.212 . . . . 3.07 111.116 178.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -54.4 -57.29 11.85 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.836 0.854 . . . . 4.7 111.926 177.089 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.44 -36.02 76.77 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 121.237 0.354 . . . . 1.96 112.59 -170.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.49 121.24 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 122.007 -0.702 . . . . 3.44 109.337 -173.102 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.5 m -97.48 -42.95 7.47 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.857 -0.423 . . . . 3.14 109.857 -176.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -144.07 97.41 3.05 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 113.664 0.987 . . . . 3.03 113.664 -178.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -94.09 135.87 34.99 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 107.675 -1.231 . . . . 1.85 107.675 178.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.3 t -129.1 108.42 10.36 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.91 -0.774 . . . . 2.99 108.91 172.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.0 p -100.28 131.12 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.106 1.363 . . . . 3.38 108.926 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -127.25 144.63 51.0 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.799 1.181 . . . . 3.12 109.475 179.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 pp -104.61 -43.72 5.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 124.415 1.086 . . . . 3.87 109.481 -171.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -46.71 -41.85 15.69 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.485 1.114 . . . . 3.87 111.71 173.17 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -106.87 1.96 25.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.671 1.188 . . . . 3.48 111.819 178.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.5 p 60.55 -6.77 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 127.925 2.49 . . . . 3.06 115.498 177.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -98.43 155.42 17.25 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.814 0.846 . . . . 5.05 111.319 -174.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.68 120.56 13.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.883 0.873 . . . . 2.31 110.513 -174.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.8 119.81 34.95 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.287 2.235 . . . . 2.91 107.865 -173.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 22.6 t -128.88 122.77 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 116.27 -1.824 . . . . 3.55 108.602 -168.332 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.91 97.49 6.57 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.965 1.257 . . . . 6.22 110.446 -179.344 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -114.2 -179.46 3.64 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.378 1.049 . . . . 3.57 112.374 -178.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -98.37 109.36 52.14 Favored Pre-proline 0 C--O 1.237 0.444 0 N-CA-C 107.454 -1.313 . . . . 3.19 107.454 176.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -78.12 69.93 7.32 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.885 2.39 . . . . 3.02 110.747 -171.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -163.31 -46.13 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.935 1.694 . . . . 4.28 109.063 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 pt -85.62 -33.1 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 117.693 0.224 . . . . 3.87 111.021 -177.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.17 160.06 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.119 -1.067 . . . . 2.91 108.119 177.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.82 156.13 24.68 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.228 -1.149 . . . . 2.48 110.228 -177.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -59.77 -33.93 96.08 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.74 2.96 . . . . 2.65 111.887 -174.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -54.87 -35.32 63.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.235 -0.29 . . . . 6.05 110.934 177.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -70.54 -40.79 73.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.272 -1.01 . . . . 3.32 108.272 -174.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 62.1 mt -53.51 -57.86 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.83 -0.804 . . . . 3.23 108.83 174.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.8 pt -56.16 -51.09 66.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 118.291 -0.861 . . . . 4.06 111.056 178.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -53.94 -47.81 70.89 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.952 1.251 . . . . 4.77 111.352 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.6 mm -57.4 -50.57 76.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 121.545 -0.722 . . . . 3.61 109.712 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.282 2.7 pp -70.85 -26.17 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 119.113 -1.035 . . . . 2.32 113.245 -177.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.09 -37.29 79.5 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.093 0.957 . . . . 4.02 110.42 169.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.88 -31.14 72.22 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.794 -0.566 . . . . 4.7 110.071 176.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.5 mt -73.36 -39.55 55.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.578 -0.527 . . . . 2.82 109.578 170.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.81 26.06 5.44 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.917 1.723 . . . . 1.35 111.454 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -104.28 179.96 4.12 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.14 -1.43 . . . . 4.12 107.14 175.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -142.28 130.58 22.24 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.63 -1.248 . . . . 5.22 107.63 173.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.91 81.88 1.84 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.133 0.973 . . . . 2.43 109.492 -168.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.8 m -97.75 120.2 37.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.162 -0.681 . . . . 2.69 109.162 -170.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -40.06 107.8 0.08 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.381 1.473 . . . . 4.35 110.631 164.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.36 43.88 2.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.24 0.83 . . . . 5.63 113.24 -175.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 . . . . . 0 C--O 1.252 1.235 0 CA-C-O 117.305 -1.331 . . . . 6.07 111.159 167.528 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.12 -0.696 . . . . 3.84 109.12 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -96.38 134.33 39.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.764 -1.569 . . . . 6.9 106.764 176.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.9 t -116.82 133.45 56.0 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 124.036 0.835 . . . . 2.96 109.204 -179.275 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -103.61 103.57 13.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.59 1.156 . . . . 4.22 109.756 -170.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.65 172.02 10.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.116 0.96 . . . . 3.99 112.516 176.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.14 153.86 43.98 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.251 -1.388 . . . . 1.92 107.251 168.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.4 mm -98.94 139.9 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 106.815 -1.55 . . . . 2.15 106.815 170.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 mtmm -111.71 112.33 23.95 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.239 -1.763 . . . . 3.84 106.239 159.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.16 -81.95 0.17 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.211 1.386 . . . . 1.29 110.132 -177.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.5 mtm 29.28 77.13 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.958 2.103 . . . . 2.94 114.707 -175.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.4 p -57.19 -43.02 82.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.605 0.762 . . . . 4.12 112.153 176.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.7 t 111.13 -42.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.965 2.506 . . . . 3.19 110.715 175.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.28 -67.42 0.19 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.41 1.484 . . . . 6.75 112.146 -174.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.99 24.24 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.922 0.489 . . . . 3.12 111.384 167.052 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.5 m -70.86 -45.82 63.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 120.974 -1.079 . . . . 2.22 109.939 -172.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.5 t -57.04 -49.78 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.08 -1.081 . . . . 2.55 108.08 175.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -54.19 -45.44 72.17 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.895 1.278 . . . . 2.32 111.868 -178.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.01 -50.39 68.68 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 121.654 -0.654 . . . . 2.49 109.837 174.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mt -49.39 -41.24 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 124.238 1.015 . . . . 2.64 110.792 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -47.49 -56.24 7.44 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.514 0.597 . . . . 3.99 111.542 176.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -64.45 -46.64 82.29 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.463 -0.569 . . . . 6.08 109.463 -177.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -55.07 -55.46 30.74 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 109.207 -0.664 . . . . 1.4 109.207 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.48 -43.98 88.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.633 -0.699 . . . . 4.04 110.371 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -50.78 -33.85 25.05 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.283 1.401 . . . . 2.58 112.474 170.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -95.97 19.02 12.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.927 0.891 . . . . 3.51 112.165 -177.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.34 -74.78 0.15 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.911 0.884 . . . . 2.98 109.535 174.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -163.26 -117.61 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.861 -0.524 . . . . 2.22 111.193 -170.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.18 -31.13 72.29 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.456 -0.658 . . . . 1.75 111.456 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.01 125.17 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 122.916 0.486 . . . . 2.45 111.274 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.08 52.17 1.38 Allowed 'General case' 0 CA--C 1.522 -0.103 0 CA-C-O 122.325 1.059 . . . . 4.01 109.705 170.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -156.46 154.73 30.87 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.403 -1.332 . . . . 2.66 107.403 169.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -141.02 119.57 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.904 -1.887 . . . . 3.7 105.904 176.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tt -131.06 70.34 1.47 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.415 -1.328 . . . . 3.16 107.415 176.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.9 t -98.53 130.21 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.294 -1.002 . . . . 2.76 108.294 175.181 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.93 97.08 8.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.298 -1.371 . . . . 2.16 107.298 168.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.1 -23.33 54.4 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.059 0.544 . . . . 3.64 111.082 175.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 52.0 mtt -75.44 -55.16 5.96 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.672 -0.642 . . . . 4.61 110.12 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.58 -22.84 37.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.968 0.507 . . . . 1.9 111.823 -175.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.48 61.78 2.88 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 124.209 0.909 . . . . 1.13 111.047 -178.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -140.91 140.17 34.46 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.834 -1.543 . . . . 4.11 106.834 172.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.0 99.11 7.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.113 1.365 . . . . 1.85 109.855 174.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.22 135.94 37.37 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 104.61 -2.367 . . . . 3.72 104.61 166.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 pt -131.12 -179.17 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.324 -1.361 . . . . 2.7 107.324 169.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -132.87 104.85 6.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.215 -0.661 . . . . 4.89 109.215 173.358 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -119.7 167.18 12.3 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.825 1.65 . . . . 4.45 112.553 178.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.48 100.72 19.7 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.745 1.618 . . . . 4.04 109.803 -174.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.55 -11.08 18.51 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.094 2.53 . . . . 2.52 114.074 -173.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -85.75 -20.45 29.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.718 0.807 . . . . 5.08 112.505 179.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 m -120.34 -39.91 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-O 118.635 -0.698 . . . . 4.36 111.554 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.18 139.01 35.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 123.282 0.633 . . . . 2.54 109.505 176.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -114.92 154.05 47.02 Favored Pre-proline 0 N--CA 1.451 -0.385 0 C-N-CA 125.779 1.632 . . . . 2.69 111.026 -178.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.97 -39.01 43.07 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.061 2.507 . . . . 1.4 112.659 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -64.79 -46.73 80.83 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.148 -0.97 . . . . 3.78 111.635 -174.34 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.11 -33.61 75.83 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.207 0.603 . . . . 4.81 112.216 175.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.12 -47.61 43.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 107.756 -1.201 . . . . 1.88 107.756 163.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.47 -48.8 79.57 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.456 -0.793 . . . . 1.92 109.597 -173.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -47.5 -49.85 24.84 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.903 0.32 . . . . 3.41 110.806 176.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.75 -53.49 54.34 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.376 0.608 . . . . 4.03 110.969 -176.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.71 -39.81 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 118.774 -0.631 . . . . 5.18 111.847 178.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -63.21 -42.36 99.28 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.612 1.097 . . . . 2.58 109.201 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.08 -49.44 75.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.498 0.719 . . . . 2.73 109.355 -179.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.1 mt -54.9 -38.66 67.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.397 -0.365 . . . . 2.72 111.77 172.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.65 29.71 2.38 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 123.891 0.758 . . . . 1.4 111.601 168.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -116.72 154.16 31.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.34 1.456 . . . . 3.78 107.681 173.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -95.72 128.07 42.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.648 -1.612 . . . . 3.01 106.648 164.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.33 133.57 51.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.455 -2.054 . . . . 1.88 105.455 163.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.05 140.29 41.93 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.498 1.124 . . . . 2.31 108.638 171.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.27 147.37 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.221 -1.029 . . . . 3.76 108.221 -179.14 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.6 mtp . . . . . 0 N--CA 1.451 -0.375 0 C-N-CA 123.765 0.826 . . . . 4.48 111.033 179.061 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 N-CA-C 107.557 -2.217 . . . . 2.56 107.557 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -104.0 133.4 49.02 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.691 0.796 . . . . 3.96 109.642 175.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.7 158.1 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.963 -1.125 . . . . 3.99 107.963 171.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.88 144.38 46.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.092 -1.818 . . . . 3.48 106.092 166.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mt -140.85 150.65 43.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.072 -1.825 . . . . 3.71 106.072 168.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.25 126.18 43.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.698 -1.223 . . . . 3.08 107.698 177.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.7 pt -98.47 127.29 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.682 -0.859 . . . . 3.15 108.682 -175.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.7 m -119.42 137.37 53.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.46 -0.941 . . . . 2.18 108.46 177.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.22 -45.75 1.16 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.336 1.446 . . . . 1.25 111.295 175.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 157.31 27.81 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.1 -0.647 . . . . 3.61 111.423 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -168.54 52.07 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.007 0.923 . . . . 3.75 109.341 171.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -165.63 137.33 3.98 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 120.882 -1.137 . . . . 3.46 109.751 178.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.47 -42.04 31.43 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.868 0.867 . . . . 3.95 111.01 175.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -55.3 -49.06 73.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.204 0.602 . . . . 2.5 110.792 175.45 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 79.0 m -63.65 -46.75 84.21 Favored 'General case' 0 N--CA 1.458 -0.053 0 O-C-N 121.707 -0.62 . . . . 2.49 109.729 -178.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.81 -49.29 70.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 122.777 0.431 . . . . 2.62 110.708 175.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -57.74 -41.76 82.54 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.119 0.568 . . . . 4.97 110.707 175.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -63.09 -41.47 99.4 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.672 -0.643 . . . . 1.94 110.686 177.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.9 mt -61.35 -52.27 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.576 0.75 . . . . 2.14 109.698 175.069 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.87 -39.09 76.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.501 -0.749 . . . . 2.34 109.473 177.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.8 t -60.66 -56.8 16.94 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.626 0.771 . . . . 1.9 110.671 176.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -30.72 70.89 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 120.303 1.41 . . . . 5.47 111.343 -175.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 mt -67.5 -59.61 3.23 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 109.233 -0.655 . . . . 2.66 109.233 171.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.7 m -54.96 -19.92 7.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.912 0.885 . . . . 2.79 111.777 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.04 -33.04 66.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.831 0.852 . . . . 5.83 111.992 173.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.3 p -75.45 166.09 24.13 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.927 0.891 . . . . 4.08 111.604 -173.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.68 -40.38 34.08 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.243 -0.286 . . . . 3.5 111.572 178.539 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.55 -35.06 37.78 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 122.833 0.254 . . . . 1.71 113.582 -169.002 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.36 133.09 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 O-C-N 121.658 -0.907 . . . . 3.06 109.128 -174.075 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.8 p -107.63 -53.44 2.62 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 122.905 0.482 . . . . 3.38 111.816 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.51 126.09 32.11 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.55 -0.907 . . . . 3.19 108.55 169.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.57 153.61 18.91 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.025 -1.102 . . . . 2.1 108.025 161.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.8 m -144.7 116.92 8.42 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.139 -1.06 . . . . 2.46 108.139 166.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 p -118.12 132.33 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.745 0.818 . . . . 2.94 110.446 -174.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -129.57 98.66 4.91 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.142 0.977 . . . . 2.49 110.878 -172.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -25.4 66.23 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.686 1.194 . . . . 3.25 112.445 -176.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.83 -32.56 53.27 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.114 0.566 . . . . 2.85 111.033 173.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.07 -9.14 12.39 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.369 1.468 . . . . 2.65 111.166 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.0 m 63.03 31.78 15.82 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.831 1.652 . . . . 2.29 112.407 -178.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.3 mmtm -105.35 153.54 21.51 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.613 0.765 . . . . 4.63 110.929 176.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.84 113.82 15.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.985 2.114 . . . . 2.03 107.19 173.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.06 134.18 38.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.143 -1.429 . . . . 2.78 107.143 173.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.4 t -135.33 129.62 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 124.027 0.931 . . . . 3.08 108.578 -174.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -111.96 93.61 4.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.43 1.092 . . . . 3.92 109.148 178.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -119.9 175.01 6.1 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.709 0.804 . . . . 3.07 111.627 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -97.86 115.75 65.74 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.672 -0.862 . . . . 3.7 108.672 174.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -76.45 71.19 6.0 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.444 2.763 . . . . 2.11 111.275 -171.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -161.62 -46.01 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.169 1.387 . . . . 4.13 109.305 177.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -87.48 -32.33 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 123.256 0.623 . . . . 2.99 111.469 -174.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.92 165.15 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 124.258 1.023 . . . . 2.48 108.406 176.436 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.91 168.37 32.34 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.403 -0.679 . . . . 1.47 111.403 -178.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.68 -34.87 49.41 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.839 3.026 . . . . 1.6 112.583 -172.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -44.94 87.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.594 -0.891 . . . . 5.92 108.594 177.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.08 -41.68 94.83 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.47 -0.937 . . . . 3.26 108.47 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 83.2 mt -55.08 -57.39 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 117.749 -1.12 . . . . 2.24 109.99 176.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . 0.264 18.0 pt -52.45 -56.03 8.51 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 CA-C-N 119.109 0.868 . . . . 3.56 109.998 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -48.86 -52.2 25.56 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.135 0.969 . . . . 4.48 111.926 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.69 -33.65 61.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 118.785 -0.626 . . . . 3.59 110.507 -175.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.35 2.6 pp -75.26 -32.33 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 114.891 1.441 . . . . 2.17 114.891 168.331 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.97 -34.21 69.7 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.307 0.958 . . . . 2.2 109.634 174.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.86 -35.88 82.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.085 0.469 . . . . 3.78 109.929 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 32.7 mm -76.18 -42.66 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.277 -0.638 . . . . 3.61 109.277 173.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.5 41.13 1.06 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.1 1.333 . . . . 1.01 111.59 178.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -112.54 -180.0 3.82 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.365 -0.976 . . . . 3.73 108.365 166.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -133.63 132.96 41.39 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.89 -1.152 . . . . 4.88 107.89 171.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.67 95.03 4.68 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 123.981 0.912 . . . . 1.84 109.778 -175.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.7 t -110.01 121.41 45.18 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.255 0.622 . . . . 2.95 109.852 -172.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -38.64 115.97 0.51 Allowed 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 126.37 1.868 . . . . 4.76 110.89 171.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -103.26 30.77 4.68 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.151 1.167 . . . . 3.9 114.151 -178.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.301 0 CA-C-O 116.999 -1.477 . . . . 7.76 111.571 177.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.226 -0.136 0 CA-C-O 120.894 0.378 . . . . 4.04 110.821 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.1 143.13 29.71 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.991 -0.443 . . . . 4.94 110.912 179.02 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -125.94 131.63 52.25 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.413 1.085 . . . . 3.07 108.109 177.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -113.71 97.25 6.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.69 -1.226 . . . . 6.24 107.69 -171.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -122.36 177.09 5.53 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.829 0.824 . . . . 3.43 110.508 -178.13 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.12 147.49 52.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.317 -1.734 . . . . 1.81 106.317 174.51 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.4 mm -98.38 132.36 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 106.814 -1.55 . . . . 1.77 106.814 177.259 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -111.46 109.14 18.95 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.171 -1.418 . . . . 6.08 107.171 170.004 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.94 -83.91 0.09 OUTLIER Glycine 0 CA--C 1.532 1.106 0 N-CA-C 110.159 -1.176 . . . . 1.15 110.159 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 47.52 70.46 0.42 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.746 1.618 . . . . 2.46 114.203 179.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.9 m -49.09 -59.33 3.73 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.451 -0.781 . . . . 3.12 112.521 170.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 t -168.59 63.66 0.06 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.541 1.064 . . . . 3.21 111.212 -175.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 31.86 56.82 0.33 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.076 1.75 . . . . 6.79 113.411 177.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.1 t -169.17 -49.52 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 122.762 1.268 . . . . 3.15 108.39 -167.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 19.7 p -61.87 -40.57 95.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.511 -0.743 . . . . 4.0 110.529 178.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 50.9 t -70.87 -31.25 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.924 -0.769 . . . . 3.23 108.924 173.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -58.57 -31.76 68.3 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.487 -0.758 . . . . 2.37 111.464 175.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -55.38 -50.05 70.71 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.231 -0.918 . . . . 4.31 109.642 170.092 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -46.93 -47.24 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 125.546 1.539 . . . . 3.73 110.023 -176.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -50.47 -59.02 4.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.449 1.119 . . . . 3.76 109.626 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -70.0 -19.31 63.33 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.997 -1.065 . . . . 5.35 112.422 -177.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -70.24 -56.0 7.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.939 -0.763 . . . . 1.15 108.939 168.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mp -59.41 -34.87 72.99 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.59 -0.694 . . . . 3.18 112.412 179.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.71 -20.87 15.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.891 1.223 . . . . 3.78 112.022 178.066 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -128.68 36.07 4.28 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.283 0.633 . . . . 5.84 110.9 174.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -67.78 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.804 -0.813 . . . . 3.26 108.804 167.7 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.27 -128.73 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.715 0.806 . . . . 2.46 108.926 -163.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.12 -20.26 68.88 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.679 0.656 . . . . 2.19 112.984 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.44 124.06 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 117.557 0.679 . . . . 3.14 110.561 176.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.85 57.53 1.56 Allowed 'General case' 0 C--N 1.339 0.129 0 CA-C-O 121.573 0.701 . . . . 3.82 110.343 172.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -155.97 159.63 39.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.863 -1.162 . . . . 2.8 107.863 160.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.85 114.8 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.672 0.789 . . . . 3.83 109.252 170.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -127.23 74.61 1.52 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.534 -0.913 . . . . 3.78 108.534 176.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.93 142.26 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 N-CA-C 109.378 -0.601 . . . . 3.39 109.378 171.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.44 94.46 4.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.772 -1.196 . . . . 2.75 107.772 165.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.08 -18.83 10.79 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.937 0.895 . . . . 4.97 112.198 172.69 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.9 ttm -66.07 -44.22 85.09 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.361 1.064 . . . . 5.0 110.62 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.77 -29.24 12.74 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.077 0.951 . . . . 2.54 111.126 -178.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.39 63.19 1.51 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.111 -1.196 . . . . 1.38 110.111 -177.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -140.4 132.11 27.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.008 -2.219 . . . . 4.34 105.008 174.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.69 105.27 12.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.555 1.159 . . . . 1.81 110.011 170.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.9 137.51 41.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.712 -1.218 . . . . 5.33 107.712 169.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.46 173.27 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.525 0.602 . . . . 3.1 110.227 171.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -116.39 102.2 9.32 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.081 1.352 . . . . 7.21 110.239 174.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -98.6 173.74 6.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.092 1.357 . . . . 4.44 113.055 171.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -124.07 100.01 36.97 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.553 1.541 . . . . 3.44 108.192 -179.132 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.8 5.36 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.72 1 C-N-CA 125.387 4.058 . . . . 3.22 115.35 -166.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.05 -17.23 16.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.533 1.533 . . . . 4.72 110.359 -177.073 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.0 p -124.86 -41.23 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.498 1.119 . . . . 5.18 110.933 178.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.36 143.6 26.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 N-CA-C 108.794 -0.817 . . . . 2.87 108.794 179.286 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.37 149.89 50.66 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 124.842 1.257 . . . . 3.59 109.402 -176.15 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -57.34 -39.34 90.38 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.951 2.434 . . . . 2.25 111.228 -177.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -60.02 -39.94 87.58 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.222 0.609 . . . . 4.53 110.995 175.021 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -65.46 -43.33 90.69 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.118 -0.697 . . . . 3.83 109.118 178.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.77 -50.52 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.625 -1.25 . . . . 2.32 107.625 174.51 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.48 66.72 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.585 -0.734 . . . . 2.24 110.807 -174.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -52.54 -49.75 64.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.728 0.811 . . . . 4.86 110.526 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -47.84 80.76 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 122.009 0.909 . . . . 4.46 109.298 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mm -59.37 -42.91 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.581 -0.736 . . . . 3.3 111.001 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -67.3 -39.05 85.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.392 0.277 . . . . 2.48 110.43 179.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.01 -54.6 44.1 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.219 1.008 . . . . 3.79 109.847 176.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.63 -46.45 73.91 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.776 -0.193 . . . . 4.81 110.829 175.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.72 39.87 0.41 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.429 -1.068 . . . . 1.77 110.429 162.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -129.65 164.96 22.77 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.222 -1.399 . . . . 3.78 107.222 178.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -98.51 132.37 44.0 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.872 -1.159 . . . . 2.5 107.872 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.54 116.51 31.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.578 -1.267 . . . . 2.57 107.578 173.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.57 138.8 50.34 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.203 -1.036 . . . . 1.83 108.203 173.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -67.01 146.3 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.3 -1.0 . . . . 3.96 108.3 178.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.1 mtp . . . . . 0 CA--C 1.535 0.368 0 C-N-CA 119.967 -0.693 . . . . 4.65 110.508 -179.754 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.429 0 N-CA-C 109.298 -1.521 . . . . 3.18 109.298 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -111.69 145.94 38.39 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 126.011 1.724 . . . . 4.78 107.548 166.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.281 1.1 pp -114.95 140.15 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.363 0.528 . . . . 5.58 109.762 150.643 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.64 123.34 48.34 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.603 2.361 . . . . 3.55 107.205 175.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.95 151.72 39.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 123.452 0.47 . . . . 4.5 110.188 173.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -94.66 126.76 40.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.582 -2.377 . . . . 3.23 104.582 175.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 pt -99.03 130.06 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.376 -0.972 . . . . 3.02 108.376 176.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.4 m -123.97 141.95 51.59 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.416 -0.957 . . . . 3.09 108.416 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.08 -37.36 3.76 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.621 1.105 . . . . 1.55 111.361 -178.387 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.27 159.06 12.93 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.053 0.541 . . . . 3.6 111.998 177.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.9 t -175.0 48.95 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.019 0.927 . . . . 4.13 110.229 170.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 8.5 t -160.39 144.26 13.96 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.958 -1.088 . . . . 4.33 111.715 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.22 -10.48 23.65 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.02 0.928 . . . . 3.98 113.305 178.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.7 t -79.2 -46.28 18.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.563 0.745 . . . . 2.99 109.091 170.009 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 5.1 t -56.95 -53.64 55.77 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 121.762 -0.586 . . . . 4.0 110.264 -177.215 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 p -51.22 -43.32 27.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.553 0.205 . . . . 3.96 111.553 175.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -32.51 74.18 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.363 0.665 . . . . 3.86 109.985 179.053 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -66.96 -56.9 8.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.804 1.242 . . . . 2.43 108.507 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 mp -45.59 -60.38 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 C-N-CA 124.471 1.108 . . . . 2.8 110.265 167.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -52.4 -44.4 65.35 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.465 0.575 . . . . 2.9 111.772 -178.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.0 t -65.4 -60.26 3.15 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.018 -1.051 . . . . 1.84 110.883 178.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -33.46 75.65 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.525 -0.734 . . . . 5.19 111.147 -171.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.93 -49.78 48.48 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.249 -0.882 . . . . 4.37 109.256 171.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.2 m -57.4 -24.43 55.38 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.164 1.347 . . . . 2.95 111.183 -177.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -57.22 -30.99 65.04 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.099 0.778 . . . . 4.87 113.099 172.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.8 m -57.03 153.98 10.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.799 1.24 . . . . 2.7 111.868 175.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -73.8 -56.19 5.28 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.826 1.25 . . . . 2.97 112.533 -176.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.45 -34.86 53.45 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 121.88 -0.513 . . . . 1.79 112.016 -171.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.18 132.56 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.184 -0.672 . . . . 3.03 109.184 -175.395 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.5 m -121.1 -38.57 2.8 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 112.965 0.728 . . . . 3.05 112.965 -177.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -142.27 140.41 32.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.884 -1.127 . . . . 4.1 110.235 164.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.86 161.43 18.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.964 -1.016 . . . . 2.27 109.789 160.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -142.44 118.94 10.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.228 -1.767 . . . . 3.22 106.228 165.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 42.9 t -112.57 129.25 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 118.196 0.453 . . . . 3.62 110.476 178.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -117.66 126.75 53.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.354 1.062 . . . . 2.48 109.189 -177.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mp -90.4 -41.01 11.72 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.794 2.038 . . . . 4.93 108.729 -170.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -43.77 -44.1 6.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.634 1.574 . . . . 2.31 110.324 172.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -100.95 -15.07 17.64 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.729 0.812 . . . . 2.75 112.464 174.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.9 m 65.86 30.58 9.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.971 1.708 . . . . 2.55 113.896 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -106.14 149.86 26.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.534 1.533 . . . . 5.53 110.3 177.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.92 112.64 15.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.154 0.982 . . . . 2.1 108.897 176.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.61 124.52 39.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.869 -1.53 . . . . 3.58 106.869 176.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.5 123.24 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 C-N-CA 125.364 1.466 . . . . 2.9 108.844 -178.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -96.37 100.65 12.25 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.221 -1.029 . . . . 4.48 108.221 -177.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -126.12 174.13 8.71 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 123.833 0.708 . . . . 3.54 109.761 -178.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -104.48 117.56 58.83 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 118.273 -0.87 . . . . 5.24 109.471 177.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -73.78 71.36 4.09 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.401 2.734 . . . . 3.04 111.882 -174.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -166.52 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.864 1.666 . . . . 3.86 110.013 174.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.2 pp -87.09 -41.22 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 118.448 0.567 . . . . 4.17 111.297 -169.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.79 170.22 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.447 1.499 . . . . 3.05 107.557 174.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.36 25.5 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.1 -1.2 . . . . 2.18 110.1 176.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.69 -45.78 23.62 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.021 2.48 . . . . 2.1 110.768 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.4 ttm105 -48.37 -39.45 22.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.679 1.192 . . . . 7.83 113.106 -178.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -53.34 58.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.333 -0.617 . . . . 3.96 109.333 173.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.97 -44.55 82.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 109.442 -0.577 . . . . 2.27 109.442 -178.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.9 mt -51.89 -56.42 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.165 0.986 . . . . 3.08 108.498 174.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -55.17 -43.98 74.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.015 -1.053 . . . . 4.97 112.512 178.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.2 mm -63.92 -34.25 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.704 -0.623 . . . . 2.95 110.35 -177.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 27.3 pt -74.57 -33.52 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 119.812 1.187 . . . . 2.58 113.377 168.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -56.04 -25.98 47.1 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.475 1.034 . . . . 3.06 111.47 176.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.74 -34.49 75.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.835 0.454 . . . . 3.9 110.029 176.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.3 mt -79.31 -44.4 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.178 -0.675 . . . . 3.09 109.178 172.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.77 36.19 2.64 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 124.314 0.959 . . . . 1.43 110.868 -177.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -96.89 168.18 10.64 Favored 'General case' 0 C--N 1.338 0.083 0 N-CA-C 108.23 -1.026 . . . . 4.22 108.23 165.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -125.19 123.01 38.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.226 -1.768 . . . . 4.18 106.226 -177.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -111.0 107.91 17.47 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.838 1.255 . . . . 2.38 108.48 174.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.5 m -108.29 114.95 29.21 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.42 -0.955 . . . . 3.4 108.42 168.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -35.75 107.14 0.05 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 126.735 2.014 . . . . 5.08 110.122 170.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.93 -36.7 25.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.378 -0.601 . . . . 4.71 109.378 -175.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.109 0 C-N-CA 125.668 1.587 . . . . 5.91 112.713 -165.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 . . . . . 0 C--O 1.223 -0.329 0 N-CA-C 109.967 -0.383 . . . . 3.62 109.967 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -90.75 130.85 36.69 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.097 0.959 . . . . 6.09 109.464 -159.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.3 t -138.02 123.33 19.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.971 0.508 . . . . 2.62 110.227 177.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -98.64 106.76 19.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.913 1.685 . . . . 4.02 107.788 174.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.6 171.82 11.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.384 -0.969 . . . . 3.61 108.384 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.21 144.95 35.03 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.314 -0.866 . . . . 2.11 109.352 175.037 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.3 mm -99.16 126.14 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 106.178 -1.786 . . . . 2.83 106.178 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -95.56 99.06 10.98 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.658 -1.608 . . . . 4.55 106.658 174.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.65 -94.18 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.623 -1.391 . . . . 1.76 109.623 178.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.0 mtt 58.66 90.66 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.485 1.514 . . . . 3.5 113.789 179.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -14.72 33.93 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.083 -1.011 . . . . 2.75 113.125 172.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 t 72.88 -59.97 0.55 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 126.239 1.816 . . . . 4.07 112.395 -178.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.25 -74.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.993 2.117 . . . . 5.63 113.103 -174.385 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.5 p -154.24 15.17 0.46 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.668 0.387 . . . . 3.55 111.706 168.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.7 m -69.42 -53.3 20.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.286 -1.376 . . . . 2.7 107.286 -170.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.9 t -61.73 -39.83 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 119.554 -0.858 . . . . 2.96 109.759 -175.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.1 t -53.08 -46.65 68.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.893 0.477 . . . . 2.71 111.311 173.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -63.07 -49.26 75.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.251 -0.906 . . . . 2.67 109.351 176.509 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 mp -49.9 -53.53 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.322 0.649 . . . . 3.12 109.546 178.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -48.62 -52.71 21.69 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.99 1.316 . . . . 4.5 111.5 175.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -70.24 -24.0 63.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.256 -0.902 . . . . 5.52 111.006 -176.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -71.66 -44.81 63.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.305 -0.872 . . . . 1.26 109.933 170.034 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.83 -37.6 79.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.127 0.571 . . . . 2.9 110.947 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -26.97 6.58 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.481 0.549 . . . . 1.94 112.481 172.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -109.7 19.38 19.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.489 1.116 . . . . 5.66 111.381 -177.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -73.76 -67.22 0.62 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.612 -0.884 . . . . 3.23 108.612 174.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.6 -96.55 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.852 1.261 . . . . 2.28 109.443 173.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.38 -5.82 89.58 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.897 -0.502 . . . . 1.39 112.658 -176.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.36 114.11 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 118.044 0.922 . . . . 3.58 109.682 176.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.68 53.05 1.61 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.539 -1.282 . . . . 4.41 107.539 179.109 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.73 153.24 16.72 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.804 -1.184 . . . . 2.27 107.804 158.334 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.2 94.77 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 125.421 1.488 . . . . 3.57 106.989 172.312 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -116.34 66.31 0.71 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.275 -1.379 . . . . 3.37 107.275 176.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 t -97.47 130.92 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.585 -0.894 . . . . 3.02 108.585 175.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.52 96.8 6.98 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.844 -1.169 . . . . 2.3 107.844 175.069 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.58 -12.95 37.11 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.333 0.515 . . . . 4.45 111.888 178.436 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -43.61 13.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.095 0.958 . . . . 6.97 111.41 -178.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.71 -36.26 15.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.74 0.816 . . . . 1.91 111.017 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.19 62.28 1.23 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.53 1.538 . . . . 0.98 111.101 178.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -143.41 138.8 29.6 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.588 -1.634 . . . . 3.96 106.588 177.08 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.37 98.91 8.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 124.443 1.089 . . . . 1.97 112.326 171.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -94.09 131.42 39.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 105.996 -1.853 . . . . 4.92 105.996 169.156 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 pt -133.44 -179.16 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 O-C-N 121.816 -0.552 . . . . 2.59 109.603 170.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -124.68 119.06 27.91 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.728 -0.669 . . . . 4.66 109.768 160.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -114.73 154.66 28.1 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.777 1.631 . . . . 3.22 110.525 170.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.26 111.35 63.47 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.2 0.6 . . . . 3.4 109.704 176.626 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.85 -19.75 69.49 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.837 3.025 . . . . 2.06 112.845 -171.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -62.94 -24.37 67.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.701 -0.666 . . . . 3.74 112.752 177.283 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.87 -43.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 118.944 0.793 . . . . 3.51 111.496 -173.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.19 147.95 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 108.48 -0.933 . . . . 2.23 108.48 176.623 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -126.92 150.96 73.21 Favored Pre-proline 0 N--CA 1.451 -0.379 0 C-N-CA 125.075 1.35 . . . . 2.47 109.179 177.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.27 -36.38 94.99 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.629 2.219 . . . . 1.35 111.69 -175.019 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -41.68 99.25 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 121.916 -0.49 . . . . 4.61 110.959 177.42 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -59.99 -44.45 94.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.101 0.561 . . . . 3.06 109.973 177.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -54.03 -48.48 64.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.988 -1.116 . . . . 1.95 107.988 172.694 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.43 -44.99 95.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.016 -0.538 . . . . 2.08 111.004 -176.334 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -53.54 -50.39 65.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.934 -1.104 . . . . 2.82 110.169 171.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.62 -53.66 48.69 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.427 0.691 . . . . 3.54 109.34 -176.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 pp -68.74 -33.88 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 119.306 -0.958 . . . . 5.11 112.019 -178.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -57.92 -41.45 82.73 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 120.269 1.395 . . . . 2.78 108.574 -179.001 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -60.83 -50.92 71.48 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.619 -0.511 . . . . 2.74 109.619 177.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mt -54.38 -41.91 69.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.058 0.543 . . . . 2.97 111.917 177.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.18 43.71 0.32 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.468 0.556 . . . . 1.15 112.123 164.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -134.2 -177.01 4.39 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.081 1.352 . . . . 3.11 110.198 179.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -114.08 129.21 56.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.093 0.957 . . . . 2.27 108.898 162.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.99 129.32 44.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.253 -1.388 . . . . 2.41 107.253 168.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.47 118.74 12.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.255 -1.387 . . . . 1.78 107.255 173.351 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 t -56.34 153.58 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.683 -0.858 . . . . 3.5 108.683 174.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 111.802 0.297 . . . . 5.21 111.802 178.448 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.721 0 N-CA-C 109.146 -1.582 . . . . 2.56 109.146 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.54 116.37 28.81 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.125 -2.546 . . . . 3.5 104.125 176.722 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.03 161.91 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 O-C-N 125.412 1.695 . . . . 4.32 110.047 170.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.91 125.2 50.71 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 127.329 2.252 . . . . 3.64 110.003 -175.305 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -119.62 127.52 53.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.675 1.19 . . . . 3.94 108.214 172.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.6 m -95.78 122.68 38.82 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.673 -1.603 . . . . 3.15 106.673 176.383 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -102.56 114.0 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.483 1.113 . . . . 2.61 109.979 -172.022 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 84.6 m -107.23 124.0 49.11 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.262 0.625 . . . . 2.34 110.267 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 127.16 -27.92 4.69 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.262 1.41 . . . . 1.0 111.585 177.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 34.8 ttp -71.52 146.24 48.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.88 -0.777 . . . . 3.07 111.661 -176.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 t -164.05 41.52 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.616 0.766 . . . . 3.46 110.817 174.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -163.29 145.05 9.75 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.192 -0.943 . . . . 3.66 111.551 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.75 -42.04 67.78 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.252 1.021 . . . . 3.2 111.787 176.087 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -53.46 -48.77 68.56 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.732 -0.605 . . . . 2.53 110.12 174.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 96.7 m -64.8 -41.45 95.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.082 0.553 . . . . 2.58 110.26 -178.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -52.47 -51.95 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.227 -0.286 . . . . 2.27 110.227 169.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.11 -33.22 75.0 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.826 -0.435 . . . . 4.22 109.826 -176.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -65.28 -57.15 9.17 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.489 1.116 . . . . 2.46 109.576 178.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.5 mt -56.2 -51.42 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 121.457 -0.777 . . . . 2.1 110.098 177.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.82 -45.96 85.38 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.542 -0.742 . . . . 2.42 110.101 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.3 t -49.25 -53.72 20.22 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.283 0.947 . . . . 2.19 109.76 172.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -31.36 72.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.809 -0.557 . . . . 3.9 111.067 -172.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.6 mt -72.23 -61.39 1.81 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.536 -0.913 . . . . 3.07 108.536 174.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 60.9 p -54.41 -19.66 6.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.601 1.161 . . . . 3.15 113.099 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -57.53 -33.42 68.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.697 0.68 . . . . 5.29 112.03 171.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.7 m -62.38 132.04 51.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.599 1.56 . . . . 2.68 111.069 -176.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.04 -53.89 46.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.319 0.648 . . . . 4.83 112.473 177.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.87 -16.95 78.17 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.837 -0.424 . . . . 1.61 113.394 -169.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.2 tt -68.86 133.84 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 118.387 1.094 . . . . 3.0 109.171 -176.195 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.9 m -104.32 -51.62 3.08 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 121.929 0.092 . . . . 3.33 110.859 -177.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -141.49 116.44 9.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.091 -0.707 . . . . 4.1 109.091 176.448 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.12 143.27 32.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.049 -0.723 . . . . 1.86 109.049 163.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.0 m -135.89 119.58 17.18 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.126 -1.064 . . . . 2.2 108.126 174.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.5 p -117.53 131.91 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.572 1.149 . . . . 3.16 110.601 -177.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -128.59 86.67 2.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.027 0.931 . . . . 2.23 110.298 -172.204 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -53.93 -26.56 26.01 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.997 1.319 . . . . 3.47 113.012 179.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.81 -34.83 65.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.417 0.687 . . . . 2.47 110.967 176.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.74 -10.04 11.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.821 1.649 . . . . 2.51 111.393 -178.293 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.7 m 69.46 22.39 6.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.836 2.054 . . . . 2.58 112.318 178.446 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -102.43 156.06 17.85 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 125.291 1.437 . . . . 5.38 111.343 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.06 115.82 7.74 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.089 1.355 . . . . 1.66 110.462 174.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.03 126.42 37.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.219 -1.4 . . . . 3.37 107.219 170.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.3 131.4 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.928 1.691 . . . . 2.89 107.409 176.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -115.07 95.9 5.43 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.038 1.335 . . . . 3.78 110.023 178.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.48 -176.77 3.15 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.494 1.118 . . . . 3.16 111.22 -177.133 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -106.77 111.31 63.89 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.097 -1.075 . . . . 3.14 108.097 175.044 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.21 68.3 7.93 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.916 2.411 . . . . 1.77 111.626 -167.339 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -162.57 -42.95 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.471 1.508 . . . . 3.0 109.729 174.481 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pp -79.39 -35.98 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.296 0.57 . . . . 3.26 110.168 -175.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.6 166.02 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.601 1.56 . . . . 2.08 108.955 179.165 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.41 168.44 29.08 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.066 -1.614 . . . . 1.43 109.066 178.076 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.35 -44.59 36.92 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.42 2.746 . . . . 1.49 111.851 -172.278 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -46.08 -42.27 13.32 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.183 1.179 . . . . 6.94 114.183 -177.204 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.51 -47.48 83.75 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.512 -0.475 . . . . 3.25 109.72 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 85.1 mt -58.59 -45.86 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.929 -0.767 . . . . 1.83 108.929 178.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 83.6 mt -51.93 -59.47 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.541 -0.911 . . . . 3.03 108.541 174.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -46.24 66.78 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.874 0.761 . . . . 4.92 111.245 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.2 mm -54.66 -50.66 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 121.413 -0.804 . . . . 2.69 110.119 177.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.261 2.5 pp -71.14 -26.12 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.01 -1.056 . . . . 2.55 113.653 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.82 -38.77 76.17 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.762 0.71 . . . . 3.22 109.848 168.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -59.84 -40.73 89.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.57 0.7 . . . . 3.18 109.182 -179.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 51.2 mt -70.63 -42.01 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.361 0.664 . . . . 1.93 109.827 175.573 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.1 34.19 5.21 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.434 1.493 . . . . 0.96 111.187 -175.535 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -99.88 176.14 5.54 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.098 0.949 . . . . 3.8 110.019 168.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -129.86 111.42 12.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.704 -1.591 . . . . 5.66 106.704 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.0 103.03 12.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.682 1.193 . . . . 1.83 107.982 178.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.8 m -109.66 110.33 21.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.664 1.586 . . . . 2.46 107.144 -174.233 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.45 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.405 1.482 . . . . 4.52 111.384 -178.224 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 50.31 33.35 7.33 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.325 0.861 . . . . 4.61 113.325 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.331 -1.318 . . . . 8.97 109.826 -166.699 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 121.533 0.682 . . . . 3.43 110.327 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -92.83 123.12 35.86 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.617 1.167 . . . . 6.59 109.896 -171.043 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 t -108.99 124.29 50.47 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.188 -1.042 . . . . 3.1 108.188 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -102.47 103.66 14.05 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.187 1.395 . . . . 4.33 107.48 -178.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -130.63 173.99 10.35 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.926 0.869 . . . . 4.02 111.036 176.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -122.44 150.29 42.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.032 -0.986 . . . . 3.86 108.757 173.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.2 mm -99.32 113.73 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 106.51 -1.663 . . . . 2.08 106.51 173.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -99.47 93.46 5.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.587 -1.264 . . . . 3.77 107.587 175.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.18 -77.29 0.08 OUTLIER Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.637 -0.985 . . . . 1.28 110.637 178.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.0 mmt 54.31 88.27 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.291 1.836 . . . . 2.33 113.79 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 m -55.85 -64.39 0.87 Allowed 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.259 -0.901 . . . . 3.61 112.477 177.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.7 t -169.7 56.19 0.04 OUTLIER 'General case' 0 C--N 1.345 0.397 0 CA-C-N 118.46 0.573 . . . . 3.71 109.945 -176.172 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 41.47 49.09 3.49 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.769 1.227 . . . . 6.72 112.707 178.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.4 t -164.18 -45.13 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.304 0.642 . . . . 3.46 110.264 -172.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.5 t -66.44 -36.82 83.75 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 120.743 -1.223 . . . . 2.25 110.277 -178.37 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.8 t -63.58 -30.63 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.657 0.741 . . . . 2.99 110.012 173.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -66.33 -31.03 71.57 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.54 -0.725 . . . . 2.27 110.884 175.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.74 -48.82 65.38 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.096 -1.003 . . . . 2.99 110.232 169.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mt -38.52 -44.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.598 0.759 . . . . 2.74 112.163 171.022 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -42.81 -57.8 2.63 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.536 0.734 . . . . 5.15 112.509 178.412 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -67.23 -40.25 86.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.225 -0.287 . . . . 6.24 110.225 -177.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -56.09 -53.53 55.89 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.767 -0.827 . . . . 1.22 108.767 -177.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.16 -43.83 97.96 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 119.493 -0.289 . . . . 3.96 111.279 177.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -22.21 24.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.872 0.76 . . . . 2.51 112.967 176.635 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -115.53 33.65 5.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.433 0.693 . . . . 3.88 111.549 175.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -84.73 -88.81 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.704 -1.591 . . . . 3.34 106.704 168.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -143.74 -126.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.908 1.283 . . . . 2.18 109.837 178.147 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.49 32.85 1.38 Allowed Glycine 0 CA--C 1.532 1.139 0 O-C-N 120.7 -1.25 . . . . 2.19 113.709 -171.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.19 117.99 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 106.936 -1.505 . . . . 2.68 106.936 174.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.05 53.38 1.57 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.211 1.005 . . . . 4.41 109.718 -178.547 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.5 m -161.84 132.08 4.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.146 -1.427 . . . . 3.09 107.146 171.586 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.75 117.04 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.414 -1.328 . . . . 4.1 107.414 176.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 tt -124.87 78.03 1.66 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.332 -0.988 . . . . 3.28 108.332 -179.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 t -99.98 137.1 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.182 -0.673 . . . . 2.9 109.182 173.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.93 98.39 7.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.543 -0.91 . . . . 2.15 108.543 169.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.94 -8.66 7.57 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.205 1.002 . . . . 3.93 112.865 175.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.3 mtt -80.34 -48.63 12.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.113 0.965 . . . . 5.09 110.011 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.59 -27.3 17.44 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.793 0.837 . . . . 2.21 111.805 -175.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 61.67 2.25 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.764 -0.934 . . . . 1.16 110.764 -177.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -140.0 139.08 35.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.38 -1.711 . . . . 3.39 106.38 173.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.21 105.1 13.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.439 1.087 . . . . 2.18 109.91 165.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -97.63 133.68 41.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.538 -2.023 . . . . 3.67 105.538 164.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 pt -129.94 167.05 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.54 -1.281 . . . . 3.3 107.54 169.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.37 105.12 10.59 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 124.393 1.077 . . . . 6.12 108.794 172.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -104.66 -179.51 3.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.255 1.822 . . . . 4.21 111.46 175.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.4 108.18 17.54 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.342 1.057 . . . . 3.83 111.316 175.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.43 -7.97 22.36 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.242 2.628 . . . . 2.23 113.586 -168.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.41 -16.37 57.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.222 0.919 . . . . 3.17 111.393 173.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.9 t -124.73 -47.89 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 118.476 0.58 . . . . 3.57 110.23 -172.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.85 146.79 20.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.014 0.925 . . . . 2.74 109.029 -173.425 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -123.48 154.88 66.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 124.213 1.005 . . . . 2.96 113.178 179.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.87 -38.19 81.14 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.547 2.165 . . . . 1.65 111.243 174.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 mp -54.44 -60.54 3.2 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.391 -0.818 . . . . 3.82 111.494 178.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -57.13 -35.29 69.3 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.325 -0.859 . . . . 3.86 112.734 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.28 -41.45 61.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.94 -0.763 . . . . 2.09 108.94 171.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.51 -38.59 81.34 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.076 -0.511 . . . . 2.52 111.341 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -63.48 -51.15 66.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.197 -0.939 . . . . 3.02 109.98 175.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.22 -52.22 59.62 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.376 0.608 . . . . 3.52 111.424 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pp -65.46 -37.82 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.283 -0.886 . . . . 5.17 112.308 -179.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.93 -31.88 71.94 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.04 0.837 . . . . 2.98 110.683 177.232 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.57 -52.45 63.38 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 109.252 -0.647 . . . . 3.53 109.252 174.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -55.0 -42.71 72.85 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.673 0.249 . . . . 4.37 111.673 172.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.28 48.39 0.43 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.293 0.949 . . . . 1.34 111.129 171.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -135.04 162.92 31.08 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.509 1.124 . . . . 3.61 109.675 -176.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -100.27 122.99 43.95 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.892 1.277 . . . . 4.03 107.623 167.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.16 82.67 1.98 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.512 1.525 . . . . 1.69 108.824 172.154 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.66 101.82 13.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.611 -1.177 . . . . 2.49 108.985 -176.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.36 158.28 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.438 1.495 . . . . 4.39 112.08 176.649 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.38 0 CA-C-N 114.853 -1.067 . . . . 7.67 111.287 167.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.889 0 N-CA-C 110.487 -1.045 . . . . 3.73 110.487 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.405 ' CG ' ' HE3' ' A' ' 123' ' ' LYS . 21.0 t30 -106.01 131.83 52.83 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 117.599 0.7 . . . . 3.66 109.909 153.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.54 169.0 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 130.776 3.63 . . . . 4.28 105.627 175.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -117.06 119.79 36.35 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.953 1.701 . . . . 4.14 110.07 179.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.2 mt -113.63 137.62 51.34 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.316 0.646 . . . . 3.26 109.444 -179.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 m -100.48 131.11 46.57 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 108.171 -1.048 . . . . 2.31 108.171 173.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -95.53 122.62 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.748 1.619 . . . . 3.03 107.762 175.64 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 63.8 m -112.22 134.59 53.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.922 -1.14 . . . . 2.49 107.922 175.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 112.14 -36.3 4.22 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.495 1.045 . . . . 1.72 111.557 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -57.32 129.47 41.92 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.183 0.593 . . . . 2.49 111.204 -178.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -157.03 91.96 1.23 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.072 -1.455 . . . . 4.14 107.072 169.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 63.3 m 84.2 -134.18 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.593 1.957 . . . . 5.03 111.087 178.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 60.07 -6.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.059 1.744 . . . . 7.96 114.581 -170.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.46 29.42 11.09 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.408 -0.807 . . . . 4.84 110.186 -158.225 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -33.43 69.29 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 123.079 1.418 . . . . 2.57 111.358 -171.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.4 t -52.53 -43.42 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.862 1.665 . . . . 2.81 110.561 174.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -58.01 -47.81 81.93 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.462 1.125 . . . . 3.28 108.526 -176.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.251 1.2 p-10 -70.99 -38.35 72.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.84 -1.073 . . . . 3.32 112.003 179.076 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.5 mt -57.14 -54.11 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.815 1.188 . . . . 2.19 109.906 173.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -52.83 -49.95 64.68 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 108.717 -0.845 . . . . 2.9 108.717 176.391 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.2 t -52.4 -51.67 57.84 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 122.021 -0.424 . . . . 2.08 111.945 177.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -61.56 -40.07 93.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.174 -0.954 . . . . 3.25 111.414 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.8 mt -63.58 -60.81 2.86 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.534 0.607 . . . . 3.06 110.145 175.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.6 m -54.33 -20.18 6.76 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.315 1.446 . . . . 2.91 112.321 177.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.5 mtp-105 -61.8 -28.82 69.73 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.802 0.667 . . . . 5.87 112.802 172.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.1 p -69.53 166.19 19.42 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 119.828 1.194 . . . . 3.5 110.892 -179.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.75 -39.61 30.66 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.071 -0.393 . . . . 3.51 111.346 176.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.33 -50.46 7.43 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 112.256 -0.338 . . . . 1.26 112.256 -170.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.68 144.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.851 -1.166 . . . . 4.52 107.851 176.309 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.0 m -142.51 -44.9 0.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.473 0.709 . . . . 4.19 109.845 171.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -100.51 103.36 14.69 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.016 -1.846 . . . . 3.47 106.016 176.63 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.04 149.01 41.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.501 -1.296 . . . . 2.06 107.501 165.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.9 m -142.87 135.71 27.97 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.213 -1.032 . . . . 2.69 108.213 162.779 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.41 118.68 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.53 1.532 . . . . 3.56 106.939 -177.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.06 105.51 10.7 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.902 1.281 . . . . 2.38 110.3 -171.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pp -74.05 -39.07 63.77 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 125.851 1.66 . . . . 3.11 111.878 -172.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.71 -40.39 62.94 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.194 0.998 . . . . 2.15 110.901 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.07 -12.51 24.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.779 1.232 . . . . 2.23 111.08 175.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.2 m 54.1 43.52 30.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.883 1.273 . . . . 2.49 111.925 -176.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -128.22 163.43 24.73 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 117.618 0.19 . . . . 4.1 110.734 166.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.96 136.9 32.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.281 1.432 . . . . 1.92 108.702 173.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.81 136.36 53.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.201 1.4 . . . . 3.73 107.583 171.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.4 m -134.3 136.11 53.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 116.805 -1.569 . . . . 3.36 107.327 -177.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.405 ' HE3' ' CG ' ' A' ' 81' ' ' ASN . 4.1 mtpt -115.25 105.13 12.52 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 120.456 1.48 . . . . 4.0 108.453 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -115.15 179.81 3.85 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.289 1.435 . . . . 4.26 110.894 175.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -100.51 117.37 63.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 125.089 1.355 . . . . 3.03 108.355 173.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -82.52 57.9 6.29 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.663 2.242 . . . . 1.98 112.351 -168.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -147.38 -49.57 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.482 1.513 . . . . 3.98 108.661 174.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pt -77.28 -33.25 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 122.382 -0.199 . . . . 2.35 111.05 -176.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.24 165.7 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.289 1.036 . . . . 2.28 108.373 -177.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.23 165.65 33.88 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.273 -1.131 . . . . 1.48 110.273 -175.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.71 -35.73 78.39 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.698 2.932 . . . . 1.65 112.637 -170.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 10.2 mtt-85 -50.99 -40.53 58.23 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.897 0.702 . . . . 7.1 112.897 178.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.46 -46.8 84.57 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.306 0.574 . . . . 3.39 109.645 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.68 -45.01 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.504 0.721 . . . . 2.12 109.574 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.7 mt -55.98 -58.64 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 108.704 -0.85 . . . . 2.98 108.704 175.023 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -49.28 -49.59 42.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.747 1.158 . . . . 4.33 112.851 177.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 52.0 mt -48.68 -56.21 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.612 -0.514 . . . . 3.51 109.612 176.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.253 2.2 pp -70.84 -26.68 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 113.509 0.929 . . . . 2.51 113.509 -178.294 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.37 -38.58 80.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.311 0.959 . . . . 2.5 109.683 168.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -66.08 -39.85 90.38 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.444 -0.576 . . . . 3.23 109.444 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.1 mt -62.23 -38.84 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.873 -0.417 . . . . 2.17 109.873 169.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.72 29.24 9.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.762 1.649 . . . . 0.98 110.825 -177.096 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -100.31 178.99 4.6 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 117.982 0.891 . . . . 3.44 108.99 175.21 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -127.88 104.51 7.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.609 -1.256 . . . . 5.32 107.609 -178.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.68 103.84 15.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.136 -1.431 . . . . 1.95 107.136 174.205 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.4 t -97.12 -179.19 4.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.236 -1.394 . . . . 2.62 107.236 169.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.5 117.94 22.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.278 -1.749 . . . . 4.92 106.278 171.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.56 90.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.862 -0.421 . . . . 4.07 109.862 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 C--O 1.249 1.048 0 C-N-CA 127.192 2.197 . . . . 6.38 111.22 -178.473 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.121 0 N-CA-C 108.589 -0.893 . . . . 7.42 108.589 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.19 153.88 17.85 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.198 -1.408 . . . . 6.91 107.198 166.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 117.97 21.68 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.509 -1.293 . . . . 3.96 107.509 178.01 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -99.89 102.67 14.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.277 1.831 . . . . 6.88 109.849 -176.061 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.277 0.0 OUTLIER -130.3 159.86 35.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.185 0.993 . . . . 3.57 111.572 176.223 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.63 152.05 30.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.001 -1.0 . . . . 2.38 108.375 173.273 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mm -99.95 137.89 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 106.437 -1.69 . . . . 1.84 106.437 175.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -119.38 98.55 6.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.27 -1.011 . . . . 4.43 108.27 169.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.45 -94.65 0.13 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 109.119 -1.592 . . . . 1.81 109.119 177.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 mtp 67.86 90.48 0.09 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.012 1.725 . . . . 3.14 113.503 173.366 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -57.4 -28.55 63.34 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.973 0.731 . . . . 3.99 112.973 175.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 t 78.38 -48.5 0.46 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.009 1.324 . . . . 4.99 112.068 177.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -36.15 -70.01 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.802 1.641 . . . . 5.34 112.063 -179.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.3 p -161.49 18.99 0.11 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.254 0.465 . . . . 3.91 112.254 172.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 27.1 m -70.23 -52.12 25.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.329 -0.989 . . . . 2.61 108.329 -170.292 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.53 -39.27 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 109.702 -0.481 . . . . 4.3 109.702 177.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -61.95 -37.51 85.0 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.933 0.893 . . . . 2.7 113.344 177.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -41.29 64.0 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.732 -1.23 . . . . 2.86 110.866 171.201 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.0 mt -60.29 -48.62 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.258 1.023 . . . . 3.11 110.18 -174.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -51.52 -45.62 63.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.632 0.73 . . . . 4.34 111.079 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -64.6 -43.59 93.31 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 124.654 1.182 . . . . 7.25 110.343 -179.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.91 -52.27 64.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.129 -0.487 . . . . 1.96 109.825 173.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -29.39 66.48 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.016 0.747 . . . . 2.85 113.016 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -55.0 -22.07 14.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.907 1.23 . . . . 3.62 111.666 174.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -123.93 33.68 5.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.638 0.775 . . . . 5.4 110.182 178.182 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -64.26 0.89 Allowed 'General case' 0 C--N 1.343 0.314 0 N-CA-C 108.796 -0.816 . . . . 2.88 108.796 174.776 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.05 -133.85 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.833 1.253 . . . . 2.42 108.112 -172.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.66 -16.96 74.49 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.556 1.071 . . . . 2.03 113.009 -178.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 p -60.35 122.4 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 121.949 -0.736 . . . . 3.04 110.279 177.483 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.55 50.55 2.15 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 121.209 0.528 . . . . 4.83 111.119 177.239 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.7 m -155.44 153.73 30.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.299 -1.371 . . . . 4.66 107.299 167.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.33 132.06 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 104.815 -2.291 . . . . 4.38 104.815 161.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -141.35 83.73 1.88 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.007 -1.108 . . . . 3.61 108.007 174.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.0 p -98.8 147.16 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.27 -1.011 . . . . 3.31 108.27 174.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.52 103.87 9.81 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.322 -1.362 . . . . 2.91 107.322 167.188 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -27.54 66.4 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.608 0.763 . . . . 3.63 110.817 175.376 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 46.3 mtt -66.26 -58.8 4.58 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.944 0.898 . . . . 4.15 110.209 -178.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.75 -25.35 38.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.938 0.495 . . . . 2.76 111.414 -178.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.69 57.94 2.79 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.508 1.052 . . . . 1.42 110.878 179.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -140.31 147.1 39.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.865 -1.064 . . . . 4.1 108.693 179.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.63 101.17 6.99 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.145 1.378 . . . . 2.11 112.192 177.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -99.57 122.62 42.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.004 -1.06 . . . . 4.77 108.375 172.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.06 -179.5 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.742 1.155 . . . . 3.35 111.179 171.708 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -134.72 90.28 2.63 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.021 0.928 . . . . 8.86 112.561 -174.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.7 179.93 4.81 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.506 1.122 . . . . 4.87 113.974 -176.469 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -126.16 98.74 32.36 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 128.03 2.532 . . . . 4.87 108.283 176.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.62 27.89 0.38 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.917 3.078 . . . . 3.94 113.555 -170.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -108.15 -16.21 14.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.888 1.675 . . . . 4.65 110.669 165.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.1 t -116.66 -60.9 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.762 1.225 . . . . 4.12 108.067 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.65 124.99 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.646 0.778 . . . . 2.72 110.297 -177.509 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -101.62 172.08 4.76 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.09 1.756 . . . . 3.34 110.956 -177.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -75.45 -15.24 19.89 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.622 1.548 . . . . 3.29 112.259 -178.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.257 0.5 OUTLIER -73.08 -60.0 2.44 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.442 -0.786 . . . . 5.68 110.396 175.601 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -57.45 -32.37 66.86 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.284 -0.885 . . . . 3.34 112.281 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.3 tt -55.98 -45.34 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.878 -1.156 . . . . 3.0 107.878 175.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.87 73.56 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.364 -0.835 . . . . 2.72 110.42 -178.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.91 -44.9 94.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 119.459 1.027 . . . . 3.15 110.073 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -55.62 -52.69 62.95 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 109.195 -0.669 . . . . 3.66 109.195 175.326 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 mm -63.15 -41.86 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 120.246 -0.582 . . . . 3.54 111.839 -174.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -46.25 89.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.4 1.08 . . . . 2.99 110.421 175.037 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.19 -50.28 74.29 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.154 0.582 . . . . 3.98 109.829 178.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 29.1 mt -55.62 -36.43 66.97 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.311 0.644 . . . . 2.99 110.882 175.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.16 28.75 2.98 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 124.082 0.849 . . . . 2.13 111.149 165.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -117.53 157.02 27.05 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.995 -1.483 . . . . 4.57 106.995 177.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -96.5 116.36 28.94 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.797 -1.186 . . . . 3.1 107.797 169.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.87 123.92 43.45 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 108.096 -1.076 . . . . 1.96 108.096 166.412 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.92 132.14 50.95 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.28 -1.007 . . . . 2.55 108.28 170.158 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.46 160.04 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 124.619 1.168 . . . . 5.29 108.336 -177.236 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.8 mmt . . . . . 0 CA--C 1.534 0.341 0 O-C-N 123.935 0.772 . . . . 5.55 110.472 168.303 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.733 0 N-CA-C 109.714 -1.354 . . . . 3.22 109.714 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.34 113.4 24.98 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 104.469 -2.419 . . . . 3.45 104.469 159.532 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.4 pp -98.3 158.76 3.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.072 -1.825 . . . . 4.67 106.072 158.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.48 155.69 38.5 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.122 -1.807 . . . . 3.91 106.122 174.166 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -147.79 163.52 36.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.637 -0.221 . . . . 4.28 111.18 168.283 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 m -98.89 126.49 44.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.602 1.961 . . . . 3.14 107.261 171.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.02 125.5 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.856 -0.794 . . . . 2.78 108.856 176.675 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.5 t -108.03 163.31 13.26 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.326 -0.62 . . . . 4.06 109.326 170.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.34 -39.27 2.94 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.846 1.213 . . . . 1.75 112.583 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -58.92 132.73 54.87 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.879 0.871 . . . . 3.17 110.953 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 m -148.01 40.94 0.99 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.904 1.281 . . . . 3.49 109.861 176.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -169.19 136.83 1.86 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.88 -1.137 . . . . 3.84 111.1 177.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.13 64.94 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.576 -0.703 . . . . 3.71 112.118 177.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.6 t -56.45 -42.08 77.54 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.638 -0.664 . . . . 3.27 110.365 173.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 84.5 m -63.24 -44.4 95.31 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.75 -0.833 . . . . 2.73 108.75 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.6 t -53.87 -58.86 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.522 0.729 . . . . 2.82 110.543 175.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -57.11 -41.88 79.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.678 0.752 . . . . 5.61 111.316 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -59.77 -55.09 38.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.821 0.848 . . . . 1.95 110.338 177.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.8 mt -47.39 -50.63 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 125.657 1.583 . . . . 1.88 109.234 174.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -56.53 -47.25 79.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.217 1.007 . . . . 3.76 109.947 177.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.9 m -58.15 -44.21 87.75 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.999 -1.063 . . . . 3.27 111.384 174.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -64.28 -50.19 68.87 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.444 -0.785 . . . . 3.75 110.265 -177.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.71 -47.23 79.08 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.36 -0.607 . . . . 3.41 109.36 -179.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.8 m -58.38 -21.21 49.35 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.034 0.934 . . . . 3.39 112.584 176.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -64.96 -19.17 65.83 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.4 -0.813 . . . . 6.04 112.71 172.342 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.3 m -71.22 150.72 45.02 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.681 1.193 . . . . 2.82 110.431 178.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -69.3 -48.94 60.13 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.869 0.868 . . . . 3.09 111.887 179.188 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.43 -28.56 61.44 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 122.287 -0.258 . . . . 2.43 112.939 -166.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.51 142.18 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.368 -0.975 . . . . 2.84 108.368 178.437 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 22.4 p -124.21 -39.12 2.37 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.891 0.7 . . . . 4.48 112.891 173.434 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.34 125.26 18.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.246 -1.39 . . . . 4.65 107.246 -178.582 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.88 168.16 12.63 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.376 0.67 . . . . 2.52 110.308 165.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.4 m -143.87 128.09 17.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.625 -0.88 . . . . 2.3 108.625 160.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 52.1 t -107.32 126.61 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.822 0.849 . . . . 3.79 110.223 178.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.76 101.09 6.46 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.075 1.75 . . . . 2.51 110.128 -168.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.14 -31.8 62.89 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 126.146 1.778 . . . . 3.12 111.979 -174.253 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.6 -34.18 61.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.783 0.433 . . . . 2.55 110.981 175.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.83 -4.67 19.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.108 1.363 . . . . 2.61 111.218 176.608 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.5 m 59.71 28.8 18.31 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.659 1.183 . . . . 2.7 113.128 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -124.37 165.16 18.2 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.028 0.831 . . . . 3.9 112.973 176.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.45 127.28 43.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.573 2.349 . . . . 2.42 107.588 179.382 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.02 123.47 48.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.002 -1.851 . . . . 3.33 106.002 175.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.1 t -130.32 123.38 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.163 -1.051 . . . . 2.84 108.163 -170.016 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 96.93 9.73 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.099 -1.445 . . . . 4.95 107.099 176.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.9 -177.87 3.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.449 1.5 . . . . 4.3 111.019 178.309 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -127.2 112.83 21.53 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.059 0.943 . . . . 5.18 108.917 175.736 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.43 50.23 3.44 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.577 3.518 . . . . 2.92 113.523 -171.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -141.59 -52.19 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.484 1.513 . . . . 5.85 107.495 171.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 pt -80.29 -31.69 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 119.399 -0.334 . . . . 3.43 111.302 -177.262 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.67 164.67 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 110.156 -0.313 . . . . 2.71 110.156 -177.679 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.99 150.24 20.11 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.912 -0.938 . . . . 2.0 111.64 -167.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -57.22 -36.62 99.08 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.966 2.444 . . . . 1.85 110.535 178.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -34.75 67.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.119 -0.491 . . . . 7.5 111.474 179.136 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -69.99 -44.04 70.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.761 -0.829 . . . . 3.29 108.761 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 17.1 mm -52.42 -54.97 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.414 -0.958 . . . . 3.77 108.414 178.16 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.4 pt -59.2 -57.01 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 117.885 -1.055 . . . . 3.95 109.879 179.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -44.46 -46.59 9.72 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.0 0.818 . . . . 5.81 112.401 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.4 mm -51.07 -60.24 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 118.836 -0.602 . . . . 2.61 110.019 173.047 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.29 0.0 OUTLIER -70.4 -26.93 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 117.628 -1.629 . . . . 3.85 113.909 -176.273 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.48 -34.84 78.65 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.783 -0.573 . . . . 2.68 110.538 172.128 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -66.6 -36.13 81.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.884 -0.784 . . . . 2.84 108.884 176.288 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 38.2 mt -65.37 -44.28 94.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 119.84 -0.744 . . . . 2.58 109.691 174.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.98 27.86 3.33 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.694 1.14 . . . . 1.5 112.032 -177.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -98.5 -178.18 3.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.863 -1.532 . . . . 4.12 106.863 158.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -139.36 130.69 26.85 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.741 -1.207 . . . . 5.19 107.741 174.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.64 117.48 34.13 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.936 -0.765 . . . . 2.37 108.936 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.2 t -109.04 115.55 30.29 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.361 -1.348 . . . . 2.75 107.361 174.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.47 115.58 4.0 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.764 -1.198 . . . . 6.28 107.764 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.28 -34.83 20.26 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 123.61 0.569 . . . . 4.77 110.538 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 C--O 1.262 1.735 0 C-N-CA 128.131 2.572 . . . . 5.86 115.633 175.396 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.513 -0.461 0 CA-C-O 121.717 0.77 . . . . 3.27 111.822 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.5 152.52 20.9 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.445 -1.252 . . . . 4.34 108.899 -178.123 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.9 p -143.2 138.55 29.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 123.608 0.567 . . . . 2.78 109.629 167.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.41 109.13 21.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.613 1.565 . . . . 5.49 109.379 177.659 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.37 166.91 15.12 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.786 0.803 . . . . 4.08 109.279 172.197 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.3 136.24 54.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.807 -1.553 . . . . 2.1 106.807 176.037 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.6 mm -98.2 136.02 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.593 -1.262 . . . . 1.91 107.593 -177.36 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -114.0 136.51 52.83 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.061 -1.089 . . . . 3.51 108.061 168.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.9 -80.6 0.27 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.04 1.781 . . . . 1.12 109.962 -174.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.2 mmm 56.91 56.45 5.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.957 2.103 . . . . 2.65 114.521 170.193 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -43.51 -63.95 0.74 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.774 1.398 . . . . 3.16 114.774 -173.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.3 t -167.9 59.47 0.07 Allowed 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.066 0.848 . . . . 3.72 109.621 -176.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 42.86 48.75 5.04 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.476 1.111 . . . . 6.17 111.994 -179.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.0 t -161.74 -40.21 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.005 0.522 . . . . 2.94 111.364 -172.307 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.39 -43.5 81.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 118.731 -1.188 . . . . 2.47 109.357 -178.487 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.5 t -55.33 -40.61 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.486 -0.931 . . . . 2.92 108.486 173.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -60.19 -37.4 80.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.002 0.43 . . . . 2.46 111.982 177.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -45.45 80.85 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.36 -0.838 . . . . 3.09 110.047 173.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.49 -47.75 70.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.245 1.018 . . . . 2.27 110.198 176.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -50.02 -49.18 51.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.888 0.875 . . . . 4.26 111.478 175.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -64.71 -38.23 90.3 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 122.114 -0.366 . . . . 5.7 110.346 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -61.19 -53.05 61.87 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.934 -0.395 . . . . 1.24 109.934 176.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.73 -37.26 75.78 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 118.22 0.464 . . . . 2.88 111.381 -179.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.58 -19.05 5.19 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.206 0.817 . . . . 1.98 113.206 174.41 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -118.36 20.9 12.92 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.325 0.65 . . . . 3.97 112.499 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -68.16 -62.56 1.34 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.094 0.861 . . . . 2.53 109.866 173.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.91 -128.47 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.384 1.474 . . . . 2.2 108.038 -168.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.84 14.56 3.53 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 119.487 1.04 . . . . 1.44 115.043 -173.409 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.09 122.26 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.593 1.157 . . . . 2.53 108.133 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.87 53.29 1.38 Allowed 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.448 0.642 . . . . 3.41 110.566 179.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 t -160.05 147.13 16.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.555 -1.276 . . . . 2.39 107.555 170.627 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.82 116.0 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 106.608 -1.627 . . . . 3.46 106.608 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 tt -131.67 72.41 1.5 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.851 -1.166 . . . . 2.99 107.851 177.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 p -97.27 153.11 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.64 -0.874 . . . . 3.45 108.64 172.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.02 100.26 6.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.577 -1.268 . . . . 2.09 107.577 163.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.2 mt -58.05 -19.12 29.19 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.207 1.003 . . . . 3.83 111.762 172.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -49.81 64.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.852 0.861 . . . . 5.79 109.696 178.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.88 -31.85 13.5 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.121 0.968 . . . . 1.79 111.749 -174.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.22 55.3 1.98 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.511 1.053 . . . . 0.93 111.307 -178.423 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.95 131.64 31.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 117.835 -1.079 . . . . 3.99 108.491 177.097 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.49 105.13 14.65 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 125.333 1.453 . . . . 1.85 110.563 170.536 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.5 130.36 45.75 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 106.639 -1.615 . . . . 4.59 106.639 165.146 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.2 pt -133.04 169.6 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-N 119.292 0.951 . . . . 2.82 109.897 170.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.7 105.99 12.6 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 124.699 1.199 . . . . 4.62 111.124 172.543 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -98.27 -176.34 3.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.928 2.091 . . . . 3.74 112.188 170.422 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -127.64 111.64 20.77 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.781 1.633 . . . . 3.24 110.151 167.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.87 20.13 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.391 3.394 . . . . 2.12 113.885 -173.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -99.27 -39.37 8.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.616 1.166 . . . . 3.86 110.323 169.061 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.3 m -109.74 -34.13 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 118.743 0.701 . . . . 3.55 111.26 -176.278 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.98 130.9 74.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 109.618 -0.512 . . . . 2.23 109.618 176.818 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -110.47 149.18 39.87 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 124.195 0.998 . . . . 3.46 109.878 -179.518 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -54.34 -40.66 81.83 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.408 2.739 . . . . 1.81 112.419 -178.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mp -57.54 -49.1 77.44 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.783 -0.573 . . . . 4.9 111.013 177.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -60.3 -40.34 90.13 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.183 0.516 . . . . 3.05 110.293 179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.15 -50.65 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.67 -1.233 . . . . 2.16 107.67 173.181 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.08 -41.63 83.86 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.942 -0.572 . . . . 1.98 110.855 -174.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -56.33 -46.03 80.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.173 0.589 . . . . 2.93 110.469 175.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.13 -51.59 63.78 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.621 -0.511 . . . . 4.05 109.621 176.03 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 mm -58.17 -45.88 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.784 0.326 . . . . 3.33 111.26 -179.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -61.58 -43.06 99.55 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.122 -0.466 . . . . 3.47 111.783 178.004 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.45 -49.02 78.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.6 0.636 . . . . 2.31 110.067 176.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -59.63 -27.12 66.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.111 0.564 . . . . 2.87 111.754 175.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.0 40.16 2.35 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.596 -1.002 . . . . 1.25 110.596 165.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -131.93 170.74 14.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.419 1.488 . . . . 3.1 108.029 178.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -115.01 121.46 43.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.351 -0.981 . . . . 3.83 108.351 169.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.03 117.7 34.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.381 -1.711 . . . . 2.05 106.381 163.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.78 144.18 45.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 105.979 -1.86 . . . . 1.89 105.979 166.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.1 t -71.46 152.17 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.474 -1.306 . . . . 3.42 107.474 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.8 ptm . . . . . 0 N--CA 1.447 -0.578 0 CA-C-N 116.193 -0.458 . . . . 4.69 110.404 174.313 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.078 0 N-CA-C 110.519 -1.032 . . . . 2.09 110.519 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -143.31 95.43 2.75 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 119.803 1.802 . . . . 2.79 110.911 172.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.33 145.52 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 C-N-CA 126.095 1.758 . . . . 5.66 108.169 178.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.4 148.25 31.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.071 1.348 . . . . 3.44 110.629 173.173 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -140.89 161.4 37.92 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.296 1.038 . . . . 3.47 109.069 -178.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.09 138.57 35.19 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 120.181 1.355 . . . . 2.94 109.069 172.235 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.2 mt -94.98 117.14 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.731 -1.211 . . . . 3.78 107.731 176.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 21.4 m -98.46 124.63 43.28 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.252 -1.388 . . . . 2.53 107.252 171.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.82 -43.75 1.51 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.116 1.341 . . . . 1.1 111.337 175.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.88 121.65 8.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.726 0.81 . . . . 3.27 110.938 174.523 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -166.09 26.33 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.842 0.857 . . . . 3.34 111.074 166.07 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 31.1 p -172.47 168.21 5.46 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.296 -0.878 . . . . 6.39 110.026 -167.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 58.99 6.9 0.72 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.983 2.113 . . . . 8.16 113.574 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.5 m 38.11 47.47 0.96 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.336 0.589 . . . . 5.1 110.734 -154.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.6 p -55.15 -21.99 15.39 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.711 1.204 . . . . 3.09 112.417 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 t -30.0 -55.9 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.029 1.332 . . . . 2.38 111.327 157.036 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -58.85 -40.23 83.66 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.189 0.596 . . . . 4.68 111.067 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -64.87 -46.65 80.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.866 -0.521 . . . . 2.16 110.008 177.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.97 -52.51 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.143 0.577 . . . . 1.73 110.029 179.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -55.73 -43.62 76.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.568 1.947 . . . . 2.44 108.966 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.5 t -59.74 -51.35 70.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.792 -0.567 . . . . 2.39 110.064 174.329 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -53.87 -53.85 46.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.85 0.75 . . . . 3.35 110.705 -178.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.48 -48.52 74.91 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.545 -0.462 . . . . 4.05 110.318 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.5 m -63.27 -19.44 64.57 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.369 1.068 . . . . 2.97 112.235 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.5 mtt-85 -63.28 -21.59 66.34 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.373 -0.823 . . . . 5.65 111.52 170.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.36 169.53 17.12 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.557 1.071 . . . . 3.74 110.422 -177.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -80.12 -47.53 14.64 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.164 0.586 . . . . 2.28 111.656 -175.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.72 -37.57 66.96 Favored Glycine 0 CA--C 1.524 0.606 0 O-C-N 122.139 -0.351 . . . . 1.14 113.006 -168.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.74 123.49 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 122.111 -0.64 . . . . 2.99 109.432 -173.501 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.7 m -101.56 -51.78 3.38 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 122.477 0.311 . . . . 2.8 111.497 -178.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -140.55 111.34 6.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.049 -0.722 . . . . 3.43 109.049 -177.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.15 155.05 16.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.889 -0.782 . . . . 1.91 108.889 166.786 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.8 p -143.73 92.97 2.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.787 -1.19 . . . . 2.89 107.787 169.07 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -96.52 140.02 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.241 -1.022 . . . . 3.45 108.241 179.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.37 108.15 8.02 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.851 0.86 . . . . 2.23 109.54 -168.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.38 -27.78 65.61 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.154 0.798 . . . . 3.24 113.154 -171.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.61 71.52 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.138 0.975 . . . . 2.64 110.05 -176.518 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.3 -28.33 13.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.702 2.001 . . . . 2.5 109.334 175.864 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.2 m 71.92 40.55 0.73 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.13 1.772 . . . . 3.09 110.429 -174.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -101.21 163.31 12.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 123.839 0.712 . . . . 6.6 110.818 172.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.82 108.17 5.54 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.104 2.161 . . . . 1.92 109.105 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 mp -96.68 131.0 43.8 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.697 -1.223 . . . . 3.28 107.697 178.299 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.36 113.65 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.452 1.101 . . . . 2.77 108.538 -173.363 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.84 92.53 5.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 117.78 -1.105 . . . . 5.17 110.351 176.375 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -109.82 -177.15 3.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.682 0.674 . . . . 3.28 110.817 176.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -108.24 115.95 57.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.789 -1.189 . . . . 3.05 107.789 173.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.47 68.94 8.16 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.042 2.495 . . . . 2.23 111.841 -162.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -161.67 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.79 1.236 . . . . 3.0 109.613 175.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.4 pt -80.25 -39.2 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 123.964 0.906 . . . . 2.72 110.811 -174.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.93 170.71 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.906 0.882 . . . . 2.53 108.657 178.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.05 159.46 28.03 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.443 -1.063 . . . . 1.95 110.443 178.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.34 -32.17 72.59 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.32 2.68 . . . . 2.73 110.719 -175.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -51.53 -37.42 49.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.508 1.123 . . . . 8.87 111.016 175.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.34 -45.22 66.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.607 -1.257 . . . . 2.78 107.607 -176.138 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 88.6 mt -60.73 -52.66 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 118.542 -0.742 . . . . 2.37 109.213 -177.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.3 pt -50.55 -57.09 2.85 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 108.617 -0.883 . . . . 4.89 108.617 175.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -54.39 -44.11 72.02 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.461 0.911 . . . . 6.99 113.461 -177.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.3 mm -55.65 -50.23 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.468 -0.568 . . . . 3.08 109.468 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 25.3 pt -71.06 -28.14 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.907 -1.121 . . . . 3.32 112.725 -179.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -59.05 -30.97 68.43 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.225 0.921 . . . . 3.55 110.293 173.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.08 -42.74 95.25 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.579 -0.526 . . . . 2.58 109.579 174.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.4 mt -71.91 -33.17 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.273 0.629 . . . . 2.35 109.845 178.263 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.53 22.05 7.97 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.347 1.451 . . . . 1.21 111.249 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -105.8 157.13 17.67 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.143 0.971 . . . . 3.12 108.866 167.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -126.18 138.28 53.64 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 107.713 -1.218 . . . . 4.57 107.713 -179.334 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -111.06 110.5 21.07 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.622 1.169 . . . . 2.67 108.342 178.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 68.2 m -141.47 122.89 14.96 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.022 -1.466 . . . . 2.7 110.483 176.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 0.05 103.33 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.936 2.894 . . . . 6.72 114.633 174.718 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.03 -35.61 66.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.668 -0.682 . . . . 6.28 111.333 177.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.012 -1.471 . . . . 9.36 113.828 -177.85 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.225 -0.221 0 CA-C-O 121.272 0.558 . . . . 2.8 109.782 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -95.27 137.6 34.11 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.623 -1.251 . . . . 4.11 107.623 -170.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 16.7 t -125.03 145.28 49.98 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 123.89 0.876 . . . . 2.94 109.004 176.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -121.05 91.2 3.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.749 1.62 . . . . 4.9 108.976 -172.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 pp -124.29 167.59 14.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.046 0.45 . . . . 4.06 110.834 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.44 168.92 8.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.917 -1.142 . . . . 4.13 107.917 163.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.9 mm -102.04 122.28 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 105.064 -2.199 . . . . 2.18 105.064 164.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.47 99.41 11.07 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 104.837 -2.282 . . . . 4.83 104.837 178.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.81 -59.75 0.38 Allowed Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.418 -0.657 . . . . 1.1 112.193 178.019 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.6 mtp 21.68 84.91 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.332 2.653 . . . . 3.04 114.399 -178.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 p -57.03 -56.49 21.08 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.911 -0.566 . . . . 3.4 112.36 -175.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.9 m 135.23 -60.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 129.013 2.925 . . . . 4.21 108.434 -179.361 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.89 -69.51 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.506 1.923 . . . . 5.92 112.644 -165.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 p -163.98 28.07 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 122.477 1.132 . . . . 3.25 109.945 163.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.5 t -75.06 -41.14 59.61 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.477 -0.783 . . . . 2.45 110.346 -168.069 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.58 -43.87 66.62 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 N-CA-C 108.566 -0.901 . . . . 3.93 108.566 170.172 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -44.85 80.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.203 -0.453 . . . . 2.52 110.326 179.391 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.427 HD21 ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -65.25 -37.26 86.67 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 121.976 -0.453 . . . . 3.36 111.138 176.867 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.63 -46.12 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 123.808 0.843 . . . . 4.11 110.161 175.168 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -57.74 -49.57 76.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.757 0.313 . . . . 4.25 110.791 -179.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -33.4 75.84 Favored 'General case' 0 CA--C 1.521 -0.149 0 O-C-N 121.726 -0.609 . . . . 6.6 110.978 -179.18 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.427 ' ND2' HD21 ' A' ' 21' ' ' ASN . 3.2 m-80 -67.24 -60.33 2.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.127 -0.694 . . . . 1.57 109.127 178.274 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.2 mt -53.73 -50.49 65.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 119.005 -0.522 . . . . 3.31 111.828 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.29 -18.25 60.8 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.788 1.176 . . . . 3.37 113.261 -176.335 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm -95.38 0.05 53.09 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.501 1.297 . . . . 5.07 114.501 171.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.12 -60.26 3.12 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 120.244 1.384 . . . . 3.08 110.59 175.182 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.41 -97.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.917 1.687 . . . . 2.14 109.4 175.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.9 -0.64 82.38 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 121.873 -0.517 . . . . 1.22 113.773 -171.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.71 114.83 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 CA-C-N 118.652 1.226 . . . . 2.37 109.251 178.293 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mp -131.12 52.04 2.09 Favored 'General case' 0 C--N 1.338 0.086 0 N-CA-C 108.982 -0.748 . . . . 4.27 108.982 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.8 t -159.56 120.17 3.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.332 -1.359 . . . . 2.54 107.332 171.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.5 m -107.76 122.38 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.624 1.17 . . . . 3.46 108.597 173.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tt -137.93 82.35 1.91 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.921 -0.712 . . . . 3.03 109.693 172.516 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 t -102.58 127.16 56.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 116.231 -0.441 . . . . 2.82 110.839 173.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.51 97.75 9.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.367 -1.346 . . . . 1.95 107.367 168.428 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.95 -26.29 62.08 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.097 0.559 . . . . 3.7 110.835 173.151 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.7 mtt -68.03 -57.97 5.26 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.204 1.001 . . . . 3.88 110.324 -178.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.98 -25.23 30.19 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.069 0.548 . . . . 1.78 111.56 -177.019 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.81 61.16 2.32 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 124.771 1.177 . . . . 0.97 110.798 -178.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -142.17 131.75 23.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.142 -1.429 . . . . 3.29 107.142 174.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.45 102.25 10.88 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 124.631 1.207 . . . . 2.11 110.688 171.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.41 138.84 39.6 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.831 -1.174 . . . . 4.17 107.831 168.563 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.24 166.55 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.392 -1.336 . . . . 3.02 107.392 -177.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -124.49 90.46 3.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.576 0.751 . . . . 4.36 109.765 -172.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -95.3 -177.99 4.29 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.648 1.979 . . . . 3.26 112.155 -176.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.78 94.85 24.14 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.724 1.61 . . . . 2.97 108.946 -176.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -55.81 -22.63 38.14 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.253 2.635 . . . . 2.15 113.828 -174.146 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -64.13 -32.34 73.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.448 1.099 . . . . 3.56 112.37 177.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.75 -26.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 113.536 0.939 . . . . 3.63 113.536 -175.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.44 133.22 69.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 N-CA-C 108.436 -0.95 . . . . 2.05 108.436 174.065 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -107.2 154.26 40.59 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.603 1.161 . . . . 3.16 110.088 175.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -60.5 -35.72 89.27 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.587 2.191 . . . . 1.38 111.261 -178.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 pp -60.89 -43.57 98.3 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.567 -0.708 . . . . 4.72 112.152 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.02 -40.65 78.54 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.298 0.639 . . . . 3.7 109.418 177.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -49.92 -51.68 15.82 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 106.883 -1.525 . . . . 1.87 106.883 173.09 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.47 -42.34 82.39 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.476 -0.784 . . . . 1.97 109.715 -175.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.35 -48.56 71.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.607 0.763 . . . . 3.53 110.021 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -44.09 92.34 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.296 0.57 . . . . 3.7 109.604 179.699 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.9 mm -62.6 -44.46 99.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 O-C-N 121.817 -0.552 . . . . 3.57 110.994 179.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -63.62 -45.26 91.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.627 -0.508 . . . . 2.48 109.627 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.29 -50.4 71.5 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.773 0.829 . . . . 2.21 110.194 177.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.73 -36.19 82.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 121.193 -0.203 . . . . 4.7 110.469 -175.952 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 129.43 26.5 0.88 Allowed Glycine 0 C--N 1.34 0.799 0 CA-C-O 119.792 -0.449 . . . . 1.77 112.988 164.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -118.66 177.94 4.65 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.015 0.926 . . . . 3.2 110.985 173.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.54 142.13 41.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.856 -1.535 . . . . 2.33 106.856 160.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.4 131.95 55.75 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.095 -1.076 . . . . 2.14 108.095 163.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.4 124.87 26.41 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.71 -0.478 . . . . 2.04 109.71 174.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.02 148.42 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.844 1.658 . . . . 3.81 109.266 172.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.5 mtp . . . . . 0 CA--C 1.532 0.268 0 O-C-N 123.856 0.722 . . . . 4.73 110.986 -177.944 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 106.935 -2.466 . . . . 1.96 106.935 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.45 133.08 43.33 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.405 1.482 . . . . 2.81 107.634 169.387 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.426 ' CD1' ' N ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -142.22 161.22 19.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 129.387 3.075 . . . . 4.22 104.977 166.342 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.64 153.34 32.48 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.182 -1.784 . . . . 3.48 106.182 167.016 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mp -127.17 147.01 50.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.745 0.653 . . . . 3.2 110.077 162.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.3 m -92.97 117.3 29.9 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.909 -1.515 . . . . 3.25 106.909 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.41 104.24 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 123.768 0.827 . . . . 2.73 109.415 -174.563 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.3 m -96.9 136.14 37.88 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.522 -1.288 . . . . 2.44 107.522 175.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.22 -33.31 4.58 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.701 1.143 . . . . 1.18 112.124 177.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.7 ptp -64.05 160.72 17.45 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.372 0.586 . . . . 3.41 112.54 -177.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 t -172.41 40.03 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.167 0.987 . . . . 3.42 110.394 168.524 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -164.76 133.7 3.54 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.04 -1.038 . . . . 3.79 111.711 -176.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.55 81.72 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.071 0.548 . . . . 3.37 111.174 177.366 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.8 t -56.46 -47.64 78.74 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.228 -0.92 . . . . 2.74 109.825 174.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.4 m -60.25 -43.95 95.67 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.874 -0.516 . . . . 2.31 110.366 177.455 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.65 -50.62 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 O-C-N 122.332 -0.23 . . . . 3.18 111.286 177.072 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -59.19 -39.24 81.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.075 0.95 . . . . 4.79 109.673 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -62.56 -50.6 70.68 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.626 0.37 . . . . 1.99 110.128 176.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.0 mt -55.99 -55.95 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.842 -0.429 . . . . 2.24 109.842 177.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.52 -42.45 67.42 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.716 0.807 . . . . 3.0 110.86 177.795 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 p -62.69 -52.05 64.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.536 1.062 . . . . 2.82 110.843 177.212 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -63.6 -39.45 94.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.133 0.879 . . . . 6.91 111.286 -174.235 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.89 -46.25 65.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.241 -0.885 . . . . 3.63 109.24 177.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 95.9 m -55.84 -26.03 44.78 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.206 0.912 . . . . 3.04 111.563 176.004 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -61.65 -20.45 63.41 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.376 0.88 . . . . 5.2 113.376 174.075 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.9 m -66.3 150.79 48.31 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.154 1.382 . . . . 2.4 110.909 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -68.34 -50.82 50.61 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.05 0.94 . . . . 2.36 111.756 177.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.99 -26.67 61.76 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 123.52 0.581 . . . . 1.36 113.569 -169.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.45 140.35 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.467 -0.938 . . . . 4.08 108.467 -177.21 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 24.8 p -115.49 -64.0 1.38 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 122.621 0.369 . . . . 3.89 111.006 -175.05 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -135.57 119.01 16.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.171 -1.048 . . . . 4.47 108.171 174.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.62 161.02 14.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.728 -0.471 . . . . 1.73 109.728 164.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.8 t -142.81 111.61 6.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.698 -1.223 . . . . 2.58 107.698 168.169 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 68.9 t -98.93 123.17 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.912 1.285 . . . . 3.48 109.458 -177.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -130.11 113.42 14.48 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.041 0.837 . . . . 1.83 112.644 -172.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 pp -77.88 -37.98 46.88 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 124.126 0.971 . . . . 3.53 112.853 -171.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.67 70.13 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.344 0.592 . . . . 2.38 110.86 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -35.69 16.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.779 1.232 . . . . 2.43 109.633 177.423 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.1 m 90.18 17.53 0.04 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.321 1.848 . . . . 2.86 111.463 175.77 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -125.64 160.42 29.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.626 0.648 . . . . 3.96 110.446 175.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -130.74 125.82 34.83 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.127 1.371 . . . . 1.91 108.24 179.146 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -92.55 129.19 38.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.423 -2.065 . . . . 2.77 105.423 177.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.72 139.06 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.312 -0.996 . . . . 2.98 108.312 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -114.76 96.93 5.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.61 0.764 . . . . 4.63 109.602 173.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.66 -179.77 3.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.202 0.456 . . . . 3.38 110.744 176.827 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -110.08 110.74 58.57 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 108.562 -0.903 . . . . 3.4 108.562 175.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.57 63.12 8.69 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.506 2.804 . . . . 1.87 113.049 -164.302 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -148.03 -50.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.873 1.669 . . . . 4.18 108.184 172.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.37 -32.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 123.468 0.707 . . . . 2.7 111.33 -173.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.85 163.63 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.9 -1.148 . . . . 2.43 107.9 172.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.93 154.87 26.17 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.361 -1.095 . . . . 1.46 110.361 -179.407 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -60.44 -33.08 94.41 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.383 2.722 . . . . 1.42 111.71 -175.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -57.28 -38.36 73.83 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.585 0.354 . . . . 6.13 110.784 178.122 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -67.23 -45.2 77.49 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.081 -1.081 . . . . 2.85 108.081 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.78 -56.53 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 118.355 -0.831 . . . . 2.55 109.266 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 pt -53.5 -54.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 118.55 0.614 . . . . 3.62 110.559 176.49 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -56.24 -45.47 79.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 119.789 1.177 . . . . 5.94 112.869 -175.384 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.6 mm -69.05 -40.13 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 121.366 -0.834 . . . . 4.69 110.072 -178.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.86 -29.72 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 120.12 -1.612 . . . . 2.48 112.195 176.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -59.36 -29.59 67.78 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.674 -0.642 . . . . 3.96 111.107 170.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.61 -38.69 92.06 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.963 -0.755 . . . . 4.73 108.963 176.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.7 mt -70.77 -37.44 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.494 -0.558 . . . . 2.6 109.494 172.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.46 28.62 5.38 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.054 1.311 . . . . 1.14 111.02 178.298 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -99.57 -178.91 4.03 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.828 -1.545 . . . . 3.36 106.828 172.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -141.54 128.34 20.46 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.537 -1.283 . . . . 6.01 107.537 177.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.84 94.62 4.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.656 0.782 . . . . 1.94 109.794 -172.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.6 t -98.61 96.83 8.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.799 1.24 . . . . 2.82 107.745 -168.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.55 101.25 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.041 1.737 . . . . 5.11 111.875 179.477 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 55.95 35.91 26.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.621 0.769 . . . . 5.26 111.895 178.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 108.847 -0.797 . . . . 8.6 108.847 -176.377 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 105.74 -1.948 . . . . 3.82 105.74 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -97.02 165.78 11.91 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.626 0.771 . . . . 3.93 109.682 173.598 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.57 126.57 17.29 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 119.067 -0.492 . . . . 2.73 110.635 164.812 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -99.19 104.69 16.67 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.718 1.607 . . . . 3.97 109.537 178.121 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 172.34 10.97 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.219 0.533 . . . . 3.24 109.677 172.413 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.49 138.55 54.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.286 -1.375 . . . . 1.75 107.286 173.212 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.8 mm -100.17 129.88 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.527 -1.286 . . . . 1.94 107.527 177.209 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -108.89 120.71 43.32 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.666 -1.235 . . . . 3.32 107.666 172.762 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.77 -56.28 0.33 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.258 0.932 . . . . 1.67 112.095 177.467 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.3 mtt 25.54 77.14 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.078 2.151 . . . . 2.64 115.522 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m -55.26 -54.68 40.44 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.719 -0.613 . . . . 2.97 112.489 178.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.3 41.4 0.1 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.013 0.435 . . . . 4.21 111.355 -169.075 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 51.33 31.14 6.7 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.349 1.459 . . . . 6.08 113.911 177.888 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -154.11 -42.79 0.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.424 1.489 . . . . 2.99 110.905 -172.305 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.42 -46.91 88.31 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.622 -0.674 . . . . 2.15 110.588 -177.716 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.04 -43.36 36.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 123.086 0.554 . . . . 3.16 109.902 171.964 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -61.04 -47.92 84.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.479 -0.563 . . . . 2.82 109.479 -179.062 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -46.93 88.32 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 122.178 -0.326 . . . . 2.72 110.454 178.347 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.9 mt -50.1 -55.06 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.415 1.086 . . . . 3.18 110.292 175.648 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -32.71 74.17 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.491 1.139 . . . . 6.29 110.563 -176.811 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -32.47 73.84 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 119.634 -1.917 . . . . 4.9 111.603 172.086 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -66.32 -38.33 87.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.21 -0.663 . . . . 1.68 109.21 171.883 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.12 -39.54 78.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.327 0.512 . . . . 2.93 110.086 173.235 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -20.61 5.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.135 1.161 . . . . 3.64 114.135 173.27 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -107.88 9.67 28.73 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.612 0.765 . . . . 4.0 112.647 179.029 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -67.22 -67.94 0.42 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.664 0.785 . . . . 2.37 110.443 178.393 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -167.59 -101.68 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.061 0.944 . . . . 2.66 109.136 177.431 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.57 23.71 6.29 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.5 -0.75 . . . . 1.38 113.22 -175.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.2 t -95.44 113.17 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.751 1.221 . . . . 3.51 109.271 178.553 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 mp -139.6 54.04 1.69 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.225 0.466 . . . . 3.87 111.172 177.272 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 m -157.08 152.65 26.7 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.047 -1.094 . . . . 2.5 108.047 155.097 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 p -141.03 96.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.636 1.174 . . . . 3.75 107.979 179.779 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.71 80.75 1.99 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 108.223 -1.028 . . . . 3.87 108.223 -177.494 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.6 t -99.53 129.35 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.206 -0.665 . . . . 2.84 109.206 174.53 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.44 81.8 3.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.37 -1.715 . . . . 2.01 106.37 170.353 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.83 -16.61 4.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.767 0.827 . . . . 4.43 111.609 176.374 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 6.3 tpt -67.51 -38.8 84.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.401 2.28 . . . . 4.83 110.774 176.739 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.87 -36.2 4.23 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.851 1.26 . . . . 2.08 111.624 -168.45 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.85 58.7 0.98 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.11 1.338 . . . . 1.1 111.36 179.518 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -141.71 133.35 26.99 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.631 -1.248 . . . . 3.48 107.631 170.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.78 120.28 41.01 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 1.74 110.709 170.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.502 ' OE2' ' NZ ' ' A' ' 47' ' ' LYS . 30.0 tt0 -109.84 115.12 29.24 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.843 0.857 . . . . 4.1 108.874 166.49 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.6 mt -107.92 168.07 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 125.39 1.476 . . . . 3.7 108.872 170.707 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.502 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -126.59 108.2 10.91 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.103 0.961 . . . . 5.34 109.168 162.263 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -104.04 177.99 4.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.805 2.042 . . . . 3.19 111.114 174.401 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -121.38 114.3 31.84 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.194 1.397 . . . . 3.22 109.866 171.267 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.13 -22.44 69.89 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.069 2.513 . . . . 2.04 113.553 179.044 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -35.41 80.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.421 1.009 . . . . 3.5 111.188 -179.99 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -116.32 -31.58 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-N 118.591 0.632 . . . . 3.37 111.61 -171.136 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.73 132.46 70.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 123.752 0.821 . . . . 2.15 109.178 178.408 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -107.46 151.58 41.0 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.195 1.398 . . . . 2.66 111.149 179.443 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -59.79 -34.55 95.79 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.636 2.224 . . . . 1.42 111.981 -179.848 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.6 -53.19 60.89 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.466 -0.771 . . . . 4.11 110.643 179.818 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.45 -36.17 82.85 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.965 -0.459 . . . . 4.36 110.929 178.874 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.07 -49.97 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.028 -1.471 . . . . 2.07 107.028 171.632 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.92 90.93 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.386 -0.37 . . . . 2.04 111.236 -177.262 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -56.7 -43.96 81.05 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.852 -0.53 . . . . 2.59 109.726 175.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.64 -49.87 69.53 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 110.123 -0.325 . . . . 3.55 110.123 176.099 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -63.28 -48.2 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.294 0.569 . . . . 3.21 111.251 -176.781 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -40.92 96.86 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.935 -0.575 . . . . 2.07 110.483 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.32 -50.92 65.9 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.469 0.577 . . . . 2.5 110.305 177.049 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.5 mt -54.17 -33.77 58.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.914 0.486 . . . . 3.14 111.112 174.799 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.09 37.24 1.54 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.56 -1.016 . . . . 1.33 110.56 164.369 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -129.77 170.07 14.33 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.798 -1.186 . . . . 3.63 107.798 -179.753 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -111.06 122.74 48.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.082 -0.71 . . . . 2.59 109.082 170.331 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.84 122.27 43.15 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.443 -1.317 . . . . 1.9 107.443 163.49 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.9 144.49 48.82 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.794 -1.558 . . . . 1.89 106.794 167.235 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -75.49 156.89 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 108.032 -1.099 . . . . 3.69 108.032 -179.424 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.8 ptm . . . . . 0 N--CA 1.438 -1.038 0 C-N-CA 119.238 -0.985 . . . . 5.0 111.025 174.486 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 109.761 -1.336 . . . . 2.2 109.761 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -145.79 96.08 2.75 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 114.879 1.437 . . . . 3.64 114.879 -178.553 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.33 143.77 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 106.589 -1.634 . . . . 5.03 106.589 -174.268 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -104.87 150.2 25.04 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.115 -1.809 . . . . 3.57 106.115 172.966 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mp -135.91 154.82 51.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.32 -0.992 . . . . 3.34 108.32 167.631 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.38 125.87 40.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.835 -1.913 . . . . 2.61 105.835 173.752 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 pt -98.37 139.28 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.757 -1.201 . . . . 2.88 107.757 178.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.3 m -125.22 140.21 53.05 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.634 0.773 . . . . 2.82 109.252 174.65 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.93 -21.66 12.14 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.622 1.582 . . . . 1.19 113.334 171.8 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.66 130.85 1.35 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.087 0.955 . . . . 3.73 112.523 168.603 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.8 m -130.54 2.73 4.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.209 0.604 . . . . 4.38 111.114 -178.02 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.2 p 178.74 154.83 0.41 Allowed 'General case' 0 C--N 1.341 0.231 0 O-C-N 121.165 -0.959 . . . . 4.13 109.181 -174.637 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.91 -27.66 65.45 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.579 0.752 . . . . 3.42 112.724 -178.354 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 m -51.65 -41.43 61.34 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.343 -0.848 . . . . 2.67 111.141 169.815 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 90.8 m -65.54 -45.72 82.33 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.599 -0.519 . . . . 2.56 109.599 -179.602 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.7 t -53.28 -54.73 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.562 1.145 . . . . 2.37 109.924 175.444 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -57.26 -45.37 84.05 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.966 0.507 . . . . 5.12 110.168 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -61.98 -45.79 92.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.144 -0.348 . . . . 1.76 110.968 179.077 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.7 mt -56.27 -49.63 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.93 -0.767 . . . . 1.93 108.93 176.583 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -58.57 -47.69 83.41 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.354 -0.61 . . . . 2.28 109.354 178.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.5 t -50.83 -50.06 57.44 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.92 0.488 . . . . 1.78 110.07 174.703 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -61.53 -37.93 85.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.551 -0.718 . . . . 3.48 111.838 -178.99 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.6 mt -70.19 -60.91 2.0 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.78 -1.192 . . . . 2.92 107.78 178.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.4 p -54.86 -20.67 9.28 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.206 1.402 . . . . 3.14 113.147 -179.069 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -59.26 -25.67 64.27 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.456 0.539 . . . . 4.55 112.456 171.279 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 39.1 m -66.68 154.28 41.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.352 1.461 . . . . 2.46 111.337 -178.559 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -72.87 -54.23 9.29 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.293 1.037 . . . . 2.32 111.869 179.295 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.34 -36.2 63.34 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 121.401 0.445 . . . . 1.16 112.37 -172.605 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.76 126.52 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 121.774 -0.839 . . . . 3.27 109.81 -173.309 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.0 m -98.8 -51.25 3.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.553 0.341 . . . . 2.95 110.963 179.168 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.407 ' CZ ' ' HG3' ' A' ' 123' ' ' LYS . 36.2 p90 -140.9 111.6 6.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.325 -0.369 . . . . 3.29 110.082 -178.749 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -96.6 153.69 17.71 Favored 'General case' 0 C--O 1.227 -0.082 0 N-CA-C 108.373 -0.973 . . . . 1.76 108.373 167.014 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -142.83 125.51 15.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 107.041 -1.466 . . . . 2.47 107.041 169.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 p -123.88 128.22 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.348 1.059 . . . . 3.01 109.734 -172.501 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.88 106.36 6.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.74 0.781 . . . . 2.09 111.112 -168.791 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -69.29 -19.24 63.9 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 124.304 1.042 . . . . 3.29 113.328 179.155 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.01 94.5 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.786 -0.449 . . . . 2.32 109.786 176.004 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.06 -28.99 17.59 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.124 0.97 . . . . 2.43 110.189 175.338 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.41 34.34 0.37 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.24 1.416 . . . . 2.49 111.319 -175.261 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -138.6 166.74 23.55 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.923 -0.485 . . . . 4.47 111.064 175.217 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -136.66 135.53 38.33 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.819 1.648 . . . . 1.91 108.733 -178.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.01 134.55 40.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.717 -1.586 . . . . 2.61 106.717 174.323 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.4 127.99 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.032 0.533 . . . . 3.3 110.001 -178.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 12.6 mmtp -116.06 87.44 2.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.615 0.766 . . . . 4.51 109.425 -172.783 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -119.63 170.39 9.23 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.456 1.098 . . . . 4.07 111.738 -178.255 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -96.99 114.02 63.96 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 108.182 -1.044 . . . . 3.37 108.182 -179.053 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.72 67.95 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.137 2.558 . . . . 1.63 110.997 -172.917 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -160.46 -47.65 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.831 1.252 . . . . 3.18 109.125 176.886 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -85.79 -30.31 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 122.928 0.491 . . . . 2.29 111.561 -173.145 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.74 162.04 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.155 -1.054 . . . . 2.01 108.155 171.477 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -133.77 163.16 24.49 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.167 -1.573 . . . . 1.89 109.167 178.786 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -63.39 -35.86 58.98 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.92 2.413 . . . . 2.09 111.852 -175.968 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.17 -40.41 73.88 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.149 0.431 . . . . 5.52 111.606 -174.071 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -51.1 71.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.647 -0.871 . . . . 3.32 108.647 178.992 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 53.6 mt -58.82 -50.25 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.532 -0.914 . . . . 2.16 108.532 -179.589 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 78.4 mt -46.08 -58.74 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 118.432 -0.794 . . . . 3.46 109.193 172.812 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -49.62 -49.86 45.21 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.697 1.135 . . . . 4.51 112.15 177.24 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.4 mm -51.08 -55.55 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 118.206 0.457 . . . . 3.0 110.576 177.184 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.295 0.0 OUTLIER -68.68 -32.51 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 118.339 -1.345 . . . . 3.97 113.311 -179.705 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.46 -40.28 90.66 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.368 1.44 . . . . 2.22 110.666 173.838 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -63.33 -36.92 85.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.339 0.656 . . . . 3.44 109.818 177.1 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.6 mt -69.22 -39.7 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 120.171 -0.611 . . . . 2.0 110.935 172.475 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.8 30.73 6.64 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.386 1.47 . . . . 0.86 111.64 -171.597 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -108.27 166.16 10.96 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.009 0.904 . . . . 3.13 108.907 164.088 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -129.53 130.03 45.25 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 106.704 -1.591 . . . . 5.11 106.704 -178.942 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.09 103.18 10.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.407 1.483 . . . . 1.87 109.144 -175.685 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.5 t -121.25 120.34 34.86 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 123.314 0.646 . . . . 3.26 110.539 -177.482 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -37.1 119.59 0.69 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.581 1.552 . . . . 4.31 111.248 170.94 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -119.78 61.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.83 1.652 . . . . 4.16 109.464 175.717 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.252 1.217 0 O-C-N 125.737 1.898 . . . . 6.25 109.545 162.866 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 106.784 -1.562 . . . . 9.86 106.784 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.34 89.51 3.25 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 107.421 -1.325 . . . . 4.79 107.421 167.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.24 124.19 8.29 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.083 1.855 . . . . 3.26 110.393 -174.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -110.35 135.49 51.0 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.592 -0.892 . . . . 2.96 108.592 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -91.73 140.73 29.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.665 -0.865 . . . . 4.16 108.665 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.5 t -119.6 132.24 55.67 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.048 -1.093 . . . . 3.17 108.048 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -106.01 102.69 12.1 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.674 1.189 . . . . 3.74 108.533 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.415 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.5 pt? -130.36 171.9 12.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.401 0.62 . . . . 3.53 111.713 174.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.05 153.33 38.77 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.451 -1.315 . . . . 2.02 107.451 172.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.9 mm -97.64 148.05 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 106.541 -1.652 . . . . 2.05 106.541 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -126.43 132.93 51.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.419 -1.697 . . . . 3.64 106.419 159.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.16 -94.45 0.2 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 108.062 -2.015 . . . . 1.29 108.062 -168.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.2 mtt 50.92 75.01 0.2 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.176 1.39 . . . . 2.87 112.552 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -37.87 37.79 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.565 -0.731 . . . . 2.88 111.758 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.1 t 133.6 -74.66 0.0 OUTLIER 'General case' 0 C--N 1.347 0.471 0 C-N-CA 127.104 2.162 . . . . 4.18 109.471 162.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.23 -44.0 89.64 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.053 0.76 . . . . 6.41 113.053 -160.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 m -153.56 0.47 0.24 Allowed 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 114.689 1.366 . . . . 3.3 114.689 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.26 -42.44 68.79 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.985 1.266 . . . . 2.68 110.227 -174.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -53.58 -46.35 60.42 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 108.703 -0.851 . . . . 3.14 108.703 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -60.64 -41.59 95.22 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.387 0.613 . . . . 3.53 111.545 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -61.42 -52.32 65.06 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.625 -0.672 . . . . 2.36 109.81 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.6 mt -47.66 -50.4 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.331 1.052 . . . . 3.06 110.822 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -49.8 -49.13 49.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.117 0.567 . . . . 4.75 112.055 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -65.25 -40.0 93.44 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.918 -0.489 . . . . 10.07 110.214 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -59.4 -53.5 57.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.662 -0.496 . . . . 1.7 109.662 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.49 -41.83 86.19 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.969 -0.457 . . . . 3.72 111.748 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -54.58 -19.49 6.06 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.977 0.732 . . . . 2.07 112.977 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -110.54 3.04 19.13 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 117.865 -1.064 . . . . 4.06 113.069 175.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -60.37 -68.03 0.34 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 120.359 1.436 . . . . 2.98 110.97 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -168.96 -117.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.306 0.642 . . . . 2.36 109.987 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.47 -8.53 76.08 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.557 -0.58 . . . . 1.6 113.341 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.48 122.16 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 118.628 1.214 . . . . 2.4 110.231 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.54 51.93 1.34 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.435 0.636 . . . . 4.27 111.613 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -160.72 132.58 5.89 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.595 -1.631 . . . . 2.39 106.595 161.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.9 m -118.36 132.57 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.771 -1.937 . . . . 3.33 105.771 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -140.0 74.88 1.48 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.052 -1.462 . . . . 3.49 107.052 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -97.39 127.88 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.432 -0.951 . . . . 3.05 108.432 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.78 93.49 5.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.301 -1.74 . . . . 2.49 106.301 166.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.46 -28.13 65.03 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.28 0.632 . . . . 4.36 110.499 176.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 40.9 mtt -59.39 -64.35 0.97 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.448 1.099 . . . . 4.17 110.425 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.0 -26.83 54.33 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.391 -0.822 . . . . 1.85 110.552 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.63 61.23 1.8 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 125.009 1.29 . . . . 1.22 110.545 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -138.52 144.39 39.93 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.412 -1.329 . . . . 6.84 107.412 175.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.38 102.08 9.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.283 1.433 . . . . 2.32 109.35 167.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -96.17 134.67 38.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.301 -2.111 . . . . 4.76 105.301 165.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 pt -140.1 171.27 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.634 -1.247 . . . . 2.73 107.634 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -120.47 108.17 13.77 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.658 0.663 . . . . 5.13 111.952 167.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -97.52 -179.67 4.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.684 2.393 . . . . 3.42 111.907 174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -134.97 98.86 12.74 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.065 1.346 . . . . 4.92 109.322 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.68 -26.87 75.58 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.754 2.969 . . . . 1.94 113.185 -162.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -75.04 -10.5 59.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.939 0.495 . . . . 3.6 111.753 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.3 -49.37 2.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 124.102 0.961 . . . . 4.05 109.954 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.59 147.5 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.71 1.204 . . . . 3.66 107.958 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -124.17 151.89 66.48 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.484 1.114 . . . . 2.83 108.869 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.4 -34.87 97.44 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.747 2.298 . . . . 1.8 112.127 -172.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -71.28 -35.07 71.2 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.567 0.58 . . . . 4.17 112.567 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -58.02 -48.33 80.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.407 0.683 . . . . 3.16 109.22 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -52.47 -53.28 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 106.931 -1.507 . . . . 2.33 106.931 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.33 73.78 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.008 -0.542 . . . . 2.2 109.964 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -45.79 74.84 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.3 0.64 . . . . 2.66 110.645 176.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -47.51 81.57 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.387 0.613 . . . . 3.56 110.119 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.2 mm -67.36 -41.84 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.548 -0.72 . . . . 3.55 111.008 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -44.86 95.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.94 1.296 . . . . 2.32 109.443 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.04 -51.62 68.88 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.067 0.547 . . . . 2.17 109.842 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.3 mt -58.94 -31.1 68.37 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.567 -0.288 . . . . 4.66 111.767 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.89 27.63 2.93 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.145 0.879 . . . . 1.17 111.923 163.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -119.31 167.35 11.97 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.102 1.361 . . . . 3.43 108.274 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -96.82 132.74 42.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.183 -1.414 . . . . 2.52 107.183 164.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.09 119.37 39.28 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.162 -1.792 . . . . 1.72 106.162 163.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.53 122.44 29.23 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.063 -1.088 . . . . 2.5 108.063 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.415 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.9 t -56.89 144.05 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 109.551 -0.537 . . . . 3.3 109.551 171.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.6 mtp -53.99 -46.78 71.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.361 -0.836 . . . . 4.63 109.245 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 166.45 -43.78 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 131.255 3.822 . . . . 4.19 102.441 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.91 63.61 7.65 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 124.621 2.153 . . . . 7.54 111.616 -165.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -40.24 -21.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 1 C-N-CA 132.493 4.317 . . . . 4.84 115.47 168.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -172.84 -97.31 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.6 0.76 . . . . 4.62 110.34 162.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.89 58.57 0.88 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.204 -1.958 . . . . 3.78 108.204 -168.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.9 -116.91 0.09 Allowed 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 117.401 -1.285 . . . . 5.36 111.704 -156.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -107.84 115.0 29.34 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 121.752 2.069 . . . . 5.11 109.335 -175.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.12 -49.24 4.19 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.392 -1.883 . . . . 2.26 108.392 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.83 82.53 3.03 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 127.469 2.308 . . . . 4.5 107.572 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.41 172.63 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.665 0.745 . . . . 3.79 109.005 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -142.34 157.39 44.86 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 124.26 1.024 . . . . 4.56 108.402 170.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.6 mt -143.0 147.39 35.05 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.581 1.152 . . . . 3.38 109.138 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.64 119.34 34.94 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.72 -1.585 . . . . 2.92 106.72 165.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.24 116.0 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.712 1.205 . . . . 3.12 108.165 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.7 m -106.58 147.49 29.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.149 1.38 . . . . 3.69 107.986 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.4 -40.29 2.48 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.635 1.112 . . . . 1.21 111.279 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -58.96 141.67 53.13 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.458 0.703 . . . . 3.26 110.648 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.8 t -159.94 37.68 0.18 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.092 0.557 . . . . 3.75 111.328 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 51.8 t -162.71 142.06 9.07 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.257 -0.902 . . . . 3.63 110.732 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.78 -45.31 49.55 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.878 0.871 . . . . 3.46 111.441 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 m -56.21 -39.74 72.96 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.816 -0.553 . . . . 2.9 111.649 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 78.7 m -64.97 -46.81 79.96 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.838 -0.801 . . . . 2.82 108.838 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.1 t -50.91 -55.06 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.167 0.587 . . . . 2.38 110.593 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -59.38 -42.47 91.74 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.865 0.84 . . . . 4.23 109.581 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.59 -49.36 75.53 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.136 1.374 . . . . 2.5 110.906 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -54.75 -50.08 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.233 0.613 . . . . 2.5 109.677 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.86 -41.39 99.36 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.195 0.598 . . . . 2.38 109.507 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.7 t -56.15 -52.88 62.78 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.116 0.566 . . . . 1.76 110.475 171.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -51.98 -45.8 64.61 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.639 -0.663 . . . . 3.5 110.77 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.23 -60.19 3.26 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.732 -1.21 . . . . 2.93 107.732 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -52.92 -23.2 6.68 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.822 0.701 . . . . 2.88 112.429 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -64.89 -25.53 67.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 120.36 -0.536 . . . . 5.52 112.305 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 m -69.69 135.09 49.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.195 1.798 . . . . 2.84 110.384 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.9 p-10 -52.38 -51.22 60.14 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.139 0.975 . . . . 2.47 113.565 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.29 -36.96 43.4 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 122.094 -0.379 . . . . 1.28 113.277 -170.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.38 121.57 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 O-C-N 121.753 -0.851 . . . . 2.81 109.307 -168.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.7 m -102.64 -40.11 6.77 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.665 0.386 . . . . 3.16 111.141 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -141.74 127.69 19.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.291 0.496 . . . . 3.3 110.378 164.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -98.45 155.61 17.17 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.707 -1.22 . . . . 1.75 107.707 162.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.0 m -144.36 106.17 4.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 118.048 -0.977 . . . . 2.95 108.687 165.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.1 p -98.76 126.66 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.216 0.916 . . . . 3.56 112.496 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.87 101.59 7.15 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.844 1.257 . . . . 2.03 109.947 -172.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 pp -75.49 -29.2 59.47 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.367 1.467 . . . . 3.27 113.062 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.32 85.55 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 121.716 0.77 . . . . 2.2 109.171 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.8 -30.9 18.65 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.27 1.828 . . . . 2.73 109.138 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 74.1 m 64.76 50.48 2.03 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.974 1.709 . . . . 2.94 110.261 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -139.71 166.15 25.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.618 -0.719 . . . . 3.54 110.816 158.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -130.38 132.7 45.91 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.073 2.149 . . . . 1.7 107.917 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.49 138.56 34.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.711 -1.218 . . . . 2.99 107.711 172.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.1 t -131.42 128.64 61.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.624 1.17 . . . . 3.49 108.811 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -121.67 94.36 4.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.106 0.963 . . . . 4.31 109.123 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -128.4 -177.94 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.719 0.691 . . . . 4.01 111.528 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -99.65 115.3 65.73 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.0 0.92 . . . . 3.38 109.476 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.28 69.52 7.56 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.256 2.637 . . . . 1.82 112.084 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -163.56 -44.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.694 1.198 . . . . 3.99 109.928 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pt -81.69 -30.71 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 122.275 -0.266 . . . . 2.61 111.318 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.01 171.38 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.76 -1.57 . . . . 2.52 106.76 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.11 160.98 28.76 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.789 -0.924 . . . . 2.16 110.789 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.85 -36.59 90.31 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.93 3.086 . . . . 2.03 112.231 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -35.64 74.74 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 123.01 0.524 . . . . 7.25 110.177 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.36 -43.19 82.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.175 0.898 . . . . 3.3 109.622 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 68.7 mt -57.96 -48.14 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.447 -0.575 . . . . 2.11 109.447 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 60.1 mt -51.41 -60.8 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 108.82 -0.807 . . . . 3.25 108.82 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -44.44 -52.7 7.59 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.633 1.173 . . . . 5.45 112.378 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.4 mm -51.99 -53.64 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 109.253 -0.647 . . . . 3.28 109.253 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.272 2.3 pp -70.34 -26.83 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 114.034 1.124 . . . . 2.32 114.034 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -62.74 -38.16 89.4 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.321 0.964 . . . . 3.35 109.418 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -63.88 -35.87 82.08 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.609 0.764 . . . . 5.06 109.017 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 47.7 mt -68.38 -49.3 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 110.052 -0.351 . . . . 2.14 110.052 170.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.91 30.53 2.31 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.943 1.735 . . . . 1.15 112.488 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -102.06 179.06 4.43 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.944 1.372 . . . . 3.3 109.757 166.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -132.94 118.03 18.38 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 108.007 -1.108 . . . . 5.29 108.007 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.07 100.06 9.57 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.554 1.142 . . . . 1.94 109.755 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.6 m -109.37 112.73 25.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.189 0.995 . . . . 2.94 108.587 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -33.07 105.81 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 126.447 1.899 . . . . 5.35 110.101 168.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.93 -34.76 71.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.345 -0.843 . . . . 3.83 110.314 -171.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.249 1.044 0 C-N-CA 128.156 2.582 . . . . 5.82 114.604 169.187 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 108.201 -1.037 . . . . 9.86 108.201 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.41 125.61 91.83 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.659 1.583 . . . . 4.79 111.797 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.24 110.92 2.8 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 121.39 1.394 . . . . 3.26 110.742 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.89 146.35 51.73 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.193 1.797 . . . . 2.96 106.478 175.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -103.23 154.53 19.24 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.747 -1.205 . . . . 4.16 107.747 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 p -142.32 130.34 21.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.316 0.488 . . . . 3.17 112.316 169.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -98.27 103.69 15.66 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.126 2.17 . . . . 3.74 110.271 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.39 176.64 5.77 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.744 0.783 . . . . 3.53 110.199 171.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.87 151.51 43.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.259 -1.386 . . . . 2.02 107.259 168.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.5 mm -95.85 148.04 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.538 -1.653 . . . . 2.05 106.538 171.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -121.64 106.43 11.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.46 -1.311 . . . . 3.64 107.46 163.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.8 -93.65 0.12 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.746 -1.342 . . . . 1.29 109.746 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 mtt 54.25 80.66 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.137 1.375 . . . . 2.87 113.808 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.14 -20.47 17.78 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.847 0.859 . . . . 2.88 112.671 170.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.4 t 74.79 -79.5 0.04 OUTLIER 'General case' 0 C--N 1.342 0.255 0 N-CA-C 107.642 -1.244 . . . . 4.18 107.642 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 4.83 -87.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 128.418 2.687 . . . . 6.41 112.813 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.1 m -138.22 22.49 2.78 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.292 0.637 . . . . 3.3 109.982 160.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.5 m -69.69 -53.49 18.31 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 119.342 -0.943 . . . . 2.68 109.125 -168.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.5 t -50.03 -39.65 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.348 0.594 . . . . 3.14 110.381 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.12 -46.83 87.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.491 0.663 . . . . 3.53 111.221 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -64.57 -46.52 82.39 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.836 -1.165 . . . . 2.36 110.804 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -46.57 -53.7 2.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 C-N-CA 124.868 1.267 . . . . 3.06 108.842 175.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -45.68 -56.26 5.45 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.393 0.616 . . . . 4.75 110.858 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -24.33 61.48 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.151 0.98 . . . . 10.07 110.874 -173.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -69.98 -57.35 5.11 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.683 -0.858 . . . . 1.7 108.683 173.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.03 -42.03 89.22 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 118.522 0.601 . . . . 3.72 110.562 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -22.51 19.93 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.513 0.56 . . . . 2.07 112.513 177.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -124.28 32.16 5.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.944 0.898 . . . . 4.06 111.229 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -74.18 -76.84 0.12 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.021 -1.103 . . . . 2.98 108.021 165.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.74 -118.69 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.276 0.63 . . . . 2.36 110.0 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.82 -13.03 80.89 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 119.522 1.056 . . . . 1.6 113.049 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.08 125.86 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 117.61 0.705 . . . . 2.4 112.215 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.91 57.01 1.41 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.701 1.2 . . . . 4.27 108.093 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.5 t -160.32 154.4 23.12 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 120.535 -1.353 . . . . 2.39 108.141 149.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.4 t -132.94 106.74 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.681 -1.229 . . . . 3.33 107.681 167.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 tt -124.25 73.79 1.26 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.509 -1.293 . . . . 3.49 107.509 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.75 128.0 55.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 109.003 -0.74 . . . . 3.05 109.003 174.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.94 98.07 9.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.654 -1.239 . . . . 2.49 107.654 170.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 tp -61.67 -26.83 68.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.267 1.027 . . . . 4.36 110.258 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -50.75 43.42 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.784 -0.573 . . . . 4.17 110.108 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.5 -7.22 26.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.545 0.738 . . . . 1.85 112.555 -169.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.38 66.98 2.13 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.181 -1.168 . . . . 1.22 110.181 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 131.16 20.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.106 -1.232 . . . . 6.84 108.839 171.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.06 90.2 3.24 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.992 2.117 . . . . 2.32 110.521 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -102.95 130.08 49.91 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.254 -1.388 . . . . 4.76 107.254 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 pt -140.13 -179.6 2.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 O-C-N 121.236 -0.915 . . . . 2.73 108.585 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -132.67 104.71 6.78 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.27 0.628 . . . . 5.13 110.007 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -106.27 172.55 6.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.83 1.252 . . . . 3.42 113.265 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -114.56 101.49 54.32 Favored Pre-proline 0 N--CA 1.444 -0.75 0 C-N-CA 129.212 3.005 . . . . 4.92 109.627 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.11 8.91 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.749 1.633 . . . . 1.94 113.978 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -91.05 -26.83 18.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.533 1.133 . . . . 3.6 112.039 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.69 -63.35 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 105.566 -2.012 . . . . 4.05 105.566 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.46 170.07 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 120.242 -0.583 . . . . 3.66 110.35 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.86 159.54 68.26 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.742 1.217 . . . . 2.83 108.416 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.24 -40.78 30.64 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.46 2.107 . . . . 1.8 111.256 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -58.22 -40.71 82.36 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.993 -0.442 . . . . 4.17 111.184 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -61.16 -44.94 96.53 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.893 0.877 . . . . 3.16 110.656 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -49.66 -57.92 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.368 0 N-CA-C 106.212 -1.773 . . . . 2.33 106.212 170.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.03 -43.51 86.84 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.473 -0.785 . . . . 2.2 110.165 -170.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -50.1 65.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.569 1.548 . . . . 2.66 110.049 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.06 -45.83 86.4 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.574 0.702 . . . . 3.56 109.707 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.6 mm -61.59 -44.03 97.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 116.291 -0.413 . . . . 3.55 110.373 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -64.96 -40.86 95.65 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.234 -0.916 . . . . 2.32 110.012 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -61.1 -50.44 73.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.935 0.894 . . . . 2.17 109.932 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.38 -35.18 80.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.3 -0.56 . . . . 4.66 110.781 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.29 23.4 1.75 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 123.386 0.517 . . . . 1.17 112.708 163.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -112.79 158.71 19.79 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.889 0.845 . . . . 3.43 109.68 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -95.43 133.35 39.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.045 -1.465 . . . . 2.52 107.045 167.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.06 125.31 44.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.111 0.964 . . . . 1.72 108.531 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.19 134.88 44.66 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.408 -0.59 . . . . 2.5 109.408 171.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.15 151.8 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.315 1.046 . . . . 3.3 110.726 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.0 mtp -74.9 -3.76 33.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.649 -0.705 . . . . 4.63 111.946 173.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 98.51 7.37 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 129.111 2.964 . . . . 4.19 110.666 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -156.5 65.16 0.54 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 123.428 1.585 . . . . 7.54 108.45 -166.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -24.79 -63.28 0.06 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 112.429 -2.168 . . . . 4.84 113.927 173.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -179.58 -71.24 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 119.255 0.934 . . . . 4.62 111.365 -167.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.58 83.78 1.61 Allowed Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 109.355 -1.498 . . . . 3.78 109.355 -175.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.0 t -135.34 -105.41 0.22 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 118.734 -0.651 . . . . 5.36 112.648 -177.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -114.67 142.18 46.83 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.004 -1.48 . . . . 5.11 107.004 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.26 -43.72 2.54 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.642 -0.983 . . . . 2.26 110.642 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -129.39 119.34 23.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.917 0.887 . . . . 4.5 111.283 169.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.27 157.02 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.547 -1.279 . . . . 3.79 107.547 172.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.94 141.54 32.96 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.813 0.845 . . . . 4.56 109.632 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.6 mt -141.47 143.77 34.03 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 109.099 -0.704 . . . . 3.38 109.099 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.57 130.63 43.72 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 107.726 -1.212 . . . . 2.92 107.726 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 pp -111.4 99.88 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.331 1.052 . . . . 3.12 110.671 -169.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.1 p -97.31 129.51 44.58 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.875 -0.787 . . . . 3.69 108.875 -175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.86 -26.98 6.98 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.349 0.976 . . . . 1.21 111.326 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.0 mtm -63.11 149.03 46.21 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.125 -0.632 . . . . 3.26 112.211 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -169.82 41.92 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.939 1.295 . . . . 3.75 109.287 172.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -166.04 140.63 4.54 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 121.107 -0.996 . . . . 3.63 112.895 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.08 -42.62 81.02 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.447 0.699 . . . . 3.46 110.751 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.3 m -50.48 -45.14 56.15 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.228 0.611 . . . . 2.9 110.807 173.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 75.5 m -64.39 -50.94 65.68 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.017 -0.735 . . . . 2.82 109.017 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 78.7 t -48.32 -51.77 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.08 0.552 . . . . 2.38 110.664 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -59.17 -34.71 72.42 Favored 'General case' 0 C--O 1.227 -0.086 0 CA-C-O 120.722 0.296 . . . . 4.23 110.335 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -63.4 -58.86 5.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.86 0.864 . . . . 2.5 109.393 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.2 mp -52.94 -52.22 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.366 -0.605 . . . . 2.5 109.366 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.28 -49.76 73.32 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.175 -0.676 . . . . 2.38 109.175 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 t -53.73 -46.77 70.94 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 122.047 -0.408 . . . . 1.76 110.529 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -65.18 -38.11 89.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.124 0.57 . . . . 3.5 111.791 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 47.7 mt -70.91 -62.64 1.32 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.373 -0.973 . . . . 2.93 108.373 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.4 m -50.29 -24.36 2.88 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.633 2.373 . . . . 2.88 112.692 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -32.12 62.58 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.288 0.477 . . . . 5.52 112.288 172.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.2 m -59.42 144.54 46.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.573 1.149 . . . . 2.84 111.118 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -66.8 -47.97 70.43 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.968 0.907 . . . . 2.47 111.552 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.74 -30.21 66.45 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 123.527 0.584 . . . . 1.28 113.293 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.9 tt -69.61 130.26 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 122.117 -0.637 . . . . 2.81 110.277 -167.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 37.7 m -99.64 -49.77 4.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.753 -0.203 . . . . 3.16 110.824 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -141.31 122.65 14.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.274 -0.639 . . . . 3.3 109.274 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.88 156.12 16.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.265 -1.013 . . . . 1.75 108.265 161.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.5 t -141.05 122.25 14.77 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 107.276 -1.379 . . . . 2.95 107.276 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.59 117.2 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.691 1.196 . . . . 3.56 108.825 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.26 97.72 5.18 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.131 0.967 . . . . 2.03 111.525 -171.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 pp -59.72 -22.07 61.53 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.412 0.893 . . . . 3.27 113.412 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.53 -38.28 49.12 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.454 0.645 . . . . 2.2 109.471 -176.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.5 p -88.79 -20.08 25.17 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 125.011 1.324 . . . . 2.73 109.353 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.5 m 73.25 21.48 3.05 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.885 2.074 . . . . 2.94 111.096 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -130.24 157.3 42.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.899 0.857 . . . . 3.54 112.083 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.27 122.47 29.7 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.061 2.145 . . . . 1.7 107.366 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mp -99.87 137.86 37.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.542 1.537 . . . . 2.99 107.451 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.73 122.63 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.825 1.25 . . . . 3.49 109.346 -169.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -111.37 87.94 2.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.665 -0.683 . . . . 4.31 109.615 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -117.55 173.33 6.78 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.858 0.863 . . . . 4.01 110.657 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -98.49 112.61 62.78 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 108.397 -0.964 . . . . 3.38 108.397 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.02 73.65 4.81 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.39 2.726 . . . . 1.82 111.991 -165.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -162.1 -43.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.228 1.411 . . . . 3.99 110.153 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 pt -83.77 -31.77 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 123.762 0.825 . . . . 2.61 111.281 -170.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.68 158.96 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.337 -0.986 . . . . 2.52 108.337 171.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -126.71 159.93 20.99 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.099 1.333 . . . . 2.16 109.958 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.7 -36.17 42.77 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.125 2.55 . . . . 2.03 111.356 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.17 -40.71 74.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.748 1.219 . . . . 7.25 110.869 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -66.05 -43.91 86.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.671 -0.492 . . . . 3.3 109.671 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.45 -47.68 89.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.645 -0.872 . . . . 2.11 108.645 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.7 mt -53.05 -56.19 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 123.825 0.85 . . . . 3.25 109.529 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -48.34 64.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.366 0.985 . . . . 5.45 110.824 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.0 mm -54.74 -52.99 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 122.047 -0.408 . . . . 3.28 110.065 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.257 2.5 pp -70.52 -27.85 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.764 -1.21 . . . . 2.32 113.419 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.29 -32.85 73.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.36 0.527 . . . . 3.35 110.646 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -57.31 -42.94 82.78 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.844 -0.798 . . . . 5.06 108.844 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.8 mt -73.8 -40.57 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.771 -0.65 . . . . 2.14 109.517 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.38 37.0 3.41 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.007 1.289 . . . . 1.15 110.92 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -99.49 178.1 4.97 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.262 -1.014 . . . . 3.3 108.262 160.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -140.63 125.87 18.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 107.027 -1.471 . . . . 5.29 107.027 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.59 106.45 14.88 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.498 1.519 . . . . 1.94 108.722 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.9 t -123.6 136.27 54.42 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 118.423 0.556 . . . . 2.94 110.496 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp -32.24 119.91 0.29 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.808 2.043 . . . . 5.35 113.27 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.56 49.03 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.085 0.954 . . . . 3.83 111.211 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.332 0 CA-C-O 116.042 -1.932 . . . . 5.82 107.356 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 109.11 -0.7 . . . . 8.21 109.11 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.79 98.79 0.04 OUTLIER Pre-proline 0 C--O 1.219 -0.515 0 C-N-CA 125.184 1.393 . . . . 4.38 109.311 -166.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.39 141.5 22.85 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.547 2.165 . . . . 3.07 110.754 -170.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -116.32 141.56 48.0 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.418 -0.956 . . . . 4.0 108.418 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -90.64 157.08 17.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.99 -1.855 . . . . 4.84 105.99 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.22 121.92 20.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.695 -1.594 . . . . 3.21 106.695 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -102.3 90.59 3.95 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.313 1.845 . . . . 4.98 109.05 -173.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.68 171.26 8.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.576 0.703 . . . . 3.7 111.204 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.48 143.03 46.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.394 -0.965 . . . . 1.92 108.394 166.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.3 mm -99.44 139.29 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 107.276 -1.379 . . . . 2.24 107.276 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -125.97 123.01 37.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.074 -1.454 . . . . 3.83 107.074 168.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.58 -69.66 0.25 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.224 1.392 . . . . 1.74 110.442 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.9 mmt 37.09 71.2 0.15 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.758 2.023 . . . . 2.71 114.254 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -52.56 -60.52 3.15 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.469 -0.769 . . . . 3.5 113.064 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 t -165.87 48.67 0.08 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 119.518 -0.873 . . . . 4.19 111.816 -172.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.05 51.91 15.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.454 1.102 . . . . 6.73 112.243 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.3 m -175.18 -36.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.039 1.335 . . . . 4.09 110.96 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.71 -42.86 77.12 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 120.965 -1.084 . . . . 2.43 110.536 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.0 -43.98 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.348 -0.612 . . . . 3.01 109.348 168.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -62.07 -30.78 71.23 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.459 0.647 . . . . 2.86 111.861 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -71.47 -46.45 59.87 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 120.98 -1.075 . . . . 3.52 110.706 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.8 mt -49.28 -45.98 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.397 0.679 . . . . 2.71 110.823 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -45.19 -48.07 12.48 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.444 0.565 . . . . 4.17 112.216 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.0 mtm105 -66.02 -34.09 77.29 Favored 'General case' 0 C--N 1.339 0.115 0 O-C-N 121.754 -0.591 . . . . 6.9 110.753 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -63.7 -54.55 33.7 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.241 -1.022 . . . . 1.16 108.241 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mp -60.19 -36.44 77.63 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 111.953 0.353 . . . . 3.01 111.953 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -19.45 6.34 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.178 -0.951 . . . . 2.34 113.128 173.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -118.77 21.31 12.54 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.656 -0.688 . . . . 4.46 112.519 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -66.69 -68.36 0.38 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.355 0.98 . . . . 3.09 109.292 168.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.57 -125.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.419 0.687 . . . . 2.09 109.161 -167.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.0 -10.07 61.07 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 121.85 -0.531 . . . . 1.56 113.389 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -74.95 120.59 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 118.739 1.269 . . . . 2.99 110.38 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.86 53.07 1.09 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.068 0.396 . . . . 3.56 112.068 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' A' ' 47' ' ' LYS . 29.1 t -158.16 137.0 11.34 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 106.731 -1.581 . . . . 2.98 106.731 171.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.25 101.79 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.607 -1.627 . . . . 3.83 106.607 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -129.3 76.39 1.72 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.158 -1.793 . . . . 3.27 106.158 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.21 141.55 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.945 -1.131 . . . . 3.28 107.945 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -112.85 101.82 9.87 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.263 -1.754 . . . . 2.13 106.263 164.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 tp -55.65 -33.0 63.67 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.488 1.115 . . . . 4.45 109.037 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -48.97 77.29 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.545 0.738 . . . . 6.66 110.571 -174.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.05 -30.48 16.74 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.499 0.72 . . . . 2.38 110.875 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.35 57.69 1.74 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.984 1.278 . . . . 1.17 110.603 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -140.05 144.56 36.94 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.131 0.966 . . . . 3.93 108.856 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.49 116.24 29.95 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.151 0.98 . . . . 1.92 111.398 164.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -97.78 123.79 41.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.716 -1.216 . . . . 4.33 107.716 157.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mt -114.01 164.87 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 108.136 -1.061 . . . . 4.2 108.136 167.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' CB ' ' HB3' ' A' ' 34' ' ' SER . 10.3 ttmt -124.65 108.93 12.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.739 1.215 . . . . 4.66 110.194 166.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -116.83 177.26 4.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.1 2.16 . . . . 4.05 112.634 175.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.42 107.63 23.81 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.641 1.576 . . . . 3.19 107.559 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.93 6.81 2.28 Favored 'Trans proline' 0 N--CA 1.455 -0.753 1 C-N-CA 125.512 4.142 . . . . 2.64 113.605 -168.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -86.73 -22.16 26.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.46 0.704 . . . . 3.83 111.207 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.73 -56.01 3.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-N 118.566 0.621 . . . . 4.32 109.876 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.31 142.77 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.549 -1.278 . . . . 2.38 107.549 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.26 150.79 54.78 Favored Pre-proline 0 N--CA 1.453 -0.293 0 C-N-CA 124.798 1.239 . . . . 3.21 109.583 -174.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.18 -44.27 35.46 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.758 2.305 . . . . 1.55 111.627 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -39.72 94.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.372 -0.83 . . . . 4.39 111.488 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -58.47 -43.69 89.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.005 0.522 . . . . 4.22 110.352 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.57 -42.39 29.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 N-CA-C 108.727 -0.842 . . . . 2.64 108.727 173.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.32 -38.59 74.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.12 0.486 . . . . 2.67 111.152 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -63.88 -51.48 64.38 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.491 -0.755 . . . . 3.01 110.109 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -54.26 -51.91 63.05 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.91 0.323 . . . . 4.8 111.695 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 pp -61.25 -42.73 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.649 -0.657 . . . . 5.55 111.741 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.41 -35.15 80.06 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.663 -0.648 . . . . 3.22 110.758 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -64.27 -50.75 66.69 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.174 0.59 . . . . 2.59 109.901 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.3 mt -55.08 -35.38 64.5 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.163 0.585 . . . . 2.92 111.129 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.4 39.88 1.44 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.558 1.075 . . . . 1.45 110.589 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -135.43 156.97 48.04 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.528 1.531 . . . . 3.67 107.596 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -104.94 129.75 53.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.695 -1.224 . . . . 3.63 107.695 171.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.62 112.32 17.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.392 -1.707 . . . . 2.05 106.392 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.53 129.45 55.8 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.356 1.035 . . . . 1.83 108.916 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.8 154.29 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.788 0.835 . . . . 3.85 109.153 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.0 mtt -51.23 -56.26 13.82 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.19 -0.459 . . . . 4.23 110.525 170.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -170.7 54.72 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.551 0.532 . . . . 4.85 111.136 -171.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 11.23 64.93 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 128.447 2.699 . . . . 9.84 114.053 -170.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -103.86 -47.38 4.22 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 112.628 -2.078 . . . . 8.07 110.074 -166.228 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 93.79 -103.49 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.835 2.054 . . . . 4.53 112.139 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.49 84.02 1.77 Allowed Glycine 0 C--N 1.335 0.502 0 CA-C-N 119.377 0.99 . . . . 3.58 114.671 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 t -162.74 -61.11 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.915 -0.402 . . . . 5.46 109.915 154.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -142.75 123.35 14.09 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.364 -1.347 . . . . 5.8 107.364 -163.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.41 -61.76 4.67 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 107.913 -2.075 . . . . 2.79 107.913 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.05 110.94 23.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.225 0.61 . . . . 2.45 109.489 175.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.5 pp -129.67 174.96 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.799 0.84 . . . . 4.77 110.874 164.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.52 ' HB2' ' CE1' ' A' ' 75' ' ' TYR . 0.9 OUTLIER -111.3 150.93 28.97 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 128.041 2.536 . . . . 4.41 109.401 174.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.2 mt -142.34 139.58 31.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.563 0.745 . . . . 3.58 110.03 172.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.1 t -97.1 124.45 41.12 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.33 0.968 . . . . 2.43 109.51 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -95.9 106.51 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.185 -0.672 . . . . 2.62 109.185 -171.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.9 m -98.83 133.74 42.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.903 -1.147 . . . . 2.37 107.903 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.62 -44.96 1.32 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.918 1.247 . . . . 1.0 112.013 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.52 150.82 41.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.662 0.731 . . . . 3.6 111.349 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -162.5 44.65 0.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.543 0.687 . . . . 3.76 110.057 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 48.9 t -161.99 136.67 6.98 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.826 -1.171 . . . . 3.34 110.721 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.6 -39.15 49.23 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.055 0.942 . . . . 3.67 111.352 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 m -56.23 -44.2 79.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.611 -0.681 . . . . 2.54 111.394 174.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 64.1 m -68.58 -49.98 55.25 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.222 -0.659 . . . . 2.79 109.222 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 78.8 t -43.49 -60.4 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.775 1.23 . . . . 2.24 109.792 170.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -59.13 -43.31 91.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.239 1.016 . . . . 3.86 111.105 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -62.48 -47.68 82.92 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.578 0.751 . . . . 1.89 110.673 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.7 mt -56.02 -49.42 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.388 -0.967 . . . . 1.8 108.388 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.57 -45.11 92.8 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.679 -0.489 . . . . 2.58 109.679 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.1 m -57.02 -48.82 77.59 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.358 0.663 . . . . 2.74 110.736 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -60.01 -38.64 83.24 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.723 0.809 . . . . 4.87 111.493 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 42.6 mt -67.81 -60.5 2.48 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.693 -1.225 . . . . 2.66 107.693 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.6 p -55.74 -17.37 5.86 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.278 0.631 . . . . 2.82 112.64 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -60.99 -24.49 66.18 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.615 -0.678 . . . . 6.89 112.412 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.1 m -73.86 166.13 23.89 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.407 1.483 . . . . 2.43 111.505 -167.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -76.57 -58.32 3.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.65 1.18 . . . . 3.28 111.722 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.69 -45.73 8.35 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.362 -1.095 . . . . 1.75 110.362 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.44 131.29 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.485 -0.561 . . . . 3.58 109.485 175.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.2 t -131.53 -39.21 1.14 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.217 1.007 . . . . 3.74 110.875 172.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.06 112.18 17.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.704 -1.591 . . . . 3.64 106.704 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.75 166.69 16.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.672 -0.862 . . . . 2.31 108.672 163.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 m -142.59 138.34 30.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.69 -1.226 . . . . 2.56 107.69 163.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.66 105.12 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.207 1.003 . . . . 2.97 108.616 -171.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -112.61 102.47 10.54 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.12 0.968 . . . . 2.05 110.573 -168.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -29.7 68.95 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.079 1.352 . . . . 3.82 113.638 -173.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.32 -44.75 95.77 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.797 0.839 . . . . 2.66 109.964 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.74 -25.63 26.32 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.519 1.127 . . . . 2.2 109.623 170.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.2 m 73.97 24.31 2.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.127 1.771 . . . . 2.41 111.509 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -116.06 150.33 37.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.459 1.027 . . . . 3.84 110.425 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.14 107.57 4.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.82 1.248 . . . . 1.96 112.595 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.82 141.5 28.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.245 1.021 . . . . 3.97 110.794 173.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.8 m -133.94 135.3 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 126.029 1.732 . . . . 3.74 106.475 -173.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.15 104.21 14.11 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 108.292 -1.003 . . . . 4.44 108.292 171.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -113.43 -179.55 3.67 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.782 0.833 . . . . 4.26 111.199 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.79 114.32 37.62 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.165 1.386 . . . . 3.73 108.587 171.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.96 57.83 6.69 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.677 2.918 . . . . 2.42 112.511 -169.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -147.11 -52.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.634 1.573 . . . . 4.59 107.539 172.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 pt -83.94 -25.71 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 123.178 0.591 . . . . 2.9 112.27 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -147.03 169.73 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.075 -0.713 . . . . 2.3 109.075 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.57 165.75 30.09 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 111.145 -0.782 . . . . 1.56 111.145 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.18 -32.99 41.51 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.535 2.823 . . . . 1.71 111.505 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -52.37 -39.62 61.02 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.369 0.604 . . . . 7.47 111.188 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -72.26 -38.28 68.9 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.355 -0.98 . . . . 4.42 108.355 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 81.3 mt -58.03 -54.14 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.648 -0.501 . . . . 2.11 109.648 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 22.2 pt -56.25 -55.01 21.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.404 -0.591 . . . . 4.1 109.404 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -47.52 -46.28 27.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 119.117 0.871 . . . . 5.03 112.931 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 mm -59.07 -42.7 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 O-C-N 121.735 -0.603 . . . . 2.55 111.682 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.3 pt -76.93 -28.99 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 113.785 1.032 . . . . 3.06 113.785 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.38 -28.33 65.06 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.363 -0.836 . . . . 3.06 110.301 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -60.77 -41.0 94.66 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.638 -0.504 . . . . 5.49 109.638 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 27.7 mt -70.79 -40.95 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.887 -0.782 . . . . 2.19 108.887 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.62 31.61 3.39 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.393 1.473 . . . . 1.09 110.729 -176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -108.9 166.82 10.53 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 108.782 -0.822 . . . . 3.33 108.782 169.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -137.59 133.72 34.74 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 106.985 -1.487 . . . . 4.59 106.985 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.45 92.66 3.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.981 1.712 . . . . 2.43 109.239 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.3 p -146.87 105.47 3.82 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 117.021 -1.466 . . . . 3.03 112.581 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.3 -70.56 0.09 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 121.361 1.891 . . . . 9.37 114.031 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.447 ' HA ' ' CB ' ' A' ' 83' ' ' GLU 0.361 . . 40.68 80.09 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.334 2.254 . . . . 5.99 116.891 -163.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.917 0 C-N-CA 128.643 2.777 . . . . 7.06 103.875 172.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 118.771 -0.633 . . . . 16.45 109.338 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.61 154.19 38.03 Favored Pre-proline 0 N--CA 1.452 -0.37 0 O-C-N 124.54 1.15 . . . . 7.96 108.081 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -90.73 29.79 0.38 Allowed 'Trans proline' 0 CA--C 1.514 -0.497 0 N-CA-C 117.37 2.027 . . . . 5.34 117.37 -158.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -106.33 109.38 21.29 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 111.648 -2.524 . . . . 4.28 107.84 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.84 154.36 18.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.274 -1.33 . . . . 5.08 107.75 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.6 t -141.71 132.25 25.39 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.674 0.67 . . . . 3.52 109.507 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -107.83 87.35 2.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.983 1.313 . . . . 3.81 108.983 -162.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.19 177.69 4.55 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.51 0.671 . . . . 3.92 110.59 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.86 151.79 49.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.74 -1.578 . . . . 2.88 106.74 172.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.1 mm -99.3 120.57 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.296 -1.372 . . . . 1.67 107.296 171.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -101.47 87.44 3.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.677 -1.972 . . . . 5.29 105.677 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.12 -87.71 0.08 OUTLIER Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.117 -1.193 . . . . 1.31 110.117 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.2 ptp 41.51 69.72 0.33 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.263 1.825 . . . . 2.8 115.636 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -53.33 -13.32 0.53 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.822 1.416 . . . . 3.24 114.822 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.8 t 74.58 -61.76 0.48 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.397 1.879 . . . . 3.39 111.217 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.15 -72.69 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.741 2.416 . . . . 6.7 113.043 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.6 p -157.51 10.88 0.2 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 113.027 0.751 . . . . 4.73 113.027 166.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -50.64 30.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.423 -1.325 . . . . 2.6 107.423 -169.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 p -49.72 -48.71 20.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 109.783 -0.451 . . . . 4.31 109.783 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 m -54.77 -46.98 74.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.667 0.787 . . . . 2.62 112.552 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -63.82 -45.49 89.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.978 -1.076 . . . . 2.88 110.122 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.83 -45.02 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.314 1.046 . . . . 3.22 109.291 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -56.08 -50.52 70.77 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.209 1.403 . . . . 5.31 110.779 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -61.4 -39.53 91.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.084 0.554 . . . . 5.93 109.979 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -63.4 -51.58 65.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.554 -0.536 . . . . 1.53 109.554 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -57.26 9.25 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.487 1.115 . . . . 4.09 111.783 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.8 -18.67 34.24 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.946 1.091 . . . . 3.51 113.946 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -102.79 5.64 38.86 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.039 1.336 . . . . 3.97 114.136 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -57.33 -64.68 0.81 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 121.169 1.804 . . . . 3.77 111.611 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -168.47 -133.99 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.434 -1.691 . . . . 2.43 106.434 -169.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.78 33.13 1.23 Allowed Glycine 0 CA--C 1.534 1.221 0 CA-C-N 119.929 1.241 . . . . 1.64 113.61 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.41 124.22 60.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 N-CA-C 105.559 -2.015 . . . . 2.5 105.559 165.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 49.65 1.68 Allowed 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.073 -0.714 . . . . 3.72 109.073 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.3 t -161.88 148.41 13.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.559 -1.275 . . . . 3.0 107.559 173.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.25 120.59 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.964 -1.865 . . . . 3.89 105.964 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.41 71.46 1.47 Allowed 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.262 -1.014 . . . . 3.44 108.262 168.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.3 m -98.14 160.89 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.511 0.672 . . . . 3.43 110.49 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.24 99.65 5.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.426 -1.694 . . . . 2.46 106.426 170.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.7 -27.35 64.77 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.239 1.415 . . . . 4.5 109.869 171.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -69.14 -43.15 74.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.838 0.855 . . . . 5.4 111.688 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.43 -37.96 9.39 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.234 1.014 . . . . 2.17 110.104 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.4 62.94 0.83 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 126.082 1.801 . . . . 1.08 111.011 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -143.04 144.37 32.25 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.834 -1.172 . . . . 3.59 107.834 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.23 105.83 12.18 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.959 1.304 . . . . 1.66 111.174 171.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.66 136.39 38.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 105.64 -1.985 . . . . 4.31 105.64 166.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.9 pt -136.34 174.13 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.039 -1.097 . . . . 2.86 108.039 169.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -134.64 111.48 10.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.967 1.307 . . . . 5.71 109.488 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -124.38 177.31 5.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.86 1.664 . . . . 4.58 113.526 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -113.43 106.0 54.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.343 1.457 . . . . 4.02 111.128 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.47 -10.78 29.88 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.69 2.26 . . . . 3.43 114.296 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -65.89 -18.38 65.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.859 0.754 . . . . 4.13 112.397 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.87 -45.85 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 123.287 0.635 . . . . 4.1 110.281 -170.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.66 153.59 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 109.255 -0.646 . . . . 2.91 109.255 175.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -130.62 150.08 75.35 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.911 1.685 . . . . 2.82 108.952 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -62.29 -39.27 48.52 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.075 2.516 . . . . 2.03 111.998 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.43 -46.98 87.8 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.495 -0.753 . . . . 5.5 109.91 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -59.79 -37.28 78.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.972 0.509 . . . . 3.05 111.128 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.5 mt -54.16 -56.36 10.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 107.202 -1.407 . . . . 2.43 107.202 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.1 -44.48 74.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.104 -0.498 . . . . 2.89 111.002 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -48.67 -52.2 24.52 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.134 0.974 . . . . 4.6 110.301 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -49.08 73.52 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.087 0.47 . . . . 3.54 109.811 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -62.4 -37.16 78.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 122.099 -0.376 . . . . 3.78 110.928 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -65.81 -45.17 83.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.629 -0.508 . . . . 2.89 109.629 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -59.02 -50.07 75.5 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.89 -0.411 . . . . 2.46 109.89 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.0 mt -53.49 -45.12 69.52 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.31 0.644 . . . . 3.38 111.241 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.87 30.63 0.87 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.807 0.718 . . . . 1.35 112.363 166.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -129.95 163.79 25.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.401 1.48 . . . . 3.36 108.951 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -99.84 122.6 43.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.63 -1.248 . . . . 2.29 107.63 170.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.04 122.54 45.47 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.727 -1.583 . . . . 2.21 106.727 165.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.27 141.62 50.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.772 -1.196 . . . . 2.0 107.772 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 p -67.97 149.09 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.107 -0.701 . . . . 3.95 109.107 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.2 mtt -55.38 -43.73 75.42 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.99 -0.374 . . . . 5.34 109.99 173.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 174.84 -58.85 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 127.964 2.506 . . . . 4.57 105.589 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.2 90.23 5.42 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.596 1.959 . . . . 7.96 109.092 -165.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.7 28.58 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.763 1.394 . . . . 6.57 114.763 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 57.57 -154.75 0.34 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.107 1.363 . . . . 4.2 113.125 174.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -102.96 91.33 0.84 Allowed Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 125.727 1.632 . . . . 4.18 109.427 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.5 m -77.9 64.54 3.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.628 1.214 . . . . 6.64 110.136 162.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 t70 66.25 -70.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 127.811 2.444 . . . . 4.98 113.733 165.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.49 -23.92 27.53 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 109.715 -1.354 . . . . 3.22 109.715 171.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -93.1 102.86 15.19 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.574 -2.009 . . . . 2.8 105.574 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.51 143.04 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 108.111 -1.07 . . . . 3.97 108.111 175.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -95.92 146.91 24.21 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.349 -1.723 . . . . 4.41 106.349 170.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.3 mt -137.73 158.96 43.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.172 -1.788 . . . . 3.36 106.172 166.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.75 123.43 42.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.333 -1.729 . . . . 2.37 106.333 170.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.3 pt -97.82 140.18 18.47 Favored 'Isoleucine or valine' 0 C--N 1.336 0.009 0 N-CA-C 108.465 -0.939 . . . . 3.1 108.465 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.4 m -129.03 138.18 51.75 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.814 0.845 . . . . 2.33 109.42 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.51 -35.32 2.7 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 126.032 1.777 . . . . 1.25 112.146 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -30.48 103.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.964 1.706 . . . . 3.85 114.565 172.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.5 m -100.6 -4.81 27.77 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.268 0.627 . . . . 4.0 111.063 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.66 165.52 14.33 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 120.646 -1.284 . . . . 4.14 110.25 177.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.06 -36.79 61.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.54 0.336 . . . . 3.61 110.712 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.3 t -48.46 -45.9 37.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.37 0.668 . . . . 2.82 111.364 173.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 64.2 m -59.77 -53.78 53.98 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 108.759 -0.83 . . . . 2.66 108.759 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.7 t -52.41 -43.6 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.389 0.676 . . . . 2.49 111.027 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -65.21 -42.31 93.61 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.362 -0.977 . . . . 3.33 108.362 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -42.01 97.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.022 -0.362 . . . . 3.85 110.022 176.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.28 -53.66 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.683 -0.858 . . . . 1.89 108.683 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -54.97 -45.19 74.95 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.644 1.178 . . . . 3.24 108.834 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -53.75 -52.85 58.84 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.927 -0.483 . . . . 1.68 111.612 172.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -60.36 -35.2 75.12 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 120.823 -1.173 . . . . 3.14 111.716 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.49 -59.07 3.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.194 -1.039 . . . . 2.8 108.194 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.8 p -57.05 -19.03 16.65 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.077 0.951 . . . . 2.88 112.637 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.93 -31.84 67.2 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.048 -0.407 . . . . 4.88 111.499 171.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 17.4 m -65.45 142.64 58.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.569 1.547 . . . . 2.43 110.923 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -64.83 -48.1 75.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.459 1.103 . . . . 2.58 111.697 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.19 -32.85 57.8 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.97 -0.35 . . . . 1.39 112.741 -171.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.48 134.61 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 117.899 0.85 . . . . 3.2 109.039 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.8 t -107.71 -49.82 3.17 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.08 0.4 . . . . 4.09 112.08 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -136.65 121.64 18.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.482 -0.933 . . . . 3.04 108.482 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.43 133.15 44.16 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.009 -0.737 . . . . 1.76 109.009 166.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.5 m -113.4 102.73 10.6 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 107.901 -1.148 . . . . 2.43 107.901 168.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -108.43 140.33 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.233 -0.654 . . . . 3.98 109.233 175.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.37 95.58 3.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.165 0.983 . . . . 2.31 110.599 -169.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.72 -33.02 72.26 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.993 1.317 . . . . 3.44 112.685 -174.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.78 -33.74 17.36 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.071 0.948 . . . . 2.56 111.308 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.66 -5.93 12.16 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.743 1.617 . . . . 2.68 111.426 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.0 m 63.41 27.87 15.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.056 1.742 . . . . 2.4 111.989 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -99.02 158.08 15.9 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.348 0.659 . . . . 4.73 110.642 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -139.13 101.62 4.32 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.506 1.922 . . . . 2.19 108.455 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.79 103.62 15.26 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.185 0.994 . . . . 2.83 108.319 -176.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.6 m -102.12 127.56 55.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 124.612 1.165 . . . . 3.32 109.688 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.36 103.75 14.2 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.457 1.103 . . . . 5.0 108.619 172.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -121.51 -174.67 2.91 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.149 1.379 . . . . 4.02 110.257 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -111.59 111.9 54.32 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 119.153 0.888 . . . . 3.21 109.424 176.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.35 72.18 6.65 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.973 2.449 . . . . 2.2 111.937 -164.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.33 -43.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.206 1.402 . . . . 3.73 109.669 172.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.1 pt -85.73 -31.81 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 124.149 0.98 . . . . 2.59 110.827 -174.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.29 161.67 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.791 1.236 . . . . 2.37 108.296 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.02 162.95 29.33 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.969 -1.252 . . . . 1.65 109.969 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -59.89 -34.38 95.41 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.602 2.868 . . . . 1.61 111.375 -173.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -36.3 69.01 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 122.991 0.517 . . . . 5.34 111.337 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -69.9 -45.7 67.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.617 -0.882 . . . . 3.22 108.617 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.8 -49.38 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.29 -1.004 . . . . 1.92 108.29 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.5 mt -49.66 -59.99 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 118.369 -0.824 . . . . 2.9 109.05 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -49.65 -50.89 41.45 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.891 1.223 . . . . 4.29 112.713 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.62 -52.31 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.737 -0.602 . . . . 2.91 110.864 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.259 2.4 pp -70.43 -26.11 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 120.777 -1.202 . . . . 2.27 113.716 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -60.77 -39.45 88.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.575 0.625 . . . . 2.61 110.224 169.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.11 -40.37 81.02 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.999 -0.741 . . . . 3.43 108.999 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.7 mt -72.73 -42.16 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.99 -0.55 . . . . 1.96 110.095 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.37 35.12 4.53 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.997 1.284 . . . . 1.07 111.383 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -97.35 176.01 6.05 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.286 -1.005 . . . . 3.14 108.286 163.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -133.42 131.05 39.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.071 -1.455 . . . . 4.55 107.071 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.87 99.0 6.37 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.647 1.579 . . . . 1.95 109.551 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 58.4 m -111.49 114.85 28.23 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.886 0.875 . . . . 2.21 110.701 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -35.88 113.06 0.19 Allowed 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 127.793 2.437 . . . . 4.5 111.216 169.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -103.14 68.45 0.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.706 0.765 . . . . 4.1 110.85 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.291 1.436 . . . . 6.93 110.32 171.972 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 106.086 -1.82 . . . . 9.14 106.086 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.82 100.11 25.81 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 119.981 1.264 . . . . 4.8 109.121 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -69.49 134.51 28.74 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.246 1.964 . . . . 3.73 110.473 -174.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.53 141.88 35.25 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.376 0.67 . . . . 4.55 110.911 -177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -96.51 140.15 31.57 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.578 -0.701 . . . . 5.33 109.677 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.9 t -119.39 136.19 54.4 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.338 1.055 . . . . 2.85 110.115 174.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -106.99 90.06 3.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.401 1.881 . . . . 6.13 111.075 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.271 0.3 OUTLIER -118.13 167.39 11.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.249 1.023 . . . . 3.83 113.087 176.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.69 161.05 20.31 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.594 -1.632 . . . . 2.94 106.594 165.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.0 mm -100.16 136.81 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 105.552 -2.018 . . . . 2.09 105.552 167.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -121.85 78.01 1.42 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.06 -1.459 . . . . 6.31 107.06 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.96 -76.73 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.737 -0.945 . . . . 1.38 110.737 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mpt? 57.98 89.18 0.05 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.664 1.586 . . . . 2.81 112.715 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.9 m -59.18 -60.72 3.41 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.583 -0.698 . . . . 3.39 110.961 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.5 t -167.72 88.18 0.27 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.689 -1.226 . . . . 4.33 107.689 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 1.94 65.87 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 129.189 2.996 . . . . 6.81 115.476 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t 173.61 -43.89 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 125.218 1.407 . . . . 3.97 108.537 -168.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 t -66.42 -40.76 89.73 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.833 -1.167 . . . . 3.35 111.32 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.9 -32.02 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 121.799 -0.563 . . . . 2.88 110.464 167.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 t -69.51 -27.2 64.98 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.039 -0.413 . . . . 3.7 111.253 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.59 -47.75 74.65 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.598 -1.314 . . . . 2.86 109.599 171.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.2 mt -42.74 -37.99 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 121.354 -0.841 . . . . 2.6 112.966 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -47.71 -55.37 9.66 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.719 0.691 . . . . 3.7 112.821 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -64.52 -36.01 82.82 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.48 -0.762 . . . . 7.21 109.858 -172.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -61.7 -54.22 45.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.94 -1.133 . . . . 1.34 107.94 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -54.97 -44.58 74.52 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 112.173 0.434 . . . . 3.13 112.173 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.82 -21.1 3.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.907 0.776 . . . . 2.27 112.814 175.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 5.05 13.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 117.843 -1.075 . . . . 6.29 112.61 177.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -64.12 -58.42 6.7 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.678 1.126 . . . . 2.77 110.735 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.5 -135.84 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 O-C-N 122.002 -0.436 . . . . 2.19 110.48 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.79 -15.09 47.1 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.929 1.252 . . . . 1.64 113.465 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.28 125.34 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 117.981 0.891 . . . . 2.95 111.755 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 mt -141.53 44.32 1.74 Allowed 'General case' 0 C--N 1.342 0.257 0 CA-C-O 119.286 -0.387 . . . . 4.35 111.074 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -158.13 149.1 20.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.451 -0.574 . . . . 3.23 109.451 169.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.98 70.26 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 124.902 1.281 . . . . 3.93 109.275 -170.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.304 0.7 OUTLIER -102.32 78.93 1.79 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 119.234 -0.986 . . . . 6.09 110.26 -177.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p -96.91 145.76 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.002 -0.999 . . . . 3.81 108.81 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.59 99.78 6.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.963 -1.495 . . . . 2.58 106.963 163.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.6 mt -56.88 -26.65 59.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.007 0.923 . . . . 4.01 111.441 172.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.1 ttt -56.55 -57.59 11.7 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.226 1.01 . . . . 5.1 110.197 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.29 -27.57 22.81 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.798 0.839 . . . . 2.36 110.898 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.89 57.59 2.25 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.552 1.072 . . . . 1.17 110.567 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.34 132.18 35.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.178 -1.045 . . . . 4.56 108.178 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.9 102.62 11.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.584 2.354 . . . . 2.09 109.273 171.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -96.95 137.91 35.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.326 -1.731 . . . . 3.37 106.326 164.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.3 pt -143.49 171.61 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.178 -1.045 . . . . 2.91 108.178 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -125.74 105.48 9.01 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.828 0.851 . . . . 6.47 109.971 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -97.53 169.79 9.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.052 2.541 . . . . 3.72 113.007 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -117.26 100.7 53.11 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 106.096 -1.816 . . . . 2.96 106.096 171.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.75 -29.62 43.05 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.535 3.49 . . . . 2.87 114.704 -170.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -65.65 -18.82 65.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.7 1.6 . . . . 4.6 112.469 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.3 m -126.8 -38.22 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.343 0.657 . . . . 4.25 111.46 -175.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.93 149.88 17.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-N 118.887 0.767 . . . . 2.55 109.268 173.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -129.6 150.34 75.42 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 124.634 1.173 . . . . 3.48 109.287 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -56.22 -37.24 97.0 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.114 2.542 . . . . 1.84 111.263 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.6 mp -54.64 -41.71 70.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.26 0.624 . . . . 4.13 111.344 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -69.49 -40.97 76.73 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.546 -0.721 . . . . 3.7 109.564 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -45.22 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.06 -1.089 . . . . 2.37 108.06 172.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.53 -42.97 93.51 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.904 -0.589 . . . . 2.43 110.804 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -59.4 -51.63 69.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 121.773 -0.58 . . . . 3.11 110.19 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -56.06 15.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.208 0.528 . . . . 3.47 111.137 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.12 -40.23 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 121.187 -0.946 . . . . 5.09 112.559 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.59 -32.6 74.27 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.492 -0.755 . . . . 3.14 110.85 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.31 -51.29 61.63 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.503 0.592 . . . . 2.65 109.648 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.07 -38.63 68.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.416 -0.514 . . . . 4.53 111.808 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.77 45.47 0.65 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.676 -0.97 . . . . 1.57 110.676 171.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -131.95 157.09 44.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.72 1.208 . . . . 3.99 108.035 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -99.82 129.71 45.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.944 -1.502 . . . . 2.53 106.944 166.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.38 124.71 45.2 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.222 -1.399 . . . . 2.21 107.222 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.53 119.98 27.23 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.155 0.909 . . . . 2.02 109.946 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 p -68.33 141.31 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 125.065 1.346 . . . . 3.7 108.737 166.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.2 ptm -40.55 -52.03 2.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 124.486 1.117 . . . . 6.98 111.357 -172.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -160.31 41.34 0.18 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.796 1.238 . . . . 3.93 109.068 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 29.03 51.92 0.07 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.171 1.788 . . . . 10.1 111.95 -164.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -70.45 -70.44 0.3 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.657 -1.979 . . . . 6.93 105.657 -174.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 73.54 120.08 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.783 2.833 . . . . 5.13 109.352 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -145.14 104.29 0.31 Allowed Glycine 0 C--N 1.336 0.57 0 CA-C-N 118.393 0.542 . . . . 3.64 111.938 -160.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 t -169.99 -56.47 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.811 -0.811 . . . . 5.43 108.811 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -153.5 147.12 25.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 104.968 -2.234 . . . . 5.25 104.968 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.11 -59.48 4.48 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 108.107 -1.997 . . . . 2.24 108.107 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.46 107.02 13.3 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.275 1.43 . . . . 2.37 108.467 -166.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.6 148.02 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 120.336 1.425 . . . . 3.55 112.455 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 1.0 OUTLIER -109.11 124.0 50.08 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.15 1.78 . . . . 4.47 112.621 -175.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.7 mt -128.76 138.83 52.32 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.315 1.046 . . . . 3.3 109.418 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.96 124.1 47.83 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.808 -1.182 . . . . 2.75 107.808 -177.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.37 105.49 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.713 1.205 . . . . 2.75 109.715 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.8 p -101.77 126.26 48.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.575 -0.898 . . . . 3.5 108.575 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.64 -34.3 3.66 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.128 0.87 . . . . 1.44 111.034 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -63.36 130.94 46.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.083 0.553 . . . . 3.37 109.808 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 p -137.54 22.58 2.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.965 1.306 . . . . 4.28 110.693 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 5.3 t -157.25 141.19 16.1 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 121.298 -0.876 . . . . 3.35 111.881 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.6 -35.13 79.93 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.214 0.606 . . . . 3.31 111.456 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 p -53.4 -47.3 69.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.504 -0.554 . . . . 2.89 109.504 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 59.7 m -59.26 -49.76 76.6 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 119.22 -0.419 . . . . 3.39 110.129 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.4 t -49.36 -50.15 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 118.237 0.471 . . . . 2.83 110.544 175.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -60.63 -40.81 93.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.768 -0.456 . . . . 5.24 109.768 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -42.47 96.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.865 -0.522 . . . . 2.66 110.253 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.8 mt -61.42 -51.47 72.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.111 -1.07 . . . . 2.08 108.111 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -55.67 -45.88 77.64 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.676 1.19 . . . . 2.23 109.61 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.8 t -54.95 -54.82 37.88 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.687 -0.633 . . . . 2.4 110.637 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -51.2 -61.32 2.3 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.194 0.452 . . . . 3.34 110.261 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.85 -39.32 91.45 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.768 -0.373 . . . . 3.52 110.415 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 96.3 m -59.73 -19.24 48.82 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.54 0.609 . . . . 3.0 112.1 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -66.49 -27.02 67.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 119.166 -1.014 . . . . 5.35 111.919 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 81.3 m -63.54 126.58 27.98 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.631 0.773 . . . . 2.94 111.597 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -38.51 -59.63 0.89 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.651 1.98 . . . . 3.49 113.845 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.22 -28.36 68.29 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.231 0.469 . . . . 1.74 113.319 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.78 118.8 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 O-C-N 121.359 -1.083 . . . . 2.6 109.475 -168.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.2 m -102.92 -44.86 5.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.857 0.318 . . . . 3.1 111.857 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -142.12 128.8 20.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.406 -0.961 . . . . 3.09 108.406 166.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.75 162.52 12.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.87 -0.332 . . . . 1.84 110.375 161.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m -145.0 113.05 6.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.45 -0.945 . . . . 2.45 108.45 162.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 p -110.03 128.93 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.75 0.705 . . . . 2.84 110.962 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -125.04 90.4 3.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.145 0.978 . . . . 2.17 110.951 -166.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.09 -32.5 55.01 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.287 1.435 . . . . 3.45 112.964 -174.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.71 -32.12 65.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.259 0.624 . . . . 2.84 111.154 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.53 -14.45 11.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.145 1.378 . . . . 2.83 111.202 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.4 m 65.99 28.29 10.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.101 1.361 . . . . 2.98 111.951 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.403 ' NZ ' ' O ' ' A' ' 149' ' ' GLN . 44.3 mmtt -96.75 152.84 18.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.312 1.445 . . . . 3.49 109.703 173.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.26 106.36 4.35 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.521 1.128 . . . . 1.91 109.383 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.3 mp -95.43 130.19 42.32 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.633 -1.247 . . . . 3.98 107.633 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.1 t -128.28 123.9 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.031 0.932 . . . . 2.72 108.75 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -105.55 92.06 4.03 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.918 0.887 . . . . 3.81 109.136 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -115.35 173.7 6.38 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.761 0.709 . . . . 3.93 111.098 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -100.26 112.68 64.65 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 108.886 -0.783 . . . . 2.74 108.886 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.72 70.03 7.11 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.649 2.899 . . . . 1.99 111.217 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -165.05 -47.95 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.523 1.529 . . . . 3.04 108.836 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.6 pt -84.85 -37.48 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.121 0.969 . . . . 2.94 111.103 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.7 tp -136.86 169.3 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.304 0.642 . . . . 3.72 109.458 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.25 170.77 32.17 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.64 -1.784 . . . . 1.97 108.64 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -58.41 -35.65 98.44 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.27 2.646 . . . . 1.93 111.285 -171.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.9 ptm85 -56.63 -30.55 63.41 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.18 0.807 . . . . 6.33 113.18 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.36 -50.03 67.11 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.231 -1.026 . . . . 3.37 108.231 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 42.5 mt -63.32 -44.17 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.512 -1.222 . . . . 2.0 108.123 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.54 -57.2 5.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 118.476 -0.773 . . . . 2.72 109.366 172.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -49.58 -51.14 39.15 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.302 1.41 . . . . 4.36 112.36 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.6 mm -54.16 -53.72 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.019 0.528 . . . . 2.84 110.377 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 pp -70.36 -29.72 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 120.967 -1.083 . . . . 2.43 113.108 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -59.04 -41.79 88.71 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 119.143 0.883 . . . . 2.8 109.309 168.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -64.82 -37.92 89.23 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.483 -0.562 . . . . 2.99 109.483 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.7 mt -62.83 -44.96 99.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 122.006 -0.434 . . . . 1.98 110.437 170.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.19 28.21 5.02 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.381 1.467 . . . . 1.03 111.941 -174.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -101.67 -179.81 4.12 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.42 1.11 . . . . 3.59 108.929 164.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -139.1 126.55 21.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.635 -1.617 . . . . 5.0 106.635 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.62 91.16 3.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.315 1.846 . . . . 1.93 108.373 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 68.3 m -102.82 131.45 49.69 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.092 -0.707 . . . . 2.45 109.092 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 mt -41.25 109.87 0.14 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.26 1.824 . . . . 4.61 111.37 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.09 -20.93 22.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.742 -0.663 . . . . 4.72 110.741 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.403 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.375 0 C-N-CA 125.91 1.684 . . . . 6.35 112.062 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.3 mtm . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 106.439 -1.689 . . . . 7.76 106.439 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.48 112.98 15.85 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-O 117.024 -1.465 . . . . 5.06 107.904 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -87.68 148.57 7.29 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.903 2.402 . . . . 3.43 109.621 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -114.36 164.19 14.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.41 -1.329 . . . . 3.93 107.41 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.56 147.95 41.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.444 -0.947 . . . . 5.76 108.444 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.4 p -141.18 140.38 34.02 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.871 -0.788 . . . . 4.42 108.871 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -120.72 103.52 9.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.693 -1.966 . . . . 4.26 105.693 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -132.66 160.37 36.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.136 -1.061 . . . . 3.14 108.136 175.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.41 171.83 7.34 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.545 -0.909 . . . . 3.6 108.545 173.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.2 mm -99.84 126.74 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.098 -1.815 . . . . 2.16 106.098 162.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -102.36 95.86 6.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.348 -2.093 . . . . 4.57 105.348 166.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.38 -77.26 0.11 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.14 0.876 . . . . 1.28 110.961 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 mtp 35.53 76.22 0.05 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.933 2.093 . . . . 3.33 114.831 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 p -41.04 -54.0 2.89 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.669 0.787 . . . . 3.78 112.448 171.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t 119.13 -62.95 0.0 OUTLIER 'General case' 0 C--N 1.342 0.266 0 C-N-CA 129.355 3.062 . . . . 3.55 107.659 -174.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -22.51 -77.5 0.01 OUTLIER 'General case' 0 C--N 1.344 0.341 0 C-N-CA 127.659 2.384 . . . . 6.53 113.148 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 t -161.82 21.9 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.487 0.661 . . . . 3.06 110.945 165.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -71.89 -41.28 68.17 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 120.91 -1.119 . . . . 2.47 110.256 -163.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.68 -46.89 79.64 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.684 -0.858 . . . . 2.62 108.684 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 t -55.79 -48.63 75.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.294 0.569 . . . . 2.55 110.285 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.25 -49.3 74.67 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.827 -0.434 . . . . 2.56 109.827 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.6 mt -56.06 -49.93 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.886 0.874 . . . . 3.07 109.509 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.5 mm-40 -61.94 -39.08 90.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.892 0.877 . . . . 7.03 112.393 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -44.38 93.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.105 -0.702 . . . . 5.95 109.105 175.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -61.69 -37.12 82.95 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.883 -0.51 . . . . 1.47 110.031 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.79 -52.72 33.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.93 0.892 . . . . 3.0 110.958 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.67 -26.53 56.63 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.784 1.175 . . . . 3.49 112.608 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -74.22 0.63 13.5 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 116.782 -1.58 . . . . 3.9 115.125 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -48.67 -84.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 121.044 1.747 . . . . 3.01 112.581 174.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.84 -90.91 0.0 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.686 0.795 . . . . 3.38 110.095 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.15 -26.18 74.21 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.369 -0.692 . . . . 1.63 111.369 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.1 t -61.06 128.6 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.069 -0.715 . . . . 3.35 109.069 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.19 53.5 1.08 Allowed 'General case' 0 C--N 1.337 0.053 0 C-N-CA 121.099 -0.241 . . . . 4.01 111.207 163.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.1 t -158.1 139.22 13.28 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 120.926 -1.109 . . . . 2.61 110.549 167.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 p -126.53 107.89 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 125.94 1.696 . . . . 3.77 107.432 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -126.22 72.24 1.3 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.503 -1.666 . . . . 3.08 106.503 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.4 t -103.55 141.09 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.843 -0.799 . . . . 2.93 108.843 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.25 95.75 5.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.551 -0.907 . . . . 2.41 108.551 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.97 -18.19 4.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.022 0.529 . . . . 3.91 112.309 169.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.8 mtt -69.13 -50.54 46.97 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.3 0.64 . . . . 4.23 110.116 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.08 -30.69 12.89 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.715 0.806 . . . . 2.34 111.435 -172.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.38 64.08 1.4 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.837 1.208 . . . . 1.2 110.479 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -141.0 138.5 33.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.384 -1.709 . . . . 3.92 106.384 171.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.09 92.74 3.94 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 124.868 1.355 . . . . 2.02 112.301 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.92 119.59 35.67 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.996 -1.113 . . . . 4.67 107.996 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.99 163.35 20.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 126.379 1.872 . . . . 3.71 108.858 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -122.34 106.08 10.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.588 0.755 . . . . 4.47 110.083 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -100.11 173.36 6.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.075 1.75 . . . . 3.43 113.272 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -122.85 102.86 37.66 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.239 1.815 . . . . 4.06 109.27 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -45.8 -36.02 14.38 Favored 'Trans proline' 0 C--N 1.355 0.913 1 C-N-CA 126.076 4.517 . . . . 2.93 113.743 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.39 -29.11 68.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.224 1.409 . . . . 3.36 111.69 -170.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.89 -32.45 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.684 0.794 . . . . 3.69 112.261 -174.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.56 146.2 25.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 107.947 -1.131 . . . . 2.16 107.947 173.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -124.27 146.51 51.97 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.149 1.38 . . . . 2.6 109.394 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.72 -38.5 49.29 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.313 2.676 . . . . 1.78 112.057 -171.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -57.58 -45.62 85.01 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.879 -0.513 . . . . 4.15 111.005 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -61.05 -43.18 99.28 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.002 0.921 . . . . 3.39 109.904 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.37 -53.2 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.251 -1.388 . . . . 2.32 107.251 171.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.17 85.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 110.019 -0.363 . . . . 2.78 110.019 -173.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -55.89 -42.55 76.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.292 0.637 . . . . 3.32 110.86 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.2 -43.25 87.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.394 0.543 . . . . 4.17 110.129 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.1 mm -65.4 -44.03 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.671 -0.643 . . . . 3.42 110.607 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -58.46 -41.96 86.34 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.288 0.635 . . . . 3.38 111.279 174.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -63.76 -48.73 75.78 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.174 0.59 . . . . 2.91 109.984 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.8 mt -56.22 -35.51 67.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.645 0.378 . . . . 2.86 111.323 173.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.82 25.57 3.6 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.216 0.912 . . . . 1.42 112.077 168.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -115.48 168.79 9.68 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.055 1.742 . . . . 3.27 108.643 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -104.06 142.55 34.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.801 -1.185 . . . . 2.4 107.801 165.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.81 112.38 17.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.78 -1.563 . . . . 1.96 106.78 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.85 129.33 48.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.656 -0.868 . . . . 1.91 108.656 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.7 p -47.69 145.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 125.484 1.513 . . . . 3.91 109.702 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -55.2 -40.03 70.29 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.751 -0.659 . . . . 5.87 110.273 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 168.11 -43.87 0.0 OUTLIER 'General case' 0 C--O 1.235 0.333 0 C-N-CA 130.697 3.599 . . . . 6.37 106.231 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.412 ' OD1' ' NZ ' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -125.48 95.65 4.53 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.494 1.518 . . . . 7.65 107.441 -176.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -40.2 -58.44 1.48 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.131 1.372 . . . . 6.58 112.656 178.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 133.79 167.83 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 130.8 3.64 . . . . 5.02 105.811 -175.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 82' ' ' ILE . . . -75.71 83.55 0.91 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.923 -1.132 . . . . 3.45 112.395 173.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.3 m -75.15 61.84 1.16 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.132 1.773 . . . . 5.67 111.043 168.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 81' ' ' ASN . 12.3 t70 54.88 109.2 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 128.526 2.73 . . . . 4.31 115.958 159.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.58 -47.23 3.73 Favored Glycine 0 C--N 1.341 0.857 0 N-CA-C 107.17 -2.372 . . . . 1.97 107.17 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 79' ' ' ASP . 0.4 OUTLIER -91.15 96.49 10.61 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 105.477 -2.046 . . . . 2.49 105.477 172.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.416 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 5.6 pt -123.06 145.69 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 O-C-N 123.211 0.319 . . . . 4.12 110.213 173.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.98 157.35 15.94 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.491 -1.67 . . . . 3.54 106.491 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 pp -147.51 161.72 40.52 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.091 -0.707 . . . . 3.9 109.091 161.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.6 m -99.73 127.86 45.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.624 1.17 . . . . 2.91 108.815 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 pp -99.57 127.61 52.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 C-N-CA 123.079 0.552 . . . . 2.64 110.311 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.5 m -106.45 142.6 35.84 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.722 0.809 . . . . 2.38 109.188 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.65 -24.26 17.78 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.653 1.121 . . . . 0.97 113.061 172.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.2 ttm -66.28 143.6 57.11 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.063 0.931 . . . . 3.0 111.274 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.6 t -162.0 37.18 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.925 0.49 . . . . 3.24 110.593 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.1 t -164.62 138.35 5.1 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.605 -1.31 . . . . 3.25 111.509 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.27 -40.17 81.15 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.243 0.617 . . . . 3.16 110.895 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -43.23 70.44 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.494 -0.753 . . . . 3.02 109.612 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 91.2 m -67.76 -42.38 81.84 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.157 -0.449 . . . . 2.39 110.796 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.95 -50.35 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 118.864 0.756 . . . . 3.36 110.509 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -59.23 -37.0 76.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.766 -0.457 . . . . 4.12 109.766 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -65.25 -49.11 70.9 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.275 -0.266 . . . . 1.7 110.663 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.07 -48.27 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 109.438 -0.579 . . . . 1.92 109.438 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -58.63 -49.3 78.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.443 -0.947 . . . . 2.46 108.443 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.1 t -52.45 -46.38 66.42 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.1 0.56 . . . . 1.87 110.122 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -63.33 -41.47 98.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.284 0.634 . . . . 3.54 111.723 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.6 mt -67.34 -58.59 4.51 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.538 -1.282 . . . . 2.73 107.538 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.3 p -57.05 -18.74 15.43 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.133 0.973 . . . . 2.92 112.749 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.16 -34.45 66.17 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.943 -0.473 . . . . 7.1 111.65 170.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.5 m -67.44 149.22 50.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.407 1.883 . . . . 2.28 111.458 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -64.47 -52.68 56.71 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.347 1.059 . . . . 2.47 111.891 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.21 -27.41 59.94 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 122.175 -0.328 . . . . 1.15 113.074 -168.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.52 132.02 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 117.647 0.723 . . . . 2.84 109.538 -173.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 49.6 m -103.03 -58.21 1.91 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.249 0.619 . . . . 2.76 111.19 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -134.69 113.7 11.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.2 -0.667 . . . . 4.25 109.2 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.24 149.88 21.54 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 108.102 -1.073 . . . . 1.82 108.102 165.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.7 t -143.03 109.01 5.18 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 108.19 -1.041 . . . . 2.93 108.19 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.44 138.99 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.322 1.449 . . . . 3.05 110.686 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.21 93.64 2.85 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.74 1.216 . . . . 1.9 110.665 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 pp -60.11 -17.62 41.38 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.538 1.135 . . . . 3.29 113.83 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.71 86.75 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.458 0.572 . . . . 2.19 109.574 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.82 -39.91 10.02 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.505 1.122 . . . . 2.33 108.905 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.1 m 88.94 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 127.568 2.347 . . . . 2.14 110.539 -169.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.412 ' NZ ' ' OD1' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -107.0 157.95 17.41 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.365 -0.606 . . . . 4.9 109.365 175.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.57 144.26 34.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.812 -1.09 . . . . 2.26 109.944 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.413 HD11 ' CE1' ' A' ' 75' ' ' TYR . 4.3 mm? -94.79 143.31 26.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.462 -0.94 . . . . 4.0 108.462 163.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.74 124.16 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.634 -1.987 . . . . 2.63 105.634 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -108.64 92.44 4.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.086 -1.079 . . . . 4.0 108.086 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -113.33 -178.56 3.41 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 124.014 0.926 . . . . 3.1 108.83 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -113.99 110.75 48.5 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 108.322 -0.992 . . . . 2.98 108.322 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.32 68.47 8.27 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.924 2.416 . . . . 1.74 112.229 -166.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.34 -44.92 0.07 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.617 1.567 . . . . 3.31 109.206 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.6 pt -86.67 -30.73 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 123.365 0.666 . . . . 2.56 111.559 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.2 162.63 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.426 -0.953 . . . . 2.24 108.426 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.79 167.84 31.64 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.837 -0.905 . . . . 1.58 110.837 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.12 -39.01 62.81 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.811 3.008 . . . . 1.61 112.334 -169.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.76 -39.43 52.33 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.471 0.545 . . . . 6.79 112.471 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.51 -45.0 81.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.602 -0.518 . . . . 3.37 109.602 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 88.3 mt -58.67 -49.29 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.815 -0.809 . . . . 1.76 108.815 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.2 mt -49.57 -59.31 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 N-CA-C 108.445 -0.946 . . . . 3.15 108.445 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -50.07 -47.55 53.5 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.105 -0.997 . . . . 5.92 111.365 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 82.4 mt -55.54 -50.12 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.447 -0.783 . . . . 3.61 109.646 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 12.7 pt -70.37 -30.14 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 118.108 -0.949 . . . . 2.34 112.861 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.77 -42.48 79.47 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.829 1.195 . . . . 3.02 109.068 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.71 -34.32 76.91 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.758 1.223 . . . . 3.45 109.232 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.9 mt -75.39 -41.21 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.264 0.626 . . . . 1.99 111.376 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.55 30.44 6.19 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.847 1.689 . . . . 0.99 112.433 -172.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -105.31 171.58 7.25 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.727 1.263 . . . . 3.42 110.304 167.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -129.04 117.63 21.22 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 106.655 -1.609 . . . . 4.84 106.655 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.06 102.54 11.95 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 125.292 1.437 . . . . 1.86 108.616 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.0 p -98.85 112.7 24.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.092 -1.447 . . . . 3.49 107.092 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.2 mt -49.78 105.86 0.1 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.523 -1.288 . . . . 6.82 107.523 166.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.67 -38.48 33.53 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.333 -0.617 . . . . 4.03 109.333 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 126.72 2.008 . . . . 7.01 113.167 -179.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 107.312 -1.366 . . . . 11.9 107.312 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.75 123.34 79.1 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 119.968 1.258 . . . . 4.38 108.94 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.51 111.48 3.26 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 N-CA-C 109.165 -1.129 . . . . 3.94 109.165 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.79 158.47 44.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.449 -1.686 . . . . 4.28 106.449 170.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -123.09 152.13 41.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.331 1.052 . . . . 4.23 109.585 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.5 t -140.87 127.98 20.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.774 -0.825 . . . . 3.06 108.774 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -101.01 98.73 9.15 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.986 1.715 . . . . 4.97 109.082 -171.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.456 ' CB ' ' HA ' ' A' ' 71' ' ' VAL 0.273 1.4 pt? -125.44 176.55 6.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.943 0.877 . . . . 3.35 112.383 176.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.36 147.11 47.21 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.186 -1.412 . . . . 2.23 107.186 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.1 mm -99.05 140.07 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 106.264 -1.754 . . . . 2.09 106.264 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -115.41 76.69 1.02 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.293 -1.003 . . . . 3.97 108.293 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.25 -69.96 0.04 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.952 -1.259 . . . . 1.31 109.952 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 31.38 72.1 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.734 2.013 . . . . 2.82 115.646 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -53.08 -16.62 1.18 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.557 1.543 . . . . 3.05 114.053 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.2 t 74.79 -56.68 0.63 Allowed 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 126.28 1.832 . . . . 3.47 111.767 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -23.15 -75.44 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 127.523 2.329 . . . . 6.55 112.917 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.8 m -154.66 17.44 0.45 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.83 0.852 . . . . 3.7 111.541 162.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.83 -51.83 36.48 Favored 'General case' 0 C--O 1.224 -0.242 0 O-C-N 121.051 -1.031 . . . . 2.3 109.618 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -51.67 -47.86 37.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 CA-C-N 118.458 0.572 . . . . 2.46 109.689 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -56.95 -49.66 75.0 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.545 0.688 . . . . 3.5 110.609 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -59.1 -51.7 68.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.612 -0.68 . . . . 2.64 109.677 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.8 mt -51.32 -47.57 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.334 1.454 . . . . 2.52 110.859 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -55.38 -53.19 59.26 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.877 0.762 . . . . 4.06 110.482 174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -65.58 -31.55 72.66 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.395 -0.815 . . . . 5.62 111.438 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -68.66 -51.29 43.61 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.255 1.022 . . . . 1.19 109.697 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.33 -40.35 67.93 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.084 0.954 . . . . 2.95 110.663 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.67 -19.72 2.58 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.66 0.615 . . . . 2.7 112.66 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -126.63 24.06 6.68 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.216 1.406 . . . . 4.72 111.831 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.38 -82.57 0.05 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.091 -1.078 . . . . 3.2 108.091 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.44 -132.74 0.08 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.074 0.95 . . . . 2.21 109.19 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.38 33.17 1.35 Allowed Glycine 0 CA--C 1.531 1.06 0 O-C-N 120.909 -1.12 . . . . 1.49 113.816 -174.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.3 p -104.31 118.79 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.682 1.593 . . . . 2.52 108.923 170.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.1 mp -134.24 53.38 2.0 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.406 -0.961 . . . . 4.54 108.406 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.66 149.42 14.88 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.419 -1.326 . . . . 2.78 107.419 173.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.92 100.84 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 106.404 -1.702 . . . . 3.79 106.404 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.72 71.89 1.05 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.046 -1.094 . . . . 4.07 108.046 176.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.77 133.6 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.432 -0.951 . . . . 2.85 108.432 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.36 83.06 1.71 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.033 -1.099 . . . . 2.17 108.033 173.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.49 -24.03 1.87 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.466 1.506 . . . . 3.9 112.267 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -70.16 -40.06 74.96 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.806 1.242 . . . . 5.85 111.785 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.24 -31.89 11.49 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.513 1.125 . . . . 2.03 110.991 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.79 61.17 1.71 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 125.072 1.32 . . . . 1.04 110.565 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -141.23 136.83 32.1 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.181 -1.414 . . . . 4.42 107.181 171.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.34 102.15 10.82 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.283 1.433 . . . . 1.72 109.683 170.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -98.67 135.88 39.54 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.777 -1.934 . . . . 4.28 105.777 166.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.09 174.34 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.978 -1.119 . . . . 3.55 107.978 168.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.74 103.44 6.83 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.753 0.821 . . . . 6.53 108.797 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -117.6 167.83 10.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.103 1.361 . . . . 4.6 113.755 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -99.26 106.32 38.16 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 127.202 2.201 . . . . 3.17 110.452 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.01 -4.44 13.53 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.103 1.869 . . . . 2.84 114.35 -172.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -88.62 -20.84 24.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.926 0.785 . . . . 4.46 110.907 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.97 -30.48 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.505 1.122 . . . . 3.77 110.091 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.98 155.96 17.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.666 0.746 . . . . 2.44 109.257 173.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -132.31 154.27 81.54 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.416 2.286 . . . . 2.94 108.379 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.28 -40.13 34.03 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.634 2.223 . . . . 1.62 112.194 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -63.76 -40.27 96.3 Favored 'General case' 0 C--O 1.225 -0.227 0 O-C-N 121.763 -0.586 . . . . 3.96 110.868 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -58.36 -45.83 87.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.943 0.897 . . . . 2.95 110.334 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.9 mt -53.98 -56.06 11.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.851 -1.537 . . . . 2.31 106.851 172.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.95 -41.32 70.95 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.787 -0.642 . . . . 2.66 110.578 -173.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -53.84 -50.18 66.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.23 1.412 . . . . 2.77 109.387 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -48.46 72.12 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.379 0.609 . . . . 3.47 109.777 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.7 mm -63.22 -40.33 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.129 -0.357 . . . . 3.64 110.564 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -64.9 -42.19 94.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.735 -0.469 . . . . 2.78 109.735 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -60.46 -47.89 84.15 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.138 0.575 . . . . 2.98 109.562 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.18 -33.52 71.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.209 0.604 . . . . 2.97 111.629 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.9 27.72 3.92 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.172 0.892 . . . . 1.46 111.632 168.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -118.91 162.3 18.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.994 1.717 . . . . 3.53 108.694 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -98.31 129.19 45.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.931 1.293 . . . . 3.69 107.973 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.4 110.61 21.8 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.984 1.314 . . . . 1.78 108.507 174.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.93 122.92 35.96 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.122 0.419 . . . . 2.37 109.977 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.456 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.4 t -58.38 148.23 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 123.24 0.616 . . . . 3.99 110.931 172.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 39.8 mtt -58.63 -36.11 73.56 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 119.076 -0.488 . . . . 5.85 111.449 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 128.95 -25.94 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.565 1 C-N-CA 134.237 5.015 . . . . 5.25 110.42 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -40.71 -30.04 0.11 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 129.618 3.167 . . . . 8.3 112.19 166.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 81.11 -88.9 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.924 1.29 . . . . 6.81 110.318 169.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 159.15 -64.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.875 1.67 . . . . 3.6 111.389 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.62 -42.79 1.26 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.763 -0.935 . . . . 5.15 110.763 -162.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.4 m 18.2 45.22 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.89 2.876 . . . . 7.23 115.777 -173.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 t70 41.42 105.6 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 129.724 3.21 . . . . 5.26 114.353 -171.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.96 -30.67 9.35 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.038 -1.225 . . . . 2.37 110.038 -174.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.32 73.09 2.13 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.847 1.259 . . . . 2.81 109.139 -167.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.28 155.68 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.584 -0.895 . . . . 3.31 108.584 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.84 140.69 50.41 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.636 1.174 . . . . 2.76 107.998 173.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 mp -130.68 149.53 52.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.844 -0.799 . . . . 3.15 108.844 171.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.63 130.77 44.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.311 1.044 . . . . 2.4 108.614 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.8 mt -99.92 115.28 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.635 -0.506 . . . . 4.03 109.635 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.8 p -107.84 89.13 2.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.926 1.29 . . . . 3.57 109.543 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.6 -45.8 0.57 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.798 -0.921 . . . . 1.15 110.798 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -56.41 136.64 53.73 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 110.221 -0.289 . . . . 3.19 110.221 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -158.2 34.71 0.24 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.103 0.561 . . . . 3.42 110.891 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 34.0 t -158.91 144.23 16.22 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.548 -0.72 . . . . 3.63 110.617 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.15 -39.12 42.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.153 0.981 . . . . 3.25 111.995 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.2 p -53.6 -46.27 70.34 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.906 -0.497 . . . . 4.28 110.74 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 65.6 m -67.98 -45.96 72.68 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.909 -0.774 . . . . 2.38 108.909 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -51.91 -49.58 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.042 0.937 . . . . 2.61 109.591 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -64.38 -37.66 88.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.776 -0.824 . . . . 4.03 108.776 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -59.87 -52.61 64.71 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.63 0.772 . . . . 2.71 110.347 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.1 mt -54.17 -54.13 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.654 0.782 . . . . 2.02 109.045 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.6 -45.17 85.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.806 -0.442 . . . . 3.13 109.806 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.8 t -54.69 -49.31 70.98 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.507 0.723 . . . . 2.15 110.583 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -34.8 78.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.412 -0.805 . . . . 3.21 111.274 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.3 mt -71.57 -58.16 3.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.778 -0.823 . . . . 2.7 108.778 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.5 p -56.21 -22.73 31.13 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 111.915 0.339 . . . . 2.52 111.915 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.31 -27.09 69.09 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.457 0.91 . . . . 5.47 113.457 174.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.1 p -69.4 172.71 6.73 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 119.822 1.192 . . . . 3.92 111.246 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -88.62 -47.21 8.45 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.222 -0.899 . . . . 3.98 110.278 173.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.47 -34.09 51.06 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.471 -0.627 . . . . 1.26 113.587 -170.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.97 135.17 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 119.145 1.472 . . . . 3.39 109.251 -176.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -105.27 -44.67 4.68 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 122.407 0.283 . . . . 3.98 111.624 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.413 ' CZ ' ' HG3' ' A' ' 123' ' ' LYS . 27.2 p90 -139.7 122.75 16.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.67 -1.604 . . . . 3.19 106.67 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.85 143.82 45.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.564 -0.854 . . . . 1.88 109.795 164.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.6 m -133.56 119.99 20.19 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.037 -1.468 . . . . 2.55 107.037 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 p -122.55 133.55 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 123.631 0.772 . . . . 2.89 109.079 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -127.92 99.98 5.73 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.961 0.886 . . . . 2.26 109.216 -171.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.416 ' CD1' ' H ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -55.62 -21.43 17.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.756 1.622 . . . . 4.15 113.743 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.76 -41.36 62.57 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.933 -0.765 . . . . 2.28 108.933 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.2 p -88.11 -15.28 36.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.711 1.204 . . . . 3.27 111.191 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.8 t 65.11 25.64 12.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.869 1.268 . . . . 2.77 110.778 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.56 149.28 50.22 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.412 0.685 . . . . 3.65 110.941 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -125.15 115.64 20.78 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.68 2.392 . . . . 1.86 108.199 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.42 116.55 29.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.003 -1.48 . . . . 3.05 107.003 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.3 m -111.58 140.12 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.025 0.93 . . . . 3.17 109.799 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 2.2 mmtp -123.19 95.89 4.78 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-O 118.511 -0.757 . . . . 4.38 110.063 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -121.52 178.52 4.78 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.706 1.002 . . . . 3.04 113.706 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -104.64 110.42 64.33 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.233 1.013 . . . . 3.48 108.687 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.9 62.51 6.59 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.609 2.873 . . . . 1.75 112.788 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -148.25 -52.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.123 1.769 . . . . 3.02 107.72 172.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -86.98 -32.67 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.442 0.697 . . . . 2.55 111.413 -172.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.78 165.82 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.429 -1.693 . . . . 2.55 106.429 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.94 164.46 31.32 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 109.852 -1.299 . . . . 1.9 109.852 -176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.23 -40.86 46.69 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.032 2.488 . . . . 2.05 110.2 -171.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -48.35 -38.47 19.32 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 113.47 0.915 . . . . 8.55 113.47 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.1 -44.92 75.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.681 -0.859 . . . . 3.44 108.681 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.13 -47.59 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.383 -0.969 . . . . 2.26 108.383 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.9 mt -54.12 -60.69 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.004 -0.739 . . . . 3.01 109.004 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -51.61 -45.74 63.34 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 119.59 1.086 . . . . 4.38 111.055 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.6 mt -54.17 -53.49 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 121.664 -0.647 . . . . 3.36 110.076 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.253 2.1 pp -67.83 -30.83 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 121.109 -0.994 . . . . 2.27 112.891 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -55.89 -39.94 72.3 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.798 0.726 . . . . 2.98 110.107 170.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -63.06 -35.86 81.65 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.756 -0.461 . . . . 2.65 109.756 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.5 mt -68.26 -44.33 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.562 -0.533 . . . . 2.06 109.562 172.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.35 32.6 2.51 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.273 1.416 . . . . 0.88 111.182 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -99.28 178.41 4.91 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.116 0.958 . . . . 3.67 108.891 165.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -141.05 124.38 16.59 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.57 -1.641 . . . . 4.93 106.57 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.97 94.78 4.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.307 1.443 . . . . 1.81 108.706 -174.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.3 m -103.0 117.66 35.08 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.997 0.919 . . . . 2.32 110.456 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 mp -45.73 117.89 1.62 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.786 1.634 . . . . 5.14 110.108 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -109.57 13.44 23.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.37 0.668 . . . . 4.43 112.303 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? . . . . . 0 C--O 1.25 1.129 0 C-N-CA 125.486 1.514 . . . . 7.39 109.811 161.214 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmt . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 106.744 -1.576 . . . . 8.07 106.744 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.39 112.21 7.24 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 118.693 0.679 . . . . 3.93 109.28 -167.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.05 108.66 2.68 Favored 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.294 1.329 . . . . 3.07 110.283 -171.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -118.05 158.64 24.62 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.291 -1.744 . . . . 2.98 106.291 170.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.51 166.51 10.49 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 107.758 -1.201 . . . . 4.75 107.758 166.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.97 120.25 11.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.579 1.081 . . . . 3.83 108.933 170.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -98.2 90.23 4.77 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.556 0.742 . . . . 4.04 110.267 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.56 165.72 15.97 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.704 0.764 . . . . 3.75 111.04 175.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.424 HE22 ' CB ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -120.14 156.32 31.3 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.303 -0.999 . . . . 3.12 108.303 174.379 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.1 144.44 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 107.677 -1.231 . . . . 2.04 107.677 172.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -116.54 125.07 51.36 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.678 -1.231 . . . . 6.01 107.678 162.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 147.86 -81.14 0.2 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.188 1.375 . . . . 1.4 109.998 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.9 mtt 57.92 66.64 1.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.825 1.25 . . . . 2.34 113.013 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -46.52 -54.71 8.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.862 1.265 . . . . 3.25 113.303 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.2 p -167.83 44.48 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.516 0.598 . . . . 6.34 111.323 -170.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.67 35.44 8.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.274 1.029 . . . . 5.67 112.681 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 m -152.24 -43.26 0.11 Allowed 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.385 1.474 . . . . 3.12 110.555 -173.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.55 -46.15 87.45 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.347 -0.845 . . . . 3.35 109.937 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.3 t -52.69 -39.64 31.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 O-C-N 122.184 -0.322 . . . . 2.84 110.437 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -59.7 -42.73 93.63 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.085 0.469 . . . . 2.62 110.868 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -66.19 -47.6 73.39 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.31 -0.869 . . . . 2.63 109.631 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.41 -46.98 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 122.211 -0.306 . . . . 3.38 110.418 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -57.6 -41.15 80.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.292 1.037 . . . . 6.96 112.39 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -46.48 89.07 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.355 -0.98 . . . . 6.39 108.355 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -58.0 -45.16 87.27 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.072 -0.49 . . . . 1.65 110.557 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.2 -58.56 6.24 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.533 0.733 . . . . 3.42 111.424 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -19.99 65.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.812 1.187 . . . . 3.98 112.921 -175.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -90.39 -0.92 57.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.713 1.375 . . . . 5.54 114.713 168.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -53.1 -70.63 0.09 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.848 1.658 . . . . 3.09 111.012 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.7 -81.47 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.42 1.088 . . . . 2.5 110.66 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.52 -28.71 73.61 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.889 -0.484 . . . . 1.92 111.889 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 t -61.34 116.16 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.209 1.004 . . . . 3.88 110.284 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.66 54.66 1.67 Allowed 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.861 -1.533 . . . . 4.37 106.861 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.4 t -160.39 161.48 33.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 120.887 -1.133 . . . . 2.99 110.42 155.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.81 109.43 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 127.277 2.231 . . . . 3.9 106.779 172.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tt -135.54 63.05 1.61 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.114 -1.069 . . . . 3.0 108.114 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -96.12 149.09 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.143 -1.058 . . . . 3.74 108.143 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.22 100.0 6.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.113 -1.44 . . . . 2.49 107.113 166.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.41 -15.38 60.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.277 0.631 . . . . 3.78 112.158 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.4 mmt -72.39 -52.81 14.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.533 0.733 . . . . 6.02 110.405 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.33 -34.02 21.93 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.95 0.5 . . . . 1.99 110.974 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.94 62.79 1.28 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.035 1.303 . . . . 1.23 110.899 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -140.14 137.04 34.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.887 -1.523 . . . . 4.75 106.887 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.07 96.35 5.99 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 125.044 1.338 . . . . 2.13 109.791 173.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -98.65 136.5 38.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.481 -2.044 . . . . 3.64 105.481 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.98 177.92 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 N-CA-C 106.079 -1.823 . . . . 2.98 106.079 172.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -129.84 99.92 5.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.785 0.434 . . . . 4.71 110.386 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -94.47 -177.86 4.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.621 1.968 . . . . 3.81 112.857 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -127.67 108.52 20.65 Favored Pre-proline 0 N--CA 1.444 -0.765 0 CA-C-N 114.169 -1.378 . . . . 3.43 108.003 169.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.22 -3.01 10.79 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.581 2.187 . . . . 2.24 112.764 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.67 -39.6 64.31 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.797 1.18 . . . . 3.58 110.708 172.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -110.01 -19.18 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 118.291 0.496 . . . . 4.17 110.335 -166.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 pt -131.7 -176.48 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 107.484 -1.302 . . . . 3.77 107.484 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.64 155.94 59.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 125.418 1.487 . . . . 2.99 108.449 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.39 -35.6 60.54 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.309 2.006 . . . . 1.63 110.192 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.94 -37.99 84.27 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 122.064 -0.397 . . . . 3.95 111.94 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -67.74 -45.54 74.7 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.964 0.905 . . . . 3.08 110.372 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.9 mt -48.5 -56.76 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 106.546 -1.65 . . . . 2.38 106.546 167.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.59 89.31 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.07 -0.514 . . . . 2.69 110.777 -170.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -52.27 -49.78 63.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.81 1.644 . . . . 3.17 109.604 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.74 -50.27 44.9 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.154 0.502 . . . . 4.32 109.797 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -65.99 -38.9 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 121.919 -0.488 . . . . 3.4 110.958 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -64.11 -46.28 84.91 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.567 -0.531 . . . . 2.9 109.567 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -57.8 -52.43 65.51 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.316 0.646 . . . . 2.63 109.817 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.3 mt -58.77 -38.78 79.25 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.27 -0.423 . . . . 3.25 111.576 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.79 33.33 0.65 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 123.367 0.508 . . . . 1.37 112.59 163.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -133.02 163.64 28.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.733 1.213 . . . . 3.79 110.365 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -97.41 128.73 44.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.97 -1.493 . . . . 2.54 106.97 171.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.85 124.33 52.13 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.491 -1.3 . . . . 1.83 107.491 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.424 ' CB ' HE22 ' A' ' 9' ' ' GLN . . . -128.49 138.01 52.06 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.558 -1.275 . . . . 2.41 107.558 168.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -60.64 141.14 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.536 -0.913 . . . . 4.18 108.536 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.6 mtt -42.84 -55.14 3.81 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.805 1.242 . . . . 5.51 110.604 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -164.82 -52.23 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.727 2.011 . . . . 6.27 107.303 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -83.25 -89.5 0.09 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.633 -0.698 . . . . 7.63 112.867 -168.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 152.72 -105.96 0.0 OUTLIER 'General case' 0 C--N 1.345 0.409 0 C-N-CA 128.478 2.711 . . . . 4.7 111.965 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -119.97 -61.85 1.55 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.25 2.22 . . . . 3.82 111.712 -167.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.47 85.29 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 125.591 1.567 . . . . 3.13 113.391 171.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.7 t -162.39 -81.75 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.235 1.017 . . . . 6.22 113.132 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -113.87 126.77 55.55 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.541 1.137 . . . . 4.64 109.114 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.76 -35.4 2.5 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.686 -0.965 . . . . 2.38 110.686 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.99 101.84 4.13 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.236 1.414 . . . . 2.86 108.66 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -125.87 155.31 35.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 125.55 1.54 . . . . 4.0 108.123 -167.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -131.38 153.17 49.93 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.121 1.368 . . . . 4.24 107.396 174.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.07 162.71 32.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.151 -1.425 . . . . 3.55 107.151 170.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.42 133.52 41.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.965 -2.235 . . . . 3.04 104.965 170.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.6 pp -106.16 117.59 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 123.54 0.736 . . . . 3.12 109.652 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.6 m -105.6 136.79 44.54 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.577 -1.268 . . . . 2.49 107.577 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.28 -45.24 1.34 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.493 1.044 . . . . 1.43 111.151 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -62.26 132.96 54.42 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.39 -0.476 . . . . 3.42 110.345 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -156.89 42.01 0.35 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.373 0.669 . . . . 4.93 110.303 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.6 t -162.4 144.92 11.1 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 120.711 -1.243 . . . . 3.78 110.523 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.49 -40.37 62.29 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.697 0.799 . . . . 4.08 110.897 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -54.67 -47.1 74.02 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.897 -0.502 . . . . 2.92 110.364 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.8 m -64.6 -44.76 89.58 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.06 0.544 . . . . 2.16 109.596 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.4 t -51.14 -51.17 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 122.589 0.356 . . . . 2.74 110.074 171.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -62.28 -37.84 87.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.208 -0.664 . . . . 3.66 109.208 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -59.95 -55.02 39.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.183 0.993 . . . . 2.66 110.185 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.8 mt -54.91 -56.4 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.301 -0.629 . . . . 2.86 109.301 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.86 -43.32 76.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.19 0.996 . . . . 3.38 108.938 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.3 t -53.82 -47.18 71.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.643 0.656 . . . . 1.95 111.069 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -63.96 -42.74 97.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.63 -1.294 . . . . 3.53 111.54 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -54.89 37.59 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.359 -0.978 . . . . 3.94 108.359 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.0 p -59.11 -25.03 63.48 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.647 0.61 . . . . 2.83 112.647 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -72.52 -16.27 61.78 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.187 0.903 . . . . 4.81 112.357 175.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.5 m -80.55 152.82 28.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.915 0.886 . . . . 2.26 109.528 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -72.41 -49.49 33.36 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.197 0.999 . . . . 2.74 112.555 -175.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.75 -40.26 7.76 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 121.702 0.612 . . . . 1.26 111.71 -167.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.4 mm -53.66 136.11 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.06 -0.719 . . . . 3.37 109.06 168.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 38.6 p -123.25 -25.69 4.43 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.33 0.493 . . . . 3.9 112.33 166.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.07 112.51 6.8 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.258 -1.756 . . . . 3.18 106.258 -169.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -115.55 157.65 23.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.154 -1.054 . . . . 1.87 108.154 163.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 61.8 m -144.72 118.46 9.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.048 -1.464 . . . . 2.55 107.048 170.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.92 134.3 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 108.57 -0.9 . . . . 4.2 108.57 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.2 88.76 2.9 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.678 0.751 . . . . 2.86 109.146 -167.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -54.2 -30.18 48.86 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.315 1.046 . . . . 4.3 112.13 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.59 65.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.101 0.96 . . . . 3.05 111.088 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.74 -9.8 15.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.32 1.448 . . . . 2.97 110.949 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.3 m 66.58 30.58 8.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.574 1.55 . . . . 2.32 111.713 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -105.74 158.15 16.93 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.292 0.637 . . . . 4.96 110.683 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.11 109.4 8.91 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.235 1.814 . . . . 2.41 107.988 174.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.9 mp -98.55 131.06 45.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.722 -1.214 . . . . 3.53 107.722 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.65 133.82 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.371 1.068 . . . . 3.57 108.555 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -117.67 93.75 4.27 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.041 -1.096 . . . . 4.11 108.041 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -122.28 168.76 11.65 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.645 1.178 . . . . 2.91 112.284 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -98.13 113.47 63.95 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 109.266 -0.642 . . . . 2.65 109.266 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.53 67.86 7.71 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.695 2.93 . . . . 1.95 111.474 -172.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -160.49 -46.86 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.159 1.384 . . . . 3.55 108.874 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.1 pt -86.66 -28.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 123.692 0.797 . . . . 2.47 111.876 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.53 165.04 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.159 -1.052 . . . . 2.44 108.159 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.98 162.5 28.94 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 109.874 -1.29 . . . . 1.74 109.874 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -62.57 -35.13 72.48 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.425 2.75 . . . . 1.75 111.516 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -52.71 -42.06 64.5 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 112.759 0.651 . . . . 6.28 112.759 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.57 -39.0 74.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.459 -0.896 . . . . 3.36 109.565 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.1 -47.57 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.967 -0.753 . . . . 2.22 108.967 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 52.2 mt -55.36 -56.48 11.45 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 124.015 0.926 . . . . 3.12 109.573 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -49.89 -50.44 45.92 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 119.461 1.028 . . . . 4.94 110.619 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 50.7 mt -54.88 -55.33 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 122.557 0.343 . . . . 3.42 110.154 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.7 pp -68.21 -29.59 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.774 -1.204 . . . . 2.14 112.951 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.11 -35.86 74.18 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.401 0.546 . . . . 3.08 110.657 171.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.62 -37.76 82.49 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.471 -0.566 . . . . 4.73 109.471 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.0 mt -72.92 -40.5 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 109.212 -0.662 . . . . 2.37 109.212 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.7 33.97 2.95 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.047 1.308 . . . . 1.51 110.961 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -99.19 177.4 5.23 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 108.233 -1.025 . . . . 4.44 108.233 164.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -141.38 120.88 13.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.099 -1.815 . . . . 5.26 106.099 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.0 110.81 22.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.533 1.533 . . . . 1.96 108.727 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.7 m -130.35 134.33 47.09 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.477 0.711 . . . . 3.27 110.935 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -37.97 127.88 1.25 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.063 2.145 . . . . 5.03 110.151 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -103.93 -12.09 17.06 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 116.445 -1.74 . . . . 3.73 113.343 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 . . . . . 0 C--O 1.259 1.597 0 C-N-CA 129.4 3.08 . . . . 6.85 114.554 152.267 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 mtm . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 105.225 -2.139 . . . . 10.27 105.225 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -53.49 113.79 5.3 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 119.189 0.904 . . . . 4.47 111.405 -168.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.54 97.74 1.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.502 1.468 . . . . 3.06 111.361 -171.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -123.53 141.16 52.27 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 126.965 2.106 . . . . 2.99 106.471 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -95.45 157.89 15.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.586 1.555 . . . . 4.93 107.448 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.9 p -140.95 133.79 28.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 122.544 0.337 . . . . 3.52 110.215 168.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -104.01 105.58 15.8 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 125.665 1.586 . . . . 4.27 108.371 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -134.63 169.46 17.27 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.472 -0.491 . . . . 3.02 110.969 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.22 138.95 51.37 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.012 -1.848 . . . . 1.84 106.012 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.8 mm -97.93 134.04 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 106.802 -1.555 . . . . 2.17 106.802 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -104.51 123.29 47.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.533 -1.654 . . . . 4.23 106.533 160.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.84 -27.38 3.06 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.367 0.985 . . . . 3.06 111.472 -175.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.2 ptt? -57.92 167.67 1.14 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.791 -0.829 . . . . 4.1 111.405 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 m 77.11 -8.81 1.63 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.801 1.24 . . . . 10.24 112.016 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.8 m -114.45 136.01 53.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.888 0.875 . . . . 6.49 109.645 -173.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 42.33 -106.15 0.08 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.357 1.463 . . . . 7.04 109.894 -174.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 p -158.95 38.84 0.22 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.918 0.866 . . . . 3.65 109.308 171.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.66 -42.96 63.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.76 -0.655 . . . . 3.01 110.443 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -57.08 -42.01 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 122.252 1.025 . . . . 3.57 109.378 171.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.95 -46.07 82.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.863 -1.062 . . . . 2.8 111.293 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -60.83 -46.41 90.66 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.267 -0.896 . . . . 2.58 110.519 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.0 mt -47.68 -40.29 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 C-N-CA 124.153 0.981 . . . . 2.93 111.637 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -47.31 -60.34 2.57 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.117 0.567 . . . . 5.15 111.974 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -37.29 72.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.327 -0.62 . . . . 6.96 109.327 -173.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -56.61 -54.85 41.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.186 -0.461 . . . . 1.24 110.066 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.404 ' HG ' ' CE2' ' A' ' 61' ' ' PHE . 6.7 mt -58.7 -44.37 90.3 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 118.652 0.66 . . . . 3.39 111.137 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.08 -11.26 1.04 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 114.285 1.217 . . . . 1.97 114.285 171.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.11 3.75 11.4 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.955 -1.091 . . . . 4.58 111.974 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.73 -65.9 0.66 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.851 1.205 . . . . 2.52 110.515 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.28 -131.36 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.122 0.569 . . . . 2.23 109.951 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.42 -0.94 80.47 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 119.501 1.046 . . . . 1.85 113.096 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.91 127.61 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 O-C-N 121.523 -0.986 . . . . 2.66 111.298 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.52 54.01 1.12 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.284 0.846 . . . . 3.49 113.284 173.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 t -157.15 143.68 18.16 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 107.02 -1.474 . . . . 2.7 107.02 165.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.0 92.53 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.04 -1.837 . . . . 3.29 106.04 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -116.53 79.78 1.37 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.351 -1.722 . . . . 4.35 106.351 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.9 p -98.73 128.23 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.453 -0.943 . . . . 3.49 108.453 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.39 74.98 2.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.957 -1.868 . . . . 2.02 105.957 172.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.86 -29.88 3.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.393 1.077 . . . . 4.23 111.87 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.2 ttt -72.65 -36.18 67.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.947 1.299 . . . . 4.83 111.135 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.71 -48.02 5.65 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 124.177 0.991 . . . . 2.03 109.191 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.23 58.24 0.35 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 125.48 1.514 . . . . 1.18 111.599 167.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -142.97 136.91 28.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.12 -1.067 . . . . 3.87 108.12 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.64 110.36 22.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.637 1.575 . . . . 1.84 111.597 168.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -99.51 111.36 23.72 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.081 -1.081 . . . . 4.65 108.081 167.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.9 mt -109.57 167.04 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.684 0.794 . . . . 3.96 109.066 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -123.61 108.23 12.37 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.871 0.868 . . . . 4.73 109.107 162.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -113.81 163.4 15.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.73 1.212 . . . . 4.15 111.336 168.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -105.71 106.37 56.21 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 127.215 2.206 . . . . 4.62 110.075 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.69 2.21 1.77 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.057 2.505 . . . . 2.05 114.015 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -83.14 -22.75 33.22 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.128 1.371 . . . . 4.49 110.408 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.1 t -123.42 -65.44 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.2 -1.037 . . . . 3.68 108.2 -171.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.26 155.14 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.276 -0.638 . . . . 2.37 109.276 174.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -129.27 151.74 78.29 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.692 1.597 . . . . 2.59 108.004 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.91 -38.42 79.21 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.841 2.361 . . . . 1.29 112.149 -172.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -59.51 -41.09 89.14 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.328 -0.857 . . . . 4.09 111.255 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -61.2 -40.54 94.35 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.307 0.643 . . . . 3.03 110.254 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.75 -46.45 74.17 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 N-CA-C 107.746 -1.205 . . . . 2.13 107.746 171.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.4 94.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.064 0.459 . . . . 1.98 111.036 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -57.77 -52.89 63.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.468 -0.77 . . . . 2.58 110.34 173.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.404 ' CE2' ' HG ' ' A' ' 26' ' ' LEU . 8.0 t80 -51.0 -55.5 17.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.429 0.692 . . . . 6.83 111.496 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 pp -61.4 -39.87 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 121.065 -1.022 . . . . 5.45 111.647 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.58 -33.72 76.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.343 0.52 . . . . 3.08 110.816 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.51 -50.3 67.95 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.485 -0.561 . . . . 2.51 109.485 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.1 mt -58.65 -35.73 73.0 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.937 -0.305 . . . . 3.03 111.402 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.08 31.19 2.52 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 123.92 0.771 . . . . 1.33 111.915 169.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -112.16 164.64 12.95 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.625 1.57 . . . . 3.51 109.04 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -102.9 136.05 43.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.02 -1.474 . . . . 2.6 107.02 164.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.3 127.04 38.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.216 -1.772 . . . . 1.82 106.216 169.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.4 138.98 33.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.009 0.818 . . . . 1.88 109.328 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.84 144.46 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 116.138 -0.483 . . . . 3.72 109.734 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.7 mtp -49.31 -42.93 42.85 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.098 0.959 . . . . 4.77 111.23 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -170.3 -57.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 127.245 2.218 . . . . 5.92 105.177 170.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -79.78 -92.49 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 130.256 3.423 . . . . 6.84 112.871 -168.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 76' ' ' ALA . 21.9 p90 157.48 -58.48 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 130.265 3.426 . . . . 5.09 110.996 -171.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.413 ' N ' ' CD1' ' A' ' 75' ' ' TYR . . . 167.14 -82.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.935 1.694 . . . . 4.18 115.134 -168.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.78 94.26 1.06 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.777 -0.929 . . . . 3.49 110.777 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 t -136.64 -66.2 0.54 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 119.383 -0.341 . . . . 6.04 111.201 168.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -147.91 136.84 22.0 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.937 -1.135 . . . . 4.89 107.937 -171.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.0 -64.14 4.28 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 107.366 -2.294 . . . . 2.14 107.366 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -102.65 110.06 21.88 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.381 1.472 . . . . 2.68 109.046 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.96 138.91 53.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 O-C-N 123.332 0.395 . . . . 3.57 110.67 175.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -110.33 141.36 43.45 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.128 1.371 . . . . 4.42 108.326 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.79 156.45 44.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.298 -0.63 . . . . 4.3 109.298 174.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.31 121.75 39.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 105.018 -2.216 . . . . 2.51 105.018 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 pp -100.88 121.07 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.14 -0.689 . . . . 2.6 109.14 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.2 p -106.92 142.79 35.98 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.27 0.628 . . . . 3.46 109.348 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.74 -26.17 10.31 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.741 1.162 . . . . 1.48 112.742 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.0 ttp -67.51 108.62 2.9 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.641 -0.917 . . . . 3.6 112.096 -169.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.7 m -117.86 7.77 12.47 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.044 0.938 . . . . 3.27 111.923 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 23.9 p -163.07 151.21 13.78 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 120.742 -1.224 . . . . 3.65 112.08 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.54 72.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.683 0.793 . . . . 3.83 111.411 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.2 m -53.29 -40.96 65.14 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.284 -0.885 . . . . 3.12 110.785 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.1 m -69.89 -40.93 75.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.615 -0.707 . . . . 2.82 110.04 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.0 t -50.35 -57.21 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 118.636 0.653 . . . . 2.63 109.557 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -58.58 -45.71 88.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.358 0.663 . . . . 4.35 110.205 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -61.21 -50.62 72.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.0 0.52 . . . . 1.77 110.84 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 41.7 mt -56.27 -47.2 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.089 -0.708 . . . . 1.87 109.089 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.28 -49.49 74.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.634 -0.876 . . . . 2.81 108.634 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.3 t -52.52 -50.45 62.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.719 0.808 . . . . 1.99 110.159 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -61.31 -42.37 98.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.753 -0.592 . . . . 3.76 111.31 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.5 mt -67.18 -56.26 10.68 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.932 -1.136 . . . . 2.83 107.932 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.7 p -55.33 -17.78 5.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.484 0.714 . . . . 2.89 112.703 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -13.77 62.59 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.502 -0.749 . . . . 6.83 112.398 171.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -80.83 153.86 27.45 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.389 1.876 . . . . 2.4 109.63 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -67.39 -64.44 0.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.943 0.897 . . . . 3.14 111.353 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.32 -32.41 58.08 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 122.253 -0.279 . . . . 1.27 112.921 -172.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.07 112.52 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.733 0.766 . . . . 2.67 109.616 -172.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.6 m -99.3 -41.32 7.5 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.561 0.344 . . . . 2.71 110.265 -172.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.402 ' CE2' ' HG3' ' A' ' 123' ' ' LYS . 54.2 p90 -140.15 121.22 14.69 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.468 -0.567 . . . . 3.6 109.468 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.18 140.8 37.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.72 -0.844 . . . . 1.7 108.72 165.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -132.69 116.98 17.29 Favored 'General case' 0 C--O 1.228 -0.052 0 N-CA-C 108.29 -1.004 . . . . 2.01 108.29 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 m -112.28 135.23 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.591 1.157 . . . . 3.31 109.087 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.32 89.55 2.57 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.332 0.969 . . . . 1.8 111.211 -173.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -24.51 67.04 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 125.22 1.408 . . . . 4.28 113.718 -170.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.81 70.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.654 0.381 . . . . 2.27 110.397 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.83 -13.12 12.02 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.477 1.511 . . . . 2.12 111.317 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.3 m 69.13 15.8 8.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.319 1.847 . . . . 2.25 114.326 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -95.16 158.0 15.65 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 120.127 1.33 . . . . 4.23 108.464 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.53 125.15 17.98 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.225 1.01 . . . . 1.7 108.652 168.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.26 114.42 26.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.637 -1.616 . . . . 2.46 106.637 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 m -106.75 135.06 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.048 0.84 . . . . 3.43 111.687 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.402 ' HG3' ' CE2' ' A' ' 110' ' ' TYR . 9.2 mmmt -113.01 95.97 5.69 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.13 1.372 . . . . 4.47 109.524 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -122.95 174.16 7.35 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.843 0.747 . . . . 3.96 111.362 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -105.19 110.07 63.99 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 108.564 -0.902 . . . . 3.13 108.564 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.53 69.01 6.83 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.48 2.787 . . . . 2.09 111.305 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -158.45 -48.53 0.06 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.875 1.27 . . . . 3.21 108.917 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pt -82.83 -28.93 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.406 0.682 . . . . 2.86 110.867 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.64 163.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.575 -0.898 . . . . 2.32 108.575 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.71 161.5 28.24 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.444 -1.462 . . . . 1.91 109.444 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.52 -37.62 87.9 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.557 2.838 . . . . 2.1 111.713 -172.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -52.21 -36.65 52.7 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.262 0.838 . . . . 7.93 113.262 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.43 -46.02 67.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.453 -0.573 . . . . 3.42 109.453 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.4 mt -57.46 -45.32 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.631 -0.878 . . . . 2.15 108.631 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.7 mt -53.85 -61.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 118.354 -0.831 . . . . 3.59 109.055 173.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.15 -49.49 32.17 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.913 1.233 . . . . 6.12 111.174 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.5 mt -53.05 -60.11 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.808 -0.812 . . . . 3.11 108.808 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.3 pp -65.9 -30.56 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 119.375 -0.93 . . . . 2.33 113.279 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.43 -40.53 94.78 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.111 0.869 . . . . 2.55 109.758 170.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -64.98 -37.47 87.76 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.079 -0.712 . . . . 2.84 109.079 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.35 -43.29 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.075 -0.391 . . . . 2.21 109.956 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.61 31.56 4.83 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.57 1.557 . . . . 1.12 111.619 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -99.62 174.93 6.01 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.315 1.057 . . . . 3.55 108.652 165.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -139.02 119.15 13.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.055 -1.831 . . . . 4.59 106.055 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.19 109.42 20.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.129 1.771 . . . . 1.77 108.793 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 26.6 m -117.14 113.72 22.66 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.944 0.497 . . . . 2.53 110.274 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -31.34 115.2 0.14 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.391 1.876 . . . . 4.49 112.039 169.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -101.17 15.69 27.93 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.637 1.347 . . . . 3.69 114.637 -161.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.085 -1.436 . . . . 5.64 112.618 -175.76 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.08 -1.082 . . . . 8.05 108.08 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.76 110.94 10.24 Favored Pre-proline 0 CA--C 1.533 0.304 0 O-C-N 123.858 0.724 . . . . 5.4 109.529 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.62 114.79 4.11 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 N-CA-C 108.173 -1.51 . . . . 4.7 108.173 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.75 158.87 15.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.564 -1.643 . . . . 3.83 106.564 166.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -126.2 149.04 49.3 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.546 1.538 . . . . 5.92 106.951 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.1 p -140.53 146.03 37.58 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.829 -0.804 . . . . 4.58 108.829 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.15 109.68 19.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.041 -1.466 . . . . 5.99 107.041 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.458 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 2.3 pt? -133.69 174.72 10.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.071 0.938 . . . . 3.39 111.192 170.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.78 137.75 40.16 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.023 -1.103 . . . . 2.42 108.023 176.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 mm -98.67 126.51 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 106.972 -1.492 . . . . 2.15 106.972 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -102.48 103.55 13.92 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.064 -1.828 . . . . 4.89 106.064 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.23 -89.46 0.1 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.287 -1.525 . . . . 1.26 109.287 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.4 mtt 47.1 73.67 0.18 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.169 1.388 . . . . 3.33 113.497 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -57.56 -11.8 2.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.75 1.22 . . . . 3.32 113.653 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.5 t 73.97 -66.03 0.32 Allowed 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 126.187 1.795 . . . . 3.6 110.878 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -15.4 -74.51 0.01 OUTLIER 'General case' 0 C--N 1.342 0.279 0 C-N-CA 128.368 2.667 . . . . 7.62 113.219 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.8 m -153.37 19.26 0.55 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.498 0.719 . . . . 4.71 111.07 161.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 31.7 m -70.64 -47.5 59.74 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 121.093 -1.004 . . . . 2.82 109.211 -169.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -54.81 -49.83 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.752 -0.462 . . . . 4.38 109.752 175.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -55.55 -48.38 74.82 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.175 0.59 . . . . 2.84 111.433 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -58.75 -47.92 82.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.615 -0.513 . . . . 3.09 109.615 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -46.4 -50.89 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.632 1.173 . . . . 3.01 110.051 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -54.51 -54.54 39.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.472 0.578 . . . . 4.39 111.168 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -59.9 -43.04 95.04 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.166 -0.47 . . . . 6.15 110.3 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -56.52 -57.44 12.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.267 0.627 . . . . 1.48 109.478 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mp -57.68 -44.99 86.17 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 119.014 -0.517 . . . . 3.13 111.679 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -54.85 -20.68 9.24 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.428 1.013 . . . . 2.17 113.481 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -112.05 15.37 20.65 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.712 1.004 . . . . 4.24 113.712 173.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -70.02 -64.54 0.87 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.949 1.25 . . . . 2.77 110.229 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.73 -124.09 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.929 0.492 . . . . 2.45 110.713 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.74 -25.62 69.2 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 118.795 0.725 . . . . 1.65 111.987 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.95 125.73 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 O-C-N 122.446 -0.444 . . . . 2.51 110.036 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 pp -143.12 50.55 1.41 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.71 0.767 . . . . 4.13 109.765 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.8 t -160.64 149.53 16.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.092 -1.077 . . . . 2.58 108.092 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.0 129.7 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.046 -1.094 . . . . 3.69 108.046 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -142.52 74.28 1.44 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.104 -1.073 . . . . 3.63 108.104 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 m -97.33 159.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 121.372 -0.83 . . . . 3.99 108.995 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.88 90.6 2.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.307 -1.368 . . . . 3.38 107.307 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 tp -51.86 -27.44 12.67 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.881 1.672 . . . . 4.74 110.358 172.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.3 mtp -59.16 -38.65 80.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.187 0.995 . . . . 3.84 111.603 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.3 -31.47 7.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.473 0.709 . . . . 3.48 111.449 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.49 61.59 0.96 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.457 1.503 . . . . 2.19 110.403 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -142.08 142.7 32.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.429 -1.323 . . . . 4.2 107.429 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.08 101.34 7.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.968 0.907 . . . . 2.48 110.43 171.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -102.31 131.05 49.15 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.161 -2.162 . . . . 5.69 105.161 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.7 pt -136.74 171.71 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 120.434 -1.416 . . . . 3.42 108.988 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.22 99.77 6.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.422 1.089 . . . . 6.6 108.356 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -100.05 -179.17 4.07 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.686 1.194 . . . . 5.0 110.206 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -128.25 103.3 20.53 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.597 1.159 . . . . 3.98 110.894 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.25 -8.32 18.29 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.796 3.664 . . . . 3.03 114.84 -167.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -92.86 -8.94 42.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.352 0.661 . . . . 4.79 111.598 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.5 -47.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 123.934 0.894 . . . . 4.66 110.21 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.36 143.25 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 108.08 -1.081 . . . . 3.2 108.08 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.89 142.72 26.44 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 124.352 1.061 . . . . 3.3 109.143 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -57.39 -40.39 81.96 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.12 2.546 . . . . 2.05 111.505 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.24 -43.37 98.99 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.319 0.648 . . . . 5.88 110.371 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -63.05 -40.24 97.12 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.902 0.481 . . . . 3.79 110.103 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -53.4 19.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 N-CA-C 106.915 -1.513 . . . . 2.19 106.915 170.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.15 -45.46 79.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.99 -0.55 . . . . 2.2 110.599 -172.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.69 -49.94 56.16 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.486 0.715 . . . . 4.06 110.485 174.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.44 -48.9 65.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.527 0.679 . . . . 3.49 109.858 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -64.01 -39.06 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 122.081 -0.387 . . . . 3.37 111.413 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -65.56 -44.56 86.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.731 -0.47 . . . . 2.57 109.731 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.0 -50.51 73.83 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.714 -0.476 . . . . 2.5 109.714 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.7 mt -55.62 -40.58 72.3 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.387 -0.369 . . . . 2.95 111.629 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.37 33.46 1.03 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 123.516 0.579 . . . . 1.28 112.017 165.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -124.44 162.02 24.79 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.704 1.202 . . . . 3.13 108.86 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.81 130.46 41.37 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.138 -1.43 . . . . 2.58 107.138 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.59 111.38 24.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.836 1.254 . . . . 2.34 108.117 173.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.31 116.28 19.57 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.621 -0.511 . . . . 2.35 109.621 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.458 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.8 t -68.71 155.45 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.187 1.795 . . . . 3.75 111.36 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mtt -87.91 19.92 3.33 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.176 0.99 . . . . 5.76 111.267 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 80.93 -36.86 0.13 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.597 1.559 . . . . 3.88 109.718 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.63 67.21 0.06 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.043 1.737 . . . . 8.61 110.758 163.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.429 ' CE2' ' ND2' ' A' ' 81' ' ' ASN . 38.5 p90 -68.24 -25.81 65.37 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 127.771 2.428 . . . . 4.66 114.447 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 142.76 -150.25 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 129.121 2.968 . . . . 3.67 105.628 -168.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.19 97.95 0.81 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 108.135 -1.986 . . . . 3.08 108.135 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 t -160.37 -56.02 0.06 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.486 0.643 . . . . 5.7 110.996 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.32 134.76 45.62 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.447 -0.946 . . . . 4.7 108.447 -176.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.05 -46.42 2.69 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.208 -0.757 . . . . 2.84 111.208 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.429 ' ND2' ' CE2' ' A' ' 75' ' ' TYR . 50.9 t30 -129.65 128.33 42.38 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.359 -1.348 . . . . 2.99 107.359 169.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.89 154.11 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 107.096 -1.446 . . . . 4.22 107.096 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.22 141.14 51.55 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 123.477 0.711 . . . . 3.14 110.143 169.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.66 149.28 52.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.37 -2.085 . . . . 3.53 105.37 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.5 127.92 46.71 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 104.87 -2.27 . . . . 2.3 104.87 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.01 136.78 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 O-C-N 123.863 0.727 . . . . 2.84 109.065 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.2 m -128.34 115.2 17.9 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.372 1.069 . . . . 2.45 109.401 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.38 -38.13 1.72 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.174 1.369 . . . . 1.33 111.438 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.6 mtp -45.94 119.55 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.667 1.187 . . . . 3.23 111.763 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.0 m -129.66 17.02 5.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.922 0.889 . . . . 3.72 110.676 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 47.5 t -165.56 141.26 5.15 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 120.827 -1.171 . . . . 3.46 109.993 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.92 -32.51 66.02 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.709 0.686 . . . . 3.67 111.495 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -53.12 -37.92 62.18 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.756 -0.59 . . . . 2.51 110.469 173.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 85.8 m -62.53 -49.74 74.12 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 109.265 -0.643 . . . . 2.17 109.265 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.9 t -49.87 -45.54 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 122.506 0.322 . . . . 2.27 110.712 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -48.67 80.73 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.065 -0.346 . . . . 3.8 110.065 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -38.88 92.59 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 119.812 -0.755 . . . . 3.48 110.484 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.5 mt -64.76 -54.29 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.43 -0.952 . . . . 2.38 108.43 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -49.46 -49.77 43.99 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 126.337 1.855 . . . . 4.39 109.251 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.0 t -50.17 -50.43 49.13 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 119.368 -0.349 . . . . 2.22 111.317 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -50.2 68.52 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.03 0.832 . . . . 3.79 112.3 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.75 -45.13 87.71 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 120.841 -1.162 . . . . 4.04 110.892 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 87.2 m -61.11 -16.93 49.58 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.707 0.803 . . . . 3.72 111.061 173.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -17.71 64.83 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 118.624 -0.703 . . . . 5.78 111.733 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.9 p -72.66 -176.41 1.95 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 120.159 1.345 . . . . 4.23 110.885 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -94.29 -50.35 5.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.541 1.137 . . . . 2.4 111.083 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.47 -41.37 30.31 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 122.245 -0.285 . . . . 1.56 112.768 -168.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.17 126.34 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.751 -0.833 . . . . 3.96 108.751 -173.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.0 m -112.36 -46.32 3.19 Favored 'General case' 0 CA--C 1.522 -0.11 0 N-CA-C 111.824 0.305 . . . . 3.21 111.824 -174.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -136.42 125.15 23.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.718 -1.216 . . . . 4.1 107.718 167.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.17 159.99 21.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.784 -1.191 . . . . 1.8 107.784 161.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.0 m -142.98 105.12 4.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.794 -1.187 . . . . 2.56 107.794 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.1 t -98.36 115.67 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 125.968 1.707 . . . . 3.53 107.596 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -119.0 106.37 12.37 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 118.943 0.792 . . . . 2.14 110.484 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 pp -72.59 -29.92 63.92 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.467 1.107 . . . . 3.15 112.447 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.52 -43.22 89.1 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.395 0.678 . . . . 2.02 110.341 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -28.69 19.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.786 1.234 . . . . 2.34 110.314 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.35 21.91 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.162 1.785 . . . . 3.37 111.155 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -99.08 160.82 13.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.607 1.563 . . . . 3.94 110.216 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.48 130.13 24.25 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.408 -0.96 . . . . 1.86 108.408 166.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -95.54 143.27 26.99 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.24 -1.393 . . . . 2.94 107.24 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.35 128.7 25.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 124.998 1.319 . . . . 3.11 109.027 -173.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -118.54 106.65 12.88 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.006 -0.739 . . . . 4.64 109.006 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -125.44 175.8 7.26 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.802 0.841 . . . . 4.13 110.318 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -97.82 113.58 63.86 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 108.009 -1.108 . . . . 3.75 108.009 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.6 67.96 7.11 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.524 2.816 . . . . 2.45 111.222 -173.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -162.49 -47.64 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.719 1.208 . . . . 3.93 109.026 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 pt -86.39 -32.18 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 122.539 0.335 . . . . 3.12 111.524 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.68 163.05 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 107.939 -1.134 . . . . 2.48 107.939 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.21 160.82 28.37 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.456 -1.458 . . . . 2.15 109.456 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.36 -35.78 89.8 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.511 2.807 . . . . 2.14 111.665 -172.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -32.66 69.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 112.39 0.515 . . . . 7.76 112.39 -175.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.79 -48.45 68.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.976 -0.75 . . . . 3.68 108.976 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 74.9 mt -58.3 -45.18 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.533 -0.914 . . . . 2.34 108.533 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 80.4 mt -52.44 -61.09 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 117.566 -1.207 . . . . 3.41 108.889 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.26 -51.8 17.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.399 1.454 . . . . 6.0 110.996 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.0 mm -52.89 -49.92 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.599 0.636 . . . . 2.86 110.104 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.288 2.5 pp -70.75 -31.53 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 121.173 -0.954 . . . . 2.48 113.31 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.5 -39.76 84.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.74 1.155 . . . . 3.06 109.813 169.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -35.41 77.27 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.196 1.398 . . . . 3.17 108.867 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 78.1 mt -77.27 -41.81 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 122.542 0.337 . . . . 1.97 110.724 172.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.31 30.98 5.45 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.598 1.57 . . . . 1.06 111.583 -173.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -98.33 175.3 6.1 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.422 1.111 . . . . 3.2 108.251 165.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -135.92 126.36 26.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.191 -2.151 . . . . 5.24 105.191 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.6 100.57 7.2 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.648 1.579 . . . . 1.93 107.466 -175.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.1 m -146.8 117.2 7.44 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 117.896 -1.049 . . . . 4.09 111.408 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.99 -102.0 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.217 -0.896 . . . . 8.09 109.588 170.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 41.1 40.21 1.04 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.434 1.493 . . . . 7.85 111.814 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 . . . . . 0 C--O 1.248 0.99 0 N-CA-C 114.726 1.38 . . . . 7.35 114.726 -169.942 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 107.146 -1.427 . . . . 8.75 107.146 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.33 111.71 47.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 117.361 -1.304 . . . . 5.41 108.429 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -84.05 151.2 12.47 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.291 2.661 . . . . 3.59 109.734 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.03 142.48 32.89 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 123.264 0.625 . . . . 4.51 109.78 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 152.39 19.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 123.891 0.744 . . . . 4.12 110.547 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.7 t -119.65 137.45 53.88 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.562 -0.903 . . . . 3.07 108.562 168.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -102.33 103.55 14.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.847 1.659 . . . . 4.86 108.973 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.444 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.8 pt? -125.8 176.91 6.6 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.894 0.854 . . . . 3.53 111.236 171.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.82 136.45 34.04 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.225 -1.028 . . . . 2.25 108.225 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.6 mm -93.69 121.25 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 107.004 -1.48 . . . . 1.93 107.004 -169.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.75 102.17 11.75 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.583 -2.377 . . . . 5.02 104.583 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.47 -89.27 0.09 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 109.785 -1.326 . . . . 1.16 109.785 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.2 mmt 46.98 77.32 0.09 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.079 1.752 . . . . 2.62 113.375 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 p -65.62 -58.41 5.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.464 -0.773 . . . . 3.67 111.528 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 49.68 0.07 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 119.976 -0.689 . . . . 4.33 110.784 -172.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 47.66 36.27 5.37 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.822 0.849 . . . . 6.37 111.593 -177.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -129.4 -51.66 1.18 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.698 1.199 . . . . 4.11 109.635 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 23.4 t -68.79 -43.25 76.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 118.434 -1.306 . . . . 3.73 109.811 -174.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -38.65 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 122.125 0.965 . . . . 3.36 109.399 173.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -65.83 -41.55 91.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.084 -0.962 . . . . 2.93 111.26 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.57 -38.17 70.99 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 120.801 -1.187 . . . . 3.11 111.667 172.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.0 mt -49.4 -42.79 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.494 1.118 . . . . 2.2 109.968 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -41.14 -56.46 2.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.635 0.731 . . . . 4.44 112.515 172.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -68.57 -27.51 66.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.873 0.869 . . . . 6.07 110.79 -175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -69.48 -57.4 5.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.436 -0.95 . . . . 1.21 108.436 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.11 -40.6 85.87 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 118.745 0.702 . . . . 3.55 110.261 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -24.56 5.94 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 112.771 0.656 . . . . 2.14 112.771 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -127.31 25.43 6.15 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.273 0.629 . . . . 4.75 111.734 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -76.77 -58.15 3.44 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.995 -0.742 . . . . 2.83 108.995 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -162.56 -131.87 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.015 0.526 . . . . 2.1 109.972 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.49 -2.44 42.69 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.761 0.696 . . . . 1.5 113.767 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -80.22 122.38 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.163 0.981 . . . . 2.5 109.382 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.1 51.36 2.13 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.774 0.797 . . . . 3.53 109.933 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 t -161.6 151.14 16.47 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.246 -1.761 . . . . 2.31 106.246 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -140.72 124.35 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.172 -1.788 . . . . 3.59 106.172 166.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.73 87.89 2.55 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.144 0.973 . . . . 5.5 110.492 169.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.59 139.92 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.249 -1.019 . . . . 3.53 108.249 172.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -109.3 100.97 10.01 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.967 -1.864 . . . . 2.5 105.967 162.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.74 -33.61 70.45 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.258 1.023 . . . . 4.89 109.052 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -53.07 62.41 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.56 1.144 . . . . 5.62 110.78 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.73 -25.39 22.33 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.347 0.659 . . . . 2.5 111.388 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.66 55.68 2.65 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.741 1.162 . . . . 1.46 110.957 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -135.33 139.42 44.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.175 0.988 . . . . 4.14 108.336 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.66 105.3 13.45 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 124.682 1.193 . . . . 1.69 109.765 167.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.31 144.49 28.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.591 -1.633 . . . . 3.72 106.591 163.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.64 172.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.536 -1.283 . . . . 3.3 107.536 166.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -115.4 112.32 22.15 Favored 'General case' 0 C--N 1.34 0.178 0 O-C-N 124.054 0.846 . . . . 4.39 110.206 167.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -105.21 172.33 6.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.598 1.559 . . . . 4.08 110.758 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -117.17 106.34 47.37 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.894 1.278 . . . . 3.42 109.001 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.15 -12.56 30.36 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 124.609 3.539 . . . . 2.65 113.819 -160.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -96.46 0.86 50.97 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.177 0.591 . . . . 3.18 111.3 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.0 t -118.85 -49.03 3.73 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 123.979 0.912 . . . . 3.36 109.478 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.16 149.97 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.833 1.253 . . . . 2.25 108.344 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.23 140.06 27.54 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 106.564 -1.643 . . . . 2.98 106.564 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -56.69 -38.78 94.91 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.022 2.482 . . . . 1.78 112.06 -172.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mp -52.06 -43.83 64.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.681 0.792 . . . . 4.68 111.061 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -39.51 94.08 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.137 -0.69 . . . . 3.35 109.137 -176.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -52.11 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.493 -1.299 . . . . 2.4 107.493 172.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.82 -45.53 86.01 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 123.365 0.415 . . . . 2.34 110.263 -173.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.5 -45.99 69.87 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.068 0.547 . . . . 3.31 110.944 172.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.37 -46.83 87.58 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.379 0.609 . . . . 3.72 109.863 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mm -58.76 -44.21 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.916 -0.49 . . . . 3.53 110.991 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -63.69 -39.77 95.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.348 0.659 . . . . 3.22 111.507 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -62.62 -46.69 87.08 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.977 0.511 . . . . 2.12 109.702 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 mt -58.21 -36.85 73.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.549 0.34 . . . . 2.71 111.742 172.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.88 24.56 3.03 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.268 0.937 . . . . 1.07 112.469 167.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 18' ' ' CYS . 2.1 m-30 -115.12 160.91 19.1 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.188 1.395 . . . . 3.74 109.118 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -98.03 119.21 36.27 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.321 -0.992 . . . . 4.04 108.321 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.31 91.11 5.06 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.087 1.355 . . . . 2.11 107.947 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.71 97.5 8.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.596 -1.631 . . . . 2.17 106.596 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.444 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -60.81 155.67 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.187 -1.37 . . . . 4.77 110.104 169.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.24 -50.18 73.69 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.568 -0.901 . . . . 6.08 108.568 168.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.49 ' C ' ' H ' ' A' ' 75' ' ' TYR . 3.2 tt0 -171.37 21.58 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.21 0.819 . . . . 8.15 113.21 175.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 64.03 -16.33 0.07 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.592 1.701 . . . . 10.74 115.592 -172.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.49 ' H ' ' C ' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -52.71 -49.79 64.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.314 1.446 . . . . 6.18 109.018 -168.23 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 67.81 -116.61 0.19 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.337 1.055 . . . . 4.55 111.33 161.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.85 -48.52 0.17 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 107.986 -2.046 . . . . 4.81 107.986 169.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 32.08 44.93 0.04 OUTLIER 'General case' 0 C--N 1.345 0.389 0 C-N-CA 127.86 2.464 . . . . 8.45 114.909 163.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 53.48 86.26 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.14 2.176 . . . . 6.73 112.903 162.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.46 3.85 88.91 Favored Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 126.412 1.958 . . . . 3.12 109.899 -170.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.45 70.26 2.65 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.534 1.667 . . . . 2.59 107.739 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.42 161.25 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.521 -0.918 . . . . 3.79 108.521 -178.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.12 148.09 44.06 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.522 0.729 . . . . 2.87 109.611 177.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.02 147.45 52.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.908 1.283 . . . . 3.7 108.505 172.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 m -98.02 126.31 43.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 105.971 -1.863 . . . . 2.98 105.971 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.03 134.69 35.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 109.181 -0.674 . . . . 2.53 109.181 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.5 m -125.74 140.56 52.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.115 -1.439 . . . . 2.72 107.115 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.44 -22.53 5.87 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.912 1.244 . . . . 1.33 111.89 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -51.74 139.49 21.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.061 1.134 . . . . 4.43 114.061 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.2 t -147.0 11.02 1.04 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.384 0.674 . . . . 4.95 111.902 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.04 144.83 1.03 Allowed 'General case' 0 C--N 1.342 0.277 0 O-C-N 120.455 -1.403 . . . . 4.16 110.084 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.69 -34.0 66.98 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.422 0.689 . . . . 3.28 111.782 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.8 m -43.48 -49.01 7.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.753 0.421 . . . . 2.51 110.991 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.52 -36.82 83.78 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.825 0.284 . . . . 3.55 111.059 -177.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.83 -56.59 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.636 -0.876 . . . . 3.06 108.636 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -59.85 -35.73 75.37 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.801 0.81 . . . . 3.39 110.556 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -63.19 -49.41 74.35 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.814 1.646 . . . . 1.74 111.252 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 34.5 mt -58.49 -45.3 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.716 -0.846 . . . . 2.24 108.716 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -55.32 -48.7 73.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.239 0.616 . . . . 3.33 110.194 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.8 t -51.91 -53.43 41.01 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.334 0.97 . . . . 1.74 110.889 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.34 -39.68 73.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.321 -0.862 . . . . 3.64 112.056 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.4 -60.41 2.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.576 -1.268 . . . . 3.16 107.576 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.0 p -54.93 -20.97 10.17 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.855 0.862 . . . . 3.64 112.754 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.1 mtt85 -60.73 -34.1 73.91 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.88 0.696 . . . . 6.86 112.88 171.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.1 m -57.36 150.23 18.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.604 0.762 . . . . 2.48 111.621 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -68.87 -56.0 9.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.155 0.982 . . . . 2.69 112.336 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.89 -28.18 65.32 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.972 -0.451 . . . . 1.11 111.972 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.34 122.62 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.718 -0.871 . . . . 2.77 109.426 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.7 m -104.35 -41.25 5.82 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.163 0.185 . . . . 2.7 111.225 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CZ ' ' HG2' ' A' ' 123' ' ' LYS . 30.3 p90 -138.25 122.39 18.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.017 -0.735 . . . . 4.42 109.017 172.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.73 135.28 46.4 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 107.419 -1.326 . . . . 1.98 107.419 163.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.7 t -127.8 121.94 31.44 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.205 0.457 . . . . 2.56 110.488 164.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.54 114.37 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.014 1.326 . . . . 3.39 111.111 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -106.81 88.75 2.82 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.708 1.603 . . . . 1.97 110.43 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.58 -33.19 69.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.374 1.87 . . . . 2.96 111.683 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.24 -31.51 53.62 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.379 1.072 . . . . 2.31 111.477 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.08 -0.14 12.82 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.01 1.324 . . . . 2.04 110.495 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.0 m 59.85 20.63 9.54 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.039 1.336 . . . . 2.44 113.176 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -97.61 150.63 20.94 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.484 0.714 . . . . 4.65 110.604 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.02 106.14 7.08 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.663 1.985 . . . . 1.97 108.124 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.01 108.93 20.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.469 -2.048 . . . . 2.88 105.469 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.5 p -113.95 127.0 71.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 3.37 108.412 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HG2' ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -114.87 105.6 13.19 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 123.929 0.892 . . . . 5.92 110.044 -176.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -124.01 -177.37 3.74 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.003 0.814 . . . . 2.9 111.804 -174.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -105.38 106.81 57.39 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.2 -1.407 . . . . 3.56 107.2 178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.71 66.11 8.82 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.519 2.813 . . . . 1.73 111.088 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -161.51 -48.34 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.484 1.514 . . . . 3.24 108.623 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.9 pt -86.28 -32.59 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 123.698 0.799 . . . . 2.3 111.23 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.02 163.68 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.287 0.635 . . . . 2.12 109.574 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.39 166.44 26.44 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.452 -1.059 . . . . 1.45 110.452 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.19 -37.11 19.31 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.397 2.731 . . . . 1.56 111.156 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -50.05 -39.06 40.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.237 0.615 . . . . 7.02 111.471 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.25 -38.99 71.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.506 -0.924 . . . . 4.35 108.506 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.15 -49.02 85.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.486 0.714 . . . . 2.06 109.165 172.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 77.1 mt -51.51 -53.04 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.704 -0.85 . . . . 2.75 108.704 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -48.79 75.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.364 -0.835 . . . . 4.38 111.872 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 49.9 mt -49.92 -56.08 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.894 -0.78 . . . . 3.62 108.894 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.256 2.2 pp -67.25 -30.38 49.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 113.194 0.813 . . . . 2.45 113.194 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -60.79 -37.78 83.09 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.511 1.051 . . . . 2.61 110.15 170.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -69.33 -31.39 69.82 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.758 -0.46 . . . . 3.89 109.758 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.2 mt -66.72 -45.14 88.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.898 -0.501 . . . . 2.43 109.765 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.07 31.94 3.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.667 1.603 . . . . 1.29 111.343 -175.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.87 174.46 6.19 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.927 0.864 . . . . 3.78 109.068 171.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -125.96 123.26 38.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.622 -1.622 . . . . 5.11 106.622 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -115.81 100.77 8.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.357 1.463 . . . . 1.94 108.91 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.4 p -98.42 99.25 10.42 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.012 -1.107 . . . . 4.09 108.012 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.91 98.9 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.489 1.915 . . . . 4.58 110.811 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 48.38 42.7 18.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.951 0.901 . . . . 4.72 112.23 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 116.893 -1.527 . . . . 8.44 108.716 -175.267 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 106.856 -1.535 . . . . 9.18 106.856 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.92 110.28 44.16 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.059 0.944 . . . . 4.21 108.843 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.51 134.36 11.1 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.424 2.75 . . . . 2.93 109.903 -178.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.62 135.65 51.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.032 -1.47 . . . . 4.18 107.032 -169.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HZ1' ' CD ' ' A' ' 45' ' ' GLU . 32.2 ttmt -94.93 151.67 19.0 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 119.645 1.111 . . . . 5.12 109.376 176.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.66 133.63 40.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.441 -1.254 . . . . 3.15 108.531 167.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -103.67 118.49 36.84 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.657 1.583 . . . . 4.69 109.135 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.8 pt? -141.09 179.93 6.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.567 0.747 . . . . 3.05 111.488 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.62 146.38 52.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.327 -0.99 . . . . 1.95 108.327 173.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 mm -100.95 136.19 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 107.442 -1.318 . . . . 2.12 107.442 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -108.98 125.3 51.91 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.157 -1.423 . . . . 3.78 107.157 164.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.02 -79.98 0.17 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.507 1.051 . . . . 1.05 110.957 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.9 mtt 45.26 78.73 0.06 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.22 1.808 . . . . 2.11 114.685 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -54.29 -60.78 2.88 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.75 0.648 . . . . 3.08 112.75 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -169.59 68.27 0.06 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.443 0.565 . . . . 3.34 110.321 -174.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 34.37 41.52 0.05 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.304 2.242 . . . . 6.72 115.78 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -160.14 -41.05 0.05 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.192 1.397 . . . . 3.7 111.27 -171.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.2 t -70.88 -38.53 73.06 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.673 -1.267 . . . . 2.76 111.01 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.8 t -59.4 -34.96 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.434 0.635 . . . . 2.8 109.397 167.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.27 -40.84 96.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.37 -0.831 . . . . 2.61 111.088 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -44.85 83.42 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.752 -1.218 . . . . 2.46 110.451 172.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.3 mt -47.36 -31.24 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 123.249 0.62 . . . . 2.59 111.854 175.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -46.54 -59.22 3.13 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.588 0.631 . . . . 5.25 111.539 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -71.55 -21.43 61.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.424 -0.353 . . . . 5.35 111.834 -173.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -67.59 -57.59 6.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.407 -1.331 . . . . 1.19 107.407 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.27 -41.71 99.05 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 118.39 0.541 . . . . 2.76 111.237 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.54 -17.91 9.97 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.582 -0.699 . . . . 2.29 112.59 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -123.58 27.48 7.37 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.56 0.744 . . . . 4.59 111.406 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -81.2 -61.45 1.95 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.932 0.893 . . . . 2.69 110.04 172.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.16 -138.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.138 0.575 . . . . 2.19 109.927 -172.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.22 -18.09 66.76 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 119.068 0.849 . . . . 1.52 112.541 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.38 121.02 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 O-C-N 121.842 -0.799 . . . . 2.74 110.862 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 pp -142.16 50.05 1.53 Allowed 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 121.86 0.838 . . . . 3.4 110.336 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -157.92 144.51 17.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.713 -1.588 . . . . 2.54 106.713 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.4 t -138.61 112.64 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 104.553 -2.388 . . . . 3.68 104.553 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.94 86.77 2.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 122.219 1.009 . . . . 3.82 109.128 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.18 157.1 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.07 -0.968 . . . . 3.55 109.11 171.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.38 98.42 5.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.116 -1.809 . . . . 2.27 106.116 159.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 mp -62.33 -20.82 64.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.014 0.37 . . . . 4.67 111.242 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 40.4 ttm -73.83 -37.03 64.96 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.368 1.067 . . . . 3.83 110.735 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.57 -23.2 14.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.6 0.76 . . . . 2.08 111.797 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.17 62.29 1.83 Allowed Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.475 1.036 . . . . 1.34 111.322 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -144.0 140.37 29.55 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.487 -1.301 . . . . 4.8 107.487 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.21 108.49 16.67 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.616 1.167 . . . . 2.0 110.104 165.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' CD ' ' HZ1' ' A' ' 5' ' ' LYS . 2.0 pt-20 -104.09 148.7 25.95 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.442 1.019 . . . . 4.01 109.082 158.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.5 pt -137.53 177.76 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.187 -1.412 . . . . 2.78 107.187 176.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.11 110.75 13.87 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 119.137 -0.459 . . . . 4.17 110.644 165.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -115.59 -178.43 3.38 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.232 1.813 . . . . 4.04 111.475 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -122.83 106.58 34.22 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 127.675 2.39 . . . . 4.54 110.095 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.19 10.53 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.614 2.876 . . . . 2.24 113.358 -173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.32 -19.01 18.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.494 0.718 . . . . 3.52 110.724 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.08 -66.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.115 -1.069 . . . . 3.84 108.115 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.07 142.26 13.63 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-O 120.859 0.361 . . . . 2.14 110.299 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.39 149.06 41.52 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.302 1.441 . . . . 2.86 109.939 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.97 -19.97 67.27 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.942 2.428 . . . . 1.51 112.546 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -70.59 -60.35 2.31 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.986 -0.746 . . . . 3.93 108.986 173.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -59.76 -33.57 71.85 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.1 -0.375 . . . . 3.56 111.963 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.87 -47.06 41.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 N-CA-C 107.321 -1.363 . . . . 2.29 107.321 171.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.56 -36.65 81.23 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.697 -0.683 . . . . 2.22 110.686 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -59.57 -45.39 91.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.843 0.747 . . . . 2.62 109.568 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -52.16 63.47 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.185 -0.672 . . . . 3.59 109.185 176.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mm -63.48 -42.77 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 O-C-N 122.007 -0.433 . . . . 3.28 112.123 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -44.45 95.64 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.23 1.012 . . . . 2.33 110.356 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -60.39 -53.94 51.54 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.671 0.788 . . . . 2.16 108.899 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.7 mt -50.36 -39.82 47.58 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.648 0.779 . . . . 2.73 111.775 174.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.56 37.55 1.07 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.637 -0.985 . . . . 1.16 110.637 167.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -130.92 158.79 39.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.41 -1.33 . . . . 3.47 107.41 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -99.24 119.58 38.13 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.243 -1.021 . . . . 2.29 108.243 171.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.66 119.72 36.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.417 -1.327 . . . . 2.29 107.417 168.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.46 124.94 27.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.099 -1.074 . . . . 1.84 108.099 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.465 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 21.8 t -60.78 151.69 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 124.546 1.139 . . . . 3.89 111.261 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -25.55 65.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.955 -0.566 . . . . 5.14 110.984 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 123.59 -55.91 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.579 1 C-N-CA 134.097 4.959 . . . . 4.69 103.97 175.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.62 61.73 6.67 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.865 0.691 . . . . 7.78 112.865 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -43.55 -58.06 2.82 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.773 0.657 . . . . 5.61 112.773 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 47.08 -158.39 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.776 1.631 . . . . 5.78 113.486 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 57.02 27.63 57.37 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 126.592 2.044 . . . . 3.74 112.8 167.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.7 m -82.05 -59.08 2.69 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.054 -1.091 . . . . 5.8 108.054 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -176.77 -88.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 120.475 -0.49 . . . . 4.89 110.59 -163.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.19 5.7 61.25 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 109.616 -1.393 . . . . 3.9 109.616 159.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -95.79 111.12 23.16 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 107.637 -1.246 . . . . 3.36 107.637 164.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.73 161.81 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 125.445 1.716 . . . . 3.94 107.136 173.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.84 154.42 21.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.828 1.251 . . . . 3.17 108.292 165.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -142.42 151.87 42.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.332 0.653 . . . . 4.31 110.518 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 m -99.95 132.1 45.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.831 1.652 . . . . 2.98 107.296 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.5 mt -99.1 124.69 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.965 -0.754 . . . . 3.83 108.965 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.7 m -110.56 100.98 9.69 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.247 0.619 . . . . 2.57 109.342 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.57 -34.35 2.12 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.621 1.105 . . . . 1.24 111.216 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -58.23 141.8 49.58 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.383 0.673 . . . . 3.11 111.811 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 51.8 m -153.57 84.46 1.18 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.858 1.663 . . . . 4.57 106.558 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 63.3 m 51.09 -110.51 0.48 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.017 1.327 . . . . 7.13 111.602 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 48.72 -144.11 0.44 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.164 1.385 . . . . 6.38 110.3 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.5 t -89.15 9.4 25.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 118.849 -0.596 . . . . 4.63 109.97 164.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.54 -56.93 6.66 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 119.506 1.048 . . . . 3.46 110.082 -166.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.5 t -49.6 -46.41 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.321 1.049 . . . . 2.13 109.92 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -63.82 -36.28 83.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.125 -0.489 . . . . 4.68 109.927 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -63.45 -52.79 59.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.556 0.742 . . . . 2.47 109.691 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mt -53.92 -53.99 23.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 109.496 -0.557 . . . . 2.07 109.496 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -56.95 -45.69 82.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.907 -0.568 . . . . 2.16 109.758 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.3 t -54.29 -54.07 45.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.822 0.737 . . . . 1.96 110.857 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -34.54 72.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 121.169 -0.957 . . . . 3.15 111.147 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -71.07 -60.63 2.12 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.429 -0.952 . . . . 2.78 108.429 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.1 p -56.34 -18.78 11.86 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.06 0.763 . . . . 2.98 113.06 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -61.48 -33.23 73.42 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.767 0.712 . . . . 6.37 112.466 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.7 m -62.35 152.4 34.05 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.077 0.951 . . . . 2.7 111.387 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -70.64 -52.96 17.8 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.317 1.047 . . . . 2.3 111.502 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.49 -43.04 20.72 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.572 -0.611 . . . . 1.22 111.572 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.66 134.64 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.855 -0.794 . . . . 2.98 108.855 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.8 t -128.0 -35.95 2.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.756 0.823 . . . . 3.66 110.845 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -110.11 92.0 3.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.951 -1.5 . . . . 4.46 106.951 -173.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.49 135.11 47.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.165 -1.791 . . . . 1.7 106.165 160.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 t -140.23 108.75 5.87 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.477 -1.305 . . . . 2.47 107.477 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.5 t -101.63 107.55 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.521 1.128 . . . . 3.29 109.341 -173.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.97 80.12 2.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.561 1.144 . . . . 2.11 109.818 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 pp -53.56 -26.63 22.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.012 0.925 . . . . 3.14 113.042 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.48 -35.23 65.3 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.342 0.657 . . . . 2.49 111.248 176.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -7.61 18.79 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.264 1.425 . . . . 2.38 110.78 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.4 m 73.51 3.9 4.66 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.003 1.721 . . . . 2.41 112.406 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -98.09 165.33 11.95 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.132 0.973 . . . . 4.05 112.0 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -137.51 136.12 37.38 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.66 1.184 . . . . 1.9 108.651 168.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.96 132.18 43.76 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.959 -1.867 . . . . 3.55 105.959 171.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.0 t -125.44 142.01 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 105.345 -2.094 . . . . 2.8 105.345 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -125.06 99.52 6.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.458 1.103 . . . . 4.36 109.255 169.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -109.68 -178.78 3.63 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.645 1.578 . . . . 3.03 109.106 173.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -114.41 113.12 45.81 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.201 1.4 . . . . 4.16 107.651 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.01 58.72 6.8 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.754 2.303 . . . . 2.2 112.479 -164.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -145.77 -49.89 0.23 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.894 1.677 . . . . 4.74 108.242 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -80.34 -32.03 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 122.34 -0.225 . . . . 2.64 111.205 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.41 162.94 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.942 -1.132 . . . . 2.17 107.942 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.23 163.91 27.71 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.628 -1.389 . . . . 1.49 109.628 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.72 -41.26 39.85 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.101 2.534 . . . . 1.52 110.396 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -40.05 25.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.184 0.809 . . . . 7.09 113.184 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.38 -47.96 79.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.18 -0.674 . . . . 2.71 109.18 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.31 -46.76 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.493 -0.928 . . . . 1.81 108.493 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.2 mt -53.66 -54.24 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 109.121 -0.696 . . . . 2.63 109.121 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -54.65 -47.24 73.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.935 0.789 . . . . 4.53 111.702 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.2 mm -54.17 -56.47 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.863 -0.421 . . . . 3.04 109.863 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 pp -66.57 -30.96 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 120.973 -1.08 . . . . 2.46 113.119 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.31 -38.38 73.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.312 0.645 . . . . 3.39 109.917 170.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -65.99 -36.49 83.45 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.485 -0.561 . . . . 3.01 109.485 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.7 mt -68.38 -40.84 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.395 -0.594 . . . . 2.21 109.395 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.13 33.18 3.52 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.518 1.532 . . . . 1.17 111.007 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -101.35 176.67 5.16 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.279 1.039 . . . . 4.5 108.364 166.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -134.92 125.67 27.15 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.413 -1.328 . . . . 6.07 107.413 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.22 106.15 14.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.983 1.313 . . . . 1.86 109.74 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.57 94.75 6.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.848 1.659 . . . . 2.99 108.572 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.79 103.76 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.663 1.585 . . . . 4.88 110.501 172.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 46.75 43.76 13.33 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.744 0.818 . . . . 5.02 112.397 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.158 -0.925 . . . . 10.4 108.531 177.612 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.291 -1.374 . . . . 10.56 107.291 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.58 97.91 7.3 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 119.319 0.963 . . . . 5.83 108.698 -172.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.33 130.24 11.8 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.266 1.977 . . . . 3.79 109.107 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.49 131.84 53.87 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.853 0.835 . . . . 3.85 109.163 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.7 151.35 19.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.86 -1.904 . . . . 4.97 105.86 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.8 t -123.25 141.41 52.01 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 117.837 -1.078 . . . . 2.93 108.333 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -123.85 100.53 6.8 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.752 -0.833 . . . . 4.76 108.752 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.04 168.02 13.93 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.38 1.086 . . . . 3.98 110.736 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.68 146.16 43.9 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.65 -1.611 . . . . 2.24 106.65 169.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.5 mm -102.37 130.54 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.614 -1.254 . . . . 2.18 107.614 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -118.78 117.87 30.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.494 -1.669 . . . . 4.0 106.494 167.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.78 -99.91 0.18 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.127 -1.589 . . . . 1.14 109.127 -174.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 58.5 76.25 0.35 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.172 1.789 . . . . 2.51 113.288 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -48.96 -58.73 4.41 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.893 0.877 . . . . 3.19 112.698 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.56 52.63 0.05 OUTLIER 'General case' 0 C--N 1.346 0.449 0 C-N-CA 119.211 -0.995 . . . . 5.29 111.37 -175.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.46 41.12 20.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.97 0.908 . . . . 5.4 112.399 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -151.82 -43.19 0.11 Allowed 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.494 1.118 . . . . 3.07 110.881 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.36 -46.99 83.96 Favored 'General case' 0 C--O 1.226 -0.167 0 O-C-N 121.052 -1.03 . . . . 3.16 109.132 -176.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.18 -36.98 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.967 0.889 . . . . 3.4 109.996 174.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -65.8 -31.19 72.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.921 -0.581 . . . . 2.08 112.336 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -38.19 71.82 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.93 -1.106 . . . . 3.09 110.171 172.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.0 mt -59.85 -39.96 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.264 1.026 . . . . 2.87 110.256 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.9 -58.26 2.47 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.791 0.836 . . . . 5.73 112.08 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.53 -39.99 88.9 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.924 0.392 . . . . 5.88 110.144 -172.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -54.45 -56.66 16.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.519 -0.764 . . . . 1.47 109.266 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mt -65.67 -36.25 83.12 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 113.313 0.857 . . . . 3.7 113.313 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -21.9 3.65 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 118.283 0.492 . . . . 2.81 112.165 168.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -123.75 30.88 6.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.152 0.581 . . . . 4.35 112.42 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.32 -80.08 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.582 0.628 . . . . 3.54 109.371 167.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.29 -114.28 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.516 0.726 . . . . 2.31 110.469 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.5 -9.58 69.13 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 119.248 0.931 . . . . 1.35 112.984 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.8 t -59.22 119.75 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 118.366 1.083 . . . . 3.5 109.092 167.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.45 49.6 1.71 Allowed 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.496 0.665 . . . . 3.35 110.448 162.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 t -159.66 151.13 19.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.566 -1.272 . . . . 2.46 107.566 161.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.01 120.11 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.399 -2.074 . . . . 3.65 105.399 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 tt -138.75 89.72 2.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.936 -1.876 . . . . 3.52 105.936 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.7 p -106.29 135.63 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.3 -1.0 . . . . 3.53 108.3 172.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -104.76 102.69 12.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.247 -1.76 . . . . 2.27 106.247 164.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tp -57.57 -33.7 68.44 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.054 1.342 . . . . 3.88 109.182 169.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 62.8 mtt -59.29 -47.67 84.49 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.537 0.735 . . . . 5.0 110.901 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.3 -25.86 16.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.915 0.886 . . . . 2.21 111.446 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.4 55.71 2.82 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.615 1.102 . . . . 1.09 110.833 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 128.74 27.86 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.04 -1.096 . . . . 3.7 108.04 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.07 117.32 30.24 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 124.518 1.136 . . . . 2.06 111.071 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -113.63 142.47 45.96 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.609 0.719 . . . . 3.98 110.641 162.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.5 mt -121.25 168.16 13.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 125.595 1.558 . . . . 4.64 106.893 171.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -133.84 105.54 6.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.098 0.559 . . . . 4.6 109.568 170.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -102.69 -176.22 3.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.8 2.04 . . . . 4.22 111.792 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -109.35 129.93 23.34 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.252 1.421 . . . . 4.17 107.7 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.57 41.49 1.15 Allowed 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.46 2.774 . . . . 4.37 112.334 -166.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -163.41 24.42 0.08 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.041 0.936 . . . . 3.49 110.392 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.13 -50.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 107.027 -1.471 . . . . 4.1 107.027 -174.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.35 153.01 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.837 -0.801 . . . . 4.12 108.837 176.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -125.77 158.49 65.12 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 106.373 -1.714 . . . . 3.69 106.373 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.44 -27.9 54.39 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.528 1.485 . . . . 1.7 110.438 -165.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -56.74 -42.17 78.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.123 0.969 . . . . 4.65 111.239 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.6 -52.52 57.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.976 0.807 . . . . 2.85 109.856 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -47.7 -54.16 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.071 -1.085 . . . . 2.81 108.071 168.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.35 -35.05 74.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.158 -0.474 . . . . 3.2 111.308 -172.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -58.2 -47.39 83.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.506 1.122 . . . . 3.42 109.269 -178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -54.11 -53.14 57.34 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.747 -0.464 . . . . 3.84 109.747 174.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.0 mm -59.07 -48.16 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.04 0.448 . . . . 3.64 110.631 -174.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.3 -45.79 90.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.381 0.673 . . . . 2.71 111.164 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.36 -49.81 76.1 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.504 0.593 . . . . 2.56 110.192 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mt -57.97 -28.03 64.0 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.688 0.795 . . . . 3.14 111.793 174.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.43 36.15 3.91 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.11 -1.196 . . . . 1.85 110.11 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -120.13 162.07 19.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.187 1.795 . . . . 3.12 106.445 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -104.1 124.43 49.06 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.598 -0.89 . . . . 2.74 108.598 168.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.35 121.96 45.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.506 -1.294 . . . . 2.68 107.506 162.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.52 156.54 48.72 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.767 -1.198 . . . . 2.41 107.767 169.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.28 153.96 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.841 -1.072 . . . . 4.55 110.004 -164.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.8 mtp -83.18 38.81 0.62 Allowed 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.719 0.808 . . . . 5.16 111.578 172.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 66.55 -49.09 0.45 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.37 2.668 . . . . 4.97 112.776 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -29.95 -40.06 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.97 2.508 . . . . 8.12 114.572 164.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.44 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER 82.86 -64.17 0.11 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.304 1.441 . . . . 8.13 111.896 173.365 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 75' ' ' TYR . . . 124.4 -89.14 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.328 2.251 . . . . 3.93 114.249 175.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 166.31 -130.38 2.13 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.751 -0.94 . . . . 7.22 110.751 -148.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.51 -29.58 0.18 Allowed 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.039 -1.271 . . . . 9.03 114.113 -175.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -150.5 53.98 0.9 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.3 1.44 . . . . 10.83 108.248 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 47.28 47.96 21.19 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 125.927 1.727 . . . . 3.72 109.455 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.57 71.79 1.53 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.507 1.523 . . . . 3.5 108.044 -165.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.8 148.3 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.855 -1.535 . . . . 4.46 106.855 -173.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -117.76 145.57 44.4 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 123.46 0.704 . . . . 3.79 109.152 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.94 157.45 43.64 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.128 0.971 . . . . 3.81 109.899 -175.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.46 133.58 41.85 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 106.778 -1.564 . . . . 3.35 106.778 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.08 110.76 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.522 -0.918 . . . . 3.04 108.522 173.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.0 m -98.93 137.81 36.95 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.946 -1.131 . . . . 2.88 107.946 172.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.3 -28.19 14.48 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.487 1.042 . . . . 1.58 112.806 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -75.0 122.91 24.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 117.914 0.857 . . . . 3.84 110.537 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 m -138.88 44.31 2.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.162 0.985 . . . . 3.64 109.748 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 11.0 t -165.73 140.8 4.86 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.268 -0.895 . . . . 5.01 112.167 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.66 75.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.027 0.531 . . . . 3.69 111.361 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.4 m -53.55 -45.69 69.95 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.439 -0.788 . . . . 2.99 110.036 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.0 m -64.85 -44.97 88.02 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.188 -0.91 . . . . 3.49 109.493 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 37.2 t -46.32 -60.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 118.772 0.714 . . . . 3.1 110.749 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -56.7 -45.14 81.99 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.686 0.755 . . . . 4.71 110.357 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.72 -50.76 72.57 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.808 0.843 . . . . 2.24 111.166 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.2 mt -54.6 -50.53 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.041 -1.096 . . . . 2.18 108.041 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.77 -44.32 86.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.697 0.799 . . . . 2.66 110.299 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.8 t -56.07 -55.76 28.98 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.829 -0.434 . . . . 2.46 109.829 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -43.15 77.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.274 0.63 . . . . 4.43 112.572 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.39 -58.91 5.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.756 -0.831 . . . . 3.11 108.756 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.8 m -53.09 -23.65 8.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.673 1.189 . . . . 3.06 111.432 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -4.45 8.88 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.028 1.121 . . . . 6.49 114.028 174.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.3 m -84.74 149.73 25.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.055 1.742 . . . . 2.69 109.646 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -67.0 -53.56 30.15 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.89 0.876 . . . . 3.17 112.004 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.94 -21.03 69.12 Favored Glycine 0 CA--C 1.528 0.871 0 O-C-N 122.157 -0.34 . . . . 1.77 113.202 -170.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.75 129.54 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 121.138 -1.213 . . . . 2.87 109.154 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.9 m -103.98 -51.65 3.11 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 119.403 -0.332 . . . . 3.06 111.867 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 123' ' ' LYS . 43.6 p90 -140.0 114.98 9.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.373 0.533 . . . . 3.25 110.014 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.49 149.69 23.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.988 -0.745 . . . . 1.89 108.988 165.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.9 m -139.34 115.61 10.44 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.347 -1.353 . . . . 2.7 107.347 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.16 119.78 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 118.227 0.467 . . . . 3.58 110.358 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -118.78 87.98 2.84 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.817 0.818 . . . . 3.13 109.612 -168.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.65 -32.1 28.12 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 125.724 1.61 . . . . 3.87 112.025 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.62 -36.28 69.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.525 0.73 . . . . 4.07 111.158 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.99 -20.08 15.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.96 1.304 . . . . 3.62 110.439 177.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 78.79 7.05 2.23 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.656 1.583 . . . . 3.08 111.407 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -96.37 148.86 22.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.66 1.584 . . . . 4.79 110.057 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.41 119.29 25.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.281 2.232 . . . . 2.4 107.605 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.88 122.85 40.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.701 -1.962 . . . . 3.94 105.701 174.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.35 133.95 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.4 -0.963 . . . . 3.95 108.4 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.408 ' HG3' ' CE2' ' A' ' 110' ' ' TYR . 4.8 mmmt -116.12 110.4 18.8 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.363 1.065 . . . . 3.58 109.272 177.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.25 176.71 7.2 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 118.498 0.59 . . . . 3.64 111.933 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -96.73 109.05 46.61 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 107.008 -1.479 . . . . 3.96 107.008 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.36 64.36 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.534 2.823 . . . . 3.8 111.07 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.21 -44.88 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.426 1.49 . . . . 4.71 109.321 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -90.88 -29.81 4.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 118.003 0.365 . . . . 3.8 111.254 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.76 164.81 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.225 1.01 . . . . 3.2 108.53 -175.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -149.68 167.05 29.81 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.011 -0.835 . . . . 3.28 111.011 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -60.82 -34.38 91.54 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.243 3.295 . . . . 3.14 111.953 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -54.17 -37.62 64.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.557 0.743 . . . . 8.52 112.062 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.58 -43.46 84.87 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.05 0.452 . . . . 4.33 109.834 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 14.1 mm -56.07 -48.7 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.712 0.805 . . . . 4.22 109.189 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.9 mt -53.46 -57.89 4.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 123.513 0.725 . . . . 4.13 109.382 172.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.0 tttp -49.36 -48.39 46.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 119.264 0.938 . . . . 5.13 112.74 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.6 mt -51.46 -52.71 19.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.055 -0.721 . . . . 5.52 109.055 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.309 2.2 pp -70.62 -29.15 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 118.892 -1.123 . . . . 2.43 114.021 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -58.11 -45.05 87.93 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.356 0.98 . . . . 3.23 109.019 170.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.88 -37.12 85.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.041 0.536 . . . . 3.7 109.558 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.8 mt -66.37 -41.67 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.99 -0.444 . . . . 2.52 110.483 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.68 30.75 6.34 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.337 1.446 . . . . 1.49 111.8 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -101.16 -179.78 4.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.549 1.175 . . . . 3.16 108.771 163.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -133.79 121.13 21.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.938 -1.504 . . . . 5.84 106.938 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.78 115.38 30.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.177 1.391 . . . . 2.49 108.249 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.8 t -135.28 128.32 31.61 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 117.78 -1.105 . . . . 3.9 108.606 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 pp -25.42 109.74 0.03 OUTLIER 'General case' 0 C--N 1.341 0.214 0 C-N-CA 127.626 2.37 . . . . 7.04 109.705 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.85 -37.62 55.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.745 -0.662 . . . . 6.29 110.782 -173.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 C--O 1.245 0.824 0 CA-C-O 116.149 -1.881 . . . . 9.63 111.079 -179.877 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mmt . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 105.473 -2.047 . . . . 9.7 105.473 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.93 108.66 1.98 Allowed Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 125.084 1.354 . . . . 5.01 109.867 -167.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -80.18 111.58 2.68 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 121.355 1.37 . . . . 3.75 111.713 -166.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -132.63 128.06 36.28 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 124.384 1.074 . . . . 3.19 110.256 -172.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.408 ' NZ ' ' O ' ' A' ' 149' ' ' GLN . 2.7 ttpt -93.16 136.45 33.4 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.289 -1.004 . . . . 7.32 108.289 -175.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.3 t -125.07 130.25 51.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.029 -1.441 . . . . 3.3 110.534 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -102.3 96.28 6.85 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 126.615 1.966 . . . . 6.39 111.125 -171.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.468 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.3 pt? -128.46 174.49 9.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.307 1.051 . . . . 3.59 112.839 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.09 155.7 42.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.977 -1.49 . . . . 2.02 106.977 169.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.4 mm -98.72 145.16 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.418 -1.327 . . . . 1.69 107.418 171.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -118.86 128.07 54.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.645 -1.613 . . . . 3.92 106.645 162.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.86 -54.12 0.48 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.933 0.777 . . . . 1.32 112.037 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.0 mtt 11.85 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.946 2.498 . . . . 2.83 115.595 -172.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.3 p -62.36 -61.2 2.62 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.697 -0.627 . . . . 4.95 111.104 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.8 t -162.87 48.18 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.984 0.421 . . . . 3.99 110.205 -173.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 55.52 22.18 4.94 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.275 1.03 . . . . 7.69 113.553 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 m -130.71 -38.96 1.27 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.931 0.892 . . . . 4.12 111.732 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 m -64.41 -48.4 75.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 O-C-N 121.427 -0.796 . . . . 3.88 109.228 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 81.8 t -55.39 -39.92 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.006 -0.739 . . . . 2.88 109.006 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 t -58.99 -42.06 89.15 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.971 -0.559 . . . . 3.56 110.856 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -43.33 69.04 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.251 -1.53 . . . . 3.34 111.242 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.3 mt -52.7 -49.61 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.768 1.227 . . . . 2.74 109.375 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -55.23 -38.22 68.19 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.241 -0.912 . . . . 4.21 111.946 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -68.07 -31.84 71.76 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.1 -1.0 . . . . 9.89 110.366 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -65.82 -49.45 68.18 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.69 -0.856 . . . . 1.69 108.69 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -57.04 -37.54 71.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 112.695 0.628 . . . . 2.66 112.695 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -54.78 -18.58 4.93 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.219 -0.926 . . . . 2.81 112.819 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -116.99 23.86 11.6 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.643 0.777 . . . . 3.79 112.271 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -71.98 -69.17 0.41 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.945 0.793 . . . . 2.79 109.632 167.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.2 -118.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.162 0.985 . . . . 2.05 109.568 -171.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.19 -23.76 68.3 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.829 -0.544 . . . . 1.72 113.106 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.2 p -60.1 111.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.914 0.886 . . . . 2.74 111.556 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.17 52.32 1.37 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.068 -1.086 . . . . 3.62 108.068 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.3 t -162.9 152.88 15.97 Favored 'General case' 0 CA--C 1.521 -0.154 0 O-C-N 119.866 -1.772 . . . . 2.2 108.498 156.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.14 74.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 125.365 1.466 . . . . 3.63 108.981 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.88 68.79 1.02 Allowed 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.473 -0.767 . . . . 6.76 109.18 -177.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.99 157.42 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.561 -0.903 . . . . 4.3 108.561 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.71 103.04 8.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.06 -1.459 . . . . 2.48 107.06 170.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.4 mt -67.31 -15.69 63.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.895 0.878 . . . . 4.57 110.962 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 17.2 ttt -76.25 -47.86 22.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.584 1.154 . . . . 5.49 109.885 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.72 -35.83 12.61 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.595 1.158 . . . . 2.34 111.271 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.73 74.85 1.29 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 124.612 1.101 . . . . 1.53 110.627 -174.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -140.58 141.03 35.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.986 -2.227 . . . . 3.97 104.986 165.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.87 101.63 9.22 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 124.036 0.835 . . . . 1.89 108.82 163.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -96.75 133.87 40.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.2 -1.407 . . . . 4.09 107.2 165.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.67 160.33 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.993 -1.854 . . . . 4.21 105.993 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -121.11 105.58 10.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 123.264 0.353 . . . . 5.67 110.587 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -104.13 -177.09 3.27 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 126.81 2.044 . . . . 4.11 112.757 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -122.15 109.12 33.66 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.809 2.044 . . . . 4.72 109.12 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.71 -11.29 23.11 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.756 2.304 . . . . 2.73 114.722 -175.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -95.21 -4.5 45.78 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.885 0.766 . . . . 6.08 110.938 -170.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.5 p -134.29 -37.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.585 1.154 . . . . 4.6 111.184 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.53 153.02 20.71 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 N-CA-C 109.024 -0.732 . . . . 2.54 109.024 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -138.02 152.81 72.73 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.639 1.176 . . . . 3.43 109.86 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.57 -37.14 39.09 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.711 2.274 . . . . 2.11 111.757 -170.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.1 -40.95 95.67 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.8 -0.563 . . . . 4.55 112.085 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -61.88 -44.58 96.51 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.264 0.625 . . . . 3.74 109.984 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -52.3 -54.97 12.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 N-CA-C 106.986 -1.487 . . . . 2.71 106.986 170.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.01 -45.95 71.65 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.948 -0.569 . . . . 2.86 110.255 -172.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -51.06 -51.15 56.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.966 0.906 . . . . 4.94 110.022 175.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -45.16 75.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.318 0.58 . . . . 4.04 110.183 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.82 -37.7 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 O-C-N 121.939 -0.476 . . . . 3.36 110.515 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -66.28 -41.07 90.36 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.382 -0.599 . . . . 3.35 109.382 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.4 -50.8 72.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.866 0.466 . . . . 3.23 109.998 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.0 mt -57.67 -32.46 67.35 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 111.889 0.329 . . . . 2.78 111.889 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.85 35.11 1.9 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.458 1.028 . . . . 1.78 111.445 166.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -132.18 164.05 27.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.054 1.342 . . . . 3.42 109.149 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -102.72 124.83 48.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.867 -1.16 . . . . 2.44 107.867 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.97 122.3 44.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.829 -1.175 . . . . 1.92 107.829 166.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.98 118.59 24.79 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.555 -0.906 . . . . 2.22 108.555 174.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.468 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 7.1 p -69.07 160.3 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 125.169 1.388 . . . . 4.16 110.247 171.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -51.76 68.46 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.3 0.572 . . . . 7.02 110.15 168.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.45 106.06 0.23 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 100.886 -3.746 . . . . 7.35 100.886 -173.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' CB ' HG13 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -67.94 126.43 29.43 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 119.64 1.109 . . . . 11.36 108.389 -166.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . 0.259 2.9 p90 -143.43 -72.58 0.29 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 112.682 -2.054 . . . . 5.94 112.868 -176.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 101.72 125.67 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 127.893 2.477 . . . . 5.74 108.786 -172.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -130.33 109.83 0.96 Allowed Glycine 0 C--N 1.334 0.421 0 CA-C-O 118.19 -1.339 . . . . 3.02 110.834 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.2 t -173.77 -56.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.4 1.1 . . . . 5.23 111.055 170.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -155.24 141.64 18.65 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 127.147 2.179 . . . . 5.15 105.16 -175.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.44 -30.65 1.43 Allowed Glycine 0 CA--C 1.531 1.054 0 O-C-N 120.268 -1.52 . . . . 2.4 112.264 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.65 118.14 10.32 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 104.907 -2.257 . . . . 2.77 104.907 174.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.3 mm -131.6 165.82 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.657 0.783 . . . . 3.59 109.062 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -131.1 149.03 52.78 Favored 'General case' 0 N--CA 1.438 -1.056 0 O-C-N 124.51 1.131 . . . . 4.68 111.551 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.51 151.04 38.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.344 1.027 . . . . 3.64 109.221 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.99 132.87 43.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.27 -2.122 . . . . 2.29 105.27 174.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.5 pt -98.62 139.46 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.191 -1.04 . . . . 3.11 108.191 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.4 m -136.64 140.66 42.93 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.219 -1.4 . . . . 2.7 107.219 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.51 -20.62 15.49 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.5 1.048 . . . . 1.18 112.669 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.42 148.78 26.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.494 1.147 . . . . 3.77 112.073 176.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.6 t -134.89 -9.97 2.34 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.586 1.154 . . . . 4.53 112.521 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 35.4 t -160.03 158.35 30.34 Favored 'General case' 0 C--N 1.341 0.237 0 O-C-N 120.952 -1.092 . . . . 3.42 108.598 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.33 -37.26 35.88 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.375 1.07 . . . . 3.34 112.028 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -45.53 -42.13 10.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.732 0.813 . . . . 2.49 111.721 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 81.5 m -62.51 -53.18 58.57 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 109.134 -0.691 . . . . 2.41 109.134 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -45.33 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.648 -0.657 . . . . 3.23 111.65 176.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -62.43 -35.31 78.85 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.696 -0.483 . . . . 4.12 109.696 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -61.63 -60.84 3.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.535 1.134 . . . . 2.7 109.035 176.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -44.4 -57.12 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 123.733 0.813 . . . . 3.1 110.073 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.57 -45.02 93.09 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 120.173 -0.611 . . . . 2.59 109.794 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.9 t -53.74 -57.57 10.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.48 0.712 . . . . 2.32 110.519 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -55.15 -38.06 67.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.446 0.906 . . . . 7.62 113.446 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.1 mt -71.05 -56.7 5.6 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.681 -1.97 . . . . 3.27 105.681 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 53.7 m -50.08 -21.51 1.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.86 2.064 . . . . 2.68 112.499 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -68.22 -24.61 64.95 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.578 0.751 . . . . 6.05 112.97 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.4 m -62.42 170.18 2.53 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.141 0.576 . . . . 2.9 110.707 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -82.59 -49.91 9.34 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.137 -0.977 . . . . 3.3 110.302 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.46 -30.98 66.07 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.444 1.021 . . . . 1.44 112.425 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -49.77 105.35 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.313 0.645 . . . . 3.92 110.843 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 59.8 m -104.39 -31.31 9.58 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.729 0.412 . . . . 2.91 110.522 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.26 114.07 8.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.345 -1.724 . . . . 4.52 106.345 -175.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -117.85 157.33 26.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.076 -1.453 . . . . 2.08 107.076 155.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.0 t -141.98 136.48 30.37 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.904 -1.517 . . . . 2.69 106.904 166.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.2 133.83 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 123.841 0.857 . . . . 3.33 110.052 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -132.34 116.06 16.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.681 1.192 . . . . 2.01 110.256 -170.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.4 mt -75.43 -46.82 30.4 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 127.251 2.22 . . . . 4.02 110.859 -172.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.59 -35.44 4.01 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.581 1.552 . . . . 2.55 111.705 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.92 -4.37 13.28 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.548 1.939 . . . . 2.37 111.281 -177.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 63.6 m 52.73 31.85 11.09 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.054 1.342 . . . . 2.55 112.508 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -108.2 151.0 26.52 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.484 0.713 . . . . 5.7 110.509 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.86 116.84 10.47 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.269 1.028 . . . . 1.74 108.599 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mp -102.03 128.79 48.33 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 126.607 1.963 . . . . 3.76 106.451 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.82 131.75 50.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.309 -0.626 . . . . 3.87 109.309 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -113.33 83.94 1.92 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.717 0.807 . . . . 4.93 110.651 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -113.97 171.94 7.29 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.65 1.58 . . . . 3.01 109.317 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -96.33 117.75 65.93 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 108.93 -0.767 . . . . 3.13 108.93 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.7 70.85 6.77 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.287 2.658 . . . . 2.04 111.013 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -164.29 -44.95 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.082 1.353 . . . . 4.11 109.709 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 25.7 pt -76.83 -38.73 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 123.377 0.671 . . . . 3.04 110.364 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.18 156.09 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.998 1.319 . . . . 3.26 108.127 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -121.82 158.66 16.52 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.048 -1.221 . . . . 2.49 110.048 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -62.52 -43.39 22.21 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.801 2.334 . . . . 2.16 110.056 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -54.21 -37.68 64.83 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 122.759 0.424 . . . . 6.11 111.907 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.79 -44.19 70.6 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.752 -1.203 . . . . 4.84 107.752 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.51 -48.99 86.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 108.604 -0.887 . . . . 2.55 108.604 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 64.2 mt -50.26 -58.75 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 124.237 1.015 . . . . 2.9 108.958 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -53.09 -45.76 68.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.032 -1.043 . . . . 6.11 112.488 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.2 mm -56.29 -46.08 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 109.965 -0.383 . . . . 4.04 109.965 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 27.4 pt -72.35 -34.77 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 121.112 -0.993 . . . . 2.43 113.109 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -56.05 -36.86 68.51 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.171 0.896 . . . . 2.64 109.279 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.25 -25.52 68.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.061 -0.518 . . . . 3.63 110.057 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.3 mt -86.89 -39.26 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.155 0.582 . . . . 2.46 109.708 172.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.33 27.42 5.3 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.129 1.347 . . . . 1.93 111.342 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -99.28 170.35 8.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.299 1.049 . . . . 3.13 108.954 165.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -135.53 144.87 46.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.835 -1.172 . . . . 6.74 107.835 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.4 103.08 7.99 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.136 1.775 . . . . 2.11 109.31 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.45 112.66 19.25 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.656 0.782 . . . . 3.12 109.932 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -17.71 106.68 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.983 2.513 . . . . 5.08 113.191 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.52 -40.22 23.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.94 -0.573 . . . . 4.33 110.403 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.408 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 14.9 mt-30 . . . . . 0 C--O 1.256 1.441 0 CA-C-O 115.403 -2.236 . . . . 6.92 116.994 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 106.48 -1.674 . . . . 8.78 106.48 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.34 119.34 6.51 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.502 -2.036 . . . . 4.14 105.502 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -91.1 147.2 3.66 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.42 2.747 . . . . 3.28 110.443 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -127.89 154.46 45.48 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 107.487 -1.301 . . . . 3.95 107.487 -176.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -92.37 159.17 15.7 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.506 1.522 . . . . 6.16 107.348 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 30.8 p -152.14 145.97 25.13 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 118.426 0.557 . . . . 4.05 111.3 166.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.96 102.49 11.49 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.273 1.029 . . . . 5.6 109.001 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.58 168.83 8.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.069 0.938 . . . . 3.75 111.113 172.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.12 156.31 33.9 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.549 -1.278 . . . . 1.98 107.549 167.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.3 mm -99.13 141.06 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 107.608 -1.256 . . . . 2.29 107.608 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -119.55 121.78 40.14 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.236 -1.765 . . . . 3.62 106.236 160.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.57 -83.68 0.15 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.644 1.116 . . . . 1.32 110.396 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.5 mmt 54.07 71.58 0.51 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.708 1.603 . . . . 2.62 113.6 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -55.26 -61.95 1.99 Allowed 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.616 -0.677 . . . . 2.81 112.374 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.0 t -168.59 64.57 0.06 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.757 0.708 . . . . 3.55 110.034 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 38.86 44.65 0.86 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.452 1.501 . . . . 6.59 112.912 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.5 t -160.81 -41.8 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.054 0.542 . . . . 3.46 110.528 -166.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -61.78 -40.3 94.71 Favored 'General case' 0 CA--C 1.527 0.08 0 O-C-N 120.889 -1.132 . . . . 2.9 109.833 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.44 -32.48 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 121.871 -0.518 . . . . 2.52 110.456 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 m -66.85 -37.56 84.7 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.102 -0.639 . . . . 2.71 111.428 176.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.262 0.3 OUTLIER -71.9 -35.14 69.64 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.556 -1.34 . . . . 3.63 112.146 171.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 mt -48.15 -51.41 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.712 -0.617 . . . . 3.2 110.965 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -34.37 -55.13 0.53 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.083 0.953 . . . . 4.35 110.907 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -68.8 -30.46 69.04 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.0 1.32 . . . . 9.26 110.285 -170.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -65.48 -57.94 7.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.513 -0.921 . . . . 2.12 108.513 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.83 -38.8 79.48 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.568 -0.16 . . . . 2.75 110.568 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -49.57 -26.64 3.68 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.949 0.9 . . . . 2.65 112.53 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -123.29 22.55 9.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.176 -0.916 . . . . 5.21 112.858 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -61.93 -68.88 0.28 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.433 1.015 . . . . 3.24 110.756 165.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.8 -130.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.938 0.495 . . . . 2.0 109.828 -163.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.07 -13.26 72.68 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 118.791 0.723 . . . . 1.41 112.959 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.95 127.16 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 118.417 1.108 . . . . 2.21 110.635 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 pp -142.69 51.81 1.43 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.41 0.624 . . . . 3.53 111.032 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 t -156.66 151.61 26.09 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.015 -0.735 . . . . 2.41 109.015 164.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.83 69.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.553 1.541 . . . . 3.71 108.583 -171.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tt -98.05 74.17 2.26 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.14 -1.059 . . . . 3.36 108.14 -173.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.7 t -104.81 136.95 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.849 -0.614 . . . . 3.24 109.435 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -113.74 98.84 7.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.56 -0.904 . . . . 2.46 108.56 173.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.5 -17.49 45.65 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.585 0.754 . . . . 4.08 112.607 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 6.1 mtm -70.05 -55.95 8.2 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.137 0.494 . . . . 5.2 109.781 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.89 -24.88 22.39 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.398 0.679 . . . . 1.95 111.429 -175.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.93 68.32 1.54 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.185 -1.166 . . . . 1.22 110.185 -174.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.24 139.46 41.02 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.574 -2.009 . . . . 3.69 105.574 171.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.91 101.48 9.53 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 124.641 1.213 . . . . 1.76 111.878 169.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -97.97 136.0 38.87 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.799 -1.185 . . . . 5.14 107.799 169.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 pt -141.51 168.57 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.88 -0.785 . . . . 2.61 108.88 171.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -120.6 97.96 5.81 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 119.072 -0.489 . . . . 4.35 110.151 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -102.27 178.97 4.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 124.611 1.194 . . . . 3.32 112.156 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -123.38 104.53 34.42 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 127.96 2.504 . . . . 4.35 110.056 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.66 26.95 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 124.336 3.357 . . . . 2.09 112.717 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -106.1 -20.83 13.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.959 1.303 . . . . 3.19 110.76 165.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 87.9 t -117.6 -72.06 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 N-CA-C 108.246 -1.02 . . . . 3.79 108.246 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.12 140.62 15.5 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.079 0 N-CA-C 108.853 -0.795 . . . . 2.13 108.853 176.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -121.38 153.05 58.61 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.358 1.063 . . . . 2.77 108.421 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.46 -39.57 87.95 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.897 2.398 . . . . 1.28 112.739 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.23 -42.55 98.8 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.491 -0.755 . . . . 3.74 111.477 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -62.07 -39.99 94.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.027 0.531 . . . . 3.7 110.544 175.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.44 -51.04 45.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.359 -1.349 . . . . 2.09 107.359 171.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.37 -39.68 70.4 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 119.238 -0.411 . . . . 2.09 111.152 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -57.64 -47.82 81.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.101 0.864 . . . . 2.49 110.394 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -46.15 82.66 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.053 0.454 . . . . 4.11 110.44 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -67.9 -45.39 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.483 -0.761 . . . . 3.4 111.23 -175.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -33.38 72.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.852 -0.594 . . . . 2.35 110.877 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.96 -50.24 72.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.905 0.775 . . . . 2.18 110.225 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.81 -28.73 67.01 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 118.087 -1.445 . . . . 5.03 111.195 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.55 31.42 2.16 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.178 -0.769 . . . . 1.28 111.178 171.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -109.25 168.36 9.44 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.282 -0.636 . . . . 3.38 109.282 169.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -107.64 129.66 54.98 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.794 -0.817 . . . . 2.57 108.794 168.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.93 123.27 48.7 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.615 0.766 . . . . 1.77 109.074 166.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.81 162.48 31.9 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.891 1.277 . . . . 2.07 107.658 166.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 m -75.9 151.73 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 108.701 -0.851 . . . . 3.97 108.701 -171.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -51.15 62.1 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.844 -0.799 . . . . 5.2 108.844 171.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 179.64 -50.15 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.037 1.735 . . . . 5.49 111.223 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -32.45 -57.56 0.34 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.999 2.52 . . . . 7.63 116.725 169.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.42 ' CE1' ' ND2' ' A' ' 81' ' ' ASN 0.301 0.5 OUTLIER 66.61 -42.9 0.41 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.989 2.516 . . . . 4.57 114.289 -172.461 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.02 -53.38 0.03 OUTLIER 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.823 1.192 . . . . 4.13 113.536 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 43.2 54.15 5.46 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.309 0.957 . . . . 3.06 115.08 172.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.1 t -142.06 -56.45 0.46 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.898 1.349 . . . . 4.84 113.099 -173.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -161.02 135.87 7.47 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 106.979 -1.489 . . . . 4.41 106.979 -171.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.18 -37.96 2.0 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 120.036 1.289 . . . . 2.39 111.64 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.42 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -137.75 84.47 2.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.619 1.167 . . . . 3.01 109.082 -179.423 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -102.52 157.71 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 108.803 -0.814 . . . . 3.75 108.803 -175.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.49 157.1 44.39 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.555 -0.716 . . . . 3.63 111.287 175.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 mt -144.14 155.99 44.15 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.049 0.94 . . . . 3.32 109.845 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.11 122.74 41.62 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 106.659 -1.608 . . . . 2.41 106.659 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.3 pt -97.93 111.65 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-O 122.015 0.912 . . . . 2.96 109.321 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 m -103.72 145.06 30.63 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.496 1.118 . . . . 2.38 108.702 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.29 -33.84 5.87 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.292 0.948 . . . . 1.24 111.436 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.7 151.93 36.96 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.398 0.599 . . . . 3.6 110.948 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 t -163.39 33.83 0.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.597 0.359 . . . . 3.62 111.103 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.0 p -162.15 145.1 11.61 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.381 -0.824 . . . . 4.55 111.658 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.0 -34.92 70.52 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.573 1.149 . . . . 3.53 111.334 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 t -54.2 -50.06 67.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.642 0.377 . . . . 2.75 110.046 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 55.6 m -68.14 -45.96 72.13 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.961 -0.462 . . . . 2.81 110.125 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.4 t -48.75 -57.18 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.937 1.695 . . . . 2.55 109.921 172.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -59.0 -43.96 91.58 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.686 -0.634 . . . . 4.54 111.017 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -60.78 -42.88 98.41 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.347 0.659 . . . . 1.76 110.876 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.0 mt -57.28 -50.41 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 108.321 -0.992 . . . . 1.94 108.321 174.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -53.51 -43.67 68.48 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.029 -0.51 . . . . 2.67 110.425 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.4 t -57.96 -50.4 73.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.544 0.738 . . . . 2.28 111.305 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -37.35 78.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.25 -0.906 . . . . 3.25 110.933 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.4 mt -70.59 -51.34 28.91 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.837 -0.801 . . . . 2.85 108.837 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.6 p -60.05 -17.07 36.53 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.936 0.717 . . . . 2.39 112.936 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -59.82 -33.91 72.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 119.298 -0.961 . . . . 5.7 112.338 168.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.8 m -73.34 142.51 47.07 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.706 0.803 . . . . 2.46 111.162 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -66.0 -42.38 89.83 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.361 0.874 . . . . 3.08 113.361 -173.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.29 -39.29 27.03 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.127 -1.189 . . . . 1.12 110.127 -170.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.33 126.36 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.975 -0.75 . . . . 4.83 108.975 168.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.1 t -124.41 -26.3 3.93 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.676 0.791 . . . . 4.43 111.585 165.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.62 93.97 3.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.694 -1.965 . . . . 3.44 105.694 -172.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.98 151.45 21.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.219 -1.401 . . . . 1.84 107.219 158.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.7 t -142.23 110.83 6.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.213 -1.773 . . . . 2.55 106.213 167.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.4 m -104.89 147.64 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 118.048 0.385 . . . . 3.67 110.774 176.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.73 102.31 4.7 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.305 0.574 . . . . 2.5 110.395 -174.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 pp -61.94 -19.12 62.4 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.345 0.868 . . . . 3.43 113.345 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.14 -40.75 64.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.908 -0.775 . . . . 2.71 108.908 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.1 p -90.14 -25.35 20.74 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.004 0.921 . . . . 3.65 110.344 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 p 77.9 9.68 2.27 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 128.257 2.623 . . . . 3.36 112.894 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -99.71 151.18 21.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.163 0.982 . . . . 4.3 111.767 174.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -117.25 117.48 29.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.855 2.462 . . . . 1.89 107.0 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.5 mp -99.83 131.23 45.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.547 -1.279 . . . . 4.11 107.547 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 83.0 t -140.78 128.94 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.378 1.071 . . . . 3.24 109.682 -170.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -116.45 93.03 4.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.951 -0.759 . . . . 4.39 108.951 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -113.98 169.48 8.97 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.654 1.182 . . . . 2.97 109.777 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -105.28 115.6 61.83 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.289 1.036 . . . . 3.68 109.708 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.86 65.17 7.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.856 3.037 . . . . 1.89 112.83 -170.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -143.29 -51.14 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.671 1.588 . . . . 3.58 108.219 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -34.48 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 122.96 0.504 . . . . 3.77 111.096 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.5 tp -145.79 168.49 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.078 -0.712 . . . . 3.31 109.078 -174.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.96 169.86 31.33 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.181 -1.168 . . . . 1.55 110.181 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -61.22 -35.31 85.88 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.278 2.652 . . . . 1.64 110.801 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -51.93 -39.68 59.56 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 112.458 0.54 . . . . 7.82 112.458 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.05 -44.45 84.54 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.209 -0.663 . . . . 3.17 109.209 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.97 -55.95 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.24 -0.652 . . . . 2.33 109.24 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 pt -54.61 -57.1 7.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-O 118.003 -0.998 . . . . 3.99 109.334 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -47.77 -50.59 25.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.125 1.33 . . . . 5.01 112.839 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.4 mm -52.91 -54.7 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.423 -0.584 . . . . 3.06 109.423 175.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.287 2.6 pp -71.49 -25.0 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 119.077 -1.049 . . . . 2.38 113.538 -176.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -63.86 -32.06 73.45 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.327 1.051 . . . . 3.03 110.32 169.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -62.17 -39.24 92.02 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.214 -0.661 . . . . 2.98 109.214 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.2 mt -66.78 -42.01 88.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.409 -0.589 . . . . 2.43 109.409 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.91 22.61 5.6 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.874 1.702 . . . . 1.48 111.511 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -99.06 -178.71 4.02 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.52 -1.289 . . . . 3.51 107.52 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -140.6 135.65 31.98 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.157 -1.053 . . . . 4.36 108.157 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -122.87 96.67 5.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.236 1.014 . . . . 2.28 109.765 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.1 p -123.43 127.21 48.1 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.425 0.69 . . . . 2.79 110.918 -173.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -14.92 113.13 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.109 2.564 . . . . 4.97 115.086 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -107.29 48.61 0.83 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.698 0.999 . . . . 5.03 113.698 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 . . . . . 0 C--O 1.254 1.319 0 CA-C-O 117.798 -1.096 . . . . 6.72 112.366 177.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 105.932 -1.877 . . . . 13.72 105.932 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.282 . . 98.66 -33.86 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 118.402 2.742 . . . . 6.83 118.402 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.437 ' CB ' ' HE3' ' A' ' 47' ' ' LYS . 72.6 Cg_endo -80.36 125.47 5.74 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 CA-C-N 122.751 2.018 . . . . 5.2 109.549 171.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -124.85 -176.97 3.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.754 0.821 . . . . 4.17 109.393 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -110.3 154.75 23.03 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.409 0.684 . . . . 4.64 110.58 165.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.9 t -125.78 130.18 50.93 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.142 0.977 . . . . 3.22 109.424 170.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.52 106.37 16.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 128.388 2.675 . . . . 4.46 110.027 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 -179.19 5.4 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.458 -0.776 . . . . 4.65 110.617 173.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.16 161.58 28.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.49 -1.3 . . . . 3.08 107.49 173.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mm -97.16 134.84 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.878 -1.897 . . . . 2.19 105.878 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -117.58 67.83 0.75 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.537 -1.283 . . . . 4.51 107.537 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.4 -69.4 0.06 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.152 -0.779 . . . . 1.46 111.152 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.08 93.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.521 2.328 . . . . 2.94 116.883 176.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.44 -22.7 21.6 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.387 1.075 . . . . 3.22 113.589 170.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 89.5 m 75.57 -62.9 0.43 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.938 1.695 . . . . 6.55 110.078 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.98 -75.29 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.495 2.318 . . . . 5.04 112.925 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.3 p -160.02 14.28 0.13 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.432 0.901 . . . . 2.99 113.432 169.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.92 -45.05 64.93 Favored 'General case' 0 N--CA 1.462 0.126 0 O-C-N 121.239 -0.913 . . . . 3.33 110.071 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -53.67 -47.13 61.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.418 -0.956 . . . . 2.48 108.418 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.02 -41.53 64.79 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.353 0.661 . . . . 2.17 112.073 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -67.41 -49.27 64.53 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.969 -0.382 . . . . 2.72 109.969 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.3 mt -48.96 -45.32 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.963 0.905 . . . . 2.65 110.586 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -44.62 -57.38 3.68 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.042 0.837 . . . . 4.7 111.194 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -61.6 -39.17 90.27 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.154 0.982 . . . . 5.84 110.208 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -62.65 -57.38 11.24 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.963 -0.755 . . . . 1.35 108.963 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.12 -31.42 72.61 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.036 -0.415 . . . . 4.42 111.009 -175.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.58 -35.01 3.68 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.445 0.566 . . . . 1.9 112.257 168.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -110.2 24.19 13.33 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.377 0.671 . . . . 5.07 112.135 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.34 -72.24 0.17 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.034 0.534 . . . . 3.55 109.596 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.38 -120.88 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.418 0.687 . . . . 2.24 109.998 -172.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.17 -11.23 63.67 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.782 0.719 . . . . 1.63 113.183 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -75.46 122.56 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.691 -0.888 . . . . 2.48 109.464 173.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.21 49.35 1.93 Allowed 'General case' 0 C--N 1.34 0.164 0 CA-C-O 120.786 0.327 . . . . 3.53 110.577 173.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.6 m -150.53 156.11 40.78 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.291 -1.003 . . . . 3.57 108.291 165.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.0 p -140.29 117.01 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 107.37 -1.345 . . . . 4.01 107.37 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -140.44 79.59 1.71 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 108.172 -1.047 . . . . 3.7 108.172 172.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.1 t -99.4 136.58 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.135 -0.939 . . . . 3.18 108.551 169.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.88 96.58 6.25 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.608 -1.256 . . . . 2.47 107.608 167.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.66 -21.04 24.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.906 0.882 . . . . 3.68 111.669 175.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -59.0 5.12 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.793 1.237 . . . . 3.77 109.547 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.22 20.3 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.99 0.916 . . . . 2.63 111.102 -172.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.71 63.96 1.86 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.154 -1.178 . . . . 1.34 110.154 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.77 137.36 41.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.253 -2.128 . . . . 3.46 105.253 169.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.85 104.51 11.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.784 1.302 . . . . 1.91 109.61 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -111.74 144.65 40.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.244 0.545 . . . . 4.03 109.719 167.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.08 178.78 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 124.444 1.097 . . . . 2.81 109.147 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HE3' ' CB ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -124.74 94.92 4.33 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.033 0.933 . . . . 10.08 110.213 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -99.99 169.51 9.14 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.414 2.285 . . . . 3.89 113.476 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.93 97.43 41.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.849 1.66 . . . . 3.09 108.858 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -53.22 -21.31 16.72 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.663 3.576 . . . . 3.02 114.817 -171.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -77.98 -25.52 48.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.5 1.52 . . . . 4.51 111.285 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 p -121.34 -31.19 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 123.988 0.915 . . . . 4.44 112.522 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.11 135.32 63.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 123.601 0.76 . . . . 2.42 109.189 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -120.46 154.83 56.81 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.505 1.122 . . . . 3.16 111.84 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.23 -30.19 92.35 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.152 1.901 . . . . 1.87 111.607 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -42.25 94.15 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.797 0.726 . . . . 4.92 111.705 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -71.17 -41.08 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.686 0.794 . . . . 3.63 110.745 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.8 -42.34 42.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 108.255 -1.017 . . . . 2.17 108.255 170.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.23 86.59 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.519 -0.764 . . . . 2.41 111.172 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -59.93 -52.96 63.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.278 -0.889 . . . . 3.11 109.655 171.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -54.86 19.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.94 0.4 . . . . 3.91 110.846 -177.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.05 -44.26 98.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.503 0.557 . . . . 5.12 112.503 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.64 -39.35 84.06 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.587 1.085 . . . . 2.49 110.226 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.37 -47.75 72.38 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.648 0.779 . . . . 2.58 109.636 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.7 mt -53.81 -33.07 54.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.184 0.594 . . . . 2.6 111.452 170.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.58 33.09 2.97 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.262 -1.135 . . . . 1.31 110.262 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -124.67 149.56 47.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.763 -1.569 . . . . 3.17 106.763 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.81 129.66 44.2 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.017 -1.475 . . . . 3.22 107.017 170.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.77 120.19 36.63 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.63 -1.619 . . . . 1.89 106.63 175.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.89 128.28 34.28 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.424 -1.262 . . . . 2.01 107.923 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.4 t -49.29 151.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.012 1.325 . . . . 3.99 108.832 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.31 -44.15 79.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.283 -0.266 . . . . 4.25 110.283 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.15 -65.04 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 105.227 -2.138 . . . . 4.13 105.227 175.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -85.89 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.07 -1.423 . . . . 6.17 112.609 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.415 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER 155.29 -30.2 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 115.502 -2.189 . . . . 5.03 114.671 -153.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 75' ' ' TYR . . . 130.05 -58.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 122.237 2.289 . . . . 4.24 112.692 -170.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.65 89.14 0.15 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.277 -0.729 . . . . 3.68 111.277 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.0 t -138.48 -98.84 0.18 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 117.236 0.518 . . . . 5.66 111.937 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.35 152.1 21.48 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.832 -1.914 . . . . 5.41 105.832 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.31 -71.78 2.86 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 106.757 -2.537 . . . . 2.57 106.757 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -104.23 126.13 51.08 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.719 1.208 . . . . 4.01 109.366 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.71 149.72 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 C-N-CA 124.297 1.039 . . . . 3.24 108.253 175.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -125.37 146.51 49.56 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.35 1.06 . . . . 3.67 110.536 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.46 149.63 39.48 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.269 1.027 . . . . 3.54 108.744 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.32 132.2 42.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.404 -1.702 . . . . 2.57 106.404 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 pp -106.59 113.39 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 O-C-N 123.909 0.756 . . . . 2.64 110.727 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.5 m -104.43 139.33 39.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.177 0.991 . . . . 3.0 108.794 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.1 -27.8 11.3 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.995 1.283 . . . . 1.24 111.984 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 5.3 tmm? -63.8 131.65 48.48 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.845 0.858 . . . . 3.57 109.901 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 m -144.77 34.9 1.14 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.588 1.155 . . . . 3.34 109.331 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 43.3 t -165.82 129.61 2.2 Favored 'General case' 0 C--N 1.341 0.239 0 O-C-N 120.854 -1.154 . . . . 3.29 111.908 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.43 -35.89 63.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.542 0.737 . . . . 3.46 111.785 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 t -53.73 -46.94 70.99 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.134 0.492 . . . . 2.63 110.257 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 35.1 m -62.58 -46.24 89.23 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.112 -0.699 . . . . 2.96 109.112 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.5 t -52.79 -53.03 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.098 0.408 . . . . 2.59 110.783 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -56.85 -44.88 82.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.158 0.504 . . . . 3.86 110.746 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -60.74 -47.68 85.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.891 0.476 . . . . 1.97 110.639 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.3 mt -55.83 -52.64 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.746 -0.835 . . . . 1.96 108.746 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -56.24 -42.06 76.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.837 0.855 . . . . 3.18 110.134 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.2 t -57.94 -55.51 33.96 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.923 0.329 . . . . 2.38 110.815 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -50.82 64.7 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.666 -0.646 . . . . 3.33 110.999 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.8 mt -55.82 -58.0 9.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 119.22 -0.419 . . . . 3.04 110.051 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.8 m -53.67 -25.17 16.92 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.61 1.164 . . . . 2.39 111.549 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -62.39 -28.29 69.67 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.881 -0.512 . . . . 7.45 111.348 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.3 m -68.08 118.31 11.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.448 1.499 . . . . 2.47 111.225 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -33.05 -55.82 0.39 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.637 1.975 . . . . 2.96 114.033 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.55 -29.14 60.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 119.513 -0.604 . . . . 1.72 113.354 -171.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.1 127.94 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.522 -1.288 . . . . 4.31 107.522 -174.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 36.9 p -99.16 -51.4 3.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 118.303 0.501 . . . . 4.4 110.437 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -131.95 128.66 38.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.322 -0.992 . . . . 3.81 108.322 169.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.99 128.26 53.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.879 -1.156 . . . . 1.87 107.879 165.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.2 m -115.45 112.32 22.1 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 117.707 -1.14 . . . . 2.8 109.498 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 t -114.47 131.55 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 120.325 1.421 . . . . 3.52 112.651 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -125.67 106.44 9.73 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.489 1.115 . . . . 2.11 111.226 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -22.92 59.5 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 125.172 1.389 . . . . 3.29 113.266 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.73 80.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.149 0.5 . . . . 2.21 110.073 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.22 -34.82 10.19 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.243 1.417 . . . . 2.32 110.402 177.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.4 m 79.78 38.55 0.11 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.407 1.883 . . . . 2.47 110.875 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.9 144.05 46.64 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 123.539 0.736 . . . . 3.77 109.436 173.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.18 120.65 29.28 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.249 2.62 . . . . 1.99 107.679 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.8 mp -115.07 104.43 11.87 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.623 1.569 . . . . 3.44 110.254 -170.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.3 m -103.82 135.86 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.6 1.16 . . . . 3.36 111.114 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.71 104.52 11.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.858 -1.164 . . . . 5.77 107.858 174.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -123.25 176.47 6.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.667 1.587 . . . . 3.93 112.258 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -98.7 113.55 64.49 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 108.49 -0.93 . . . . 3.18 108.49 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.31 71.52 6.72 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.772 2.981 . . . . 2.03 111.346 -167.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -168.59 -48.43 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.318 1.047 . . . . 4.48 109.337 -173.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.6 pt -83.75 -33.05 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.819 0.847 . . . . 3.01 110.917 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.92 160.59 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.318 1.047 . . . . 2.3 109.144 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.87 169.63 23.81 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.623 1.106 . . . . 1.73 110.45 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.97 -40.44 11.93 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.233 2.622 . . . . 2.04 111.092 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -51.32 -37.21 46.51 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.359 0.664 . . . . 7.18 112.396 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.77 -45.37 78.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.619 -0.882 . . . . 4.27 108.619 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 64.2 mt -60.73 -46.65 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 108.644 -0.872 . . . . 2.39 108.644 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 77.2 mt -51.2 -58.46 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 118.363 -0.827 . . . . 3.23 108.972 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -48.53 -50.25 32.75 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.568 1.076 . . . . 5.46 110.606 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.5 mm -55.6 -50.02 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 109.85 -0.426 . . . . 2.81 109.85 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.283 2.5 pp -70.11 -28.52 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 119.197 -1.001 . . . . 2.68 113.615 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -63.71 -42.26 97.98 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.566 1.076 . . . . 2.29 109.896 170.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -60.0 -39.24 85.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.79 0.836 . . . . 3.36 109.16 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.2 mt -71.01 -39.0 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 O-C-N 122.259 -0.275 . . . . 2.24 110.941 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.03 29.48 8.0 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.499 1.523 . . . . 0.96 112.096 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -99.65 177.11 5.25 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.689 1.245 . . . . 3.67 109.443 165.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -130.78 120.14 23.32 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.045 -1.465 . . . . 5.69 107.045 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.06 113.31 26.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.502 1.521 . . . . 2.3 108.654 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.8 m -123.13 114.23 20.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.101 0.41 . . . . 2.58 111.028 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.6 mt -28.29 114.58 0.08 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 128.222 2.609 . . . . 5.0 111.923 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.86 23.9 5.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.442 0.697 . . . . 4.16 112.68 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.456 -1.259 . . . . 6.08 110.78 168.687 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 106.233 -1.766 . . . . 13.87 106.233 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.24 132.87 95.4 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-N 119.663 1.12 . . . . 4.87 108.128 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.91 77.91 3.16 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 CA-C-O 123.523 1.384 . . . . 4.83 113.197 -162.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -111.11 123.81 50.94 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 112.519 -2.128 . . . . 4.94 109.786 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.12 148.9 23.08 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.424 1.09 . . . . 4.67 108.356 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.1 t -135.89 134.77 39.12 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.784 -1.191 . . . . 2.84 107.784 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -103.65 98.01 7.95 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 124.244 0.965 . . . . 4.96 109.02 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.414 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 2.6 pt? -121.67 169.73 10.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.957 0.884 . . . . 3.16 111.364 172.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.02 142.67 49.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.24 -1.022 . . . . 2.27 108.24 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.4 mm -98.18 146.92 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.674 -1.232 . . . . 1.66 107.674 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 68' ' ' GLU . 20.8 mtmt -128.2 96.74 4.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.565 -1.643 . . . . 4.64 106.565 171.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.14 -70.98 0.09 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.952 -1.259 . . . . 1.75 109.952 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 ptm 29.03 70.47 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.48 2.312 . . . . 3.87 116.053 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.69 -14.32 2.17 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.764 1.626 . . . . 3.47 114.16 175.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t 71.66 -63.49 0.42 Allowed 'General case' 0 C--N 1.339 0.128 0 C-N-CA 126.372 1.869 . . . . 3.08 111.373 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -16.17 -73.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 128.177 2.591 . . . . 7.47 113.224 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -157.5 24.11 0.29 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.856 0.862 . . . . 4.33 110.654 159.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.0 m -71.01 -52.98 16.44 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.296 -0.877 . . . . 2.66 109.178 -170.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.7 t -50.24 -46.83 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.019 -0.734 . . . . 2.96 109.019 173.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 t -54.91 -51.9 64.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.46 0.704 . . . . 3.94 110.875 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -40.53 80.19 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 121.331 -0.856 . . . . 2.78 110.386 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mt -55.93 -50.71 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.781 1.232 . . . . 2.61 109.548 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -52.22 -44.44 64.79 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.63 0.65 . . . . 4.19 111.27 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -69.22 -40.46 77.94 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.748 -1.22 . . . . 6.81 111.588 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -61.7 -53.75 51.84 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 122.116 -0.365 . . . . 1.39 110.043 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.54 -39.01 70.03 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.677 0.791 . . . . 4.0 110.361 175.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.17 -23.97 9.66 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.212 0.915 . . . . 2.09 112.902 173.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -106.12 21.13 17.86 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.108 0.963 . . . . 4.63 112.491 176.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -70.34 -72.64 0.19 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.802 -0.814 . . . . 3.56 108.802 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.42 -105.08 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.839 1.256 . . . . 2.88 107.859 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.83 25.33 24.05 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.241 -1.31 . . . . 2.4 113.352 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.5 p -96.0 120.74 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 119.373 1.587 . . . . 2.85 109.308 168.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 mp -139.54 53.72 1.7 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 108.96 -0.756 . . . . 4.08 108.96 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 t -161.64 156.51 23.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.869 -1.9 . . . . 3.66 105.869 165.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.29 110.05 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 106.7 -1.593 . . . . 3.84 106.7 175.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -128.98 76.87 1.75 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.822 -1.177 . . . . 4.16 107.822 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 t -97.84 127.09 50.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 109.541 -0.54 . . . . 3.26 109.541 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.84 88.24 3.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.93 -1.137 . . . . 3.22 107.93 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.5 tp -53.33 -22.98 8.14 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.029 1.332 . . . . 4.56 110.805 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -35.04 68.77 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.388 0.675 . . . . 6.33 111.285 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.49 -39.44 4.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.955 0.902 . . . . 3.52 110.926 -172.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.99 63.41 0.81 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 125.916 1.722 . . . . 1.82 110.47 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -142.35 136.68 29.89 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.127 -1.805 . . . . 5.01 106.127 172.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.43 95.02 4.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.434 1.084 . . . . 2.49 109.272 172.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -101.51 137.43 39.84 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.805 -1.554 . . . . 5.74 106.805 171.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.77 -178.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 107.316 -1.365 . . . . 4.0 107.316 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.58 106.2 6.88 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.753 -1.203 . . . . 6.6 107.753 176.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -117.41 176.23 5.25 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 124.762 1.289 . . . . 4.49 114.459 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -113.37 107.3 53.67 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.895 1.278 . . . . 3.87 111.348 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.48 -11.37 31.33 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.991 2.461 . . . . 3.52 112.929 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.37 -21.33 64.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 120.203 1.365 . . . . 4.18 111.228 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -128.59 -46.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.44 0.696 . . . . 5.06 110.403 -169.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.37 147.61 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 121.913 0.863 . . . . 3.56 109.43 174.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -128.04 150.07 72.7 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 125.69 1.596 . . . . 3.66 108.776 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -58.42 -29.8 89.49 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.261 2.641 . . . . 2.38 111.596 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -49.55 77.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.245 1.418 . . . . 3.34 109.718 172.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -68.11 -38.55 82.39 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.933 -0.479 . . . . 3.03 109.726 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -46.25 89.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 107.486 -1.302 . . . . 2.43 107.486 172.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.48 -44.52 95.84 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 122.973 0.509 . . . . 2.27 110.397 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -60.1 -51.25 70.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.661 -0.649 . . . . 3.32 110.94 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.11 -48.43 73.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.612 0.642 . . . . 5.07 112.176 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.07 -39.63 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 121.261 -0.9 . . . . 5.45 111.658 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.5 -34.9 79.35 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.518 0.599 . . . . 3.42 110.511 177.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.18 -52.02 65.48 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.459 -0.571 . . . . 2.83 109.459 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.6 mt -58.45 -29.95 66.55 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.828 0.307 . . . . 3.02 111.828 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.36 31.54 3.73 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 124.512 1.053 . . . . 1.6 111.336 167.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.59 161.48 19.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.63 1.572 . . . . 3.18 108.405 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' A' ' 11' ' ' LYS . 52.7 mt-10 -98.45 134.58 41.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.77 -1.567 . . . . 2.2 106.77 163.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.49 127.23 46.14 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.919 -1.882 . . . . 1.94 105.919 169.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.48 123.98 23.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.201 -1.037 . . . . 2.13 108.201 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.414 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.5 t -71.1 145.26 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.057 -1.09 . . . . 4.04 108.057 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.4 mtt -56.38 -48.39 76.96 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.04 -0.726 . . . . 5.21 109.04 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 158.38 -34.19 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.829 1 C-N-CA 133.542 4.737 . . . . 6.4 108.191 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -64.97 71.44 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.302 1.841 . . . . 8.5 111.247 174.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -73.72 -20.88 60.39 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.87 1.668 . . . . 5.24 114.056 -176.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 133.3 -150.83 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 128.854 2.862 . . . . 3.99 108.874 -172.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 150.56 94.58 0.12 Allowed Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 109.021 -1.632 . . . . 3.19 109.021 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.1 t -163.62 -25.63 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 115.963 1.838 . . . . 6.13 115.963 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 80' ' ' GLY . 31.3 t70 -80.9 -136.95 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.55 1.068 . . . . 6.63 108.354 -176.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.459 ' H ' ' CG ' ' A' ' 79' ' ' ASP . . . -65.19 -21.24 68.0 Favored Glycine 0 N--CA 1.436 -1.341 0 O-C-N 120.179 -1.576 . . . . 3.66 109.597 152.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.33 104.63 17.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.594 -1.632 . . . . 2.84 106.594 -176.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.94 157.72 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 106.94 -1.504 . . . . 4.21 106.94 172.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -123.06 160.7 25.81 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.947 -1.024 . . . . 3.91 110.176 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 pp -143.78 159.92 41.66 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.638 -1.164 . . . . 4.4 110.229 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.8 m -109.36 131.67 54.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.374 1.87 . . . . 3.4 107.943 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.53 98.08 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.733 1.613 . . . . 2.89 110.706 -170.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.3 m -95.53 112.52 24.23 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.877 -0.786 . . . . 2.75 108.877 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 135.3 -22.98 3.5 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.486 1.041 . . . . 1.42 111.921 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.1 ttp -70.74 133.59 46.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.021 -0.693 . . . . 3.56 111.719 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.2 m -151.53 39.44 0.65 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.844 0.858 . . . . 3.96 110.239 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.5 t -167.96 138.94 2.82 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.963 -1.086 . . . . 3.1 110.71 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.7 67.2 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.474 0.654 . . . . 3.54 111.856 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.9 m -53.47 -43.93 68.54 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.256 -0.902 . . . . 3.1 110.275 170.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.0 m -64.4 -42.24 96.21 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.888 0.475 . . . . 2.17 109.849 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.7 t -52.23 -55.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.721 0.808 . . . . 2.22 108.826 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.7 m170 -61.66 -36.6 81.29 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 109.737 -0.468 . . . . 4.56 109.737 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -59.01 -60.71 3.44 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.959 -0.756 . . . . 2.63 108.959 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.6 mt -49.59 -49.2 19.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 C-N-CA 124.472 1.109 . . . . 2.41 110.051 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -54.38 -52.93 60.13 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.222 1.009 . . . . 2.47 109.786 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.0 m -66.85 -25.16 66.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.431 0.692 . . . . 2.91 112.186 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -46.87 49.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 120.865 -1.147 . . . . 3.94 111.816 170.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.58 -45.8 64.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.272 0.942 . . . . 4.72 108.888 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.0 p -60.43 -12.45 9.52 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.702 0.63 . . . . 2.28 112.702 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -53.57 -34.29 57.8 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.634 -0.666 . . . . 4.92 111.349 167.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.4 p -78.44 164.88 24.39 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 118.936 0.789 . . . . 3.45 110.907 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -82.89 -44.87 14.9 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.887 0.875 . . . . 2.98 111.188 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.01 -36.58 64.47 Favored Glycine 0 C--N 1.335 0.523 0 O-C-N 122.236 -0.29 . . . . 1.64 112.606 -170.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -66.21 130.19 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.127 -0.694 . . . . 3.19 109.127 -174.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.0 t -109.81 -53.46 2.67 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.422 0.289 . . . . 4.13 111.466 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.41 124.88 31.21 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.694 -1.224 . . . . 4.64 107.694 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.39 161.82 15.27 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.525 -0.546 . . . . 1.6 109.525 153.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.4 m -139.27 110.24 6.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.696 -1.594 . . . . 2.26 106.696 168.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.68 132.74 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.446 1.099 . . . . 2.79 110.115 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.42 119.16 12.45 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.96 0.886 . . . . 2.19 111.545 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -71.36 -31.05 66.87 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.322 1.449 . . . . 3.43 112.778 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.99 81.74 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.522 0.677 . . . . 2.14 109.947 -176.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.67 -36.65 65.37 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.352 -0.84 . . . . 2.4 109.363 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.3 t 85.23 14.78 0.17 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 126.473 1.909 . . . . 3.68 111.462 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.86 164.74 16.2 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.471 0.708 . . . . 5.67 111.029 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.74 143.57 47.22 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.04 1.336 . . . . 2.29 108.567 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -99.46 146.02 26.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.535 1.147 . . . . 3.06 108.122 165.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.4 t -134.93 136.67 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 126.349 1.859 . . . . 3.36 107.869 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -113.22 109.52 18.9 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.276 1.43 . . . . 4.78 108.81 166.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -127.51 -176.1 3.65 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.654 1.115 . . . . 3.26 111.098 173.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -103.0 112.32 65.7 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 108.307 -0.998 . . . . 3.13 108.307 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.99 67.65 8.0 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.874 2.383 . . . . 2.59 111.962 -166.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -165.25 -43.93 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.227 1.411 . . . . 3.84 109.59 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pp -79.68 -40.48 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 122.852 0.461 . . . . 3.74 110.303 -177.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.7 tp -135.42 178.23 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.237 1.015 . . . . 3.5 109.398 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.84 -178.81 34.17 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.031 -2.027 . . . . 2.05 108.031 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.11 -40.19 34.96 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.12 1.88 . . . . 1.78 110.285 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 -50.94 -40.07 56.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.485 1.114 . . . . 6.35 113.511 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.75 -52.66 64.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.56 -0.533 . . . . 4.21 109.56 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.72 -44.79 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.336 -0.987 . . . . 2.69 108.336 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.2 mt -51.9 -61.32 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 123.711 0.804 . . . . 2.88 109.105 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.68 -46.31 67.2 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.269 0.94 . . . . 5.3 110.835 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.5 mm -57.13 -51.68 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 121.974 -0.454 . . . . 2.87 109.856 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.13 -27.2 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 120.701 -1.249 . . . . 2.38 112.925 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -59.68 -35.39 74.35 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.659 -0.65 . . . . 3.01 110.349 170.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.52 -35.56 79.79 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.472 -0.566 . . . . 3.36 109.472 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.4 mt -69.85 -45.63 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.681 -0.488 . . . . 2.29 109.681 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.19 31.33 2.26 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.612 1.577 . . . . 1.01 111.66 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -99.06 -179.52 4.28 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.92 0.86 . . . . 3.41 109.69 171.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -139.33 105.19 5.16 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 107.774 -1.195 . . . . 5.46 107.774 -175.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.88 98.96 9.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.913 1.285 . . . . 2.04 109.267 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 51.8 m -101.44 115.91 31.58 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.618 -1.253 . . . . 2.8 107.618 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.38 101.28 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.772 1.229 . . . . 5.45 109.469 170.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.65 -38.77 77.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.922 -0.581 . . . . 3.96 110.168 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 126.168 1.787 . . . . 7.83 112.804 -175.542 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mmt . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 117.019 -1.467 . . . . 10.55 107.702 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.03 102.84 9.95 Favored Pre-proline 0 N--CA 1.454 -0.225 0 CA-C-N 119.824 1.193 . . . . 4.19 107.9 -171.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -82.67 110.81 1.94 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.109 1.872 . . . . 3.19 110.105 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -99.37 172.35 7.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.448 -0.796 . . . . 3.03 109.419 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.64 161.59 18.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.708 -1.219 . . . . 5.65 107.708 169.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.31 132.72 26.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.492 -0.929 . . . . 3.66 108.492 162.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -109.08 93.72 4.66 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.137 1.375 . . . . 4.93 109.125 -171.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -116.65 173.75 6.45 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.472 1.13 . . . . 3.74 111.22 177.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.38 156.89 42.41 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.804 -1.924 . . . . 2.19 105.804 174.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mm -97.87 134.26 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 106.454 -1.684 . . . . 2.09 106.454 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -106.5 117.53 34.29 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 105.768 -1.938 . . . . 5.12 105.768 158.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.5 -101.49 0.24 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.3 -1.12 . . . . 1.66 110.3 -175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.3 mtt 60.14 89.04 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.886 1.674 . . . . 2.79 114.529 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -30.88 71.13 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.467 -0.771 . . . . 2.91 111.231 166.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.0 t 78.05 -58.35 0.46 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.141 1.376 . . . . 4.29 111.187 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -19.03 -68.46 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.91 2.484 . . . . 6.0 113.139 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.9 m -156.17 24.87 0.36 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.12 0.968 . . . . 2.98 110.509 162.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.1 m -70.99 -51.53 25.03 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.283 -0.886 . . . . 2.51 109.939 -169.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.4 t -47.68 -50.53 8.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 N-CA-C 109.1 -0.704 . . . . 3.24 109.1 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -49.99 -48.85 52.11 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.134 0.574 . . . . 3.17 112.54 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -39.13 74.85 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.464 -0.772 . . . . 3.01 111.212 178.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.3 mt -59.89 -48.84 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.812 1.245 . . . . 2.75 109.063 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.24 -49.73 41.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.458 0.572 . . . . 3.77 110.896 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -63.77 -34.57 78.18 Favored 'General case' 0 N--CA 1.458 -0.029 0 O-C-N 121.596 -0.69 . . . . 6.18 111.056 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.97 -51.8 65.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.641 -0.503 . . . . 1.33 109.641 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.29 -37.54 75.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.975 0.352 . . . . 3.55 111.449 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -23.96 3.02 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.701 -1.25 . . . . 2.98 112.078 173.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -126.08 34.86 4.78 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.231 -0.89 . . . . 4.98 112.941 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -69.46 -70.54 0.27 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.992 1.269 . . . . 4.65 111.96 169.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.29 -132.38 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.524 -0.917 . . . . 2.57 108.524 -164.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.83 15.85 29.65 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-O 118.139 -1.367 . . . . 1.82 113.112 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.26 128.76 53.24 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 119.961 1.88 . . . . 2.81 107.241 163.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 53.46 1.98 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.904 -1.147 . . . . 3.91 107.904 172.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.1 t -156.25 143.85 19.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.307 -1.738 . . . . 2.45 106.307 174.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.6 132.19 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.452 -1.684 . . . . 3.36 106.452 174.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tt -139.05 83.68 1.97 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.785 -0.82 . . . . 3.39 108.785 172.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.32 139.57 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 107.909 -1.145 . . . . 3.1 107.909 171.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.14 99.67 7.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 106.938 -1.504 . . . . 2.52 106.938 165.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.02 -27.15 66.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.897 0.879 . . . . 3.58 110.679 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 36.6 mtt -63.28 -60.52 3.29 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.517 0.727 . . . . 3.99 110.353 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.24 -29.07 47.98 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.795 -0.639 . . . . 2.64 110.91 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.05 61.18 1.77 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.227 -1.149 . . . . 1.26 110.227 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -134.82 144.08 47.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.539 -1.652 . . . . 4.41 106.539 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.57 104.22 9.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.444 1.097 . . . . 1.98 108.265 165.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.61 137.93 50.89 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.77 0.714 . . . . 4.43 109.478 169.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.48 172.2 16.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 O-C-N 121.919 -0.488 . . . . 3.43 110.594 178.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.03 105.33 10.53 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.286 1.034 . . . . 5.28 111.012 173.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -106.15 171.48 7.32 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.077 1.751 . . . . 3.81 112.916 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.96 112.0 38.63 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.822 1.649 . . . . 3.61 107.764 174.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.4 36.38 0.62 Allowed 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.892 3.061 . . . . 2.64 114.286 -155.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -129.27 -15.64 4.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.03 0.932 . . . . 3.93 112.398 170.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.1 t -106.06 -35.21 3.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 C-N-CA 124.379 1.072 . . . . 3.66 109.43 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.83 150.69 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 105.351 -2.092 . . . . 2.55 105.351 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -135.7 155.25 78.27 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.881 1.272 . . . . 3.29 111.416 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.57 -34.07 88.74 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.024 2.483 . . . . 1.73 112.662 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.38 -56.54 19.91 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.211 0.529 . . . . 3.49 110.805 176.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.99 -31.7 69.52 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.77 -0.581 . . . . 4.75 110.964 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.66 -50.68 57.86 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 N-CA-C 107.269 -1.382 . . . . 2.25 107.269 168.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.4 76.15 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.462 -0.335 . . . . 2.18 110.19 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.32 -48.41 79.02 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 119.04 -0.505 . . . . 2.62 111.011 175.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.61 -52.23 62.87 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 109.246 -0.65 . . . . 3.82 109.246 176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.6 mm -62.84 -44.6 99.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 122.27 -0.269 . . . . 3.87 111.059 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.71 -47.7 79.38 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.204 1.001 . . . . 2.02 111.173 173.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.23 -48.83 80.07 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.241 0.473 . . . . 2.35 109.876 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.9 mt -58.27 -32.2 68.17 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.906 -0.588 . . . . 2.98 111.3 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.8 25.08 3.45 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 123.976 0.798 . . . . 1.35 111.604 164.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -119.03 158.21 26.27 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.767 -1.568 . . . . 4.49 106.767 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -97.03 128.15 43.7 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.059 -1.089 . . . . 2.42 108.059 167.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.38 115.18 27.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.344 -1.354 . . . . 2.04 107.344 169.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.43 142.92 39.5 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.559 -1.275 . . . . 2.02 107.559 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 t -59.49 153.4 4.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.19 0.596 . . . . 3.66 110.003 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 mtm -66.79 -7.39 21.02 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.77 0.656 . . . . 5.98 112.77 171.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 82.72 -22.73 0.23 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.837 2.455 . . . . 4.58 110.699 -171.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -41.23 -50.2 3.61 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 127.111 2.164 . . . . 8.91 111.646 164.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.4 t80 70.37 -35.25 0.32 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.876 1.67 . . . . 6.44 113.001 -176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 78.79 -46.52 0.4 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 127.719 2.408 . . . . 5.44 113.622 164.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 79' ' ' ASP . . . 99.37 72.77 1.05 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 108.165 -1.974 . . . . 2.72 108.165 -166.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.79 44.15 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.136 1.774 . . . . 7.14 111.285 159.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 77' ' ' GLY . 11.3 t0 47.65 114.31 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 130.947 3.699 . . . . 4.88 115.566 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.46 -43.96 1.74 Allowed Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 108.101 -2.0 . . . . 2.8 108.101 -167.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -98.69 59.03 1.23 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.605 1.202 . . . . 3.71 109.668 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.3 mm -92.0 139.74 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.185 -1.413 . . . . 3.7 107.185 -167.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -106.84 149.38 27.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.218 -1.03 . . . . 2.96 108.218 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.8 mt -144.24 152.44 40.83 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 122.899 0.479 . . . . 3.5 110.054 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.01 135.86 38.41 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.878 -1.527 . . . . 3.0 106.878 173.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.37 109.0 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 108.289 -1.004 . . . . 3.08 108.289 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.4 m -96.44 134.16 39.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.283 -1.377 . . . . 2.9 107.283 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.25 -15.71 54.05 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.521 1.058 . . . . 1.79 113.002 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -76.56 124.05 27.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.192 1.496 . . . . 3.84 110.807 -174.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -129.58 9.83 5.56 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.75 0.82 . . . . 5.57 113.1 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 50.2 t -155.23 134.31 12.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.675 1.125 . . . . 5.32 111.546 -173.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.8 -38.95 61.89 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.537 0.735 . . . . 3.9 112.83 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -49.64 -39.25 35.4 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.295 -0.878 . . . . 3.28 111.842 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 74.1 m -61.91 -34.14 75.52 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.986 -0.446 . . . . 2.5 110.597 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.6 t -58.58 -50.78 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.18 -0.674 . . . . 3.29 109.18 174.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -60.63 -41.34 94.71 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.78 -0.822 . . . . 3.69 108.78 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -59.07 -52.34 66.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.0 0.92 . . . . 2.83 110.11 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.1 mt -56.26 -53.15 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.013 0.925 . . . . 1.76 109.867 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.14 -37.77 86.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.685 -0.487 . . . . 2.22 109.685 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -59.57 -53.57 56.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.039 -0.356 . . . . 2.37 110.039 171.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.32 -47.42 66.02 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.285 0.634 . . . . 4.7 111.372 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.3 -59.47 4.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.125 -0.694 . . . . 2.59 109.125 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.6 m -55.3 -19.75 9.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.863 1.265 . . . . 2.88 112.144 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -31.88 63.14 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.324 0.65 . . . . 6.11 111.131 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.1 m -70.47 151.08 45.52 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.991 2.117 . . . . 3.19 111.908 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -72.54 -49.08 35.16 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.814 0.446 . . . . 3.94 111.964 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.98 -34.77 71.18 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 122.193 -0.317 . . . . 1.83 112.56 -172.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.31 124.12 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 O-C-N 121.881 -0.776 . . . . 3.25 110.395 -170.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 59.7 m -99.65 -49.65 4.32 Favored 'General case' 0 CA--C 1.522 -0.114 0 O-C-N 122.978 0.174 . . . . 3.45 111.082 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -140.82 124.23 16.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.437 -0.579 . . . . 3.38 109.437 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -98.52 153.79 18.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.222 -1.029 . . . . 2.25 108.222 161.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.6 t -142.73 109.77 5.57 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.43 -1.322 . . . . 3.03 107.43 169.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.5 p -114.15 121.82 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.669 0.788 . . . . 3.14 111.188 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -122.72 105.13 9.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.05 0.94 . . . . 3.32 110.072 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.28 -22.94 65.31 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.08 0.771 . . . . 3.94 113.08 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.02 -54.51 7.05 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.886 -0.783 . . . . 4.19 108.886 -172.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.4 p -69.73 -25.28 63.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.08 0.952 . . . . 4.36 109.998 172.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.2 m 74.02 19.03 3.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.426 1.891 . . . . 3.14 111.732 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -113.81 149.17 35.35 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.559 0.744 . . . . 4.54 110.531 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.01 115.87 16.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.723 2.009 . . . . 2.63 108.516 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 mt -100.62 130.54 46.69 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.465 -1.309 . . . . 3.8 107.465 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.3 t -131.04 121.19 48.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.65 -0.87 . . . . 3.44 108.65 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -100.62 93.77 5.76 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.754 1.221 . . . . 3.9 109.624 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -111.18 -179.51 3.75 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.444 0.698 . . . . 3.42 110.338 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -108.4 109.97 61.64 Favored Pre-proline 0 C--O 1.236 0.39 0 N-CA-C 107.502 -1.295 . . . . 3.94 107.502 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.27 63.42 8.72 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.29 2.66 . . . . 2.27 112.119 -167.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -147.17 -51.5 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.033 1.733 . . . . 4.05 108.343 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.15 -35.33 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 110.401 -0.222 . . . . 3.82 110.401 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.11 159.52 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 108.17 -1.048 . . . . 2.47 108.17 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.33 164.31 25.93 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.59 -1.404 . . . . 1.91 109.59 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -63.07 -44.18 16.53 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.047 2.498 . . . . 2.06 111.03 -172.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -51.06 -40.86 59.3 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 113.614 0.968 . . . . 7.61 113.614 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -63.08 -47.4 83.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.94 -0.763 . . . . 2.75 108.94 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 97.5 mt -56.86 -50.18 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.878 -0.786 . . . . 1.86 108.878 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.7 mt -48.85 -60.67 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-O 118.399 -0.81 . . . . 3.29 109.004 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.62 -48.17 39.63 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.221 0.919 . . . . 4.05 110.716 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 9.9 mm -54.18 -48.76 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 118.31 -0.852 . . . . 2.65 110.849 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.332 0.0 OUTLIER -72.97 -31.74 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 120.436 1.471 . . . . 3.9 114.154 174.152 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.05 -36.56 70.66 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.113 1.324 . . . . 2.4 110.246 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -70.43 -24.36 62.89 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.1 0.96 . . . . 4.36 110.778 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 30.1 mt -75.36 -43.77 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.481 0.582 . . . . 2.41 109.455 166.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.93 31.94 2.36 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.793 1.663 . . . . 1.14 111.284 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -114.13 160.73 18.62 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.726 -1.212 . . . . 3.73 107.726 165.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -124.46 131.97 53.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.847 -1.168 . . . . 5.79 107.847 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.86 105.9 13.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.2 1.0 . . . . 2.27 109.533 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.0 m -134.21 117.78 16.88 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 117.616 -1.183 . . . . 2.64 111.156 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -5.23 98.93 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.5 2.72 . . . . 6.26 114.964 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.09 65.45 1.5 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.932 0.893 . . . . 6.0 111.872 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 C--O 1.25 1.101 0 C-N-CA 125.253 1.421 . . . . 7.31 107.729 168.182 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mtm . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 117.495 -1.241 . . . . 17.34 113.327 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.5 -27.1 0.34 Allowed Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 117.688 2.477 . . . . 6.69 117.688 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.52 112.18 3.13 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 122.672 1.99 . . . . 3.93 109.552 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -106.94 126.15 51.94 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.436 0.694 . . . . 3.85 110.545 -168.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -92.08 141.76 28.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.558 -0.534 . . . . 4.29 109.558 -176.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.3 p -119.57 154.94 33.14 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.866 -1.161 . . . . 3.92 107.866 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -115.9 105.57 12.82 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.71 -1.218 . . . . 4.41 107.71 173.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mt -114.32 170.59 8.19 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.173 0.987 . . . . 3.81 109.73 172.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.06 146.61 47.02 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.441 -1.689 . . . . 1.79 106.441 168.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 mm -98.04 142.9 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 107.307 -1.368 . . . . 1.82 107.307 172.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -117.2 126.73 53.25 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.217 -1.031 . . . . 4.48 108.217 165.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.28 -57.83 0.39 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.559 1.076 . . . . 1.94 111.089 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.1 mtt 24.91 73.09 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.119 2.167 . . . . 2.53 115.643 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -59.24 -57.54 12.59 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.729 0.64 . . . . 3.24 112.729 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.3 t -166.79 61.81 0.09 Allowed 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.722 0.692 . . . . 4.38 112.031 -171.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 38.52 50.31 1.53 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.59 1.556 . . . . 5.86 112.765 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.7 t -167.63 -45.6 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.812 0.845 . . . . 3.19 109.223 -168.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.8 t -65.42 -45.51 83.63 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.507 -0.746 . . . . 2.12 109.794 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.2 -22.68 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 121.337 -0.852 . . . . 2.94 112.031 170.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -39.49 94.73 Favored 'General case' 0 C--O 1.223 -0.301 0 O-C-N 120.848 -1.157 . . . . 2.14 110.537 167.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -36.16 71.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.081 -1.012 . . . . 3.78 111.089 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -49.15 -32.9 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.122 0.969 . . . . 3.11 111.787 172.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -55.17 -53.0 61.53 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.523 0.729 . . . . 5.11 110.653 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.93 -43.76 67.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.745 -0.661 . . . . 6.12 109.679 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -54.52 -52.56 61.61 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.698 -0.482 . . . . 3.2 109.698 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.9 mt -66.3 -41.06 90.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.901 -0.571 . . . . 3.55 112.111 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -22.84 16.44 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.552 1.069 . . . . 2.07 111.957 172.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -116.1 33.48 5.5 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.935 0.494 . . . . 3.77 112.269 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -75.58 -93.76 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.249 -1.389 . . . . 3.82 107.249 161.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.51 -101.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.249 1.019 . . . . 1.94 110.325 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.92 -23.27 67.39 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 119.248 0.931 . . . . 1.43 113.437 -176.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.4 p -74.82 130.26 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.009 1.404 . . . . 2.44 111.311 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -141.89 54.22 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.828 1.299 . . . . 3.2 110.807 173.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.82 143.25 17.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.991 -1.485 . . . . 2.54 106.991 169.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.9 t -133.92 100.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 106.271 -1.752 . . . . 3.24 106.271 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -119.1 78.39 1.28 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.212 -1.033 . . . . 3.12 108.212 175.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.96 126.98 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 109.306 -0.627 . . . . 2.85 109.306 173.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.94 95.79 7.12 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.997 -1.482 . . . . 2.17 106.997 167.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.43 -22.82 63.86 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.362 0.265 . . . . 4.19 110.707 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 10.8 tpt -65.3 -46.85 78.72 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.389 1.075 . . . . 4.93 110.56 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.62 -30.34 13.33 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.288 1.035 . . . . 1.9 111.061 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.94 66.58 1.27 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 125.016 1.293 . . . . 1.01 111.003 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -142.05 132.69 25.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.244 -1.762 . . . . 4.02 106.244 172.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.24 103.4 12.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 124.368 1.043 . . . . 1.84 109.697 168.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -106.72 146.7 30.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.002 -1.11 . . . . 3.46 108.002 166.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 pp -139.62 166.62 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 106.647 -1.612 . . . . 3.8 106.647 174.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 107.21 15.5 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.138 1.375 . . . . 5.38 108.456 171.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -104.52 -178.8 3.76 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.245 1.018 . . . . 3.18 112.578 171.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.18 104.06 35.44 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.215 1.406 . . . . 3.92 109.335 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.98 -5.07 16.13 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.678 2.252 . . . . 2.31 112.991 -172.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -75.98 -15.35 60.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.703 0.683 . . . . 3.69 111.72 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.5 p -125.68 -41.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 118.772 0.715 . . . . 3.93 109.518 -172.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 pp -113.3 -177.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 121.315 0.579 . . . . 3.97 111.477 170.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -139.45 155.92 71.77 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 104.575 -2.38 . . . . 3.11 104.575 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -59.5 -34.2 97.09 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.739 1.626 . . . . 1.8 110.493 -175.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.79 -43.73 77.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.74 -0.648 . . . . 4.73 111.549 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -65.7 -43.45 89.17 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.745 1.157 . . . . 2.77 110.818 -174.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.0 mt -51.79 -55.78 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.065 -1.457 . . . . 2.85 107.065 169.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.06 -43.59 78.08 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.782 -0.644 . . . . 2.59 111.121 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -54.46 -46.82 73.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.28 1.032 . . . . 3.66 110.021 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.54 -48.03 72.48 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.837 -0.431 . . . . 4.79 109.837 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.8 mm -60.29 -43.28 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 122.228 -0.295 . . . . 3.88 111.182 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -64.48 -44.89 89.58 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.007 -0.368 . . . . 3.33 110.007 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.13 -43.94 98.1 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.848 0.859 . . . . 4.67 109.961 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.93 -47.63 74.18 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 123.922 0.889 . . . . 4.31 108.878 173.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.61 34.12 1.12 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.919 0.771 . . . . 1.88 112.02 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -119.31 165.68 13.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.993 1.317 . . . . 3.59 109.199 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -99.95 139.02 36.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.318 -0.993 . . . . 2.18 108.318 162.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.9 122.89 38.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.736 -1.95 . . . . 2.11 105.736 165.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.02 142.88 46.51 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 108.457 -0.942 . . . . 1.94 108.457 174.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.62 136.03 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 124.127 0.971 . . . . 3.81 109.482 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -55.02 28.44 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.911 0.884 . . . . 5.11 109.202 166.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 119' ' ' LYS . 3.9 mt-10 -177.36 -54.89 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.632 1.973 . . . . 5.23 108.244 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.89 79.5 0.21 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.588 1.155 . . . . 7.58 111.02 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.428 ' CE2' ' ND2' ' A' ' 81' ' ' ASN . 46.3 p90 -63.07 -26.79 69.0 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.031 1.732 . . . . 4.4 111.827 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 132.8 84.76 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 128.764 2.825 . . . . 3.95 111.733 170.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -98.04 89.65 0.99 Allowed Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.537 -0.839 . . . . 3.29 111.023 -174.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.8 t -158.68 18.24 0.2 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 114.462 1.282 . . . . 5.4 114.462 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.89 68.96 0.52 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.205 0.526 . . . . 4.41 110.943 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.97 -52.4 4.4 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 107.936 -2.065 . . . . 2.34 107.936 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.428 ' ND2' ' CE2' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -92.26 79.95 5.03 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.569 -1.641 . . . . 3.49 106.569 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.83 148.71 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 118.514 0.597 . . . . 4.15 111.123 178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.05 154.86 17.77 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.779 -0.823 . . . . 2.82 108.779 174.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.71 142.1 47.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.88 -1.155 . . . . 3.79 107.88 168.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.0 m -96.05 123.96 39.87 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.016 -1.476 . . . . 3.68 107.016 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.67 112.22 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 123.51 0.724 . . . . 2.51 110.111 -172.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.4 m -101.04 135.48 42.43 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.741 -0.837 . . . . 2.43 108.741 176.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.88 -30.31 8.17 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.775 1.179 . . . . 1.41 112.283 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 131.26 50.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.535 1.134 . . . . 3.63 111.009 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.7 m -148.69 46.23 1.02 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.093 0.957 . . . . 3.88 110.254 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.0 t -169.61 139.86 2.1 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 120.987 -1.07 . . . . 3.11 110.857 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.38 -44.77 68.9 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.873 0.469 . . . . 3.11 110.638 174.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.1 m -52.45 -39.54 61.2 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.758 0.823 . . . . 3.06 112.06 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.417 ' SG ' ' CZ ' ' A' ' 143' ' ' PHE . 2.4 t -63.41 -55.42 24.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.129 -0.693 . . . . 3.84 109.129 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.7 t -46.81 -50.34 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.68 -0.691 . . . . 2.23 110.653 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -47.16 84.77 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.317 -0.623 . . . . 4.43 109.317 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -45.92 91.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.789 -0.448 . . . . 3.58 109.789 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.5 mt -58.77 -49.72 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.47 -0.567 . . . . 2.07 109.47 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -56.37 -50.0 72.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.115 0.966 . . . . 2.44 108.539 177.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 66.9 m -60.42 -36.25 77.71 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.845 0.858 . . . . 2.87 112.419 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -66.76 -50.36 62.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.55 -0.719 . . . . 3.4 109.773 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.76 -42.32 70.58 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.023 -0.732 . . . . 3.88 109.023 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.6 p -55.8 -16.05 3.99 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.374 0.879 . . . . 2.82 113.374 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -27.47 69.2 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.104 0.866 . . . . 5.54 111.383 172.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.8 m -60.49 150.7 30.48 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.92 1.688 . . . . 2.39 110.385 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -73.65 -54.73 7.45 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.398 0.679 . . . . 2.26 112.114 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.17 -32.84 68.98 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 121.387 0.437 . . . . 1.68 112.688 -172.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.96 119.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.817 -0.813 . . . . 3.31 109.73 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.7 m -102.79 -49.16 3.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.727 0.411 . . . . 3.19 111.018 -174.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.4 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 36.2 p90 -142.04 117.42 10.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.575 -0.726 . . . . 3.53 109.46 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.85 155.19 17.17 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 118.865 -1.134 . . . . 2.31 110.721 161.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -140.81 114.46 8.86 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.464 -0.569 . . . . 3.13 109.464 160.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 p -109.66 140.65 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.727 0.694 . . . . 3.01 112.764 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.23 104.61 6.56 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-O 121.972 0.891 . . . . 2.27 111.857 -171.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.438 ' CD1' ' H ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -65.9 -20.01 66.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.625 1.57 . . . . 3.9 114.061 -177.305 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.71 70.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.18 0.445 . . . . 2.13 110.757 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.22 -18.02 10.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.605 1.562 . . . . 2.38 111.164 -173.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.4 m 72.43 17.63 4.7 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 126.713 2.005 . . . . 2.04 112.426 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.429 ' NZ ' ' OE1' ' A' ' 73' ' ' GLU . 25.3 mmtm -101.11 135.74 42.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.862 1.265 . . . . 3.96 110.371 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -114.09 110.9 20.74 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 126.049 1.74 . . . . 2.03 109.094 175.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.82 125.16 35.64 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 105.892 -1.892 . . . . 4.0 105.892 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.3 t -130.98 132.1 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.353 1.061 . . . . 3.59 109.463 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.4 ' HG2' ' CE1' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -119.71 88.12 2.87 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.466 0.706 . . . . 4.29 109.65 -174.293 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -108.64 -179.48 3.88 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.558 1.161 . . . . 3.05 111.76 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -107.36 112.78 62.51 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 124.25 1.02 . . . . 4.13 108.324 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.79 67.41 8.62 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.162 2.575 . . . . 2.45 111.115 -171.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -161.52 -46.75 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.03 1.332 . . . . 3.78 109.413 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.5 pt -84.24 -31.25 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 123.021 0.528 . . . . 2.75 110.722 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.88 161.7 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 124.446 1.099 . . . . 2.22 108.156 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.68 162.06 28.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.672 -1.371 . . . . 1.7 109.672 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -57.18 -36.45 99.11 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.655 2.903 . . . . 1.69 111.57 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -49.92 -37.18 30.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.467 0.707 . . . . 7.72 112.616 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.15 -44.66 71.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.2 0.524 . . . . 3.3 109.639 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.53 -45.87 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.27 -1.011 . . . . 1.85 108.27 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.4 mt -53.29 -60.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 118.027 -0.987 . . . . 2.97 108.685 175.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -46.26 -53.17 11.18 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 120.18 1.355 . . . . 4.71 111.012 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 90.0 mt -51.22 -53.12 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.428 0.558 . . . . 3.68 110.068 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.252 2.5 pp -71.08 -28.25 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 114.032 1.123 . . . . 2.68 114.032 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -61.63 -42.9 99.54 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.158 0.89 . . . . 3.11 109.063 170.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -39.81 87.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.891 0.877 . . . . 4.36 108.734 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 74.6 mt -71.22 -41.54 75.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 O-C-N 122.348 -0.22 . . . . 2.5 110.957 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.13 32.65 6.04 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.291 1.424 . . . . 1.68 111.899 -173.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.417 ' CZ ' ' SG ' ' A' ' 94' ' ' CYS . 27.4 m-85 -101.5 -178.77 3.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.325 1.063 . . . . 3.73 109.507 165.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -135.89 114.43 11.79 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 105.798 -1.927 . . . . 6.16 105.798 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.07 108.4 19.89 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.05 1.74 . . . . 1.9 108.73 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 m -104.65 95.29 5.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.115 -1.439 . . . . 2.96 107.115 -174.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.15 84.68 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.865 1.666 . . . . 6.43 111.262 -177.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 47.31 52.94 11.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.722 0.809 . . . . 5.73 109.965 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 116.406 -1.759 . . . . 7.97 108.683 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ttt . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 118.188 -0.91 . . . . 14.53 109.269 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 161.02 -44.42 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 127.268 2.227 . . . . 5.49 114.896 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.6 122.87 9.31 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 121.74 1.657 . . . . 4.41 108.618 168.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -125.61 154.2 42.62 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.703 1.201 . . . . 3.5 109.335 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -93.61 152.03 19.28 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.315 0.646 . . . . 4.04 111.697 177.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 t -140.83 128.05 20.96 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.552 1.141 . . . . 2.52 110.282 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -105.63 101.16 10.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.434 1.893 . . . . 5.34 110.864 -176.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.99 173.38 8.71 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.223 0.92 . . . . 3.8 111.17 175.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -124.8 149.03 47.82 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.31 -0.869 . . . . 3.15 109.163 165.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -96.11 124.82 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.88 -1.526 . . . . 1.81 106.88 177.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -100.47 111.91 24.21 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.707 -1.96 . . . . 3.96 105.707 173.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.65 -78.0 0.16 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.178 0.894 . . . . 1.25 111.306 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.0 mtm 42.24 79.99 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.477 1.911 . . . . 2.9 114.205 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.7 m -53.14 -55.74 21.78 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.492 -0.755 . . . . 2.77 112.232 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t -164.09 56.55 0.16 Allowed 'General case' 0 C--N 1.344 0.343 0 C-N-CA 119.527 -0.869 . . . . 3.65 111.904 -174.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 40.23 44.99 1.68 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.464 1.506 . . . . 7.03 112.832 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.4 t -171.91 -43.03 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.413 0.685 . . . . 4.11 109.682 -166.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.96 -43.06 99.82 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.998 -1.064 . . . . 2.36 110.393 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -51.55 -39.69 23.57 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 O-C-N 122.053 -0.404 . . . . 3.13 110.203 170.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 t -60.58 -33.46 72.74 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.359 0.412 . . . . 2.82 110.737 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.19 -54.95 10.65 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.037 -1.039 . . . . 2.48 109.895 170.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mp -44.33 -56.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 122.893 0.477 . . . . 3.26 110.919 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.61 -35.42 72.42 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.184 -0.947 . . . . 4.59 112.594 -176.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -67.48 -34.58 77.45 Favored 'General case' 0 N--CA 1.458 -0.035 0 O-C-N 121.082 -1.012 . . . . 8.11 109.779 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -65.41 -48.06 74.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.929 -0.767 . . . . 1.78 108.929 173.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.32 -36.6 68.9 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.704 0.684 . . . . 4.62 112.144 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.85 -22.96 6.07 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.822 0.675 . . . . 1.94 112.822 174.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -110.45 21.1 17.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.103 0.961 . . . . 4.28 112.059 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -72.98 -64.82 0.89 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.229 0.612 . . . . 3.51 109.705 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.35 -123.9 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.439 1.096 . . . . 2.53 108.064 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.84 -0.23 54.37 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 119.039 0.836 . . . . 1.66 114.594 -173.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -82.11 102.79 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.055 1.427 . . . . 2.78 109.275 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -120.56 52.35 1.17 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 122.145 0.974 . . . . 3.35 110.688 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.1 m -159.81 143.86 14.6 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.494 -1.298 . . . . 3.93 107.494 172.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.88 116.69 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 105.663 -1.977 . . . . 3.48 105.663 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pp -139.02 90.39 2.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 119.591 -0.844 . . . . 5.78 111.381 166.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -99.5 163.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.426 -0.796 . . . . 3.87 109.951 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.58 101.73 6.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.568 -1.271 . . . . 2.32 107.568 167.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.75 -17.59 64.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.958 0.903 . . . . 4.26 111.325 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 49.4 mtm -68.58 -55.52 11.32 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.87 0.868 . . . . 5.23 109.941 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.71 -26.88 24.03 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.047 0.539 . . . . 2.27 111.494 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.88 65.86 1.67 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.313 -1.115 . . . . 1.12 110.313 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -141.01 140.9 34.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.909 -1.515 . . . . 3.72 106.909 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.74 110.19 18.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.677 1.191 . . . . 1.92 110.236 170.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.32 134.06 42.73 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.572 -1.64 . . . . 4.52 106.572 168.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.51 168.69 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.217 0.917 . . . . 2.75 111.117 167.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.67 109.85 19.26 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 123.911 0.885 . . . . 4.6 110.228 163.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -98.63 -176.75 3.46 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 127.96 2.504 . . . . 3.62 111.022 170.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -138.06 108.67 8.25 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.861 1.264 . . . . 3.81 109.443 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.59 8.47 1.23 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 124.497 3.465 . . . . 2.54 113.997 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -95.82 -13.92 23.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.276 1.398 . . . . 4.0 111.688 167.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.2 m -130.23 -42.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 118.929 0.786 . . . . 3.85 112.853 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.21 137.42 48.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 N-CA-C 107.21 -1.404 . . . . 2.5 107.21 177.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.5 mm100 -119.67 149.91 49.17 Favored Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 108.219 -1.03 . . . . 3.63 108.219 -175.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -61.04 -35.78 85.48 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.449 2.099 . . . . 1.61 111.308 -173.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -58.21 -45.42 87.65 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.839 -0.538 . . . . 4.37 111.439 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -58.48 -44.76 89.47 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.657 0.783 . . . . 3.62 110.008 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.28 -56.41 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.04 -1.837 . . . . 1.91 106.04 172.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.51 -44.81 95.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.916 -0.584 . . . . 1.79 111.142 -170.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -55.96 -44.27 78.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.747 0.819 . . . . 2.85 110.283 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.56 -42.99 95.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.399 -0.593 . . . . 4.34 109.399 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mm -60.18 -43.34 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.859 -0.526 . . . . 3.2 110.141 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -63.42 -42.41 98.72 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.549 0.739 . . . . 2.92 111.683 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.98 -50.66 72.88 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.582 0.628 . . . . 2.61 109.741 175.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.65 -34.65 67.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.515 0.726 . . . . 2.76 111.62 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.93 37.63 1.24 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.161 0.886 . . . . 1.43 111.093 166.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -133.15 169.46 16.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.773 1.629 . . . . 3.52 107.002 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -113.3 129.32 56.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.315 -0.624 . . . . 2.44 109.315 169.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.06 120.44 38.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.551 -1.648 . . . . 1.6 106.551 168.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.03 133.88 46.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.074 -1.454 . . . . 1.92 107.074 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.15 154.36 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.508 -0.923 . . . . 3.52 108.508 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -5.33 39.01 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.97 -1.014 . . . . 5.83 111.892 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 94.16 7.75 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 129.282 3.033 . . . . 4.3 111.302 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -76.15 0.46 Allowed 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 125.93 1.692 . . . . 7.15 107.946 168.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.11 -44.73 0.05 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.325 1.602 . . . . 6.3 115.325 -160.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.29 100.83 12.55 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.387 1.475 . . . . 5.76 113.9 -157.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.45 63.46 0.21 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.777 -0.929 . . . . 3.36 110.777 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.81 -67.29 0.27 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.943 -0.551 . . . . 5.02 112.076 -175.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -173.88 120.51 0.29 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.546 -1.279 . . . . 4.97 107.546 -168.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.99 -55.0 4.9 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 108.345 -1.902 . . . . 2.61 108.345 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.4 104.18 14.25 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.196 -1.409 . . . . 2.76 107.196 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.02 170.4 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.152 -1.425 . . . . 3.84 107.152 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.33 151.06 46.09 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.497 0.719 . . . . 2.69 111.948 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.2 mt -136.94 146.16 45.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.901 1.28 . . . . 2.95 107.674 -172.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.04 127.9 55.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.392 -1.336 . . . . 2.6 107.392 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.26 117.41 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.37 -1.715 . . . . 2.9 106.37 -171.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.2 p -98.72 141.91 30.93 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.013 -1.106 . . . . 3.69 108.013 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.52 -17.68 28.52 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 119.348 -0.695 . . . . 2.37 113.257 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -79.92 140.46 36.69 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.199 1.5 . . . . 3.17 111.023 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 t -155.37 85.91 1.07 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.216 -1.031 . . . . 5.39 108.216 176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 77.8 m 59.86 -99.2 0.09 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.017 1.327 . . . . 6.78 111.386 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 43.37 -148.49 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.508 1.923 . . . . 6.24 110.7 -168.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.9 t -79.76 -6.31 57.01 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.346 -0.613 . . . . 4.19 109.346 159.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.4 t -59.76 -49.96 75.67 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.39 -0.818 . . . . 3.61 109.817 -167.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.7 p -46.48 -61.19 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.375 1.07 . . . . 3.84 111.447 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -65.04 -31.01 72.03 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.369 0.668 . . . . 4.94 110.579 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -69.08 -48.95 61.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.225 1.01 . . . . 1.99 110.333 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.5 mt -58.95 -47.9 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.216 -1.031 . . . . 2.03 108.216 175.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -50.69 -54.35 23.89 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.508 -0.553 . . . . 2.57 109.508 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.3 t -52.34 -48.06 65.7 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.471 0.708 . . . . 2.22 111.093 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -60.59 -39.05 86.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.216 -0.928 . . . . 3.19 111.201 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 25.5 mt -71.25 -61.65 1.69 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.196 -1.038 . . . . 2.63 108.196 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 74.0 p -59.31 -19.21 44.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.323 1.049 . . . . 2.82 112.736 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -57.15 -36.24 70.5 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 119.291 -0.385 . . . . 5.22 110.7 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 t -75.33 174.84 9.01 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.649 0.738 . . . . 3.78 111.597 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -85.27 -47.72 9.78 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.11 0.964 . . . . 2.28 111.428 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.72 -35.56 80.56 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-O 119.974 -0.348 . . . . 1.25 112.916 -170.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.67 119.08 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 117.552 0.676 . . . . 4.07 109.339 -172.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.8 m -95.72 -47.13 6.32 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 109.658 -0.497 . . . . 3.04 109.658 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -142.55 92.54 2.42 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 112.859 0.688 . . . . 5.03 112.859 -176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.42 145.13 24.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.665 -1.235 . . . . 2.0 107.665 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 m -141.76 109.31 5.64 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.572 -0.899 . . . . 2.78 108.572 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.3 p -99.91 124.73 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.918 1.287 . . . . 3.32 109.475 -177.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.32 88.27 2.91 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.309 1.443 . . . . 2.15 109.626 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 pp -66.18 -20.84 66.26 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 125.408 1.483 . . . . 3.16 113.295 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.57 97.56 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.382 0.537 . . . . 2.59 109.965 176.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -19.09 20.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.893 1.277 . . . . 2.38 110.41 175.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.5 m 65.83 37.18 5.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.167 1.387 . . . . 2.15 110.647 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.96 157.45 37.76 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.43 0.559 . . . . 3.87 109.499 171.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.42 131.58 26.43 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.128 0.971 . . . . 2.01 109.386 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.92 129.68 45.26 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.942 1.697 . . . . 3.44 107.166 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.15 124.45 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.263 1.425 . . . . 3.62 110.49 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.65 94.74 5.15 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 107.57 -1.27 . . . . 5.13 107.57 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -111.12 -177.71 3.28 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 124.239 0.962 . . . . 2.91 110.397 174.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.86 116.69 60.4 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 108.255 -1.017 . . . . 2.85 108.255 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -81.32 68.55 8.16 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.893 2.396 . . . . 1.96 111.135 -167.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -165.86 -44.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.748 1.219 . . . . 3.33 109.669 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.8 pt -79.72 -38.23 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 123.109 0.564 . . . . 2.67 111.136 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.54 158.28 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 123.576 0.75 . . . . 2.48 109.118 175.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -124.07 168.76 16.17 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.861 1.22 . . . . 1.94 110.452 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.0 -41.88 6.96 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.718 2.279 . . . . 1.76 110.383 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.48 -39.59 57.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.678 0.791 . . . . 7.6 112.487 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.95 -49.58 75.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.667 0.787 . . . . 3.95 109.332 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.21 -47.28 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.563 -0.903 . . . . 2.04 108.563 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 95.2 mt -52.52 -59.25 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.538 -0.912 . . . . 2.83 108.538 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -49.05 -48.86 43.66 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 119.159 0.891 . . . . 5.14 112.431 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 mm -51.59 -53.51 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.82 -0.437 . . . . 3.7 109.82 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.315 2.0 pp -70.75 -26.99 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 114.385 1.254 . . . . 2.57 114.385 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.36 -43.5 96.47 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 119.359 0.981 . . . . 2.65 109.078 169.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -63.97 -38.29 90.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.18 -0.674 . . . . 3.21 109.18 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.44 -44.84 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 122.227 -0.296 . . . . 1.89 110.257 171.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.38 23.85 5.58 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.536 1.541 . . . . 1.35 112.629 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -100.59 178.78 4.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.268 1.534 . . . . 4.04 108.802 164.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -136.93 130.39 31.52 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.146 -1.798 . . . . 5.05 106.146 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.98 97.24 5.18 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.717 1.607 . . . . 2.47 108.073 -171.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.7 p -143.22 134.17 25.52 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.269 -0.641 . . . . 2.84 109.269 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.31 -94.35 0.0 OUTLIER 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.138 1.375 . . . . 9.0 109.12 170.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 37.47 36.38 0.08 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.445 1.898 . . . . 6.97 113.367 -169.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.224 -1.37 . . . . 6.5 110.912 -176.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 107.845 -1.169 . . . . 10.3 107.845 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.03 123.03 87.97 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.824 0.738 . . . . 4.55 109.376 -174.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.11 107.37 2.47 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.84 1.694 . . . . 3.16 111.025 -172.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -125.92 146.24 49.93 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.762 1.625 . . . . 3.08 106.733 176.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -104.37 154.48 19.78 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.704 0.802 . . . . 5.24 110.812 179.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 54.1 t -143.19 140.72 30.87 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.42 0.688 . . . . 3.02 110.939 170.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -109.57 92.3 3.99 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.076 2.15 . . . . 4.79 109.698 -173.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.262 1.5 pp -119.07 164.58 15.3 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.068 0.937 . . . . 3.74 112.195 176.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.15 154.72 18.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.487 -1.301 . . . . 2.45 107.487 166.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.4 mm -97.78 145.45 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 106.628 -1.619 . . . . 2.0 106.628 160.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -123.77 123.13 39.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.039 -1.837 . . . . 4.57 106.039 158.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.04 -81.38 0.19 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 108.792 -1.723 . . . . 1.31 108.792 -172.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 28.43 73.15 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.064 2.146 . . . . 2.84 115.335 178.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -16.63 2.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.214 1.406 . . . . 3.42 113.781 174.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.8 t 78.25 -48.67 0.47 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.745 1.618 . . . . 3.95 112.433 173.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.25 -70.29 0.11 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.448 1.499 . . . . 5.74 111.776 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 p -159.96 15.13 0.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.13 0.572 . . . . 3.21 112.43 172.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.7 m -70.69 -48.3 55.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.573 -0.705 . . . . 2.52 109.385 -168.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.0 t -47.96 -51.69 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.365 -0.976 . . . . 3.11 108.365 172.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -59.22 -34.29 72.0 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.906 1.282 . . . . 1.99 113.675 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -45.52 58.77 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.233 -0.292 . . . . 3.01 110.321 172.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.6 mt -56.23 -47.34 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.895 0.878 . . . . 2.34 109.213 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -47.63 -53.45 14.76 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.391 0.676 . . . . 4.48 110.837 175.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.0 mtt85 -67.9 -30.21 69.5 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.629 0.771 . . . . 7.25 112.378 -175.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -69.07 -55.77 9.76 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.75 -0.833 . . . . 1.36 108.75 175.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -61.06 -36.07 78.63 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.067 0.547 . . . . 4.58 110.792 -176.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -24.61 6.2 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.896 0.702 . . . . 3.33 112.896 171.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -119.55 30.22 7.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.748 0.819 . . . . 4.92 111.537 178.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -77.8 -89.27 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 105.686 -1.968 . . . . 3.3 105.686 163.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.54 -91.24 0.06 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.489 0.716 . . . . 2.22 111.044 177.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.27 -15.75 68.44 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.287 -0.729 . . . . 1.84 112.593 -171.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.45 109.71 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 CA-C-N 118.102 0.951 . . . . 3.01 109.168 177.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.3 mt -138.59 50.59 1.86 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.89 -0.782 . . . . 4.85 108.89 177.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 t -159.86 152.68 21.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.217 -1.771 . . . . 3.15 106.217 159.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.17 102.07 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.122 -1.807 . . . . 3.3 106.122 -178.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -127.24 74.2 1.49 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.419 -1.697 . . . . 3.95 106.419 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.13 123.66 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.427 -0.953 . . . . 3.08 108.427 174.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.75 92.65 6.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.692 -1.966 . . . . 2.45 105.692 169.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 tp -54.71 -30.04 54.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.24 1.416 . . . . 4.49 110.192 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 31.7 mtt -66.51 -54.32 25.24 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.418 0.687 . . . . 4.08 110.421 -178.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.11 -23.59 28.4 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.151 0.58 . . . . 2.17 111.484 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.54 63.78 2.28 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.059 1.314 . . . . 1.23 110.9 -176.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.0 pttm -140.98 140.58 34.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.751 -1.203 . . . . 4.05 107.751 170.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.72 104.44 11.36 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 124.435 1.084 . . . . 2.12 112.975 173.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -98.01 125.76 43.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.259 -1.385 . . . . 4.31 107.259 172.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.0 mt -126.06 163.29 28.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 107.027 -1.471 . . . . 3.74 107.027 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -123.98 105.75 9.84 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.435 -0.95 . . . . 4.8 108.435 165.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -117.54 159.8 22.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.397 1.479 . . . . 4.15 110.027 172.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -98.95 111.15 60.05 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.931 0.893 . . . . 3.74 110.297 -179.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.08 -3.84 7.92 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.076 3.184 . . . . 2.2 113.623 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -73.25 -44.99 58.43 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 120.07 1.305 . . . . 4.64 110.741 169.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -108.59 -30.22 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 122.175 -0.328 . . . . 3.84 111.427 -165.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.51 131.96 69.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 108.655 -0.868 . . . . 2.58 108.655 177.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.02 150.7 39.05 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.605 1.562 . . . . 2.91 109.773 -177.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -51.94 -52.58 8.65 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.37 2.713 . . . . 1.51 112.247 179.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -60.4 -43.76 96.35 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.419 -0.8 . . . . 4.17 111.265 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -57.77 -37.62 73.99 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.944 0.498 . . . . 3.94 111.101 174.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.31 -50.11 67.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 107.568 -1.271 . . . . 2.28 107.568 171.175 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.84 -43.87 77.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.988 -0.551 . . . . 2.65 110.203 -175.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -53.12 -46.84 68.94 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.305 0.502 . . . . 2.74 110.75 175.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -48.79 79.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.002 0.43 . . . . 3.83 110.371 177.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -64.53 -44.04 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 121.961 -0.462 . . . . 3.32 111.012 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -42.69 98.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.448 1.099 . . . . 2.71 110.247 176.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.77 -49.15 77.55 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.39 0.541 . . . . 2.6 109.974 177.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 mt -56.24 -37.03 69.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.399 0.279 . . . . 2.77 111.583 174.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.94 26.51 2.75 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.239 0.923 . . . . 1.46 112.242 167.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -118.5 167.72 11.33 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.35 1.46 . . . . 3.21 107.96 176.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -98.55 143.74 28.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.373 -0.973 . . . . 2.59 108.373 163.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.74 135.16 48.13 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.801 0.84 . . . . 2.08 108.79 162.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.63 138.72 30.91 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.912 0.885 . . . . 2.48 109.731 171.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 p -87.19 152.84 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 125.613 1.565 . . . . 3.58 109.499 178.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.7 mtt -51.26 -53.25 37.29 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 123.371 0.419 . . . . 4.48 111.605 178.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -166.77 70.96 0.11 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.512 -0.922 . . . . 5.1 108.512 -172.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -21.86 101.16 0.02 OUTLIER 'General case' 0 C--N 1.341 0.203 0 C-N-CA 126.663 1.985 . . . . 10.43 114.704 -162.09 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.422 ' CZ ' ' HA3' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -136.26 -67.58 0.51 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.611 -1.631 . . . . 7.3 107.559 -161.056 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 99.41 -85.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.494 2.317 . . . . 4.61 109.853 176.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.422 ' HA3' ' CZ ' ' A' ' 75' ' ' TYR . . . 107.6 69.2 0.68 Allowed Glycine 0 C--N 1.336 0.537 0 N-CA-C 115.885 1.114 . . . . 2.87 115.885 163.121 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.88 -73.58 0.16 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 118.953 -1.099 . . . . 4.44 113.616 -173.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -150.4 144.88 25.73 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 103.961 -2.607 . . . . 4.96 103.961 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.83 -32.37 1.47 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.441 1.018 . . . . 2.07 112.004 -178.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.01 114.44 8.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.067 -1.457 . . . . 2.37 107.067 173.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -128.01 160.85 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.405 -1.331 . . . . 3.78 107.405 176.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.8 153.83 28.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.23 -1.026 . . . . 3.97 108.23 169.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 mp -133.01 141.21 48.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.705 0.802 . . . . 3.42 109.027 163.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.4 m -94.74 125.97 39.75 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.356 -1.72 . . . . 3.82 106.356 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.8 mt -101.52 123.36 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.241 -0.651 . . . . 4.75 109.241 -174.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.5 m -96.5 124.65 40.56 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.819 -1.178 . . . . 2.66 107.819 172.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 117.22 -34.82 4.41 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.95 1.262 . . . . 1.34 112.161 175.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 55.7 ttp -50.44 120.52 4.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.998 0.899 . . . . 3.32 110.98 177.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.4 6.18 1.27 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.526 0.935 . . . . 4.4 113.526 -170.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.4 t -156.01 142.21 18.32 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.084 1.311 . . . . 3.41 111.243 -178.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.19 64.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.568 1.147 . . . . 4.04 112.271 -175.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.24 -49.5 66.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.124 0.97 . . . . 3.57 110.739 171.33 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 88.4 m -64.17 -46.56 83.48 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.011 -0.737 . . . . 2.21 109.011 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.2 t -47.67 -59.0 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.279 1.032 . . . . 2.62 109.778 175.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -57.68 -44.33 85.73 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 122.997 0.519 . . . . 5.73 111.285 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -62.69 -47.66 82.67 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.836 0.455 . . . . 1.85 110.627 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.35 -48.75 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.744 -0.836 . . . . 1.96 108.744 177.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -59.74 -46.45 89.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.427 -0.582 . . . . 3.1 109.427 178.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.6 t -52.0 -46.64 64.99 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.577 0.626 . . . . 1.77 110.811 174.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -60.18 -50.65 72.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.747 -0.596 . . . . 3.98 110.89 177.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.7 mt -58.0 -56.81 17.15 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 118.378 0.536 . . . . 3.29 109.587 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 33.3 m -50.04 -19.15 0.66 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.144 1.778 . . . . 2.74 112.912 173.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -67.37 -16.46 64.26 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.058 0.845 . . . . 6.13 112.251 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.0 m -72.38 155.0 40.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.169 1.387 . . . . 2.42 110.838 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -74.47 -52.82 10.91 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.962 0.905 . . . . 2.65 111.7 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.36 -37.75 80.13 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.786 -0.525 . . . . 1.53 111.786 -172.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.51 136.94 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.706 -0.85 . . . . 2.83 108.706 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.8 m -137.22 -12.92 1.61 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.482 -0.761 . . . . 4.39 112.394 171.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.91 118.34 10.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.786 -2.301 . . . . 3.53 104.786 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.49 161.04 28.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.314 -1.365 . . . . 1.83 107.314 166.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.0 m -141.07 111.96 7.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 118.915 -0.564 . . . . 2.45 109.505 161.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.71 134.52 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.641 0.776 . . . . 2.86 110.542 171.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.65 108.47 5.67 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.53 1.157 . . . . 2.5 110.967 -171.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.71 -41.18 98.13 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.544 1.937 . . . . 5.37 112.081 -173.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.22 62.45 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.277 0.631 . . . . 3.07 111.094 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 -15.81 15.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.455 1.902 . . . . 2.83 110.199 -177.252 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.1 t 71.56 20.27 4.83 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.517 2.327 . . . . 2.71 112.145 168.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -131.55 172.82 11.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.271 0.558 . . . . 3.48 110.741 177.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.06 134.35 48.07 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.739 1.216 . . . . 2.33 109.377 170.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.39 123.35 35.65 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 104.484 -2.413 . . . . 2.75 104.484 172.429 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.4 t -124.14 129.39 74.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.372 -1.344 . . . . 2.75 107.372 -176.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.12 88.15 2.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.7 -1.222 . . . . 4.37 107.7 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -113.04 164.71 13.13 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.055 0.942 . . . . 2.93 111.311 174.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -99.04 116.63 65.11 Favored Pre-proline 0 C--O 1.237 0.423 0 C-N-CA 123.932 0.893 . . . . 3.01 109.344 177.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -78.22 68.22 7.97 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.236 2.624 . . . . 2.21 111.546 -173.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.54 -47.34 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.245 1.018 . . . . 3.22 109.348 173.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -81.59 -30.88 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 122.922 0.489 . . . . 2.49 110.924 -177.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -135.25 163.39 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.91 -0.774 . . . . 2.31 108.91 176.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.49 163.54 28.18 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.488 -1.445 . . . . 2.1 109.488 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.45 -35.67 81.54 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.857 3.038 . . . . 2.49 112.565 -170.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -40.62 75.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.92 -0.488 . . . . 8.44 111.316 -175.258 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.92 -38.99 72.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 119.148 -1.021 . . . . 3.85 109.969 -177.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 83.4 mt -56.65 -48.68 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.674 -0.862 . . . . 2.42 108.674 173.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.9 mt -50.51 -60.33 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 118.111 -0.947 . . . . 3.95 108.671 173.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -51.47 -44.71 62.51 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.959 1.254 . . . . 5.39 112.469 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.4 mm -56.05 -54.39 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.449 -0.782 . . . . 3.22 109.491 176.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.256 2.5 pp -68.18 -25.53 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 120.861 -1.149 . . . . 3.07 113.392 -178.498 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.34 -39.52 87.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.954 0.797 . . . . 3.51 109.932 168.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.77 -40.59 97.76 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.994 -0.743 . . . . 3.81 108.994 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.8 mt -66.41 -43.09 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 110.02 -0.363 . . . . 2.12 110.02 173.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.01 33.42 4.96 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.647 1.594 . . . . 0.97 111.536 -175.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -103.81 177.3 4.88 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.403 1.102 . . . . 3.68 109.264 166.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -129.79 121.98 27.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.176 -1.787 . . . . 5.13 106.176 172.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.84 113.27 26.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.574 1.15 . . . . 2.11 108.691 179.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.1 m -110.66 98.61 7.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.758 1.623 . . . . 2.65 107.991 -173.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.59 98.71 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.186 1.794 . . . . 6.37 111.003 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 48.53 45.19 21.12 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.74 0.816 . . . . 6.15 111.289 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 . . . . . 0 C--O 1.248 1.006 0 N-CA-C 106.537 -1.653 . . . . 9.85 106.537 -175.587 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 mtm . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 107.081 -1.451 . . . . 11.56 107.081 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.52 71.04 25.85 Favored Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 124.349 1.031 . . . . 7.72 109.508 -178.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.35 149.37 75.26 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.449 1.432 . . . . 6.52 108.998 174.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -98.96 175.59 5.88 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.916 1.286 . . . . 5.12 107.544 176.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -96.79 142.66 28.53 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.697 0.681 . . . . 5.42 111.572 -172.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.0 t -141.1 126.53 18.74 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.077 0.551 . . . . 3.32 111.826 172.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -97.43 101.69 13.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.255 2.222 . . . . 4.76 108.187 175.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.34 167.35 11.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 122.344 1.069 . . . . 4.24 108.616 173.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.63 136.86 33.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.641 -0.874 . . . . 2.1 108.641 175.204 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.02 138.06 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 105.34 -2.096 . . . . 2.18 105.34 -178.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -106.95 125.17 50.65 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.201 -1.037 . . . . 4.15 108.201 170.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.23 -88.23 0.28 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.787 1.66 . . . . 1.76 109.494 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.4 mpt? 66.13 144.32 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.502 1.921 . . . . 2.82 112.416 -169.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -109.34 -19.08 13.41 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.495 1.118 . . . . 3.4 110.702 172.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.4 t 65.73 -65.23 0.18 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.183 1.793 . . . . 3.25 112.001 -170.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.36 -73.25 0.02 OUTLIER 'General case' 0 C--N 1.342 0.264 0 C-N-CA 128.083 2.553 . . . . 6.7 113.413 -175.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.63 13.07 0.09 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.006 0.743 . . . . 3.36 113.006 166.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.3 m -74.85 -41.57 59.59 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 120.169 -1.582 . . . . 3.13 110.768 -171.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.87 -31.86 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.878 -0.786 . . . . 2.96 108.878 176.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -61.06 -52.13 66.24 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.919 -0.488 . . . . 2.21 110.72 170.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -53.15 -45.76 68.55 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.877 -1.139 . . . . 2.96 110.833 175.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -43.88 -38.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.61 1.164 . . . . 2.64 111.613 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -52.24 -58.41 6.7 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.268 0.627 . . . . 4.84 111.469 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -67.11 -37.58 84.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.655 -0.498 . . . . 4.99 109.655 -176.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -55.68 -56.8 16.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.414 -0.587 . . . . 1.37 109.414 178.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 mp -61.18 -42.43 98.56 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.822 0.737 . . . . 3.39 110.969 177.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -22.25 18.84 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.781 0.719 . . . . 2.15 112.537 178.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -113.01 16.53 19.32 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.414 0.894 . . . . 3.91 113.414 175.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.41 -69.5 0.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.265 -1.013 . . . . 3.16 108.265 165.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.13 -134.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.163 1.385 . . . . 3.07 107.951 -176.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.11 35.69 1.28 Allowed Glycine 0 CA--C 1.538 1.499 0 CA-C-N 120.255 1.389 . . . . 2.74 114.847 -172.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.89 77.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 125.306 1.443 . . . . 2.77 109.454 175.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.47 51.55 0.77 Allowed 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 108.602 -0.888 . . . . 4.46 108.602 -172.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -163.79 126.02 2.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.607 -1.257 . . . . 2.59 107.607 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.1 t -128.48 114.52 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.998 -1.482 . . . . 3.73 106.998 176.255 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -123.68 79.57 1.71 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.612 -1.255 . . . . 4.45 107.612 174.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 t -97.76 128.26 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 109.054 -0.721 . . . . 3.31 109.054 173.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.31 86.81 3.99 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.333 -1.358 . . . . 3.23 107.333 176.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.8 mt -57.25 -5.38 0.29 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.958 1.096 . . . . 4.05 113.958 176.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 28.5 mtp -97.66 -42.51 7.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.268 1.427 . . . . 4.19 110.468 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.3 -38.12 12.25 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.644 0.778 . . . . 3.18 110.879 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.89 60.14 1.04 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 126.216 1.865 . . . . 1.82 111.649 173.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -138.19 137.47 37.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 105.412 -2.07 . . . . 4.59 105.412 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.5 92.94 4.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.185 0.928 . . . . 2.03 110.119 169.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.04 111.63 23.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.112 -2.551 . . . . 6.19 104.112 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 pt -117.38 174.94 3.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 O-C-N 120.325 -1.484 . . . . 3.5 108.414 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -131.12 108.61 9.87 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.924 -0.399 . . . . 6.05 109.924 170.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -117.32 164.78 14.32 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.618 1.567 . . . . 4.09 113.288 174.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -99.0 106.12 36.0 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.646 1.978 . . . . 4.2 109.978 177.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.05 9.66 0.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.354 2.703 . . . . 3.61 113.701 -171.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -97.85 -21.32 16.98 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.535 0.734 . . . . 5.1 111.038 173.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.9 t -111.01 -62.45 2.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 N-CA-C 108.34 -0.985 . . . . 4.88 108.34 -175.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.96 144.42 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 N-CA-C 109.115 -0.698 . . . . 3.07 109.115 176.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -113.49 151.78 44.77 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 125.008 1.323 . . . . 3.66 108.328 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.26 -39.38 85.21 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.716 2.277 . . . . 2.22 111.314 -175.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -38.4 69.61 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.461 -0.774 . . . . 4.16 112.505 -178.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -57.3 -43.65 83.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.998 -0.741 . . . . 3.26 108.998 172.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.2 -47.56 55.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 108.51 -0.922 . . . . 2.33 108.51 168.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.49 -38.69 78.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 119.898 -0.721 . . . . 2.43 110.266 -171.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -52.65 -50.85 62.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.047 0.939 . . . . 3.09 109.971 177.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -48.15 70.54 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.501 -0.555 . . . . 3.68 109.501 177.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.5 mm -62.77 -39.85 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 122.164 -0.335 . . . . 3.28 111.08 -178.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -67.38 -42.92 82.59 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.813 -0.439 . . . . 2.64 109.813 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -60.58 -49.9 75.67 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.029 0.532 . . . . 2.32 109.878 176.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.61 -36.42 69.42 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.02 0.528 . . . . 2.85 111.032 175.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.24 41.67 0.95 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.127 -0.789 . . . . 1.47 111.127 165.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -132.59 162.88 30.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.277 1.031 . . . . 4.39 109.168 -174.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -93.17 124.11 36.91 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 106.914 -1.513 . . . . 2.69 106.914 171.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.38 124.63 43.16 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.853 -1.165 . . . . 2.27 107.853 167.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.66 113.46 9.71 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.789 -0.819 . . . . 2.06 108.789 172.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 t -72.83 158.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.836 0.855 . . . . 3.85 110.171 -178.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.4 mtt -77.53 -4.75 47.24 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.296 0.85 . . . . 5.0 113.296 174.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 81.67 18.56 0.4 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.594 1.957 . . . . 5.12 111.732 -177.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -83.13 -37.09 24.22 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.266 -0.896 . . . . 7.46 108.71 165.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.497 ' CE1' ' ND2' ' A' ' 81' ' ' ASN 0.336 14.9 p90 54.69 -63.69 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 129.958 3.303 . . . . 5.16 113.958 -179.489 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 148.99 82.56 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 129.023 2.929 . . . . 4.14 111.517 175.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.93 104.96 3.18 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 110.172 -1.171 . . . . 3.14 110.172 -175.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.71 -47.62 0.09 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.535 0.569 . . . . 4.69 112.535 -170.235 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -134.55 109.18 8.52 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.029 -1.471 . . . . 4.48 107.029 -165.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.81 -51.17 4.52 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 109.592 -1.403 . . . . 3.08 109.592 176.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.497 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 21.4 t-20 -115.21 122.92 47.51 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.682 -2.34 . . . . 3.45 104.682 175.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.71 158.9 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.553 -1.277 . . . . 4.23 107.553 168.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.7 157.32 39.36 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 123.333 0.653 . . . . 3.33 109.471 171.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 pp -147.31 161.6 40.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.585 -0.734 . . . . 3.64 110.333 172.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.9 126.3 44.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.15 -1.426 . . . . 2.2 107.15 173.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.65 127.08 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.57 -0.9 . . . . 2.99 108.57 176.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.6 m -118.02 112.08 19.79 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.034 -1.099 . . . . 2.47 108.034 176.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.96 -25.76 1.15 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.656 1.122 . . . . 1.8 111.386 -172.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.9 tpp -61.25 120.72 10.92 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 121.978 -0.719 . . . . 3.75 111.389 -174.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.7 t -130.49 4.92 4.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.29 0.636 . . . . 3.58 111.463 176.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.27 153.12 6.41 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 120.654 -1.278 . . . . 4.41 111.682 177.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.89 -32.62 66.06 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.319 0.647 . . . . 3.89 111.148 173.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.9 t -51.99 -43.95 63.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.949 0.5 . . . . 3.21 110.525 171.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.5 m -63.91 -53.51 49.22 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 108.41 -0.959 . . . . 2.61 108.41 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 82.1 t -43.39 -54.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.194 0.998 . . . . 2.35 110.71 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -59.05 -40.0 83.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.685 -0.234 . . . . 5.14 110.958 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -66.89 -46.34 75.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.874 -0.516 . . . . 1.84 110.579 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.6 mm -55.65 -50.46 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.616 -0.883 . . . . 3.11 108.616 176.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -59.75 -45.54 91.91 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 118.842 -0.599 . . . . 2.11 110.057 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.3 m -55.44 -39.87 70.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.826 0.739 . . . . 3.49 111.622 175.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.44 -39.27 81.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.016 -0.428 . . . . 3.65 111.193 175.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.92 -58.25 5.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.338 -0.986 . . . . 2.57 108.338 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.9 p -57.27 -15.39 5.96 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.597 1.159 . . . . 2.63 113.13 176.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -35.66 64.26 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.517 -0.739 . . . . 6.99 111.583 167.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.8 m -66.85 144.77 56.08 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.632 1.573 . . . . 2.69 111.1 -175.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -68.17 -47.3 68.35 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.011 0.925 . . . . 2.85 111.432 177.114 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.27 -21.75 74.92 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.62 -0.544 . . . . 1.98 113.139 -168.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.2 156.77 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.596 -0.89 . . . . 3.28 108.596 177.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.9 m -140.0 -39.8 0.45 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.39 -0.819 . . . . 4.35 112.348 168.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.39 95.02 4.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.94 -1.504 . . . . 3.8 106.94 -168.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -96.51 155.32 16.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.984 -1.117 . . . . 2.34 107.984 168.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.3 m -140.22 111.27 7.01 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.005 -0.434 . . . . 2.43 110.276 159.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.19 133.38 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.749 1.219 . . . . 2.95 110.657 -178.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.92 104.92 5.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.594 1.158 . . . . 2.28 110.803 -171.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 pp -70.53 -21.6 62.71 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 124.204 1.002 . . . . 3.84 112.649 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.41 91.39 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.398 -0.593 . . . . 2.74 109.398 -179.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.07 -34.48 16.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.941 0.897 . . . . 2.91 110.049 170.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.96 45.51 0.15 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.312 -0.996 . . . . 3.61 108.312 -168.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.06 167.72 20.43 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.852 -0.613 . . . . 4.8 111.592 165.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.5 141.83 46.85 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.624 1.169 . . . . 2.26 108.695 171.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.53 137.92 36.49 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.127 -1.805 . . . . 3.21 106.127 168.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.16 129.89 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.484 -0.932 . . . . 4.03 108.484 -179.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.83 105.57 13.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.079 -1.082 . . . . 4.4 108.079 -176.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -137.04 168.75 18.99 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.172 0.92 . . . . 3.33 111.714 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -97.29 115.79 65.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.681 -0.488 . . . . 3.79 109.681 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.36 55.06 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.343 2.696 . . . . 2.59 112.552 -166.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -143.76 -51.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.489 1.516 . . . . 3.74 108.012 172.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pt -77.38 -31.75 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 122.438 -0.163 . . . . 3.6 110.987 -176.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.88 163.54 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.985 -0.746 . . . . 2.8 108.985 -178.03 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.75 164.73 31.82 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.256 -1.137 . . . . 2.19 110.256 -176.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -61.55 -38.5 62.07 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.575 2.85 . . . . 2.13 111.817 -168.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -31.83 62.95 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 113.086 0.772 . . . . 7.98 113.086 -176.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.87 -40.63 65.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 118.498 -1.281 . . . . 3.31 110.231 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.3 -48.14 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.543 -0.91 . . . . 2.28 108.543 171.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.18 -60.99 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 108.799 -0.815 . . . . 3.22 108.799 174.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.98 -50.23 19.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.14 0.882 . . . . 5.19 113.147 178.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.8 -53.57 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 121.933 -0.479 . . . . 3.15 109.858 177.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.268 2.5 pp -68.16 -29.24 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.287 -0.883 . . . . 2.53 113.278 -177.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.71 -41.98 78.35 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.158 0.89 . . . . 4.0 109.54 169.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -61.45 -40.26 93.85 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.41 0.684 . . . . 3.76 109.295 -179.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.9 mt -68.91 -38.95 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 122.865 0.466 . . . . 2.25 110.153 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.16 33.49 6.55 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.975 1.274 . . . . 1.07 110.771 -171.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -99.48 175.03 5.98 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 107.914 -1.143 . . . . 4.77 107.914 167.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -135.25 121.7 20.53 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.01 -1.478 . . . . 5.27 107.01 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.03 100.89 10.18 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.613 1.165 . . . . 2.46 109.56 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.6 m -99.13 104.12 16.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.394 -0.965 . . . . 2.39 108.394 174.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 mt -48.03 107.74 0.14 Allowed 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 125.323 1.449 . . . . 7.32 108.346 171.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -84.4 -31.23 24.79 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.606 -0.887 . . . . 4.47 108.606 175.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 127.563 2.345 . . . . 9.53 112.678 165.462 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 117.63 -1.176 . . . . 10.32 107.829 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.23 99.56 40.23 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 124.162 0.985 . . . . 5.37 109.07 -171.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.64 143.83 30.88 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.571 2.847 . . . . 4.02 110.232 -175.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -133.68 154.44 50.93 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.75 0.42 . . . . 3.71 110.734 -171.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -123.84 147.09 47.91 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 124.604 1.161 . . . . 5.96 110.292 -179.037 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.17 137.15 51.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.693 -1.225 . . . . 2.86 107.693 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -121.64 96.08 4.93 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.786 -1.19 . . . . 5.54 107.786 -172.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.2 177.4 4.74 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.711 0.767 . . . . 3.93 111.095 -176.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.18 149.42 49.98 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.693 1.597 . . . . 1.96 107.19 166.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mm -103.11 126.35 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 106.859 -1.534 . . . . 2.27 106.859 175.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -107.24 138.11 44.04 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.158 -1.053 . . . . 3.72 108.158 160.328 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 144.84 -88.32 0.17 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.342 1.449 . . . . 1.07 109.685 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt 55.86 73.89 0.41 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.263 1.425 . . . . 2.29 113.554 171.125 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m -50.12 -59.95 3.42 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.072 0.768 . . . . 2.85 113.072 -178.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 t -170.01 63.08 0.05 OUTLIER 'General case' 0 C--N 1.343 0.323 0 CA-C-N 118.522 0.601 . . . . 4.67 110.119 -175.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 41.89 47.97 3.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.887 1.275 . . . . 5.86 112.898 176.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.01 -40.1 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.451 0.7 . . . . 2.67 110.905 -174.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -67.63 -42.59 82.05 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.029 -1.044 . . . . 2.3 109.733 -177.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.38 -32.59 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 O-C-N 121.219 -0.925 . . . . 2.59 109.955 170.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -62.69 -25.8 68.34 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.597 -1.314 . . . . 2.01 112.133 173.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.95 -36.85 70.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.2 -0.937 . . . . 2.78 110.42 173.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 mt -49.51 -42.76 17.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-O 118.91 -0.567 . . . . 3.82 110.496 174.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -46.2 -58.41 3.68 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.377 0.535 . . . . 5.88 111.519 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -66.83 -39.93 87.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.981 0.512 . . . . 5.1 110.053 -173.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -58.42 -58.24 9.41 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.777 -0.647 . . . . 1.19 109.289 178.215 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.77 -39.67 92.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 119.176 -0.44 . . . . 3.54 111.058 -177.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.67 -34.71 3.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.67 0.788 . . . . 2.5 111.604 172.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -121.7 29.58 7.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.296 0.639 . . . . 3.83 111.914 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -72.87 -69.1 0.43 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.888 -0.782 . . . . 3.8 108.888 170.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.78 -143.37 0.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.014 0.926 . . . . 1.93 108.805 -167.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.9 -15.07 40.7 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 119.144 0.884 . . . . 1.55 114.039 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.3 79.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.567 1.147 . . . . 2.52 112.351 -177.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.86 52.52 1.68 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.225 1.012 . . . . 3.59 109.34 -178.344 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 m -160.48 145.05 14.3 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.305 -0.872 . . . . 3.77 109.099 172.422 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.9 t -140.87 112.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.046 -2.205 . . . . 3.61 105.046 171.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -131.57 79.83 1.9 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.496 0.665 . . . . 4.4 110.065 175.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 p -98.98 150.75 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 115.81 -0.632 . . . . 3.56 109.624 173.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.17 113.34 15.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.784 -1.191 . . . . 2.67 107.784 163.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 tp -62.67 -32.78 73.91 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.554 1.542 . . . . 4.27 109.869 176.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 28.7 mtt -57.62 -55.63 32.37 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.383 0.611 . . . . 3.76 110.192 -177.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.28 -21.6 25.67 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.268 -0.878 . . . . 2.62 110.928 -177.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.39 53.28 6.84 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 110.27 -1.132 . . . . 1.37 110.27 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -128.17 130.65 48.37 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.126 -1.435 . . . . 5.06 107.126 178.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.55 107.6 18.52 Favored 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 125.259 1.424 . . . . 2.27 109.194 167.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -99.29 131.87 45.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.751 -1.574 . . . . 4.6 106.751 166.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.73 163.91 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 119.104 0.865 . . . . 3.33 111.338 161.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.38 106.83 15.43 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.274 2.23 . . . . 9.34 107.562 175.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -106.76 -179.48 3.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.338 1.055 . . . . 4.07 113.14 171.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.66 118.88 14.75 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.238 1.415 . . . . 3.25 108.033 175.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.65 -16.43 38.03 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.9 3.067 . . . . 3.16 113.069 -165.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -72.44 -11.82 60.84 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.981 0.363 . . . . 3.56 111.981 -177.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.08 -46.93 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 123.438 0.695 . . . . 3.79 111.227 -170.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.12 152.47 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.141 0.576 . . . . 2.42 109.99 174.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -127.08 156.96 73.6 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 125.316 1.446 . . . . 2.59 109.696 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.19 -9.7 27.01 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.368 2.045 . . . . 1.66 112.276 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mp -73.54 -61.88 1.68 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.59 0.756 . . . . 3.43 110.159 172.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -32.41 73.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.481 -0.327 . . . . 5.05 111.195 -174.2 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.5 tt -58.79 -51.04 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.66 -1.607 . . . . 2.57 106.66 173.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.85 98.1 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.267 -0.424 . . . . 1.97 110.225 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -55.53 -46.41 77.08 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.433 -0.581 . . . . 2.42 109.433 174.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.24 -49.81 74.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.128 -0.693 . . . . 3.69 109.128 -177.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.6 mm -55.57 -47.19 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 121.926 -0.484 . . . . 3.74 111.505 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.47 -47.56 81.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.989 0.516 . . . . 2.47 111.331 176.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.67 -49.82 71.67 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.42 0.688 . . . . 2.38 110.391 -178.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.34 -43.24 53.99 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.761 1.224 . . . . 3.06 110.528 173.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.18 40.36 0.34 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 111.123 -0.791 . . . . 1.47 111.123 162.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -137.81 160.86 38.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.058 -0.719 . . . . 4.24 109.058 -175.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -98.52 117.39 32.83 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.595 -1.261 . . . . 2.77 107.595 170.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.57 111.45 23.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.409 -1.7 . . . . 2.03 106.409 164.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.02 154.59 46.49 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 106.708 -1.59 . . . . 1.83 106.708 169.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.02 148.59 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 115.446 -0.797 . . . . 4.9 109.202 -172.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.4 ptm -62.06 -39.41 92.3 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.016 -0.673 . . . . 4.83 111.066 177.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 176.86 -41.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 129.246 3.019 . . . . 6.4 108.351 168.529 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -81.53 -47.2 13.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.659 1.183 . . . . 7.15 113.299 -168.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.7 p90 53.55 10.4 0.22 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.756 2.423 . . . . 6.29 114.451 -168.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.29 157.54 36.85 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 120.595 -1.316 . . . . 6.09 113.942 -154.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.21 16.79 80.24 Favored Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 113.14 -1.845 . . . . 4.33 110.34 177.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 t -57.67 -34.74 69.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.745 1.218 . . . . 8.67 109.083 177.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 p30 167.66 80.75 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.286 0.847 . . . . 10.14 113.286 -170.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.52 -10.51 16.92 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.688 -0.965 . . . . 3.16 110.688 -167.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.0 76.95 1.08 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.925 -1.139 . . . . 3.33 107.925 -140.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.8 pt -105.92 158.54 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.689 -0.486 . . . . 4.89 109.689 177.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -106.76 144.09 33.92 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 124.026 0.829 . . . . 4.49 109.989 169.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 mt -131.57 145.46 51.73 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.843 0.857 . . . . 3.53 109.126 175.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.52 124.2 44.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.147 0.979 . . . . 3.77 108.66 179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.34 110.97 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 O-C-N 123.57 0.544 . . . . 3.05 110.124 -176.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.9 p -96.53 164.97 12.38 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.539 -0.912 . . . . 3.14 108.539 177.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.5 -33.89 3.17 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 121.914 -0.491 . . . . 1.98 112.262 -178.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.69 142.17 50.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 117.991 0.896 . . . . 4.03 111.414 178.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 m -155.26 46.74 0.51 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.783 0.833 . . . . 3.95 108.782 172.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.7 t -165.36 143.69 6.19 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.263 -0.898 . . . . 3.88 111.136 174.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.66 -46.5 81.06 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 109.546 -0.538 . . . . 3.59 109.546 175.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.1 m -50.19 -41.44 49.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.753 0.821 . . . . 2.94 112.006 174.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.59 -50.68 62.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.249 -0.649 . . . . 2.51 109.249 -177.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -48.34 -54.77 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.122 0.569 . . . . 2.93 110.506 170.406 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.31 -39.6 83.56 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.842 0.829 . . . . 3.46 111.088 -176.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -63.67 -44.33 94.07 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.912 0.885 . . . . 2.24 110.499 175.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.6 mt -60.26 -46.88 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.593 -0.521 . . . . 2.16 109.593 176.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -55.8 -45.95 78.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.796 -0.446 . . . . 2.19 109.796 174.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.9 m -57.16 -48.19 79.32 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 117.82 0.282 . . . . 2.69 111.519 175.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -55.09 -52.36 63.48 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.825 0.739 . . . . 3.86 110.565 177.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.4 mt -57.93 -59.41 5.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.004 -0.739 . . . . 2.98 109.004 179.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 59.2 m -51.06 -26.06 5.81 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.772 1.629 . . . . 2.42 112.244 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -64.83 -19.77 66.04 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.77 -0.581 . . . . 4.8 112.359 177.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.5 m -68.87 139.12 55.15 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.731 1.212 . . . . 3.07 111.116 178.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -54.4 -57.29 11.85 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.836 0.854 . . . . 4.7 111.926 177.089 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.44 -36.02 76.77 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 121.237 0.354 . . . . 1.96 112.59 -170.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.49 121.24 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 122.007 -0.702 . . . . 3.44 109.337 -173.102 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.5 m -97.48 -42.95 7.47 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.857 -0.423 . . . . 3.14 109.857 -176.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -144.07 97.41 3.05 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 113.664 0.987 . . . . 3.03 113.664 -178.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -94.09 135.87 34.99 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 107.675 -1.231 . . . . 1.85 107.675 178.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.3 t -129.1 108.42 10.36 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.91 -0.774 . . . . 2.99 108.91 172.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.0 p -100.28 131.12 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.106 1.363 . . . . 3.38 108.926 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -127.25 144.63 51.0 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.799 1.181 . . . . 3.12 109.475 179.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 pp -104.61 -43.72 5.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 124.415 1.086 . . . . 3.87 109.481 -171.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -46.71 -41.85 15.69 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.485 1.114 . . . . 3.87 111.71 173.17 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -106.87 1.96 25.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.671 1.188 . . . . 3.48 111.819 178.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.5 p 60.55 -6.77 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 127.925 2.49 . . . . 3.06 115.498 177.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -98.43 155.42 17.25 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.814 0.846 . . . . 5.05 111.319 -174.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.68 120.56 13.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.883 0.873 . . . . 2.31 110.513 -174.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.8 119.81 34.95 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.287 2.235 . . . . 2.91 107.865 -173.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 22.6 t -128.88 122.77 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 116.27 -1.824 . . . . 3.55 108.602 -168.332 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.91 97.49 6.57 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.965 1.257 . . . . 6.22 110.446 -179.344 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -114.2 -179.46 3.64 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.378 1.049 . . . . 3.57 112.374 -178.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -98.37 109.36 52.14 Favored Pre-proline 0 C--O 1.237 0.444 0 N-CA-C 107.454 -1.313 . . . . 3.19 107.454 176.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -78.12 69.93 7.32 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.885 2.39 . . . . 3.02 110.747 -171.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -163.31 -46.13 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.935 1.694 . . . . 4.28 109.063 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 pt -85.62 -33.1 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 117.693 0.224 . . . . 3.87 111.021 -177.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.17 160.06 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.119 -1.067 . . . . 2.91 108.119 177.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.82 156.13 24.68 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.228 -1.149 . . . . 2.48 110.228 -177.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -59.77 -33.93 96.08 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.74 2.96 . . . . 2.65 111.887 -174.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -54.87 -35.32 63.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.235 -0.29 . . . . 6.05 110.934 177.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -70.54 -40.79 73.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.272 -1.01 . . . . 3.32 108.272 -174.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 62.1 mt -53.51 -57.86 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.83 -0.804 . . . . 3.23 108.83 174.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.8 pt -56.16 -51.09 66.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 118.291 -0.861 . . . . 4.06 111.056 178.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -53.94 -47.81 70.89 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.952 1.251 . . . . 4.77 111.352 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.6 mm -57.4 -50.57 76.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 121.545 -0.722 . . . . 3.61 109.712 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.282 2.7 pp -70.85 -26.17 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 119.113 -1.035 . . . . 2.32 113.245 -177.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.09 -37.29 79.5 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.093 0.957 . . . . 4.02 110.42 169.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.88 -31.14 72.22 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.794 -0.566 . . . . 4.7 110.071 176.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.5 mt -73.36 -39.55 55.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.578 -0.527 . . . . 2.82 109.578 170.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.81 26.06 5.44 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.917 1.723 . . . . 1.35 111.454 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -104.28 179.96 4.12 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.14 -1.43 . . . . 4.12 107.14 175.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -142.28 130.58 22.24 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.63 -1.248 . . . . 5.22 107.63 173.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.91 81.88 1.84 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.133 0.973 . . . . 2.43 109.492 -168.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.8 m -97.75 120.2 37.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.162 -0.681 . . . . 2.69 109.162 -170.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -40.06 107.8 0.08 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.381 1.473 . . . . 4.35 110.631 164.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.36 43.88 2.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.24 0.83 . . . . 5.63 113.24 -175.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 . . . . . 0 C--O 1.252 1.235 0 CA-C-O 117.305 -1.331 . . . . 6.07 111.159 167.528 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.467 0.411 0 N-CA-C 106.368 -1.716 . . . . 9.68 106.368 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.88 116.14 10.54 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 127.072 2.149 . . . . 4.54 111.246 -169.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -84.01 81.81 2.07 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 CA-C-O 123.485 1.369 . . . . 3.77 113.7 -162.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -113.66 122.34 46.87 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 111.603 -2.544 . . . . 3.84 109.12 176.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -96.38 134.33 39.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.764 -1.569 . . . . 6.9 106.764 176.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.9 t -116.82 133.45 56.0 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 124.036 0.835 . . . . 2.96 109.204 -179.275 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -103.61 103.57 13.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.59 1.156 . . . . 4.22 109.756 -170.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.65 172.02 10.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.116 0.96 . . . . 3.99 112.516 176.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.14 153.86 43.98 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.251 -1.388 . . . . 1.92 107.251 168.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.4 mm -98.94 139.9 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 106.815 -1.55 . . . . 2.15 106.815 170.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 mtmm -111.71 112.33 23.95 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.239 -1.763 . . . . 3.84 106.239 159.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.16 -81.95 0.17 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.211 1.386 . . . . 1.29 110.132 -177.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.5 mtm 29.28 77.13 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.958 2.103 . . . . 2.94 114.707 -175.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.4 p -57.19 -43.02 82.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.605 0.762 . . . . 4.12 112.153 176.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.7 t 111.13 -42.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.965 2.506 . . . . 3.19 110.715 175.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.28 -67.42 0.19 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.41 1.484 . . . . 6.75 112.146 -174.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.99 24.24 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.922 0.489 . . . . 3.12 111.384 167.052 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.5 m -70.86 -45.82 63.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 120.974 -1.079 . . . . 2.22 109.939 -172.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.5 t -57.04 -49.78 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.08 -1.081 . . . . 2.55 108.08 175.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -54.19 -45.44 72.17 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.895 1.278 . . . . 2.32 111.868 -178.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.01 -50.39 68.68 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 121.654 -0.654 . . . . 2.49 109.837 174.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mt -49.39 -41.24 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 124.238 1.015 . . . . 2.64 110.792 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -47.49 -56.24 7.44 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.514 0.597 . . . . 3.99 111.542 176.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -64.45 -46.64 82.29 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.463 -0.569 . . . . 6.08 109.463 -177.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -55.07 -55.46 30.74 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 109.207 -0.664 . . . . 1.4 109.207 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.48 -43.98 88.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.633 -0.699 . . . . 4.04 110.371 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -50.78 -33.85 25.05 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.283 1.401 . . . . 2.58 112.474 170.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -95.97 19.02 12.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.927 0.891 . . . . 3.51 112.165 -177.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.34 -74.78 0.15 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.911 0.884 . . . . 2.98 109.535 174.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -163.26 -117.61 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.861 -0.524 . . . . 2.22 111.193 -170.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.18 -31.13 72.29 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.456 -0.658 . . . . 1.75 111.456 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.01 125.17 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 122.916 0.486 . . . . 2.45 111.274 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.08 52.17 1.38 Allowed 'General case' 0 CA--C 1.522 -0.103 0 CA-C-O 122.325 1.059 . . . . 4.01 109.705 170.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -156.46 154.73 30.87 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.403 -1.332 . . . . 2.66 107.403 169.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -141.02 119.57 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.904 -1.887 . . . . 3.7 105.904 176.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tt -131.06 70.34 1.47 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.415 -1.328 . . . . 3.16 107.415 176.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.9 t -98.53 130.21 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.294 -1.002 . . . . 2.76 108.294 175.181 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.93 97.08 8.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.298 -1.371 . . . . 2.16 107.298 168.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.1 -23.33 54.4 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.059 0.544 . . . . 3.64 111.082 175.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 52.0 mtt -75.44 -55.16 5.96 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.672 -0.642 . . . . 4.61 110.12 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.58 -22.84 37.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.968 0.507 . . . . 1.9 111.823 -175.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.48 61.78 2.88 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 124.209 0.909 . . . . 1.13 111.047 -178.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -140.91 140.17 34.46 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.834 -1.543 . . . . 4.11 106.834 172.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.0 99.11 7.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.113 1.365 . . . . 1.85 109.855 174.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.22 135.94 37.37 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 104.61 -2.367 . . . . 3.72 104.61 166.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 pt -131.12 -179.17 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.324 -1.361 . . . . 2.7 107.324 169.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -132.87 104.85 6.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.215 -0.661 . . . . 4.89 109.215 173.358 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -119.7 167.18 12.3 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.825 1.65 . . . . 4.45 112.553 178.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.48 100.72 19.7 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.745 1.618 . . . . 4.04 109.803 -174.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.55 -11.08 18.51 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.094 2.53 . . . . 2.52 114.074 -173.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -85.75 -20.45 29.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.718 0.807 . . . . 5.08 112.505 179.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 m -120.34 -39.91 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-O 118.635 -0.698 . . . . 4.36 111.554 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.18 139.01 35.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 123.282 0.633 . . . . 2.54 109.505 176.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -114.92 154.05 47.02 Favored Pre-proline 0 N--CA 1.451 -0.385 0 C-N-CA 125.779 1.632 . . . . 2.69 111.026 -178.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.97 -39.01 43.07 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.061 2.507 . . . . 1.4 112.659 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -64.79 -46.73 80.83 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.148 -0.97 . . . . 3.78 111.635 -174.34 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.11 -33.61 75.83 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.207 0.603 . . . . 4.81 112.216 175.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.12 -47.61 43.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 107.756 -1.201 . . . . 1.88 107.756 163.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.47 -48.8 79.57 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.456 -0.793 . . . . 1.92 109.597 -173.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -47.5 -49.85 24.84 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.903 0.32 . . . . 3.41 110.806 176.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.75 -53.49 54.34 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.376 0.608 . . . . 4.03 110.969 -176.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.71 -39.81 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 118.774 -0.631 . . . . 5.18 111.847 178.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -63.21 -42.36 99.28 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.612 1.097 . . . . 2.58 109.201 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.08 -49.44 75.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.498 0.719 . . . . 2.73 109.355 -179.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.1 mt -54.9 -38.66 67.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.397 -0.365 . . . . 2.72 111.77 172.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.65 29.71 2.38 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 123.891 0.758 . . . . 1.4 111.601 168.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -116.72 154.16 31.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.34 1.456 . . . . 3.78 107.681 173.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -95.72 128.07 42.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.648 -1.612 . . . . 3.01 106.648 164.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.33 133.57 51.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.455 -2.054 . . . . 1.88 105.455 163.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.05 140.29 41.93 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.498 1.124 . . . . 2.31 108.638 171.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.27 147.37 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.221 -1.029 . . . . 3.76 108.221 -179.14 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.6 mtp -50.11 -50.06 49.72 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.765 0.826 . . . . 4.48 111.033 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.02 -64.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.357 -1.72 . . . . 4.5 106.357 178.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -68.06 -91.08 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.618 1.167 . . . . 7.39 111.999 -174.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 148.36 -119.88 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 128.943 2.897 . . . . 4.71 107.684 -169.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.85 -77.31 0.6 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.059 1.343 . . . . 3.96 110.087 168.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.25 84.3 1.02 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.744 -0.942 . . . . 3.06 110.744 176.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.8 t -155.02 -68.47 0.13 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.002 0.521 . . . . 5.52 112.203 174.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -103.17 119.16 38.35 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.744 1.217 . . . . 4.4 108.103 -172.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.25 -62.6 4.55 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.557 -2.217 . . . . 2.56 107.557 178.134 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -104.0 133.4 49.02 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.691 0.796 . . . . 3.96 109.642 175.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.7 158.1 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.963 -1.125 . . . . 3.99 107.963 171.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.88 144.38 46.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.092 -1.818 . . . . 3.48 106.092 166.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mt -140.85 150.65 43.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.072 -1.825 . . . . 3.71 106.072 168.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.25 126.18 43.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.698 -1.223 . . . . 3.08 107.698 177.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.7 pt -98.47 127.29 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.682 -0.859 . . . . 3.15 108.682 -175.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.7 m -119.42 137.37 53.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.46 -0.941 . . . . 2.18 108.46 177.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.22 -45.75 1.16 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.336 1.446 . . . . 1.25 111.295 175.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 157.31 27.81 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.1 -0.647 . . . . 3.61 111.423 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -168.54 52.07 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.007 0.923 . . . . 3.75 109.341 171.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -165.63 137.33 3.98 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 120.882 -1.137 . . . . 3.46 109.751 178.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.47 -42.04 31.43 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.868 0.867 . . . . 3.95 111.01 175.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -55.3 -49.06 73.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.204 0.602 . . . . 2.5 110.792 175.45 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 79.0 m -63.65 -46.75 84.21 Favored 'General case' 0 N--CA 1.458 -0.053 0 O-C-N 121.707 -0.62 . . . . 2.49 109.729 -178.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.81 -49.29 70.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 122.777 0.431 . . . . 2.62 110.708 175.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -57.74 -41.76 82.54 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.119 0.568 . . . . 4.97 110.707 175.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -63.09 -41.47 99.4 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.672 -0.643 . . . . 1.94 110.686 177.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.9 mt -61.35 -52.27 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.576 0.75 . . . . 2.14 109.698 175.069 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.87 -39.09 76.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.501 -0.749 . . . . 2.34 109.473 177.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.8 t -60.66 -56.8 16.94 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.626 0.771 . . . . 1.9 110.671 176.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -30.72 70.89 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 120.303 1.41 . . . . 5.47 111.343 -175.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 mt -67.5 -59.61 3.23 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 109.233 -0.655 . . . . 2.66 109.233 171.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.7 m -54.96 -19.92 7.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.912 0.885 . . . . 2.79 111.777 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.04 -33.04 66.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.831 0.852 . . . . 5.83 111.992 173.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.3 p -75.45 166.09 24.13 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.927 0.891 . . . . 4.08 111.604 -173.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.68 -40.38 34.08 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.243 -0.286 . . . . 3.5 111.572 178.539 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.55 -35.06 37.78 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 122.833 0.254 . . . . 1.71 113.582 -169.002 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.36 133.09 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 O-C-N 121.658 -0.907 . . . . 3.06 109.128 -174.075 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.8 p -107.63 -53.44 2.62 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 122.905 0.482 . . . . 3.38 111.816 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.51 126.09 32.11 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.55 -0.907 . . . . 3.19 108.55 169.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.57 153.61 18.91 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.025 -1.102 . . . . 2.1 108.025 161.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.8 m -144.7 116.92 8.42 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.139 -1.06 . . . . 2.46 108.139 166.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 p -118.12 132.33 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.745 0.818 . . . . 2.94 110.446 -174.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -129.57 98.66 4.91 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.142 0.977 . . . . 2.49 110.878 -172.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -25.4 66.23 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.686 1.194 . . . . 3.25 112.445 -176.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.83 -32.56 53.27 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.114 0.566 . . . . 2.85 111.033 173.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.07 -9.14 12.39 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.369 1.468 . . . . 2.65 111.166 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.0 m 63.03 31.78 15.82 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.831 1.652 . . . . 2.29 112.407 -178.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.3 mmtm -105.35 153.54 21.51 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.613 0.765 . . . . 4.63 110.929 176.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.84 113.82 15.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.985 2.114 . . . . 2.03 107.19 173.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.06 134.18 38.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.143 -1.429 . . . . 2.78 107.143 173.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.4 t -135.33 129.62 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 124.027 0.931 . . . . 3.08 108.578 -174.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -111.96 93.61 4.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.43 1.092 . . . . 3.92 109.148 178.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -119.9 175.01 6.1 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.709 0.804 . . . . 3.07 111.627 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -97.86 115.75 65.74 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.672 -0.862 . . . . 3.7 108.672 174.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -76.45 71.19 6.0 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.444 2.763 . . . . 2.11 111.275 -171.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -161.62 -46.01 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.169 1.387 . . . . 4.13 109.305 177.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -87.48 -32.33 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 123.256 0.623 . . . . 2.99 111.469 -174.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.92 165.15 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 124.258 1.023 . . . . 2.48 108.406 176.436 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.91 168.37 32.34 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.403 -0.679 . . . . 1.47 111.403 -178.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.68 -34.87 49.41 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.839 3.026 . . . . 1.6 112.583 -172.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -44.94 87.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.594 -0.891 . . . . 5.92 108.594 177.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.08 -41.68 94.83 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.47 -0.937 . . . . 3.26 108.47 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 83.2 mt -55.08 -57.39 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 117.749 -1.12 . . . . 2.24 109.99 176.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . 0.264 18.0 pt -52.45 -56.03 8.51 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 CA-C-N 119.109 0.868 . . . . 3.56 109.998 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -48.86 -52.2 25.56 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.135 0.969 . . . . 4.48 111.926 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.69 -33.65 61.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 118.785 -0.626 . . . . 3.59 110.507 -175.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.35 2.6 pp -75.26 -32.33 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 114.891 1.441 . . . . 2.17 114.891 168.331 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.97 -34.21 69.7 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.307 0.958 . . . . 2.2 109.634 174.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.86 -35.88 82.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.085 0.469 . . . . 3.78 109.929 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 32.7 mm -76.18 -42.66 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.277 -0.638 . . . . 3.61 109.277 173.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.5 41.13 1.06 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.1 1.333 . . . . 1.01 111.59 178.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -112.54 -180.0 3.82 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.365 -0.976 . . . . 3.73 108.365 166.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -133.63 132.96 41.39 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.89 -1.152 . . . . 4.88 107.89 171.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.67 95.03 4.68 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 123.981 0.912 . . . . 1.84 109.778 -175.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.7 t -110.01 121.41 45.18 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.255 0.622 . . . . 2.95 109.852 -172.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -38.64 115.97 0.51 Allowed 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 126.37 1.868 . . . . 4.76 110.89 171.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -103.26 30.77 4.68 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.151 1.167 . . . . 3.9 114.151 -178.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.301 0 CA-C-O 116.999 -1.477 . . . . 7.76 111.571 177.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 mtt . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 108.705 -0.85 . . . . 11.45 108.705 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.6 89.89 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.102 0.961 . . . . 6.21 111.757 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.66 125.85 14.48 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.745 1.63 . . . . 4.91 110.539 -175.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.48 137.91 39.18 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.132 0.573 . . . . 4.04 110.821 -176.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.1 143.13 29.71 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.991 -0.443 . . . . 4.94 110.912 179.02 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -125.94 131.63 52.25 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.413 1.085 . . . . 3.07 108.109 177.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -113.71 97.25 6.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.69 -1.226 . . . . 6.24 107.69 -171.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -122.36 177.09 5.53 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.829 0.824 . . . . 3.43 110.508 -178.13 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.12 147.49 52.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.317 -1.734 . . . . 1.81 106.317 174.51 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.4 mm -98.38 132.36 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 106.814 -1.55 . . . . 1.77 106.814 177.259 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -111.46 109.14 18.95 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.171 -1.418 . . . . 6.08 107.171 170.004 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.94 -83.91 0.09 OUTLIER Glycine 0 CA--C 1.532 1.106 0 N-CA-C 110.159 -1.176 . . . . 1.15 110.159 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 47.52 70.46 0.42 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.746 1.618 . . . . 2.46 114.203 179.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.9 m -49.09 -59.33 3.73 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.451 -0.781 . . . . 3.12 112.521 170.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 t -168.59 63.66 0.06 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.541 1.064 . . . . 3.21 111.212 -175.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 31.86 56.82 0.33 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.076 1.75 . . . . 6.79 113.411 177.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.1 t -169.17 -49.52 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 122.762 1.268 . . . . 3.15 108.39 -167.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 19.7 p -61.87 -40.57 95.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.511 -0.743 . . . . 4.0 110.529 178.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 50.9 t -70.87 -31.25 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.924 -0.769 . . . . 3.23 108.924 173.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -58.57 -31.76 68.3 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.487 -0.758 . . . . 2.37 111.464 175.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -55.38 -50.05 70.71 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.231 -0.918 . . . . 4.31 109.642 170.092 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -46.93 -47.24 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 125.546 1.539 . . . . 3.73 110.023 -176.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -50.47 -59.02 4.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.449 1.119 . . . . 3.76 109.626 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -70.0 -19.31 63.33 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.997 -1.065 . . . . 5.35 112.422 -177.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -70.24 -56.0 7.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.939 -0.763 . . . . 1.15 108.939 168.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mp -59.41 -34.87 72.99 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.59 -0.694 . . . . 3.18 112.412 179.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.71 -20.87 15.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.891 1.223 . . . . 3.78 112.022 178.066 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -128.68 36.07 4.28 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.283 0.633 . . . . 5.84 110.9 174.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -67.78 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.804 -0.813 . . . . 3.26 108.804 167.7 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.27 -128.73 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.715 0.806 . . . . 2.46 108.926 -163.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.12 -20.26 68.88 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.679 0.656 . . . . 2.19 112.984 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.44 124.06 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 117.557 0.679 . . . . 3.14 110.561 176.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.85 57.53 1.56 Allowed 'General case' 0 C--N 1.339 0.129 0 CA-C-O 121.573 0.701 . . . . 3.82 110.343 172.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -155.97 159.63 39.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.863 -1.162 . . . . 2.8 107.863 160.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.85 114.8 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.672 0.789 . . . . 3.83 109.252 170.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -127.23 74.61 1.52 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.534 -0.913 . . . . 3.78 108.534 176.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.93 142.26 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 N-CA-C 109.378 -0.601 . . . . 3.39 109.378 171.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.44 94.46 4.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.772 -1.196 . . . . 2.75 107.772 165.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.08 -18.83 10.79 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.937 0.895 . . . . 4.97 112.198 172.69 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.9 ttm -66.07 -44.22 85.09 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.361 1.064 . . . . 5.0 110.62 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.77 -29.24 12.74 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.077 0.951 . . . . 2.54 111.126 -178.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.39 63.19 1.51 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.111 -1.196 . . . . 1.38 110.111 -177.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -140.4 132.11 27.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.008 -2.219 . . . . 4.34 105.008 174.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.69 105.27 12.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.555 1.159 . . . . 1.81 110.011 170.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.9 137.51 41.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.712 -1.218 . . . . 5.33 107.712 169.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.46 173.27 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.525 0.602 . . . . 3.1 110.227 171.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -116.39 102.2 9.32 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.081 1.352 . . . . 7.21 110.239 174.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -98.6 173.74 6.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.092 1.357 . . . . 4.44 113.055 171.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -124.07 100.01 36.97 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.553 1.541 . . . . 3.44 108.192 -179.132 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.8 5.36 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.72 1 C-N-CA 125.387 4.058 . . . . 3.22 115.35 -166.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.05 -17.23 16.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.533 1.533 . . . . 4.72 110.359 -177.073 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.0 p -124.86 -41.23 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.498 1.119 . . . . 5.18 110.933 178.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.36 143.6 26.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 N-CA-C 108.794 -0.817 . . . . 2.87 108.794 179.286 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.37 149.89 50.66 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 124.842 1.257 . . . . 3.59 109.402 -176.15 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -57.34 -39.34 90.38 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.951 2.434 . . . . 2.25 111.228 -177.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -60.02 -39.94 87.58 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.222 0.609 . . . . 4.53 110.995 175.021 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -65.46 -43.33 90.69 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.118 -0.697 . . . . 3.83 109.118 178.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.77 -50.52 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.625 -1.25 . . . . 2.32 107.625 174.51 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.48 66.72 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.585 -0.734 . . . . 2.24 110.807 -174.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -52.54 -49.75 64.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.728 0.811 . . . . 4.86 110.526 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -47.84 80.76 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 122.009 0.909 . . . . 4.46 109.298 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mm -59.37 -42.91 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.581 -0.736 . . . . 3.3 111.001 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -67.3 -39.05 85.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.392 0.277 . . . . 2.48 110.43 179.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.01 -54.6 44.1 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.219 1.008 . . . . 3.79 109.847 176.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.63 -46.45 73.91 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.776 -0.193 . . . . 4.81 110.829 175.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.72 39.87 0.41 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.429 -1.068 . . . . 1.77 110.429 162.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -129.65 164.96 22.77 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.222 -1.399 . . . . 3.78 107.222 178.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -98.51 132.37 44.0 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.872 -1.159 . . . . 2.5 107.872 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.54 116.51 31.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.578 -1.267 . . . . 2.57 107.578 173.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.57 138.8 50.34 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.203 -1.036 . . . . 1.83 108.203 173.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -67.01 146.3 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.3 -1.0 . . . . 3.96 108.3 178.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.1 mtp -57.94 -46.68 84.67 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.967 -0.693 . . . . 4.65 110.508 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 167.71 94.84 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 128.652 2.781 . . . . 5.15 105.46 -179.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 48.5 41.86 17.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 123.356 1.551 . . . . 8.36 114.697 172.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . 0.29 0.6 OUTLIER 59.99 -88.35 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.85 1.66 . . . . 5.31 113.714 170.03 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 142.69 158.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.989 2.515 . . . . 6.88 111.47 -173.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.4 ' CA ' ' HA ' ' A' ' 82' ' ' ILE . . . -71.23 70.83 0.8 Allowed Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 123.822 0.725 . . . . 5.25 114.414 171.167 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.8 t -86.87 -58.97 2.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.792 -0.818 . . . . 5.43 108.792 174.05 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 81' ' ' ASN . 8.0 m-20 -163.09 129.07 3.26 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 106.817 -1.549 . . . . 7.34 106.817 -162.06 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.61 -38.89 3.01 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 122.039 2.2 . . . . 3.18 109.298 170.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 79' ' ' ASP . 7.6 t30 -111.69 145.94 38.39 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 126.011 1.724 . . . . 4.78 107.548 166.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.4 ' HA ' ' CA ' ' A' ' 77' ' ' GLY 0.281 1.1 pp -114.95 140.15 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.363 0.528 . . . . 5.58 109.762 150.643 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.64 123.34 48.34 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.603 2.361 . . . . 3.55 107.205 175.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.95 151.72 39.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 123.452 0.47 . . . . 4.5 110.188 173.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -94.66 126.76 40.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.582 -2.377 . . . . 3.23 104.582 175.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 pt -99.03 130.06 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.376 -0.972 . . . . 3.02 108.376 176.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.4 m -123.97 141.95 51.59 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.416 -0.957 . . . . 3.09 108.416 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.08 -37.36 3.76 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.621 1.105 . . . . 1.55 111.361 -178.387 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.27 159.06 12.93 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.053 0.541 . . . . 3.6 111.998 177.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.9 t -175.0 48.95 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.019 0.927 . . . . 4.13 110.229 170.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 8.5 t -160.39 144.26 13.96 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.958 -1.088 . . . . 4.33 111.715 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.22 -10.48 23.65 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.02 0.928 . . . . 3.98 113.305 178.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.7 t -79.2 -46.28 18.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.563 0.745 . . . . 2.99 109.091 170.009 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 5.1 t -56.95 -53.64 55.77 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 121.762 -0.586 . . . . 4.0 110.264 -177.215 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 p -51.22 -43.32 27.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.553 0.205 . . . . 3.96 111.553 175.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -32.51 74.18 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.363 0.665 . . . . 3.86 109.985 179.053 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -66.96 -56.9 8.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.804 1.242 . . . . 2.43 108.507 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 mp -45.59 -60.38 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 C-N-CA 124.471 1.108 . . . . 2.8 110.265 167.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -52.4 -44.4 65.35 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.465 0.575 . . . . 2.9 111.772 -178.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.0 t -65.4 -60.26 3.15 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.018 -1.051 . . . . 1.84 110.883 178.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -33.46 75.65 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.525 -0.734 . . . . 5.19 111.147 -171.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.93 -49.78 48.48 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.249 -0.882 . . . . 4.37 109.256 171.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.2 m -57.4 -24.43 55.38 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.164 1.347 . . . . 2.95 111.183 -177.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -57.22 -30.99 65.04 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.099 0.778 . . . . 4.87 113.099 172.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.8 m -57.03 153.98 10.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.799 1.24 . . . . 2.7 111.868 175.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -73.8 -56.19 5.28 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.826 1.25 . . . . 2.97 112.533 -176.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.45 -34.86 53.45 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 121.88 -0.513 . . . . 1.79 112.016 -171.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.18 132.56 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.184 -0.672 . . . . 3.03 109.184 -175.395 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.5 m -121.1 -38.57 2.8 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 112.965 0.728 . . . . 3.05 112.965 -177.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -142.27 140.41 32.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.884 -1.127 . . . . 4.1 110.235 164.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.86 161.43 18.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.964 -1.016 . . . . 2.27 109.789 160.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -142.44 118.94 10.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.228 -1.767 . . . . 3.22 106.228 165.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 42.9 t -112.57 129.25 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 118.196 0.453 . . . . 3.62 110.476 178.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -117.66 126.75 53.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.354 1.062 . . . . 2.48 109.189 -177.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mp -90.4 -41.01 11.72 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.794 2.038 . . . . 4.93 108.729 -170.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -43.77 -44.1 6.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.634 1.574 . . . . 2.31 110.324 172.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -100.95 -15.07 17.64 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.729 0.812 . . . . 2.75 112.464 174.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.9 m 65.86 30.58 9.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.971 1.708 . . . . 2.55 113.896 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -106.14 149.86 26.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.534 1.533 . . . . 5.53 110.3 177.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.92 112.64 15.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.154 0.982 . . . . 2.1 108.897 176.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.61 124.52 39.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.869 -1.53 . . . . 3.58 106.869 176.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.5 123.24 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 C-N-CA 125.364 1.466 . . . . 2.9 108.844 -178.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -96.37 100.65 12.25 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.221 -1.029 . . . . 4.48 108.221 -177.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -126.12 174.13 8.71 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 123.833 0.708 . . . . 3.54 109.761 -178.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -104.48 117.56 58.83 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 118.273 -0.87 . . . . 5.24 109.471 177.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -73.78 71.36 4.09 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.401 2.734 . . . . 3.04 111.882 -174.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -166.52 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.864 1.666 . . . . 3.86 110.013 174.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.2 pp -87.09 -41.22 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 118.448 0.567 . . . . 4.17 111.297 -169.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.79 170.22 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.447 1.499 . . . . 3.05 107.557 174.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.36 25.5 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.1 -1.2 . . . . 2.18 110.1 176.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.69 -45.78 23.62 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.021 2.48 . . . . 2.1 110.768 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.4 ttm105 -48.37 -39.45 22.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.679 1.192 . . . . 7.83 113.106 -178.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -53.34 58.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.333 -0.617 . . . . 3.96 109.333 173.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.97 -44.55 82.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 109.442 -0.577 . . . . 2.27 109.442 -178.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.9 mt -51.89 -56.42 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.165 0.986 . . . . 3.08 108.498 174.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -55.17 -43.98 74.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.015 -1.053 . . . . 4.97 112.512 178.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.2 mm -63.92 -34.25 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.704 -0.623 . . . . 2.95 110.35 -177.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 27.3 pt -74.57 -33.52 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 119.812 1.187 . . . . 2.58 113.377 168.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -56.04 -25.98 47.1 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.475 1.034 . . . . 3.06 111.47 176.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.74 -34.49 75.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.835 0.454 . . . . 3.9 110.029 176.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.3 mt -79.31 -44.4 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.178 -0.675 . . . . 3.09 109.178 172.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.77 36.19 2.64 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 124.314 0.959 . . . . 1.43 110.868 -177.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -96.89 168.18 10.64 Favored 'General case' 0 C--N 1.338 0.083 0 N-CA-C 108.23 -1.026 . . . . 4.22 108.23 165.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -125.19 123.01 38.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.226 -1.768 . . . . 4.18 106.226 -177.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -111.0 107.91 17.47 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.838 1.255 . . . . 2.38 108.48 174.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.5 m -108.29 114.95 29.21 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.42 -0.955 . . . . 3.4 108.42 168.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -35.75 107.14 0.05 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 126.735 2.014 . . . . 5.08 110.122 170.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.93 -36.7 25.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.378 -0.601 . . . . 4.71 109.378 -175.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.109 0 C-N-CA 125.668 1.587 . . . . 5.91 112.713 -165.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 106.421 -1.696 . . . . 10.35 106.421 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.51 42.04 0.72 Allowed Pre-proline 0 C--O 1.222 -0.368 0 CA-C-O 117.874 -1.06 . . . . 6.46 112.05 -173.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -67.99 157.42 61.86 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.757 2.305 . . . . 6.52 112.911 -160.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -111.83 160.45 17.34 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.092 1.757 . . . . 3.62 109.967 -167.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -90.75 130.85 36.69 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.097 0.959 . . . . 6.09 109.464 -159.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.3 t -138.02 123.33 19.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.971 0.508 . . . . 2.62 110.227 177.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -98.64 106.76 19.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.913 1.685 . . . . 4.02 107.788 174.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.6 171.82 11.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.384 -0.969 . . . . 3.61 108.384 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.21 144.95 35.03 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.314 -0.866 . . . . 2.11 109.352 175.037 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.3 mm -99.16 126.14 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 106.178 -1.786 . . . . 2.83 106.178 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -95.56 99.06 10.98 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.658 -1.608 . . . . 4.55 106.658 174.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.65 -94.18 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.623 -1.391 . . . . 1.76 109.623 178.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.0 mtt 58.66 90.66 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.485 1.514 . . . . 3.5 113.789 179.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -14.72 33.93 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.083 -1.011 . . . . 2.75 113.125 172.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 t 72.88 -59.97 0.55 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 126.239 1.816 . . . . 4.07 112.395 -178.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.25 -74.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.993 2.117 . . . . 5.63 113.103 -174.385 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.5 p -154.24 15.17 0.46 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.668 0.387 . . . . 3.55 111.706 168.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.7 m -69.42 -53.3 20.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.286 -1.376 . . . . 2.7 107.286 -170.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.9 t -61.73 -39.83 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 119.554 -0.858 . . . . 2.96 109.759 -175.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.1 t -53.08 -46.65 68.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.893 0.477 . . . . 2.71 111.311 173.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -63.07 -49.26 75.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.251 -0.906 . . . . 2.67 109.351 176.509 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 mp -49.9 -53.53 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.322 0.649 . . . . 3.12 109.546 178.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -48.62 -52.71 21.69 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.99 1.316 . . . . 4.5 111.5 175.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -70.24 -24.0 63.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.256 -0.902 . . . . 5.52 111.006 -176.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -71.66 -44.81 63.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.305 -0.872 . . . . 1.26 109.933 170.034 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.83 -37.6 79.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.127 0.571 . . . . 2.9 110.947 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -26.97 6.58 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.481 0.549 . . . . 1.94 112.481 172.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -109.7 19.38 19.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.489 1.116 . . . . 5.66 111.381 -177.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -73.76 -67.22 0.62 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.612 -0.884 . . . . 3.23 108.612 174.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.6 -96.55 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.852 1.261 . . . . 2.28 109.443 173.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.38 -5.82 89.58 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.897 -0.502 . . . . 1.39 112.658 -176.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.36 114.11 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 118.044 0.922 . . . . 3.58 109.682 176.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.68 53.05 1.61 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.539 -1.282 . . . . 4.41 107.539 179.109 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.73 153.24 16.72 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.804 -1.184 . . . . 2.27 107.804 158.334 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.2 94.77 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 125.421 1.488 . . . . 3.57 106.989 172.312 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -116.34 66.31 0.71 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.275 -1.379 . . . . 3.37 107.275 176.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 t -97.47 130.92 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.585 -0.894 . . . . 3.02 108.585 175.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.52 96.8 6.98 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.844 -1.169 . . . . 2.3 107.844 175.069 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.58 -12.95 37.11 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.333 0.515 . . . . 4.45 111.888 178.436 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -43.61 13.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.095 0.958 . . . . 6.97 111.41 -178.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.71 -36.26 15.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.74 0.816 . . . . 1.91 111.017 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.19 62.28 1.23 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.53 1.538 . . . . 0.98 111.101 178.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -143.41 138.8 29.6 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.588 -1.634 . . . . 3.96 106.588 177.08 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.37 98.91 8.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 124.443 1.089 . . . . 1.97 112.326 171.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -94.09 131.42 39.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 105.996 -1.853 . . . . 4.92 105.996 169.156 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 pt -133.44 -179.16 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 O-C-N 121.816 -0.552 . . . . 2.59 109.603 170.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -124.68 119.06 27.91 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.728 -0.669 . . . . 4.66 109.768 160.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -114.73 154.66 28.1 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.777 1.631 . . . . 3.22 110.525 170.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.26 111.35 63.47 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.2 0.6 . . . . 3.4 109.704 176.626 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.85 -19.75 69.49 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.837 3.025 . . . . 2.06 112.845 -171.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -62.94 -24.37 67.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.701 -0.666 . . . . 3.74 112.752 177.283 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.87 -43.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 118.944 0.793 . . . . 3.51 111.496 -173.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.19 147.95 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 108.48 -0.933 . . . . 2.23 108.48 176.623 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -126.92 150.96 73.21 Favored Pre-proline 0 N--CA 1.451 -0.379 0 C-N-CA 125.075 1.35 . . . . 2.47 109.179 177.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.27 -36.38 94.99 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.629 2.219 . . . . 1.35 111.69 -175.019 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -41.68 99.25 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 121.916 -0.49 . . . . 4.61 110.959 177.42 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -59.99 -44.45 94.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.101 0.561 . . . . 3.06 109.973 177.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -54.03 -48.48 64.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.988 -1.116 . . . . 1.95 107.988 172.694 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.43 -44.99 95.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.016 -0.538 . . . . 2.08 111.004 -176.334 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -53.54 -50.39 65.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.934 -1.104 . . . . 2.82 110.169 171.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.62 -53.66 48.69 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.427 0.691 . . . . 3.54 109.34 -176.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 pp -68.74 -33.88 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 119.306 -0.958 . . . . 5.11 112.019 -178.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -57.92 -41.45 82.73 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 120.269 1.395 . . . . 2.78 108.574 -179.001 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -60.83 -50.92 71.48 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.619 -0.511 . . . . 2.74 109.619 177.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mt -54.38 -41.91 69.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.058 0.543 . . . . 2.97 111.917 177.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.18 43.71 0.32 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.468 0.556 . . . . 1.15 112.123 164.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -134.2 -177.01 4.39 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.081 1.352 . . . . 3.11 110.198 179.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -114.08 129.21 56.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.093 0.957 . . . . 2.27 108.898 162.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.99 129.32 44.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.253 -1.388 . . . . 2.41 107.253 168.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.47 118.74 12.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.255 -1.387 . . . . 1.78 107.255 173.351 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 t -56.34 153.58 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.683 -0.858 . . . . 3.5 108.683 174.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -15.21 47.11 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.802 0.297 . . . . 5.21 111.802 178.448 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 112.98 -48.1 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.364 1 C-N-CA 132.558 4.343 . . . . 4.93 106.484 174.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -91.53 77.5 5.71 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.322 1.049 . . . . 7.48 110.792 169.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.431 ' CE1' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -46.54 -52.74 12.78 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.224 1.01 . . . . 5.93 113.146 -178.0 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 139.51 159.68 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 128.791 2.837 . . . . 4.78 109.726 -179.001 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -49.73 89.57 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.704 -0.68 . . . . 3.65 113.634 144.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.5 -51.54 8.67 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 109.031 -0.729 . . . . 5.31 109.031 163.435 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -158.43 -102.34 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.675 0.39 . . . . 4.7 111.229 -171.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.32 -28.39 68.05 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 125.711 1.624 . . . . 2.56 109.146 173.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.431 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -91.54 116.37 28.81 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.125 -2.546 . . . . 3.5 104.125 176.722 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.03 161.91 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 O-C-N 125.412 1.695 . . . . 4.32 110.047 170.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.91 125.2 50.71 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 127.329 2.252 . . . . 3.64 110.003 -175.305 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -119.62 127.52 53.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.675 1.19 . . . . 3.94 108.214 172.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.6 m -95.78 122.68 38.82 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.673 -1.603 . . . . 3.15 106.673 176.383 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -102.56 114.0 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.483 1.113 . . . . 2.61 109.979 -172.022 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 84.6 m -107.23 124.0 49.11 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.262 0.625 . . . . 2.34 110.267 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 127.16 -27.92 4.69 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.262 1.41 . . . . 1.0 111.585 177.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 34.8 ttp -71.52 146.24 48.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.88 -0.777 . . . . 3.07 111.661 -176.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 t -164.05 41.52 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.616 0.766 . . . . 3.46 110.817 174.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -163.29 145.05 9.75 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.192 -0.943 . . . . 3.66 111.551 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.75 -42.04 67.78 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.252 1.021 . . . . 3.2 111.787 176.087 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -53.46 -48.77 68.56 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.732 -0.605 . . . . 2.53 110.12 174.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 96.7 m -64.8 -41.45 95.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.082 0.553 . . . . 2.58 110.26 -178.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -52.47 -51.95 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.227 -0.286 . . . . 2.27 110.227 169.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.11 -33.22 75.0 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.826 -0.435 . . . . 4.22 109.826 -176.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -65.28 -57.15 9.17 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.489 1.116 . . . . 2.46 109.576 178.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.5 mt -56.2 -51.42 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 121.457 -0.777 . . . . 2.1 110.098 177.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.82 -45.96 85.38 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.542 -0.742 . . . . 2.42 110.101 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.3 t -49.25 -53.72 20.22 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.283 0.947 . . . . 2.19 109.76 172.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -31.36 72.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.809 -0.557 . . . . 3.9 111.067 -172.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.6 mt -72.23 -61.39 1.81 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.536 -0.913 . . . . 3.07 108.536 174.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 60.9 p -54.41 -19.66 6.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.601 1.161 . . . . 3.15 113.099 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -57.53 -33.42 68.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.697 0.68 . . . . 5.29 112.03 171.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.7 m -62.38 132.04 51.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.599 1.56 . . . . 2.68 111.069 -176.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.04 -53.89 46.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.319 0.648 . . . . 4.83 112.473 177.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.87 -16.95 78.17 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.837 -0.424 . . . . 1.61 113.394 -169.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.2 tt -68.86 133.84 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 118.387 1.094 . . . . 3.0 109.171 -176.195 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.9 m -104.32 -51.62 3.08 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 121.929 0.092 . . . . 3.33 110.859 -177.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -141.49 116.44 9.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.091 -0.707 . . . . 4.1 109.091 176.448 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.12 143.27 32.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.049 -0.723 . . . . 1.86 109.049 163.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.0 m -135.89 119.58 17.18 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.126 -1.064 . . . . 2.2 108.126 174.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.5 p -117.53 131.91 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.572 1.149 . . . . 3.16 110.601 -177.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -128.59 86.67 2.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.027 0.931 . . . . 2.23 110.298 -172.204 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -53.93 -26.56 26.01 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.997 1.319 . . . . 3.47 113.012 179.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.81 -34.83 65.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.417 0.687 . . . . 2.47 110.967 176.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.74 -10.04 11.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.821 1.649 . . . . 2.51 111.393 -178.293 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.7 m 69.46 22.39 6.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.836 2.054 . . . . 2.58 112.318 178.446 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -102.43 156.06 17.85 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 125.291 1.437 . . . . 5.38 111.343 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.06 115.82 7.74 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.089 1.355 . . . . 1.66 110.462 174.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.03 126.42 37.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.219 -1.4 . . . . 3.37 107.219 170.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.3 131.4 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.928 1.691 . . . . 2.89 107.409 176.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -115.07 95.9 5.43 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.038 1.335 . . . . 3.78 110.023 178.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.48 -176.77 3.15 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.494 1.118 . . . . 3.16 111.22 -177.133 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -106.77 111.31 63.89 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.097 -1.075 . . . . 3.14 108.097 175.044 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.21 68.3 7.93 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.916 2.411 . . . . 1.77 111.626 -167.339 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -162.57 -42.95 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.471 1.508 . . . . 3.0 109.729 174.481 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pp -79.39 -35.98 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.296 0.57 . . . . 3.26 110.168 -175.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.6 166.02 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.601 1.56 . . . . 2.08 108.955 179.165 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.41 168.44 29.08 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.066 -1.614 . . . . 1.43 109.066 178.076 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.35 -44.59 36.92 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.42 2.746 . . . . 1.49 111.851 -172.278 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -46.08 -42.27 13.32 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.183 1.179 . . . . 6.94 114.183 -177.204 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.51 -47.48 83.75 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.512 -0.475 . . . . 3.25 109.72 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 85.1 mt -58.59 -45.86 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.929 -0.767 . . . . 1.83 108.929 178.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 83.6 mt -51.93 -59.47 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.541 -0.911 . . . . 3.03 108.541 174.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -46.24 66.78 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.874 0.761 . . . . 4.92 111.245 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.2 mm -54.66 -50.66 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 121.413 -0.804 . . . . 2.69 110.119 177.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.261 2.5 pp -71.14 -26.12 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.01 -1.056 . . . . 2.55 113.653 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.82 -38.77 76.17 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.762 0.71 . . . . 3.22 109.848 168.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -59.84 -40.73 89.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.57 0.7 . . . . 3.18 109.182 -179.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 51.2 mt -70.63 -42.01 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.361 0.664 . . . . 1.93 109.827 175.573 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.1 34.19 5.21 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.434 1.493 . . . . 0.96 111.187 -175.535 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -99.88 176.14 5.54 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.098 0.949 . . . . 3.8 110.019 168.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -129.86 111.42 12.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.704 -1.591 . . . . 5.66 106.704 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.0 103.03 12.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.682 1.193 . . . . 1.83 107.982 178.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.8 m -109.66 110.33 21.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.664 1.586 . . . . 2.46 107.144 -174.233 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.45 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.405 1.482 . . . . 4.52 111.384 -178.224 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 50.31 33.35 7.33 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.325 0.861 . . . . 4.61 113.325 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.331 -1.318 . . . . 8.97 109.826 -166.699 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 mtt . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 108.011 -1.107 . . . . 8.76 108.011 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.35 114.17 65.54 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 117.274 -1.346 . . . . 6.54 107.471 175.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -93.61 148.21 2.25 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.774 2.983 . . . . 4.68 110.423 177.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -106.08 129.4 54.18 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.367 -0.833 . . . . 3.43 110.327 -168.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -92.83 123.12 35.86 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.617 1.167 . . . . 6.59 109.896 -171.043 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 t -108.99 124.29 50.47 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.188 -1.042 . . . . 3.1 108.188 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -102.47 103.66 14.05 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.187 1.395 . . . . 4.33 107.48 -178.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -130.63 173.99 10.35 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.926 0.869 . . . . 4.02 111.036 176.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -122.44 150.29 42.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.032 -0.986 . . . . 3.86 108.757 173.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.2 mm -99.32 113.73 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 106.51 -1.663 . . . . 2.08 106.51 173.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -99.47 93.46 5.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.587 -1.264 . . . . 3.77 107.587 175.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.18 -77.29 0.08 OUTLIER Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.637 -0.985 . . . . 1.28 110.637 178.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.0 mmt 54.31 88.27 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.291 1.836 . . . . 2.33 113.79 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 m -55.85 -64.39 0.87 Allowed 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.259 -0.901 . . . . 3.61 112.477 177.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.7 t -169.7 56.19 0.04 OUTLIER 'General case' 0 C--N 1.345 0.397 0 CA-C-N 118.46 0.573 . . . . 3.71 109.945 -176.172 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 41.47 49.09 3.49 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.769 1.227 . . . . 6.72 112.707 178.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.4 t -164.18 -45.13 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.304 0.642 . . . . 3.46 110.264 -172.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.5 t -66.44 -36.82 83.75 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 120.743 -1.223 . . . . 2.25 110.277 -178.37 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.8 t -63.58 -30.63 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.657 0.741 . . . . 2.99 110.012 173.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -66.33 -31.03 71.57 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.54 -0.725 . . . . 2.27 110.884 175.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.74 -48.82 65.38 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.096 -1.003 . . . . 2.99 110.232 169.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mt -38.52 -44.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.598 0.759 . . . . 2.74 112.163 171.022 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -42.81 -57.8 2.63 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.536 0.734 . . . . 5.15 112.509 178.412 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -67.23 -40.25 86.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.225 -0.287 . . . . 6.24 110.225 -177.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -56.09 -53.53 55.89 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.767 -0.827 . . . . 1.22 108.767 -177.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.16 -43.83 97.96 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 119.493 -0.289 . . . . 3.96 111.279 177.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -22.21 24.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.872 0.76 . . . . 2.51 112.967 176.635 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -115.53 33.65 5.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.433 0.693 . . . . 3.88 111.549 175.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -84.73 -88.81 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.704 -1.591 . . . . 3.34 106.704 168.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -143.74 -126.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.908 1.283 . . . . 2.18 109.837 178.147 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.49 32.85 1.38 Allowed Glycine 0 CA--C 1.532 1.139 0 O-C-N 120.7 -1.25 . . . . 2.19 113.709 -171.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.19 117.99 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 106.936 -1.505 . . . . 2.68 106.936 174.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.05 53.38 1.57 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.211 1.005 . . . . 4.41 109.718 -178.547 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.5 m -161.84 132.08 4.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.146 -1.427 . . . . 3.09 107.146 171.586 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.75 117.04 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.414 -1.328 . . . . 4.1 107.414 176.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 tt -124.87 78.03 1.66 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.332 -0.988 . . . . 3.28 108.332 -179.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 t -99.98 137.1 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.182 -0.673 . . . . 2.9 109.182 173.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.93 98.39 7.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.543 -0.91 . . . . 2.15 108.543 169.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.94 -8.66 7.57 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.205 1.002 . . . . 3.93 112.865 175.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.3 mtt -80.34 -48.63 12.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.113 0.965 . . . . 5.09 110.011 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.59 -27.3 17.44 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.793 0.837 . . . . 2.21 111.805 -175.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 61.67 2.25 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.764 -0.934 . . . . 1.16 110.764 -177.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -140.0 139.08 35.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.38 -1.711 . . . . 3.39 106.38 173.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.21 105.1 13.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.439 1.087 . . . . 2.18 109.91 165.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -97.63 133.68 41.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.538 -2.023 . . . . 3.67 105.538 164.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 pt -129.94 167.05 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.54 -1.281 . . . . 3.3 107.54 169.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.37 105.12 10.59 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 124.393 1.077 . . . . 6.12 108.794 172.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -104.66 -179.51 3.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.255 1.822 . . . . 4.21 111.46 175.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.4 108.18 17.54 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.342 1.057 . . . . 3.83 111.316 175.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.43 -7.97 22.36 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.242 2.628 . . . . 2.23 113.586 -168.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.41 -16.37 57.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.222 0.919 . . . . 3.17 111.393 173.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.9 t -124.73 -47.89 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 118.476 0.58 . . . . 3.57 110.23 -172.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.85 146.79 20.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.014 0.925 . . . . 2.74 109.029 -173.425 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -123.48 154.88 66.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 124.213 1.005 . . . . 2.96 113.178 179.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.87 -38.19 81.14 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.547 2.165 . . . . 1.65 111.243 174.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 mp -54.44 -60.54 3.2 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.391 -0.818 . . . . 3.82 111.494 178.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -57.13 -35.29 69.3 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.325 -0.859 . . . . 3.86 112.734 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.28 -41.45 61.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.94 -0.763 . . . . 2.09 108.94 171.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.51 -38.59 81.34 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.076 -0.511 . . . . 2.52 111.341 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -63.48 -51.15 66.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.197 -0.939 . . . . 3.02 109.98 175.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.22 -52.22 59.62 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.376 0.608 . . . . 3.52 111.424 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pp -65.46 -37.82 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.283 -0.886 . . . . 5.17 112.308 -179.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.93 -31.88 71.94 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.04 0.837 . . . . 2.98 110.683 177.232 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.57 -52.45 63.38 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 109.252 -0.647 . . . . 3.53 109.252 174.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -55.0 -42.71 72.85 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.673 0.249 . . . . 4.37 111.673 172.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.28 48.39 0.43 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.293 0.949 . . . . 1.34 111.129 171.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -135.04 162.92 31.08 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.509 1.124 . . . . 3.61 109.675 -176.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -100.27 122.99 43.95 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.892 1.277 . . . . 4.03 107.623 167.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.16 82.67 1.98 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.512 1.525 . . . . 1.69 108.824 172.154 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.66 101.82 13.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.611 -1.177 . . . . 2.49 108.985 -176.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.36 158.28 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.438 1.495 . . . . 4.39 112.08 176.649 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -56.01 -50.58 70.47 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.853 -1.067 . . . . 7.67 111.287 167.246 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.86 61.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.008 1.323 . . . . 7.26 108.537 -175.394 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -17.11 71.56 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 130.107 3.363 . . . . 10.55 117.005 -173.536 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.474 ' CE2' ' HB2' ' A' ' 83' ' ' GLU . 5.3 p90 -95.89 -56.2 2.74 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.51 -1.223 . . . . 6.35 113.533 -167.411 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . 0.252 . . 125.56 -108.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 130.374 3.47 . . . . 5.27 110.255 177.359 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.17 79.68 1.47 Allowed Glycine 0 C--N 1.336 0.548 0 CA-C-N 119.981 1.264 . . . . 3.15 114.41 167.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.4 t 178.22 -28.88 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.766 2.026 . . . . 5.79 111.113 168.46 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 80' ' ' GLY . 26.9 t70 -78.71 -139.8 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.009 -0.737 . . . . 4.97 109.009 177.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' H ' ' CG ' ' A' ' 79' ' ' ASP . . . -82.84 9.39 59.91 Favored Glycine 0 N--CA 1.443 -0.889 0 O-C-N 120.332 -1.48 . . . . 3.73 110.487 166.555 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.405 ' CG ' ' HE3' ' A' ' 123' ' ' LYS . 21.0 t30 -106.01 131.83 52.83 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 117.599 0.7 . . . . 3.66 109.909 153.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.54 169.0 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 130.776 3.63 . . . . 4.28 105.627 175.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.474 ' HB2' ' CE2' ' A' ' 75' ' ' TYR . 2.0 tt0 -117.06 119.79 36.35 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.953 1.701 . . . . 4.14 110.07 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.2 mt -113.63 137.62 51.34 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.316 0.646 . . . . 3.26 109.444 -179.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 m -100.48 131.11 46.57 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 108.171 -1.048 . . . . 2.31 108.171 173.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -95.53 122.62 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.748 1.619 . . . . 3.03 107.762 175.64 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 63.8 m -112.22 134.59 53.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.922 -1.14 . . . . 2.49 107.922 175.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 112.14 -36.3 4.22 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.495 1.045 . . . . 1.72 111.557 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -57.32 129.47 41.92 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.183 0.593 . . . . 2.49 111.204 -178.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -157.03 91.96 1.23 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.072 -1.455 . . . . 4.14 107.072 169.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 63.3 m 84.2 -134.18 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.593 1.957 . . . . 5.03 111.087 178.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 60.07 -6.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.059 1.744 . . . . 7.96 114.581 -170.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.46 29.42 11.09 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.408 -0.807 . . . . 4.84 110.186 -158.225 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -33.43 69.29 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 123.079 1.418 . . . . 2.57 111.358 -171.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.4 t -52.53 -43.42 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.862 1.665 . . . . 2.81 110.561 174.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -58.01 -47.81 81.93 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.462 1.125 . . . . 3.28 108.526 -176.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.251 1.2 p-10 -70.99 -38.35 72.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.84 -1.073 . . . . 3.32 112.003 179.076 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.5 mt -57.14 -54.11 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.815 1.188 . . . . 2.19 109.906 173.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -52.83 -49.95 64.68 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 108.717 -0.845 . . . . 2.9 108.717 176.391 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.2 t -52.4 -51.67 57.84 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 122.021 -0.424 . . . . 2.08 111.945 177.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -61.56 -40.07 93.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.174 -0.954 . . . . 3.25 111.414 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.8 mt -63.58 -60.81 2.86 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.534 0.607 . . . . 3.06 110.145 175.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.6 m -54.33 -20.18 6.76 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.315 1.446 . . . . 2.91 112.321 177.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.5 mtp-105 -61.8 -28.82 69.73 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.802 0.667 . . . . 5.87 112.802 172.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.1 p -69.53 166.19 19.42 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 119.828 1.194 . . . . 3.5 110.892 -179.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.75 -39.61 30.66 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.071 -0.393 . . . . 3.51 111.346 176.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.33 -50.46 7.43 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 112.256 -0.338 . . . . 1.26 112.256 -170.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.68 144.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.851 -1.166 . . . . 4.52 107.851 176.309 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.0 m -142.51 -44.9 0.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.473 0.709 . . . . 4.19 109.845 171.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -100.51 103.36 14.69 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.016 -1.846 . . . . 3.47 106.016 176.63 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.04 149.01 41.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.501 -1.296 . . . . 2.06 107.501 165.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.9 m -142.87 135.71 27.97 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.213 -1.032 . . . . 2.69 108.213 162.779 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.41 118.68 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.53 1.532 . . . . 3.56 106.939 -177.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.06 105.51 10.7 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.902 1.281 . . . . 2.38 110.3 -171.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pp -74.05 -39.07 63.77 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 125.851 1.66 . . . . 3.11 111.878 -172.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.71 -40.39 62.94 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.194 0.998 . . . . 2.15 110.901 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.07 -12.51 24.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.779 1.232 . . . . 2.23 111.08 175.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.2 m 54.1 43.52 30.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.883 1.273 . . . . 2.49 111.925 -176.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -128.22 163.43 24.73 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 117.618 0.19 . . . . 4.1 110.734 166.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.96 136.9 32.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.281 1.432 . . . . 1.92 108.702 173.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.81 136.36 53.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.201 1.4 . . . . 3.73 107.583 171.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.4 m -134.3 136.11 53.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 116.805 -1.569 . . . . 3.36 107.327 -177.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.405 ' HE3' ' CG ' ' A' ' 81' ' ' ASN . 4.1 mtpt -115.25 105.13 12.52 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 120.456 1.48 . . . . 4.0 108.453 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -115.15 179.81 3.85 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.289 1.435 . . . . 4.26 110.894 175.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -100.51 117.37 63.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 125.089 1.355 . . . . 3.03 108.355 173.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -82.52 57.9 6.29 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.663 2.242 . . . . 1.98 112.351 -168.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -147.38 -49.57 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.482 1.513 . . . . 3.98 108.661 174.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pt -77.28 -33.25 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 122.382 -0.199 . . . . 2.35 111.05 -176.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.24 165.7 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.289 1.036 . . . . 2.28 108.373 -177.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.23 165.65 33.88 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.273 -1.131 . . . . 1.48 110.273 -175.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.71 -35.73 78.39 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.698 2.932 . . . . 1.65 112.637 -170.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 10.2 mtt-85 -50.99 -40.53 58.23 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.897 0.702 . . . . 7.1 112.897 178.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.46 -46.8 84.57 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.306 0.574 . . . . 3.39 109.645 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.68 -45.01 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.504 0.721 . . . . 2.12 109.574 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.7 mt -55.98 -58.64 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 108.704 -0.85 . . . . 2.98 108.704 175.023 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -49.28 -49.59 42.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.747 1.158 . . . . 4.33 112.851 177.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 52.0 mt -48.68 -56.21 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.612 -0.514 . . . . 3.51 109.612 176.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.253 2.2 pp -70.84 -26.68 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 113.509 0.929 . . . . 2.51 113.509 -178.294 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.37 -38.58 80.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.311 0.959 . . . . 2.5 109.683 168.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -66.08 -39.85 90.38 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.444 -0.576 . . . . 3.23 109.444 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.1 mt -62.23 -38.84 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.873 -0.417 . . . . 2.17 109.873 169.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.72 29.24 9.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.762 1.649 . . . . 0.98 110.825 -177.096 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -100.31 178.99 4.6 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 117.982 0.891 . . . . 3.44 108.99 175.21 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -127.88 104.51 7.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.609 -1.256 . . . . 5.32 107.609 -178.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.68 103.84 15.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.136 -1.431 . . . . 1.95 107.136 174.205 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.4 t -97.12 -179.19 4.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.236 -1.394 . . . . 2.62 107.236 169.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.5 117.94 22.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.278 -1.749 . . . . 4.92 106.278 171.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.56 90.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.862 -0.421 . . . . 4.07 109.862 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 C--O 1.249 1.048 0 C-N-CA 127.192 2.197 . . . . 6.38 111.22 -178.473 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 mmt . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 107.22 -1.4 . . . . 12.83 107.22 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.12 87.65 39.71 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.187 0.995 . . . . 7.45 111.097 -166.142 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.04 155.55 67.62 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 121.953 1.769 . . . . 6.12 109.809 172.25 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.53 158.93 43.29 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.082 0.953 . . . . 7.42 108.589 172.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.19 153.88 17.85 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.198 -1.408 . . . . 6.91 107.198 166.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 117.97 21.68 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.509 -1.293 . . . . 3.96 107.509 178.01 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -99.89 102.67 14.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.277 1.831 . . . . 6.88 109.849 -176.061 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.277 0.0 OUTLIER -130.3 159.86 35.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.185 0.993 . . . . 3.57 111.572 176.223 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.63 152.05 30.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.001 -1.0 . . . . 2.38 108.375 173.273 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mm -99.95 137.89 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 106.437 -1.69 . . . . 1.84 106.437 175.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -119.38 98.55 6.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.27 -1.011 . . . . 4.43 108.27 169.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.45 -94.65 0.13 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 109.119 -1.592 . . . . 1.81 109.119 177.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 mtp 67.86 90.48 0.09 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.012 1.725 . . . . 3.14 113.503 173.366 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -57.4 -28.55 63.34 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.973 0.731 . . . . 3.99 112.973 175.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 t 78.38 -48.5 0.46 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.009 1.324 . . . . 4.99 112.068 177.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -36.15 -70.01 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.802 1.641 . . . . 5.34 112.063 -179.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.3 p -161.49 18.99 0.11 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.254 0.465 . . . . 3.91 112.254 172.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 27.1 m -70.23 -52.12 25.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.329 -0.989 . . . . 2.61 108.329 -170.292 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.53 -39.27 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 109.702 -0.481 . . . . 4.3 109.702 177.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -61.95 -37.51 85.0 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.933 0.893 . . . . 2.7 113.344 177.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -41.29 64.0 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.732 -1.23 . . . . 2.86 110.866 171.201 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.0 mt -60.29 -48.62 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.258 1.023 . . . . 3.11 110.18 -174.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -51.52 -45.62 63.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.632 0.73 . . . . 4.34 111.079 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -64.6 -43.59 93.31 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 124.654 1.182 . . . . 7.25 110.343 -179.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.91 -52.27 64.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.129 -0.487 . . . . 1.96 109.825 173.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -29.39 66.48 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.016 0.747 . . . . 2.85 113.016 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -55.0 -22.07 14.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.907 1.23 . . . . 3.62 111.666 174.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -123.93 33.68 5.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.638 0.775 . . . . 5.4 110.182 178.182 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -64.26 0.89 Allowed 'General case' 0 C--N 1.343 0.314 0 N-CA-C 108.796 -0.816 . . . . 2.88 108.796 174.776 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.05 -133.85 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.833 1.253 . . . . 2.42 108.112 -172.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.66 -16.96 74.49 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.556 1.071 . . . . 2.03 113.009 -178.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 p -60.35 122.4 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 121.949 -0.736 . . . . 3.04 110.279 177.483 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.55 50.55 2.15 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 121.209 0.528 . . . . 4.83 111.119 177.239 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.7 m -155.44 153.73 30.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.299 -1.371 . . . . 4.66 107.299 167.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.33 132.06 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 104.815 -2.291 . . . . 4.38 104.815 161.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -141.35 83.73 1.88 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.007 -1.108 . . . . 3.61 108.007 174.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.0 p -98.8 147.16 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.27 -1.011 . . . . 3.31 108.27 174.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.52 103.87 9.81 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.322 -1.362 . . . . 2.91 107.322 167.188 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -27.54 66.4 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.608 0.763 . . . . 3.63 110.817 175.376 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 46.3 mtt -66.26 -58.8 4.58 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.944 0.898 . . . . 4.15 110.209 -178.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.75 -25.35 38.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.938 0.495 . . . . 2.76 111.414 -178.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.69 57.94 2.79 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.508 1.052 . . . . 1.42 110.878 179.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -140.31 147.1 39.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.865 -1.064 . . . . 4.1 108.693 179.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.63 101.17 6.99 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.145 1.378 . . . . 2.11 112.192 177.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -99.57 122.62 42.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.004 -1.06 . . . . 4.77 108.375 172.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.06 -179.5 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.742 1.155 . . . . 3.35 111.179 171.708 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -134.72 90.28 2.63 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.021 0.928 . . . . 8.86 112.561 -174.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.7 179.93 4.81 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.506 1.122 . . . . 4.87 113.974 -176.469 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -126.16 98.74 32.36 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 128.03 2.532 . . . . 4.87 108.283 176.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.62 27.89 0.38 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.917 3.078 . . . . 3.94 113.555 -170.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -108.15 -16.21 14.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.888 1.675 . . . . 4.65 110.669 165.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.1 t -116.66 -60.9 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.762 1.225 . . . . 4.12 108.067 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.65 124.99 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.646 0.778 . . . . 2.72 110.297 -177.509 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -101.62 172.08 4.76 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.09 1.756 . . . . 3.34 110.956 -177.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -75.45 -15.24 19.89 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.622 1.548 . . . . 3.29 112.259 -178.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.257 0.5 OUTLIER -73.08 -60.0 2.44 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.442 -0.786 . . . . 5.68 110.396 175.601 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -57.45 -32.37 66.86 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.284 -0.885 . . . . 3.34 112.281 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.3 tt -55.98 -45.34 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.878 -1.156 . . . . 3.0 107.878 175.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.87 73.56 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.364 -0.835 . . . . 2.72 110.42 -178.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.91 -44.9 94.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 119.459 1.027 . . . . 3.15 110.073 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -55.62 -52.69 62.95 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 109.195 -0.669 . . . . 3.66 109.195 175.326 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 mm -63.15 -41.86 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 120.246 -0.582 . . . . 3.54 111.839 -174.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -46.25 89.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.4 1.08 . . . . 2.99 110.421 175.037 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.19 -50.28 74.29 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.154 0.582 . . . . 3.98 109.829 178.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 29.1 mt -55.62 -36.43 66.97 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.311 0.644 . . . . 2.99 110.882 175.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.16 28.75 2.98 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 124.082 0.849 . . . . 2.13 111.149 165.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -117.53 157.02 27.05 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.995 -1.483 . . . . 4.57 106.995 177.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -96.5 116.36 28.94 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.797 -1.186 . . . . 3.1 107.797 169.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.87 123.92 43.45 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 108.096 -1.076 . . . . 1.96 108.096 166.412 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.92 132.14 50.95 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.28 -1.007 . . . . 2.55 108.28 170.158 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.46 160.04 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 124.619 1.168 . . . . 5.29 108.336 -177.236 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.8 mmt -49.95 -64.56 0.77 Allowed 'General case' 0 CA--C 1.534 0.341 0 O-C-N 123.935 0.772 . . . . 5.55 110.472 168.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 154.64 65.31 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 130.322 3.449 . . . . 8.31 106.061 -173.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 36.34 50.84 0.78 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.289 1.436 . . . . 10.98 111.803 -173.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -63.46 -59.53 4.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 112.932 -1.94 . . . . 8.66 109.868 -178.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.17 -101.7 0.13 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 128.371 2.668 . . . . 4.3 112.519 175.325 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.83 89.9 0.2 Allowed Glycine 0 CA--C 1.536 1.379 0 C-N-CA 123.998 0.809 . . . . 4.19 113.235 -178.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.2 t 179.65 -80.14 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.027 2.131 . . . . 5.7 108.092 171.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.05 132.04 53.41 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 105.13 -2.174 . . . . 6.99 105.13 179.804 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.83 -59.07 4.99 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 122.434 2.379 . . . . 3.22 109.714 160.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.34 113.4 24.98 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 104.469 -2.419 . . . . 3.45 104.469 159.532 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.4 pp -98.3 158.76 3.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.072 -1.825 . . . . 4.67 106.072 158.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.48 155.69 38.5 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.122 -1.807 . . . . 3.91 106.122 174.166 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -147.79 163.52 36.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.637 -0.221 . . . . 4.28 111.18 168.283 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 m -98.89 126.49 44.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.602 1.961 . . . . 3.14 107.261 171.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.02 125.5 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.856 -0.794 . . . . 2.78 108.856 176.675 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.5 t -108.03 163.31 13.26 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.326 -0.62 . . . . 4.06 109.326 170.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.34 -39.27 2.94 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.846 1.213 . . . . 1.75 112.583 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -58.92 132.73 54.87 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.879 0.871 . . . . 3.17 110.953 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 m -148.01 40.94 0.99 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.904 1.281 . . . . 3.49 109.861 176.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -169.19 136.83 1.86 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.88 -1.137 . . . . 3.84 111.1 177.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.13 64.94 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.576 -0.703 . . . . 3.71 112.118 177.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.6 t -56.45 -42.08 77.54 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.638 -0.664 . . . . 3.27 110.365 173.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 84.5 m -63.24 -44.4 95.31 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.75 -0.833 . . . . 2.73 108.75 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.6 t -53.87 -58.86 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.522 0.729 . . . . 2.82 110.543 175.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -57.11 -41.88 79.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.678 0.752 . . . . 5.61 111.316 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -59.77 -55.09 38.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.821 0.848 . . . . 1.95 110.338 177.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.8 mt -47.39 -50.63 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 125.657 1.583 . . . . 1.88 109.234 174.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -56.53 -47.25 79.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.217 1.007 . . . . 3.76 109.947 177.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.9 m -58.15 -44.21 87.75 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.999 -1.063 . . . . 3.27 111.384 174.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -64.28 -50.19 68.87 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.444 -0.785 . . . . 3.75 110.265 -177.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.71 -47.23 79.08 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.36 -0.607 . . . . 3.41 109.36 -179.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.8 m -58.38 -21.21 49.35 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.034 0.934 . . . . 3.39 112.584 176.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -64.96 -19.17 65.83 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.4 -0.813 . . . . 6.04 112.71 172.342 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.3 m -71.22 150.72 45.02 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.681 1.193 . . . . 2.82 110.431 178.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -69.3 -48.94 60.13 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.869 0.868 . . . . 3.09 111.887 179.188 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.43 -28.56 61.44 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 122.287 -0.258 . . . . 2.43 112.939 -166.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.51 142.18 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.368 -0.975 . . . . 2.84 108.368 178.437 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 22.4 p -124.21 -39.12 2.37 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.891 0.7 . . . . 4.48 112.891 173.434 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.34 125.26 18.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.246 -1.39 . . . . 4.65 107.246 -178.582 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.88 168.16 12.63 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.376 0.67 . . . . 2.52 110.308 165.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.4 m -143.87 128.09 17.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.625 -0.88 . . . . 2.3 108.625 160.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 52.1 t -107.32 126.61 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.822 0.849 . . . . 3.79 110.223 178.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.76 101.09 6.46 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.075 1.75 . . . . 2.51 110.128 -168.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.14 -31.8 62.89 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 126.146 1.778 . . . . 3.12 111.979 -174.253 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.6 -34.18 61.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.783 0.433 . . . . 2.55 110.981 175.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.83 -4.67 19.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.108 1.363 . . . . 2.61 111.218 176.608 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.5 m 59.71 28.8 18.31 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.659 1.183 . . . . 2.7 113.128 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -124.37 165.16 18.2 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.028 0.831 . . . . 3.9 112.973 176.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.45 127.28 43.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.573 2.349 . . . . 2.42 107.588 179.382 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.02 123.47 48.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.002 -1.851 . . . . 3.33 106.002 175.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.1 t -130.32 123.38 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.163 -1.051 . . . . 2.84 108.163 -170.016 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 96.93 9.73 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.099 -1.445 . . . . 4.95 107.099 176.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.9 -177.87 3.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.449 1.5 . . . . 4.3 111.019 178.309 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -127.2 112.83 21.53 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.059 0.943 . . . . 5.18 108.917 175.736 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.43 50.23 3.44 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.577 3.518 . . . . 2.92 113.523 -171.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -141.59 -52.19 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.484 1.513 . . . . 5.85 107.495 171.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 pt -80.29 -31.69 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 119.399 -0.334 . . . . 3.43 111.302 -177.262 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.67 164.67 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 110.156 -0.313 . . . . 2.71 110.156 -177.679 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.99 150.24 20.11 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.912 -0.938 . . . . 2.0 111.64 -167.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -57.22 -36.62 99.08 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.966 2.444 . . . . 1.85 110.535 178.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -34.75 67.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.119 -0.491 . . . . 7.5 111.474 179.136 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -69.99 -44.04 70.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.761 -0.829 . . . . 3.29 108.761 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 17.1 mm -52.42 -54.97 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.414 -0.958 . . . . 3.77 108.414 178.16 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.4 pt -59.2 -57.01 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 117.885 -1.055 . . . . 3.95 109.879 179.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -44.46 -46.59 9.72 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.0 0.818 . . . . 5.81 112.401 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.4 mm -51.07 -60.24 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 118.836 -0.602 . . . . 2.61 110.019 173.047 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.29 0.0 OUTLIER -70.4 -26.93 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 117.628 -1.629 . . . . 3.85 113.909 -176.273 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.48 -34.84 78.65 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.783 -0.573 . . . . 2.68 110.538 172.128 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -66.6 -36.13 81.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.884 -0.784 . . . . 2.84 108.884 176.288 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 38.2 mt -65.37 -44.28 94.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 119.84 -0.744 . . . . 2.58 109.691 174.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.98 27.86 3.33 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.694 1.14 . . . . 1.5 112.032 -177.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -98.5 -178.18 3.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.863 -1.532 . . . . 4.12 106.863 158.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -139.36 130.69 26.85 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.741 -1.207 . . . . 5.19 107.741 174.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.64 117.48 34.13 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.936 -0.765 . . . . 2.37 108.936 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.2 t -109.04 115.55 30.29 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.361 -1.348 . . . . 2.75 107.361 174.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.47 115.58 4.0 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.764 -1.198 . . . . 6.28 107.764 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.28 -34.83 20.26 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 123.61 0.569 . . . . 4.77 110.538 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 C--O 1.262 1.735 0 C-N-CA 128.131 2.572 . . . . 5.86 115.633 175.396 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtt . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 117.384 -1.293 . . . . 8.26 107.571 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.69 107.25 1.86 Allowed Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 119.2 0.909 . . . . 3.82 109.788 -170.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.03 110.68 2.94 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.672 1.581 . . . . 3.13 111.616 -163.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.44 119.92 21.27 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.35 -0.841 . . . . 3.27 111.822 -165.524 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.5 152.52 20.9 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.445 -1.252 . . . . 4.34 108.899 -178.123 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.9 p -143.2 138.55 29.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 123.608 0.567 . . . . 2.78 109.629 167.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.41 109.13 21.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.613 1.565 . . . . 5.49 109.379 177.659 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.37 166.91 15.12 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.786 0.803 . . . . 4.08 109.279 172.197 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.3 136.24 54.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.807 -1.553 . . . . 2.1 106.807 176.037 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.6 mm -98.2 136.02 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.593 -1.262 . . . . 1.91 107.593 -177.36 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -114.0 136.51 52.83 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.061 -1.089 . . . . 3.51 108.061 168.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.9 -80.6 0.27 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.04 1.781 . . . . 1.12 109.962 -174.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.2 mmm 56.91 56.45 5.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.957 2.103 . . . . 2.65 114.521 170.193 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -43.51 -63.95 0.74 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.774 1.398 . . . . 3.16 114.774 -173.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.3 t -167.9 59.47 0.07 Allowed 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.066 0.848 . . . . 3.72 109.621 -176.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 42.86 48.75 5.04 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.476 1.111 . . . . 6.17 111.994 -179.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.0 t -161.74 -40.21 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.005 0.522 . . . . 2.94 111.364 -172.307 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.39 -43.5 81.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 118.731 -1.188 . . . . 2.47 109.357 -178.487 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.5 t -55.33 -40.61 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.486 -0.931 . . . . 2.92 108.486 173.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -60.19 -37.4 80.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.002 0.43 . . . . 2.46 111.982 177.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -45.45 80.85 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.36 -0.838 . . . . 3.09 110.047 173.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.49 -47.75 70.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.245 1.018 . . . . 2.27 110.198 176.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -50.02 -49.18 51.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.888 0.875 . . . . 4.26 111.478 175.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -64.71 -38.23 90.3 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 122.114 -0.366 . . . . 5.7 110.346 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -61.19 -53.05 61.87 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.934 -0.395 . . . . 1.24 109.934 176.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.73 -37.26 75.78 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 118.22 0.464 . . . . 2.88 111.381 -179.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.58 -19.05 5.19 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.206 0.817 . . . . 1.98 113.206 174.41 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -118.36 20.9 12.92 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.325 0.65 . . . . 3.97 112.499 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -68.16 -62.56 1.34 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.094 0.861 . . . . 2.53 109.866 173.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.91 -128.47 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.384 1.474 . . . . 2.2 108.038 -168.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.84 14.56 3.53 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 119.487 1.04 . . . . 1.44 115.043 -173.409 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.09 122.26 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.593 1.157 . . . . 2.53 108.133 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.87 53.29 1.38 Allowed 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.448 0.642 . . . . 3.41 110.566 179.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 t -160.05 147.13 16.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.555 -1.276 . . . . 2.39 107.555 170.627 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.82 116.0 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 106.608 -1.627 . . . . 3.46 106.608 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 tt -131.67 72.41 1.5 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.851 -1.166 . . . . 2.99 107.851 177.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 p -97.27 153.11 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.64 -0.874 . . . . 3.45 108.64 172.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.02 100.26 6.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.577 -1.268 . . . . 2.09 107.577 163.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.2 mt -58.05 -19.12 29.19 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.207 1.003 . . . . 3.83 111.762 172.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -49.81 64.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.852 0.861 . . . . 5.79 109.696 178.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.88 -31.85 13.5 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.121 0.968 . . . . 1.79 111.749 -174.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.22 55.3 1.98 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.511 1.053 . . . . 0.93 111.307 -178.423 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.95 131.64 31.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 117.835 -1.079 . . . . 3.99 108.491 177.097 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.49 105.13 14.65 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 125.333 1.453 . . . . 1.85 110.563 170.536 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.5 130.36 45.75 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 106.639 -1.615 . . . . 4.59 106.639 165.146 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.2 pt -133.04 169.6 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-N 119.292 0.951 . . . . 2.82 109.897 170.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.7 105.99 12.6 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 124.699 1.199 . . . . 4.62 111.124 172.543 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -98.27 -176.34 3.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.928 2.091 . . . . 3.74 112.188 170.422 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -127.64 111.64 20.77 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.781 1.633 . . . . 3.24 110.151 167.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.87 20.13 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.391 3.394 . . . . 2.12 113.885 -173.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -99.27 -39.37 8.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.616 1.166 . . . . 3.86 110.323 169.061 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.3 m -109.74 -34.13 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 118.743 0.701 . . . . 3.55 111.26 -176.278 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.98 130.9 74.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 109.618 -0.512 . . . . 2.23 109.618 176.818 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -110.47 149.18 39.87 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 124.195 0.998 . . . . 3.46 109.878 -179.518 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -54.34 -40.66 81.83 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.408 2.739 . . . . 1.81 112.419 -178.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mp -57.54 -49.1 77.44 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.783 -0.573 . . . . 4.9 111.013 177.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -60.3 -40.34 90.13 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.183 0.516 . . . . 3.05 110.293 179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.15 -50.65 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.67 -1.233 . . . . 2.16 107.67 173.181 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.08 -41.63 83.86 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.942 -0.572 . . . . 1.98 110.855 -174.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -56.33 -46.03 80.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.173 0.589 . . . . 2.93 110.469 175.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.13 -51.59 63.78 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.621 -0.511 . . . . 4.05 109.621 176.03 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 mm -58.17 -45.88 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.784 0.326 . . . . 3.33 111.26 -179.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -61.58 -43.06 99.55 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.122 -0.466 . . . . 3.47 111.783 178.004 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.45 -49.02 78.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.6 0.636 . . . . 2.31 110.067 176.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -59.63 -27.12 66.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.111 0.564 . . . . 2.87 111.754 175.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.0 40.16 2.35 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.596 -1.002 . . . . 1.25 110.596 165.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -131.93 170.74 14.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.419 1.488 . . . . 3.1 108.029 178.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -115.01 121.46 43.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.351 -0.981 . . . . 3.83 108.351 169.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.03 117.7 34.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.381 -1.711 . . . . 2.05 106.381 163.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.78 144.18 45.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 105.979 -1.86 . . . . 1.89 105.979 166.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.1 t -71.46 152.17 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.474 -1.306 . . . . 3.42 107.474 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.8 ptm -58.55 -28.81 65.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.193 -0.458 . . . . 4.69 110.404 174.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.289 14.1 tt0 123.47 -8.85 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.801 1 C-N-CA 132.304 4.242 . . . . 4.4 110.43 175.979 . . . . . . . . 3 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.61 -55.14 6.68 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 125.361 1.464 . . . . 7.27 111.491 171.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.458 ' CE1' ' ND2' ' A' ' 81' ' ' ASN 0.274 0.4 OUTLIER 60.12 -28.54 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.791 1.774 . . . . 4.67 115.791 -164.431 . . . . . . . . 4 4 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 106.83 -135.93 0.0 OUTLIER 'General case' 0 C--N 1.345 0.403 0 C-N-CA 129.372 3.069 . . . . 4.64 111.625 170.763 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.88 77.87 0.34 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 127.691 2.567 . . . . 3.47 108.149 169.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.66 76.66 0.29 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.928 0.891 . . . . 6.88 109.302 174.359 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 2.95 99.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 129.396 3.079 . . . . 4.13 114.183 -173.685 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.37 -1.23 66.66 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.519 -1.032 . . . . 2.09 110.519 -168.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.458 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 15.0 t30 -143.31 95.43 2.75 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 119.803 1.802 . . . . 2.79 110.911 172.564 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.33 145.52 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 C-N-CA 126.095 1.758 . . . . 5.66 108.169 178.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.4 148.25 31.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.071 1.348 . . . . 3.44 110.629 173.173 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -140.89 161.4 37.92 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.296 1.038 . . . . 3.47 109.069 -178.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.09 138.57 35.19 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 120.181 1.355 . . . . 2.94 109.069 172.235 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.2 mt -94.98 117.14 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.731 -1.211 . . . . 3.78 107.731 176.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 21.4 m -98.46 124.63 43.28 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.252 -1.388 . . . . 2.53 107.252 171.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.82 -43.75 1.51 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.116 1.341 . . . . 1.1 111.337 175.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.88 121.65 8.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.726 0.81 . . . . 3.27 110.938 174.523 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -166.09 26.33 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.842 0.857 . . . . 3.34 111.074 166.07 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 31.1 p -172.47 168.21 5.46 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.296 -0.878 . . . . 6.39 110.026 -167.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 58.99 6.9 0.72 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.983 2.113 . . . . 8.16 113.574 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.5 m 38.11 47.47 0.96 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.336 0.589 . . . . 5.1 110.734 -154.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.6 p -55.15 -21.99 15.39 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.711 1.204 . . . . 3.09 112.417 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 t -30.0 -55.9 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.029 1.332 . . . . 2.38 111.327 157.036 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -58.85 -40.23 83.66 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.189 0.596 . . . . 4.68 111.067 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -64.87 -46.65 80.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.866 -0.521 . . . . 2.16 110.008 177.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.97 -52.51 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.143 0.577 . . . . 1.73 110.029 179.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -55.73 -43.62 76.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.568 1.947 . . . . 2.44 108.966 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.5 t -59.74 -51.35 70.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.792 -0.567 . . . . 2.39 110.064 174.329 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -53.87 -53.85 46.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.85 0.75 . . . . 3.35 110.705 -178.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.48 -48.52 74.91 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.545 -0.462 . . . . 4.05 110.318 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.5 m -63.27 -19.44 64.57 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.369 1.068 . . . . 2.97 112.235 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.5 mtt-85 -63.28 -21.59 66.34 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.373 -0.823 . . . . 5.65 111.52 170.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.36 169.53 17.12 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.557 1.071 . . . . 3.74 110.422 -177.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -80.12 -47.53 14.64 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.164 0.586 . . . . 2.28 111.656 -175.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.72 -37.57 66.96 Favored Glycine 0 CA--C 1.524 0.606 0 O-C-N 122.139 -0.351 . . . . 1.14 113.006 -168.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.74 123.49 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 122.111 -0.64 . . . . 2.99 109.432 -173.501 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.7 m -101.56 -51.78 3.38 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 122.477 0.311 . . . . 2.8 111.497 -178.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -140.55 111.34 6.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.049 -0.722 . . . . 3.43 109.049 -177.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.15 155.05 16.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.889 -0.782 . . . . 1.91 108.889 166.786 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.8 p -143.73 92.97 2.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.787 -1.19 . . . . 2.89 107.787 169.07 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -96.52 140.02 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.241 -1.022 . . . . 3.45 108.241 179.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.37 108.15 8.02 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.851 0.86 . . . . 2.23 109.54 -168.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.38 -27.78 65.61 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.154 0.798 . . . . 3.24 113.154 -171.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.61 71.52 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.138 0.975 . . . . 2.64 110.05 -176.518 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.3 -28.33 13.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.702 2.001 . . . . 2.5 109.334 175.864 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.2 m 71.92 40.55 0.73 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.13 1.772 . . . . 3.09 110.429 -174.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -101.21 163.31 12.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 123.839 0.712 . . . . 6.6 110.818 172.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.82 108.17 5.54 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.104 2.161 . . . . 1.92 109.105 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 mp -96.68 131.0 43.8 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.697 -1.223 . . . . 3.28 107.697 178.299 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.36 113.65 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.452 1.101 . . . . 2.77 108.538 -173.363 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.84 92.53 5.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 117.78 -1.105 . . . . 5.17 110.351 176.375 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -109.82 -177.15 3.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.682 0.674 . . . . 3.28 110.817 176.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -108.24 115.95 57.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.789 -1.189 . . . . 3.05 107.789 173.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.47 68.94 8.16 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.042 2.495 . . . . 2.23 111.841 -162.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -161.67 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.79 1.236 . . . . 3.0 109.613 175.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.4 pt -80.25 -39.2 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 123.964 0.906 . . . . 2.72 110.811 -174.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.93 170.71 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.906 0.882 . . . . 2.53 108.657 178.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.05 159.46 28.03 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.443 -1.063 . . . . 1.95 110.443 178.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.34 -32.17 72.59 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.32 2.68 . . . . 2.73 110.719 -175.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -51.53 -37.42 49.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.508 1.123 . . . . 8.87 111.016 175.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.34 -45.22 66.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.607 -1.257 . . . . 2.78 107.607 -176.138 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 88.6 mt -60.73 -52.66 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 118.542 -0.742 . . . . 2.37 109.213 -177.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.3 pt -50.55 -57.09 2.85 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 108.617 -0.883 . . . . 4.89 108.617 175.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -54.39 -44.11 72.02 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.461 0.911 . . . . 6.99 113.461 -177.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.3 mm -55.65 -50.23 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.468 -0.568 . . . . 3.08 109.468 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 25.3 pt -71.06 -28.14 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.907 -1.121 . . . . 3.32 112.725 -179.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -59.05 -30.97 68.43 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.225 0.921 . . . . 3.55 110.293 173.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.08 -42.74 95.25 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.579 -0.526 . . . . 2.58 109.579 174.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.4 mt -71.91 -33.17 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.273 0.629 . . . . 2.35 109.845 178.263 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.53 22.05 7.97 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.347 1.451 . . . . 1.21 111.249 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -105.8 157.13 17.67 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.143 0.971 . . . . 3.12 108.866 167.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -126.18 138.28 53.64 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 107.713 -1.218 . . . . 4.57 107.713 -179.334 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -111.06 110.5 21.07 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.622 1.169 . . . . 2.67 108.342 178.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 68.2 m -141.47 122.89 14.96 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.022 -1.466 . . . . 2.7 110.483 176.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 0.05 103.33 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.936 2.894 . . . . 6.72 114.633 174.718 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.03 -35.61 66.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.668 -0.682 . . . . 6.28 111.333 177.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.012 -1.471 . . . . 9.36 113.828 -177.85 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mtt . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 105.874 -1.898 . . . . 9.25 105.874 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.02 103.99 8.47 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 120.692 1.587 . . . . 3.97 110.25 -171.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.56 110.44 2.42 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.762 1.641 . . . . 2.82 112.015 -167.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -117.52 132.73 56.49 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.329 1.452 . . . . 2.8 109.782 -176.118 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -95.27 137.6 34.11 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.623 -1.251 . . . . 4.11 107.623 -170.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 16.7 t -125.03 145.28 49.98 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 123.89 0.876 . . . . 2.94 109.004 176.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -121.05 91.2 3.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.749 1.62 . . . . 4.9 108.976 -172.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 pp -124.29 167.59 14.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.046 0.45 . . . . 4.06 110.834 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.44 168.92 8.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.917 -1.142 . . . . 4.13 107.917 163.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.9 mm -102.04 122.28 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 105.064 -2.199 . . . . 2.18 105.064 164.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.47 99.41 11.07 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 104.837 -2.282 . . . . 4.83 104.837 178.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.81 -59.75 0.38 Allowed Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.418 -0.657 . . . . 1.1 112.193 178.019 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.6 mtp 21.68 84.91 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.332 2.653 . . . . 3.04 114.399 -178.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 p -57.03 -56.49 21.08 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.911 -0.566 . . . . 3.4 112.36 -175.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.9 m 135.23 -60.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 129.013 2.925 . . . . 4.21 108.434 -179.361 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.89 -69.51 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.506 1.923 . . . . 5.92 112.644 -165.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 p -163.98 28.07 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 122.477 1.132 . . . . 3.25 109.945 163.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.5 t -75.06 -41.14 59.61 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.477 -0.783 . . . . 2.45 110.346 -168.069 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.58 -43.87 66.62 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 N-CA-C 108.566 -0.901 . . . . 3.93 108.566 170.172 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -44.85 80.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.203 -0.453 . . . . 2.52 110.326 179.391 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.427 HD21 ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -65.25 -37.26 86.67 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 121.976 -0.453 . . . . 3.36 111.138 176.867 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.63 -46.12 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 123.808 0.843 . . . . 4.11 110.161 175.168 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -57.74 -49.57 76.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.757 0.313 . . . . 4.25 110.791 -179.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -33.4 75.84 Favored 'General case' 0 CA--C 1.521 -0.149 0 O-C-N 121.726 -0.609 . . . . 6.6 110.978 -179.18 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.427 ' ND2' HD21 ' A' ' 21' ' ' ASN . 3.2 m-80 -67.24 -60.33 2.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.127 -0.694 . . . . 1.57 109.127 178.274 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.2 mt -53.73 -50.49 65.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 119.005 -0.522 . . . . 3.31 111.828 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.29 -18.25 60.8 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.788 1.176 . . . . 3.37 113.261 -176.335 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm -95.38 0.05 53.09 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.501 1.297 . . . . 5.07 114.501 171.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.12 -60.26 3.12 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 120.244 1.384 . . . . 3.08 110.59 175.182 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.41 -97.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.917 1.687 . . . . 2.14 109.4 175.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.9 -0.64 82.38 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 121.873 -0.517 . . . . 1.22 113.773 -171.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.71 114.83 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 CA-C-N 118.652 1.226 . . . . 2.37 109.251 178.293 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mp -131.12 52.04 2.09 Favored 'General case' 0 C--N 1.338 0.086 0 N-CA-C 108.982 -0.748 . . . . 4.27 108.982 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.8 t -159.56 120.17 3.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.332 -1.359 . . . . 2.54 107.332 171.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.5 m -107.76 122.38 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.624 1.17 . . . . 3.46 108.597 173.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tt -137.93 82.35 1.91 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.921 -0.712 . . . . 3.03 109.693 172.516 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 t -102.58 127.16 56.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 116.231 -0.441 . . . . 2.82 110.839 173.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.51 97.75 9.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.367 -1.346 . . . . 1.95 107.367 168.428 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.95 -26.29 62.08 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.097 0.559 . . . . 3.7 110.835 173.151 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.7 mtt -68.03 -57.97 5.26 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.204 1.001 . . . . 3.88 110.324 -178.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.98 -25.23 30.19 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.069 0.548 . . . . 1.78 111.56 -177.019 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.81 61.16 2.32 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 124.771 1.177 . . . . 0.97 110.798 -178.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -142.17 131.75 23.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.142 -1.429 . . . . 3.29 107.142 174.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.45 102.25 10.88 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 124.631 1.207 . . . . 2.11 110.688 171.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.41 138.84 39.6 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.831 -1.174 . . . . 4.17 107.831 168.563 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.24 166.55 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.392 -1.336 . . . . 3.02 107.392 -177.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -124.49 90.46 3.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.576 0.751 . . . . 4.36 109.765 -172.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -95.3 -177.99 4.29 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.648 1.979 . . . . 3.26 112.155 -176.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.78 94.85 24.14 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.724 1.61 . . . . 2.97 108.946 -176.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -55.81 -22.63 38.14 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.253 2.635 . . . . 2.15 113.828 -174.146 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -64.13 -32.34 73.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.448 1.099 . . . . 3.56 112.37 177.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.75 -26.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 113.536 0.939 . . . . 3.63 113.536 -175.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.44 133.22 69.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 N-CA-C 108.436 -0.95 . . . . 2.05 108.436 174.065 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -107.2 154.26 40.59 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.603 1.161 . . . . 3.16 110.088 175.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -60.5 -35.72 89.27 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.587 2.191 . . . . 1.38 111.261 -178.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 pp -60.89 -43.57 98.3 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.567 -0.708 . . . . 4.72 112.152 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.02 -40.65 78.54 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.298 0.639 . . . . 3.7 109.418 177.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -49.92 -51.68 15.82 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 106.883 -1.525 . . . . 1.87 106.883 173.09 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.47 -42.34 82.39 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.476 -0.784 . . . . 1.97 109.715 -175.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.35 -48.56 71.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.607 0.763 . . . . 3.53 110.021 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -44.09 92.34 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.296 0.57 . . . . 3.7 109.604 179.699 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.9 mm -62.6 -44.46 99.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 O-C-N 121.817 -0.552 . . . . 3.57 110.994 179.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -63.62 -45.26 91.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.627 -0.508 . . . . 2.48 109.627 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.29 -50.4 71.5 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.773 0.829 . . . . 2.21 110.194 177.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.73 -36.19 82.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 121.193 -0.203 . . . . 4.7 110.469 -175.952 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 129.43 26.5 0.88 Allowed Glycine 0 C--N 1.34 0.799 0 CA-C-O 119.792 -0.449 . . . . 1.77 112.988 164.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -118.66 177.94 4.65 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.015 0.926 . . . . 3.2 110.985 173.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.54 142.13 41.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.856 -1.535 . . . . 2.33 106.856 160.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.4 131.95 55.75 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.095 -1.076 . . . . 2.14 108.095 163.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.4 124.87 26.41 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.71 -0.478 . . . . 2.04 109.71 174.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.02 148.42 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.844 1.658 . . . . 3.81 109.266 172.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.5 mtp -46.47 -52.96 12.11 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.856 0.722 . . . . 4.73 110.986 -177.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -165.87 108.44 0.77 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 100.938 -3.727 . . . . 5.01 100.938 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.37 122.34 9.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.978 1.263 . . . . 10.38 112.311 -165.358 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.72 -74.48 0.13 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.28 -1.782 . . . . 7.0 108.402 -160.165 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 94.48 -89.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 126.993 2.117 . . . . 4.58 109.034 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.93 87.39 0.69 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 114.618 0.607 . . . . 2.84 114.618 172.317 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.6 t -163.0 -42.66 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 119.062 -0.494 . . . . 5.31 111.559 164.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -146.84 136.19 22.76 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.071 -1.455 . . . . 4.41 107.071 176.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.2 -62.29 4.6 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 106.935 -2.466 . . . . 1.96 106.935 176.658 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.45 133.08 43.33 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.405 1.482 . . . . 2.81 107.634 169.387 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.426 ' CD1' ' N ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -142.22 161.22 19.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 129.387 3.075 . . . . 4.22 104.977 166.342 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.64 153.34 32.48 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.182 -1.784 . . . . 3.48 106.182 167.016 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mp -127.17 147.01 50.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.745 0.653 . . . . 3.2 110.077 162.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.3 m -92.97 117.3 29.9 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.909 -1.515 . . . . 3.25 106.909 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.41 104.24 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 123.768 0.827 . . . . 2.73 109.415 -174.563 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.3 m -96.9 136.14 37.88 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.522 -1.288 . . . . 2.44 107.522 175.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.22 -33.31 4.58 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.701 1.143 . . . . 1.18 112.124 177.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.7 ptp -64.05 160.72 17.45 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.372 0.586 . . . . 3.41 112.54 -177.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 t -172.41 40.03 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.167 0.987 . . . . 3.42 110.394 168.524 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -164.76 133.7 3.54 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.04 -1.038 . . . . 3.79 111.711 -176.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.55 81.72 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.071 0.548 . . . . 3.37 111.174 177.366 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.8 t -56.46 -47.64 78.74 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.228 -0.92 . . . . 2.74 109.825 174.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.4 m -60.25 -43.95 95.67 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.874 -0.516 . . . . 2.31 110.366 177.455 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.65 -50.62 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 O-C-N 122.332 -0.23 . . . . 3.18 111.286 177.072 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -59.19 -39.24 81.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.075 0.95 . . . . 4.79 109.673 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -62.56 -50.6 70.68 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.626 0.37 . . . . 1.99 110.128 176.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.0 mt -55.99 -55.95 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.842 -0.429 . . . . 2.24 109.842 177.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.52 -42.45 67.42 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.716 0.807 . . . . 3.0 110.86 177.795 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 p -62.69 -52.05 64.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.536 1.062 . . . . 2.82 110.843 177.212 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -63.6 -39.45 94.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.133 0.879 . . . . 6.91 111.286 -174.235 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.89 -46.25 65.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.241 -0.885 . . . . 3.63 109.24 177.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 95.9 m -55.84 -26.03 44.78 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.206 0.912 . . . . 3.04 111.563 176.004 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -61.65 -20.45 63.41 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.376 0.88 . . . . 5.2 113.376 174.075 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.9 m -66.3 150.79 48.31 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.154 1.382 . . . . 2.4 110.909 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -68.34 -50.82 50.61 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.05 0.94 . . . . 2.36 111.756 177.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.99 -26.67 61.76 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 123.52 0.581 . . . . 1.36 113.569 -169.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.45 140.35 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.467 -0.938 . . . . 4.08 108.467 -177.21 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 24.8 p -115.49 -64.0 1.38 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 122.621 0.369 . . . . 3.89 111.006 -175.05 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -135.57 119.01 16.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.171 -1.048 . . . . 4.47 108.171 174.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.62 161.02 14.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.728 -0.471 . . . . 1.73 109.728 164.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.8 t -142.81 111.61 6.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.698 -1.223 . . . . 2.58 107.698 168.169 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 68.9 t -98.93 123.17 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.912 1.285 . . . . 3.48 109.458 -177.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -130.11 113.42 14.48 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.041 0.837 . . . . 1.83 112.644 -172.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 pp -77.88 -37.98 46.88 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 124.126 0.971 . . . . 3.53 112.853 -171.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.67 70.13 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.344 0.592 . . . . 2.38 110.86 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -35.69 16.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.779 1.232 . . . . 2.43 109.633 177.423 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.1 m 90.18 17.53 0.04 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.321 1.848 . . . . 2.86 111.463 175.77 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -125.64 160.42 29.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.626 0.648 . . . . 3.96 110.446 175.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -130.74 125.82 34.83 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.127 1.371 . . . . 1.91 108.24 179.146 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -92.55 129.19 38.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.423 -2.065 . . . . 2.77 105.423 177.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.72 139.06 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.312 -0.996 . . . . 2.98 108.312 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -114.76 96.93 5.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.61 0.764 . . . . 4.63 109.602 173.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.66 -179.77 3.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.202 0.456 . . . . 3.38 110.744 176.827 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -110.08 110.74 58.57 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 108.562 -0.903 . . . . 3.4 108.562 175.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.57 63.12 8.69 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.506 2.804 . . . . 1.87 113.049 -164.302 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -148.03 -50.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.873 1.669 . . . . 4.18 108.184 172.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.37 -32.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 123.468 0.707 . . . . 2.7 111.33 -173.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.85 163.63 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.9 -1.148 . . . . 2.43 107.9 172.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.93 154.87 26.17 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.361 -1.095 . . . . 1.46 110.361 -179.407 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -60.44 -33.08 94.41 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.383 2.722 . . . . 1.42 111.71 -175.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -57.28 -38.36 73.83 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.585 0.354 . . . . 6.13 110.784 178.122 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -67.23 -45.2 77.49 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.081 -1.081 . . . . 2.85 108.081 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.78 -56.53 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 118.355 -0.831 . . . . 2.55 109.266 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 pt -53.5 -54.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 118.55 0.614 . . . . 3.62 110.559 176.49 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -56.24 -45.47 79.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 119.789 1.177 . . . . 5.94 112.869 -175.384 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.6 mm -69.05 -40.13 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 121.366 -0.834 . . . . 4.69 110.072 -178.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.86 -29.72 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 120.12 -1.612 . . . . 2.48 112.195 176.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -59.36 -29.59 67.78 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.674 -0.642 . . . . 3.96 111.107 170.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.61 -38.69 92.06 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.963 -0.755 . . . . 4.73 108.963 176.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.7 mt -70.77 -37.44 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.494 -0.558 . . . . 2.6 109.494 172.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.46 28.62 5.38 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.054 1.311 . . . . 1.14 111.02 178.298 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -99.57 -178.91 4.03 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.828 -1.545 . . . . 3.36 106.828 172.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -141.54 128.34 20.46 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.537 -1.283 . . . . 6.01 107.537 177.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.84 94.62 4.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.656 0.782 . . . . 1.94 109.794 -172.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.6 t -98.61 96.83 8.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.799 1.24 . . . . 2.82 107.745 -168.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.55 101.25 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.041 1.737 . . . . 5.11 111.875 179.477 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 55.95 35.91 26.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.621 0.769 . . . . 5.26 111.895 178.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 108.847 -0.797 . . . . 8.6 108.847 -176.377 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 mmt . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 116.634 -1.651 . . . . 9.23 106.623 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.56 153.15 66.08 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.793 1.237 . . . . 4.14 110.257 -176.343 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -92.75 115.72 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.843 2.362 . . . . 3.21 112.22 -179.221 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -140.55 146.54 38.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.74 -1.948 . . . . 3.82 105.74 169.293 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -97.02 165.78 11.91 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.626 0.771 . . . . 3.93 109.682 173.598 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.57 126.57 17.29 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 119.067 -0.492 . . . . 2.73 110.635 164.812 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -99.19 104.69 16.67 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.718 1.607 . . . . 3.97 109.537 178.121 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 172.34 10.97 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.219 0.533 . . . . 3.24 109.677 172.413 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.49 138.55 54.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.286 -1.375 . . . . 1.75 107.286 173.212 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.8 mm -100.17 129.88 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.527 -1.286 . . . . 1.94 107.527 177.209 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -108.89 120.71 43.32 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.666 -1.235 . . . . 3.32 107.666 172.762 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.77 -56.28 0.33 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.258 0.932 . . . . 1.67 112.095 177.467 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.3 mtt 25.54 77.14 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.078 2.151 . . . . 2.64 115.522 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m -55.26 -54.68 40.44 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.719 -0.613 . . . . 2.97 112.489 178.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.3 41.4 0.1 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.013 0.435 . . . . 4.21 111.355 -169.075 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 51.33 31.14 6.7 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.349 1.459 . . . . 6.08 113.911 177.888 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -154.11 -42.79 0.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.424 1.489 . . . . 2.99 110.905 -172.305 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.42 -46.91 88.31 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.622 -0.674 . . . . 2.15 110.588 -177.716 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.04 -43.36 36.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 123.086 0.554 . . . . 3.16 109.902 171.964 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -61.04 -47.92 84.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.479 -0.563 . . . . 2.82 109.479 -179.062 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -46.93 88.32 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 122.178 -0.326 . . . . 2.72 110.454 178.347 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.9 mt -50.1 -55.06 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.415 1.086 . . . . 3.18 110.292 175.648 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -32.71 74.17 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.491 1.139 . . . . 6.29 110.563 -176.811 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -32.47 73.84 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 119.634 -1.917 . . . . 4.9 111.603 172.086 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -66.32 -38.33 87.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.21 -0.663 . . . . 1.68 109.21 171.883 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.12 -39.54 78.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.327 0.512 . . . . 2.93 110.086 173.235 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -20.61 5.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.135 1.161 . . . . 3.64 114.135 173.27 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -107.88 9.67 28.73 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.612 0.765 . . . . 4.0 112.647 179.029 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -67.22 -67.94 0.42 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.664 0.785 . . . . 2.37 110.443 178.393 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -167.59 -101.68 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.061 0.944 . . . . 2.66 109.136 177.431 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.57 23.71 6.29 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.5 -0.75 . . . . 1.38 113.22 -175.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.2 t -95.44 113.17 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.751 1.221 . . . . 3.51 109.271 178.553 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 mp -139.6 54.04 1.69 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.225 0.466 . . . . 3.87 111.172 177.272 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 m -157.08 152.65 26.7 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.047 -1.094 . . . . 2.5 108.047 155.097 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 p -141.03 96.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.636 1.174 . . . . 3.75 107.979 179.779 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.71 80.75 1.99 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 108.223 -1.028 . . . . 3.87 108.223 -177.494 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.6 t -99.53 129.35 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.206 -0.665 . . . . 2.84 109.206 174.53 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.44 81.8 3.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.37 -1.715 . . . . 2.01 106.37 170.353 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.83 -16.61 4.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.767 0.827 . . . . 4.43 111.609 176.374 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 6.3 tpt -67.51 -38.8 84.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.401 2.28 . . . . 4.83 110.774 176.739 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.87 -36.2 4.23 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.851 1.26 . . . . 2.08 111.624 -168.45 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.85 58.7 0.98 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.11 1.338 . . . . 1.1 111.36 179.518 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -141.71 133.35 26.99 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.631 -1.248 . . . . 3.48 107.631 170.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.78 120.28 41.01 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 1.74 110.709 170.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.502 ' OE2' ' NZ ' ' A' ' 47' ' ' LYS . 30.0 tt0 -109.84 115.12 29.24 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.843 0.857 . . . . 4.1 108.874 166.49 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.6 mt -107.92 168.07 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 125.39 1.476 . . . . 3.7 108.872 170.707 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.502 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -126.59 108.2 10.91 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.103 0.961 . . . . 5.34 109.168 162.263 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -104.04 177.99 4.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.805 2.042 . . . . 3.19 111.114 174.401 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -121.38 114.3 31.84 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.194 1.397 . . . . 3.22 109.866 171.267 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.13 -22.44 69.89 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.069 2.513 . . . . 2.04 113.553 179.044 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -35.41 80.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.421 1.009 . . . . 3.5 111.188 -179.99 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -116.32 -31.58 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-N 118.591 0.632 . . . . 3.37 111.61 -171.136 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.73 132.46 70.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 123.752 0.821 . . . . 2.15 109.178 178.408 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -107.46 151.58 41.0 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.195 1.398 . . . . 2.66 111.149 179.443 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -59.79 -34.55 95.79 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.636 2.224 . . . . 1.42 111.981 -179.848 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.6 -53.19 60.89 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.466 -0.771 . . . . 4.11 110.643 179.818 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.45 -36.17 82.85 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.965 -0.459 . . . . 4.36 110.929 178.874 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.07 -49.97 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.028 -1.471 . . . . 2.07 107.028 171.632 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.92 90.93 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.386 -0.37 . . . . 2.04 111.236 -177.262 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -56.7 -43.96 81.05 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.852 -0.53 . . . . 2.59 109.726 175.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.64 -49.87 69.53 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 110.123 -0.325 . . . . 3.55 110.123 176.099 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -63.28 -48.2 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.294 0.569 . . . . 3.21 111.251 -176.781 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -40.92 96.86 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.935 -0.575 . . . . 2.07 110.483 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.32 -50.92 65.9 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.469 0.577 . . . . 2.5 110.305 177.049 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.5 mt -54.17 -33.77 58.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.914 0.486 . . . . 3.14 111.112 174.799 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.09 37.24 1.54 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.56 -1.016 . . . . 1.33 110.56 164.369 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -129.77 170.07 14.33 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.798 -1.186 . . . . 3.63 107.798 -179.753 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -111.06 122.74 48.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.082 -0.71 . . . . 2.59 109.082 170.331 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.84 122.27 43.15 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.443 -1.317 . . . . 1.9 107.443 163.49 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.9 144.49 48.82 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.794 -1.558 . . . . 1.89 106.794 167.235 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -75.49 156.89 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 108.032 -1.099 . . . . 3.69 108.032 -179.424 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.8 ptm -63.9 -48.38 76.86 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 119.238 -0.985 . . . . 5.0 111.025 174.486 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 161.34 -57.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 129.974 3.31 . . . . 4.04 107.682 177.821 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.04 -29.78 68.75 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 125.367 1.467 . . . . 7.26 113.116 -172.318 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.496 ' CE1' ' ND2' ' A' ' 81' ' ' ASN 0.324 2.2 p90 65.49 -56.34 0.33 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 128.321 2.648 . . . . 4.45 113.339 -173.573 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -165.76 -71.25 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 120.411 1.46 . . . . 3.45 113.217 -172.771 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 95.21 67.1 0.99 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.253 -1.539 . . . . 3.3 109.253 -178.541 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.3 t -156.42 -153.08 0.41 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.064 1.432 . . . . 5.1 112.692 -172.886 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.84 126.3 29.61 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.405 1.482 . . . . 4.81 108.398 -157.692 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.59 -36.56 3.23 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 109.761 -1.336 . . . . 2.2 109.761 -173.173 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.496 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 1.2 p-10 -145.79 96.08 2.75 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 114.879 1.437 . . . . 3.64 114.879 -178.553 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.33 143.77 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 106.589 -1.634 . . . . 5.03 106.589 -174.268 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -104.87 150.2 25.04 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.115 -1.809 . . . . 3.57 106.115 172.966 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mp -135.91 154.82 51.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.32 -0.992 . . . . 3.34 108.32 167.631 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.38 125.87 40.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.835 -1.913 . . . . 2.61 105.835 173.752 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 pt -98.37 139.28 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.757 -1.201 . . . . 2.88 107.757 178.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.3 m -125.22 140.21 53.05 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.634 0.773 . . . . 2.82 109.252 174.65 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.93 -21.66 12.14 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.622 1.582 . . . . 1.19 113.334 171.8 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.66 130.85 1.35 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.087 0.955 . . . . 3.73 112.523 168.603 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.8 m -130.54 2.73 4.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.209 0.604 . . . . 4.38 111.114 -178.02 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.2 p 178.74 154.83 0.41 Allowed 'General case' 0 C--N 1.341 0.231 0 O-C-N 121.165 -0.959 . . . . 4.13 109.181 -174.637 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.91 -27.66 65.45 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.579 0.752 . . . . 3.42 112.724 -178.354 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 m -51.65 -41.43 61.34 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.343 -0.848 . . . . 2.67 111.141 169.815 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 90.8 m -65.54 -45.72 82.33 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.599 -0.519 . . . . 2.56 109.599 -179.602 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.7 t -53.28 -54.73 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.562 1.145 . . . . 2.37 109.924 175.444 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -57.26 -45.37 84.05 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.966 0.507 . . . . 5.12 110.168 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -61.98 -45.79 92.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.144 -0.348 . . . . 1.76 110.968 179.077 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.7 mt -56.27 -49.63 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.93 -0.767 . . . . 1.93 108.93 176.583 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -58.57 -47.69 83.41 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.354 -0.61 . . . . 2.28 109.354 178.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.5 t -50.83 -50.06 57.44 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.92 0.488 . . . . 1.78 110.07 174.703 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -61.53 -37.93 85.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.551 -0.718 . . . . 3.48 111.838 -178.99 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.6 mt -70.19 -60.91 2.0 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.78 -1.192 . . . . 2.92 107.78 178.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.4 p -54.86 -20.67 9.28 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.206 1.402 . . . . 3.14 113.147 -179.069 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -59.26 -25.67 64.27 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.456 0.539 . . . . 4.55 112.456 171.279 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 39.1 m -66.68 154.28 41.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.352 1.461 . . . . 2.46 111.337 -178.559 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -72.87 -54.23 9.29 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.293 1.037 . . . . 2.32 111.869 179.295 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.34 -36.2 63.34 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 121.401 0.445 . . . . 1.16 112.37 -172.605 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.76 126.52 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 121.774 -0.839 . . . . 3.27 109.81 -173.309 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.0 m -98.8 -51.25 3.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.553 0.341 . . . . 2.95 110.963 179.168 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.407 ' CZ ' ' HG3' ' A' ' 123' ' ' LYS . 36.2 p90 -140.9 111.6 6.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.325 -0.369 . . . . 3.29 110.082 -178.749 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -96.6 153.69 17.71 Favored 'General case' 0 C--O 1.227 -0.082 0 N-CA-C 108.373 -0.973 . . . . 1.76 108.373 167.014 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -142.83 125.51 15.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 107.041 -1.466 . . . . 2.47 107.041 169.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 p -123.88 128.22 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.348 1.059 . . . . 3.01 109.734 -172.501 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.88 106.36 6.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.74 0.781 . . . . 2.09 111.112 -168.791 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -69.29 -19.24 63.9 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 124.304 1.042 . . . . 3.29 113.328 179.155 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.01 94.5 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.786 -0.449 . . . . 2.32 109.786 176.004 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.06 -28.99 17.59 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.124 0.97 . . . . 2.43 110.189 175.338 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.41 34.34 0.37 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.24 1.416 . . . . 2.49 111.319 -175.261 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -138.6 166.74 23.55 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.923 -0.485 . . . . 4.47 111.064 175.217 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -136.66 135.53 38.33 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.819 1.648 . . . . 1.91 108.733 -178.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.01 134.55 40.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.717 -1.586 . . . . 2.61 106.717 174.323 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.4 127.99 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.032 0.533 . . . . 3.3 110.001 -178.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 12.6 mmtp -116.06 87.44 2.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.615 0.766 . . . . 4.51 109.425 -172.783 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -119.63 170.39 9.23 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.456 1.098 . . . . 4.07 111.738 -178.255 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -96.99 114.02 63.96 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 108.182 -1.044 . . . . 3.37 108.182 -179.053 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.72 67.95 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.137 2.558 . . . . 1.63 110.997 -172.917 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -160.46 -47.65 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.831 1.252 . . . . 3.18 109.125 176.886 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -85.79 -30.31 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 122.928 0.491 . . . . 2.29 111.561 -173.145 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.74 162.04 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.155 -1.054 . . . . 2.01 108.155 171.477 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -133.77 163.16 24.49 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.167 -1.573 . . . . 1.89 109.167 178.786 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -63.39 -35.86 58.98 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.92 2.413 . . . . 2.09 111.852 -175.968 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.17 -40.41 73.88 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.149 0.431 . . . . 5.52 111.606 -174.071 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -51.1 71.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.647 -0.871 . . . . 3.32 108.647 178.992 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 53.6 mt -58.82 -50.25 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.532 -0.914 . . . . 2.16 108.532 -179.589 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 78.4 mt -46.08 -58.74 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 118.432 -0.794 . . . . 3.46 109.193 172.812 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -49.62 -49.86 45.21 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.697 1.135 . . . . 4.51 112.15 177.24 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.4 mm -51.08 -55.55 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 118.206 0.457 . . . . 3.0 110.576 177.184 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.295 0.0 OUTLIER -68.68 -32.51 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 118.339 -1.345 . . . . 3.97 113.311 -179.705 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.46 -40.28 90.66 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.368 1.44 . . . . 2.22 110.666 173.838 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -63.33 -36.92 85.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.339 0.656 . . . . 3.44 109.818 177.1 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.6 mt -69.22 -39.7 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 120.171 -0.611 . . . . 2.0 110.935 172.475 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.8 30.73 6.64 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.386 1.47 . . . . 0.86 111.64 -171.597 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -108.27 166.16 10.96 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.009 0.904 . . . . 3.13 108.907 164.088 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -129.53 130.03 45.25 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 106.704 -1.591 . . . . 5.11 106.704 -178.942 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.09 103.18 10.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.407 1.483 . . . . 1.87 109.144 -175.685 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.5 t -121.25 120.34 34.86 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 123.314 0.646 . . . . 3.26 110.539 -177.482 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -37.1 119.59 0.69 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.581 1.552 . . . . 4.31 111.248 170.94 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -119.78 61.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.83 1.652 . . . . 4.16 109.464 175.717 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.252 1.217 0 O-C-N 125.737 1.898 . . . . 6.25 109.545 162.866 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 108.592 -0.892 . . . . 2.96 108.592 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -91.73 140.73 29.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.665 -0.865 . . . . 3.52 108.665 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.5 t -119.6 132.24 55.67 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.048 -1.093 . . . . 2.44 108.048 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -106.01 102.69 12.1 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.674 1.189 . . . . 2.7 108.533 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.5 pt? -130.36 171.9 12.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.401 0.62 . . . . 2.59 111.713 174.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.468 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -122.05 153.33 38.77 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.451 -1.315 . . . . 1.87 107.451 172.162 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.9 mm -97.64 148.05 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 106.541 -1.652 . . . . 1.24 106.541 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -126.43 132.93 51.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.419 -1.697 . . . . 3.06 106.419 159.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.16 -94.45 0.2 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 108.062 -2.015 . . . . 1.29 108.062 -168.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.2 mtt 50.92 75.01 0.2 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.176 1.39 . . . . 1.93 112.552 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -37.87 37.79 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.565 -0.731 . . . . 2.17 111.758 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.1 t 133.6 -74.66 0.0 OUTLIER 'General case' 0 C--N 1.347 0.471 0 C-N-CA 127.104 2.162 . . . . 3.12 109.471 162.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.23 -44.0 89.64 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.053 0.76 . . . . 5.51 113.053 -160.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 m -153.56 0.47 0.24 Allowed 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 114.689 1.366 . . . . 2.95 114.689 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.26 -42.44 68.79 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.985 1.266 . . . . 1.7 110.227 -174.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -53.58 -46.35 60.42 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 108.703 -0.851 . . . . 2.0 108.703 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -60.64 -41.59 95.22 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.387 0.613 . . . . 2.75 111.545 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -61.42 -52.32 65.06 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.625 -0.672 . . . . 2.36 109.81 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.6 mt -47.66 -50.4 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.331 1.052 . . . . 1.84 110.822 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -49.8 -49.13 49.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.117 0.567 . . . . 4.75 112.055 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -65.25 -40.0 93.44 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.918 -0.489 . . . . 8.69 110.214 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -59.4 -53.5 57.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.662 -0.496 . . . . 1.7 109.662 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.49 -41.83 86.19 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.969 -0.457 . . . . 2.44 111.748 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -54.58 -19.49 6.06 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.977 0.732 . . . . 2.07 112.977 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -110.54 3.04 19.13 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 117.865 -1.064 . . . . 3.25 113.069 175.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -60.37 -68.03 0.34 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 120.359 1.436 . . . . 2.98 110.97 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -168.96 -117.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.306 0.642 . . . . 1.37 109.987 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.47 -8.53 76.08 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.557 -0.58 . . . . 1.6 113.341 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.48 122.16 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 118.628 1.214 . . . . 1.39 110.231 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.54 51.93 1.34 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.435 0.636 . . . . 3.15 111.613 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -160.72 132.58 5.89 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.595 -1.631 . . . . 2.06 106.595 161.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.9 m -118.36 132.57 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.771 -1.937 . . . . 2.51 105.771 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -140.0 74.88 1.48 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.052 -1.462 . . . . 2.62 107.052 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -97.39 127.88 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.432 -0.951 . . . . 2.09 108.432 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.78 93.49 5.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.301 -1.74 . . . . 1.35 106.301 166.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.46 -28.13 65.03 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.28 0.632 . . . . 3.39 110.499 176.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 40.9 mtt -59.39 -64.35 0.97 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.448 1.099 . . . . 3.36 110.425 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.0 -26.83 54.33 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.391 -0.822 . . . . 1.43 110.552 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.63 61.23 1.8 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 125.009 1.29 . . . . 1.15 110.545 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -138.52 144.39 39.93 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.412 -1.329 . . . . 5.86 107.412 175.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.38 102.08 9.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.283 1.433 . . . . 1.24 109.35 167.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -96.17 134.67 38.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.301 -2.111 . . . . 4.76 105.301 165.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 pt -140.1 171.27 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.634 -1.247 . . . . 1.78 107.634 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -120.47 108.17 13.77 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.658 0.663 . . . . 4.46 111.952 167.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.537 ' HB2' HD12 ' A' ' 53' ' ' ILE . 8.2 p90 -97.52 -179.67 4.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.684 2.393 . . . . 2.38 111.907 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -134.97 98.86 12.74 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.065 1.346 . . . . 4.92 109.322 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.68 -26.87 75.58 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.754 2.969 . . . . 1.85 113.185 -162.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -75.04 -10.5 59.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.939 0.495 . . . . 3.6 111.753 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.3 -49.37 2.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 124.102 0.961 . . . . 3.08 109.954 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -115.59 147.5 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.71 1.204 . . . . 2.32 107.958 179.038 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -124.17 151.89 66.48 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.484 1.114 . . . . 2.83 108.869 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.4 -34.87 97.44 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.747 2.298 . . . . 1.64 112.127 -172.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -71.28 -35.07 71.2 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.567 0.58 . . . . 3.37 112.567 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -58.02 -48.33 80.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.407 0.683 . . . . 3.16 109.22 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -52.47 -53.28 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 106.931 -1.507 . . . . 1.39 106.931 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.33 73.78 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.008 -0.542 . . . . 1.11 109.964 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -45.79 74.84 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.3 0.64 . . . . 2.66 110.645 176.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -47.51 81.57 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.387 0.613 . . . . 2.28 110.119 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 69' ' ' ALA . 6.2 mm -67.36 -41.84 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.548 -0.72 . . . . 2.64 111.008 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -44.86 95.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.94 1.296 . . . . 2.16 109.443 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.04 -51.62 68.88 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.067 0.547 . . . . 2.17 109.842 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.3 mt -58.94 -31.1 68.37 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.567 -0.288 . . . . 3.32 111.767 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.89 27.63 2.93 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.145 0.879 . . . . 1.09 111.923 163.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -119.31 167.35 11.97 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.102 1.361 . . . . 2.24 108.274 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -96.82 132.74 42.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.183 -1.414 . . . . 2.52 107.183 164.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.404 ' HB2' HG13 ' A' ' 62' ' ' ILE . . . -108.09 119.37 39.28 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.162 -1.792 . . . . 0.82 106.162 163.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.468 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -129.53 122.44 29.23 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.063 -1.088 . . . . 1.13 108.063 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.431 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.9 t -56.89 144.05 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 109.551 -0.537 . . . . 2.35 109.551 171.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.6 mtp . . . . . 0 N--CA 1.448 -0.527 0 CA-C-N 115.361 -0.836 . . . . 3.69 109.245 171.098 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 108.392 -1.883 . . . . 2.05 108.392 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.83 82.53 3.03 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 127.469 2.308 . . . . 4.5 107.572 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.41 172.63 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.665 0.745 . . . . 2.94 109.005 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -142.34 157.39 44.86 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 124.26 1.024 . . . . 4.56 108.402 170.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.6 mt -143.0 147.39 35.05 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.581 1.152 . . . . 2.33 109.138 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.64 119.34 34.94 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.72 -1.585 . . . . 1.78 106.72 165.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.24 116.0 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.712 1.205 . . . . 1.98 108.165 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.7 m -106.58 147.49 29.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.149 1.38 . . . . 2.46 107.986 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.4 -40.29 2.48 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.635 1.112 . . . . 1.2 111.279 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -58.96 141.67 53.13 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.458 0.703 . . . . 2.57 110.648 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.8 t -159.94 37.68 0.18 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.092 0.557 . . . . 3.2 111.328 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 51.8 t -162.71 142.06 9.07 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.257 -0.902 . . . . 2.72 110.732 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.78 -45.31 49.55 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.878 0.871 . . . . 2.76 111.441 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 m -56.21 -39.74 72.96 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.816 -0.553 . . . . 2.43 111.649 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 78.7 m -64.97 -46.81 79.96 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.838 -0.801 . . . . 1.85 108.838 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.1 t -50.91 -55.06 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.167 0.587 . . . . 1.36 110.593 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -59.38 -42.47 91.74 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.865 0.84 . . . . 3.69 109.581 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.59 -49.36 75.53 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.136 1.374 . . . . 1.88 110.906 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -54.75 -50.08 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.233 0.613 . . . . 1.41 109.677 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.86 -41.39 99.36 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.195 0.598 . . . . 2.38 109.507 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.7 t -56.15 -52.88 62.78 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.116 0.566 . . . . 1.35 110.475 171.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -51.98 -45.8 64.61 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.639 -0.663 . . . . 2.69 110.77 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.23 -60.19 3.26 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.732 -1.21 . . . . 1.93 107.732 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -52.92 -23.2 6.68 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.822 0.701 . . . . 2.26 112.429 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -64.89 -25.53 67.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 120.36 -0.536 . . . . 4.36 112.305 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 m -69.69 135.09 49.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.195 1.798 . . . . 1.79 110.384 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.9 p-10 -52.38 -51.22 60.14 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.139 0.975 . . . . 2.18 113.565 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.29 -36.96 43.4 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 122.094 -0.379 . . . . 1.25 113.277 -170.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.38 121.57 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 O-C-N 121.753 -0.851 . . . . 1.78 109.307 -168.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.7 m -102.64 -40.11 6.77 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.665 0.386 . . . . 2.26 111.141 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -141.74 127.69 19.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.291 0.496 . . . . 2.18 110.378 164.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -98.45 155.61 17.17 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.707 -1.22 . . . . 0.99 107.707 162.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.0 m -144.36 106.17 4.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 118.048 -0.977 . . . . 2.14 108.687 165.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 120' ' ' ALA . 11.1 p -98.76 126.66 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.216 0.916 . . . . 2.35 112.496 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.87 101.59 7.15 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.844 1.257 . . . . 1.21 109.947 -172.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 pp -75.49 -29.2 59.47 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.367 1.467 . . . . 2.2 113.062 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.32 85.55 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 121.716 0.77 . . . . 1.72 109.171 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.8 -30.9 18.65 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.27 1.828 . . . . 2.47 109.138 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 74.1 m 64.76 50.48 2.03 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.974 1.709 . . . . 2.07 110.261 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -139.71 166.15 25.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.618 -0.719 . . . . 2.81 110.816 158.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.408 ' HB2' HG23 ' A' ' 113' ' ' VAL . . . -130.38 132.7 45.91 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.073 2.149 . . . . 0.97 107.917 -176.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.49 138.56 34.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.711 -1.218 . . . . 2.01 107.711 172.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.1 t -131.42 128.64 61.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.624 1.17 . . . . 2.27 108.811 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -121.67 94.36 4.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.106 0.963 . . . . 3.43 109.123 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -128.4 -177.94 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.719 0.691 . . . . 2.62 111.528 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -99.65 115.3 65.73 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.0 0.92 . . . . 3.38 109.476 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.28 69.52 7.56 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.256 2.637 . . . . 1.82 112.084 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -163.56 -44.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.694 1.198 . . . . 3.99 109.928 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pt -81.69 -30.71 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 122.275 -0.266 . . . . 1.71 111.318 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.01 171.38 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.76 -1.57 . . . . 1.63 106.76 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.11 160.98 28.76 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.789 -0.924 . . . . 1.91 110.789 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.85 -36.59 90.31 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.93 3.086 . . . . 1.92 112.231 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -35.64 74.74 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 123.01 0.524 . . . . 6.47 110.177 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.36 -43.19 82.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.175 0.898 . . . . 3.3 109.622 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 68.7 mt -57.96 -48.14 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.447 -0.575 . . . . 1.34 109.447 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 60.1 mt -51.41 -60.8 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 108.82 -0.807 . . . . 2.15 108.82 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -44.44 -52.7 7.59 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.633 1.173 . . . . 4.58 112.378 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.4 mm -51.99 -53.64 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 109.253 -0.647 . . . . 2.28 109.253 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.272 2.3 pp -70.34 -26.83 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 114.034 1.124 . . . . 1.33 114.034 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -62.74 -38.16 89.4 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.321 0.964 . . . . 3.35 109.418 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -63.88 -35.87 82.08 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.609 0.764 . . . . 5.06 109.017 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 47.7 mt -68.38 -49.3 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 110.052 -0.351 . . . . 1.3 110.052 170.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.91 30.53 2.31 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.943 1.735 . . . . 1.12 112.488 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -102.06 179.06 4.43 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.944 1.372 . . . . 2.1 109.757 166.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -132.94 118.03 18.38 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 108.007 -1.108 . . . . 4.41 108.007 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.07 100.06 9.57 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.554 1.142 . . . . 1.2 109.755 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.6 m -109.37 112.73 25.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.189 0.995 . . . . 2.31 108.587 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -33.07 105.81 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 126.447 1.899 . . . . 4.43 110.101 168.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.93 -34.76 71.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.345 -0.843 . . . . 3.37 110.314 -171.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.249 1.044 0 C-N-CA 128.156 2.582 . . . . 5.82 114.604 169.187 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 106.478 -1.675 . . . . 2.96 106.478 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -103.23 154.53 19.24 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.747 -1.205 . . . . 3.52 107.747 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.616 ' SG ' HD21 ' A' ' 8' ' ' LEU . 12.6 p -142.32 130.34 21.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.316 0.488 . . . . 2.44 112.316 169.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -98.27 103.69 15.66 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.126 2.17 . . . . 2.7 110.271 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.616 HD21 ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -122.39 176.64 5.77 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.744 0.783 . . . . 2.59 110.199 171.329 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.87 151.51 43.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.259 -1.386 . . . . 1.87 107.259 168.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 44' ' ' ALA . 20.5 mm -95.85 148.04 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.538 -1.653 . . . . 1.24 106.538 171.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -121.64 106.43 11.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.46 -1.311 . . . . 3.06 107.46 163.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.8 -93.65 0.12 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.746 -1.342 . . . . 1.29 109.746 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 mtt 54.25 80.66 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.137 1.375 . . . . 1.93 113.808 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.14 -20.47 17.78 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.847 0.859 . . . . 2.17 112.671 170.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.4 t 74.79 -79.5 0.04 OUTLIER 'General case' 0 C--N 1.342 0.255 0 N-CA-C 107.642 -1.244 . . . . 3.12 107.642 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 4.83 -87.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 128.418 2.687 . . . . 5.51 112.813 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.1 m -138.22 22.49 2.78 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.292 0.637 . . . . 2.95 109.982 160.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.5 m -69.69 -53.49 18.31 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 119.342 -0.943 . . . . 1.7 109.125 -168.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.5 t -50.03 -39.65 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.348 0.594 . . . . 2.0 110.381 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.12 -46.83 87.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.491 0.663 . . . . 2.75 111.221 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -64.57 -46.52 82.39 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.836 -1.165 . . . . 2.36 110.804 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -46.57 -53.7 2.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 C-N-CA 124.868 1.267 . . . . 1.84 108.842 175.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -45.68 -56.26 5.45 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.393 0.616 . . . . 4.75 110.858 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -24.33 61.48 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.151 0.98 . . . . 8.69 110.874 -173.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -69.98 -57.35 5.11 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.683 -0.858 . . . . 1.7 108.683 173.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.03 -42.03 89.22 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 118.522 0.601 . . . . 2.44 110.562 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -22.51 19.93 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.513 0.56 . . . . 2.07 112.513 177.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -124.28 32.16 5.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.944 0.898 . . . . 3.25 111.229 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -74.18 -76.84 0.12 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.021 -1.103 . . . . 2.98 108.021 165.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.74 -118.69 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.276 0.63 . . . . 1.37 110.0 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.82 -13.03 80.89 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 119.522 1.056 . . . . 1.6 113.049 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.08 125.86 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 117.61 0.705 . . . . 1.39 112.215 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.91 57.01 1.41 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.701 1.2 . . . . 3.15 108.093 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.5 t -160.32 154.4 23.12 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 120.535 -1.353 . . . . 2.06 108.141 149.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.4 t -132.94 106.74 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.681 -1.229 . . . . 2.51 107.681 167.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 tt -124.25 73.79 1.26 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.509 -1.293 . . . . 2.62 107.509 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' A' ' 44' ' ' ALA . 58.6 t -102.75 128.0 55.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 109.003 -0.74 . . . . 2.09 109.003 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.94 98.07 9.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.654 -1.239 . . . . 1.35 107.654 170.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 tp -61.67 -26.83 68.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.267 1.027 . . . . 3.39 110.258 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -50.75 43.42 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.784 -0.573 . . . . 3.36 110.108 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.5 -7.22 26.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.545 0.738 . . . . 1.43 112.555 -169.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.38 66.98 2.13 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.181 -1.168 . . . . 1.15 110.181 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 131.16 20.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.106 -1.232 . . . . 5.86 108.839 171.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.507 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -110.06 90.2 3.24 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.992 2.117 . . . . 1.24 110.521 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -102.95 130.08 49.91 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.254 -1.388 . . . . 4.76 107.254 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 pt -140.13 -179.6 2.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 O-C-N 121.236 -0.915 . . . . 1.78 108.585 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -132.67 104.71 6.78 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.27 0.628 . . . . 4.46 110.007 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -106.27 172.55 6.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.83 1.252 . . . . 2.38 113.265 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -114.56 101.49 54.32 Favored Pre-proline 0 N--CA 1.444 -0.75 0 C-N-CA 129.212 3.005 . . . . 4.92 109.627 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.11 8.91 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.749 1.633 . . . . 1.85 113.978 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -91.05 -26.83 18.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.533 1.133 . . . . 3.6 112.039 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.69 -63.35 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 105.566 -2.012 . . . . 3.08 105.566 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.46 170.07 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 120.242 -0.583 . . . . 2.32 110.35 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.86 159.54 68.26 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.742 1.217 . . . . 2.83 108.416 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.24 -40.78 30.64 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.46 2.107 . . . . 1.64 111.256 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -58.22 -40.71 82.36 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.993 -0.442 . . . . 3.37 111.184 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -61.16 -44.94 96.53 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.893 0.877 . . . . 3.16 110.656 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -49.66 -57.92 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.368 0 N-CA-C 106.212 -1.773 . . . . 1.39 106.212 170.539 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -58.03 -43.51 86.84 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.473 -0.785 . . . . 1.11 110.165 -170.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -50.1 65.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.569 1.548 . . . . 2.66 110.049 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.06 -45.83 86.4 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.574 0.702 . . . . 2.28 109.707 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.534 HG21 ' HB2' ' A' ' 69' ' ' ALA . 5.6 mm -61.59 -44.03 97.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 116.291 -0.413 . . . . 2.64 110.373 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -64.96 -40.86 95.65 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.234 -0.916 . . . . 2.16 110.012 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -61.1 -50.44 73.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.935 0.894 . . . . 2.17 109.932 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.38 -35.18 80.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.3 -0.56 . . . . 3.32 110.781 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.29 23.4 1.75 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 123.386 0.517 . . . . 1.09 112.708 163.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.425 ' O ' HG22 ' A' ' 62' ' ' ILE . 2.5 m-30 -112.79 158.71 19.79 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.889 0.845 . . . . 2.24 109.68 174.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -95.43 133.35 39.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.045 -1.465 . . . . 2.52 107.045 167.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.534 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -123.06 125.31 44.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.111 0.964 . . . . 0.82 108.531 169.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.19 134.88 44.66 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.408 -0.59 . . . . 1.13 109.408 171.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 2.3 t -53.15 151.8 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.315 1.046 . . . . 2.35 110.726 175.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.0 mtp . . . . . 0 N--CA 1.449 -0.494 0 CA-C-N 115.649 -0.705 . . . . 3.69 111.946 173.038 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.771 0 N-CA-C 110.642 -0.983 . . . . 2.05 110.642 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.465 ' C ' HD13 ' A' ' 82' ' ' ILE . 31.9 p-10 -129.39 119.34 23.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.917 0.887 . . . . 4.5 111.283 169.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.547 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -112.27 157.02 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.547 -1.279 . . . . 2.94 107.547 172.421 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.94 141.54 32.96 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.813 0.845 . . . . 4.56 109.632 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.6 mt -141.47 143.77 34.03 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 109.099 -0.704 . . . . 2.33 109.099 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.57 130.63 43.72 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 107.726 -1.212 . . . . 1.78 107.726 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 pp -111.4 99.88 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.331 1.052 . . . . 1.98 110.671 -169.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.1 p -97.31 129.51 44.58 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.875 -0.787 . . . . 2.46 108.875 -175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.86 -26.98 6.98 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.349 0.976 . . . . 1.2 111.326 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.487 ' SD ' HD13 ' A' ' 98' ' ' ILE . 3.0 mtm -63.11 149.03 46.21 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.125 -0.632 . . . . 2.57 112.211 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -169.82 41.92 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.939 1.295 . . . . 3.2 109.287 172.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -166.04 140.63 4.54 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 121.107 -0.996 . . . . 2.72 112.895 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.08 -42.62 81.02 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.447 0.699 . . . . 2.76 110.751 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.3 m -50.48 -45.14 56.15 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.228 0.611 . . . . 2.43 110.807 173.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 75.5 m -64.39 -50.94 65.68 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.017 -0.735 . . . . 1.85 109.017 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 78.7 t -48.32 -51.77 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.08 0.552 . . . . 1.36 110.664 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -59.17 -34.71 72.42 Favored 'General case' 0 C--O 1.227 -0.086 0 CA-C-O 120.722 0.296 . . . . 3.69 110.335 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -63.4 -58.86 5.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.86 0.864 . . . . 1.88 109.393 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.487 HD13 ' SD ' ' A' ' 89' ' ' MET . 3.2 mp -52.94 -52.22 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.366 -0.605 . . . . 1.41 109.366 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.28 -49.76 73.32 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.175 -0.676 . . . . 2.38 109.175 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 t -53.73 -46.77 70.94 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 122.047 -0.408 . . . . 1.35 110.529 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -65.18 -38.11 89.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.124 0.57 . . . . 2.69 111.791 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.497 HD22 HG11 ' A' ' 122' ' ' VAL . 47.7 mt -70.91 -62.64 1.32 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.373 -0.973 . . . . 1.93 108.373 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.4 m -50.29 -24.36 2.88 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.633 2.373 . . . . 2.26 112.692 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -32.12 62.58 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.288 0.477 . . . . 4.36 112.288 172.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.2 m -59.42 144.54 46.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.573 1.149 . . . . 1.79 111.118 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -66.8 -47.97 70.43 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.968 0.907 . . . . 2.18 111.552 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.74 -30.21 66.45 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 123.527 0.584 . . . . 1.25 113.293 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.9 tt -69.61 130.26 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 122.117 -0.637 . . . . 1.78 110.277 -167.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 37.7 m -99.64 -49.77 4.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.753 -0.203 . . . . 2.26 110.824 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -141.31 122.65 14.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.274 -0.639 . . . . 2.18 109.274 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.88 156.12 16.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.265 -1.013 . . . . 0.99 108.265 161.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.5 t -141.05 122.25 14.77 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 107.276 -1.379 . . . . 2.14 107.276 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.59 117.2 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.691 1.196 . . . . 2.35 108.825 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.26 97.72 5.18 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.131 0.967 . . . . 1.21 111.525 -171.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 pp -59.72 -22.07 61.53 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.412 0.893 . . . . 2.2 113.412 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.53 -38.28 49.12 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.454 0.645 . . . . 1.72 109.471 -176.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.5 p -88.79 -20.08 25.17 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 125.011 1.324 . . . . 2.47 109.353 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.5 m 73.25 21.48 3.05 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.885 2.074 . . . . 2.07 111.096 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -130.24 157.3 42.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.899 0.857 . . . . 2.81 112.083 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.27 122.47 29.7 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.061 2.145 . . . . 0.97 107.366 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mp -99.87 137.86 37.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.542 1.537 . . . . 2.01 107.451 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.497 HG11 HD22 ' A' ' 102' ' ' LEU . 3.5 m -136.73 122.63 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.825 1.25 . . . . 2.27 109.346 -169.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -111.37 87.94 2.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.665 -0.683 . . . . 3.43 109.615 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -117.55 173.33 6.78 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.858 0.863 . . . . 2.62 110.657 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -98.49 112.61 62.78 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 108.397 -0.964 . . . . 3.38 108.397 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.02 73.65 4.81 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.39 2.726 . . . . 1.82 111.991 -165.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -162.1 -43.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.228 1.411 . . . . 3.99 110.153 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 pt -83.77 -31.77 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 123.762 0.825 . . . . 1.71 111.281 -170.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.68 158.96 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.337 -0.986 . . . . 1.63 108.337 171.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -126.71 159.93 20.99 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.099 1.333 . . . . 1.91 109.958 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.7 -36.17 42.77 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.125 2.55 . . . . 1.92 111.356 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.17 -40.71 74.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.748 1.219 . . . . 6.47 110.869 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -66.05 -43.91 86.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.671 -0.492 . . . . 3.3 109.671 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.45 -47.68 89.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.645 -0.872 . . . . 1.34 108.645 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.7 mt -53.05 -56.19 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 123.825 0.85 . . . . 2.15 109.529 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -48.34 64.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.366 0.985 . . . . 4.58 110.824 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.0 mm -54.74 -52.99 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 122.047 -0.408 . . . . 2.28 110.065 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.257 2.5 pp -70.52 -27.85 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.764 -1.21 . . . . 1.33 113.419 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.29 -32.85 73.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.36 0.527 . . . . 3.35 110.646 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -57.31 -42.94 82.78 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.844 -0.798 . . . . 5.06 108.844 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.8 mt -73.8 -40.57 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.771 -0.65 . . . . 1.3 109.517 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.38 37.0 3.41 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.007 1.289 . . . . 1.12 110.92 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.459 ' CD2' HD11 ' A' ' 98' ' ' ILE . 30.5 m-85 -99.49 178.1 4.97 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.262 -1.014 . . . . 2.1 108.262 160.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -140.63 125.87 18.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 107.027 -1.471 . . . . 4.41 107.027 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.59 106.45 14.88 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.498 1.519 . . . . 1.2 108.722 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.9 t -123.6 136.27 54.42 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 118.423 0.556 . . . . 2.31 110.496 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp -32.24 119.91 0.29 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.808 2.043 . . . . 4.43 113.27 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.56 49.03 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.085 0.954 . . . . 3.37 111.211 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.332 0 CA-C-O 116.042 -1.932 . . . . 5.82 107.356 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 108.418 -0.956 . . . . 4.0 108.418 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -90.64 157.08 17.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.99 -1.855 . . . . 3.98 105.99 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.495 ' SG ' HD11 ' A' ' 8' ' ' LEU . 0.5 OUTLIER -135.22 121.92 20.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.695 -1.594 . . . . 2.29 106.695 177.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.43 ' C ' HD13 ' A' ' 8' ' ' LEU . 62.8 m-85 -102.3 90.59 3.95 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.313 1.845 . . . . 3.71 109.05 -173.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.592 HD12 ' HB ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -117.68 171.26 8.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.576 0.703 . . . . 2.77 111.204 178.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.456 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -116.48 143.03 46.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.394 -0.965 . . . . 1.82 108.394 166.203 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.417 HG12 ' HB2' ' A' ' 44' ' ' ALA . 42.3 mm -99.44 139.29 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 107.276 -1.379 . . . . 1.04 107.276 175.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -125.97 123.01 37.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.074 -1.454 . . . . 2.97 107.074 168.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.58 -69.66 0.25 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.224 1.392 . . . . 1.74 110.442 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.9 mmt 37.09 71.2 0.15 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.758 2.023 . . . . 2.71 114.254 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -52.56 -60.52 3.15 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.469 -0.769 . . . . 2.73 113.064 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 t -165.87 48.67 0.08 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 119.518 -0.873 . . . . 3.78 111.816 -172.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.05 51.91 15.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.454 1.102 . . . . 5.67 112.243 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.3 m -175.18 -36.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.039 1.335 . . . . 3.39 110.96 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.71 -42.86 77.12 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 120.965 -1.084 . . . . 2.02 110.536 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.0 -43.98 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.348 -0.612 . . . . 1.85 109.348 168.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -62.07 -30.78 71.23 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.459 0.647 . . . . 2.26 111.861 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -71.47 -46.45 59.87 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 120.98 -1.075 . . . . 3.52 110.706 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.513 HG12 HD13 ' A' ' 65' ' ' LEU . 50.8 mt -49.28 -45.98 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.397 0.679 . . . . 1.5 110.823 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -45.19 -48.07 12.48 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.444 0.565 . . . . 4.17 112.216 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.0 mtm105 -66.02 -34.09 77.29 Favored 'General case' 0 C--N 1.339 0.115 0 O-C-N 121.754 -0.591 . . . . 5.62 110.753 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -63.7 -54.55 33.7 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.241 -1.022 . . . . 1.16 108.241 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mp -60.19 -36.44 77.63 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 111.953 0.353 . . . . 1.97 111.953 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -19.45 6.34 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.178 -0.951 . . . . 1.78 113.128 173.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -118.77 21.31 12.54 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.656 -0.688 . . . . 3.68 112.519 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -66.69 -68.36 0.38 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.355 0.98 . . . . 3.09 109.292 168.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.57 -125.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.419 0.687 . . . . 1.29 109.161 -167.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.0 -10.07 61.07 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 121.85 -0.531 . . . . 1.51 113.389 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -74.95 120.59 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 118.739 1.269 . . . . 1.96 110.38 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.86 53.07 1.09 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.068 0.396 . . . . 2.74 112.068 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.487 ' HB3' ' CB ' ' A' ' 47' ' ' LYS . 29.1 t -158.16 137.0 11.34 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 106.731 -1.581 . . . . 2.03 106.731 171.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.25 101.79 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.607 -1.627 . . . . 2.63 106.607 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -129.3 76.39 1.72 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.158 -1.793 . . . . 2.35 106.158 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.21 141.55 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.945 -1.131 . . . . 2.09 107.945 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -112.85 101.82 9.87 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.263 -1.754 . . . . 1.27 106.263 164.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 tp -55.65 -33.0 63.67 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.488 1.115 . . . . 3.46 109.037 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -48.97 77.29 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.545 0.738 . . . . 5.67 110.571 -174.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.05 -30.48 16.74 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.499 0.72 . . . . 1.54 110.875 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.35 57.69 1.74 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.984 1.278 . . . . 1.17 110.603 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -140.05 144.56 36.94 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.131 0.966 . . . . 3.24 108.856 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.417 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -112.49 116.24 29.95 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.151 0.98 . . . . 1.1 111.398 164.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -97.78 123.79 41.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.716 -1.216 . . . . 4.33 107.716 157.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mt -114.01 164.87 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 108.136 -1.061 . . . . 3.0 108.136 167.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.487 ' CB ' ' HB3' ' A' ' 34' ' ' SER . 10.3 ttmt -124.65 108.93 12.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.739 1.215 . . . . 3.88 110.194 166.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -116.83 177.26 4.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.1 2.16 . . . . 2.74 112.634 175.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.42 107.63 23.81 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.641 1.576 . . . . 3.19 107.559 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.93 6.81 2.28 Favored 'Trans proline' 0 N--CA 1.455 -0.753 1 C-N-CA 125.512 4.142 . . . . 2.47 113.605 -168.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -86.73 -22.16 26.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.46 0.704 . . . . 3.83 111.207 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.73 -56.01 3.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-N 118.566 0.621 . . . . 3.22 109.876 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.31 142.77 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.549 -1.278 . . . . 1.88 107.549 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.26 150.79 54.78 Favored Pre-proline 0 N--CA 1.453 -0.293 0 C-N-CA 124.798 1.239 . . . . 2.58 109.583 -174.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.18 -44.27 35.46 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.758 2.305 . . . . 1.51 111.627 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -63.97 -39.72 94.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.372 -0.83 . . . . 3.36 111.488 178.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -58.47 -43.69 89.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.005 0.522 . . . . 4.22 110.352 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.57 -42.39 29.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 N-CA-C 108.727 -0.842 . . . . 1.59 108.727 173.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 56' ' ' LEU . . . -57.32 -38.59 74.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.12 0.486 . . . . 1.72 111.152 -176.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -63.88 -51.48 64.38 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.491 -0.755 . . . . 3.01 110.109 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -54.26 -51.91 63.05 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.91 0.323 . . . . 3.52 111.695 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.621 HD13 ' H ' ' A' ' 69' ' ' ALA . 2.4 pp -61.25 -42.73 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.649 -0.657 . . . . 4.57 111.741 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.41 -35.15 80.06 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.663 -0.648 . . . . 2.49 110.758 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -64.27 -50.75 66.69 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.174 0.59 . . . . 2.59 109.901 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.513 HD13 HG12 ' A' ' 22' ' ' ILE . 15.3 mt -55.08 -35.38 64.5 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.163 0.585 . . . . 1.93 111.129 173.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.4 39.88 1.44 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.558 1.075 . . . . 1.45 110.589 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -135.43 156.97 48.04 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.528 1.531 . . . . 2.33 107.596 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -104.94 129.75 53.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.695 -1.224 . . . . 3.63 107.695 171.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.621 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -123.62 112.32 17.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.392 -1.707 . . . . 1.09 106.392 171.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -117.53 129.45 55.8 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.356 1.035 . . . . 0.95 108.916 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.592 ' HB ' HD12 ' A' ' 8' ' ' LEU . 7.1 p -81.8 154.29 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.788 0.835 . . . . 2.73 109.153 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.0 mtt . . . . . 0 N--CA 1.454 -0.246 0 CA-C-N 116.19 -0.459 . . . . 3.51 110.525 170.012 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.877 0 N-CA-C 107.913 -2.075 . . . . 2.35 107.913 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.05 110.94 23.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.225 0.61 . . . . 2.28 109.489 175.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 82' ' ' ILE . 1.5 pp -129.67 174.96 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.799 0.84 . . . . 3.6 110.874 164.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.468 ' CB ' ' HA ' ' A' ' 148' ' ' ALA . 0.9 OUTLIER -111.3 150.93 28.97 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 128.041 2.536 . . . . 4.41 109.401 174.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.2 mt -142.34 139.58 31.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.563 0.745 . . . . 2.47 110.03 172.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.1 t -97.1 124.45 41.12 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.33 0.968 . . . . 1.99 109.51 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -95.9 106.51 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.185 -0.672 . . . . 1.67 109.185 -171.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.9 m -98.83 133.74 42.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.903 -1.147 . . . . 1.46 107.903 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.62 -44.96 1.32 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.918 1.247 . . . . 0.97 112.013 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.52 150.82 41.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.662 0.731 . . . . 2.62 111.349 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -162.5 44.65 0.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.543 0.687 . . . . 2.92 110.057 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 48.9 t -161.99 136.67 6.98 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.826 -1.171 . . . . 2.88 110.721 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.6 -39.15 49.23 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.055 0.942 . . . . 2.88 111.352 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 m -56.23 -44.2 79.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.611 -0.681 . . . . 2.07 111.394 174.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 64.1 m -68.58 -49.98 55.25 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.222 -0.659 . . . . 1.85 109.222 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 113' ' ' VAL . 78.8 t -43.49 -60.4 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.775 1.23 . . . . 1.27 109.792 170.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -59.13 -43.31 91.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.239 1.016 . . . . 3.57 111.105 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -62.48 -47.68 82.92 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.578 0.751 . . . . 1.89 110.673 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.7 mt -56.02 -49.42 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.388 -0.967 . . . . 0.96 108.388 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.57 -45.11 92.8 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.679 -0.489 . . . . 2.58 109.679 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.1 m -57.02 -48.82 77.59 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.358 0.663 . . . . 2.07 110.736 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -60.01 -38.64 83.24 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.723 0.809 . . . . 3.73 111.493 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.436 HD21 HG23 ' A' ' 134' ' ' ILE . 42.6 mt -67.81 -60.5 2.48 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.693 -1.225 . . . . 1.67 107.693 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.6 p -55.74 -17.37 5.86 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.278 0.631 . . . . 1.68 112.64 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -60.99 -24.49 66.18 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.615 -0.678 . . . . 5.66 112.412 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.1 m -73.86 166.13 23.89 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.407 1.483 . . . . 1.53 111.505 -167.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -76.57 -58.32 3.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.65 1.18 . . . . 3.28 111.722 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.69 -45.73 8.35 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.362 -1.095 . . . . 1.73 110.362 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 122' ' ' VAL . 0.4 OUTLIER -60.44 131.29 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.485 -0.561 . . . . 2.46 109.485 175.292 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.2 t -131.53 -39.21 1.14 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.217 1.007 . . . . 2.83 110.875 172.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.06 112.18 17.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.704 -1.591 . . . . 2.43 106.704 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.75 166.69 16.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.672 -0.862 . . . . 1.33 108.672 163.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 m -142.59 138.34 30.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.69 -1.226 . . . . 1.81 107.69 163.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 95' ' ' VAL . 7.1 p -129.66 105.12 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.207 1.003 . . . . 1.93 108.616 -171.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -112.61 102.47 10.54 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.12 0.968 . . . . 1.13 110.573 -168.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -29.7 68.95 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.079 1.352 . . . . 2.63 113.638 -173.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.32 -44.75 95.77 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.797 0.839 . . . . 1.57 109.964 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.74 -25.63 26.32 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.519 1.127 . . . . 1.68 109.623 170.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.2 m 73.97 24.31 2.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.127 1.771 . . . . 1.42 111.509 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -116.06 150.33 37.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.459 1.027 . . . . 3.09 110.425 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.14 107.57 4.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.82 1.248 . . . . 0.99 112.595 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.82 141.5 28.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.245 1.021 . . . . 2.7 110.794 173.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.616 ' HB ' HD11 ' A' ' 108' ' ' ILE . 11.8 m -133.94 135.3 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 126.029 1.732 . . . . 2.54 106.475 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.15 104.21 14.11 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 108.292 -1.003 . . . . 3.46 108.292 171.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -113.43 -179.55 3.67 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.782 0.833 . . . . 2.93 111.199 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.79 114.32 37.62 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.165 1.386 . . . . 3.73 108.587 171.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.96 57.83 6.69 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.677 2.918 . . . . 2.38 112.511 -169.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -147.11 -52.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.634 1.573 . . . . 4.59 107.539 172.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 pt -83.94 -25.71 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 123.178 0.591 . . . . 1.89 112.27 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -147.03 169.73 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.075 -0.713 . . . . 1.51 109.075 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.57 165.75 30.09 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 111.145 -0.782 . . . . 1.41 111.145 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.18 -32.99 41.51 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.535 2.823 . . . . 1.58 111.505 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.414 ' HA ' HG12 ' A' ' 135' ' ' ILE . 19.1 ptt180 -52.37 -39.62 61.02 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.369 0.604 . . . . 6.61 111.188 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -72.26 -38.28 68.9 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.355 -0.98 . . . . 4.42 108.355 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.436 HG23 HD21 ' A' ' 102' ' ' LEU . 81.3 mt -58.03 -54.14 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.648 -0.501 . . . . 1.21 109.648 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 132' ' ' ARG . 22.2 pt -56.25 -55.01 21.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.404 -0.591 . . . . 3.1 109.404 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -47.52 -46.28 27.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 119.117 0.871 . . . . 4.04 112.931 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 mm -59.07 -42.7 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 O-C-N 121.735 -0.603 . . . . 1.71 111.682 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.3 pt -76.93 -28.99 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 113.785 1.032 . . . . 1.91 113.785 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.38 -28.33 65.06 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.363 -0.836 . . . . 3.06 110.301 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -60.77 -41.0 94.66 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.638 -0.504 . . . . 5.49 109.638 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 27.7 mt -70.79 -40.95 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.887 -0.782 . . . . 1.28 108.887 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.62 31.61 3.39 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.393 1.473 . . . . 1.02 110.729 -176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -108.9 166.82 10.53 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 108.782 -0.822 . . . . 2.13 108.782 169.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -137.59 133.72 34.74 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 106.985 -1.487 . . . . 3.46 106.985 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.45 92.66 3.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.981 1.712 . . . . 1.54 109.239 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.3 p -146.87 105.47 3.82 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 117.021 -1.466 . . . . 2.11 112.581 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.3 -70.56 0.09 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 121.361 1.891 . . . . 8.07 114.031 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HA ' ' CB ' ' A' ' 83' ' ' GLU 0.361 . . 40.68 80.09 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.334 2.254 . . . . 5.16 116.891 -163.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.917 0 C-N-CA 128.643 2.777 . . . . 7.06 103.875 172.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 107.84 -1.17 . . . . 4.28 107.84 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.84 154.36 18.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.274 -1.33 . . . . 4.34 107.75 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.6 t -141.71 132.25 25.39 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.674 0.67 . . . . 2.33 109.507 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -107.83 87.35 2.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.983 1.313 . . . . 2.86 108.983 -162.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.19 177.69 4.55 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.51 0.671 . . . . 2.72 110.59 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.86 151.79 49.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.74 -1.578 . . . . 2.47 106.74 172.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.1 mm -99.3 120.57 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.296 -1.372 . . . . 0.71 107.296 171.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -101.47 87.44 3.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.677 -1.972 . . . . 4.5 105.677 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.12 -87.71 0.08 OUTLIER Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.117 -1.193 . . . . 1.31 110.117 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.2 ptp 41.51 69.72 0.33 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.263 1.825 . . . . 1.96 115.636 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -53.33 -13.32 0.53 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.822 1.416 . . . . 2.54 114.822 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.8 t 74.58 -61.76 0.48 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.397 1.879 . . . . 3.0 111.217 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.15 -72.69 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.741 2.416 . . . . 5.95 113.043 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.6 p -157.51 10.88 0.2 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 113.027 0.751 . . . . 4.34 113.027 166.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -50.64 30.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.423 -1.325 . . . . 2.24 107.423 -169.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 p -49.72 -48.71 20.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 109.783 -0.451 . . . . 3.05 109.783 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 m -54.77 -46.98 74.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.667 0.787 . . . . 2.49 112.552 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -63.82 -45.49 89.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.978 -1.076 . . . . 2.88 110.122 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.431 HG13 HD13 ' A' ' 65' ' ' LEU . 1.2 mp -55.83 -45.02 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.314 1.046 . . . . 2.22 109.291 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -56.08 -50.52 70.77 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.209 1.403 . . . . 5.31 110.779 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -61.4 -39.53 91.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.084 0.554 . . . . 4.97 109.979 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -63.4 -51.58 65.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.554 -0.536 . . . . 1.53 109.554 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -57.26 9.25 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.487 1.115 . . . . 2.81 111.783 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.8 -18.67 34.24 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.946 1.091 . . . . 2.57 113.946 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -102.79 5.64 38.86 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.039 1.336 . . . . 3.2 114.136 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -57.33 -64.68 0.81 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 121.169 1.804 . . . . 3.77 111.611 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -168.47 -133.99 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.434 -1.691 . . . . 1.37 106.434 -169.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.78 33.13 1.23 Allowed Glycine 0 CA--C 1.534 1.221 0 CA-C-N 119.929 1.241 . . . . 1.64 113.61 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.41 124.22 60.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 N-CA-C 105.559 -2.015 . . . . 1.59 105.559 165.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 49.65 1.68 Allowed 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.073 -0.714 . . . . 2.62 109.073 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.3 t -161.88 148.41 13.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.559 -1.275 . . . . 2.29 107.559 173.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.25 120.59 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.964 -1.865 . . . . 2.88 105.964 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.41 71.46 1.47 Allowed 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.262 -1.014 . . . . 2.6 108.262 168.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.3 m -98.14 160.89 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.511 0.672 . . . . 2.37 110.49 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.24 99.65 5.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.426 -1.694 . . . . 1.43 106.426 170.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.7 -27.35 64.77 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.239 1.415 . . . . 3.6 109.869 171.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -69.14 -43.15 74.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.838 0.855 . . . . 4.55 111.688 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.43 -37.96 9.39 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.234 1.014 . . . . 1.56 110.104 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.4 62.94 0.83 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 126.082 1.801 . . . . 1.08 111.011 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -143.04 144.37 32.25 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.834 -1.172 . . . . 2.8 107.834 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.23 105.83 12.18 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.959 1.304 . . . . 1.06 111.174 171.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.66 136.39 38.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 105.64 -1.985 . . . . 4.31 105.64 166.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.9 pt -136.34 174.13 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.039 -1.097 . . . . 1.82 108.039 169.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -134.64 111.48 10.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.967 1.307 . . . . 4.94 109.488 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -124.38 177.31 5.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.86 1.664 . . . . 3.31 113.526 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -113.43 106.0 54.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.343 1.457 . . . . 4.02 111.128 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.47 -10.78 29.88 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.69 2.26 . . . . 2.92 114.296 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -65.89 -18.38 65.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.859 0.754 . . . . 4.13 112.397 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.87 -45.85 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 123.287 0.635 . . . . 2.95 110.281 -170.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.452 HD11 ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -94.66 153.59 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 109.255 -0.646 . . . . 2.15 109.255 175.433 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -130.62 150.08 75.35 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.911 1.685 . . . . 2.82 108.952 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -62.29 -39.27 48.52 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.075 2.516 . . . . 1.96 111.998 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.43 -46.98 87.8 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.495 -0.753 . . . . 4.67 109.91 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -59.79 -37.28 78.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.972 0.509 . . . . 3.05 111.128 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.452 ' CD1' HD11 ' A' ' 53' ' ' ILE . 1.5 mt -54.16 -56.36 10.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 107.202 -1.407 . . . . 1.67 107.202 169.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.1 -44.48 74.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.104 -0.498 . . . . 1.6 111.002 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -48.67 -52.2 24.52 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.134 0.974 . . . . 4.6 110.301 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -49.08 73.52 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.087 0.47 . . . . 2.37 109.811 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -62.4 -37.16 78.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 122.099 -0.376 . . . . 2.7 110.928 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -65.81 -45.17 83.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.629 -0.508 . . . . 1.98 109.629 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -59.02 -50.07 75.5 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.89 -0.411 . . . . 2.46 109.89 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.431 HD13 HG13 ' A' ' 22' ' ' ILE . 21.0 mt -53.49 -45.12 69.52 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.31 0.644 . . . . 2.52 111.241 176.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.87 30.63 0.87 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.807 0.718 . . . . 1.29 112.363 166.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -129.95 163.79 25.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.401 1.48 . . . . 2.14 108.951 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -99.84 122.6 43.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.63 -1.248 . . . . 2.29 107.63 170.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.04 122.54 45.47 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.727 -1.583 . . . . 1.09 106.727 165.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.27 141.62 50.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.772 -1.196 . . . . 1.05 107.772 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 p -67.97 149.09 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.107 -0.701 . . . . 3.0 109.107 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.2 mtt . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 109.99 -0.374 . . . . 4.57 109.99 173.186 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 124' ' ' PHE . . . . . . . . 0 N--CA 1.437 -1.263 0 N-CA-C 109.715 -1.354 . . . . 2.07 109.715 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -93.1 102.86 15.19 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.574 -2.009 . . . . 2.72 105.574 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.51 143.04 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 108.111 -1.07 . . . . 2.95 108.111 175.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -95.92 146.91 24.21 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.349 -1.723 . . . . 4.41 106.349 170.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.3 mt -137.73 158.96 43.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.172 -1.788 . . . . 2.29 106.172 166.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.75 123.43 42.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.333 -1.729 . . . . 1.64 106.333 170.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.3 pt -97.82 140.18 18.47 Favored 'Isoleucine or valine' 0 C--N 1.336 0.009 0 N-CA-C 108.465 -0.939 . . . . 1.89 108.465 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.4 m -129.03 138.18 51.75 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.814 0.845 . . . . 1.66 109.42 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.51 -35.32 2.7 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 126.032 1.777 . . . . 1.18 112.146 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -30.48 103.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.964 1.706 . . . . 3.56 114.565 172.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.5 m -100.6 -4.81 27.77 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.268 0.627 . . . . 3.51 111.063 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.66 165.52 14.33 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 120.646 -1.284 . . . . 3.34 110.25 177.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.06 -36.79 61.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.54 0.336 . . . . 2.87 110.712 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.3 t -48.46 -45.9 37.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.37 0.668 . . . . 2.08 111.364 173.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.437 ' HA ' HD21 ' A' ' 97' ' ' ASN . 64.2 m -59.77 -53.78 53.98 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 108.759 -0.83 . . . . 2.03 108.759 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.436 HG21 HD22 ' A' ' 115' ' ' LEU . 58.7 t -52.41 -43.6 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.389 0.676 . . . . 1.55 111.027 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -65.21 -42.31 93.61 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.362 -0.977 . . . . 2.56 108.362 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.437 HD21 ' HA ' ' A' ' 94' ' ' CYS . 0.1 OUTLIER -63.92 -42.01 97.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.022 -0.362 . . . . 3.85 110.022 176.553 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.28 -53.66 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.683 -0.858 . . . . 1.07 108.683 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -54.97 -45.19 74.95 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.644 1.178 . . . . 3.24 108.834 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -53.75 -52.85 58.84 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.927 -0.483 . . . . 1.33 111.612 172.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.457 ' HG2' HD11 ' A' ' 141' ' ' ILE . 4.1 mptp? -60.36 -35.2 75.12 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 120.823 -1.173 . . . . 2.43 111.716 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.49 -59.07 3.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.194 -1.039 . . . . 1.8 108.194 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.8 p -57.05 -19.03 16.65 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.077 0.951 . . . . 1.88 112.637 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.93 -31.84 67.2 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.048 -0.407 . . . . 3.8 111.499 171.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 17.4 m -65.45 142.64 58.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.569 1.547 . . . . 1.61 110.923 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -64.83 -48.1 75.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.459 1.103 . . . . 2.58 111.697 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.19 -32.85 57.8 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.97 -0.35 . . . . 1.36 112.741 -171.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.48 134.61 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 117.899 0.85 . . . . 2.27 109.039 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.8 t -107.71 -49.82 3.17 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.08 0.4 . . . . 3.26 112.08 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -136.65 121.64 18.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.482 -0.933 . . . . 2.0 108.482 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.43 133.15 44.16 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.009 -0.737 . . . . 0.94 109.009 166.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.5 m -113.4 102.73 10.6 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 107.901 -1.148 . . . . 2.21 107.901 168.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -108.43 140.33 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.233 -0.654 . . . . 2.76 109.233 175.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.37 95.58 3.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.165 0.983 . . . . 1.52 110.599 -169.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.436 HD22 HG21 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -60.72 -33.02 72.26 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.993 1.317 . . . . 2.28 112.685 -174.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.78 -33.74 17.36 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.071 0.948 . . . . 1.77 111.308 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.66 -5.93 12.16 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.743 1.617 . . . . 2.08 111.426 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.0 m 63.41 27.87 15.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.056 1.742 . . . . 1.45 111.989 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -99.02 158.08 15.9 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.348 0.659 . . . . 3.76 110.642 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -139.13 101.62 4.32 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.506 1.922 . . . . 1.15 108.455 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.79 103.62 15.26 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.185 0.994 . . . . 1.87 108.319 -176.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.6 m -102.12 127.56 55.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 124.612 1.165 . . . . 2.08 109.688 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.36 103.75 14.2 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.457 1.103 . . . . 3.91 108.619 172.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.415 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 13.9 p90 -121.51 -174.67 2.91 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.149 1.379 . . . . 2.69 110.257 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -111.59 111.9 54.32 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 119.153 0.888 . . . . 3.21 109.424 176.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.35 72.18 6.65 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.973 2.449 . . . . 2.2 111.937 -164.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.33 -43.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.206 1.402 . . . . 3.73 109.669 172.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.1 pt -85.73 -31.81 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 124.149 0.98 . . . . 1.83 110.827 -174.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.29 161.67 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.791 1.236 . . . . 1.58 108.296 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.02 162.95 29.33 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.969 -1.252 . . . . 1.53 109.969 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -59.89 -34.38 95.41 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.602 2.868 . . . . 1.53 111.375 -173.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -36.3 69.01 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 122.991 0.517 . . . . 4.72 111.337 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -69.9 -45.7 67.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.617 -0.882 . . . . 3.22 108.617 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.8 -49.38 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.29 -1.004 . . . . 1.22 108.29 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.5 mt -49.66 -59.99 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 118.369 -0.824 . . . . 1.94 109.05 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -49.65 -50.89 41.45 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.891 1.223 . . . . 3.6 112.713 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.62 -52.31 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.737 -0.602 . . . . 1.95 110.864 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.455 ' HA ' HD12 ' A' ' 141' ' ' ILE 0.259 2.4 pp -70.43 -26.11 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 120.777 -1.202 . . . . 1.29 113.716 -177.732 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -60.77 -39.45 88.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.575 0.625 . . . . 2.61 110.224 169.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.11 -40.37 81.02 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.999 -0.741 . . . . 3.43 108.999 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.457 HD11 ' HG2' ' A' ' 101' ' ' LYS . 48.7 mt -72.73 -42.16 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.095 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.37 35.12 4.53 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.997 1.284 . . . . 1.02 111.383 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 141' ' ' ILE . 58.2 m-85 -97.35 176.01 6.05 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.286 -1.005 . . . . 2.02 108.286 163.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -133.42 131.05 39.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.071 -1.455 . . . . 3.4 107.071 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.87 99.0 6.37 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.647 1.579 . . . . 1.3 109.551 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 58.4 m -111.49 114.85 28.23 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.886 0.875 . . . . 1.76 110.701 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -35.88 113.06 0.19 Allowed 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 127.793 2.437 . . . . 3.81 111.216 169.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -103.14 68.45 0.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.706 0.765 . . . . 3.68 110.85 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.291 1.436 . . . . 6.93 110.32 171.972 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 120.619 0.247 . . . . 4.55 110.911 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -96.51 140.15 31.57 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.578 -0.701 . . . . 4.35 109.677 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.9 t -119.39 136.19 54.4 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.338 1.055 . . . . 2.25 110.115 174.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -106.99 90.06 3.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.401 1.881 . . . . 4.68 111.075 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 71' ' ' VAL 0.271 0.3 OUTLIER -118.13 167.39 11.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.249 1.023 . . . . 2.81 113.087 176.408 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.69 161.05 20.31 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.594 -1.632 . . . . 2.94 106.594 165.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.0 mm -100.16 136.81 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 105.552 -2.018 . . . . 1.03 105.552 167.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -121.85 78.01 1.42 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.06 -1.459 . . . . 5.27 107.06 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.96 -76.73 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.737 -0.945 . . . . 1.38 110.737 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mpt? 57.98 89.18 0.05 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.664 1.586 . . . . 1.86 112.715 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.9 m -59.18 -60.72 3.41 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.583 -0.698 . . . . 2.45 110.961 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.5 t -167.72 88.18 0.27 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.689 -1.226 . . . . 3.36 107.689 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 1.94 65.87 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 129.189 2.996 . . . . 5.84 115.476 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t 173.61 -43.89 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 125.218 1.407 . . . . 3.38 108.537 -168.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 t -66.42 -40.76 89.73 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.833 -1.167 . . . . 2.03 111.32 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.9 -32.02 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 121.799 -0.563 . . . . 1.8 110.464 167.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 t -69.51 -27.2 64.98 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.039 -0.413 . . . . 3.16 111.253 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.59 -47.75 74.65 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.598 -1.314 . . . . 2.86 109.599 171.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.2 mt -42.74 -37.99 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 121.354 -0.841 . . . . 1.38 112.966 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -47.71 -55.37 9.66 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.719 0.691 . . . . 3.7 112.821 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -64.52 -36.01 82.82 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.48 -0.762 . . . . 6.38 109.858 -172.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -61.7 -54.22 45.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.94 -1.133 . . . . 1.34 107.94 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -54.97 -44.58 74.52 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 112.173 0.434 . . . . 2.13 112.173 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.82 -21.1 3.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.907 0.776 . . . . 1.93 112.814 175.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 5.05 13.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 117.843 -1.075 . . . . 5.31 112.61 177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -64.12 -58.42 6.7 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.678 1.126 . . . . 2.77 110.735 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.5 -135.84 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 O-C-N 122.002 -0.436 . . . . 1.33 110.48 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.79 -15.09 47.1 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.929 1.252 . . . . 1.49 113.465 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.28 125.34 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 117.981 0.891 . . . . 1.72 111.755 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 mt -141.53 44.32 1.74 Allowed 'General case' 0 C--N 1.342 0.257 0 CA-C-O 119.286 -0.387 . . . . 3.5 111.074 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -158.13 149.1 20.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.451 -0.574 . . . . 2.76 109.451 169.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.98 70.26 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 124.902 1.281 . . . . 2.7 109.275 -170.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.304 0.7 OUTLIER -102.32 78.93 1.79 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 119.234 -0.986 . . . . 5.03 110.26 -177.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p -96.91 145.76 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.002 -0.999 . . . . 2.51 108.81 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.59 99.78 6.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.963 -1.495 . . . . 1.44 106.963 163.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.6 mt -56.88 -26.65 59.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.007 0.923 . . . . 2.88 111.441 172.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.1 ttt -56.55 -57.59 11.7 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.226 1.01 . . . . 4.1 110.197 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.29 -27.57 22.81 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.798 0.839 . . . . 1.41 110.898 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.89 57.59 2.25 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.552 1.072 . . . . 1.16 110.567 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.34 132.18 35.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.178 -1.045 . . . . 3.69 108.178 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.9 102.62 11.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.584 2.354 . . . . 0.95 109.273 171.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -96.95 137.91 35.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.326 -1.731 . . . . 3.37 106.326 164.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.3 pt -143.49 171.61 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.178 -1.045 . . . . 1.82 108.178 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -125.74 105.48 9.01 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.828 0.851 . . . . 5.34 109.971 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -97.53 169.79 9.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.052 2.541 . . . . 2.68 113.007 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -117.26 100.7 53.11 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 106.096 -1.816 . . . . 2.89 106.096 171.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.75 -29.62 43.05 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.535 3.49 . . . . 2.87 114.704 -170.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -65.65 -18.82 65.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.7 1.6 . . . . 4.6 112.469 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.3 m -126.8 -38.22 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.343 0.657 . . . . 3.12 111.46 -175.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.93 149.88 17.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-N 118.887 0.767 . . . . 1.87 109.268 173.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -129.6 150.34 75.42 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 124.634 1.173 . . . . 3.48 109.287 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -56.22 -37.24 97.0 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.114 2.542 . . . . 1.78 111.263 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.6 mp -54.64 -41.71 70.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.26 0.624 . . . . 3.08 111.344 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -69.49 -40.97 76.73 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.546 -0.721 . . . . 3.7 109.564 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -45.22 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.06 -1.089 . . . . 1.47 108.06 172.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.53 -42.97 93.51 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.904 -0.589 . . . . 1.66 110.804 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -59.4 -51.63 69.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 121.773 -0.58 . . . . 3.11 110.19 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -56.06 15.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.208 0.528 . . . . 2.22 111.137 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.526 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.4 pp -62.12 -40.23 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 121.187 -0.946 . . . . 4.19 112.559 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -32.6 74.27 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.492 -0.755 . . . . 2.55 110.85 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.31 -51.29 61.63 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.503 0.592 . . . . 2.65 109.648 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.07 -38.63 68.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.416 -0.514 . . . . 3.69 111.808 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.77 45.47 0.65 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.676 -0.97 . . . . 1.53 110.676 171.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -131.95 157.09 44.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.72 1.208 . . . . 2.62 108.035 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -99.82 129.71 45.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.944 -1.502 . . . . 2.53 106.944 166.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.526 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -121.38 124.71 45.2 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.222 -1.399 . . . . 1.24 107.222 173.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.53 119.98 27.23 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.155 0.909 . . . . 0.98 109.946 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 2.2 p -68.33 141.31 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 125.065 1.346 . . . . 2.73 108.737 166.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.2 ptm . . . . . 0 N--CA 1.455 -0.194 0 O-C-N 124.486 1.117 . . . . 5.76 111.357 -172.63 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 108.107 -1.997 . . . . 1.84 108.107 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.614 ' C ' HD13 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -118.46 107.02 13.3 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.275 1.43 . . . . 2.37 108.467 -166.101 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.614 HD13 ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -127.6 148.02 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 120.336 1.425 . . . . 2.73 112.455 -178.368 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.11 124.0 50.08 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.15 1.78 . . . . 4.47 112.621 -175.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.7 mt -128.76 138.83 52.32 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.315 1.046 . . . . 2.36 109.418 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.6 OUTLIER -102.96 124.1 47.83 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.808 -1.182 . . . . 2.28 107.808 -177.428 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.37 105.49 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.713 1.205 . . . . 1.76 109.715 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.8 p -101.77 126.26 48.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.575 -0.898 . . . . 2.26 108.575 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.64 -34.3 3.66 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.128 0.87 . . . . 1.36 111.034 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -63.36 130.94 46.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.083 0.553 . . . . 2.88 109.808 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 p -137.54 22.58 2.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.965 1.306 . . . . 3.72 110.693 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 5.3 t -157.25 141.19 16.1 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 121.298 -0.876 . . . . 2.95 111.881 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.6 -35.13 79.93 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.214 0.606 . . . . 2.61 111.456 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 p -53.4 -47.3 69.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.504 -0.554 . . . . 2.18 109.504 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 59.7 m -59.26 -49.76 76.6 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 119.22 -0.419 . . . . 2.5 110.129 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.4 t -49.36 -50.15 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 118.237 0.471 . . . . 1.61 110.544 175.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -60.63 -40.81 93.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.768 -0.456 . . . . 4.66 109.768 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.23 -42.47 96.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.865 -0.522 . . . . 2.66 110.253 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.8 mt -61.42 -51.47 72.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.111 -1.07 . . . . 1.3 108.111 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -55.67 -45.88 77.64 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.676 1.19 . . . . 2.23 109.61 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.8 t -54.95 -54.82 37.88 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.687 -0.633 . . . . 1.82 110.637 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -51.2 -61.32 2.3 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.194 0.452 . . . . 2.71 110.261 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.85 -39.32 91.45 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.768 -0.373 . . . . 2.23 110.415 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 96.3 m -59.73 -19.24 48.82 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.54 0.609 . . . . 1.84 112.1 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -66.49 -27.02 67.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 119.166 -1.014 . . . . 4.47 111.919 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 81.3 m -63.54 126.58 27.98 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.631 0.773 . . . . 2.19 111.597 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -38.51 -59.63 0.89 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.651 1.98 . . . . 3.4 113.845 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.22 -28.36 68.29 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.231 0.469 . . . . 1.67 113.319 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.78 118.8 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 O-C-N 121.359 -1.083 . . . . 1.75 109.475 -168.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.2 m -102.92 -44.86 5.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.857 0.318 . . . . 2.71 111.857 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -142.12 128.8 20.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.406 -0.961 . . . . 1.99 108.406 166.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.75 162.52 12.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.87 -0.332 . . . . 0.87 110.375 161.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m -145.0 113.05 6.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.45 -0.945 . . . . 1.73 108.45 162.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 p -110.03 128.93 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.75 0.705 . . . . 1.89 110.962 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -125.04 90.4 3.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.145 0.978 . . . . 1.53 110.951 -166.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.09 -32.5 55.01 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.287 1.435 . . . . 2.61 112.964 -174.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.71 -32.12 65.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.259 0.624 . . . . 2.0 111.154 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.53 -14.45 11.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.145 1.378 . . . . 1.93 111.202 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.4 m 65.99 28.29 10.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.101 1.361 . . . . 1.89 111.951 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.458 ' HD3' ' HB1' ' A' ' 148' ' ' ALA . 44.3 mmtt -96.75 152.84 18.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.312 1.445 . . . . 2.87 109.703 173.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.26 106.36 4.35 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.521 1.128 . . . . 0.99 109.383 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.3 mp -95.43 130.19 42.32 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.633 -1.247 . . . . 2.85 107.633 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.1 t -128.28 123.9 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.031 0.932 . . . . 1.91 108.75 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -105.55 92.06 4.03 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.918 0.887 . . . . 2.99 109.136 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -115.35 173.7 6.38 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.761 0.709 . . . . 2.54 111.098 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -100.26 112.68 64.65 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 108.886 -0.783 . . . . 2.74 108.886 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.72 70.03 7.11 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.649 2.899 . . . . 1.99 111.217 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -165.05 -47.95 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.523 1.529 . . . . 3.04 108.836 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.6 pt -84.85 -37.48 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.121 0.969 . . . . 2.17 111.103 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.7 tp -136.86 169.3 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.304 0.642 . . . . 2.08 109.458 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.25 170.77 32.17 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.64 -1.784 . . . . 1.75 108.64 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -58.41 -35.65 98.44 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.27 2.646 . . . . 1.8 111.285 -171.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.9 ptm85 -56.63 -30.55 63.41 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.18 0.807 . . . . 5.4 113.18 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.36 -50.03 67.11 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.231 -1.026 . . . . 3.37 108.231 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 42.5 mt -63.32 -44.17 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.512 -1.222 . . . . 1.1 108.123 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.54 -57.2 5.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 118.476 -0.773 . . . . 1.87 109.366 172.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -49.58 -51.14 39.15 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.302 1.41 . . . . 3.46 112.36 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.6 mm -54.16 -53.72 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.019 0.528 . . . . 1.81 110.377 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 pp -70.36 -29.72 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 120.967 -1.083 . . . . 1.44 113.108 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -59.04 -41.79 88.71 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 119.143 0.883 . . . . 2.8 109.309 168.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -64.82 -37.92 89.23 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.483 -0.562 . . . . 2.99 109.483 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.7 mt -62.83 -44.96 99.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 122.006 -0.434 . . . . 1.09 110.437 170.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.19 28.21 5.02 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.381 1.467 . . . . 1.03 111.941 -174.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -101.67 -179.81 4.12 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.42 1.11 . . . . 2.24 108.929 164.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -139.1 126.55 21.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.635 -1.617 . . . . 3.88 106.635 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.62 91.16 3.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.315 1.846 . . . . 1.21 108.373 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 68.3 m -102.82 131.45 49.69 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.092 -0.707 . . . . 2.27 109.092 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 mt -41.25 109.87 0.14 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.26 1.824 . . . . 3.77 111.37 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.663 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -90.09 -20.93 22.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.742 -0.663 . . . . 4.01 110.741 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.403 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.375 0 C-N-CA 125.91 1.684 . . . . 6.35 112.062 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 107.41 -1.329 . . . . 3.93 107.41 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.56 147.95 41.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.444 -0.947 . . . . 4.9 108.444 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.4 p -141.18 140.38 34.02 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.871 -0.788 . . . . 3.09 108.871 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -120.72 103.52 9.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.693 -1.966 . . . . 3.04 105.693 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.581 HD12 ' HB1' ' A' ' 69' ' ' ALA . 2.1 pt? -132.66 160.37 36.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.136 -1.061 . . . . 2.22 108.136 175.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.495 HE22 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -101.41 171.83 7.34 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.545 -0.909 . . . . 3.47 108.545 173.062 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.2 mm -99.84 126.74 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.098 -1.815 . . . . 0.99 106.098 162.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -102.36 95.86 6.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.348 -2.093 . . . . 3.68 105.348 166.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.38 -77.26 0.11 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.14 0.876 . . . . 1.28 110.961 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 mtp 35.53 76.22 0.05 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.933 2.093 . . . . 2.12 114.831 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 p -41.04 -54.0 2.89 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.669 0.787 . . . . 2.84 112.448 171.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t 119.13 -62.95 0.0 OUTLIER 'General case' 0 C--N 1.342 0.266 0 C-N-CA 129.355 3.062 . . . . 2.85 107.659 -174.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -22.51 -77.5 0.01 OUTLIER 'General case' 0 C--N 1.344 0.341 0 C-N-CA 127.659 2.384 . . . . 5.81 113.148 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 t -161.82 21.9 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.487 0.661 . . . . 2.85 110.945 165.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -71.89 -41.28 68.17 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 120.91 -1.119 . . . . 2.15 110.256 -163.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.68 -46.89 79.64 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.684 -0.858 . . . . 1.46 108.684 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 t -55.79 -48.63 75.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.294 0.569 . . . . 2.39 110.285 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.25 -49.3 74.67 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.827 -0.434 . . . . 2.56 109.827 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.6 mt -56.06 -49.93 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.886 0.874 . . . . 1.92 109.509 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.479 ' CD ' HG21 ' A' ' 37' ' ' VAL . 82.5 mm-40 -61.94 -39.08 90.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.892 0.877 . . . . 7.03 112.393 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -44.38 93.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.105 -0.702 . . . . 5.02 109.105 175.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -61.69 -37.12 82.95 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.883 -0.51 . . . . 1.47 110.031 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.79 -52.72 33.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.93 0.892 . . . . 2.06 110.958 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.424 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 3.9 pt20 -56.67 -26.53 56.63 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.784 1.175 . . . . 2.5 112.608 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -74.22 0.63 13.5 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 116.782 -1.58 . . . . 2.96 115.125 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -48.67 -84.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 121.044 1.747 . . . . 3.01 112.581 174.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.84 -90.91 0.0 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.686 0.795 . . . . 2.33 110.095 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.15 -26.18 74.21 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.369 -0.692 . . . . 1.62 111.369 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.424 ' CG1' ' HA ' ' A' ' 27' ' ' GLN . 1.1 t -61.06 128.6 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.069 -0.715 . . . . 2.24 109.069 172.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.19 53.5 1.08 Allowed 'General case' 0 C--N 1.337 0.053 0 C-N-CA 121.099 -0.241 . . . . 3.03 111.207 163.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.1 t -158.1 139.22 13.28 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 120.926 -1.109 . . . . 1.9 110.549 167.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 p -126.53 107.89 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 125.94 1.696 . . . . 2.89 107.432 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -126.22 72.24 1.3 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.503 -1.666 . . . . 2.43 106.503 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.538 HG22 ' HA ' ' A' ' 44' ' ' ALA . 44.4 t -103.55 141.09 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.843 -0.799 . . . . 1.89 108.843 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.25 95.75 5.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.551 -0.907 . . . . 1.43 108.551 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.97 -18.19 4.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.022 0.529 . . . . 3.05 112.309 169.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.8 mtt -69.13 -50.54 46.97 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.3 0.64 . . . . 3.61 110.116 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.08 -30.69 12.89 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.715 0.806 . . . . 1.48 111.435 -172.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.38 64.08 1.4 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.837 1.208 . . . . 1.2 110.479 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -141.0 138.5 33.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.384 -1.709 . . . . 2.93 106.384 171.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.538 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -117.09 92.74 3.94 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 124.868 1.355 . . . . 1.27 112.301 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.92 119.59 35.67 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.996 -1.113 . . . . 4.67 107.996 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.99 163.35 20.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 126.379 1.872 . . . . 2.6 108.858 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -122.34 106.08 10.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.588 0.755 . . . . 3.91 110.083 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.513 ' HB2' HD12 ' A' ' 53' ' ' ILE . 18.6 p90 -100.11 173.36 6.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.075 1.75 . . . . 2.38 113.272 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -122.85 102.86 37.66 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.239 1.815 . . . . 4.06 109.27 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -45.8 -36.02 14.38 Favored 'Trans proline' 0 C--N 1.355 0.913 1 C-N-CA 126.076 4.517 . . . . 2.3 113.743 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.39 -29.11 68.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.224 1.409 . . . . 3.36 111.69 -170.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.89 -32.45 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.684 0.794 . . . . 2.79 112.261 -174.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.513 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -120.56 146.2 25.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 107.947 -1.131 . . . . 1.6 107.947 173.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -124.27 146.51 51.97 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.149 1.38 . . . . 2.44 109.394 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.72 -38.5 49.29 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.313 2.676 . . . . 1.69 112.057 -171.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -57.58 -45.62 85.01 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.879 -0.513 . . . . 3.26 111.005 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -61.05 -43.18 99.28 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.002 0.921 . . . . 3.39 109.904 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.401 ' CD1' HD11 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -52.37 -53.2 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.251 -1.388 . . . . 1.12 107.251 171.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.17 85.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 110.019 -0.363 . . . . 1.47 110.019 -173.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -55.89 -42.55 76.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.292 0.637 . . . . 2.76 110.86 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.2 -43.25 87.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.394 0.543 . . . . 2.79 110.129 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 69' ' ' ALA . 6.1 mm -65.4 -44.03 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.671 -0.643 . . . . 2.57 110.607 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -58.46 -41.96 86.34 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.288 0.635 . . . . 3.38 111.279 174.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -63.76 -48.73 75.78 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.174 0.59 . . . . 2.91 109.984 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.8 mt -56.22 -35.51 67.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.645 0.378 . . . . 2.08 111.323 173.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.82 25.57 3.6 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.216 0.912 . . . . 1.34 112.077 168.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -115.48 168.79 9.68 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.055 1.742 . . . . 2.09 108.643 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -104.06 142.55 34.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.801 -1.185 . . . . 2.4 107.801 165.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.581 ' HB1' HD12 ' A' ' 8' ' ' LEU . . . -123.81 112.38 17.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.78 -1.563 . . . . 0.96 106.78 175.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB3' HE22 ' A' ' 9' ' ' GLN . . . -126.85 129.33 48.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.656 -0.868 . . . . 0.93 108.656 175.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.7 p -47.69 145.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 125.484 1.513 . . . . 2.86 109.702 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.5 ptt? . . . . . 0 N--CA 1.447 -0.625 0 CA-C-N 115.751 -0.659 . . . . 4.95 110.273 -175.16 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.615 0 N-CA-C 107.17 -2.372 . . . . 1.64 107.17 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.15 96.49 10.61 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 105.477 -2.046 . . . . 2.49 105.477 172.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.6 pt -123.06 145.69 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 O-C-N 123.211 0.319 . . . . 2.96 110.213 173.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.401 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.0 OUTLIER -96.98 157.35 15.94 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.491 -1.67 . . . . 3.54 106.491 178.797 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.63 HD13 ' HB1' ' A' ' 145' ' ' ALA . 4.6 pp -147.51 161.72 40.52 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.091 -0.707 . . . . 2.97 109.091 161.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.6 m -99.73 127.86 45.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.624 1.17 . . . . 1.83 108.815 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 pp -99.57 127.61 52.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 C-N-CA 123.079 0.552 . . . . 1.59 110.311 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.5 m -106.45 142.6 35.84 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.722 0.809 . . . . 1.36 109.188 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.65 -24.26 17.78 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.653 1.121 . . . . 0.95 113.061 172.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.2 ttm -66.28 143.6 57.11 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.063 0.931 . . . . 2.6 111.274 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.6 t -162.0 37.18 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.925 0.49 . . . . 2.58 110.593 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.1 t -164.62 138.35 5.1 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.605 -1.31 . . . . 2.82 111.509 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.27 -40.17 81.15 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.243 0.617 . . . . 2.62 110.895 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -43.23 70.44 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.494 -0.753 . . . . 2.44 109.612 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 91.2 m -67.76 -42.38 81.84 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.157 -0.449 . . . . 2.06 110.796 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.95 -50.35 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 118.864 0.756 . . . . 2.06 110.509 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -59.23 -37.0 76.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.766 -0.457 . . . . 3.4 109.766 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -65.25 -49.11 70.9 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.275 -0.266 . . . . 1.7 110.663 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.07 -48.27 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 109.438 -0.579 . . . . 0.92 109.438 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -58.63 -49.3 78.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.443 -0.947 . . . . 2.46 108.443 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.1 t -52.45 -46.38 66.42 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.1 0.56 . . . . 1.38 110.122 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.454 ' HG2' HD11 ' A' ' 141' ' ' ILE . 13.7 mptt -63.33 -41.47 98.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.284 0.634 . . . . 2.96 111.723 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.6 mt -67.34 -58.59 4.51 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.538 -1.282 . . . . 1.78 107.538 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.3 p -57.05 -18.74 15.43 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.133 0.973 . . . . 1.85 112.749 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.16 -34.45 66.17 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.943 -0.473 . . . . 6.0 111.65 170.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.5 m -67.44 149.22 50.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.407 1.883 . . . . 1.64 111.458 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -64.47 -52.68 56.71 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.347 1.059 . . . . 2.47 111.891 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.21 -27.41 59.94 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 122.175 -0.328 . . . . 1.1 113.074 -168.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.52 132.02 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 117.647 0.723 . . . . 1.96 109.538 -173.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 49.6 m -103.03 -58.21 1.91 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.249 0.619 . . . . 1.96 111.19 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -134.69 113.7 11.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.2 -0.667 . . . . 2.69 109.2 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.24 149.88 21.54 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 108.102 -1.073 . . . . 0.84 108.102 165.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.7 t -143.03 109.01 5.18 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 108.19 -1.041 . . . . 1.94 108.19 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.44 138.99 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.322 1.449 . . . . 2.1 110.686 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.21 93.64 2.85 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.74 1.216 . . . . 1.18 110.665 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 pp -60.11 -17.62 41.38 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.538 1.135 . . . . 2.28 113.83 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.71 86.75 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.458 0.572 . . . . 1.48 109.574 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.82 -39.91 10.02 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.505 1.122 . . . . 2.09 108.905 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.1 m 88.94 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 127.568 2.347 . . . . 1.3 110.539 -169.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.0 157.95 17.41 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.365 -0.606 . . . . 4.09 109.365 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.57 144.26 34.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.812 -1.09 . . . . 1.11 109.944 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.491 ' HA ' HD13 ' A' ' 121' ' ' LEU . 4.3 mm? -94.79 143.31 26.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.462 -0.94 . . . . 2.9 108.462 163.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.74 124.16 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.634 -1.987 . . . . 1.72 105.634 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -108.64 92.44 4.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.086 -1.079 . . . . 3.14 108.086 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -113.33 -178.56 3.41 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 124.014 0.926 . . . . 2.13 108.83 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -113.99 110.75 48.5 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 108.322 -0.992 . . . . 2.98 108.322 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.32 68.47 8.27 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.924 2.416 . . . . 1.74 112.229 -166.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.34 -44.92 0.07 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.617 1.567 . . . . 3.31 109.206 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.6 pt -86.67 -30.73 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 123.365 0.666 . . . . 1.66 111.559 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.2 162.63 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.426 -0.953 . . . . 1.44 108.426 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.79 167.84 31.64 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.837 -0.905 . . . . 1.44 110.837 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.12 -39.01 62.81 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.811 3.008 . . . . 1.49 112.334 -169.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.76 -39.43 52.33 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.471 0.545 . . . . 6.06 112.471 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.51 -45.0 81.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.602 -0.518 . . . . 3.37 109.602 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 88.3 mt -58.67 -49.29 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.815 -0.809 . . . . 1.15 108.815 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.2 mt -49.57 -59.31 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 N-CA-C 108.445 -0.946 . . . . 2.13 108.445 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -50.07 -47.55 53.5 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.105 -0.997 . . . . 5.02 111.365 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 82.4 mt -55.54 -50.12 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.447 -0.783 . . . . 2.69 109.646 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 145' ' ' ALA . 12.7 pt -70.37 -30.14 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 118.108 -0.949 . . . . 1.26 112.861 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.77 -42.48 79.47 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.829 1.195 . . . . 3.02 109.068 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.71 -34.32 76.91 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.758 1.223 . . . . 3.45 109.232 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.454 HD11 ' HG2' ' A' ' 101' ' ' LYS . 75.9 mt -75.39 -41.21 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.264 0.626 . . . . 1.04 111.376 172.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.55 30.44 6.19 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.847 1.689 . . . . 0.91 112.433 -172.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -105.31 171.58 7.25 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.727 1.263 . . . . 2.17 110.304 167.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -129.04 117.63 21.22 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 106.655 -1.609 . . . . 4.4 106.655 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.63 ' HB1' HD13 ' A' ' 84' ' ' LEU . . . -106.06 102.54 11.95 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 125.292 1.437 . . . . 1.09 108.616 174.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.0 p -98.85 112.7 24.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.092 -1.447 . . . . 2.52 107.092 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 83' ' ' GLU . 1.2 mt -49.78 105.86 0.1 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.523 -1.288 . . . . 5.69 107.523 166.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.67 -38.48 33.53 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.333 -0.617 . . . . 3.81 109.333 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 126.72 2.008 . . . . 6.91 113.167 -179.848 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 106.449 -1.686 . . . . 3.29 106.449 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -123.09 152.13 41.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.331 1.052 . . . . 3.51 109.585 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.5 t -140.87 127.98 20.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.774 -0.825 . . . . 2.07 108.774 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -101.01 98.73 9.15 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.986 1.715 . . . . 3.73 109.082 -171.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.476 ' CB ' ' HA ' ' A' ' 71' ' ' VAL 0.273 1.4 pt? -125.44 176.55 6.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.943 0.877 . . . . 2.16 112.383 176.207 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.601 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -136.36 147.11 47.21 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.186 -1.412 . . . . 1.79 107.186 176.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.1 mm -99.05 140.07 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 106.264 -1.754 . . . . 0.84 106.264 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -115.41 76.69 1.02 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.293 -1.003 . . . . 3.13 108.293 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.25 -69.96 0.04 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.952 -1.259 . . . . 1.23 109.952 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 31.38 72.1 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.734 2.013 . . . . 2.54 115.646 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -53.08 -16.62 1.18 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.557 1.543 . . . . 2.41 114.053 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.2 t 74.79 -56.68 0.63 Allowed 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 126.28 1.832 . . . . 3.36 111.767 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -23.15 -75.44 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 127.523 2.329 . . . . 5.69 112.917 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.8 m -154.66 17.44 0.45 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.83 0.852 . . . . 3.05 111.541 162.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.83 -51.83 36.48 Favored 'General case' 0 C--O 1.224 -0.242 0 O-C-N 121.051 -1.031 . . . . 1.85 109.618 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -51.67 -47.86 37.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 CA-C-N 118.458 0.572 . . . . 1.48 109.689 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -56.95 -49.66 75.0 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.545 0.688 . . . . 2.87 110.609 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -59.1 -51.7 68.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.612 -0.68 . . . . 2.64 109.677 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 67' ' ' PHE . 2.8 mt -51.32 -47.57 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.334 1.454 . . . . 1.45 110.859 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -55.38 -53.19 59.26 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.877 0.762 . . . . 4.06 110.482 174.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -65.58 -31.55 72.66 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.395 -0.815 . . . . 4.47 111.438 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -68.66 -51.29 43.61 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.255 1.022 . . . . 1.19 109.697 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.33 -40.35 67.93 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.084 0.954 . . . . 1.93 110.663 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.67 -19.72 2.58 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.66 0.615 . . . . 2.7 112.66 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -126.63 24.06 6.68 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.216 1.406 . . . . 3.88 111.831 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.38 -82.57 0.05 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.091 -1.078 . . . . 3.2 108.091 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.44 -132.74 0.08 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.074 0.95 . . . . 1.28 109.19 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.38 33.17 1.35 Allowed Glycine 0 CA--C 1.531 1.06 0 O-C-N 120.909 -1.12 . . . . 1.31 113.816 -174.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.412 ' C ' HD12 ' A' ' 33' ' ' LEU . 14.3 p -104.31 118.79 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.682 1.593 . . . . 1.57 108.923 170.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 33' ' ' LEU . 4.1 mp -134.24 53.38 2.0 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.406 -0.961 . . . . 3.32 108.406 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.66 149.42 14.88 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.419 -1.326 . . . . 2.09 107.419 173.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.92 100.84 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 106.404 -1.702 . . . . 2.83 106.404 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.72 71.89 1.05 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.046 -1.094 . . . . 3.24 108.046 176.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.77 133.6 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.432 -0.951 . . . . 1.84 108.432 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.36 83.06 1.71 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.033 -1.099 . . . . 1.28 108.033 173.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.49 -24.03 1.87 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.466 1.506 . . . . 2.88 112.267 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -70.16 -40.06 74.96 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.806 1.242 . . . . 4.75 111.785 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.24 -31.89 11.49 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.513 1.125 . . . . 1.38 110.991 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.79 61.17 1.71 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 125.072 1.32 . . . . 1.0 110.565 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -141.23 136.83 32.1 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.181 -1.414 . . . . 3.66 107.181 171.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.34 102.15 10.82 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.283 1.433 . . . . 1.05 109.683 170.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -98.67 135.88 39.54 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.777 -1.934 . . . . 4.28 105.777 166.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.45 HD12 HD21 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -135.09 174.34 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.978 -1.119 . . . . 2.29 107.978 168.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.74 103.44 6.83 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.753 0.821 . . . . 5.55 108.797 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -117.6 167.83 10.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.103 1.361 . . . . 3.31 113.755 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -99.26 106.32 38.16 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 127.202 2.201 . . . . 3.17 110.452 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.01 -4.44 13.53 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.103 1.869 . . . . 2.7 114.35 -172.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -88.62 -20.84 24.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.926 0.785 . . . . 4.46 110.907 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.97 -30.48 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.505 1.122 . . . . 2.8 110.091 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.45 HD11 ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -115.98 155.96 17.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.666 0.746 . . . . 1.74 109.257 173.019 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -132.31 154.27 81.54 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.416 2.286 . . . . 2.94 108.379 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.28 -40.13 34.03 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.634 2.223 . . . . 1.54 112.194 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -63.76 -40.27 96.3 Favored 'General case' 0 C--O 1.225 -0.227 0 O-C-N 121.763 -0.586 . . . . 2.82 110.868 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -58.36 -45.83 87.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.943 0.897 . . . . 2.95 110.334 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.45 ' CD1' HD11 ' A' ' 53' ' ' ILE . 1.9 mt -53.98 -56.06 11.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.851 -1.537 . . . . 1.32 106.851 172.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.95 -41.32 70.95 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.787 -0.642 . . . . 1.44 110.578 -173.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -53.84 -50.18 66.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.23 1.412 . . . . 2.77 109.387 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -48.46 72.12 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.379 0.609 . . . . 2.21 109.777 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.7 mm -63.22 -40.33 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.129 -0.357 . . . . 2.67 110.564 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -64.9 -42.19 94.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.735 -0.469 . . . . 1.96 109.735 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -60.46 -47.89 84.15 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.138 0.575 . . . . 2.98 109.562 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.18 -33.52 71.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.209 0.604 . . . . 2.04 111.629 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.9 27.72 3.92 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.172 0.892 . . . . 1.39 111.632 168.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.44 ' CD2' HD13 ' A' ' 22' ' ' ILE . 2.6 m-30 -118.91 162.3 18.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.994 1.717 . . . . 2.18 108.694 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -98.31 129.19 45.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.931 1.293 . . . . 3.69 107.973 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.4 110.61 21.8 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.984 1.314 . . . . 1.17 108.507 174.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -126.93 122.92 35.96 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.122 0.419 . . . . 1.21 109.977 175.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.476 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.4 t -58.38 148.23 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 123.24 0.616 . . . . 3.14 110.931 172.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 39.8 mtt . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 119.076 -0.488 . . . . 4.96 111.449 179.659 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.985 0 N-CA-C 110.038 -1.225 . . . . 1.85 110.038 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.32 73.09 2.13 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.847 1.259 . . . . 2.81 109.139 -167.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.28 155.68 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.584 -0.895 . . . . 2.62 108.584 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.84 140.69 50.41 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.636 1.174 . . . . 2.76 107.998 173.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 mp -130.68 149.53 52.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.844 -0.799 . . . . 2.14 108.844 171.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.63 130.77 44.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.311 1.044 . . . . 1.65 108.614 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.8 mt -99.92 115.28 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.635 -0.506 . . . . 2.94 109.635 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.8 p -107.84 89.13 2.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.926 1.29 . . . . 2.46 109.543 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.6 -45.8 0.57 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.798 -0.921 . . . . 1.1 110.798 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -56.41 136.64 53.73 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 110.221 -0.289 . . . . 2.1 110.221 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -158.2 34.71 0.24 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.103 0.561 . . . . 2.88 110.891 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 34.0 t -158.91 144.23 16.22 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.548 -0.72 . . . . 2.61 110.617 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.15 -39.12 42.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.153 0.981 . . . . 2.63 111.995 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.2 p -53.6 -46.27 70.34 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.906 -0.497 . . . . 3.46 110.74 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 65.6 m -67.98 -45.96 72.68 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.909 -0.774 . . . . 1.82 108.909 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.425 HG21 HD12 ' A' ' 115' ' ' LEU . 61.1 t -51.91 -49.58 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.042 0.937 . . . . 1.63 109.591 175.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -64.38 -37.66 88.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.776 -0.824 . . . . 3.27 108.776 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -59.87 -52.61 64.71 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.63 0.772 . . . . 2.12 110.347 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.1 mt -54.17 -54.13 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.654 0.782 . . . . 1.06 109.045 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.6 -45.17 85.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.806 -0.442 . . . . 3.13 109.806 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.8 t -54.69 -49.31 70.98 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.507 0.723 . . . . 1.82 110.583 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -34.8 78.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.412 -0.805 . . . . 2.57 111.274 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.3 mt -71.57 -58.16 3.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.778 -0.823 . . . . 1.8 108.778 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.5 p -56.21 -22.73 31.13 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 111.915 0.339 . . . . 2.38 111.915 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.31 -27.09 69.09 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.457 0.91 . . . . 4.79 113.457 174.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.1 p -69.4 172.71 6.73 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 119.822 1.192 . . . . 2.63 111.246 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -88.62 -47.21 8.45 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.222 -0.899 . . . . 3.98 110.278 173.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.47 -34.09 51.06 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.471 -0.627 . . . . 1.19 113.587 -170.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.97 135.17 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 119.145 1.472 . . . . 2.34 109.251 -176.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -105.27 -44.67 4.68 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 122.407 0.283 . . . . 2.81 111.624 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.431 ' CZ ' ' HG3' ' A' ' 123' ' ' LYS . 27.2 p90 -139.7 122.75 16.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.67 -1.604 . . . . 2.09 106.67 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.85 143.82 45.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.564 -0.854 . . . . 1.43 109.795 164.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.6 m -133.56 119.99 20.19 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.037 -1.468 . . . . 1.93 107.037 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 p -122.55 133.55 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 123.631 0.772 . . . . 1.9 109.079 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -127.92 99.98 5.73 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.961 0.886 . . . . 1.34 109.216 -171.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.591 ' H ' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -55.62 -21.43 17.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.756 1.622 . . . . 3.09 113.743 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.406 ' N ' HD22 ' A' ' 115' ' ' LEU . . . -73.76 -41.36 62.57 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.933 -0.765 . . . . 1.43 108.933 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.2 p -88.11 -15.28 36.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.711 1.204 . . . . 3.27 111.191 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.8 t 65.11 25.64 12.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.869 1.268 . . . . 1.98 110.778 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.56 149.28 50.22 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.412 0.685 . . . . 2.77 110.941 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -125.15 115.64 20.78 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.68 2.392 . . . . 0.93 108.199 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.42 116.55 29.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.003 -1.48 . . . . 2.19 107.003 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.3 m -111.58 140.12 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.025 0.93 . . . . 2.07 109.799 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.431 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 2.2 mmtp -123.19 95.89 4.78 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-O 118.511 -0.757 . . . . 3.68 110.063 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -121.52 178.52 4.78 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.706 1.002 . . . . 2.08 113.706 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -104.64 110.42 64.33 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.233 1.013 . . . . 3.48 108.687 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.9 62.51 6.59 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.609 2.873 . . . . 1.71 112.788 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -148.25 -52.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.123 1.769 . . . . 2.97 107.72 172.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -86.98 -32.67 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.442 0.697 . . . . 1.81 111.413 -172.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.78 165.82 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.429 -1.693 . . . . 1.66 106.429 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.94 164.46 31.32 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 109.852 -1.299 . . . . 1.79 109.852 -176.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.23 -40.86 46.69 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.032 2.488 . . . . 1.93 110.2 -171.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -48.35 -38.47 19.32 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 113.47 0.915 . . . . 7.79 113.47 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.1 -44.92 75.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.681 -0.859 . . . . 3.44 108.681 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.13 -47.59 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.383 -0.969 . . . . 1.56 108.383 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.9 mt -54.12 -60.69 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.004 -0.739 . . . . 2.13 109.004 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -51.61 -45.74 63.34 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 119.59 1.086 . . . . 3.62 111.055 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.6 mt -54.17 -53.49 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 121.664 -0.647 . . . . 2.33 110.076 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.253 2.1 pp -67.83 -30.83 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 121.109 -0.994 . . . . 1.24 112.891 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -55.89 -39.94 72.3 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.798 0.726 . . . . 2.98 110.107 170.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -63.06 -35.86 81.65 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.756 -0.461 . . . . 2.65 109.756 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.5 mt -68.26 -44.33 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.562 -0.533 . . . . 0.96 109.562 172.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.35 32.6 2.51 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.273 1.416 . . . . 0.86 111.182 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -99.28 178.41 4.91 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.116 0.958 . . . . 2.44 108.891 165.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -141.05 124.38 16.59 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.57 -1.641 . . . . 3.72 106.57 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.97 94.78 4.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.307 1.443 . . . . 1.18 108.706 -174.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.3 m -103.0 117.66 35.08 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.997 0.919 . . . . 1.67 110.456 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 mp -45.73 117.89 1.62 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.786 1.634 . . . . 4.29 110.108 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -109.57 13.44 23.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.37 0.668 . . . . 3.44 112.303 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? . . . . . 0 C--O 1.25 1.129 0 C-N-CA 125.486 1.514 . . . . 7.39 109.811 161.214 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 106.291 -1.744 . . . . 2.98 106.291 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.51 166.51 10.49 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 107.758 -1.201 . . . . 4.0 107.758 166.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.97 120.25 11.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.579 1.081 . . . . 3.56 108.933 170.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -98.2 90.23 4.77 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.556 0.742 . . . . 2.88 110.267 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.56 165.72 15.97 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.704 0.764 . . . . 2.67 111.04 175.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.14 156.32 31.3 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.303 -0.999 . . . . 1.94 108.303 174.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.1 144.44 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 107.677 -1.231 . . . . 0.99 107.677 172.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -116.54 125.07 51.36 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.678 -1.231 . . . . 4.91 107.678 162.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 147.86 -81.14 0.2 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.188 1.375 . . . . 1.4 109.998 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.9 mtt 57.92 66.64 1.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.825 1.25 . . . . 2.05 113.013 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -46.52 -54.71 8.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.862 1.265 . . . . 2.57 113.303 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.2 p -167.83 44.48 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.516 0.598 . . . . 5.5 111.323 -170.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.67 35.44 8.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.274 1.029 . . . . 4.8 112.681 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 m -152.24 -43.26 0.11 Allowed 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.385 1.474 . . . . 2.46 110.555 -173.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.55 -46.15 87.45 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.347 -0.845 . . . . 2.16 109.937 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.536 ' HB ' HD21 ' A' ' 39' ' ' LEU . 54.3 t -52.69 -39.64 31.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 O-C-N 122.184 -0.322 . . . . 1.96 110.437 171.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -59.7 -42.73 93.63 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.085 0.469 . . . . 2.29 110.868 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -66.19 -47.6 73.39 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.31 -0.869 . . . . 2.63 109.631 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.41 -46.98 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 122.211 -0.306 . . . . 2.25 110.418 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -57.6 -41.15 80.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.292 1.037 . . . . 6.96 112.39 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -46.48 89.07 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.355 -0.98 . . . . 5.57 108.355 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -58.0 -45.16 87.27 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.072 -0.49 . . . . 1.59 110.557 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.552 HD11 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -52.2 -58.56 6.24 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.533 0.733 . . . . 2.6 111.424 172.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -64.42 -19.99 65.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.812 1.187 . . . . 2.32 112.921 -175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -90.39 -0.92 57.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.713 1.375 . . . . 4.56 114.713 168.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -53.1 -70.63 0.09 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.848 1.658 . . . . 3.09 111.012 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.7 -81.47 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.42 1.088 . . . . 1.37 110.66 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.52 -28.71 73.61 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.889 -0.484 . . . . 1.6 111.889 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 t -61.34 116.16 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.209 1.004 . . . . 2.89 110.284 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.66 54.66 1.67 Allowed 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.861 -1.533 . . . . 3.36 106.861 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.4 t -160.39 161.48 33.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 120.887 -1.133 . . . . 2.2 110.42 155.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.81 109.43 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 127.277 2.231 . . . . 2.84 106.779 172.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tt -135.54 63.05 1.61 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.114 -1.069 . . . . 2.41 108.114 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -96.12 149.09 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.143 -1.058 . . . . 2.59 108.143 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.22 100.0 6.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.113 -1.44 . . . . 1.37 107.113 166.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.536 HD21 ' HB ' ' A' ' 19' ' ' VAL . 17.2 mt -64.41 -15.38 60.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.277 0.631 . . . . 2.89 112.158 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.4 mmt -72.39 -52.81 14.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.533 0.733 . . . . 5.11 110.405 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.33 -34.02 21.93 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.95 0.5 . . . . 1.5 110.974 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.94 62.79 1.28 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.035 1.303 . . . . 1.23 110.899 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -140.14 137.04 34.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.887 -1.523 . . . . 3.68 106.887 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.07 96.35 5.99 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 125.044 1.338 . . . . 1.11 109.791 173.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -98.65 136.5 38.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.481 -2.044 . . . . 3.64 105.481 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.98 177.92 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 N-CA-C 106.079 -1.823 . . . . 2.11 106.079 172.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -129.84 99.92 5.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.785 0.434 . . . . 4.09 110.386 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -94.47 -177.86 4.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.621 1.968 . . . . 2.63 112.857 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -127.67 108.52 20.65 Favored Pre-proline 0 N--CA 1.444 -0.765 0 CA-C-N 114.169 -1.378 . . . . 3.43 108.003 169.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.22 -3.01 10.79 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.581 2.187 . . . . 2.13 112.764 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.67 -39.6 64.31 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.797 1.18 . . . . 3.58 110.708 172.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -110.01 -19.18 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 118.291 0.496 . . . . 3.0 110.335 -166.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 pt -131.7 -176.48 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 107.484 -1.302 . . . . 2.29 107.484 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.64 155.94 59.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 125.418 1.487 . . . . 2.41 108.449 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.39 -35.6 60.54 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.309 2.006 . . . . 1.52 110.192 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.94 -37.99 84.27 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 122.064 -0.397 . . . . 2.82 111.94 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -67.74 -45.54 74.7 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.964 0.905 . . . . 3.08 110.372 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.9 mt -48.5 -56.76 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 106.546 -1.65 . . . . 1.5 106.546 167.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.59 89.31 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.07 -0.514 . . . . 1.52 110.777 -170.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -52.27 -49.78 63.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.81 1.644 . . . . 2.5 109.604 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.74 -50.27 44.9 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.154 0.502 . . . . 3.03 109.797 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.552 HD11 HD11 ' A' ' 26' ' ' LEU . 5.9 mm -65.99 -38.9 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 121.919 -0.488 . . . . 2.48 110.958 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -64.11 -46.28 84.91 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.567 -0.531 . . . . 2.04 109.567 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -57.8 -52.43 65.51 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.316 0.646 . . . . 2.63 109.817 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.3 mt -58.77 -38.78 79.25 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.27 -0.423 . . . . 2.45 111.576 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.79 33.33 0.65 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 123.367 0.508 . . . . 1.32 112.59 163.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -133.02 163.64 28.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.733 1.213 . . . . 2.55 110.365 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -97.41 128.73 44.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.97 -1.493 . . . . 2.54 106.97 171.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.85 124.33 52.13 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.491 -1.3 . . . . 1.02 107.491 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.49 138.01 52.06 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.558 -1.275 . . . . 1.29 107.558 168.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -60.64 141.14 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.536 -0.913 . . . . 3.25 108.536 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.6 mtt . . . . . 0 N--CA 1.45 -0.45 0 C-N-CA 124.805 1.242 . . . . 4.75 110.604 176.647 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.7 0 N-CA-C 110.686 -0.965 . . . . 2.26 110.686 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.99 101.84 4.13 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.236 1.414 . . . . 2.54 108.66 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.733 ' N ' HD12 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -125.87 155.31 35.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 125.55 1.54 . . . . 3.09 108.123 -167.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.74 ' OE1' ' HB3' ' A' ' 148' ' ' ALA . 2.6 pp20? -131.38 153.17 49.93 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.121 1.368 . . . . 4.24 107.396 174.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.07 162.71 32.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.151 -1.425 . . . . 2.42 107.151 170.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.596 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -97.42 133.52 41.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.965 -2.235 . . . . 2.1 104.965 170.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.411 ' O ' HD12 ' A' ' 86' ' ' ILE . 1.6 pp -106.16 117.59 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 123.54 0.736 . . . . 1.95 109.652 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.6 m -105.6 136.79 44.54 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.577 -1.268 . . . . 1.67 107.577 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.28 -45.24 1.34 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.493 1.044 . . . . 1.43 111.151 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -62.26 132.96 54.42 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.39 -0.476 . . . . 2.72 110.345 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -156.89 42.01 0.35 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.373 0.669 . . . . 3.91 110.303 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.6 t -162.4 144.92 11.1 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 120.711 -1.243 . . . . 2.84 110.523 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.49 -40.37 62.29 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.697 0.799 . . . . 3.18 110.897 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -54.67 -47.1 74.02 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.897 -0.502 . . . . 2.0 110.364 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.8 m -64.6 -44.76 89.58 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.06 0.544 . . . . 2.1 109.596 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.4 t -51.14 -51.17 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 122.589 0.356 . . . . 1.66 110.074 171.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -62.28 -37.84 87.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.208 -0.664 . . . . 2.65 109.208 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -59.95 -55.02 39.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.183 0.993 . . . . 1.99 110.185 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.8 mt -54.91 -56.4 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.301 -0.629 . . . . 1.59 109.301 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.86 -43.32 76.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.19 0.996 . . . . 3.38 108.938 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.3 t -53.82 -47.18 71.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.643 0.656 . . . . 1.27 111.069 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -63.96 -42.74 97.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.63 -1.294 . . . . 2.79 111.54 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.423 HD23 ' CB ' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -61.44 -54.89 37.59 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.359 -0.978 . . . . 2.62 108.359 176.246 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.0 p -59.11 -25.03 63.48 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.647 0.61 . . . . 1.85 112.647 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -72.52 -16.27 61.78 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.187 0.903 . . . . 4.0 112.357 175.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.5 m -80.55 152.82 28.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.915 0.886 . . . . 1.83 109.528 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -72.41 -49.49 33.36 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.197 0.999 . . . . 2.74 112.555 -175.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.75 -40.26 7.76 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 121.702 0.612 . . . . 1.16 111.71 -167.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.514 HD11 ' HB ' ' A' ' 122' ' ' VAL . 2.4 mm -53.66 136.11 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.06 -0.719 . . . . 2.21 109.06 168.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 38.6 p -123.25 -25.69 4.43 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.33 0.493 . . . . 2.98 112.33 166.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.07 112.51 6.8 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.258 -1.756 . . . . 2.02 106.258 -169.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.423 ' CB ' HD23 ' A' ' 102' ' ' LEU . . . -115.55 157.65 23.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.154 -1.054 . . . . 1.12 108.154 163.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 61.8 m -144.72 118.46 9.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.048 -1.464 . . . . 2.05 107.048 170.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.92 134.3 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 108.57 -0.9 . . . . 2.93 108.57 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.2 88.76 2.9 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.678 0.751 . . . . 1.82 109.146 -167.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -54.2 -30.18 48.86 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.315 1.046 . . . . 2.92 112.13 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.59 65.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.101 0.96 . . . . 2.0 111.088 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.74 -9.8 15.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.32 1.448 . . . . 2.35 110.949 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.3 m 66.58 30.58 8.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.574 1.55 . . . . 1.49 111.713 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -105.74 158.15 16.93 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.292 0.637 . . . . 3.97 110.683 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.11 109.4 8.91 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.235 1.814 . . . . 1.26 107.988 174.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.9 mp -98.55 131.06 45.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.722 -1.214 . . . . 2.49 107.722 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.514 ' HB ' HD11 ' A' ' 108' ' ' ILE . 19.7 m -132.65 133.82 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.371 1.068 . . . . 2.44 108.555 -174.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -117.67 93.75 4.27 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.041 -1.096 . . . . 3.36 108.041 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -122.28 168.76 11.65 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.645 1.178 . . . . 1.91 112.284 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -98.13 113.47 63.95 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 109.266 -0.642 . . . . 2.65 109.266 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.53 67.86 7.71 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.695 2.93 . . . . 1.95 111.474 -172.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -160.49 -46.86 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.159 1.384 . . . . 3.55 108.874 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.1 pt -86.66 -28.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 123.692 0.797 . . . . 1.88 111.876 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.53 165.04 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.159 -1.052 . . . . 1.56 108.159 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.98 162.5 28.94 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 109.874 -1.29 . . . . 1.62 109.874 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -62.57 -35.13 72.48 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.425 2.75 . . . . 1.67 111.516 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -52.71 -42.06 64.5 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 112.759 0.651 . . . . 5.47 112.759 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.57 -39.0 74.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.459 -0.896 . . . . 3.36 109.565 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.1 -47.57 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.967 -0.753 . . . . 1.44 108.967 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 52.2 mt -55.36 -56.48 11.45 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 124.015 0.926 . . . . 2.08 109.573 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -49.89 -50.44 45.92 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 119.461 1.028 . . . . 4.06 110.619 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 50.7 mt -54.88 -55.33 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 122.557 0.343 . . . . 2.36 110.154 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.7 pp -68.21 -29.59 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.774 -1.204 . . . . 1.32 112.951 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.11 -35.86 74.18 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.401 0.546 . . . . 3.08 110.657 171.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.62 -37.76 82.49 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.471 -0.566 . . . . 4.73 109.471 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.0 mt -72.92 -40.5 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 109.212 -0.662 . . . . 1.64 109.212 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.7 33.97 2.95 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.047 1.308 . . . . 1.42 110.961 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -99.19 177.4 5.23 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 108.233 -1.025 . . . . 3.03 108.233 164.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -141.38 120.88 13.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.099 -1.815 . . . . 4.52 106.099 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.0 110.81 22.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.533 1.533 . . . . 1.37 108.727 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.7 m -130.35 134.33 47.09 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.477 0.711 . . . . 2.86 110.935 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -37.97 127.88 1.25 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.063 2.145 . . . . 4.32 110.151 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.74 ' HB3' ' OE1' ' A' ' 83' ' ' GLU . . . -103.93 -12.09 17.06 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 116.445 -1.74 . . . . 3.3 113.343 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 . . . . . 0 C--O 1.259 1.597 0 C-N-CA 129.4 3.08 . . . . 6.85 114.554 152.267 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 106.471 -1.677 . . . . 2.99 106.471 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -95.45 157.89 15.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.586 1.555 . . . . 4.11 107.448 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.9 p -140.95 133.79 28.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 122.544 0.337 . . . . 2.98 110.215 168.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -104.01 105.58 15.8 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 125.665 1.586 . . . . 3.09 108.371 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.464 HD21 HD12 ' A' ' 46' ' ' ILE . 1.7 pt? -134.63 169.46 17.27 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.472 -0.491 . . . . 2.17 110.969 172.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.22 138.95 51.37 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.012 -1.848 . . . . 1.73 106.012 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.8 mm -97.93 134.04 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 106.802 -1.555 . . . . 1.04 106.802 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -104.51 123.29 47.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.533 -1.654 . . . . 3.34 106.533 160.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.84 -27.38 3.06 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.367 0.985 . . . . 3.06 111.472 -175.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.2 ptt? -57.92 167.67 1.14 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.791 -0.829 . . . . 2.78 111.405 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 m 77.11 -8.81 1.63 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.801 1.24 . . . . 9.25 112.016 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.8 m -114.45 136.01 53.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.888 0.875 . . . . 6.49 109.645 -173.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 42.33 -106.15 0.08 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.357 1.463 . . . . 6.29 109.894 -174.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 p -158.95 38.84 0.22 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.918 0.866 . . . . 3.13 109.308 171.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.66 -42.96 63.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.76 -0.655 . . . . 1.93 110.443 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -57.08 -42.01 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 122.252 1.025 . . . . 2.28 109.378 171.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.95 -46.07 82.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.863 -1.062 . . . . 2.8 111.293 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -60.83 -46.41 90.66 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.267 -0.896 . . . . 2.58 110.519 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.0 mt -47.68 -40.29 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 C-N-CA 124.153 0.981 . . . . 1.71 111.637 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -47.31 -60.34 2.57 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.117 0.567 . . . . 5.15 111.974 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -37.29 72.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.327 -0.62 . . . . 6.11 109.327 -173.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -56.61 -54.85 41.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.186 -0.461 . . . . 1.24 110.066 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mt -58.7 -44.37 90.3 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 118.652 0.66 . . . . 2.16 111.137 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.08 -11.26 1.04 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 114.285 1.217 . . . . 1.8 114.285 171.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.11 3.75 11.4 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.955 -1.091 . . . . 3.81 111.974 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.73 -65.9 0.66 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.851 1.205 . . . . 2.52 110.515 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.28 -131.36 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.122 0.569 . . . . 1.46 109.951 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.42 -0.94 80.47 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 119.501 1.046 . . . . 1.69 113.096 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.91 127.61 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 O-C-N 121.523 -0.986 . . . . 1.61 111.298 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.52 54.01 1.12 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.284 0.846 . . . . 2.38 113.284 173.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 t -157.15 143.68 18.16 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 107.02 -1.474 . . . . 1.87 107.02 165.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.0 92.53 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.04 -1.837 . . . . 2.45 106.04 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -116.53 79.78 1.37 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.351 -1.722 . . . . 3.27 106.351 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.9 p -98.73 128.23 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.453 -0.943 . . . . 2.22 108.453 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.39 74.98 2.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.957 -1.868 . . . . 1.21 105.957 172.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.86 -29.88 3.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.393 1.077 . . . . 3.16 111.87 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.2 ttt -72.65 -36.18 67.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.947 1.299 . . . . 4.03 111.135 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.71 -48.02 5.65 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 124.177 0.991 . . . . 1.32 109.191 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.23 58.24 0.35 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 125.48 1.514 . . . . 1.11 111.599 167.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -142.97 136.91 28.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.12 -1.067 . . . . 3.09 108.12 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.64 110.36 22.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.637 1.575 . . . . 1.0 111.597 168.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -99.51 111.36 23.72 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.081 -1.081 . . . . 4.65 108.081 167.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.464 HD12 HD21 ' A' ' 8' ' ' LEU . 13.9 mt -109.57 167.04 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.684 0.794 . . . . 2.62 109.066 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -123.61 108.23 12.37 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.871 0.868 . . . . 4.03 109.107 162.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -113.81 163.4 15.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.73 1.212 . . . . 2.84 111.336 168.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -105.71 106.37 56.21 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 127.215 2.206 . . . . 4.62 110.075 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.69 2.21 1.77 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.057 2.505 . . . . 1.92 114.015 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -83.14 -22.75 33.22 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.128 1.371 . . . . 4.49 110.408 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.1 t -123.42 -65.44 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.2 -1.037 . . . . 2.75 108.2 -171.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -87.26 155.14 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.276 -0.638 . . . . 1.46 109.276 174.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -129.27 151.74 78.29 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.692 1.597 . . . . 2.59 108.004 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.91 -38.42 79.21 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.841 2.361 . . . . 1.21 112.149 -172.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -59.51 -41.09 89.14 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.328 -0.857 . . . . 2.92 111.255 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -61.2 -40.54 94.35 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.307 0.643 . . . . 3.03 110.254 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.503 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -54.75 -46.45 74.17 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 N-CA-C 107.746 -1.205 . . . . 1.1 107.746 171.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.4 94.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.064 0.459 . . . . 1.21 111.036 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -57.77 -52.89 63.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.468 -0.77 . . . . 2.53 110.34 173.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -51.0 -55.5 17.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.429 0.692 . . . . 5.17 111.496 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.558 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.5 pp -61.4 -39.87 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 121.065 -1.022 . . . . 4.43 111.647 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.58 -33.72 76.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.343 0.52 . . . . 3.08 110.816 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.51 -50.3 67.95 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.485 -0.561 . . . . 2.51 109.485 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.1 mt -58.65 -35.73 73.0 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.937 -0.305 . . . . 2.04 111.402 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.08 31.19 2.52 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 123.92 0.771 . . . . 1.18 111.915 169.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -112.16 164.64 12.95 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.625 1.57 . . . . 2.1 109.04 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -102.9 136.05 43.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.02 -1.474 . . . . 2.6 107.02 164.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.558 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -130.3 127.04 38.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.216 -1.772 . . . . 0.94 106.216 169.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.4 138.98 33.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.009 0.818 . . . . 0.92 109.328 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.84 144.46 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 116.138 -0.483 . . . . 2.77 109.734 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.7 mtp . . . . . 0 CA--C 1.532 0.285 0 C-N-CA 124.098 0.959 . . . . 3.91 111.23 -175.518 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 107.366 -2.294 . . . . 1.72 107.366 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -102.65 110.06 21.88 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.381 1.472 . . . . 2.68 109.046 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.96 138.91 53.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 O-C-N 123.332 0.395 . . . . 2.71 110.67 175.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -110.33 141.36 43.45 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.128 1.371 . . . . 4.42 108.326 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.492 ' N ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -142.79 156.45 44.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.298 -0.63 . . . . 3.29 109.298 174.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.414 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.6 OUTLIER -97.31 121.75 39.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 105.018 -2.216 . . . . 1.56 105.018 -177.093 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 pp -100.88 121.07 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.14 -0.689 . . . . 1.57 109.14 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.2 p -106.92 142.79 35.98 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.27 0.628 . . . . 2.15 109.348 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.74 -26.17 10.31 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.741 1.162 . . . . 1.48 112.742 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.474 ' SD ' HD12 ' A' ' 98' ' ' ILE . 4.0 ttp -67.51 108.62 2.9 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.641 -0.917 . . . . 3.0 112.096 -169.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.7 m -117.86 7.77 12.47 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.044 0.938 . . . . 2.46 111.923 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 23.9 p -163.07 151.21 13.78 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 120.742 -1.224 . . . . 2.93 112.08 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.54 72.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.683 0.793 . . . . 2.94 111.411 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.2 m -53.29 -40.96 65.14 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.284 -0.885 . . . . 2.62 110.785 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.1 m -69.89 -40.93 75.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.615 -0.707 . . . . 1.79 110.04 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.0 t -50.35 -57.21 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 118.636 0.653 . . . . 1.47 109.557 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -58.58 -45.71 88.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.358 0.663 . . . . 4.2 110.205 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -61.21 -50.62 72.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.0 0.52 . . . . 1.77 110.84 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.474 HD12 ' SD ' ' A' ' 89' ' ' MET . 41.7 mt -56.27 -47.2 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.089 -0.708 . . . . 1.03 109.089 177.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.28 -49.49 74.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.634 -0.876 . . . . 2.81 108.634 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.3 t -52.52 -50.45 62.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.719 0.808 . . . . 1.48 110.159 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -61.31 -42.37 98.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.753 -0.592 . . . . 3.2 111.31 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.5 mt -67.18 -56.26 10.68 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.932 -1.136 . . . . 1.85 107.932 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.7 p -55.33 -17.78 5.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.484 0.714 . . . . 1.86 112.703 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -13.77 62.59 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.502 -0.749 . . . . 5.53 112.398 171.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -80.83 153.86 27.45 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.389 1.876 . . . . 1.85 109.63 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -67.39 -64.44 0.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.943 0.897 . . . . 3.03 111.353 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.32 -32.41 58.08 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 122.253 -0.279 . . . . 1.2 112.921 -172.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.07 112.52 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.733 0.766 . . . . 1.81 109.616 -172.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.6 m -99.3 -41.32 7.5 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.561 0.344 . . . . 2.27 110.265 -172.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 123' ' ' LYS . 54.2 p90 -140.15 121.22 14.69 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.468 -0.567 . . . . 2.39 109.468 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.18 140.8 37.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.72 -0.844 . . . . 1.09 108.72 165.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -132.69 116.98 17.29 Favored 'General case' 0 C--O 1.228 -0.052 0 N-CA-C 108.29 -1.004 . . . . 1.59 108.29 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.604 HG12 ' HB1' ' A' ' 120' ' ' ALA . 3.0 m -112.28 135.23 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.591 1.157 . . . . 2.24 109.087 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.32 89.55 2.57 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.332 0.969 . . . . 1.17 111.211 -173.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -24.51 67.04 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 125.22 1.408 . . . . 3.11 113.718 -170.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.81 70.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.654 0.381 . . . . 1.45 110.397 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.83 -13.12 12.02 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.477 1.511 . . . . 1.76 111.317 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.3 m 69.13 15.8 8.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.319 1.847 . . . . 1.31 114.326 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -95.16 158.0 15.65 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 120.127 1.33 . . . . 3.25 108.464 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.604 ' HB1' HG12 ' A' ' 113' ' ' VAL . . . -140.53 125.15 17.98 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.225 1.01 . . . . 0.86 108.652 168.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.26 114.42 26.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.637 -1.616 . . . . 1.67 106.637 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 m -106.75 135.06 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.048 0.84 . . . . 2.26 111.687 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HG3' ' CE2' ' A' ' 110' ' ' TYR . 9.2 mmmt -113.01 95.97 5.69 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.13 1.372 . . . . 3.51 109.524 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -122.95 174.16 7.35 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.843 0.747 . . . . 2.52 111.362 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -105.19 110.07 63.99 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 108.564 -0.902 . . . . 3.13 108.564 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.53 69.01 6.83 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.48 2.787 . . . . 1.97 111.305 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -158.45 -48.53 0.06 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.875 1.27 . . . . 3.21 108.917 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pt -82.83 -28.93 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.406 0.682 . . . . 1.82 110.867 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.64 163.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.575 -0.898 . . . . 1.62 108.575 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.71 161.5 28.24 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.444 -1.462 . . . . 1.76 109.444 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.52 -37.62 87.9 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.557 2.838 . . . . 1.98 111.713 -172.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -52.21 -36.65 52.7 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.262 0.838 . . . . 7.07 113.262 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.43 -46.02 67.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.453 -0.573 . . . . 3.42 109.453 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.4 mt -57.46 -45.32 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.631 -0.878 . . . . 1.39 108.631 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.7 mt -53.85 -61.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 118.354 -0.831 . . . . 2.39 109.055 173.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.15 -49.49 32.17 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.913 1.233 . . . . 5.43 111.174 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.5 mt -53.05 -60.11 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.808 -0.812 . . . . 2.12 108.808 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.3 pp -65.9 -30.56 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 119.375 -0.93 . . . . 1.35 113.279 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.43 -40.53 94.78 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.111 0.869 . . . . 2.55 109.758 170.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -64.98 -37.47 87.76 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.079 -0.712 . . . . 2.84 109.079 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.35 -43.29 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.075 -0.391 . . . . 1.15 109.956 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.61 31.56 4.83 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.57 1.557 . . . . 1.07 111.619 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -99.62 174.93 6.01 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.315 1.057 . . . . 2.2 108.652 165.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -139.02 119.15 13.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.055 -1.831 . . . . 4.03 106.055 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.19 109.42 20.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.129 1.771 . . . . 1.11 108.793 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 26.6 m -117.14 113.72 22.66 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.944 0.497 . . . . 1.8 110.274 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -31.34 115.2 0.14 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.391 1.876 . . . . 3.86 112.039 169.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.414 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -101.17 15.69 27.93 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.637 1.347 . . . . 3.16 114.637 -161.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.085 -1.436 . . . . 5.64 112.618 -175.76 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 106.564 -1.643 . . . . 3.04 106.564 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -126.2 149.04 49.3 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.546 1.538 . . . . 4.95 106.951 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.1 p -140.53 146.03 37.58 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.829 -0.804 . . . . 3.41 108.829 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.15 109.68 19.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.041 -1.466 . . . . 4.65 107.041 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.478 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 2.3 pt? -133.69 174.72 10.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.071 0.938 . . . . 2.37 111.192 170.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.78 137.75 40.16 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.023 -1.103 . . . . 2.32 108.023 176.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 mm -98.67 126.51 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 106.972 -1.492 . . . . 1.32 106.972 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -102.48 103.55 13.92 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.064 -1.828 . . . . 4.02 106.064 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.23 -89.46 0.1 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.287 -1.525 . . . . 1.26 109.287 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.4 mtt 47.1 73.67 0.18 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.169 1.388 . . . . 2.11 113.497 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -57.56 -11.8 2.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.75 1.22 . . . . 2.7 113.653 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.5 t 73.97 -66.03 0.32 Allowed 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 126.187 1.795 . . . . 2.95 110.878 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -15.4 -74.51 0.01 OUTLIER 'General case' 0 C--N 1.342 0.279 0 C-N-CA 128.368 2.667 . . . . 6.81 113.219 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.8 m -153.37 19.26 0.55 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.498 0.719 . . . . 4.06 111.07 161.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 31.7 m -70.64 -47.5 59.74 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 121.093 -1.004 . . . . 2.13 109.211 -169.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -54.81 -49.83 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.752 -0.462 . . . . 2.93 109.752 175.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -55.55 -48.38 74.82 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.175 0.59 . . . . 2.35 111.433 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -58.75 -47.92 82.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.615 -0.513 . . . . 3.09 109.615 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -46.4 -50.89 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.632 1.173 . . . . 1.88 110.051 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -54.51 -54.54 39.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.472 0.578 . . . . 4.39 111.168 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -59.9 -43.04 95.04 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.166 -0.47 . . . . 5.0 110.3 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -56.52 -57.44 12.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.267 0.627 . . . . 1.48 109.478 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mp -57.68 -44.99 86.17 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 119.014 -0.517 . . . . 2.23 111.679 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -54.85 -20.68 9.24 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.428 1.013 . . . . 2.0 113.481 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -112.05 15.37 20.65 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.712 1.004 . . . . 3.43 113.712 173.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -70.02 -64.54 0.87 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.949 1.25 . . . . 2.77 110.229 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.73 -124.09 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.929 0.492 . . . . 1.44 110.713 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.74 -25.62 69.2 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 118.795 0.725 . . . . 1.64 111.987 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 46' ' ' ILE . 4.9 p -62.95 125.73 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 O-C-N 122.446 -0.444 . . . . 1.59 110.036 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 pp -143.12 50.55 1.41 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.71 0.767 . . . . 3.07 109.765 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.8 t -160.64 149.53 16.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.092 -1.077 . . . . 1.99 108.092 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.0 129.7 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.046 -1.094 . . . . 2.68 108.046 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -142.52 74.28 1.44 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.104 -1.073 . . . . 2.94 108.104 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 m -97.33 159.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 121.372 -0.83 . . . . 2.98 108.995 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.88 90.6 2.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.307 -1.368 . . . . 2.12 107.307 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 tp -51.86 -27.44 12.67 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.881 1.672 . . . . 3.49 110.358 172.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.3 mtp -59.16 -38.65 80.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.187 0.995 . . . . 3.51 111.603 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.3 -31.47 7.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.473 0.709 . . . . 2.7 111.449 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.49 61.59 0.96 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.457 1.503 . . . . 2.19 110.403 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -142.08 142.7 32.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.429 -1.323 . . . . 3.42 107.429 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.08 101.34 7.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.968 0.907 . . . . 1.53 110.43 171.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -102.31 131.05 49.15 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.161 -2.162 . . . . 5.69 105.161 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 32' ' ' VAL . 13.7 pt -136.74 171.71 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 120.434 -1.416 . . . . 2.39 108.988 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.22 99.77 6.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.422 1.089 . . . . 5.85 108.356 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.529 ' HB2' HD12 ' A' ' 53' ' ' ILE . 31.8 p90 -100.05 -179.17 4.07 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.686 1.194 . . . . 3.64 110.206 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -128.25 103.3 20.53 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.597 1.159 . . . . 3.98 110.894 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.25 -8.32 18.29 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.796 3.664 . . . . 2.91 114.84 -167.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -92.86 -8.94 42.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.352 0.661 . . . . 4.79 111.598 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.5 -47.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 123.934 0.894 . . . . 3.63 110.21 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.529 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -116.36 143.25 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 108.08 -1.081 . . . . 2.33 108.08 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.89 142.72 26.44 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 124.352 1.061 . . . . 2.85 109.143 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -57.39 -40.39 81.96 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.12 2.546 . . . . 1.97 111.505 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.24 -43.37 98.99 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.319 0.648 . . . . 4.99 110.371 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -63.05 -40.24 97.12 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.902 0.481 . . . . 3.79 110.103 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.457 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -52.35 -53.4 19.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 N-CA-C 106.915 -1.513 . . . . 1.42 106.915 170.817 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.15 -45.46 79.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.99 -0.55 . . . . 1.44 110.599 -172.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.69 -49.94 56.16 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.486 0.715 . . . . 4.06 110.485 174.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.44 -48.9 65.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.527 0.679 . . . . 2.26 109.858 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -64.01 -39.06 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 122.081 -0.387 . . . . 2.5 111.413 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -65.56 -44.56 86.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.731 -0.47 . . . . 2.01 109.731 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.0 -50.51 73.83 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.714 -0.476 . . . . 2.5 109.714 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.7 mt -55.62 -40.58 72.3 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.387 -0.369 . . . . 2.14 111.629 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.37 33.46 1.03 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 123.516 0.579 . . . . 1.17 112.017 165.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -124.44 162.02 24.79 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.704 1.202 . . . . 1.95 108.86 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.81 130.46 41.37 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.138 -1.43 . . . . 2.58 107.138 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.59 111.38 24.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.836 1.254 . . . . 1.14 108.117 173.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.31 116.28 19.57 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.621 -0.511 . . . . 1.42 109.621 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.478 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.8 t -68.71 155.45 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.187 1.795 . . . . 2.8 111.36 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mtt . . . . . 0 CA--C 1.53 0.176 0 C-N-CA 124.176 0.99 . . . . 5.08 111.267 173.804 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.672 0 N-CA-C 111.208 -0.757 . . . . 2.62 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.543 ' C ' HD13 ' A' ' 82' ' ' ILE . 50.9 t30 -129.65 128.33 42.38 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.359 -1.348 . . . . 2.99 107.359 169.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.543 HD13 ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -125.89 154.11 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 107.096 -1.446 . . . . 3.17 107.096 175.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.22 141.14 51.55 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 123.477 0.711 . . . . 3.14 110.143 169.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.66 149.28 52.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.37 -2.085 . . . . 2.47 105.37 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 147' ' ' LEU . 0.4 OUTLIER -100.5 127.92 46.71 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 104.87 -2.27 . . . . 1.66 104.87 176.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.01 136.78 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 O-C-N 123.863 0.727 . . . . 1.77 109.065 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.2 m -128.34 115.2 17.9 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.372 1.069 . . . . 1.66 109.401 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.38 -38.13 1.72 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.174 1.369 . . . . 1.12 111.438 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.6 mtp -45.94 119.55 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.667 1.187 . . . . 3.23 111.763 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.0 m -129.66 17.02 5.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.922 0.889 . . . . 2.9 110.676 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 47.5 t -165.56 141.26 5.15 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 120.827 -1.171 . . . . 2.6 109.993 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.92 -32.51 66.02 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.709 0.686 . . . . 2.98 111.495 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -53.12 -37.92 62.18 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.756 -0.59 . . . . 1.91 110.469 173.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 85.8 m -62.53 -49.74 74.12 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 109.265 -0.643 . . . . 1.77 109.265 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.9 t -49.87 -45.54 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 122.506 0.322 . . . . 1.38 110.712 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -48.67 80.73 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.065 -0.346 . . . . 2.88 110.065 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -38.88 92.59 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 119.812 -0.755 . . . . 3.48 110.484 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.437 HD11 ' CE2' ' A' ' 143' ' ' PHE . 81.5 mt -64.76 -54.29 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.43 -0.952 . . . . 1.35 108.43 -177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -49.46 -49.77 43.99 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 126.337 1.855 . . . . 4.39 109.251 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.0 t -50.17 -50.43 49.13 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 119.368 -0.349 . . . . 1.87 111.317 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -50.2 68.52 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.03 0.832 . . . . 3.09 112.3 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.75 -45.13 87.71 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 120.841 -1.162 . . . . 3.0 110.892 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 87.2 m -61.11 -16.93 49.58 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.707 0.803 . . . . 2.27 111.061 173.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -17.71 64.83 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 118.624 -0.703 . . . . 4.75 111.733 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.9 p -72.66 -176.41 1.95 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 120.159 1.345 . . . . 2.89 110.885 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -94.29 -50.35 5.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.541 1.137 . . . . 2.39 111.083 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.47 -41.37 30.31 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 122.245 -0.285 . . . . 1.56 112.768 -168.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.17 126.34 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.751 -0.833 . . . . 2.68 108.751 -173.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.0 m -112.36 -46.32 3.19 Favored 'General case' 0 CA--C 1.522 -0.11 0 N-CA-C 111.824 0.305 . . . . 2.4 111.824 -174.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.45 ' CE2' ' HG3' ' A' ' 123' ' ' LYS . 49.5 p90 -136.42 125.15 23.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.718 -1.216 . . . . 2.87 107.718 167.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.17 159.99 21.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.784 -1.191 . . . . 0.91 107.784 161.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.0 m -142.98 105.12 4.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.794 -1.187 . . . . 1.85 107.794 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.1 t -98.36 115.67 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 125.968 1.707 . . . . 2.36 107.596 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -119.0 106.37 12.37 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 118.943 0.792 . . . . 1.22 110.484 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 pp -72.59 -29.92 63.92 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.467 1.107 . . . . 2.19 112.447 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.52 -43.22 89.1 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.395 0.678 . . . . 1.4 110.341 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -28.69 19.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.786 1.234 . . . . 1.76 110.314 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.35 21.91 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.162 1.785 . . . . 2.13 111.155 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -99.08 160.82 13.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.607 1.563 . . . . 3.26 110.216 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.48 130.13 24.25 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.408 -0.96 . . . . 0.96 108.408 166.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -95.54 143.27 26.99 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.24 -1.393 . . . . 1.72 107.24 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.35 128.7 25.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 124.998 1.319 . . . . 1.98 109.027 -173.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HG3' ' CE2' ' A' ' 110' ' ' TYR . 1.8 mmmt -118.54 106.65 12.88 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.006 -0.739 . . . . 3.73 109.006 176.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -125.44 175.8 7.26 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.802 0.841 . . . . 2.79 110.318 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -97.82 113.58 63.86 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 108.009 -1.108 . . . . 3.75 108.009 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.6 67.96 7.11 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.524 2.816 . . . . 2.45 111.222 -173.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -162.49 -47.64 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.719 1.208 . . . . 3.93 109.026 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 pt -86.39 -32.18 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 122.539 0.335 . . . . 2.26 111.524 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.68 163.05 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 107.939 -1.134 . . . . 2.04 107.939 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.21 160.82 28.37 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.456 -1.458 . . . . 1.99 109.456 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.36 -35.78 89.8 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.511 2.807 . . . . 2.04 111.665 -172.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -32.66 69.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 112.39 0.515 . . . . 6.69 112.39 -175.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.79 -48.45 68.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.976 -0.75 . . . . 3.68 108.976 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 74.9 mt -58.3 -45.18 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.533 -0.914 . . . . 1.5 108.533 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 80.4 mt -52.44 -61.09 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 117.566 -1.207 . . . . 2.29 108.889 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.26 -51.8 17.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.399 1.454 . . . . 5.07 110.996 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.0 mm -52.89 -49.92 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.599 0.636 . . . . 2.09 110.104 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.288 2.5 pp -70.75 -31.53 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 121.173 -0.954 . . . . 1.44 113.31 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.5 -39.76 84.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.74 1.155 . . . . 3.06 109.813 169.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -35.41 77.27 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.196 1.398 . . . . 3.17 108.867 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 78.1 mt -77.27 -41.81 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 122.542 0.337 . . . . 0.99 110.724 172.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.31 30.98 5.45 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.598 1.57 . . . . 1.06 111.583 -173.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 98' ' ' ILE . 46.1 m-85 -98.33 175.3 6.1 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.422 1.111 . . . . 1.99 108.251 165.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -135.92 126.36 26.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.191 -2.151 . . . . 3.91 105.191 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.6 100.57 7.2 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.648 1.579 . . . . 1.44 107.466 -175.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.1 m -146.8 117.2 7.44 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 117.896 -1.049 . . . . 3.05 111.408 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.424 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 0.2 OUTLIER -166.99 -102.0 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.217 -0.896 . . . . 6.81 109.588 170.37 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 41.1 40.21 1.04 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.434 1.493 . . . . 6.86 111.814 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 . . . . . 0 C--O 1.248 0.99 0 N-CA-C 114.726 1.38 . . . . 7.35 114.726 -169.942 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.514 -0.414 0 N-CA-C 109.78 -0.452 . . . . 4.51 109.78 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 152.39 19.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 123.891 0.744 . . . . 3.45 110.547 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.7 t -119.65 137.45 53.88 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.562 -0.903 . . . . 2.06 108.562 168.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -102.33 103.55 14.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.847 1.659 . . . . 3.67 108.973 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.565 ' HB3' HG13 ' A' ' 71' ' ' VAL . 1.8 pt? -125.8 176.91 6.6 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.894 0.854 . . . . 2.61 111.236 171.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.47 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -139.82 136.45 34.04 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.225 -1.028 . . . . 1.79 108.225 176.331 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 44' ' ' ALA . 29.6 mm -93.69 121.25 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 107.004 -1.48 . . . . 0.79 107.004 -169.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.75 102.17 11.75 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.583 -2.377 . . . . 4.09 104.583 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.47 -89.27 0.09 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 109.785 -1.326 . . . . 1.16 109.785 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.2 mmt 46.98 77.32 0.09 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.079 1.752 . . . . 2.28 113.375 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 p -65.62 -58.41 5.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.464 -0.773 . . . . 2.7 111.528 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 49.68 0.07 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 119.976 -0.689 . . . . 3.6 110.784 -172.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 47.66 36.27 5.37 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.822 0.849 . . . . 5.31 111.593 -177.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -129.4 -51.66 1.18 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.698 1.199 . . . . 3.25 109.635 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 23.4 t -68.79 -43.25 76.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 118.434 -1.306 . . . . 2.42 109.811 -174.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -38.65 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 122.125 0.965 . . . . 2.28 109.399 173.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -65.83 -41.55 91.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.084 -0.962 . . . . 2.45 111.26 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -71.57 -38.17 70.99 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 120.801 -1.187 . . . . 3.11 111.667 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.0 mt -49.4 -42.79 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.494 1.118 . . . . 1.4 109.968 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -41.14 -56.46 2.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.635 0.731 . . . . 4.44 112.515 172.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -68.57 -27.51 66.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.873 0.869 . . . . 5.04 110.79 -175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -69.48 -57.4 5.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.436 -0.95 . . . . 1.21 108.436 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.11 -40.6 85.87 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 118.745 0.702 . . . . 2.29 110.261 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -24.56 5.94 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 112.771 0.656 . . . . 2.07 112.771 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -127.31 25.43 6.15 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.273 0.629 . . . . 4.03 111.734 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -76.77 -58.15 3.44 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.995 -0.742 . . . . 2.83 108.995 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -162.56 -131.87 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.015 0.526 . . . . 1.21 109.972 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.49 -2.44 42.69 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.761 0.696 . . . . 1.43 113.767 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -80.22 122.38 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.163 0.981 . . . . 1.33 109.382 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.1 51.36 2.13 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.774 0.797 . . . . 2.56 109.933 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 t -161.6 151.14 16.47 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.246 -1.761 . . . . 1.64 106.246 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -140.72 124.35 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.172 -1.788 . . . . 2.54 106.172 166.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.73 87.89 2.55 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.144 0.973 . . . . 4.33 110.492 169.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.59 139.92 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.249 -1.019 . . . . 2.3 108.249 172.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -109.3 100.97 10.01 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.967 -1.864 . . . . 1.55 105.967 162.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.74 -33.61 70.45 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.258 1.023 . . . . 3.93 109.052 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -53.07 62.41 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.56 1.144 . . . . 4.6 110.78 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.73 -25.39 22.33 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.347 0.659 . . . . 1.86 111.388 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.66 55.68 2.65 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.741 1.162 . . . . 1.46 110.957 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -135.33 139.42 44.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.175 0.988 . . . . 3.29 108.336 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -112.66 105.3 13.45 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 124.682 1.193 . . . . 0.9 109.765 167.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.31 144.49 28.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.591 -1.633 . . . . 3.72 106.591 163.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.64 172.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.536 -1.283 . . . . 2.07 107.536 166.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -115.4 112.32 22.15 Favored 'General case' 0 C--N 1.34 0.178 0 O-C-N 124.054 0.846 . . . . 3.8 110.206 167.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.519 ' HB2' HD12 ' A' ' 53' ' ' ILE . 7.8 p90 -105.21 172.33 6.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.598 1.559 . . . . 2.72 110.758 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -117.17 106.34 47.37 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.894 1.278 . . . . 3.42 109.001 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.15 -12.56 30.36 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 124.609 3.539 . . . . 2.42 113.819 -160.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -96.46 0.86 50.97 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.177 0.591 . . . . 3.18 111.3 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.0 t -118.85 -49.03 3.73 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 123.979 0.912 . . . . 2.6 109.478 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.623 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -121.16 149.97 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.833 1.253 . . . . 1.48 108.344 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.23 140.06 27.54 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 106.564 -1.643 . . . . 2.98 106.564 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -56.69 -38.78 94.91 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.022 2.482 . . . . 1.66 112.06 -172.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mp -52.06 -43.83 64.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.681 0.792 . . . . 3.6 111.061 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -39.51 94.08 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.137 -0.69 . . . . 3.35 109.137 -176.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.623 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -54.55 -52.11 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.493 -1.299 . . . . 1.32 107.493 172.317 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.82 -45.53 86.01 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 123.365 0.415 . . . . 1.24 110.263 -173.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.5 -45.99 69.87 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.068 0.547 . . . . 3.31 110.944 172.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.37 -46.83 87.58 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.379 0.609 . . . . 2.52 109.863 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mm -58.76 -44.21 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.916 -0.49 . . . . 2.76 110.991 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -63.69 -39.77 95.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.348 0.659 . . . . 3.22 111.507 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -62.62 -46.69 87.08 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.977 0.511 . . . . 2.12 109.702 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 mt -58.21 -36.85 73.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.549 0.34 . . . . 1.9 111.742 172.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.88 24.56 3.03 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.268 0.937 . . . . 0.98 112.469 167.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 18' ' ' CYS . 2.1 m-30 -115.12 160.91 19.1 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.188 1.395 . . . . 2.35 109.118 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -98.03 119.21 36.27 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.321 -0.992 . . . . 4.04 108.321 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.31 91.11 5.06 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.087 1.355 . . . . 1.15 107.947 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -98.71 97.5 8.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.596 -1.631 . . . . 1.07 106.596 177.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.565 HG13 ' HB3' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -60.81 155.67 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.187 -1.37 . . . . 4.0 110.104 169.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.568 -0.901 . . . . 4.89 108.568 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.813 0 CA-C-O 117.674 -1.626 . . . . 2.22 109.899 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.442 HD22 ' C ' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -96.45 70.26 2.65 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.534 1.667 . . . . 2.59 107.739 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.42 161.25 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.521 -0.918 . . . . 2.87 108.521 -178.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.12 148.09 44.06 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.522 0.729 . . . . 2.87 109.611 177.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.49 HD13 ' HB1' ' A' ' 145' ' ' ALA . 0.1 OUTLIER -131.02 147.45 52.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.908 1.283 . . . . 2.68 108.505 172.332 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 m -98.02 126.31 43.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 105.971 -1.863 . . . . 1.85 105.971 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.03 134.69 35.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 109.181 -0.674 . . . . 1.47 109.181 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.5 m -125.74 140.56 52.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.115 -1.439 . . . . 1.78 107.115 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.44 -22.53 5.87 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.912 1.244 . . . . 1.33 111.89 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -51.74 139.49 21.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.061 1.134 . . . . 3.85 114.061 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.2 t -147.0 11.02 1.04 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.384 0.674 . . . . 3.98 111.902 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.04 144.83 1.03 Allowed 'General case' 0 C--N 1.342 0.277 0 O-C-N 120.455 -1.403 . . . . 3.48 110.084 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.69 -34.0 66.98 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.422 0.689 . . . . 2.57 111.782 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.8 m -43.48 -49.01 7.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.753 0.421 . . . . 2.12 110.991 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.52 -36.82 83.78 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.825 0.284 . . . . 2.75 111.059 -177.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.83 -56.59 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.636 -0.876 . . . . 1.94 108.636 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -59.85 -35.73 75.37 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.801 0.81 . . . . 2.6 110.556 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -63.19 -49.41 74.35 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.814 1.646 . . . . 1.66 111.252 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 34.5 mt -58.49 -45.3 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.716 -0.846 . . . . 1.1 108.716 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -55.32 -48.7 73.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.239 0.616 . . . . 3.33 110.194 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.8 t -51.91 -53.43 41.01 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.334 0.97 . . . . 1.39 110.889 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.34 -39.68 73.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.321 -0.862 . . . . 2.81 112.056 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.4 -60.41 2.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.576 -1.268 . . . . 2.15 107.576 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.0 p -54.93 -20.97 10.17 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.855 0.862 . . . . 2.26 112.754 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.1 mtt85 -60.73 -34.1 73.91 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.88 0.696 . . . . 5.6 112.88 171.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.1 m -57.36 150.23 18.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.604 0.762 . . . . 1.74 111.621 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -68.87 -56.0 9.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.155 0.982 . . . . 2.69 112.336 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.89 -28.18 65.32 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.972 -0.451 . . . . 1.07 111.972 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.34 122.62 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.718 -0.871 . . . . 1.95 109.426 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.7 m -104.35 -41.25 5.82 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.163 0.185 . . . . 2.03 111.225 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.429 ' CZ ' ' HG2' ' A' ' 123' ' ' LYS . 30.3 p90 -138.25 122.39 18.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.017 -0.735 . . . . 2.83 109.017 172.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.73 135.28 46.4 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 107.419 -1.326 . . . . 1.05 107.419 163.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.7 t -127.8 121.94 31.44 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.205 0.457 . . . . 2.17 110.488 164.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.54 114.37 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.014 1.326 . . . . 2.48 111.111 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -106.81 88.75 2.82 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.708 1.603 . . . . 1.2 110.43 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.58 -33.19 69.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.374 1.87 . . . . 1.98 111.683 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.24 -31.51 53.62 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.379 1.072 . . . . 1.38 111.477 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.08 -0.14 12.82 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.01 1.324 . . . . 1.75 110.495 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.0 m 59.85 20.63 9.54 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.039 1.336 . . . . 1.43 113.176 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -97.61 150.63 20.94 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.484 0.714 . . . . 3.74 110.604 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.02 106.14 7.08 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.663 1.985 . . . . 0.82 108.124 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.01 108.93 20.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.469 -2.048 . . . . 2.04 105.469 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.5 p -113.95 127.0 71.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 2.19 108.412 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.429 ' HG2' ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -114.87 105.6 13.19 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 123.929 0.892 . . . . 4.86 110.044 -176.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -124.01 -177.37 3.74 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.003 0.814 . . . . 1.94 111.804 -174.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -105.38 106.81 57.39 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.2 -1.407 . . . . 3.56 107.2 178.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.71 66.11 8.82 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.519 2.813 . . . . 1.72 111.088 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -161.51 -48.34 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.484 1.514 . . . . 3.24 108.623 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.9 pt -86.28 -32.59 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 123.698 0.799 . . . . 1.54 111.23 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.02 163.68 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.287 0.635 . . . . 1.33 109.574 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.39 166.44 26.44 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.452 -1.059 . . . . 1.34 110.452 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.19 -37.11 19.31 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.397 2.731 . . . . 1.48 111.156 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -50.05 -39.06 40.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.237 0.615 . . . . 6.32 111.471 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.25 -38.99 71.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.506 -0.924 . . . . 4.35 108.506 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.15 -49.02 85.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.486 0.714 . . . . 1.03 109.165 172.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 77.1 mt -51.51 -53.04 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.704 -0.85 . . . . 1.81 108.704 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -48.79 75.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.364 -0.835 . . . . 3.64 111.872 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 49.9 mt -49.92 -56.08 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.894 -0.78 . . . . 2.3 108.894 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.256 2.2 pp -67.25 -30.38 49.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 113.194 0.813 . . . . 1.55 113.194 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -60.79 -37.78 83.09 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.511 1.051 . . . . 2.61 110.15 170.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -69.33 -31.39 69.82 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.758 -0.46 . . . . 3.89 109.758 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.2 mt -66.72 -45.14 88.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.898 -0.501 . . . . 1.38 109.765 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.07 31.94 3.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.667 1.603 . . . . 1.2 111.343 -175.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.87 174.46 6.19 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.927 0.864 . . . . 2.49 109.068 171.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -125.96 123.26 38.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.622 -1.622 . . . . 3.95 106.622 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.49 ' HB1' HD13 ' A' ' 84' ' ' LEU . . . -115.81 100.77 8.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.357 1.463 . . . . 1.23 108.91 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.4 p -98.42 99.25 10.42 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.012 -1.107 . . . . 3.21 108.012 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -47.91 98.9 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.489 1.915 . . . . 4.0 110.811 176.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 48.38 42.7 18.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.951 0.901 . . . . 3.75 112.23 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 116.893 -1.527 . . . . 8.44 108.716 -175.267 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 107.032 -1.47 . . . . 3.59 107.032 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.41 ' HA ' ' HG3' ' A' ' 47' ' ' LYS . 32.2 ttmt -94.93 151.67 19.0 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 119.645 1.111 . . . . 4.18 109.376 176.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.66 133.63 40.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.441 -1.254 . . . . 2.06 108.531 167.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -103.67 118.49 36.84 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.657 1.583 . . . . 3.4 109.135 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.463 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.8 pt? -141.09 179.93 6.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.567 0.747 . . . . 2.16 111.488 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -130.62 146.38 52.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.327 -0.99 . . . . 1.59 108.327 173.209 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 mm -100.95 136.19 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 107.442 -1.318 . . . . 0.99 107.442 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -108.98 125.3 51.91 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.157 -1.423 . . . . 3.09 107.157 164.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.02 -79.98 0.17 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.507 1.051 . . . . 1.05 110.957 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.9 mtt 45.26 78.73 0.06 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.22 1.808 . . . . 2.07 114.685 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -54.29 -60.78 2.88 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.75 0.648 . . . . 2.17 112.75 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -169.59 68.27 0.06 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.443 0.565 . . . . 3.11 110.321 -174.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 34.37 41.52 0.05 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.304 2.242 . . . . 5.75 115.78 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -160.14 -41.05 0.05 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.192 1.397 . . . . 3.38 111.27 -171.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.2 t -70.88 -38.53 73.06 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.673 -1.267 . . . . 1.69 111.01 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.605 ' HB ' HD21 ' A' ' 39' ' ' LEU . 95.8 t -59.4 -34.96 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.434 0.635 . . . . 1.94 109.397 167.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.27 -40.84 96.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.37 -0.831 . . . . 2.38 111.088 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -44.85 83.42 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.752 -1.218 . . . . 2.46 110.451 172.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.544 HG12 HD13 ' A' ' 65' ' ' LEU . 3.3 mt -47.36 -31.24 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 123.249 0.62 . . . . 1.51 111.854 175.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -46.54 -59.22 3.13 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.588 0.631 . . . . 5.25 111.539 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -71.55 -21.43 61.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.424 -0.353 . . . . 4.69 111.834 -173.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -67.59 -57.59 6.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.407 -1.331 . . . . 1.18 107.407 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.567 HD11 HD11 ' A' ' 62' ' ' ILE . 5.2 mp -63.27 -41.71 99.05 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 118.39 0.541 . . . . 1.97 111.237 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.54 -17.91 9.97 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.582 -0.699 . . . . 2.13 112.59 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -123.58 27.48 7.37 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.56 0.744 . . . . 3.7 111.406 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -81.2 -61.45 1.95 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.932 0.893 . . . . 2.69 110.04 172.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.16 -138.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.138 0.575 . . . . 1.23 109.927 -172.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.22 -18.09 66.76 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 119.068 0.849 . . . . 1.52 112.541 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.38 121.02 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 O-C-N 121.842 -0.799 . . . . 1.58 110.862 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 pp -142.16 50.05 1.53 Allowed 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 121.86 0.838 . . . . 2.46 110.336 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -157.92 144.51 17.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.713 -1.588 . . . . 1.64 106.713 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.4 t -138.61 112.64 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 104.553 -2.388 . . . . 2.69 104.553 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.94 86.77 2.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 122.219 1.009 . . . . 2.68 109.128 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 44' ' ' ALA . 19.7 m -97.18 157.1 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.07 -0.968 . . . . 2.34 109.11 171.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.38 98.42 5.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.116 -1.809 . . . . 1.36 106.116 159.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.605 HD21 ' HB ' ' A' ' 19' ' ' VAL . 4.0 mp -62.33 -20.82 64.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.014 0.37 . . . . 3.63 111.242 176.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 40.4 ttm -73.83 -37.03 64.96 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.368 1.067 . . . . 3.04 110.735 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.57 -23.2 14.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.6 0.76 . . . . 1.69 111.797 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.17 62.29 1.83 Allowed Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.475 1.036 . . . . 1.29 111.322 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -144.0 140.37 29.55 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.487 -1.301 . . . . 4.02 107.487 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.435 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -115.21 108.49 16.67 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.616 1.167 . . . . 1.02 110.104 165.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -104.09 148.7 25.95 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.442 1.019 . . . . 4.01 109.082 158.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.5 pt -137.53 177.76 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.187 -1.412 . . . . 2.04 107.187 176.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HG3' ' HA ' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -126.11 110.75 13.87 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 119.137 -0.459 . . . . 3.63 110.644 165.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -115.59 -178.43 3.38 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.232 1.813 . . . . 2.73 111.475 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -122.83 106.58 34.22 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 127.675 2.39 . . . . 4.54 110.095 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.19 10.53 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.614 2.876 . . . . 2.11 113.358 -173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.32 -19.01 18.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.494 0.718 . . . . 3.52 110.724 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.08 -66.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.115 -1.069 . . . . 2.81 108.115 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -94.07 142.26 13.63 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-O 120.859 0.361 . . . . 1.6 110.299 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.39 149.06 41.52 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.302 1.441 . . . . 2.64 109.939 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.97 -19.97 67.27 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.942 2.428 . . . . 1.44 112.546 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -70.59 -60.35 2.31 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.986 -0.746 . . . . 2.92 108.986 173.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -59.76 -33.57 71.85 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.1 -0.375 . . . . 3.56 111.963 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.559 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -51.87 -47.06 41.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 N-CA-C 107.321 -1.363 . . . . 1.32 107.321 171.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.56 -36.65 81.23 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.697 -0.683 . . . . 1.29 110.686 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -59.57 -45.39 91.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.843 0.747 . . . . 2.6 109.568 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -52.16 63.47 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.185 -0.672 . . . . 2.34 109.185 176.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.567 HD11 HD11 ' A' ' 26' ' ' LEU . 9.8 mm -63.48 -42.77 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 O-C-N 122.007 -0.433 . . . . 2.54 112.123 -176.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -44.45 95.64 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.23 1.012 . . . . 2.29 110.356 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -60.39 -53.94 51.54 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.671 0.788 . . . . 2.16 108.899 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.544 HD13 HG12 ' A' ' 22' ' ' ILE . 4.7 mt -50.36 -39.82 47.58 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.648 0.779 . . . . 1.9 111.775 174.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.56 37.55 1.07 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.637 -0.985 . . . . 1.06 110.637 167.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -130.92 158.79 39.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.41 -1.33 . . . . 2.22 107.41 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -99.24 119.58 38.13 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.243 -1.021 . . . . 2.29 108.243 171.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.66 119.72 36.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.417 -1.327 . . . . 0.91 107.417 168.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -133.46 124.94 27.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.099 -1.074 . . . . 0.93 108.099 174.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 21.8 t -60.78 151.69 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 124.546 1.139 . . . . 2.79 111.261 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.378 0 CA-C-N 115.955 -0.566 . . . . 4.43 110.984 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 109.616 -1.393 . . . . 3.06 109.616 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -95.79 111.12 23.16 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 107.637 -1.246 . . . . 3.36 107.637 164.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.73 161.81 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 125.445 1.716 . . . . 2.95 107.136 173.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.84 154.42 21.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.828 1.251 . . . . 3.17 108.292 165.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -142.42 151.87 42.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.332 0.653 . . . . 3.1 110.518 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 m -99.95 132.1 45.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.831 1.652 . . . . 1.86 107.296 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.585 HD13 HD13 ' A' ' 98' ' ' ILE . 8.5 mt -99.1 124.69 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.965 -0.754 . . . . 2.42 108.965 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.7 m -110.56 100.98 9.69 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.247 0.619 . . . . 1.57 109.342 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.57 -34.35 2.12 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.621 1.105 . . . . 1.24 111.216 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -58.23 141.8 49.58 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.383 0.673 . . . . 2.46 111.811 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 51.8 m -153.57 84.46 1.18 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.858 1.663 . . . . 3.48 106.558 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 63.3 m 51.09 -110.51 0.48 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.017 1.327 . . . . 6.31 111.602 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 48.72 -144.11 0.44 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.164 1.385 . . . . 5.25 110.3 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.5 t -89.15 9.4 25.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 118.849 -0.596 . . . . 3.84 109.97 164.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.54 -56.93 6.66 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 119.506 1.048 . . . . 3.02 110.082 -166.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.5 t -49.6 -46.41 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.321 1.049 . . . . 1.26 109.92 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -63.82 -36.28 83.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.125 -0.489 . . . . 3.54 109.927 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -63.45 -52.79 59.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.556 0.742 . . . . 1.85 109.691 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.585 HD13 HD13 ' A' ' 86' ' ' ILE . 4.0 mt -53.92 -53.99 23.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 109.496 -0.557 . . . . 1.25 109.496 178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -56.95 -45.69 82.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.907 -0.568 . . . . 2.16 109.758 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.3 t -54.29 -54.07 45.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.822 0.737 . . . . 1.53 110.857 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -34.54 72.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 121.169 -0.957 . . . . 2.45 111.147 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -71.07 -60.63 2.12 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.429 -0.952 . . . . 2.05 108.429 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.1 p -56.34 -18.78 11.86 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.06 0.763 . . . . 1.73 113.06 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -61.48 -33.23 73.42 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.767 0.712 . . . . 5.59 112.466 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.7 m -62.35 152.4 34.05 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.077 0.951 . . . . 1.64 111.387 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -70.64 -52.96 17.8 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.317 1.047 . . . . 2.23 111.502 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.49 -43.04 20.72 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.572 -0.611 . . . . 1.15 111.572 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.66 134.64 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.855 -0.794 . . . . 2.0 108.855 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.8 t -128.0 -35.95 2.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.756 0.823 . . . . 2.97 110.845 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -110.11 92.0 3.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.951 -1.5 . . . . 3.02 106.951 -173.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.49 135.11 47.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.165 -1.791 . . . . 0.99 106.165 160.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 t -140.23 108.75 5.87 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.477 -1.305 . . . . 1.6 107.477 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.5 t -101.63 107.55 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.521 1.128 . . . . 2.33 109.341 -173.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.97 80.12 2.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.561 1.144 . . . . 1.51 109.818 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 pp -53.56 -26.63 22.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.012 0.925 . . . . 2.26 113.042 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.48 -35.23 65.3 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.342 0.657 . . . . 1.7 111.248 176.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -7.61 18.79 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.264 1.425 . . . . 1.82 110.78 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.4 m 73.51 3.9 4.66 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.003 1.721 . . . . 1.6 112.406 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -98.09 165.33 11.95 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.132 0.973 . . . . 3.18 112.0 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -137.51 136.12 37.38 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.66 1.184 . . . . 1.05 108.651 168.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.96 132.18 43.76 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.959 -1.867 . . . . 2.59 105.959 171.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.0 t -125.44 142.01 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 105.345 -2.094 . . . . 1.86 105.345 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -125.06 99.52 6.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.458 1.103 . . . . 3.45 109.255 169.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -109.68 -178.78 3.63 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.645 1.578 . . . . 2.15 109.106 173.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -114.41 113.12 45.81 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.201 1.4 . . . . 4.16 107.651 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.01 58.72 6.8 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.754 2.303 . . . . 2.15 112.479 -164.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -145.77 -49.89 0.23 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.894 1.677 . . . . 4.74 108.242 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -80.34 -32.03 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 122.34 -0.225 . . . . 1.64 111.205 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.41 162.94 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.942 -1.132 . . . . 1.41 107.942 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.23 163.91 27.71 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.628 -1.389 . . . . 1.37 109.628 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.72 -41.26 39.85 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.101 2.534 . . . . 1.44 110.396 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -40.05 25.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.184 0.809 . . . . 6.21 113.184 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.38 -47.96 79.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.18 -0.674 . . . . 2.71 109.18 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.31 -46.76 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.493 -0.928 . . . . 1.03 108.493 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.2 mt -53.66 -54.24 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 109.121 -0.696 . . . . 1.82 109.121 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -54.65 -47.24 73.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.935 0.789 . . . . 3.68 111.702 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.2 mm -54.17 -56.47 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.863 -0.421 . . . . 1.94 109.863 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 pp -66.57 -30.96 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 120.973 -1.08 . . . . 1.37 113.119 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.31 -38.38 73.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.312 0.645 . . . . 3.39 109.917 170.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -65.99 -36.49 83.45 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.485 -0.561 . . . . 3.01 109.485 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.7 mt -68.38 -40.84 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.395 -0.594 . . . . 1.25 109.395 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.13 33.18 3.52 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.518 1.532 . . . . 1.17 111.007 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -101.35 176.67 5.16 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.279 1.039 . . . . 3.05 108.364 166.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -134.92 125.67 27.15 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.413 -1.328 . . . . 4.81 107.413 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.22 106.15 14.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.983 1.313 . . . . 1.32 109.74 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.57 94.75 6.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.848 1.659 . . . . 2.14 108.572 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.79 103.76 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.663 1.585 . . . . 4.22 110.501 172.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 46.75 43.76 13.33 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.744 0.818 . . . . 4.23 112.397 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.158 -0.925 . . . . 10.4 108.531 177.612 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 121.853 0.835 . . . . 3.85 109.163 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.7 151.35 19.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.86 -1.904 . . . . 4.23 105.86 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.413 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 5.8 t -123.25 141.41 52.01 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 117.837 -1.078 . . . . 1.9 108.333 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -123.85 100.53 6.8 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.752 -0.833 . . . . 3.55 108.752 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -125.04 168.02 13.93 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.38 1.086 . . . . 3.03 110.736 177.135 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.68 146.16 43.9 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.65 -1.611 . . . . 1.7 106.65 169.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.5 mm -102.37 130.54 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.614 -1.254 . . . . 1.12 107.614 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -118.78 117.87 30.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.494 -1.669 . . . . 3.25 106.494 167.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.78 -99.91 0.18 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.127 -1.589 . . . . 1.12 109.127 -174.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 58.5 76.25 0.35 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.172 1.789 . . . . 1.67 113.288 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -48.96 -58.73 4.41 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.893 0.877 . . . . 2.59 112.698 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.56 52.63 0.05 OUTLIER 'General case' 0 C--N 1.346 0.449 0 C-N-CA 119.211 -0.995 . . . . 4.14 111.37 -175.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.46 41.12 20.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.97 0.908 . . . . 4.52 112.399 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -151.82 -43.19 0.11 Allowed 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.494 1.118 . . . . 2.16 110.881 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.36 -46.99 83.96 Favored 'General case' 0 C--O 1.226 -0.167 0 O-C-N 121.052 -1.03 . . . . 2.01 109.132 -176.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.18 -36.98 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.967 0.889 . . . . 2.25 109.996 174.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -65.8 -31.19 72.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.921 -0.581 . . . . 1.9 112.336 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -38.19 71.82 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.93 -1.106 . . . . 3.09 110.171 172.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.573 HG12 HD13 ' A' ' 65' ' ' LEU . 54.0 mt -59.85 -39.96 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.264 1.026 . . . . 1.58 110.256 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.9 -58.26 2.47 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.791 0.836 . . . . 5.73 112.08 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.53 -39.99 88.9 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.924 0.392 . . . . 4.88 110.144 -172.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -54.45 -56.66 16.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.519 -0.764 . . . . 1.47 109.266 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mt -65.67 -36.25 83.12 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 113.313 0.857 . . . . 2.53 113.313 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -21.9 3.65 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 118.283 0.492 . . . . 2.81 112.165 168.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -123.75 30.88 6.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.152 0.581 . . . . 3.53 112.42 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.32 -80.08 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.582 0.628 . . . . 3.54 109.371 167.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.29 -114.28 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.516 0.726 . . . . 1.28 110.469 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.5 -9.58 69.13 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 119.248 0.931 . . . . 1.33 112.984 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.8 t -59.22 119.75 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 118.366 1.083 . . . . 2.35 109.092 167.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.45 49.6 1.71 Allowed 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.496 0.665 . . . . 2.43 110.448 162.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 t -159.66 151.13 19.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.566 -1.272 . . . . 1.64 107.566 161.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.01 120.11 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.399 -2.074 . . . . 2.53 105.399 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 tt -138.75 89.72 2.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.936 -1.876 . . . . 2.41 105.936 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.7 p -106.29 135.63 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.3 -1.0 . . . . 2.31 108.3 172.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -104.76 102.69 12.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.247 -1.76 . . . . 1.22 106.247 164.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tp -57.57 -33.7 68.44 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.054 1.342 . . . . 2.94 109.182 169.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 62.8 mtt -59.29 -47.67 84.49 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.537 0.735 . . . . 4.09 110.901 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.3 -25.86 16.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.915 0.886 . . . . 1.27 111.446 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.4 55.71 2.82 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.615 1.102 . . . . 1.09 110.833 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 128.74 27.86 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.04 -1.096 . . . . 2.98 108.04 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.07 117.32 30.24 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 124.518 1.136 . . . . 1.09 111.071 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -113.63 142.47 45.96 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.609 0.719 . . . . 3.98 110.641 162.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.5 mt -121.25 168.16 13.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 125.595 1.558 . . . . 3.45 106.893 171.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -133.84 105.54 6.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.098 0.559 . . . . 4.18 109.568 170.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.465 ' CD2' HD11 ' A' ' 53' ' ' ILE . 5.0 p90 -102.69 -176.22 3.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.8 2.04 . . . . 3.13 111.792 174.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -109.35 129.93 23.34 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.252 1.421 . . . . 4.17 107.7 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.57 41.49 1.15 Allowed 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.46 2.774 . . . . 4.03 112.334 -166.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -163.41 24.42 0.08 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.041 0.936 . . . . 3.49 110.392 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.13 -50.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 107.027 -1.471 . . . . 3.22 107.027 -174.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.465 HD11 ' CD2' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -126.35 153.01 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.837 -0.801 . . . . 2.67 108.837 176.005 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -125.77 158.49 65.12 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 106.373 -1.714 . . . . 3.69 106.373 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.44 -27.9 54.39 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.528 1.485 . . . . 1.64 110.438 -165.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -56.74 -42.17 78.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.123 0.969 . . . . 3.56 111.239 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.6 -52.52 57.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.976 0.807 . . . . 2.84 109.856 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.421 HD12 HD11 ' A' ' 53' ' ' ILE . 1.2 mt -47.7 -54.16 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.071 -1.085 . . . . 1.84 108.071 168.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.35 -35.05 74.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.158 -0.474 . . . . 1.9 111.308 -172.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -58.2 -47.39 83.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.506 1.122 . . . . 3.42 109.269 -178.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -54.11 -53.14 57.34 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.747 -0.464 . . . . 2.5 109.747 174.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.409 HG21 ' HB2' ' A' ' 69' ' ' ALA . 11.0 mm -59.07 -48.16 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.04 0.448 . . . . 2.71 110.631 -174.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.3 -45.79 90.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.381 0.673 . . . . 2.71 111.164 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.36 -49.81 76.1 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.504 0.593 . . . . 2.56 110.192 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.573 HD13 HG12 ' A' ' 22' ' ' ILE . 2.0 mt -57.97 -28.03 64.0 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.688 0.795 . . . . 1.98 111.793 174.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.43 36.15 3.91 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.11 -1.196 . . . . 1.69 110.11 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -120.13 162.07 19.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.187 1.795 . . . . 1.94 106.445 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -104.1 124.43 49.06 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.598 -0.89 . . . . 2.74 108.598 168.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.409 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -108.35 121.96 45.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.506 -1.294 . . . . 1.28 107.506 162.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.52 156.54 48.72 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.767 -1.198 . . . . 1.44 107.767 169.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.28 153.96 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.841 -1.072 . . . . 3.7 110.004 -164.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.8 mtp . . . . . 0 C--O 1.226 -0.174 0 C-N-CA 123.719 0.808 . . . . 4.77 111.578 172.963 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.288 0 N-CA-C 109.455 -1.458 . . . . 3.25 109.455 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.57 71.79 1.53 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.507 1.523 . . . . 3.5 108.044 -165.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.8 148.3 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.855 -1.535 . . . . 3.44 106.855 -173.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -117.76 145.57 44.4 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 123.46 0.704 . . . . 3.79 109.152 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.41 HD13 ' HB1' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -146.94 157.45 43.64 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.128 0.971 . . . . 2.79 109.899 -175.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.46 133.58 41.85 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 106.778 -1.564 . . . . 2.92 106.778 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.08 110.76 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.522 -0.918 . . . . 2.26 108.522 173.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.0 m -98.93 137.81 36.95 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.946 -1.131 . . . . 1.89 107.946 172.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.3 -28.19 14.48 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.487 1.042 . . . . 1.58 112.806 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -75.0 122.91 24.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 117.914 0.857 . . . . 2.76 110.537 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 m -138.88 44.31 2.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.162 0.985 . . . . 2.9 109.748 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 11.0 t -165.73 140.8 4.86 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.268 -0.895 . . . . 3.55 112.167 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.66 75.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.027 0.531 . . . . 2.84 111.361 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.4 m -53.55 -45.69 69.95 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.439 -0.788 . . . . 2.54 110.036 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.0 m -64.85 -44.97 88.02 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.188 -0.91 . . . . 2.53 109.493 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 37.2 t -46.32 -60.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 118.772 0.714 . . . . 1.95 110.749 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -56.7 -45.14 81.99 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.686 0.755 . . . . 4.01 110.357 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.72 -50.76 72.57 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.808 0.843 . . . . 2.24 111.166 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.2 mt -54.6 -50.53 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.041 -1.096 . . . . 1.38 108.041 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.77 -44.32 86.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.697 0.799 . . . . 2.66 110.299 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.8 t -56.07 -55.76 28.98 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.829 -0.434 . . . . 2.06 109.829 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -43.15 77.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.274 0.63 . . . . 3.55 112.572 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.39 -58.91 5.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.756 -0.831 . . . . 2.11 108.756 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.8 m -53.09 -23.65 8.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.673 1.189 . . . . 1.7 111.432 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -4.45 8.88 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.028 1.121 . . . . 5.27 114.028 174.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.3 m -84.74 149.73 25.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.055 1.742 . . . . 1.86 109.646 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -67.0 -53.56 30.15 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.89 0.876 . . . . 3.17 112.004 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.94 -21.03 69.12 Favored Glycine 0 CA--C 1.528 0.871 0 O-C-N 122.157 -0.34 . . . . 1.65 113.202 -170.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.75 129.54 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 121.138 -1.213 . . . . 2.07 109.154 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.9 m -103.98 -51.65 3.11 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 119.403 -0.332 . . . . 2.11 111.867 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.462 ' CE2' ' HG3' ' A' ' 123' ' ' LYS . 43.6 p90 -140.0 114.98 9.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.373 0.533 . . . . 2.15 110.014 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.49 149.69 23.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.988 -0.745 . . . . 1.41 108.988 165.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.9 m -139.34 115.61 10.44 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.347 -1.353 . . . . 2.03 107.347 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.16 119.78 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 118.227 0.467 . . . . 2.58 110.358 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -118.78 87.98 2.84 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.817 0.818 . . . . 2.3 109.612 -168.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.65 -32.1 28.12 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 125.724 1.61 . . . . 3.01 112.025 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.62 -36.28 69.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.525 0.73 . . . . 3.01 111.158 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.99 -20.08 15.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.96 1.304 . . . . 2.72 110.439 177.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 78.79 7.05 2.23 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.656 1.583 . . . . 2.09 111.407 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -96.37 148.86 22.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.66 1.584 . . . . 3.84 110.057 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.41 119.29 25.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.281 2.232 . . . . 1.67 107.605 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.88 122.85 40.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.701 -1.962 . . . . 3.12 105.701 174.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.35 133.95 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.4 -0.963 . . . . 2.58 108.4 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 110' ' ' TYR . 4.8 mmmt -116.12 110.4 18.8 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.363 1.065 . . . . 3.04 109.272 177.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.25 176.71 7.2 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 118.498 0.59 . . . . 2.78 111.933 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -96.73 109.05 46.61 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 107.008 -1.479 . . . . 3.96 107.008 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.36 64.36 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.534 2.823 . . . . 3.8 111.07 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.21 -44.88 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.426 1.49 . . . . 4.06 109.321 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -90.88 -29.81 4.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 118.003 0.365 . . . . 3.16 111.254 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.76 164.81 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.225 1.01 . . . . 2.97 108.53 -175.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -149.68 167.05 29.81 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.011 -0.835 . . . . 3.03 111.011 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -60.82 -34.38 91.54 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.243 3.295 . . . . 3.03 111.953 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -54.17 -37.62 64.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.557 0.743 . . . . 7.69 112.062 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.58 -43.46 84.87 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.05 0.452 . . . . 4.33 109.834 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 14.1 mm -56.07 -48.7 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.712 0.805 . . . . 2.72 109.189 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.9 mt -53.46 -57.89 4.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 123.513 0.725 . . . . 2.84 109.382 172.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.0 tttp -49.36 -48.39 46.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 119.264 0.938 . . . . 4.28 112.74 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.6 mt -51.46 -52.71 19.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.055 -0.721 . . . . 4.26 109.055 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.309 2.2 pp -70.62 -29.15 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 118.892 -1.123 . . . . 1.54 114.021 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -58.11 -45.05 87.93 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.356 0.98 . . . . 3.23 109.019 170.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.88 -37.12 85.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.041 0.536 . . . . 3.7 109.558 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.8 mt -66.37 -41.67 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.99 -0.444 . . . . 1.83 110.483 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.68 30.75 6.34 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.337 1.446 . . . . 1.42 111.8 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -101.16 -179.78 4.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.549 1.175 . . . . 1.98 108.771 163.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -133.79 121.13 21.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.938 -1.504 . . . . 4.37 106.938 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.41 ' HB1' HD13 ' A' ' 84' ' ' LEU . . . -103.78 115.38 30.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.177 1.391 . . . . 1.84 108.249 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.8 t -135.28 128.32 31.61 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 117.78 -1.105 . . . . 2.87 108.606 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 pp -25.42 109.74 0.03 OUTLIER 'General case' 0 C--N 1.341 0.214 0 C-N-CA 127.626 2.37 . . . . 6.16 109.705 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.85 -37.62 55.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.745 -0.662 . . . . 5.91 110.782 -173.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 C--O 1.245 0.824 0 CA-C-O 116.149 -1.881 . . . . 9.63 111.079 -179.877 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.514 -0.413 0 N-CA-C 110.256 -0.276 . . . . 3.09 110.256 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.408 ' NZ ' ' O ' ' A' ' 149' ' ' GLN . 2.7 ttpt -93.16 136.45 33.4 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.289 -1.004 . . . . 6.57 108.289 -175.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.3 t -125.07 130.25 51.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.029 -1.441 . . . . 2.39 110.534 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -102.3 96.28 6.85 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 126.615 1.966 . . . . 5.03 111.125 -171.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.489 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.3 pt? -128.46 174.49 9.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.307 1.051 . . . . 2.59 112.839 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.6 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -127.09 155.7 42.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.977 -1.49 . . . . 2.02 106.977 169.64 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 44' ' ' ALA . 31.4 mm -98.72 145.16 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.418 -1.327 . . . . 0.79 107.418 171.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -118.86 128.07 54.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.645 -1.613 . . . . 3.1 106.645 162.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.86 -54.12 0.48 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.933 0.777 . . . . 1.32 112.037 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.0 mtt 11.85 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.946 2.498 . . . . 2.4 115.595 -172.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.3 p -62.36 -61.2 2.62 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.697 -0.627 . . . . 3.71 111.104 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.8 t -162.87 48.18 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.984 0.421 . . . . 3.34 110.205 -173.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 55.52 22.18 4.94 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.275 1.03 . . . . 6.72 113.553 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 m -130.71 -38.96 1.27 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.931 0.892 . . . . 4.12 111.732 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 m -64.41 -48.4 75.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 O-C-N 121.427 -0.796 . . . . 2.36 109.228 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 81.8 t -55.39 -39.92 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.006 -0.739 . . . . 2.21 109.006 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 t -58.99 -42.06 89.15 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.971 -0.559 . . . . 3.03 110.856 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -43.33 69.04 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.251 -1.53 . . . . 3.34 111.242 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.3 mt -52.7 -49.61 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.768 1.227 . . . . 1.56 109.375 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -55.23 -38.22 68.19 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.241 -0.912 . . . . 4.21 111.946 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -68.07 -31.84 71.76 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.1 -1.0 . . . . 8.52 110.366 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -65.82 -49.45 68.18 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.69 -0.856 . . . . 1.69 108.69 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -57.04 -37.54 71.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 112.695 0.628 . . . . 1.86 112.695 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -54.78 -18.58 4.93 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.219 -0.926 . . . . 2.13 112.819 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -116.99 23.86 11.6 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.643 0.777 . . . . 2.97 112.271 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -71.98 -69.17 0.41 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.945 0.793 . . . . 2.79 109.632 167.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.2 -118.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.162 0.985 . . . . 1.14 109.568 -171.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.19 -23.76 68.3 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.829 -0.544 . . . . 1.5 113.106 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 32' ' ' VAL . 1.2 p -60.1 111.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.914 0.886 . . . . 1.81 111.556 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.17 52.32 1.37 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.068 -1.086 . . . . 2.6 108.068 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.3 t -162.9 152.88 15.97 Favored 'General case' 0 CA--C 1.521 -0.154 0 O-C-N 119.866 -1.772 . . . . 2.03 108.498 156.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.14 74.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 125.365 1.466 . . . . 2.48 108.981 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.88 68.79 1.02 Allowed 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.473 -0.767 . . . . 5.47 109.18 -177.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.99 157.42 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.561 -0.903 . . . . 3.05 108.561 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.71 103.04 8.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.06 -1.459 . . . . 1.78 107.06 170.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.4 mt -67.31 -15.69 63.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.895 0.878 . . . . 3.54 110.962 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 17.2 ttt -76.25 -47.86 22.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.584 1.154 . . . . 4.66 109.885 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.72 -35.83 12.61 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.595 1.158 . . . . 1.72 111.271 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.73 74.85 1.29 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 124.612 1.101 . . . . 1.49 110.627 -174.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -140.58 141.03 35.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.986 -2.227 . . . . 3.06 104.986 165.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.414 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -114.87 101.63 9.22 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 124.036 0.835 . . . . 1.14 108.82 163.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -96.75 133.87 40.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.2 -1.407 . . . . 4.09 107.2 165.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.67 160.33 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.993 -1.854 . . . . 2.97 105.993 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -121.11 105.58 10.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 123.264 0.353 . . . . 4.55 110.587 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.463 ' HB2' HD12 ' A' ' 53' ' ' ILE . 25.4 p90 -104.13 -177.09 3.27 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 126.81 2.044 . . . . 2.9 112.757 174.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -122.15 109.12 33.66 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.809 2.044 . . . . 4.72 109.12 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.71 -11.29 23.11 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.756 2.304 . . . . 2.73 114.722 -175.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -95.21 -4.5 45.78 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.885 0.766 . . . . 6.08 110.938 -170.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.5 p -134.29 -37.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.585 1.154 . . . . 3.59 111.184 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -118.53 153.02 20.71 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 N-CA-C 109.024 -0.732 . . . . 1.97 109.024 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -138.02 152.81 72.73 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.639 1.176 . . . . 3.43 109.86 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.57 -37.14 39.09 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.711 2.274 . . . . 1.96 111.757 -170.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.1 -40.95 95.67 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.8 -0.563 . . . . 3.54 112.085 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -61.88 -44.58 96.51 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.264 0.625 . . . . 3.74 109.984 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -52.3 -54.97 12.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 N-CA-C 106.986 -1.487 . . . . 1.49 106.986 170.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.01 -45.95 71.65 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.948 -0.569 . . . . 1.64 110.255 -172.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -51.06 -51.15 56.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.966 0.906 . . . . 4.94 110.022 175.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -45.16 75.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.318 0.58 . . . . 2.74 110.183 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 69' ' ' ALA . 7.3 mm -65.82 -37.7 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 O-C-N 121.939 -0.476 . . . . 2.65 110.515 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -66.28 -41.07 90.36 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.382 -0.599 . . . . 3.01 109.382 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.4 -50.8 72.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.866 0.466 . . . . 3.23 109.998 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.0 mt -57.67 -32.46 67.35 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 111.889 0.329 . . . . 1.95 111.889 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.85 35.11 1.9 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.458 1.028 . . . . 1.65 111.445 166.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -132.18 164.05 27.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.054 1.342 . . . . 2.19 109.149 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -102.72 124.83 48.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.867 -1.16 . . . . 2.44 107.867 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.405 ' HB2' HG13 ' A' ' 62' ' ' ILE . . . -102.97 122.3 44.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.829 -1.175 . . . . 1.28 107.829 166.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.6 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -126.98 118.59 24.79 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.555 -0.906 . . . . 1.26 108.555 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.489 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 7.1 p -69.07 160.3 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 125.169 1.388 . . . . 3.15 110.247 171.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 121.3 0.572 . . . . 6.03 110.15 168.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.054 0 N-CA-C 112.264 -0.334 . . . . 2.4 112.264 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.681 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -142.65 118.14 10.32 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 104.907 -2.257 . . . . 2.66 104.907 174.268 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.681 HD13 ' O ' ' A' ' 81' ' ' ASN . 2.3 mm -131.6 165.82 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.657 0.783 . . . . 2.98 109.062 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -131.1 149.03 52.78 Favored 'General case' 0 N--CA 1.438 -1.056 0 O-C-N 124.51 1.131 . . . . 4.68 111.551 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.51 151.04 38.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.344 1.027 . . . . 2.55 109.221 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.99 132.87 43.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.27 -2.122 . . . . 1.63 105.27 174.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.5 pt -98.62 139.46 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.191 -1.04 . . . . 1.87 108.191 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.4 m -136.64 140.66 42.93 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.219 -1.4 . . . . 1.91 107.219 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.51 -20.62 15.49 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.5 1.048 . . . . 1.18 112.669 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.42 148.78 26.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.494 1.147 . . . . 3.24 112.073 176.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.6 t -134.89 -9.97 2.34 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.586 1.154 . . . . 3.78 112.521 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 35.4 t -160.03 158.35 30.34 Favored 'General case' 0 C--N 1.341 0.237 0 O-C-N 120.952 -1.092 . . . . 2.72 108.598 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.33 -37.26 35.88 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.375 1.07 . . . . 2.63 112.028 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -45.53 -42.13 10.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.732 0.813 . . . . 1.98 111.721 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 81.5 m -62.51 -53.18 58.57 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 109.134 -0.691 . . . . 1.75 109.134 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -45.33 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.648 -0.657 . . . . 2.01 111.65 176.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -62.43 -35.31 78.85 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.696 -0.483 . . . . 3.18 109.696 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -61.63 -60.84 3.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.535 1.134 . . . . 2.44 109.035 176.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -44.4 -57.12 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 123.733 0.813 . . . . 2.03 110.073 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.57 -45.02 93.09 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 120.173 -0.611 . . . . 2.59 109.794 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.9 t -53.74 -57.57 10.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.48 0.712 . . . . 2.11 110.519 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.538 ' CE ' HG22 ' A' ' 138' ' ' ILE . 10.7 mtpt -55.15 -38.06 67.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.446 0.906 . . . . 6.41 113.446 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.1 mt -71.05 -56.7 5.6 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.681 -1.97 . . . . 2.33 105.681 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.447 ' HA ' HG21 ' A' ' 108' ' ' ILE . 53.7 m -50.08 -21.51 1.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.86 2.064 . . . . 2.22 112.499 176.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -68.22 -24.61 64.95 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.578 0.751 . . . . 4.88 112.97 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.4 m -62.42 170.18 2.53 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.141 0.576 . . . . 2.17 110.707 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -82.59 -49.91 9.34 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.137 -0.977 . . . . 3.3 110.302 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.46 -30.98 66.07 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.444 1.021 . . . . 1.3 112.425 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.447 HG21 ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER -49.77 105.35 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.313 0.645 . . . . 2.78 110.843 178.435 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 59.8 m -104.39 -31.31 9.58 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.729 0.412 . . . . 2.29 110.522 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.26 114.07 8.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.345 -1.724 . . . . 2.86 106.345 -175.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -117.85 157.33 26.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.076 -1.453 . . . . 1.21 107.076 155.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.0 t -141.98 136.48 30.37 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.904 -1.517 . . . . 1.76 106.904 166.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.2 133.83 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 123.841 0.857 . . . . 2.1 110.052 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -132.34 116.06 16.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.681 1.192 . . . . 1.3 110.256 -170.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.4 mt -75.43 -46.82 30.4 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 127.251 2.22 . . . . 2.92 110.859 -172.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.59 -35.44 4.01 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.581 1.552 . . . . 1.7 111.705 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.92 -4.37 13.28 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.548 1.939 . . . . 1.87 111.281 -177.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 63.6 m 52.73 31.85 11.09 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.054 1.342 . . . . 1.47 112.508 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -108.2 151.0 26.52 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.484 0.713 . . . . 4.74 110.509 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.86 116.84 10.47 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.269 1.028 . . . . 0.96 108.599 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mp -102.03 128.79 48.33 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 126.607 1.963 . . . . 2.61 106.451 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.82 131.75 50.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.309 -0.626 . . . . 2.66 109.309 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -113.33 83.94 1.92 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.717 0.807 . . . . 3.89 110.651 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -113.97 171.94 7.29 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.65 1.58 . . . . 2.05 109.317 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -96.33 117.75 65.93 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 108.93 -0.767 . . . . 3.13 108.93 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.7 70.85 6.77 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.287 2.658 . . . . 2.04 111.013 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -164.29 -44.95 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.082 1.353 . . . . 4.11 109.709 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 25.7 pt -76.83 -38.73 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 123.377 0.671 . . . . 2.4 110.364 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.18 156.09 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.998 1.319 . . . . 2.12 108.127 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -121.82 158.66 16.52 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.048 -1.221 . . . . 2.28 110.048 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -62.52 -43.39 22.21 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.801 2.334 . . . . 2.02 110.056 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -54.21 -37.68 64.83 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 122.759 0.424 . . . . 5.42 111.907 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.79 -44.19 70.6 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.752 -1.203 . . . . 4.84 107.752 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.51 -48.99 86.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 108.604 -0.887 . . . . 1.67 108.604 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 64.2 mt -50.26 -58.75 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 124.237 1.015 . . . . 2.18 108.958 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -53.09 -45.76 68.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.032 -1.043 . . . . 5.28 112.488 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.2 mm -56.29 -46.08 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 109.965 -0.383 . . . . 2.83 109.965 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.538 HG22 ' CE ' ' A' ' 101' ' ' LYS . 27.4 pt -72.35 -34.77 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 121.112 -0.993 . . . . 1.46 113.109 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -56.05 -36.86 68.51 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.171 0.896 . . . . 2.64 109.279 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.25 -25.52 68.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.061 -0.518 . . . . 3.63 110.057 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.3 mt -86.89 -39.26 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.155 0.582 . . . . 1.95 109.708 172.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.33 27.42 5.3 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.129 1.347 . . . . 1.73 111.342 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -99.28 170.35 8.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.299 1.049 . . . . 1.91 108.954 165.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -135.53 144.87 46.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.835 -1.172 . . . . 5.36 107.835 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.4 103.08 7.99 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.136 1.775 . . . . 1.38 109.31 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.45 112.66 19.25 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.656 0.782 . . . . 2.19 109.932 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -17.71 106.68 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.983 2.513 . . . . 4.33 113.191 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.52 -40.22 23.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.94 -0.573 . . . . 3.65 110.403 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.408 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 14.9 mt-30 . . . . . 0 C--O 1.256 1.441 0 CA-C-O 115.403 -2.236 . . . . 6.92 116.994 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 . . . . . 0 C--O 1.223 -0.32 0 N-CA-C 107.487 -1.301 . . . . 3.95 107.487 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -92.37 159.17 15.7 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.506 1.522 . . . . 5.33 107.348 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.457 ' SG ' HD21 ' A' ' 8' ' ' LEU . 30.8 p -152.14 145.97 25.13 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 118.426 0.557 . . . . 2.66 111.3 166.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.96 102.49 11.49 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.273 1.029 . . . . 4.18 109.001 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -106.58 168.83 8.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.069 0.938 . . . . 2.72 111.113 172.468 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.12 156.31 33.9 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.549 -1.278 . . . . 1.68 107.549 167.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.3 mm -99.13 141.06 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 107.608 -1.256 . . . . 1.14 107.608 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -119.55 121.78 40.14 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.236 -1.765 . . . . 2.85 106.236 160.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.57 -83.68 0.15 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.644 1.116 . . . . 1.32 110.396 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.5 mmt 54.07 71.58 0.51 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.708 1.603 . . . . 1.94 113.6 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -55.26 -61.95 1.99 Allowed 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.616 -0.677 . . . . 2.15 112.374 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.0 t -168.59 64.57 0.06 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.757 0.708 . . . . 3.07 110.034 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 38.86 44.65 0.86 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.452 1.501 . . . . 5.7 112.912 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.5 t -160.81 -41.8 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.054 0.542 . . . . 3.0 110.528 -166.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -61.78 -40.3 94.71 Favored 'General case' 0 CA--C 1.527 0.08 0 O-C-N 120.889 -1.132 . . . . 1.94 109.833 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.672 ' HB ' HD21 ' A' ' 39' ' ' LEU . 77.0 t -61.44 -32.48 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 121.871 -0.518 . . . . 1.8 110.456 171.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 m -66.85 -37.56 84.7 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.102 -0.639 . . . . 2.2 111.428 176.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.262 0.3 OUTLIER -71.9 -35.14 69.64 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.556 -1.34 . . . . 3.63 112.146 171.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 mt -48.15 -51.41 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.712 -0.617 . . . . 2.08 110.965 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -34.37 -55.13 0.53 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.083 0.953 . . . . 4.35 110.907 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -68.8 -30.46 69.04 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.0 1.32 . . . . 8.11 110.285 -170.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -65.48 -57.94 7.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.513 -0.921 . . . . 1.94 108.513 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.83 -38.8 79.48 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.568 -0.16 . . . . 2.02 110.568 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -49.57 -26.64 3.68 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.949 0.9 . . . . 2.65 112.53 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -123.29 22.55 9.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.176 -0.916 . . . . 4.4 112.858 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -61.93 -68.88 0.28 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.433 1.015 . . . . 3.24 110.756 165.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.8 -130.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.938 0.495 . . . . 1.12 109.828 -163.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.07 -13.26 72.68 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 118.791 0.723 . . . . 1.41 112.959 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 46' ' ' ILE . 8.2 p -60.95 127.16 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 118.417 1.108 . . . . 1.3 110.635 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 pp -142.69 51.81 1.43 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.41 0.624 . . . . 2.52 111.032 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 t -156.66 151.61 26.09 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.015 -0.735 . . . . 1.59 109.015 164.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.83 69.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.553 1.541 . . . . 2.74 108.583 -171.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tt -98.05 74.17 2.26 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.14 -1.059 . . . . 2.3 108.14 -173.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.428 HG11 ' CG1' ' A' ' 19' ' ' VAL . 17.7 t -104.81 136.95 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.849 -0.614 . . . . 2.21 109.435 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -113.74 98.84 7.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.56 -0.904 . . . . 1.34 108.56 173.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.672 HD21 ' HB ' ' A' ' 19' ' ' VAL . 18.2 mt -60.5 -17.49 45.65 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.585 0.754 . . . . 2.92 112.607 173.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 6.1 mtm -70.05 -55.95 8.2 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.137 0.494 . . . . 4.26 109.781 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.89 -24.88 22.39 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.398 0.679 . . . . 1.49 111.429 -175.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.93 68.32 1.54 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.185 -1.166 . . . . 1.22 110.185 -174.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.24 139.46 41.02 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.574 -2.009 . . . . 2.89 105.574 171.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.91 101.48 9.53 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 124.641 1.213 . . . . 0.88 111.878 169.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -97.97 136.0 38.87 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.799 -1.185 . . . . 5.14 107.799 169.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 32' ' ' VAL . 37.2 pt -141.51 168.57 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.88 -0.785 . . . . 1.87 108.88 171.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -120.6 97.96 5.81 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 119.072 -0.489 . . . . 3.73 110.151 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -102.27 178.97 4.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 124.611 1.194 . . . . 2.3 112.156 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -123.38 104.53 34.42 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 127.96 2.504 . . . . 4.35 110.056 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.66 26.95 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 124.336 3.357 . . . . 2.09 112.717 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -106.1 -20.83 13.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.959 1.303 . . . . 3.19 110.76 165.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 87.9 t -117.6 -72.06 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 N-CA-C 108.246 -1.02 . . . . 2.74 108.246 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.47 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -88.12 140.62 15.5 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.079 0 N-CA-C 108.853 -0.795 . . . . 1.5 108.853 176.682 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -121.38 153.05 58.61 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.358 1.063 . . . . 2.77 108.421 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.46 -39.57 87.95 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.897 2.398 . . . . 1.21 112.739 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.23 -42.55 98.8 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.491 -0.755 . . . . 2.84 111.477 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -62.07 -39.99 94.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.027 0.531 . . . . 3.7 110.544 175.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.47 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -53.44 -51.04 45.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.359 -1.349 . . . . 1.09 107.359 171.102 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.37 -39.68 70.4 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 119.238 -0.411 . . . . 1.14 111.152 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -57.64 -47.82 81.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.101 0.864 . . . . 2.49 110.394 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -46.15 82.66 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.053 0.454 . . . . 2.76 110.44 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -67.9 -45.39 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.483 -0.761 . . . . 2.51 111.23 -175.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -33.38 72.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.852 -0.594 . . . . 2.35 110.877 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.96 -50.24 72.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.905 0.775 . . . . 2.18 110.225 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.81 -28.73 67.01 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 118.087 -1.445 . . . . 3.8 111.195 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.55 31.42 2.16 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.178 -0.769 . . . . 1.1 111.178 171.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -109.25 168.36 9.44 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.282 -0.636 . . . . 2.18 109.282 169.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -107.64 129.66 54.98 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.794 -0.817 . . . . 2.57 108.794 168.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.93 123.27 48.7 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.615 0.766 . . . . 0.79 109.074 166.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.81 162.48 31.9 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.891 1.277 . . . . 1.05 107.658 166.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 1.6 m -75.9 151.73 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 108.701 -0.851 . . . . 2.98 108.701 -171.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 108.844 -0.799 . . . . 4.37 108.844 171.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.826 0 N-CA-C 111.64 -0.584 . . . . 2.39 111.64 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.75 84.47 2.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.619 1.167 . . . . 3.01 109.082 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -102.52 157.71 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 108.803 -0.814 . . . . 2.98 108.803 -175.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.49 157.1 44.39 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.555 -0.716 . . . . 3.63 111.287 175.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 mt -144.14 155.99 44.15 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.049 0.94 . . . . 2.33 109.845 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.623 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -98.11 122.74 41.62 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 106.659 -1.608 . . . . 1.69 106.659 177.064 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.3 pt -97.93 111.65 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-O 122.015 0.912 . . . . 2.04 109.321 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 m -103.72 145.06 30.63 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.496 1.118 . . . . 1.88 108.702 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.29 -33.84 5.87 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.292 0.948 . . . . 1.16 111.436 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.7 151.93 36.96 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.398 0.599 . . . . 2.76 110.948 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 t -163.39 33.83 0.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.597 0.359 . . . . 2.93 111.103 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.0 p -162.15 145.1 11.61 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.381 -0.824 . . . . 3.37 111.658 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.0 -34.92 70.52 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.573 1.149 . . . . 2.76 111.334 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 t -54.2 -50.06 67.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.642 0.377 . . . . 2.28 110.046 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 55.6 m -68.14 -45.96 72.13 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.961 -0.462 . . . . 1.78 110.125 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.407 ' CG1' HG23 ' A' ' 113' ' ' VAL . 89.4 t -48.75 -57.18 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.937 1.695 . . . . 1.35 109.921 172.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -59.0 -43.96 91.58 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.686 -0.634 . . . . 3.46 111.017 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -60.78 -42.88 98.41 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.347 0.659 . . . . 1.7 110.876 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.0 mt -57.28 -50.41 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 108.321 -0.992 . . . . 0.84 108.321 174.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -53.51 -43.67 68.48 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.029 -0.51 . . . . 2.67 110.425 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.4 t -57.96 -50.4 73.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.544 0.738 . . . . 1.4 111.305 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -37.35 78.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.25 -0.906 . . . . 2.5 110.933 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.4 mt -70.59 -51.34 28.91 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.837 -0.801 . . . . 1.82 108.837 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.6 p -60.05 -17.07 36.53 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.936 0.717 . . . . 1.9 112.936 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -59.82 -33.91 72.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 119.298 -0.961 . . . . 4.56 112.338 168.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.8 m -73.34 142.51 47.07 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.706 0.803 . . . . 1.77 111.162 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -66.0 -42.38 89.83 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.361 0.874 . . . . 3.08 113.361 -173.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.29 -39.29 27.03 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.127 -1.189 . . . . 1.07 110.127 -170.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.33 126.36 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.975 -0.75 . . . . 3.6 108.975 168.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.1 t -124.41 -26.3 3.93 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.676 0.791 . . . . 3.32 111.585 165.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.62 93.97 3.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.694 -1.965 . . . . 2.32 105.694 -172.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.98 151.45 21.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.219 -1.401 . . . . 1.31 107.219 158.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.7 t -142.23 110.83 6.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.213 -1.773 . . . . 1.65 106.213 167.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.407 HG23 ' CG1' ' A' ' 95' ' ' VAL . 6.4 m -104.89 147.64 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 118.048 0.385 . . . . 2.59 110.774 176.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.73 102.31 4.7 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.305 0.574 . . . . 1.65 110.395 -174.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 pp -61.94 -19.12 62.4 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.345 0.868 . . . . 2.55 113.345 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.14 -40.75 64.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.908 -0.775 . . . . 1.99 108.908 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.1 p -90.14 -25.35 20.74 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.004 0.921 . . . . 3.37 110.344 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 p 77.9 9.68 2.27 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 128.257 2.623 . . . . 2.33 112.894 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -99.71 151.18 21.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.163 0.982 . . . . 3.4 111.767 174.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -117.25 117.48 29.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.855 2.462 . . . . 0.96 107.0 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.5 mp -99.83 131.23 45.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.547 -1.279 . . . . 2.84 107.547 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 83.0 t -140.78 128.94 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.378 1.071 . . . . 2.04 109.682 -170.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -116.45 93.03 4.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.951 -0.759 . . . . 3.6 108.951 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -113.98 169.48 8.97 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.654 1.182 . . . . 1.99 109.777 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.561 ' HB3' HD11 ' A' ' 128' ' ' ILE . 35.6 t0 -105.28 115.6 61.83 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.289 1.036 . . . . 3.68 109.708 -179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.86 65.17 7.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.856 3.037 . . . . 1.89 112.83 -170.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -143.29 -51.14 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.671 1.588 . . . . 3.44 108.219 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 128' ' ' ILE . 0.0 OUTLIER -77.89 -34.48 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 122.96 0.504 . . . . 2.46 111.096 -177.644 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.5 tp -145.79 168.49 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.078 -0.712 . . . . 1.91 109.078 -174.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.96 169.86 31.33 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.181 -1.168 . . . . 1.41 110.181 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -61.22 -35.31 85.88 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.278 2.652 . . . . 1.54 110.801 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -51.93 -39.68 59.56 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 112.458 0.54 . . . . 6.99 112.458 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.05 -44.45 84.54 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.209 -0.663 . . . . 3.17 109.209 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.97 -55.95 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.24 -0.652 . . . . 1.47 109.24 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 pt -54.61 -57.1 7.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-O 118.003 -0.998 . . . . 3.1 109.334 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -47.77 -50.59 25.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.125 1.33 . . . . 4.12 112.839 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.4 mm -52.91 -54.7 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.423 -0.584 . . . . 1.94 109.423 175.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.287 2.6 pp -71.49 -25.0 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 119.077 -1.049 . . . . 1.47 113.538 -176.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -63.86 -32.06 73.45 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.327 1.051 . . . . 3.03 110.32 169.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -62.17 -39.24 92.02 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.214 -0.661 . . . . 2.98 109.214 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.2 mt -66.78 -42.01 88.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.409 -0.589 . . . . 1.4 109.409 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.91 22.61 5.6 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.874 1.702 . . . . 1.48 111.511 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -99.06 -178.71 4.02 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.52 -1.289 . . . . 2.24 107.52 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -140.6 135.65 31.98 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.157 -1.053 . . . . 3.18 108.157 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -122.87 96.67 5.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.236 1.014 . . . . 1.54 109.765 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.1 p -123.43 127.21 48.1 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.425 0.69 . . . . 2.42 110.918 -173.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.417 HD12 ' OE1' ' A' ' 149' ' ' GLN . 0.4 OUTLIER -14.92 113.13 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.109 2.564 . . . . 4.2 115.086 175.729 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.623 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -107.29 48.61 0.83 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.698 0.999 . . . . 5.03 113.698 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.417 ' OE1' HD12 ' A' ' 147' ' ' LEU . 7.0 pm0 . . . . . 0 C--O 1.254 1.319 0 CA-C-O 117.798 -1.096 . . . . 6.72 112.366 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 109.393 -0.595 . . . . 3.82 109.393 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -110.3 154.75 23.03 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.409 0.684 . . . . 3.84 110.58 165.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.9 t -125.78 130.18 50.93 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.142 0.977 . . . . 2.33 109.424 170.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.52 106.37 16.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 128.388 2.675 . . . . 3.27 110.027 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 -179.19 5.4 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.458 -0.776 . . . . 3.33 110.617 173.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.16 161.58 28.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.49 -1.3 . . . . 2.36 107.49 173.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mm -97.16 134.84 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.878 -1.897 . . . . 1.05 105.878 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -117.58 67.83 0.75 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.537 -1.283 . . . . 3.1 107.537 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.4 -69.4 0.06 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.152 -0.779 . . . . 1.38 111.152 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.08 93.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.521 2.328 . . . . 2.51 116.883 176.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.44 -22.7 21.6 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.387 1.075 . . . . 2.39 113.589 170.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 89.5 m 75.57 -62.9 0.43 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.938 1.695 . . . . 5.74 110.078 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.98 -75.29 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.495 2.318 . . . . 4.32 112.925 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.3 p -160.02 14.28 0.13 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.432 0.901 . . . . 2.22 113.432 169.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.92 -45.05 64.93 Favored 'General case' 0 N--CA 1.462 0.126 0 O-C-N 121.239 -0.913 . . . . 1.9 110.071 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -53.67 -47.13 61.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.418 -0.956 . . . . 1.62 108.418 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.02 -41.53 64.79 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.353 0.661 . . . . 1.95 112.073 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -67.41 -49.27 64.53 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.969 -0.382 . . . . 2.72 109.969 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.491 HG12 HD13 ' A' ' 65' ' ' LEU . 69.3 mt -48.96 -45.32 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.963 0.905 . . . . 1.43 110.586 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -44.62 -57.38 3.68 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.042 0.837 . . . . 4.7 111.194 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -61.6 -39.17 90.27 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.154 0.982 . . . . 4.92 110.208 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -62.65 -57.38 11.24 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.963 -0.755 . . . . 1.35 108.963 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.12 -31.42 72.61 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.036 -0.415 . . . . 3.35 111.009 -175.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.58 -35.01 3.68 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.445 0.566 . . . . 1.79 112.257 168.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -110.2 24.19 13.33 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.377 0.671 . . . . 3.89 112.135 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.34 -72.24 0.17 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.034 0.534 . . . . 3.55 109.596 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.38 -120.88 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.418 0.687 . . . . 1.21 109.998 -172.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.17 -11.23 63.67 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.782 0.719 . . . . 1.59 113.183 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -75.46 122.56 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.691 -0.888 . . . . 1.5 109.464 173.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.21 49.35 1.93 Allowed 'General case' 0 C--N 1.34 0.164 0 CA-C-O 120.786 0.327 . . . . 2.68 110.577 173.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.6 m -150.53 156.11 40.78 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.291 -1.003 . . . . 3.1 108.291 165.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.0 p -140.29 117.01 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 107.37 -1.345 . . . . 2.84 107.37 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -140.44 79.59 1.71 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 108.172 -1.047 . . . . 2.55 108.172 172.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.1 t -99.4 136.58 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.135 -0.939 . . . . 2.27 108.551 169.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.88 96.58 6.25 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.608 -1.256 . . . . 1.52 107.608 167.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.66 -21.04 24.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.906 0.882 . . . . 2.62 111.669 175.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -59.0 5.12 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.793 1.237 . . . . 3.02 109.547 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.22 20.3 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.99 0.916 . . . . 1.68 111.102 -172.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.71 63.96 1.86 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.154 -1.178 . . . . 1.34 110.154 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.77 137.36 41.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.253 -2.128 . . . . 2.56 105.253 169.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.85 104.51 11.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.784 1.302 . . . . 1.26 109.61 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -111.74 144.65 40.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.244 0.545 . . . . 4.03 109.719 167.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.08 178.78 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 124.444 1.097 . . . . 1.83 109.147 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.74 94.92 4.33 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.033 0.933 . . . . 8.85 110.213 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.412 ' HB2' HD12 ' A' ' 53' ' ' ILE . 1.9 p90 -99.99 169.51 9.14 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.414 2.285 . . . . 2.88 113.476 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.93 97.43 41.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.849 1.66 . . . . 2.89 108.858 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -53.22 -21.31 16.72 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.663 3.576 . . . . 3.02 114.817 -171.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -77.98 -25.52 48.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.5 1.52 . . . . 4.51 111.285 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 p -121.34 -31.19 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 123.988 0.915 . . . . 3.42 112.522 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -128.11 135.32 63.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 123.601 0.76 . . . . 1.8 109.189 179.548 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -120.46 154.83 56.81 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.505 1.122 . . . . 3.16 111.84 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.23 -30.19 92.35 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.152 1.901 . . . . 1.8 111.607 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -42.25 94.15 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.797 0.726 . . . . 3.94 111.705 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -71.17 -41.08 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.686 0.794 . . . . 3.63 110.745 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.8 -42.34 42.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 108.255 -1.017 . . . . 1.54 108.255 170.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.23 86.59 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.519 -0.764 . . . . 1.51 111.172 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -59.93 -52.96 63.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.278 -0.889 . . . . 3.11 109.655 171.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -54.86 19.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.94 0.4 . . . . 2.66 110.846 -177.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.3 pp -62.05 -44.26 98.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.503 0.557 . . . . 4.13 112.503 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.64 -39.35 84.06 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.587 1.085 . . . . 2.19 110.226 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.37 -47.75 72.38 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.648 0.779 . . . . 2.58 109.636 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.491 HD13 HG12 ' A' ' 22' ' ' ILE . 11.7 mt -53.81 -33.07 54.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.184 0.594 . . . . 1.78 111.452 170.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.58 33.09 2.97 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.262 -1.135 . . . . 1.18 110.262 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -124.67 149.56 47.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.763 -1.569 . . . . 1.96 106.763 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.81 129.66 44.2 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.017 -1.475 . . . . 3.22 107.017 170.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.552 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -118.77 120.19 36.63 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.63 -1.619 . . . . 0.88 106.63 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.89 128.28 34.28 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.424 -1.262 . . . . 0.95 107.923 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.4 t -49.29 151.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.012 1.325 . . . . 3.01 108.832 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 110.283 -0.266 . . . . 3.46 110.283 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.688 0 N-CA-C 106.757 -2.537 . . . . 1.94 106.757 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -104.23 126.13 51.08 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.719 1.208 . . . . 4.01 109.366 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.71 149.72 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 C-N-CA 124.297 1.039 . . . . 2.49 108.253 175.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -125.37 146.51 49.56 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.35 1.06 . . . . 3.67 110.536 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.46 149.63 39.48 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.269 1.027 . . . . 2.4 108.744 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.32 132.2 42.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.404 -1.702 . . . . 2.03 106.404 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 pp -106.59 113.39 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 O-C-N 123.909 0.756 . . . . 1.75 110.727 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.5 m -104.43 139.33 39.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.177 0.991 . . . . 1.87 108.794 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.1 -27.8 11.3 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.995 1.283 . . . . 1.21 111.984 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 5.3 tmm? -63.8 131.65 48.48 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.845 0.858 . . . . 2.8 109.901 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 m -144.77 34.9 1.14 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.588 1.155 . . . . 2.55 109.331 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 43.3 t -165.82 129.61 2.2 Favored 'General case' 0 C--N 1.341 0.239 0 O-C-N 120.854 -1.154 . . . . 2.79 111.908 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.43 -35.89 63.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.542 0.737 . . . . 2.73 111.785 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 t -53.73 -46.94 70.99 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.134 0.492 . . . . 2.24 110.257 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 35.1 m -62.58 -46.24 89.23 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.112 -0.699 . . . . 2.09 109.112 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.5 t -52.79 -53.03 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.098 0.408 . . . . 1.34 110.783 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -56.85 -44.88 82.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.158 0.504 . . . . 3.12 110.746 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -60.74 -47.68 85.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.891 0.476 . . . . 1.97 110.639 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.3 mt -55.83 -52.64 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.746 -0.835 . . . . 1.04 108.746 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -56.24 -42.06 76.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.837 0.855 . . . . 3.18 110.134 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.2 t -57.94 -55.51 33.96 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.923 0.329 . . . . 1.74 110.815 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -50.82 64.7 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.666 -0.646 . . . . 2.58 110.999 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.8 mt -55.82 -58.0 9.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 119.22 -0.419 . . . . 1.96 110.051 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.8 m -53.67 -25.17 16.92 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.61 1.164 . . . . 2.22 111.549 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -62.39 -28.29 69.67 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.881 -0.512 . . . . 6.55 111.348 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.3 m -68.08 118.31 11.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.448 1.499 . . . . 2.26 111.225 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -33.05 -55.82 0.39 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.637 1.975 . . . . 2.92 114.033 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.55 -29.14 60.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 119.513 -0.604 . . . . 1.72 113.354 -171.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.1 127.94 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.522 -1.288 . . . . 3.19 107.522 -174.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 36.9 p -99.16 -51.4 3.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 118.303 0.501 . . . . 3.51 110.437 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -131.95 128.66 38.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.322 -0.992 . . . . 2.4 108.322 169.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.99 128.26 53.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.879 -1.156 . . . . 1.19 107.879 165.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.2 m -115.45 112.32 22.1 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 117.707 -1.14 . . . . 2.65 109.498 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 t -114.47 131.55 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 120.325 1.421 . . . . 2.32 112.651 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -125.67 106.44 9.73 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.489 1.115 . . . . 1.11 111.226 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -22.92 59.5 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 125.172 1.389 . . . . 2.32 113.266 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.73 80.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.149 0.5 . . . . 1.46 110.073 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.22 -34.82 10.19 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.243 1.417 . . . . 2.07 110.402 177.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.4 m 79.78 38.55 0.11 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.407 1.883 . . . . 1.77 110.875 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.9 144.05 46.64 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 123.539 0.736 . . . . 3.01 109.436 173.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.18 120.65 29.28 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.249 2.62 . . . . 1.1 107.679 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.8 mp -115.07 104.43 11.87 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.623 1.569 . . . . 2.41 110.254 -170.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.3 m -103.82 135.86 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.6 1.16 . . . . 2.36 111.114 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.71 104.52 11.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.858 -1.164 . . . . 4.73 107.858 174.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -123.25 176.47 6.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.667 1.587 . . . . 2.48 112.258 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -98.7 113.55 64.49 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 108.49 -0.93 . . . . 3.18 108.49 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.31 71.52 6.72 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.772 2.981 . . . . 2.0 111.346 -167.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -168.59 -48.43 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.318 1.047 . . . . 4.48 109.337 -173.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.6 pt -83.75 -33.05 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.819 0.847 . . . . 1.9 110.917 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.92 160.59 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.318 1.047 . . . . 1.6 109.144 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.87 169.63 23.81 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.623 1.106 . . . . 1.58 110.45 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.97 -40.44 11.93 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.233 2.622 . . . . 1.88 111.092 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -51.32 -37.21 46.51 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.359 0.664 . . . . 6.45 112.396 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.77 -45.37 78.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.619 -0.882 . . . . 4.27 108.619 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 64.2 mt -60.73 -46.65 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 108.644 -0.872 . . . . 1.33 108.644 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 77.2 mt -51.2 -58.46 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 118.363 -0.827 . . . . 2.22 108.972 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -48.53 -50.25 32.75 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.568 1.076 . . . . 4.53 110.606 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.5 mm -55.6 -50.02 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 109.85 -0.426 . . . . 1.8 109.85 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.283 2.5 pp -70.11 -28.52 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 119.197 -1.001 . . . . 1.74 113.615 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -63.71 -42.26 97.98 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.566 1.076 . . . . 2.29 109.896 170.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -60.0 -39.24 85.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.79 0.836 . . . . 3.36 109.16 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.2 mt -71.01 -39.0 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 O-C-N 122.259 -0.275 . . . . 1.07 110.941 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.03 29.48 8.0 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.499 1.523 . . . . 0.93 112.096 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -99.65 177.11 5.25 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.689 1.245 . . . . 2.29 109.443 165.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -130.78 120.14 23.32 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.045 -1.465 . . . . 4.45 107.045 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.06 113.31 26.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.502 1.521 . . . . 1.82 108.654 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.8 m -123.13 114.23 20.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.101 0.41 . . . . 2.04 111.028 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.6 mt -28.29 114.58 0.08 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 128.222 2.609 . . . . 4.06 111.923 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.86 23.9 5.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.442 0.697 . . . . 3.5 112.68 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.456 -1.259 . . . . 5.73 110.78 168.687 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--O 1.223 -0.322 0 N-CA-C 109.786 -0.45 . . . . 4.94 109.786 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.12 148.9 23.08 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.424 1.09 . . . . 3.91 108.356 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.1 t -135.89 134.77 39.12 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.784 -1.191 . . . . 2.84 107.784 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -103.65 98.01 7.95 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 124.244 0.965 . . . . 3.92 109.02 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 2.6 pt? -121.67 169.73 10.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.957 0.884 . . . . 2.15 111.364 172.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.02 142.67 49.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.24 -1.022 . . . . 2.05 108.24 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.41 HG12 ' HB2' ' A' ' 44' ' ' ALA . 26.4 mm -98.18 146.92 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.674 -1.232 . . . . 0.85 107.674 -178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -128.2 96.74 4.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.565 -1.643 . . . . 3.67 106.565 171.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.14 -70.98 0.09 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.952 -1.259 . . . . 1.75 109.952 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 ptm 29.03 70.47 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.48 2.312 . . . . 2.48 116.053 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.69 -14.32 2.17 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.764 1.626 . . . . 2.54 114.16 175.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t 71.66 -63.49 0.42 Allowed 'General case' 0 C--N 1.339 0.128 0 C-N-CA 126.372 1.869 . . . . 2.94 111.373 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -16.17 -73.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 128.177 2.591 . . . . 6.57 113.224 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -157.5 24.11 0.29 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.856 0.862 . . . . 3.82 110.654 159.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.0 m -71.01 -52.98 16.44 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.296 -0.877 . . . . 1.92 109.178 -170.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.7 t -50.24 -46.83 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.019 -0.734 . . . . 1.94 109.019 173.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 t -54.91 -51.9 64.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.46 0.704 . . . . 3.23 110.875 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -68.65 -40.53 80.19 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 121.331 -0.856 . . . . 2.78 110.386 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mt -55.93 -50.71 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.781 1.232 . . . . 1.49 109.548 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -52.22 -44.44 64.79 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.63 0.65 . . . . 4.19 111.27 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -69.22 -40.46 77.94 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.748 -1.22 . . . . 5.84 111.588 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -61.7 -53.75 51.84 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 122.116 -0.365 . . . . 1.34 110.043 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.54 -39.01 70.03 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.677 0.791 . . . . 3.04 110.361 175.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.17 -23.97 9.66 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.212 0.915 . . . . 1.72 112.902 173.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -106.12 21.13 17.86 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.108 0.963 . . . . 3.68 112.491 176.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.417 ' HG3' ' CD2' ' A' ' 61' ' ' PHE . 33.0 tt0 -70.34 -72.64 0.19 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.802 -0.814 . . . . 3.56 108.802 177.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.42 -105.08 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.839 1.256 . . . . 1.95 107.859 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.83 25.33 24.05 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.241 -1.31 . . . . 2.4 113.352 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.65 ' C ' HD12 ' A' ' 33' ' ' LEU . 8.5 p -96.0 120.74 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 119.373 1.587 . . . . 2.08 109.308 168.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 32' ' ' VAL . 3.5 mp -139.54 53.72 1.7 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 108.96 -0.756 . . . . 2.94 108.96 -178.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 t -161.64 156.51 23.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.869 -1.9 . . . . 2.89 105.869 165.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.29 110.05 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 106.7 -1.593 . . . . 2.71 106.7 175.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -128.98 76.87 1.75 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.822 -1.177 . . . . 3.45 107.822 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 t -97.84 127.09 50.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 109.541 -0.54 . . . . 2.41 109.541 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.84 88.24 3.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.93 -1.137 . . . . 2.18 107.93 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.5 tp -53.33 -22.98 8.14 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.029 1.332 . . . . 3.69 110.805 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -35.04 68.77 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.388 0.675 . . . . 5.73 111.285 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.49 -39.44 4.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.955 0.902 . . . . 2.6 110.926 -172.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.99 63.41 0.81 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 125.916 1.722 . . . . 1.82 110.47 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -142.35 136.68 29.89 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.127 -1.805 . . . . 4.01 106.127 172.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -117.43 95.02 4.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.434 1.084 . . . . 1.5 109.272 172.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -101.51 137.43 39.84 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.805 -1.554 . . . . 5.74 106.805 171.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.484 ' H ' HD13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -133.77 -178.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 107.316 -1.365 . . . . 2.84 107.316 177.491 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.58 106.2 6.88 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.753 -1.203 . . . . 5.92 107.753 176.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -117.41 176.23 5.25 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 124.762 1.289 . . . . 3.52 114.459 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -113.37 107.3 53.67 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.895 1.278 . . . . 3.87 111.348 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.48 -11.37 31.33 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.991 2.461 . . . . 3.37 112.929 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.37 -21.33 64.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 120.203 1.365 . . . . 3.57 111.228 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -128.59 -46.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.44 0.696 . . . . 3.85 110.403 -169.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.748 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -92.37 147.61 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 121.913 0.863 . . . . 2.69 109.43 174.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -128.04 150.07 72.7 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 125.69 1.596 . . . . 3.66 108.776 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -58.42 -29.8 89.49 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.261 2.641 . . . . 2.15 111.596 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -49.55 77.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.245 1.418 . . . . 2.55 109.718 172.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -68.11 -38.55 82.39 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.933 -0.479 . . . . 3.03 109.726 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.748 HD12 HD11 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -58.36 -46.25 89.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 107.486 -1.302 . . . . 1.71 107.486 172.929 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.48 -44.52 95.84 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 122.973 0.509 . . . . 1.35 110.397 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -60.1 -51.25 70.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.661 -0.649 . . . . 2.34 110.94 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.417 ' CD2' ' HG3' ' A' ' 29' ' ' GLU . 0.6 OUTLIER -55.11 -48.43 73.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.612 0.642 . . . . 3.69 112.176 -179.623 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.567 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.5 pp -67.07 -39.63 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 121.261 -0.9 . . . . 4.33 111.658 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.5 -34.9 79.35 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.518 0.599 . . . . 3.42 110.511 177.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.18 -52.02 65.48 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.459 -0.571 . . . . 2.83 109.459 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.6 mt -58.45 -29.95 66.55 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.828 0.307 . . . . 2.19 111.828 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.36 31.54 3.73 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 124.512 1.053 . . . . 1.43 111.336 167.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.59 161.48 19.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.63 1.572 . . . . 2.01 108.405 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -98.45 134.58 41.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.77 -1.567 . . . . 2.2 106.77 163.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.567 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -125.49 127.23 46.14 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.919 -1.882 . . . . 1.08 105.919 169.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.48 123.98 23.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.201 -1.037 . . . . 1.13 108.201 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.433 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.5 t -71.1 145.26 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.057 -1.09 . . . . 2.98 108.057 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.4 mtt . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 109.04 -0.726 . . . . 4.62 109.04 173.336 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.341 0 N-CA-C 109.597 -1.401 . . . . 2.6 109.597 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.33 104.63 17.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.594 -1.632 . . . . 2.84 106.594 -176.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.504 HD11 ' CE1' ' A' ' 124' ' ' PHE . 0.0 OUTLIER -130.94 157.72 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 106.94 -1.504 . . . . 3.28 106.94 172.346 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -123.06 160.7 25.81 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.947 -1.024 . . . . 3.91 110.176 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 pp -143.78 159.92 41.66 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.638 -1.164 . . . . 3.12 110.229 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.8 m -109.36 131.67 54.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.374 1.87 . . . . 2.27 107.943 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.53 98.08 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.733 1.613 . . . . 1.76 110.706 -170.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.3 m -95.53 112.52 24.23 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.877 -0.786 . . . . 1.92 108.877 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 135.3 -22.98 3.5 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.486 1.041 . . . . 1.31 111.921 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.1 ttp -70.74 133.59 46.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.021 -0.693 . . . . 2.72 111.719 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.2 m -151.53 39.44 0.65 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.844 0.858 . . . . 3.22 110.239 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.5 t -167.96 138.94 2.82 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.963 -1.086 . . . . 2.5 110.71 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.7 67.2 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.474 0.654 . . . . 2.67 111.856 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.9 m -53.47 -43.93 68.54 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.256 -0.902 . . . . 2.2 110.275 170.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.0 m -64.4 -42.24 96.21 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.888 0.475 . . . . 1.74 109.849 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.763 HG13 HG13 ' A' ' 113' ' ' VAL . 46.7 t -52.23 -55.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.721 0.808 . . . . 1.23 108.826 173.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.7 m170 -61.66 -36.6 81.29 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 109.737 -0.468 . . . . 3.77 109.737 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -59.01 -60.71 3.44 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.959 -0.756 . . . . 2.01 108.959 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.6 mt -49.59 -49.2 19.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 C-N-CA 124.472 1.109 . . . . 1.06 110.051 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -54.38 -52.93 60.13 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.222 1.009 . . . . 2.47 109.786 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.0 m -66.85 -25.16 66.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.431 0.692 . . . . 2.16 112.186 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -46.87 49.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 120.865 -1.147 . . . . 3.3 111.816 170.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.58 -45.8 64.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.272 0.942 . . . . 3.53 108.888 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.0 p -60.43 -12.45 9.52 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.702 0.63 . . . . 2.28 112.702 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -53.57 -34.29 57.8 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.634 -0.666 . . . . 4.01 111.349 167.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.4 p -78.44 164.88 24.39 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 118.936 0.789 . . . . 2.41 110.907 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -82.89 -44.87 14.9 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.887 0.875 . . . . 2.39 111.188 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.742 ' HA3' HD11 ' A' ' 128' ' ' ILE . . . -71.01 -36.58 64.47 Favored Glycine 0 C--N 1.335 0.523 0 O-C-N 122.236 -0.29 . . . . 1.61 112.606 -170.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -66.21 130.19 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.127 -0.694 . . . . 2.2 109.127 -174.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.0 t -109.81 -53.46 2.67 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.422 0.289 . . . . 3.36 111.466 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CD2' ' HG3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -131.41 124.88 31.21 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.694 -1.224 . . . . 3.13 107.694 175.069 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.39 161.82 15.27 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.525 -0.546 . . . . 0.91 109.525 153.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.4 m -139.27 110.24 6.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.696 -1.594 . . . . 1.72 106.696 168.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.763 HG13 HG13 ' A' ' 95' ' ' VAL . 3.3 p -108.68 132.74 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.446 1.099 . . . . 1.81 110.115 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.42 119.16 12.45 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.96 0.886 . . . . 1.32 111.545 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.641 ' H ' HD23 ' A' ' 115' ' ' LEU . 2.4 pt? -71.36 -31.05 66.87 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.322 1.449 . . . . 2.49 112.778 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.99 81.74 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.522 0.677 . . . . 1.61 109.947 -176.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.67 -36.65 65.37 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.352 -0.84 . . . . 1.9 109.363 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.3 t 85.23 14.78 0.17 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 126.473 1.909 . . . . 2.52 111.462 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.86 164.74 16.2 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.471 0.708 . . . . 4.64 111.029 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.74 143.57 47.22 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.04 1.336 . . . . 1.26 108.567 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -99.46 146.02 26.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.535 1.147 . . . . 1.96 108.122 165.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.4 t -134.93 136.67 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 126.349 1.859 . . . . 2.26 107.869 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HG3' ' CD2' ' A' ' 110' ' ' TYR . 19.7 mmmt -113.22 109.52 18.9 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.276 1.43 . . . . 3.88 108.81 166.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.504 ' CE1' HD11 ' A' ' 82' ' ' ILE . 0.9 OUTLIER -127.51 -176.1 3.65 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.654 1.115 . . . . 2.36 111.098 173.769 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -103.0 112.32 65.7 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 108.307 -0.998 . . . . 3.13 108.307 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.99 67.65 8.0 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.874 2.383 . . . . 2.44 111.962 -166.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -165.25 -43.93 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.227 1.411 . . . . 3.84 109.59 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.742 HD11 ' HA3' ' A' ' 107' ' ' GLY . 2.6 pp -79.68 -40.48 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 122.852 0.461 . . . . 2.45 110.303 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.672 ' HB ' HD12 ' A' ' 128' ' ' ILE . 1.7 tp -135.42 178.23 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.237 1.015 . . . . 2.38 109.398 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.84 -178.81 34.17 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.031 -2.027 . . . . 1.87 108.031 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.11 -40.19 34.96 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.12 1.88 . . . . 1.72 110.285 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 -50.94 -40.07 56.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.485 1.114 . . . . 5.52 113.511 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.75 -52.66 64.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.56 -0.533 . . . . 4.21 109.56 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.72 -44.79 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.336 -0.987 . . . . 1.69 108.336 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.2 mt -51.9 -61.32 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 123.711 0.804 . . . . 1.94 109.105 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.68 -46.31 67.2 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.269 0.94 . . . . 4.52 110.835 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.5 mm -57.13 -51.68 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 121.974 -0.454 . . . . 2.12 109.856 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.13 -27.2 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 120.701 -1.249 . . . . 1.35 112.925 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -59.68 -35.39 74.35 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.659 -0.65 . . . . 3.01 110.349 170.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.52 -35.56 79.79 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.472 -0.566 . . . . 3.36 109.472 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.4 mt -69.85 -45.63 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.681 -0.488 . . . . 1.2 109.681 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.19 31.33 2.26 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.612 1.577 . . . . 0.94 111.66 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -99.06 -179.52 4.28 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.92 0.86 . . . . 2.23 109.69 171.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -139.33 105.19 5.16 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 107.774 -1.195 . . . . 4.13 107.774 -175.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.88 98.96 9.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.913 1.285 . . . . 1.6 109.267 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 51.8 m -101.44 115.91 31.58 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.618 -1.253 . . . . 2.05 107.618 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.38 101.28 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.772 1.229 . . . . 4.68 109.469 170.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.65 -38.77 77.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.922 -0.581 . . . . 3.96 110.168 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 126.168 1.787 . . . . 7.83 112.804 -175.542 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.419 -0.586 . . . . 3.03 109.419 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.64 161.59 18.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.708 -1.219 . . . . 4.78 107.708 169.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.31 132.72 26.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.492 -0.929 . . . . 2.55 108.492 162.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -109.08 93.72 4.66 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.137 1.375 . . . . 3.76 109.125 -171.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.441 HD22 ' H ' ' A' ' 8' ' ' LEU 0.279 0.0 OUTLIER -116.65 173.75 6.45 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.472 1.13 . . . . 3.01 111.22 177.705 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.38 156.89 42.41 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.804 -1.924 . . . . 1.6 105.804 174.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mm -97.87 134.26 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 106.454 -1.684 . . . . 1.14 106.454 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -106.5 117.53 34.29 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 105.768 -1.938 . . . . 4.3 105.768 158.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.5 -101.49 0.24 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.3 -1.12 . . . . 1.66 110.3 -175.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.3 mtt 60.14 89.04 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.886 1.674 . . . . 1.85 114.529 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -30.88 71.13 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.467 -0.771 . . . . 2.24 111.231 166.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.0 t 78.05 -58.35 0.46 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.141 1.376 . . . . 3.76 111.187 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -19.03 -68.46 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.91 2.484 . . . . 5.25 113.139 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.9 m -156.17 24.87 0.36 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.12 0.968 . . . . 2.66 110.509 162.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.1 m -70.99 -51.53 25.03 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.283 -0.886 . . . . 1.56 109.939 -169.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.4 t -47.68 -50.53 8.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 N-CA-C 109.1 -0.704 . . . . 2.13 109.1 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -49.99 -48.85 52.11 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.134 0.574 . . . . 2.3 112.54 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -39.13 74.85 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.464 -0.772 . . . . 3.01 111.212 178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.3 mt -59.89 -48.84 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.812 1.245 . . . . 1.54 109.063 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.24 -49.73 41.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.458 0.572 . . . . 3.77 110.896 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -63.77 -34.57 78.18 Favored 'General case' 0 N--CA 1.458 -0.029 0 O-C-N 121.596 -0.69 . . . . 5.44 111.056 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.97 -51.8 65.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.641 -0.503 . . . . 1.32 109.641 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.29 -37.54 75.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.975 0.352 . . . . 2.36 111.449 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.68 -23.96 3.02 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.701 -1.25 . . . . 2.87 112.078 173.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -126.08 34.86 4.78 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.231 -0.89 . . . . 3.97 112.941 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' CG ' HG13 ' A' ' 32' ' ' VAL . 6.3 pt-20 -69.46 -70.54 0.27 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.992 1.269 . . . . 4.65 111.96 169.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.29 -132.38 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.524 -0.917 . . . . 1.36 108.524 -164.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.83 15.85 29.65 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-O 118.139 -1.367 . . . . 1.64 113.112 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.465 HG13 ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -101.26 128.76 53.24 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 119.961 1.88 . . . . 1.69 107.241 163.265 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 53.46 1.98 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.904 -1.147 . . . . 3.05 107.904 172.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.1 t -156.25 143.85 19.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.307 -1.738 . . . . 1.87 106.307 174.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.6 132.19 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.452 -1.684 . . . . 2.21 106.452 174.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tt -139.05 83.68 1.97 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.785 -0.82 . . . . 2.2 108.785 172.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.32 139.57 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 107.909 -1.145 . . . . 2.08 107.909 171.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.14 99.67 7.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 106.938 -1.504 . . . . 1.43 106.938 165.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.02 -27.15 66.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.897 0.879 . . . . 2.62 110.679 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 36.6 mtt -63.28 -60.52 3.29 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.517 0.727 . . . . 3.25 110.353 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.24 -29.07 47.98 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.795 -0.639 . . . . 1.7 110.91 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.05 61.18 1.77 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.227 -1.149 . . . . 1.26 110.227 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -134.82 144.08 47.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.539 -1.652 . . . . 3.51 106.539 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.427 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -121.57 104.22 9.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.444 1.097 . . . . 1.11 108.265 165.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.61 137.93 50.89 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.77 0.714 . . . . 4.43 109.478 169.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.48 172.2 16.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 O-C-N 121.919 -0.488 . . . . 2.36 110.594 178.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.03 105.33 10.53 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.286 1.034 . . . . 4.44 111.012 173.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -106.15 171.48 7.32 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.077 1.751 . . . . 2.83 112.916 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.96 112.0 38.63 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.822 1.649 . . . . 3.61 107.764 174.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.4 36.38 0.62 Allowed 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.892 3.061 . . . . 2.46 114.286 -155.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -129.27 -15.64 4.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.03 0.932 . . . . 3.93 112.398 170.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.1 t -106.06 -35.21 3.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 C-N-CA 124.379 1.072 . . . . 2.88 109.43 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.574 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -132.83 150.69 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 105.351 -2.092 . . . . 1.83 105.351 179.176 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -135.7 155.25 78.27 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.881 1.272 . . . . 3.29 111.416 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.57 -34.07 88.74 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.024 2.483 . . . . 1.55 112.662 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.38 -56.54 19.91 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.211 0.529 . . . . 2.51 110.805 176.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.99 -31.7 69.52 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.77 -0.581 . . . . 4.75 110.964 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.574 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -54.66 -50.68 57.86 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 N-CA-C 107.269 -1.382 . . . . 1.29 107.269 168.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.4 76.15 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.462 -0.335 . . . . 1.25 110.19 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.32 -48.41 79.02 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 119.04 -0.505 . . . . 2.62 111.011 175.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.61 -52.23 62.87 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 109.246 -0.65 . . . . 2.51 109.246 176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.6 mm -62.84 -44.6 99.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 122.27 -0.269 . . . . 2.99 111.059 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.71 -47.7 79.38 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.204 1.001 . . . . 2.02 111.173 173.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.23 -48.83 80.07 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.241 0.473 . . . . 2.35 109.876 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.9 mt -58.27 -32.2 68.17 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.906 -0.588 . . . . 2.04 111.3 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.8 25.08 3.45 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 123.976 0.798 . . . . 1.21 111.604 164.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -119.03 158.21 26.27 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.767 -1.568 . . . . 3.04 106.767 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -97.03 128.15 43.7 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.059 -1.089 . . . . 2.42 108.059 167.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.38 115.18 27.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.344 -1.354 . . . . 1.31 107.344 169.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.43 142.92 39.5 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.559 -1.275 . . . . 1.15 107.559 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 t -59.49 153.4 4.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.19 0.596 . . . . 2.69 110.003 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 mtm . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 112.77 0.656 . . . . 4.99 112.77 171.105 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.45 0 N-CA-C 108.101 -2.0 . . . . 2.3 108.101 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -98.69 59.03 1.23 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.605 1.202 . . . . 3.71 109.668 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.3 mm -92.0 139.74 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.185 -1.413 . . . . 2.74 107.185 -167.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -106.84 149.38 27.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.218 -1.03 . . . . 2.96 108.218 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.8 mt -144.24 152.44 40.83 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 122.899 0.479 . . . . 2.45 110.054 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.01 135.86 38.41 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.878 -1.527 . . . . 2.63 106.878 173.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.448 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -97.37 109.0 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 108.289 -1.004 . . . . 2.09 108.289 -179.195 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.4 m -96.44 134.16 39.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.283 -1.377 . . . . 1.88 107.283 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.25 -15.71 54.05 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.521 1.058 . . . . 1.79 113.002 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -76.56 124.05 27.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.192 1.496 . . . . 3.39 110.807 -174.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -129.58 9.83 5.56 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.75 0.82 . . . . 4.83 113.1 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 50.2 t -155.23 134.31 12.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.675 1.125 . . . . 3.85 111.546 -173.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.8 -38.95 61.89 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.537 0.735 . . . . 2.81 112.83 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -49.64 -39.25 35.4 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.295 -0.878 . . . . 2.47 111.842 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 74.1 m -61.91 -34.14 75.52 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.986 -0.446 . . . . 2.29 110.597 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.6 t -58.58 -50.78 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.18 -0.674 . . . . 2.17 109.18 174.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -60.63 -41.34 94.71 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.78 -0.822 . . . . 2.77 108.78 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -59.07 -52.34 66.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.0 0.92 . . . . 2.26 110.11 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.1 mt -56.26 -53.15 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.013 0.925 . . . . 0.98 109.867 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.14 -37.77 86.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.685 -0.487 . . . . 2.22 109.685 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -59.57 -53.57 56.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.039 -0.356 . . . . 1.46 110.039 171.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.32 -47.42 66.02 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.285 0.634 . . . . 3.65 111.372 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.3 -59.47 4.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.125 -0.694 . . . . 1.68 109.125 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.6 m -55.3 -19.75 9.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.863 1.265 . . . . 1.78 112.144 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -31.88 63.14 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.324 0.65 . . . . 5.48 111.131 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.1 m -70.47 151.08 45.52 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.991 2.117 . . . . 1.98 111.908 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -72.54 -49.08 35.16 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.814 0.446 . . . . 3.94 111.964 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.98 -34.77 71.18 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 122.193 -0.317 . . . . 1.72 112.56 -172.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.31 124.12 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 O-C-N 121.881 -0.776 . . . . 2.33 110.395 -170.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 59.7 m -99.65 -49.65 4.32 Favored 'General case' 0 CA--C 1.522 -0.114 0 O-C-N 122.978 0.174 . . . . 2.63 111.082 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -140.82 124.23 16.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.437 -0.579 . . . . 2.26 109.437 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -98.52 153.79 18.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.222 -1.029 . . . . 1.09 108.222 161.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.6 t -142.73 109.77 5.57 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.43 -1.322 . . . . 2.78 107.43 169.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.5 p -114.15 121.82 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.669 0.788 . . . . 2.24 111.188 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -122.72 105.13 9.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.05 0.94 . . . . 2.46 110.072 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.28 -22.94 65.31 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.08 0.771 . . . . 3.15 113.08 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.02 -54.51 7.05 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.886 -0.783 . . . . 3.12 108.886 -172.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.4 p -69.73 -25.28 63.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.08 0.952 . . . . 4.36 109.998 172.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.423 ' O ' HD12 ' A' ' 86' ' ' ILE . 17.2 m 74.02 19.03 3.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.426 1.891 . . . . 2.39 111.732 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -113.81 149.17 35.35 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.559 0.744 . . . . 3.46 110.531 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.01 115.87 16.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.723 2.009 . . . . 1.5 108.516 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 mt -100.62 130.54 46.69 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.465 -1.309 . . . . 2.68 107.465 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.3 t -131.04 121.19 48.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.65 -0.87 . . . . 2.33 108.65 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -100.62 93.77 5.76 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.754 1.221 . . . . 3.16 109.624 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -111.18 -179.51 3.75 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.444 0.698 . . . . 2.46 110.338 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -108.4 109.97 61.64 Favored Pre-proline 0 C--O 1.236 0.39 0 N-CA-C 107.502 -1.295 . . . . 3.94 107.502 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.27 63.42 8.72 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.29 2.66 . . . . 2.16 112.119 -167.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -147.17 -51.5 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.033 1.733 . . . . 4.05 108.343 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.15 -35.33 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 110.401 -0.222 . . . . 2.55 110.401 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.11 159.52 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 108.17 -1.048 . . . . 1.78 108.17 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.33 164.31 25.93 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.59 -1.404 . . . . 1.77 109.59 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -63.07 -44.18 16.53 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.047 2.498 . . . . 1.94 111.03 -172.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -51.06 -40.86 59.3 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 113.614 0.968 . . . . 6.75 113.614 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -63.08 -47.4 83.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.94 -0.763 . . . . 2.75 108.94 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.413 ' O ' HD13 ' A' ' 138' ' ' ILE . 97.5 mt -56.86 -50.18 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.878 -0.786 . . . . 1.18 108.878 177.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.7 mt -48.85 -60.67 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-O 118.399 -0.81 . . . . 2.18 109.004 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.62 -48.17 39.63 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.221 0.919 . . . . 3.26 110.716 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 9.9 mm -54.18 -48.76 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 118.31 -0.852 . . . . 1.8 110.849 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 134' ' ' ILE 0.332 0.0 OUTLIER -72.97 -31.74 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 120.436 1.471 . . . . 2.8 114.154 174.152 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.05 -36.56 70.66 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.113 1.324 . . . . 2.4 110.246 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -70.43 -24.36 62.89 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.1 0.96 . . . . 4.36 110.778 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 30.1 mt -75.36 -43.77 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.481 0.582 . . . . 1.37 109.455 166.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.93 31.94 2.36 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.793 1.663 . . . . 1.14 111.284 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -114.13 160.73 18.62 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.726 -1.212 . . . . 2.58 107.726 165.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -124.46 131.97 53.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.847 -1.168 . . . . 4.3 107.847 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.86 105.9 13.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.2 1.0 . . . . 1.36 109.533 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.0 m -134.21 117.78 16.88 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 117.616 -1.183 . . . . 2.24 111.156 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -5.23 98.93 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.5 2.72 . . . . 5.28 114.964 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.09 65.45 1.5 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.932 0.893 . . . . 5.63 111.872 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 C--O 1.25 1.101 0 C-N-CA 125.253 1.421 . . . . 7.25 107.729 168.182 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 120.747 0.308 . . . . 3.85 110.545 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -92.08 141.76 28.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.558 -0.534 . . . . 3.79 109.558 -176.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.3 p -119.57 154.94 33.14 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.866 -1.161 . . . . 2.76 107.866 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -115.9 105.57 12.82 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.71 -1.218 . . . . 3.32 107.71 173.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mt -114.32 170.59 8.19 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.173 0.987 . . . . 2.77 109.73 172.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.06 146.61 47.02 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.441 -1.689 . . . . 1.79 106.441 168.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 mm -98.04 142.9 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 107.307 -1.368 . . . . 0.92 107.307 172.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -117.2 126.73 53.25 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.217 -1.031 . . . . 3.38 108.217 165.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.28 -57.83 0.39 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.559 1.076 . . . . 1.94 111.089 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.1 mtt 24.91 73.09 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.119 2.167 . . . . 2.13 115.643 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -59.24 -57.54 12.59 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.729 0.64 . . . . 2.5 112.729 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.3 t -166.79 61.81 0.09 Allowed 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.722 0.692 . . . . 3.91 112.031 -171.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 38.52 50.31 1.53 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.59 1.556 . . . . 5.04 112.765 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.7 t -167.63 -45.6 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.812 0.845 . . . . 2.51 109.223 -168.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.8 t -65.42 -45.51 83.63 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.507 -0.746 . . . . 1.54 109.794 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.2 -22.68 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 121.337 -0.852 . . . . 1.91 112.031 170.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -39.49 94.73 Favored 'General case' 0 C--O 1.223 -0.301 0 O-C-N 120.848 -1.157 . . . . 1.81 110.537 167.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -36.16 71.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.081 -1.012 . . . . 3.78 111.089 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -49.15 -32.9 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.122 0.969 . . . . 1.96 111.787 172.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -55.17 -53.0 61.53 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.523 0.729 . . . . 5.11 110.653 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.93 -43.76 67.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.745 -0.661 . . . . 5.35 109.679 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -54.52 -52.56 61.61 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.698 -0.482 . . . . 3.2 109.698 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.531 HD21 HD11 ' A' ' 62' ' ' ILE . 24.9 mt -66.3 -41.06 90.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.901 -0.571 . . . . 2.47 112.111 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -22.84 16.44 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.552 1.069 . . . . 2.07 111.957 172.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -116.1 33.48 5.5 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.935 0.494 . . . . 3.11 112.269 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.438 ' OE1' HG12 ' A' ' 32' ' ' VAL . 5.4 tm-20 -75.58 -93.76 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.249 -1.389 . . . . 3.82 107.249 161.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.51 -101.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.249 1.019 . . . . 1.04 110.325 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.92 -23.27 67.39 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 119.248 0.931 . . . . 1.24 113.437 -176.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.438 HG12 ' OE1' ' A' ' 29' ' ' GLU . 9.4 p -74.82 130.26 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.009 1.404 . . . . 1.52 111.311 -175.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -141.89 54.22 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.828 1.299 . . . . 2.22 110.807 173.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.82 143.25 17.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.991 -1.485 . . . . 1.68 106.991 169.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.428 ' HA ' HG22 ' A' ' 46' ' ' ILE . 84.9 t -133.92 100.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 106.271 -1.752 . . . . 2.37 106.271 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -119.1 78.39 1.28 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.212 -1.033 . . . . 2.47 108.212 175.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.96 126.98 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 109.306 -0.627 . . . . 1.86 109.306 173.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.94 95.79 7.12 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.997 -1.482 . . . . 1.1 106.997 167.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.43 -22.82 63.86 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.362 0.265 . . . . 3.21 110.707 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 10.8 tpt -65.3 -46.85 78.72 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.389 1.075 . . . . 4.12 110.56 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.62 -30.34 13.33 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.288 1.035 . . . . 1.29 111.061 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.94 66.58 1.27 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 125.016 1.293 . . . . 1.01 111.003 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -142.05 132.69 25.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.244 -1.762 . . . . 3.08 106.244 172.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.24 103.4 12.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 124.368 1.043 . . . . 0.95 109.697 168.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -106.72 146.7 30.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.002 -1.11 . . . . 3.46 108.002 166.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.543 HD12 ' C ' ' A' ' 46' ' ' ILE . 1.9 pp -139.62 166.62 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 106.647 -1.612 . . . . 2.72 106.647 174.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 107.21 15.5 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.138 1.375 . . . . 4.48 108.456 171.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.526 ' CD2' HD11 ' A' ' 53' ' ' ILE . 26.1 p90 -104.52 -178.8 3.76 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.245 1.018 . . . . 2.2 112.578 171.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.18 104.06 35.44 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.215 1.406 . . . . 3.92 109.335 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.98 -5.07 16.13 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.678 2.252 . . . . 2.28 112.991 -172.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -75.98 -15.35 60.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.703 0.683 . . . . 3.69 111.72 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.5 p -125.68 -41.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 118.772 0.715 . . . . 2.91 109.518 -172.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.526 HD11 ' CD2' ' A' ' 48' ' ' TYR . 2.1 pp -113.3 -177.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 121.315 0.579 . . . . 2.48 111.477 170.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -139.45 155.92 71.77 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 104.575 -2.38 . . . . 3.11 104.575 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -59.5 -34.2 97.09 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.739 1.626 . . . . 1.73 110.493 -175.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.79 -43.73 77.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.74 -0.648 . . . . 3.92 111.549 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -65.7 -43.45 89.17 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.745 1.157 . . . . 2.69 110.818 -174.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.0 mt -51.79 -55.78 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.065 -1.457 . . . . 1.88 107.065 169.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.06 -43.59 78.08 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.782 -0.644 . . . . 1.8 111.121 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -54.46 -46.82 73.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.28 1.032 . . . . 2.64 110.021 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.54 -48.03 72.48 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.837 -0.431 . . . . 3.44 109.837 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.531 HD11 HD21 ' A' ' 26' ' ' LEU . 7.8 mm -60.29 -43.28 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 122.228 -0.295 . . . . 2.99 111.182 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -64.48 -44.89 89.58 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.007 -0.368 . . . . 2.26 110.007 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.13 -43.94 98.1 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.848 0.859 . . . . 4.67 109.961 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.93 -47.63 74.18 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 123.922 0.889 . . . . 3.1 108.878 173.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.61 34.12 1.12 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.919 0.771 . . . . 1.72 112.02 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -119.31 165.68 13.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.993 1.317 . . . . 2.33 109.199 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -99.95 139.02 36.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.318 -0.993 . . . . 2.18 108.318 162.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.9 122.89 38.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.736 -1.95 . . . . 0.95 105.736 165.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.02 142.88 46.51 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 108.457 -0.942 . . . . 0.98 108.457 174.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 71' ' ' VAL . 0.5 OUTLIER -67.62 136.03 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 124.127 0.971 . . . . 2.85 109.482 -177.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 C-N-CA 123.911 0.884 . . . . 4.27 109.202 166.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.692 0 N-CA-C 107.936 -2.065 . . . . 2.03 107.936 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.26 79.95 5.03 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.569 -1.641 . . . . 3.49 106.569 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -121.83 148.71 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 118.514 0.597 . . . . 3.13 111.123 178.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -99.05 154.86 17.77 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.779 -0.823 . . . . 2.82 108.779 174.133 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 147' ' ' LEU . 1.3 mp -133.71 142.1 47.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.88 -1.155 . . . . 2.92 107.88 168.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.0 m -96.05 123.96 39.87 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.016 -1.476 . . . . 2.6 107.016 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.67 112.22 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 123.51 0.724 . . . . 1.62 110.111 -172.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.4 m -101.04 135.48 42.43 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.741 -0.837 . . . . 1.95 108.741 176.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.88 -30.31 8.17 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.775 1.179 . . . . 1.28 112.283 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 131.26 50.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.535 1.134 . . . . 2.82 111.009 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.7 m -148.69 46.23 1.02 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.093 0.957 . . . . 3.0 110.254 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.0 t -169.61 139.86 2.1 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 120.987 -1.07 . . . . 2.65 110.857 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.38 -44.77 68.9 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.873 0.469 . . . . 2.47 110.638 174.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.1 m -52.45 -39.54 61.2 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.758 0.823 . . . . 2.35 112.06 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.4 t -63.41 -55.42 24.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.129 -0.693 . . . . 3.1 109.129 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.503 HG13 HG13 ' A' ' 113' ' ' VAL . 6.7 t -46.81 -50.34 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.68 -0.691 . . . . 1.32 110.653 172.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -47.16 84.77 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.317 -0.623 . . . . 3.05 109.317 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.09 -45.92 91.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.789 -0.448 . . . . 3.58 109.789 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.5 mt -58.77 -49.72 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -56.37 -50.0 72.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.115 0.966 . . . . 2.44 108.539 177.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 66.9 m -60.42 -36.25 77.71 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.845 0.858 . . . . 2.13 112.419 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -66.76 -50.36 62.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.55 -0.719 . . . . 2.73 109.773 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.76 -42.32 70.58 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.023 -0.732 . . . . 2.64 109.023 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.6 p -55.8 -16.05 3.99 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.374 0.879 . . . . 2.34 113.374 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -27.47 69.2 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.104 0.866 . . . . 4.38 111.383 172.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.8 m -60.49 150.7 30.48 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.92 1.688 . . . . 1.49 110.385 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -73.65 -54.73 7.45 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.398 0.679 . . . . 2.26 112.114 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.17 -32.84 68.98 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 121.387 0.437 . . . . 1.68 112.688 -172.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.96 119.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.817 -0.813 . . . . 2.51 109.73 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.7 m -102.79 -49.16 3.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.727 0.411 . . . . 2.29 111.018 -174.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.409 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 36.2 p90 -142.04 117.42 10.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.575 -0.726 . . . . 2.51 109.46 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.85 155.19 17.17 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 118.865 -1.134 . . . . 1.44 110.721 161.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -140.81 114.46 8.86 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.464 -0.569 . . . . 2.6 109.464 160.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.503 HG13 HG13 ' A' ' 95' ' ' VAL . 2.7 p -109.66 140.65 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.727 0.694 . . . . 2.0 112.764 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.23 104.61 6.56 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-O 121.972 0.891 . . . . 1.47 111.857 -171.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.771 ' H ' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -65.9 -20.01 66.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.625 1.57 . . . . 2.97 114.061 -177.305 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.71 70.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.18 0.445 . . . . 1.46 110.757 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.22 -18.02 10.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.605 1.562 . . . . 1.84 111.164 -173.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.4 m 72.43 17.63 4.7 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 126.713 2.005 . . . . 1.45 112.426 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -101.11 135.74 42.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.862 1.265 . . . . 2.98 110.371 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 83' ' ' GLU . . . -114.09 110.9 20.74 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 126.049 1.74 . . . . 1.4 109.094 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.82 125.16 35.64 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 105.892 -1.892 . . . . 2.67 105.892 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.3 t -130.98 132.1 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.353 1.061 . . . . 2.31 109.463 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -119.71 88.12 2.87 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.466 0.706 . . . . 3.4 109.65 -174.293 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -108.64 -179.48 3.88 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.558 1.161 . . . . 2.19 111.76 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -107.36 112.78 62.51 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 124.25 1.02 . . . . 4.13 108.324 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.79 67.41 8.62 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.162 2.575 . . . . 2.4 111.115 -171.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -161.52 -46.75 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.03 1.332 . . . . 3.78 109.413 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.5 pt -84.24 -31.25 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 123.021 0.528 . . . . 1.91 110.722 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.88 161.7 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 124.446 1.099 . . . . 1.58 108.156 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.68 162.06 28.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.672 -1.371 . . . . 1.55 109.672 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -57.18 -36.45 99.11 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.655 2.903 . . . . 1.57 111.57 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -49.92 -37.18 30.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.467 0.707 . . . . 6.9 112.616 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.15 -44.66 71.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.2 0.524 . . . . 3.3 109.639 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.53 -45.87 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.27 -1.011 . . . . 1.09 108.27 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.4 mt -53.29 -60.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 118.027 -0.987 . . . . 2.03 108.685 175.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -46.26 -53.17 11.18 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 120.18 1.355 . . . . 3.92 111.012 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 90.0 mt -51.22 -53.12 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.428 0.558 . . . . 2.43 110.068 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.252 2.5 pp -71.08 -28.25 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 114.032 1.123 . . . . 1.65 114.032 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -61.63 -42.9 99.54 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.158 0.89 . . . . 3.11 109.063 170.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -39.81 87.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.891 0.877 . . . . 4.36 108.734 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.503 HG21 ' CE2' ' A' ' 143' ' ' PHE . 74.6 mt -71.22 -41.54 75.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 O-C-N 122.348 -0.22 . . . . 1.64 110.957 175.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.13 32.65 6.04 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.291 1.424 . . . . 1.54 111.899 -173.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.503 ' CE2' HG21 ' A' ' 141' ' ' ILE . 27.4 m-85 -101.5 -178.77 3.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.325 1.063 . . . . 2.38 109.507 165.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -135.89 114.43 11.79 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 105.798 -1.927 . . . . 5.7 105.798 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.07 108.4 19.89 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.05 1.74 . . . . 1.32 108.73 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 m -104.65 95.29 5.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.115 -1.439 . . . . 2.24 107.115 -174.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -62.15 84.68 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.865 1.666 . . . . 5.36 111.262 -177.338 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 47.31 52.94 11.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.722 0.809 . . . . 4.7 109.965 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 116.406 -1.759 . . . . 7.67 108.683 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 . . . . . 0 CA--C 1.528 0.127 0 N-CA-C 109.335 -0.617 . . . . 3.04 109.335 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -93.61 152.03 19.28 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.315 0.646 . . . . 3.39 111.697 177.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 t -140.83 128.05 20.96 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.552 1.141 . . . . 2.17 110.282 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -105.63 101.16 10.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.434 1.893 . . . . 3.94 110.864 -176.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.638 HD22 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -124.99 173.38 8.71 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.223 0.92 . . . . 2.69 111.17 175.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.406 ' OE1' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -124.8 149.03 47.82 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.31 -0.869 . . . . 3.15 109.163 165.335 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -96.11 124.82 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.88 -1.526 . . . . 0.88 106.88 177.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -100.47 111.91 24.21 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.707 -1.96 . . . . 3.25 105.707 173.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.65 -78.0 0.16 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.178 0.894 . . . . 1.25 111.306 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.0 mtm 42.24 79.99 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.477 1.911 . . . . 2.73 114.205 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.7 m -53.14 -55.74 21.78 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.492 -0.755 . . . . 2.13 112.232 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t -164.09 56.55 0.16 Allowed 'General case' 0 C--N 1.344 0.343 0 C-N-CA 119.527 -0.869 . . . . 3.04 111.904 -174.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 40.23 44.99 1.68 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.464 1.506 . . . . 5.99 112.832 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.4 t -171.91 -43.03 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.413 0.685 . . . . 3.39 109.682 -166.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.96 -43.06 99.82 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.998 -1.064 . . . . 1.69 110.393 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -51.55 -39.69 23.57 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 O-C-N 122.053 -0.404 . . . . 1.92 110.203 170.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 t -60.58 -33.46 72.74 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.359 0.412 . . . . 2.42 110.737 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.19 -54.95 10.65 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.037 -1.039 . . . . 2.48 109.895 170.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mp -44.33 -56.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 122.893 0.477 . . . . 2.34 110.919 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.61 -35.42 72.42 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.184 -0.947 . . . . 4.59 112.594 -176.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -67.48 -34.58 77.45 Favored 'General case' 0 N--CA 1.458 -0.035 0 O-C-N 121.082 -1.012 . . . . 7.13 109.779 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -65.41 -48.06 74.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.929 -0.767 . . . . 1.78 108.929 173.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.32 -36.6 68.9 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.704 0.684 . . . . 3.45 112.144 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.85 -22.96 6.07 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.822 0.675 . . . . 1.7 112.822 174.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -110.45 21.1 17.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.103 0.961 . . . . 3.52 112.059 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -72.98 -64.82 0.89 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.229 0.612 . . . . 3.51 109.705 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.35 -123.9 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.439 1.096 . . . . 1.52 108.064 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.84 -0.23 54.37 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 119.039 0.836 . . . . 1.54 114.594 -173.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -82.11 102.79 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.055 1.427 . . . . 1.66 109.275 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -120.56 52.35 1.17 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 122.145 0.974 . . . . 2.41 110.688 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.1 m -159.81 143.86 14.6 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.494 -1.298 . . . . 2.91 107.494 172.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.88 116.69 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 105.663 -1.977 . . . . 2.47 105.663 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pp -139.02 90.39 2.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 119.591 -0.844 . . . . 4.66 111.381 166.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -99.5 163.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.426 -0.796 . . . . 2.67 109.951 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.58 101.73 6.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.568 -1.271 . . . . 1.33 107.568 167.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.75 -17.59 64.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.958 0.903 . . . . 3.32 111.325 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 49.4 mtm -68.58 -55.52 11.32 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.87 0.868 . . . . 4.37 109.941 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.71 -26.88 24.03 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.047 0.539 . . . . 1.46 111.494 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.88 65.86 1.67 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.313 -1.115 . . . . 1.12 110.313 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -141.01 140.9 34.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.909 -1.515 . . . . 3.11 106.909 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.638 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -116.74 110.19 18.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.677 1.191 . . . . 0.96 110.236 170.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.32 134.06 42.73 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.572 -1.64 . . . . 4.52 106.572 168.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.4 HD12 HD21 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -136.51 168.69 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.217 0.917 . . . . 1.77 111.117 167.884 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.67 109.85 19.26 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 123.911 0.885 . . . . 3.96 110.228 163.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.45 ' HB2' HD12 ' A' ' 53' ' ' ILE . 2.6 p90 -98.63 -176.75 3.46 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 127.96 2.504 . . . . 2.6 111.022 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -138.06 108.67 8.25 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.861 1.264 . . . . 3.81 109.443 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.59 8.47 1.23 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 124.497 3.465 . . . . 2.41 113.997 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -95.82 -13.92 23.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.276 1.398 . . . . 4.0 111.688 167.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.2 m -130.23 -42.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 118.929 0.786 . . . . 2.78 112.853 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.45 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -115.21 137.42 48.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 N-CA-C 107.21 -1.404 . . . . 1.81 107.21 177.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.5 mm100 -119.67 149.91 49.17 Favored Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 108.219 -1.03 . . . . 3.63 108.219 -175.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -61.04 -35.78 85.48 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.449 2.099 . . . . 1.53 111.308 -173.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -58.21 -45.42 87.65 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.839 -0.538 . . . . 3.52 111.439 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -58.48 -44.76 89.47 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.657 0.783 . . . . 3.62 110.008 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.28 -56.41 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.04 -1.837 . . . . 1.3 106.04 172.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.51 -44.81 95.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.916 -0.584 . . . . 1.15 111.142 -170.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -55.96 -44.27 78.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.747 0.819 . . . . 2.85 110.283 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.56 -42.99 95.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.399 -0.593 . . . . 3.19 109.399 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mm -60.18 -43.34 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.859 -0.526 . . . . 2.5 110.141 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -63.42 -42.41 98.72 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.549 0.739 . . . . 2.92 111.683 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.98 -50.66 72.88 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.582 0.628 . . . . 2.61 109.741 175.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.65 -34.65 67.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.515 0.726 . . . . 1.84 111.62 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.93 37.63 1.24 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.161 0.886 . . . . 1.34 111.093 166.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -133.15 169.46 16.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.773 1.629 . . . . 2.16 107.002 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -113.3 129.32 56.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.315 -0.624 . . . . 2.44 109.315 169.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.06 120.44 38.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.551 -1.648 . . . . 0.79 106.551 168.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.406 ' HB3' ' OE1' ' A' ' 9' ' ' GLN . . . -131.03 133.88 46.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.074 -1.454 . . . . 0.89 107.074 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.15 154.36 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.508 -0.923 . . . . 2.49 108.508 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.658 0 CA-C-N 114.97 -1.014 . . . . 4.7 111.892 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.095 0 N-CA-C 108.345 -1.902 . . . . 2.16 108.345 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -103.4 104.18 14.25 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.196 -1.409 . . . . 2.76 107.196 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.02 170.4 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.152 -1.425 . . . . 2.9 107.152 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.33 151.06 46.09 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.497 0.719 . . . . 2.69 111.948 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.2 mt -136.94 146.16 45.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.901 1.28 . . . . 2.01 107.674 -172.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.04 127.9 55.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.392 -1.336 . . . . 1.91 107.392 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.768 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -97.26 117.41 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.37 -1.715 . . . . 1.8 106.37 -171.662 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.2 p -98.72 141.91 30.93 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.013 -1.106 . . . . 2.51 108.013 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.52 -17.68 28.52 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 119.348 -0.695 . . . . 2.01 113.257 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -79.92 140.46 36.69 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.199 1.5 . . . . 2.28 111.023 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 t -155.37 85.91 1.07 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.216 -1.031 . . . . 4.5 108.216 176.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 77.8 m 59.86 -99.2 0.09 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.017 1.327 . . . . 6.49 111.386 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 43.37 -148.49 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.508 1.923 . . . . 5.41 110.7 -168.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.9 t -79.76 -6.31 57.01 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.346 -0.613 . . . . 3.6 109.346 159.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.4 t -59.76 -49.96 75.67 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.39 -0.818 . . . . 3.31 109.817 -167.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.7 p -46.48 -61.19 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.375 1.07 . . . . 2.64 111.447 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -65.04 -31.01 72.03 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.369 0.668 . . . . 3.86 110.579 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.576 HD21 HD13 ' A' ' 141' ' ' ILE . 3.5 t30 -69.08 -48.95 61.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.225 1.01 . . . . 1.68 110.333 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.5 mt -58.95 -47.9 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.216 -1.031 . . . . 0.99 108.216 175.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -50.69 -54.35 23.89 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.508 -0.553 . . . . 2.57 109.508 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.3 t -52.34 -48.06 65.7 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.471 0.708 . . . . 1.68 111.093 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -60.59 -39.05 86.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.216 -0.928 . . . . 2.52 111.201 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 25.5 mt -71.25 -61.65 1.69 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.196 -1.038 . . . . 1.69 108.196 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 74.0 p -59.31 -19.21 44.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.323 1.049 . . . . 1.72 112.736 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -57.15 -36.24 70.5 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 119.291 -0.385 . . . . 4.35 110.7 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 t -75.33 174.84 9.01 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.649 0.738 . . . . 3.02 111.597 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -85.27 -47.72 9.78 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.11 0.964 . . . . 2.28 111.428 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.72 -35.56 80.56 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-O 119.974 -0.348 . . . . 1.19 112.916 -170.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.67 119.08 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 117.552 0.676 . . . . 2.89 109.339 -172.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.8 m -95.72 -47.13 6.32 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 109.658 -0.497 . . . . 2.39 109.658 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -142.55 92.54 2.42 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 112.859 0.688 . . . . 3.47 112.859 -176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.42 145.13 24.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.665 -1.235 . . . . 0.89 107.665 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 m -141.76 109.31 5.64 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.572 -0.899 . . . . 2.37 108.572 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.3 p -99.91 124.73 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.918 1.287 . . . . 2.17 109.475 -177.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.32 88.27 2.91 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.309 1.443 . . . . 1.49 109.626 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 pp -66.18 -20.84 66.26 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 125.408 1.483 . . . . 2.25 113.295 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.57 97.56 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.382 0.537 . . . . 1.73 109.965 176.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -19.09 20.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.893 1.277 . . . . 1.82 110.41 175.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.5 m 65.83 37.18 5.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.167 1.387 . . . . 1.64 110.647 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.96 157.45 37.76 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.43 0.559 . . . . 3.05 109.499 171.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.42 131.58 26.43 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.128 0.971 . . . . 1.07 109.386 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.92 129.68 45.26 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.942 1.697 . . . . 2.23 107.166 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.15 124.45 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.263 1.425 . . . . 2.39 110.49 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.65 94.74 5.15 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 107.57 -1.27 . . . . 4.26 107.57 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -111.12 -177.71 3.28 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 124.239 0.962 . . . . 1.96 110.397 174.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.86 116.69 60.4 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 108.255 -1.017 . . . . 2.85 108.255 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -81.32 68.55 8.16 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.893 2.396 . . . . 1.96 111.135 -167.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -165.86 -44.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.748 1.219 . . . . 3.33 109.669 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.8 pt -79.72 -38.23 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 123.109 0.564 . . . . 1.81 111.136 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.54 158.28 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 123.576 0.75 . . . . 1.63 109.118 175.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -124.07 168.76 16.17 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.861 1.22 . . . . 1.7 110.452 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.0 -41.88 6.96 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.718 2.279 . . . . 1.61 110.383 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.48 -39.59 57.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.678 0.791 . . . . 6.62 112.487 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.95 -49.58 75.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.667 0.787 . . . . 3.95 109.332 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.21 -47.28 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.563 -0.903 . . . . 1.34 108.563 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 95.2 mt -52.52 -59.25 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.538 -0.912 . . . . 2.01 108.538 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -49.05 -48.86 43.66 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 119.159 0.891 . . . . 4.13 112.431 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 mm -51.59 -53.51 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.82 -0.437 . . . . 2.46 109.82 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.315 2.0 pp -70.75 -26.99 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 114.385 1.254 . . . . 1.5 114.385 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.36 -43.5 96.47 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 119.359 0.981 . . . . 2.65 109.078 169.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -63.97 -38.29 90.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.18 -0.674 . . . . 3.21 109.18 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.576 HD13 HD21 ' A' ' 97' ' ' ASN . 73.2 mt -64.44 -44.84 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 122.227 -0.296 . . . . 1.15 110.257 171.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.38 23.85 5.58 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.536 1.541 . . . . 1.25 112.629 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -100.59 178.78 4.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.268 1.534 . . . . 2.81 108.802 164.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -136.93 130.39 31.52 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.146 -1.798 . . . . 4.05 106.146 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.98 97.24 5.18 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.717 1.607 . . . . 1.36 108.073 -171.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.7 p -143.22 134.17 25.52 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.269 -0.641 . . . . 1.9 109.269 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -174.31 -94.35 0.0 OUTLIER 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.138 1.375 . . . . 7.69 109.12 170.791 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 37.47 36.38 0.08 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.445 1.898 . . . . 6.04 113.367 -169.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.224 -1.37 . . . . 6.32 110.912 -176.084 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 106.733 -1.581 . . . . 2.82 106.733 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -104.37 154.48 19.78 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.704 0.802 . . . . 4.42 110.812 179.009 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 54.1 t -143.19 140.72 30.87 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.42 0.688 . . . . 2.18 110.939 170.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -109.57 92.3 3.99 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.076 2.15 . . . . 3.55 109.698 -173.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.521 HD12 ' HB3' ' A' ' 44' ' ' ALA 0.262 1.5 pp -119.07 164.58 15.3 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.068 0.937 . . . . 2.71 112.195 176.45 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.15 154.72 18.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.487 -1.301 . . . . 2.45 107.487 166.431 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.407 HG12 ' HB2' ' A' ' 44' ' ' ALA . 14.4 mm -97.78 145.45 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 106.628 -1.619 . . . . 0.84 106.628 160.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -123.77 123.13 39.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.039 -1.837 . . . . 3.37 106.039 158.105 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.04 -81.38 0.19 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 108.792 -1.723 . . . . 1.29 108.792 -172.01 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 28.43 73.15 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.064 2.146 . . . . 2.33 115.335 178.522 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -16.63 2.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.214 1.406 . . . . 2.32 113.781 174.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.8 t 78.25 -48.67 0.47 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.745 1.618 . . . . 3.95 112.433 173.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.25 -70.29 0.11 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.448 1.499 . . . . 4.86 111.776 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 p -159.96 15.13 0.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.13 0.572 . . . . 2.49 112.43 172.139 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.7 m -70.69 -48.3 55.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.573 -0.705 . . . . 2.3 109.385 -168.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.0 t -47.96 -51.69 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.365 -0.976 . . . . 2.07 108.365 172.025 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -59.22 -34.29 72.0 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.906 1.282 . . . . 1.83 113.675 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -45.52 58.77 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.233 -0.292 . . . . 3.01 110.321 172.195 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.6 mt -56.23 -47.34 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.895 0.878 . . . . 1.61 109.213 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -47.63 -53.45 14.76 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.391 0.676 . . . . 4.48 110.837 175.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.0 mtt85 -67.9 -30.21 69.5 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.629 0.771 . . . . 5.8 112.378 -175.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -69.07 -55.77 9.76 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.75 -0.833 . . . . 1.36 108.75 175.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -61.06 -36.07 78.63 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.067 0.547 . . . . 3.6 110.792 -176.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.78 -24.61 6.2 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.896 0.702 . . . . 3.33 112.896 171.563 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -119.55 30.22 7.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.748 0.819 . . . . 4.06 111.537 178.45 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -77.8 -89.27 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 105.686 -1.968 . . . . 3.3 105.686 163.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.54 -91.24 0.06 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.489 0.716 . . . . 1.12 111.044 177.263 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.27 -15.75 68.44 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.287 -0.729 . . . . 1.81 112.593 -171.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.45 109.71 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 CA-C-N 118.102 0.951 . . . . 2.17 109.168 177.301 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.3 mt -138.59 50.59 1.86 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.89 -0.782 . . . . 3.73 108.89 177.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 t -159.86 152.68 21.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.217 -1.771 . . . . 2.18 106.217 159.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.17 102.07 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.122 -1.807 . . . . 2.21 106.122 -178.711 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -127.24 74.2 1.49 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.419 -1.697 . . . . 2.91 106.419 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.13 123.66 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.427 -0.953 . . . . 2.26 108.427 174.017 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.75 92.65 6.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.692 -1.966 . . . . 1.41 105.692 169.109 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 tp -54.71 -30.04 54.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.24 1.416 . . . . 3.44 110.192 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 31.7 mtt -66.51 -54.32 25.24 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.418 0.687 . . . . 3.29 110.421 -178.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.11 -23.59 28.4 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.151 0.58 . . . . 1.43 111.484 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.54 63.78 2.28 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.059 1.314 . . . . 1.2 110.9 -176.142 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.0 pttm -140.98 140.58 34.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.751 -1.203 . . . . 3.16 107.751 170.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.521 ' HB3' HD12 ' A' ' 8' ' ' LEU . . . -116.72 104.44 11.36 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 124.435 1.084 . . . . 0.96 112.975 173.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -98.01 125.76 43.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.259 -1.385 . . . . 4.31 107.259 172.273 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.0 mt -126.06 163.29 28.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 107.027 -1.471 . . . . 2.7 107.027 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -123.98 105.75 9.84 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.435 -0.95 . . . . 4.16 108.435 165.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -117.54 159.8 22.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.397 1.479 . . . . 3.09 110.027 172.449 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -98.95 111.15 60.05 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.931 0.893 . . . . 3.74 110.297 -179.248 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.08 -3.84 7.92 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.076 3.184 . . . . 2.12 113.623 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -73.25 -44.99 58.43 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 120.07 1.305 . . . . 4.64 110.741 169.199 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -108.59 -30.22 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 122.175 -0.328 . . . . 2.77 111.427 -165.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.402 HD11 ' CG1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -127.51 131.96 69.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 108.655 -0.868 . . . . 1.77 108.655 177.34 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.02 150.7 39.05 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.605 1.562 . . . . 2.67 109.773 -177.488 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -51.94 -52.58 8.65 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.37 2.713 . . . . 1.36 112.247 179.351 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -60.4 -43.76 96.35 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.419 -0.8 . . . . 3.09 111.265 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -57.77 -37.62 73.99 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.944 0.498 . . . . 3.94 111.101 174.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.402 ' CG1' HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -55.31 -50.11 67.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 107.568 -1.271 . . . . 1.18 107.568 171.175 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.84 -43.87 77.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.988 -0.551 . . . . 1.42 110.203 -175.812 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -53.12 -46.84 68.94 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.305 0.502 . . . . 2.74 110.75 175.406 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -48.79 79.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.002 0.43 . . . . 2.52 110.371 177.423 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -64.53 -44.04 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 121.961 -0.462 . . . . 2.6 111.012 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -42.69 98.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.448 1.099 . . . . 2.47 110.247 176.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.77 -49.15 77.55 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.39 0.541 . . . . 2.6 109.974 177.016 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 mt -56.24 -37.03 69.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.399 0.279 . . . . 1.95 111.583 174.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.94 26.51 2.75 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.239 0.923 . . . . 1.35 112.242 167.146 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -118.5 167.72 11.33 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.35 1.46 . . . . 2.03 107.96 176.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -98.55 143.74 28.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.373 -0.973 . . . . 2.59 108.373 163.523 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.74 135.16 48.13 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.801 0.84 . . . . 1.14 108.79 162.544 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.63 138.72 30.91 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.912 0.885 . . . . 1.26 109.731 171.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 p -87.19 152.84 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 125.613 1.565 . . . . 2.71 109.499 178.245 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.7 mtt . . . . . 0 CA--C 1.533 0.294 0 O-C-N 123.371 0.419 . . . . 3.66 111.605 178.275 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.087 0 N-CA-C 112.004 -0.439 . . . . 2.03 112.004 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.504 ' C ' HD13 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -142.01 114.44 8.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.067 -1.457 . . . . 2.37 107.067 173.647 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.504 HD13 ' C ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER -128.01 160.85 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.405 -1.331 . . . . 2.88 107.405 176.825 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.8 153.83 28.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.23 -1.026 . . . . 3.97 108.23 169.51 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 mp -133.01 141.21 48.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.705 0.802 . . . . 2.46 109.027 163.314 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.4 m -94.74 125.97 39.75 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.356 -1.72 . . . . 2.61 106.356 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.8 mt -101.52 123.36 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.241 -0.651 . . . . 3.46 109.241 -174.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.5 m -96.5 124.65 40.56 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.819 -1.178 . . . . 1.77 107.819 172.022 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 117.22 -34.82 4.41 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.95 1.262 . . . . 1.34 112.161 175.378 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 55.7 ttp -50.44 120.52 4.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.998 0.899 . . . . 2.96 110.98 177.267 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.4 6.18 1.27 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.526 0.935 . . . . 3.32 113.526 -170.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.4 t -156.01 142.21 18.32 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.084 1.311 . . . . 2.74 111.243 -178.282 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.19 64.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.568 1.147 . . . . 3.13 112.271 -175.075 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.24 -49.5 66.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.124 0.97 . . . . 3.19 110.739 171.33 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 88.4 m -64.17 -46.56 83.48 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.011 -0.737 . . . . 1.87 109.011 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.519 HG13 HG13 ' A' ' 113' ' ' VAL . 91.2 t -47.67 -59.0 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.279 1.032 . . . . 1.55 109.778 175.038 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -57.68 -44.33 85.73 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 122.997 0.519 . . . . 4.5 111.285 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -62.69 -47.66 82.67 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.836 0.455 . . . . 1.85 110.627 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.437 HD11 ' CE2' ' A' ' 143' ' ' PHE . 81.2 mt -57.35 -48.75 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.744 -0.836 . . . . 1.14 108.744 177.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -59.74 -46.45 89.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.427 -0.582 . . . . 3.1 109.427 178.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.6 t -52.0 -46.64 64.99 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.577 0.626 . . . . 1.28 110.811 174.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -60.18 -50.65 72.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.747 -0.596 . . . . 3.41 110.89 177.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.7 mt -58.0 -56.81 17.15 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 118.378 0.536 . . . . 2.17 109.587 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 33.3 m -50.04 -19.15 0.66 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.144 1.778 . . . . 1.73 112.912 173.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -67.37 -16.46 64.26 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.058 0.845 . . . . 5.26 112.251 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.0 m -72.38 155.0 40.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.169 1.387 . . . . 1.75 110.838 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -74.47 -52.82 10.91 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.962 0.905 . . . . 2.65 111.7 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.36 -37.75 80.13 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.786 -0.525 . . . . 1.45 111.786 -172.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.51 136.94 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.706 -0.85 . . . . 1.76 108.706 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.8 m -137.22 -12.92 1.61 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.482 -0.761 . . . . 3.41 112.394 171.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.91 118.34 10.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.786 -2.301 . . . . 2.33 104.786 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.49 161.04 28.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.314 -1.365 . . . . 1.08 107.314 166.461 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.0 m -141.07 111.96 7.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 118.915 -0.564 . . . . 1.83 109.505 161.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.519 HG13 HG13 ' A' ' 95' ' ' VAL . 7.4 p -95.71 134.52 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.641 0.776 . . . . 1.84 110.542 171.416 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.65 108.47 5.67 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.53 1.157 . . . . 1.37 110.967 -171.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.71 -41.18 98.13 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.544 1.937 . . . . 4.33 112.081 -173.676 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.22 62.45 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.277 0.631 . . . . 2.31 111.094 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 -15.81 15.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.455 1.902 . . . . 2.44 110.199 -177.252 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.1 t 71.56 20.27 4.83 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.517 2.327 . . . . 1.84 112.145 168.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -131.55 172.82 11.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.271 0.558 . . . . 2.64 110.741 177.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . . . -129.06 134.35 48.07 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.739 1.216 . . . . 1.17 109.377 170.288 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.39 123.35 35.65 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 104.484 -2.413 . . . . 1.87 104.484 172.429 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.4 t -124.14 129.39 74.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.372 -1.344 . . . . 1.78 107.372 -176.038 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.12 88.15 2.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.7 -1.222 . . . . 3.47 107.7 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -113.04 164.71 13.13 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.055 0.942 . . . . 2.03 111.311 174.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -99.04 116.63 65.11 Favored Pre-proline 0 C--O 1.237 0.423 0 C-N-CA 123.932 0.893 . . . . 3.01 109.344 177.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -78.22 68.22 7.97 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.236 2.624 . . . . 2.11 111.546 -173.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.54 -47.34 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.245 1.018 . . . . 3.22 109.348 173.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -81.59 -30.88 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 122.922 0.489 . . . . 1.76 110.924 -177.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -135.25 163.39 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.91 -0.774 . . . . 1.8 108.91 176.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.49 163.54 28.18 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.488 -1.445 . . . . 1.99 109.488 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.45 -35.67 81.54 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.857 3.038 . . . . 2.38 112.565 -170.334 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -40.62 75.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.92 -0.488 . . . . 7.78 111.316 -175.258 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.92 -38.99 72.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 119.148 -1.021 . . . . 3.85 109.969 -177.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 83.4 mt -56.65 -48.68 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.674 -0.862 . . . . 1.67 108.674 173.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.9 mt -50.51 -60.33 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 118.111 -0.947 . . . . 2.82 108.671 173.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -51.47 -44.71 62.51 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.959 1.254 . . . . 4.52 112.469 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.4 mm -56.05 -54.39 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.449 -0.782 . . . . 2.38 109.491 176.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.256 2.5 pp -68.18 -25.53 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 120.861 -1.149 . . . . 1.78 113.392 -178.498 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.34 -39.52 87.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.954 0.797 . . . . 3.51 109.932 168.07 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.77 -40.59 97.76 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.994 -0.743 . . . . 3.81 108.994 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.8 mt -66.41 -43.09 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 110.02 -0.363 . . . . 1.08 110.02 173.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.01 33.42 4.96 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.647 1.594 . . . . 0.9 111.536 -175.777 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 98' ' ' ILE . 51.2 m-85 -103.81 177.3 4.88 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.403 1.102 . . . . 2.42 109.264 166.622 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -129.79 121.98 27.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.176 -1.787 . . . . 4.04 106.176 172.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.84 113.27 26.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.574 1.15 . . . . 1.46 108.691 179.059 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.1 m -110.66 98.61 7.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.758 1.623 . . . . 1.93 107.991 -173.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.59 98.71 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.186 1.794 . . . . 5.4 111.003 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 48.53 45.19 21.12 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.74 0.816 . . . . 4.98 111.289 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 . . . . . 0 C--O 1.248 1.006 0 N-CA-C 106.537 -1.653 . . . . 9.85 106.537 -175.587 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 107.544 -1.28 . . . . 4.83 107.544 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -96.79 142.66 28.53 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.697 0.681 . . . . 4.32 111.572 -172.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.0 t -141.1 126.53 18.74 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.077 0.551 . . . . 2.67 111.826 172.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -97.43 101.69 13.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.255 2.222 . . . . 3.72 108.187 175.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -119.34 167.35 11.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 122.344 1.069 . . . . 3.09 108.616 173.991 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.471 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -140.63 136.86 33.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.641 -0.874 . . . . 1.97 108.641 175.204 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.02 138.06 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 105.34 -2.096 . . . . 1.15 105.34 -178.743 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -106.95 125.17 50.65 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.201 -1.037 . . . . 3.58 108.201 170.524 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.23 -88.23 0.28 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.787 1.66 . . . . 1.5 109.494 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.4 mpt? 66.13 144.32 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.502 1.921 . . . . 2.68 112.416 -169.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -109.34 -19.08 13.41 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.495 1.118 . . . . 2.39 110.702 172.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.4 t 65.73 -65.23 0.18 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.183 1.793 . . . . 2.96 112.001 -170.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.36 -73.25 0.02 OUTLIER 'General case' 0 C--N 1.342 0.264 0 C-N-CA 128.083 2.553 . . . . 5.85 113.413 -175.541 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.63 13.07 0.09 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.006 0.743 . . . . 3.16 113.006 166.277 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.3 m -74.85 -41.57 59.59 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 120.169 -1.582 . . . . 2.25 110.768 -171.568 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.87 -31.86 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.878 -0.786 . . . . 2.01 108.878 176.203 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -61.06 -52.13 66.24 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.919 -0.488 . . . . 2.21 110.72 170.785 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -53.15 -45.76 68.55 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.877 -1.139 . . . . 2.96 110.833 175.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -43.88 -38.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.61 1.164 . . . . 1.62 111.613 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -52.24 -58.41 6.7 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.268 0.627 . . . . 4.84 111.469 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -67.11 -37.58 84.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.655 -0.498 . . . . 4.32 109.655 -176.54 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -55.68 -56.8 16.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.414 -0.587 . . . . 1.37 109.414 178.438 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 mp -61.18 -42.43 98.56 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.822 0.737 . . . . 2.41 110.969 177.49 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -22.25 18.84 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.781 0.719 . . . . 1.89 112.537 178.813 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -113.01 16.53 19.32 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.414 0.894 . . . . 3.15 113.414 175.887 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.41 -69.5 0.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.265 -1.013 . . . . 2.82 108.265 165.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.13 -134.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.163 1.385 . . . . 2.22 107.951 -176.193 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.11 35.69 1.28 Allowed Glycine 0 CA--C 1.538 1.499 0 CA-C-N 120.255 1.389 . . . . 2.6 114.847 -172.372 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.89 77.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 125.306 1.443 . . . . 2.77 109.454 175.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.47 51.55 0.77 Allowed 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 108.602 -0.888 . . . . 3.41 108.602 -172.726 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -163.79 126.02 2.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.607 -1.257 . . . . 1.83 107.607 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.1 t -128.48 114.52 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.998 -1.482 . . . . 2.81 106.998 176.255 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -123.68 79.57 1.71 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.612 -1.255 . . . . 3.65 107.612 174.095 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 t -97.76 128.26 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 109.054 -0.721 . . . . 2.46 109.054 173.935 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.31 86.81 3.99 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.333 -1.358 . . . . 2.21 107.333 176.091 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.8 mt -57.25 -5.38 0.29 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.958 1.096 . . . . 3.1 113.958 176.604 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 28.5 mtp -97.66 -42.51 7.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.268 1.427 . . . . 3.99 110.468 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.3 -38.12 12.25 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.644 0.778 . . . . 2.39 110.879 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.89 60.14 1.04 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 126.216 1.865 . . . . 1.82 111.649 173.447 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -138.19 137.47 37.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 105.412 -2.07 . . . . 3.58 105.412 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.5 92.94 4.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.185 0.928 . . . . 1.41 110.119 169.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.04 111.63 23.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.112 -2.551 . . . . 6.19 104.112 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 pt -117.38 174.94 3.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 O-C-N 120.325 -1.484 . . . . 2.51 108.414 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -131.12 108.61 9.87 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.924 -0.399 . . . . 5.51 109.924 170.285 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -117.32 164.78 14.32 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.618 1.567 . . . . 3.09 113.288 174.758 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -99.0 106.12 36.0 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.646 1.978 . . . . 3.88 109.978 177.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.05 9.66 0.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.354 2.703 . . . . 3.61 113.701 -171.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -97.85 -21.32 16.98 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.535 0.734 . . . . 5.1 111.038 173.249 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.9 t -111.01 -62.45 2.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 N-CA-C 108.34 -0.985 . . . . 3.86 108.34 -175.248 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.498 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -98.96 144.42 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 N-CA-C 109.115 -0.698 . . . . 2.58 109.115 176.541 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -113.49 151.78 44.77 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 125.008 1.323 . . . . 3.66 108.328 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.26 -39.38 85.21 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.716 2.277 . . . . 2.11 111.314 -175.136 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.574 HD22 ' C ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -72.01 -38.4 69.61 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.461 -0.774 . . . . 3.16 112.505 -178.431 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -57.3 -43.65 83.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.998 -0.741 . . . . 3.26 108.998 172.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.498 HD12 HD11 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -53.2 -47.56 55.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 108.51 -0.922 . . . . 1.44 108.51 168.808 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.49 -38.69 78.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 119.898 -0.721 . . . . 1.19 110.266 -171.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -52.65 -50.85 62.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.047 0.939 . . . . 2.83 109.971 177.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -48.15 70.54 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.501 -0.555 . . . . 2.41 109.501 177.583 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.5 mm -62.77 -39.85 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 122.164 -0.335 . . . . 2.43 111.08 -178.794 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -67.38 -42.92 82.59 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.813 -0.439 . . . . 1.84 109.813 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -60.58 -49.9 75.67 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.029 0.532 . . . . 2.32 109.878 176.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.61 -36.42 69.42 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.02 0.528 . . . . 2.07 111.032 175.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.24 41.67 0.95 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.127 -0.789 . . . . 1.34 111.127 165.447 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -132.59 162.88 30.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.277 1.031 . . . . 3.0 109.168 -174.74 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -93.17 124.11 36.91 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 106.914 -1.513 . . . . 2.69 106.914 171.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.38 124.63 43.16 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.853 -1.165 . . . . 1.3 107.853 167.628 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -137.66 113.46 9.71 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.789 -0.819 . . . . 1.12 108.789 172.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 4.5 t -72.83 158.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.836 0.855 . . . . 2.65 110.171 -178.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.4 mtt . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 113.296 0.85 . . . . 4.22 113.296 174.361 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.374 0 N-CA-C 109.592 -1.403 . . . . 2.6 109.592 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -115.21 122.92 47.51 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.682 -2.34 . . . . 2.89 104.682 175.62 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.71 158.9 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.553 -1.277 . . . . 3.42 107.553 168.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.7 157.32 39.36 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 123.333 0.653 . . . . 3.33 109.471 171.437 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 pp -147.31 161.6 40.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.585 -0.734 . . . . 2.55 110.333 172.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.9 126.3 44.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.15 -1.426 . . . . 2.05 107.15 173.343 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.65 127.08 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.57 -0.9 . . . . 1.81 108.57 176.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.6 m -118.02 112.08 19.79 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.034 -1.099 . . . . 1.9 108.034 176.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.96 -25.76 1.15 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.656 1.122 . . . . 1.56 111.386 -172.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.9 tpp -61.25 120.72 10.92 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 121.978 -0.719 . . . . 2.83 111.389 -174.566 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.7 t -130.49 4.92 4.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.29 0.636 . . . . 2.44 111.463 176.55 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.27 153.12 6.41 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 120.654 -1.278 . . . . 3.5 111.682 177.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.89 -32.62 66.06 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.319 0.647 . . . . 3.11 111.148 173.574 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.9 t -51.99 -43.95 63.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.949 0.5 . . . . 2.21 110.525 171.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.5 m -63.91 -53.51 49.22 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 108.41 -0.959 . . . . 1.89 108.41 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 82.1 t -43.39 -54.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.194 0.998 . . . . 1.38 110.71 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -59.05 -40.0 83.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.685 -0.234 . . . . 4.25 110.958 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -66.89 -46.34 75.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.874 -0.516 . . . . 1.62 110.579 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.6 mm -55.65 -50.46 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.616 -0.883 . . . . 1.62 108.616 176.345 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -59.75 -45.54 91.91 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 118.842 -0.599 . . . . 2.11 110.057 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.3 m -55.44 -39.87 70.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.826 0.739 . . . . 2.71 111.622 175.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.44 -39.27 81.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.016 -0.428 . . . . 2.98 111.193 175.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.92 -58.25 5.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.338 -0.986 . . . . 1.7 108.338 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.9 p -57.27 -15.39 5.96 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.597 1.159 . . . . 2.09 113.13 176.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -35.66 64.26 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.517 -0.739 . . . . 5.5 111.583 167.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.8 m -66.85 144.77 56.08 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.632 1.573 . . . . 1.77 111.1 -175.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -68.17 -47.3 68.35 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.011 0.925 . . . . 2.69 111.432 177.114 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.27 -21.75 74.92 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.62 -0.544 . . . . 1.89 113.139 -168.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.2 156.77 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.596 -0.89 . . . . 2.29 108.596 177.803 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.9 m -140.0 -39.8 0.45 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.39 -0.819 . . . . 3.4 112.348 168.042 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.39 95.02 4.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.94 -1.504 . . . . 2.59 106.94 -168.476 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -96.51 155.32 16.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.984 -1.117 . . . . 0.99 107.984 168.047 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.3 m -140.22 111.27 7.01 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.005 -0.434 . . . . 1.85 110.276 159.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.19 133.38 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.749 1.219 . . . . 2.01 110.657 -178.312 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.92 104.92 5.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.594 1.158 . . . . 1.44 110.803 -171.009 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 pp -70.53 -21.6 62.71 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 124.204 1.002 . . . . 2.75 112.649 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.41 91.39 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.398 -0.593 . . . . 1.94 109.398 -179.051 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.07 -34.48 16.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.941 0.897 . . . . 2.34 110.049 170.795 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.96 45.51 0.15 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.312 -0.996 . . . . 2.36 108.312 -168.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.06 167.72 20.43 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.852 -0.613 . . . . 4.07 111.592 165.411 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.5 141.83 46.85 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.624 1.169 . . . . 1.13 108.695 171.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.53 137.92 36.49 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.127 -1.805 . . . . 2.02 106.127 168.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.16 129.89 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.484 -0.932 . . . . 2.95 108.484 -179.405 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.83 105.57 13.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.079 -1.082 . . . . 3.43 108.079 -176.267 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -137.04 168.75 18.99 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.172 0.92 . . . . 2.48 111.714 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -97.29 115.79 65.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.681 -0.488 . . . . 3.79 109.681 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.36 55.06 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.343 2.696 . . . . 2.49 112.552 -166.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -143.76 -51.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.489 1.516 . . . . 3.16 108.012 172.51 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pt -77.38 -31.75 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 122.438 -0.163 . . . . 2.51 110.987 -176.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.88 163.54 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.985 -0.746 . . . . 2.1 108.985 -178.03 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.75 164.73 31.82 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.256 -1.137 . . . . 2.05 110.256 -176.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -61.55 -38.5 62.07 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.575 2.85 . . . . 2.04 111.817 -168.182 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -31.83 62.95 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 113.086 0.772 . . . . 7.14 113.086 -176.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.87 -40.63 65.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 118.498 -1.281 . . . . 3.31 110.231 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.3 -48.14 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.543 -0.91 . . . . 1.46 108.543 171.656 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.18 -60.99 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 108.799 -0.815 . . . . 2.26 108.799 174.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.98 -50.23 19.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.14 0.882 . . . . 4.36 113.147 178.553 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.8 -53.57 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 121.933 -0.479 . . . . 2.13 109.858 177.132 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.268 2.5 pp -68.16 -29.24 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.287 -0.883 . . . . 1.54 113.278 -177.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.71 -41.98 78.35 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.158 0.89 . . . . 4.0 109.54 169.287 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -61.45 -40.26 93.85 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.41 0.684 . . . . 3.76 109.295 -179.358 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.9 mt -68.91 -38.95 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 122.865 0.466 . . . . 1.08 110.153 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.16 33.49 6.55 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.975 1.274 . . . . 1.07 110.771 -171.633 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -99.48 175.03 5.98 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 107.914 -1.143 . . . . 3.37 107.914 167.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -135.25 121.7 20.53 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.01 -1.478 . . . . 3.89 107.01 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.03 100.89 10.18 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.613 1.165 . . . . 1.5 109.56 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.6 m -99.13 104.12 16.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.394 -0.965 . . . . 1.96 108.394 174.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 mt -48.03 107.74 0.14 Allowed 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 125.323 1.449 . . . . 6.18 108.346 171.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -84.4 -31.23 24.79 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.606 -0.887 . . . . 4.47 108.606 175.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 127.563 2.345 . . . . 8.84 112.678 165.462 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 119.885 -0.102 . . . . 3.54 110.734 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -123.84 147.09 47.91 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 124.604 1.161 . . . . 4.82 110.292 -179.037 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.17 137.15 51.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.693 -1.225 . . . . 2.44 107.693 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -121.64 96.08 4.93 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.786 -1.19 . . . . 4.28 107.786 -172.403 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.2 177.4 4.74 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.711 0.767 . . . . 3.06 111.095 -176.443 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.18 149.42 49.98 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.693 1.597 . . . . 1.57 107.19 166.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mm -103.11 126.35 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 106.859 -1.534 . . . . 1.1 106.859 175.83 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -107.24 138.11 44.04 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.158 -1.053 . . . . 3.05 108.158 160.328 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 144.84 -88.32 0.17 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.342 1.449 . . . . 1.07 109.685 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt 55.86 73.89 0.41 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.263 1.425 . . . . 1.68 113.554 171.125 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m -50.12 -59.95 3.42 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.072 0.768 . . . . 2.31 113.072 -178.548 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 t -170.01 63.08 0.05 OUTLIER 'General case' 0 C--N 1.343 0.323 0 CA-C-N 118.522 0.601 . . . . 3.53 110.119 -175.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 41.89 47.97 3.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.887 1.275 . . . . 4.92 112.898 176.291 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.01 -40.1 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.451 0.7 . . . . 2.31 110.905 -174.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -67.63 -42.59 82.05 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.029 -1.044 . . . . 1.78 109.733 -177.523 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.38 -32.59 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 O-C-N 121.219 -0.925 . . . . 1.7 109.955 170.368 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -62.69 -25.8 68.34 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.597 -1.314 . . . . 1.73 112.133 173.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.95 -36.85 70.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.2 -0.937 . . . . 2.78 110.42 173.632 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.407 HG12 HD13 ' A' ' 65' ' ' LEU . 19.9 mt -49.51 -42.76 17.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-O 118.91 -0.567 . . . . 2.42 110.496 174.616 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -46.2 -58.41 3.68 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.377 0.535 . . . . 5.88 111.519 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -66.83 -39.93 87.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.981 0.512 . . . . 4.47 110.053 -173.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -58.42 -58.24 9.41 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.777 -0.647 . . . . 1.19 109.289 178.215 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.77 -39.67 92.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 119.176 -0.44 . . . . 2.57 111.058 -177.288 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.67 -34.71 3.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.67 0.788 . . . . 2.13 111.604 172.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -121.7 29.58 7.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.296 0.639 . . . . 3.22 111.914 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -72.87 -69.1 0.43 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.888 -0.782 . . . . 3.8 108.888 170.199 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.78 -143.37 0.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.014 0.926 . . . . 1.02 108.805 -167.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.9 -15.07 40.7 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 119.144 0.884 . . . . 1.55 114.039 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.3 79.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.567 1.147 . . . . 1.52 112.351 -177.302 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.86 52.52 1.68 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.225 1.012 . . . . 2.58 109.34 -178.344 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 m -160.48 145.05 14.3 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.305 -0.872 . . . . 2.78 109.099 172.422 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.9 t -140.87 112.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.046 -2.205 . . . . 2.79 105.046 171.393 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -131.57 79.83 1.9 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.496 0.665 . . . . 3.19 110.065 175.56 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 p -98.98 150.75 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 115.81 -0.632 . . . . 2.29 109.624 173.716 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.17 113.34 15.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.784 -1.191 . . . . 1.48 107.784 163.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 tp -62.67 -32.78 73.91 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.554 1.542 . . . . 3.28 109.869 176.583 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 28.7 mtt -57.62 -55.63 32.37 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.383 0.611 . . . . 3.1 110.192 -177.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.28 -21.6 25.67 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.268 -0.878 . . . . 1.94 110.928 -177.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.39 53.28 6.84 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 110.27 -1.132 . . . . 1.37 110.27 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -128.17 130.65 48.37 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.126 -1.435 . . . . 3.99 107.126 178.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.55 107.6 18.52 Favored 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 125.259 1.424 . . . . 1.17 109.194 167.534 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -99.29 131.87 45.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.751 -1.574 . . . . 4.6 106.751 166.259 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.73 163.91 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 119.104 0.865 . . . . 2.27 111.338 161.766 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.38 106.83 15.43 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.274 2.23 . . . . 8.21 107.562 175.803 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.404 ' HB2' HD12 ' A' ' 53' ' ' ILE . 19.3 p90 -106.76 -179.48 3.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.338 1.055 . . . . 3.01 113.14 171.558 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.66 118.88 14.75 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.238 1.415 . . . . 3.25 108.033 175.698 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.65 -16.43 38.03 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.9 3.067 . . . . 2.88 113.069 -165.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -72.44 -11.82 60.84 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.981 0.363 . . . . 3.56 111.981 -177.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.08 -46.93 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 123.438 0.695 . . . . 2.88 111.227 -170.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.55 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -114.12 152.47 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.141 0.576 . . . . 1.66 109.99 174.38 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -127.08 156.96 73.6 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 125.316 1.446 . . . . 2.59 109.696 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.19 -9.7 27.01 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.368 2.045 . . . . 1.54 112.276 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mp -73.54 -61.88 1.68 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.59 0.756 . . . . 2.56 110.159 172.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -32.41 73.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.481 -0.327 . . . . 5.05 111.195 -174.2 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.55 HD12 HD11 ' A' ' 53' ' ' ILE . 1.5 tt -58.79 -51.04 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.66 -1.607 . . . . 1.62 106.66 173.274 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.85 98.1 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.267 -0.424 . . . . 1.21 110.225 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -55.53 -46.41 77.08 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.433 -0.581 . . . . 2.42 109.433 174.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.24 -49.81 74.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.128 -0.693 . . . . 2.49 109.128 -177.67 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 69' ' ' ALA . 5.6 mm -55.57 -47.19 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 121.926 -0.484 . . . . 2.78 111.505 178.36 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.47 -47.56 81.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.989 0.516 . . . . 2.47 111.331 176.176 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.67 -49.82 71.67 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.42 0.688 . . . . 2.38 110.391 -178.117 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.407 HD13 HG12 ' A' ' 22' ' ' ILE . 4.3 mt -50.34 -43.24 53.99 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.761 1.224 . . . . 2.26 110.528 173.405 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.18 40.36 0.34 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 111.123 -0.791 . . . . 1.44 111.123 162.317 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -137.81 160.86 38.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.058 -0.719 . . . . 2.85 109.058 -175.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -98.52 117.39 32.83 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.595 -1.261 . . . . 2.77 107.595 170.53 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.516 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -96.57 111.45 23.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.409 -1.7 . . . . 1.03 106.409 164.05 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.02 154.59 46.49 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 106.708 -1.59 . . . . 0.95 106.708 169.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.02 148.59 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 115.446 -0.797 . . . . 3.86 109.202 -172.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.4 ptm . . . . . 0 CA--C 1.536 0.412 0 C-N-CA 120.016 -0.673 . . . . 3.79 111.066 177.561 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 124' ' ' PHE . . . . . . . . 0 N--CA 1.444 -0.804 0 N-CA-C 110.688 -0.965 . . . . 2.88 110.688 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -108.0 76.95 1.08 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.925 -1.139 . . . . 3.26 107.925 -140.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.8 pt -105.92 158.54 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.689 -0.486 . . . . 3.7 109.689 177.608 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -106.76 144.09 33.92 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 124.026 0.829 . . . . 4.49 109.989 169.124 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 mt -131.57 145.46 51.73 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.843 0.857 . . . . 2.41 109.126 175.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.52 124.2 44.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.147 0.979 . . . . 2.93 108.66 179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.34 110.97 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 O-C-N 123.57 0.544 . . . . 2.06 110.124 -176.582 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.9 p -96.53 164.97 12.38 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.539 -0.912 . . . . 2.74 108.539 177.244 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.5 -33.89 3.17 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 121.914 -0.491 . . . . 1.98 112.262 -178.222 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.69 142.17 50.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 117.991 0.896 . . . . 3.26 111.414 178.618 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 m -155.26 46.74 0.51 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.783 0.833 . . . . 3.3 108.782 172.595 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.7 t -165.36 143.69 6.19 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.263 -0.898 . . . . 3.63 111.136 174.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.66 -46.5 81.06 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 109.546 -0.538 . . . . 2.77 109.546 175.12 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.1 m -50.19 -41.44 49.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.753 0.821 . . . . 2.21 112.006 174.756 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.59 -50.68 62.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.249 -0.649 . . . . 2.49 109.249 -177.177 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -48.34 -54.77 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.122 0.569 . . . . 1.73 110.506 170.406 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.31 -39.6 83.56 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.842 0.829 . . . . 2.9 111.088 -176.415 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -63.67 -44.33 94.07 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.912 0.885 . . . . 2.24 110.499 175.429 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.6 mt -60.26 -46.88 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.593 -0.521 . . . . 1.02 109.593 176.094 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -55.8 -45.95 78.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.796 -0.446 . . . . 2.19 109.796 174.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.9 m -57.16 -48.19 79.32 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 117.82 0.282 . . . . 1.88 111.519 175.255 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -55.09 -52.36 63.48 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.825 0.739 . . . . 2.89 110.565 177.08 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.4 mt -57.93 -59.41 5.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.004 -0.739 . . . . 1.97 109.004 179.636 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 59.2 m -51.06 -26.06 5.81 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.772 1.629 . . . . 2.04 112.244 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -64.83 -19.77 66.04 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.77 -0.581 . . . . 4.05 112.359 177.622 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.5 m -68.87 139.12 55.15 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.731 1.212 . . . . 2.24 111.116 178.162 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -54.4 -57.29 11.85 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.836 0.854 . . . . 4.22 111.926 177.089 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.44 -36.02 76.77 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 121.237 0.354 . . . . 1.85 112.59 -170.478 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.49 121.24 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 122.007 -0.702 . . . . 2.51 109.337 -173.102 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.5 m -97.48 -42.95 7.47 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.857 -0.423 . . . . 2.42 109.857 -176.019 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.471 ' CE2' ' HD3' ' A' ' 123' ' ' LYS . 36.7 p90 -144.07 97.41 3.05 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 113.664 0.987 . . . . 1.94 113.664 -178.418 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -94.09 135.87 34.99 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 107.675 -1.231 . . . . 1.19 107.675 178.563 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.3 t -129.1 108.42 10.36 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.91 -0.774 . . . . 2.52 108.91 172.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 120' ' ' ALA . 5.0 p -100.28 131.12 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.106 1.363 . . . . 2.57 108.926 -179.366 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -127.25 144.63 51.0 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.799 1.181 . . . . 2.62 109.475 179.031 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 pp -104.61 -43.72 5.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 124.415 1.086 . . . . 3.06 109.481 -171.311 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -46.71 -41.85 15.69 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.485 1.114 . . . . 2.8 111.71 173.17 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -106.87 1.96 25.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.671 1.188 . . . . 2.64 111.819 178.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.5 p 60.55 -6.77 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 127.925 2.49 . . . . 2.27 115.498 177.425 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -98.43 155.42 17.25 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.814 0.846 . . . . 4.31 111.319 -174.155 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.65 ' HB2' HG23 ' A' ' 113' ' ' VAL . . . -140.68 120.56 13.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.883 0.873 . . . . 1.41 110.513 -174.669 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.8 119.81 34.95 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.287 2.235 . . . . 2.14 107.865 -173.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 22.6 t -128.88 122.77 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 116.27 -1.824 . . . . 2.34 108.602 -168.332 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.471 ' HD3' ' CE2' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -112.91 97.49 6.57 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.965 1.257 . . . . 5.4 110.446 -179.344 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.414 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 50.2 p90 -114.2 -179.46 3.64 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.378 1.049 . . . . 2.65 112.374 -178.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -98.37 109.36 52.14 Favored Pre-proline 0 C--O 1.237 0.444 0 N-CA-C 107.454 -1.313 . . . . 3.19 107.454 176.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -78.12 69.93 7.32 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.885 2.39 . . . . 3.02 110.747 -171.42 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -163.31 -46.13 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.935 1.694 . . . . 4.28 109.063 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 pt -85.62 -33.1 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 117.693 0.224 . . . . 2.69 111.021 -177.086 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.17 160.06 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.119 -1.067 . . . . 2.38 108.119 177.288 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.82 156.13 24.68 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.228 -1.149 . . . . 2.35 110.228 -177.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -59.77 -33.93 96.08 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.74 2.96 . . . . 2.5 111.887 -174.228 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -54.87 -35.32 63.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.235 -0.29 . . . . 5.23 110.934 177.606 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -70.54 -40.79 73.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.272 -1.01 . . . . 3.32 108.272 -174.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 62.1 mt -53.51 -57.86 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.83 -0.804 . . . . 2.22 108.83 174.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.8 pt -56.16 -51.09 66.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 118.291 -0.861 . . . . 3.3 111.056 178.602 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -53.94 -47.81 70.89 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.952 1.251 . . . . 3.89 111.352 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.6 mm -57.4 -50.57 76.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 121.545 -0.722 . . . . 2.56 109.712 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.282 2.7 pp -70.85 -26.17 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 119.113 -1.035 . . . . 1.39 113.245 -177.831 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.09 -37.29 79.5 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.093 0.957 . . . . 4.02 110.42 169.448 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.88 -31.14 72.22 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.794 -0.566 . . . . 4.7 110.071 176.237 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.5 mt -73.36 -39.55 55.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.578 -0.527 . . . . 1.65 109.578 170.795 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.81 26.06 5.44 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.917 1.723 . . . . 1.29 111.454 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -104.28 179.96 4.12 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.14 -1.43 . . . . 2.86 107.14 175.356 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -142.28 130.58 22.24 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.63 -1.248 . . . . 4.02 107.63 173.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.91 81.88 1.84 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.133 0.973 . . . . 1.79 109.492 -168.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.8 m -97.75 120.2 37.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.162 -0.681 . . . . 2.17 109.162 -170.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -40.06 107.8 0.08 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.381 1.473 . . . . 3.56 110.631 164.615 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.36 43.88 2.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.24 0.83 . . . . 4.95 113.24 -175.277 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 . . . . . 0 C--O 1.252 1.235 0 CA-C-O 117.305 -1.331 . . . . 6.07 111.159 167.528 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.12 -0.696 . . . . 3.84 109.12 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -96.38 134.33 39.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.764 -1.569 . . . . 5.97 106.764 176.632 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.9 t -116.82 133.45 56.0 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 124.036 0.835 . . . . 2.01 109.204 -179.275 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -103.61 103.57 13.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.59 1.156 . . . . 2.95 109.756 -170.108 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.65 172.02 10.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.116 0.96 . . . . 2.7 112.516 176.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.14 153.86 43.98 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.251 -1.388 . . . . 1.64 107.251 168.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.4 mm -98.94 139.9 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 106.815 -1.55 . . . . 1.12 106.815 170.74 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 mtmm -111.71 112.33 23.95 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.239 -1.763 . . . . 2.98 106.239 159.588 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.16 -81.95 0.17 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.211 1.386 . . . . 1.29 110.132 -177.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.5 mtm 29.28 77.13 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.958 2.103 . . . . 1.98 114.707 -175.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.4 p -57.19 -43.02 82.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.605 0.762 . . . . 3.26 112.153 176.505 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.7 t 111.13 -42.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.965 2.506 . . . . 3.01 110.715 175.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.28 -67.42 0.19 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.41 1.484 . . . . 5.93 112.146 -174.478 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.99 24.24 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.922 0.489 . . . . 3.0 111.384 167.052 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.5 m -70.86 -45.82 63.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 120.974 -1.079 . . . . 1.83 109.939 -172.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.5 t -57.04 -49.78 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.08 -1.081 . . . . 1.53 108.08 175.467 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -54.19 -45.44 72.17 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.895 1.278 . . . . 2.32 111.868 -178.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.01 -50.39 68.68 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 121.654 -0.654 . . . . 2.49 109.837 174.781 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mt -49.39 -41.24 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 124.238 1.015 . . . . 1.6 110.792 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -47.49 -56.24 7.44 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.514 0.597 . . . . 3.99 111.542 176.199 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -64.45 -46.64 82.29 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.463 -0.569 . . . . 5.02 109.463 -177.214 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -55.07 -55.46 30.74 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 109.207 -0.664 . . . . 1.4 109.207 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.48 -43.98 88.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.633 -0.699 . . . . 2.9 110.371 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -50.78 -33.85 25.05 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.283 1.401 . . . . 1.87 112.474 170.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -95.97 19.02 12.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.927 0.891 . . . . 2.81 112.165 -177.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.4 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 5.4 tp10 -72.34 -74.78 0.15 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.911 0.884 . . . . 2.97 109.535 174.535 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -163.26 -117.61 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.861 -0.524 . . . . 1.35 111.193 -170.379 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.18 -31.13 72.29 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.456 -0.658 . . . . 1.75 111.456 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 29' ' ' GLU . 3.5 p -59.01 125.17 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 122.916 0.486 . . . . 1.59 111.274 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.08 52.17 1.38 Allowed 'General case' 0 CA--C 1.522 -0.103 0 CA-C-O 122.325 1.059 . . . . 2.8 109.705 170.626 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -156.46 154.73 30.87 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.403 -1.332 . . . . 2.03 107.403 169.601 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -141.02 119.57 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.904 -1.887 . . . . 2.63 105.904 176.187 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tt -131.06 70.34 1.47 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.415 -1.328 . . . . 2.55 107.415 176.01 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.9 t -98.53 130.21 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.294 -1.002 . . . . 1.87 108.294 175.181 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.93 97.08 8.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.298 -1.371 . . . . 1.21 107.298 168.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.1 -23.33 54.4 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.059 0.544 . . . . 2.66 111.082 175.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 52.0 mtt -75.44 -55.16 5.96 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.672 -0.642 . . . . 3.87 110.12 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.58 -22.84 37.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.968 0.507 . . . . 1.29 111.823 -175.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.48 61.78 2.88 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 124.209 0.909 . . . . 1.07 111.047 -178.629 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -140.91 140.17 34.46 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.834 -1.543 . . . . 3.1 106.834 172.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.0 99.11 7.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.113 1.365 . . . . 0.86 109.855 174.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.22 135.94 37.37 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 104.61 -2.367 . . . . 3.72 104.61 166.784 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 pt -131.12 -179.17 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.324 -1.361 . . . . 1.78 107.324 169.26 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -132.87 104.85 6.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.215 -0.661 . . . . 4.19 109.215 173.358 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.428 ' HB2' HD12 ' A' ' 53' ' ' ILE . 6.6 p90 -119.7 167.18 12.3 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.825 1.65 . . . . 3.07 112.553 178.429 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.48 100.72 19.7 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.745 1.618 . . . . 4.04 109.803 -174.552 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.55 -11.08 18.51 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.094 2.53 . . . . 2.41 114.074 -173.347 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -85.75 -20.45 29.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.718 0.807 . . . . 5.08 112.505 179.432 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 m -120.34 -39.91 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-O 118.635 -0.698 . . . . 3.42 111.554 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -110.18 139.01 35.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 123.282 0.633 . . . . 1.78 109.505 176.985 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.517 ' HB3' HD23 ' A' ' 56' ' ' LEU . 1.1 mp0 -114.92 154.05 47.02 Favored Pre-proline 0 N--CA 1.451 -0.385 0 C-N-CA 125.779 1.632 . . . . 2.69 111.026 -178.753 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.97 -39.01 43.07 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.061 2.507 . . . . 1.3 112.659 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 54' ' ' GLN . 2.3 pt? -64.79 -46.73 80.83 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.148 -0.97 . . . . 2.81 111.635 -174.34 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.11 -33.61 75.83 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.207 0.603 . . . . 4.81 112.216 175.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.12 -47.61 43.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 107.756 -1.201 . . . . 1.05 107.756 163.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 56' ' ' LEU . . . -58.47 -48.8 79.57 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.456 -0.793 . . . . 1.15 109.597 -173.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -47.5 -49.85 24.84 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.903 0.32 . . . . 3.41 110.806 176.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.75 -53.49 54.34 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.376 0.608 . . . . 2.68 110.969 -176.548 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.689 HD13 ' H ' ' A' ' 69' ' ' ALA . 2.2 pp -63.71 -39.81 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 118.774 -0.631 . . . . 4.17 111.847 178.43 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -63.21 -42.36 99.28 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.612 1.097 . . . . 1.93 109.201 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.08 -49.44 75.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.498 0.719 . . . . 2.73 109.355 -179.572 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.1 mt -54.9 -38.66 67.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.397 -0.365 . . . . 1.81 111.77 172.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.65 29.71 2.38 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 123.891 0.758 . . . . 1.28 111.601 168.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -116.72 154.16 31.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.34 1.456 . . . . 2.4 107.681 173.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -95.72 128.07 42.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.648 -1.612 . . . . 3.01 106.648 164.061 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.689 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -107.33 133.57 51.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.455 -2.054 . . . . 0.93 105.455 163.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.05 140.29 41.93 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.498 1.124 . . . . 0.99 108.638 171.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.27 147.37 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.221 -1.029 . . . . 2.88 108.221 -179.14 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.6 mtp . . . . . 0 N--CA 1.451 -0.375 0 C-N-CA 123.765 0.826 . . . . 3.52 111.033 179.061 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 N-CA-C 107.557 -2.217 . . . . 2.07 107.557 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.532 ' C ' HD13 ' A' ' 82' ' ' ILE . 6.2 p-10 -104.0 133.4 49.02 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.691 0.796 . . . . 3.96 109.642 175.338 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.532 HD13 ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -127.7 158.1 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.963 -1.125 . . . . 3.12 107.963 171.647 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.88 144.38 46.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.092 -1.818 . . . . 3.48 106.092 166.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mt -140.85 150.65 43.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.072 -1.825 . . . . 2.54 106.072 168.526 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -98.25 126.18 43.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.698 -1.223 . . . . 1.82 107.698 177.113 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.7 pt -98.47 127.29 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.682 -0.859 . . . . 1.95 108.682 -175.855 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.7 m -119.42 137.37 53.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.46 -0.941 . . . . 1.64 108.46 177.003 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.22 -45.75 1.16 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.336 1.446 . . . . 1.12 111.295 175.125 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 157.31 27.81 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.1 -0.647 . . . . 3.33 111.423 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -168.54 52.07 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.007 0.923 . . . . 3.35 109.341 171.626 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -165.63 137.33 3.98 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 120.882 -1.137 . . . . 2.62 109.751 178.647 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.47 -42.04 31.43 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.868 0.867 . . . . 3.06 111.01 175.641 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -55.3 -49.06 73.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.204 0.602 . . . . 1.89 110.792 175.45 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 79.0 m -63.65 -46.75 84.21 Favored 'General case' 0 N--CA 1.458 -0.053 0 O-C-N 121.707 -0.62 . . . . 1.8 109.729 -178.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.81 -49.29 70.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 122.777 0.431 . . . . 1.71 110.708 175.444 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -57.74 -41.76 82.54 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.119 0.568 . . . . 4.62 110.707 175.827 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -63.09 -41.47 99.4 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.672 -0.643 . . . . 1.59 110.686 177.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.9 mt -61.35 -52.27 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.576 0.75 . . . . 1.0 109.698 175.069 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.87 -39.09 76.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.501 -0.749 . . . . 2.34 109.473 177.59 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.8 t -60.66 -56.8 16.94 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.626 0.771 . . . . 1.36 110.671 176.547 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -30.72 70.89 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 120.303 1.41 . . . . 4.54 111.343 -175.181 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 mt -67.5 -59.61 3.23 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 109.233 -0.655 . . . . 1.72 109.233 171.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.7 m -54.96 -19.92 7.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.912 0.885 . . . . 1.81 111.777 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.04 -33.04 66.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.831 0.852 . . . . 5.19 111.992 173.498 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.3 p -75.45 166.09 24.13 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.927 0.891 . . . . 2.78 111.604 -173.282 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.68 -40.38 34.08 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.243 -0.286 . . . . 3.5 111.572 178.539 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.55 -35.06 37.78 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 122.833 0.254 . . . . 1.59 113.582 -169.002 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.36 133.09 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 O-C-N 121.658 -0.907 . . . . 2.19 109.128 -174.075 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.8 p -107.63 -53.44 2.62 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 122.905 0.482 . . . . 2.48 111.816 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.51 126.09 32.11 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.55 -0.907 . . . . 2.05 108.55 169.725 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.57 153.61 18.91 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.025 -1.102 . . . . 1.07 108.025 161.331 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.8 m -144.7 116.92 8.42 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.139 -1.06 . . . . 2.01 108.139 166.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 p -118.12 132.33 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.745 0.818 . . . . 1.92 110.446 -174.519 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -129.57 98.66 4.91 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.142 0.977 . . . . 1.48 110.878 -172.126 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -25.4 66.23 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.686 1.194 . . . . 2.18 112.445 -176.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.83 -32.56 53.27 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.114 0.566 . . . . 1.9 111.033 173.046 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.07 -9.14 12.39 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.369 1.468 . . . . 2.24 111.166 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.0 m 63.03 31.78 15.82 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.831 1.652 . . . . 1.42 112.407 -178.599 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.3 mmtm -105.35 153.54 21.51 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.613 0.765 . . . . 3.63 110.929 176.018 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.84 113.82 15.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.985 2.114 . . . . 1.06 107.19 173.18 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.06 134.18 38.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.143 -1.429 . . . . 1.82 107.143 173.581 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.4 t -135.33 129.62 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 124.027 0.931 . . . . 2.0 108.578 -174.04 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -111.96 93.61 4.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.43 1.092 . . . . 3.13 109.148 178.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -119.9 175.01 6.1 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.709 0.804 . . . . 2.17 111.627 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -97.86 115.75 65.74 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.672 -0.862 . . . . 3.7 108.672 174.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -76.45 71.19 6.0 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.444 2.763 . . . . 2.09 111.275 -171.191 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -161.62 -46.01 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.169 1.387 . . . . 4.13 109.305 177.145 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -87.48 -32.33 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 123.256 0.623 . . . . 2.04 111.469 -174.292 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.92 165.15 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 124.258 1.023 . . . . 1.6 108.406 176.436 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.91 168.37 32.34 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.403 -0.679 . . . . 1.36 111.403 -178.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.68 -34.87 49.41 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.839 3.026 . . . . 1.49 112.583 -172.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -44.94 87.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.594 -0.891 . . . . 5.2 108.594 177.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.08 -41.68 94.83 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.47 -0.937 . . . . 3.26 108.47 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 83.2 mt -55.08 -57.39 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 117.749 -1.12 . . . . 1.21 109.99 176.491 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . 0.264 18.0 pt -52.45 -56.03 8.51 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 CA-C-N 119.109 0.868 . . . . 2.47 109.998 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -48.86 -52.2 25.56 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.135 0.969 . . . . 3.71 111.926 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.69 -33.65 61.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 118.785 -0.626 . . . . 2.5 110.507 -175.69 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.35 2.6 pp -75.26 -32.33 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 114.891 1.441 . . . . 1.24 114.891 168.331 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.97 -34.21 69.7 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.307 0.958 . . . . 2.2 109.634 174.003 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.86 -35.88 82.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.085 0.469 . . . . 3.78 109.929 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 32.7 mm -76.18 -42.66 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.277 -0.638 . . . . 2.4 109.277 173.452 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.5 41.13 1.06 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.1 1.333 . . . . 0.96 111.59 178.279 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -112.54 -180.0 3.82 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.365 -0.976 . . . . 2.34 108.365 166.466 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -133.63 132.96 41.39 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.89 -1.152 . . . . 3.67 107.89 171.58 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.67 95.03 4.68 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 123.981 0.912 . . . . 1.45 109.778 -175.329 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.7 t -110.01 121.41 45.18 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.255 0.622 . . . . 2.75 109.852 -172.172 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -38.64 115.97 0.51 Allowed 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 126.37 1.868 . . . . 4.06 110.89 171.801 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.584 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -103.26 30.77 4.68 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.151 1.167 . . . . 3.23 114.151 -178.686 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.301 0 CA-C-O 116.999 -1.477 . . . . 7.76 111.571 177.535 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.226 -0.136 0 CA-C-O 120.894 0.378 . . . . 3.8 110.821 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.1 143.13 29.71 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.991 -0.443 . . . . 3.98 110.912 179.02 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -125.94 131.63 52.25 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.413 1.085 . . . . 2.79 108.109 177.479 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -113.71 97.25 6.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.69 -1.226 . . . . 4.89 107.69 -171.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 44' ' ' ALA 0.252 0.0 OUTLIER -122.36 177.09 5.53 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.829 0.824 . . . . 2.38 110.508 -178.13 . . . . . . . . 4 4 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.477 ' OE1' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -132.12 147.49 52.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.317 -1.734 . . . . 1.63 106.317 174.51 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.4 mm -98.38 132.36 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 106.814 -1.55 . . . . 0.77 106.814 177.259 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -111.46 109.14 18.95 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.171 -1.418 . . . . 5.01 107.171 170.004 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.94 -83.91 0.09 OUTLIER Glycine 0 CA--C 1.532 1.106 0 N-CA-C 110.159 -1.176 . . . . 1.15 110.159 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 47.52 70.46 0.42 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.746 1.618 . . . . 1.95 114.203 179.119 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.9 m -49.09 -59.33 3.73 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.451 -0.781 . . . . 2.36 112.521 170.697 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 t -168.59 63.66 0.06 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.541 1.064 . . . . 3.11 111.212 -175.257 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.408 ' HA ' HD22 ' A' ' 39' ' ' LEU . . . 31.86 56.82 0.33 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.076 1.75 . . . . 5.82 113.411 177.362 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.1 t -169.17 -49.52 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 122.762 1.268 . . . . 2.87 108.39 -167.569 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 19.7 p -61.87 -40.57 95.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.511 -0.743 . . . . 3.5 110.529 178.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.711 ' HB ' HD21 ' A' ' 39' ' ' LEU . 50.9 t -70.87 -31.25 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.924 -0.769 . . . . 1.95 108.924 173.008 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -58.57 -31.76 68.3 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.487 -0.758 . . . . 1.89 111.464 175.127 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -55.38 -50.05 70.71 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.231 -0.918 . . . . 3.21 109.642 170.092 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.42 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -46.93 -47.24 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 125.546 1.539 . . . . 2.48 110.023 -176.509 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -50.47 -59.02 4.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.449 1.119 . . . . 3.76 109.626 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -70.0 -19.31 63.33 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.997 -1.065 . . . . 4.68 112.422 -177.336 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -70.24 -56.0 7.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.939 -0.763 . . . . 1.15 108.939 168.284 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.42 HD12 ' O ' ' A' ' 22' ' ' ILE . 1.2 mp -59.41 -34.87 72.99 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.59 -0.694 . . . . 2.15 112.412 179.029 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.71 -20.87 15.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.891 1.223 . . . . 3.24 112.022 178.066 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -128.68 36.07 4.28 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.283 0.633 . . . . 4.8 110.9 174.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -67.78 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.804 -0.813 . . . . 3.26 108.804 167.7 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.27 -128.73 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.715 0.806 . . . . 1.66 108.926 -163.187 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.12 -20.26 68.88 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.679 0.656 . . . . 2.09 112.984 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.44 124.06 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 117.557 0.679 . . . . 2.05 110.561 176.696 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.85 57.53 1.56 Allowed 'General case' 0 C--N 1.339 0.129 0 CA-C-O 121.573 0.701 . . . . 3.14 110.343 172.749 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -155.97 159.63 39.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.863 -1.162 . . . . 1.93 107.863 160.354 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.85 114.8 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.672 0.789 . . . . 2.57 109.252 170.65 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -127.23 74.61 1.52 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.534 -0.913 . . . . 2.71 108.534 176.666 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.93 142.26 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 N-CA-C 109.378 -0.601 . . . . 2.49 109.378 171.31 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.44 94.46 4.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.772 -1.196 . . . . 1.69 107.772 165.586 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.711 HD21 ' HB ' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -56.08 -18.83 10.79 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.937 0.895 . . . . 3.85 112.198 172.69 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.9 ttm -66.07 -44.22 85.09 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.361 1.064 . . . . 4.12 110.62 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.77 -29.24 12.74 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.077 0.951 . . . . 1.65 111.126 -178.757 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.39 63.19 1.51 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.111 -1.196 . . . . 1.31 110.111 -177.119 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -140.4 132.11 27.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.008 -2.219 . . . . 3.5 105.008 174.303 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 8' ' ' LEU . . . -115.69 105.27 12.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.555 1.159 . . . . 1.26 110.011 170.155 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.9 137.51 41.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.712 -1.218 . . . . 5.33 107.712 169.829 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.43 ' CD1' HD11 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -138.46 173.27 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.525 0.602 . . . . 2.15 110.227 171.027 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -116.39 102.2 9.32 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.081 1.352 . . . . 5.95 110.239 174.548 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.544 ' HB2' HD12 ' A' ' 53' ' ' ILE . 8.0 p90 -98.6 173.74 6.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.092 1.357 . . . . 3.43 113.055 171.126 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -124.07 100.01 36.97 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.553 1.541 . . . . 3.08 108.192 -179.132 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.8 5.36 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.72 1 C-N-CA 125.387 4.058 . . . . 3.11 115.35 -166.37 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.05 -17.23 16.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.533 1.533 . . . . 4.72 110.359 -177.073 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.0 p -124.86 -41.23 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.498 1.119 . . . . 4.16 110.933 178.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -116.36 143.6 26.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 N-CA-C 108.794 -0.817 . . . . 2.35 108.794 179.286 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.37 149.89 50.66 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 124.842 1.257 . . . . 3.43 109.402 -176.15 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -57.34 -39.34 90.38 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.951 2.434 . . . . 2.08 111.228 -177.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -60.02 -39.94 87.58 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.222 0.609 . . . . 3.51 110.995 175.021 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -65.46 -43.33 90.69 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.118 -0.697 . . . . 3.83 109.118 178.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.77 -50.52 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.625 -1.25 . . . . 1.38 107.625 174.51 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.48 66.72 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.585 -0.734 . . . . 1.47 110.807 -174.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -52.54 -49.75 64.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.728 0.811 . . . . 4.86 110.526 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -47.84 80.76 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 122.009 0.909 . . . . 3.26 109.298 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mm -59.37 -42.91 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.581 -0.736 . . . . 2.5 111.001 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -67.3 -39.05 85.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.392 0.277 . . . . 2.46 110.43 179.522 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.01 -54.6 44.1 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.219 1.008 . . . . 3.79 109.847 176.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.63 -46.45 73.91 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.776 -0.193 . . . . 3.91 110.829 175.63 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.72 39.87 0.41 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.429 -1.068 . . . . 1.74 110.429 162.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -129.65 164.96 22.77 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.222 -1.399 . . . . 2.32 107.222 178.151 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -98.51 132.37 44.0 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.872 -1.159 . . . . 2.5 107.872 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.54 116.51 31.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.578 -1.267 . . . . 1.3 107.578 173.025 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB3' ' OE1' ' A' ' 9' ' ' GLN . . . -130.57 138.8 50.34 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.203 -1.036 . . . . 0.9 108.203 173.649 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -67.01 146.3 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.3 -1.0 . . . . 2.93 108.3 178.082 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.1 mtp . . . . . 0 CA--C 1.535 0.368 0 C-N-CA 119.967 -0.693 . . . . 3.8 110.508 -179.754 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.429 0 N-CA-C 109.298 -1.521 . . . . 2.68 109.298 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.435 HD22 ' HB3' ' A' ' 121' ' ' LEU . 21.8 t-20 -111.69 145.94 38.39 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 126.011 1.724 . . . . 4.17 107.548 166.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.449 HD12 ' O ' ' A' ' 82' ' ' ILE 0.281 1.1 pp -114.95 140.15 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.363 0.528 . . . . 4.42 109.762 150.643 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.541 ' OE1' ' HB3' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -107.64 123.34 48.34 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.603 2.361 . . . . 3.51 107.205 175.796 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.436 HD13 ' CB ' ' A' ' 145' ' ' ALA . 4.6 pp -120.95 151.72 39.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 123.452 0.47 . . . . 3.69 110.188 173.585 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -94.66 126.76 40.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.582 -2.377 . . . . 2.32 104.582 175.516 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 pt -99.03 130.06 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.376 -0.972 . . . . 1.82 108.376 176.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.4 m -123.97 141.95 51.59 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.416 -0.957 . . . . 2.12 108.416 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.08 -37.36 3.76 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.621 1.105 . . . . 1.43 111.361 -178.387 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.417 ' HB2' ' SG ' ' A' ' 94' ' ' CYS . 0.0 OUTLIER -61.27 159.06 12.93 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.053 0.541 . . . . 2.78 111.998 177.861 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.9 t -175.0 48.95 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.019 0.927 . . . . 3.3 110.229 170.07 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 8.5 t -160.39 144.26 13.96 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.958 -1.088 . . . . 2.88 111.715 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.22 -10.48 23.65 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.02 0.928 . . . . 3.13 113.305 178.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.7 t -79.2 -46.28 18.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.563 0.745 . . . . 2.84 109.091 170.009 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 89' ' ' MET . 5.1 t -56.95 -53.64 55.77 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 121.762 -0.586 . . . . 3.45 110.264 -177.215 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 p -51.22 -43.32 27.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.553 0.205 . . . . 2.83 111.553 175.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -32.51 74.18 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.363 0.665 . . . . 3.1 109.985 179.053 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -66.96 -56.9 8.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.804 1.242 . . . . 2.19 108.507 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 mp -45.59 -60.38 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 C-N-CA 124.471 1.108 . . . . 1.61 110.265 167.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -52.4 -44.4 65.35 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.465 0.575 . . . . 2.9 111.772 -178.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.0 t -65.4 -60.26 3.15 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.018 -1.051 . . . . 1.84 110.883 178.654 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -33.46 75.65 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.525 -0.734 . . . . 4.06 111.147 -171.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.93 -49.78 48.48 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.249 -0.882 . . . . 3.24 109.256 171.098 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.2 m -57.4 -24.43 55.38 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.164 1.347 . . . . 2.52 111.183 -177.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -57.22 -30.99 65.04 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.099 0.778 . . . . 4.31 113.099 172.479 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.8 m -57.03 153.98 10.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.799 1.24 . . . . 1.86 111.868 175.726 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -73.8 -56.19 5.28 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.826 1.25 . . . . 2.97 112.533 -176.061 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.403 ' HA3' HD11 ' A' ' 128' ' ' ILE . . . -74.45 -34.86 53.45 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 121.88 -0.513 . . . . 1.75 112.016 -171.538 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.18 132.56 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.184 -0.672 . . . . 2.0 109.184 -175.395 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.5 m -121.1 -38.57 2.8 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 112.965 0.728 . . . . 2.71 112.965 -177.334 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -142.27 140.41 32.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.884 -1.127 . . . . 2.75 110.235 164.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.86 161.43 18.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.964 -1.016 . . . . 1.54 109.789 160.767 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -142.44 118.94 10.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.228 -1.767 . . . . 2.23 106.228 165.574 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 42.9 t -112.57 129.25 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 118.196 0.453 . . . . 2.55 110.476 178.543 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -117.66 126.75 53.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.354 1.062 . . . . 1.38 109.189 -177.455 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mp -90.4 -41.01 11.72 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.794 2.038 . . . . 3.81 108.729 -170.399 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -43.77 -44.1 6.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.634 1.574 . . . . 1.41 110.324 172.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -100.95 -15.07 17.64 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.729 0.812 . . . . 2.35 112.464 174.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.9 m 65.86 30.58 9.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.971 1.708 . . . . 1.77 113.896 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -106.14 149.86 26.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.534 1.533 . . . . 4.53 110.3 177.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.92 112.64 15.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.154 0.982 . . . . 1.24 108.897 176.486 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.435 ' HB3' HD22 ' A' ' 81' ' ' ASN . 4.1 mm? -95.61 124.52 39.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.869 -1.53 . . . . 2.58 106.869 176.77 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.5 123.24 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 C-N-CA 125.364 1.466 . . . . 1.86 108.844 -178.322 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -96.37 100.65 12.25 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.221 -1.029 . . . . 3.69 108.221 -177.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -126.12 174.13 8.71 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 123.833 0.708 . . . . 2.69 109.761 -178.014 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -104.48 117.56 58.83 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 118.273 -0.87 . . . . 5.24 109.471 177.686 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -73.78 71.36 4.09 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.401 2.734 . . . . 2.97 111.882 -174.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -166.52 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.864 1.666 . . . . 3.86 110.013 174.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.534 HD12 ' HB ' ' A' ' 129' ' ' ILE . 2.2 pp -87.09 -41.22 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 118.448 0.567 . . . . 3.22 111.297 -169.741 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.534 ' HB ' HD12 ' A' ' 128' ' ' ILE . 0.4 OUTLIER -128.79 170.22 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.447 1.499 . . . . 2.12 107.557 174.384 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.36 25.5 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.1 -1.2 . . . . 1.99 110.1 176.269 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.69 -45.78 23.62 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.021 2.48 . . . . 1.99 110.768 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.4 ttm105 -48.37 -39.45 22.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.679 1.192 . . . . 6.91 113.106 -178.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -53.34 58.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.333 -0.617 . . . . 3.96 109.333 173.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.97 -44.55 82.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 109.442 -0.577 . . . . 1.21 109.442 -178.035 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' A' ' 145' ' ' ALA . 86.9 mt -51.89 -56.42 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.165 0.986 . . . . 2.27 108.498 174.06 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -55.17 -43.98 74.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.015 -1.053 . . . . 4.04 112.512 178.297 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.2 mm -63.92 -34.25 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.704 -0.623 . . . . 2.05 110.35 -177.48 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 145' ' ' ALA . 27.3 pt -74.57 -33.52 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 119.812 1.187 . . . . 1.58 113.377 168.888 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -56.04 -25.98 47.1 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.475 1.034 . . . . 3.06 111.47 176.352 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.74 -34.49 75.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.835 0.454 . . . . 3.9 110.029 176.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.3 mt -79.31 -44.4 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.178 -0.675 . . . . 1.79 109.178 172.085 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.77 36.19 2.64 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 124.314 0.959 . . . . 1.43 110.868 -177.099 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -96.89 168.18 10.64 Favored 'General case' 0 C--N 1.338 0.083 0 N-CA-C 108.23 -1.026 . . . . 2.81 108.23 165.764 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -125.19 123.01 38.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.226 -1.768 . . . . 3.54 106.226 -177.231 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.436 ' CB ' HD13 ' A' ' 84' ' ' LEU . . . -111.0 107.91 17.47 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.838 1.255 . . . . 2.11 108.48 174.546 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.5 m -108.29 114.95 29.21 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.42 -0.955 . . . . 2.65 108.42 168.112 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -35.75 107.14 0.05 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 126.735 2.014 . . . . 4.27 110.122 170.619 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.632 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -82.93 -36.7 25.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.378 -0.601 . . . . 3.67 109.378 -175.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.109 0 C-N-CA 125.668 1.587 . . . . 5.91 112.713 -165.211 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 . . . . . 0 C--O 1.223 -0.329 0 N-CA-C 109.967 -0.383 . . . . 3.61 109.967 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -90.75 130.85 36.69 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.097 0.959 . . . . 5.12 109.464 -159.517 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.3 t -138.02 123.33 19.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.971 0.508 . . . . 1.85 110.227 177.808 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -98.64 106.76 19.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.913 1.685 . . . . 2.91 107.788 174.819 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -128.6 171.82 11.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.384 -0.969 . . . . 2.6 108.384 179.226 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.453 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -141.21 144.95 35.03 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.314 -0.866 . . . . 1.54 109.352 175.037 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.3 mm -99.16 126.14 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 106.178 -1.786 . . . . 1.55 106.178 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -95.56 99.06 10.98 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.658 -1.608 . . . . 3.61 106.658 174.425 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.65 -94.18 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.623 -1.391 . . . . 1.76 109.623 178.429 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.0 mtt 58.66 90.66 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.485 1.514 . . . . 2.39 113.789 179.588 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -14.72 33.93 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.083 -1.011 . . . . 2.11 113.125 172.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 t 72.88 -59.97 0.55 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 126.239 1.816 . . . . 4.06 112.395 -178.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.25 -74.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.993 2.117 . . . . 4.81 113.103 -174.385 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.5 p -154.24 15.17 0.46 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.668 0.387 . . . . 2.67 111.706 168.71 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.7 m -69.42 -53.3 20.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.286 -1.376 . . . . 1.8 107.286 -170.372 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.541 ' HB ' HD11 ' A' ' 39' ' ' LEU . 71.9 t -61.73 -39.83 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 119.554 -0.858 . . . . 1.74 109.759 -175.551 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.1 t -53.08 -46.65 68.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.893 0.477 . . . . 2.39 111.311 173.576 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -63.07 -49.26 75.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.251 -0.906 . . . . 2.67 109.351 176.509 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.541 HG13 HD13 ' A' ' 65' ' ' LEU . 1.3 mp -49.9 -53.53 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.322 0.649 . . . . 2.05 109.546 178.85 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -48.62 -52.71 21.69 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.99 1.316 . . . . 4.5 111.5 175.782 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -70.24 -24.0 63.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.256 -0.902 . . . . 4.85 111.006 -176.994 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -71.66 -44.81 63.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.305 -0.872 . . . . 1.26 109.933 170.034 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.83 -37.6 79.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.127 0.571 . . . . 1.99 110.947 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -26.97 6.58 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.481 0.549 . . . . 1.81 112.481 172.081 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -109.7 19.38 19.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.489 1.116 . . . . 4.67 111.381 -177.429 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -73.76 -67.22 0.62 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.612 -0.884 . . . . 3.23 108.612 174.627 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.6 -96.55 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.852 1.261 . . . . 1.23 109.443 173.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.38 -5.82 89.58 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.897 -0.502 . . . . 1.39 112.658 -176.924 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.36 114.11 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 118.044 0.922 . . . . 2.56 109.682 176.981 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.68 53.05 1.61 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.539 -1.282 . . . . 3.39 107.539 179.109 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -162.73 153.24 16.72 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.804 -1.184 . . . . 1.65 107.804 158.334 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.2 94.77 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 125.421 1.488 . . . . 2.52 106.989 172.312 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -116.34 66.31 0.71 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.275 -1.379 . . . . 2.52 107.275 176.801 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 t -97.47 130.92 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.585 -0.894 . . . . 1.93 108.585 175.438 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.52 96.8 6.98 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.844 -1.169 . . . . 1.17 107.844 175.069 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.541 HD11 ' HB ' ' A' ' 19' ' ' VAL . 2.8 mm? -63.58 -12.95 37.11 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.333 0.515 . . . . 3.6 111.888 178.436 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -43.61 13.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.095 0.958 . . . . 5.84 111.41 -178.791 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.71 -36.26 15.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.74 0.816 . . . . 1.24 111.017 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.19 62.28 1.23 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.53 1.538 . . . . 0.98 111.101 178.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -143.41 138.8 29.6 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.588 -1.634 . . . . 3.14 106.588 177.08 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.37 98.91 8.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 124.443 1.089 . . . . 0.83 112.326 171.295 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -94.09 131.42 39.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 105.996 -1.853 . . . . 4.92 105.996 169.156 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 pt -133.44 -179.16 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 O-C-N 121.816 -0.552 . . . . 1.71 109.603 170.54 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 34' ' ' SER . 43.5 mtmt -124.68 119.06 27.91 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.728 -0.669 . . . . 4.11 109.768 160.749 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.559 ' HB2' HD12 ' A' ' 53' ' ' ILE . 11.7 p90 -114.73 154.66 28.1 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.777 1.631 . . . . 2.16 110.525 170.222 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.26 111.35 63.47 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.2 0.6 . . . . 3.4 109.704 176.626 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.85 -19.75 69.49 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.837 3.025 . . . . 2.06 112.845 -171.191 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -62.94 -24.37 67.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.701 -0.666 . . . . 3.74 112.752 177.283 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.87 -43.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 118.944 0.793 . . . . 2.55 111.496 -173.02 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -102.19 147.95 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 108.48 -0.933 . . . . 1.38 108.48 176.623 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -126.92 150.96 73.21 Favored Pre-proline 0 N--CA 1.451 -0.379 0 C-N-CA 125.075 1.35 . . . . 2.47 109.179 177.934 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.27 -36.38 94.99 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.629 2.219 . . . . 1.25 111.69 -175.019 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -41.68 99.25 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 121.916 -0.49 . . . . 3.54 110.959 177.42 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -59.99 -44.45 94.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.101 0.561 . . . . 3.06 109.973 177.317 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.401 HD12 HD11 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -54.03 -48.48 64.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 172.694 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.43 -44.99 95.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.016 -0.538 . . . . 1.15 111.004 -176.334 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -53.54 -50.39 65.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.934 -1.104 . . . . 2.82 110.169 171.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.62 -53.66 48.69 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.427 0.691 . . . . 2.36 109.34 -176.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.7 HG12 ' HB2' ' A' ' 69' ' ' ALA . 1.8 pp -68.74 -33.88 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 119.306 -0.958 . . . . 4.06 112.019 -178.677 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -57.92 -41.45 82.73 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 120.269 1.395 . . . . 2.01 108.574 -179.001 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -60.83 -50.92 71.48 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.619 -0.511 . . . . 2.74 109.619 177.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.541 HD13 HG13 ' A' ' 22' ' ' ILE . 11.0 mt -54.38 -41.91 69.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.058 0.543 . . . . 2.13 111.917 177.261 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.18 43.71 0.32 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.468 0.556 . . . . 1.05 112.123 164.305 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -134.2 -177.01 4.39 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.081 1.352 . . . . 1.9 110.198 179.091 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -114.08 129.21 56.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.093 0.957 . . . . 2.27 108.898 162.789 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.7 ' HB2' HG12 ' A' ' 62' ' ' ILE . . . -97.99 129.32 44.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.253 -1.388 . . . . 1.3 107.253 168.267 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.453 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -139.47 118.74 12.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.255 -1.387 . . . . 0.98 107.255 173.351 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 23.2 t -56.34 153.58 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.683 -0.858 . . . . 2.68 108.683 174.962 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 111.802 0.297 . . . . 4.17 111.802 178.448 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 124' ' ' PHE . . . . . . . . 0 N--CA 1.43 -1.721 0 N-CA-C 109.146 -1.582 . . . . 1.81 109.146 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.49 ' HB2' ' CD ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -91.54 116.37 28.81 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.125 -2.546 . . . . 3.5 104.125 176.722 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.03 161.91 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 O-C-N 125.412 1.695 . . . . 3.3 110.047 170.977 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.91 125.2 50.71 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 127.329 2.252 . . . . 3.64 110.003 -175.305 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.439 HD12 ' HB1' ' A' ' 145' ' ' ALA . 4.4 mm? -119.62 127.52 53.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.675 1.19 . . . . 2.8 108.214 172.812 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.6 m -95.78 122.68 38.82 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.673 -1.603 . . . . 2.1 106.673 176.383 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.495 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.4 OUTLIER -102.56 114.0 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.483 1.113 . . . . 1.63 109.979 -172.022 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 84.6 m -107.23 124.0 49.11 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.262 0.625 . . . . 1.44 110.267 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 127.16 -27.92 4.69 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.262 1.41 . . . . 0.99 111.585 177.738 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 34.8 ttp -71.52 146.24 48.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.88 -0.777 . . . . 2.66 111.661 -176.869 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 t -164.05 41.52 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.616 0.766 . . . . 2.8 110.817 174.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -163.29 145.05 9.75 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.192 -0.943 . . . . 2.59 111.551 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.75 -42.04 67.78 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.252 1.021 . . . . 2.61 111.787 176.087 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -53.46 -48.77 68.56 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.732 -0.605 . . . . 2.1 110.12 174.529 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 96.7 m -64.8 -41.45 95.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.082 0.553 . . . . 1.82 110.26 -178.254 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -52.47 -51.95 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.227 -0.286 . . . . 1.34 110.227 169.814 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.11 -33.22 75.0 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.826 -0.435 . . . . 3.19 109.826 -176.894 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -65.28 -57.15 9.17 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.489 1.116 . . . . 1.8 109.576 178.521 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.5 mt -56.2 -51.42 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 121.457 -0.777 . . . . 1.05 110.098 177.569 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.82 -45.96 85.38 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.542 -0.742 . . . . 2.42 110.101 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.3 t -49.25 -53.72 20.22 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.283 0.947 . . . . 1.91 109.76 172.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -31.36 72.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.809 -0.557 . . . . 3.12 111.067 -172.947 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.6 mt -72.23 -61.39 1.81 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.536 -0.913 . . . . 1.97 108.536 174.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 60.9 p -54.41 -19.66 6.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.601 1.161 . . . . 2.14 113.099 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -57.53 -33.42 68.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.697 0.68 . . . . 4.37 112.03 171.236 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.7 m -62.38 132.04 51.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.599 1.56 . . . . 1.83 111.069 -176.112 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.04 -53.89 46.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.319 0.648 . . . . 4.83 112.473 177.919 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.444 ' HA3' HD11 ' A' ' 128' ' ' ILE . . . -78.87 -16.95 78.17 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.837 -0.424 . . . . 1.46 113.394 -169.933 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.51 HD11 HG13 ' A' ' 122' ' ' VAL . 4.2 tt -68.86 133.84 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 118.387 1.094 . . . . 2.0 109.171 -176.195 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.9 m -104.32 -51.62 3.08 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 121.929 0.092 . . . . 2.5 110.859 -177.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -141.49 116.44 9.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.091 -0.707 . . . . 2.59 109.091 176.448 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.12 143.27 32.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.049 -0.723 . . . . 1.08 109.049 163.419 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.0 m -135.89 119.58 17.18 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.126 -1.064 . . . . 1.46 108.126 174.511 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.5 p -117.53 131.91 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.572 1.149 . . . . 2.2 110.601 -177.935 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -128.59 86.67 2.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.027 0.931 . . . . 1.38 110.298 -172.204 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -53.93 -26.56 26.01 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.997 1.319 . . . . 2.51 113.012 179.677 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.81 -34.83 65.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.417 0.687 . . . . 1.66 110.967 176.28 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.74 -10.04 11.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.821 1.649 . . . . 1.94 111.393 -178.293 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.431 ' O ' HD12 ' A' ' 86' ' ' ILE . 8.7 m 69.46 22.39 6.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.836 2.054 . . . . 1.48 112.318 178.446 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -102.43 156.06 17.85 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 125.291 1.437 . . . . 4.63 111.343 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.06 115.82 7.74 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.089 1.355 . . . . 0.84 110.462 174.618 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 121' ' ' LEU . 3.9 mm? -92.03 126.42 37.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.219 -1.4 . . . . 2.41 107.219 170.736 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.51 HG13 HD11 ' A' ' 108' ' ' ILE . 2.3 t -114.3 131.4 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.928 1.691 . . . . 1.8 107.409 176.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.49 ' CD ' ' HB2' ' A' ' 81' ' ' ASN . 2.1 mmmt -115.07 95.9 5.43 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.038 1.335 . . . . 3.05 110.023 178.45 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.413 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -118.48 -176.77 3.15 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.494 1.118 . . . . 2.09 111.22 -177.133 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -106.77 111.31 63.89 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.097 -1.075 . . . . 3.14 108.097 175.044 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.21 68.3 7.93 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.916 2.411 . . . . 1.77 111.626 -167.339 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -162.57 -42.95 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.471 1.508 . . . . 3.0 109.729 174.481 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.514 HD12 ' HB ' ' A' ' 129' ' ' ILE . 2.0 pp -79.39 -35.98 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.296 0.57 . . . . 2.07 110.168 -175.265 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.514 ' HB ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -131.6 166.02 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.601 1.56 . . . . 1.32 108.955 179.165 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.41 168.44 29.08 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.066 -1.614 . . . . 1.3 109.066 178.076 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.35 -44.59 36.92 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.42 2.746 . . . . 1.39 111.851 -172.278 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -46.08 -42.27 13.32 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.183 1.179 . . . . 6.16 114.183 -177.204 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.51 -47.48 83.75 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.512 -0.475 . . . . 3.25 109.72 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 85.1 mt -58.59 -45.86 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.929 -0.767 . . . . 1.11 108.929 178.503 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 83.6 mt -51.93 -59.47 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.541 -0.911 . . . . 2.05 108.541 174.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -46.24 66.78 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.874 0.761 . . . . 4.17 111.245 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.2 mm -54.66 -50.66 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 121.413 -0.804 . . . . 1.91 110.119 177.211 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.261 2.5 pp -71.14 -26.12 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.01 -1.056 . . . . 1.47 113.653 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.82 -38.77 76.17 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.762 0.71 . . . . 3.22 109.848 168.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -59.84 -40.73 89.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.57 0.7 . . . . 3.18 109.182 -179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 51.2 mt -70.63 -42.01 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.361 0.664 . . . . 1.01 109.827 175.573 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.1 34.19 5.21 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.434 1.493 . . . . 0.91 111.187 -175.535 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -99.88 176.14 5.54 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.098 0.949 . . . . 2.37 110.019 168.823 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -129.86 111.42 12.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.704 -1.591 . . . . 4.34 106.704 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.439 ' HB1' HD12 ' A' ' 84' ' ' LEU . . . -104.0 103.03 12.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.682 1.193 . . . . 1.12 107.982 178.845 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.8 m -109.66 110.33 21.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.664 1.586 . . . . 1.95 107.144 -174.233 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.45 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.405 1.482 . . . . 3.97 111.384 -178.224 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 50.31 33.35 7.33 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.325 0.861 . . . . 3.7 113.325 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.331 -1.318 . . . . 8.97 109.826 -166.699 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 121.533 0.682 . . . . 3.43 110.327 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -92.83 123.12 35.86 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.617 1.167 . . . . 5.93 109.896 -171.043 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 t -108.99 124.29 50.47 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.188 -1.042 . . . . 2.38 108.188 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -102.47 103.66 14.05 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.187 1.395 . . . . 3.11 107.48 -178.348 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.1 pt? -130.63 173.99 10.35 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.926 0.869 . . . . 2.79 111.036 176.087 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.44 150.29 42.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.032 -0.986 . . . . 2.2 108.757 173.535 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 44' ' ' ALA . 39.2 mm -99.32 113.73 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 106.51 -1.663 . . . . 1.37 106.51 173.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -99.47 93.46 5.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.587 -1.264 . . . . 3.01 107.587 175.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.18 -77.29 0.08 OUTLIER Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.637 -0.985 . . . . 1.28 110.637 178.902 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.0 mmt 54.31 88.27 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.291 1.836 . . . . 2.13 113.79 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 m -55.85 -64.39 0.87 Allowed 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.259 -0.901 . . . . 2.55 112.477 177.493 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.7 t -169.7 56.19 0.04 OUTLIER 'General case' 0 C--N 1.345 0.397 0 CA-C-N 118.46 0.573 . . . . 3.33 109.945 -176.172 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 41.47 49.09 3.49 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.769 1.227 . . . . 5.61 112.707 178.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.4 t -164.18 -45.13 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.304 0.642 . . . . 2.81 110.264 -172.584 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.5 t -66.44 -36.82 83.75 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 120.743 -1.223 . . . . 1.83 110.277 -178.37 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.8 t -63.58 -30.63 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.657 0.741 . . . . 1.75 110.012 173.423 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -66.33 -31.03 71.57 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.54 -0.725 . . . . 1.95 110.884 175.039 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.74 -48.82 65.38 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.096 -1.003 . . . . 2.99 110.232 169.474 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mt -38.52 -44.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.598 0.759 . . . . 1.49 112.163 171.022 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -42.81 -57.8 2.63 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.536 0.734 . . . . 5.15 112.509 178.412 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -67.23 -40.25 86.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.225 -0.287 . . . . 5.48 110.225 -177.373 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -56.09 -53.53 55.89 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.767 -0.827 . . . . 1.22 108.767 -177.748 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.16 -43.83 97.96 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 119.493 -0.289 . . . . 3.0 111.279 177.228 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -22.21 24.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.872 0.76 . . . . 2.0 112.967 176.635 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -115.53 33.65 5.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.433 0.693 . . . . 3.12 111.549 175.465 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -84.73 -88.81 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.704 -1.591 . . . . 3.34 106.704 168.387 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -143.74 -126.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.908 1.283 . . . . 1.35 109.837 178.147 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.49 32.85 1.38 Allowed Glycine 0 CA--C 1.532 1.139 0 O-C-N 120.7 -1.25 . . . . 2.19 113.709 -171.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.19 117.99 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 106.936 -1.505 . . . . 1.55 106.936 174.815 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.05 53.38 1.57 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.211 1.005 . . . . 3.3 109.718 -178.547 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.5 m -161.84 132.08 4.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.146 -1.427 . . . . 2.12 107.146 171.586 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.75 117.04 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.414 -1.328 . . . . 2.84 107.414 176.781 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 tt -124.87 78.03 1.66 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.332 -0.988 . . . . 2.58 108.332 -179.336 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 t -99.98 137.1 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.182 -0.673 . . . . 2.04 109.182 173.57 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.93 98.39 7.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.543 -0.91 . . . . 1.12 108.543 169.727 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.94 -8.66 7.57 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.205 1.002 . . . . 3.04 112.865 175.274 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.3 mtt -80.34 -48.63 12.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.113 0.965 . . . . 4.15 110.011 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.59 -27.3 17.44 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.793 0.837 . . . . 1.24 111.805 -175.118 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 61.67 2.25 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.764 -0.934 . . . . 1.16 110.764 -177.107 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -140.0 139.08 35.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.38 -1.711 . . . . 2.72 106.38 173.141 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -111.21 105.1 13.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.439 1.087 . . . . 1.18 109.91 165.829 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -97.63 133.68 41.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.538 -2.023 . . . . 3.67 105.538 164.797 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 pt -129.94 167.05 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.54 -1.281 . . . . 2.09 107.54 169.377 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.37 105.12 10.59 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 124.393 1.077 . . . . 5.33 108.794 172.671 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.631 ' HB2' HD12 ' A' ' 53' ' ' ILE . 12.9 p90 -104.66 -179.51 3.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.255 1.822 . . . . 2.85 111.46 175.79 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.4 108.18 17.54 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.342 1.057 . . . . 3.83 111.316 175.476 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.43 -7.97 22.36 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.242 2.628 . . . . 2.11 113.586 -168.0 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.41 -16.37 57.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.222 0.919 . . . . 3.17 111.393 173.75 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.9 t -124.73 -47.89 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 118.476 0.58 . . . . 2.5 110.23 -172.225 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.631 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -116.85 146.79 20.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.014 0.925 . . . . 1.61 109.029 -173.425 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -123.48 154.88 66.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 124.213 1.005 . . . . 2.96 113.178 179.68 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.87 -38.19 81.14 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.547 2.165 . . . . 1.55 111.243 174.306 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 3.1 mp -54.44 -60.54 3.2 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.391 -0.818 . . . . 2.95 111.494 178.475 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -57.13 -35.29 69.3 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.325 -0.859 . . . . 3.86 112.734 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.502 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -55.28 -41.45 61.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.94 -0.763 . . . . 1.25 108.94 171.947 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 56' ' ' LEU . . . -59.51 -38.59 81.34 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.076 -0.511 . . . . 1.62 111.341 -179.619 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -63.48 -51.15 66.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.197 -0.939 . . . . 3.02 109.98 175.025 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.22 -52.22 59.62 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.376 0.608 . . . . 2.25 111.424 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.547 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.3 pp -65.46 -37.82 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.283 -0.886 . . . . 4.21 112.308 -179.567 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.93 -31.88 71.94 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.04 0.837 . . . . 2.94 110.683 177.232 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.57 -52.45 63.38 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 109.252 -0.647 . . . . 3.53 109.252 174.677 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -55.0 -42.71 72.85 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.673 0.249 . . . . 3.51 111.673 172.03 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.28 48.39 0.43 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.293 0.949 . . . . 1.3 111.129 171.233 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -135.04 162.92 31.08 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.509 1.124 . . . . 2.34 109.675 -176.706 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -100.27 122.99 43.95 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.892 1.277 . . . . 2.96 107.623 167.808 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.547 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -104.16 82.67 1.98 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.512 1.525 . . . . 0.87 108.824 172.154 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.66 101.82 13.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.611 -1.177 . . . . 1.67 108.985 -176.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -70.36 158.28 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.438 1.495 . . . . 3.45 112.08 176.649 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.38 0 CA-C-N 114.853 -1.067 . . . . 6.49 111.287 167.246 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.889 0 N-CA-C 110.487 -1.045 . . . . 2.87 110.487 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.487 ' CG ' ' HE3' ' A' ' 123' ' ' LYS . 21.0 t30 -106.01 131.83 52.83 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 117.599 0.7 . . . . 3.66 109.909 153.542 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.585 ' H ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -141.54 169.0 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 130.776 3.63 . . . . 3.13 105.627 175.937 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -117.06 119.79 36.35 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.953 1.701 . . . . 4.14 110.07 179.007 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.2 mt -113.63 137.62 51.34 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.316 0.646 . . . . 2.3 109.444 -179.086 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 m -100.48 131.11 46.57 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 108.171 -1.048 . . . . 1.68 108.171 173.252 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.518 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.5 OUTLIER -95.53 122.62 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.748 1.619 . . . . 1.9 107.762 175.64 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 63.8 m -112.22 134.59 53.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.922 -1.14 . . . . 1.76 107.922 175.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 112.14 -36.3 4.22 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.495 1.045 . . . . 1.72 111.557 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.512 ' HE3' HD13 ' A' ' 86' ' ' ILE . 2.9 tmm? -57.32 129.47 41.92 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.183 0.593 . . . . 2.23 111.204 -178.727 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -157.03 91.96 1.23 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.072 -1.455 . . . . 3.25 107.072 169.118 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 63.3 m 84.2 -134.18 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.593 1.957 . . . . 4.9 111.087 178.007 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 60.07 -6.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.059 1.744 . . . . 6.89 114.581 -170.646 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.46 29.42 11.09 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.408 -0.807 . . . . 4.07 110.186 -158.225 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -33.43 69.29 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 123.079 1.418 . . . . 2.31 111.358 -171.986 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.4 t -52.53 -43.42 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.862 1.665 . . . . 1.68 110.561 174.583 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -58.01 -47.81 81.93 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.462 1.125 . . . . 2.68 108.526 -176.053 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.251 1.2 p-10 -70.99 -38.35 72.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.84 -1.073 . . . . 3.32 112.003 179.076 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.5 mt -57.14 -54.11 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.815 1.188 . . . . 0.96 109.906 173.818 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -52.83 -49.95 64.68 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 108.717 -0.845 . . . . 2.9 108.717 176.391 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.2 t -52.4 -51.67 57.84 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 122.021 -0.424 . . . . 1.5 111.945 177.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -61.56 -40.07 93.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.174 -0.954 . . . . 2.58 111.414 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.8 mt -63.58 -60.81 2.86 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.534 0.607 . . . . 1.99 110.145 175.898 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.6 m -54.33 -20.18 6.76 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.315 1.446 . . . . 1.86 112.321 177.427 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.5 mtp-105 -61.8 -28.82 69.73 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.802 0.667 . . . . 4.69 112.802 172.811 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.1 p -69.53 166.19 19.42 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 119.828 1.194 . . . . 2.3 110.892 -179.604 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.75 -39.61 30.66 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.071 -0.393 . . . . 3.51 111.346 176.721 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.33 -50.46 7.43 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 112.256 -0.338 . . . . 1.16 112.256 -170.673 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.68 144.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.851 -1.166 . . . . 3.27 107.851 176.309 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.0 m -142.51 -44.9 0.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.473 0.709 . . . . 3.27 109.845 171.468 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -100.51 103.36 14.69 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.016 -1.846 . . . . 2.3 106.016 176.63 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.04 149.01 41.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.501 -1.296 . . . . 0.98 107.501 165.435 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.9 m -142.87 135.71 27.97 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.213 -1.032 . . . . 1.93 108.213 162.779 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.41 118.68 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.53 1.532 . . . . 2.43 106.939 -177.756 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.06 105.51 10.7 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.902 1.281 . . . . 1.32 110.3 -171.713 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pp -74.05 -39.07 63.77 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 125.851 1.66 . . . . 2.04 111.878 -172.076 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.71 -40.39 62.94 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.194 0.998 . . . . 1.41 110.901 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.07 -12.51 24.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.779 1.232 . . . . 1.88 111.08 175.88 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.2 m 54.1 43.52 30.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.883 1.273 . . . . 1.55 111.925 -176.34 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -128.22 163.43 24.73 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 117.618 0.19 . . . . 3.33 110.734 166.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.96 136.9 32.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.281 1.432 . . . . 1.01 108.702 173.039 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -117.81 136.36 53.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.201 1.4 . . . . 2.46 107.583 171.916 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.4 m -134.3 136.11 53.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 116.805 -1.569 . . . . 2.1 107.327 -177.419 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.487 ' HE3' ' CG ' ' A' ' 81' ' ' ASN . 4.1 mtpt -115.25 105.13 12.52 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 120.456 1.48 . . . . 3.36 108.453 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -115.15 179.81 3.85 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.289 1.435 . . . . 2.75 110.894 175.218 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -100.51 117.37 63.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 125.089 1.355 . . . . 3.03 108.355 173.292 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -82.52 57.9 6.29 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.663 2.242 . . . . 1.95 112.351 -168.701 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -147.38 -49.57 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.482 1.513 . . . . 3.86 108.661 174.846 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pt -77.28 -33.25 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 122.382 -0.199 . . . . 1.62 111.05 -176.165 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.24 165.7 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.289 1.036 . . . . 1.43 108.373 -177.406 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.23 165.65 33.88 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.273 -1.131 . . . . 1.38 110.273 -175.129 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.71 -35.73 78.39 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.698 2.932 . . . . 1.57 112.637 -170.283 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 10.2 mtt-85 -50.99 -40.53 58.23 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.897 0.702 . . . . 6.13 112.897 178.714 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.46 -46.8 84.57 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.306 0.574 . . . . 3.39 109.645 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.68 -45.01 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.504 0.721 . . . . 1.06 109.574 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.7 mt -55.98 -58.64 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 108.704 -0.85 . . . . 2.03 108.704 175.023 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -49.28 -49.59 42.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.747 1.158 . . . . 3.6 112.851 177.153 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 52.0 mt -48.68 -56.21 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.612 -0.514 . . . . 2.44 109.612 176.039 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.253 2.2 pp -70.84 -26.68 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 113.509 0.929 . . . . 1.52 113.509 -178.294 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.37 -38.58 80.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.311 0.959 . . . . 2.5 109.683 168.642 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -66.08 -39.85 90.38 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.444 -0.576 . . . . 3.23 109.444 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.1 mt -62.23 -38.84 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.873 -0.417 . . . . 1.26 109.873 169.319 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.72 29.24 9.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.762 1.649 . . . . 0.98 110.825 -177.096 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -100.31 178.99 4.6 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 117.982 0.891 . . . . 2.31 108.99 175.21 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -127.88 104.51 7.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.609 -1.256 . . . . 4.16 107.609 -178.477 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.68 103.84 15.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.136 -1.431 . . . . 1.28 107.136 174.205 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.4 t -97.12 -179.19 4.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.236 -1.394 . . . . 2.26 107.236 169.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.5 117.94 22.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.278 -1.749 . . . . 4.0 106.278 171.772 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.56 90.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.862 -0.421 . . . . 3.35 109.862 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 C--O 1.249 1.048 0 C-N-CA 127.192 2.197 . . . . 6.38 111.22 -178.473 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.121 0 N-CA-C 108.589 -0.893 . . . . 7.42 108.589 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.19 153.88 17.85 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.198 -1.408 . . . . 5.85 107.198 166.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 117.97 21.68 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.509 -1.293 . . . . 3.65 107.509 178.01 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -99.89 102.67 14.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.277 1.831 . . . . 5.4 109.849 -176.061 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 44' ' ' ALA 0.277 0.0 OUTLIER -130.3 159.86 35.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.185 0.993 . . . . 2.46 111.572 176.223 . . . . . . . . 4 4 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -113.63 152.05 30.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.001 -1.0 . . . . 2.18 108.375 173.273 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mm -99.95 137.89 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 106.437 -1.69 . . . . 1.07 106.437 175.752 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -119.38 98.55 6.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.27 -1.011 . . . . 3.79 108.27 169.718 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.45 -94.65 0.13 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 109.119 -1.592 . . . . 1.81 109.119 177.631 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 mtp 67.86 90.48 0.09 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.012 1.725 . . . . 2.33 113.503 173.366 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -57.4 -28.55 63.34 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.973 0.731 . . . . 3.01 112.973 175.599 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 t 78.38 -48.5 0.46 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.009 1.324 . . . . 4.99 112.068 177.859 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -36.15 -70.01 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.802 1.641 . . . . 4.41 112.063 -179.119 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.3 p -161.49 18.99 0.11 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.254 0.465 . . . . 2.68 112.254 172.244 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 27.1 m -70.23 -52.12 25.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.329 -0.989 . . . . 2.53 108.329 -170.292 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.53 -39.27 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 109.702 -0.481 . . . . 2.93 109.702 177.756 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -61.95 -37.51 85.0 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.933 0.893 . . . . 2.1 113.344 177.891 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -41.29 64.0 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.732 -1.23 . . . . 2.86 110.866 171.201 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.441 HG12 HD13 ' A' ' 65' ' ' LEU . 88.0 mt -60.29 -48.62 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.258 1.023 . . . . 1.88 110.18 -174.354 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HB2' HG11 ' A' ' 35' ' ' VAL . 1.8 pp20? -51.52 -45.62 63.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.632 0.73 . . . . 4.34 111.079 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -64.6 -43.59 93.31 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 124.654 1.182 . . . . 6.51 110.343 -179.15 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.91 -52.27 64.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.129 -0.487 . . . . 1.95 109.825 173.914 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -29.39 66.48 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.016 0.747 . . . . 1.98 113.016 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -55.0 -22.07 14.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.907 1.23 . . . . 3.41 111.666 174.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -123.93 33.68 5.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.638 0.775 . . . . 4.21 110.182 178.182 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -64.26 0.89 Allowed 'General case' 0 C--N 1.343 0.314 0 N-CA-C 108.796 -0.816 . . . . 2.53 108.796 174.776 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.05 -133.85 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.833 1.253 . . . . 1.53 108.112 -172.114 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.66 -16.96 74.49 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.556 1.071 . . . . 1.94 113.009 -178.901 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 p -60.35 122.4 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 121.949 -0.736 . . . . 2.04 110.279 177.483 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.55 50.55 2.15 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 121.209 0.528 . . . . 4.12 111.119 177.239 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.7 m -155.44 153.73 30.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.299 -1.371 . . . . 3.8 107.299 167.769 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 23' ' ' GLU . 11.4 p -143.33 132.06 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 104.815 -2.291 . . . . 3.17 104.815 161.57 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 36' ' ' LEU . 2.2 tm? -141.35 83.73 1.88 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.007 -1.108 . . . . 2.6 108.007 174.697 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.0 p -98.8 147.16 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.27 -1.011 . . . . 2.1 108.27 174.649 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.52 103.87 9.81 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.322 -1.362 . . . . 1.92 107.322 167.188 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -27.54 66.4 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.608 0.763 . . . . 2.61 110.817 175.376 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 46.3 mtt -66.26 -58.8 4.58 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.944 0.898 . . . . 3.33 110.209 -178.64 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.75 -25.35 38.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.938 0.495 . . . . 2.08 111.414 -178.228 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.69 57.94 2.79 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.508 1.052 . . . . 1.42 110.878 179.693 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -140.31 147.1 39.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.865 -1.064 . . . . 3.21 108.693 179.423 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.504 ' HB3' HD22 ' A' ' 8' ' ' LEU . . . -124.63 101.17 6.99 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.145 1.378 . . . . 1.73 112.192 177.013 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -99.57 122.62 42.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.004 -1.06 . . . . 4.77 108.375 172.701 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.06 -179.5 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.742 1.155 . . . . 2.62 111.179 171.708 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -134.72 90.28 2.63 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.021 0.928 . . . . 7.69 112.561 -174.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.7 179.93 4.81 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.506 1.122 . . . . 3.77 113.974 -176.469 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -126.16 98.74 32.36 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 128.03 2.532 . . . . 4.87 108.283 176.377 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.62 27.89 0.38 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.917 3.078 . . . . 3.69 113.555 -170.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -108.15 -16.21 14.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.888 1.675 . . . . 4.65 110.669 165.693 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.1 t -116.66 -60.9 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.762 1.225 . . . . 3.25 108.067 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.65 124.99 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.646 0.778 . . . . 2.35 110.297 -177.509 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -101.62 172.08 4.76 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.09 1.756 . . . . 3.0 110.956 -177.645 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -75.45 -15.24 19.89 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.622 1.548 . . . . 2.76 112.259 -178.105 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.257 0.5 OUTLIER -73.08 -60.0 2.44 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.442 -0.786 . . . . 4.56 110.396 175.601 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -57.45 -32.37 66.86 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.284 -0.885 . . . . 2.77 112.281 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.3 tt -55.98 -45.34 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.878 -1.156 . . . . 1.67 107.878 175.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.87 73.56 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.364 -0.835 . . . . 1.94 110.42 -178.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.91 -44.9 94.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 119.459 1.027 . . . . 2.43 110.073 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -55.62 -52.69 62.95 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 109.195 -0.669 . . . . 2.34 109.195 175.326 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 mm -63.15 -41.86 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 120.246 -0.582 . . . . 2.73 111.839 -174.581 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -46.25 89.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.4 1.08 . . . . 2.9 110.421 175.037 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.19 -50.28 74.29 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.154 0.582 . . . . 3.98 109.829 178.555 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.441 HD13 HG12 ' A' ' 22' ' ' ILE . 29.1 mt -55.62 -36.43 66.97 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.311 0.644 . . . . 2.2 110.882 175.654 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.16 28.75 2.98 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 124.082 0.849 . . . . 1.95 111.149 165.698 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -117.53 157.02 27.05 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.995 -1.483 . . . . 3.12 106.995 177.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -96.5 116.36 28.94 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.797 -1.186 . . . . 3.1 107.797 169.466 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.87 123.92 43.45 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 108.096 -1.076 . . . . 1.67 108.096 166.412 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -126.92 132.14 50.95 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.28 -1.007 . . . . 1.84 108.28 170.158 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.485 ' HA ' ' HB3' ' A' ' 8' ' ' LEU . 2.2 t -89.46 160.04 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 124.619 1.168 . . . . 4.25 108.336 -177.236 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.8 mmt . . . . . 0 CA--C 1.534 0.341 0 O-C-N 123.935 0.772 . . . . 5.44 110.472 168.303 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.733 0 N-CA-C 109.714 -1.354 . . . . 2.79 109.714 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.34 113.4 24.98 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 104.469 -2.419 . . . . 3.23 104.469 159.532 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.405 HG13 ' CD1' ' A' ' 124' ' ' PHE . 1.4 pp -98.3 158.76 3.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.072 -1.825 . . . . 3.57 106.072 158.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.48 155.69 38.5 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.122 -1.807 . . . . 3.91 106.122 174.166 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.526 HD13 ' HB1' ' A' ' 145' ' ' ALA . 4.2 pp -147.79 163.52 36.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.637 -0.221 . . . . 3.32 111.18 168.283 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 m -98.89 126.49 44.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.602 1.961 . . . . 1.96 107.261 171.727 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.02 125.5 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.856 -0.794 . . . . 1.62 108.856 176.675 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.5 t -108.03 163.31 13.26 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.326 -0.62 . . . . 3.65 109.326 170.703 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.34 -39.27 2.94 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.846 1.213 . . . . 1.42 112.583 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -58.92 132.73 54.87 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.879 0.871 . . . . 2.5 110.953 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 m -148.01 40.94 0.99 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.904 1.281 . . . . 2.75 109.861 176.355 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -169.19 136.83 1.86 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.88 -1.137 . . . . 2.78 111.1 177.613 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.13 64.94 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.576 -0.703 . . . . 2.9 112.118 177.917 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.6 t -56.45 -42.08 77.54 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.638 -0.664 . . . . 2.43 110.365 173.589 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 84.5 m -63.24 -44.4 95.31 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.75 -0.833 . . . . 1.75 108.75 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.6 t -53.87 -58.86 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.522 0.729 . . . . 1.63 110.543 175.691 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -57.11 -41.88 79.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.678 0.752 . . . . 4.42 111.316 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -59.77 -55.09 38.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.821 0.848 . . . . 1.95 110.338 177.779 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.8 mt -47.39 -50.63 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 125.657 1.583 . . . . 0.83 109.234 174.677 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -56.53 -47.25 79.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.217 1.007 . . . . 3.76 109.947 177.918 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.9 m -58.15 -44.21 87.75 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.999 -1.063 . . . . 2.57 111.384 174.806 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.629 ' HG3' HD11 ' A' ' 141' ' ' ILE . 14.3 mmmt -64.28 -50.19 68.87 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.444 -0.785 . . . . 2.96 110.265 -177.101 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.71 -47.23 79.08 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.36 -0.607 . . . . 2.49 109.36 -179.688 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.8 m -58.38 -21.21 49.35 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.034 0.934 . . . . 2.63 112.584 176.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -64.96 -19.17 65.83 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.4 -0.813 . . . . 5.27 112.71 172.342 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.3 m -71.22 150.72 45.02 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.681 1.193 . . . . 1.87 110.431 178.531 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -69.3 -48.94 60.13 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.869 0.868 . . . . 3.09 111.887 179.188 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.43 -28.56 61.44 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 122.287 -0.258 . . . . 2.43 112.939 -166.674 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.51 142.18 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.368 -0.975 . . . . 2.0 108.368 178.437 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 22.4 p -124.21 -39.12 2.37 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.891 0.7 . . . . 3.31 112.891 173.434 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.34 125.26 18.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.246 -1.39 . . . . 3.12 107.246 -178.582 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.88 168.16 12.63 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.376 0.67 . . . . 1.67 110.308 165.171 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.4 m -143.87 128.09 17.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.625 -0.88 . . . . 1.76 108.625 160.531 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 52.1 t -107.32 126.61 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.822 0.849 . . . . 2.59 110.223 178.067 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.76 101.09 6.46 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.075 1.75 . . . . 1.61 110.128 -168.336 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.14 -31.8 62.89 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 126.146 1.778 . . . . 2.09 111.979 -174.253 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.6 -34.18 61.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.783 0.433 . . . . 1.6 110.981 175.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.83 -4.67 19.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.108 1.363 . . . . 2.29 111.218 176.608 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.5 m 59.71 28.8 18.31 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.659 1.183 . . . . 1.62 113.128 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -124.37 165.16 18.2 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.028 0.831 . . . . 2.97 112.973 176.09 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.45 127.28 43.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.573 2.349 . . . . 1.41 107.588 179.382 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.02 123.47 48.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.002 -1.851 . . . . 2.61 106.002 175.802 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.1 t -130.32 123.38 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.163 -1.051 . . . . 1.89 108.163 -170.016 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 96.93 9.73 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.099 -1.445 . . . . 4.26 107.099 176.92 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.405 ' CD1' HG13 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -107.9 -177.87 3.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.449 1.5 . . . . 3.43 111.019 178.309 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -127.2 112.83 21.53 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.059 0.943 . . . . 5.18 108.917 175.736 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.43 50.23 3.44 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.577 3.518 . . . . 2.81 113.523 -171.067 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -141.59 -52.19 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.484 1.513 . . . . 5.85 107.495 171.364 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 pt -80.29 -31.69 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 119.399 -0.334 . . . . 2.5 111.302 -177.262 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.67 164.67 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 110.156 -0.313 . . . . 2.06 110.156 -177.679 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.99 150.24 20.11 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.912 -0.938 . . . . 1.7 111.64 -167.116 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -57.22 -36.62 99.08 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.966 2.444 . . . . 1.75 110.535 178.241 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -34.75 67.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.119 -0.491 . . . . 6.32 111.474 179.136 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -69.99 -44.04 70.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.761 -0.829 . . . . 3.29 108.761 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.424 ' O ' HD13 ' A' ' 138' ' ' ILE . 17.1 mm -52.42 -54.97 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.414 -0.958 . . . . 2.23 108.414 178.16 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.699 HG22 ' HB3' ' A' ' 145' ' ' ALA . 9.4 pt -59.2 -57.01 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 117.885 -1.055 . . . . 2.9 109.879 179.04 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -44.46 -46.59 9.72 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.0 0.818 . . . . 4.73 112.401 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.4 mm -51.07 -60.24 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 118.836 -0.602 . . . . 1.77 110.019 173.047 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.518 HG22 HD12 ' A' ' 141' ' ' ILE 0.29 0.0 OUTLIER -70.4 -26.93 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 117.628 -1.629 . . . . 2.77 113.909 -176.273 . . . . . . . . 4 4 . 1 . 028 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.48 -34.84 78.65 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.783 -0.573 . . . . 2.68 110.538 172.128 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -66.6 -36.13 81.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.884 -0.784 . . . . 2.84 108.884 176.288 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.629 HD11 ' HG3' ' A' ' 101' ' ' LYS . 38.2 mt -65.37 -44.28 94.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 119.84 -0.744 . . . . 1.61 109.691 174.557 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.98 27.86 3.33 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.694 1.14 . . . . 1.44 112.032 -177.685 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -98.5 -178.18 3.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.863 -1.532 . . . . 2.66 106.863 158.682 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -139.36 130.69 26.85 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.741 -1.207 . . . . 3.83 107.741 174.815 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.699 ' HB3' HG22 ' A' ' 135' ' ' ILE . . . -105.64 117.48 34.13 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.936 -0.765 . . . . 2.08 108.936 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.2 t -109.04 115.55 30.29 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.361 -1.348 . . . . 2.26 107.361 174.415 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.47 115.58 4.0 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.764 -1.198 . . . . 5.25 107.764 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.28 -34.83 20.26 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 123.61 0.569 . . . . 4.0 110.538 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 C--O 1.262 1.735 0 C-N-CA 128.131 2.572 . . . . 5.86 115.633 175.396 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.513 -0.461 0 CA-C-O 121.717 0.77 . . . . 3.27 111.822 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.5 152.52 20.9 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.445 -1.252 . . . . 3.67 108.899 -178.123 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.615 ' SG ' HD11 ' A' ' 8' ' ' LEU . 21.9 p -143.2 138.55 29.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 123.608 0.567 . . . . 2.49 109.629 167.976 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.493 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -100.41 109.13 21.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.613 1.565 . . . . 4.25 109.379 177.659 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.615 HD11 ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -124.37 166.91 15.12 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.786 0.803 . . . . 2.99 109.279 172.197 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.3 136.24 54.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.807 -1.553 . . . . 1.77 106.807 176.037 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.6 mm -98.2 136.02 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.593 -1.262 . . . . 0.81 107.593 -177.36 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -114.0 136.51 52.83 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.061 -1.089 . . . . 2.84 108.061 168.175 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.9 -80.6 0.27 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.04 1.781 . . . . 1.12 109.962 -174.03 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.2 mmm 56.91 56.45 5.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.957 2.103 . . . . 2.16 114.521 170.193 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -43.51 -63.95 0.74 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.774 1.398 . . . . 2.21 114.774 -173.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.3 t -167.9 59.47 0.07 Allowed 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.066 0.848 . . . . 3.33 109.621 -176.907 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 42.86 48.75 5.04 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.476 1.111 . . . . 5.22 111.994 -179.675 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.0 t -161.74 -40.21 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.005 0.522 . . . . 2.57 111.364 -172.307 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.39 -43.5 81.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 118.731 -1.188 . . . . 1.47 109.357 -178.487 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.5 t -55.33 -40.61 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.486 -0.931 . . . . 1.9 108.486 173.868 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -60.19 -37.4 80.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.002 0.43 . . . . 1.95 111.982 177.913 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -45.45 80.85 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.36 -0.838 . . . . 3.09 110.047 173.88 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.49 -47.75 70.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.245 1.018 . . . . 1.36 110.198 176.599 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -50.02 -49.18 51.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.888 0.875 . . . . 4.26 111.478 175.679 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -64.71 -38.23 90.3 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 122.114 -0.366 . . . . 4.85 110.346 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -61.19 -53.05 61.87 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.934 -0.395 . . . . 1.24 109.934 176.471 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.73 -37.26 75.78 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 118.22 0.464 . . . . 2.06 111.381 -179.297 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.58 -19.05 5.19 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.206 0.817 . . . . 1.81 113.206 174.41 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -118.36 20.9 12.92 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.325 0.65 . . . . 3.11 112.499 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -68.16 -62.56 1.34 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.094 0.861 . . . . 2.53 109.866 173.553 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.91 -128.47 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.384 1.474 . . . . 1.18 108.038 -168.239 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.84 14.56 3.53 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 119.487 1.04 . . . . 1.33 115.043 -173.409 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.09 122.26 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.593 1.157 . . . . 1.51 108.133 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.87 53.29 1.38 Allowed 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.448 0.642 . . . . 2.44 110.566 179.116 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 t -160.05 147.13 16.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.555 -1.276 . . . . 1.65 107.555 170.627 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.82 116.0 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 106.608 -1.627 . . . . 2.47 106.608 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 tt -131.67 72.41 1.5 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.851 -1.166 . . . . 2.34 107.851 177.846 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 p -97.27 153.11 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.64 -0.874 . . . . 2.26 108.64 172.646 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.02 100.26 6.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.577 -1.268 . . . . 1.19 107.577 163.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.2 mt -58.05 -19.12 29.19 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.207 1.003 . . . . 2.89 111.762 172.103 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -49.81 64.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.852 0.861 . . . . 4.8 109.696 178.465 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.88 -31.85 13.5 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.121 0.968 . . . . 1.19 111.749 -174.387 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.22 55.3 1.98 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.511 1.053 . . . . 0.93 111.307 -178.423 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.95 131.64 31.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 117.835 -1.079 . . . . 3.15 108.491 177.097 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.406 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -108.49 105.13 14.65 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 125.333 1.453 . . . . 0.94 110.563 170.536 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.5 130.36 45.75 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 106.639 -1.615 . . . . 4.59 106.639 165.146 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.2 pt -133.04 169.6 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-N 119.292 0.951 . . . . 1.91 109.897 170.544 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.7 105.99 12.6 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 124.699 1.199 . . . . 4.01 111.124 172.543 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -98.27 -176.34 3.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.928 2.091 . . . . 2.58 112.188 170.422 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -127.64 111.64 20.77 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.781 1.633 . . . . 3.24 110.151 167.745 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.87 20.13 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.391 3.394 . . . . 2.12 113.885 -173.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -99.27 -39.37 8.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.616 1.166 . . . . 3.86 110.323 169.061 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.3 m -109.74 -34.13 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 118.743 0.701 . . . . 2.72 111.26 -176.278 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.475 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -120.98 130.9 74.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 109.618 -0.512 . . . . 1.64 109.618 176.818 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -110.47 149.18 39.87 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 124.195 0.998 . . . . 3.46 109.878 -179.518 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -54.34 -40.66 81.83 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.408 2.739 . . . . 1.62 112.419 -178.803 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mp -57.54 -49.1 77.44 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.783 -0.573 . . . . 3.94 111.013 177.577 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -60.3 -40.34 90.13 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.183 0.516 . . . . 3.05 110.293 179.834 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.475 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -54.15 -50.65 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.67 -1.233 . . . . 1.05 107.67 173.181 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.08 -41.63 83.86 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.942 -0.572 . . . . 1.24 110.855 -174.433 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -56.33 -46.03 80.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.173 0.589 . . . . 2.32 110.469 175.009 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.13 -51.59 63.78 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.621 -0.511 . . . . 2.71 109.621 176.03 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 mm -58.17 -45.88 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.784 0.326 . . . . 2.47 111.26 -179.209 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -61.58 -43.06 99.55 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.122 -0.466 . . . . 3.47 111.783 178.004 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.45 -49.02 78.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.6 0.636 . . . . 2.31 110.067 176.403 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -59.63 -27.12 66.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.111 0.564 . . . . 2.1 111.754 175.641 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.0 40.16 2.35 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.596 -1.002 . . . . 1.15 110.596 165.803 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -131.93 170.74 14.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.419 1.488 . . . . 1.88 108.029 178.657 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -115.01 121.46 43.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.351 -0.981 . . . . 3.83 108.351 169.553 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.03 117.7 34.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.381 -1.711 . . . . 0.95 106.381 163.068 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.78 144.18 45.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 105.979 -1.86 . . . . 0.91 105.979 166.83 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.1 t -71.46 152.17 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.474 -1.306 . . . . 2.41 107.474 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.8 ptm . . . . . 0 N--CA 1.447 -0.578 0 CA-C-N 116.193 -0.458 . . . . 3.78 110.404 174.313 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.078 0 N-CA-C 110.519 -1.032 . . . . 2.09 110.519 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -143.31 95.43 2.75 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 119.803 1.802 . . . . 2.79 110.911 172.564 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.33 145.52 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 C-N-CA 126.095 1.758 . . . . 4.71 108.169 178.637 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.426 ' HB2' HD12 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -109.4 148.25 31.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.071 1.348 . . . . 3.44 110.629 173.173 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -140.89 161.4 37.92 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.296 1.038 . . . . 2.41 109.069 -178.175 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.09 138.57 35.19 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 120.181 1.355 . . . . 2.19 109.069 172.235 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.501 HD13 HD13 ' A' ' 98' ' ' ILE . 6.2 mt -94.98 117.14 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.731 -1.211 . . . . 2.67 107.731 176.572 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 21.4 m -98.46 124.63 43.28 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.252 -1.388 . . . . 1.41 107.252 171.184 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.82 -43.75 1.51 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.116 1.341 . . . . 1.02 111.337 175.616 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.88 121.65 8.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.726 0.81 . . . . 2.42 110.938 174.523 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -166.09 26.33 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.842 0.857 . . . . 2.91 111.074 166.07 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 31.1 p -172.47 168.21 5.46 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.296 -0.878 . . . . 5.47 110.026 -167.557 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 58.99 6.9 0.72 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.983 2.113 . . . . 7.23 113.574 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.5 m 38.11 47.47 0.96 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.336 0.589 . . . . 4.43 110.734 -154.646 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.6 p -55.15 -21.99 15.39 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.711 1.204 . . . . 2.39 112.417 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.523 HG13 ' CG2' ' A' ' 113' ' ' VAL . 7.2 t -30.0 -55.9 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.029 1.332 . . . . 1.47 111.327 157.036 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -58.85 -40.23 83.66 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.189 0.596 . . . . 3.66 111.067 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.672 HD21 HD13 ' A' ' 141' ' ' ILE . 3.1 t30 -64.87 -46.65 80.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.866 -0.521 . . . . 2.08 110.008 177.026 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.501 HD13 HD13 ' A' ' 86' ' ' ILE . 96.9 mt -59.97 -52.51 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.143 0.577 . . . . 0.95 110.029 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -55.73 -43.62 76.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.568 1.947 . . . . 2.44 108.966 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.5 t -59.74 -51.35 70.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.792 -0.567 . . . . 1.9 110.064 174.329 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -53.87 -53.85 46.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.85 0.75 . . . . 2.52 110.705 -178.842 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.48 -48.52 74.91 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.545 -0.462 . . . . 2.76 110.318 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.5 m -63.27 -19.44 64.57 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.369 1.068 . . . . 1.79 112.235 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.5 mtt-85 -63.28 -21.59 66.34 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.373 -0.823 . . . . 4.87 111.52 170.582 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.36 169.53 17.12 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.557 1.071 . . . . 3.04 110.422 -177.962 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -80.12 -47.53 14.64 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.164 0.586 . . . . 2.26 111.656 -175.804 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.72 -37.57 66.96 Favored Glycine 0 CA--C 1.524 0.606 0 O-C-N 122.139 -0.351 . . . . 1.09 113.006 -168.479 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.74 123.49 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 122.111 -0.64 . . . . 2.1 109.432 -173.501 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.7 m -101.56 -51.78 3.38 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 122.477 0.311 . . . . 1.97 111.497 -178.032 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CE1' ' HG3' ' A' ' 123' ' ' LYS . 27.4 p90 -140.55 111.34 6.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.049 -0.722 . . . . 2.3 109.049 -177.779 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.15 155.05 16.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.889 -0.782 . . . . 1.09 108.889 166.786 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.8 p -143.73 92.97 2.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.787 -1.19 . . . . 1.87 107.787 169.07 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.523 ' CG2' HG13 ' A' ' 95' ' ' VAL . 2.4 m -96.52 140.02 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.241 -1.022 . . . . 2.33 108.241 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.37 108.15 8.02 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.851 0.86 . . . . 1.42 109.54 -168.368 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.38 -27.78 65.61 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.154 0.798 . . . . 2.25 113.154 -171.449 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.61 71.52 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.138 0.975 . . . . 1.74 110.05 -176.518 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.3 -28.33 13.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.702 2.001 . . . . 1.77 109.334 175.864 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.2 m 71.92 40.55 0.73 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.13 1.772 . . . . 2.22 110.429 -174.539 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -101.21 163.31 12.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 123.839 0.712 . . . . 5.82 110.818 172.168 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.82 108.17 5.54 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.104 2.161 . . . . 0.96 109.105 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 83' ' ' GLU . 2.8 mp -96.68 131.0 43.8 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.697 -1.223 . . . . 2.13 107.697 178.299 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.477 HG11 ' CD1' ' A' ' 134' ' ' ILE . 69.9 t -131.36 113.65 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.452 1.101 . . . . 1.77 108.538 -173.363 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HG3' ' CE1' ' A' ' 110' ' ' TYR . 0.7 OUTLIER -99.84 92.53 5.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 117.78 -1.105 . . . . 4.27 110.351 176.375 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -109.82 -177.15 3.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.682 0.674 . . . . 2.28 110.817 176.624 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -108.24 115.95 57.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.789 -1.189 . . . . 3.05 107.789 173.758 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.47 68.94 8.16 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.042 2.495 . . . . 2.12 111.841 -162.752 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -161.67 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.79 1.236 . . . . 3.0 109.613 175.839 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.4 pt -80.25 -39.2 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 123.964 0.906 . . . . 1.69 110.811 -174.629 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.93 170.71 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.906 0.882 . . . . 1.55 108.657 178.81 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.05 159.46 28.03 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.443 -1.063 . . . . 1.8 110.443 178.626 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.34 -32.17 72.59 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.32 2.68 . . . . 2.52 110.719 -175.714 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -51.53 -37.42 49.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.508 1.123 . . . . 8.04 111.016 175.794 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.34 -45.22 66.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.607 -1.257 . . . . 2.78 107.607 -176.138 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.477 ' CD1' HG11 ' A' ' 122' ' ' VAL . 88.6 mt -60.73 -52.66 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 118.542 -0.742 . . . . 1.44 109.213 -177.714 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.72 HG22 ' HB3' ' A' ' 145' ' ' ALA . 17.3 pt -50.55 -57.09 2.85 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 108.617 -0.883 . . . . 3.92 108.617 175.512 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -54.39 -44.11 72.02 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.461 0.911 . . . . 5.95 113.461 -177.575 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.3 mm -55.65 -50.23 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.468 -0.568 . . . . 1.97 109.468 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.478 ' HA ' HD12 ' A' ' 141' ' ' ILE . 25.3 pt -71.06 -28.14 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.907 -1.121 . . . . 2.15 112.725 -179.226 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -59.05 -30.97 68.43 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.225 0.921 . . . . 3.55 110.293 173.623 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.08 -42.74 95.25 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.579 -0.526 . . . . 2.58 109.579 174.608 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.672 HD13 HD21 ' A' ' 97' ' ' ASN . 25.4 mt -71.91 -33.17 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.273 0.629 . . . . 1.22 109.845 178.263 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.53 22.05 7.97 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.347 1.451 . . . . 1.21 111.249 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.472 ' CD2' HD11 ' A' ' 98' ' ' ILE . 9.8 m-85 -105.8 157.13 17.67 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.143 0.971 . . . . 1.93 108.866 167.991 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -126.18 138.28 53.64 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 107.713 -1.218 . . . . 3.44 107.713 -179.334 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.72 ' HB3' HG22 ' A' ' 135' ' ' ILE . . . -111.06 110.5 21.07 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.622 1.169 . . . . 1.61 108.342 178.986 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 68.2 m -141.47 122.89 14.96 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.022 -1.466 . . . . 2.07 110.483 176.56 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 0.05 103.33 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.936 2.894 . . . . 5.73 114.633 174.718 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.03 -35.61 66.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.668 -0.682 . . . . 5.87 111.333 177.624 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.012 -1.471 . . . . 8.77 113.828 -177.85 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.225 -0.221 0 CA-C-O 121.272 0.558 . . . . 2.8 109.782 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -95.27 137.6 34.11 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.623 -1.251 . . . . 3.4 107.623 -170.429 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 16.7 t -125.03 145.28 49.98 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 123.89 0.876 . . . . 2.04 109.004 176.645 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -121.05 91.2 3.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.749 1.62 . . . . 3.61 108.976 -172.972 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.548 HD12 ' HB3' ' A' ' 44' ' ' ALA . 3.1 pp -124.29 167.59 14.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.046 0.45 . . . . 3.01 110.834 178.8 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.44 168.92 8.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.917 -1.142 . . . . 3.8 107.917 163.775 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.9 mm -102.04 122.28 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 105.064 -2.199 . . . . 1.16 105.064 164.214 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.47 99.41 11.07 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 104.837 -2.282 . . . . 3.79 104.837 178.822 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.81 -59.75 0.38 Allowed Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.418 -0.657 . . . . 1.1 112.193 178.019 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.6 mtp 21.68 84.91 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.332 2.653 . . . . 1.87 114.399 -178.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 p -57.03 -56.49 21.08 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.911 -0.566 . . . . 2.87 112.36 -175.056 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.9 m 135.23 -60.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 129.013 2.925 . . . . 3.84 108.434 -179.361 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.89 -69.51 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.506 1.923 . . . . 5.2 112.644 -165.301 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 p -163.98 28.07 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 122.477 1.132 . . . . 2.52 109.945 163.595 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.5 t -75.06 -41.14 59.61 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.477 -0.783 . . . . 1.71 110.346 -168.069 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.58 -43.87 66.62 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 N-CA-C 108.566 -0.901 . . . . 2.88 108.566 170.172 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -44.85 80.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.203 -0.453 . . . . 1.93 110.326 179.391 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -37.26 86.67 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 121.976 -0.453 . . . . 3.36 111.138 176.867 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.63 -46.12 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 123.808 0.843 . . . . 2.8 110.161 175.168 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -57.74 -49.57 76.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.757 0.313 . . . . 4.25 110.791 -179.076 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -33.4 75.84 Favored 'General case' 0 CA--C 1.521 -0.149 0 O-C-N 121.726 -0.609 . . . . 5.95 110.978 -179.18 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -67.24 -60.33 2.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.127 -0.694 . . . . 1.57 109.127 178.274 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.557 HD21 HD11 ' A' ' 62' ' ' ILE . 10.2 mt -53.73 -50.49 65.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 119.005 -0.522 . . . . 2.55 111.828 179.636 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -62.29 -18.25 60.8 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.788 1.176 . . . . 2.97 113.261 -176.335 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm -95.38 0.05 53.09 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.501 1.297 . . . . 4.14 114.501 171.194 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.12 -60.26 3.12 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 120.244 1.384 . . . . 3.08 110.59 175.182 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.41 -97.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.917 1.687 . . . . 1.15 109.4 175.141 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.9 -0.64 82.38 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 121.873 -0.517 . . . . 1.2 113.773 -171.728 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.71 114.83 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 CA-C-N 118.652 1.226 . . . . 1.4 109.251 178.293 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mp -131.12 52.04 2.09 Favored 'General case' 0 C--N 1.338 0.086 0 N-CA-C 108.982 -0.748 . . . . 3.18 108.982 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.8 t -159.56 120.17 3.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.332 -1.359 . . . . 1.67 107.332 171.444 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.5 m -107.76 122.38 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.624 1.17 . . . . 2.5 108.597 173.471 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tt -137.93 82.35 1.91 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.921 -0.712 . . . . 2.35 109.693 172.516 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 t -102.58 127.16 56.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 116.231 -0.441 . . . . 1.84 110.839 173.738 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.51 97.75 9.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.367 -1.346 . . . . 1.06 107.367 168.428 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.95 -26.29 62.08 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.097 0.559 . . . . 2.84 110.835 173.151 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.7 mtt -68.03 -57.97 5.26 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.204 1.001 . . . . 3.25 110.324 -178.377 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.98 -25.23 30.19 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.069 0.548 . . . . 1.25 111.56 -177.019 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.81 61.16 2.32 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 124.771 1.177 . . . . 0.97 110.798 -178.763 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -142.17 131.75 23.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.142 -1.429 . . . . 2.66 107.142 174.436 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.548 ' HB3' HD12 ' A' ' 8' ' ' LEU . . . -110.45 102.25 10.88 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 124.631 1.207 . . . . 0.87 110.688 171.129 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.41 138.84 39.6 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.831 -1.174 . . . . 4.17 107.831 168.563 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.24 166.55 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.392 -1.336 . . . . 2.01 107.392 -177.693 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -124.49 90.46 3.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.576 0.751 . . . . 3.7 109.765 -172.362 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.456 ' HB2' HD12 ' A' ' 53' ' ' ILE . 9.7 p90 -95.3 -177.99 4.29 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.648 1.979 . . . . 2.23 112.155 -176.858 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.78 94.85 24.14 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.724 1.61 . . . . 2.97 108.946 -176.931 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -55.81 -22.63 38.14 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.253 2.635 . . . . 2.15 113.828 -174.146 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -64.13 -32.34 73.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.448 1.099 . . . . 3.56 112.37 177.967 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.75 -26.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 113.536 0.939 . . . . 2.62 113.536 -175.188 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -123.44 133.22 69.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 N-CA-C 108.436 -0.95 . . . . 1.42 108.436 174.065 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -107.2 154.26 40.59 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.603 1.161 . . . . 3.16 110.088 175.91 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -60.5 -35.72 89.27 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.587 2.191 . . . . 1.33 111.261 -178.616 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 pp -60.89 -43.57 98.3 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.567 -0.708 . . . . 3.7 112.152 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.02 -40.65 78.54 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.298 0.639 . . . . 3.7 109.418 177.835 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.431 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -49.92 -51.68 15.82 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 106.883 -1.525 . . . . 1.12 106.883 173.09 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.47 -42.34 82.39 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.476 -0.784 . . . . 1.23 109.715 -175.805 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.35 -48.56 71.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.607 0.763 . . . . 3.53 110.021 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -44.09 92.34 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.296 0.57 . . . . 2.46 109.604 179.699 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.557 HD11 HD21 ' A' ' 26' ' ' LEU . 8.9 mm -62.6 -44.46 99.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 O-C-N 121.817 -0.552 . . . . 2.75 110.994 179.155 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -63.62 -45.26 91.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.627 -0.508 . . . . 2.34 109.627 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.29 -50.4 71.5 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.773 0.829 . . . . 2.21 110.194 177.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.42 HD12 ' C ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -65.73 -36.19 82.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 121.193 -0.203 . . . . 3.44 110.469 -175.952 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 129.43 26.5 0.88 Allowed Glycine 0 C--N 1.34 0.799 0 CA-C-O 119.792 -0.449 . . . . 1.63 112.988 164.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -118.66 177.94 4.65 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.015 0.926 . . . . 1.99 110.985 173.033 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.54 142.13 41.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.856 -1.535 . . . . 2.33 106.856 160.523 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.4 131.95 55.75 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.095 -1.076 . . . . 1.07 108.095 163.648 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.4 124.87 26.41 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.71 -0.478 . . . . 1.04 109.71 174.227 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.02 148.42 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.844 1.658 . . . . 2.56 109.266 172.636 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.5 mtp . . . . . 0 CA--C 1.532 0.268 0 O-C-N 123.856 0.722 . . . . 3.69 110.986 -177.944 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 106.935 -2.466 . . . . 1.59 106.935 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.45 133.08 43.33 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.405 1.482 . . . . 2.47 107.634 169.387 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.59 ' H ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -142.22 161.22 19.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 129.387 3.075 . . . . 3.25 104.977 166.342 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.64 153.34 32.48 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.182 -1.784 . . . . 3.48 106.182 167.016 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mp -127.17 147.01 50.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.745 0.653 . . . . 2.2 110.077 162.712 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.3 m -92.97 117.3 29.9 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.909 -1.515 . . . . 2.26 106.909 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.437 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.6 OUTLIER -96.41 104.24 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 123.768 0.827 . . . . 1.63 109.415 -174.563 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.3 m -96.9 136.14 37.88 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.522 -1.288 . . . . 1.4 107.522 175.556 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.22 -33.31 4.58 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.701 1.143 . . . . 1.09 112.124 177.705 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.7 ptp -64.05 160.72 17.45 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.372 0.586 . . . . 2.27 112.54 -177.656 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 t -172.41 40.03 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.167 0.987 . . . . 2.63 110.394 168.524 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -164.76 133.7 3.54 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.04 -1.038 . . . . 2.68 111.711 -176.443 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.55 81.72 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.071 0.548 . . . . 2.66 111.174 177.366 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.8 t -56.46 -47.64 78.74 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.228 -0.92 . . . . 2.23 109.825 174.449 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.4 m -60.25 -43.95 95.67 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.874 -0.516 . . . . 2.13 110.366 177.455 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.65 -50.62 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 O-C-N 122.332 -0.23 . . . . 1.78 111.286 177.072 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -59.19 -39.24 81.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.075 0.95 . . . . 3.68 109.673 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -62.56 -50.6 70.68 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.626 0.37 . . . . 1.99 110.128 176.865 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.415 HD11 ' CE2' ' A' ' 143' ' ' PHE . 51.0 mt -55.99 -55.95 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.842 -0.429 . . . . 1.33 109.842 177.517 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.52 -42.45 67.42 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.716 0.807 . . . . 3.0 110.86 177.795 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 p -62.69 -52.05 64.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.536 1.062 . . . . 1.75 110.843 177.212 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -63.6 -39.45 94.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.133 0.879 . . . . 5.58 111.286 -174.235 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.89 -46.25 65.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.241 -0.885 . . . . 2.58 109.24 177.544 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 95.9 m -55.84 -26.03 44.78 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.206 0.912 . . . . 1.7 111.563 176.004 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -61.65 -20.45 63.41 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.376 0.88 . . . . 4.35 113.376 174.075 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.9 m -66.3 150.79 48.31 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.154 1.382 . . . . 1.77 110.909 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -68.34 -50.82 50.61 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.05 0.94 . . . . 2.36 111.756 177.375 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.99 -26.67 61.76 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 123.52 0.581 . . . . 1.23 113.569 -169.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.45 140.35 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.467 -0.938 . . . . 2.85 108.467 -177.21 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 24.8 p -115.49 -64.0 1.38 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 122.621 0.369 . . . . 2.92 111.006 -175.05 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.404 ' CZ ' ' HG3' ' A' ' 123' ' ' LYS . 42.0 p90 -135.57 119.01 16.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.171 -1.048 . . . . 2.91 108.171 174.879 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.62 161.02 14.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.728 -0.471 . . . . 0.8 109.728 164.709 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.8 t -142.81 111.61 6.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.698 -1.223 . . . . 2.2 107.698 168.169 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 68.9 t -98.93 123.17 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.912 1.285 . . . . 2.31 109.458 -177.885 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -130.11 113.42 14.48 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.041 0.837 . . . . 1.28 112.644 -172.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 pp -77.88 -37.98 46.88 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 124.126 0.971 . . . . 2.49 112.853 -171.87 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.67 70.13 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.344 0.592 . . . . 1.43 110.86 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -35.69 16.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.779 1.232 . . . . 1.71 109.633 177.423 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.1 m 90.18 17.53 0.04 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.321 1.848 . . . . 1.82 111.463 175.77 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -125.64 160.42 29.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.626 0.648 . . . . 3.02 110.446 175.693 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -130.74 125.82 34.83 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.127 1.371 . . . . 0.83 108.24 179.146 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -92.55 129.19 38.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.423 -2.065 . . . . 1.71 105.423 177.935 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.72 139.06 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.312 -0.996 . . . . 1.83 108.312 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 13.0 mmmm -114.76 96.93 5.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.61 0.764 . . . . 3.83 109.602 173.067 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.66 -179.77 3.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.202 0.456 . . . . 2.28 110.744 176.827 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -110.08 110.74 58.57 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 108.562 -0.903 . . . . 3.4 108.562 175.297 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.57 63.12 8.69 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.506 2.804 . . . . 1.87 113.049 -164.302 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -148.03 -50.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.873 1.669 . . . . 4.18 108.184 172.009 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.37 -32.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 123.468 0.707 . . . . 1.87 111.33 -173.599 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.85 163.63 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.9 -1.148 . . . . 1.54 107.9 172.934 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.93 154.87 26.17 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.361 -1.095 . . . . 1.37 110.361 -179.407 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -60.44 -33.08 94.41 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.383 2.722 . . . . 1.41 111.71 -175.547 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -57.28 -38.36 73.83 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.585 0.354 . . . . 5.38 110.784 178.122 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -67.23 -45.2 77.49 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.081 -1.081 . . . . 2.85 108.081 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.78 -56.53 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 118.355 -0.831 . . . . 1.36 109.266 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 pt -53.5 -54.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 118.55 0.614 . . . . 2.46 110.559 176.49 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -56.24 -45.47 79.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 119.789 1.177 . . . . 5.07 112.869 -175.384 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.6 mm -69.05 -40.13 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 121.366 -0.834 . . . . 3.62 110.072 -178.816 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.86 -29.72 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 120.12 -1.612 . . . . 1.43 112.195 176.931 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -59.36 -29.59 67.78 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.674 -0.642 . . . . 3.96 111.107 170.225 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.61 -38.69 92.06 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.963 -0.755 . . . . 4.73 108.963 176.728 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.7 mt -70.77 -37.44 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.494 -0.558 . . . . 1.41 109.494 172.61 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.46 28.62 5.38 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.054 1.311 . . . . 1.08 111.02 178.298 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.415 ' CE2' HD11 ' A' ' 98' ' ' ILE . 3.7 m-85 -99.57 -178.91 4.03 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.828 -1.545 . . . . 2.12 106.828 172.641 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -141.54 128.34 20.46 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.537 -1.283 . . . . 4.75 107.537 177.093 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.84 94.62 4.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.656 0.782 . . . . 1.13 109.794 -172.748 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.6 t -98.61 96.83 8.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.799 1.24 . . . . 2.07 107.745 -168.682 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.55 101.25 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.041 1.737 . . . . 4.3 111.875 179.477 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 55.95 35.91 26.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.621 0.769 . . . . 4.24 111.895 178.545 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 108.847 -0.797 . . . . 8.6 108.847 -176.377 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 105.74 -1.948 . . . . 3.82 105.74 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -97.02 165.78 11.91 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.626 0.771 . . . . 3.34 109.682 173.598 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.57 126.57 17.29 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 119.067 -0.492 . . . . 1.93 110.635 164.812 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -99.19 104.69 16.67 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.718 1.607 . . . . 2.76 109.537 178.121 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.435 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -127.9 172.34 10.97 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.219 0.533 . . . . 2.39 109.677 172.413 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.578 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -121.49 138.55 54.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.286 -1.375 . . . . 1.7 107.286 173.212 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.8 mm -100.17 129.88 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.527 -1.286 . . . . 1.05 107.527 177.209 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -108.89 120.71 43.32 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.666 -1.235 . . . . 2.63 107.666 172.762 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.77 -56.28 0.33 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.258 0.932 . . . . 1.67 112.095 177.467 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.3 mtt 25.54 77.14 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.078 2.151 . . . . 2.47 115.522 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m -55.26 -54.68 40.44 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.719 -0.613 . . . . 2.41 112.489 178.906 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.3 41.4 0.1 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.013 0.435 . . . . 4.21 111.355 -169.075 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 51.33 31.14 6.7 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.349 1.459 . . . . 5.09 113.911 177.888 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -154.11 -42.79 0.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.424 1.489 . . . . 2.94 110.905 -172.305 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.42 -46.91 88.31 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.622 -0.674 . . . . 1.62 110.588 -177.716 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.04 -43.36 36.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 123.086 0.554 . . . . 2.1 109.902 171.964 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -61.04 -47.92 84.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.479 -0.563 . . . . 2.51 109.479 -179.062 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -46.93 88.32 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 122.178 -0.326 . . . . 2.72 110.454 178.347 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.9 mt -50.1 -55.06 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.415 1.086 . . . . 2.05 110.292 175.648 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' CD ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -66.79 -32.71 74.17 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.491 1.139 . . . . 6.29 110.563 -176.811 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -32.47 73.84 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 119.634 -1.917 . . . . 4.17 111.603 172.086 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -66.32 -38.33 87.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.21 -0.663 . . . . 1.68 109.21 171.883 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.12 -39.54 78.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.327 0.512 . . . . 2.03 110.086 173.235 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.415 ' N ' HE21 ' A' ' 27' ' ' GLN . 0.0 OUTLIER -53.55 -20.61 5.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.135 1.161 . . . . 3.42 114.135 173.27 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -107.88 9.67 28.73 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.612 0.765 . . . . 3.18 112.647 179.029 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -67.22 -67.94 0.42 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.664 0.785 . . . . 2.37 110.443 178.393 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -167.59 -101.68 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.061 0.944 . . . . 1.49 109.136 177.431 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.57 23.71 6.29 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.5 -0.75 . . . . 1.36 113.22 -175.976 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.2 t -95.44 113.17 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.751 1.221 . . . . 2.36 109.271 178.553 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 mp -139.6 54.04 1.69 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.225 0.466 . . . . 2.81 111.172 177.272 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 m -157.08 152.65 26.7 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.047 -1.094 . . . . 1.69 108.047 155.097 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.453 HG23 ' CD ' ' A' ' 23' ' ' GLU . 2.1 p -141.03 96.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.636 1.174 . . . . 2.73 107.979 179.779 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.71 80.75 1.99 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 108.223 -1.028 . . . . 3.03 108.223 -177.494 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.6 t -99.53 129.35 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.206 -0.665 . . . . 1.97 109.206 174.53 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.44 81.8 3.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.37 -1.715 . . . . 1.2 106.37 170.353 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.83 -16.61 4.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.767 0.827 . . . . 3.44 111.609 176.374 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 6.3 tpt -67.51 -38.8 84.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.401 2.28 . . . . 3.83 110.774 176.739 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.87 -36.2 4.23 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.851 1.26 . . . . 1.5 111.624 -168.45 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.85 58.7 0.98 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.11 1.338 . . . . 1.1 111.36 179.518 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -141.71 133.35 26.99 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.631 -1.248 . . . . 2.68 107.631 170.701 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.78 120.28 41.01 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 0.92 110.709 170.935 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.46 ' OE2' ' NZ ' ' A' ' 47' ' ' LYS . 30.0 tt0 -109.84 115.12 29.24 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.843 0.857 . . . . 4.1 108.874 166.49 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.6 mt -107.92 168.07 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 125.39 1.476 . . . . 2.52 108.872 170.707 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.46 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -126.59 108.2 10.91 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.103 0.961 . . . . 4.59 109.168 162.263 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.472 ' HB2' HD12 ' A' ' 53' ' ' ILE . 12.6 p90 -104.04 177.99 4.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.805 2.042 . . . . 2.19 111.114 174.401 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -121.38 114.3 31.84 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.194 1.397 . . . . 3.22 109.866 171.267 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.13 -22.44 69.89 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.069 2.513 . . . . 2.04 113.553 179.044 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -35.41 80.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.421 1.009 . . . . 3.45 111.188 -179.99 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -116.32 -31.58 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-N 118.591 0.632 . . . . 2.51 111.61 -171.136 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.472 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -126.73 132.46 70.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 123.752 0.821 . . . . 1.46 109.178 178.408 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -107.46 151.58 41.0 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.195 1.398 . . . . 2.66 111.149 179.443 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -59.79 -34.55 95.79 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.636 2.224 . . . . 1.31 111.981 -179.848 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.6 -53.19 60.89 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.466 -0.771 . . . . 3.15 110.643 179.818 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.45 -36.17 82.85 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.965 -0.459 . . . . 4.36 110.929 178.874 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.462 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -53.07 -49.97 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.028 -1.471 . . . . 1.09 107.028 171.632 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.92 90.93 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.386 -0.37 . . . . 1.13 111.236 -177.262 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -56.7 -43.96 81.05 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.852 -0.53 . . . . 2.46 109.726 175.995 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.64 -49.87 69.53 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 110.123 -0.325 . . . . 2.31 110.123 176.099 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -63.28 -48.2 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.294 0.569 . . . . 2.4 111.251 -176.781 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -40.92 96.86 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.935 -0.575 . . . . 2.05 110.483 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.32 -50.92 65.9 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.469 0.577 . . . . 2.5 110.305 177.049 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.5 mt -54.17 -33.77 58.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.914 0.486 . . . . 2.1 111.112 174.799 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.09 37.24 1.54 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.56 -1.016 . . . . 1.2 110.56 164.369 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -129.77 170.07 14.33 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.798 -1.186 . . . . 2.44 107.798 -179.753 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -111.06 122.74 48.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.082 -0.71 . . . . 2.59 109.082 170.331 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.84 122.27 43.15 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.443 -1.317 . . . . 0.84 107.443 163.49 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -121.9 144.49 48.82 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.794 -1.558 . . . . 0.92 106.794 167.235 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.43 ' HA ' ' HB3' ' A' ' 8' ' ' LEU . 2.9 t -75.49 156.89 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 108.032 -1.099 . . . . 2.49 108.032 -179.424 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.8 ptm . . . . . 0 N--CA 1.438 -1.038 0 C-N-CA 119.238 -0.985 . . . . 4.1 111.025 174.486 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 109.761 -1.336 . . . . 2.07 109.761 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.486 ' HB2' ' CD ' ' A' ' 123' ' ' LYS . 1.2 p-10 -145.79 96.08 2.75 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 114.879 1.437 . . . . 3.64 114.879 -178.553 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.33 143.77 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 106.589 -1.634 . . . . 3.98 106.589 -174.268 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -104.87 150.2 25.04 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.115 -1.809 . . . . 3.57 106.115 172.966 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mp -135.91 154.82 51.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.32 -0.992 . . . . 2.26 108.32 167.631 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -95.38 125.87 40.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.835 -1.913 . . . . 1.5 105.835 173.752 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 pt -98.37 139.28 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.757 -1.201 . . . . 1.77 107.757 178.892 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.3 m -125.22 140.21 53.05 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.634 0.773 . . . . 1.56 109.252 174.65 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.93 -21.66 12.14 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.622 1.582 . . . . 1.19 113.334 171.8 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.66 130.85 1.35 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.087 0.955 . . . . 3.56 112.523 168.603 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.8 m -130.54 2.73 4.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.209 0.604 . . . . 3.88 111.114 -178.02 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.2 p 178.74 154.83 0.41 Allowed 'General case' 0 C--N 1.341 0.231 0 O-C-N 121.165 -0.959 . . . . 3.25 109.181 -174.637 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.91 -27.66 65.45 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.579 0.752 . . . . 2.63 112.724 -178.354 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 m -51.65 -41.43 61.34 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.343 -0.848 . . . . 2.0 111.141 169.815 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 90.8 m -65.54 -45.72 82.33 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.599 -0.519 . . . . 1.75 109.599 -179.602 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.7 t -53.28 -54.73 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.562 1.145 . . . . 1.42 109.924 175.444 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -57.26 -45.37 84.05 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.966 0.507 . . . . 3.82 110.168 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -61.98 -45.79 92.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.144 -0.348 . . . . 1.62 110.968 179.077 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.7 mt -56.27 -49.63 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.93 -0.767 . . . . 0.88 108.93 176.583 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -58.57 -47.69 83.41 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.354 -0.61 . . . . 2.28 109.354 178.983 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.5 t -50.83 -50.06 57.44 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.92 0.488 . . . . 1.32 110.07 174.703 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.494 ' HG2' HD11 ' A' ' 141' ' ' ILE . 13.2 mptt -61.53 -37.93 85.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.551 -0.718 . . . . 2.76 111.838 -178.99 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.6 mt -70.19 -60.91 2.0 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.78 -1.192 . . . . 1.82 107.78 178.202 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.4 p -54.86 -20.67 9.28 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.206 1.402 . . . . 2.01 113.147 -179.069 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -59.26 -25.67 64.27 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.456 0.539 . . . . 3.82 112.456 171.279 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 39.1 m -66.68 154.28 41.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.352 1.461 . . . . 1.48 111.337 -178.559 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -72.87 -54.23 9.29 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.293 1.037 . . . . 2.32 111.869 179.295 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.34 -36.2 63.34 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 121.401 0.445 . . . . 1.13 112.37 -172.605 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.76 126.52 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 121.774 -0.839 . . . . 2.23 109.81 -173.309 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.0 m -98.8 -51.25 3.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.553 0.341 . . . . 2.05 110.963 179.168 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.423 ' CZ ' ' HG3' ' A' ' 123' ' ' LYS . 36.2 p90 -140.9 111.6 6.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.325 -0.369 . . . . 2.13 110.082 -178.749 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -96.6 153.69 17.71 Favored 'General case' 0 C--O 1.227 -0.082 0 N-CA-C 108.373 -0.973 . . . . 0.82 108.373 167.014 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -142.83 125.51 15.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 107.041 -1.466 . . . . 2.11 107.041 169.202 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 p -123.88 128.22 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.348 1.059 . . . . 1.96 109.734 -172.501 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.88 106.36 6.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.74 0.781 . . . . 1.09 111.112 -168.791 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -69.29 -19.24 63.9 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 124.304 1.042 . . . . 2.26 113.328 179.155 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.01 94.5 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.786 -0.449 . . . . 1.38 109.786 176.004 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.06 -28.99 17.59 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.124 0.97 . . . . 1.83 110.189 175.338 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.41 34.34 0.37 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.24 1.416 . . . . 1.55 111.319 -175.261 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -138.6 166.74 23.55 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.923 -0.485 . . . . 3.52 111.064 175.217 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -136.66 135.53 38.33 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.819 1.648 . . . . 0.82 108.733 -178.956 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.01 134.55 40.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.717 -1.586 . . . . 1.77 106.717 174.323 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.4 127.99 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.032 0.533 . . . . 2.11 110.001 -178.853 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.486 ' CD ' ' HB2' ' A' ' 81' ' ' ASN . 12.6 mmtp -116.06 87.44 2.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.615 0.766 . . . . 3.53 109.425 -172.783 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -119.63 170.39 9.23 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.456 1.098 . . . . 2.61 111.738 -178.255 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -96.99 114.02 63.96 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 108.182 -1.044 . . . . 3.37 108.182 -179.053 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.72 67.95 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.137 2.558 . . . . 1.63 110.997 -172.917 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -160.46 -47.65 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.831 1.252 . . . . 3.18 109.125 176.886 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -85.79 -30.31 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 122.928 0.491 . . . . 1.57 111.561 -173.145 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.74 162.04 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.155 -1.054 . . . . 1.42 108.155 171.477 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -133.77 163.16 24.49 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.167 -1.573 . . . . 1.7 109.167 178.786 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -63.39 -35.86 58.98 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.92 2.413 . . . . 1.98 111.852 -175.968 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.17 -40.41 73.88 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.149 0.431 . . . . 4.9 111.606 -174.071 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -51.1 71.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.647 -0.871 . . . . 3.32 108.647 178.992 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.436 ' O ' HD13 ' A' ' 138' ' ' ILE . 53.6 mt -58.82 -50.25 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.532 -0.914 . . . . 1.33 108.532 -179.589 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 78.4 mt -46.08 -58.74 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 118.432 -0.794 . . . . 2.32 109.193 172.812 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -49.62 -49.86 45.21 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.697 1.135 . . . . 3.84 112.15 177.24 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.4 mm -51.08 -55.55 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 118.206 0.457 . . . . 1.96 110.576 177.184 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.436 HD13 ' O ' ' A' ' 134' ' ' ILE 0.295 0.0 OUTLIER -68.68 -32.51 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 118.339 -1.345 . . . . 2.81 113.311 -179.705 . . . . . . . . 4 4 . 1 . 031 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.46 -40.28 90.66 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.368 1.44 . . . . 2.22 110.666 173.838 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -63.33 -36.92 85.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.339 0.656 . . . . 3.44 109.818 177.1 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.494 HD11 ' HG2' ' A' ' 101' ' ' LYS . 80.6 mt -69.22 -39.7 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 120.171 -0.611 . . . . 0.93 110.935 172.475 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.8 30.73 6.64 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.386 1.47 . . . . 0.83 111.64 -171.597 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.442 ' CE2' HG21 ' A' ' 141' ' ' ILE . 23.1 m-85 -108.27 166.16 10.96 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.009 0.904 . . . . 1.93 108.907 164.088 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -129.53 130.03 45.25 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 106.704 -1.591 . . . . 3.87 106.704 -178.942 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.09 103.18 10.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.407 1.483 . . . . 1.15 109.144 -175.685 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.5 t -121.25 120.34 34.86 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 123.314 0.646 . . . . 2.44 110.539 -177.482 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -37.1 119.59 0.69 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.581 1.552 . . . . 3.67 111.248 170.94 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.415 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -119.78 61.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.83 1.652 . . . . 3.54 109.464 175.717 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.252 1.217 0 O-C-N 125.737 1.898 . . . . 6.25 109.545 162.866 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 106.784 -1.562 . . . . 9.23 106.784 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.34 89.51 3.25 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 107.421 -1.325 . . . . 4.32 107.421 167.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.24 124.19 8.29 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.083 1.855 . . . . 2.88 110.393 -174.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -110.35 135.49 51.0 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.592 -0.892 . . . . 2.96 108.592 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -91.73 140.73 29.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.665 -0.865 . . . . 3.52 108.665 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.5 t -119.6 132.24 55.67 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.048 -1.093 . . . . 2.44 108.048 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -106.01 102.69 12.1 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.674 1.189 . . . . 2.7 108.533 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.5 pt? -130.36 171.9 12.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.401 0.62 . . . . 2.59 111.713 174.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.468 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -122.05 153.33 38.77 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.451 -1.315 . . . . 1.87 107.451 172.162 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.9 mm -97.64 148.05 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 106.541 -1.652 . . . . 1.24 106.541 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -126.43 132.93 51.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.419 -1.697 . . . . 3.06 106.419 159.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.16 -94.45 0.2 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 108.062 -2.015 . . . . 1.29 108.062 -168.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.2 mtt 50.92 75.01 0.2 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.176 1.39 . . . . 1.93 112.552 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -37.87 37.79 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.565 -0.731 . . . . 2.17 111.758 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.1 t 133.6 -74.66 0.0 OUTLIER 'General case' 0 C--N 1.347 0.471 0 C-N-CA 127.104 2.162 . . . . 3.12 109.471 162.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.23 -44.0 89.64 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.053 0.76 . . . . 5.51 113.053 -160.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 m -153.56 0.47 0.24 Allowed 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 114.689 1.366 . . . . 2.95 114.689 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.26 -42.44 68.79 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.985 1.266 . . . . 1.7 110.227 -174.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -53.58 -46.35 60.42 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 108.703 -0.851 . . . . 2.0 108.703 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -60.64 -41.59 95.22 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.387 0.613 . . . . 2.75 111.545 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -61.42 -52.32 65.06 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.625 -0.672 . . . . 2.36 109.81 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.6 mt -47.66 -50.4 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.331 1.052 . . . . 1.84 110.822 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -49.8 -49.13 49.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.117 0.567 . . . . 4.75 112.055 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -65.25 -40.0 93.44 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.918 -0.489 . . . . 8.69 110.214 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -59.4 -53.5 57.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.662 -0.496 . . . . 1.7 109.662 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.49 -41.83 86.19 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.969 -0.457 . . . . 2.44 111.748 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -54.58 -19.49 6.06 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.977 0.732 . . . . 2.07 112.977 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -110.54 3.04 19.13 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 117.865 -1.064 . . . . 3.25 113.069 175.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -60.37 -68.03 0.34 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 120.359 1.436 . . . . 2.98 110.97 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -168.96 -117.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.306 0.642 . . . . 1.37 109.987 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.47 -8.53 76.08 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.557 -0.58 . . . . 1.6 113.341 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.48 122.16 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 118.628 1.214 . . . . 1.39 110.231 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.54 51.93 1.34 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.435 0.636 . . . . 3.15 111.613 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -160.72 132.58 5.89 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.595 -1.631 . . . . 2.06 106.595 161.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.9 m -118.36 132.57 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.771 -1.937 . . . . 2.51 105.771 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -140.0 74.88 1.48 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.052 -1.462 . . . . 2.62 107.052 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -97.39 127.88 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.432 -0.951 . . . . 2.09 108.432 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.78 93.49 5.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.301 -1.74 . . . . 1.35 106.301 166.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.46 -28.13 65.03 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.28 0.632 . . . . 3.39 110.499 176.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 40.9 mtt -59.39 -64.35 0.97 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.448 1.099 . . . . 3.36 110.425 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.0 -26.83 54.33 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.391 -0.822 . . . . 1.43 110.552 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.63 61.23 1.8 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 125.009 1.29 . . . . 1.15 110.545 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -138.52 144.39 39.93 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.412 -1.329 . . . . 5.86 107.412 175.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.38 102.08 9.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.283 1.433 . . . . 1.24 109.35 167.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -96.17 134.67 38.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.301 -2.111 . . . . 4.76 105.301 165.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 pt -140.1 171.27 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.634 -1.247 . . . . 1.78 107.634 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -120.47 108.17 13.77 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.658 0.663 . . . . 4.46 111.952 167.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.537 ' HB2' HD12 ' A' ' 53' ' ' ILE . 8.2 p90 -97.52 -179.67 4.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.684 2.393 . . . . 2.38 111.907 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -134.97 98.86 12.74 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.065 1.346 . . . . 4.92 109.322 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.68 -26.87 75.58 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.754 2.969 . . . . 1.85 113.185 -162.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -75.04 -10.5 59.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.939 0.495 . . . . 3.6 111.753 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.3 -49.37 2.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 124.102 0.961 . . . . 3.08 109.954 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -115.59 147.5 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.71 1.204 . . . . 2.32 107.958 179.038 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -124.17 151.89 66.48 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.484 1.114 . . . . 2.83 108.869 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.4 -34.87 97.44 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.747 2.298 . . . . 1.64 112.127 -172.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -71.28 -35.07 71.2 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.567 0.58 . . . . 3.37 112.567 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -58.02 -48.33 80.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.407 0.683 . . . . 3.16 109.22 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -52.47 -53.28 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 106.931 -1.507 . . . . 1.39 106.931 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.33 73.78 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.008 -0.542 . . . . 1.11 109.964 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -45.79 74.84 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.3 0.64 . . . . 2.66 110.645 176.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -47.51 81.57 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.387 0.613 . . . . 2.28 110.119 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 69' ' ' ALA . 6.2 mm -67.36 -41.84 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.548 -0.72 . . . . 2.64 111.008 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -44.86 95.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.94 1.296 . . . . 2.16 109.443 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.04 -51.62 68.88 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.067 0.547 . . . . 2.17 109.842 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.3 mt -58.94 -31.1 68.37 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.567 -0.288 . . . . 3.32 111.767 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.89 27.63 2.93 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.145 0.879 . . . . 1.09 111.923 163.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -119.31 167.35 11.97 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.102 1.361 . . . . 2.24 108.274 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -96.82 132.74 42.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.183 -1.414 . . . . 2.52 107.183 164.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.404 ' HB2' HG13 ' A' ' 62' ' ' ILE . . . -108.09 119.37 39.28 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.162 -1.792 . . . . 0.82 106.162 163.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.468 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -129.53 122.44 29.23 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.063 -1.088 . . . . 1.13 108.063 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.431 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.9 t -56.89 144.05 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 109.551 -0.537 . . . . 2.35 109.551 171.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.6 mtp -53.99 -46.78 71.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.361 -0.836 . . . . 3.69 109.245 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.407 ' H ' HG12 ' A' ' 71' ' ' VAL . 2.1 tt0 166.45 -43.78 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 131.255 3.822 . . . . 4.19 102.441 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.91 63.61 7.65 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 124.621 2.153 . . . . 7.54 111.616 -165.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -40.24 -21.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 1 C-N-CA 132.493 4.317 . . . . 4.35 115.47 168.264 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -172.84 -97.31 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.6 0.76 . . . . 3.93 110.34 162.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.89 58.57 0.88 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.204 -1.958 . . . . 3.78 108.204 -168.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.9 -116.91 0.09 Allowed 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 117.401 -1.285 . . . . 5.21 111.704 -156.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -107.84 115.0 29.34 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 121.752 2.069 . . . . 5.11 109.335 -175.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.12 -49.24 4.19 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.392 -1.883 . . . . 2.05 108.392 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.83 82.53 3.03 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 127.469 2.308 . . . . 4.5 107.572 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.41 172.63 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.665 0.745 . . . . 2.94 109.005 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -142.34 157.39 44.86 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 124.26 1.024 . . . . 4.56 108.402 170.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.6 mt -143.0 147.39 35.05 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.581 1.152 . . . . 2.33 109.138 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.64 119.34 34.94 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.72 -1.585 . . . . 1.78 106.72 165.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.24 116.0 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.712 1.205 . . . . 1.98 108.165 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.7 m -106.58 147.49 29.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.149 1.38 . . . . 2.46 107.986 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.4 -40.29 2.48 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.635 1.112 . . . . 1.2 111.279 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -58.96 141.67 53.13 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.458 0.703 . . . . 2.57 110.648 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.8 t -159.94 37.68 0.18 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.092 0.557 . . . . 3.2 111.328 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 51.8 t -162.71 142.06 9.07 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.257 -0.902 . . . . 2.72 110.732 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.78 -45.31 49.55 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.878 0.871 . . . . 2.76 111.441 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 m -56.21 -39.74 72.96 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.816 -0.553 . . . . 2.43 111.649 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 78.7 m -64.97 -46.81 79.96 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.838 -0.801 . . . . 1.85 108.838 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.1 t -50.91 -55.06 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.167 0.587 . . . . 1.36 110.593 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -59.38 -42.47 91.74 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.865 0.84 . . . . 3.69 109.581 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.59 -49.36 75.53 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.136 1.374 . . . . 1.88 110.906 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -54.75 -50.08 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.233 0.613 . . . . 1.41 109.677 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.86 -41.39 99.36 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.195 0.598 . . . . 2.38 109.507 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.7 t -56.15 -52.88 62.78 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.116 0.566 . . . . 1.35 110.475 171.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -51.98 -45.8 64.61 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.639 -0.663 . . . . 2.69 110.77 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.23 -60.19 3.26 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.732 -1.21 . . . . 1.93 107.732 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -52.92 -23.2 6.68 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.822 0.701 . . . . 2.26 112.429 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -64.89 -25.53 67.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 120.36 -0.536 . . . . 4.36 112.305 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 m -69.69 135.09 49.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.195 1.798 . . . . 1.79 110.384 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.9 p-10 -52.38 -51.22 60.14 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.139 0.975 . . . . 2.18 113.565 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.29 -36.96 43.4 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 122.094 -0.379 . . . . 1.25 113.277 -170.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.38 121.57 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 O-C-N 121.753 -0.851 . . . . 1.78 109.307 -168.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.7 m -102.64 -40.11 6.77 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.665 0.386 . . . . 2.26 111.141 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -141.74 127.69 19.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.291 0.496 . . . . 2.18 110.378 164.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -98.45 155.61 17.17 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.707 -1.22 . . . . 0.99 107.707 162.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.0 m -144.36 106.17 4.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 118.048 -0.977 . . . . 2.14 108.687 165.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 120' ' ' ALA . 11.1 p -98.76 126.66 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.216 0.916 . . . . 2.35 112.496 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.87 101.59 7.15 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.844 1.257 . . . . 1.21 109.947 -172.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 pp -75.49 -29.2 59.47 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.367 1.467 . . . . 2.2 113.062 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.32 85.55 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 121.716 0.77 . . . . 1.72 109.171 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.8 -30.9 18.65 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.27 1.828 . . . . 2.47 109.138 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 74.1 m 64.76 50.48 2.03 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.974 1.709 . . . . 2.07 110.261 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -139.71 166.15 25.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.618 -0.719 . . . . 2.81 110.816 158.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.408 ' HB2' HG23 ' A' ' 113' ' ' VAL . . . -130.38 132.7 45.91 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.073 2.149 . . . . 0.97 107.917 -176.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.49 138.56 34.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.711 -1.218 . . . . 2.01 107.711 172.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.1 t -131.42 128.64 61.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.624 1.17 . . . . 2.27 108.811 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -121.67 94.36 4.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.106 0.963 . . . . 3.43 109.123 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -128.4 -177.94 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.719 0.691 . . . . 2.62 111.528 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -99.65 115.3 65.73 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.0 0.92 . . . . 3.38 109.476 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.28 69.52 7.56 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.256 2.637 . . . . 1.82 112.084 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -163.56 -44.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.694 1.198 . . . . 3.99 109.928 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pt -81.69 -30.71 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 122.275 -0.266 . . . . 1.71 111.318 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.01 171.38 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.76 -1.57 . . . . 1.63 106.76 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.11 160.98 28.76 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.789 -0.924 . . . . 1.91 110.789 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.85 -36.59 90.31 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.93 3.086 . . . . 1.92 112.231 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -35.64 74.74 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 123.01 0.524 . . . . 6.47 110.177 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.36 -43.19 82.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.175 0.898 . . . . 3.3 109.622 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 68.7 mt -57.96 -48.14 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.447 -0.575 . . . . 1.34 109.447 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 60.1 mt -51.41 -60.8 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 108.82 -0.807 . . . . 2.15 108.82 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -44.44 -52.7 7.59 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.633 1.173 . . . . 4.58 112.378 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.4 mm -51.99 -53.64 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 109.253 -0.647 . . . . 2.28 109.253 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.272 2.3 pp -70.34 -26.83 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 114.034 1.124 . . . . 1.33 114.034 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -62.74 -38.16 89.4 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.321 0.964 . . . . 3.35 109.418 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -63.88 -35.87 82.08 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.609 0.764 . . . . 5.06 109.017 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 47.7 mt -68.38 -49.3 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 110.052 -0.351 . . . . 1.3 110.052 170.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.91 30.53 2.31 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.943 1.735 . . . . 1.12 112.488 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -102.06 179.06 4.43 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.944 1.372 . . . . 2.1 109.757 166.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -132.94 118.03 18.38 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 108.007 -1.108 . . . . 4.41 108.007 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.07 100.06 9.57 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.554 1.142 . . . . 1.2 109.755 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.6 m -109.37 112.73 25.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.189 0.995 . . . . 2.31 108.587 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -33.07 105.81 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 126.447 1.899 . . . . 4.43 110.101 168.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.93 -34.76 71.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.345 -0.843 . . . . 3.37 110.314 -171.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.249 1.044 0 C-N-CA 128.156 2.582 . . . . 5.82 114.604 169.187 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 108.201 -1.037 . . . . 9.23 108.201 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.41 125.61 91.83 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.659 1.583 . . . . 4.32 111.797 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.24 110.92 2.8 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 121.39 1.394 . . . . 2.88 110.742 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.89 146.35 51.73 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.193 1.797 . . . . 2.96 106.478 175.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -103.23 154.53 19.24 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.747 -1.205 . . . . 3.52 107.747 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.616 ' SG ' HD21 ' A' ' 8' ' ' LEU . 12.6 p -142.32 130.34 21.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.316 0.488 . . . . 2.44 112.316 169.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -98.27 103.69 15.66 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.126 2.17 . . . . 2.7 110.271 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.616 HD21 ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -122.39 176.64 5.77 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.744 0.783 . . . . 2.59 110.199 171.329 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.87 151.51 43.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.259 -1.386 . . . . 1.87 107.259 168.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 44' ' ' ALA . 20.5 mm -95.85 148.04 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.538 -1.653 . . . . 1.24 106.538 171.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -121.64 106.43 11.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.46 -1.311 . . . . 3.06 107.46 163.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.8 -93.65 0.12 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.746 -1.342 . . . . 1.29 109.746 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 mtt 54.25 80.66 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.137 1.375 . . . . 1.93 113.808 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.14 -20.47 17.78 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.847 0.859 . . . . 2.17 112.671 170.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.4 t 74.79 -79.5 0.04 OUTLIER 'General case' 0 C--N 1.342 0.255 0 N-CA-C 107.642 -1.244 . . . . 3.12 107.642 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 4.83 -87.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 128.418 2.687 . . . . 5.51 112.813 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.1 m -138.22 22.49 2.78 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.292 0.637 . . . . 2.95 109.982 160.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.5 m -69.69 -53.49 18.31 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 119.342 -0.943 . . . . 1.7 109.125 -168.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.5 t -50.03 -39.65 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.348 0.594 . . . . 2.0 110.381 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.12 -46.83 87.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.491 0.663 . . . . 2.75 111.221 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -64.57 -46.52 82.39 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.836 -1.165 . . . . 2.36 110.804 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -46.57 -53.7 2.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 C-N-CA 124.868 1.267 . . . . 1.84 108.842 175.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -45.68 -56.26 5.45 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.393 0.616 . . . . 4.75 110.858 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -24.33 61.48 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.151 0.98 . . . . 8.69 110.874 -173.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -69.98 -57.35 5.11 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.683 -0.858 . . . . 1.7 108.683 173.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.03 -42.03 89.22 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 118.522 0.601 . . . . 2.44 110.562 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -22.51 19.93 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.513 0.56 . . . . 2.07 112.513 177.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -124.28 32.16 5.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.944 0.898 . . . . 3.25 111.229 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -74.18 -76.84 0.12 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.021 -1.103 . . . . 2.98 108.021 165.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.74 -118.69 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.276 0.63 . . . . 1.37 110.0 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.82 -13.03 80.89 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 119.522 1.056 . . . . 1.6 113.049 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.08 125.86 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 117.61 0.705 . . . . 1.39 112.215 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.91 57.01 1.41 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.701 1.2 . . . . 3.15 108.093 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.5 t -160.32 154.4 23.12 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 120.535 -1.353 . . . . 2.06 108.141 149.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.4 t -132.94 106.74 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.681 -1.229 . . . . 2.51 107.681 167.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 tt -124.25 73.79 1.26 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.509 -1.293 . . . . 2.62 107.509 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' A' ' 44' ' ' ALA . 58.6 t -102.75 128.0 55.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 109.003 -0.74 . . . . 2.09 109.003 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.94 98.07 9.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.654 -1.239 . . . . 1.35 107.654 170.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 tp -61.67 -26.83 68.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.267 1.027 . . . . 3.39 110.258 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -50.75 43.42 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.784 -0.573 . . . . 3.36 110.108 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.5 -7.22 26.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.545 0.738 . . . . 1.43 112.555 -169.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.38 66.98 2.13 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.181 -1.168 . . . . 1.15 110.181 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 131.16 20.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.106 -1.232 . . . . 5.86 108.839 171.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.507 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -110.06 90.2 3.24 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.992 2.117 . . . . 1.24 110.521 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -102.95 130.08 49.91 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.254 -1.388 . . . . 4.76 107.254 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 pt -140.13 -179.6 2.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 O-C-N 121.236 -0.915 . . . . 1.78 108.585 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -132.67 104.71 6.78 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.27 0.628 . . . . 4.46 110.007 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -106.27 172.55 6.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.83 1.252 . . . . 2.38 113.265 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -114.56 101.49 54.32 Favored Pre-proline 0 N--CA 1.444 -0.75 0 C-N-CA 129.212 3.005 . . . . 4.92 109.627 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.11 8.91 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.749 1.633 . . . . 1.85 113.978 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -91.05 -26.83 18.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.533 1.133 . . . . 3.6 112.039 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.69 -63.35 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 105.566 -2.012 . . . . 3.08 105.566 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.46 170.07 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 120.242 -0.583 . . . . 2.32 110.35 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.86 159.54 68.26 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.742 1.217 . . . . 2.83 108.416 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.24 -40.78 30.64 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.46 2.107 . . . . 1.64 111.256 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -58.22 -40.71 82.36 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.993 -0.442 . . . . 3.37 111.184 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -61.16 -44.94 96.53 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.893 0.877 . . . . 3.16 110.656 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -49.66 -57.92 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.368 0 N-CA-C 106.212 -1.773 . . . . 1.39 106.212 170.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -58.03 -43.51 86.84 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.473 -0.785 . . . . 1.11 110.165 -170.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -50.1 65.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.569 1.548 . . . . 2.66 110.049 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.06 -45.83 86.4 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.574 0.702 . . . . 2.28 109.707 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.534 HG21 ' HB2' ' A' ' 69' ' ' ALA . 5.6 mm -61.59 -44.03 97.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 116.291 -0.413 . . . . 2.64 110.373 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -64.96 -40.86 95.65 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.234 -0.916 . . . . 2.16 110.012 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -61.1 -50.44 73.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.935 0.894 . . . . 2.17 109.932 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.38 -35.18 80.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.3 -0.56 . . . . 3.32 110.781 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.29 23.4 1.75 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 123.386 0.517 . . . . 1.09 112.708 163.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.425 ' O ' HG22 ' A' ' 62' ' ' ILE . 2.5 m-30 -112.79 158.71 19.79 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.889 0.845 . . . . 2.24 109.68 174.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -95.43 133.35 39.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.045 -1.465 . . . . 2.52 107.045 167.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.534 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -123.06 125.31 44.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.111 0.964 . . . . 0.82 108.531 169.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.19 134.88 44.66 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.408 -0.59 . . . . 1.13 109.408 171.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 2.3 t -53.15 151.8 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.315 1.046 . . . . 2.35 110.726 175.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.0 mtp -74.9 -3.76 33.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.649 -0.705 . . . . 3.69 111.946 173.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 98.51 7.37 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 129.111 2.964 . . . . 4.19 110.666 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -156.5 65.16 0.54 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 123.428 1.585 . . . . 7.54 108.45 -166.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -24.79 -63.28 0.06 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 112.429 -2.168 . . . . 4.35 113.927 173.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -179.58 -71.24 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 119.255 0.934 . . . . 3.93 111.365 -167.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.58 83.78 1.61 Allowed Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 109.355 -1.498 . . . . 3.78 109.355 -175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.0 t -135.34 -105.41 0.22 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 118.734 -0.651 . . . . 5.21 112.648 -177.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -114.67 142.18 46.83 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.004 -1.48 . . . . 5.11 107.004 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.26 -43.72 2.54 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.642 -0.983 . . . . 2.05 110.642 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.465 ' C ' HD13 ' A' ' 82' ' ' ILE . 31.9 p-10 -129.39 119.34 23.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.917 0.887 . . . . 4.5 111.283 169.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.547 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -112.27 157.02 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.547 -1.279 . . . . 2.94 107.547 172.421 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.94 141.54 32.96 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.813 0.845 . . . . 4.56 109.632 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.6 mt -141.47 143.77 34.03 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 109.099 -0.704 . . . . 2.33 109.099 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.57 130.63 43.72 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 107.726 -1.212 . . . . 1.78 107.726 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 pp -111.4 99.88 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.331 1.052 . . . . 1.98 110.671 -169.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.1 p -97.31 129.51 44.58 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.875 -0.787 . . . . 2.46 108.875 -175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.86 -26.98 6.98 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.349 0.976 . . . . 1.2 111.326 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.487 ' SD ' HD13 ' A' ' 98' ' ' ILE . 3.0 mtm -63.11 149.03 46.21 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.125 -0.632 . . . . 2.57 112.211 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -169.82 41.92 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.939 1.295 . . . . 3.2 109.287 172.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -166.04 140.63 4.54 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 121.107 -0.996 . . . . 2.72 112.895 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.08 -42.62 81.02 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.447 0.699 . . . . 2.76 110.751 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.3 m -50.48 -45.14 56.15 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.228 0.611 . . . . 2.43 110.807 173.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 75.5 m -64.39 -50.94 65.68 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.017 -0.735 . . . . 1.85 109.017 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 78.7 t -48.32 -51.77 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.08 0.552 . . . . 1.36 110.664 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -59.17 -34.71 72.42 Favored 'General case' 0 C--O 1.227 -0.086 0 CA-C-O 120.722 0.296 . . . . 3.69 110.335 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -63.4 -58.86 5.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.86 0.864 . . . . 1.88 109.393 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.487 HD13 ' SD ' ' A' ' 89' ' ' MET . 3.2 mp -52.94 -52.22 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.366 -0.605 . . . . 1.41 109.366 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.28 -49.76 73.32 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.175 -0.676 . . . . 2.38 109.175 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 t -53.73 -46.77 70.94 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 122.047 -0.408 . . . . 1.35 110.529 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -65.18 -38.11 89.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.124 0.57 . . . . 2.69 111.791 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.497 HD22 HG11 ' A' ' 122' ' ' VAL . 47.7 mt -70.91 -62.64 1.32 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.373 -0.973 . . . . 1.93 108.373 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.4 m -50.29 -24.36 2.88 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.633 2.373 . . . . 2.26 112.692 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -32.12 62.58 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.288 0.477 . . . . 4.36 112.288 172.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.2 m -59.42 144.54 46.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.573 1.149 . . . . 1.79 111.118 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -66.8 -47.97 70.43 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.968 0.907 . . . . 2.18 111.552 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.74 -30.21 66.45 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 123.527 0.584 . . . . 1.25 113.293 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.9 tt -69.61 130.26 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 122.117 -0.637 . . . . 1.78 110.277 -167.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 37.7 m -99.64 -49.77 4.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.753 -0.203 . . . . 2.26 110.824 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -141.31 122.65 14.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.274 -0.639 . . . . 2.18 109.274 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.88 156.12 16.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.265 -1.013 . . . . 0.99 108.265 161.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.5 t -141.05 122.25 14.77 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 107.276 -1.379 . . . . 2.14 107.276 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.59 117.2 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.691 1.196 . . . . 2.35 108.825 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.26 97.72 5.18 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.131 0.967 . . . . 1.21 111.525 -171.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 pp -59.72 -22.07 61.53 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.412 0.893 . . . . 2.2 113.412 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.53 -38.28 49.12 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.454 0.645 . . . . 1.72 109.471 -176.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.5 p -88.79 -20.08 25.17 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 125.011 1.324 . . . . 2.47 109.353 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.5 m 73.25 21.48 3.05 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.885 2.074 . . . . 2.07 111.096 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -130.24 157.3 42.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.899 0.857 . . . . 2.81 112.083 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.27 122.47 29.7 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.061 2.145 . . . . 0.97 107.366 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mp -99.87 137.86 37.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.542 1.537 . . . . 2.01 107.451 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.497 HG11 HD22 ' A' ' 102' ' ' LEU . 3.5 m -136.73 122.63 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.825 1.25 . . . . 2.27 109.346 -169.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -111.37 87.94 2.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.665 -0.683 . . . . 3.43 109.615 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -117.55 173.33 6.78 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.858 0.863 . . . . 2.62 110.657 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -98.49 112.61 62.78 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 108.397 -0.964 . . . . 3.38 108.397 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.02 73.65 4.81 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.39 2.726 . . . . 1.82 111.991 -165.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -162.1 -43.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.228 1.411 . . . . 3.99 110.153 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 pt -83.77 -31.77 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 123.762 0.825 . . . . 1.71 111.281 -170.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.68 158.96 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.337 -0.986 . . . . 1.63 108.337 171.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -126.71 159.93 20.99 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.099 1.333 . . . . 1.91 109.958 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.7 -36.17 42.77 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.125 2.55 . . . . 1.92 111.356 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.17 -40.71 74.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.748 1.219 . . . . 6.47 110.869 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -66.05 -43.91 86.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.671 -0.492 . . . . 3.3 109.671 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.45 -47.68 89.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.645 -0.872 . . . . 1.34 108.645 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.7 mt -53.05 -56.19 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 123.825 0.85 . . . . 2.15 109.529 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -48.34 64.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.366 0.985 . . . . 4.58 110.824 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.0 mm -54.74 -52.99 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 122.047 -0.408 . . . . 2.28 110.065 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.257 2.5 pp -70.52 -27.85 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.764 -1.21 . . . . 1.33 113.419 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.29 -32.85 73.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.36 0.527 . . . . 3.35 110.646 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -57.31 -42.94 82.78 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.844 -0.798 . . . . 5.06 108.844 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.8 mt -73.8 -40.57 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.771 -0.65 . . . . 1.3 109.517 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.38 37.0 3.41 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.007 1.289 . . . . 1.12 110.92 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.459 ' CD2' HD11 ' A' ' 98' ' ' ILE . 30.5 m-85 -99.49 178.1 4.97 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.262 -1.014 . . . . 2.1 108.262 160.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -140.63 125.87 18.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 107.027 -1.471 . . . . 4.41 107.027 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.59 106.45 14.88 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.498 1.519 . . . . 1.2 108.722 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.9 t -123.6 136.27 54.42 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 118.423 0.556 . . . . 2.31 110.496 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp -32.24 119.91 0.29 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.808 2.043 . . . . 4.43 113.27 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.56 49.03 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.085 0.954 . . . . 3.37 111.211 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.332 0 CA-C-O 116.042 -1.932 . . . . 5.82 107.356 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 109.11 -0.7 . . . . 7.68 109.11 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.79 98.79 0.04 OUTLIER Pre-proline 0 C--O 1.219 -0.515 0 C-N-CA 125.184 1.393 . . . . 3.97 109.311 -166.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.39 141.5 22.85 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.547 2.165 . . . . 2.89 110.754 -170.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -116.32 141.56 48.0 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.418 -0.956 . . . . 4.0 108.418 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -90.64 157.08 17.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.99 -1.855 . . . . 3.98 105.99 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.495 ' SG ' HD11 ' A' ' 8' ' ' LEU . 0.5 OUTLIER -135.22 121.92 20.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.695 -1.594 . . . . 2.29 106.695 177.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.43 ' C ' HD13 ' A' ' 8' ' ' LEU . 62.8 m-85 -102.3 90.59 3.95 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.313 1.845 . . . . 3.71 109.05 -173.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.592 HD12 ' HB ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -117.68 171.26 8.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.576 0.703 . . . . 2.77 111.204 178.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.456 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -116.48 143.03 46.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.394 -0.965 . . . . 1.82 108.394 166.203 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.417 HG12 ' HB2' ' A' ' 44' ' ' ALA . 42.3 mm -99.44 139.29 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 107.276 -1.379 . . . . 1.04 107.276 175.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -125.97 123.01 37.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.074 -1.454 . . . . 2.97 107.074 168.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.58 -69.66 0.25 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.224 1.392 . . . . 1.74 110.442 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.9 mmt 37.09 71.2 0.15 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.758 2.023 . . . . 2.71 114.254 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -52.56 -60.52 3.15 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.469 -0.769 . . . . 2.73 113.064 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 t -165.87 48.67 0.08 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 119.518 -0.873 . . . . 3.78 111.816 -172.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.05 51.91 15.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.454 1.102 . . . . 5.67 112.243 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.3 m -175.18 -36.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.039 1.335 . . . . 3.39 110.96 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.71 -42.86 77.12 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 120.965 -1.084 . . . . 2.02 110.536 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.0 -43.98 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.348 -0.612 . . . . 1.85 109.348 168.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -62.07 -30.78 71.23 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.459 0.647 . . . . 2.26 111.861 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -71.47 -46.45 59.87 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 120.98 -1.075 . . . . 3.52 110.706 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.513 HG12 HD13 ' A' ' 65' ' ' LEU . 50.8 mt -49.28 -45.98 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.397 0.679 . . . . 1.5 110.823 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -45.19 -48.07 12.48 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.444 0.565 . . . . 4.17 112.216 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.0 mtm105 -66.02 -34.09 77.29 Favored 'General case' 0 C--N 1.339 0.115 0 O-C-N 121.754 -0.591 . . . . 5.62 110.753 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -63.7 -54.55 33.7 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.241 -1.022 . . . . 1.16 108.241 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mp -60.19 -36.44 77.63 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 111.953 0.353 . . . . 1.97 111.953 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -19.45 6.34 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.178 -0.951 . . . . 1.78 113.128 173.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -118.77 21.31 12.54 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.656 -0.688 . . . . 3.68 112.519 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -66.69 -68.36 0.38 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.355 0.98 . . . . 3.09 109.292 168.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.57 -125.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.419 0.687 . . . . 1.29 109.161 -167.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.0 -10.07 61.07 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 121.85 -0.531 . . . . 1.51 113.389 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -74.95 120.59 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 118.739 1.269 . . . . 1.96 110.38 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.86 53.07 1.09 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.068 0.396 . . . . 2.74 112.068 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.487 ' HB3' ' CB ' ' A' ' 47' ' ' LYS . 29.1 t -158.16 137.0 11.34 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 106.731 -1.581 . . . . 2.03 106.731 171.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.25 101.79 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.607 -1.627 . . . . 2.63 106.607 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -129.3 76.39 1.72 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.158 -1.793 . . . . 2.35 106.158 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.21 141.55 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.945 -1.131 . . . . 2.09 107.945 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -112.85 101.82 9.87 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.263 -1.754 . . . . 1.27 106.263 164.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 tp -55.65 -33.0 63.67 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.488 1.115 . . . . 3.46 109.037 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -48.97 77.29 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.545 0.738 . . . . 5.67 110.571 -174.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.05 -30.48 16.74 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.499 0.72 . . . . 1.54 110.875 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.35 57.69 1.74 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.984 1.278 . . . . 1.17 110.603 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -140.05 144.56 36.94 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.131 0.966 . . . . 3.24 108.856 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.417 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -112.49 116.24 29.95 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.151 0.98 . . . . 1.1 111.398 164.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -97.78 123.79 41.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.716 -1.216 . . . . 4.33 107.716 157.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mt -114.01 164.87 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 108.136 -1.061 . . . . 3.0 108.136 167.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.487 ' CB ' ' HB3' ' A' ' 34' ' ' SER . 10.3 ttmt -124.65 108.93 12.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.739 1.215 . . . . 3.88 110.194 166.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -116.83 177.26 4.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.1 2.16 . . . . 2.74 112.634 175.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.42 107.63 23.81 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.641 1.576 . . . . 3.19 107.559 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.93 6.81 2.28 Favored 'Trans proline' 0 N--CA 1.455 -0.753 1 C-N-CA 125.512 4.142 . . . . 2.47 113.605 -168.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -86.73 -22.16 26.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.46 0.704 . . . . 3.83 111.207 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.73 -56.01 3.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-N 118.566 0.621 . . . . 3.22 109.876 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.31 142.77 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.549 -1.278 . . . . 1.88 107.549 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.26 150.79 54.78 Favored Pre-proline 0 N--CA 1.453 -0.293 0 C-N-CA 124.798 1.239 . . . . 2.58 109.583 -174.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.18 -44.27 35.46 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.758 2.305 . . . . 1.51 111.627 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -63.97 -39.72 94.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.372 -0.83 . . . . 3.36 111.488 178.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -58.47 -43.69 89.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.005 0.522 . . . . 4.22 110.352 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.57 -42.39 29.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 N-CA-C 108.727 -0.842 . . . . 1.59 108.727 173.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 56' ' ' LEU . . . -57.32 -38.59 74.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.12 0.486 . . . . 1.72 111.152 -176.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -63.88 -51.48 64.38 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.491 -0.755 . . . . 3.01 110.109 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -54.26 -51.91 63.05 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.91 0.323 . . . . 3.52 111.695 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.621 HD13 ' H ' ' A' ' 69' ' ' ALA . 2.4 pp -61.25 -42.73 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.649 -0.657 . . . . 4.57 111.741 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.41 -35.15 80.06 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.663 -0.648 . . . . 2.49 110.758 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -64.27 -50.75 66.69 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.174 0.59 . . . . 2.59 109.901 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.513 HD13 HG12 ' A' ' 22' ' ' ILE . 15.3 mt -55.08 -35.38 64.5 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.163 0.585 . . . . 1.93 111.129 173.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.4 39.88 1.44 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.558 1.075 . . . . 1.45 110.589 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -135.43 156.97 48.04 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.528 1.531 . . . . 2.33 107.596 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -104.94 129.75 53.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.695 -1.224 . . . . 3.63 107.695 171.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.621 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -123.62 112.32 17.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.392 -1.707 . . . . 1.09 106.392 171.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -117.53 129.45 55.8 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.356 1.035 . . . . 0.95 108.916 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.592 ' HB ' HD12 ' A' ' 8' ' ' LEU . 7.1 p -81.8 154.29 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.788 0.835 . . . . 2.73 109.153 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.0 mtt -51.23 -56.26 13.82 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.19 -0.459 . . . . 3.51 110.525 170.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' H ' HG22 ' A' ' 71' ' ' VAL . 2.4 tt0 -170.7 54.72 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.551 0.532 . . . . 4.85 111.136 -171.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.483 ' HA ' HG21 ' A' ' 71' ' ' VAL . 0.2 OUTLIER 11.23 64.93 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 128.447 2.699 . . . . 9.84 114.053 -170.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.493 ' CE1' ' HB2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -103.86 -47.38 4.22 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 112.628 -2.078 . . . . 7.23 110.074 -166.228 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 93.79 -103.49 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.835 2.054 . . . . 3.61 112.139 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 82' ' ' ILE . . . 100.49 84.02 1.77 Allowed Glycine 0 C--N 1.335 0.502 0 CA-C-N 119.377 0.99 . . . . 3.58 114.671 175.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 t -162.74 -61.11 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.915 -0.402 . . . . 5.26 109.915 154.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -142.75 123.35 14.09 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.364 -1.347 . . . . 5.8 107.364 -163.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.41 -61.76 4.67 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 107.913 -2.075 . . . . 2.35 107.913 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -102.05 110.94 23.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.225 0.61 . . . . 2.28 109.489 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.485 ' C ' HD12 ' A' ' 82' ' ' ILE . 1.5 pp -129.67 174.96 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.799 0.84 . . . . 3.6 110.874 164.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' HB2' ' CE1' ' A' ' 75' ' ' TYR . 0.9 OUTLIER -111.3 150.93 28.97 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 128.041 2.536 . . . . 4.41 109.401 174.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.2 mt -142.34 139.58 31.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.563 0.745 . . . . 2.47 110.03 172.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.1 t -97.1 124.45 41.12 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.33 0.968 . . . . 1.99 109.51 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -95.9 106.51 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.185 -0.672 . . . . 1.67 109.185 -171.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.9 m -98.83 133.74 42.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.903 -1.147 . . . . 1.46 107.903 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.62 -44.96 1.32 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.918 1.247 . . . . 0.97 112.013 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.52 150.82 41.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.662 0.731 . . . . 2.62 111.349 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -162.5 44.65 0.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.543 0.687 . . . . 2.92 110.057 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 48.9 t -161.99 136.67 6.98 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.826 -1.171 . . . . 2.88 110.721 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.6 -39.15 49.23 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.055 0.942 . . . . 2.88 111.352 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 m -56.23 -44.2 79.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.611 -0.681 . . . . 2.07 111.394 174.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 64.1 m -68.58 -49.98 55.25 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.222 -0.659 . . . . 1.85 109.222 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 113' ' ' VAL . 78.8 t -43.49 -60.4 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.775 1.23 . . . . 1.27 109.792 170.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -59.13 -43.31 91.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.239 1.016 . . . . 3.57 111.105 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -62.48 -47.68 82.92 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.578 0.751 . . . . 1.89 110.673 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.7 mt -56.02 -49.42 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.388 -0.967 . . . . 0.96 108.388 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.57 -45.11 92.8 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.679 -0.489 . . . . 2.58 109.679 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.1 m -57.02 -48.82 77.59 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.358 0.663 . . . . 2.07 110.736 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -60.01 -38.64 83.24 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.723 0.809 . . . . 3.73 111.493 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.436 HD21 HG23 ' A' ' 134' ' ' ILE . 42.6 mt -67.81 -60.5 2.48 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.693 -1.225 . . . . 1.67 107.693 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.6 p -55.74 -17.37 5.86 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.278 0.631 . . . . 1.68 112.64 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -60.99 -24.49 66.18 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.615 -0.678 . . . . 5.66 112.412 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.1 m -73.86 166.13 23.89 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.407 1.483 . . . . 1.53 111.505 -167.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -76.57 -58.32 3.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.65 1.18 . . . . 3.28 111.722 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.69 -45.73 8.35 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.362 -1.095 . . . . 1.73 110.362 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 122' ' ' VAL . 0.4 OUTLIER -60.44 131.29 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.485 -0.561 . . . . 2.46 109.485 175.292 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.2 t -131.53 -39.21 1.14 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.217 1.007 . . . . 2.83 110.875 172.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.06 112.18 17.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.704 -1.591 . . . . 2.43 106.704 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.75 166.69 16.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.672 -0.862 . . . . 1.33 108.672 163.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 m -142.59 138.34 30.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.69 -1.226 . . . . 1.81 107.69 163.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 95' ' ' VAL . 7.1 p -129.66 105.12 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.207 1.003 . . . . 1.93 108.616 -171.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -112.61 102.47 10.54 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.12 0.968 . . . . 1.13 110.573 -168.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -29.7 68.95 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.079 1.352 . . . . 2.63 113.638 -173.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.32 -44.75 95.77 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.797 0.839 . . . . 1.57 109.964 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.74 -25.63 26.32 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.519 1.127 . . . . 1.68 109.623 170.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.2 m 73.97 24.31 2.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.127 1.771 . . . . 1.42 111.509 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -116.06 150.33 37.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.459 1.027 . . . . 3.09 110.425 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.14 107.57 4.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.82 1.248 . . . . 0.99 112.595 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.82 141.5 28.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.245 1.021 . . . . 2.7 110.794 173.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.616 ' HB ' HD11 ' A' ' 108' ' ' ILE . 11.8 m -133.94 135.3 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 126.029 1.732 . . . . 2.54 106.475 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.15 104.21 14.11 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 108.292 -1.003 . . . . 3.46 108.292 171.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -113.43 -179.55 3.67 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.782 0.833 . . . . 2.93 111.199 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.79 114.32 37.62 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.165 1.386 . . . . 3.73 108.587 171.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.96 57.83 6.69 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.677 2.918 . . . . 2.38 112.511 -169.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -147.11 -52.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.634 1.573 . . . . 4.59 107.539 172.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 pt -83.94 -25.71 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 123.178 0.591 . . . . 1.89 112.27 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -147.03 169.73 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.075 -0.713 . . . . 1.51 109.075 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.57 165.75 30.09 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 111.145 -0.782 . . . . 1.41 111.145 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.18 -32.99 41.51 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.535 2.823 . . . . 1.58 111.505 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.414 ' HA ' HG12 ' A' ' 135' ' ' ILE . 19.1 ptt180 -52.37 -39.62 61.02 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.369 0.604 . . . . 6.61 111.188 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -72.26 -38.28 68.9 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.355 -0.98 . . . . 4.42 108.355 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.436 HG23 HD21 ' A' ' 102' ' ' LEU . 81.3 mt -58.03 -54.14 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.648 -0.501 . . . . 1.21 109.648 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 132' ' ' ARG . 22.2 pt -56.25 -55.01 21.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.404 -0.591 . . . . 3.1 109.404 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -47.52 -46.28 27.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 119.117 0.871 . . . . 4.04 112.931 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 mm -59.07 -42.7 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 O-C-N 121.735 -0.603 . . . . 1.71 111.682 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.3 pt -76.93 -28.99 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 113.785 1.032 . . . . 1.91 113.785 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.38 -28.33 65.06 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.363 -0.836 . . . . 3.06 110.301 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -60.77 -41.0 94.66 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.638 -0.504 . . . . 5.49 109.638 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 27.7 mt -70.79 -40.95 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.887 -0.782 . . . . 1.28 108.887 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.62 31.61 3.39 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.393 1.473 . . . . 1.02 110.729 -176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -108.9 166.82 10.53 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 108.782 -0.822 . . . . 2.13 108.782 169.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -137.59 133.72 34.74 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 106.985 -1.487 . . . . 3.46 106.985 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.45 92.66 3.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.981 1.712 . . . . 1.54 109.239 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.3 p -146.87 105.47 3.82 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 117.021 -1.466 . . . . 2.11 112.581 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.3 -70.56 0.09 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 121.361 1.891 . . . . 8.07 114.031 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HA ' ' CB ' ' A' ' 83' ' ' GLU 0.361 . . 40.68 80.09 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.334 2.254 . . . . 5.16 116.891 -163.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.917 0 C-N-CA 128.643 2.777 . . . . 7.06 103.875 172.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 118.771 -0.633 . . . . 15.62 109.338 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.61 154.19 38.03 Favored Pre-proline 0 N--CA 1.452 -0.37 0 O-C-N 124.54 1.15 . . . . 7.44 108.081 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -90.73 29.79 0.38 Allowed 'Trans proline' 0 CA--C 1.514 -0.497 0 N-CA-C 117.37 2.027 . . . . 4.22 117.37 -158.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -106.33 109.38 21.29 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 111.648 -2.524 . . . . 4.28 107.84 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.84 154.36 18.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.274 -1.33 . . . . 4.34 107.75 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.6 t -141.71 132.25 25.39 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.674 0.67 . . . . 2.33 109.507 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -107.83 87.35 2.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.983 1.313 . . . . 2.86 108.983 -162.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.19 177.69 4.55 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.51 0.671 . . . . 2.72 110.59 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.86 151.79 49.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.74 -1.578 . . . . 2.47 106.74 172.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.1 mm -99.3 120.57 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.296 -1.372 . . . . 0.71 107.296 171.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -101.47 87.44 3.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.677 -1.972 . . . . 4.5 105.677 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.12 -87.71 0.08 OUTLIER Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.117 -1.193 . . . . 1.31 110.117 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.2 ptp 41.51 69.72 0.33 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.263 1.825 . . . . 1.96 115.636 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -53.33 -13.32 0.53 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.822 1.416 . . . . 2.54 114.822 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.8 t 74.58 -61.76 0.48 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.397 1.879 . . . . 3.0 111.217 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.15 -72.69 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.741 2.416 . . . . 5.95 113.043 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.6 p -157.51 10.88 0.2 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 113.027 0.751 . . . . 4.34 113.027 166.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -50.64 30.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.423 -1.325 . . . . 2.24 107.423 -169.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 p -49.72 -48.71 20.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 109.783 -0.451 . . . . 3.05 109.783 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 m -54.77 -46.98 74.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.667 0.787 . . . . 2.49 112.552 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -63.82 -45.49 89.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.978 -1.076 . . . . 2.88 110.122 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.431 HG13 HD13 ' A' ' 65' ' ' LEU . 1.2 mp -55.83 -45.02 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.314 1.046 . . . . 2.22 109.291 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -56.08 -50.52 70.77 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.209 1.403 . . . . 5.31 110.779 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -61.4 -39.53 91.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.084 0.554 . . . . 4.97 109.979 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -63.4 -51.58 65.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.554 -0.536 . . . . 1.53 109.554 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -57.26 9.25 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.487 1.115 . . . . 2.81 111.783 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.8 -18.67 34.24 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.946 1.091 . . . . 2.57 113.946 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -102.79 5.64 38.86 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.039 1.336 . . . . 3.2 114.136 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -57.33 -64.68 0.81 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 121.169 1.804 . . . . 3.77 111.611 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -168.47 -133.99 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.434 -1.691 . . . . 1.37 106.434 -169.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.78 33.13 1.23 Allowed Glycine 0 CA--C 1.534 1.221 0 CA-C-N 119.929 1.241 . . . . 1.64 113.61 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.41 124.22 60.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 N-CA-C 105.559 -2.015 . . . . 1.59 105.559 165.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 49.65 1.68 Allowed 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.073 -0.714 . . . . 2.62 109.073 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.3 t -161.88 148.41 13.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.559 -1.275 . . . . 2.29 107.559 173.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.25 120.59 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.964 -1.865 . . . . 2.88 105.964 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.41 71.46 1.47 Allowed 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.262 -1.014 . . . . 2.6 108.262 168.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.3 m -98.14 160.89 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.511 0.672 . . . . 2.37 110.49 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.24 99.65 5.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.426 -1.694 . . . . 1.43 106.426 170.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.7 -27.35 64.77 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.239 1.415 . . . . 3.6 109.869 171.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -69.14 -43.15 74.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.838 0.855 . . . . 4.55 111.688 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.43 -37.96 9.39 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.234 1.014 . . . . 1.56 110.104 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.4 62.94 0.83 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 126.082 1.801 . . . . 1.08 111.011 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -143.04 144.37 32.25 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.834 -1.172 . . . . 2.8 107.834 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.23 105.83 12.18 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.959 1.304 . . . . 1.06 111.174 171.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.66 136.39 38.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 105.64 -1.985 . . . . 4.31 105.64 166.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.9 pt -136.34 174.13 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.039 -1.097 . . . . 1.82 108.039 169.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -134.64 111.48 10.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.967 1.307 . . . . 4.94 109.488 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -124.38 177.31 5.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.86 1.664 . . . . 3.31 113.526 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -113.43 106.0 54.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.343 1.457 . . . . 4.02 111.128 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.47 -10.78 29.88 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.69 2.26 . . . . 2.92 114.296 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -65.89 -18.38 65.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.859 0.754 . . . . 4.13 112.397 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.87 -45.85 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 123.287 0.635 . . . . 2.95 110.281 -170.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.452 HD11 ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -94.66 153.59 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 109.255 -0.646 . . . . 2.15 109.255 175.433 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -130.62 150.08 75.35 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.911 1.685 . . . . 2.82 108.952 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -62.29 -39.27 48.52 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.075 2.516 . . . . 1.96 111.998 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.43 -46.98 87.8 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.495 -0.753 . . . . 4.67 109.91 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -59.79 -37.28 78.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.972 0.509 . . . . 3.05 111.128 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.452 ' CD1' HD11 ' A' ' 53' ' ' ILE . 1.5 mt -54.16 -56.36 10.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 107.202 -1.407 . . . . 1.67 107.202 169.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.1 -44.48 74.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.104 -0.498 . . . . 1.6 111.002 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -48.67 -52.2 24.52 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.134 0.974 . . . . 4.6 110.301 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -49.08 73.52 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.087 0.47 . . . . 2.37 109.811 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -62.4 -37.16 78.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 122.099 -0.376 . . . . 2.7 110.928 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -65.81 -45.17 83.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.629 -0.508 . . . . 1.98 109.629 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -59.02 -50.07 75.5 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.89 -0.411 . . . . 2.46 109.89 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.431 HD13 HG13 ' A' ' 22' ' ' ILE . 21.0 mt -53.49 -45.12 69.52 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.31 0.644 . . . . 2.52 111.241 176.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.87 30.63 0.87 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.807 0.718 . . . . 1.29 112.363 166.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -129.95 163.79 25.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.401 1.48 . . . . 2.14 108.951 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -99.84 122.6 43.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.63 -1.248 . . . . 2.29 107.63 170.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.04 122.54 45.47 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.727 -1.583 . . . . 1.09 106.727 165.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.27 141.62 50.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.772 -1.196 . . . . 1.05 107.772 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.515 HG21 ' HB3' ' A' ' 75' ' ' TYR . 4.3 p -67.97 149.09 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.107 -0.701 . . . . 3.0 109.107 -176.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.2 mtt -55.38 -43.73 75.42 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.99 -0.374 . . . . 4.57 109.99 173.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 174.84 -58.85 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 127.964 2.506 . . . . 4.12 105.589 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.2 90.23 5.42 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.596 1.959 . . . . 7.96 109.092 -165.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.515 ' HB3' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -68.7 28.58 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.763 1.394 . . . . 5.54 114.763 175.015 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.409 ' HB1' ' H ' ' A' ' 77' ' ' GLY . . . 57.57 -154.75 0.34 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.107 1.363 . . . . 3.3 113.125 174.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.409 ' H ' ' HB1' ' A' ' 76' ' ' ALA . . . -102.96 91.33 0.84 Allowed Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 125.727 1.632 . . . . 4.18 109.427 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.5 m -77.9 64.54 3.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.628 1.214 . . . . 6.64 110.136 162.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 t70 66.25 -70.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 127.811 2.444 . . . . 4.98 113.733 165.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 124' ' ' PHE . . . -91.49 -23.92 27.53 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 109.715 -1.354 . . . . 2.07 109.715 171.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -93.1 102.86 15.19 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.574 -2.009 . . . . 2.72 105.574 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.51 143.04 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 108.111 -1.07 . . . . 2.95 108.111 175.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -95.92 146.91 24.21 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.349 -1.723 . . . . 4.41 106.349 170.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.3 mt -137.73 158.96 43.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.172 -1.788 . . . . 2.29 106.172 166.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.75 123.43 42.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.333 -1.729 . . . . 1.64 106.333 170.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.3 pt -97.82 140.18 18.47 Favored 'Isoleucine or valine' 0 C--N 1.336 0.009 0 N-CA-C 108.465 -0.939 . . . . 1.89 108.465 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.4 m -129.03 138.18 51.75 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.814 0.845 . . . . 1.66 109.42 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.51 -35.32 2.7 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 126.032 1.777 . . . . 1.18 112.146 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -30.48 103.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.964 1.706 . . . . 3.56 114.565 172.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.5 m -100.6 -4.81 27.77 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.268 0.627 . . . . 3.51 111.063 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.66 165.52 14.33 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 120.646 -1.284 . . . . 3.34 110.25 177.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.06 -36.79 61.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.54 0.336 . . . . 2.87 110.712 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.3 t -48.46 -45.9 37.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.37 0.668 . . . . 2.08 111.364 173.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.437 ' HA ' HD21 ' A' ' 97' ' ' ASN . 64.2 m -59.77 -53.78 53.98 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 108.759 -0.83 . . . . 2.03 108.759 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.436 HG21 HD22 ' A' ' 115' ' ' LEU . 58.7 t -52.41 -43.6 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.389 0.676 . . . . 1.55 111.027 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -65.21 -42.31 93.61 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.362 -0.977 . . . . 2.56 108.362 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.437 HD21 ' HA ' ' A' ' 94' ' ' CYS . 0.1 OUTLIER -63.92 -42.01 97.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.022 -0.362 . . . . 3.85 110.022 176.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.28 -53.66 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.683 -0.858 . . . . 1.07 108.683 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -54.97 -45.19 74.95 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.644 1.178 . . . . 3.24 108.834 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -53.75 -52.85 58.84 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.927 -0.483 . . . . 1.33 111.612 172.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' HG2' HD11 ' A' ' 141' ' ' ILE . 4.1 mptp? -60.36 -35.2 75.12 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 120.823 -1.173 . . . . 2.43 111.716 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.49 -59.07 3.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.194 -1.039 . . . . 1.8 108.194 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.8 p -57.05 -19.03 16.65 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.077 0.951 . . . . 1.88 112.637 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.93 -31.84 67.2 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.048 -0.407 . . . . 3.8 111.499 171.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 17.4 m -65.45 142.64 58.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.569 1.547 . . . . 1.61 110.923 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -64.83 -48.1 75.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.459 1.103 . . . . 2.58 111.697 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.19 -32.85 57.8 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.97 -0.35 . . . . 1.36 112.741 -171.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.48 134.61 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 117.899 0.85 . . . . 2.27 109.039 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.8 t -107.71 -49.82 3.17 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.08 0.4 . . . . 3.26 112.08 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -136.65 121.64 18.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.482 -0.933 . . . . 2.0 108.482 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.43 133.15 44.16 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.009 -0.737 . . . . 0.94 109.009 166.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.5 m -113.4 102.73 10.6 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 107.901 -1.148 . . . . 2.21 107.901 168.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -108.43 140.33 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.233 -0.654 . . . . 2.76 109.233 175.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.37 95.58 3.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.165 0.983 . . . . 1.52 110.599 -169.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.436 HD22 HG21 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -60.72 -33.02 72.26 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.993 1.317 . . . . 2.28 112.685 -174.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.78 -33.74 17.36 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.071 0.948 . . . . 1.77 111.308 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.66 -5.93 12.16 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.743 1.617 . . . . 2.08 111.426 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.0 m 63.41 27.87 15.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.056 1.742 . . . . 1.45 111.989 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -99.02 158.08 15.9 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.348 0.659 . . . . 3.76 110.642 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -139.13 101.62 4.32 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.506 1.922 . . . . 1.15 108.455 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.79 103.62 15.26 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.185 0.994 . . . . 1.87 108.319 -176.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.6 m -102.12 127.56 55.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 124.612 1.165 . . . . 2.08 109.688 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.36 103.75 14.2 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.457 1.103 . . . . 3.91 108.619 172.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.415 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 13.9 p90 -121.51 -174.67 2.91 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.149 1.379 . . . . 2.69 110.257 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -111.59 111.9 54.32 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 119.153 0.888 . . . . 3.21 109.424 176.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.35 72.18 6.65 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.973 2.449 . . . . 2.2 111.937 -164.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.33 -43.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.206 1.402 . . . . 3.73 109.669 172.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.1 pt -85.73 -31.81 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 124.149 0.98 . . . . 1.83 110.827 -174.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.29 161.67 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.791 1.236 . . . . 1.58 108.296 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.02 162.95 29.33 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.969 -1.252 . . . . 1.53 109.969 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -59.89 -34.38 95.41 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.602 2.868 . . . . 1.53 111.375 -173.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -36.3 69.01 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 122.991 0.517 . . . . 4.72 111.337 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -69.9 -45.7 67.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.617 -0.882 . . . . 3.22 108.617 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.8 -49.38 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.29 -1.004 . . . . 1.22 108.29 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.5 mt -49.66 -59.99 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 118.369 -0.824 . . . . 1.94 109.05 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -49.65 -50.89 41.45 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.891 1.223 . . . . 3.6 112.713 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.62 -52.31 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.737 -0.602 . . . . 1.95 110.864 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.455 ' HA ' HD12 ' A' ' 141' ' ' ILE 0.259 2.4 pp -70.43 -26.11 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 120.777 -1.202 . . . . 1.29 113.716 -177.732 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -60.77 -39.45 88.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.575 0.625 . . . . 2.61 110.224 169.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.11 -40.37 81.02 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.999 -0.741 . . . . 3.43 108.999 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.457 HD11 ' HG2' ' A' ' 101' ' ' LYS . 48.7 mt -72.73 -42.16 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.095 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.37 35.12 4.53 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.997 1.284 . . . . 1.02 111.383 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 141' ' ' ILE . 58.2 m-85 -97.35 176.01 6.05 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.286 -1.005 . . . . 2.02 108.286 163.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -133.42 131.05 39.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.071 -1.455 . . . . 3.4 107.071 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.87 99.0 6.37 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.647 1.579 . . . . 1.3 109.551 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 58.4 m -111.49 114.85 28.23 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.886 0.875 . . . . 1.76 110.701 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -35.88 113.06 0.19 Allowed 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 127.793 2.437 . . . . 3.81 111.216 169.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -103.14 68.45 0.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.706 0.765 . . . . 3.68 110.85 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.291 1.436 . . . . 6.93 110.32 171.972 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 106.086 -1.82 . . . . 8.52 106.086 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.82 100.11 25.81 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 119.981 1.264 . . . . 4.65 109.121 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -69.49 134.51 28.74 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.246 1.964 . . . . 3.52 110.473 -174.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.53 141.88 35.25 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.376 0.67 . . . . 4.55 110.911 -177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -96.51 140.15 31.57 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.578 -0.701 . . . . 4.35 109.677 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.9 t -119.39 136.19 54.4 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.338 1.055 . . . . 2.25 110.115 174.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -106.99 90.06 3.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.401 1.881 . . . . 4.68 111.075 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 71' ' ' VAL 0.271 0.3 OUTLIER -118.13 167.39 11.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.249 1.023 . . . . 2.81 113.087 176.408 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.69 161.05 20.31 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.594 -1.632 . . . . 2.94 106.594 165.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.0 mm -100.16 136.81 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 105.552 -2.018 . . . . 1.03 105.552 167.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -121.85 78.01 1.42 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.06 -1.459 . . . . 5.27 107.06 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.96 -76.73 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.737 -0.945 . . . . 1.38 110.737 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mpt? 57.98 89.18 0.05 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.664 1.586 . . . . 1.86 112.715 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.9 m -59.18 -60.72 3.41 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.583 -0.698 . . . . 2.45 110.961 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.5 t -167.72 88.18 0.27 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.689 -1.226 . . . . 3.36 107.689 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 1.94 65.87 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 129.189 2.996 . . . . 5.84 115.476 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t 173.61 -43.89 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 125.218 1.407 . . . . 3.38 108.537 -168.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 t -66.42 -40.76 89.73 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.833 -1.167 . . . . 2.03 111.32 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.9 -32.02 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 121.799 -0.563 . . . . 1.8 110.464 167.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 t -69.51 -27.2 64.98 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.039 -0.413 . . . . 3.16 111.253 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.59 -47.75 74.65 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.598 -1.314 . . . . 2.86 109.599 171.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.2 mt -42.74 -37.99 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 121.354 -0.841 . . . . 1.38 112.966 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -47.71 -55.37 9.66 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.719 0.691 . . . . 3.7 112.821 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -64.52 -36.01 82.82 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.48 -0.762 . . . . 6.38 109.858 -172.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -61.7 -54.22 45.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.94 -1.133 . . . . 1.34 107.94 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -54.97 -44.58 74.52 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 112.173 0.434 . . . . 2.13 112.173 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.82 -21.1 3.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.907 0.776 . . . . 1.93 112.814 175.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 5.05 13.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 117.843 -1.075 . . . . 5.31 112.61 177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -64.12 -58.42 6.7 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.678 1.126 . . . . 2.77 110.735 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.5 -135.84 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 O-C-N 122.002 -0.436 . . . . 1.33 110.48 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.79 -15.09 47.1 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.929 1.252 . . . . 1.49 113.465 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.28 125.34 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 117.981 0.891 . . . . 1.72 111.755 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 mt -141.53 44.32 1.74 Allowed 'General case' 0 C--N 1.342 0.257 0 CA-C-O 119.286 -0.387 . . . . 3.5 111.074 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -158.13 149.1 20.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.451 -0.574 . . . . 2.76 109.451 169.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.98 70.26 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 124.902 1.281 . . . . 2.7 109.275 -170.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.304 0.7 OUTLIER -102.32 78.93 1.79 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 119.234 -0.986 . . . . 5.03 110.26 -177.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p -96.91 145.76 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.002 -0.999 . . . . 2.51 108.81 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.59 99.78 6.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.963 -1.495 . . . . 1.44 106.963 163.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.6 mt -56.88 -26.65 59.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.007 0.923 . . . . 2.88 111.441 172.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.1 ttt -56.55 -57.59 11.7 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.226 1.01 . . . . 4.1 110.197 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.29 -27.57 22.81 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.798 0.839 . . . . 1.41 110.898 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.89 57.59 2.25 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.552 1.072 . . . . 1.16 110.567 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.34 132.18 35.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.178 -1.045 . . . . 3.69 108.178 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.9 102.62 11.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.584 2.354 . . . . 0.95 109.273 171.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -96.95 137.91 35.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.326 -1.731 . . . . 3.37 106.326 164.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.3 pt -143.49 171.61 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.178 -1.045 . . . . 1.82 108.178 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -125.74 105.48 9.01 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.828 0.851 . . . . 5.34 109.971 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -97.53 169.79 9.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.052 2.541 . . . . 2.68 113.007 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -117.26 100.7 53.11 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 106.096 -1.816 . . . . 2.89 106.096 171.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.75 -29.62 43.05 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.535 3.49 . . . . 2.87 114.704 -170.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -65.65 -18.82 65.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.7 1.6 . . . . 4.6 112.469 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.3 m -126.8 -38.22 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.343 0.657 . . . . 3.12 111.46 -175.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.93 149.88 17.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-N 118.887 0.767 . . . . 1.87 109.268 173.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -129.6 150.34 75.42 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 124.634 1.173 . . . . 3.48 109.287 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -56.22 -37.24 97.0 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.114 2.542 . . . . 1.78 111.263 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.6 mp -54.64 -41.71 70.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.26 0.624 . . . . 3.08 111.344 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -69.49 -40.97 76.73 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.546 -0.721 . . . . 3.7 109.564 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -45.22 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.06 -1.089 . . . . 1.47 108.06 172.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.53 -42.97 93.51 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.904 -0.589 . . . . 1.66 110.804 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -59.4 -51.63 69.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 121.773 -0.58 . . . . 3.11 110.19 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -56.06 15.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.208 0.528 . . . . 2.22 111.137 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.526 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.4 pp -62.12 -40.23 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 121.187 -0.946 . . . . 4.19 112.559 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -32.6 74.27 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.492 -0.755 . . . . 2.55 110.85 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.31 -51.29 61.63 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.503 0.592 . . . . 2.65 109.648 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.07 -38.63 68.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.416 -0.514 . . . . 3.69 111.808 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.77 45.47 0.65 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.676 -0.97 . . . . 1.53 110.676 171.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -131.95 157.09 44.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.72 1.208 . . . . 2.62 108.035 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -99.82 129.71 45.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.944 -1.502 . . . . 2.53 106.944 166.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.526 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -121.38 124.71 45.2 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.222 -1.399 . . . . 1.24 107.222 173.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.53 119.98 27.23 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.155 0.909 . . . . 0.98 109.946 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 2.2 p -68.33 141.31 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 125.065 1.346 . . . . 2.73 108.737 166.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.2 ptm -40.55 -52.03 2.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 124.486 1.117 . . . . 5.76 111.357 -172.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -160.31 41.34 0.18 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.796 1.238 . . . . 3.93 109.068 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.407 ' HA ' ' CG2' ' A' ' 71' ' ' VAL . 1.9 m-20 29.03 51.92 0.07 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.171 1.788 . . . . 10.1 111.95 -164.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -70.45 -70.44 0.3 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.657 -1.979 . . . . 6.15 105.657 -174.472 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 73.54 120.08 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.783 2.833 . . . . 4.2 109.352 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.416 ' HA3' ' CZ ' ' A' ' 75' ' ' TYR . . . -145.14 104.29 0.31 Allowed Glycine 0 C--N 1.336 0.57 0 CA-C-N 118.393 0.542 . . . . 3.64 111.938 -160.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 t -169.99 -56.47 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.811 -0.811 . . . . 4.89 108.811 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -153.5 147.12 25.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 104.968 -2.234 . . . . 5.25 104.968 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.11 -59.48 4.48 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 108.107 -1.997 . . . . 1.84 108.107 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.614 ' C ' HD13 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -118.46 107.02 13.3 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.275 1.43 . . . . 2.37 108.467 -166.101 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.614 HD13 ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -127.6 148.02 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 120.336 1.425 . . . . 2.73 112.455 -178.368 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 1.0 OUTLIER -109.11 124.0 50.08 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.15 1.78 . . . . 4.47 112.621 -175.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.7 mt -128.76 138.83 52.32 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.315 1.046 . . . . 2.36 109.418 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.6 OUTLIER -102.96 124.1 47.83 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.808 -1.182 . . . . 2.28 107.808 -177.428 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.37 105.49 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.713 1.205 . . . . 1.76 109.715 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.8 p -101.77 126.26 48.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.575 -0.898 . . . . 2.26 108.575 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.64 -34.3 3.66 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.128 0.87 . . . . 1.36 111.034 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -63.36 130.94 46.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.083 0.553 . . . . 2.88 109.808 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 p -137.54 22.58 2.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.965 1.306 . . . . 3.72 110.693 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 5.3 t -157.25 141.19 16.1 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 121.298 -0.876 . . . . 2.95 111.881 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.6 -35.13 79.93 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.214 0.606 . . . . 2.61 111.456 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 p -53.4 -47.3 69.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.504 -0.554 . . . . 2.18 109.504 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 59.7 m -59.26 -49.76 76.6 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 119.22 -0.419 . . . . 2.5 110.129 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.4 t -49.36 -50.15 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 118.237 0.471 . . . . 1.61 110.544 175.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -60.63 -40.81 93.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.768 -0.456 . . . . 4.66 109.768 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.23 -42.47 96.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.865 -0.522 . . . . 2.66 110.253 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.8 mt -61.42 -51.47 72.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.111 -1.07 . . . . 1.3 108.111 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -55.67 -45.88 77.64 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.676 1.19 . . . . 2.23 109.61 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.8 t -54.95 -54.82 37.88 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.687 -0.633 . . . . 1.82 110.637 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -51.2 -61.32 2.3 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.194 0.452 . . . . 2.71 110.261 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.85 -39.32 91.45 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.768 -0.373 . . . . 2.23 110.415 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 96.3 m -59.73 -19.24 48.82 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.54 0.609 . . . . 1.84 112.1 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -66.49 -27.02 67.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 119.166 -1.014 . . . . 4.47 111.919 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 81.3 m -63.54 126.58 27.98 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.631 0.773 . . . . 2.19 111.597 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -38.51 -59.63 0.89 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.651 1.98 . . . . 3.4 113.845 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.22 -28.36 68.29 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.231 0.469 . . . . 1.67 113.319 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.78 118.8 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 O-C-N 121.359 -1.083 . . . . 1.75 109.475 -168.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.2 m -102.92 -44.86 5.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.857 0.318 . . . . 2.71 111.857 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -142.12 128.8 20.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.406 -0.961 . . . . 1.99 108.406 166.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.75 162.52 12.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.87 -0.332 . . . . 0.87 110.375 161.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m -145.0 113.05 6.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.45 -0.945 . . . . 1.73 108.45 162.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 p -110.03 128.93 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.75 0.705 . . . . 1.89 110.962 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -125.04 90.4 3.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.145 0.978 . . . . 1.53 110.951 -166.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.09 -32.5 55.01 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.287 1.435 . . . . 2.61 112.964 -174.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.71 -32.12 65.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.259 0.624 . . . . 2.0 111.154 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.53 -14.45 11.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.145 1.378 . . . . 1.93 111.202 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.4 m 65.99 28.29 10.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.101 1.361 . . . . 1.89 111.951 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.458 ' HD3' ' HB1' ' A' ' 148' ' ' ALA . 44.3 mmtt -96.75 152.84 18.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.312 1.445 . . . . 2.87 109.703 173.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.26 106.36 4.35 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.521 1.128 . . . . 0.99 109.383 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.3 mp -95.43 130.19 42.32 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.633 -1.247 . . . . 2.85 107.633 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.1 t -128.28 123.9 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.031 0.932 . . . . 1.91 108.75 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -105.55 92.06 4.03 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.918 0.887 . . . . 2.99 109.136 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -115.35 173.7 6.38 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.761 0.709 . . . . 2.54 111.098 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -100.26 112.68 64.65 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 108.886 -0.783 . . . . 2.74 108.886 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.72 70.03 7.11 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.649 2.899 . . . . 1.99 111.217 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -165.05 -47.95 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.523 1.529 . . . . 3.04 108.836 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.6 pt -84.85 -37.48 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.121 0.969 . . . . 2.17 111.103 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.7 tp -136.86 169.3 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.304 0.642 . . . . 2.08 109.458 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.25 170.77 32.17 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.64 -1.784 . . . . 1.75 108.64 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -58.41 -35.65 98.44 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.27 2.646 . . . . 1.8 111.285 -171.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.9 ptm85 -56.63 -30.55 63.41 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.18 0.807 . . . . 5.4 113.18 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.36 -50.03 67.11 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.231 -1.026 . . . . 3.37 108.231 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 42.5 mt -63.32 -44.17 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.512 -1.222 . . . . 1.1 108.123 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.54 -57.2 5.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 118.476 -0.773 . . . . 1.87 109.366 172.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -49.58 -51.14 39.15 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.302 1.41 . . . . 3.46 112.36 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.6 mm -54.16 -53.72 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.019 0.528 . . . . 1.81 110.377 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 pp -70.36 -29.72 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 120.967 -1.083 . . . . 1.44 113.108 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -59.04 -41.79 88.71 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 119.143 0.883 . . . . 2.8 109.309 168.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -64.82 -37.92 89.23 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.483 -0.562 . . . . 2.99 109.483 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.7 mt -62.83 -44.96 99.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 122.006 -0.434 . . . . 1.09 110.437 170.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.19 28.21 5.02 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.381 1.467 . . . . 1.03 111.941 -174.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -101.67 -179.81 4.12 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.42 1.11 . . . . 2.24 108.929 164.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -139.1 126.55 21.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.635 -1.617 . . . . 3.88 106.635 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.62 91.16 3.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.315 1.846 . . . . 1.21 108.373 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 68.3 m -102.82 131.45 49.69 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.092 -0.707 . . . . 2.27 109.092 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 mt -41.25 109.87 0.14 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.26 1.824 . . . . 3.77 111.37 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.663 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -90.09 -20.93 22.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.742 -0.663 . . . . 4.01 110.741 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.403 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.375 0 C-N-CA 125.91 1.684 . . . . 6.35 112.062 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.3 mtm . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 106.439 -1.689 . . . . 7.26 106.439 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.48 112.98 15.85 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-O 117.024 -1.465 . . . . 4.25 107.904 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -87.68 148.57 7.29 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.903 2.402 . . . . 3.03 109.621 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -114.36 164.19 14.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.41 -1.329 . . . . 3.93 107.41 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.56 147.95 41.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.444 -0.947 . . . . 4.9 108.444 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.4 p -141.18 140.38 34.02 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.871 -0.788 . . . . 3.09 108.871 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -120.72 103.52 9.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.693 -1.966 . . . . 3.04 105.693 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.581 HD12 ' HB1' ' A' ' 69' ' ' ALA . 2.1 pt? -132.66 160.37 36.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.136 -1.061 . . . . 2.22 108.136 175.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.495 HE22 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -101.41 171.83 7.34 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.545 -0.909 . . . . 3.47 108.545 173.062 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.2 mm -99.84 126.74 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.098 -1.815 . . . . 0.99 106.098 162.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -102.36 95.86 6.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.348 -2.093 . . . . 3.68 105.348 166.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.38 -77.26 0.11 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.14 0.876 . . . . 1.28 110.961 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 mtp 35.53 76.22 0.05 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.933 2.093 . . . . 2.12 114.831 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 p -41.04 -54.0 2.89 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.669 0.787 . . . . 2.84 112.448 171.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t 119.13 -62.95 0.0 OUTLIER 'General case' 0 C--N 1.342 0.266 0 C-N-CA 129.355 3.062 . . . . 2.85 107.659 -174.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -22.51 -77.5 0.01 OUTLIER 'General case' 0 C--N 1.344 0.341 0 C-N-CA 127.659 2.384 . . . . 5.81 113.148 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 t -161.82 21.9 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.487 0.661 . . . . 2.85 110.945 165.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -71.89 -41.28 68.17 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 120.91 -1.119 . . . . 2.15 110.256 -163.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.68 -46.89 79.64 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.684 -0.858 . . . . 1.46 108.684 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 t -55.79 -48.63 75.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.294 0.569 . . . . 2.39 110.285 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.25 -49.3 74.67 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.827 -0.434 . . . . 2.56 109.827 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.6 mt -56.06 -49.93 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.886 0.874 . . . . 1.92 109.509 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.479 ' CD ' HG21 ' A' ' 37' ' ' VAL . 82.5 mm-40 -61.94 -39.08 90.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.892 0.877 . . . . 7.03 112.393 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -44.38 93.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.105 -0.702 . . . . 5.02 109.105 175.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -61.69 -37.12 82.95 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.883 -0.51 . . . . 1.47 110.031 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.79 -52.72 33.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.93 0.892 . . . . 2.06 110.958 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.424 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 3.9 pt20 -56.67 -26.53 56.63 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.784 1.175 . . . . 2.5 112.608 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -74.22 0.63 13.5 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 116.782 -1.58 . . . . 2.96 115.125 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -48.67 -84.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 121.044 1.747 . . . . 3.01 112.581 174.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.84 -90.91 0.0 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.686 0.795 . . . . 2.33 110.095 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.15 -26.18 74.21 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.369 -0.692 . . . . 1.62 111.369 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.424 ' CG1' ' HA ' ' A' ' 27' ' ' GLN . 1.1 t -61.06 128.6 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.069 -0.715 . . . . 2.24 109.069 172.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.19 53.5 1.08 Allowed 'General case' 0 C--N 1.337 0.053 0 C-N-CA 121.099 -0.241 . . . . 3.03 111.207 163.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.1 t -158.1 139.22 13.28 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 120.926 -1.109 . . . . 1.9 110.549 167.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 p -126.53 107.89 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 125.94 1.696 . . . . 2.89 107.432 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -126.22 72.24 1.3 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.503 -1.666 . . . . 2.43 106.503 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.538 HG22 ' HA ' ' A' ' 44' ' ' ALA . 44.4 t -103.55 141.09 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.843 -0.799 . . . . 1.89 108.843 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.25 95.75 5.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.551 -0.907 . . . . 1.43 108.551 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.97 -18.19 4.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.022 0.529 . . . . 3.05 112.309 169.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.8 mtt -69.13 -50.54 46.97 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.3 0.64 . . . . 3.61 110.116 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.08 -30.69 12.89 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.715 0.806 . . . . 1.48 111.435 -172.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.38 64.08 1.4 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.837 1.208 . . . . 1.2 110.479 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -141.0 138.5 33.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.384 -1.709 . . . . 2.93 106.384 171.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.538 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -117.09 92.74 3.94 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 124.868 1.355 . . . . 1.27 112.301 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.92 119.59 35.67 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.996 -1.113 . . . . 4.67 107.996 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.99 163.35 20.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 126.379 1.872 . . . . 2.6 108.858 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -122.34 106.08 10.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.588 0.755 . . . . 3.91 110.083 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.513 ' HB2' HD12 ' A' ' 53' ' ' ILE . 18.6 p90 -100.11 173.36 6.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.075 1.75 . . . . 2.38 113.272 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -122.85 102.86 37.66 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.239 1.815 . . . . 4.06 109.27 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -45.8 -36.02 14.38 Favored 'Trans proline' 0 C--N 1.355 0.913 1 C-N-CA 126.076 4.517 . . . . 2.3 113.743 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.39 -29.11 68.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.224 1.409 . . . . 3.36 111.69 -170.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.89 -32.45 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.684 0.794 . . . . 2.79 112.261 -174.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.513 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -120.56 146.2 25.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 107.947 -1.131 . . . . 1.6 107.947 173.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -124.27 146.51 51.97 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.149 1.38 . . . . 2.44 109.394 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.72 -38.5 49.29 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.313 2.676 . . . . 1.69 112.057 -171.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -57.58 -45.62 85.01 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.879 -0.513 . . . . 3.26 111.005 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -61.05 -43.18 99.28 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.002 0.921 . . . . 3.39 109.904 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.401 ' CD1' HD11 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -52.37 -53.2 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.251 -1.388 . . . . 1.12 107.251 171.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.17 85.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 110.019 -0.363 . . . . 1.47 110.019 -173.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -55.89 -42.55 76.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.292 0.637 . . . . 2.76 110.86 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.2 -43.25 87.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.394 0.543 . . . . 2.79 110.129 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 69' ' ' ALA . 6.1 mm -65.4 -44.03 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.671 -0.643 . . . . 2.57 110.607 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -58.46 -41.96 86.34 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.288 0.635 . . . . 3.38 111.279 174.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -63.76 -48.73 75.78 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.174 0.59 . . . . 2.91 109.984 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.8 mt -56.22 -35.51 67.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.645 0.378 . . . . 2.08 111.323 173.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.82 25.57 3.6 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.216 0.912 . . . . 1.34 112.077 168.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -115.48 168.79 9.68 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.055 1.742 . . . . 2.09 108.643 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -104.06 142.55 34.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.801 -1.185 . . . . 2.4 107.801 165.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.581 ' HB1' HD12 ' A' ' 8' ' ' LEU . . . -123.81 112.38 17.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.78 -1.563 . . . . 0.96 106.78 175.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB3' HE22 ' A' ' 9' ' ' GLN . . . -126.85 129.33 48.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.656 -0.868 . . . . 0.93 108.656 175.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.7 p -47.69 145.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 125.484 1.513 . . . . 2.86 109.702 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -55.2 -40.03 70.29 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.751 -0.659 . . . . 4.95 110.273 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 168.11 -43.87 0.0 OUTLIER 'General case' 0 C--O 1.235 0.333 0 C-N-CA 130.697 3.599 . . . . 6.37 106.231 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.48 95.65 4.53 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.494 1.518 . . . . 7.65 107.441 -176.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.545 ' CE1' HD11 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -40.2 -58.44 1.48 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.131 1.372 . . . . 5.6 112.656 178.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 133.79 167.83 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 130.8 3.64 . . . . 4.12 105.811 -175.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' A' ' 82' ' ' ILE . . . -75.71 83.55 0.91 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.923 -1.132 . . . . 2.96 112.395 173.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.3 m -75.15 61.84 1.16 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.132 1.773 . . . . 5.44 111.043 168.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.3 t70 54.88 109.2 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 128.526 2.73 . . . . 4.31 115.958 159.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.58 -47.23 3.73 Favored Glycine 0 C--N 1.341 0.857 0 N-CA-C 107.17 -2.372 . . . . 1.64 107.17 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.15 96.49 10.61 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 105.477 -2.046 . . . . 2.49 105.477 172.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.611 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 5.6 pt -123.06 145.69 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 O-C-N 123.211 0.319 . . . . 2.96 110.213 173.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.401 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.0 OUTLIER -96.98 157.35 15.94 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.491 -1.67 . . . . 3.54 106.491 178.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.63 HD13 ' HB1' ' A' ' 145' ' ' ALA . 4.6 pp -147.51 161.72 40.52 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.091 -0.707 . . . . 2.97 109.091 161.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.6 m -99.73 127.86 45.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.624 1.17 . . . . 1.83 108.815 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 pp -99.57 127.61 52.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 C-N-CA 123.079 0.552 . . . . 1.59 110.311 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.5 m -106.45 142.6 35.84 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.722 0.809 . . . . 1.36 109.188 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.65 -24.26 17.78 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.653 1.121 . . . . 0.95 113.061 172.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.2 ttm -66.28 143.6 57.11 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.063 0.931 . . . . 2.6 111.274 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.6 t -162.0 37.18 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.925 0.49 . . . . 2.58 110.593 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.1 t -164.62 138.35 5.1 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.605 -1.31 . . . . 2.82 111.509 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.27 -40.17 81.15 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.243 0.617 . . . . 2.62 110.895 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -43.23 70.44 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.494 -0.753 . . . . 2.44 109.612 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 91.2 m -67.76 -42.38 81.84 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.157 -0.449 . . . . 2.06 110.796 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.95 -50.35 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 118.864 0.756 . . . . 2.06 110.509 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -59.23 -37.0 76.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.766 -0.457 . . . . 3.4 109.766 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -65.25 -49.11 70.9 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.275 -0.266 . . . . 1.7 110.663 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.07 -48.27 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 109.438 -0.579 . . . . 0.92 109.438 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -58.63 -49.3 78.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.443 -0.947 . . . . 2.46 108.443 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.1 t -52.45 -46.38 66.42 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.1 0.56 . . . . 1.38 110.122 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.454 ' HG2' HD11 ' A' ' 141' ' ' ILE . 13.7 mptt -63.33 -41.47 98.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.284 0.634 . . . . 2.96 111.723 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.6 mt -67.34 -58.59 4.51 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.538 -1.282 . . . . 1.78 107.538 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.3 p -57.05 -18.74 15.43 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.133 0.973 . . . . 1.85 112.749 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.16 -34.45 66.17 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.943 -0.473 . . . . 6.0 111.65 170.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.5 m -67.44 149.22 50.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.407 1.883 . . . . 1.64 111.458 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -64.47 -52.68 56.71 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.347 1.059 . . . . 2.47 111.891 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.21 -27.41 59.94 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 122.175 -0.328 . . . . 1.1 113.074 -168.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.52 132.02 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 117.647 0.723 . . . . 1.96 109.538 -173.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 49.6 m -103.03 -58.21 1.91 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.249 0.619 . . . . 1.96 111.19 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -134.69 113.7 11.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.2 -0.667 . . . . 2.69 109.2 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.24 149.88 21.54 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 108.102 -1.073 . . . . 0.84 108.102 165.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.7 t -143.03 109.01 5.18 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 108.19 -1.041 . . . . 1.94 108.19 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.44 138.99 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.322 1.449 . . . . 2.1 110.686 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.21 93.64 2.85 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.74 1.216 . . . . 1.18 110.665 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 pp -60.11 -17.62 41.38 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.538 1.135 . . . . 2.28 113.83 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.71 86.75 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.458 0.572 . . . . 1.48 109.574 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.82 -39.91 10.02 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.505 1.122 . . . . 2.09 108.905 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.1 m 88.94 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 127.568 2.347 . . . . 1.3 110.539 -169.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.0 157.95 17.41 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.365 -0.606 . . . . 4.09 109.365 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.57 144.26 34.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.812 -1.09 . . . . 1.11 109.944 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.545 HD11 ' CE1' ' A' ' 75' ' ' TYR . 4.3 mm? -94.79 143.31 26.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.462 -0.94 . . . . 2.9 108.462 163.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.74 124.16 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.634 -1.987 . . . . 1.72 105.634 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -108.64 92.44 4.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.086 -1.079 . . . . 3.14 108.086 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -113.33 -178.56 3.41 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 124.014 0.926 . . . . 2.13 108.83 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -113.99 110.75 48.5 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 108.322 -0.992 . . . . 2.98 108.322 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.32 68.47 8.27 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.924 2.416 . . . . 1.74 112.229 -166.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.34 -44.92 0.07 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.617 1.567 . . . . 3.31 109.206 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.6 pt -86.67 -30.73 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 123.365 0.666 . . . . 1.66 111.559 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.2 162.63 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.426 -0.953 . . . . 1.44 108.426 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.79 167.84 31.64 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.837 -0.905 . . . . 1.44 110.837 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.12 -39.01 62.81 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.811 3.008 . . . . 1.49 112.334 -169.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.76 -39.43 52.33 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.471 0.545 . . . . 6.06 112.471 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.51 -45.0 81.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.602 -0.518 . . . . 3.37 109.602 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 88.3 mt -58.67 -49.29 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.815 -0.809 . . . . 1.15 108.815 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.2 mt -49.57 -59.31 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 N-CA-C 108.445 -0.946 . . . . 2.13 108.445 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -50.07 -47.55 53.5 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.105 -0.997 . . . . 5.02 111.365 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 82.4 mt -55.54 -50.12 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.447 -0.783 . . . . 2.69 109.646 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 145' ' ' ALA . 12.7 pt -70.37 -30.14 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 118.108 -0.949 . . . . 1.26 112.861 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.77 -42.48 79.47 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.829 1.195 . . . . 3.02 109.068 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.71 -34.32 76.91 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.758 1.223 . . . . 3.45 109.232 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.454 HD11 ' HG2' ' A' ' 101' ' ' LYS . 75.9 mt -75.39 -41.21 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.264 0.626 . . . . 1.04 111.376 172.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.55 30.44 6.19 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.847 1.689 . . . . 0.91 112.433 -172.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -105.31 171.58 7.25 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.727 1.263 . . . . 2.17 110.304 167.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -129.04 117.63 21.22 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 106.655 -1.609 . . . . 4.4 106.655 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.63 ' HB1' HD13 ' A' ' 84' ' ' LEU . . . -106.06 102.54 11.95 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 125.292 1.437 . . . . 1.09 108.616 174.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.0 p -98.85 112.7 24.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.092 -1.447 . . . . 2.52 107.092 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 83' ' ' GLU . 1.2 mt -49.78 105.86 0.1 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.523 -1.288 . . . . 5.69 107.523 166.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.67 -38.48 33.53 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.333 -0.617 . . . . 3.81 109.333 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 126.72 2.008 . . . . 6.91 113.167 -179.848 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.586 ' SD ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 107.312 -1.366 . . . . 11.1 107.312 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.75 123.34 79.1 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 119.968 1.258 . . . . 4.38 108.94 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.51 111.48 3.26 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 N-CA-C 109.165 -1.129 . . . . 3.58 109.165 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.79 158.47 44.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.449 -1.686 . . . . 3.29 106.449 170.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -123.09 152.13 41.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.331 1.052 . . . . 3.51 109.585 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.5 t -140.87 127.98 20.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.774 -0.825 . . . . 2.07 108.774 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -101.01 98.73 9.15 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.986 1.715 . . . . 3.73 109.082 -171.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.476 ' CB ' ' HA ' ' A' ' 71' ' ' VAL 0.273 1.4 pt? -125.44 176.55 6.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.943 0.877 . . . . 2.16 112.383 176.207 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.601 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -136.36 147.11 47.21 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.186 -1.412 . . . . 1.79 107.186 176.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.1 mm -99.05 140.07 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 106.264 -1.754 . . . . 0.84 106.264 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -115.41 76.69 1.02 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.293 -1.003 . . . . 3.13 108.293 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.25 -69.96 0.04 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.952 -1.259 . . . . 1.23 109.952 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 31.38 72.1 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.734 2.013 . . . . 2.54 115.646 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -53.08 -16.62 1.18 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.557 1.543 . . . . 2.41 114.053 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.2 t 74.79 -56.68 0.63 Allowed 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 126.28 1.832 . . . . 3.36 111.767 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -23.15 -75.44 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 127.523 2.329 . . . . 5.69 112.917 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.8 m -154.66 17.44 0.45 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.83 0.852 . . . . 3.05 111.541 162.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.83 -51.83 36.48 Favored 'General case' 0 C--O 1.224 -0.242 0 O-C-N 121.051 -1.031 . . . . 1.85 109.618 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -51.67 -47.86 37.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 CA-C-N 118.458 0.572 . . . . 1.48 109.689 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -56.95 -49.66 75.0 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.545 0.688 . . . . 2.87 110.609 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -59.1 -51.7 68.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.612 -0.68 . . . . 2.64 109.677 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 67' ' ' PHE . 2.8 mt -51.32 -47.57 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.334 1.454 . . . . 1.45 110.859 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -55.38 -53.19 59.26 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.877 0.762 . . . . 4.06 110.482 174.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -65.58 -31.55 72.66 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.395 -0.815 . . . . 4.47 111.438 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -68.66 -51.29 43.61 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.255 1.022 . . . . 1.19 109.697 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.33 -40.35 67.93 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.084 0.954 . . . . 1.93 110.663 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.67 -19.72 2.58 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.66 0.615 . . . . 2.7 112.66 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -126.63 24.06 6.68 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.216 1.406 . . . . 3.88 111.831 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.38 -82.57 0.05 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.091 -1.078 . . . . 3.2 108.091 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.44 -132.74 0.08 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.074 0.95 . . . . 1.28 109.19 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.38 33.17 1.35 Allowed Glycine 0 CA--C 1.531 1.06 0 O-C-N 120.909 -1.12 . . . . 1.31 113.816 -174.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.412 ' C ' HD12 ' A' ' 33' ' ' LEU . 14.3 p -104.31 118.79 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.682 1.593 . . . . 1.57 108.923 170.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.586 HD13 ' SD ' ' A' ' 1' ' ' MET . 4.1 mp -134.24 53.38 2.0 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.406 -0.961 . . . . 3.32 108.406 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.66 149.42 14.88 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.419 -1.326 . . . . 2.09 107.419 173.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.92 100.84 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 106.404 -1.702 . . . . 2.83 106.404 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.72 71.89 1.05 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.046 -1.094 . . . . 3.24 108.046 176.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.77 133.6 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.432 -0.951 . . . . 1.84 108.432 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.36 83.06 1.71 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.033 -1.099 . . . . 1.28 108.033 173.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.49 -24.03 1.87 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.466 1.506 . . . . 2.88 112.267 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -70.16 -40.06 74.96 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.806 1.242 . . . . 4.75 111.785 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.24 -31.89 11.49 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.513 1.125 . . . . 1.38 110.991 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.79 61.17 1.71 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 125.072 1.32 . . . . 1.0 110.565 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -141.23 136.83 32.1 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.181 -1.414 . . . . 3.66 107.181 171.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.34 102.15 10.82 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.283 1.433 . . . . 1.05 109.683 170.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -98.67 135.88 39.54 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.777 -1.934 . . . . 4.28 105.777 166.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.45 HD12 HD21 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -135.09 174.34 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.978 -1.119 . . . . 2.29 107.978 168.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.74 103.44 6.83 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.753 0.821 . . . . 5.55 108.797 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -117.6 167.83 10.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.103 1.361 . . . . 3.31 113.755 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -99.26 106.32 38.16 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 127.202 2.201 . . . . 3.17 110.452 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.01 -4.44 13.53 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.103 1.869 . . . . 2.7 114.35 -172.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -88.62 -20.84 24.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.926 0.785 . . . . 4.46 110.907 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.97 -30.48 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.505 1.122 . . . . 2.8 110.091 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.45 HD11 ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -115.98 155.96 17.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.666 0.746 . . . . 1.74 109.257 173.019 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -132.31 154.27 81.54 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.416 2.286 . . . . 2.94 108.379 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.28 -40.13 34.03 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.634 2.223 . . . . 1.54 112.194 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -63.76 -40.27 96.3 Favored 'General case' 0 C--O 1.225 -0.227 0 O-C-N 121.763 -0.586 . . . . 2.82 110.868 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -58.36 -45.83 87.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.943 0.897 . . . . 2.95 110.334 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.45 ' CD1' HD11 ' A' ' 53' ' ' ILE . 1.9 mt -53.98 -56.06 11.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.851 -1.537 . . . . 1.32 106.851 172.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.95 -41.32 70.95 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.787 -0.642 . . . . 1.44 110.578 -173.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -53.84 -50.18 66.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.23 1.412 . . . . 2.77 109.387 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -48.46 72.12 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.379 0.609 . . . . 2.21 109.777 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.7 mm -63.22 -40.33 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.129 -0.357 . . . . 2.67 110.564 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -64.9 -42.19 94.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.735 -0.469 . . . . 1.96 109.735 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -60.46 -47.89 84.15 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.138 0.575 . . . . 2.98 109.562 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.18 -33.52 71.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.209 0.604 . . . . 2.04 111.629 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.9 27.72 3.92 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.172 0.892 . . . . 1.39 111.632 168.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.44 ' CD2' HD13 ' A' ' 22' ' ' ILE . 2.6 m-30 -118.91 162.3 18.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.994 1.717 . . . . 2.18 108.694 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -98.31 129.19 45.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.931 1.293 . . . . 3.69 107.973 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.4 110.61 21.8 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.984 1.314 . . . . 1.17 108.507 174.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -126.93 122.92 35.96 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.122 0.419 . . . . 1.21 109.977 175.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.476 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.4 t -58.38 148.23 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 123.24 0.616 . . . . 3.14 110.931 172.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 39.8 mtt -58.63 -36.11 73.56 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 119.076 -0.488 . . . . 4.96 111.449 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 128.95 -25.94 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.565 1 C-N-CA 134.237 5.015 . . . . 5.16 110.42 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -40.71 -30.04 0.11 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 129.618 3.167 . . . . 8.3 112.19 166.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.403 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.3 OUTLIER 81.11 -88.9 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.924 1.29 . . . . 6.12 110.318 169.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 75' ' ' TYR . . . 159.15 -64.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.875 1.67 . . . . 2.99 111.389 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.62 -42.79 1.26 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.763 -0.935 . . . . 5.15 110.763 -162.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.4 m 18.2 45.22 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.89 2.876 . . . . 6.85 115.777 -173.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 t70 41.42 105.6 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 129.724 3.21 . . . . 5.26 114.353 -171.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.96 -30.67 9.35 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.038 -1.225 . . . . 1.85 110.038 -174.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.32 73.09 2.13 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.847 1.259 . . . . 2.81 109.139 -167.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.28 155.68 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.584 -0.895 . . . . 2.62 108.584 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.84 140.69 50.41 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.636 1.174 . . . . 2.76 107.998 173.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 mp -130.68 149.53 52.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.844 -0.799 . . . . 2.14 108.844 171.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.63 130.77 44.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.311 1.044 . . . . 1.65 108.614 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.8 mt -99.92 115.28 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.635 -0.506 . . . . 2.94 109.635 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.8 p -107.84 89.13 2.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.926 1.29 . . . . 2.46 109.543 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.6 -45.8 0.57 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.798 -0.921 . . . . 1.1 110.798 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -56.41 136.64 53.73 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 110.221 -0.289 . . . . 2.1 110.221 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -158.2 34.71 0.24 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.103 0.561 . . . . 2.88 110.891 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 34.0 t -158.91 144.23 16.22 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.548 -0.72 . . . . 2.61 110.617 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.15 -39.12 42.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.153 0.981 . . . . 2.63 111.995 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.2 p -53.6 -46.27 70.34 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.906 -0.497 . . . . 3.46 110.74 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 65.6 m -67.98 -45.96 72.68 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.909 -0.774 . . . . 1.82 108.909 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.425 HG21 HD12 ' A' ' 115' ' ' LEU . 61.1 t -51.91 -49.58 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.042 0.937 . . . . 1.63 109.591 175.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -64.38 -37.66 88.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.776 -0.824 . . . . 3.27 108.776 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -59.87 -52.61 64.71 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.63 0.772 . . . . 2.12 110.347 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.1 mt -54.17 -54.13 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.654 0.782 . . . . 1.06 109.045 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.6 -45.17 85.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.806 -0.442 . . . . 3.13 109.806 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.8 t -54.69 -49.31 70.98 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.507 0.723 . . . . 1.82 110.583 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -34.8 78.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.412 -0.805 . . . . 2.57 111.274 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.3 mt -71.57 -58.16 3.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.778 -0.823 . . . . 1.8 108.778 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.5 p -56.21 -22.73 31.13 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 111.915 0.339 . . . . 2.38 111.915 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.31 -27.09 69.09 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.457 0.91 . . . . 4.79 113.457 174.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.1 p -69.4 172.71 6.73 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 119.822 1.192 . . . . 2.63 111.246 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -88.62 -47.21 8.45 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.222 -0.899 . . . . 3.98 110.278 173.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.47 -34.09 51.06 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.471 -0.627 . . . . 1.19 113.587 -170.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.97 135.17 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 119.145 1.472 . . . . 2.34 109.251 -176.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -105.27 -44.67 4.68 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 122.407 0.283 . . . . 2.81 111.624 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.431 ' CZ ' ' HG3' ' A' ' 123' ' ' LYS . 27.2 p90 -139.7 122.75 16.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.67 -1.604 . . . . 2.09 106.67 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.85 143.82 45.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.564 -0.854 . . . . 1.43 109.795 164.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.6 m -133.56 119.99 20.19 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.037 -1.468 . . . . 1.93 107.037 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 p -122.55 133.55 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 123.631 0.772 . . . . 1.9 109.079 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -127.92 99.98 5.73 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.961 0.886 . . . . 1.34 109.216 -171.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.591 ' H ' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -55.62 -21.43 17.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.756 1.622 . . . . 3.09 113.743 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.406 ' N ' HD22 ' A' ' 115' ' ' LEU . . . -73.76 -41.36 62.57 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.933 -0.765 . . . . 1.43 108.933 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.2 p -88.11 -15.28 36.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.711 1.204 . . . . 3.27 111.191 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.8 t 65.11 25.64 12.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.869 1.268 . . . . 1.98 110.778 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.56 149.28 50.22 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.412 0.685 . . . . 2.77 110.941 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -125.15 115.64 20.78 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.68 2.392 . . . . 0.93 108.199 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.42 116.55 29.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.003 -1.48 . . . . 2.19 107.003 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.3 m -111.58 140.12 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.025 0.93 . . . . 2.07 109.799 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.431 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 2.2 mmtp -123.19 95.89 4.78 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-O 118.511 -0.757 . . . . 3.68 110.063 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -121.52 178.52 4.78 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.706 1.002 . . . . 2.08 113.706 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -104.64 110.42 64.33 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.233 1.013 . . . . 3.48 108.687 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.9 62.51 6.59 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.609 2.873 . . . . 1.71 112.788 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -148.25 -52.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.123 1.769 . . . . 2.97 107.72 172.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -86.98 -32.67 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.442 0.697 . . . . 1.81 111.413 -172.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.78 165.82 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.429 -1.693 . . . . 1.66 106.429 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.94 164.46 31.32 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 109.852 -1.299 . . . . 1.79 109.852 -176.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.23 -40.86 46.69 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.032 2.488 . . . . 1.93 110.2 -171.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -48.35 -38.47 19.32 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 113.47 0.915 . . . . 7.79 113.47 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.1 -44.92 75.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.681 -0.859 . . . . 3.44 108.681 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.13 -47.59 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.383 -0.969 . . . . 1.56 108.383 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.9 mt -54.12 -60.69 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.004 -0.739 . . . . 2.13 109.004 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -51.61 -45.74 63.34 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 119.59 1.086 . . . . 3.62 111.055 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.6 mt -54.17 -53.49 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 121.664 -0.647 . . . . 2.33 110.076 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.253 2.1 pp -67.83 -30.83 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 121.109 -0.994 . . . . 1.24 112.891 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -55.89 -39.94 72.3 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.798 0.726 . . . . 2.98 110.107 170.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -63.06 -35.86 81.65 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.756 -0.461 . . . . 2.65 109.756 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.5 mt -68.26 -44.33 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.562 -0.533 . . . . 0.96 109.562 172.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.35 32.6 2.51 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.273 1.416 . . . . 0.86 111.182 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -99.28 178.41 4.91 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.116 0.958 . . . . 2.44 108.891 165.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -141.05 124.38 16.59 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.57 -1.641 . . . . 3.72 106.57 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.97 94.78 4.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.307 1.443 . . . . 1.18 108.706 -174.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.3 m -103.0 117.66 35.08 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.997 0.919 . . . . 1.67 110.456 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 mp -45.73 117.89 1.62 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.786 1.634 . . . . 4.29 110.108 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -109.57 13.44 23.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.37 0.668 . . . . 3.44 112.303 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? . . . . . 0 C--O 1.25 1.129 0 C-N-CA 125.486 1.514 . . . . 7.39 109.811 161.214 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmt . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 106.744 -1.576 . . . . 7.57 106.744 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.39 112.21 7.24 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 118.693 0.679 . . . . 3.63 109.28 -167.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.05 108.66 2.68 Favored 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.294 1.329 . . . . 2.77 110.283 -171.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -118.05 158.64 24.62 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.291 -1.744 . . . . 2.98 106.291 170.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.51 166.51 10.49 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 107.758 -1.201 . . . . 4.0 107.758 166.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.97 120.25 11.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.579 1.081 . . . . 3.56 108.933 170.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -98.2 90.23 4.77 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.556 0.742 . . . . 2.88 110.267 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.56 165.72 15.97 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.704 0.764 . . . . 2.67 111.04 175.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.14 156.32 31.3 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.303 -0.999 . . . . 1.94 108.303 174.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.1 144.44 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 107.677 -1.231 . . . . 0.99 107.677 172.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -116.54 125.07 51.36 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.678 -1.231 . . . . 4.91 107.678 162.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 147.86 -81.14 0.2 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.188 1.375 . . . . 1.4 109.998 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.9 mtt 57.92 66.64 1.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.825 1.25 . . . . 2.05 113.013 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -46.52 -54.71 8.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.862 1.265 . . . . 2.57 113.303 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.2 p -167.83 44.48 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.516 0.598 . . . . 5.5 111.323 -170.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.67 35.44 8.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.274 1.029 . . . . 4.8 112.681 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 m -152.24 -43.26 0.11 Allowed 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.385 1.474 . . . . 2.46 110.555 -173.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.55 -46.15 87.45 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.347 -0.845 . . . . 2.16 109.937 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.536 ' HB ' HD21 ' A' ' 39' ' ' LEU . 54.3 t -52.69 -39.64 31.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 O-C-N 122.184 -0.322 . . . . 1.96 110.437 171.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -59.7 -42.73 93.63 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.085 0.469 . . . . 2.29 110.868 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -66.19 -47.6 73.39 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.31 -0.869 . . . . 2.63 109.631 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.41 -46.98 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 122.211 -0.306 . . . . 2.25 110.418 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -57.6 -41.15 80.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.292 1.037 . . . . 6.96 112.39 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -46.48 89.07 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.355 -0.98 . . . . 5.57 108.355 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -58.0 -45.16 87.27 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.072 -0.49 . . . . 1.59 110.557 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.552 HD11 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -52.2 -58.56 6.24 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.533 0.733 . . . . 2.6 111.424 172.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -64.42 -19.99 65.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.812 1.187 . . . . 2.32 112.921 -175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -90.39 -0.92 57.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.713 1.375 . . . . 4.56 114.713 168.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -53.1 -70.63 0.09 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.848 1.658 . . . . 3.09 111.012 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.7 -81.47 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.42 1.088 . . . . 1.37 110.66 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.52 -28.71 73.61 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.889 -0.484 . . . . 1.6 111.889 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 t -61.34 116.16 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.209 1.004 . . . . 2.89 110.284 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.66 54.66 1.67 Allowed 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.861 -1.533 . . . . 3.36 106.861 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.4 t -160.39 161.48 33.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 120.887 -1.133 . . . . 2.2 110.42 155.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.81 109.43 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 127.277 2.231 . . . . 2.84 106.779 172.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tt -135.54 63.05 1.61 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.114 -1.069 . . . . 2.41 108.114 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -96.12 149.09 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.143 -1.058 . . . . 2.59 108.143 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.22 100.0 6.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.113 -1.44 . . . . 1.37 107.113 166.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.536 HD21 ' HB ' ' A' ' 19' ' ' VAL . 17.2 mt -64.41 -15.38 60.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.277 0.631 . . . . 2.89 112.158 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.4 mmt -72.39 -52.81 14.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.533 0.733 . . . . 5.11 110.405 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.33 -34.02 21.93 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.95 0.5 . . . . 1.5 110.974 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.94 62.79 1.28 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.035 1.303 . . . . 1.23 110.899 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -140.14 137.04 34.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.887 -1.523 . . . . 3.68 106.887 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.07 96.35 5.99 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 125.044 1.338 . . . . 1.11 109.791 173.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -98.65 136.5 38.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.481 -2.044 . . . . 3.64 105.481 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.98 177.92 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 N-CA-C 106.079 -1.823 . . . . 2.11 106.079 172.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -129.84 99.92 5.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.785 0.434 . . . . 4.09 110.386 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -94.47 -177.86 4.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.621 1.968 . . . . 2.63 112.857 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -127.67 108.52 20.65 Favored Pre-proline 0 N--CA 1.444 -0.765 0 CA-C-N 114.169 -1.378 . . . . 3.43 108.003 169.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.22 -3.01 10.79 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.581 2.187 . . . . 2.13 112.764 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.67 -39.6 64.31 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.797 1.18 . . . . 3.58 110.708 172.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -110.01 -19.18 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 118.291 0.496 . . . . 3.0 110.335 -166.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 pt -131.7 -176.48 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 107.484 -1.302 . . . . 2.29 107.484 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.64 155.94 59.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 125.418 1.487 . . . . 2.41 108.449 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.39 -35.6 60.54 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.309 2.006 . . . . 1.52 110.192 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.94 -37.99 84.27 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 122.064 -0.397 . . . . 2.82 111.94 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -67.74 -45.54 74.7 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.964 0.905 . . . . 3.08 110.372 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.9 mt -48.5 -56.76 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 106.546 -1.65 . . . . 1.5 106.546 167.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.59 89.31 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.07 -0.514 . . . . 1.52 110.777 -170.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -52.27 -49.78 63.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.81 1.644 . . . . 2.5 109.604 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.74 -50.27 44.9 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.154 0.502 . . . . 3.03 109.797 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.552 HD11 HD11 ' A' ' 26' ' ' LEU . 5.9 mm -65.99 -38.9 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 121.919 -0.488 . . . . 2.48 110.958 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -64.11 -46.28 84.91 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.567 -0.531 . . . . 2.04 109.567 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -57.8 -52.43 65.51 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.316 0.646 . . . . 2.63 109.817 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.3 mt -58.77 -38.78 79.25 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.27 -0.423 . . . . 2.45 111.576 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.79 33.33 0.65 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 123.367 0.508 . . . . 1.32 112.59 163.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -133.02 163.64 28.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.733 1.213 . . . . 2.55 110.365 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -97.41 128.73 44.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.97 -1.493 . . . . 2.54 106.97 171.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.85 124.33 52.13 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.491 -1.3 . . . . 1.02 107.491 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.49 138.01 52.06 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.558 -1.275 . . . . 1.29 107.558 168.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -60.64 141.14 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.536 -0.913 . . . . 3.25 108.536 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.6 mtt -42.84 -55.14 3.81 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.805 1.242 . . . . 4.75 110.604 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -164.82 -52.23 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.727 2.011 . . . . 6.27 107.303 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -83.25 -89.5 0.09 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.633 -0.698 . . . . 7.63 112.867 -168.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.4 ' CE2' HD23 ' A' ' 121' ' ' LEU . 0.0 OUTLIER 152.72 -105.96 0.0 OUTLIER 'General case' 0 C--N 1.345 0.409 0 C-N-CA 128.478 2.711 . . . . 4.3 111.965 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -119.97 -61.85 1.55 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.25 2.22 . . . . 3.22 111.712 -167.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 82' ' ' ILE . . . 63.47 85.29 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 125.591 1.567 . . . . 3.13 113.391 171.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.7 t -162.39 -81.75 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.235 1.017 . . . . 5.6 113.132 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -113.87 126.77 55.55 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.541 1.137 . . . . 4.64 109.114 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.76 -35.4 2.5 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.686 -0.965 . . . . 2.26 110.686 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.99 101.84 4.13 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.236 1.414 . . . . 2.54 108.66 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.733 ' N ' HD12 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -125.87 155.31 35.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 125.55 1.54 . . . . 3.09 108.123 -167.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.74 ' OE1' ' HB3' ' A' ' 148' ' ' ALA . 2.6 pp20? -131.38 153.17 49.93 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.121 1.368 . . . . 4.24 107.396 174.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.07 162.71 32.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.151 -1.425 . . . . 2.42 107.151 170.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.596 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -97.42 133.52 41.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.965 -2.235 . . . . 2.1 104.965 170.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.411 ' O ' HD12 ' A' ' 86' ' ' ILE . 1.6 pp -106.16 117.59 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 123.54 0.736 . . . . 1.95 109.652 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.6 m -105.6 136.79 44.54 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.577 -1.268 . . . . 1.67 107.577 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.28 -45.24 1.34 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.493 1.044 . . . . 1.43 111.151 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -62.26 132.96 54.42 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.39 -0.476 . . . . 2.72 110.345 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -156.89 42.01 0.35 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.373 0.669 . . . . 3.91 110.303 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.6 t -162.4 144.92 11.1 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 120.711 -1.243 . . . . 2.84 110.523 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.49 -40.37 62.29 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.697 0.799 . . . . 3.18 110.897 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -54.67 -47.1 74.02 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.897 -0.502 . . . . 2.0 110.364 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.8 m -64.6 -44.76 89.58 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.06 0.544 . . . . 2.1 109.596 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.4 t -51.14 -51.17 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 122.589 0.356 . . . . 1.66 110.074 171.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -62.28 -37.84 87.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.208 -0.664 . . . . 2.65 109.208 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -59.95 -55.02 39.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.183 0.993 . . . . 1.99 110.185 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.8 mt -54.91 -56.4 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.301 -0.629 . . . . 1.59 109.301 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.86 -43.32 76.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.19 0.996 . . . . 3.38 108.938 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.3 t -53.82 -47.18 71.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.643 0.656 . . . . 1.27 111.069 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -63.96 -42.74 97.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.63 -1.294 . . . . 2.79 111.54 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.423 HD23 ' CB ' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -61.44 -54.89 37.59 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.359 -0.978 . . . . 2.62 108.359 176.246 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.0 p -59.11 -25.03 63.48 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.647 0.61 . . . . 1.85 112.647 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -72.52 -16.27 61.78 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.187 0.903 . . . . 4.0 112.357 175.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.5 m -80.55 152.82 28.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.915 0.886 . . . . 1.83 109.528 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -72.41 -49.49 33.36 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.197 0.999 . . . . 2.74 112.555 -175.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.75 -40.26 7.76 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 121.702 0.612 . . . . 1.16 111.71 -167.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.514 HD11 ' HB ' ' A' ' 122' ' ' VAL . 2.4 mm -53.66 136.11 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.06 -0.719 . . . . 2.21 109.06 168.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 38.6 p -123.25 -25.69 4.43 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.33 0.493 . . . . 2.98 112.33 166.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.07 112.51 6.8 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.258 -1.756 . . . . 2.02 106.258 -169.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.423 ' CB ' HD23 ' A' ' 102' ' ' LEU . . . -115.55 157.65 23.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.154 -1.054 . . . . 1.12 108.154 163.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 61.8 m -144.72 118.46 9.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.048 -1.464 . . . . 2.05 107.048 170.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.92 134.3 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 108.57 -0.9 . . . . 2.93 108.57 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.2 88.76 2.9 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.678 0.751 . . . . 1.82 109.146 -167.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -54.2 -30.18 48.86 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.315 1.046 . . . . 2.92 112.13 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.59 65.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.101 0.96 . . . . 2.0 111.088 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.74 -9.8 15.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.32 1.448 . . . . 2.35 110.949 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.3 m 66.58 30.58 8.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.574 1.55 . . . . 1.49 111.713 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -105.74 158.15 16.93 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.292 0.637 . . . . 3.97 110.683 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.11 109.4 8.91 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.235 1.814 . . . . 1.26 107.988 174.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.4 HD23 ' CE2' ' A' ' 75' ' ' TYR . 8.9 mp -98.55 131.06 45.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.722 -1.214 . . . . 2.49 107.722 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.514 ' HB ' HD11 ' A' ' 108' ' ' ILE . 19.7 m -132.65 133.82 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.371 1.068 . . . . 2.44 108.555 -174.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -117.67 93.75 4.27 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.041 -1.096 . . . . 3.36 108.041 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -122.28 168.76 11.65 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.645 1.178 . . . . 1.91 112.284 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -98.13 113.47 63.95 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 109.266 -0.642 . . . . 2.65 109.266 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.53 67.86 7.71 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.695 2.93 . . . . 1.95 111.474 -172.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -160.49 -46.86 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.159 1.384 . . . . 3.55 108.874 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.1 pt -86.66 -28.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 123.692 0.797 . . . . 1.88 111.876 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.53 165.04 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.159 -1.052 . . . . 1.56 108.159 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.98 162.5 28.94 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 109.874 -1.29 . . . . 1.62 109.874 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -62.57 -35.13 72.48 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.425 2.75 . . . . 1.67 111.516 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -52.71 -42.06 64.5 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 112.759 0.651 . . . . 5.47 112.759 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.57 -39.0 74.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.459 -0.896 . . . . 3.36 109.565 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.1 -47.57 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.967 -0.753 . . . . 1.44 108.967 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 52.2 mt -55.36 -56.48 11.45 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 124.015 0.926 . . . . 2.08 109.573 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -49.89 -50.44 45.92 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 119.461 1.028 . . . . 4.06 110.619 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 50.7 mt -54.88 -55.33 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 122.557 0.343 . . . . 2.36 110.154 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.7 pp -68.21 -29.59 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.774 -1.204 . . . . 1.32 112.951 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.11 -35.86 74.18 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.401 0.546 . . . . 3.08 110.657 171.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.62 -37.76 82.49 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.471 -0.566 . . . . 4.73 109.471 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.0 mt -72.92 -40.5 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 109.212 -0.662 . . . . 1.64 109.212 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.7 33.97 2.95 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.047 1.308 . . . . 1.42 110.961 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -99.19 177.4 5.23 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 108.233 -1.025 . . . . 3.03 108.233 164.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -141.38 120.88 13.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.099 -1.815 . . . . 4.52 106.099 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.0 110.81 22.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.533 1.533 . . . . 1.37 108.727 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.7 m -130.35 134.33 47.09 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.477 0.711 . . . . 2.86 110.935 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -37.97 127.88 1.25 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.063 2.145 . . . . 4.32 110.151 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.74 ' HB3' ' OE1' ' A' ' 83' ' ' GLU . . . -103.93 -12.09 17.06 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 116.445 -1.74 . . . . 3.3 113.343 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 . . . . . 0 C--O 1.259 1.597 0 C-N-CA 129.4 3.08 . . . . 6.85 114.554 152.267 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 mtm . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 105.225 -2.139 . . . . 9.59 105.225 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -53.49 113.79 5.3 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 119.189 0.904 . . . . 4.2 111.405 -168.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.54 97.74 1.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.502 1.468 . . . . 2.74 111.361 -171.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -123.53 141.16 52.27 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 126.965 2.106 . . . . 2.99 106.471 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -95.45 157.89 15.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.586 1.555 . . . . 4.11 107.448 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.9 p -140.95 133.79 28.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 122.544 0.337 . . . . 2.98 110.215 168.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -104.01 105.58 15.8 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 125.665 1.586 . . . . 3.09 108.371 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.464 HD21 HD12 ' A' ' 46' ' ' ILE . 1.7 pt? -134.63 169.46 17.27 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.472 -0.491 . . . . 2.17 110.969 172.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.22 138.95 51.37 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.012 -1.848 . . . . 1.73 106.012 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.8 mm -97.93 134.04 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 106.802 -1.555 . . . . 1.04 106.802 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -104.51 123.29 47.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.533 -1.654 . . . . 3.34 106.533 160.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.84 -27.38 3.06 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.367 0.985 . . . . 3.06 111.472 -175.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.2 ptt? -57.92 167.67 1.14 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.791 -0.829 . . . . 2.78 111.405 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 m 77.11 -8.81 1.63 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.801 1.24 . . . . 9.25 112.016 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.8 m -114.45 136.01 53.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.888 0.875 . . . . 6.49 109.645 -173.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 42.33 -106.15 0.08 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.357 1.463 . . . . 6.29 109.894 -174.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 p -158.95 38.84 0.22 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.918 0.866 . . . . 3.13 109.308 171.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.66 -42.96 63.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.76 -0.655 . . . . 1.93 110.443 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -57.08 -42.01 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 122.252 1.025 . . . . 2.28 109.378 171.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.95 -46.07 82.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.863 -1.062 . . . . 2.8 111.293 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -60.83 -46.41 90.66 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.267 -0.896 . . . . 2.58 110.519 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.0 mt -47.68 -40.29 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 C-N-CA 124.153 0.981 . . . . 1.71 111.637 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -47.31 -60.34 2.57 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.117 0.567 . . . . 5.15 111.974 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -37.29 72.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.327 -0.62 . . . . 6.11 109.327 -173.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -56.61 -54.85 41.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.186 -0.461 . . . . 1.24 110.066 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mt -58.7 -44.37 90.3 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 118.652 0.66 . . . . 2.16 111.137 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.08 -11.26 1.04 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 114.285 1.217 . . . . 1.8 114.285 171.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.11 3.75 11.4 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.955 -1.091 . . . . 3.81 111.974 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.73 -65.9 0.66 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.851 1.205 . . . . 2.52 110.515 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.28 -131.36 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.122 0.569 . . . . 1.46 109.951 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.42 -0.94 80.47 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 119.501 1.046 . . . . 1.69 113.096 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.91 127.61 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 O-C-N 121.523 -0.986 . . . . 1.61 111.298 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.52 54.01 1.12 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.284 0.846 . . . . 2.38 113.284 173.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 t -157.15 143.68 18.16 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 107.02 -1.474 . . . . 1.87 107.02 165.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.0 92.53 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.04 -1.837 . . . . 2.45 106.04 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -116.53 79.78 1.37 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.351 -1.722 . . . . 3.27 106.351 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.9 p -98.73 128.23 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.453 -0.943 . . . . 2.22 108.453 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.39 74.98 2.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.957 -1.868 . . . . 1.21 105.957 172.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.86 -29.88 3.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.393 1.077 . . . . 3.16 111.87 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.2 ttt -72.65 -36.18 67.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.947 1.299 . . . . 4.03 111.135 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.71 -48.02 5.65 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 124.177 0.991 . . . . 1.32 109.191 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.23 58.24 0.35 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 125.48 1.514 . . . . 1.11 111.599 167.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -142.97 136.91 28.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.12 -1.067 . . . . 3.09 108.12 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.64 110.36 22.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.637 1.575 . . . . 1.0 111.597 168.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -99.51 111.36 23.72 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.081 -1.081 . . . . 4.65 108.081 167.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.464 HD12 HD21 ' A' ' 8' ' ' LEU . 13.9 mt -109.57 167.04 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.684 0.794 . . . . 2.62 109.066 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -123.61 108.23 12.37 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.871 0.868 . . . . 4.03 109.107 162.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -113.81 163.4 15.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.73 1.212 . . . . 2.84 111.336 168.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -105.71 106.37 56.21 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 127.215 2.206 . . . . 4.62 110.075 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.69 2.21 1.77 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.057 2.505 . . . . 1.92 114.015 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -83.14 -22.75 33.22 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.128 1.371 . . . . 4.49 110.408 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.1 t -123.42 -65.44 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.2 -1.037 . . . . 2.75 108.2 -171.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -87.26 155.14 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.276 -0.638 . . . . 1.46 109.276 174.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -129.27 151.74 78.29 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.692 1.597 . . . . 2.59 108.004 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.91 -38.42 79.21 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.841 2.361 . . . . 1.21 112.149 -172.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -59.51 -41.09 89.14 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.328 -0.857 . . . . 2.92 111.255 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -61.2 -40.54 94.35 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.307 0.643 . . . . 3.03 110.254 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.503 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -54.75 -46.45 74.17 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 N-CA-C 107.746 -1.205 . . . . 1.1 107.746 171.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.4 94.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.064 0.459 . . . . 1.21 111.036 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -57.77 -52.89 63.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.468 -0.77 . . . . 2.53 110.34 173.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -51.0 -55.5 17.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.429 0.692 . . . . 5.17 111.496 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.558 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.5 pp -61.4 -39.87 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 121.065 -1.022 . . . . 4.43 111.647 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.58 -33.72 76.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.343 0.52 . . . . 3.08 110.816 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.51 -50.3 67.95 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.485 -0.561 . . . . 2.51 109.485 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.1 mt -58.65 -35.73 73.0 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.937 -0.305 . . . . 2.04 111.402 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.08 31.19 2.52 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 123.92 0.771 . . . . 1.18 111.915 169.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -112.16 164.64 12.95 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.625 1.57 . . . . 2.1 109.04 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -102.9 136.05 43.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.02 -1.474 . . . . 2.6 107.02 164.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.558 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -130.3 127.04 38.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.216 -1.772 . . . . 0.94 106.216 169.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.4 138.98 33.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.009 0.818 . . . . 0.92 109.328 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.84 144.46 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 116.138 -0.483 . . . . 2.77 109.734 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.7 mtp -49.31 -42.93 42.85 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.098 0.959 . . . . 3.91 111.23 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -170.3 -57.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 127.245 2.218 . . . . 5.92 105.177 170.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -79.78 -92.49 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 130.256 3.423 . . . . 6.84 112.871 -168.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 76' ' ' ALA . 21.9 p90 157.48 -58.48 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 130.265 3.426 . . . . 4.39 110.996 -171.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.413 ' N ' ' CD1' ' A' ' 75' ' ' TYR . . . 167.14 -82.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.935 1.694 . . . . 3.53 115.134 -168.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.78 94.26 1.06 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.777 -0.929 . . . . 3.49 110.777 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 t -136.64 -66.2 0.54 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 119.383 -0.341 . . . . 5.46 111.201 168.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -147.91 136.84 22.0 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.937 -1.135 . . . . 4.89 107.937 -171.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.0 -64.14 4.28 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 107.366 -2.294 . . . . 1.72 107.366 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -102.65 110.06 21.88 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.381 1.472 . . . . 2.68 109.046 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.96 138.91 53.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 O-C-N 123.332 0.395 . . . . 2.71 110.67 175.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -110.33 141.36 43.45 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.128 1.371 . . . . 4.42 108.326 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.492 ' N ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -142.79 156.45 44.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.298 -0.63 . . . . 3.29 109.298 174.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.414 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.6 OUTLIER -97.31 121.75 39.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 105.018 -2.216 . . . . 1.56 105.018 -177.093 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 pp -100.88 121.07 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.14 -0.689 . . . . 1.57 109.14 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.2 p -106.92 142.79 35.98 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.27 0.628 . . . . 2.15 109.348 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.74 -26.17 10.31 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.741 1.162 . . . . 1.48 112.742 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.474 ' SD ' HD12 ' A' ' 98' ' ' ILE . 4.0 ttp -67.51 108.62 2.9 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.641 -0.917 . . . . 3.0 112.096 -169.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.7 m -117.86 7.77 12.47 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.044 0.938 . . . . 2.46 111.923 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 23.9 p -163.07 151.21 13.78 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 120.742 -1.224 . . . . 2.93 112.08 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.54 72.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.683 0.793 . . . . 2.94 111.411 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.2 m -53.29 -40.96 65.14 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.284 -0.885 . . . . 2.62 110.785 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.1 m -69.89 -40.93 75.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.615 -0.707 . . . . 1.79 110.04 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.0 t -50.35 -57.21 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 118.636 0.653 . . . . 1.47 109.557 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -58.58 -45.71 88.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.358 0.663 . . . . 4.2 110.205 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -61.21 -50.62 72.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.0 0.52 . . . . 1.77 110.84 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.474 HD12 ' SD ' ' A' ' 89' ' ' MET . 41.7 mt -56.27 -47.2 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.089 -0.708 . . . . 1.03 109.089 177.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.28 -49.49 74.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.634 -0.876 . . . . 2.81 108.634 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.3 t -52.52 -50.45 62.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.719 0.808 . . . . 1.48 110.159 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -61.31 -42.37 98.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.753 -0.592 . . . . 3.2 111.31 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.5 mt -67.18 -56.26 10.68 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.932 -1.136 . . . . 1.85 107.932 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.7 p -55.33 -17.78 5.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.484 0.714 . . . . 1.86 112.703 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -13.77 62.59 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.502 -0.749 . . . . 5.53 112.398 171.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -80.83 153.86 27.45 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.389 1.876 . . . . 1.85 109.63 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -67.39 -64.44 0.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.943 0.897 . . . . 3.03 111.353 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.32 -32.41 58.08 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 122.253 -0.279 . . . . 1.2 112.921 -172.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.07 112.52 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.733 0.766 . . . . 1.81 109.616 -172.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.6 m -99.3 -41.32 7.5 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.561 0.344 . . . . 2.27 110.265 -172.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 123' ' ' LYS . 54.2 p90 -140.15 121.22 14.69 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.468 -0.567 . . . . 2.39 109.468 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.18 140.8 37.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.72 -0.844 . . . . 1.09 108.72 165.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -132.69 116.98 17.29 Favored 'General case' 0 C--O 1.228 -0.052 0 N-CA-C 108.29 -1.004 . . . . 1.59 108.29 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.604 HG12 ' HB1' ' A' ' 120' ' ' ALA . 3.0 m -112.28 135.23 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.591 1.157 . . . . 2.24 109.087 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.32 89.55 2.57 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.332 0.969 . . . . 1.17 111.211 -173.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -24.51 67.04 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 125.22 1.408 . . . . 3.11 113.718 -170.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.81 70.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.654 0.381 . . . . 1.45 110.397 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.83 -13.12 12.02 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.477 1.511 . . . . 1.76 111.317 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.3 m 69.13 15.8 8.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.319 1.847 . . . . 1.31 114.326 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -95.16 158.0 15.65 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 120.127 1.33 . . . . 3.25 108.464 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.604 ' HB1' HG12 ' A' ' 113' ' ' VAL . . . -140.53 125.15 17.98 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.225 1.01 . . . . 0.86 108.652 168.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.26 114.42 26.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.637 -1.616 . . . . 1.67 106.637 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 m -106.75 135.06 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.048 0.84 . . . . 2.26 111.687 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HG3' ' CE2' ' A' ' 110' ' ' TYR . 9.2 mmmt -113.01 95.97 5.69 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.13 1.372 . . . . 3.51 109.524 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -122.95 174.16 7.35 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.843 0.747 . . . . 2.52 111.362 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -105.19 110.07 63.99 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 108.564 -0.902 . . . . 3.13 108.564 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.53 69.01 6.83 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.48 2.787 . . . . 1.97 111.305 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -158.45 -48.53 0.06 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.875 1.27 . . . . 3.21 108.917 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pt -82.83 -28.93 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.406 0.682 . . . . 1.82 110.867 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.64 163.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.575 -0.898 . . . . 1.62 108.575 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.71 161.5 28.24 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.444 -1.462 . . . . 1.76 109.444 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.52 -37.62 87.9 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.557 2.838 . . . . 1.98 111.713 -172.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -52.21 -36.65 52.7 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.262 0.838 . . . . 7.07 113.262 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.43 -46.02 67.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.453 -0.573 . . . . 3.42 109.453 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.4 mt -57.46 -45.32 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.631 -0.878 . . . . 1.39 108.631 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.7 mt -53.85 -61.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 118.354 -0.831 . . . . 2.39 109.055 173.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.15 -49.49 32.17 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.913 1.233 . . . . 5.43 111.174 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.5 mt -53.05 -60.11 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.808 -0.812 . . . . 2.12 108.808 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.3 pp -65.9 -30.56 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 119.375 -0.93 . . . . 1.35 113.279 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.43 -40.53 94.78 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.111 0.869 . . . . 2.55 109.758 170.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -64.98 -37.47 87.76 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.079 -0.712 . . . . 2.84 109.079 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.35 -43.29 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.075 -0.391 . . . . 1.15 109.956 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.61 31.56 4.83 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.57 1.557 . . . . 1.07 111.619 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -99.62 174.93 6.01 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.315 1.057 . . . . 2.2 108.652 165.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -139.02 119.15 13.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.055 -1.831 . . . . 4.03 106.055 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.19 109.42 20.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.129 1.771 . . . . 1.11 108.793 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 26.6 m -117.14 113.72 22.66 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.944 0.497 . . . . 1.8 110.274 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -31.34 115.2 0.14 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.391 1.876 . . . . 3.86 112.039 169.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.414 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -101.17 15.69 27.93 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.637 1.347 . . . . 3.16 114.637 -161.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.085 -1.436 . . . . 5.64 112.618 -175.76 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.08 -1.082 . . . . 7.51 108.08 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.76 110.94 10.24 Favored Pre-proline 0 CA--C 1.533 0.304 0 O-C-N 123.858 0.724 . . . . 4.48 109.529 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.62 114.79 4.11 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 N-CA-C 108.173 -1.51 . . . . 4.37 108.173 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.75 158.87 15.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.564 -1.643 . . . . 3.04 106.564 166.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -126.2 149.04 49.3 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.546 1.538 . . . . 4.95 106.951 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.1 p -140.53 146.03 37.58 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.829 -0.804 . . . . 3.41 108.829 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.15 109.68 19.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.041 -1.466 . . . . 4.65 107.041 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.478 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 2.3 pt? -133.69 174.72 10.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.071 0.938 . . . . 2.37 111.192 170.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.78 137.75 40.16 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.023 -1.103 . . . . 2.32 108.023 176.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 mm -98.67 126.51 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 106.972 -1.492 . . . . 1.32 106.972 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -102.48 103.55 13.92 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.064 -1.828 . . . . 4.02 106.064 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.23 -89.46 0.1 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.287 -1.525 . . . . 1.26 109.287 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.4 mtt 47.1 73.67 0.18 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.169 1.388 . . . . 2.11 113.497 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -57.56 -11.8 2.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.75 1.22 . . . . 2.7 113.653 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.5 t 73.97 -66.03 0.32 Allowed 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 126.187 1.795 . . . . 2.95 110.878 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -15.4 -74.51 0.01 OUTLIER 'General case' 0 C--N 1.342 0.279 0 C-N-CA 128.368 2.667 . . . . 6.81 113.219 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.8 m -153.37 19.26 0.55 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.498 0.719 . . . . 4.06 111.07 161.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 31.7 m -70.64 -47.5 59.74 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 121.093 -1.004 . . . . 2.13 109.211 -169.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -54.81 -49.83 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.752 -0.462 . . . . 2.93 109.752 175.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -55.55 -48.38 74.82 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.175 0.59 . . . . 2.35 111.433 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -58.75 -47.92 82.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.615 -0.513 . . . . 3.09 109.615 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -46.4 -50.89 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.632 1.173 . . . . 1.88 110.051 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -54.51 -54.54 39.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.472 0.578 . . . . 4.39 111.168 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -59.9 -43.04 95.04 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.166 -0.47 . . . . 5.0 110.3 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -56.52 -57.44 12.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.267 0.627 . . . . 1.48 109.478 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mp -57.68 -44.99 86.17 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 119.014 -0.517 . . . . 2.23 111.679 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -54.85 -20.68 9.24 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.428 1.013 . . . . 2.0 113.481 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -112.05 15.37 20.65 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.712 1.004 . . . . 3.43 113.712 173.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -70.02 -64.54 0.87 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.949 1.25 . . . . 2.77 110.229 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.73 -124.09 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.929 0.492 . . . . 1.44 110.713 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.74 -25.62 69.2 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 118.795 0.725 . . . . 1.64 111.987 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 46' ' ' ILE . 4.9 p -62.95 125.73 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 O-C-N 122.446 -0.444 . . . . 1.59 110.036 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 pp -143.12 50.55 1.41 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.71 0.767 . . . . 3.07 109.765 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.8 t -160.64 149.53 16.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.092 -1.077 . . . . 1.99 108.092 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.0 129.7 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.046 -1.094 . . . . 2.68 108.046 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -142.52 74.28 1.44 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.104 -1.073 . . . . 2.94 108.104 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 m -97.33 159.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 121.372 -0.83 . . . . 2.98 108.995 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.88 90.6 2.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.307 -1.368 . . . . 2.12 107.307 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 tp -51.86 -27.44 12.67 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.881 1.672 . . . . 3.49 110.358 172.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.3 mtp -59.16 -38.65 80.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.187 0.995 . . . . 3.51 111.603 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.3 -31.47 7.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.473 0.709 . . . . 2.7 111.449 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.49 61.59 0.96 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.457 1.503 . . . . 2.19 110.403 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -142.08 142.7 32.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.429 -1.323 . . . . 3.42 107.429 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.08 101.34 7.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.968 0.907 . . . . 1.53 110.43 171.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -102.31 131.05 49.15 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.161 -2.162 . . . . 5.69 105.161 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 32' ' ' VAL . 13.7 pt -136.74 171.71 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 120.434 -1.416 . . . . 2.39 108.988 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.22 99.77 6.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.422 1.089 . . . . 5.85 108.356 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.529 ' HB2' HD12 ' A' ' 53' ' ' ILE . 31.8 p90 -100.05 -179.17 4.07 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.686 1.194 . . . . 3.64 110.206 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -128.25 103.3 20.53 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.597 1.159 . . . . 3.98 110.894 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.25 -8.32 18.29 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.796 3.664 . . . . 2.91 114.84 -167.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -92.86 -8.94 42.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.352 0.661 . . . . 4.79 111.598 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.5 -47.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 123.934 0.894 . . . . 3.63 110.21 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.529 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -116.36 143.25 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 108.08 -1.081 . . . . 2.33 108.08 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.89 142.72 26.44 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 124.352 1.061 . . . . 2.85 109.143 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -57.39 -40.39 81.96 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.12 2.546 . . . . 1.97 111.505 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.24 -43.37 98.99 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.319 0.648 . . . . 4.99 110.371 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -63.05 -40.24 97.12 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.902 0.481 . . . . 3.79 110.103 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.457 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -52.35 -53.4 19.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 N-CA-C 106.915 -1.513 . . . . 1.42 106.915 170.817 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.15 -45.46 79.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.99 -0.55 . . . . 1.44 110.599 -172.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.69 -49.94 56.16 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.486 0.715 . . . . 4.06 110.485 174.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.44 -48.9 65.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.527 0.679 . . . . 2.26 109.858 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -64.01 -39.06 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 122.081 -0.387 . . . . 2.5 111.413 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -65.56 -44.56 86.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.731 -0.47 . . . . 2.01 109.731 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.0 -50.51 73.83 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.714 -0.476 . . . . 2.5 109.714 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.7 mt -55.62 -40.58 72.3 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.387 -0.369 . . . . 2.14 111.629 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.37 33.46 1.03 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 123.516 0.579 . . . . 1.17 112.017 165.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -124.44 162.02 24.79 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.704 1.202 . . . . 1.95 108.86 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.81 130.46 41.37 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.138 -1.43 . . . . 2.58 107.138 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.59 111.38 24.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.836 1.254 . . . . 1.14 108.117 173.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.31 116.28 19.57 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.621 -0.511 . . . . 1.42 109.621 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.478 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.8 t -68.71 155.45 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.187 1.795 . . . . 2.8 111.36 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mtt -87.91 19.92 3.33 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.176 0.99 . . . . 5.08 111.267 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 80.93 -36.86 0.13 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.597 1.559 . . . . 3.88 109.718 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.63 67.21 0.06 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.043 1.737 . . . . 8.61 110.758 163.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.429 ' CE2' ' ND2' ' A' ' 81' ' ' ASN . 38.5 p90 -68.24 -25.81 65.37 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 127.771 2.428 . . . . 4.11 114.447 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 142.76 -150.25 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 129.121 2.968 . . . . 2.94 105.628 -168.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.19 97.95 0.81 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 108.135 -1.986 . . . . 3.08 108.135 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 t -160.37 -56.02 0.06 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.486 0.643 . . . . 5.7 110.996 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.32 134.76 45.62 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.447 -0.946 . . . . 4.7 108.447 -176.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.05 -46.42 2.69 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.208 -0.757 . . . . 2.62 111.208 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.543 ' C ' HD13 ' A' ' 82' ' ' ILE . 50.9 t30 -129.65 128.33 42.38 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.359 -1.348 . . . . 2.99 107.359 169.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.543 HD13 ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -125.89 154.11 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 107.096 -1.446 . . . . 3.17 107.096 175.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.22 141.14 51.55 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 123.477 0.711 . . . . 3.14 110.143 169.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.66 149.28 52.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.37 -2.085 . . . . 2.47 105.37 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 147' ' ' LEU . 0.4 OUTLIER -100.5 127.92 46.71 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 104.87 -2.27 . . . . 1.66 104.87 176.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.01 136.78 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 O-C-N 123.863 0.727 . . . . 1.77 109.065 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.2 m -128.34 115.2 17.9 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.372 1.069 . . . . 1.66 109.401 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.38 -38.13 1.72 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.174 1.369 . . . . 1.12 111.438 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.6 mtp -45.94 119.55 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.667 1.187 . . . . 3.23 111.763 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.0 m -129.66 17.02 5.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.922 0.889 . . . . 2.9 110.676 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 47.5 t -165.56 141.26 5.15 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 120.827 -1.171 . . . . 2.6 109.993 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.92 -32.51 66.02 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.709 0.686 . . . . 2.98 111.495 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -53.12 -37.92 62.18 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.756 -0.59 . . . . 1.91 110.469 173.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 85.8 m -62.53 -49.74 74.12 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 109.265 -0.643 . . . . 1.77 109.265 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.9 t -49.87 -45.54 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 122.506 0.322 . . . . 1.38 110.712 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -48.67 80.73 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.065 -0.346 . . . . 2.88 110.065 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -38.88 92.59 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 119.812 -0.755 . . . . 3.48 110.484 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.437 HD11 ' CE2' ' A' ' 143' ' ' PHE . 81.5 mt -64.76 -54.29 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.43 -0.952 . . . . 1.35 108.43 -177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -49.46 -49.77 43.99 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 126.337 1.855 . . . . 4.39 109.251 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.0 t -50.17 -50.43 49.13 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 119.368 -0.349 . . . . 1.87 111.317 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -50.2 68.52 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.03 0.832 . . . . 3.09 112.3 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.75 -45.13 87.71 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 120.841 -1.162 . . . . 3.0 110.892 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 87.2 m -61.11 -16.93 49.58 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.707 0.803 . . . . 2.27 111.061 173.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -17.71 64.83 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 118.624 -0.703 . . . . 4.75 111.733 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.9 p -72.66 -176.41 1.95 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 120.159 1.345 . . . . 2.89 110.885 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -94.29 -50.35 5.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.541 1.137 . . . . 2.39 111.083 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.47 -41.37 30.31 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 122.245 -0.285 . . . . 1.56 112.768 -168.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.17 126.34 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.751 -0.833 . . . . 2.68 108.751 -173.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.0 m -112.36 -46.32 3.19 Favored 'General case' 0 CA--C 1.522 -0.11 0 N-CA-C 111.824 0.305 . . . . 2.4 111.824 -174.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.45 ' CE2' ' HG3' ' A' ' 123' ' ' LYS . 49.5 p90 -136.42 125.15 23.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.718 -1.216 . . . . 2.87 107.718 167.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.17 159.99 21.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.784 -1.191 . . . . 0.91 107.784 161.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.0 m -142.98 105.12 4.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.794 -1.187 . . . . 1.85 107.794 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.1 t -98.36 115.67 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 125.968 1.707 . . . . 2.36 107.596 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -119.0 106.37 12.37 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 118.943 0.792 . . . . 1.22 110.484 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 pp -72.59 -29.92 63.92 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.467 1.107 . . . . 2.19 112.447 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.52 -43.22 89.1 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.395 0.678 . . . . 1.4 110.341 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -28.69 19.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.786 1.234 . . . . 1.76 110.314 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.35 21.91 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.162 1.785 . . . . 2.13 111.155 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -99.08 160.82 13.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.607 1.563 . . . . 3.26 110.216 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.48 130.13 24.25 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.408 -0.96 . . . . 0.96 108.408 166.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -95.54 143.27 26.99 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.24 -1.393 . . . . 1.72 107.24 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.35 128.7 25.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 124.998 1.319 . . . . 1.98 109.027 -173.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HG3' ' CE2' ' A' ' 110' ' ' TYR . 1.8 mmmt -118.54 106.65 12.88 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.006 -0.739 . . . . 3.73 109.006 176.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -125.44 175.8 7.26 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.802 0.841 . . . . 2.79 110.318 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -97.82 113.58 63.86 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 108.009 -1.108 . . . . 3.75 108.009 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.6 67.96 7.11 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.524 2.816 . . . . 2.45 111.222 -173.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -162.49 -47.64 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.719 1.208 . . . . 3.93 109.026 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 pt -86.39 -32.18 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 122.539 0.335 . . . . 2.26 111.524 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.68 163.05 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 107.939 -1.134 . . . . 2.04 107.939 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.21 160.82 28.37 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.456 -1.458 . . . . 1.99 109.456 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.36 -35.78 89.8 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.511 2.807 . . . . 2.04 111.665 -172.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -32.66 69.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 112.39 0.515 . . . . 6.69 112.39 -175.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.79 -48.45 68.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.976 -0.75 . . . . 3.68 108.976 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 74.9 mt -58.3 -45.18 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.533 -0.914 . . . . 1.5 108.533 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 80.4 mt -52.44 -61.09 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 117.566 -1.207 . . . . 2.29 108.889 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.26 -51.8 17.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.399 1.454 . . . . 5.07 110.996 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.0 mm -52.89 -49.92 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.599 0.636 . . . . 2.09 110.104 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.288 2.5 pp -70.75 -31.53 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 121.173 -0.954 . . . . 1.44 113.31 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.5 -39.76 84.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.74 1.155 . . . . 3.06 109.813 169.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -35.41 77.27 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.196 1.398 . . . . 3.17 108.867 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 78.1 mt -77.27 -41.81 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 122.542 0.337 . . . . 0.99 110.724 172.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.31 30.98 5.45 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.598 1.57 . . . . 1.06 111.583 -173.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 98' ' ' ILE . 46.1 m-85 -98.33 175.3 6.1 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.422 1.111 . . . . 1.99 108.251 165.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -135.92 126.36 26.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.191 -2.151 . . . . 3.91 105.191 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.6 100.57 7.2 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.648 1.579 . . . . 1.44 107.466 -175.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.1 m -146.8 117.2 7.44 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 117.896 -1.049 . . . . 3.05 111.408 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.424 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 0.2 OUTLIER -166.99 -102.0 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.217 -0.896 . . . . 6.81 109.588 170.37 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 41.1 40.21 1.04 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.434 1.493 . . . . 6.86 111.814 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 . . . . . 0 C--O 1.248 0.99 0 N-CA-C 114.726 1.38 . . . . 7.35 114.726 -169.942 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 107.146 -1.427 . . . . 7.93 107.146 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.33 111.71 47.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 117.361 -1.304 . . . . 4.52 108.429 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -84.05 151.2 12.47 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.291 2.661 . . . . 3.2 109.734 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.03 142.48 32.89 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 123.264 0.625 . . . . 4.51 109.78 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 152.39 19.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 123.891 0.744 . . . . 3.45 110.547 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.7 t -119.65 137.45 53.88 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.562 -0.903 . . . . 2.06 108.562 168.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -102.33 103.55 14.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.847 1.659 . . . . 3.67 108.973 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.565 ' HB3' HG13 ' A' ' 71' ' ' VAL . 1.8 pt? -125.8 176.91 6.6 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.894 0.854 . . . . 2.61 111.236 171.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.47 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -139.82 136.45 34.04 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.225 -1.028 . . . . 1.79 108.225 176.331 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 44' ' ' ALA . 29.6 mm -93.69 121.25 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 107.004 -1.48 . . . . 0.79 107.004 -169.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.75 102.17 11.75 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.583 -2.377 . . . . 4.09 104.583 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.47 -89.27 0.09 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 109.785 -1.326 . . . . 1.16 109.785 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.2 mmt 46.98 77.32 0.09 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.079 1.752 . . . . 2.28 113.375 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 p -65.62 -58.41 5.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.464 -0.773 . . . . 2.7 111.528 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 49.68 0.07 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 119.976 -0.689 . . . . 3.6 110.784 -172.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 47.66 36.27 5.37 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.822 0.849 . . . . 5.31 111.593 -177.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -129.4 -51.66 1.18 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.698 1.199 . . . . 3.25 109.635 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 23.4 t -68.79 -43.25 76.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 118.434 -1.306 . . . . 2.42 109.811 -174.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -38.65 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 122.125 0.965 . . . . 2.28 109.399 173.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -65.83 -41.55 91.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.084 -0.962 . . . . 2.45 111.26 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -71.57 -38.17 70.99 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 120.801 -1.187 . . . . 3.11 111.667 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.0 mt -49.4 -42.79 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.494 1.118 . . . . 1.4 109.968 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -41.14 -56.46 2.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.635 0.731 . . . . 4.44 112.515 172.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -68.57 -27.51 66.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.873 0.869 . . . . 5.04 110.79 -175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -69.48 -57.4 5.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.436 -0.95 . . . . 1.21 108.436 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.11 -40.6 85.87 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 118.745 0.702 . . . . 2.29 110.261 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -24.56 5.94 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 112.771 0.656 . . . . 2.07 112.771 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -127.31 25.43 6.15 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.273 0.629 . . . . 4.03 111.734 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -76.77 -58.15 3.44 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.995 -0.742 . . . . 2.83 108.995 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -162.56 -131.87 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.015 0.526 . . . . 1.21 109.972 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.49 -2.44 42.69 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.761 0.696 . . . . 1.43 113.767 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -80.22 122.38 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.163 0.981 . . . . 1.33 109.382 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.1 51.36 2.13 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.774 0.797 . . . . 2.56 109.933 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 t -161.6 151.14 16.47 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.246 -1.761 . . . . 1.64 106.246 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -140.72 124.35 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.172 -1.788 . . . . 2.54 106.172 166.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.73 87.89 2.55 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.144 0.973 . . . . 4.33 110.492 169.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.59 139.92 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.249 -1.019 . . . . 2.3 108.249 172.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -109.3 100.97 10.01 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.967 -1.864 . . . . 1.55 105.967 162.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.74 -33.61 70.45 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.258 1.023 . . . . 3.93 109.052 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -53.07 62.41 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.56 1.144 . . . . 4.6 110.78 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.73 -25.39 22.33 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.347 0.659 . . . . 1.86 111.388 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.66 55.68 2.65 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.741 1.162 . . . . 1.46 110.957 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -135.33 139.42 44.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.175 0.988 . . . . 3.29 108.336 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -112.66 105.3 13.45 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 124.682 1.193 . . . . 0.9 109.765 167.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.31 144.49 28.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.591 -1.633 . . . . 3.72 106.591 163.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.64 172.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.536 -1.283 . . . . 2.07 107.536 166.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -115.4 112.32 22.15 Favored 'General case' 0 C--N 1.34 0.178 0 O-C-N 124.054 0.846 . . . . 3.8 110.206 167.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.519 ' HB2' HD12 ' A' ' 53' ' ' ILE . 7.8 p90 -105.21 172.33 6.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.598 1.559 . . . . 2.72 110.758 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -117.17 106.34 47.37 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.894 1.278 . . . . 3.42 109.001 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.15 -12.56 30.36 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 124.609 3.539 . . . . 2.42 113.819 -160.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -96.46 0.86 50.97 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.177 0.591 . . . . 3.18 111.3 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.0 t -118.85 -49.03 3.73 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 123.979 0.912 . . . . 2.6 109.478 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.623 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -121.16 149.97 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.833 1.253 . . . . 1.48 108.344 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.23 140.06 27.54 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 106.564 -1.643 . . . . 2.98 106.564 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -56.69 -38.78 94.91 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.022 2.482 . . . . 1.66 112.06 -172.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mp -52.06 -43.83 64.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.681 0.792 . . . . 3.6 111.061 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -39.51 94.08 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.137 -0.69 . . . . 3.35 109.137 -176.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.623 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -54.55 -52.11 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.493 -1.299 . . . . 1.32 107.493 172.317 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.82 -45.53 86.01 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 123.365 0.415 . . . . 1.24 110.263 -173.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.5 -45.99 69.87 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.068 0.547 . . . . 3.31 110.944 172.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.37 -46.83 87.58 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.379 0.609 . . . . 2.52 109.863 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mm -58.76 -44.21 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.916 -0.49 . . . . 2.76 110.991 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -63.69 -39.77 95.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.348 0.659 . . . . 3.22 111.507 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -62.62 -46.69 87.08 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.977 0.511 . . . . 2.12 109.702 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 mt -58.21 -36.85 73.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.549 0.34 . . . . 1.9 111.742 172.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.88 24.56 3.03 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.268 0.937 . . . . 0.98 112.469 167.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 18' ' ' CYS . 2.1 m-30 -115.12 160.91 19.1 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.188 1.395 . . . . 2.35 109.118 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -98.03 119.21 36.27 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.321 -0.992 . . . . 4.04 108.321 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.31 91.11 5.06 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.087 1.355 . . . . 1.15 107.947 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -98.71 97.5 8.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.596 -1.631 . . . . 1.07 106.596 177.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.565 HG13 ' HB3' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -60.81 155.67 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.187 -1.37 . . . . 4.0 110.104 169.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.24 -50.18 73.69 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.568 -0.901 . . . . 4.89 108.568 168.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -171.37 21.58 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.21 0.819 . . . . 8.15 113.21 175.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 64.03 -16.33 0.07 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.592 1.701 . . . . 10.74 115.592 -172.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.452 ' CZ ' ' HG2' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -52.71 -49.79 64.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.314 1.446 . . . . 5.92 109.018 -168.23 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 67.81 -116.61 0.19 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.337 1.055 . . . . 3.74 111.33 161.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.85 -48.52 0.17 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 107.986 -2.046 . . . . 4.81 107.986 169.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 32.08 44.93 0.04 OUTLIER 'General case' 0 C--N 1.345 0.389 0 C-N-CA 127.86 2.464 . . . . 7.94 114.909 163.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 53.48 86.26 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.14 2.176 . . . . 6.73 112.903 162.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.46 3.85 88.91 Favored Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 126.412 1.958 . . . . 2.22 109.899 -170.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -96.45 70.26 2.65 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.534 1.667 . . . . 2.59 107.739 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.42 161.25 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.521 -0.918 . . . . 2.87 108.521 -178.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.452 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -120.12 148.09 44.06 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.522 0.729 . . . . 2.87 109.611 177.152 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.49 HD13 ' HB1' ' A' ' 145' ' ' ALA . 0.1 OUTLIER -131.02 147.45 52.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.908 1.283 . . . . 2.68 108.505 172.332 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 m -98.02 126.31 43.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 105.971 -1.863 . . . . 1.85 105.971 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.03 134.69 35.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 109.181 -0.674 . . . . 1.47 109.181 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.5 m -125.74 140.56 52.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.115 -1.439 . . . . 1.78 107.115 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.44 -22.53 5.87 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.912 1.244 . . . . 1.33 111.89 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -51.74 139.49 21.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.061 1.134 . . . . 3.85 114.061 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.2 t -147.0 11.02 1.04 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.384 0.674 . . . . 3.98 111.902 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.04 144.83 1.03 Allowed 'General case' 0 C--N 1.342 0.277 0 O-C-N 120.455 -1.403 . . . . 3.48 110.084 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.69 -34.0 66.98 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.422 0.689 . . . . 2.57 111.782 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.8 m -43.48 -49.01 7.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.753 0.421 . . . . 2.12 110.991 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.52 -36.82 83.78 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.825 0.284 . . . . 2.75 111.059 -177.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.83 -56.59 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.636 -0.876 . . . . 1.94 108.636 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -59.85 -35.73 75.37 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.801 0.81 . . . . 2.6 110.556 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -63.19 -49.41 74.35 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.814 1.646 . . . . 1.66 111.252 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 34.5 mt -58.49 -45.3 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.716 -0.846 . . . . 1.1 108.716 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -55.32 -48.7 73.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.239 0.616 . . . . 3.33 110.194 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.8 t -51.91 -53.43 41.01 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.334 0.97 . . . . 1.39 110.889 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.34 -39.68 73.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.321 -0.862 . . . . 2.81 112.056 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.4 -60.41 2.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.576 -1.268 . . . . 2.15 107.576 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.0 p -54.93 -20.97 10.17 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.855 0.862 . . . . 2.26 112.754 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.1 mtt85 -60.73 -34.1 73.91 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.88 0.696 . . . . 5.6 112.88 171.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.1 m -57.36 150.23 18.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.604 0.762 . . . . 1.74 111.621 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -68.87 -56.0 9.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.155 0.982 . . . . 2.69 112.336 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.89 -28.18 65.32 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.972 -0.451 . . . . 1.07 111.972 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.34 122.62 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.718 -0.871 . . . . 1.95 109.426 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.7 m -104.35 -41.25 5.82 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.163 0.185 . . . . 2.03 111.225 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.429 ' CZ ' ' HG2' ' A' ' 123' ' ' LYS . 30.3 p90 -138.25 122.39 18.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.017 -0.735 . . . . 2.83 109.017 172.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.73 135.28 46.4 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 107.419 -1.326 . . . . 1.05 107.419 163.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.7 t -127.8 121.94 31.44 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.205 0.457 . . . . 2.17 110.488 164.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.54 114.37 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.014 1.326 . . . . 2.48 111.111 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -106.81 88.75 2.82 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.708 1.603 . . . . 1.2 110.43 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.58 -33.19 69.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.374 1.87 . . . . 1.98 111.683 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.24 -31.51 53.62 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.379 1.072 . . . . 1.38 111.477 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.08 -0.14 12.82 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.01 1.324 . . . . 1.75 110.495 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.0 m 59.85 20.63 9.54 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.039 1.336 . . . . 1.43 113.176 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -97.61 150.63 20.94 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.484 0.714 . . . . 3.74 110.604 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.02 106.14 7.08 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.663 1.985 . . . . 0.82 108.124 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.01 108.93 20.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.469 -2.048 . . . . 2.04 105.469 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.5 p -113.95 127.0 71.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 2.19 108.412 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.429 ' HG2' ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -114.87 105.6 13.19 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 123.929 0.892 . . . . 4.86 110.044 -176.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -124.01 -177.37 3.74 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.003 0.814 . . . . 1.94 111.804 -174.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -105.38 106.81 57.39 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.2 -1.407 . . . . 3.56 107.2 178.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.71 66.11 8.82 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.519 2.813 . . . . 1.72 111.088 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -161.51 -48.34 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.484 1.514 . . . . 3.24 108.623 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.9 pt -86.28 -32.59 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 123.698 0.799 . . . . 1.54 111.23 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.02 163.68 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.287 0.635 . . . . 1.33 109.574 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.39 166.44 26.44 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.452 -1.059 . . . . 1.34 110.452 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.19 -37.11 19.31 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.397 2.731 . . . . 1.48 111.156 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -50.05 -39.06 40.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.237 0.615 . . . . 6.32 111.471 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.25 -38.99 71.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.506 -0.924 . . . . 4.35 108.506 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.15 -49.02 85.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.486 0.714 . . . . 1.03 109.165 172.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 77.1 mt -51.51 -53.04 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.704 -0.85 . . . . 1.81 108.704 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -48.79 75.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.364 -0.835 . . . . 3.64 111.872 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 49.9 mt -49.92 -56.08 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.894 -0.78 . . . . 2.3 108.894 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.256 2.2 pp -67.25 -30.38 49.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 113.194 0.813 . . . . 1.55 113.194 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -60.79 -37.78 83.09 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.511 1.051 . . . . 2.61 110.15 170.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -69.33 -31.39 69.82 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.758 -0.46 . . . . 3.89 109.758 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.2 mt -66.72 -45.14 88.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.898 -0.501 . . . . 1.38 109.765 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.07 31.94 3.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.667 1.603 . . . . 1.2 111.343 -175.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.87 174.46 6.19 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.927 0.864 . . . . 2.49 109.068 171.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -125.96 123.26 38.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.622 -1.622 . . . . 3.95 106.622 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.49 ' HB1' HD13 ' A' ' 84' ' ' LEU . . . -115.81 100.77 8.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.357 1.463 . . . . 1.23 108.91 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.4 p -98.42 99.25 10.42 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.012 -1.107 . . . . 3.21 108.012 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -47.91 98.9 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.489 1.915 . . . . 4.0 110.811 176.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 48.38 42.7 18.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.951 0.901 . . . . 3.75 112.23 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 116.893 -1.527 . . . . 8.44 108.716 -175.267 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 106.856 -1.535 . . . . 8.36 106.856 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.92 110.28 44.16 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.059 0.944 . . . . 3.77 108.843 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.51 134.36 11.1 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.424 2.75 . . . . 2.71 109.903 -178.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.62 135.65 51.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.032 -1.47 . . . . 3.59 107.032 -169.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.41 ' HA ' ' HG3' ' A' ' 47' ' ' LYS . 32.2 ttmt -94.93 151.67 19.0 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 119.645 1.111 . . . . 4.18 109.376 176.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.66 133.63 40.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.441 -1.254 . . . . 2.06 108.531 167.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -103.67 118.49 36.84 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.657 1.583 . . . . 3.4 109.135 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.463 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.8 pt? -141.09 179.93 6.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.567 0.747 . . . . 2.16 111.488 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -130.62 146.38 52.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.327 -0.99 . . . . 1.59 108.327 173.209 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 mm -100.95 136.19 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 107.442 -1.318 . . . . 0.99 107.442 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -108.98 125.3 51.91 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.157 -1.423 . . . . 3.09 107.157 164.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.02 -79.98 0.17 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.507 1.051 . . . . 1.05 110.957 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.9 mtt 45.26 78.73 0.06 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.22 1.808 . . . . 2.07 114.685 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -54.29 -60.78 2.88 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.75 0.648 . . . . 2.17 112.75 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -169.59 68.27 0.06 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.443 0.565 . . . . 3.11 110.321 -174.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 34.37 41.52 0.05 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.304 2.242 . . . . 5.75 115.78 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -160.14 -41.05 0.05 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.192 1.397 . . . . 3.38 111.27 -171.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.2 t -70.88 -38.53 73.06 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.673 -1.267 . . . . 1.69 111.01 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.605 ' HB ' HD21 ' A' ' 39' ' ' LEU . 95.8 t -59.4 -34.96 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.434 0.635 . . . . 1.94 109.397 167.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.27 -40.84 96.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.37 -0.831 . . . . 2.38 111.088 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -44.85 83.42 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.752 -1.218 . . . . 2.46 110.451 172.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.544 HG12 HD13 ' A' ' 65' ' ' LEU . 3.3 mt -47.36 -31.24 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 123.249 0.62 . . . . 1.51 111.854 175.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -46.54 -59.22 3.13 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.588 0.631 . . . . 5.25 111.539 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -71.55 -21.43 61.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.424 -0.353 . . . . 4.69 111.834 -173.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -67.59 -57.59 6.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.407 -1.331 . . . . 1.18 107.407 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.567 HD11 HD11 ' A' ' 62' ' ' ILE . 5.2 mp -63.27 -41.71 99.05 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 118.39 0.541 . . . . 1.97 111.237 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.54 -17.91 9.97 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.582 -0.699 . . . . 2.13 112.59 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -123.58 27.48 7.37 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.56 0.744 . . . . 3.7 111.406 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -81.2 -61.45 1.95 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.932 0.893 . . . . 2.69 110.04 172.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.16 -138.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.138 0.575 . . . . 1.23 109.927 -172.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.22 -18.09 66.76 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 119.068 0.849 . . . . 1.52 112.541 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.38 121.02 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 O-C-N 121.842 -0.799 . . . . 1.58 110.862 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 pp -142.16 50.05 1.53 Allowed 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 121.86 0.838 . . . . 2.46 110.336 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -157.92 144.51 17.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.713 -1.588 . . . . 1.64 106.713 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.4 t -138.61 112.64 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 104.553 -2.388 . . . . 2.69 104.553 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.94 86.77 2.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 122.219 1.009 . . . . 2.68 109.128 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 44' ' ' ALA . 19.7 m -97.18 157.1 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.07 -0.968 . . . . 2.34 109.11 171.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.38 98.42 5.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.116 -1.809 . . . . 1.36 106.116 159.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.605 HD21 ' HB ' ' A' ' 19' ' ' VAL . 4.0 mp -62.33 -20.82 64.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.014 0.37 . . . . 3.63 111.242 176.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 40.4 ttm -73.83 -37.03 64.96 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.368 1.067 . . . . 3.04 110.735 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.57 -23.2 14.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.6 0.76 . . . . 1.69 111.797 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.17 62.29 1.83 Allowed Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.475 1.036 . . . . 1.29 111.322 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -144.0 140.37 29.55 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.487 -1.301 . . . . 4.02 107.487 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.435 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -115.21 108.49 16.67 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.616 1.167 . . . . 1.02 110.104 165.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -104.09 148.7 25.95 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.442 1.019 . . . . 4.01 109.082 158.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.5 pt -137.53 177.76 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.187 -1.412 . . . . 2.04 107.187 176.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HG3' ' HA ' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -126.11 110.75 13.87 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 119.137 -0.459 . . . . 3.63 110.644 165.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -115.59 -178.43 3.38 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.232 1.813 . . . . 2.73 111.475 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -122.83 106.58 34.22 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 127.675 2.39 . . . . 4.54 110.095 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.19 10.53 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.614 2.876 . . . . 2.11 113.358 -173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.32 -19.01 18.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.494 0.718 . . . . 3.52 110.724 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.08 -66.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.115 -1.069 . . . . 2.81 108.115 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -94.07 142.26 13.63 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-O 120.859 0.361 . . . . 1.6 110.299 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.39 149.06 41.52 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.302 1.441 . . . . 2.64 109.939 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.97 -19.97 67.27 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.942 2.428 . . . . 1.44 112.546 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -70.59 -60.35 2.31 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.986 -0.746 . . . . 2.92 108.986 173.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -59.76 -33.57 71.85 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.1 -0.375 . . . . 3.56 111.963 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.559 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -51.87 -47.06 41.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 N-CA-C 107.321 -1.363 . . . . 1.32 107.321 171.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.56 -36.65 81.23 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.697 -0.683 . . . . 1.29 110.686 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -59.57 -45.39 91.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.843 0.747 . . . . 2.6 109.568 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -52.16 63.47 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.185 -0.672 . . . . 2.34 109.185 176.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.567 HD11 HD11 ' A' ' 26' ' ' LEU . 9.8 mm -63.48 -42.77 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 O-C-N 122.007 -0.433 . . . . 2.54 112.123 -176.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -44.45 95.64 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.23 1.012 . . . . 2.29 110.356 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -60.39 -53.94 51.54 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.671 0.788 . . . . 2.16 108.899 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.544 HD13 HG12 ' A' ' 22' ' ' ILE . 4.7 mt -50.36 -39.82 47.58 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.648 0.779 . . . . 1.9 111.775 174.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.56 37.55 1.07 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.637 -0.985 . . . . 1.06 110.637 167.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -130.92 158.79 39.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.41 -1.33 . . . . 2.22 107.41 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -99.24 119.58 38.13 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.243 -1.021 . . . . 2.29 108.243 171.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.66 119.72 36.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.417 -1.327 . . . . 0.91 107.417 168.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -133.46 124.94 27.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.099 -1.074 . . . . 0.93 108.099 174.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 21.8 t -60.78 151.69 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 124.546 1.139 . . . . 2.79 111.261 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -25.55 65.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.955 -0.566 . . . . 4.43 110.984 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.421 ' H ' HG12 ' A' ' 71' ' ' VAL . 28.5 tt0 123.59 -55.91 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.579 1 C-N-CA 134.097 4.959 . . . . 4.69 103.97 175.113 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.62 61.73 6.67 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.865 0.691 . . . . 7.78 112.865 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -43.55 -58.06 2.82 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.773 0.657 . . . . 5.5 112.773 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 47.08 -158.39 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.776 1.631 . . . . 4.77 113.486 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 57.02 27.63 57.37 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 126.592 2.044 . . . . 3.74 112.8 167.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.7 m -82.05 -59.08 2.69 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.054 -1.091 . . . . 5.52 108.054 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.401 ' HB3' ' H ' ' A' ' 80' ' ' GLY . 8.0 t0 -176.77 -88.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 120.475 -0.49 . . . . 4.89 110.59 -163.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 79' ' ' ASP . . . -98.19 5.7 61.25 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 109.616 -1.393 . . . . 3.06 109.616 159.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -95.79 111.12 23.16 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 107.637 -1.246 . . . . 3.36 107.637 164.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.73 161.81 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 125.445 1.716 . . . . 2.95 107.136 173.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.84 154.42 21.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.828 1.251 . . . . 3.17 108.292 165.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -142.42 151.87 42.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.332 0.653 . . . . 3.1 110.518 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 m -99.95 132.1 45.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.831 1.652 . . . . 1.86 107.296 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.585 HD13 HD13 ' A' ' 98' ' ' ILE . 8.5 mt -99.1 124.69 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.965 -0.754 . . . . 2.42 108.965 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.7 m -110.56 100.98 9.69 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.247 0.619 . . . . 1.57 109.342 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.57 -34.35 2.12 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.621 1.105 . . . . 1.24 111.216 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -58.23 141.8 49.58 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.383 0.673 . . . . 2.46 111.811 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 51.8 m -153.57 84.46 1.18 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.858 1.663 . . . . 3.48 106.558 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 63.3 m 51.09 -110.51 0.48 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.017 1.327 . . . . 6.31 111.602 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 48.72 -144.11 0.44 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.164 1.385 . . . . 5.25 110.3 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.5 t -89.15 9.4 25.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 118.849 -0.596 . . . . 3.84 109.97 164.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.54 -56.93 6.66 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 119.506 1.048 . . . . 3.02 110.082 -166.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.5 t -49.6 -46.41 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.321 1.049 . . . . 1.26 109.92 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -63.82 -36.28 83.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.125 -0.489 . . . . 3.54 109.927 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -63.45 -52.79 59.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.556 0.742 . . . . 1.85 109.691 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.585 HD13 HD13 ' A' ' 86' ' ' ILE . 4.0 mt -53.92 -53.99 23.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 109.496 -0.557 . . . . 1.25 109.496 178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -56.95 -45.69 82.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.907 -0.568 . . . . 2.16 109.758 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.3 t -54.29 -54.07 45.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.822 0.737 . . . . 1.53 110.857 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -34.54 72.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 121.169 -0.957 . . . . 2.45 111.147 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -71.07 -60.63 2.12 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.429 -0.952 . . . . 2.05 108.429 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.1 p -56.34 -18.78 11.86 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.06 0.763 . . . . 1.73 113.06 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -61.48 -33.23 73.42 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.767 0.712 . . . . 5.59 112.466 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.7 m -62.35 152.4 34.05 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.077 0.951 . . . . 1.64 111.387 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -70.64 -52.96 17.8 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.317 1.047 . . . . 2.23 111.502 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.49 -43.04 20.72 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.572 -0.611 . . . . 1.15 111.572 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.66 134.64 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.855 -0.794 . . . . 2.0 108.855 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.8 t -128.0 -35.95 2.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.756 0.823 . . . . 2.97 110.845 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -110.11 92.0 3.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.951 -1.5 . . . . 3.02 106.951 -173.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.49 135.11 47.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.165 -1.791 . . . . 0.99 106.165 160.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 t -140.23 108.75 5.87 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.477 -1.305 . . . . 1.6 107.477 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.5 t -101.63 107.55 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.521 1.128 . . . . 2.33 109.341 -173.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.97 80.12 2.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.561 1.144 . . . . 1.51 109.818 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 pp -53.56 -26.63 22.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.012 0.925 . . . . 2.26 113.042 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.48 -35.23 65.3 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.342 0.657 . . . . 1.7 111.248 176.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -7.61 18.79 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.264 1.425 . . . . 1.82 110.78 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.4 m 73.51 3.9 4.66 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.003 1.721 . . . . 1.6 112.406 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -98.09 165.33 11.95 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.132 0.973 . . . . 3.18 112.0 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -137.51 136.12 37.38 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.66 1.184 . . . . 1.05 108.651 168.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.96 132.18 43.76 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.959 -1.867 . . . . 2.59 105.959 171.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.0 t -125.44 142.01 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 105.345 -2.094 . . . . 1.86 105.345 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -125.06 99.52 6.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.458 1.103 . . . . 3.45 109.255 169.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -109.68 -178.78 3.63 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.645 1.578 . . . . 2.15 109.106 173.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -114.41 113.12 45.81 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.201 1.4 . . . . 4.16 107.651 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.01 58.72 6.8 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.754 2.303 . . . . 2.15 112.479 -164.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -145.77 -49.89 0.23 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.894 1.677 . . . . 4.74 108.242 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -80.34 -32.03 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 122.34 -0.225 . . . . 1.64 111.205 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.41 162.94 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.942 -1.132 . . . . 1.41 107.942 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.23 163.91 27.71 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.628 -1.389 . . . . 1.37 109.628 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.72 -41.26 39.85 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.101 2.534 . . . . 1.44 110.396 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -40.05 25.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.184 0.809 . . . . 6.21 113.184 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.38 -47.96 79.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.18 -0.674 . . . . 2.71 109.18 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.31 -46.76 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.493 -0.928 . . . . 1.03 108.493 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.2 mt -53.66 -54.24 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 109.121 -0.696 . . . . 1.82 109.121 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -54.65 -47.24 73.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.935 0.789 . . . . 3.68 111.702 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.2 mm -54.17 -56.47 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.863 -0.421 . . . . 1.94 109.863 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 pp -66.57 -30.96 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 120.973 -1.08 . . . . 1.37 113.119 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.31 -38.38 73.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.312 0.645 . . . . 3.39 109.917 170.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -65.99 -36.49 83.45 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.485 -0.561 . . . . 3.01 109.485 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.7 mt -68.38 -40.84 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.395 -0.594 . . . . 1.25 109.395 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.13 33.18 3.52 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.518 1.532 . . . . 1.17 111.007 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -101.35 176.67 5.16 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.279 1.039 . . . . 3.05 108.364 166.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -134.92 125.67 27.15 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.413 -1.328 . . . . 4.81 107.413 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.22 106.15 14.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.983 1.313 . . . . 1.32 109.74 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.57 94.75 6.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.848 1.659 . . . . 2.14 108.572 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.79 103.76 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.663 1.585 . . . . 4.22 110.501 172.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 46.75 43.76 13.33 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.744 0.818 . . . . 4.23 112.397 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.158 -0.925 . . . . 10.4 108.531 177.612 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.291 -1.374 . . . . 9.64 107.291 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.58 97.91 7.3 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 119.319 0.963 . . . . 5.17 108.698 -172.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.33 130.24 11.8 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.266 1.977 . . . . 3.4 109.107 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.49 131.84 53.87 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.853 0.835 . . . . 3.85 109.163 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.7 151.35 19.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.86 -1.904 . . . . 4.23 105.86 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.413 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 5.8 t -123.25 141.41 52.01 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 117.837 -1.078 . . . . 1.9 108.333 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -123.85 100.53 6.8 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.752 -0.833 . . . . 3.55 108.752 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -125.04 168.02 13.93 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.38 1.086 . . . . 3.03 110.736 177.135 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.68 146.16 43.9 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.65 -1.611 . . . . 1.7 106.65 169.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.5 mm -102.37 130.54 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.614 -1.254 . . . . 1.12 107.614 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -118.78 117.87 30.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.494 -1.669 . . . . 3.25 106.494 167.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.78 -99.91 0.18 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.127 -1.589 . . . . 1.12 109.127 -174.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 58.5 76.25 0.35 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.172 1.789 . . . . 1.67 113.288 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -48.96 -58.73 4.41 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.893 0.877 . . . . 2.59 112.698 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.56 52.63 0.05 OUTLIER 'General case' 0 C--N 1.346 0.449 0 C-N-CA 119.211 -0.995 . . . . 4.14 111.37 -175.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.46 41.12 20.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.97 0.908 . . . . 4.52 112.399 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -151.82 -43.19 0.11 Allowed 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.494 1.118 . . . . 2.16 110.881 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.36 -46.99 83.96 Favored 'General case' 0 C--O 1.226 -0.167 0 O-C-N 121.052 -1.03 . . . . 2.01 109.132 -176.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.18 -36.98 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.967 0.889 . . . . 2.25 109.996 174.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -65.8 -31.19 72.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.921 -0.581 . . . . 1.9 112.336 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -38.19 71.82 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.93 -1.106 . . . . 3.09 110.171 172.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.573 HG12 HD13 ' A' ' 65' ' ' LEU . 54.0 mt -59.85 -39.96 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.264 1.026 . . . . 1.58 110.256 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.9 -58.26 2.47 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.791 0.836 . . . . 5.73 112.08 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.53 -39.99 88.9 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.924 0.392 . . . . 4.88 110.144 -172.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -54.45 -56.66 16.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.519 -0.764 . . . . 1.47 109.266 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mt -65.67 -36.25 83.12 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 113.313 0.857 . . . . 2.53 113.313 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -21.9 3.65 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 118.283 0.492 . . . . 2.81 112.165 168.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -123.75 30.88 6.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.152 0.581 . . . . 3.53 112.42 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.32 -80.08 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.582 0.628 . . . . 3.54 109.371 167.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.29 -114.28 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.516 0.726 . . . . 1.28 110.469 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.5 -9.58 69.13 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 119.248 0.931 . . . . 1.33 112.984 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.8 t -59.22 119.75 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 118.366 1.083 . . . . 2.35 109.092 167.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.45 49.6 1.71 Allowed 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.496 0.665 . . . . 2.43 110.448 162.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 t -159.66 151.13 19.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.566 -1.272 . . . . 1.64 107.566 161.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.01 120.11 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.399 -2.074 . . . . 2.53 105.399 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 tt -138.75 89.72 2.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.936 -1.876 . . . . 2.41 105.936 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.7 p -106.29 135.63 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.3 -1.0 . . . . 2.31 108.3 172.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -104.76 102.69 12.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.247 -1.76 . . . . 1.22 106.247 164.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tp -57.57 -33.7 68.44 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.054 1.342 . . . . 2.94 109.182 169.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 62.8 mtt -59.29 -47.67 84.49 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.537 0.735 . . . . 4.09 110.901 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.3 -25.86 16.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.915 0.886 . . . . 1.27 111.446 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.4 55.71 2.82 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.615 1.102 . . . . 1.09 110.833 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 128.74 27.86 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.04 -1.096 . . . . 2.98 108.04 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.07 117.32 30.24 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 124.518 1.136 . . . . 1.09 111.071 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -113.63 142.47 45.96 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.609 0.719 . . . . 3.98 110.641 162.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.5 mt -121.25 168.16 13.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 125.595 1.558 . . . . 3.45 106.893 171.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -133.84 105.54 6.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.098 0.559 . . . . 4.18 109.568 170.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.465 ' CD2' HD11 ' A' ' 53' ' ' ILE . 5.0 p90 -102.69 -176.22 3.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.8 2.04 . . . . 3.13 111.792 174.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -109.35 129.93 23.34 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.252 1.421 . . . . 4.17 107.7 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.57 41.49 1.15 Allowed 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.46 2.774 . . . . 4.03 112.334 -166.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -163.41 24.42 0.08 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.041 0.936 . . . . 3.49 110.392 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.13 -50.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 107.027 -1.471 . . . . 3.22 107.027 -174.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.465 HD11 ' CD2' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -126.35 153.01 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.837 -0.801 . . . . 2.67 108.837 176.005 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -125.77 158.49 65.12 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 106.373 -1.714 . . . . 3.69 106.373 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.44 -27.9 54.39 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.528 1.485 . . . . 1.64 110.438 -165.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -56.74 -42.17 78.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.123 0.969 . . . . 3.56 111.239 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.6 -52.52 57.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.976 0.807 . . . . 2.84 109.856 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.421 HD12 HD11 ' A' ' 53' ' ' ILE . 1.2 mt -47.7 -54.16 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.071 -1.085 . . . . 1.84 108.071 168.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.35 -35.05 74.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.158 -0.474 . . . . 1.9 111.308 -172.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -58.2 -47.39 83.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.506 1.122 . . . . 3.42 109.269 -178.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -54.11 -53.14 57.34 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.747 -0.464 . . . . 2.5 109.747 174.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.409 HG21 ' HB2' ' A' ' 69' ' ' ALA . 11.0 mm -59.07 -48.16 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.04 0.448 . . . . 2.71 110.631 -174.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.3 -45.79 90.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.381 0.673 . . . . 2.71 111.164 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.36 -49.81 76.1 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.504 0.593 . . . . 2.56 110.192 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.573 HD13 HG12 ' A' ' 22' ' ' ILE . 2.0 mt -57.97 -28.03 64.0 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.688 0.795 . . . . 1.98 111.793 174.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.43 36.15 3.91 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.11 -1.196 . . . . 1.69 110.11 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -120.13 162.07 19.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.187 1.795 . . . . 1.94 106.445 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -104.1 124.43 49.06 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.598 -0.89 . . . . 2.74 108.598 168.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.409 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -108.35 121.96 45.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.506 -1.294 . . . . 1.28 107.506 162.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.52 156.54 48.72 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.767 -1.198 . . . . 1.44 107.767 169.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.28 153.96 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.841 -1.072 . . . . 3.7 110.004 -164.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.8 mtp -83.18 38.81 0.62 Allowed 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.719 0.808 . . . . 4.77 111.578 172.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 66.55 -49.09 0.45 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.37 2.668 . . . . 4.67 112.776 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -29.95 -40.06 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.97 2.508 . . . . 8.12 114.572 164.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.44 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER 82.86 -64.17 0.11 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.304 1.441 . . . . 7.32 111.896 173.365 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 75' ' ' TYR . . . 124.4 -89.14 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.328 2.251 . . . . 3.12 114.249 175.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.413 ' HA2' ' H ' ' A' ' 81' ' ' ASN . . . 166.31 -130.38 2.13 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.751 -0.94 . . . . 7.22 110.751 -148.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.51 -29.58 0.18 Allowed 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.039 -1.271 . . . . 8.45 114.113 -175.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -150.5 53.98 0.9 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.3 1.44 . . . . 10.83 108.248 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 47.28 47.96 21.19 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 125.927 1.727 . . . . 3.25 109.455 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.413 ' H ' ' HA2' ' A' ' 77' ' ' GLY . 0.2 OUTLIER -100.57 71.79 1.53 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.507 1.523 . . . . 3.5 108.044 -165.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.8 148.3 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.855 -1.535 . . . . 3.44 106.855 -173.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -117.76 145.57 44.4 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 123.46 0.704 . . . . 3.79 109.152 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.41 HD13 ' HB1' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -146.94 157.45 43.64 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.128 0.971 . . . . 2.79 109.899 -175.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.46 133.58 41.85 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 106.778 -1.564 . . . . 2.92 106.778 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.08 110.76 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.522 -0.918 . . . . 2.26 108.522 173.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.0 m -98.93 137.81 36.95 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.946 -1.131 . . . . 1.89 107.946 172.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.3 -28.19 14.48 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.487 1.042 . . . . 1.58 112.806 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -75.0 122.91 24.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 117.914 0.857 . . . . 2.76 110.537 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 m -138.88 44.31 2.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.162 0.985 . . . . 2.9 109.748 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 11.0 t -165.73 140.8 4.86 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.268 -0.895 . . . . 3.55 112.167 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.66 75.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.027 0.531 . . . . 2.84 111.361 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.4 m -53.55 -45.69 69.95 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.439 -0.788 . . . . 2.54 110.036 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.0 m -64.85 -44.97 88.02 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.188 -0.91 . . . . 2.53 109.493 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 37.2 t -46.32 -60.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 118.772 0.714 . . . . 1.95 110.749 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -56.7 -45.14 81.99 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.686 0.755 . . . . 4.01 110.357 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.72 -50.76 72.57 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.808 0.843 . . . . 2.24 111.166 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.2 mt -54.6 -50.53 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.041 -1.096 . . . . 1.38 108.041 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.77 -44.32 86.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.697 0.799 . . . . 2.66 110.299 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.8 t -56.07 -55.76 28.98 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.829 -0.434 . . . . 2.06 109.829 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -43.15 77.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.274 0.63 . . . . 3.55 112.572 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.39 -58.91 5.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.756 -0.831 . . . . 2.11 108.756 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.8 m -53.09 -23.65 8.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.673 1.189 . . . . 1.7 111.432 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -4.45 8.88 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.028 1.121 . . . . 5.27 114.028 174.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.3 m -84.74 149.73 25.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.055 1.742 . . . . 1.86 109.646 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -67.0 -53.56 30.15 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.89 0.876 . . . . 3.17 112.004 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.94 -21.03 69.12 Favored Glycine 0 CA--C 1.528 0.871 0 O-C-N 122.157 -0.34 . . . . 1.65 113.202 -170.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.75 129.54 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 121.138 -1.213 . . . . 2.07 109.154 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.9 m -103.98 -51.65 3.11 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 119.403 -0.332 . . . . 2.11 111.867 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.462 ' CE2' ' HG3' ' A' ' 123' ' ' LYS . 43.6 p90 -140.0 114.98 9.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.373 0.533 . . . . 2.15 110.014 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.49 149.69 23.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.988 -0.745 . . . . 1.41 108.988 165.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.9 m -139.34 115.61 10.44 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.347 -1.353 . . . . 2.03 107.347 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.16 119.78 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 118.227 0.467 . . . . 2.58 110.358 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -118.78 87.98 2.84 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.817 0.818 . . . . 2.3 109.612 -168.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.65 -32.1 28.12 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 125.724 1.61 . . . . 3.01 112.025 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.62 -36.28 69.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.525 0.73 . . . . 3.01 111.158 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.99 -20.08 15.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.96 1.304 . . . . 2.72 110.439 177.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 78.79 7.05 2.23 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.656 1.583 . . . . 2.09 111.407 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -96.37 148.86 22.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.66 1.584 . . . . 3.84 110.057 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.41 119.29 25.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.281 2.232 . . . . 1.67 107.605 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.88 122.85 40.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.701 -1.962 . . . . 3.12 105.701 174.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.35 133.95 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.4 -0.963 . . . . 2.58 108.4 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 110' ' ' TYR . 4.8 mmmt -116.12 110.4 18.8 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.363 1.065 . . . . 3.04 109.272 177.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.25 176.71 7.2 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 118.498 0.59 . . . . 2.78 111.933 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -96.73 109.05 46.61 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 107.008 -1.479 . . . . 3.96 107.008 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.36 64.36 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.534 2.823 . . . . 3.8 111.07 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.21 -44.88 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.426 1.49 . . . . 4.06 109.321 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -90.88 -29.81 4.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 118.003 0.365 . . . . 3.16 111.254 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.76 164.81 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.225 1.01 . . . . 2.97 108.53 -175.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -149.68 167.05 29.81 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.011 -0.835 . . . . 3.03 111.011 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -60.82 -34.38 91.54 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.243 3.295 . . . . 3.03 111.953 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -54.17 -37.62 64.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.557 0.743 . . . . 7.69 112.062 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.58 -43.46 84.87 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.05 0.452 . . . . 4.33 109.834 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 14.1 mm -56.07 -48.7 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.712 0.805 . . . . 2.72 109.189 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.9 mt -53.46 -57.89 4.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 123.513 0.725 . . . . 2.84 109.382 172.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.0 tttp -49.36 -48.39 46.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 119.264 0.938 . . . . 4.28 112.74 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.6 mt -51.46 -52.71 19.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.055 -0.721 . . . . 4.26 109.055 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.309 2.2 pp -70.62 -29.15 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 118.892 -1.123 . . . . 1.54 114.021 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -58.11 -45.05 87.93 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.356 0.98 . . . . 3.23 109.019 170.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.88 -37.12 85.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.041 0.536 . . . . 3.7 109.558 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.8 mt -66.37 -41.67 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.99 -0.444 . . . . 1.83 110.483 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.68 30.75 6.34 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.337 1.446 . . . . 1.42 111.8 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -101.16 -179.78 4.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.549 1.175 . . . . 1.98 108.771 163.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -133.79 121.13 21.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.938 -1.504 . . . . 4.37 106.938 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.41 ' HB1' HD13 ' A' ' 84' ' ' LEU . . . -103.78 115.38 30.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.177 1.391 . . . . 1.84 108.249 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.8 t -135.28 128.32 31.61 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 117.78 -1.105 . . . . 2.87 108.606 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 pp -25.42 109.74 0.03 OUTLIER 'General case' 0 C--N 1.341 0.214 0 C-N-CA 127.626 2.37 . . . . 6.16 109.705 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.85 -37.62 55.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.745 -0.662 . . . . 5.91 110.782 -173.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 C--O 1.245 0.824 0 CA-C-O 116.149 -1.881 . . . . 9.63 111.079 -179.877 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mmt . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 105.473 -2.047 . . . . 8.86 105.473 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.93 108.66 1.98 Allowed Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 125.084 1.354 . . . . 4.51 109.867 -167.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -80.18 111.58 2.68 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 121.355 1.37 . . . . 3.36 111.713 -166.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -132.63 128.06 36.28 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 124.384 1.074 . . . . 3.09 110.256 -172.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.408 ' NZ ' ' O ' ' A' ' 149' ' ' GLN . 2.7 ttpt -93.16 136.45 33.4 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.289 -1.004 . . . . 6.57 108.289 -175.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.3 t -125.07 130.25 51.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.029 -1.441 . . . . 2.39 110.534 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -102.3 96.28 6.85 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 126.615 1.966 . . . . 5.03 111.125 -171.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.489 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.3 pt? -128.46 174.49 9.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.307 1.051 . . . . 2.59 112.839 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.6 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -127.09 155.7 42.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.977 -1.49 . . . . 2.02 106.977 169.64 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 44' ' ' ALA . 31.4 mm -98.72 145.16 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.418 -1.327 . . . . 0.79 107.418 171.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -118.86 128.07 54.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.645 -1.613 . . . . 3.1 106.645 162.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.86 -54.12 0.48 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.933 0.777 . . . . 1.32 112.037 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.0 mtt 11.85 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.946 2.498 . . . . 2.4 115.595 -172.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.3 p -62.36 -61.2 2.62 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.697 -0.627 . . . . 3.71 111.104 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.8 t -162.87 48.18 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.984 0.421 . . . . 3.34 110.205 -173.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 55.52 22.18 4.94 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.275 1.03 . . . . 6.72 113.553 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 m -130.71 -38.96 1.27 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.931 0.892 . . . . 4.12 111.732 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 m -64.41 -48.4 75.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 O-C-N 121.427 -0.796 . . . . 2.36 109.228 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 81.8 t -55.39 -39.92 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.006 -0.739 . . . . 2.21 109.006 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 t -58.99 -42.06 89.15 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.971 -0.559 . . . . 3.03 110.856 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -43.33 69.04 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.251 -1.53 . . . . 3.34 111.242 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.3 mt -52.7 -49.61 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.768 1.227 . . . . 1.56 109.375 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -55.23 -38.22 68.19 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.241 -0.912 . . . . 4.21 111.946 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -68.07 -31.84 71.76 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.1 -1.0 . . . . 8.52 110.366 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -65.82 -49.45 68.18 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.69 -0.856 . . . . 1.69 108.69 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -57.04 -37.54 71.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 112.695 0.628 . . . . 1.86 112.695 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -54.78 -18.58 4.93 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.219 -0.926 . . . . 2.13 112.819 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -116.99 23.86 11.6 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.643 0.777 . . . . 2.97 112.271 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -71.98 -69.17 0.41 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.945 0.793 . . . . 2.79 109.632 167.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.2 -118.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.162 0.985 . . . . 1.14 109.568 -171.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.19 -23.76 68.3 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.829 -0.544 . . . . 1.5 113.106 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 32' ' ' VAL . 1.2 p -60.1 111.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.914 0.886 . . . . 1.81 111.556 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.17 52.32 1.37 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.068 -1.086 . . . . 2.6 108.068 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.3 t -162.9 152.88 15.97 Favored 'General case' 0 CA--C 1.521 -0.154 0 O-C-N 119.866 -1.772 . . . . 2.03 108.498 156.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.14 74.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 125.365 1.466 . . . . 2.48 108.981 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.88 68.79 1.02 Allowed 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.473 -0.767 . . . . 5.47 109.18 -177.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.99 157.42 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.561 -0.903 . . . . 3.05 108.561 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.71 103.04 8.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.06 -1.459 . . . . 1.78 107.06 170.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.4 mt -67.31 -15.69 63.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.895 0.878 . . . . 3.54 110.962 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 17.2 ttt -76.25 -47.86 22.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.584 1.154 . . . . 4.66 109.885 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.72 -35.83 12.61 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.595 1.158 . . . . 1.72 111.271 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.73 74.85 1.29 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 124.612 1.101 . . . . 1.49 110.627 -174.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -140.58 141.03 35.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.986 -2.227 . . . . 3.06 104.986 165.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.414 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -114.87 101.63 9.22 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 124.036 0.835 . . . . 1.14 108.82 163.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -96.75 133.87 40.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.2 -1.407 . . . . 4.09 107.2 165.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.67 160.33 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.993 -1.854 . . . . 2.97 105.993 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -121.11 105.58 10.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 123.264 0.353 . . . . 4.55 110.587 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.463 ' HB2' HD12 ' A' ' 53' ' ' ILE . 25.4 p90 -104.13 -177.09 3.27 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 126.81 2.044 . . . . 2.9 112.757 174.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -122.15 109.12 33.66 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.809 2.044 . . . . 4.72 109.12 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.71 -11.29 23.11 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.756 2.304 . . . . 2.73 114.722 -175.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -95.21 -4.5 45.78 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.885 0.766 . . . . 6.08 110.938 -170.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.5 p -134.29 -37.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.585 1.154 . . . . 3.59 111.184 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -118.53 153.02 20.71 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 N-CA-C 109.024 -0.732 . . . . 1.97 109.024 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -138.02 152.81 72.73 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.639 1.176 . . . . 3.43 109.86 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.57 -37.14 39.09 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.711 2.274 . . . . 1.96 111.757 -170.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.1 -40.95 95.67 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.8 -0.563 . . . . 3.54 112.085 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -61.88 -44.58 96.51 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.264 0.625 . . . . 3.74 109.984 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -52.3 -54.97 12.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 N-CA-C 106.986 -1.487 . . . . 1.49 106.986 170.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.01 -45.95 71.65 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.948 -0.569 . . . . 1.64 110.255 -172.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -51.06 -51.15 56.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.966 0.906 . . . . 4.94 110.022 175.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -45.16 75.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.318 0.58 . . . . 2.74 110.183 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 69' ' ' ALA . 7.3 mm -65.82 -37.7 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 O-C-N 121.939 -0.476 . . . . 2.65 110.515 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -66.28 -41.07 90.36 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.382 -0.599 . . . . 3.01 109.382 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.4 -50.8 72.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.866 0.466 . . . . 3.23 109.998 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.0 mt -57.67 -32.46 67.35 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 111.889 0.329 . . . . 1.95 111.889 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.85 35.11 1.9 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.458 1.028 . . . . 1.65 111.445 166.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -132.18 164.05 27.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.054 1.342 . . . . 2.19 109.149 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -102.72 124.83 48.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.867 -1.16 . . . . 2.44 107.867 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.405 ' HB2' HG13 ' A' ' 62' ' ' ILE . . . -102.97 122.3 44.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.829 -1.175 . . . . 1.28 107.829 166.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.6 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -126.98 118.59 24.79 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.555 -0.906 . . . . 1.26 108.555 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.591 HG21 ' HA ' ' A' ' 74' ' ' ASP . 7.1 p -69.07 160.3 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 125.169 1.388 . . . . 3.15 110.247 171.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -51.76 68.46 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.3 0.572 . . . . 6.03 110.15 168.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.45 106.06 0.23 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 100.886 -3.746 . . . . 7.35 100.886 -173.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.591 ' HA ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -67.94 126.43 29.43 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 119.64 1.109 . . . . 11.36 108.389 -166.722 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.421 ' CD2' ' HG3' ' A' ' 83' ' ' GLU 0.259 2.9 p90 -143.43 -72.58 0.29 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 112.682 -2.054 . . . . 5.94 112.868 -176.686 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 101.72 125.67 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 127.893 2.477 . . . . 5.04 108.786 -172.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -130.33 109.83 0.96 Allowed Glycine 0 C--N 1.334 0.421 0 CA-C-O 118.19 -1.339 . . . . 3.02 110.834 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.2 t -173.77 -56.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.4 1.1 . . . . 4.97 111.055 170.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -155.24 141.64 18.65 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 127.147 2.179 . . . . 5.15 105.16 -175.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.44 -30.65 1.43 Allowed Glycine 0 CA--C 1.531 1.054 0 O-C-N 120.268 -1.52 . . . . 2.4 112.264 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.681 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -142.65 118.14 10.32 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 104.907 -2.257 . . . . 2.66 104.907 174.268 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.681 HD13 ' O ' ' A' ' 81' ' ' ASN . 2.3 mm -131.6 165.82 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.657 0.783 . . . . 2.98 109.062 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.421 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 3.0 mt-10 -131.1 149.03 52.78 Favored 'General case' 0 N--CA 1.438 -1.056 0 O-C-N 124.51 1.131 . . . . 4.68 111.551 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.51 151.04 38.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.344 1.027 . . . . 2.55 109.221 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.99 132.87 43.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.27 -2.122 . . . . 1.63 105.27 174.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.5 pt -98.62 139.46 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.191 -1.04 . . . . 1.87 108.191 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.4 m -136.64 140.66 42.93 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.219 -1.4 . . . . 1.91 107.219 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.51 -20.62 15.49 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.5 1.048 . . . . 1.18 112.669 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.42 148.78 26.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.494 1.147 . . . . 3.24 112.073 176.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.6 t -134.89 -9.97 2.34 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.586 1.154 . . . . 3.78 112.521 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 35.4 t -160.03 158.35 30.34 Favored 'General case' 0 C--N 1.341 0.237 0 O-C-N 120.952 -1.092 . . . . 2.72 108.598 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.33 -37.26 35.88 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.375 1.07 . . . . 2.63 112.028 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -45.53 -42.13 10.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.732 0.813 . . . . 1.98 111.721 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 81.5 m -62.51 -53.18 58.57 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 109.134 -0.691 . . . . 1.75 109.134 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -45.33 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.648 -0.657 . . . . 2.01 111.65 176.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -62.43 -35.31 78.85 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.696 -0.483 . . . . 3.18 109.696 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -61.63 -60.84 3.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.535 1.134 . . . . 2.44 109.035 176.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -44.4 -57.12 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 123.733 0.813 . . . . 2.03 110.073 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.57 -45.02 93.09 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 120.173 -0.611 . . . . 2.59 109.794 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.9 t -53.74 -57.57 10.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.48 0.712 . . . . 2.11 110.519 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.538 ' CE ' HG22 ' A' ' 138' ' ' ILE . 10.7 mtpt -55.15 -38.06 67.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.446 0.906 . . . . 6.41 113.446 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.1 mt -71.05 -56.7 5.6 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.681 -1.97 . . . . 2.33 105.681 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.447 ' HA ' HG21 ' A' ' 108' ' ' ILE . 53.7 m -50.08 -21.51 1.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.86 2.064 . . . . 2.22 112.499 176.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -68.22 -24.61 64.95 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.578 0.751 . . . . 4.88 112.97 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.4 m -62.42 170.18 2.53 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.141 0.576 . . . . 2.17 110.707 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -82.59 -49.91 9.34 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.137 -0.977 . . . . 3.3 110.302 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.46 -30.98 66.07 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.444 1.021 . . . . 1.3 112.425 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.447 HG21 ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER -49.77 105.35 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.313 0.645 . . . . 2.78 110.843 178.435 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 59.8 m -104.39 -31.31 9.58 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.729 0.412 . . . . 2.29 110.522 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.26 114.07 8.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.345 -1.724 . . . . 2.86 106.345 -175.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -117.85 157.33 26.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.076 -1.453 . . . . 1.21 107.076 155.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.0 t -141.98 136.48 30.37 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.904 -1.517 . . . . 1.76 106.904 166.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.2 133.83 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 123.841 0.857 . . . . 2.1 110.052 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -132.34 116.06 16.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.681 1.192 . . . . 1.3 110.256 -170.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.4 mt -75.43 -46.82 30.4 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 127.251 2.22 . . . . 2.92 110.859 -172.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.59 -35.44 4.01 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.581 1.552 . . . . 1.7 111.705 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.92 -4.37 13.28 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.548 1.939 . . . . 1.87 111.281 -177.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 63.6 m 52.73 31.85 11.09 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.054 1.342 . . . . 1.47 112.508 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -108.2 151.0 26.52 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.484 0.713 . . . . 4.74 110.509 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.86 116.84 10.47 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.269 1.028 . . . . 0.96 108.599 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mp -102.03 128.79 48.33 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 126.607 1.963 . . . . 2.61 106.451 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.82 131.75 50.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.309 -0.626 . . . . 2.66 109.309 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -113.33 83.94 1.92 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.717 0.807 . . . . 3.89 110.651 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -113.97 171.94 7.29 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.65 1.58 . . . . 2.05 109.317 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -96.33 117.75 65.93 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 108.93 -0.767 . . . . 3.13 108.93 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.7 70.85 6.77 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.287 2.658 . . . . 2.04 111.013 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -164.29 -44.95 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.082 1.353 . . . . 4.11 109.709 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 25.7 pt -76.83 -38.73 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 123.377 0.671 . . . . 2.4 110.364 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.18 156.09 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.998 1.319 . . . . 2.12 108.127 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -121.82 158.66 16.52 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.048 -1.221 . . . . 2.28 110.048 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -62.52 -43.39 22.21 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.801 2.334 . . . . 2.02 110.056 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -54.21 -37.68 64.83 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 122.759 0.424 . . . . 5.42 111.907 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.79 -44.19 70.6 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.752 -1.203 . . . . 4.84 107.752 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.51 -48.99 86.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 108.604 -0.887 . . . . 1.67 108.604 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 64.2 mt -50.26 -58.75 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 124.237 1.015 . . . . 2.18 108.958 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -53.09 -45.76 68.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.032 -1.043 . . . . 5.28 112.488 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.2 mm -56.29 -46.08 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 109.965 -0.383 . . . . 2.83 109.965 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.538 HG22 ' CE ' ' A' ' 101' ' ' LYS . 27.4 pt -72.35 -34.77 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 121.112 -0.993 . . . . 1.46 113.109 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -56.05 -36.86 68.51 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.171 0.896 . . . . 2.64 109.279 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.25 -25.52 68.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.061 -0.518 . . . . 3.63 110.057 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.3 mt -86.89 -39.26 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.155 0.582 . . . . 1.95 109.708 172.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.33 27.42 5.3 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.129 1.347 . . . . 1.73 111.342 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -99.28 170.35 8.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.299 1.049 . . . . 1.91 108.954 165.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -135.53 144.87 46.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.835 -1.172 . . . . 5.36 107.835 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.4 103.08 7.99 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.136 1.775 . . . . 1.38 109.31 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.45 112.66 19.25 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.656 0.782 . . . . 2.19 109.932 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -17.71 106.68 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.983 2.513 . . . . 4.33 113.191 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.52 -40.22 23.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.94 -0.573 . . . . 3.65 110.403 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.408 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 14.9 mt-30 . . . . . 0 C--O 1.256 1.441 0 CA-C-O 115.403 -2.236 . . . . 6.92 116.994 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 106.48 -1.674 . . . . 8.3 106.48 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.34 119.34 6.51 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.502 -2.036 . . . . 3.82 105.502 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -91.1 147.2 3.66 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.42 2.747 . . . . 2.91 110.443 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 79' ' ' ASP . 23.9 mp0 -127.89 154.46 45.48 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 107.487 -1.301 . . . . 3.95 107.487 -176.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -92.37 159.17 15.7 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.506 1.522 . . . . 5.33 107.348 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.457 ' SG ' HD21 ' A' ' 8' ' ' LEU . 30.8 p -152.14 145.97 25.13 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 118.426 0.557 . . . . 2.66 111.3 166.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.96 102.49 11.49 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.273 1.029 . . . . 4.18 109.001 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -106.58 168.83 8.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.069 0.938 . . . . 2.72 111.113 172.468 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.12 156.31 33.9 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.549 -1.278 . . . . 1.68 107.549 167.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.3 mm -99.13 141.06 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 107.608 -1.256 . . . . 1.14 107.608 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -119.55 121.78 40.14 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.236 -1.765 . . . . 2.85 106.236 160.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.57 -83.68 0.15 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.644 1.116 . . . . 1.32 110.396 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.5 mmt 54.07 71.58 0.51 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.708 1.603 . . . . 1.94 113.6 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -55.26 -61.95 1.99 Allowed 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.616 -0.677 . . . . 2.15 112.374 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.0 t -168.59 64.57 0.06 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.757 0.708 . . . . 3.07 110.034 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 38.86 44.65 0.86 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.452 1.501 . . . . 5.7 112.912 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.5 t -160.81 -41.8 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.054 0.542 . . . . 3.0 110.528 -166.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -61.78 -40.3 94.71 Favored 'General case' 0 CA--C 1.527 0.08 0 O-C-N 120.889 -1.132 . . . . 1.94 109.833 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.672 ' HB ' HD21 ' A' ' 39' ' ' LEU . 77.0 t -61.44 -32.48 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 121.871 -0.518 . . . . 1.8 110.456 171.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 m -66.85 -37.56 84.7 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.102 -0.639 . . . . 2.2 111.428 176.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.262 0.3 OUTLIER -71.9 -35.14 69.64 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.556 -1.34 . . . . 3.63 112.146 171.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 mt -48.15 -51.41 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.712 -0.617 . . . . 2.08 110.965 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -34.37 -55.13 0.53 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.083 0.953 . . . . 4.35 110.907 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -68.8 -30.46 69.04 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.0 1.32 . . . . 8.11 110.285 -170.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -65.48 -57.94 7.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.513 -0.921 . . . . 1.94 108.513 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.83 -38.8 79.48 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.568 -0.16 . . . . 2.02 110.568 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -49.57 -26.64 3.68 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.949 0.9 . . . . 2.65 112.53 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -123.29 22.55 9.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.176 -0.916 . . . . 4.4 112.858 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -61.93 -68.88 0.28 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.433 1.015 . . . . 3.24 110.756 165.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.8 -130.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.938 0.495 . . . . 1.12 109.828 -163.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.07 -13.26 72.68 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 118.791 0.723 . . . . 1.41 112.959 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 46' ' ' ILE . 8.2 p -60.95 127.16 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 118.417 1.108 . . . . 1.3 110.635 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 pp -142.69 51.81 1.43 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.41 0.624 . . . . 2.52 111.032 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 t -156.66 151.61 26.09 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.015 -0.735 . . . . 1.59 109.015 164.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.83 69.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.553 1.541 . . . . 2.74 108.583 -171.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tt -98.05 74.17 2.26 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.14 -1.059 . . . . 2.3 108.14 -173.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.428 HG11 ' CG1' ' A' ' 19' ' ' VAL . 17.7 t -104.81 136.95 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.849 -0.614 . . . . 2.21 109.435 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -113.74 98.84 7.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.56 -0.904 . . . . 1.34 108.56 173.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.672 HD21 ' HB ' ' A' ' 19' ' ' VAL . 18.2 mt -60.5 -17.49 45.65 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.585 0.754 . . . . 2.92 112.607 173.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 6.1 mtm -70.05 -55.95 8.2 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.137 0.494 . . . . 4.26 109.781 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.89 -24.88 22.39 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.398 0.679 . . . . 1.49 111.429 -175.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.93 68.32 1.54 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.185 -1.166 . . . . 1.22 110.185 -174.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.24 139.46 41.02 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.574 -2.009 . . . . 2.89 105.574 171.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.91 101.48 9.53 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 124.641 1.213 . . . . 0.88 111.878 169.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -97.97 136.0 38.87 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.799 -1.185 . . . . 5.14 107.799 169.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 32' ' ' VAL . 37.2 pt -141.51 168.57 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.88 -0.785 . . . . 1.87 108.88 171.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -120.6 97.96 5.81 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 119.072 -0.489 . . . . 3.73 110.151 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -102.27 178.97 4.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 124.611 1.194 . . . . 2.3 112.156 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -123.38 104.53 34.42 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 127.96 2.504 . . . . 4.35 110.056 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.66 26.95 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 124.336 3.357 . . . . 2.09 112.717 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -106.1 -20.83 13.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.959 1.303 . . . . 3.19 110.76 165.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 87.9 t -117.6 -72.06 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 N-CA-C 108.246 -1.02 . . . . 2.74 108.246 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.47 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -88.12 140.62 15.5 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.079 0 N-CA-C 108.853 -0.795 . . . . 1.5 108.853 176.682 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -121.38 153.05 58.61 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.358 1.063 . . . . 2.77 108.421 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.46 -39.57 87.95 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.897 2.398 . . . . 1.21 112.739 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.23 -42.55 98.8 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.491 -0.755 . . . . 2.84 111.477 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -62.07 -39.99 94.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.027 0.531 . . . . 3.7 110.544 175.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.47 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -53.44 -51.04 45.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.359 -1.349 . . . . 1.09 107.359 171.102 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.37 -39.68 70.4 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 119.238 -0.411 . . . . 1.14 111.152 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -57.64 -47.82 81.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.101 0.864 . . . . 2.49 110.394 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -46.15 82.66 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.053 0.454 . . . . 2.76 110.44 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -67.9 -45.39 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.483 -0.761 . . . . 2.51 111.23 -175.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -33.38 72.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.852 -0.594 . . . . 2.35 110.877 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.96 -50.24 72.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.905 0.775 . . . . 2.18 110.225 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.81 -28.73 67.01 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 118.087 -1.445 . . . . 3.8 111.195 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.55 31.42 2.16 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.178 -0.769 . . . . 1.1 111.178 171.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -109.25 168.36 9.44 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.282 -0.636 . . . . 2.18 109.282 169.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -107.64 129.66 54.98 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.794 -0.817 . . . . 2.57 108.794 168.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.93 123.27 48.7 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.615 0.766 . . . . 0.79 109.074 166.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.81 162.48 31.9 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.891 1.277 . . . . 1.05 107.658 166.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 1.6 m -75.9 151.73 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 108.701 -0.851 . . . . 2.98 108.701 -171.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -51.15 62.1 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.844 -0.799 . . . . 4.37 108.844 171.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 179.64 -50.15 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.037 1.735 . . . . 5.49 111.223 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -32.45 -57.56 0.34 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.999 2.52 . . . . 7.63 116.725 169.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.425 ' CE2' HD23 ' A' ' 121' ' ' LEU 0.301 0.5 OUTLIER 66.61 -42.9 0.41 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.989 2.516 . . . . 4.0 114.289 -172.461 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.02 -53.38 0.03 OUTLIER 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.823 1.192 . . . . 3.49 113.536 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 43.2 54.15 5.46 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.309 0.957 . . . . 3.06 115.08 172.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.1 t -142.06 -56.45 0.46 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.898 1.349 . . . . 4.58 113.099 -173.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.411 ' HB3' HE21 ' A' ' 4' ' ' GLN . 8.5 t70 -161.02 135.87 7.47 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 106.979 -1.489 . . . . 4.41 106.979 -171.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.18 -37.96 2.0 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 120.036 1.289 . . . . 2.39 111.64 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.42 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -137.75 84.47 2.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.619 1.167 . . . . 3.01 109.082 -179.423 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -102.52 157.71 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 108.803 -0.814 . . . . 2.98 108.803 -175.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.49 157.1 44.39 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.555 -0.716 . . . . 3.63 111.287 175.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 mt -144.14 155.99 44.15 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.049 0.94 . . . . 2.33 109.845 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.623 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -98.11 122.74 41.62 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 106.659 -1.608 . . . . 1.69 106.659 177.064 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.3 pt -97.93 111.65 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-O 122.015 0.912 . . . . 2.04 109.321 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 m -103.72 145.06 30.63 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.496 1.118 . . . . 1.88 108.702 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.29 -33.84 5.87 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.292 0.948 . . . . 1.16 111.436 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.7 151.93 36.96 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.398 0.599 . . . . 2.76 110.948 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 t -163.39 33.83 0.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.597 0.359 . . . . 2.93 111.103 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.0 p -162.15 145.1 11.61 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.381 -0.824 . . . . 3.37 111.658 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.0 -34.92 70.52 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.573 1.149 . . . . 2.76 111.334 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 t -54.2 -50.06 67.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.642 0.377 . . . . 2.28 110.046 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 55.6 m -68.14 -45.96 72.13 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.961 -0.462 . . . . 1.78 110.125 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.407 ' CG1' HG23 ' A' ' 113' ' ' VAL . 89.4 t -48.75 -57.18 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.937 1.695 . . . . 1.35 109.921 172.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -59.0 -43.96 91.58 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.686 -0.634 . . . . 3.46 111.017 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -60.78 -42.88 98.41 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.347 0.659 . . . . 1.7 110.876 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.0 mt -57.28 -50.41 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 108.321 -0.992 . . . . 0.84 108.321 174.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -53.51 -43.67 68.48 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.029 -0.51 . . . . 2.67 110.425 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.4 t -57.96 -50.4 73.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.544 0.738 . . . . 1.4 111.305 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -37.35 78.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.25 -0.906 . . . . 2.5 110.933 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.4 mt -70.59 -51.34 28.91 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.837 -0.801 . . . . 1.82 108.837 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.6 p -60.05 -17.07 36.53 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.936 0.717 . . . . 1.9 112.936 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -59.82 -33.91 72.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 119.298 -0.961 . . . . 4.56 112.338 168.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.8 m -73.34 142.51 47.07 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.706 0.803 . . . . 1.77 111.162 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -66.0 -42.38 89.83 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.361 0.874 . . . . 3.08 113.361 -173.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.29 -39.29 27.03 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.127 -1.189 . . . . 1.07 110.127 -170.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.33 126.36 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.975 -0.75 . . . . 3.6 108.975 168.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.1 t -124.41 -26.3 3.93 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.676 0.791 . . . . 3.32 111.585 165.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.62 93.97 3.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.694 -1.965 . . . . 2.32 105.694 -172.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.98 151.45 21.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.219 -1.401 . . . . 1.31 107.219 158.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.7 t -142.23 110.83 6.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.213 -1.773 . . . . 1.65 106.213 167.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.407 HG23 ' CG1' ' A' ' 95' ' ' VAL . 6.4 m -104.89 147.64 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 118.048 0.385 . . . . 2.59 110.774 176.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.73 102.31 4.7 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.305 0.574 . . . . 1.65 110.395 -174.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 pp -61.94 -19.12 62.4 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.345 0.868 . . . . 2.55 113.345 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.14 -40.75 64.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.908 -0.775 . . . . 1.99 108.908 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.1 p -90.14 -25.35 20.74 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.004 0.921 . . . . 3.37 110.344 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 p 77.9 9.68 2.27 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 128.257 2.623 . . . . 2.33 112.894 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -99.71 151.18 21.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.163 0.982 . . . . 3.4 111.767 174.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -117.25 117.48 29.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.855 2.462 . . . . 0.96 107.0 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.425 HD23 ' CE2' ' A' ' 75' ' ' TYR . 5.5 mp -99.83 131.23 45.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.547 -1.279 . . . . 2.84 107.547 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 83.0 t -140.78 128.94 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.378 1.071 . . . . 2.04 109.682 -170.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -116.45 93.03 4.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.951 -0.759 . . . . 3.6 108.951 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -113.98 169.48 8.97 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.654 1.182 . . . . 1.99 109.777 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.561 ' HB3' HD11 ' A' ' 128' ' ' ILE . 35.6 t0 -105.28 115.6 61.83 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.289 1.036 . . . . 3.68 109.708 -179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.86 65.17 7.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.856 3.037 . . . . 1.89 112.83 -170.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -143.29 -51.14 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.671 1.588 . . . . 3.44 108.219 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 128' ' ' ILE . 0.0 OUTLIER -77.89 -34.48 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 122.96 0.504 . . . . 2.46 111.096 -177.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.5 tp -145.79 168.49 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.078 -0.712 . . . . 1.91 109.078 -174.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.96 169.86 31.33 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.181 -1.168 . . . . 1.41 110.181 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -61.22 -35.31 85.88 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.278 2.652 . . . . 1.54 110.801 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -51.93 -39.68 59.56 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 112.458 0.54 . . . . 6.99 112.458 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.05 -44.45 84.54 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.209 -0.663 . . . . 3.17 109.209 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.97 -55.95 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.24 -0.652 . . . . 1.47 109.24 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 pt -54.61 -57.1 7.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-O 118.003 -0.998 . . . . 3.1 109.334 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -47.77 -50.59 25.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.125 1.33 . . . . 4.12 112.839 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.4 mm -52.91 -54.7 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.423 -0.584 . . . . 1.94 109.423 175.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.287 2.6 pp -71.49 -25.0 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 119.077 -1.049 . . . . 1.47 113.538 -176.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -63.86 -32.06 73.45 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.327 1.051 . . . . 3.03 110.32 169.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -62.17 -39.24 92.02 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.214 -0.661 . . . . 2.98 109.214 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.2 mt -66.78 -42.01 88.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.409 -0.589 . . . . 1.4 109.409 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.91 22.61 5.6 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.874 1.702 . . . . 1.48 111.511 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -99.06 -178.71 4.02 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.52 -1.289 . . . . 2.24 107.52 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -140.6 135.65 31.98 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.157 -1.053 . . . . 3.18 108.157 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -122.87 96.67 5.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.236 1.014 . . . . 1.54 109.765 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.1 p -123.43 127.21 48.1 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.425 0.69 . . . . 2.42 110.918 -173.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.417 HD12 ' OE1' ' A' ' 149' ' ' GLN . 0.4 OUTLIER -14.92 113.13 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.109 2.564 . . . . 4.2 115.086 175.729 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.623 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -107.29 48.61 0.83 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.698 0.999 . . . . 5.03 113.698 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.417 ' OE1' HD12 ' A' ' 147' ' ' LEU . 7.0 pm0 . . . . . 0 C--O 1.254 1.319 0 CA-C-O 117.798 -1.096 . . . . 6.72 112.366 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 105.932 -1.877 . . . . 12.86 105.932 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.282 . . 98.66 -33.86 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 118.402 2.742 . . . . 5.75 118.402 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.448 ' CB ' ' HE3' ' A' ' 47' ' ' LYS . 72.6 Cg_endo -80.36 125.47 5.74 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 CA-C-N 122.751 2.018 . . . . 4.75 109.549 171.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -124.85 -176.97 3.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.754 0.821 . . . . 3.82 109.393 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -110.3 154.75 23.03 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.409 0.684 . . . . 3.84 110.58 165.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.9 t -125.78 130.18 50.93 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.142 0.977 . . . . 2.33 109.424 170.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.52 106.37 16.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 128.388 2.675 . . . . 3.27 110.027 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 -179.19 5.4 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.458 -0.776 . . . . 3.33 110.617 173.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.16 161.58 28.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.49 -1.3 . . . . 2.36 107.49 173.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mm -97.16 134.84 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.878 -1.897 . . . . 1.05 105.878 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -117.58 67.83 0.75 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.537 -1.283 . . . . 3.1 107.537 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.4 -69.4 0.06 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.152 -0.779 . . . . 1.38 111.152 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.08 93.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.521 2.328 . . . . 2.51 116.883 176.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.44 -22.7 21.6 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.387 1.075 . . . . 2.39 113.589 170.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 89.5 m 75.57 -62.9 0.43 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.938 1.695 . . . . 5.74 110.078 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.98 -75.29 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.495 2.318 . . . . 4.32 112.925 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.3 p -160.02 14.28 0.13 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.432 0.901 . . . . 2.22 113.432 169.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.92 -45.05 64.93 Favored 'General case' 0 N--CA 1.462 0.126 0 O-C-N 121.239 -0.913 . . . . 1.9 110.071 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -53.67 -47.13 61.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.418 -0.956 . . . . 1.62 108.418 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.02 -41.53 64.79 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.353 0.661 . . . . 1.95 112.073 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -67.41 -49.27 64.53 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.969 -0.382 . . . . 2.72 109.969 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.491 HG12 HD13 ' A' ' 65' ' ' LEU . 69.3 mt -48.96 -45.32 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.963 0.905 . . . . 1.43 110.586 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -44.62 -57.38 3.68 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.042 0.837 . . . . 4.7 111.194 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -61.6 -39.17 90.27 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.154 0.982 . . . . 4.92 110.208 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -62.65 -57.38 11.24 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.963 -0.755 . . . . 1.35 108.963 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.12 -31.42 72.61 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.036 -0.415 . . . . 3.35 111.009 -175.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.58 -35.01 3.68 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.445 0.566 . . . . 1.79 112.257 168.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -110.2 24.19 13.33 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.377 0.671 . . . . 3.89 112.135 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.34 -72.24 0.17 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.034 0.534 . . . . 3.55 109.596 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.38 -120.88 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.418 0.687 . . . . 1.21 109.998 -172.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.17 -11.23 63.67 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.782 0.719 . . . . 1.59 113.183 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -75.46 122.56 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.691 -0.888 . . . . 1.5 109.464 173.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.21 49.35 1.93 Allowed 'General case' 0 C--N 1.34 0.164 0 CA-C-O 120.786 0.327 . . . . 2.68 110.577 173.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.6 m -150.53 156.11 40.78 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.291 -1.003 . . . . 3.1 108.291 165.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.0 p -140.29 117.01 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 107.37 -1.345 . . . . 2.84 107.37 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -140.44 79.59 1.71 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 108.172 -1.047 . . . . 2.55 108.172 172.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.1 t -99.4 136.58 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.135 -0.939 . . . . 2.27 108.551 169.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.88 96.58 6.25 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.608 -1.256 . . . . 1.52 107.608 167.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.66 -21.04 24.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.906 0.882 . . . . 2.62 111.669 175.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -59.0 5.12 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.793 1.237 . . . . 3.02 109.547 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.22 20.3 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.99 0.916 . . . . 1.68 111.102 -172.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.71 63.96 1.86 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.154 -1.178 . . . . 1.34 110.154 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.77 137.36 41.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.253 -2.128 . . . . 2.56 105.253 169.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.85 104.51 11.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.784 1.302 . . . . 1.26 109.61 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -111.74 144.65 40.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.244 0.545 . . . . 4.03 109.719 167.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.08 178.78 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 124.444 1.097 . . . . 1.83 109.147 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.448 ' HE3' ' CB ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -124.74 94.92 4.33 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.033 0.933 . . . . 8.85 110.213 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.412 ' HB2' HD12 ' A' ' 53' ' ' ILE . 1.9 p90 -99.99 169.51 9.14 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.414 2.285 . . . . 2.88 113.476 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.93 97.43 41.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.849 1.66 . . . . 2.89 108.858 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -53.22 -21.31 16.72 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.663 3.576 . . . . 3.02 114.817 -171.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -77.98 -25.52 48.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.5 1.52 . . . . 4.51 111.285 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 p -121.34 -31.19 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 123.988 0.915 . . . . 3.42 112.522 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -128.11 135.32 63.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 123.601 0.76 . . . . 1.8 109.189 179.548 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -120.46 154.83 56.81 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.505 1.122 . . . . 3.16 111.84 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.23 -30.19 92.35 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.152 1.901 . . . . 1.8 111.607 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -42.25 94.15 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.797 0.726 . . . . 3.94 111.705 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -71.17 -41.08 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.686 0.794 . . . . 3.63 110.745 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.8 -42.34 42.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 108.255 -1.017 . . . . 1.54 108.255 170.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.23 86.59 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.519 -0.764 . . . . 1.51 111.172 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -59.93 -52.96 63.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.278 -0.889 . . . . 3.11 109.655 171.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -54.86 19.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.94 0.4 . . . . 2.66 110.846 -177.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.3 pp -62.05 -44.26 98.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.503 0.557 . . . . 4.13 112.503 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.64 -39.35 84.06 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.587 1.085 . . . . 2.19 110.226 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.37 -47.75 72.38 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.648 0.779 . . . . 2.58 109.636 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.491 HD13 HG12 ' A' ' 22' ' ' ILE . 11.7 mt -53.81 -33.07 54.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.184 0.594 . . . . 1.78 111.452 170.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.58 33.09 2.97 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.262 -1.135 . . . . 1.18 110.262 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -124.67 149.56 47.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.763 -1.569 . . . . 1.96 106.763 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.81 129.66 44.2 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.017 -1.475 . . . . 3.22 107.017 170.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.552 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -118.77 120.19 36.63 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.63 -1.619 . . . . 0.88 106.63 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.89 128.28 34.28 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.424 -1.262 . . . . 0.95 107.923 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.4 t -49.29 151.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.012 1.325 . . . . 3.01 108.832 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.31 -44.15 79.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.283 -0.266 . . . . 3.46 110.283 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.15 -65.04 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 105.227 -2.138 . . . . 4.13 105.227 175.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.57 ' HA ' HD21 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -60.68 -85.89 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.07 -1.423 . . . . 6.17 112.609 176.226 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.703 ' CE2' HD23 ' A' ' 121' ' ' LEU . 0.1 OUTLIER 155.29 -30.2 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 115.502 -2.189 . . . . 4.64 114.671 -153.533 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 75' ' ' TYR . . . 130.05 -58.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 122.237 2.289 . . . . 3.53 112.692 -170.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.65 89.14 0.15 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.277 -0.729 . . . . 3.68 111.277 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.0 t -138.48 -98.84 0.18 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 117.236 0.518 . . . . 4.98 111.937 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.35 152.1 21.48 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.832 -1.914 . . . . 5.41 105.832 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.31 -71.78 2.86 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 106.757 -2.537 . . . . 1.94 106.757 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -104.23 126.13 51.08 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.719 1.208 . . . . 4.01 109.366 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.71 149.72 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 C-N-CA 124.297 1.039 . . . . 2.49 108.253 175.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -125.37 146.51 49.56 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.35 1.06 . . . . 3.67 110.536 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.46 149.63 39.48 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.269 1.027 . . . . 2.4 108.744 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.32 132.2 42.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.404 -1.702 . . . . 2.03 106.404 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 pp -106.59 113.39 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 O-C-N 123.909 0.756 . . . . 1.75 110.727 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.5 m -104.43 139.33 39.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.177 0.991 . . . . 1.87 108.794 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.1 -27.8 11.3 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.995 1.283 . . . . 1.21 111.984 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 5.3 tmm? -63.8 131.65 48.48 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.845 0.858 . . . . 2.8 109.901 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 m -144.77 34.9 1.14 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.588 1.155 . . . . 2.55 109.331 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 43.3 t -165.82 129.61 2.2 Favored 'General case' 0 C--N 1.341 0.239 0 O-C-N 120.854 -1.154 . . . . 2.79 111.908 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.43 -35.89 63.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.542 0.737 . . . . 2.73 111.785 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 t -53.73 -46.94 70.99 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.134 0.492 . . . . 2.24 110.257 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 35.1 m -62.58 -46.24 89.23 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.112 -0.699 . . . . 2.09 109.112 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.5 t -52.79 -53.03 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.098 0.408 . . . . 1.34 110.783 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -56.85 -44.88 82.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.158 0.504 . . . . 3.12 110.746 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -60.74 -47.68 85.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.891 0.476 . . . . 1.97 110.639 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.3 mt -55.83 -52.64 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.746 -0.835 . . . . 1.04 108.746 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -56.24 -42.06 76.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.837 0.855 . . . . 3.18 110.134 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.2 t -57.94 -55.51 33.96 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.923 0.329 . . . . 1.74 110.815 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -50.82 64.7 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.666 -0.646 . . . . 2.58 110.999 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.8 mt -55.82 -58.0 9.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 119.22 -0.419 . . . . 1.96 110.051 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.8 m -53.67 -25.17 16.92 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.61 1.164 . . . . 2.22 111.549 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -62.39 -28.29 69.67 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.881 -0.512 . . . . 6.55 111.348 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.3 m -68.08 118.31 11.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.448 1.499 . . . . 2.26 111.225 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -33.05 -55.82 0.39 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.637 1.975 . . . . 2.92 114.033 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.55 -29.14 60.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 119.513 -0.604 . . . . 1.72 113.354 -171.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.1 127.94 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.522 -1.288 . . . . 3.19 107.522 -174.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 36.9 p -99.16 -51.4 3.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 118.303 0.501 . . . . 3.51 110.437 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -131.95 128.66 38.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.322 -0.992 . . . . 2.4 108.322 169.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.99 128.26 53.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.879 -1.156 . . . . 1.19 107.879 165.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.2 m -115.45 112.32 22.1 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 117.707 -1.14 . . . . 2.65 109.498 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 t -114.47 131.55 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 120.325 1.421 . . . . 2.32 112.651 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -125.67 106.44 9.73 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.489 1.115 . . . . 1.11 111.226 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -22.92 59.5 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 125.172 1.389 . . . . 2.32 113.266 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.73 80.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.149 0.5 . . . . 1.46 110.073 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.22 -34.82 10.19 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.243 1.417 . . . . 2.07 110.402 177.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.4 m 79.78 38.55 0.11 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.407 1.883 . . . . 1.77 110.875 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.9 144.05 46.64 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 123.539 0.736 . . . . 3.01 109.436 173.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.18 120.65 29.28 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.249 2.62 . . . . 1.1 107.679 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.703 HD23 ' CE2' ' A' ' 75' ' ' TYR . 9.8 mp -115.07 104.43 11.87 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.623 1.569 . . . . 2.41 110.254 -170.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.3 m -103.82 135.86 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.6 1.16 . . . . 2.36 111.114 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.71 104.52 11.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.858 -1.164 . . . . 4.73 107.858 174.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -123.25 176.47 6.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.667 1.587 . . . . 2.48 112.258 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -98.7 113.55 64.49 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 108.49 -0.93 . . . . 3.18 108.49 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.31 71.52 6.72 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.772 2.981 . . . . 2.0 111.346 -167.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -168.59 -48.43 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.318 1.047 . . . . 4.48 109.337 -173.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.6 pt -83.75 -33.05 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.819 0.847 . . . . 1.9 110.917 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.92 160.59 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.318 1.047 . . . . 1.6 109.144 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.87 169.63 23.81 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.623 1.106 . . . . 1.58 110.45 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.97 -40.44 11.93 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.233 2.622 . . . . 1.88 111.092 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -51.32 -37.21 46.51 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.359 0.664 . . . . 6.45 112.396 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.77 -45.37 78.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.619 -0.882 . . . . 4.27 108.619 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 64.2 mt -60.73 -46.65 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 108.644 -0.872 . . . . 1.33 108.644 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 77.2 mt -51.2 -58.46 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 118.363 -0.827 . . . . 2.22 108.972 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -48.53 -50.25 32.75 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.568 1.076 . . . . 4.53 110.606 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.5 mm -55.6 -50.02 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 109.85 -0.426 . . . . 1.8 109.85 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.283 2.5 pp -70.11 -28.52 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 119.197 -1.001 . . . . 1.74 113.615 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -63.71 -42.26 97.98 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.566 1.076 . . . . 2.29 109.896 170.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -60.0 -39.24 85.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.79 0.836 . . . . 3.36 109.16 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.2 mt -71.01 -39.0 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 O-C-N 122.259 -0.275 . . . . 1.07 110.941 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.03 29.48 8.0 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.499 1.523 . . . . 0.93 112.096 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -99.65 177.11 5.25 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.689 1.245 . . . . 2.29 109.443 165.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -130.78 120.14 23.32 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.045 -1.465 . . . . 4.45 107.045 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.06 113.31 26.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.502 1.521 . . . . 1.82 108.654 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.8 m -123.13 114.23 20.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.101 0.41 . . . . 2.04 111.028 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.6 mt -28.29 114.58 0.08 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 128.222 2.609 . . . . 4.06 111.923 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.86 23.9 5.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.442 0.697 . . . . 3.5 112.68 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.456 -1.259 . . . . 5.73 110.78 168.687 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 106.233 -1.766 . . . . 12.82 106.233 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.24 132.87 95.4 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-N 119.663 1.12 . . . . 4.61 108.128 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.91 77.91 3.16 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 CA-C-O 123.523 1.384 . . . . 4.58 113.197 -162.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -111.11 123.81 50.94 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 112.519 -2.128 . . . . 4.94 109.786 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.12 148.9 23.08 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.424 1.09 . . . . 3.91 108.356 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.1 t -135.89 134.77 39.12 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.784 -1.191 . . . . 2.84 107.784 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -103.65 98.01 7.95 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 124.244 0.965 . . . . 3.92 109.02 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 2.6 pt? -121.67 169.73 10.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.957 0.884 . . . . 2.15 111.364 172.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.02 142.67 49.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.24 -1.022 . . . . 2.05 108.24 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.41 HG12 ' HB2' ' A' ' 44' ' ' ALA . 26.4 mm -98.18 146.92 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.674 -1.232 . . . . 0.85 107.674 -178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -128.2 96.74 4.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.565 -1.643 . . . . 3.67 106.565 171.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.14 -70.98 0.09 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.952 -1.259 . . . . 1.75 109.952 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 ptm 29.03 70.47 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.48 2.312 . . . . 2.48 116.053 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.69 -14.32 2.17 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.764 1.626 . . . . 2.54 114.16 175.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t 71.66 -63.49 0.42 Allowed 'General case' 0 C--N 1.339 0.128 0 C-N-CA 126.372 1.869 . . . . 2.94 111.373 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -16.17 -73.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 128.177 2.591 . . . . 6.57 113.224 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -157.5 24.11 0.29 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.856 0.862 . . . . 3.82 110.654 159.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.0 m -71.01 -52.98 16.44 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.296 -0.877 . . . . 1.92 109.178 -170.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.7 t -50.24 -46.83 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.019 -0.734 . . . . 1.94 109.019 173.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 t -54.91 -51.9 64.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.46 0.704 . . . . 3.23 110.875 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -68.65 -40.53 80.19 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 121.331 -0.856 . . . . 2.78 110.386 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mt -55.93 -50.71 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.781 1.232 . . . . 1.49 109.548 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -52.22 -44.44 64.79 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.63 0.65 . . . . 4.19 111.27 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -69.22 -40.46 77.94 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.748 -1.22 . . . . 5.84 111.588 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -61.7 -53.75 51.84 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 122.116 -0.365 . . . . 1.34 110.043 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.54 -39.01 70.03 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.677 0.791 . . . . 3.04 110.361 175.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.17 -23.97 9.66 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.212 0.915 . . . . 1.72 112.902 173.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -106.12 21.13 17.86 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.108 0.963 . . . . 3.68 112.491 176.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.417 ' HG3' ' CD2' ' A' ' 61' ' ' PHE . 33.0 tt0 -70.34 -72.64 0.19 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.802 -0.814 . . . . 3.56 108.802 177.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.42 -105.08 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.839 1.256 . . . . 1.95 107.859 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.83 25.33 24.05 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.241 -1.31 . . . . 2.4 113.352 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.65 ' C ' HD12 ' A' ' 33' ' ' LEU . 8.5 p -96.0 120.74 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 119.373 1.587 . . . . 2.08 109.308 168.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 32' ' ' VAL . 3.5 mp -139.54 53.72 1.7 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 108.96 -0.756 . . . . 2.94 108.96 -178.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 t -161.64 156.51 23.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.869 -1.9 . . . . 2.89 105.869 165.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.29 110.05 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 106.7 -1.593 . . . . 2.71 106.7 175.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -128.98 76.87 1.75 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.822 -1.177 . . . . 3.45 107.822 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 t -97.84 127.09 50.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 109.541 -0.54 . . . . 2.41 109.541 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.84 88.24 3.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.93 -1.137 . . . . 2.18 107.93 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.5 tp -53.33 -22.98 8.14 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.029 1.332 . . . . 3.69 110.805 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -35.04 68.77 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.388 0.675 . . . . 5.73 111.285 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.49 -39.44 4.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.955 0.902 . . . . 2.6 110.926 -172.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.99 63.41 0.81 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 125.916 1.722 . . . . 1.82 110.47 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -142.35 136.68 29.89 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.127 -1.805 . . . . 4.01 106.127 172.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -117.43 95.02 4.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.434 1.084 . . . . 1.5 109.272 172.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -101.51 137.43 39.84 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.805 -1.554 . . . . 5.74 106.805 171.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.484 ' H ' HD13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -133.77 -178.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 107.316 -1.365 . . . . 2.84 107.316 177.491 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.58 106.2 6.88 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.753 -1.203 . . . . 5.92 107.753 176.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -117.41 176.23 5.25 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 124.762 1.289 . . . . 3.52 114.459 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -113.37 107.3 53.67 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.895 1.278 . . . . 3.87 111.348 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.48 -11.37 31.33 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.991 2.461 . . . . 3.37 112.929 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.37 -21.33 64.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 120.203 1.365 . . . . 3.57 111.228 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -128.59 -46.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.44 0.696 . . . . 3.85 110.403 -169.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.748 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -92.37 147.61 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 121.913 0.863 . . . . 2.69 109.43 174.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -128.04 150.07 72.7 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 125.69 1.596 . . . . 3.66 108.776 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -58.42 -29.8 89.49 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.261 2.641 . . . . 2.15 111.596 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -49.55 77.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.245 1.418 . . . . 2.55 109.718 172.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -68.11 -38.55 82.39 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.933 -0.479 . . . . 3.03 109.726 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.748 HD12 HD11 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -58.36 -46.25 89.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 107.486 -1.302 . . . . 1.71 107.486 172.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.48 -44.52 95.84 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 122.973 0.509 . . . . 1.35 110.397 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -60.1 -51.25 70.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.661 -0.649 . . . . 2.34 110.94 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.417 ' CD2' ' HG3' ' A' ' 29' ' ' GLU . 0.6 OUTLIER -55.11 -48.43 73.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.612 0.642 . . . . 3.69 112.176 -179.623 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.567 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.5 pp -67.07 -39.63 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 121.261 -0.9 . . . . 4.33 111.658 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.5 -34.9 79.35 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.518 0.599 . . . . 3.42 110.511 177.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.18 -52.02 65.48 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.459 -0.571 . . . . 2.83 109.459 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.6 mt -58.45 -29.95 66.55 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.828 0.307 . . . . 2.19 111.828 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.36 31.54 3.73 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 124.512 1.053 . . . . 1.43 111.336 167.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.59 161.48 19.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.63 1.572 . . . . 2.01 108.405 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -98.45 134.58 41.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.77 -1.567 . . . . 2.2 106.77 163.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.567 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -125.49 127.23 46.14 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.919 -1.882 . . . . 1.08 105.919 169.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.48 123.98 23.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.201 -1.037 . . . . 1.13 108.201 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.433 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.5 t -71.1 145.26 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.057 -1.09 . . . . 2.98 108.057 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.4 mtt -56.38 -48.39 76.96 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.04 -0.726 . . . . 4.62 109.04 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 158.38 -34.19 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.829 1 C-N-CA 133.542 4.737 . . . . 6.4 108.191 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -64.97 71.44 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.302 1.841 . . . . 8.5 111.247 174.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -73.72 -20.88 60.39 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.87 1.668 . . . . 4.31 114.056 -176.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 133.3 -150.83 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 128.854 2.862 . . . . 3.15 108.874 -172.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 150.56 94.58 0.12 Allowed Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 109.021 -1.632 . . . . 3.19 109.021 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.1 t -163.62 -25.63 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 115.963 1.838 . . . . 5.69 115.963 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -80.9 -136.95 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.55 1.068 . . . . 6.63 108.354 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.19 -21.24 68.0 Favored Glycine 0 N--CA 1.436 -1.341 0 O-C-N 120.179 -1.576 . . . . 2.6 109.597 152.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.33 104.63 17.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.594 -1.632 . . . . 2.84 106.594 -176.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.504 HD11 ' CE1' ' A' ' 124' ' ' PHE . 0.0 OUTLIER -130.94 157.72 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 106.94 -1.504 . . . . 3.28 106.94 172.346 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -123.06 160.7 25.81 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.947 -1.024 . . . . 3.91 110.176 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 pp -143.78 159.92 41.66 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.638 -1.164 . . . . 3.12 110.229 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.8 m -109.36 131.67 54.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.374 1.87 . . . . 2.27 107.943 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.53 98.08 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.733 1.613 . . . . 1.76 110.706 -170.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.3 m -95.53 112.52 24.23 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.877 -0.786 . . . . 1.92 108.877 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 135.3 -22.98 3.5 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.486 1.041 . . . . 1.31 111.921 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.1 ttp -70.74 133.59 46.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.021 -0.693 . . . . 2.72 111.719 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.2 m -151.53 39.44 0.65 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.844 0.858 . . . . 3.22 110.239 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.5 t -167.96 138.94 2.82 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.963 -1.086 . . . . 2.5 110.71 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.7 67.2 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.474 0.654 . . . . 2.67 111.856 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.9 m -53.47 -43.93 68.54 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.256 -0.902 . . . . 2.2 110.275 170.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.0 m -64.4 -42.24 96.21 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.888 0.475 . . . . 1.74 109.849 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.763 HG13 HG13 ' A' ' 113' ' ' VAL . 46.7 t -52.23 -55.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.721 0.808 . . . . 1.23 108.826 173.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.7 m170 -61.66 -36.6 81.29 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 109.737 -0.468 . . . . 3.77 109.737 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -59.01 -60.71 3.44 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.959 -0.756 . . . . 2.01 108.959 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.6 mt -49.59 -49.2 19.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 C-N-CA 124.472 1.109 . . . . 1.06 110.051 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -54.38 -52.93 60.13 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.222 1.009 . . . . 2.47 109.786 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.0 m -66.85 -25.16 66.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.431 0.692 . . . . 2.16 112.186 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -46.87 49.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 120.865 -1.147 . . . . 3.3 111.816 170.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.58 -45.8 64.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.272 0.942 . . . . 3.53 108.888 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.0 p -60.43 -12.45 9.52 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.702 0.63 . . . . 2.28 112.702 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -53.57 -34.29 57.8 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.634 -0.666 . . . . 4.01 111.349 167.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.4 p -78.44 164.88 24.39 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 118.936 0.789 . . . . 2.41 110.907 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -82.89 -44.87 14.9 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.887 0.875 . . . . 2.39 111.188 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.742 ' HA3' HD11 ' A' ' 128' ' ' ILE . . . -71.01 -36.58 64.47 Favored Glycine 0 C--N 1.335 0.523 0 O-C-N 122.236 -0.29 . . . . 1.61 112.606 -170.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -66.21 130.19 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.127 -0.694 . . . . 2.2 109.127 -174.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.0 t -109.81 -53.46 2.67 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.422 0.289 . . . . 3.36 111.466 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CD2' ' HG3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -131.41 124.88 31.21 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.694 -1.224 . . . . 3.13 107.694 175.069 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.39 161.82 15.27 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.525 -0.546 . . . . 0.91 109.525 153.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.4 m -139.27 110.24 6.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.696 -1.594 . . . . 1.72 106.696 168.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.763 HG13 HG13 ' A' ' 95' ' ' VAL . 3.3 p -108.68 132.74 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.446 1.099 . . . . 1.81 110.115 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.42 119.16 12.45 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.96 0.886 . . . . 1.32 111.545 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.641 ' H ' HD23 ' A' ' 115' ' ' LEU . 2.4 pt? -71.36 -31.05 66.87 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.322 1.449 . . . . 2.49 112.778 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.99 81.74 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.522 0.677 . . . . 1.61 109.947 -176.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.67 -36.65 65.37 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.352 -0.84 . . . . 1.9 109.363 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.3 t 85.23 14.78 0.17 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 126.473 1.909 . . . . 2.52 111.462 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.86 164.74 16.2 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.471 0.708 . . . . 4.64 111.029 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.74 143.57 47.22 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.04 1.336 . . . . 1.26 108.567 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -99.46 146.02 26.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.535 1.147 . . . . 1.96 108.122 165.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.4 t -134.93 136.67 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 126.349 1.859 . . . . 2.26 107.869 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HG3' ' CD2' ' A' ' 110' ' ' TYR . 19.7 mmmt -113.22 109.52 18.9 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.276 1.43 . . . . 3.88 108.81 166.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.504 ' CE1' HD11 ' A' ' 82' ' ' ILE . 0.9 OUTLIER -127.51 -176.1 3.65 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.654 1.115 . . . . 2.36 111.098 173.769 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -103.0 112.32 65.7 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 108.307 -0.998 . . . . 3.13 108.307 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.99 67.65 8.0 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.874 2.383 . . . . 2.44 111.962 -166.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -165.25 -43.93 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.227 1.411 . . . . 3.84 109.59 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.742 HD11 ' HA3' ' A' ' 107' ' ' GLY . 2.6 pp -79.68 -40.48 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 122.852 0.461 . . . . 2.45 110.303 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.672 ' HB ' HD12 ' A' ' 128' ' ' ILE . 1.7 tp -135.42 178.23 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.237 1.015 . . . . 2.38 109.398 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.84 -178.81 34.17 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.031 -2.027 . . . . 1.87 108.031 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.11 -40.19 34.96 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.12 1.88 . . . . 1.72 110.285 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 -50.94 -40.07 56.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.485 1.114 . . . . 5.52 113.511 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.75 -52.66 64.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.56 -0.533 . . . . 4.21 109.56 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.72 -44.79 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.336 -0.987 . . . . 1.69 108.336 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.2 mt -51.9 -61.32 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 123.711 0.804 . . . . 1.94 109.105 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.68 -46.31 67.2 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.269 0.94 . . . . 4.52 110.835 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.5 mm -57.13 -51.68 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 121.974 -0.454 . . . . 2.12 109.856 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.13 -27.2 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 120.701 -1.249 . . . . 1.35 112.925 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -59.68 -35.39 74.35 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.659 -0.65 . . . . 3.01 110.349 170.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.52 -35.56 79.79 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.472 -0.566 . . . . 3.36 109.472 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.4 mt -69.85 -45.63 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.681 -0.488 . . . . 1.2 109.681 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.19 31.33 2.26 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.612 1.577 . . . . 0.94 111.66 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -99.06 -179.52 4.28 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.92 0.86 . . . . 2.23 109.69 171.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -139.33 105.19 5.16 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 107.774 -1.195 . . . . 4.13 107.774 -175.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.88 98.96 9.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.913 1.285 . . . . 1.6 109.267 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 51.8 m -101.44 115.91 31.58 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.618 -1.253 . . . . 2.05 107.618 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.38 101.28 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.772 1.229 . . . . 4.68 109.469 170.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.65 -38.77 77.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.922 -0.581 . . . . 3.96 110.168 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 126.168 1.787 . . . . 7.83 112.804 -175.542 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mmt . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 117.019 -1.467 . . . . 9.62 107.702 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.03 102.84 9.95 Favored Pre-proline 0 N--CA 1.454 -0.225 0 CA-C-N 119.824 1.193 . . . . 3.87 107.9 -171.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -82.67 110.81 1.94 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.109 1.872 . . . . 2.88 110.105 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -99.37 172.35 7.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.448 -0.796 . . . . 3.03 109.419 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.64 161.59 18.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.708 -1.219 . . . . 4.78 107.708 169.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.31 132.72 26.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.492 -0.929 . . . . 2.55 108.492 162.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -109.08 93.72 4.66 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.137 1.375 . . . . 3.76 109.125 -171.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.441 HD22 ' H ' ' A' ' 8' ' ' LEU 0.279 0.0 OUTLIER -116.65 173.75 6.45 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.472 1.13 . . . . 3.01 111.22 177.705 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.38 156.89 42.41 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.804 -1.924 . . . . 1.6 105.804 174.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mm -97.87 134.26 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 106.454 -1.684 . . . . 1.14 106.454 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -106.5 117.53 34.29 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 105.768 -1.938 . . . . 4.3 105.768 158.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.5 -101.49 0.24 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.3 -1.12 . . . . 1.66 110.3 -175.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.3 mtt 60.14 89.04 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.886 1.674 . . . . 1.85 114.529 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -30.88 71.13 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.467 -0.771 . . . . 2.24 111.231 166.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.0 t 78.05 -58.35 0.46 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.141 1.376 . . . . 3.76 111.187 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -19.03 -68.46 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.91 2.484 . . . . 5.25 113.139 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.9 m -156.17 24.87 0.36 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.12 0.968 . . . . 2.66 110.509 162.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.1 m -70.99 -51.53 25.03 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.283 -0.886 . . . . 1.56 109.939 -169.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.4 t -47.68 -50.53 8.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 N-CA-C 109.1 -0.704 . . . . 2.13 109.1 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -49.99 -48.85 52.11 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.134 0.574 . . . . 2.3 112.54 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -39.13 74.85 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.464 -0.772 . . . . 3.01 111.212 178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.3 mt -59.89 -48.84 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.812 1.245 . . . . 1.54 109.063 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.24 -49.73 41.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.458 0.572 . . . . 3.77 110.896 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -63.77 -34.57 78.18 Favored 'General case' 0 N--CA 1.458 -0.029 0 O-C-N 121.596 -0.69 . . . . 5.44 111.056 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.97 -51.8 65.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.641 -0.503 . . . . 1.32 109.641 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.29 -37.54 75.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.975 0.352 . . . . 2.36 111.449 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.68 -23.96 3.02 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.701 -1.25 . . . . 2.87 112.078 173.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -126.08 34.86 4.78 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.231 -0.89 . . . . 3.97 112.941 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' CG ' HG13 ' A' ' 32' ' ' VAL . 6.3 pt-20 -69.46 -70.54 0.27 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.992 1.269 . . . . 4.65 111.96 169.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.29 -132.38 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.524 -0.917 . . . . 1.36 108.524 -164.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.83 15.85 29.65 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-O 118.139 -1.367 . . . . 1.64 113.112 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.465 HG13 ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -101.26 128.76 53.24 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 119.961 1.88 . . . . 1.69 107.241 163.265 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 53.46 1.98 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.904 -1.147 . . . . 3.05 107.904 172.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.1 t -156.25 143.85 19.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.307 -1.738 . . . . 1.87 106.307 174.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.6 132.19 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.452 -1.684 . . . . 2.21 106.452 174.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tt -139.05 83.68 1.97 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.785 -0.82 . . . . 2.2 108.785 172.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.32 139.57 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 107.909 -1.145 . . . . 2.08 107.909 171.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.14 99.67 7.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 106.938 -1.504 . . . . 1.43 106.938 165.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.02 -27.15 66.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.897 0.879 . . . . 2.62 110.679 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 36.6 mtt -63.28 -60.52 3.29 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.517 0.727 . . . . 3.25 110.353 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.24 -29.07 47.98 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.795 -0.639 . . . . 1.7 110.91 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.05 61.18 1.77 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.227 -1.149 . . . . 1.26 110.227 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -134.82 144.08 47.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.539 -1.652 . . . . 3.51 106.539 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.427 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -121.57 104.22 9.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.444 1.097 . . . . 1.11 108.265 165.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.61 137.93 50.89 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.77 0.714 . . . . 4.43 109.478 169.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.48 172.2 16.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 O-C-N 121.919 -0.488 . . . . 2.36 110.594 178.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.03 105.33 10.53 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.286 1.034 . . . . 4.44 111.012 173.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -106.15 171.48 7.32 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.077 1.751 . . . . 2.83 112.916 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.96 112.0 38.63 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.822 1.649 . . . . 3.61 107.764 174.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.4 36.38 0.62 Allowed 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.892 3.061 . . . . 2.46 114.286 -155.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -129.27 -15.64 4.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.03 0.932 . . . . 3.93 112.398 170.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.1 t -106.06 -35.21 3.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 C-N-CA 124.379 1.072 . . . . 2.88 109.43 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.574 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -132.83 150.69 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 105.351 -2.092 . . . . 1.83 105.351 179.176 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -135.7 155.25 78.27 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.881 1.272 . . . . 3.29 111.416 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.57 -34.07 88.74 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.024 2.483 . . . . 1.55 112.662 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.38 -56.54 19.91 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.211 0.529 . . . . 2.51 110.805 176.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.99 -31.7 69.52 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.77 -0.581 . . . . 4.75 110.964 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.574 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -54.66 -50.68 57.86 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 N-CA-C 107.269 -1.382 . . . . 1.29 107.269 168.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.4 76.15 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.462 -0.335 . . . . 1.25 110.19 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.32 -48.41 79.02 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 119.04 -0.505 . . . . 2.62 111.011 175.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.61 -52.23 62.87 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 109.246 -0.65 . . . . 2.51 109.246 176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.6 mm -62.84 -44.6 99.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 122.27 -0.269 . . . . 2.99 111.059 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.71 -47.7 79.38 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.204 1.001 . . . . 2.02 111.173 173.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.23 -48.83 80.07 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.241 0.473 . . . . 2.35 109.876 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.9 mt -58.27 -32.2 68.17 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.906 -0.588 . . . . 2.04 111.3 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.8 25.08 3.45 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 123.976 0.798 . . . . 1.21 111.604 164.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -119.03 158.21 26.27 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.767 -1.568 . . . . 3.04 106.767 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -97.03 128.15 43.7 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.059 -1.089 . . . . 2.42 108.059 167.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.38 115.18 27.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.344 -1.354 . . . . 1.31 107.344 169.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.43 142.92 39.5 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.559 -1.275 . . . . 1.15 107.559 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 t -59.49 153.4 4.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.19 0.596 . . . . 2.69 110.003 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 mtm -66.79 -7.39 21.02 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.77 0.656 . . . . 4.99 112.77 171.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 82.72 -22.73 0.23 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.837 2.455 . . . . 4.58 110.699 -171.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -41.23 -50.2 3.61 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 127.111 2.164 . . . . 8.91 111.646 164.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.4 t80 70.37 -35.25 0.32 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.876 1.67 . . . . 5.45 113.001 -176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 78.79 -46.52 0.4 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 127.719 2.408 . . . . 4.5 113.622 164.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 79' ' ' ASP . . . 99.37 72.77 1.05 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 108.165 -1.974 . . . . 2.72 108.165 -166.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.79 44.15 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.136 1.774 . . . . 6.19 111.285 159.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 77' ' ' GLY . 11.3 t0 47.65 114.31 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 130.947 3.699 . . . . 4.88 115.566 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.46 -43.96 1.74 Allowed Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 108.101 -2.0 . . . . 2.3 108.101 -167.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -98.69 59.03 1.23 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.605 1.202 . . . . 3.71 109.668 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.3 mm -92.0 139.74 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.185 -1.413 . . . . 2.74 107.185 -167.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -106.84 149.38 27.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.218 -1.03 . . . . 2.96 108.218 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.8 mt -144.24 152.44 40.83 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 122.899 0.479 . . . . 2.45 110.054 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.01 135.86 38.41 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.878 -1.527 . . . . 2.63 106.878 173.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.448 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -97.37 109.0 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 108.289 -1.004 . . . . 2.09 108.289 -179.195 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.4 m -96.44 134.16 39.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.283 -1.377 . . . . 1.88 107.283 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.25 -15.71 54.05 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.521 1.058 . . . . 1.79 113.002 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -76.56 124.05 27.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.192 1.496 . . . . 3.39 110.807 -174.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -129.58 9.83 5.56 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.75 0.82 . . . . 4.83 113.1 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 50.2 t -155.23 134.31 12.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.675 1.125 . . . . 3.85 111.546 -173.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.8 -38.95 61.89 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.537 0.735 . . . . 2.81 112.83 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -49.64 -39.25 35.4 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.295 -0.878 . . . . 2.47 111.842 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 74.1 m -61.91 -34.14 75.52 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.986 -0.446 . . . . 2.29 110.597 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.6 t -58.58 -50.78 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.18 -0.674 . . . . 2.17 109.18 174.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -60.63 -41.34 94.71 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.78 -0.822 . . . . 2.77 108.78 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -59.07 -52.34 66.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.0 0.92 . . . . 2.26 110.11 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.1 mt -56.26 -53.15 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.013 0.925 . . . . 0.98 109.867 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.14 -37.77 86.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.685 -0.487 . . . . 2.22 109.685 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -59.57 -53.57 56.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.039 -0.356 . . . . 1.46 110.039 171.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.32 -47.42 66.02 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.285 0.634 . . . . 3.65 111.372 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.3 -59.47 4.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.125 -0.694 . . . . 1.68 109.125 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.6 m -55.3 -19.75 9.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.863 1.265 . . . . 1.78 112.144 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -31.88 63.14 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.324 0.65 . . . . 5.48 111.131 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.1 m -70.47 151.08 45.52 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.991 2.117 . . . . 1.98 111.908 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -72.54 -49.08 35.16 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.814 0.446 . . . . 3.94 111.964 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.98 -34.77 71.18 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 122.193 -0.317 . . . . 1.72 112.56 -172.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.31 124.12 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 O-C-N 121.881 -0.776 . . . . 2.33 110.395 -170.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 59.7 m -99.65 -49.65 4.32 Favored 'General case' 0 CA--C 1.522 -0.114 0 O-C-N 122.978 0.174 . . . . 2.63 111.082 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -140.82 124.23 16.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.437 -0.579 . . . . 2.26 109.437 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -98.52 153.79 18.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.222 -1.029 . . . . 1.09 108.222 161.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.6 t -142.73 109.77 5.57 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.43 -1.322 . . . . 2.78 107.43 169.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.5 p -114.15 121.82 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.669 0.788 . . . . 2.24 111.188 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -122.72 105.13 9.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.05 0.94 . . . . 2.46 110.072 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.28 -22.94 65.31 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.08 0.771 . . . . 3.15 113.08 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.02 -54.51 7.05 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.886 -0.783 . . . . 3.12 108.886 -172.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.4 p -69.73 -25.28 63.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.08 0.952 . . . . 4.36 109.998 172.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.423 ' O ' HD12 ' A' ' 86' ' ' ILE . 17.2 m 74.02 19.03 3.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.426 1.891 . . . . 2.39 111.732 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -113.81 149.17 35.35 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.559 0.744 . . . . 3.46 110.531 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.01 115.87 16.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.723 2.009 . . . . 1.5 108.516 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 mt -100.62 130.54 46.69 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.465 -1.309 . . . . 2.68 107.465 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.3 t -131.04 121.19 48.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.65 -0.87 . . . . 2.33 108.65 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -100.62 93.77 5.76 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.754 1.221 . . . . 3.16 109.624 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -111.18 -179.51 3.75 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.444 0.698 . . . . 2.46 110.338 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -108.4 109.97 61.64 Favored Pre-proline 0 C--O 1.236 0.39 0 N-CA-C 107.502 -1.295 . . . . 3.94 107.502 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.27 63.42 8.72 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.29 2.66 . . . . 2.16 112.119 -167.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -147.17 -51.5 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.033 1.733 . . . . 4.05 108.343 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.15 -35.33 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 110.401 -0.222 . . . . 2.55 110.401 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.11 159.52 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 108.17 -1.048 . . . . 1.78 108.17 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.33 164.31 25.93 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.59 -1.404 . . . . 1.77 109.59 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -63.07 -44.18 16.53 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.047 2.498 . . . . 1.94 111.03 -172.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -51.06 -40.86 59.3 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 113.614 0.968 . . . . 6.75 113.614 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -63.08 -47.4 83.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.94 -0.763 . . . . 2.75 108.94 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.413 ' O ' HD13 ' A' ' 138' ' ' ILE . 97.5 mt -56.86 -50.18 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.878 -0.786 . . . . 1.18 108.878 177.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.7 mt -48.85 -60.67 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-O 118.399 -0.81 . . . . 2.18 109.004 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.62 -48.17 39.63 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.221 0.919 . . . . 3.26 110.716 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 9.9 mm -54.18 -48.76 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 118.31 -0.852 . . . . 1.8 110.849 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 134' ' ' ILE 0.332 0.0 OUTLIER -72.97 -31.74 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 120.436 1.471 . . . . 2.8 114.154 174.152 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.05 -36.56 70.66 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.113 1.324 . . . . 2.4 110.246 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -70.43 -24.36 62.89 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.1 0.96 . . . . 4.36 110.778 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 30.1 mt -75.36 -43.77 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.481 0.582 . . . . 1.37 109.455 166.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.93 31.94 2.36 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.793 1.663 . . . . 1.14 111.284 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -114.13 160.73 18.62 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.726 -1.212 . . . . 2.58 107.726 165.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -124.46 131.97 53.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.847 -1.168 . . . . 4.3 107.847 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.86 105.9 13.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.2 1.0 . . . . 1.36 109.533 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.0 m -134.21 117.78 16.88 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 117.616 -1.183 . . . . 2.24 111.156 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -5.23 98.93 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.5 2.72 . . . . 5.28 114.964 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.09 65.45 1.5 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.932 0.893 . . . . 5.63 111.872 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 C--O 1.25 1.101 0 C-N-CA 125.253 1.421 . . . . 7.25 107.729 168.182 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mtm . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 117.495 -1.241 . . . . 16.47 113.327 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.429 ' HA ' ' NE2' ' A' ' 4' ' ' GLN . . . -88.5 -27.1 0.34 Allowed Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 117.688 2.477 . . . . 6.03 117.688 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.52 112.18 3.13 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 122.672 1.99 . . . . 3.44 109.552 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.429 ' NE2' ' HA ' ' A' ' 2' ' ' ALA . 4.8 mm-40 -106.94 126.15 51.94 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.436 0.694 . . . . 3.85 110.545 -168.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -92.08 141.76 28.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.558 -0.534 . . . . 3.79 109.558 -176.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.3 p -119.57 154.94 33.14 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.866 -1.161 . . . . 2.76 107.866 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -115.9 105.57 12.82 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.71 -1.218 . . . . 3.32 107.71 173.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mt -114.32 170.59 8.19 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.173 0.987 . . . . 2.77 109.73 172.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.06 146.61 47.02 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.441 -1.689 . . . . 1.79 106.441 168.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 mm -98.04 142.9 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 107.307 -1.368 . . . . 0.92 107.307 172.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -117.2 126.73 53.25 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.217 -1.031 . . . . 3.38 108.217 165.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.28 -57.83 0.39 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.559 1.076 . . . . 1.94 111.089 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.1 mtt 24.91 73.09 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.119 2.167 . . . . 2.13 115.643 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -59.24 -57.54 12.59 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.729 0.64 . . . . 2.5 112.729 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.3 t -166.79 61.81 0.09 Allowed 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.722 0.692 . . . . 3.91 112.031 -171.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 38.52 50.31 1.53 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.59 1.556 . . . . 5.04 112.765 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.7 t -167.63 -45.6 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.812 0.845 . . . . 2.51 109.223 -168.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.8 t -65.42 -45.51 83.63 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.507 -0.746 . . . . 1.54 109.794 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.2 -22.68 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 121.337 -0.852 . . . . 1.91 112.031 170.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -39.49 94.73 Favored 'General case' 0 C--O 1.223 -0.301 0 O-C-N 120.848 -1.157 . . . . 1.81 110.537 167.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -36.16 71.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.081 -1.012 . . . . 3.78 111.089 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -49.15 -32.9 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.122 0.969 . . . . 1.96 111.787 172.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -55.17 -53.0 61.53 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.523 0.729 . . . . 5.11 110.653 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.93 -43.76 67.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.745 -0.661 . . . . 5.35 109.679 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -54.52 -52.56 61.61 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.698 -0.482 . . . . 3.2 109.698 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.531 HD21 HD11 ' A' ' 62' ' ' ILE . 24.9 mt -66.3 -41.06 90.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.901 -0.571 . . . . 2.47 112.111 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -22.84 16.44 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.552 1.069 . . . . 2.07 111.957 172.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -116.1 33.48 5.5 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.935 0.494 . . . . 3.11 112.269 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.438 ' OE1' HG12 ' A' ' 32' ' ' VAL . 5.4 tm-20 -75.58 -93.76 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.249 -1.389 . . . . 3.82 107.249 161.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.51 -101.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.249 1.019 . . . . 1.04 110.325 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.92 -23.27 67.39 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 119.248 0.931 . . . . 1.24 113.437 -176.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.438 HG12 ' OE1' ' A' ' 29' ' ' GLU . 9.4 p -74.82 130.26 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.009 1.404 . . . . 1.52 111.311 -175.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -141.89 54.22 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.828 1.299 . . . . 2.22 110.807 173.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.82 143.25 17.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.991 -1.485 . . . . 1.68 106.991 169.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.428 ' HA ' HG22 ' A' ' 46' ' ' ILE . 84.9 t -133.92 100.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 106.271 -1.752 . . . . 2.37 106.271 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -119.1 78.39 1.28 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.212 -1.033 . . . . 2.47 108.212 175.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.96 126.98 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 109.306 -0.627 . . . . 1.86 109.306 173.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.94 95.79 7.12 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.997 -1.482 . . . . 1.1 106.997 167.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.43 -22.82 63.86 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.362 0.265 . . . . 3.21 110.707 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 10.8 tpt -65.3 -46.85 78.72 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.389 1.075 . . . . 4.12 110.56 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.62 -30.34 13.33 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.288 1.035 . . . . 1.29 111.061 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.94 66.58 1.27 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 125.016 1.293 . . . . 1.01 111.003 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -142.05 132.69 25.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.244 -1.762 . . . . 3.08 106.244 172.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.24 103.4 12.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 124.368 1.043 . . . . 0.95 109.697 168.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -106.72 146.7 30.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.002 -1.11 . . . . 3.46 108.002 166.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.543 HD12 ' C ' ' A' ' 46' ' ' ILE . 1.9 pp -139.62 166.62 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 106.647 -1.612 . . . . 2.72 106.647 174.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 107.21 15.5 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.138 1.375 . . . . 4.48 108.456 171.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.526 ' CD2' HD11 ' A' ' 53' ' ' ILE . 26.1 p90 -104.52 -178.8 3.76 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.245 1.018 . . . . 2.2 112.578 171.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.18 104.06 35.44 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.215 1.406 . . . . 3.92 109.335 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.98 -5.07 16.13 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.678 2.252 . . . . 2.28 112.991 -172.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -75.98 -15.35 60.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.703 0.683 . . . . 3.69 111.72 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.5 p -125.68 -41.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 118.772 0.715 . . . . 2.91 109.518 -172.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.526 HD11 ' CD2' ' A' ' 48' ' ' TYR . 2.1 pp -113.3 -177.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 121.315 0.579 . . . . 2.48 111.477 170.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -139.45 155.92 71.77 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 104.575 -2.38 . . . . 3.11 104.575 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -59.5 -34.2 97.09 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.739 1.626 . . . . 1.73 110.493 -175.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.79 -43.73 77.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.74 -0.648 . . . . 3.92 111.549 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -65.7 -43.45 89.17 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.745 1.157 . . . . 2.69 110.818 -174.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.0 mt -51.79 -55.78 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.065 -1.457 . . . . 1.88 107.065 169.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.06 -43.59 78.08 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.782 -0.644 . . . . 1.8 111.121 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -54.46 -46.82 73.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.28 1.032 . . . . 2.64 110.021 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.54 -48.03 72.48 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.837 -0.431 . . . . 3.44 109.837 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.531 HD11 HD21 ' A' ' 26' ' ' LEU . 7.8 mm -60.29 -43.28 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 122.228 -0.295 . . . . 2.99 111.182 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -64.48 -44.89 89.58 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.007 -0.368 . . . . 2.26 110.007 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.13 -43.94 98.1 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.848 0.859 . . . . 4.67 109.961 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.93 -47.63 74.18 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 123.922 0.889 . . . . 3.1 108.878 173.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.61 34.12 1.12 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.919 0.771 . . . . 1.72 112.02 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -119.31 165.68 13.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.993 1.317 . . . . 2.33 109.199 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -99.95 139.02 36.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.318 -0.993 . . . . 2.18 108.318 162.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.9 122.89 38.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.736 -1.95 . . . . 0.95 105.736 165.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.02 142.88 46.51 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 108.457 -0.942 . . . . 0.98 108.457 174.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 71' ' ' VAL . 0.5 OUTLIER -67.62 136.03 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 124.127 0.971 . . . . 2.85 109.482 -177.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -55.02 28.44 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.911 0.884 . . . . 4.27 109.202 166.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -177.36 -54.89 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.632 1.973 . . . . 5.23 108.244 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.89 79.5 0.21 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.588 1.155 . . . . 7.58 111.02 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.428 ' CE2' ' ND2' ' A' ' 81' ' ' ASN . 46.3 p90 -63.07 -26.79 69.0 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.031 1.732 . . . . 3.97 111.827 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 132.8 84.76 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 128.764 2.825 . . . . 3.69 111.733 170.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -98.04 89.65 0.99 Allowed Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.537 -0.839 . . . . 3.29 111.023 -174.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.8 t -158.68 18.24 0.2 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 114.462 1.282 . . . . 5.26 114.462 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.89 68.96 0.52 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.205 0.526 . . . . 4.41 110.943 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.97 -52.4 4.4 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 107.936 -2.065 . . . . 2.03 107.936 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.428 ' ND2' ' CE2' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -92.26 79.95 5.03 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.569 -1.641 . . . . 3.49 106.569 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -121.83 148.71 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 118.514 0.597 . . . . 3.13 111.123 178.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -99.05 154.86 17.77 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.779 -0.823 . . . . 2.82 108.779 174.133 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 147' ' ' LEU . 1.3 mp -133.71 142.1 47.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.88 -1.155 . . . . 2.92 107.88 168.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.0 m -96.05 123.96 39.87 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.016 -1.476 . . . . 2.6 107.016 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.67 112.22 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 123.51 0.724 . . . . 1.62 110.111 -172.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.4 m -101.04 135.48 42.43 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.741 -0.837 . . . . 1.95 108.741 176.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.88 -30.31 8.17 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.775 1.179 . . . . 1.28 112.283 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 131.26 50.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.535 1.134 . . . . 2.82 111.009 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.7 m -148.69 46.23 1.02 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.093 0.957 . . . . 3.0 110.254 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.0 t -169.61 139.86 2.1 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 120.987 -1.07 . . . . 2.65 110.857 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.38 -44.77 68.9 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.873 0.469 . . . . 2.47 110.638 174.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.1 m -52.45 -39.54 61.2 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.758 0.823 . . . . 2.35 112.06 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.4 t -63.41 -55.42 24.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.129 -0.693 . . . . 3.1 109.129 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.503 HG13 HG13 ' A' ' 113' ' ' VAL . 6.7 t -46.81 -50.34 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.68 -0.691 . . . . 1.32 110.653 172.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -47.16 84.77 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.317 -0.623 . . . . 3.05 109.317 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.09 -45.92 91.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.789 -0.448 . . . . 3.58 109.789 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.5 mt -58.77 -49.72 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -56.37 -50.0 72.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.115 0.966 . . . . 2.44 108.539 177.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 66.9 m -60.42 -36.25 77.71 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.845 0.858 . . . . 2.13 112.419 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -66.76 -50.36 62.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.55 -0.719 . . . . 2.73 109.773 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.76 -42.32 70.58 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.023 -0.732 . . . . 2.64 109.023 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.6 p -55.8 -16.05 3.99 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.374 0.879 . . . . 2.34 113.374 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -27.47 69.2 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.104 0.866 . . . . 4.38 111.383 172.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.8 m -60.49 150.7 30.48 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.92 1.688 . . . . 1.49 110.385 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -73.65 -54.73 7.45 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.398 0.679 . . . . 2.26 112.114 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.17 -32.84 68.98 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 121.387 0.437 . . . . 1.68 112.688 -172.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.96 119.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.817 -0.813 . . . . 2.51 109.73 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.7 m -102.79 -49.16 3.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.727 0.411 . . . . 2.29 111.018 -174.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.409 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 36.2 p90 -142.04 117.42 10.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.575 -0.726 . . . . 2.51 109.46 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.85 155.19 17.17 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 118.865 -1.134 . . . . 1.44 110.721 161.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -140.81 114.46 8.86 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.464 -0.569 . . . . 2.6 109.464 160.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.503 HG13 HG13 ' A' ' 95' ' ' VAL . 2.7 p -109.66 140.65 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.727 0.694 . . . . 2.0 112.764 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.23 104.61 6.56 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-O 121.972 0.891 . . . . 1.47 111.857 -171.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.771 ' H ' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -65.9 -20.01 66.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.625 1.57 . . . . 2.97 114.061 -177.305 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.71 70.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.18 0.445 . . . . 1.46 110.757 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.22 -18.02 10.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.605 1.562 . . . . 1.84 111.164 -173.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.4 m 72.43 17.63 4.7 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 126.713 2.005 . . . . 1.45 112.426 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -101.11 135.74 42.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.862 1.265 . . . . 2.98 110.371 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 83' ' ' GLU . . . -114.09 110.9 20.74 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 126.049 1.74 . . . . 1.4 109.094 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.82 125.16 35.64 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 105.892 -1.892 . . . . 2.67 105.892 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.3 t -130.98 132.1 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.353 1.061 . . . . 2.31 109.463 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -119.71 88.12 2.87 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.466 0.706 . . . . 3.4 109.65 -174.293 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -108.64 -179.48 3.88 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.558 1.161 . . . . 2.19 111.76 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -107.36 112.78 62.51 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 124.25 1.02 . . . . 4.13 108.324 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.79 67.41 8.62 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.162 2.575 . . . . 2.4 111.115 -171.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -161.52 -46.75 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.03 1.332 . . . . 3.78 109.413 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.5 pt -84.24 -31.25 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 123.021 0.528 . . . . 1.91 110.722 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.88 161.7 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 124.446 1.099 . . . . 1.58 108.156 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.68 162.06 28.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.672 -1.371 . . . . 1.55 109.672 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -57.18 -36.45 99.11 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.655 2.903 . . . . 1.57 111.57 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -49.92 -37.18 30.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.467 0.707 . . . . 6.9 112.616 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.15 -44.66 71.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.2 0.524 . . . . 3.3 109.639 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.53 -45.87 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.27 -1.011 . . . . 1.09 108.27 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.4 mt -53.29 -60.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 118.027 -0.987 . . . . 2.03 108.685 175.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -46.26 -53.17 11.18 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 120.18 1.355 . . . . 3.92 111.012 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 90.0 mt -51.22 -53.12 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.428 0.558 . . . . 2.43 110.068 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.252 2.5 pp -71.08 -28.25 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 114.032 1.123 . . . . 1.65 114.032 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -61.63 -42.9 99.54 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.158 0.89 . . . . 3.11 109.063 170.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -39.81 87.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.891 0.877 . . . . 4.36 108.734 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.503 HG21 ' CE2' ' A' ' 143' ' ' PHE . 74.6 mt -71.22 -41.54 75.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 O-C-N 122.348 -0.22 . . . . 1.64 110.957 175.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.13 32.65 6.04 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.291 1.424 . . . . 1.54 111.899 -173.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.503 ' CE2' HG21 ' A' ' 141' ' ' ILE . 27.4 m-85 -101.5 -178.77 3.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.325 1.063 . . . . 2.38 109.507 165.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -135.89 114.43 11.79 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 105.798 -1.927 . . . . 5.7 105.798 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.07 108.4 19.89 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.05 1.74 . . . . 1.32 108.73 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 m -104.65 95.29 5.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.115 -1.439 . . . . 2.24 107.115 -174.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -62.15 84.68 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.865 1.666 . . . . 5.36 111.262 -177.338 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 47.31 52.94 11.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.722 0.809 . . . . 4.7 109.965 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 116.406 -1.759 . . . . 7.67 108.683 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ttt . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 118.188 -0.91 . . . . 13.41 109.269 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 161.02 -44.42 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 127.268 2.227 . . . . 4.68 114.896 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.6 122.87 9.31 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 121.74 1.657 . . . . 4.01 108.618 168.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -125.61 154.2 42.62 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.703 1.201 . . . . 3.04 109.335 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -93.61 152.03 19.28 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.315 0.646 . . . . 3.39 111.697 177.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 t -140.83 128.05 20.96 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.552 1.141 . . . . 2.17 110.282 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -105.63 101.16 10.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.434 1.893 . . . . 3.94 110.864 -176.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.638 HD22 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -124.99 173.38 8.71 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.223 0.92 . . . . 2.69 111.17 175.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.406 ' OE1' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -124.8 149.03 47.82 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.31 -0.869 . . . . 3.15 109.163 165.335 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -96.11 124.82 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.88 -1.526 . . . . 0.88 106.88 177.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -100.47 111.91 24.21 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.707 -1.96 . . . . 3.25 105.707 173.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.65 -78.0 0.16 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.178 0.894 . . . . 1.25 111.306 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.0 mtm 42.24 79.99 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.477 1.911 . . . . 2.73 114.205 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.7 m -53.14 -55.74 21.78 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.492 -0.755 . . . . 2.13 112.232 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t -164.09 56.55 0.16 Allowed 'General case' 0 C--N 1.344 0.343 0 C-N-CA 119.527 -0.869 . . . . 3.04 111.904 -174.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 40.23 44.99 1.68 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.464 1.506 . . . . 5.99 112.832 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.4 t -171.91 -43.03 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.413 0.685 . . . . 3.39 109.682 -166.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.96 -43.06 99.82 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.998 -1.064 . . . . 1.69 110.393 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -51.55 -39.69 23.57 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 O-C-N 122.053 -0.404 . . . . 1.92 110.203 170.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 t -60.58 -33.46 72.74 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.359 0.412 . . . . 2.42 110.737 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.19 -54.95 10.65 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.037 -1.039 . . . . 2.48 109.895 170.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mp -44.33 -56.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 122.893 0.477 . . . . 2.34 110.919 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.61 -35.42 72.42 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.184 -0.947 . . . . 4.59 112.594 -176.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -67.48 -34.58 77.45 Favored 'General case' 0 N--CA 1.458 -0.035 0 O-C-N 121.082 -1.012 . . . . 7.13 109.779 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -65.41 -48.06 74.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.929 -0.767 . . . . 1.78 108.929 173.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.32 -36.6 68.9 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.704 0.684 . . . . 3.45 112.144 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.85 -22.96 6.07 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.822 0.675 . . . . 1.7 112.822 174.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -110.45 21.1 17.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.103 0.961 . . . . 3.52 112.059 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -72.98 -64.82 0.89 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.229 0.612 . . . . 3.51 109.705 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.35 -123.9 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.439 1.096 . . . . 1.52 108.064 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.84 -0.23 54.37 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 119.039 0.836 . . . . 1.54 114.594 -173.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -82.11 102.79 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.055 1.427 . . . . 1.66 109.275 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -120.56 52.35 1.17 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 122.145 0.974 . . . . 2.41 110.688 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.1 m -159.81 143.86 14.6 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.494 -1.298 . . . . 2.91 107.494 172.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.88 116.69 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 105.663 -1.977 . . . . 2.47 105.663 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pp -139.02 90.39 2.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 119.591 -0.844 . . . . 4.66 111.381 166.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -99.5 163.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.426 -0.796 . . . . 2.67 109.951 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.58 101.73 6.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.568 -1.271 . . . . 1.33 107.568 167.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.75 -17.59 64.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.958 0.903 . . . . 3.32 111.325 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 49.4 mtm -68.58 -55.52 11.32 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.87 0.868 . . . . 4.37 109.941 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.71 -26.88 24.03 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.047 0.539 . . . . 1.46 111.494 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.88 65.86 1.67 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.313 -1.115 . . . . 1.12 110.313 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -141.01 140.9 34.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.909 -1.515 . . . . 3.11 106.909 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.638 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -116.74 110.19 18.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.677 1.191 . . . . 0.96 110.236 170.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.32 134.06 42.73 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.572 -1.64 . . . . 4.52 106.572 168.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.4 HD12 HD21 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -136.51 168.69 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.217 0.917 . . . . 1.77 111.117 167.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.67 109.85 19.26 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 123.911 0.885 . . . . 3.96 110.228 163.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.45 ' HB2' HD12 ' A' ' 53' ' ' ILE . 2.6 p90 -98.63 -176.75 3.46 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 127.96 2.504 . . . . 2.6 111.022 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -138.06 108.67 8.25 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.861 1.264 . . . . 3.81 109.443 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.59 8.47 1.23 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 124.497 3.465 . . . . 2.41 113.997 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -95.82 -13.92 23.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.276 1.398 . . . . 4.0 111.688 167.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.2 m -130.23 -42.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 118.929 0.786 . . . . 2.78 112.853 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.45 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -115.21 137.42 48.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 N-CA-C 107.21 -1.404 . . . . 1.81 107.21 177.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.5 mm100 -119.67 149.91 49.17 Favored Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 108.219 -1.03 . . . . 3.63 108.219 -175.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -61.04 -35.78 85.48 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.449 2.099 . . . . 1.53 111.308 -173.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -58.21 -45.42 87.65 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.839 -0.538 . . . . 3.52 111.439 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -58.48 -44.76 89.47 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.657 0.783 . . . . 3.62 110.008 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.28 -56.41 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.04 -1.837 . . . . 1.3 106.04 172.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.51 -44.81 95.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.916 -0.584 . . . . 1.15 111.142 -170.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -55.96 -44.27 78.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.747 0.819 . . . . 2.85 110.283 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.56 -42.99 95.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.399 -0.593 . . . . 3.19 109.399 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mm -60.18 -43.34 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.859 -0.526 . . . . 2.5 110.141 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -63.42 -42.41 98.72 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.549 0.739 . . . . 2.92 111.683 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.98 -50.66 72.88 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.582 0.628 . . . . 2.61 109.741 175.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.65 -34.65 67.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.515 0.726 . . . . 1.84 111.62 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.93 37.63 1.24 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.161 0.886 . . . . 1.34 111.093 166.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -133.15 169.46 16.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.773 1.629 . . . . 2.16 107.002 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -113.3 129.32 56.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.315 -0.624 . . . . 2.44 109.315 169.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.06 120.44 38.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.551 -1.648 . . . . 0.79 106.551 168.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.406 ' HB3' ' OE1' ' A' ' 9' ' ' GLN . . . -131.03 133.88 46.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.074 -1.454 . . . . 0.89 107.074 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.15 154.36 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.508 -0.923 . . . . 2.49 108.508 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -5.33 39.01 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.97 -1.014 . . . . 4.7 111.892 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 94.16 7.75 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 129.282 3.033 . . . . 4.3 111.302 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -76.15 0.46 Allowed 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 125.93 1.692 . . . . 7.15 107.946 168.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.11 -44.73 0.05 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.325 1.602 . . . . 5.57 115.325 -160.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.29 100.83 12.55 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.387 1.475 . . . . 4.95 113.9 -157.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.45 63.46 0.21 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.777 -0.929 . . . . 3.36 110.777 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.81 -67.29 0.27 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.943 -0.551 . . . . 4.7 112.076 -175.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -173.88 120.51 0.29 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.546 -1.279 . . . . 4.97 107.546 -168.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.99 -55.0 4.9 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 108.345 -1.902 . . . . 2.16 108.345 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -103.4 104.18 14.25 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.196 -1.409 . . . . 2.76 107.196 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.02 170.4 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.152 -1.425 . . . . 2.9 107.152 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.33 151.06 46.09 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.497 0.719 . . . . 2.69 111.948 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.2 mt -136.94 146.16 45.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.901 1.28 . . . . 2.01 107.674 -172.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.04 127.9 55.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.392 -1.336 . . . . 1.91 107.392 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.768 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -97.26 117.41 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.37 -1.715 . . . . 1.8 106.37 -171.662 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.2 p -98.72 141.91 30.93 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.013 -1.106 . . . . 2.51 108.013 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.52 -17.68 28.52 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 119.348 -0.695 . . . . 2.01 113.257 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -79.92 140.46 36.69 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.199 1.5 . . . . 2.28 111.023 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 t -155.37 85.91 1.07 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.216 -1.031 . . . . 4.5 108.216 176.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 77.8 m 59.86 -99.2 0.09 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.017 1.327 . . . . 6.49 111.386 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 43.37 -148.49 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.508 1.923 . . . . 5.41 110.7 -168.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.9 t -79.76 -6.31 57.01 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.346 -0.613 . . . . 3.6 109.346 159.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.4 t -59.76 -49.96 75.67 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.39 -0.818 . . . . 3.31 109.817 -167.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.7 p -46.48 -61.19 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.375 1.07 . . . . 2.64 111.447 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -65.04 -31.01 72.03 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.369 0.668 . . . . 3.86 110.579 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.576 HD21 HD13 ' A' ' 141' ' ' ILE . 3.5 t30 -69.08 -48.95 61.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.225 1.01 . . . . 1.68 110.333 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.5 mt -58.95 -47.9 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.216 -1.031 . . . . 0.99 108.216 175.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -50.69 -54.35 23.89 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.508 -0.553 . . . . 2.57 109.508 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.3 t -52.34 -48.06 65.7 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.471 0.708 . . . . 1.68 111.093 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -60.59 -39.05 86.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.216 -0.928 . . . . 2.52 111.201 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 25.5 mt -71.25 -61.65 1.69 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.196 -1.038 . . . . 1.69 108.196 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 74.0 p -59.31 -19.21 44.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.323 1.049 . . . . 1.72 112.736 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -57.15 -36.24 70.5 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 119.291 -0.385 . . . . 4.35 110.7 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 t -75.33 174.84 9.01 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.649 0.738 . . . . 3.02 111.597 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -85.27 -47.72 9.78 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.11 0.964 . . . . 2.28 111.428 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.72 -35.56 80.56 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-O 119.974 -0.348 . . . . 1.19 112.916 -170.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.67 119.08 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 117.552 0.676 . . . . 2.89 109.339 -172.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.8 m -95.72 -47.13 6.32 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 109.658 -0.497 . . . . 2.39 109.658 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -142.55 92.54 2.42 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 112.859 0.688 . . . . 3.47 112.859 -176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.42 145.13 24.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.665 -1.235 . . . . 0.89 107.665 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 m -141.76 109.31 5.64 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.572 -0.899 . . . . 2.37 108.572 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.3 p -99.91 124.73 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.918 1.287 . . . . 2.17 109.475 -177.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.32 88.27 2.91 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.309 1.443 . . . . 1.49 109.626 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 pp -66.18 -20.84 66.26 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 125.408 1.483 . . . . 2.25 113.295 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.57 97.56 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.382 0.537 . . . . 1.73 109.965 176.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -19.09 20.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.893 1.277 . . . . 1.82 110.41 175.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.5 m 65.83 37.18 5.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.167 1.387 . . . . 1.64 110.647 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.96 157.45 37.76 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.43 0.559 . . . . 3.05 109.499 171.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.42 131.58 26.43 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.128 0.971 . . . . 1.07 109.386 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.92 129.68 45.26 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.942 1.697 . . . . 2.23 107.166 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.15 124.45 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.263 1.425 . . . . 2.39 110.49 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.65 94.74 5.15 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 107.57 -1.27 . . . . 4.26 107.57 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -111.12 -177.71 3.28 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 124.239 0.962 . . . . 1.96 110.397 174.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.86 116.69 60.4 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 108.255 -1.017 . . . . 2.85 108.255 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -81.32 68.55 8.16 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.893 2.396 . . . . 1.96 111.135 -167.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -165.86 -44.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.748 1.219 . . . . 3.33 109.669 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.8 pt -79.72 -38.23 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 123.109 0.564 . . . . 1.81 111.136 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.54 158.28 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 123.576 0.75 . . . . 1.63 109.118 175.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -124.07 168.76 16.17 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.861 1.22 . . . . 1.7 110.452 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.0 -41.88 6.96 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.718 2.279 . . . . 1.61 110.383 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.48 -39.59 57.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.678 0.791 . . . . 6.62 112.487 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.95 -49.58 75.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.667 0.787 . . . . 3.95 109.332 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.21 -47.28 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.563 -0.903 . . . . 1.34 108.563 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 95.2 mt -52.52 -59.25 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.538 -0.912 . . . . 2.01 108.538 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -49.05 -48.86 43.66 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 119.159 0.891 . . . . 4.13 112.431 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 mm -51.59 -53.51 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.82 -0.437 . . . . 2.46 109.82 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.315 2.0 pp -70.75 -26.99 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 114.385 1.254 . . . . 1.5 114.385 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.36 -43.5 96.47 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 119.359 0.981 . . . . 2.65 109.078 169.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -63.97 -38.29 90.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.18 -0.674 . . . . 3.21 109.18 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.576 HD13 HD21 ' A' ' 97' ' ' ASN . 73.2 mt -64.44 -44.84 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 122.227 -0.296 . . . . 1.15 110.257 171.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.38 23.85 5.58 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.536 1.541 . . . . 1.25 112.629 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -100.59 178.78 4.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.268 1.534 . . . . 2.81 108.802 164.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -136.93 130.39 31.52 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.146 -1.798 . . . . 4.05 106.146 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.98 97.24 5.18 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.717 1.607 . . . . 1.36 108.073 -171.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.7 p -143.22 134.17 25.52 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.269 -0.641 . . . . 1.9 109.269 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -174.31 -94.35 0.0 OUTLIER 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.138 1.375 . . . . 7.69 109.12 170.791 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 37.47 36.38 0.08 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.445 1.898 . . . . 6.04 113.367 -169.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.224 -1.37 . . . . 6.32 110.912 -176.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 107.845 -1.169 . . . . 9.55 107.845 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.03 123.03 87.97 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.824 0.738 . . . . 4.42 109.376 -174.294 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.11 107.37 2.47 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.84 1.694 . . . . 2.79 111.025 -172.471 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -125.92 146.24 49.93 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.762 1.625 . . . . 2.82 106.733 176.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -104.37 154.48 19.78 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.704 0.802 . . . . 4.42 110.812 179.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 54.1 t -143.19 140.72 30.87 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.42 0.688 . . . . 2.18 110.939 170.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -109.57 92.3 3.99 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.076 2.15 . . . . 3.55 109.698 -173.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.521 HD12 ' HB3' ' A' ' 44' ' ' ALA 0.262 1.5 pp -119.07 164.58 15.3 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.068 0.937 . . . . 2.71 112.195 176.45 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.15 154.72 18.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.487 -1.301 . . . . 2.45 107.487 166.431 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.407 HG12 ' HB2' ' A' ' 44' ' ' ALA . 14.4 mm -97.78 145.45 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 106.628 -1.619 . . . . 0.84 106.628 160.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -123.77 123.13 39.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.039 -1.837 . . . . 3.37 106.039 158.105 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.04 -81.38 0.19 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 108.792 -1.723 . . . . 1.29 108.792 -172.01 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 28.43 73.15 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.064 2.146 . . . . 2.33 115.335 178.522 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -16.63 2.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.214 1.406 . . . . 2.32 113.781 174.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.8 t 78.25 -48.67 0.47 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.745 1.618 . . . . 3.95 112.433 173.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.25 -70.29 0.11 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.448 1.499 . . . . 4.86 111.776 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 p -159.96 15.13 0.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.13 0.572 . . . . 2.49 112.43 172.139 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.7 m -70.69 -48.3 55.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.573 -0.705 . . . . 2.3 109.385 -168.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.0 t -47.96 -51.69 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.365 -0.976 . . . . 2.07 108.365 172.025 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -59.22 -34.29 72.0 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.906 1.282 . . . . 1.83 113.675 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -45.52 58.77 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.233 -0.292 . . . . 3.01 110.321 172.195 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.6 mt -56.23 -47.34 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.895 0.878 . . . . 1.61 109.213 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -47.63 -53.45 14.76 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.391 0.676 . . . . 4.48 110.837 175.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.0 mtt85 -67.9 -30.21 69.5 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.629 0.771 . . . . 5.8 112.378 -175.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -69.07 -55.77 9.76 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.75 -0.833 . . . . 1.36 108.75 175.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -61.06 -36.07 78.63 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.067 0.547 . . . . 3.6 110.792 -176.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.78 -24.61 6.2 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.896 0.702 . . . . 3.33 112.896 171.563 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -119.55 30.22 7.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.748 0.819 . . . . 4.06 111.537 178.45 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -77.8 -89.27 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 105.686 -1.968 . . . . 3.3 105.686 163.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.54 -91.24 0.06 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.489 0.716 . . . . 1.12 111.044 177.263 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.27 -15.75 68.44 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.287 -0.729 . . . . 1.81 112.593 -171.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.45 109.71 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 CA-C-N 118.102 0.951 . . . . 2.17 109.168 177.301 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.3 mt -138.59 50.59 1.86 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.89 -0.782 . . . . 3.73 108.89 177.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 t -159.86 152.68 21.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.217 -1.771 . . . . 2.18 106.217 159.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.17 102.07 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.122 -1.807 . . . . 2.21 106.122 -178.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -127.24 74.2 1.49 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.419 -1.697 . . . . 2.91 106.419 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.13 123.66 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.427 -0.953 . . . . 2.26 108.427 174.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.75 92.65 6.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.692 -1.966 . . . . 1.41 105.692 169.109 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 tp -54.71 -30.04 54.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.24 1.416 . . . . 3.44 110.192 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 31.7 mtt -66.51 -54.32 25.24 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.418 0.687 . . . . 3.29 110.421 -178.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.11 -23.59 28.4 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.151 0.58 . . . . 1.43 111.484 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.54 63.78 2.28 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.059 1.314 . . . . 1.2 110.9 -176.142 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.0 pttm -140.98 140.58 34.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.751 -1.203 . . . . 3.16 107.751 170.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.521 ' HB3' HD12 ' A' ' 8' ' ' LEU . . . -116.72 104.44 11.36 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 124.435 1.084 . . . . 0.96 112.975 173.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -98.01 125.76 43.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.259 -1.385 . . . . 4.31 107.259 172.273 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.0 mt -126.06 163.29 28.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 107.027 -1.471 . . . . 2.7 107.027 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -123.98 105.75 9.84 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.435 -0.95 . . . . 4.16 108.435 165.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -117.54 159.8 22.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.397 1.479 . . . . 3.09 110.027 172.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -98.95 111.15 60.05 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.931 0.893 . . . . 3.74 110.297 -179.248 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.08 -3.84 7.92 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.076 3.184 . . . . 2.12 113.623 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -73.25 -44.99 58.43 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 120.07 1.305 . . . . 4.64 110.741 169.199 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -108.59 -30.22 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 122.175 -0.328 . . . . 2.77 111.427 -165.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.402 HD11 ' CG1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -127.51 131.96 69.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 108.655 -0.868 . . . . 1.77 108.655 177.34 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.02 150.7 39.05 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.605 1.562 . . . . 2.67 109.773 -177.488 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -51.94 -52.58 8.65 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.37 2.713 . . . . 1.36 112.247 179.351 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -60.4 -43.76 96.35 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.419 -0.8 . . . . 3.09 111.265 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -57.77 -37.62 73.99 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.944 0.498 . . . . 3.94 111.101 174.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.402 ' CG1' HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -55.31 -50.11 67.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 107.568 -1.271 . . . . 1.18 107.568 171.175 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.84 -43.87 77.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.988 -0.551 . . . . 1.42 110.203 -175.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -53.12 -46.84 68.94 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.305 0.502 . . . . 2.74 110.75 175.406 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -48.79 79.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.002 0.43 . . . . 2.52 110.371 177.423 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -64.53 -44.04 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 121.961 -0.462 . . . . 2.6 111.012 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -42.69 98.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.448 1.099 . . . . 2.47 110.247 176.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.77 -49.15 77.55 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.39 0.541 . . . . 2.6 109.974 177.016 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 mt -56.24 -37.03 69.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.399 0.279 . . . . 1.95 111.583 174.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.94 26.51 2.75 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.239 0.923 . . . . 1.35 112.242 167.146 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -118.5 167.72 11.33 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.35 1.46 . . . . 2.03 107.96 176.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -98.55 143.74 28.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.373 -0.973 . . . . 2.59 108.373 163.523 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.74 135.16 48.13 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.801 0.84 . . . . 1.14 108.79 162.544 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.63 138.72 30.91 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.912 0.885 . . . . 1.26 109.731 171.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 p -87.19 152.84 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 125.613 1.565 . . . . 2.71 109.499 178.245 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.7 mtt -51.26 -53.25 37.29 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 123.371 0.419 . . . . 3.66 111.605 178.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -166.77 70.96 0.11 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.512 -0.922 . . . . 4.98 108.512 -172.281 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -21.86 101.16 0.02 OUTLIER 'General case' 0 C--N 1.341 0.203 0 C-N-CA 126.663 1.985 . . . . 10.43 114.704 -162.09 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.476 ' CZ ' ' HA3' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -136.26 -67.58 0.51 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.611 -1.631 . . . . 6.58 107.559 -161.056 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 99.41 -85.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.494 2.317 . . . . 3.74 109.853 176.215 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.476 ' HA3' ' CZ ' ' A' ' 75' ' ' TYR . . . 107.6 69.2 0.68 Allowed Glycine 0 C--N 1.336 0.537 0 N-CA-C 115.885 1.114 . . . . 2.87 115.885 163.121 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.88 -73.58 0.16 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 118.953 -1.099 . . . . 4.25 113.616 -173.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -150.4 144.88 25.73 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 103.961 -2.607 . . . . 4.96 103.961 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.83 -32.37 1.47 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.441 1.018 . . . . 2.03 112.004 -178.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.504 ' C ' HD13 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -142.01 114.44 8.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.067 -1.457 . . . . 2.37 107.067 173.647 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.504 HD13 ' C ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER -128.01 160.85 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.405 -1.331 . . . . 2.88 107.405 176.825 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.413 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -113.8 153.83 28.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.23 -1.026 . . . . 3.97 108.23 169.51 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 mp -133.01 141.21 48.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.705 0.802 . . . . 2.46 109.027 163.314 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.4 m -94.74 125.97 39.75 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.356 -1.72 . . . . 2.61 106.356 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.8 mt -101.52 123.36 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.241 -0.651 . . . . 3.46 109.241 -174.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.5 m -96.5 124.65 40.56 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.819 -1.178 . . . . 1.77 107.819 172.022 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 117.22 -34.82 4.41 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.95 1.262 . . . . 1.34 112.161 175.378 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 55.7 ttp -50.44 120.52 4.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.998 0.899 . . . . 2.96 110.98 177.267 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.4 6.18 1.27 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.526 0.935 . . . . 3.32 113.526 -170.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.4 t -156.01 142.21 18.32 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.084 1.311 . . . . 2.74 111.243 -178.282 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.19 64.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.568 1.147 . . . . 3.13 112.271 -175.075 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.24 -49.5 66.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.124 0.97 . . . . 3.19 110.739 171.33 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 88.4 m -64.17 -46.56 83.48 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.011 -0.737 . . . . 1.87 109.011 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.519 HG13 HG13 ' A' ' 113' ' ' VAL . 91.2 t -47.67 -59.0 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.279 1.032 . . . . 1.55 109.778 175.038 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -57.68 -44.33 85.73 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 122.997 0.519 . . . . 4.5 111.285 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -62.69 -47.66 82.67 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.836 0.455 . . . . 1.85 110.627 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.437 HD11 ' CE2' ' A' ' 143' ' ' PHE . 81.2 mt -57.35 -48.75 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.744 -0.836 . . . . 1.14 108.744 177.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -59.74 -46.45 89.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.427 -0.582 . . . . 3.1 109.427 178.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.6 t -52.0 -46.64 64.99 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.577 0.626 . . . . 1.28 110.811 174.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -60.18 -50.65 72.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.747 -0.596 . . . . 3.41 110.89 177.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.7 mt -58.0 -56.81 17.15 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 118.378 0.536 . . . . 2.17 109.587 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 33.3 m -50.04 -19.15 0.66 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.144 1.778 . . . . 1.73 112.912 173.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -67.37 -16.46 64.26 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.058 0.845 . . . . 5.26 112.251 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.0 m -72.38 155.0 40.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.169 1.387 . . . . 1.75 110.838 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -74.47 -52.82 10.91 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.962 0.905 . . . . 2.65 111.7 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.36 -37.75 80.13 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.786 -0.525 . . . . 1.45 111.786 -172.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.51 136.94 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.706 -0.85 . . . . 1.76 108.706 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.8 m -137.22 -12.92 1.61 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.482 -0.761 . . . . 3.41 112.394 171.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.91 118.34 10.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.786 -2.301 . . . . 2.33 104.786 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.49 161.04 28.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.314 -1.365 . . . . 1.08 107.314 166.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.0 m -141.07 111.96 7.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 118.915 -0.564 . . . . 1.83 109.505 161.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.519 HG13 HG13 ' A' ' 95' ' ' VAL . 7.4 p -95.71 134.52 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.641 0.776 . . . . 1.84 110.542 171.416 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.65 108.47 5.67 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.53 1.157 . . . . 1.37 110.967 -171.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.71 -41.18 98.13 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.544 1.937 . . . . 4.33 112.081 -173.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.22 62.45 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.277 0.631 . . . . 2.31 111.094 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 -15.81 15.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.455 1.902 . . . . 2.44 110.199 -177.252 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.1 t 71.56 20.27 4.83 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.517 2.327 . . . . 1.84 112.145 168.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -131.55 172.82 11.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.271 0.558 . . . . 2.64 110.741 177.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . . . -129.06 134.35 48.07 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.739 1.216 . . . . 1.17 109.377 170.288 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.39 123.35 35.65 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 104.484 -2.413 . . . . 1.87 104.484 172.429 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.4 t -124.14 129.39 74.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.372 -1.344 . . . . 1.78 107.372 -176.038 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.12 88.15 2.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.7 -1.222 . . . . 3.47 107.7 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -113.04 164.71 13.13 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.055 0.942 . . . . 2.03 111.311 174.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -99.04 116.63 65.11 Favored Pre-proline 0 C--O 1.237 0.423 0 C-N-CA 123.932 0.893 . . . . 3.01 109.344 177.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -78.22 68.22 7.97 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.236 2.624 . . . . 2.11 111.546 -173.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.54 -47.34 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.245 1.018 . . . . 3.22 109.348 173.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -81.59 -30.88 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 122.922 0.489 . . . . 1.76 110.924 -177.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -135.25 163.39 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.91 -0.774 . . . . 1.8 108.91 176.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.49 163.54 28.18 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.488 -1.445 . . . . 1.99 109.488 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.45 -35.67 81.54 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.857 3.038 . . . . 2.38 112.565 -170.334 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -40.62 75.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.92 -0.488 . . . . 7.78 111.316 -175.258 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.92 -38.99 72.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 119.148 -1.021 . . . . 3.85 109.969 -177.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 83.4 mt -56.65 -48.68 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.674 -0.862 . . . . 1.67 108.674 173.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.9 mt -50.51 -60.33 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 118.111 -0.947 . . . . 2.82 108.671 173.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -51.47 -44.71 62.51 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.959 1.254 . . . . 4.52 112.469 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.4 mm -56.05 -54.39 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.449 -0.782 . . . . 2.38 109.491 176.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.256 2.5 pp -68.18 -25.53 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 120.861 -1.149 . . . . 1.78 113.392 -178.498 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.34 -39.52 87.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.954 0.797 . . . . 3.51 109.932 168.07 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.77 -40.59 97.76 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.994 -0.743 . . . . 3.81 108.994 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.8 mt -66.41 -43.09 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 110.02 -0.363 . . . . 1.08 110.02 173.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.01 33.42 4.96 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.647 1.594 . . . . 0.9 111.536 -175.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 98' ' ' ILE . 51.2 m-85 -103.81 177.3 4.88 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.403 1.102 . . . . 2.42 109.264 166.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -129.79 121.98 27.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.176 -1.787 . . . . 4.04 106.176 172.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.84 113.27 26.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.574 1.15 . . . . 1.46 108.691 179.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.1 m -110.66 98.61 7.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.758 1.623 . . . . 1.93 107.991 -173.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.59 98.71 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.186 1.794 . . . . 5.4 111.003 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 48.53 45.19 21.12 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.74 0.816 . . . . 4.98 111.289 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 . . . . . 0 C--O 1.248 1.006 0 N-CA-C 106.537 -1.653 . . . . 9.85 106.537 -175.587 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 mtm . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 107.081 -1.451 . . . . 10.73 107.081 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.52 71.04 25.85 Favored Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 124.349 1.031 . . . . 6.66 109.508 -178.108 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.35 149.37 75.26 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.449 1.432 . . . . 5.65 108.998 174.245 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -98.96 175.59 5.88 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.916 1.286 . . . . 4.83 107.544 176.339 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -96.79 142.66 28.53 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.697 0.681 . . . . 4.32 111.572 -172.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.0 t -141.1 126.53 18.74 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.077 0.551 . . . . 2.67 111.826 172.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -97.43 101.69 13.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.255 2.222 . . . . 3.72 108.187 175.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -119.34 167.35 11.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 122.344 1.069 . . . . 3.09 108.616 173.991 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.471 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -140.63 136.86 33.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.641 -0.874 . . . . 1.97 108.641 175.204 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.02 138.06 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 105.34 -2.096 . . . . 1.15 105.34 -178.743 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -106.95 125.17 50.65 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.201 -1.037 . . . . 3.58 108.201 170.524 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.23 -88.23 0.28 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.787 1.66 . . . . 1.5 109.494 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.4 mpt? 66.13 144.32 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.502 1.921 . . . . 2.68 112.416 -169.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -109.34 -19.08 13.41 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.495 1.118 . . . . 2.39 110.702 172.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.4 t 65.73 -65.23 0.18 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.183 1.793 . . . . 2.96 112.001 -170.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.36 -73.25 0.02 OUTLIER 'General case' 0 C--N 1.342 0.264 0 C-N-CA 128.083 2.553 . . . . 5.85 113.413 -175.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.63 13.07 0.09 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.006 0.743 . . . . 3.16 113.006 166.277 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.3 m -74.85 -41.57 59.59 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 120.169 -1.582 . . . . 2.25 110.768 -171.568 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.87 -31.86 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.878 -0.786 . . . . 2.01 108.878 176.203 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -61.06 -52.13 66.24 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.919 -0.488 . . . . 2.21 110.72 170.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -53.15 -45.76 68.55 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.877 -1.139 . . . . 2.96 110.833 175.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -43.88 -38.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.61 1.164 . . . . 1.62 111.613 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -52.24 -58.41 6.7 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.268 0.627 . . . . 4.84 111.469 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -67.11 -37.58 84.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.655 -0.498 . . . . 4.32 109.655 -176.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -55.68 -56.8 16.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.414 -0.587 . . . . 1.37 109.414 178.438 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 mp -61.18 -42.43 98.56 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.822 0.737 . . . . 2.41 110.969 177.49 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -22.25 18.84 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.781 0.719 . . . . 1.89 112.537 178.813 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -113.01 16.53 19.32 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.414 0.894 . . . . 3.15 113.414 175.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.41 -69.5 0.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.265 -1.013 . . . . 2.82 108.265 165.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.13 -134.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.163 1.385 . . . . 2.22 107.951 -176.193 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.11 35.69 1.28 Allowed Glycine 0 CA--C 1.538 1.499 0 CA-C-N 120.255 1.389 . . . . 2.6 114.847 -172.372 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.89 77.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 125.306 1.443 . . . . 2.77 109.454 175.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.47 51.55 0.77 Allowed 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 108.602 -0.888 . . . . 3.41 108.602 -172.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -163.79 126.02 2.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.607 -1.257 . . . . 1.83 107.607 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.1 t -128.48 114.52 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.998 -1.482 . . . . 2.81 106.998 176.255 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -123.68 79.57 1.71 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.612 -1.255 . . . . 3.65 107.612 174.095 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 t -97.76 128.26 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 109.054 -0.721 . . . . 2.46 109.054 173.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.31 86.81 3.99 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.333 -1.358 . . . . 2.21 107.333 176.091 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.8 mt -57.25 -5.38 0.29 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.958 1.096 . . . . 3.1 113.958 176.604 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 28.5 mtp -97.66 -42.51 7.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.268 1.427 . . . . 3.99 110.468 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.3 -38.12 12.25 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.644 0.778 . . . . 2.39 110.879 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.89 60.14 1.04 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 126.216 1.865 . . . . 1.82 111.649 173.447 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -138.19 137.47 37.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 105.412 -2.07 . . . . 3.58 105.412 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.5 92.94 4.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.185 0.928 . . . . 1.41 110.119 169.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.04 111.63 23.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.112 -2.551 . . . . 6.19 104.112 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 pt -117.38 174.94 3.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 O-C-N 120.325 -1.484 . . . . 2.51 108.414 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -131.12 108.61 9.87 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.924 -0.399 . . . . 5.51 109.924 170.285 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -117.32 164.78 14.32 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.618 1.567 . . . . 3.09 113.288 174.758 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -99.0 106.12 36.0 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.646 1.978 . . . . 3.88 109.978 177.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.05 9.66 0.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.354 2.703 . . . . 3.61 113.701 -171.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -97.85 -21.32 16.98 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.535 0.734 . . . . 5.1 111.038 173.249 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.9 t -111.01 -62.45 2.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 N-CA-C 108.34 -0.985 . . . . 3.86 108.34 -175.248 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.498 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -98.96 144.42 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 N-CA-C 109.115 -0.698 . . . . 2.58 109.115 176.541 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -113.49 151.78 44.77 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 125.008 1.323 . . . . 3.66 108.328 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.26 -39.38 85.21 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.716 2.277 . . . . 2.11 111.314 -175.136 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.574 HD22 ' C ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -72.01 -38.4 69.61 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.461 -0.774 . . . . 3.16 112.505 -178.431 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -57.3 -43.65 83.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.998 -0.741 . . . . 3.26 108.998 172.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.498 HD12 HD11 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -53.2 -47.56 55.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 108.51 -0.922 . . . . 1.44 108.51 168.808 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.49 -38.69 78.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 119.898 -0.721 . . . . 1.19 110.266 -171.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -52.65 -50.85 62.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.047 0.939 . . . . 2.83 109.971 177.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -48.15 70.54 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.501 -0.555 . . . . 2.41 109.501 177.583 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.5 mm -62.77 -39.85 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 122.164 -0.335 . . . . 2.43 111.08 -178.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -67.38 -42.92 82.59 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.813 -0.439 . . . . 1.84 109.813 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -60.58 -49.9 75.67 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.029 0.532 . . . . 2.32 109.878 176.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.61 -36.42 69.42 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.02 0.528 . . . . 2.07 111.032 175.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.24 41.67 0.95 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.127 -0.789 . . . . 1.34 111.127 165.447 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -132.59 162.88 30.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.277 1.031 . . . . 3.0 109.168 -174.74 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -93.17 124.11 36.91 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 106.914 -1.513 . . . . 2.69 106.914 171.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.38 124.63 43.16 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.853 -1.165 . . . . 1.3 107.853 167.628 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -137.66 113.46 9.71 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.789 -0.819 . . . . 1.12 108.789 172.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 4.5 t -72.83 158.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.836 0.855 . . . . 2.65 110.171 -178.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.4 mtt -77.53 -4.75 47.24 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.296 0.85 . . . . 4.22 113.296 174.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 81.67 18.56 0.4 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.594 1.957 . . . . 5.12 111.732 -177.057 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -83.13 -37.09 24.22 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.266 -0.896 . . . . 7.46 108.71 165.33 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.497 ' CE1' ' ND2' ' A' ' 81' ' ' ASN 0.336 14.9 p90 54.69 -63.69 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 129.958 3.303 . . . . 4.21 113.958 -179.489 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 148.99 82.56 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 129.023 2.929 . . . . 4.14 111.517 175.352 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.93 104.96 3.18 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 110.172 -1.171 . . . . 3.14 110.172 -175.008 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.71 -47.62 0.09 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.535 0.569 . . . . 4.2 112.535 -170.235 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -134.55 109.18 8.52 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.029 -1.471 . . . . 4.48 107.029 -165.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.81 -51.17 4.52 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 109.592 -1.403 . . . . 2.6 109.592 176.395 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.497 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 21.4 t-20 -115.21 122.92 47.51 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.682 -2.34 . . . . 2.89 104.682 175.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.71 158.9 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.553 -1.277 . . . . 3.42 107.553 168.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.7 157.32 39.36 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 123.333 0.653 . . . . 3.33 109.471 171.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 pp -147.31 161.6 40.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.585 -0.734 . . . . 2.55 110.333 172.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.9 126.3 44.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.15 -1.426 . . . . 2.05 107.15 173.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.65 127.08 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.57 -0.9 . . . . 1.81 108.57 176.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.6 m -118.02 112.08 19.79 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.034 -1.099 . . . . 1.9 108.034 176.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.96 -25.76 1.15 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.656 1.122 . . . . 1.56 111.386 -172.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.9 tpp -61.25 120.72 10.92 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 121.978 -0.719 . . . . 2.83 111.389 -174.566 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.7 t -130.49 4.92 4.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.29 0.636 . . . . 2.44 111.463 176.55 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.27 153.12 6.41 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 120.654 -1.278 . . . . 3.5 111.682 177.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.89 -32.62 66.06 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.319 0.647 . . . . 3.11 111.148 173.574 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.9 t -51.99 -43.95 63.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.949 0.5 . . . . 2.21 110.525 171.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.5 m -63.91 -53.51 49.22 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 108.41 -0.959 . . . . 1.89 108.41 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 82.1 t -43.39 -54.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.194 0.998 . . . . 1.38 110.71 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -59.05 -40.0 83.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.685 -0.234 . . . . 4.25 110.958 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -66.89 -46.34 75.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.874 -0.516 . . . . 1.62 110.579 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.6 mm -55.65 -50.46 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.616 -0.883 . . . . 1.62 108.616 176.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -59.75 -45.54 91.91 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 118.842 -0.599 . . . . 2.11 110.057 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.3 m -55.44 -39.87 70.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.826 0.739 . . . . 2.71 111.622 175.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.44 -39.27 81.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.016 -0.428 . . . . 2.98 111.193 175.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.92 -58.25 5.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.338 -0.986 . . . . 1.7 108.338 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.9 p -57.27 -15.39 5.96 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.597 1.159 . . . . 2.09 113.13 176.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -35.66 64.26 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.517 -0.739 . . . . 5.5 111.583 167.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.8 m -66.85 144.77 56.08 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.632 1.573 . . . . 1.77 111.1 -175.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -68.17 -47.3 68.35 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.011 0.925 . . . . 2.69 111.432 177.114 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.27 -21.75 74.92 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.62 -0.544 . . . . 1.89 113.139 -168.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.2 156.77 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.596 -0.89 . . . . 2.29 108.596 177.803 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.9 m -140.0 -39.8 0.45 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.39 -0.819 . . . . 3.4 112.348 168.042 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.39 95.02 4.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.94 -1.504 . . . . 2.59 106.94 -168.476 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -96.51 155.32 16.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.984 -1.117 . . . . 0.99 107.984 168.047 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.3 m -140.22 111.27 7.01 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.005 -0.434 . . . . 1.85 110.276 159.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.19 133.38 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.749 1.219 . . . . 2.01 110.657 -178.312 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.92 104.92 5.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.594 1.158 . . . . 1.44 110.803 -171.009 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 pp -70.53 -21.6 62.71 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 124.204 1.002 . . . . 2.75 112.649 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.41 91.39 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.398 -0.593 . . . . 1.94 109.398 -179.051 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.07 -34.48 16.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.941 0.897 . . . . 2.34 110.049 170.795 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.96 45.51 0.15 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.312 -0.996 . . . . 2.36 108.312 -168.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.06 167.72 20.43 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.852 -0.613 . . . . 4.07 111.592 165.411 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.5 141.83 46.85 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.624 1.169 . . . . 1.13 108.695 171.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.448 HD12 ' CE2' ' A' ' 75' ' ' TYR . 2.2 mm? -98.53 137.92 36.49 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.127 -1.805 . . . . 2.02 106.127 168.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.16 129.89 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.484 -0.932 . . . . 2.95 108.484 -179.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.83 105.57 13.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.079 -1.082 . . . . 3.43 108.079 -176.267 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -137.04 168.75 18.99 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.172 0.92 . . . . 2.48 111.714 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -97.29 115.79 65.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.681 -0.488 . . . . 3.79 109.681 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.36 55.06 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.343 2.696 . . . . 2.49 112.552 -166.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -143.76 -51.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.489 1.516 . . . . 3.16 108.012 172.51 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pt -77.38 -31.75 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 122.438 -0.163 . . . . 2.51 110.987 -176.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.88 163.54 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.985 -0.746 . . . . 2.1 108.985 -178.03 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.75 164.73 31.82 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.256 -1.137 . . . . 2.05 110.256 -176.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -61.55 -38.5 62.07 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.575 2.85 . . . . 2.04 111.817 -168.182 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -31.83 62.95 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 113.086 0.772 . . . . 7.14 113.086 -176.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.87 -40.63 65.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 118.498 -1.281 . . . . 3.31 110.231 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.3 -48.14 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.543 -0.91 . . . . 1.46 108.543 171.656 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.18 -60.99 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 108.799 -0.815 . . . . 2.26 108.799 174.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.98 -50.23 19.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.14 0.882 . . . . 4.36 113.147 178.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.8 -53.57 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 121.933 -0.479 . . . . 2.13 109.858 177.132 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.268 2.5 pp -68.16 -29.24 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.287 -0.883 . . . . 1.54 113.278 -177.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.71 -41.98 78.35 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.158 0.89 . . . . 4.0 109.54 169.287 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -61.45 -40.26 93.85 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.41 0.684 . . . . 3.76 109.295 -179.358 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.9 mt -68.91 -38.95 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 122.865 0.466 . . . . 1.08 110.153 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.16 33.49 6.55 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.975 1.274 . . . . 1.07 110.771 -171.633 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -99.48 175.03 5.98 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 107.914 -1.143 . . . . 3.37 107.914 167.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -135.25 121.7 20.53 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.01 -1.478 . . . . 3.89 107.01 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.03 100.89 10.18 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.613 1.165 . . . . 1.5 109.56 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.6 m -99.13 104.12 16.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.394 -0.965 . . . . 1.96 108.394 174.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 mt -48.03 107.74 0.14 Allowed 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 125.323 1.449 . . . . 6.18 108.346 171.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -84.4 -31.23 24.79 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.606 -0.887 . . . . 4.47 108.606 175.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 127.563 2.345 . . . . 8.84 112.678 165.462 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 117.63 -1.176 . . . . 9.49 107.829 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.23 99.56 40.23 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 124.162 0.985 . . . . 5.06 109.07 -171.315 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.64 143.83 30.88 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.571 2.847 . . . . 3.73 110.232 -175.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -133.68 154.44 50.93 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.75 0.42 . . . . 3.54 110.734 -171.244 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -123.84 147.09 47.91 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 124.604 1.161 . . . . 4.82 110.292 -179.037 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.17 137.15 51.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.693 -1.225 . . . . 2.44 107.693 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -121.64 96.08 4.93 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.786 -1.19 . . . . 4.28 107.786 -172.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.2 177.4 4.74 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.711 0.767 . . . . 3.06 111.095 -176.443 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.18 149.42 49.98 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.693 1.597 . . . . 1.57 107.19 166.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mm -103.11 126.35 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 106.859 -1.534 . . . . 1.1 106.859 175.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -107.24 138.11 44.04 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.158 -1.053 . . . . 3.05 108.158 160.328 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 144.84 -88.32 0.17 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.342 1.449 . . . . 1.07 109.685 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt 55.86 73.89 0.41 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.263 1.425 . . . . 1.68 113.554 171.125 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m -50.12 -59.95 3.42 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.072 0.768 . . . . 2.31 113.072 -178.548 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 t -170.01 63.08 0.05 OUTLIER 'General case' 0 C--N 1.343 0.323 0 CA-C-N 118.522 0.601 . . . . 3.53 110.119 -175.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 41.89 47.97 3.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.887 1.275 . . . . 4.92 112.898 176.291 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.01 -40.1 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.451 0.7 . . . . 2.31 110.905 -174.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -67.63 -42.59 82.05 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.029 -1.044 . . . . 1.78 109.733 -177.523 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.38 -32.59 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 O-C-N 121.219 -0.925 . . . . 1.7 109.955 170.368 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -62.69 -25.8 68.34 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.597 -1.314 . . . . 1.73 112.133 173.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.95 -36.85 70.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.2 -0.937 . . . . 2.78 110.42 173.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.407 HG12 HD13 ' A' ' 65' ' ' LEU . 19.9 mt -49.51 -42.76 17.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-O 118.91 -0.567 . . . . 2.42 110.496 174.616 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -46.2 -58.41 3.68 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.377 0.535 . . . . 5.88 111.519 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -66.83 -39.93 87.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.981 0.512 . . . . 4.47 110.053 -173.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -58.42 -58.24 9.41 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.777 -0.647 . . . . 1.19 109.289 178.215 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.77 -39.67 92.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 119.176 -0.44 . . . . 2.57 111.058 -177.288 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.67 -34.71 3.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.67 0.788 . . . . 2.13 111.604 172.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -121.7 29.58 7.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.296 0.639 . . . . 3.22 111.914 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -72.87 -69.1 0.43 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.888 -0.782 . . . . 3.8 108.888 170.199 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.78 -143.37 0.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.014 0.926 . . . . 1.02 108.805 -167.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.9 -15.07 40.7 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 119.144 0.884 . . . . 1.55 114.039 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.3 79.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.567 1.147 . . . . 1.52 112.351 -177.302 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.86 52.52 1.68 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.225 1.012 . . . . 2.58 109.34 -178.344 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 m -160.48 145.05 14.3 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.305 -0.872 . . . . 2.78 109.099 172.422 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.9 t -140.87 112.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.046 -2.205 . . . . 2.79 105.046 171.393 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -131.57 79.83 1.9 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.496 0.665 . . . . 3.19 110.065 175.56 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 p -98.98 150.75 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 115.81 -0.632 . . . . 2.29 109.624 173.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.17 113.34 15.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.784 -1.191 . . . . 1.48 107.784 163.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 tp -62.67 -32.78 73.91 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.554 1.542 . . . . 3.28 109.869 176.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 28.7 mtt -57.62 -55.63 32.37 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.383 0.611 . . . . 3.1 110.192 -177.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.28 -21.6 25.67 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.268 -0.878 . . . . 1.94 110.928 -177.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.39 53.28 6.84 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 110.27 -1.132 . . . . 1.37 110.27 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -128.17 130.65 48.37 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.126 -1.435 . . . . 3.99 107.126 178.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.55 107.6 18.52 Favored 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 125.259 1.424 . . . . 1.17 109.194 167.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -99.29 131.87 45.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.751 -1.574 . . . . 4.6 106.751 166.259 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.73 163.91 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 119.104 0.865 . . . . 2.27 111.338 161.766 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.38 106.83 15.43 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.274 2.23 . . . . 8.21 107.562 175.803 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.404 ' HB2' HD12 ' A' ' 53' ' ' ILE . 19.3 p90 -106.76 -179.48 3.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.338 1.055 . . . . 3.01 113.14 171.558 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.66 118.88 14.75 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.238 1.415 . . . . 3.25 108.033 175.698 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.65 -16.43 38.03 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.9 3.067 . . . . 2.88 113.069 -165.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -72.44 -11.82 60.84 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.981 0.363 . . . . 3.56 111.981 -177.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.08 -46.93 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 123.438 0.695 . . . . 2.88 111.227 -170.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.55 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -114.12 152.47 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.141 0.576 . . . . 1.66 109.99 174.38 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -127.08 156.96 73.6 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 125.316 1.446 . . . . 2.59 109.696 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.19 -9.7 27.01 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.368 2.045 . . . . 1.54 112.276 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mp -73.54 -61.88 1.68 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.59 0.756 . . . . 2.56 110.159 172.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -32.41 73.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.481 -0.327 . . . . 5.05 111.195 -174.2 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.55 HD12 HD11 ' A' ' 53' ' ' ILE . 1.5 tt -58.79 -51.04 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.66 -1.607 . . . . 1.62 106.66 173.274 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.85 98.1 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.267 -0.424 . . . . 1.21 110.225 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -55.53 -46.41 77.08 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.433 -0.581 . . . . 2.42 109.433 174.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.24 -49.81 74.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.128 -0.693 . . . . 2.49 109.128 -177.67 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 69' ' ' ALA . 5.6 mm -55.57 -47.19 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 121.926 -0.484 . . . . 2.78 111.505 178.36 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.47 -47.56 81.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.989 0.516 . . . . 2.47 111.331 176.176 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.67 -49.82 71.67 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.42 0.688 . . . . 2.38 110.391 -178.117 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.407 HD13 HG12 ' A' ' 22' ' ' ILE . 4.3 mt -50.34 -43.24 53.99 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.761 1.224 . . . . 2.26 110.528 173.405 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.18 40.36 0.34 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 111.123 -0.791 . . . . 1.44 111.123 162.317 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -137.81 160.86 38.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.058 -0.719 . . . . 2.85 109.058 -175.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -98.52 117.39 32.83 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.595 -1.261 . . . . 2.77 107.595 170.53 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.516 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -96.57 111.45 23.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.409 -1.7 . . . . 1.03 106.409 164.05 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.02 154.59 46.49 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 106.708 -1.59 . . . . 0.95 106.708 169.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -67.02 148.59 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 115.446 -0.797 . . . . 3.86 109.202 -172.67 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.4 ptm -62.06 -39.41 92.3 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.016 -0.673 . . . . 3.79 111.066 177.561 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 176.86 -41.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 129.246 3.019 . . . . 6.4 108.351 168.529 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -81.53 -47.2 13.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.659 1.183 . . . . 7.15 113.299 -168.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.409 ' HB3' HG21 ' A' ' 71' ' ' VAL . 1.7 p90 53.55 10.4 0.22 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.756 2.423 . . . . 5.86 114.451 -168.6 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.453 ' HB1' ' HA ' ' A' ' 82' ' ' ILE . . . -73.29 157.54 36.85 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 120.595 -1.316 . . . . 4.98 113.942 -154.086 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.21 16.79 80.24 Favored Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 113.14 -1.845 . . . . 4.33 110.34 177.131 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 t -57.67 -34.74 69.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.745 1.218 . . . . 8.39 109.083 177.017 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 p30 167.66 80.75 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.286 0.847 . . . . 10.14 113.286 -170.708 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 124' ' ' PHE . . . 76.52 -10.51 16.92 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.688 -0.965 . . . . 2.88 110.688 -167.688 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -108.0 76.95 1.08 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.925 -1.139 . . . . 3.26 107.925 -140.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.453 ' HA ' ' HB1' ' A' ' 76' ' ' ALA . 8.8 pt -105.92 158.54 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.689 -0.486 . . . . 3.7 109.689 177.608 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -106.76 144.09 33.92 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 124.026 0.829 . . . . 4.49 109.989 169.124 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 mt -131.57 145.46 51.73 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.843 0.857 . . . . 2.41 109.126 175.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.52 124.2 44.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.147 0.979 . . . . 2.93 108.66 179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.34 110.97 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 O-C-N 123.57 0.544 . . . . 2.06 110.124 -176.582 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.9 p -96.53 164.97 12.38 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.539 -0.912 . . . . 2.74 108.539 177.244 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.5 -33.89 3.17 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 121.914 -0.491 . . . . 1.98 112.262 -178.222 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.69 142.17 50.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 117.991 0.896 . . . . 3.26 111.414 178.618 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 m -155.26 46.74 0.51 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.783 0.833 . . . . 3.3 108.782 172.595 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.7 t -165.36 143.69 6.19 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.263 -0.898 . . . . 3.63 111.136 174.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.66 -46.5 81.06 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 109.546 -0.538 . . . . 2.77 109.546 175.12 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.1 m -50.19 -41.44 49.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.753 0.821 . . . . 2.21 112.006 174.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.59 -50.68 62.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.249 -0.649 . . . . 2.49 109.249 -177.177 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -48.34 -54.77 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.122 0.569 . . . . 1.73 110.506 170.406 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.31 -39.6 83.56 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.842 0.829 . . . . 2.9 111.088 -176.415 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -63.67 -44.33 94.07 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.912 0.885 . . . . 2.24 110.499 175.429 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.6 mt -60.26 -46.88 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.593 -0.521 . . . . 1.02 109.593 176.094 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -55.8 -45.95 78.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.796 -0.446 . . . . 2.19 109.796 174.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.9 m -57.16 -48.19 79.32 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 117.82 0.282 . . . . 1.88 111.519 175.255 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -55.09 -52.36 63.48 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.825 0.739 . . . . 2.89 110.565 177.08 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.4 mt -57.93 -59.41 5.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.004 -0.739 . . . . 1.97 109.004 179.636 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 59.2 m -51.06 -26.06 5.81 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.772 1.629 . . . . 2.04 112.244 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -64.83 -19.77 66.04 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.77 -0.581 . . . . 4.05 112.359 177.622 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.5 m -68.87 139.12 55.15 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.731 1.212 . . . . 2.24 111.116 178.162 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -54.4 -57.29 11.85 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.836 0.854 . . . . 4.22 111.926 177.089 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.44 -36.02 76.77 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 121.237 0.354 . . . . 1.85 112.59 -170.478 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.49 121.24 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 122.007 -0.702 . . . . 2.51 109.337 -173.102 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.5 m -97.48 -42.95 7.47 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.857 -0.423 . . . . 2.42 109.857 -176.019 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.471 ' CE2' ' HD3' ' A' ' 123' ' ' LYS . 36.7 p90 -144.07 97.41 3.05 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 113.664 0.987 . . . . 1.94 113.664 -178.418 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -94.09 135.87 34.99 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 107.675 -1.231 . . . . 1.19 107.675 178.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.3 t -129.1 108.42 10.36 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.91 -0.774 . . . . 2.52 108.91 172.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 120' ' ' ALA . 5.0 p -100.28 131.12 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.106 1.363 . . . . 2.57 108.926 -179.366 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -127.25 144.63 51.0 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.799 1.181 . . . . 2.62 109.475 179.031 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 pp -104.61 -43.72 5.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 124.415 1.086 . . . . 3.06 109.481 -171.311 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -46.71 -41.85 15.69 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.485 1.114 . . . . 2.8 111.71 173.17 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -106.87 1.96 25.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.671 1.188 . . . . 2.64 111.819 178.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.5 p 60.55 -6.77 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 127.925 2.49 . . . . 2.27 115.498 177.425 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -98.43 155.42 17.25 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.814 0.846 . . . . 4.31 111.319 -174.155 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.65 ' HB2' HG23 ' A' ' 113' ' ' VAL . . . -140.68 120.56 13.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.883 0.873 . . . . 1.41 110.513 -174.669 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.8 119.81 34.95 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.287 2.235 . . . . 2.14 107.865 -173.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 22.6 t -128.88 122.77 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 116.27 -1.824 . . . . 2.34 108.602 -168.332 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.471 ' HD3' ' CE2' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -112.91 97.49 6.57 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.965 1.257 . . . . 5.4 110.446 -179.344 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.414 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 50.2 p90 -114.2 -179.46 3.64 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.378 1.049 . . . . 2.65 112.374 -178.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -98.37 109.36 52.14 Favored Pre-proline 0 C--O 1.237 0.444 0 N-CA-C 107.454 -1.313 . . . . 3.19 107.454 176.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -78.12 69.93 7.32 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.885 2.39 . . . . 3.02 110.747 -171.42 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -163.31 -46.13 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.935 1.694 . . . . 4.28 109.063 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 pt -85.62 -33.1 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 117.693 0.224 . . . . 2.69 111.021 -177.086 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.17 160.06 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.119 -1.067 . . . . 2.38 108.119 177.288 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.82 156.13 24.68 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.228 -1.149 . . . . 2.35 110.228 -177.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -59.77 -33.93 96.08 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.74 2.96 . . . . 2.5 111.887 -174.228 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -54.87 -35.32 63.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.235 -0.29 . . . . 5.23 110.934 177.606 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -70.54 -40.79 73.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.272 -1.01 . . . . 3.32 108.272 -174.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 62.1 mt -53.51 -57.86 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.83 -0.804 . . . . 2.22 108.83 174.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.8 pt -56.16 -51.09 66.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 118.291 -0.861 . . . . 3.3 111.056 178.602 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -53.94 -47.81 70.89 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.952 1.251 . . . . 3.89 111.352 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.6 mm -57.4 -50.57 76.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 121.545 -0.722 . . . . 2.56 109.712 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.282 2.7 pp -70.85 -26.17 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 119.113 -1.035 . . . . 1.39 113.245 -177.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.09 -37.29 79.5 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.093 0.957 . . . . 4.02 110.42 169.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.88 -31.14 72.22 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.794 -0.566 . . . . 4.7 110.071 176.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.5 mt -73.36 -39.55 55.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.578 -0.527 . . . . 1.65 109.578 170.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.81 26.06 5.44 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.917 1.723 . . . . 1.29 111.454 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -104.28 179.96 4.12 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.14 -1.43 . . . . 2.86 107.14 175.356 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -142.28 130.58 22.24 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.63 -1.248 . . . . 4.02 107.63 173.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.91 81.88 1.84 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.133 0.973 . . . . 1.79 109.492 -168.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.8 m -97.75 120.2 37.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.162 -0.681 . . . . 2.17 109.162 -170.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -40.06 107.8 0.08 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.381 1.473 . . . . 3.56 110.631 164.615 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.36 43.88 2.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.24 0.83 . . . . 4.95 113.24 -175.277 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 . . . . . 0 C--O 1.252 1.235 0 CA-C-O 117.305 -1.331 . . . . 6.07 111.159 167.528 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.467 0.411 0 N-CA-C 106.368 -1.716 . . . . 8.75 106.368 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.88 116.14 10.54 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 127.072 2.149 . . . . 4.21 111.246 -169.257 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -84.01 81.81 2.07 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 CA-C-O 123.485 1.369 . . . . 3.51 113.7 -162.62 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -113.66 122.34 46.87 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 111.603 -2.544 . . . . 3.84 109.12 176.356 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -96.38 134.33 39.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.764 -1.569 . . . . 5.97 106.764 176.632 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.9 t -116.82 133.45 56.0 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 124.036 0.835 . . . . 2.01 109.204 -179.275 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -103.61 103.57 13.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.59 1.156 . . . . 2.95 109.756 -170.108 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.65 172.02 10.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.116 0.96 . . . . 2.7 112.516 176.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.14 153.86 43.98 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.251 -1.388 . . . . 1.64 107.251 168.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.4 mm -98.94 139.9 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 106.815 -1.55 . . . . 1.12 106.815 170.74 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 mtmm -111.71 112.33 23.95 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.239 -1.763 . . . . 2.98 106.239 159.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.16 -81.95 0.17 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.211 1.386 . . . . 1.29 110.132 -177.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.5 mtm 29.28 77.13 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.958 2.103 . . . . 1.98 114.707 -175.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.4 p -57.19 -43.02 82.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.605 0.762 . . . . 3.26 112.153 176.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.7 t 111.13 -42.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.965 2.506 . . . . 3.01 110.715 175.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.28 -67.42 0.19 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.41 1.484 . . . . 5.93 112.146 -174.478 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.99 24.24 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.922 0.489 . . . . 3.0 111.384 167.052 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.5 m -70.86 -45.82 63.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 120.974 -1.079 . . . . 1.83 109.939 -172.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.5 t -57.04 -49.78 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.08 -1.081 . . . . 1.53 108.08 175.467 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -54.19 -45.44 72.17 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.895 1.278 . . . . 2.32 111.868 -178.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.01 -50.39 68.68 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 121.654 -0.654 . . . . 2.49 109.837 174.781 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mt -49.39 -41.24 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 124.238 1.015 . . . . 1.6 110.792 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -47.49 -56.24 7.44 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.514 0.597 . . . . 3.99 111.542 176.199 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -64.45 -46.64 82.29 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.463 -0.569 . . . . 5.02 109.463 -177.214 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -55.07 -55.46 30.74 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 109.207 -0.664 . . . . 1.4 109.207 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.48 -43.98 88.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.633 -0.699 . . . . 2.9 110.371 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -50.78 -33.85 25.05 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.283 1.401 . . . . 1.87 112.474 170.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -95.97 19.02 12.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.927 0.891 . . . . 2.81 112.165 -177.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.4 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 5.4 tp10 -72.34 -74.78 0.15 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.911 0.884 . . . . 2.97 109.535 174.535 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -163.26 -117.61 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.861 -0.524 . . . . 1.35 111.193 -170.379 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.18 -31.13 72.29 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.456 -0.658 . . . . 1.75 111.456 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 29' ' ' GLU . 3.5 p -59.01 125.17 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 122.916 0.486 . . . . 1.59 111.274 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.08 52.17 1.38 Allowed 'General case' 0 CA--C 1.522 -0.103 0 CA-C-O 122.325 1.059 . . . . 2.8 109.705 170.626 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -156.46 154.73 30.87 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.403 -1.332 . . . . 2.03 107.403 169.601 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -141.02 119.57 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.904 -1.887 . . . . 2.63 105.904 176.187 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tt -131.06 70.34 1.47 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.415 -1.328 . . . . 2.55 107.415 176.01 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.9 t -98.53 130.21 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.294 -1.002 . . . . 1.87 108.294 175.181 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.93 97.08 8.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.298 -1.371 . . . . 1.21 107.298 168.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.1 -23.33 54.4 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.059 0.544 . . . . 2.66 111.082 175.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 52.0 mtt -75.44 -55.16 5.96 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.672 -0.642 . . . . 3.87 110.12 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.58 -22.84 37.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.968 0.507 . . . . 1.29 111.823 -175.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.48 61.78 2.88 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 124.209 0.909 . . . . 1.07 111.047 -178.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -140.91 140.17 34.46 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.834 -1.543 . . . . 3.1 106.834 172.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.0 99.11 7.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.113 1.365 . . . . 0.86 109.855 174.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.22 135.94 37.37 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 104.61 -2.367 . . . . 3.72 104.61 166.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 pt -131.12 -179.17 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.324 -1.361 . . . . 1.78 107.324 169.26 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -132.87 104.85 6.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.215 -0.661 . . . . 4.19 109.215 173.358 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.428 ' HB2' HD12 ' A' ' 53' ' ' ILE . 6.6 p90 -119.7 167.18 12.3 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.825 1.65 . . . . 3.07 112.553 178.429 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.48 100.72 19.7 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.745 1.618 . . . . 4.04 109.803 -174.552 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.55 -11.08 18.51 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.094 2.53 . . . . 2.41 114.074 -173.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -85.75 -20.45 29.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.718 0.807 . . . . 5.08 112.505 179.432 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 m -120.34 -39.91 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-O 118.635 -0.698 . . . . 3.42 111.554 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -110.18 139.01 35.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 123.282 0.633 . . . . 1.78 109.505 176.985 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.517 ' HB3' HD23 ' A' ' 56' ' ' LEU . 1.1 mp0 -114.92 154.05 47.02 Favored Pre-proline 0 N--CA 1.451 -0.385 0 C-N-CA 125.779 1.632 . . . . 2.69 111.026 -178.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.97 -39.01 43.07 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.061 2.507 . . . . 1.3 112.659 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 54' ' ' GLN . 2.3 pt? -64.79 -46.73 80.83 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.148 -0.97 . . . . 2.81 111.635 -174.34 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.11 -33.61 75.83 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.207 0.603 . . . . 4.81 112.216 175.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.12 -47.61 43.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 107.756 -1.201 . . . . 1.05 107.756 163.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 56' ' ' LEU . . . -58.47 -48.8 79.57 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.456 -0.793 . . . . 1.15 109.597 -173.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -47.5 -49.85 24.84 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.903 0.32 . . . . 3.41 110.806 176.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.75 -53.49 54.34 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.376 0.608 . . . . 2.68 110.969 -176.548 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.689 HD13 ' H ' ' A' ' 69' ' ' ALA . 2.2 pp -63.71 -39.81 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 118.774 -0.631 . . . . 4.17 111.847 178.43 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -63.21 -42.36 99.28 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.612 1.097 . . . . 1.93 109.201 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.08 -49.44 75.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.498 0.719 . . . . 2.73 109.355 -179.572 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.1 mt -54.9 -38.66 67.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.397 -0.365 . . . . 1.81 111.77 172.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.65 29.71 2.38 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 123.891 0.758 . . . . 1.28 111.601 168.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -116.72 154.16 31.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.34 1.456 . . . . 2.4 107.681 173.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -95.72 128.07 42.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.648 -1.612 . . . . 3.01 106.648 164.061 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.689 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -107.33 133.57 51.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.455 -2.054 . . . . 0.93 105.455 163.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.05 140.29 41.93 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.498 1.124 . . . . 0.99 108.638 171.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.27 147.37 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.221 -1.029 . . . . 2.88 108.221 -179.14 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.6 mtp -50.11 -50.06 49.72 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.765 0.826 . . . . 3.52 111.033 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.02 -64.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.357 -1.72 . . . . 4.05 106.357 178.587 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -68.06 -91.08 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.618 1.167 . . . . 7.39 111.999 -174.42 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 148.36 -119.88 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 128.943 2.897 . . . . 4.35 107.684 -169.415 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.85 -77.31 0.6 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.059 1.343 . . . . 3.28 110.087 168.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.25 84.3 1.02 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.744 -0.942 . . . . 3.06 110.744 176.498 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.8 t -155.02 -68.47 0.13 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.002 0.521 . . . . 5.52 112.203 174.578 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -103.17 119.16 38.35 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.744 1.217 . . . . 4.4 108.103 -172.168 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.25 -62.6 4.55 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.557 -2.217 . . . . 2.07 107.557 178.134 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.532 ' C ' HD13 ' A' ' 82' ' ' ILE . 6.2 p-10 -104.0 133.4 49.02 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.691 0.796 . . . . 3.96 109.642 175.338 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.532 HD13 ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -127.7 158.1 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.963 -1.125 . . . . 3.12 107.963 171.647 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.88 144.38 46.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.092 -1.818 . . . . 3.48 106.092 166.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mt -140.85 150.65 43.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.072 -1.825 . . . . 2.54 106.072 168.526 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -98.25 126.18 43.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.698 -1.223 . . . . 1.82 107.698 177.113 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.7 pt -98.47 127.29 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.682 -0.859 . . . . 1.95 108.682 -175.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.7 m -119.42 137.37 53.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.46 -0.941 . . . . 1.64 108.46 177.003 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.22 -45.75 1.16 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.336 1.446 . . . . 1.12 111.295 175.125 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 157.31 27.81 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.1 -0.647 . . . . 3.33 111.423 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -168.54 52.07 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.007 0.923 . . . . 3.35 109.341 171.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -165.63 137.33 3.98 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 120.882 -1.137 . . . . 2.62 109.751 178.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.47 -42.04 31.43 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.868 0.867 . . . . 3.06 111.01 175.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -55.3 -49.06 73.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.204 0.602 . . . . 1.89 110.792 175.45 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 79.0 m -63.65 -46.75 84.21 Favored 'General case' 0 N--CA 1.458 -0.053 0 O-C-N 121.707 -0.62 . . . . 1.8 109.729 -178.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.81 -49.29 70.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 122.777 0.431 . . . . 1.71 110.708 175.444 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -57.74 -41.76 82.54 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.119 0.568 . . . . 4.62 110.707 175.827 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -63.09 -41.47 99.4 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.672 -0.643 . . . . 1.59 110.686 177.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.9 mt -61.35 -52.27 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.576 0.75 . . . . 1.0 109.698 175.069 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.87 -39.09 76.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.501 -0.749 . . . . 2.34 109.473 177.59 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.8 t -60.66 -56.8 16.94 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.626 0.771 . . . . 1.36 110.671 176.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -30.72 70.89 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 120.303 1.41 . . . . 4.54 111.343 -175.181 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 mt -67.5 -59.61 3.23 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 109.233 -0.655 . . . . 1.72 109.233 171.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.7 m -54.96 -19.92 7.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.912 0.885 . . . . 1.81 111.777 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.04 -33.04 66.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.831 0.852 . . . . 5.19 111.992 173.498 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.3 p -75.45 166.09 24.13 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.927 0.891 . . . . 2.78 111.604 -173.282 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.68 -40.38 34.08 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.243 -0.286 . . . . 3.5 111.572 178.539 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.55 -35.06 37.78 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 122.833 0.254 . . . . 1.59 113.582 -169.002 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.36 133.09 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 O-C-N 121.658 -0.907 . . . . 2.19 109.128 -174.075 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.8 p -107.63 -53.44 2.62 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 122.905 0.482 . . . . 2.48 111.816 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.51 126.09 32.11 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.55 -0.907 . . . . 2.05 108.55 169.725 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.57 153.61 18.91 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.025 -1.102 . . . . 1.07 108.025 161.331 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.8 m -144.7 116.92 8.42 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.139 -1.06 . . . . 2.01 108.139 166.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 p -118.12 132.33 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.745 0.818 . . . . 1.92 110.446 -174.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -129.57 98.66 4.91 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.142 0.977 . . . . 1.48 110.878 -172.126 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -25.4 66.23 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.686 1.194 . . . . 2.18 112.445 -176.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.83 -32.56 53.27 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.114 0.566 . . . . 1.9 111.033 173.046 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.07 -9.14 12.39 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.369 1.468 . . . . 2.24 111.166 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.0 m 63.03 31.78 15.82 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.831 1.652 . . . . 1.42 112.407 -178.599 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.3 mmtm -105.35 153.54 21.51 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.613 0.765 . . . . 3.63 110.929 176.018 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.84 113.82 15.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.985 2.114 . . . . 1.06 107.19 173.18 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.06 134.18 38.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.143 -1.429 . . . . 1.82 107.143 173.581 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.4 t -135.33 129.62 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 124.027 0.931 . . . . 2.0 108.578 -174.04 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -111.96 93.61 4.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.43 1.092 . . . . 3.13 109.148 178.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -119.9 175.01 6.1 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.709 0.804 . . . . 2.17 111.627 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -97.86 115.75 65.74 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.672 -0.862 . . . . 3.7 108.672 174.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -76.45 71.19 6.0 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.444 2.763 . . . . 2.09 111.275 -171.191 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -161.62 -46.01 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.169 1.387 . . . . 4.13 109.305 177.145 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -87.48 -32.33 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 123.256 0.623 . . . . 2.04 111.469 -174.292 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.92 165.15 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 124.258 1.023 . . . . 1.6 108.406 176.436 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.91 168.37 32.34 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.403 -0.679 . . . . 1.36 111.403 -178.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.68 -34.87 49.41 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.839 3.026 . . . . 1.49 112.583 -172.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -44.94 87.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.594 -0.891 . . . . 5.2 108.594 177.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.08 -41.68 94.83 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.47 -0.937 . . . . 3.26 108.47 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 83.2 mt -55.08 -57.39 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 117.749 -1.12 . . . . 1.21 109.99 176.491 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . 0.264 18.0 pt -52.45 -56.03 8.51 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 CA-C-N 119.109 0.868 . . . . 2.47 109.998 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -48.86 -52.2 25.56 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.135 0.969 . . . . 3.71 111.926 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.69 -33.65 61.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 118.785 -0.626 . . . . 2.5 110.507 -175.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.35 2.6 pp -75.26 -32.33 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 114.891 1.441 . . . . 1.24 114.891 168.331 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.97 -34.21 69.7 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.307 0.958 . . . . 2.2 109.634 174.003 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.86 -35.88 82.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.085 0.469 . . . . 3.78 109.929 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 32.7 mm -76.18 -42.66 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.277 -0.638 . . . . 2.4 109.277 173.452 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.5 41.13 1.06 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.1 1.333 . . . . 0.96 111.59 178.279 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -112.54 -180.0 3.82 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.365 -0.976 . . . . 2.34 108.365 166.466 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -133.63 132.96 41.39 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.89 -1.152 . . . . 3.67 107.89 171.58 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.67 95.03 4.68 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 123.981 0.912 . . . . 1.45 109.778 -175.329 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.7 t -110.01 121.41 45.18 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.255 0.622 . . . . 2.75 109.852 -172.172 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -38.64 115.97 0.51 Allowed 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 126.37 1.868 . . . . 4.06 110.89 171.801 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.584 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -103.26 30.77 4.68 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.151 1.167 . . . . 3.23 114.151 -178.686 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.301 0 CA-C-O 116.999 -1.477 . . . . 7.76 111.571 177.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 mtt . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 108.705 -0.85 . . . . 10.54 108.705 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.6 89.89 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.102 0.961 . . . . 5.6 111.757 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.66 125.85 14.48 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.745 1.63 . . . . 4.6 110.539 -175.4 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.48 137.91 39.18 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.132 0.573 . . . . 3.8 110.821 -176.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.1 143.13 29.71 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.991 -0.443 . . . . 3.98 110.912 179.02 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -125.94 131.63 52.25 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.413 1.085 . . . . 2.79 108.109 177.479 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -113.71 97.25 6.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.69 -1.226 . . . . 4.89 107.69 -171.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 44' ' ' ALA 0.252 0.0 OUTLIER -122.36 177.09 5.53 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.829 0.824 . . . . 2.38 110.508 -178.13 . . . . . . . . 4 4 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.477 ' OE1' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -132.12 147.49 52.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.317 -1.734 . . . . 1.63 106.317 174.51 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.4 mm -98.38 132.36 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 106.814 -1.55 . . . . 0.77 106.814 177.259 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -111.46 109.14 18.95 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.171 -1.418 . . . . 5.01 107.171 170.004 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.94 -83.91 0.09 OUTLIER Glycine 0 CA--C 1.532 1.106 0 N-CA-C 110.159 -1.176 . . . . 1.15 110.159 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 47.52 70.46 0.42 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.746 1.618 . . . . 1.95 114.203 179.119 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.9 m -49.09 -59.33 3.73 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.451 -0.781 . . . . 2.36 112.521 170.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 t -168.59 63.66 0.06 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.541 1.064 . . . . 3.11 111.212 -175.257 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.408 ' HA ' HD22 ' A' ' 39' ' ' LEU . . . 31.86 56.82 0.33 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.076 1.75 . . . . 5.82 113.411 177.362 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.1 t -169.17 -49.52 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 122.762 1.268 . . . . 2.87 108.39 -167.569 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 19.7 p -61.87 -40.57 95.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.511 -0.743 . . . . 3.5 110.529 178.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.711 ' HB ' HD21 ' A' ' 39' ' ' LEU . 50.9 t -70.87 -31.25 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.924 -0.769 . . . . 1.95 108.924 173.008 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -58.57 -31.76 68.3 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.487 -0.758 . . . . 1.89 111.464 175.127 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -55.38 -50.05 70.71 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.231 -0.918 . . . . 3.21 109.642 170.092 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.42 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -46.93 -47.24 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 125.546 1.539 . . . . 2.48 110.023 -176.509 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -50.47 -59.02 4.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.449 1.119 . . . . 3.76 109.626 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -70.0 -19.31 63.33 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.997 -1.065 . . . . 4.68 112.422 -177.336 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -70.24 -56.0 7.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.939 -0.763 . . . . 1.15 108.939 168.284 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.42 HD12 ' O ' ' A' ' 22' ' ' ILE . 1.2 mp -59.41 -34.87 72.99 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.59 -0.694 . . . . 2.15 112.412 179.029 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.71 -20.87 15.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.891 1.223 . . . . 3.24 112.022 178.066 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -128.68 36.07 4.28 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.283 0.633 . . . . 4.8 110.9 174.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -67.78 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.804 -0.813 . . . . 3.26 108.804 167.7 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.27 -128.73 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.715 0.806 . . . . 1.66 108.926 -163.187 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.12 -20.26 68.88 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.679 0.656 . . . . 2.09 112.984 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.44 124.06 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 117.557 0.679 . . . . 2.05 110.561 176.696 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.85 57.53 1.56 Allowed 'General case' 0 C--N 1.339 0.129 0 CA-C-O 121.573 0.701 . . . . 3.14 110.343 172.749 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -155.97 159.63 39.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.863 -1.162 . . . . 1.93 107.863 160.354 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.85 114.8 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.672 0.789 . . . . 2.57 109.252 170.65 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -127.23 74.61 1.52 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.534 -0.913 . . . . 2.71 108.534 176.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.93 142.26 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 N-CA-C 109.378 -0.601 . . . . 2.49 109.378 171.31 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.44 94.46 4.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.772 -1.196 . . . . 1.69 107.772 165.586 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.711 HD21 ' HB ' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -56.08 -18.83 10.79 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.937 0.895 . . . . 3.85 112.198 172.69 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.9 ttm -66.07 -44.22 85.09 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.361 1.064 . . . . 4.12 110.62 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.77 -29.24 12.74 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.077 0.951 . . . . 1.65 111.126 -178.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.39 63.19 1.51 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.111 -1.196 . . . . 1.31 110.111 -177.119 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -140.4 132.11 27.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.008 -2.219 . . . . 3.5 105.008 174.303 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 8' ' ' LEU . . . -115.69 105.27 12.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.555 1.159 . . . . 1.26 110.011 170.155 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.9 137.51 41.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.712 -1.218 . . . . 5.33 107.712 169.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.43 ' CD1' HD11 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -138.46 173.27 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.525 0.602 . . . . 2.15 110.227 171.027 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -116.39 102.2 9.32 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.081 1.352 . . . . 5.95 110.239 174.548 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.544 ' HB2' HD12 ' A' ' 53' ' ' ILE . 8.0 p90 -98.6 173.74 6.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.092 1.357 . . . . 3.43 113.055 171.126 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -124.07 100.01 36.97 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.553 1.541 . . . . 3.08 108.192 -179.132 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.8 5.36 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.72 1 C-N-CA 125.387 4.058 . . . . 3.11 115.35 -166.37 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.05 -17.23 16.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.533 1.533 . . . . 4.72 110.359 -177.073 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.0 p -124.86 -41.23 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.498 1.119 . . . . 4.16 110.933 178.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -116.36 143.6 26.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 N-CA-C 108.794 -0.817 . . . . 2.35 108.794 179.286 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.37 149.89 50.66 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 124.842 1.257 . . . . 3.43 109.402 -176.15 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -57.34 -39.34 90.38 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.951 2.434 . . . . 2.08 111.228 -177.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -60.02 -39.94 87.58 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.222 0.609 . . . . 3.51 110.995 175.021 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -65.46 -43.33 90.69 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.118 -0.697 . . . . 3.83 109.118 178.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.77 -50.52 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.625 -1.25 . . . . 1.38 107.625 174.51 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.48 66.72 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.585 -0.734 . . . . 1.47 110.807 -174.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -52.54 -49.75 64.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.728 0.811 . . . . 4.86 110.526 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -47.84 80.76 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 122.009 0.909 . . . . 3.26 109.298 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mm -59.37 -42.91 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.581 -0.736 . . . . 2.5 111.001 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -67.3 -39.05 85.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.392 0.277 . . . . 2.46 110.43 179.522 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.01 -54.6 44.1 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.219 1.008 . . . . 3.79 109.847 176.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.63 -46.45 73.91 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.776 -0.193 . . . . 3.91 110.829 175.63 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.72 39.87 0.41 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.429 -1.068 . . . . 1.74 110.429 162.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -129.65 164.96 22.77 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.222 -1.399 . . . . 2.32 107.222 178.151 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -98.51 132.37 44.0 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.872 -1.159 . . . . 2.5 107.872 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.54 116.51 31.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.578 -1.267 . . . . 1.3 107.578 173.025 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB3' ' OE1' ' A' ' 9' ' ' GLN . . . -130.57 138.8 50.34 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.203 -1.036 . . . . 0.9 108.203 173.649 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -67.01 146.3 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.3 -1.0 . . . . 2.93 108.3 178.082 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.1 mtp -57.94 -46.68 84.67 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.967 -0.693 . . . . 3.8 110.508 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 167.71 94.84 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 128.652 2.781 . . . . 5.15 105.46 -179.381 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 48.5 41.86 17.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 123.356 1.551 . . . . 8.36 114.697 172.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . 0.29 0.6 OUTLIER 59.99 -88.35 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.85 1.66 . . . . 5.14 113.714 170.03 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 142.69 158.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.989 2.515 . . . . 5.69 111.47 -173.246 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.43 ' HA3' ' H ' ' A' ' 83' ' ' GLU . . . -71.23 70.83 0.8 Allowed Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 123.822 0.725 . . . . 4.36 114.414 171.167 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.8 t -86.87 -58.97 2.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.792 -0.818 . . . . 5.43 108.792 174.05 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -163.09 129.07 3.26 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 106.817 -1.549 . . . . 7.34 106.817 -162.06 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.61 -38.89 3.01 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 122.039 2.2 . . . . 2.68 109.298 170.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.435 HD22 ' HB3' ' A' ' 121' ' ' LEU . 21.8 t-20 -111.69 145.94 38.39 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 126.011 1.724 . . . . 4.17 107.548 166.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.449 HD12 ' O ' ' A' ' 82' ' ' ILE 0.281 1.1 pp -114.95 140.15 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.363 0.528 . . . . 4.42 109.762 150.643 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.541 ' OE1' ' HB3' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -107.64 123.34 48.34 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.603 2.361 . . . . 3.51 107.205 175.796 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.436 HD13 ' CB ' ' A' ' 145' ' ' ALA . 4.6 pp -120.95 151.72 39.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 123.452 0.47 . . . . 3.69 110.188 173.585 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -94.66 126.76 40.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.582 -2.377 . . . . 2.32 104.582 175.516 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 pt -99.03 130.06 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.376 -0.972 . . . . 1.82 108.376 176.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.4 m -123.97 141.95 51.59 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.416 -0.957 . . . . 2.12 108.416 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.08 -37.36 3.76 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.621 1.105 . . . . 1.43 111.361 -178.387 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.417 ' HB2' ' SG ' ' A' ' 94' ' ' CYS . 0.0 OUTLIER -61.27 159.06 12.93 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.053 0.541 . . . . 2.78 111.998 177.861 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.9 t -175.0 48.95 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.019 0.927 . . . . 3.3 110.229 170.07 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 8.5 t -160.39 144.26 13.96 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.958 -1.088 . . . . 2.88 111.715 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.22 -10.48 23.65 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.02 0.928 . . . . 3.13 113.305 178.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.7 t -79.2 -46.28 18.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.563 0.745 . . . . 2.84 109.091 170.009 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 89' ' ' MET . 5.1 t -56.95 -53.64 55.77 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 121.762 -0.586 . . . . 3.45 110.264 -177.215 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 p -51.22 -43.32 27.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.553 0.205 . . . . 2.83 111.553 175.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -32.51 74.18 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.363 0.665 . . . . 3.1 109.985 179.053 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -66.96 -56.9 8.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.804 1.242 . . . . 2.19 108.507 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 mp -45.59 -60.38 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 C-N-CA 124.471 1.108 . . . . 1.61 110.265 167.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -52.4 -44.4 65.35 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.465 0.575 . . . . 2.9 111.772 -178.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.0 t -65.4 -60.26 3.15 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.018 -1.051 . . . . 1.84 110.883 178.654 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -33.46 75.65 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.525 -0.734 . . . . 4.06 111.147 -171.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.93 -49.78 48.48 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.249 -0.882 . . . . 3.24 109.256 171.098 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.2 m -57.4 -24.43 55.38 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.164 1.347 . . . . 2.52 111.183 -177.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -57.22 -30.99 65.04 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.099 0.778 . . . . 4.31 113.099 172.479 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.8 m -57.03 153.98 10.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.799 1.24 . . . . 1.86 111.868 175.726 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -73.8 -56.19 5.28 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.826 1.25 . . . . 2.97 112.533 -176.061 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.403 ' HA3' HD11 ' A' ' 128' ' ' ILE . . . -74.45 -34.86 53.45 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 121.88 -0.513 . . . . 1.75 112.016 -171.538 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.18 132.56 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.184 -0.672 . . . . 2.0 109.184 -175.395 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.5 m -121.1 -38.57 2.8 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 112.965 0.728 . . . . 2.71 112.965 -177.334 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -142.27 140.41 32.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.884 -1.127 . . . . 2.75 110.235 164.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.86 161.43 18.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.964 -1.016 . . . . 1.54 109.789 160.767 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -142.44 118.94 10.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.228 -1.767 . . . . 2.23 106.228 165.574 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 42.9 t -112.57 129.25 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 118.196 0.453 . . . . 2.55 110.476 178.543 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -117.66 126.75 53.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.354 1.062 . . . . 1.38 109.189 -177.455 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mp -90.4 -41.01 11.72 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.794 2.038 . . . . 3.81 108.729 -170.399 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -43.77 -44.1 6.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.634 1.574 . . . . 1.41 110.324 172.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -100.95 -15.07 17.64 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.729 0.812 . . . . 2.35 112.464 174.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.9 m 65.86 30.58 9.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.971 1.708 . . . . 1.77 113.896 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -106.14 149.86 26.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.534 1.533 . . . . 4.53 110.3 177.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.92 112.64 15.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.154 0.982 . . . . 1.24 108.897 176.486 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.435 ' HB3' HD22 ' A' ' 81' ' ' ASN . 4.1 mm? -95.61 124.52 39.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.869 -1.53 . . . . 2.58 106.869 176.77 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.5 123.24 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 C-N-CA 125.364 1.466 . . . . 1.86 108.844 -178.322 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -96.37 100.65 12.25 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.221 -1.029 . . . . 3.69 108.221 -177.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -126.12 174.13 8.71 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 123.833 0.708 . . . . 2.69 109.761 -178.014 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -104.48 117.56 58.83 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 118.273 -0.87 . . . . 5.24 109.471 177.686 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -73.78 71.36 4.09 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.401 2.734 . . . . 2.97 111.882 -174.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -166.52 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.864 1.666 . . . . 3.86 110.013 174.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.534 HD12 ' HB ' ' A' ' 129' ' ' ILE . 2.2 pp -87.09 -41.22 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 118.448 0.567 . . . . 3.22 111.297 -169.741 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.534 ' HB ' HD12 ' A' ' 128' ' ' ILE . 0.4 OUTLIER -128.79 170.22 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.447 1.499 . . . . 2.12 107.557 174.384 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.36 25.5 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.1 -1.2 . . . . 1.99 110.1 176.269 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.69 -45.78 23.62 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.021 2.48 . . . . 1.99 110.768 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.4 ttm105 -48.37 -39.45 22.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.679 1.192 . . . . 6.91 113.106 -178.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -53.34 58.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.333 -0.617 . . . . 3.96 109.333 173.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.97 -44.55 82.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 109.442 -0.577 . . . . 1.21 109.442 -178.035 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' A' ' 145' ' ' ALA . 86.9 mt -51.89 -56.42 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.165 0.986 . . . . 2.27 108.498 174.06 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -55.17 -43.98 74.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.015 -1.053 . . . . 4.04 112.512 178.297 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.2 mm -63.92 -34.25 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.704 -0.623 . . . . 2.05 110.35 -177.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 145' ' ' ALA . 27.3 pt -74.57 -33.52 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 119.812 1.187 . . . . 1.58 113.377 168.888 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -56.04 -25.98 47.1 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.475 1.034 . . . . 3.06 111.47 176.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.74 -34.49 75.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.835 0.454 . . . . 3.9 110.029 176.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.3 mt -79.31 -44.4 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.178 -0.675 . . . . 1.79 109.178 172.085 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.77 36.19 2.64 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 124.314 0.959 . . . . 1.43 110.868 -177.099 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -96.89 168.18 10.64 Favored 'General case' 0 C--N 1.338 0.083 0 N-CA-C 108.23 -1.026 . . . . 2.81 108.23 165.764 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -125.19 123.01 38.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.226 -1.768 . . . . 3.54 106.226 -177.231 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.436 ' CB ' HD13 ' A' ' 84' ' ' LEU . . . -111.0 107.91 17.47 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.838 1.255 . . . . 2.11 108.48 174.546 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.5 m -108.29 114.95 29.21 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.42 -0.955 . . . . 2.65 108.42 168.112 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -35.75 107.14 0.05 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 126.735 2.014 . . . . 4.27 110.122 170.619 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.632 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -82.93 -36.7 25.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.378 -0.601 . . . . 3.67 109.378 -175.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.109 0 C-N-CA 125.668 1.587 . . . . 5.91 112.713 -165.211 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 106.421 -1.696 . . . . 9.72 106.421 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.51 42.04 0.72 Allowed Pre-proline 0 C--O 1.222 -0.368 0 CA-C-O 117.874 -1.06 . . . . 5.49 112.05 -173.756 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -67.99 157.42 61.86 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.757 2.305 . . . . 5.48 112.911 -160.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -111.83 160.45 17.34 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.092 1.757 . . . . 3.61 109.967 -167.224 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -90.75 130.85 36.69 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.097 0.959 . . . . 5.12 109.464 -159.517 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.3 t -138.02 123.33 19.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.971 0.508 . . . . 1.85 110.227 177.808 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -98.64 106.76 19.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.913 1.685 . . . . 2.91 107.788 174.819 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -128.6 171.82 11.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.384 -0.969 . . . . 2.6 108.384 179.226 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.453 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -141.21 144.95 35.03 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.314 -0.866 . . . . 1.54 109.352 175.037 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.3 mm -99.16 126.14 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 106.178 -1.786 . . . . 1.55 106.178 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -95.56 99.06 10.98 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.658 -1.608 . . . . 3.61 106.658 174.425 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.65 -94.18 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.623 -1.391 . . . . 1.76 109.623 178.429 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.0 mtt 58.66 90.66 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.485 1.514 . . . . 2.39 113.789 179.588 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -14.72 33.93 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.083 -1.011 . . . . 2.11 113.125 172.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 t 72.88 -59.97 0.55 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 126.239 1.816 . . . . 4.06 112.395 -178.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.25 -74.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.993 2.117 . . . . 4.81 113.103 -174.385 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.5 p -154.24 15.17 0.46 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.668 0.387 . . . . 2.67 111.706 168.71 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.7 m -69.42 -53.3 20.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.286 -1.376 . . . . 1.8 107.286 -170.372 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.541 ' HB ' HD11 ' A' ' 39' ' ' LEU . 71.9 t -61.73 -39.83 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 119.554 -0.858 . . . . 1.74 109.759 -175.551 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.1 t -53.08 -46.65 68.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.893 0.477 . . . . 2.39 111.311 173.576 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -63.07 -49.26 75.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.251 -0.906 . . . . 2.67 109.351 176.509 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.541 HG13 HD13 ' A' ' 65' ' ' LEU . 1.3 mp -49.9 -53.53 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.322 0.649 . . . . 2.05 109.546 178.85 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -48.62 -52.71 21.69 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.99 1.316 . . . . 4.5 111.5 175.782 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -70.24 -24.0 63.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.256 -0.902 . . . . 4.85 111.006 -176.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -71.66 -44.81 63.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.305 -0.872 . . . . 1.26 109.933 170.034 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.83 -37.6 79.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.127 0.571 . . . . 1.99 110.947 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -26.97 6.58 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.481 0.549 . . . . 1.81 112.481 172.081 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -109.7 19.38 19.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.489 1.116 . . . . 4.67 111.381 -177.429 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -73.76 -67.22 0.62 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.612 -0.884 . . . . 3.23 108.612 174.627 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.6 -96.55 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.852 1.261 . . . . 1.23 109.443 173.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.38 -5.82 89.58 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.897 -0.502 . . . . 1.39 112.658 -176.924 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.36 114.11 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 118.044 0.922 . . . . 2.56 109.682 176.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.68 53.05 1.61 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.539 -1.282 . . . . 3.39 107.539 179.109 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -162.73 153.24 16.72 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.804 -1.184 . . . . 1.65 107.804 158.334 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.2 94.77 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 125.421 1.488 . . . . 2.52 106.989 172.312 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -116.34 66.31 0.71 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.275 -1.379 . . . . 2.52 107.275 176.801 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 t -97.47 130.92 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.585 -0.894 . . . . 1.93 108.585 175.438 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.52 96.8 6.98 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.844 -1.169 . . . . 1.17 107.844 175.069 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.541 HD11 ' HB ' ' A' ' 19' ' ' VAL . 2.8 mm? -63.58 -12.95 37.11 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.333 0.515 . . . . 3.6 111.888 178.436 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -43.61 13.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.095 0.958 . . . . 5.84 111.41 -178.791 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.71 -36.26 15.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.74 0.816 . . . . 1.24 111.017 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.19 62.28 1.23 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.53 1.538 . . . . 0.98 111.101 178.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -143.41 138.8 29.6 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.588 -1.634 . . . . 3.14 106.588 177.08 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.37 98.91 8.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 124.443 1.089 . . . . 0.83 112.326 171.295 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -94.09 131.42 39.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 105.996 -1.853 . . . . 4.92 105.996 169.156 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 pt -133.44 -179.16 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 O-C-N 121.816 -0.552 . . . . 1.71 109.603 170.54 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 34' ' ' SER . 43.5 mtmt -124.68 119.06 27.91 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.728 -0.669 . . . . 4.11 109.768 160.749 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.559 ' HB2' HD12 ' A' ' 53' ' ' ILE . 11.7 p90 -114.73 154.66 28.1 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.777 1.631 . . . . 2.16 110.525 170.222 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.26 111.35 63.47 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.2 0.6 . . . . 3.4 109.704 176.626 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.85 -19.75 69.49 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.837 3.025 . . . . 2.06 112.845 -171.191 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -62.94 -24.37 67.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.701 -0.666 . . . . 3.74 112.752 177.283 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.87 -43.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 118.944 0.793 . . . . 2.55 111.496 -173.02 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -102.19 147.95 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 108.48 -0.933 . . . . 1.38 108.48 176.623 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -126.92 150.96 73.21 Favored Pre-proline 0 N--CA 1.451 -0.379 0 C-N-CA 125.075 1.35 . . . . 2.47 109.179 177.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.27 -36.38 94.99 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.629 2.219 . . . . 1.25 111.69 -175.019 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -41.68 99.25 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 121.916 -0.49 . . . . 3.54 110.959 177.42 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -59.99 -44.45 94.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.101 0.561 . . . . 3.06 109.973 177.317 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.401 HD12 HD11 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -54.03 -48.48 64.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 172.694 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.43 -44.99 95.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.016 -0.538 . . . . 1.15 111.004 -176.334 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -53.54 -50.39 65.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.934 -1.104 . . . . 2.82 110.169 171.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.62 -53.66 48.69 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.427 0.691 . . . . 2.36 109.34 -176.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.7 HG12 ' HB2' ' A' ' 69' ' ' ALA . 1.8 pp -68.74 -33.88 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 119.306 -0.958 . . . . 4.06 112.019 -178.677 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -57.92 -41.45 82.73 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 120.269 1.395 . . . . 2.01 108.574 -179.001 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -60.83 -50.92 71.48 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.619 -0.511 . . . . 2.74 109.619 177.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.541 HD13 HG13 ' A' ' 22' ' ' ILE . 11.0 mt -54.38 -41.91 69.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.058 0.543 . . . . 2.13 111.917 177.261 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.18 43.71 0.32 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.468 0.556 . . . . 1.05 112.123 164.305 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -134.2 -177.01 4.39 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.081 1.352 . . . . 1.9 110.198 179.091 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -114.08 129.21 56.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.093 0.957 . . . . 2.27 108.898 162.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.7 ' HB2' HG12 ' A' ' 62' ' ' ILE . . . -97.99 129.32 44.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.253 -1.388 . . . . 1.3 107.253 168.267 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.453 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -139.47 118.74 12.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.255 -1.387 . . . . 0.98 107.255 173.351 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 23.2 t -56.34 153.58 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.683 -0.858 . . . . 2.68 108.683 174.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -15.21 47.11 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.802 0.297 . . . . 4.17 111.802 178.448 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 112.98 -48.1 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.364 1 C-N-CA 132.558 4.343 . . . . 4.93 106.484 174.851 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -91.53 77.5 5.71 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.322 1.049 . . . . 7.48 110.792 169.141 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -46.54 -52.74 12.78 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.224 1.01 . . . . 5.37 113.146 -178.0 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 139.51 159.68 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 128.791 2.837 . . . . 3.89 109.726 -179.001 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 82' ' ' ILE . . . -49.73 89.57 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.704 -0.68 . . . . 2.86 113.634 144.928 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.5 -51.54 8.67 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 109.031 -0.729 . . . . 4.94 109.031 163.435 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -158.43 -102.34 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.675 0.39 . . . . 4.7 111.229 -171.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 124' ' ' PHE . . . -72.32 -28.39 68.05 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 125.711 1.624 . . . . 1.81 109.146 173.545 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.49 ' HB2' ' CD ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -91.54 116.37 28.81 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.125 -2.546 . . . . 3.5 104.125 176.722 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.472 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -142.03 161.91 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 O-C-N 125.412 1.695 . . . . 3.3 110.047 170.977 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.91 125.2 50.71 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 127.329 2.252 . . . . 3.64 110.003 -175.305 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.439 HD12 ' HB1' ' A' ' 145' ' ' ALA . 4.4 mm? -119.62 127.52 53.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.675 1.19 . . . . 2.8 108.214 172.812 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.6 m -95.78 122.68 38.82 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.673 -1.603 . . . . 2.1 106.673 176.383 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.495 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.4 OUTLIER -102.56 114.0 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.483 1.113 . . . . 1.63 109.979 -172.022 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 84.6 m -107.23 124.0 49.11 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.262 0.625 . . . . 1.44 110.267 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 127.16 -27.92 4.69 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.262 1.41 . . . . 0.99 111.585 177.738 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 34.8 ttp -71.52 146.24 48.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.88 -0.777 . . . . 2.66 111.661 -176.869 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 t -164.05 41.52 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.616 0.766 . . . . 2.8 110.817 174.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -163.29 145.05 9.75 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.192 -0.943 . . . . 2.59 111.551 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.75 -42.04 67.78 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.252 1.021 . . . . 2.61 111.787 176.087 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -53.46 -48.77 68.56 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.732 -0.605 . . . . 2.1 110.12 174.529 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 96.7 m -64.8 -41.45 95.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.082 0.553 . . . . 1.82 110.26 -178.254 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -52.47 -51.95 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.227 -0.286 . . . . 1.34 110.227 169.814 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.11 -33.22 75.0 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.826 -0.435 . . . . 3.19 109.826 -176.894 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -65.28 -57.15 9.17 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.489 1.116 . . . . 1.8 109.576 178.521 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.5 mt -56.2 -51.42 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 121.457 -0.777 . . . . 1.05 110.098 177.569 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.82 -45.96 85.38 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.542 -0.742 . . . . 2.42 110.101 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.3 t -49.25 -53.72 20.22 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.283 0.947 . . . . 1.91 109.76 172.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -31.36 72.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.809 -0.557 . . . . 3.12 111.067 -172.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.6 mt -72.23 -61.39 1.81 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.536 -0.913 . . . . 1.97 108.536 174.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 60.9 p -54.41 -19.66 6.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.601 1.161 . . . . 2.14 113.099 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -57.53 -33.42 68.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.697 0.68 . . . . 4.37 112.03 171.236 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.7 m -62.38 132.04 51.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.599 1.56 . . . . 1.83 111.069 -176.112 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.04 -53.89 46.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.319 0.648 . . . . 4.83 112.473 177.919 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.444 ' HA3' HD11 ' A' ' 128' ' ' ILE . . . -78.87 -16.95 78.17 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.837 -0.424 . . . . 1.46 113.394 -169.933 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.51 HD11 HG13 ' A' ' 122' ' ' VAL . 4.2 tt -68.86 133.84 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 118.387 1.094 . . . . 2.0 109.171 -176.195 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.9 m -104.32 -51.62 3.08 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 121.929 0.092 . . . . 2.5 110.859 -177.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -141.49 116.44 9.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.091 -0.707 . . . . 2.59 109.091 176.448 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.12 143.27 32.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.049 -0.723 . . . . 1.08 109.049 163.419 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.0 m -135.89 119.58 17.18 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.126 -1.064 . . . . 1.46 108.126 174.511 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.5 p -117.53 131.91 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.572 1.149 . . . . 2.2 110.601 -177.935 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -128.59 86.67 2.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.027 0.931 . . . . 1.38 110.298 -172.204 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -53.93 -26.56 26.01 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.997 1.319 . . . . 2.51 113.012 179.677 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.81 -34.83 65.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.417 0.687 . . . . 1.66 110.967 176.28 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.74 -10.04 11.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.821 1.649 . . . . 1.94 111.393 -178.293 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.431 ' O ' HD12 ' A' ' 86' ' ' ILE . 8.7 m 69.46 22.39 6.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.836 2.054 . . . . 1.48 112.318 178.446 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -102.43 156.06 17.85 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 125.291 1.437 . . . . 4.63 111.343 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.06 115.82 7.74 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.089 1.355 . . . . 0.84 110.462 174.618 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 121' ' ' LEU . 3.9 mm? -92.03 126.42 37.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.219 -1.4 . . . . 2.41 107.219 170.736 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.51 HG13 HD11 ' A' ' 108' ' ' ILE . 2.3 t -114.3 131.4 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.928 1.691 . . . . 1.8 107.409 176.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.49 ' CD ' ' HB2' ' A' ' 81' ' ' ASN . 2.1 mmmt -115.07 95.9 5.43 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.038 1.335 . . . . 3.05 110.023 178.45 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.413 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -118.48 -176.77 3.15 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.494 1.118 . . . . 2.09 111.22 -177.133 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -106.77 111.31 63.89 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.097 -1.075 . . . . 3.14 108.097 175.044 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.21 68.3 7.93 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.916 2.411 . . . . 1.77 111.626 -167.339 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -162.57 -42.95 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.471 1.508 . . . . 3.0 109.729 174.481 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.514 HD12 ' HB ' ' A' ' 129' ' ' ILE . 2.0 pp -79.39 -35.98 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.296 0.57 . . . . 2.07 110.168 -175.265 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.514 ' HB ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -131.6 166.02 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.601 1.56 . . . . 1.32 108.955 179.165 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.41 168.44 29.08 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.066 -1.614 . . . . 1.3 109.066 178.076 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.35 -44.59 36.92 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.42 2.746 . . . . 1.39 111.851 -172.278 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -46.08 -42.27 13.32 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.183 1.179 . . . . 6.16 114.183 -177.204 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.51 -47.48 83.75 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.512 -0.475 . . . . 3.25 109.72 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 85.1 mt -58.59 -45.86 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.929 -0.767 . . . . 1.11 108.929 178.503 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 83.6 mt -51.93 -59.47 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.541 -0.911 . . . . 2.05 108.541 174.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -46.24 66.78 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.874 0.761 . . . . 4.17 111.245 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.2 mm -54.66 -50.66 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 121.413 -0.804 . . . . 1.91 110.119 177.211 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.261 2.5 pp -71.14 -26.12 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.01 -1.056 . . . . 1.47 113.653 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.82 -38.77 76.17 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.762 0.71 . . . . 3.22 109.848 168.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -59.84 -40.73 89.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.57 0.7 . . . . 3.18 109.182 -179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 51.2 mt -70.63 -42.01 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.361 0.664 . . . . 1.01 109.827 175.573 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.1 34.19 5.21 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.434 1.493 . . . . 0.91 111.187 -175.535 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -99.88 176.14 5.54 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.098 0.949 . . . . 2.37 110.019 168.823 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -129.86 111.42 12.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.704 -1.591 . . . . 4.34 106.704 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.439 ' HB1' HD12 ' A' ' 84' ' ' LEU . . . -104.0 103.03 12.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.682 1.193 . . . . 1.12 107.982 178.845 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.8 m -109.66 110.33 21.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.664 1.586 . . . . 1.95 107.144 -174.233 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.45 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.405 1.482 . . . . 3.97 111.384 -178.224 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 50.31 33.35 7.33 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.325 0.861 . . . . 3.7 113.325 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.331 -1.318 . . . . 8.97 109.826 -166.699 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 mtt . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 108.011 -1.107 . . . . 8.15 108.011 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.35 114.17 65.54 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 117.274 -1.346 . . . . 5.72 107.471 175.362 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -93.61 148.21 2.25 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.774 2.983 . . . . 3.94 110.423 177.071 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -106.08 129.4 54.18 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.367 -0.833 . . . . 3.43 110.327 -168.0 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -92.83 123.12 35.86 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.617 1.167 . . . . 5.93 109.896 -171.043 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 t -108.99 124.29 50.47 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.188 -1.042 . . . . 2.38 108.188 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -102.47 103.66 14.05 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.187 1.395 . . . . 3.11 107.48 -178.348 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.1 pt? -130.63 173.99 10.35 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.926 0.869 . . . . 2.79 111.036 176.087 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.44 150.29 42.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.032 -0.986 . . . . 2.2 108.757 173.535 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 44' ' ' ALA . 39.2 mm -99.32 113.73 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 106.51 -1.663 . . . . 1.37 106.51 173.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -99.47 93.46 5.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.587 -1.264 . . . . 3.01 107.587 175.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.18 -77.29 0.08 OUTLIER Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.637 -0.985 . . . . 1.28 110.637 178.902 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.0 mmt 54.31 88.27 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.291 1.836 . . . . 2.13 113.79 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 m -55.85 -64.39 0.87 Allowed 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.259 -0.901 . . . . 2.55 112.477 177.493 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.7 t -169.7 56.19 0.04 OUTLIER 'General case' 0 C--N 1.345 0.397 0 CA-C-N 118.46 0.573 . . . . 3.33 109.945 -176.172 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 41.47 49.09 3.49 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.769 1.227 . . . . 5.61 112.707 178.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.4 t -164.18 -45.13 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.304 0.642 . . . . 2.81 110.264 -172.584 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.5 t -66.44 -36.82 83.75 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 120.743 -1.223 . . . . 1.83 110.277 -178.37 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.8 t -63.58 -30.63 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.657 0.741 . . . . 1.75 110.012 173.423 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -66.33 -31.03 71.57 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.54 -0.725 . . . . 1.95 110.884 175.039 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.74 -48.82 65.38 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.096 -1.003 . . . . 2.99 110.232 169.474 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mt -38.52 -44.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.598 0.759 . . . . 1.49 112.163 171.022 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -42.81 -57.8 2.63 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.536 0.734 . . . . 5.15 112.509 178.412 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -67.23 -40.25 86.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.225 -0.287 . . . . 5.48 110.225 -177.373 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -56.09 -53.53 55.89 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.767 -0.827 . . . . 1.22 108.767 -177.748 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.16 -43.83 97.96 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 119.493 -0.289 . . . . 3.0 111.279 177.228 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -22.21 24.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.872 0.76 . . . . 2.0 112.967 176.635 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -115.53 33.65 5.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.433 0.693 . . . . 3.12 111.549 175.465 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -84.73 -88.81 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.704 -1.591 . . . . 3.34 106.704 168.387 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -143.74 -126.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.908 1.283 . . . . 1.35 109.837 178.147 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.49 32.85 1.38 Allowed Glycine 0 CA--C 1.532 1.139 0 O-C-N 120.7 -1.25 . . . . 2.19 113.709 -171.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.19 117.99 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 106.936 -1.505 . . . . 1.55 106.936 174.815 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.05 53.38 1.57 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.211 1.005 . . . . 3.3 109.718 -178.547 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.5 m -161.84 132.08 4.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.146 -1.427 . . . . 2.12 107.146 171.586 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.75 117.04 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.414 -1.328 . . . . 2.84 107.414 176.781 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 tt -124.87 78.03 1.66 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.332 -0.988 . . . . 2.58 108.332 -179.336 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 t -99.98 137.1 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.182 -0.673 . . . . 2.04 109.182 173.57 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.93 98.39 7.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.543 -0.91 . . . . 1.12 108.543 169.727 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.94 -8.66 7.57 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.205 1.002 . . . . 3.04 112.865 175.274 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.3 mtt -80.34 -48.63 12.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.113 0.965 . . . . 4.15 110.011 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.59 -27.3 17.44 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.793 0.837 . . . . 1.24 111.805 -175.118 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 61.67 2.25 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.764 -0.934 . . . . 1.16 110.764 -177.107 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -140.0 139.08 35.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.38 -1.711 . . . . 2.72 106.38 173.141 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -111.21 105.1 13.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.439 1.087 . . . . 1.18 109.91 165.829 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -97.63 133.68 41.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.538 -2.023 . . . . 3.67 105.538 164.797 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 pt -129.94 167.05 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.54 -1.281 . . . . 2.09 107.54 169.377 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.37 105.12 10.59 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 124.393 1.077 . . . . 5.33 108.794 172.671 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.631 ' HB2' HD12 ' A' ' 53' ' ' ILE . 12.9 p90 -104.66 -179.51 3.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.255 1.822 . . . . 2.85 111.46 175.79 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.4 108.18 17.54 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.342 1.057 . . . . 3.83 111.316 175.476 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.43 -7.97 22.36 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.242 2.628 . . . . 2.11 113.586 -168.0 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.41 -16.37 57.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.222 0.919 . . . . 3.17 111.393 173.75 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.9 t -124.73 -47.89 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 118.476 0.58 . . . . 2.5 110.23 -172.225 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.631 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -116.85 146.79 20.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.014 0.925 . . . . 1.61 109.029 -173.425 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -123.48 154.88 66.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 124.213 1.005 . . . . 2.96 113.178 179.68 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.87 -38.19 81.14 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.547 2.165 . . . . 1.55 111.243 174.306 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 3.1 mp -54.44 -60.54 3.2 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.391 -0.818 . . . . 2.95 111.494 178.475 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -57.13 -35.29 69.3 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.325 -0.859 . . . . 3.86 112.734 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.502 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -55.28 -41.45 61.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.94 -0.763 . . . . 1.25 108.94 171.947 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 56' ' ' LEU . . . -59.51 -38.59 81.34 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.076 -0.511 . . . . 1.62 111.341 -179.619 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -63.48 -51.15 66.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.197 -0.939 . . . . 3.02 109.98 175.025 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.22 -52.22 59.62 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.376 0.608 . . . . 2.25 111.424 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.547 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.3 pp -65.46 -37.82 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.283 -0.886 . . . . 4.21 112.308 -179.567 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.93 -31.88 71.94 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.04 0.837 . . . . 2.94 110.683 177.232 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.57 -52.45 63.38 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 109.252 -0.647 . . . . 3.53 109.252 174.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -55.0 -42.71 72.85 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.673 0.249 . . . . 3.51 111.673 172.03 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.28 48.39 0.43 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.293 0.949 . . . . 1.3 111.129 171.233 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -135.04 162.92 31.08 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.509 1.124 . . . . 2.34 109.675 -176.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -100.27 122.99 43.95 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.892 1.277 . . . . 2.96 107.623 167.808 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.547 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -104.16 82.67 1.98 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.512 1.525 . . . . 0.87 108.824 172.154 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.66 101.82 13.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.611 -1.177 . . . . 1.67 108.985 -176.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -70.36 158.28 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.438 1.495 . . . . 3.45 112.08 176.649 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -56.01 -50.58 70.47 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.853 -1.067 . . . . 6.49 111.287 167.246 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.86 61.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.008 1.323 . . . . 7.26 108.537 -175.394 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -17.11 71.56 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 130.107 3.363 . . . . 10.55 117.005 -173.536 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 83' ' ' GLU . 5.3 p90 -95.89 -56.2 2.74 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.51 -1.223 . . . . 6.15 113.533 -167.411 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . 0.252 . . 125.56 -108.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 130.374 3.47 . . . . 4.65 110.255 177.359 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 82' ' ' ILE . . . 99.17 79.68 1.47 Allowed Glycine 0 C--N 1.336 0.548 0 CA-C-N 119.981 1.264 . . . . 2.79 114.41 167.465 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.4 t 178.22 -28.88 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.766 2.026 . . . . 5.28 111.113 168.46 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -78.71 -139.8 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.009 -0.737 . . . . 4.97 109.009 177.819 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.84 9.39 59.91 Favored Glycine 0 N--CA 1.443 -0.889 0 O-C-N 120.332 -1.48 . . . . 2.87 110.487 166.555 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.487 ' CG ' ' HE3' ' A' ' 123' ' ' LYS . 22.1 t-20 -106.01 131.83 52.83 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 117.599 0.7 . . . . 3.66 109.909 153.542 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.585 ' H ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -141.54 169.0 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 130.776 3.63 . . . . 3.13 105.627 175.937 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.466 ' HB2' ' CE2' ' A' ' 75' ' ' TYR . 2.0 tt0 -117.06 119.79 36.35 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.953 1.701 . . . . 4.14 110.07 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.2 mt -113.63 137.62 51.34 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.316 0.646 . . . . 2.3 109.444 -179.086 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 m -100.48 131.11 46.57 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 108.171 -1.048 . . . . 1.68 108.171 173.252 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.518 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.5 OUTLIER -95.53 122.62 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.748 1.619 . . . . 1.9 107.762 175.64 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 63.8 m -112.22 134.59 53.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.922 -1.14 . . . . 1.76 107.922 175.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 112.14 -36.3 4.22 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.495 1.045 . . . . 1.72 111.557 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.512 ' HE3' HD13 ' A' ' 86' ' ' ILE . 2.9 tmm? -57.32 129.47 41.92 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.183 0.593 . . . . 2.23 111.204 -178.727 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -157.03 91.96 1.23 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.072 -1.455 . . . . 3.25 107.072 169.118 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 63.3 m 84.2 -134.18 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.593 1.957 . . . . 4.9 111.087 178.007 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 60.07 -6.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.059 1.744 . . . . 6.89 114.581 -170.646 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.46 29.42 11.09 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.408 -0.807 . . . . 4.07 110.186 -158.225 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -33.43 69.29 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 123.079 1.418 . . . . 2.31 111.358 -171.986 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.4 t -52.53 -43.42 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.862 1.665 . . . . 1.68 110.561 174.583 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -58.01 -47.81 81.93 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.462 1.125 . . . . 2.68 108.526 -176.053 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.251 1.2 p-10 -70.99 -38.35 72.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.84 -1.073 . . . . 3.32 112.003 179.076 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.5 mt -57.14 -54.11 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.815 1.188 . . . . 0.96 109.906 173.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -52.83 -49.95 64.68 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 108.717 -0.845 . . . . 2.9 108.717 176.391 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.2 t -52.4 -51.67 57.84 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 122.021 -0.424 . . . . 1.5 111.945 177.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -61.56 -40.07 93.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.174 -0.954 . . . . 2.58 111.414 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.8 mt -63.58 -60.81 2.86 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.534 0.607 . . . . 1.99 110.145 175.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.6 m -54.33 -20.18 6.76 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.315 1.446 . . . . 1.86 112.321 177.427 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.5 mtp-105 -61.8 -28.82 69.73 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.802 0.667 . . . . 4.69 112.802 172.811 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.1 p -69.53 166.19 19.42 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 119.828 1.194 . . . . 2.3 110.892 -179.604 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.75 -39.61 30.66 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.071 -0.393 . . . . 3.51 111.346 176.721 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.33 -50.46 7.43 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 112.256 -0.338 . . . . 1.16 112.256 -170.673 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.68 144.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.851 -1.166 . . . . 3.27 107.851 176.309 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.0 m -142.51 -44.9 0.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.473 0.709 . . . . 3.27 109.845 171.468 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -100.51 103.36 14.69 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.016 -1.846 . . . . 2.3 106.016 176.63 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.04 149.01 41.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.501 -1.296 . . . . 0.98 107.501 165.435 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.9 m -142.87 135.71 27.97 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.213 -1.032 . . . . 1.93 108.213 162.779 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.41 118.68 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.53 1.532 . . . . 2.43 106.939 -177.756 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.06 105.51 10.7 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.902 1.281 . . . . 1.32 110.3 -171.713 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pp -74.05 -39.07 63.77 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 125.851 1.66 . . . . 2.04 111.878 -172.076 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.71 -40.39 62.94 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.194 0.998 . . . . 1.41 110.901 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.07 -12.51 24.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.779 1.232 . . . . 1.88 111.08 175.88 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.2 m 54.1 43.52 30.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.883 1.273 . . . . 1.55 111.925 -176.34 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -128.22 163.43 24.73 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 117.618 0.19 . . . . 3.33 110.734 166.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.96 136.9 32.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.281 1.432 . . . . 1.01 108.702 173.039 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -117.81 136.36 53.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.201 1.4 . . . . 2.46 107.583 171.916 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.4 m -134.3 136.11 53.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 116.805 -1.569 . . . . 2.1 107.327 -177.419 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.487 ' HE3' ' CG ' ' A' ' 81' ' ' ASN . 4.1 mtpt -115.25 105.13 12.52 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 120.456 1.48 . . . . 3.36 108.453 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -115.15 179.81 3.85 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.289 1.435 . . . . 2.75 110.894 175.218 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -100.51 117.37 63.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 125.089 1.355 . . . . 3.03 108.355 173.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -82.52 57.9 6.29 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.663 2.242 . . . . 1.95 112.351 -168.701 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -147.38 -49.57 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.482 1.513 . . . . 3.86 108.661 174.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pt -77.28 -33.25 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 122.382 -0.199 . . . . 1.62 111.05 -176.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.24 165.7 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.289 1.036 . . . . 1.43 108.373 -177.406 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.23 165.65 33.88 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.273 -1.131 . . . . 1.38 110.273 -175.129 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.71 -35.73 78.39 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.698 2.932 . . . . 1.57 112.637 -170.283 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 10.2 mtt-85 -50.99 -40.53 58.23 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.897 0.702 . . . . 6.13 112.897 178.714 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.46 -46.8 84.57 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.306 0.574 . . . . 3.39 109.645 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.68 -45.01 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.504 0.721 . . . . 1.06 109.574 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.7 mt -55.98 -58.64 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 108.704 -0.85 . . . . 2.03 108.704 175.023 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -49.28 -49.59 42.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.747 1.158 . . . . 3.6 112.851 177.153 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 52.0 mt -48.68 -56.21 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.612 -0.514 . . . . 2.44 109.612 176.039 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.253 2.2 pp -70.84 -26.68 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 113.509 0.929 . . . . 1.52 113.509 -178.294 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.37 -38.58 80.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.311 0.959 . . . . 2.5 109.683 168.642 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -66.08 -39.85 90.38 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.444 -0.576 . . . . 3.23 109.444 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.1 mt -62.23 -38.84 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.873 -0.417 . . . . 1.26 109.873 169.319 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.72 29.24 9.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.762 1.649 . . . . 0.98 110.825 -177.096 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -100.31 178.99 4.6 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 117.982 0.891 . . . . 2.31 108.99 175.21 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -127.88 104.51 7.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.609 -1.256 . . . . 4.16 107.609 -178.477 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.68 103.84 15.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.136 -1.431 . . . . 1.28 107.136 174.205 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.4 t -97.12 -179.19 4.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.236 -1.394 . . . . 2.26 107.236 169.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.5 117.94 22.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.278 -1.749 . . . . 4.0 106.278 171.772 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.56 90.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.862 -0.421 . . . . 3.35 109.862 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 C--O 1.249 1.048 0 C-N-CA 127.192 2.197 . . . . 6.38 111.22 -178.473 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 mmt . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 107.22 -1.4 . . . . 11.84 107.22 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.12 87.65 39.71 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.187 0.995 . . . . 7.12 111.097 -166.142 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.04 155.55 67.62 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 121.953 1.769 . . . . 5.95 109.809 172.25 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.53 158.93 43.29 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.082 0.953 . . . . 7.42 108.589 172.58 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.19 153.88 17.85 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.198 -1.408 . . . . 5.85 107.198 166.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 117.97 21.68 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.509 -1.293 . . . . 3.65 107.509 178.01 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -99.89 102.67 14.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.277 1.831 . . . . 5.4 109.849 -176.061 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 44' ' ' ALA 0.277 0.0 OUTLIER -130.3 159.86 35.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.185 0.993 . . . . 2.46 111.572 176.223 . . . . . . . . 4 4 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -113.63 152.05 30.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.001 -1.0 . . . . 2.18 108.375 173.273 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mm -99.95 137.89 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 106.437 -1.69 . . . . 1.07 106.437 175.752 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -119.38 98.55 6.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.27 -1.011 . . . . 3.79 108.27 169.718 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.45 -94.65 0.13 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 109.119 -1.592 . . . . 1.81 109.119 177.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 mtp 67.86 90.48 0.09 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.012 1.725 . . . . 2.33 113.503 173.366 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -57.4 -28.55 63.34 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.973 0.731 . . . . 3.01 112.973 175.599 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 t 78.38 -48.5 0.46 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.009 1.324 . . . . 4.99 112.068 177.859 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -36.15 -70.01 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.802 1.641 . . . . 4.41 112.063 -179.119 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.3 p -161.49 18.99 0.11 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.254 0.465 . . . . 2.68 112.254 172.244 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 27.1 m -70.23 -52.12 25.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.329 -0.989 . . . . 2.53 108.329 -170.292 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.53 -39.27 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 109.702 -0.481 . . . . 2.93 109.702 177.756 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -61.95 -37.51 85.0 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.933 0.893 . . . . 2.1 113.344 177.891 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -41.29 64.0 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.732 -1.23 . . . . 2.86 110.866 171.201 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.441 HG12 HD13 ' A' ' 65' ' ' LEU . 88.0 mt -60.29 -48.62 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.258 1.023 . . . . 1.88 110.18 -174.354 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HB2' HG11 ' A' ' 35' ' ' VAL . 1.8 pp20? -51.52 -45.62 63.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.632 0.73 . . . . 4.34 111.079 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -64.6 -43.59 93.31 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 124.654 1.182 . . . . 6.51 110.343 -179.15 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.91 -52.27 64.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.129 -0.487 . . . . 1.95 109.825 173.914 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -29.39 66.48 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.016 0.747 . . . . 1.98 113.016 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -55.0 -22.07 14.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.907 1.23 . . . . 3.41 111.666 174.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -123.93 33.68 5.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.638 0.775 . . . . 4.21 110.182 178.182 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -64.26 0.89 Allowed 'General case' 0 C--N 1.343 0.314 0 N-CA-C 108.796 -0.816 . . . . 2.53 108.796 174.776 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.05 -133.85 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.833 1.253 . . . . 1.53 108.112 -172.114 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.66 -16.96 74.49 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.556 1.071 . . . . 1.94 113.009 -178.901 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 p -60.35 122.4 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 121.949 -0.736 . . . . 2.04 110.279 177.483 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.55 50.55 2.15 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 121.209 0.528 . . . . 4.12 111.119 177.239 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.7 m -155.44 153.73 30.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.299 -1.371 . . . . 3.8 107.299 167.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 23' ' ' GLU . 11.4 p -143.33 132.06 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 104.815 -2.291 . . . . 3.17 104.815 161.57 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 36' ' ' LEU . 2.2 tm? -141.35 83.73 1.88 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.007 -1.108 . . . . 2.6 108.007 174.697 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.0 p -98.8 147.16 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.27 -1.011 . . . . 2.1 108.27 174.649 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.52 103.87 9.81 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.322 -1.362 . . . . 1.92 107.322 167.188 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -27.54 66.4 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.608 0.763 . . . . 2.61 110.817 175.376 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 46.3 mtt -66.26 -58.8 4.58 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.944 0.898 . . . . 3.33 110.209 -178.64 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.75 -25.35 38.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.938 0.495 . . . . 2.08 111.414 -178.228 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.69 57.94 2.79 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.508 1.052 . . . . 1.42 110.878 179.693 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -140.31 147.1 39.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.865 -1.064 . . . . 3.21 108.693 179.423 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.504 ' HB3' HD22 ' A' ' 8' ' ' LEU . . . -124.63 101.17 6.99 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.145 1.378 . . . . 1.73 112.192 177.013 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -99.57 122.62 42.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.004 -1.06 . . . . 4.77 108.375 172.701 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.06 -179.5 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.742 1.155 . . . . 2.62 111.179 171.708 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -134.72 90.28 2.63 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.021 0.928 . . . . 7.69 112.561 -174.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.7 179.93 4.81 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.506 1.122 . . . . 3.77 113.974 -176.469 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -126.16 98.74 32.36 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 128.03 2.532 . . . . 4.87 108.283 176.377 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.62 27.89 0.38 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.917 3.078 . . . . 3.69 113.555 -170.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -108.15 -16.21 14.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.888 1.675 . . . . 4.65 110.669 165.693 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.1 t -116.66 -60.9 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.762 1.225 . . . . 3.25 108.067 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.65 124.99 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.646 0.778 . . . . 2.35 110.297 -177.509 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -101.62 172.08 4.76 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.09 1.756 . . . . 3.0 110.956 -177.645 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -75.45 -15.24 19.89 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.622 1.548 . . . . 2.76 112.259 -178.105 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.257 0.5 OUTLIER -73.08 -60.0 2.44 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.442 -0.786 . . . . 4.56 110.396 175.601 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -57.45 -32.37 66.86 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.284 -0.885 . . . . 2.77 112.281 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.3 tt -55.98 -45.34 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.878 -1.156 . . . . 1.67 107.878 175.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.87 73.56 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.364 -0.835 . . . . 1.94 110.42 -178.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.91 -44.9 94.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 119.459 1.027 . . . . 2.43 110.073 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -55.62 -52.69 62.95 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 109.195 -0.669 . . . . 2.34 109.195 175.326 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 mm -63.15 -41.86 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 120.246 -0.582 . . . . 2.73 111.839 -174.581 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -46.25 89.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.4 1.08 . . . . 2.9 110.421 175.037 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.19 -50.28 74.29 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.154 0.582 . . . . 3.98 109.829 178.555 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.441 HD13 HG12 ' A' ' 22' ' ' ILE . 29.1 mt -55.62 -36.43 66.97 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.311 0.644 . . . . 2.2 110.882 175.654 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.16 28.75 2.98 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 124.082 0.849 . . . . 1.95 111.149 165.698 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -117.53 157.02 27.05 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.995 -1.483 . . . . 3.12 106.995 177.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -96.5 116.36 28.94 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.797 -1.186 . . . . 3.1 107.797 169.466 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.87 123.92 43.45 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 108.096 -1.076 . . . . 1.67 108.096 166.412 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -126.92 132.14 50.95 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.28 -1.007 . . . . 1.84 108.28 170.158 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.485 ' HA ' ' HB3' ' A' ' 8' ' ' LEU . 2.2 t -89.46 160.04 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 124.619 1.168 . . . . 4.25 108.336 -177.236 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.8 mmt -49.95 -64.56 0.77 Allowed 'General case' 0 CA--C 1.534 0.341 0 O-C-N 123.935 0.772 . . . . 5.44 110.472 168.303 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 154.64 65.31 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 130.322 3.449 . . . . 8.31 106.061 -173.407 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 36.34 50.84 0.78 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.289 1.436 . . . . 10.98 111.803 -173.399 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -63.46 -59.53 4.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 112.932 -1.94 . . . . 8.46 109.868 -178.494 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB3' ' CG ' ' A' ' 81' ' ' ASN . . . 55.17 -101.7 0.13 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 128.371 2.668 . . . . 3.39 112.519 175.325 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.83 89.9 0.2 Allowed Glycine 0 CA--C 1.536 1.379 0 C-N-CA 123.998 0.809 . . . . 4.19 113.235 -178.588 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.2 t 179.65 -80.14 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.027 2.131 . . . . 5.58 108.092 171.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.05 132.04 53.41 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 105.13 -2.174 . . . . 6.99 105.13 179.804 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.83 -59.07 4.99 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 122.434 2.379 . . . . 2.79 109.714 160.719 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.412 ' CG ' ' HB3' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -96.34 113.4 24.98 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 104.469 -2.419 . . . . 3.23 104.469 159.532 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.405 HG13 ' CD1' ' A' ' 124' ' ' PHE . 1.4 pp -98.3 158.76 3.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.072 -1.825 . . . . 3.57 106.072 158.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.48 155.69 38.5 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.122 -1.807 . . . . 3.91 106.122 174.166 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.526 HD13 ' HB1' ' A' ' 145' ' ' ALA . 4.2 pp -147.79 163.52 36.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.637 -0.221 . . . . 3.32 111.18 168.283 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 m -98.89 126.49 44.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.602 1.961 . . . . 1.96 107.261 171.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.02 125.5 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.856 -0.794 . . . . 1.62 108.856 176.675 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.5 t -108.03 163.31 13.26 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.326 -0.62 . . . . 3.65 109.326 170.703 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.34 -39.27 2.94 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.846 1.213 . . . . 1.42 112.583 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -58.92 132.73 54.87 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.879 0.871 . . . . 2.5 110.953 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 m -148.01 40.94 0.99 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.904 1.281 . . . . 2.75 109.861 176.355 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -169.19 136.83 1.86 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.88 -1.137 . . . . 2.78 111.1 177.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.13 64.94 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.576 -0.703 . . . . 2.9 112.118 177.917 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.6 t -56.45 -42.08 77.54 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.638 -0.664 . . . . 2.43 110.365 173.589 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 84.5 m -63.24 -44.4 95.31 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.75 -0.833 . . . . 1.75 108.75 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.6 t -53.87 -58.86 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.522 0.729 . . . . 1.63 110.543 175.691 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -57.11 -41.88 79.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.678 0.752 . . . . 4.42 111.316 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -59.77 -55.09 38.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.821 0.848 . . . . 1.95 110.338 177.779 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.8 mt -47.39 -50.63 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 125.657 1.583 . . . . 0.83 109.234 174.677 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -56.53 -47.25 79.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.217 1.007 . . . . 3.76 109.947 177.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.9 m -58.15 -44.21 87.75 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.999 -1.063 . . . . 2.57 111.384 174.806 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.629 ' HG3' HD11 ' A' ' 141' ' ' ILE . 14.3 mmmt -64.28 -50.19 68.87 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.444 -0.785 . . . . 2.96 110.265 -177.101 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.71 -47.23 79.08 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.36 -0.607 . . . . 2.49 109.36 -179.688 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.8 m -58.38 -21.21 49.35 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.034 0.934 . . . . 2.63 112.584 176.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -64.96 -19.17 65.83 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.4 -0.813 . . . . 5.27 112.71 172.342 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.3 m -71.22 150.72 45.02 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.681 1.193 . . . . 1.87 110.431 178.531 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -69.3 -48.94 60.13 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.869 0.868 . . . . 3.09 111.887 179.188 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.43 -28.56 61.44 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 122.287 -0.258 . . . . 2.43 112.939 -166.674 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.51 142.18 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.368 -0.975 . . . . 2.0 108.368 178.437 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 22.4 p -124.21 -39.12 2.37 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.891 0.7 . . . . 3.31 112.891 173.434 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.34 125.26 18.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.246 -1.39 . . . . 3.12 107.246 -178.582 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.88 168.16 12.63 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.376 0.67 . . . . 1.67 110.308 165.171 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.4 m -143.87 128.09 17.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.625 -0.88 . . . . 1.76 108.625 160.531 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 52.1 t -107.32 126.61 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.822 0.849 . . . . 2.59 110.223 178.067 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.76 101.09 6.46 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.075 1.75 . . . . 1.61 110.128 -168.336 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.14 -31.8 62.89 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 126.146 1.778 . . . . 2.09 111.979 -174.253 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.6 -34.18 61.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.783 0.433 . . . . 1.6 110.981 175.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.83 -4.67 19.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.108 1.363 . . . . 2.29 111.218 176.608 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.5 m 59.71 28.8 18.31 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.659 1.183 . . . . 1.62 113.128 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -124.37 165.16 18.2 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.028 0.831 . . . . 2.97 112.973 176.09 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.45 127.28 43.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.573 2.349 . . . . 1.41 107.588 179.382 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.02 123.47 48.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.002 -1.851 . . . . 2.61 106.002 175.802 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.1 t -130.32 123.38 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.163 -1.051 . . . . 1.89 108.163 -170.016 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 96.93 9.73 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.099 -1.445 . . . . 4.26 107.099 176.92 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.405 ' CD1' HG13 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -107.9 -177.87 3.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.449 1.5 . . . . 3.43 111.019 178.309 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -127.2 112.83 21.53 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.059 0.943 . . . . 5.18 108.917 175.736 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.43 50.23 3.44 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.577 3.518 . . . . 2.81 113.523 -171.067 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -141.59 -52.19 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.484 1.513 . . . . 5.85 107.495 171.364 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 pt -80.29 -31.69 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 119.399 -0.334 . . . . 2.5 111.302 -177.262 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.67 164.67 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 110.156 -0.313 . . . . 2.06 110.156 -177.679 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.99 150.24 20.11 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.912 -0.938 . . . . 1.7 111.64 -167.116 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -57.22 -36.62 99.08 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.966 2.444 . . . . 1.75 110.535 178.241 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -34.75 67.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.119 -0.491 . . . . 6.32 111.474 179.136 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -69.99 -44.04 70.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.761 -0.829 . . . . 3.29 108.761 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.424 ' O ' HD13 ' A' ' 138' ' ' ILE . 17.1 mm -52.42 -54.97 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.414 -0.958 . . . . 2.23 108.414 178.16 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.699 HG22 ' HB3' ' A' ' 145' ' ' ALA . 9.4 pt -59.2 -57.01 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 117.885 -1.055 . . . . 2.9 109.879 179.04 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -44.46 -46.59 9.72 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.0 0.818 . . . . 4.73 112.401 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.4 mm -51.07 -60.24 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 118.836 -0.602 . . . . 1.77 110.019 173.047 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.518 HG22 HD12 ' A' ' 141' ' ' ILE 0.29 0.0 OUTLIER -70.4 -26.93 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 117.628 -1.629 . . . . 2.77 113.909 -176.273 . . . . . . . . 4 4 . 1 . 028 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.48 -34.84 78.65 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.783 -0.573 . . . . 2.68 110.538 172.128 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -66.6 -36.13 81.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.884 -0.784 . . . . 2.84 108.884 176.288 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.629 HD11 ' HG3' ' A' ' 101' ' ' LYS . 38.2 mt -65.37 -44.28 94.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 119.84 -0.744 . . . . 1.61 109.691 174.557 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.98 27.86 3.33 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.694 1.14 . . . . 1.44 112.032 -177.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -98.5 -178.18 3.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.863 -1.532 . . . . 2.66 106.863 158.682 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -139.36 130.69 26.85 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.741 -1.207 . . . . 3.83 107.741 174.815 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.699 ' HB3' HG22 ' A' ' 135' ' ' ILE . . . -105.64 117.48 34.13 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.936 -0.765 . . . . 2.08 108.936 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.2 t -109.04 115.55 30.29 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.361 -1.348 . . . . 2.26 107.361 174.415 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.47 115.58 4.0 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.764 -1.198 . . . . 5.25 107.764 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.28 -34.83 20.26 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 123.61 0.569 . . . . 4.0 110.538 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 C--O 1.262 1.735 0 C-N-CA 128.131 2.572 . . . . 5.86 115.633 175.396 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtt . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 117.384 -1.293 . . . . 7.81 107.571 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.69 107.25 1.86 Allowed Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 119.2 0.909 . . . . 3.43 109.788 -170.846 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.03 110.68 2.94 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.672 1.581 . . . . 2.78 111.616 -163.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.44 119.92 21.27 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.35 -0.841 . . . . 3.27 111.822 -165.524 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.5 152.52 20.9 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.445 -1.252 . . . . 3.67 108.899 -178.123 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.615 ' SG ' HD11 ' A' ' 8' ' ' LEU . 21.9 p -143.2 138.55 29.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 123.608 0.567 . . . . 2.49 109.629 167.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.493 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -100.41 109.13 21.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.613 1.565 . . . . 4.25 109.379 177.659 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.615 HD11 ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -124.37 166.91 15.12 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.786 0.803 . . . . 2.99 109.279 172.197 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.3 136.24 54.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.807 -1.553 . . . . 1.77 106.807 176.037 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.6 mm -98.2 136.02 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.593 -1.262 . . . . 0.81 107.593 -177.36 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -114.0 136.51 52.83 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.061 -1.089 . . . . 2.84 108.061 168.175 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.9 -80.6 0.27 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.04 1.781 . . . . 1.12 109.962 -174.03 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.2 mmm 56.91 56.45 5.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.957 2.103 . . . . 2.16 114.521 170.193 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -43.51 -63.95 0.74 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.774 1.398 . . . . 2.21 114.774 -173.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.3 t -167.9 59.47 0.07 Allowed 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.066 0.848 . . . . 3.33 109.621 -176.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 42.86 48.75 5.04 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.476 1.111 . . . . 5.22 111.994 -179.675 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.0 t -161.74 -40.21 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.005 0.522 . . . . 2.57 111.364 -172.307 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.39 -43.5 81.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 118.731 -1.188 . . . . 1.47 109.357 -178.487 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.5 t -55.33 -40.61 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.486 -0.931 . . . . 1.9 108.486 173.868 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -60.19 -37.4 80.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.002 0.43 . . . . 1.95 111.982 177.913 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -45.45 80.85 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.36 -0.838 . . . . 3.09 110.047 173.88 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.49 -47.75 70.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.245 1.018 . . . . 1.36 110.198 176.599 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -50.02 -49.18 51.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.888 0.875 . . . . 4.26 111.478 175.679 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -64.71 -38.23 90.3 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 122.114 -0.366 . . . . 4.85 110.346 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -61.19 -53.05 61.87 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.934 -0.395 . . . . 1.24 109.934 176.471 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.73 -37.26 75.78 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 118.22 0.464 . . . . 2.06 111.381 -179.297 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.58 -19.05 5.19 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.206 0.817 . . . . 1.81 113.206 174.41 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -118.36 20.9 12.92 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.325 0.65 . . . . 3.11 112.499 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -68.16 -62.56 1.34 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.094 0.861 . . . . 2.53 109.866 173.553 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.91 -128.47 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.384 1.474 . . . . 1.18 108.038 -168.239 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.84 14.56 3.53 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 119.487 1.04 . . . . 1.33 115.043 -173.409 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.09 122.26 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.593 1.157 . . . . 1.51 108.133 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.87 53.29 1.38 Allowed 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.448 0.642 . . . . 2.44 110.566 179.116 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 t -160.05 147.13 16.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.555 -1.276 . . . . 1.65 107.555 170.627 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.82 116.0 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 106.608 -1.627 . . . . 2.47 106.608 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 tt -131.67 72.41 1.5 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.851 -1.166 . . . . 2.34 107.851 177.846 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 p -97.27 153.11 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.64 -0.874 . . . . 2.26 108.64 172.646 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.02 100.26 6.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.577 -1.268 . . . . 1.19 107.577 163.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.2 mt -58.05 -19.12 29.19 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.207 1.003 . . . . 2.89 111.762 172.103 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -49.81 64.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.852 0.861 . . . . 4.8 109.696 178.465 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.88 -31.85 13.5 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.121 0.968 . . . . 1.19 111.749 -174.387 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.22 55.3 1.98 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.511 1.053 . . . . 0.93 111.307 -178.423 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.95 131.64 31.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 117.835 -1.079 . . . . 3.15 108.491 177.097 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.406 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -108.49 105.13 14.65 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 125.333 1.453 . . . . 0.94 110.563 170.536 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.5 130.36 45.75 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 106.639 -1.615 . . . . 4.59 106.639 165.146 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.2 pt -133.04 169.6 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-N 119.292 0.951 . . . . 1.91 109.897 170.544 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.7 105.99 12.6 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 124.699 1.199 . . . . 4.01 111.124 172.543 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -98.27 -176.34 3.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.928 2.091 . . . . 2.58 112.188 170.422 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -127.64 111.64 20.77 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.781 1.633 . . . . 3.24 110.151 167.745 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.87 20.13 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.391 3.394 . . . . 2.12 113.885 -173.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -99.27 -39.37 8.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.616 1.166 . . . . 3.86 110.323 169.061 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.3 m -109.74 -34.13 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 118.743 0.701 . . . . 2.72 111.26 -176.278 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.475 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -120.98 130.9 74.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 109.618 -0.512 . . . . 1.64 109.618 176.818 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -110.47 149.18 39.87 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 124.195 0.998 . . . . 3.46 109.878 -179.518 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -54.34 -40.66 81.83 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.408 2.739 . . . . 1.62 112.419 -178.803 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mp -57.54 -49.1 77.44 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.783 -0.573 . . . . 3.94 111.013 177.577 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -60.3 -40.34 90.13 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.183 0.516 . . . . 3.05 110.293 179.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.475 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -54.15 -50.65 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.67 -1.233 . . . . 1.05 107.67 173.181 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.08 -41.63 83.86 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.942 -0.572 . . . . 1.24 110.855 -174.433 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -56.33 -46.03 80.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.173 0.589 . . . . 2.32 110.469 175.009 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.13 -51.59 63.78 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.621 -0.511 . . . . 2.71 109.621 176.03 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 mm -58.17 -45.88 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.784 0.326 . . . . 2.47 111.26 -179.209 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -61.58 -43.06 99.55 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.122 -0.466 . . . . 3.47 111.783 178.004 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.45 -49.02 78.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.6 0.636 . . . . 2.31 110.067 176.403 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -59.63 -27.12 66.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.111 0.564 . . . . 2.1 111.754 175.641 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.0 40.16 2.35 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.596 -1.002 . . . . 1.15 110.596 165.803 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -131.93 170.74 14.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.419 1.488 . . . . 1.88 108.029 178.657 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -115.01 121.46 43.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.351 -0.981 . . . . 3.83 108.351 169.553 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.03 117.7 34.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.381 -1.711 . . . . 0.95 106.381 163.068 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.78 144.18 45.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 105.979 -1.86 . . . . 0.91 105.979 166.83 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.625 HG12 ' H ' ' A' ' 73' ' ' GLU . 45.1 t -71.46 152.17 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.474 -1.306 . . . . 2.41 107.474 -178.188 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.8 ptm -58.55 -28.81 65.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.193 -0.458 . . . . 3.78 110.404 174.313 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.625 ' H ' HG12 ' A' ' 71' ' ' VAL 0.289 14.1 tt0 123.47 -8.85 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.801 1 C-N-CA 132.304 4.242 . . . . 4.4 110.43 175.979 . . . . . . . . 4 3 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -73.61 -55.14 6.68 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 125.361 1.464 . . . . 7.27 111.491 171.462 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.513 ' HB3' HG11 ' A' ' 71' ' ' VAL 0.274 0.4 OUTLIER 60.12 -28.54 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.791 1.774 . . . . 4.24 115.791 -164.431 . . . . . . . . 4 4 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 106.83 -135.93 0.0 OUTLIER 'General case' 0 C--N 1.345 0.403 0 C-N-CA 129.372 3.069 . . . . 3.57 111.625 170.763 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.88 77.87 0.34 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 127.691 2.567 . . . . 3.47 108.149 169.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.66 76.66 0.29 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.928 0.891 . . . . 6.5 109.302 174.359 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 2.95 99.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 129.396 3.079 . . . . 4.13 114.183 -173.685 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.37 -1.23 66.66 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.519 -1.032 . . . . 2.09 110.519 -168.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.458 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 15.0 t30 -143.31 95.43 2.75 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 119.803 1.802 . . . . 2.79 110.911 172.564 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.33 145.52 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 C-N-CA 126.095 1.758 . . . . 4.71 108.169 178.637 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 74' ' ' ASP . 0.3 OUTLIER -109.4 148.25 31.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.071 1.348 . . . . 3.44 110.629 173.173 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -140.89 161.4 37.92 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.296 1.038 . . . . 2.41 109.069 -178.175 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.09 138.57 35.19 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 120.181 1.355 . . . . 2.19 109.069 172.235 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.501 HD13 HD13 ' A' ' 98' ' ' ILE . 6.2 mt -94.98 117.14 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.731 -1.211 . . . . 2.67 107.731 176.572 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 21.4 m -98.46 124.63 43.28 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.252 -1.388 . . . . 1.41 107.252 171.184 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.82 -43.75 1.51 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.116 1.341 . . . . 1.02 111.337 175.616 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.88 121.65 8.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.726 0.81 . . . . 2.42 110.938 174.523 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -166.09 26.33 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.842 0.857 . . . . 2.91 111.074 166.07 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 31.1 p -172.47 168.21 5.46 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.296 -0.878 . . . . 5.47 110.026 -167.557 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 58.99 6.9 0.72 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.983 2.113 . . . . 7.23 113.574 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.5 m 38.11 47.47 0.96 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.336 0.589 . . . . 4.43 110.734 -154.646 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.6 p -55.15 -21.99 15.39 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.711 1.204 . . . . 2.39 112.417 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.523 HG13 ' CG2' ' A' ' 113' ' ' VAL . 7.2 t -30.0 -55.9 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.029 1.332 . . . . 1.47 111.327 157.036 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -58.85 -40.23 83.66 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.189 0.596 . . . . 3.66 111.067 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.672 HD21 HD13 ' A' ' 141' ' ' ILE . 3.1 t30 -64.87 -46.65 80.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.866 -0.521 . . . . 2.08 110.008 177.026 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.501 HD13 HD13 ' A' ' 86' ' ' ILE . 96.9 mt -59.97 -52.51 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.143 0.577 . . . . 0.95 110.029 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -55.73 -43.62 76.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.568 1.947 . . . . 2.44 108.966 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.5 t -59.74 -51.35 70.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.792 -0.567 . . . . 1.9 110.064 174.329 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -53.87 -53.85 46.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.85 0.75 . . . . 2.52 110.705 -178.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.48 -48.52 74.91 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.545 -0.462 . . . . 2.76 110.318 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.5 m -63.27 -19.44 64.57 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.369 1.068 . . . . 1.79 112.235 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.5 mtt-85 -63.28 -21.59 66.34 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.373 -0.823 . . . . 4.87 111.52 170.582 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.36 169.53 17.12 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.557 1.071 . . . . 3.04 110.422 -177.962 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -80.12 -47.53 14.64 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.164 0.586 . . . . 2.26 111.656 -175.804 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.72 -37.57 66.96 Favored Glycine 0 CA--C 1.524 0.606 0 O-C-N 122.139 -0.351 . . . . 1.09 113.006 -168.479 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.74 123.49 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 122.111 -0.64 . . . . 2.1 109.432 -173.501 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.7 m -101.56 -51.78 3.38 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 122.477 0.311 . . . . 1.97 111.497 -178.032 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CE1' ' HG3' ' A' ' 123' ' ' LYS . 27.4 p90 -140.55 111.34 6.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.049 -0.722 . . . . 2.3 109.049 -177.779 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.15 155.05 16.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.889 -0.782 . . . . 1.09 108.889 166.786 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.8 p -143.73 92.97 2.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.787 -1.19 . . . . 1.87 107.787 169.07 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.523 ' CG2' HG13 ' A' ' 95' ' ' VAL . 2.4 m -96.52 140.02 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.241 -1.022 . . . . 2.33 108.241 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.37 108.15 8.02 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.851 0.86 . . . . 1.42 109.54 -168.368 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.38 -27.78 65.61 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.154 0.798 . . . . 2.25 113.154 -171.449 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.61 71.52 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.138 0.975 . . . . 1.74 110.05 -176.518 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.3 -28.33 13.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.702 2.001 . . . . 1.77 109.334 175.864 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.2 m 71.92 40.55 0.73 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.13 1.772 . . . . 2.22 110.429 -174.539 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -101.21 163.31 12.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 123.839 0.712 . . . . 5.82 110.818 172.168 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.82 108.17 5.54 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.104 2.161 . . . . 0.96 109.105 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 83' ' ' GLU . 2.8 mp -96.68 131.0 43.8 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.697 -1.223 . . . . 2.13 107.697 178.299 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.477 HG11 ' CD1' ' A' ' 134' ' ' ILE . 69.9 t -131.36 113.65 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.452 1.101 . . . . 1.77 108.538 -173.363 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HG3' ' CE1' ' A' ' 110' ' ' TYR . 0.7 OUTLIER -99.84 92.53 5.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 117.78 -1.105 . . . . 4.27 110.351 176.375 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -109.82 -177.15 3.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.682 0.674 . . . . 2.28 110.817 176.624 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -108.24 115.95 57.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.789 -1.189 . . . . 3.05 107.789 173.758 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.47 68.94 8.16 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.042 2.495 . . . . 2.12 111.841 -162.752 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -161.67 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.79 1.236 . . . . 3.0 109.613 175.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.4 pt -80.25 -39.2 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 123.964 0.906 . . . . 1.69 110.811 -174.629 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.93 170.71 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.906 0.882 . . . . 1.55 108.657 178.81 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.05 159.46 28.03 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.443 -1.063 . . . . 1.8 110.443 178.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.34 -32.17 72.59 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.32 2.68 . . . . 2.52 110.719 -175.714 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -51.53 -37.42 49.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.508 1.123 . . . . 8.04 111.016 175.794 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.34 -45.22 66.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.607 -1.257 . . . . 2.78 107.607 -176.138 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.477 ' CD1' HG11 ' A' ' 122' ' ' VAL . 88.6 mt -60.73 -52.66 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 118.542 -0.742 . . . . 1.44 109.213 -177.714 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.72 HG22 ' HB3' ' A' ' 145' ' ' ALA . 17.3 pt -50.55 -57.09 2.85 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 108.617 -0.883 . . . . 3.92 108.617 175.512 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -54.39 -44.11 72.02 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.461 0.911 . . . . 5.95 113.461 -177.575 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.3 mm -55.65 -50.23 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.468 -0.568 . . . . 1.97 109.468 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.478 ' HA ' HD12 ' A' ' 141' ' ' ILE . 25.3 pt -71.06 -28.14 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.907 -1.121 . . . . 2.15 112.725 -179.226 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -59.05 -30.97 68.43 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.225 0.921 . . . . 3.55 110.293 173.623 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.08 -42.74 95.25 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.579 -0.526 . . . . 2.58 109.579 174.608 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.672 HD13 HD21 ' A' ' 97' ' ' ASN . 25.4 mt -71.91 -33.17 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.273 0.629 . . . . 1.22 109.845 178.263 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.53 22.05 7.97 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.347 1.451 . . . . 1.21 111.249 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.472 ' CD2' HD11 ' A' ' 98' ' ' ILE . 9.8 m-85 -105.8 157.13 17.67 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.143 0.971 . . . . 1.93 108.866 167.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -126.18 138.28 53.64 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 107.713 -1.218 . . . . 3.44 107.713 -179.334 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.72 ' HB3' HG22 ' A' ' 135' ' ' ILE . . . -111.06 110.5 21.07 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.622 1.169 . . . . 1.61 108.342 178.986 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 68.2 m -141.47 122.89 14.96 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.022 -1.466 . . . . 2.07 110.483 176.56 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 0.05 103.33 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.936 2.894 . . . . 5.73 114.633 174.718 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.03 -35.61 66.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.668 -0.682 . . . . 5.87 111.333 177.624 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.012 -1.471 . . . . 8.77 113.828 -177.85 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mtt . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 105.874 -1.898 . . . . 8.32 105.874 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.02 103.99 8.47 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 120.692 1.587 . . . . 3.71 110.25 -171.794 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.56 110.44 2.42 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.762 1.641 . . . . 2.61 112.015 -167.369 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -117.52 132.73 56.49 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.329 1.452 . . . . 2.8 109.782 -176.118 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -95.27 137.6 34.11 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.623 -1.251 . . . . 3.4 107.623 -170.429 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 16.7 t -125.03 145.28 49.98 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 123.89 0.876 . . . . 2.04 109.004 176.645 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -121.05 91.2 3.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.749 1.62 . . . . 3.61 108.976 -172.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.548 HD12 ' HB3' ' A' ' 44' ' ' ALA . 3.1 pp -124.29 167.59 14.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.046 0.45 . . . . 3.01 110.834 178.8 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.44 168.92 8.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.917 -1.142 . . . . 3.8 107.917 163.775 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.9 mm -102.04 122.28 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 105.064 -2.199 . . . . 1.16 105.064 164.214 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.47 99.41 11.07 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 104.837 -2.282 . . . . 3.79 104.837 178.822 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.81 -59.75 0.38 Allowed Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.418 -0.657 . . . . 1.1 112.193 178.019 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.6 mtp 21.68 84.91 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.332 2.653 . . . . 1.87 114.399 -178.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 p -57.03 -56.49 21.08 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.911 -0.566 . . . . 2.87 112.36 -175.056 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.9 m 135.23 -60.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 129.013 2.925 . . . . 3.84 108.434 -179.361 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.89 -69.51 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.506 1.923 . . . . 5.2 112.644 -165.301 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 p -163.98 28.07 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 122.477 1.132 . . . . 2.52 109.945 163.595 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.5 t -75.06 -41.14 59.61 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.477 -0.783 . . . . 1.71 110.346 -168.069 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.58 -43.87 66.62 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 N-CA-C 108.566 -0.901 . . . . 2.88 108.566 170.172 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -44.85 80.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.203 -0.453 . . . . 1.93 110.326 179.391 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -37.26 86.67 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 121.976 -0.453 . . . . 3.36 111.138 176.867 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.63 -46.12 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 123.808 0.843 . . . . 2.8 110.161 175.168 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -57.74 -49.57 76.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.757 0.313 . . . . 4.25 110.791 -179.076 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -33.4 75.84 Favored 'General case' 0 CA--C 1.521 -0.149 0 O-C-N 121.726 -0.609 . . . . 5.95 110.978 -179.18 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -67.24 -60.33 2.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.127 -0.694 . . . . 1.57 109.127 178.274 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.557 HD21 HD11 ' A' ' 62' ' ' ILE . 10.2 mt -53.73 -50.49 65.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 119.005 -0.522 . . . . 2.55 111.828 179.636 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -62.29 -18.25 60.8 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.788 1.176 . . . . 2.97 113.261 -176.335 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm -95.38 0.05 53.09 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.501 1.297 . . . . 4.14 114.501 171.194 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.12 -60.26 3.12 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 120.244 1.384 . . . . 3.08 110.59 175.182 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.41 -97.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.917 1.687 . . . . 1.15 109.4 175.141 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.9 -0.64 82.38 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 121.873 -0.517 . . . . 1.2 113.773 -171.728 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.71 114.83 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 CA-C-N 118.652 1.226 . . . . 1.4 109.251 178.293 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mp -131.12 52.04 2.09 Favored 'General case' 0 C--N 1.338 0.086 0 N-CA-C 108.982 -0.748 . . . . 3.18 108.982 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.8 t -159.56 120.17 3.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.332 -1.359 . . . . 1.67 107.332 171.444 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.5 m -107.76 122.38 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.624 1.17 . . . . 2.5 108.597 173.471 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tt -137.93 82.35 1.91 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.921 -0.712 . . . . 2.35 109.693 172.516 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 t -102.58 127.16 56.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 116.231 -0.441 . . . . 1.84 110.839 173.738 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.51 97.75 9.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.367 -1.346 . . . . 1.06 107.367 168.428 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.95 -26.29 62.08 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.097 0.559 . . . . 2.84 110.835 173.151 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.7 mtt -68.03 -57.97 5.26 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.204 1.001 . . . . 3.25 110.324 -178.377 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.98 -25.23 30.19 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.069 0.548 . . . . 1.25 111.56 -177.019 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.81 61.16 2.32 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 124.771 1.177 . . . . 0.97 110.798 -178.763 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -142.17 131.75 23.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.142 -1.429 . . . . 2.66 107.142 174.436 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.548 ' HB3' HD12 ' A' ' 8' ' ' LEU . . . -110.45 102.25 10.88 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 124.631 1.207 . . . . 0.87 110.688 171.129 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.41 138.84 39.6 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.831 -1.174 . . . . 4.17 107.831 168.563 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.24 166.55 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.392 -1.336 . . . . 2.01 107.392 -177.693 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -124.49 90.46 3.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.576 0.751 . . . . 3.7 109.765 -172.362 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.456 ' HB2' HD12 ' A' ' 53' ' ' ILE . 9.7 p90 -95.3 -177.99 4.29 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.648 1.979 . . . . 2.23 112.155 -176.858 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.78 94.85 24.14 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.724 1.61 . . . . 2.97 108.946 -176.931 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -55.81 -22.63 38.14 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.253 2.635 . . . . 2.15 113.828 -174.146 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -64.13 -32.34 73.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.448 1.099 . . . . 3.56 112.37 177.967 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.75 -26.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 113.536 0.939 . . . . 2.62 113.536 -175.188 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -123.44 133.22 69.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 N-CA-C 108.436 -0.95 . . . . 1.42 108.436 174.065 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -107.2 154.26 40.59 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.603 1.161 . . . . 3.16 110.088 175.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -60.5 -35.72 89.27 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.587 2.191 . . . . 1.33 111.261 -178.616 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 pp -60.89 -43.57 98.3 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.567 -0.708 . . . . 3.7 112.152 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.02 -40.65 78.54 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.298 0.639 . . . . 3.7 109.418 177.835 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.431 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -49.92 -51.68 15.82 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 106.883 -1.525 . . . . 1.12 106.883 173.09 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.47 -42.34 82.39 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.476 -0.784 . . . . 1.23 109.715 -175.805 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.35 -48.56 71.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.607 0.763 . . . . 3.53 110.021 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -44.09 92.34 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.296 0.57 . . . . 2.46 109.604 179.699 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.557 HD11 HD21 ' A' ' 26' ' ' LEU . 8.9 mm -62.6 -44.46 99.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 O-C-N 121.817 -0.552 . . . . 2.75 110.994 179.155 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -63.62 -45.26 91.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.627 -0.508 . . . . 2.34 109.627 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.29 -50.4 71.5 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.773 0.829 . . . . 2.21 110.194 177.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.42 HD12 ' C ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -65.73 -36.19 82.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 121.193 -0.203 . . . . 3.44 110.469 -175.952 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 129.43 26.5 0.88 Allowed Glycine 0 C--N 1.34 0.799 0 CA-C-O 119.792 -0.449 . . . . 1.63 112.988 164.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -118.66 177.94 4.65 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.015 0.926 . . . . 1.99 110.985 173.033 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.54 142.13 41.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.856 -1.535 . . . . 2.33 106.856 160.523 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.4 131.95 55.75 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.095 -1.076 . . . . 1.07 108.095 163.648 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.4 124.87 26.41 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.71 -0.478 . . . . 1.04 109.71 174.227 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.02 148.42 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.844 1.658 . . . . 2.56 109.266 172.636 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.5 mtp -46.47 -52.96 12.11 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.856 0.722 . . . . 3.69 110.986 -177.944 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -165.87 108.44 0.77 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 100.938 -3.727 . . . . 5.01 100.938 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.37 122.34 9.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.978 1.263 . . . . 10.38 112.311 -165.358 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.451 ' CZ ' ' HA3' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -152.72 -74.48 0.13 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.28 -1.782 . . . . 6.22 108.402 -160.165 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 94.48 -89.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 126.993 2.117 . . . . 3.83 109.034 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.451 ' HA3' ' CZ ' ' A' ' 75' ' ' TYR . . . 81.93 87.39 0.69 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 114.618 0.607 . . . . 2.84 114.618 172.317 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.6 t -163.0 -42.66 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 119.062 -0.494 . . . . 4.81 111.559 164.605 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -146.84 136.19 22.76 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.071 -1.455 . . . . 4.41 107.071 176.094 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.2 -62.29 4.6 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 106.935 -2.466 . . . . 1.59 106.935 176.658 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.45 133.08 43.33 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.405 1.482 . . . . 2.47 107.634 169.387 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.59 ' H ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -142.22 161.22 19.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 129.387 3.075 . . . . 3.25 104.977 166.342 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.409 ' HB3' ' CE1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -116.64 153.34 32.48 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.182 -1.784 . . . . 3.48 106.182 167.016 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mp -127.17 147.01 50.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.745 0.653 . . . . 2.2 110.077 162.712 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.3 m -92.97 117.3 29.9 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.909 -1.515 . . . . 2.26 106.909 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.437 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.6 OUTLIER -96.41 104.24 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 123.768 0.827 . . . . 1.63 109.415 -174.563 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.3 m -96.9 136.14 37.88 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.522 -1.288 . . . . 1.4 107.522 175.556 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.22 -33.31 4.58 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.701 1.143 . . . . 1.09 112.124 177.705 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.7 ptp -64.05 160.72 17.45 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.372 0.586 . . . . 2.27 112.54 -177.656 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 t -172.41 40.03 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.167 0.987 . . . . 2.63 110.394 168.524 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -164.76 133.7 3.54 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.04 -1.038 . . . . 2.68 111.711 -176.443 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.55 81.72 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.071 0.548 . . . . 2.66 111.174 177.366 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.8 t -56.46 -47.64 78.74 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.228 -0.92 . . . . 2.23 109.825 174.449 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.4 m -60.25 -43.95 95.67 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.874 -0.516 . . . . 2.13 110.366 177.455 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.65 -50.62 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 O-C-N 122.332 -0.23 . . . . 1.78 111.286 177.072 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -59.19 -39.24 81.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.075 0.95 . . . . 3.68 109.673 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -62.56 -50.6 70.68 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.626 0.37 . . . . 1.99 110.128 176.865 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.415 HD11 ' CE2' ' A' ' 143' ' ' PHE . 51.0 mt -55.99 -55.95 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.842 -0.429 . . . . 1.33 109.842 177.517 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.52 -42.45 67.42 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.716 0.807 . . . . 3.0 110.86 177.795 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 p -62.69 -52.05 64.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.536 1.062 . . . . 1.75 110.843 177.212 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -63.6 -39.45 94.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.133 0.879 . . . . 5.58 111.286 -174.235 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.89 -46.25 65.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.241 -0.885 . . . . 2.58 109.24 177.544 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 95.9 m -55.84 -26.03 44.78 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.206 0.912 . . . . 1.7 111.563 176.004 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -61.65 -20.45 63.41 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.376 0.88 . . . . 4.35 113.376 174.075 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.9 m -66.3 150.79 48.31 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.154 1.382 . . . . 1.77 110.909 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -68.34 -50.82 50.61 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.05 0.94 . . . . 2.36 111.756 177.375 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.99 -26.67 61.76 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 123.52 0.581 . . . . 1.23 113.569 -169.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.45 140.35 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.467 -0.938 . . . . 2.85 108.467 -177.21 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 24.8 p -115.49 -64.0 1.38 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 122.621 0.369 . . . . 2.92 111.006 -175.05 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.404 ' CZ ' ' HG3' ' A' ' 123' ' ' LYS . 42.0 p90 -135.57 119.01 16.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.171 -1.048 . . . . 2.91 108.171 174.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.62 161.02 14.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.728 -0.471 . . . . 0.8 109.728 164.709 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.8 t -142.81 111.61 6.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.698 -1.223 . . . . 2.2 107.698 168.169 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 68.9 t -98.93 123.17 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.912 1.285 . . . . 2.31 109.458 -177.885 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -130.11 113.42 14.48 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.041 0.837 . . . . 1.28 112.644 -172.859 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 pp -77.88 -37.98 46.88 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 124.126 0.971 . . . . 2.49 112.853 -171.87 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.67 70.13 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.344 0.592 . . . . 1.43 110.86 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -35.69 16.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.779 1.232 . . . . 1.71 109.633 177.423 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.1 m 90.18 17.53 0.04 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.321 1.848 . . . . 1.82 111.463 175.77 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -125.64 160.42 29.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.626 0.648 . . . . 3.02 110.446 175.693 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -130.74 125.82 34.83 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.127 1.371 . . . . 0.83 108.24 179.146 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -92.55 129.19 38.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.423 -2.065 . . . . 1.71 105.423 177.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.72 139.06 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.312 -0.996 . . . . 1.83 108.312 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 13.0 mmmm -114.76 96.93 5.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.61 0.764 . . . . 3.83 109.602 173.067 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.66 -179.77 3.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.202 0.456 . . . . 2.28 110.744 176.827 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -110.08 110.74 58.57 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 108.562 -0.903 . . . . 3.4 108.562 175.297 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.57 63.12 8.69 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.506 2.804 . . . . 1.87 113.049 -164.302 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -148.03 -50.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.873 1.669 . . . . 4.18 108.184 172.009 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.37 -32.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 123.468 0.707 . . . . 1.87 111.33 -173.599 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.85 163.63 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.9 -1.148 . . . . 1.54 107.9 172.934 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.93 154.87 26.17 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.361 -1.095 . . . . 1.37 110.361 -179.407 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -60.44 -33.08 94.41 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.383 2.722 . . . . 1.41 111.71 -175.547 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -57.28 -38.36 73.83 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.585 0.354 . . . . 5.38 110.784 178.122 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -67.23 -45.2 77.49 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.081 -1.081 . . . . 2.85 108.081 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.78 -56.53 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 118.355 -0.831 . . . . 1.36 109.266 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 pt -53.5 -54.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 118.55 0.614 . . . . 2.46 110.559 176.49 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -56.24 -45.47 79.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 119.789 1.177 . . . . 5.07 112.869 -175.384 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.6 mm -69.05 -40.13 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 121.366 -0.834 . . . . 3.62 110.072 -178.816 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.86 -29.72 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 120.12 -1.612 . . . . 1.43 112.195 176.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -59.36 -29.59 67.78 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.674 -0.642 . . . . 3.96 111.107 170.225 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.61 -38.69 92.06 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.963 -0.755 . . . . 4.73 108.963 176.728 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.7 mt -70.77 -37.44 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.494 -0.558 . . . . 1.41 109.494 172.61 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.46 28.62 5.38 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.054 1.311 . . . . 1.08 111.02 178.298 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.415 ' CE2' HD11 ' A' ' 98' ' ' ILE . 3.7 m-85 -99.57 -178.91 4.03 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.828 -1.545 . . . . 2.12 106.828 172.641 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -141.54 128.34 20.46 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.537 -1.283 . . . . 4.75 107.537 177.093 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.84 94.62 4.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.656 0.782 . . . . 1.13 109.794 -172.748 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.6 t -98.61 96.83 8.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.799 1.24 . . . . 2.07 107.745 -168.682 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.55 101.25 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.041 1.737 . . . . 4.3 111.875 179.477 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 55.95 35.91 26.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.621 0.769 . . . . 4.24 111.895 178.545 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 108.847 -0.797 . . . . 8.6 108.847 -176.377 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 mmt . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 116.634 -1.651 . . . . 8.5 106.623 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.56 153.15 66.08 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.793 1.237 . . . . 3.93 110.257 -176.343 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -92.75 115.72 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.843 2.362 . . . . 2.8 112.22 -179.221 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -140.55 146.54 38.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.74 -1.948 . . . . 3.82 105.74 169.293 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -97.02 165.78 11.91 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.626 0.771 . . . . 3.34 109.682 173.598 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.57 126.57 17.29 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 119.067 -0.492 . . . . 1.93 110.635 164.812 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -99.19 104.69 16.67 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.718 1.607 . . . . 2.76 109.537 178.121 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.435 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -127.9 172.34 10.97 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.219 0.533 . . . . 2.39 109.677 172.413 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.578 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -121.49 138.55 54.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.286 -1.375 . . . . 1.7 107.286 173.212 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.8 mm -100.17 129.88 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.527 -1.286 . . . . 1.05 107.527 177.209 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -108.89 120.71 43.32 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.666 -1.235 . . . . 2.63 107.666 172.762 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.77 -56.28 0.33 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.258 0.932 . . . . 1.67 112.095 177.467 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.3 mtt 25.54 77.14 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.078 2.151 . . . . 2.47 115.522 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m -55.26 -54.68 40.44 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.719 -0.613 . . . . 2.41 112.489 178.906 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.3 41.4 0.1 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.013 0.435 . . . . 4.21 111.355 -169.075 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 51.33 31.14 6.7 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.349 1.459 . . . . 5.09 113.911 177.888 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -154.11 -42.79 0.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.424 1.489 . . . . 2.94 110.905 -172.305 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.42 -46.91 88.31 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.622 -0.674 . . . . 1.62 110.588 -177.716 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.04 -43.36 36.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 123.086 0.554 . . . . 2.1 109.902 171.964 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -61.04 -47.92 84.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.479 -0.563 . . . . 2.51 109.479 -179.062 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -46.93 88.32 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 122.178 -0.326 . . . . 2.72 110.454 178.347 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.9 mt -50.1 -55.06 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.415 1.086 . . . . 2.05 110.292 175.648 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' CD ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -66.79 -32.71 74.17 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.491 1.139 . . . . 6.29 110.563 -176.811 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -32.47 73.84 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 119.634 -1.917 . . . . 4.17 111.603 172.086 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -66.32 -38.33 87.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.21 -0.663 . . . . 1.68 109.21 171.883 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.12 -39.54 78.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.327 0.512 . . . . 2.03 110.086 173.235 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.415 ' N ' HE21 ' A' ' 27' ' ' GLN . 0.0 OUTLIER -53.55 -20.61 5.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.135 1.161 . . . . 3.42 114.135 173.27 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -107.88 9.67 28.73 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.612 0.765 . . . . 3.18 112.647 179.029 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -67.22 -67.94 0.42 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.664 0.785 . . . . 2.37 110.443 178.393 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -167.59 -101.68 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.061 0.944 . . . . 1.49 109.136 177.431 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.57 23.71 6.29 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.5 -0.75 . . . . 1.36 113.22 -175.976 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.2 t -95.44 113.17 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.751 1.221 . . . . 2.36 109.271 178.553 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 mp -139.6 54.04 1.69 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.225 0.466 . . . . 2.81 111.172 177.272 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 m -157.08 152.65 26.7 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.047 -1.094 . . . . 1.69 108.047 155.097 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.453 HG23 ' CD ' ' A' ' 23' ' ' GLU . 2.1 p -141.03 96.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.636 1.174 . . . . 2.73 107.979 179.779 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.71 80.75 1.99 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 108.223 -1.028 . . . . 3.03 108.223 -177.494 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.6 t -99.53 129.35 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.206 -0.665 . . . . 1.97 109.206 174.53 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.44 81.8 3.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.37 -1.715 . . . . 1.2 106.37 170.353 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.83 -16.61 4.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.767 0.827 . . . . 3.44 111.609 176.374 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 6.3 tpt -67.51 -38.8 84.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.401 2.28 . . . . 3.83 110.774 176.739 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.87 -36.2 4.23 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.851 1.26 . . . . 1.5 111.624 -168.45 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.85 58.7 0.98 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.11 1.338 . . . . 1.1 111.36 179.518 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -141.71 133.35 26.99 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.631 -1.248 . . . . 2.68 107.631 170.701 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.78 120.28 41.01 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 0.92 110.709 170.935 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.46 ' OE2' ' NZ ' ' A' ' 47' ' ' LYS . 30.0 tt0 -109.84 115.12 29.24 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.843 0.857 . . . . 4.1 108.874 166.49 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.6 mt -107.92 168.07 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 125.39 1.476 . . . . 2.52 108.872 170.707 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.46 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -126.59 108.2 10.91 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.103 0.961 . . . . 4.59 109.168 162.263 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.472 ' HB2' HD12 ' A' ' 53' ' ' ILE . 12.6 p90 -104.04 177.99 4.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.805 2.042 . . . . 2.19 111.114 174.401 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -121.38 114.3 31.84 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.194 1.397 . . . . 3.22 109.866 171.267 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.13 -22.44 69.89 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.069 2.513 . . . . 2.04 113.553 179.044 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -35.41 80.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.421 1.009 . . . . 3.45 111.188 -179.99 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -116.32 -31.58 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-N 118.591 0.632 . . . . 2.51 111.61 -171.136 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.472 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -126.73 132.46 70.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 123.752 0.821 . . . . 1.46 109.178 178.408 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -107.46 151.58 41.0 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.195 1.398 . . . . 2.66 111.149 179.443 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -59.79 -34.55 95.79 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.636 2.224 . . . . 1.31 111.981 -179.848 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.6 -53.19 60.89 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.466 -0.771 . . . . 3.15 110.643 179.818 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.45 -36.17 82.85 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.965 -0.459 . . . . 4.36 110.929 178.874 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.462 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -53.07 -49.97 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.028 -1.471 . . . . 1.09 107.028 171.632 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.92 90.93 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.386 -0.37 . . . . 1.13 111.236 -177.262 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -56.7 -43.96 81.05 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.852 -0.53 . . . . 2.46 109.726 175.995 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.64 -49.87 69.53 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 110.123 -0.325 . . . . 2.31 110.123 176.099 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -63.28 -48.2 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.294 0.569 . . . . 2.4 111.251 -176.781 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -40.92 96.86 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.935 -0.575 . . . . 2.05 110.483 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.32 -50.92 65.9 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.469 0.577 . . . . 2.5 110.305 177.049 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.5 mt -54.17 -33.77 58.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.914 0.486 . . . . 2.1 111.112 174.799 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.09 37.24 1.54 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.56 -1.016 . . . . 1.2 110.56 164.369 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -129.77 170.07 14.33 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.798 -1.186 . . . . 2.44 107.798 -179.753 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -111.06 122.74 48.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.082 -0.71 . . . . 2.59 109.082 170.331 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.84 122.27 43.15 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.443 -1.317 . . . . 0.84 107.443 163.49 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -121.9 144.49 48.82 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.794 -1.558 . . . . 0.92 106.794 167.235 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.43 ' HA ' ' HB3' ' A' ' 8' ' ' LEU . 2.9 t -75.49 156.89 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 108.032 -1.099 . . . . 2.49 108.032 -179.424 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.8 ptm -63.9 -48.38 76.86 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 119.238 -0.985 . . . . 4.1 111.025 174.486 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 161.34 -57.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 129.974 3.31 . . . . 4.04 107.682 177.821 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.04 -29.78 68.75 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 125.367 1.467 . . . . 7.26 113.116 -172.318 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.441 ' HE2' ' HG ' ' A' ' 121' ' ' LEU 0.324 2.2 p90 65.49 -56.34 0.33 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 128.321 2.648 . . . . 4.03 113.339 -173.573 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -165.76 -71.25 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 120.411 1.46 . . . . 3.31 113.217 -172.771 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.457 ' HA2' ' H ' ' A' ' 83' ' ' GLU . . . 95.21 67.1 0.99 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.253 -1.539 . . . . 3.3 109.253 -178.541 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.3 t -156.42 -153.08 0.41 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.064 1.432 . . . . 4.51 112.692 -172.886 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.84 126.3 29.61 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.405 1.482 . . . . 4.81 108.398 -157.692 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.59 -36.56 3.23 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 109.761 -1.336 . . . . 2.07 109.761 -173.173 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.486 ' HB2' ' CD ' ' A' ' 123' ' ' LYS . 5.3 p30 -145.79 96.08 2.75 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 114.879 1.437 . . . . 3.64 114.879 -178.553 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.33 143.77 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 106.589 -1.634 . . . . 3.98 106.589 -174.268 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' H ' ' HA2' ' A' ' 77' ' ' GLY . 1.2 pp20? -104.87 150.2 25.04 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.115 -1.809 . . . . 3.57 106.115 172.966 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mp -135.91 154.82 51.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.32 -0.992 . . . . 2.26 108.32 167.631 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -95.38 125.87 40.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.835 -1.913 . . . . 1.5 105.835 173.752 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 pt -98.37 139.28 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.757 -1.201 . . . . 1.77 107.757 178.892 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.3 m -125.22 140.21 53.05 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.634 0.773 . . . . 1.56 109.252 174.65 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.93 -21.66 12.14 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.622 1.582 . . . . 1.19 113.334 171.8 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.66 130.85 1.35 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.087 0.955 . . . . 3.56 112.523 168.603 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.8 m -130.54 2.73 4.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.209 0.604 . . . . 3.88 111.114 -178.02 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.2 p 178.74 154.83 0.41 Allowed 'General case' 0 C--N 1.341 0.231 0 O-C-N 121.165 -0.959 . . . . 3.25 109.181 -174.637 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.91 -27.66 65.45 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.579 0.752 . . . . 2.63 112.724 -178.354 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 m -51.65 -41.43 61.34 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.343 -0.848 . . . . 2.0 111.141 169.815 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 90.8 m -65.54 -45.72 82.33 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.599 -0.519 . . . . 1.75 109.599 -179.602 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.7 t -53.28 -54.73 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.562 1.145 . . . . 1.42 109.924 175.444 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -57.26 -45.37 84.05 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.966 0.507 . . . . 3.82 110.168 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -61.98 -45.79 92.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.144 -0.348 . . . . 1.62 110.968 179.077 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.7 mt -56.27 -49.63 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.93 -0.767 . . . . 0.88 108.93 176.583 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -58.57 -47.69 83.41 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.354 -0.61 . . . . 2.28 109.354 178.983 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.5 t -50.83 -50.06 57.44 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.92 0.488 . . . . 1.32 110.07 174.703 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.494 ' HG2' HD11 ' A' ' 141' ' ' ILE . 13.2 mptt -61.53 -37.93 85.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.551 -0.718 . . . . 2.76 111.838 -178.99 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.6 mt -70.19 -60.91 2.0 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.78 -1.192 . . . . 1.82 107.78 178.202 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.4 p -54.86 -20.67 9.28 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.206 1.402 . . . . 2.01 113.147 -179.069 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -59.26 -25.67 64.27 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.456 0.539 . . . . 3.82 112.456 171.279 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 39.1 m -66.68 154.28 41.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.352 1.461 . . . . 1.48 111.337 -178.559 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -72.87 -54.23 9.29 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.293 1.037 . . . . 2.32 111.869 179.295 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.34 -36.2 63.34 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 121.401 0.445 . . . . 1.13 112.37 -172.605 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.76 126.52 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 121.774 -0.839 . . . . 2.23 109.81 -173.309 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.0 m -98.8 -51.25 3.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.553 0.341 . . . . 2.05 110.963 179.168 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.423 ' CZ ' ' HG3' ' A' ' 123' ' ' LYS . 36.2 p90 -140.9 111.6 6.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.325 -0.369 . . . . 2.13 110.082 -178.749 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -96.6 153.69 17.71 Favored 'General case' 0 C--O 1.227 -0.082 0 N-CA-C 108.373 -0.973 . . . . 0.82 108.373 167.014 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -142.83 125.51 15.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 107.041 -1.466 . . . . 2.11 107.041 169.202 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 p -123.88 128.22 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.348 1.059 . . . . 1.96 109.734 -172.501 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.88 106.36 6.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.74 0.781 . . . . 1.09 111.112 -168.791 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -69.29 -19.24 63.9 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 124.304 1.042 . . . . 2.26 113.328 179.155 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.01 94.5 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.786 -0.449 . . . . 1.38 109.786 176.004 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.06 -28.99 17.59 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.124 0.97 . . . . 1.83 110.189 175.338 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.41 34.34 0.37 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.24 1.416 . . . . 1.55 111.319 -175.261 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -138.6 166.74 23.55 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.923 -0.485 . . . . 3.52 111.064 175.217 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -136.66 135.53 38.33 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.819 1.648 . . . . 0.82 108.733 -178.956 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.441 ' HG ' ' HE2' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -98.01 134.55 40.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.717 -1.586 . . . . 1.77 106.717 174.323 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.4 127.99 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.032 0.533 . . . . 2.11 110.001 -178.853 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.486 ' CD ' ' HB2' ' A' ' 81' ' ' ASN . 12.6 mmtp -116.06 87.44 2.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.615 0.766 . . . . 3.53 109.425 -172.783 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -119.63 170.39 9.23 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.456 1.098 . . . . 2.61 111.738 -178.255 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -96.99 114.02 63.96 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 108.182 -1.044 . . . . 3.37 108.182 -179.053 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.72 67.95 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.137 2.558 . . . . 1.63 110.997 -172.917 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -160.46 -47.65 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.831 1.252 . . . . 3.18 109.125 176.886 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -85.79 -30.31 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 122.928 0.491 . . . . 1.57 111.561 -173.145 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.74 162.04 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.155 -1.054 . . . . 1.42 108.155 171.477 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -133.77 163.16 24.49 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.167 -1.573 . . . . 1.7 109.167 178.786 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -63.39 -35.86 58.98 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.92 2.413 . . . . 1.98 111.852 -175.968 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.17 -40.41 73.88 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.149 0.431 . . . . 4.9 111.606 -174.071 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -51.1 71.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.647 -0.871 . . . . 3.32 108.647 178.992 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.436 ' O ' HD13 ' A' ' 138' ' ' ILE . 53.6 mt -58.82 -50.25 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.532 -0.914 . . . . 1.33 108.532 -179.589 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 78.4 mt -46.08 -58.74 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 118.432 -0.794 . . . . 2.32 109.193 172.812 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -49.62 -49.86 45.21 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.697 1.135 . . . . 3.84 112.15 177.24 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.4 mm -51.08 -55.55 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 118.206 0.457 . . . . 1.96 110.576 177.184 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.436 HD13 ' O ' ' A' ' 134' ' ' ILE 0.295 0.0 OUTLIER -68.68 -32.51 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 118.339 -1.345 . . . . 2.81 113.311 -179.705 . . . . . . . . 4 4 . 1 . 031 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.46 -40.28 90.66 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.368 1.44 . . . . 2.22 110.666 173.838 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -63.33 -36.92 85.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.339 0.656 . . . . 3.44 109.818 177.1 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.494 HD11 ' HG2' ' A' ' 101' ' ' LYS . 80.6 mt -69.22 -39.7 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 120.171 -0.611 . . . . 0.93 110.935 172.475 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.8 30.73 6.64 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.386 1.47 . . . . 0.83 111.64 -171.597 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.442 ' CE2' HG21 ' A' ' 141' ' ' ILE . 23.1 m-85 -108.27 166.16 10.96 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.009 0.904 . . . . 1.93 108.907 164.088 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -129.53 130.03 45.25 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 106.704 -1.591 . . . . 3.87 106.704 -178.942 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.09 103.18 10.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.407 1.483 . . . . 1.15 109.144 -175.685 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.5 t -121.25 120.34 34.86 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 123.314 0.646 . . . . 2.44 110.539 -177.482 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -37.1 119.59 0.69 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.581 1.552 . . . . 3.67 111.248 170.94 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.415 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -119.78 61.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.83 1.652 . . . . 3.54 109.464 175.717 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.252 1.217 0 O-C-N 125.737 1.898 . . . . 6.25 109.545 162.866 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 108.592 -0.892 . . . . 2.96 108.592 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -91.73 140.73 29.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.665 -0.865 . . . . 3.52 108.665 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.5 t -119.6 132.24 55.67 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.048 -1.093 . . . . 2.4399999999999999 108.048 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -106.01 102.69 12.1 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.674 1.189 . . . . 2.7000000000000002 108.533 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.5 pt? -130.36 171.9 12.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.401 0.62 . . . . 2.5899999999999999 111.713 174.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.468 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -122.05 153.33 38.77 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.451 -1.315 . . . . 1.8700000000000001 107.451 172.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.9 mm -97.64 148.05 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 106.541 -1.652 . . . . 1.24 106.541 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -126.43 132.93 51.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.419 -1.697 . . . . 3.0600000000000001 106.419 159.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.16 -94.45 0.2 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 108.062 -2.015 . . . . 1.29 108.062 -168.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.2 mtt 50.92 75.01 0.2 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.176 1.39 . . . . 1.9299999999999999 112.552 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -37.87 37.79 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.565 -0.731 . . . . 2.1699999999999999 111.758 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.1 t 133.6 -74.66 0.0 OUTLIER 'General case' 0 C--N 1.347 0.471 0 C-N-CA 127.104 2.162 . . . . 3.1200000000000001 109.471 162.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.23 -44.0 89.64 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.053 0.76 . . . . 5.5099999999999998 113.053 -160.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 m -153.56 0.47 0.24 Allowed 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 114.689 1.366 . . . . 2.9500000000000002 114.689 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.26 -42.44 68.79 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.985 1.266 . . . . 1.7 110.227 -174.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -53.58 -46.35 60.42 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 108.703 -0.851 . . . . 2.0 108.703 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -60.64 -41.59 95.22 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.387 0.613 . . . . 2.75 111.545 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -61.42 -52.32 65.06 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.625 -0.672 . . . . 2.3599999999999999 109.81 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.6 mt -47.66 -50.4 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.331 1.052 . . . . 1.8400000000000001 110.822 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -49.8 -49.13 49.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.117 0.567 . . . . 4.75 112.055 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -65.25 -40.0 93.44 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.918 -0.489 . . . . 8.6899999999999995 110.214 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -59.4 -53.5 57.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.662 -0.496 . . . . 1.7 109.662 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.49 -41.83 86.19 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.969 -0.457 . . . . 2.4399999999999999 111.748 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -54.58 -19.49 6.06 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.977 0.732 . . . . 2.0699999999999998 112.977 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -110.54 3.04 19.13 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 117.865 -1.064 . . . . 3.25 113.069 175.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -60.37 -68.03 0.34 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 120.359 1.436 . . . . 2.98 110.97 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -168.96 -117.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.306 0.642 . . . . 1.3700000000000001 109.987 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.47 -8.53 76.08 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.557 -0.58 . . . . 1.6000000000000001 113.341 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.48 122.16 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 118.628 1.214 . . . . 1.3899999999999999 110.231 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.54 51.93 1.34 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.435 0.636 . . . . 3.1499999999999999 111.613 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -160.72 132.58 5.89 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.595 -1.631 . . . . 2.0600000000000001 106.595 161.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.9 m -118.36 132.57 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.771 -1.937 . . . . 2.5099999999999998 105.771 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -140.0 74.88 1.48 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.052 -1.462 . . . . 2.6200000000000001 107.052 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -97.39 127.88 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.432 -0.951 . . . . 2.0899999999999999 108.432 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.78 93.49 5.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.301 -1.74 . . . . 1.3500000000000001 106.301 166.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.46 -28.13 65.03 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.28 0.632 . . . . 3.3900000000000001 110.499 176.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 40.9 mtt -59.39 -64.35 0.97 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.448 1.099 . . . . 3.3599999999999999 110.425 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.0 -26.83 54.33 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.391 -0.822 . . . . 1.4299999999999999 110.552 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.63 61.23 1.8 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 125.009 1.29 . . . . 1.1499999999999999 110.545 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -138.52 144.39 39.93 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.412 -1.329 . . . . 5.8600000000000003 107.412 175.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.38 102.08 9.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.283 1.433 . . . . 1.24 109.35 167.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -96.17 134.67 38.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.301 -2.111 . . . . 4.7599999999999998 105.301 165.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 pt -140.1 171.27 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.634 -1.247 . . . . 1.78 107.634 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -120.47 108.17 13.77 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.658 0.663 . . . . 4.46 111.952 167.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.537 ' HB2' HD12 ' A' ' 53' ' ' ILE . 8.2 p90 -97.52 -179.67 4.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.684 2.393 . . . . 2.3799999999999999 111.907 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -134.97 98.86 12.74 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.065 1.346 . . . . 4.9199999999999999 109.322 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.68 -26.87 75.58 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.754 2.969 . . . . 1.8500000000000001 113.185 -162.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -75.04 -10.5 59.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.939 0.495 . . . . 3.6000000000000001 111.753 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.3 -49.37 2.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 124.102 0.961 . . . . 3.0800000000000001 109.954 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -115.59 147.5 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.71 1.204 . . . . 2.3199999999999998 107.958 179.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -124.17 151.89 66.48 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.484 1.114 . . . . 2.8300000000000001 108.869 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.4 -34.87 97.44 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.747 2.298 . . . . 1.6399999999999999 112.127 -172.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -71.28 -35.07 71.2 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.567 0.58 . . . . 3.3700000000000001 112.567 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -58.02 -48.33 80.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.407 0.683 . . . . 3.1600000000000001 109.22 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -52.47 -53.28 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 106.931 -1.507 . . . . 1.3899999999999999 106.931 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.33 73.78 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.008 -0.542 . . . . 1.1100000000000001 109.964 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -45.79 74.84 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.3 0.64 . . . . 2.6600000000000001 110.645 176.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -47.51 81.57 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.387 0.613 . . . . 2.2799999999999998 110.119 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 69' ' ' ALA . 6.2 mm -67.36 -41.84 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.548 -0.72 . . . . 2.6400000000000001 111.008 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -44.86 95.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.94 1.296 . . . . 2.1600000000000001 109.443 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.04 -51.62 68.88 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.067 0.547 . . . . 2.1699999999999999 109.842 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.3 mt -58.94 -31.1 68.37 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.567 -0.288 . . . . 3.3199999999999998 111.767 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.89 27.63 2.93 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.145 0.879 . . . . 1.0900000000000001 111.923 163.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -119.31 167.35 11.97 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.102 1.361 . . . . 2.2400000000000002 108.274 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -96.82 132.74 42.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.183 -1.414 . . . . 2.52 107.183 164.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.404 ' HB2' HG13 ' A' ' 62' ' ' ILE . . . -108.09 119.37 39.28 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.162 -1.792 . . . . 0.81999999999999995 106.162 163.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.468 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -129.53 122.44 29.23 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.063 -1.088 . . . . 1.1299999999999999 108.063 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.431 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.9 t -56.89 144.05 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 109.551 -0.537 . . . . 2.3500000000000001 109.551 171.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.6 mtp . . . . . 0 N--CA 1.448 -0.527 0 CA-C-N 115.361 -0.836 . . . . 3.6899999999999999 109.245 171.098 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 108.392 -1.883 . . . . 2.0499999999999998 108.392 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.83 82.53 3.03 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 127.469 2.308 . . . . 4.5 107.572 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.41 172.63 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.665 0.745 . . . . 2.9399999999999999 109.005 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -142.34 157.39 44.86 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 124.26 1.024 . . . . 4.5599999999999996 108.402 170.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.6 mt -143.0 147.39 35.05 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.581 1.152 . . . . 2.3300000000000001 109.138 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.64 119.34 34.94 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.72 -1.585 . . . . 1.78 106.72 165.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.24 116.0 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.712 1.205 . . . . 1.98 108.165 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.7 m -106.58 147.49 29.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.149 1.38 . . . . 2.46 107.986 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.4 -40.29 2.48 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.635 1.112 . . . . 1.2 111.279 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -58.96 141.67 53.13 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.458 0.703 . . . . 2.5699999999999998 110.648 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.8 t -159.94 37.68 0.18 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.092 0.557 . . . . 3.2000000000000002 111.328 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 51.8 t -162.71 142.06 9.07 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.257 -0.902 . . . . 2.7200000000000002 110.732 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.78 -45.31 49.55 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.878 0.871 . . . . 2.7599999999999998 111.441 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 m -56.21 -39.74 72.96 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.816 -0.553 . . . . 2.4300000000000002 111.649 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 78.7 m -64.97 -46.81 79.96 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.838 -0.801 . . . . 1.8500000000000001 108.838 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.1 t -50.91 -55.06 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.167 0.587 . . . . 1.3600000000000001 110.593 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -59.38 -42.47 91.74 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.865 0.84 . . . . 3.6899999999999999 109.581 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.59 -49.36 75.53 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.136 1.374 . . . . 1.8799999999999999 110.906 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -54.75 -50.08 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.233 0.613 . . . . 1.4099999999999999 109.677 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.86 -41.39 99.36 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.195 0.598 . . . . 2.3799999999999999 109.507 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.7 t -56.15 -52.88 62.78 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.116 0.566 . . . . 1.3500000000000001 110.475 171.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -51.98 -45.8 64.61 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.639 -0.663 . . . . 2.6899999999999999 110.77 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.23 -60.19 3.26 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.732 -1.21 . . . . 1.9299999999999999 107.732 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -52.92 -23.2 6.68 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.822 0.701 . . . . 2.2599999999999998 112.429 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -64.89 -25.53 67.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 120.36 -0.536 . . . . 4.3600000000000003 112.305 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 m -69.69 135.09 49.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.195 1.798 . . . . 1.79 110.384 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.9 p-10 -52.38 -51.22 60.14 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.139 0.975 . . . . 2.1800000000000002 113.565 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.29 -36.96 43.4 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 122.094 -0.379 . . . . 1.25 113.277 -170.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.38 121.57 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 O-C-N 121.753 -0.851 . . . . 1.78 109.307 -168.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.7 m -102.64 -40.11 6.77 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.665 0.386 . . . . 2.2599999999999998 111.141 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -141.74 127.69 19.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.291 0.496 . . . . 2.1800000000000002 110.378 164.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -98.45 155.61 17.17 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.707 -1.22 . . . . 0.98999999999999999 107.707 162.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.0 m -144.36 106.17 4.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 118.048 -0.977 . . . . 2.1400000000000001 108.687 165.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 120' ' ' ALA . 11.1 p -98.76 126.66 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.216 0.916 . . . . 2.3500000000000001 112.496 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.87 101.59 7.15 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.844 1.257 . . . . 1.21 109.947 -172.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 pp -75.49 -29.2 59.47 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.367 1.467 . . . . 2.2000000000000002 113.062 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.32 85.55 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 121.716 0.77 . . . . 1.72 109.171 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.8 -30.9 18.65 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.27 1.828 . . . . 2.4700000000000002 109.138 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 74.1 m 64.76 50.48 2.03 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.974 1.709 . . . . 2.0699999999999998 110.261 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -139.71 166.15 25.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.618 -0.719 . . . . 2.8100000000000001 110.816 158.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.408 ' HB2' HG23 ' A' ' 113' ' ' VAL . . . -130.38 132.7 45.91 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.073 2.149 . . . . 0.96999999999999997 107.917 -176.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.49 138.56 34.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.711 -1.218 . . . . 2.0099999999999998 107.711 172.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.1 t -131.42 128.64 61.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.624 1.17 . . . . 2.27 108.811 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -121.67 94.36 4.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.106 0.963 . . . . 3.4300000000000002 109.123 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -128.4 -177.94 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.719 0.691 . . . . 2.6200000000000001 111.528 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -99.65 115.3 65.73 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.0 0.92 . . . . 3.3799999999999999 109.476 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.28 69.52 7.56 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.256 2.637 . . . . 1.8200000000000001 112.084 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -163.56 -44.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.694 1.198 . . . . 3.9900000000000002 109.928 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pt -81.69 -30.71 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 122.275 -0.266 . . . . 1.71 111.318 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.01 171.38 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.76 -1.57 . . . . 1.6299999999999999 106.76 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.11 160.98 28.76 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.789 -0.924 . . . . 1.9099999999999999 110.789 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.85 -36.59 90.31 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.93 3.086 . . . . 1.9199999999999999 112.231 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -35.64 74.74 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 123.01 0.524 . . . . 6.4699999999999998 110.177 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.36 -43.19 82.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.175 0.898 . . . . 3.2999999999999998 109.622 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 68.7 mt -57.96 -48.14 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.447 -0.575 . . . . 1.3400000000000001 109.447 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 60.1 mt -51.41 -60.8 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 108.82 -0.807 . . . . 2.1499999999999999 108.82 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -44.44 -52.7 7.59 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.633 1.173 . . . . 4.5800000000000001 112.378 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.4 mm -51.99 -53.64 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 109.253 -0.647 . . . . 2.2799999999999998 109.253 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.272 2.3 pp -70.34 -26.83 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 114.034 1.124 . . . . 1.3300000000000001 114.034 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -62.74 -38.16 89.4 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.321 0.964 . . . . 3.3500000000000001 109.418 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -63.88 -35.87 82.08 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.609 0.764 . . . . 5.0599999999999996 109.017 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 47.7 mt -68.38 -49.3 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 110.052 -0.351 . . . . 1.3 110.052 170.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.91 30.53 2.31 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.943 1.735 . . . . 1.1200000000000001 112.488 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -102.06 179.06 4.43 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.944 1.372 . . . . 2.1000000000000001 109.757 166.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -132.94 118.03 18.38 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 108.007 -1.108 . . . . 4.4100000000000001 108.007 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.07 100.06 9.57 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.554 1.142 . . . . 1.2 109.755 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.6 m -109.37 112.73 25.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.189 0.995 . . . . 2.3100000000000001 108.587 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -33.07 105.81 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 126.447 1.899 . . . . 4.4299999999999997 110.101 168.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.93 -34.76 71.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.345 -0.843 . . . . 3.3700000000000001 110.314 -171.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.249 1.044 0 C-N-CA 128.156 2.582 . . . . 5.8200000000000003 114.604 169.187 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 106.478 -1.675 . . . . 2.96 106.478 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -103.23 154.53 19.24 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.747 -1.205 . . . . 3.52 107.747 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.616 ' SG ' HD21 ' A' ' 8' ' ' LEU . 12.6 p -142.32 130.34 21.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.316 0.488 . . . . 2.4399999999999999 112.316 169.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -98.27 103.69 15.66 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.126 2.17 . . . . 2.7000000000000002 110.271 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.616 HD21 ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -122.39 176.64 5.77 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.744 0.783 . . . . 2.5899999999999999 110.199 171.329 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.87 151.51 43.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.259 -1.386 . . . . 1.8700000000000001 107.259 168.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 44' ' ' ALA . 20.5 mm -95.85 148.04 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.538 -1.653 . . . . 1.24 106.538 171.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -121.64 106.43 11.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.46 -1.311 . . . . 3.0600000000000001 107.46 163.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.8 -93.65 0.12 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.746 -1.342 . . . . 1.29 109.746 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 mtt 54.25 80.66 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.137 1.375 . . . . 1.9299999999999999 113.808 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.14 -20.47 17.78 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.847 0.859 . . . . 2.1699999999999999 112.671 170.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.4 t 74.79 -79.5 0.04 OUTLIER 'General case' 0 C--N 1.342 0.255 0 N-CA-C 107.642 -1.244 . . . . 3.1200000000000001 107.642 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 4.83 -87.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 128.418 2.687 . . . . 5.5099999999999998 112.813 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.1 m -138.22 22.49 2.78 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.292 0.637 . . . . 2.9500000000000002 109.982 160.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.5 m -69.69 -53.49 18.31 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 119.342 -0.943 . . . . 1.7 109.125 -168.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.5 t -50.03 -39.65 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.348 0.594 . . . . 2.0 110.381 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.12 -46.83 87.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.491 0.663 . . . . 2.75 111.221 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -64.57 -46.52 82.39 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.836 -1.165 . . . . 2.3599999999999999 110.804 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -46.57 -53.7 2.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 C-N-CA 124.868 1.267 . . . . 1.8400000000000001 108.842 175.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -45.68 -56.26 5.45 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.393 0.616 . . . . 4.75 110.858 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -24.33 61.48 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.151 0.98 . . . . 8.6899999999999995 110.874 -173.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -69.98 -57.35 5.11 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.683 -0.858 . . . . 1.7 108.683 173.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.03 -42.03 89.22 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 118.522 0.601 . . . . 2.4399999999999999 110.562 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -22.51 19.93 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.513 0.56 . . . . 2.0699999999999998 112.513 177.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -124.28 32.16 5.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.944 0.898 . . . . 3.25 111.229 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -74.18 -76.84 0.12 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.021 -1.103 . . . . 2.98 108.021 165.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.74 -118.69 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.276 0.63 . . . . 1.3700000000000001 110.0 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.82 -13.03 80.89 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 119.522 1.056 . . . . 1.6000000000000001 113.049 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.08 125.86 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 117.61 0.705 . . . . 1.3899999999999999 112.215 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.91 57.01 1.41 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.701 1.2 . . . . 3.1499999999999999 108.093 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.5 t -160.32 154.4 23.12 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 120.535 -1.353 . . . . 2.0600000000000001 108.141 149.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.4 t -132.94 106.74 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.681 -1.229 . . . . 2.5099999999999998 107.681 167.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 tt -124.25 73.79 1.26 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.509 -1.293 . . . . 2.6200000000000001 107.509 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' A' ' 44' ' ' ALA . 58.6 t -102.75 128.0 55.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 109.003 -0.74 . . . . 2.0899999999999999 109.003 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.94 98.07 9.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.654 -1.239 . . . . 1.3500000000000001 107.654 170.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 tp -61.67 -26.83 68.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.267 1.027 . . . . 3.3900000000000001 110.258 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -50.75 43.42 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.784 -0.573 . . . . 3.3599999999999999 110.108 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.5 -7.22 26.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.545 0.738 . . . . 1.4299999999999999 112.555 -169.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.38 66.98 2.13 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.181 -1.168 . . . . 1.1499999999999999 110.181 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 131.16 20.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.106 -1.232 . . . . 5.8600000000000003 108.839 171.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.507 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -110.06 90.2 3.24 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.992 2.117 . . . . 1.24 110.521 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -102.95 130.08 49.91 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.254 -1.388 . . . . 4.7599999999999998 107.254 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 pt -140.13 -179.6 2.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 O-C-N 121.236 -0.915 . . . . 1.78 108.585 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -132.67 104.71 6.78 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.27 0.628 . . . . 4.46 110.007 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -106.27 172.55 6.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.83 1.252 . . . . 2.3799999999999999 113.265 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -114.56 101.49 54.32 Favored Pre-proline 0 N--CA 1.444 -0.75 0 C-N-CA 129.212 3.005 . . . . 4.9199999999999999 109.627 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.11 8.91 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.749 1.633 . . . . 1.8500000000000001 113.978 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -91.05 -26.83 18.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.533 1.133 . . . . 3.6000000000000001 112.039 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.69 -63.35 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 105.566 -2.012 . . . . 3.0800000000000001 105.566 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.46 170.07 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 120.242 -0.583 . . . . 2.3199999999999998 110.35 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.86 159.54 68.26 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.742 1.217 . . . . 2.8300000000000001 108.416 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.24 -40.78 30.64 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.46 2.107 . . . . 1.6399999999999999 111.256 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -58.22 -40.71 82.36 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.993 -0.442 . . . . 3.3700000000000001 111.184 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -61.16 -44.94 96.53 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.893 0.877 . . . . 3.1600000000000001 110.656 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -49.66 -57.92 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.368 0 N-CA-C 106.212 -1.773 . . . . 1.3899999999999999 106.212 170.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -58.03 -43.51 86.84 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.473 -0.785 . . . . 1.1100000000000001 110.165 -170.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -50.1 65.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.569 1.548 . . . . 2.6600000000000001 110.049 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.06 -45.83 86.4 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.574 0.702 . . . . 2.2799999999999998 109.707 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.534 HG21 ' HB2' ' A' ' 69' ' ' ALA . 5.6 mm -61.59 -44.03 97.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 116.291 -0.413 . . . . 2.6400000000000001 110.373 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -64.96 -40.86 95.65 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.234 -0.916 . . . . 2.1600000000000001 110.012 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -61.1 -50.44 73.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.935 0.894 . . . . 2.1699999999999999 109.932 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.38 -35.18 80.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.3 -0.56 . . . . 3.3199999999999998 110.781 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.29 23.4 1.75 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 123.386 0.517 . . . . 1.0900000000000001 112.708 163.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.425 ' O ' HG22 ' A' ' 62' ' ' ILE . 2.5 m-30 -112.79 158.71 19.79 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.889 0.845 . . . . 2.2400000000000002 109.68 174.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -95.43 133.35 39.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.045 -1.465 . . . . 2.52 107.045 167.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.534 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -123.06 125.31 44.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.111 0.964 . . . . 0.81999999999999995 108.531 169.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.19 134.88 44.66 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.408 -0.59 . . . . 1.1299999999999999 109.408 171.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 2.3 t -53.15 151.8 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.315 1.046 . . . . 2.3500000000000001 110.726 175.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.0 mtp . . . . . 0 N--CA 1.449 -0.494 0 CA-C-N 115.649 -0.705 . . . . 3.6899999999999999 111.946 173.038 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.771 0 N-CA-C 110.642 -0.983 . . . . 2.0499999999999998 110.642 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.465 ' C ' HD13 ' A' ' 82' ' ' ILE . 31.9 p-10 -129.39 119.34 23.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.917 0.887 . . . . 4.5 111.283 169.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.547 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -112.27 157.02 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.547 -1.279 . . . . 2.9399999999999999 107.547 172.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.94 141.54 32.96 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.813 0.845 . . . . 4.5599999999999996 109.632 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.6 mt -141.47 143.77 34.03 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 109.099 -0.704 . . . . 2.3300000000000001 109.099 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.57 130.63 43.72 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 107.726 -1.212 . . . . 1.78 107.726 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 pp -111.4 99.88 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.331 1.052 . . . . 1.98 110.671 -169.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.1 p -97.31 129.51 44.58 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.875 -0.787 . . . . 2.46 108.875 -175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.86 -26.98 6.98 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.349 0.976 . . . . 1.2 111.326 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.487 ' SD ' HD13 ' A' ' 98' ' ' ILE . 3.0 mtm -63.11 149.03 46.21 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.125 -0.632 . . . . 2.5699999999999998 112.211 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -169.82 41.92 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.939 1.295 . . . . 3.2000000000000002 109.287 172.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -166.04 140.63 4.54 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 121.107 -0.996 . . . . 2.7200000000000002 112.895 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.08 -42.62 81.02 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.447 0.699 . . . . 2.7599999999999998 110.751 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.3 m -50.48 -45.14 56.15 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.228 0.611 . . . . 2.4300000000000002 110.807 173.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 75.5 m -64.39 -50.94 65.68 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.017 -0.735 . . . . 1.8500000000000001 109.017 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 78.7 t -48.32 -51.77 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.08 0.552 . . . . 1.3600000000000001 110.664 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -59.17 -34.71 72.42 Favored 'General case' 0 C--O 1.227 -0.086 0 CA-C-O 120.722 0.296 . . . . 3.6899999999999999 110.335 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -63.4 -58.86 5.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.86 0.864 . . . . 1.8799999999999999 109.393 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.487 HD13 ' SD ' ' A' ' 89' ' ' MET . 3.2 mp -52.94 -52.22 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.366 -0.605 . . . . 1.4099999999999999 109.366 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.28 -49.76 73.32 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.175 -0.676 . . . . 2.3799999999999999 109.175 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 t -53.73 -46.77 70.94 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 122.047 -0.408 . . . . 1.3500000000000001 110.529 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -65.18 -38.11 89.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.124 0.57 . . . . 2.6899999999999999 111.791 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.497 HD22 HG11 ' A' ' 122' ' ' VAL . 47.7 mt -70.91 -62.64 1.32 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.373 -0.973 . . . . 1.9299999999999999 108.373 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.4 m -50.29 -24.36 2.88 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.633 2.373 . . . . 2.2599999999999998 112.692 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -32.12 62.58 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.288 0.477 . . . . 4.3600000000000003 112.288 172.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.2 m -59.42 144.54 46.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.573 1.149 . . . . 1.79 111.118 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -66.8 -47.97 70.43 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.968 0.907 . . . . 2.1800000000000002 111.552 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.74 -30.21 66.45 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 123.527 0.584 . . . . 1.25 113.293 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.9 tt -69.61 130.26 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 122.117 -0.637 . . . . 1.78 110.277 -167.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 37.7 m -99.64 -49.77 4.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.753 -0.203 . . . . 2.2599999999999998 110.824 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -141.31 122.65 14.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.274 -0.639 . . . . 2.1800000000000002 109.274 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.88 156.12 16.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.265 -1.013 . . . . 0.98999999999999999 108.265 161.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.5 t -141.05 122.25 14.77 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 107.276 -1.379 . . . . 2.1400000000000001 107.276 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.59 117.2 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.691 1.196 . . . . 2.3500000000000001 108.825 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.26 97.72 5.18 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.131 0.967 . . . . 1.21 111.525 -171.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 pp -59.72 -22.07 61.53 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.412 0.893 . . . . 2.2000000000000002 113.412 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.53 -38.28 49.12 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.454 0.645 . . . . 1.72 109.471 -176.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.5 p -88.79 -20.08 25.17 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 125.011 1.324 . . . . 2.4700000000000002 109.353 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.5 m 73.25 21.48 3.05 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.885 2.074 . . . . 2.0699999999999998 111.096 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -130.24 157.3 42.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.899 0.857 . . . . 2.8100000000000001 112.083 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.27 122.47 29.7 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.061 2.145 . . . . 0.96999999999999997 107.366 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mp -99.87 137.86 37.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.542 1.537 . . . . 2.0099999999999998 107.451 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.497 HG11 HD22 ' A' ' 102' ' ' LEU . 3.5 m -136.73 122.63 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.825 1.25 . . . . 2.27 109.346 -169.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -111.37 87.94 2.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.665 -0.683 . . . . 3.4300000000000002 109.615 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -117.55 173.33 6.78 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.858 0.863 . . . . 2.6200000000000001 110.657 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -98.49 112.61 62.78 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 108.397 -0.964 . . . . 3.3799999999999999 108.397 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.02 73.65 4.81 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.39 2.726 . . . . 1.8200000000000001 111.991 -165.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -162.1 -43.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.228 1.411 . . . . 3.9900000000000002 110.153 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 pt -83.77 -31.77 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 123.762 0.825 . . . . 1.71 111.281 -170.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.68 158.96 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.337 -0.986 . . . . 1.6299999999999999 108.337 171.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -126.71 159.93 20.99 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.099 1.333 . . . . 1.9099999999999999 109.958 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.7 -36.17 42.77 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.125 2.55 . . . . 1.9199999999999999 111.356 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.17 -40.71 74.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.748 1.219 . . . . 6.4699999999999998 110.869 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -66.05 -43.91 86.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.671 -0.492 . . . . 3.2999999999999998 109.671 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.45 -47.68 89.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.645 -0.872 . . . . 1.3400000000000001 108.645 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.7 mt -53.05 -56.19 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 123.825 0.85 . . . . 2.1499999999999999 109.529 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -48.34 64.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.366 0.985 . . . . 4.5800000000000001 110.824 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.0 mm -54.74 -52.99 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 122.047 -0.408 . . . . 2.2799999999999998 110.065 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.257 2.5 pp -70.52 -27.85 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.764 -1.21 . . . . 1.3300000000000001 113.419 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.29 -32.85 73.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.36 0.527 . . . . 3.3500000000000001 110.646 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -57.31 -42.94 82.78 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.844 -0.798 . . . . 5.0599999999999996 108.844 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.8 mt -73.8 -40.57 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.771 -0.65 . . . . 1.3 109.517 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.38 37.0 3.41 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.007 1.289 . . . . 1.1200000000000001 110.92 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.459 ' CD2' HD11 ' A' ' 98' ' ' ILE . 30.5 m-85 -99.49 178.1 4.97 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.262 -1.014 . . . . 2.1000000000000001 108.262 160.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -140.63 125.87 18.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 107.027 -1.471 . . . . 4.4100000000000001 107.027 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.59 106.45 14.88 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.498 1.519 . . . . 1.2 108.722 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.9 t -123.6 136.27 54.42 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 118.423 0.556 . . . . 2.3100000000000001 110.496 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp -32.24 119.91 0.29 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.808 2.043 . . . . 4.4299999999999997 113.27 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.56 49.03 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.085 0.954 . . . . 3.3700000000000001 111.211 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.332 0 CA-C-O 116.042 -1.932 . . . . 5.8200000000000003 107.356 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 108.418 -0.956 . . . . 4.0 108.418 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -90.64 157.08 17.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.99 -1.855 . . . . 3.98 105.99 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.495 ' SG ' HD11 ' A' ' 8' ' ' LEU . 0.5 OUTLIER -135.22 121.92 20.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.695 -1.594 . . . . 2.29 106.695 177.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.43 ' C ' HD13 ' A' ' 8' ' ' LEU . 62.8 m-85 -102.3 90.59 3.95 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.313 1.845 . . . . 3.71 109.05 -173.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.592 HD12 ' HB ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -117.68 171.26 8.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.576 0.703 . . . . 2.77 111.204 178.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.456 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -116.48 143.03 46.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.394 -0.965 . . . . 1.8200000000000001 108.394 166.203 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.417 HG12 ' HB2' ' A' ' 44' ' ' ALA . 42.3 mm -99.44 139.29 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 107.276 -1.379 . . . . 1.04 107.276 175.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -125.97 123.01 37.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.074 -1.454 . . . . 2.9700000000000002 107.074 168.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.58 -69.66 0.25 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.224 1.392 . . . . 1.74 110.442 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.9 mmt 37.09 71.2 0.15 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.758 2.023 . . . . 2.71 114.254 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -52.56 -60.52 3.15 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.469 -0.769 . . . . 2.73 113.064 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 t -165.87 48.67 0.08 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 119.518 -0.873 . . . . 3.7799999999999998 111.816 -172.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.05 51.91 15.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.454 1.102 . . . . 5.6699999999999999 112.243 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.3 m -175.18 -36.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.039 1.335 . . . . 3.3900000000000001 110.96 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.71 -42.86 77.12 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 120.965 -1.084 . . . . 2.02 110.536 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.0 -43.98 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.348 -0.612 . . . . 1.8500000000000001 109.348 168.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -62.07 -30.78 71.23 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.459 0.647 . . . . 2.2599999999999998 111.861 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -71.47 -46.45 59.87 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 120.98 -1.075 . . . . 3.52 110.706 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.513 HG12 HD13 ' A' ' 65' ' ' LEU . 50.8 mt -49.28 -45.98 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.397 0.679 . . . . 1.5 110.823 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -45.19 -48.07 12.48 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.444 0.565 . . . . 4.1699999999999999 112.216 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.0 mtm105 -66.02 -34.09 77.29 Favored 'General case' 0 C--N 1.339 0.115 0 O-C-N 121.754 -0.591 . . . . 5.6200000000000001 110.753 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -63.7 -54.55 33.7 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.241 -1.022 . . . . 1.1599999999999999 108.241 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mp -60.19 -36.44 77.63 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 111.953 0.353 . . . . 1.97 111.953 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -19.45 6.34 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.178 -0.951 . . . . 1.78 113.128 173.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -118.77 21.31 12.54 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.656 -0.688 . . . . 3.6800000000000002 112.519 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -66.69 -68.36 0.38 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.355 0.98 . . . . 3.0899999999999999 109.292 168.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.57 -125.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.419 0.687 . . . . 1.29 109.161 -167.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.0 -10.07 61.07 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 121.85 -0.531 . . . . 1.51 113.389 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -74.95 120.59 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 118.739 1.269 . . . . 1.96 110.38 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.86 53.07 1.09 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.068 0.396 . . . . 2.7400000000000002 112.068 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.487 ' HB3' ' CB ' ' A' ' 47' ' ' LYS . 29.1 t -158.16 137.0 11.34 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 106.731 -1.581 . . . . 2.0299999999999998 106.731 171.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.25 101.79 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.607 -1.627 . . . . 2.6299999999999999 106.607 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -129.3 76.39 1.72 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.158 -1.793 . . . . 2.3500000000000001 106.158 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.21 141.55 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.945 -1.131 . . . . 2.0899999999999999 107.945 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -112.85 101.82 9.87 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.263 -1.754 . . . . 1.27 106.263 164.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 tp -55.65 -33.0 63.67 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.488 1.115 . . . . 3.46 109.037 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -48.97 77.29 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.545 0.738 . . . . 5.6699999999999999 110.571 -174.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.05 -30.48 16.74 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.499 0.72 . . . . 1.54 110.875 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.35 57.69 1.74 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.984 1.278 . . . . 1.1699999999999999 110.603 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -140.05 144.56 36.94 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.131 0.966 . . . . 3.2400000000000002 108.856 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.417 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -112.49 116.24 29.95 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.151 0.98 . . . . 1.1000000000000001 111.398 164.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -97.78 123.79 41.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.716 -1.216 . . . . 4.3300000000000001 107.716 157.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mt -114.01 164.87 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 108.136 -1.061 . . . . 3.0 108.136 167.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.487 ' CB ' ' HB3' ' A' ' 34' ' ' SER . 10.3 ttmt -124.65 108.93 12.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.739 1.215 . . . . 3.8799999999999999 110.194 166.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -116.83 177.26 4.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.1 2.16 . . . . 2.7400000000000002 112.634 175.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.42 107.63 23.81 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.641 1.576 . . . . 3.1899999999999999 107.559 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.93 6.81 2.28 Favored 'Trans proline' 0 N--CA 1.455 -0.753 1 C-N-CA 125.512 4.142 . . . . 2.4700000000000002 113.605 -168.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -86.73 -22.16 26.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.46 0.704 . . . . 3.8300000000000001 111.207 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.73 -56.01 3.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-N 118.566 0.621 . . . . 3.2200000000000002 109.876 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.31 142.77 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.549 -1.278 . . . . 1.8799999999999999 107.549 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.26 150.79 54.78 Favored Pre-proline 0 N--CA 1.453 -0.293 0 C-N-CA 124.798 1.239 . . . . 2.5800000000000001 109.583 -174.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.18 -44.27 35.46 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.758 2.305 . . . . 1.51 111.627 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -63.97 -39.72 94.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.372 -0.83 . . . . 3.3599999999999999 111.488 178.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -58.47 -43.69 89.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.005 0.522 . . . . 4.2199999999999998 110.352 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.57 -42.39 29.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 N-CA-C 108.727 -0.842 . . . . 1.5900000000000001 108.727 173.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 56' ' ' LEU . . . -57.32 -38.59 74.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.12 0.486 . . . . 1.72 111.152 -176.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -63.88 -51.48 64.38 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.491 -0.755 . . . . 3.0099999999999998 110.109 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -54.26 -51.91 63.05 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.91 0.323 . . . . 3.52 111.695 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.621 HD13 ' H ' ' A' ' 69' ' ' ALA . 2.4 pp -61.25 -42.73 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.649 -0.657 . . . . 4.5700000000000003 111.741 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.404 ' NE2' HD11 ' A' ' 62' ' ' ILE . 0.9 OUTLIER -65.41 -35.15 80.06 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.663 -0.648 . . . . 2.4900000000000002 110.758 178.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -64.27 -50.75 66.69 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.174 0.59 . . . . 2.5899999999999999 109.901 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.513 HD13 HG12 ' A' ' 22' ' ' ILE . 15.3 mt -55.08 -35.38 64.5 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.163 0.585 . . . . 1.9299999999999999 111.129 173.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.4 39.88 1.44 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.558 1.075 . . . . 1.45 110.589 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -135.43 156.97 48.04 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.528 1.531 . . . . 2.3300000000000001 107.596 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -104.94 129.75 53.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.695 -1.224 . . . . 3.6299999999999999 107.695 171.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.621 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -123.62 112.32 17.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.392 -1.707 . . . . 1.0900000000000001 106.392 171.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -117.53 129.45 55.8 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.356 1.035 . . . . 0.94999999999999996 108.916 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.592 ' HB ' HD12 ' A' ' 8' ' ' LEU . 7.1 p -81.8 154.29 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.788 0.835 . . . . 2.73 109.153 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.0 mtt . . . . . 0 N--CA 1.454 -0.246 0 CA-C-N 116.19 -0.459 . . . . 3.5099999999999998 110.525 170.012 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.877 0 N-CA-C 107.913 -2.075 . . . . 2.3500000000000001 107.913 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.05 110.94 23.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.225 0.61 . . . . 2.2799999999999998 109.489 175.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.485 ' C ' HD12 ' A' ' 82' ' ' ILE . 1.5 pp -129.67 174.96 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.799 0.84 . . . . 3.6000000000000001 110.874 164.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.468 ' CB ' ' HA ' ' A' ' 148' ' ' ALA . 0.9 OUTLIER -111.3 150.93 28.97 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 128.041 2.536 . . . . 4.4100000000000001 109.401 174.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.2 mt -142.34 139.58 31.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.563 0.745 . . . . 2.4700000000000002 110.03 172.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.1 t -97.1 124.45 41.12 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.33 0.968 . . . . 1.99 109.51 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -95.9 106.51 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.185 -0.672 . . . . 1.6699999999999999 109.185 -171.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.9 m -98.83 133.74 42.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.903 -1.147 . . . . 1.46 107.903 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.62 -44.96 1.32 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.918 1.247 . . . . 0.96999999999999997 112.013 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.52 150.82 41.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.662 0.731 . . . . 2.6200000000000001 111.349 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -162.5 44.65 0.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.543 0.687 . . . . 2.9199999999999999 110.057 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 48.9 t -161.99 136.67 6.98 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.826 -1.171 . . . . 2.8799999999999999 110.721 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.6 -39.15 49.23 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.055 0.942 . . . . 2.8799999999999999 111.352 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 m -56.23 -44.2 79.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.611 -0.681 . . . . 2.0699999999999998 111.394 174.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 64.1 m -68.58 -49.98 55.25 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.222 -0.659 . . . . 1.8500000000000001 109.222 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 113' ' ' VAL . 78.8 t -43.49 -60.4 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.775 1.23 . . . . 1.27 109.792 170.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -59.13 -43.31 91.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.239 1.016 . . . . 3.5699999999999998 111.105 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -62.48 -47.68 82.92 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.578 0.751 . . . . 1.8899999999999999 110.673 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.7 mt -56.02 -49.42 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.388 -0.967 . . . . 0.95999999999999996 108.388 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.57 -45.11 92.8 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.679 -0.489 . . . . 2.5800000000000001 109.679 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.1 m -57.02 -48.82 77.59 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.358 0.663 . . . . 2.0699999999999998 110.736 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -60.01 -38.64 83.24 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.723 0.809 . . . . 3.73 111.493 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.436 HD21 HG23 ' A' ' 134' ' ' ILE . 42.6 mt -67.81 -60.5 2.48 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.693 -1.225 . . . . 1.6699999999999999 107.693 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.6 p -55.74 -17.37 5.86 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.278 0.631 . . . . 1.6799999999999999 112.64 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -60.99 -24.49 66.18 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.615 -0.678 . . . . 5.6600000000000001 112.412 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.1 m -73.86 166.13 23.89 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.407 1.483 . . . . 1.53 111.505 -167.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -76.57 -58.32 3.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.65 1.18 . . . . 3.2799999999999998 111.722 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.69 -45.73 8.35 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.362 -1.095 . . . . 1.73 110.362 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 122' ' ' VAL . 0.4 OUTLIER -60.44 131.29 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.485 -0.561 . . . . 2.46 109.485 175.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.2 t -131.53 -39.21 1.14 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.217 1.007 . . . . 2.8300000000000001 110.875 172.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.06 112.18 17.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.704 -1.591 . . . . 2.4300000000000002 106.704 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.75 166.69 16.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.672 -0.862 . . . . 1.3300000000000001 108.672 163.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 m -142.59 138.34 30.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.69 -1.226 . . . . 1.8100000000000001 107.69 163.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 95' ' ' VAL . 7.1 p -129.66 105.12 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.207 1.003 . . . . 1.9299999999999999 108.616 -171.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -112.61 102.47 10.54 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.12 0.968 . . . . 1.1299999999999999 110.573 -168.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -29.7 68.95 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.079 1.352 . . . . 2.6299999999999999 113.638 -173.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.32 -44.75 95.77 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.797 0.839 . . . . 1.5700000000000001 109.964 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.74 -25.63 26.32 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.519 1.127 . . . . 1.6799999999999999 109.623 170.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.2 m 73.97 24.31 2.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.127 1.771 . . . . 1.4199999999999999 111.509 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -116.06 150.33 37.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.459 1.027 . . . . 3.0899999999999999 110.425 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.14 107.57 4.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.82 1.248 . . . . 0.98999999999999999 112.595 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.82 141.5 28.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.245 1.021 . . . . 2.7000000000000002 110.794 173.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.616 ' HB ' HD11 ' A' ' 108' ' ' ILE . 11.8 m -133.94 135.3 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 126.029 1.732 . . . . 2.54 106.475 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.15 104.21 14.11 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 108.292 -1.003 . . . . 3.46 108.292 171.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -113.43 -179.55 3.67 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.782 0.833 . . . . 2.9300000000000002 111.199 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.79 114.32 37.62 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.165 1.386 . . . . 3.73 108.587 171.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.96 57.83 6.69 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.677 2.918 . . . . 2.3799999999999999 112.511 -169.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -147.11 -52.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.634 1.573 . . . . 4.5899999999999999 107.539 172.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 pt -83.94 -25.71 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 123.178 0.591 . . . . 1.8899999999999999 112.27 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -147.03 169.73 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.075 -0.713 . . . . 1.51 109.075 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.57 165.75 30.09 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 111.145 -0.782 . . . . 1.4099999999999999 111.145 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.18 -32.99 41.51 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.535 2.823 . . . . 1.5800000000000001 111.505 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.414 ' HA ' HG12 ' A' ' 135' ' ' ILE . 19.1 ptt180 -52.37 -39.62 61.02 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.369 0.604 . . . . 6.6100000000000003 111.188 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -72.26 -38.28 68.9 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.355 -0.98 . . . . 4.4199999999999999 108.355 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.436 HG23 HD21 ' A' ' 102' ' ' LEU . 81.3 mt -58.03 -54.14 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.648 -0.501 . . . . 1.21 109.648 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 132' ' ' ARG . 22.2 pt -56.25 -55.01 21.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.404 -0.591 . . . . 3.1000000000000001 109.404 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -47.52 -46.28 27.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 119.117 0.871 . . . . 4.04 112.931 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 mm -59.07 -42.7 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 O-C-N 121.735 -0.603 . . . . 1.71 111.682 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.3 pt -76.93 -28.99 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 113.785 1.032 . . . . 1.9099999999999999 113.785 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.38 -28.33 65.06 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.363 -0.836 . . . . 3.0600000000000001 110.301 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -60.77 -41.0 94.66 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.638 -0.504 . . . . 5.4900000000000002 109.638 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 27.7 mt -70.79 -40.95 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.887 -0.782 . . . . 1.28 108.887 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.62 31.61 3.39 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.393 1.473 . . . . 1.02 110.729 -176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -108.9 166.82 10.53 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 108.782 -0.822 . . . . 2.1299999999999999 108.782 169.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -137.59 133.72 34.74 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 106.985 -1.487 . . . . 3.46 106.985 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.45 92.66 3.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.981 1.712 . . . . 1.54 109.239 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.3 p -146.87 105.47 3.82 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 117.021 -1.466 . . . . 2.1099999999999999 112.581 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.3 -70.56 0.09 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 121.361 1.891 . . . . 8.0700000000000003 114.031 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HA ' ' CB ' ' A' ' 83' ' ' GLU 0.361 . . 40.68 80.09 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.334 2.254 . . . . 5.1600000000000001 116.891 -163.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.917 0 C-N-CA 128.643 2.777 . . . . 7.0599999999999996 103.875 172.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 107.84 -1.17 . . . . 4.2800000000000002 107.84 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.84 154.36 18.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.274 -1.33 . . . . 4.3399999999999999 107.75 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.6 t -141.71 132.25 25.39 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.674 0.67 . . . . 2.3300000000000001 109.507 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -107.83 87.35 2.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.983 1.313 . . . . 2.8599999999999999 108.983 -162.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.19 177.69 4.55 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.51 0.671 . . . . 2.7200000000000002 110.59 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.86 151.79 49.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.74 -1.578 . . . . 2.4700000000000002 106.74 172.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.1 mm -99.3 120.57 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.296 -1.372 . . . . 0.70999999999999996 107.296 171.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -101.47 87.44 3.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.677 -1.972 . . . . 4.5 105.677 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.12 -87.71 0.08 OUTLIER Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.117 -1.193 . . . . 1.3100000000000001 110.117 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.2 ptp 41.51 69.72 0.33 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.263 1.825 . . . . 1.96 115.636 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -53.33 -13.32 0.53 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.822 1.416 . . . . 2.54 114.822 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.8 t 74.58 -61.76 0.48 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.397 1.879 . . . . 3.0 111.217 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.15 -72.69 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.741 2.416 . . . . 5.9500000000000002 113.043 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.6 p -157.51 10.88 0.2 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 113.027 0.751 . . . . 4.3399999999999999 113.027 166.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -50.64 30.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.423 -1.325 . . . . 2.2400000000000002 107.423 -169.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 p -49.72 -48.71 20.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 109.783 -0.451 . . . . 3.0499999999999998 109.783 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 m -54.77 -46.98 74.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.667 0.787 . . . . 2.4900000000000002 112.552 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -63.82 -45.49 89.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.978 -1.076 . . . . 2.8799999999999999 110.122 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.431 HG13 HD13 ' A' ' 65' ' ' LEU . 1.2 mp -55.83 -45.02 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.314 1.046 . . . . 2.2200000000000002 109.291 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -56.08 -50.52 70.77 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.209 1.403 . . . . 5.3099999999999996 110.779 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -61.4 -39.53 91.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.084 0.554 . . . . 4.9699999999999998 109.979 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -63.4 -51.58 65.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.554 -0.536 . . . . 1.53 109.554 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -57.26 9.25 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.487 1.115 . . . . 2.8100000000000001 111.783 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.8 -18.67 34.24 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.946 1.091 . . . . 2.5699999999999998 113.946 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -102.79 5.64 38.86 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.039 1.336 . . . . 3.2000000000000002 114.136 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -57.33 -64.68 0.81 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 121.169 1.804 . . . . 3.77 111.611 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -168.47 -133.99 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.434 -1.691 . . . . 1.3700000000000001 106.434 -169.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.78 33.13 1.23 Allowed Glycine 0 CA--C 1.534 1.221 0 CA-C-N 119.929 1.241 . . . . 1.6399999999999999 113.61 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.41 124.22 60.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 N-CA-C 105.559 -2.015 . . . . 1.5900000000000001 105.559 165.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 49.65 1.68 Allowed 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.073 -0.714 . . . . 2.6200000000000001 109.073 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.3 t -161.88 148.41 13.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.559 -1.275 . . . . 2.29 107.559 173.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.25 120.59 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.964 -1.865 . . . . 2.8799999999999999 105.964 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.41 71.46 1.47 Allowed 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.262 -1.014 . . . . 2.6000000000000001 108.262 168.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.3 m -98.14 160.89 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.511 0.672 . . . . 2.3700000000000001 110.49 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.24 99.65 5.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.426 -1.694 . . . . 1.4299999999999999 106.426 170.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.7 -27.35 64.77 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.239 1.415 . . . . 3.6000000000000001 109.869 171.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -69.14 -43.15 74.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.838 0.855 . . . . 4.5499999999999998 111.688 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.43 -37.96 9.39 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.234 1.014 . . . . 1.5600000000000001 110.104 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.4 62.94 0.83 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 126.082 1.801 . . . . 1.0800000000000001 111.011 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -143.04 144.37 32.25 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.834 -1.172 . . . . 2.7999999999999998 107.834 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.23 105.83 12.18 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.959 1.304 . . . . 1.0600000000000001 111.174 171.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.66 136.39 38.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 105.64 -1.985 . . . . 4.3099999999999996 105.64 166.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.9 pt -136.34 174.13 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.039 -1.097 . . . . 1.8200000000000001 108.039 169.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -134.64 111.48 10.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.967 1.307 . . . . 4.9400000000000004 109.488 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -124.38 177.31 5.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.86 1.664 . . . . 3.3100000000000001 113.526 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -113.43 106.0 54.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.343 1.457 . . . . 4.0199999999999996 111.128 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.47 -10.78 29.88 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.69 2.26 . . . . 2.9199999999999999 114.296 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -65.89 -18.38 65.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.859 0.754 . . . . 4.1299999999999999 112.397 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.87 -45.85 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 123.287 0.635 . . . . 2.9500000000000002 110.281 -170.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.452 HD11 ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -94.66 153.59 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 109.255 -0.646 . . . . 2.1499999999999999 109.255 175.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -130.62 150.08 75.35 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.911 1.685 . . . . 2.8199999999999998 108.952 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -62.29 -39.27 48.52 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.075 2.516 . . . . 1.96 111.998 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.43 -46.98 87.8 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.495 -0.753 . . . . 4.6699999999999999 109.91 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -59.79 -37.28 78.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.972 0.509 . . . . 3.0499999999999998 111.128 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.452 ' CD1' HD11 ' A' ' 53' ' ' ILE . 1.5 mt -54.16 -56.36 10.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 107.202 -1.407 . . . . 1.6699999999999999 107.202 169.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.1 -44.48 74.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.104 -0.498 . . . . 1.6000000000000001 111.002 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -48.67 -52.2 24.52 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.134 0.974 . . . . 4.5999999999999996 110.301 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -49.08 73.52 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.087 0.47 . . . . 2.3700000000000001 109.811 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -62.4 -37.16 78.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 122.099 -0.376 . . . . 2.7000000000000002 110.928 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -65.81 -45.17 83.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.629 -0.508 . . . . 1.98 109.629 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -59.02 -50.07 75.5 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.89 -0.411 . . . . 2.46 109.89 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.431 HD13 HG13 ' A' ' 22' ' ' ILE . 21.0 mt -53.49 -45.12 69.52 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.31 0.644 . . . . 2.52 111.241 176.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.87 30.63 0.87 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.807 0.718 . . . . 1.29 112.363 166.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -129.95 163.79 25.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.401 1.48 . . . . 2.1400000000000001 108.951 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -99.84 122.6 43.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.63 -1.248 . . . . 2.29 107.63 170.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.04 122.54 45.47 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.727 -1.583 . . . . 1.0900000000000001 106.727 165.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.27 141.62 50.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.772 -1.196 . . . . 1.05 107.772 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 p -67.97 149.09 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.107 -0.701 . . . . 3.0 109.107 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.2 mtt . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 109.99 -0.374 . . . . 4.5700000000000003 109.99 173.186 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 124' ' ' PHE . . . . . . . . 0 N--CA 1.437 -1.263 0 N-CA-C 109.715 -1.354 . . . . 2.0699999999999998 109.715 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -93.1 102.86 15.19 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.574 -2.009 . . . . 2.7200000000000002 105.574 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.51 143.04 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 108.111 -1.07 . . . . 2.9500000000000002 108.111 175.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -95.92 146.91 24.21 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.349 -1.723 . . . . 4.4100000000000001 106.349 170.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.3 mt -137.73 158.96 43.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.172 -1.788 . . . . 2.29 106.172 166.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.75 123.43 42.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.333 -1.729 . . . . 1.6399999999999999 106.333 170.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.3 pt -97.82 140.18 18.47 Favored 'Isoleucine or valine' 0 C--N 1.336 0.009 0 N-CA-C 108.465 -0.939 . . . . 1.8899999999999999 108.465 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.4 m -129.03 138.18 51.75 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.814 0.845 . . . . 1.6599999999999999 109.42 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.51 -35.32 2.7 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 126.032 1.777 . . . . 1.1799999999999999 112.146 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -30.48 103.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.964 1.706 . . . . 3.5600000000000001 114.565 172.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.5 m -100.6 -4.81 27.77 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.268 0.627 . . . . 3.5099999999999998 111.063 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.66 165.52 14.33 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 120.646 -1.284 . . . . 3.3399999999999999 110.25 177.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.06 -36.79 61.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.54 0.336 . . . . 2.8700000000000001 110.712 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.3 t -48.46 -45.9 37.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.37 0.668 . . . . 2.0800000000000001 111.364 173.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 64.2 m -59.77 -53.78 53.98 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 108.759 -0.83 . . . . 2.0299999999999998 108.759 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.436 HG21 HD22 ' A' ' 115' ' ' LEU . 58.7 t -52.41 -43.6 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.389 0.676 . . . . 1.55 111.027 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -65.21 -42.31 93.61 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.362 -0.977 . . . . 2.5600000000000001 108.362 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -42.01 97.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.022 -0.362 . . . . 3.8500000000000001 110.022 176.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.28 -53.66 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.683 -0.858 . . . . 1.0700000000000001 108.683 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -54.97 -45.19 74.95 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.644 1.178 . . . . 3.2400000000000002 108.834 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -53.75 -52.85 58.84 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.927 -0.483 . . . . 1.3300000000000001 111.612 172.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.457 ' HG2' HD11 ' A' ' 141' ' ' ILE . 4.1 mptp? -60.36 -35.2 75.12 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 120.823 -1.173 . . . . 2.4300000000000002 111.716 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.49 -59.07 3.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.194 -1.039 . . . . 1.8 108.194 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.8 p -57.05 -19.03 16.65 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.077 0.951 . . . . 1.8799999999999999 112.637 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.93 -31.84 67.2 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.048 -0.407 . . . . 3.7999999999999998 111.499 171.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 17.4 m -65.45 142.64 58.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.569 1.547 . . . . 1.6100000000000001 110.923 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -64.83 -48.1 75.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.459 1.103 . . . . 2.5800000000000001 111.697 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.19 -32.85 57.8 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.97 -0.35 . . . . 1.3600000000000001 112.741 -171.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.48 134.61 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 117.899 0.85 . . . . 2.27 109.039 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.8 t -107.71 -49.82 3.17 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.08 0.4 . . . . 3.2599999999999998 112.08 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -136.65 121.64 18.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.482 -0.933 . . . . 2.0 108.482 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.43 133.15 44.16 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.009 -0.737 . . . . 0.93999999999999995 109.009 166.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.5 m -113.4 102.73 10.6 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 107.901 -1.148 . . . . 2.21 107.901 168.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -108.43 140.33 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.233 -0.654 . . . . 2.7599999999999998 109.233 175.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.37 95.58 3.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.165 0.983 . . . . 1.52 110.599 -169.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.436 HD22 HG21 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -60.72 -33.02 72.26 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.993 1.317 . . . . 2.2799999999999998 112.685 -174.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.78 -33.74 17.36 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.071 0.948 . . . . 1.77 111.308 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.66 -5.93 12.16 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.743 1.617 . . . . 2.0800000000000001 111.426 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.0 m 63.41 27.87 15.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.056 1.742 . . . . 1.45 111.989 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -99.02 158.08 15.9 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.348 0.659 . . . . 3.7599999999999998 110.642 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -139.13 101.62 4.32 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.506 1.922 . . . . 1.1499999999999999 108.455 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.79 103.62 15.26 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.185 0.994 . . . . 1.8700000000000001 108.319 -176.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.6 m -102.12 127.56 55.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 124.612 1.165 . . . . 2.0800000000000001 109.688 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.36 103.75 14.2 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.457 1.103 . . . . 3.9100000000000001 108.619 172.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.415 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 13.9 p90 -121.51 -174.67 2.91 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.149 1.379 . . . . 2.6899999999999999 110.257 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -111.59 111.9 54.32 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 119.153 0.888 . . . . 3.21 109.424 176.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.35 72.18 6.65 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.973 2.449 . . . . 2.2000000000000002 111.937 -164.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.33 -43.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.206 1.402 . . . . 3.73 109.669 172.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.1 pt -85.73 -31.81 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 124.149 0.98 . . . . 1.8300000000000001 110.827 -174.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.29 161.67 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.791 1.236 . . . . 1.5800000000000001 108.296 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.02 162.95 29.33 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.969 -1.252 . . . . 1.53 109.969 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -59.89 -34.38 95.41 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.602 2.868 . . . . 1.53 111.375 -173.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -36.3 69.01 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 122.991 0.517 . . . . 4.7199999999999998 111.337 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -69.9 -45.7 67.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.617 -0.882 . . . . 3.2200000000000002 108.617 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.8 -49.38 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.29 -1.004 . . . . 1.22 108.29 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.5 mt -49.66 -59.99 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 118.369 -0.824 . . . . 1.9399999999999999 109.05 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -49.65 -50.89 41.45 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.891 1.223 . . . . 3.6000000000000001 112.713 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.62 -52.31 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.737 -0.602 . . . . 1.95 110.864 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.455 ' HA ' HD12 ' A' ' 141' ' ' ILE 0.259 2.4 pp -70.43 -26.11 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 120.777 -1.202 . . . . 1.29 113.716 -177.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -60.77 -39.45 88.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.575 0.625 . . . . 2.6099999999999999 110.224 169.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.11 -40.37 81.02 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.999 -0.741 . . . . 3.4300000000000002 108.999 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.457 HD11 ' HG2' ' A' ' 101' ' ' LYS . 48.7 mt -72.73 -42.16 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.095 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.37 35.12 4.53 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.997 1.284 . . . . 1.02 111.383 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 141' ' ' ILE . 58.2 m-85 -97.35 176.01 6.05 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.286 -1.005 . . . . 2.02 108.286 163.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -133.42 131.05 39.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.071 -1.455 . . . . 3.3999999999999999 107.071 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.87 99.0 6.37 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.647 1.579 . . . . 1.3 109.551 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 58.4 m -111.49 114.85 28.23 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.886 0.875 . . . . 1.76 110.701 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -35.88 113.06 0.19 Allowed 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 127.793 2.437 . . . . 3.8100000000000001 111.216 169.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -103.14 68.45 0.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.706 0.765 . . . . 3.6800000000000002 110.85 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.291 1.436 . . . . 6.9299999999999997 110.32 171.972 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 120.619 0.247 . . . . 4.5499999999999998 110.911 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -96.51 140.15 31.57 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.578 -0.701 . . . . 4.3499999999999996 109.677 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.9 t -119.39 136.19 54.4 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.338 1.055 . . . . 2.25 110.115 174.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -106.99 90.06 3.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.401 1.881 . . . . 4.6799999999999997 111.075 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 71' ' ' VAL 0.271 0.3 OUTLIER -118.13 167.39 11.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.249 1.023 . . . . 2.8100000000000001 113.087 176.408 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.69 161.05 20.31 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.594 -1.632 . . . . 2.9399999999999999 106.594 165.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.0 mm -100.16 136.81 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 105.552 -2.018 . . . . 1.03 105.552 167.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -121.85 78.01 1.42 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.06 -1.459 . . . . 5.2699999999999996 107.06 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.96 -76.73 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.737 -0.945 . . . . 1.3799999999999999 110.737 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mpt? 57.98 89.18 0.05 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.664 1.586 . . . . 1.8600000000000001 112.715 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.9 m -59.18 -60.72 3.41 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.583 -0.698 . . . . 2.4500000000000002 110.961 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.5 t -167.72 88.18 0.27 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.689 -1.226 . . . . 3.3599999999999999 107.689 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 1.94 65.87 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 129.189 2.996 . . . . 5.8399999999999999 115.476 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t 173.61 -43.89 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 125.218 1.407 . . . . 3.3799999999999999 108.537 -168.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 t -66.42 -40.76 89.73 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.833 -1.167 . . . . 2.0299999999999998 111.32 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.9 -32.02 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 121.799 -0.563 . . . . 1.8 110.464 167.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 t -69.51 -27.2 64.98 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.039 -0.413 . . . . 3.1600000000000001 111.253 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.59 -47.75 74.65 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.598 -1.314 . . . . 2.8599999999999999 109.599 171.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.2 mt -42.74 -37.99 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 121.354 -0.841 . . . . 1.3799999999999999 112.966 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -47.71 -55.37 9.66 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.719 0.691 . . . . 3.7000000000000002 112.821 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -64.52 -36.01 82.82 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.48 -0.762 . . . . 6.3799999999999999 109.858 -172.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -61.7 -54.22 45.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.94 -1.133 . . . . 1.3400000000000001 107.94 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -54.97 -44.58 74.52 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 112.173 0.434 . . . . 2.1299999999999999 112.173 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.82 -21.1 3.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.907 0.776 . . . . 1.9299999999999999 112.814 175.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 5.05 13.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 117.843 -1.075 . . . . 5.3099999999999996 112.61 177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -64.12 -58.42 6.7 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.678 1.126 . . . . 2.77 110.735 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.5 -135.84 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 O-C-N 122.002 -0.436 . . . . 1.3300000000000001 110.48 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.79 -15.09 47.1 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.929 1.252 . . . . 1.49 113.465 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.28 125.34 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 117.981 0.891 . . . . 1.72 111.755 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 mt -141.53 44.32 1.74 Allowed 'General case' 0 C--N 1.342 0.257 0 CA-C-O 119.286 -0.387 . . . . 3.5 111.074 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -158.13 149.1 20.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.451 -0.574 . . . . 2.7599999999999998 109.451 169.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.98 70.26 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 124.902 1.281 . . . . 2.7000000000000002 109.275 -170.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.304 0.7 OUTLIER -102.32 78.93 1.79 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 119.234 -0.986 . . . . 5.0300000000000002 110.26 -177.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p -96.91 145.76 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.002 -0.999 . . . . 2.5099999999999998 108.81 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.59 99.78 6.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.963 -1.495 . . . . 1.4399999999999999 106.963 163.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.6 mt -56.88 -26.65 59.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.007 0.923 . . . . 2.8799999999999999 111.441 172.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.1 ttt -56.55 -57.59 11.7 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.226 1.01 . . . . 4.0999999999999996 110.197 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.29 -27.57 22.81 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.798 0.839 . . . . 1.4099999999999999 110.898 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.89 57.59 2.25 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.552 1.072 . . . . 1.1599999999999999 110.567 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.34 132.18 35.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.178 -1.045 . . . . 3.6899999999999999 108.178 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.9 102.62 11.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.584 2.354 . . . . 0.94999999999999996 109.273 171.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -96.95 137.91 35.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.326 -1.731 . . . . 3.3700000000000001 106.326 164.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.3 pt -143.49 171.61 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.178 -1.045 . . . . 1.8200000000000001 108.178 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -125.74 105.48 9.01 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.828 0.851 . . . . 5.3399999999999999 109.971 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -97.53 169.79 9.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.052 2.541 . . . . 2.6800000000000002 113.007 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -117.26 100.7 53.11 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 106.096 -1.816 . . . . 2.8900000000000001 106.096 171.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.75 -29.62 43.05 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.535 3.49 . . . . 2.8700000000000001 114.704 -170.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -65.65 -18.82 65.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.7 1.6 . . . . 4.5999999999999996 112.469 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.3 m -126.8 -38.22 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.343 0.657 . . . . 3.1200000000000001 111.46 -175.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.93 149.88 17.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-N 118.887 0.767 . . . . 1.8700000000000001 109.268 173.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -129.6 150.34 75.42 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 124.634 1.173 . . . . 3.48 109.287 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -56.22 -37.24 97.0 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.114 2.542 . . . . 1.78 111.263 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.6 mp -54.64 -41.71 70.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.26 0.624 . . . . 3.0800000000000001 111.344 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -69.49 -40.97 76.73 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.546 -0.721 . . . . 3.7000000000000002 109.564 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -45.22 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.06 -1.089 . . . . 1.47 108.06 172.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.53 -42.97 93.51 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.904 -0.589 . . . . 1.6599999999999999 110.804 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -59.4 -51.63 69.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 121.773 -0.58 . . . . 3.1099999999999999 110.19 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -56.06 15.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.208 0.528 . . . . 2.2200000000000002 111.137 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.526 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.4 pp -62.12 -40.23 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 121.187 -0.946 . . . . 4.1900000000000004 112.559 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.59 -32.6 74.27 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.492 -0.755 . . . . 2.5499999999999998 110.85 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.31 -51.29 61.63 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.503 0.592 . . . . 2.6499999999999999 109.648 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.07 -38.63 68.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.416 -0.514 . . . . 3.6899999999999999 111.808 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.77 45.47 0.65 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.676 -0.97 . . . . 1.53 110.676 171.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -131.95 157.09 44.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.72 1.208 . . . . 2.6200000000000001 108.035 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -99.82 129.71 45.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.944 -1.502 . . . . 2.5299999999999998 106.944 166.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.526 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -121.38 124.71 45.2 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.222 -1.399 . . . . 1.24 107.222 173.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.53 119.98 27.23 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.155 0.909 . . . . 0.97999999999999998 109.946 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 2.2 p -68.33 141.31 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 125.065 1.346 . . . . 2.73 108.737 166.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.2 ptm . . . . . 0 N--CA 1.455 -0.194 0 O-C-N 124.486 1.117 . . . . 5.7599999999999998 111.357 -172.63 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 108.107 -1.997 . . . . 1.8400000000000001 108.107 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.614 ' C ' HD13 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -118.46 107.02 13.3 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.275 1.43 . . . . 2.3700000000000001 108.467 -166.101 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.614 HD13 ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -127.6 148.02 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 120.336 1.425 . . . . 2.73 112.455 -178.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.11 124.0 50.08 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.15 1.78 . . . . 4.4699999999999998 112.621 -175.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.7 mt -128.76 138.83 52.32 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.315 1.046 . . . . 2.3599999999999999 109.418 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.6 OUTLIER -102.96 124.1 47.83 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.808 -1.182 . . . . 2.2799999999999998 107.808 -177.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.37 105.49 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.713 1.205 . . . . 1.76 109.715 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.8 p -101.77 126.26 48.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.575 -0.898 . . . . 2.2599999999999998 108.575 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.64 -34.3 3.66 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.128 0.87 . . . . 1.3600000000000001 111.034 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -63.36 130.94 46.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.083 0.553 . . . . 2.8799999999999999 109.808 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 p -137.54 22.58 2.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.965 1.306 . . . . 3.7200000000000002 110.693 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 5.3 t -157.25 141.19 16.1 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 121.298 -0.876 . . . . 2.9500000000000002 111.881 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.6 -35.13 79.93 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.214 0.606 . . . . 2.6099999999999999 111.456 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 p -53.4 -47.3 69.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.504 -0.554 . . . . 2.1800000000000002 109.504 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 59.7 m -59.26 -49.76 76.6 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 119.22 -0.419 . . . . 2.5 110.129 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.4 t -49.36 -50.15 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 118.237 0.471 . . . . 1.6100000000000001 110.544 175.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -60.63 -40.81 93.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.768 -0.456 . . . . 4.6600000000000001 109.768 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -42.47 96.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.865 -0.522 . . . . 2.6600000000000001 110.253 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.8 mt -61.42 -51.47 72.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.111 -1.07 . . . . 1.3 108.111 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -55.67 -45.88 77.64 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.676 1.19 . . . . 2.23 109.61 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.8 t -54.95 -54.82 37.88 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.687 -0.633 . . . . 1.8200000000000001 110.637 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -51.2 -61.32 2.3 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.194 0.452 . . . . 2.71 110.261 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.85 -39.32 91.45 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.768 -0.373 . . . . 2.23 110.415 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 96.3 m -59.73 -19.24 48.82 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.54 0.609 . . . . 1.8400000000000001 112.1 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -66.49 -27.02 67.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 119.166 -1.014 . . . . 4.4699999999999998 111.919 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 81.3 m -63.54 126.58 27.98 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.631 0.773 . . . . 2.1899999999999999 111.597 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -38.51 -59.63 0.89 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.651 1.98 . . . . 3.3999999999999999 113.845 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.22 -28.36 68.29 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.231 0.469 . . . . 1.6699999999999999 113.319 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.78 118.8 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 O-C-N 121.359 -1.083 . . . . 1.75 109.475 -168.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.2 m -102.92 -44.86 5.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.857 0.318 . . . . 2.71 111.857 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -142.12 128.8 20.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.406 -0.961 . . . . 1.99 108.406 166.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.75 162.52 12.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.87 -0.332 . . . . 0.87 110.375 161.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m -145.0 113.05 6.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.45 -0.945 . . . . 1.73 108.45 162.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 p -110.03 128.93 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.75 0.705 . . . . 1.8899999999999999 110.962 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -125.04 90.4 3.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.145 0.978 . . . . 1.53 110.951 -166.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.09 -32.5 55.01 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.287 1.435 . . . . 2.6099999999999999 112.964 -174.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.71 -32.12 65.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.259 0.624 . . . . 2.0 111.154 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.53 -14.45 11.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.145 1.378 . . . . 1.9299999999999999 111.202 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.4 m 65.99 28.29 10.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.101 1.361 . . . . 1.8899999999999999 111.951 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.458 ' HD3' ' HB1' ' A' ' 148' ' ' ALA . 44.3 mmtt -96.75 152.84 18.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.312 1.445 . . . . 2.8700000000000001 109.703 173.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.26 106.36 4.35 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.521 1.128 . . . . 0.98999999999999999 109.383 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.3 mp -95.43 130.19 42.32 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.633 -1.247 . . . . 2.8500000000000001 107.633 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.1 t -128.28 123.9 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.031 0.932 . . . . 1.9099999999999999 108.75 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -105.55 92.06 4.03 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.918 0.887 . . . . 2.9900000000000002 109.136 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -115.35 173.7 6.38 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.761 0.709 . . . . 2.54 111.098 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -100.26 112.68 64.65 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 108.886 -0.783 . . . . 2.7400000000000002 108.886 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.72 70.03 7.11 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.649 2.899 . . . . 1.99 111.217 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -165.05 -47.95 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.523 1.529 . . . . 3.04 108.836 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.6 pt -84.85 -37.48 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.121 0.969 . . . . 2.1699999999999999 111.103 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.7 tp -136.86 169.3 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.304 0.642 . . . . 2.0800000000000001 109.458 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.25 170.77 32.17 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.64 -1.784 . . . . 1.75 108.64 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -58.41 -35.65 98.44 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.27 2.646 . . . . 1.8 111.285 -171.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.9 ptm85 -56.63 -30.55 63.41 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.18 0.807 . . . . 5.4000000000000004 113.18 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.36 -50.03 67.11 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.231 -1.026 . . . . 3.3700000000000001 108.231 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 42.5 mt -63.32 -44.17 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.512 -1.222 . . . . 1.1000000000000001 108.123 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.54 -57.2 5.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 118.476 -0.773 . . . . 1.8700000000000001 109.366 172.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -49.58 -51.14 39.15 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.302 1.41 . . . . 3.46 112.36 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.6 mm -54.16 -53.72 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.019 0.528 . . . . 1.8100000000000001 110.377 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 pp -70.36 -29.72 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 120.967 -1.083 . . . . 1.4399999999999999 113.108 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -59.04 -41.79 88.71 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 119.143 0.883 . . . . 2.7999999999999998 109.309 168.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -64.82 -37.92 89.23 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.483 -0.562 . . . . 2.9900000000000002 109.483 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.7 mt -62.83 -44.96 99.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 122.006 -0.434 . . . . 1.0900000000000001 110.437 170.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.19 28.21 5.02 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.381 1.467 . . . . 1.03 111.941 -174.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -101.67 -179.81 4.12 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.42 1.11 . . . . 2.2400000000000002 108.929 164.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -139.1 126.55 21.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.635 -1.617 . . . . 3.8799999999999999 106.635 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.62 91.16 3.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.315 1.846 . . . . 1.21 108.373 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 68.3 m -102.82 131.45 49.69 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.092 -0.707 . . . . 2.27 109.092 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 mt -41.25 109.87 0.14 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.26 1.824 . . . . 3.77 111.37 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.663 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -90.09 -20.93 22.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.742 -0.663 . . . . 4.0099999999999998 110.741 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.403 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.375 0 C-N-CA 125.91 1.684 . . . . 6.3499999999999996 112.062 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 107.41 -1.329 . . . . 3.9300000000000002 107.41 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.56 147.95 41.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.444 -0.947 . . . . 4.9000000000000004 108.444 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.4 p -141.18 140.38 34.02 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.871 -0.788 . . . . 3.0899999999999999 108.871 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -120.72 103.52 9.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.693 -1.966 . . . . 3.04 105.693 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.581 HD12 ' HB1' ' A' ' 69' ' ' ALA . 2.1 pt? -132.66 160.37 36.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.136 -1.061 . . . . 2.2200000000000002 108.136 175.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.495 HE22 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -101.41 171.83 7.34 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.545 -0.909 . . . . 3.4700000000000002 108.545 173.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.2 mm -99.84 126.74 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.098 -1.815 . . . . 0.98999999999999999 106.098 162.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -102.36 95.86 6.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.348 -2.093 . . . . 3.6800000000000002 105.348 166.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.38 -77.26 0.11 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.14 0.876 . . . . 1.28 110.961 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 mtp 35.53 76.22 0.05 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.933 2.093 . . . . 2.1200000000000001 114.831 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 p -41.04 -54.0 2.89 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.669 0.787 . . . . 2.8399999999999999 112.448 171.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t 119.13 -62.95 0.0 OUTLIER 'General case' 0 C--N 1.342 0.266 0 C-N-CA 129.355 3.062 . . . . 2.8500000000000001 107.659 -174.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -22.51 -77.5 0.01 OUTLIER 'General case' 0 C--N 1.344 0.341 0 C-N-CA 127.659 2.384 . . . . 5.8099999999999996 113.148 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 t -161.82 21.9 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.487 0.661 . . . . 2.8500000000000001 110.945 165.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -71.89 -41.28 68.17 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 120.91 -1.119 . . . . 2.1499999999999999 110.256 -163.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.68 -46.89 79.64 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.684 -0.858 . . . . 1.46 108.684 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 t -55.79 -48.63 75.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.294 0.569 . . . . 2.3900000000000001 110.285 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.25 -49.3 74.67 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.827 -0.434 . . . . 2.5600000000000001 109.827 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.6 mt -56.06 -49.93 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.886 0.874 . . . . 1.9199999999999999 109.509 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.479 ' CD ' HG21 ' A' ' 37' ' ' VAL . 82.5 mm-40 -61.94 -39.08 90.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.892 0.877 . . . . 7.0300000000000002 112.393 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -44.38 93.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.105 -0.702 . . . . 5.0199999999999996 109.105 175.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -61.69 -37.12 82.95 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.883 -0.51 . . . . 1.47 110.031 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.79 -52.72 33.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.93 0.892 . . . . 2.0600000000000001 110.958 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.474 HE22 HG11 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -56.67 -26.53 56.63 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.784 1.175 . . . . 2.5 112.608 176.179 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -74.22 0.63 13.5 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 116.782 -1.58 . . . . 2.96 115.125 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -48.67 -84.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 121.044 1.747 . . . . 3.0099999999999998 112.581 174.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.84 -90.91 0.0 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.686 0.795 . . . . 2.3300000000000001 110.095 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.15 -26.18 74.21 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.369 -0.692 . . . . 1.6200000000000001 111.369 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.424 ' CG1' ' HA ' ' A' ' 27' ' ' GLN . 1.1 t -61.06 128.6 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.069 -0.715 . . . . 2.2400000000000002 109.069 172.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.19 53.5 1.08 Allowed 'General case' 0 C--N 1.337 0.053 0 C-N-CA 121.099 -0.241 . . . . 3.0299999999999998 111.207 163.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.1 t -158.1 139.22 13.28 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 120.926 -1.109 . . . . 1.8999999999999999 110.549 167.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.474 HG11 HE22 ' A' ' 27' ' ' GLN . 1.6 p -126.53 107.89 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 125.94 1.696 . . . . 2.8900000000000001 107.432 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -126.22 72.24 1.3 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.503 -1.666 . . . . 2.4300000000000002 106.503 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.538 HG22 ' HA ' ' A' ' 44' ' ' ALA . 44.4 t -103.55 141.09 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.843 -0.799 . . . . 1.8899999999999999 108.843 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.25 95.75 5.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.551 -0.907 . . . . 1.4299999999999999 108.551 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.97 -18.19 4.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.022 0.529 . . . . 3.0499999999999998 112.309 169.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.8 mtt -69.13 -50.54 46.97 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.3 0.64 . . . . 3.6099999999999999 110.116 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.08 -30.69 12.89 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.715 0.806 . . . . 1.48 111.435 -172.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.38 64.08 1.4 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.837 1.208 . . . . 1.2 110.479 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -141.0 138.5 33.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.384 -1.709 . . . . 2.9300000000000002 106.384 171.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.538 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -117.09 92.74 3.94 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 124.868 1.355 . . . . 1.27 112.301 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.92 119.59 35.67 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.996 -1.113 . . . . 4.6699999999999999 107.996 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.99 163.35 20.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 126.379 1.872 . . . . 2.6000000000000001 108.858 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -122.34 106.08 10.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.588 0.755 . . . . 3.9100000000000001 110.083 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.513 ' HB2' HD12 ' A' ' 53' ' ' ILE . 18.6 p90 -100.11 173.36 6.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.075 1.75 . . . . 2.3799999999999999 113.272 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -122.85 102.86 37.66 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.239 1.815 . . . . 4.0599999999999996 109.27 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -45.8 -36.02 14.38 Favored 'Trans proline' 0 C--N 1.355 0.913 1 C-N-CA 126.076 4.517 . . . . 2.2999999999999998 113.743 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.39 -29.11 68.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.224 1.409 . . . . 3.3599999999999999 111.69 -170.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.89 -32.45 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.684 0.794 . . . . 2.79 112.261 -174.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.513 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -120.56 146.2 25.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 107.947 -1.131 . . . . 1.6000000000000001 107.947 173.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -124.27 146.51 51.97 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.149 1.38 . . . . 2.4399999999999999 109.394 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.72 -38.5 49.29 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.313 2.676 . . . . 1.6899999999999999 112.057 -171.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -57.58 -45.62 85.01 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.879 -0.513 . . . . 3.2599999999999998 111.005 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -61.05 -43.18 99.28 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.002 0.921 . . . . 3.3900000000000001 109.904 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.401 ' CD1' HD11 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -52.37 -53.2 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.251 -1.388 . . . . 1.1200000000000001 107.251 171.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.17 85.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 110.019 -0.363 . . . . 1.47 110.019 -173.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -55.89 -42.55 76.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.292 0.637 . . . . 2.7599999999999998 110.86 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.2 -43.25 87.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.394 0.543 . . . . 2.79 110.129 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 69' ' ' ALA . 6.1 mm -65.4 -44.03 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.671 -0.643 . . . . 2.5699999999999998 110.607 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -58.46 -41.96 86.34 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.288 0.635 . . . . 3.3799999999999999 111.279 174.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -63.76 -48.73 75.78 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.174 0.59 . . . . 2.9100000000000001 109.984 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.8 mt -56.22 -35.51 67.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.645 0.378 . . . . 2.0800000000000001 111.323 173.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.82 25.57 3.6 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.216 0.912 . . . . 1.3400000000000001 112.077 168.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -115.48 168.79 9.68 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.055 1.742 . . . . 2.0899999999999999 108.643 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -104.06 142.55 34.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.801 -1.185 . . . . 2.3999999999999999 107.801 165.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.581 ' HB1' HD12 ' A' ' 8' ' ' LEU . . . -123.81 112.38 17.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.78 -1.563 . . . . 0.95999999999999996 106.78 175.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB3' HE22 ' A' ' 9' ' ' GLN . . . -126.85 129.33 48.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.656 -0.868 . . . . 0.93000000000000005 108.656 175.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.7 p -47.69 145.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 125.484 1.513 . . . . 2.8599999999999999 109.702 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.5 ptt? . . . . . 0 N--CA 1.447 -0.625 0 CA-C-N 115.751 -0.659 . . . . 4.9500000000000002 110.273 -175.16 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.615 0 N-CA-C 107.17 -2.372 . . . . 1.6399999999999999 107.17 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.15 96.49 10.61 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 105.477 -2.046 . . . . 2.4900000000000002 105.477 172.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.6 pt -123.06 145.69 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 O-C-N 123.211 0.319 . . . . 2.96 110.213 173.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.401 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.0 OUTLIER -96.98 157.35 15.94 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.491 -1.67 . . . . 3.54 106.491 178.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.63 HD13 ' HB1' ' A' ' 145' ' ' ALA . 4.6 pp -147.51 161.72 40.52 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.091 -0.707 . . . . 2.9700000000000002 109.091 161.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.6 m -99.73 127.86 45.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.624 1.17 . . . . 1.8300000000000001 108.815 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 pp -99.57 127.61 52.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 C-N-CA 123.079 0.552 . . . . 1.5900000000000001 110.311 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.5 m -106.45 142.6 35.84 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.722 0.809 . . . . 1.3600000000000001 109.188 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.65 -24.26 17.78 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.653 1.121 . . . . 0.94999999999999996 113.061 172.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.2 ttm -66.28 143.6 57.11 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.063 0.931 . . . . 2.6000000000000001 111.274 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.6 t -162.0 37.18 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.925 0.49 . . . . 2.5800000000000001 110.593 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.1 t -164.62 138.35 5.1 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.605 -1.31 . . . . 2.8199999999999998 111.509 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.27 -40.17 81.15 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.243 0.617 . . . . 2.6200000000000001 110.895 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -43.23 70.44 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.494 -0.753 . . . . 2.4399999999999999 109.612 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 91.2 m -67.76 -42.38 81.84 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.157 -0.449 . . . . 2.0600000000000001 110.796 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.95 -50.35 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 118.864 0.756 . . . . 2.0600000000000001 110.509 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -59.23 -37.0 76.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.766 -0.457 . . . . 3.3999999999999999 109.766 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -65.25 -49.11 70.9 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.275 -0.266 . . . . 1.7 110.663 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.07 -48.27 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 109.438 -0.579 . . . . 0.92000000000000004 109.438 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -58.63 -49.3 78.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.443 -0.947 . . . . 2.46 108.443 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.1 t -52.45 -46.38 66.42 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.1 0.56 . . . . 1.3799999999999999 110.122 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.454 ' HG2' HD11 ' A' ' 141' ' ' ILE . 13.7 mptt -63.33 -41.47 98.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.284 0.634 . . . . 2.96 111.723 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.6 mt -67.34 -58.59 4.51 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.538 -1.282 . . . . 1.78 107.538 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.3 p -57.05 -18.74 15.43 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.133 0.973 . . . . 1.8500000000000001 112.749 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.16 -34.45 66.17 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.943 -0.473 . . . . 6.0 111.65 170.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.5 m -67.44 149.22 50.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.407 1.883 . . . . 1.6399999999999999 111.458 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -64.47 -52.68 56.71 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.347 1.059 . . . . 2.4700000000000002 111.891 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.21 -27.41 59.94 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 122.175 -0.328 . . . . 1.1000000000000001 113.074 -168.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.52 132.02 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 117.647 0.723 . . . . 1.96 109.538 -173.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 49.6 m -103.03 -58.21 1.91 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.249 0.619 . . . . 1.96 111.19 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -134.69 113.7 11.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.2 -0.667 . . . . 2.6899999999999999 109.2 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.24 149.88 21.54 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 108.102 -1.073 . . . . 0.83999999999999997 108.102 165.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.7 t -143.03 109.01 5.18 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 108.19 -1.041 . . . . 1.9399999999999999 108.19 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.44 138.99 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.322 1.449 . . . . 2.1000000000000001 110.686 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.21 93.64 2.85 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.74 1.216 . . . . 1.1799999999999999 110.665 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 pp -60.11 -17.62 41.38 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.538 1.135 . . . . 2.2799999999999998 113.83 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.71 86.75 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.458 0.572 . . . . 1.48 109.574 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.82 -39.91 10.02 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.505 1.122 . . . . 2.0899999999999999 108.905 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.1 m 88.94 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 127.568 2.347 . . . . 1.3 110.539 -169.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.0 157.95 17.41 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.365 -0.606 . . . . 4.0899999999999999 109.365 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.57 144.26 34.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.812 -1.09 . . . . 1.1100000000000001 109.944 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.491 ' HA ' HD13 ' A' ' 121' ' ' LEU . 4.3 mm? -94.79 143.31 26.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.462 -0.94 . . . . 2.8999999999999999 108.462 163.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.74 124.16 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.634 -1.987 . . . . 1.72 105.634 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -108.64 92.44 4.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.086 -1.079 . . . . 3.1400000000000001 108.086 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -113.33 -178.56 3.41 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 124.014 0.926 . . . . 2.1299999999999999 108.83 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -113.99 110.75 48.5 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 108.322 -0.992 . . . . 2.98 108.322 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.32 68.47 8.27 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.924 2.416 . . . . 1.74 112.229 -166.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.34 -44.92 0.07 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.617 1.567 . . . . 3.3100000000000001 109.206 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.6 pt -86.67 -30.73 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 123.365 0.666 . . . . 1.6599999999999999 111.559 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.2 162.63 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.426 -0.953 . . . . 1.4399999999999999 108.426 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.79 167.84 31.64 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.837 -0.905 . . . . 1.4399999999999999 110.837 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.12 -39.01 62.81 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.811 3.008 . . . . 1.49 112.334 -169.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.76 -39.43 52.33 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.471 0.545 . . . . 6.0599999999999996 112.471 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.51 -45.0 81.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.602 -0.518 . . . . 3.3700000000000001 109.602 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 88.3 mt -58.67 -49.29 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.815 -0.809 . . . . 1.1499999999999999 108.815 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.2 mt -49.57 -59.31 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 N-CA-C 108.445 -0.946 . . . . 2.1299999999999999 108.445 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -50.07 -47.55 53.5 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.105 -0.997 . . . . 5.0199999999999996 111.365 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 82.4 mt -55.54 -50.12 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.447 -0.783 . . . . 2.6899999999999999 109.646 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 145' ' ' ALA . 12.7 pt -70.37 -30.14 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 118.108 -0.949 . . . . 1.26 112.861 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.77 -42.48 79.47 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.829 1.195 . . . . 3.02 109.068 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.71 -34.32 76.91 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.758 1.223 . . . . 3.4500000000000002 109.232 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.454 HD11 ' HG2' ' A' ' 101' ' ' LYS . 75.9 mt -75.39 -41.21 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.264 0.626 . . . . 1.04 111.376 172.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.55 30.44 6.19 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.847 1.689 . . . . 0.91000000000000003 112.433 -172.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -105.31 171.58 7.25 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.727 1.263 . . . . 2.1699999999999999 110.304 167.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -129.04 117.63 21.22 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 106.655 -1.609 . . . . 4.4000000000000004 106.655 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.63 ' HB1' HD13 ' A' ' 84' ' ' LEU . . . -106.06 102.54 11.95 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 125.292 1.437 . . . . 1.0900000000000001 108.616 174.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.0 p -98.85 112.7 24.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.092 -1.447 . . . . 2.52 107.092 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 83' ' ' GLU . 1.2 mt -49.78 105.86 0.1 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.523 -1.288 . . . . 5.6900000000000004 107.523 166.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.67 -38.48 33.53 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.333 -0.617 . . . . 3.8100000000000001 109.333 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 126.72 2.008 . . . . 6.9100000000000001 113.167 -179.848 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 106.449 -1.686 . . . . 3.29 106.449 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -123.09 152.13 41.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.331 1.052 . . . . 3.5099999999999998 109.585 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.5 t -140.87 127.98 20.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.774 -0.825 . . . . 2.0699999999999998 108.774 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -101.01 98.73 9.15 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.986 1.715 . . . . 3.73 109.082 -171.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.476 ' CB ' ' HA ' ' A' ' 71' ' ' VAL 0.273 1.4 pt? -125.44 176.55 6.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.943 0.877 . . . . 2.1600000000000001 112.383 176.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.601 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -136.36 147.11 47.21 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.186 -1.412 . . . . 1.79 107.186 176.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.1 mm -99.05 140.07 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 106.264 -1.754 . . . . 0.83999999999999997 106.264 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -115.41 76.69 1.02 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.293 -1.003 . . . . 3.1299999999999999 108.293 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.25 -69.96 0.04 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.952 -1.259 . . . . 1.23 109.952 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 31.38 72.1 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.734 2.013 . . . . 2.54 115.646 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -53.08 -16.62 1.18 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.557 1.543 . . . . 2.4100000000000001 114.053 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.2 t 74.79 -56.68 0.63 Allowed 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 126.28 1.832 . . . . 3.3599999999999999 111.767 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -23.15 -75.44 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 127.523 2.329 . . . . 5.6900000000000004 112.917 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.8 m -154.66 17.44 0.45 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.83 0.852 . . . . 3.0499999999999998 111.541 162.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.83 -51.83 36.48 Favored 'General case' 0 C--O 1.224 -0.242 0 O-C-N 121.051 -1.031 . . . . 1.8500000000000001 109.618 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -51.67 -47.86 37.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 CA-C-N 118.458 0.572 . . . . 1.48 109.689 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -56.95 -49.66 75.0 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.545 0.688 . . . . 2.8700000000000001 110.609 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -59.1 -51.7 68.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.612 -0.68 . . . . 2.6400000000000001 109.677 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 67' ' ' PHE . 2.8 mt -51.32 -47.57 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.334 1.454 . . . . 1.45 110.859 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -55.38 -53.19 59.26 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.877 0.762 . . . . 4.0599999999999996 110.482 174.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -65.58 -31.55 72.66 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.395 -0.815 . . . . 4.4699999999999998 111.438 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -68.66 -51.29 43.61 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.255 1.022 . . . . 1.1899999999999999 109.697 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.33 -40.35 67.93 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.084 0.954 . . . . 1.9299999999999999 110.663 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.67 -19.72 2.58 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.66 0.615 . . . . 2.7000000000000002 112.66 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -126.63 24.06 6.68 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.216 1.406 . . . . 3.8799999999999999 111.831 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.38 -82.57 0.05 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.091 -1.078 . . . . 3.2000000000000002 108.091 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.44 -132.74 0.08 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.074 0.95 . . . . 1.28 109.19 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.38 33.17 1.35 Allowed Glycine 0 CA--C 1.531 1.06 0 O-C-N 120.909 -1.12 . . . . 1.3100000000000001 113.816 -174.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.412 ' C ' HD12 ' A' ' 33' ' ' LEU . 14.3 p -104.31 118.79 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.682 1.593 . . . . 1.5700000000000001 108.923 170.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 33' ' ' LEU . 4.1 mp -134.24 53.38 2.0 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.406 -0.961 . . . . 3.3199999999999998 108.406 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.66 149.42 14.88 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.419 -1.326 . . . . 2.0899999999999999 107.419 173.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.92 100.84 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 106.404 -1.702 . . . . 2.8300000000000001 106.404 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.72 71.89 1.05 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.046 -1.094 . . . . 3.2400000000000002 108.046 176.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.77 133.6 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.432 -0.951 . . . . 1.8400000000000001 108.432 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.36 83.06 1.71 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.033 -1.099 . . . . 1.28 108.033 173.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.49 -24.03 1.87 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.466 1.506 . . . . 2.8799999999999999 112.267 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -70.16 -40.06 74.96 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.806 1.242 . . . . 4.75 111.785 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.24 -31.89 11.49 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.513 1.125 . . . . 1.3799999999999999 110.991 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.79 61.17 1.71 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 125.072 1.32 . . . . 1.0 110.565 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -141.23 136.83 32.1 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.181 -1.414 . . . . 3.6600000000000001 107.181 171.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.34 102.15 10.82 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.283 1.433 . . . . 1.05 109.683 170.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -98.67 135.88 39.54 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.777 -1.934 . . . . 4.2800000000000002 105.777 166.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.45 HD12 HD21 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -135.09 174.34 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.978 -1.119 . . . . 2.29 107.978 168.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.74 103.44 6.83 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.753 0.821 . . . . 5.5499999999999998 108.797 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -117.6 167.83 10.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.103 1.361 . . . . 3.3100000000000001 113.755 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -99.26 106.32 38.16 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 127.202 2.201 . . . . 3.1699999999999999 110.452 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.01 -4.44 13.53 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.103 1.869 . . . . 2.7000000000000002 114.35 -172.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -88.62 -20.84 24.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.926 0.785 . . . . 4.46 110.907 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.97 -30.48 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.505 1.122 . . . . 2.7999999999999998 110.091 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.45 HD11 ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -115.98 155.96 17.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.666 0.746 . . . . 1.74 109.257 173.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -132.31 154.27 81.54 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.416 2.286 . . . . 2.9399999999999999 108.379 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.28 -40.13 34.03 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.634 2.223 . . . . 1.54 112.194 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -63.76 -40.27 96.3 Favored 'General case' 0 C--O 1.225 -0.227 0 O-C-N 121.763 -0.586 . . . . 2.8199999999999998 110.868 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -58.36 -45.83 87.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.943 0.897 . . . . 2.9500000000000002 110.334 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.45 ' CD1' HD11 ' A' ' 53' ' ' ILE . 1.9 mt -53.98 -56.06 11.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.851 -1.537 . . . . 1.3200000000000001 106.851 172.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.95 -41.32 70.95 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.787 -0.642 . . . . 1.4399999999999999 110.578 -173.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -53.84 -50.18 66.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.23 1.412 . . . . 2.77 109.387 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -48.46 72.12 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.379 0.609 . . . . 2.21 109.777 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.7 mm -63.22 -40.33 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.129 -0.357 . . . . 2.6699999999999999 110.564 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -64.9 -42.19 94.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.735 -0.469 . . . . 1.96 109.735 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -60.46 -47.89 84.15 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.138 0.575 . . . . 2.98 109.562 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.18 -33.52 71.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.209 0.604 . . . . 2.04 111.629 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.9 27.72 3.92 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.172 0.892 . . . . 1.3899999999999999 111.632 168.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.44 ' CD2' HD13 ' A' ' 22' ' ' ILE . 2.6 m-30 -118.91 162.3 18.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.994 1.717 . . . . 2.1800000000000002 108.694 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -98.31 129.19 45.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.931 1.293 . . . . 3.6899999999999999 107.973 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.4 110.61 21.8 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.984 1.314 . . . . 1.1699999999999999 108.507 174.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -126.93 122.92 35.96 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.122 0.419 . . . . 1.21 109.977 175.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.476 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.4 t -58.38 148.23 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 123.24 0.616 . . . . 3.1400000000000001 110.931 172.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 39.8 mtt . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 119.076 -0.488 . . . . 4.96 111.449 179.659 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.985 0 N-CA-C 110.038 -1.225 . . . . 1.8500000000000001 110.038 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.32 73.09 2.13 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.847 1.259 . . . . 2.8100000000000001 109.139 -167.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.28 155.68 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.584 -0.895 . . . . 2.6200000000000001 108.584 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.84 140.69 50.41 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.636 1.174 . . . . 2.7599999999999998 107.998 173.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 mp -130.68 149.53 52.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.844 -0.799 . . . . 2.1400000000000001 108.844 171.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.63 130.77 44.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.311 1.044 . . . . 1.6499999999999999 108.614 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.8 mt -99.92 115.28 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.635 -0.506 . . . . 2.9399999999999999 109.635 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.8 p -107.84 89.13 2.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.926 1.29 . . . . 2.46 109.543 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.6 -45.8 0.57 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.798 -0.921 . . . . 1.1000000000000001 110.798 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -56.41 136.64 53.73 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 110.221 -0.289 . . . . 2.1000000000000001 110.221 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -158.2 34.71 0.24 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.103 0.561 . . . . 2.8799999999999999 110.891 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 34.0 t -158.91 144.23 16.22 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.548 -0.72 . . . . 2.6099999999999999 110.617 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.15 -39.12 42.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.153 0.981 . . . . 2.6299999999999999 111.995 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.2 p -53.6 -46.27 70.34 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.906 -0.497 . . . . 3.46 110.74 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 65.6 m -67.98 -45.96 72.68 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.909 -0.774 . . . . 1.8200000000000001 108.909 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.425 HG21 HD12 ' A' ' 115' ' ' LEU . 61.1 t -51.91 -49.58 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.042 0.937 . . . . 1.6299999999999999 109.591 175.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -64.38 -37.66 88.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.776 -0.824 . . . . 3.27 108.776 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -59.87 -52.61 64.71 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.63 0.772 . . . . 2.1200000000000001 110.347 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.1 mt -54.17 -54.13 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.654 0.782 . . . . 1.0600000000000001 109.045 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.6 -45.17 85.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.806 -0.442 . . . . 3.1299999999999999 109.806 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.8 t -54.69 -49.31 70.98 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.507 0.723 . . . . 1.8200000000000001 110.583 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -34.8 78.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.412 -0.805 . . . . 2.5699999999999998 111.274 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.3 mt -71.57 -58.16 3.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.778 -0.823 . . . . 1.8 108.778 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.5 p -56.21 -22.73 31.13 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 111.915 0.339 . . . . 2.3799999999999999 111.915 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.31 -27.09 69.09 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.457 0.91 . . . . 4.79 113.457 174.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.1 p -69.4 172.71 6.73 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 119.822 1.192 . . . . 2.6299999999999999 111.246 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -88.62 -47.21 8.45 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.222 -0.899 . . . . 3.98 110.278 173.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.47 -34.09 51.06 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.471 -0.627 . . . . 1.1899999999999999 113.587 -170.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.97 135.17 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 119.145 1.472 . . . . 2.3399999999999999 109.251 -176.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -105.27 -44.67 4.68 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 122.407 0.283 . . . . 2.8100000000000001 111.624 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.431 ' CZ ' ' HG3' ' A' ' 123' ' ' LYS . 27.2 p90 -139.7 122.75 16.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.67 -1.604 . . . . 2.0899999999999999 106.67 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.85 143.82 45.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.564 -0.854 . . . . 1.4299999999999999 109.795 164.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.6 m -133.56 119.99 20.19 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.037 -1.468 . . . . 1.9299999999999999 107.037 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 p -122.55 133.55 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 123.631 0.772 . . . . 1.8999999999999999 109.079 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -127.92 99.98 5.73 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.961 0.886 . . . . 1.3400000000000001 109.216 -171.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.591 HD13 ' H ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -55.62 -21.43 17.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.756 1.622 . . . . 3.0899999999999999 113.743 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.406 ' N ' HD22 ' A' ' 115' ' ' LEU . . . -73.76 -41.36 62.57 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.933 -0.765 . . . . 1.4299999999999999 108.933 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.2 p -88.11 -15.28 36.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.711 1.204 . . . . 3.27 111.191 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.8 t 65.11 25.64 12.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.869 1.268 . . . . 1.98 110.778 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.56 149.28 50.22 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.412 0.685 . . . . 2.77 110.941 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -125.15 115.64 20.78 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.68 2.392 . . . . 0.93000000000000005 108.199 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.42 116.55 29.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.003 -1.48 . . . . 2.1899999999999999 107.003 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.3 m -111.58 140.12 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.025 0.93 . . . . 2.0699999999999998 109.799 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.431 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 2.2 mmtp -123.19 95.89 4.78 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-O 118.511 -0.757 . . . . 3.6800000000000002 110.063 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -121.52 178.52 4.78 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.706 1.002 . . . . 2.0800000000000001 113.706 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -104.64 110.42 64.33 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.233 1.013 . . . . 3.48 108.687 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.9 62.51 6.59 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.609 2.873 . . . . 1.71 112.788 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -148.25 -52.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.123 1.769 . . . . 2.9700000000000002 107.72 172.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -86.98 -32.67 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.442 0.697 . . . . 1.8100000000000001 111.413 -172.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.78 165.82 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.429 -1.693 . . . . 1.6599999999999999 106.429 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.94 164.46 31.32 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 109.852 -1.299 . . . . 1.79 109.852 -176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.23 -40.86 46.69 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.032 2.488 . . . . 1.9299999999999999 110.2 -171.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -48.35 -38.47 19.32 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 113.47 0.915 . . . . 7.79 113.47 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.1 -44.92 75.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.681 -0.859 . . . . 3.4399999999999999 108.681 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.13 -47.59 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.383 -0.969 . . . . 1.5600000000000001 108.383 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.9 mt -54.12 -60.69 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.004 -0.739 . . . . 2.1299999999999999 109.004 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -51.61 -45.74 63.34 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 119.59 1.086 . . . . 3.6200000000000001 111.055 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.6 mt -54.17 -53.49 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 121.664 -0.647 . . . . 2.3300000000000001 110.076 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.253 2.1 pp -67.83 -30.83 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 121.109 -0.994 . . . . 1.24 112.891 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -55.89 -39.94 72.3 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.798 0.726 . . . . 2.98 110.107 170.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -63.06 -35.86 81.65 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.756 -0.461 . . . . 2.6499999999999999 109.756 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.5 mt -68.26 -44.33 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.562 -0.533 . . . . 0.95999999999999996 109.562 172.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.35 32.6 2.51 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.273 1.416 . . . . 0.85999999999999999 111.182 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -99.28 178.41 4.91 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.116 0.958 . . . . 2.4399999999999999 108.891 165.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -141.05 124.38 16.59 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.57 -1.641 . . . . 3.7200000000000002 106.57 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.97 94.78 4.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.307 1.443 . . . . 1.1799999999999999 108.706 -174.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.3 m -103.0 117.66 35.08 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.997 0.919 . . . . 1.6699999999999999 110.456 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 mp -45.73 117.89 1.62 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.786 1.634 . . . . 4.29 110.108 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -109.57 13.44 23.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.37 0.668 . . . . 3.4399999999999999 112.303 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? . . . . . 0 C--O 1.25 1.129 0 C-N-CA 125.486 1.514 . . . . 7.3899999999999997 109.811 161.214 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 106.291 -1.744 . . . . 2.98 106.291 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.51 166.51 10.49 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 107.758 -1.201 . . . . 4.0 107.758 166.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.97 120.25 11.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.579 1.081 . . . . 3.5600000000000001 108.933 170.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -98.2 90.23 4.77 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.556 0.742 . . . . 2.8799999999999999 110.267 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.56 165.72 15.97 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.704 0.764 . . . . 2.6699999999999999 111.04 175.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.806 HE22 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -120.14 156.32 31.3 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.303 -0.999 . . . . 1.9399999999999999 108.303 174.379 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.1 144.44 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 107.677 -1.231 . . . . 0.98999999999999999 107.677 172.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -116.54 125.07 51.36 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.678 -1.231 . . . . 4.9100000000000001 107.678 162.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 147.86 -81.14 0.2 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.188 1.375 . . . . 1.3999999999999999 109.998 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.9 mtt 57.92 66.64 1.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.825 1.25 . . . . 2.0499999999999998 113.013 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -46.52 -54.71 8.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.862 1.265 . . . . 2.5699999999999998 113.303 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.2 p -167.83 44.48 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.516 0.598 . . . . 5.5 111.323 -170.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.67 35.44 8.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.274 1.029 . . . . 4.7999999999999998 112.681 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 m -152.24 -43.26 0.11 Allowed 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.385 1.474 . . . . 2.46 110.555 -173.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.55 -46.15 87.45 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.347 -0.845 . . . . 2.1600000000000001 109.937 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.536 ' HB ' HD21 ' A' ' 39' ' ' LEU . 54.3 t -52.69 -39.64 31.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 O-C-N 122.184 -0.322 . . . . 1.96 110.437 171.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -59.7 -42.73 93.63 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.085 0.469 . . . . 2.29 110.868 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -66.19 -47.6 73.39 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.31 -0.869 . . . . 2.6299999999999999 109.631 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.41 -46.98 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 122.211 -0.306 . . . . 2.25 110.418 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -57.6 -41.15 80.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.292 1.037 . . . . 6.96 112.39 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -46.48 89.07 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.355 -0.98 . . . . 5.5700000000000003 108.355 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -58.0 -45.16 87.27 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.072 -0.49 . . . . 1.5900000000000001 110.557 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.552 HD11 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -52.2 -58.56 6.24 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.533 0.733 . . . . 2.6000000000000001 111.424 172.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -19.99 65.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.812 1.187 . . . . 2.3199999999999998 112.921 -175.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -90.39 -0.92 57.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.713 1.375 . . . . 4.5599999999999996 114.713 168.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -53.1 -70.63 0.09 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.848 1.658 . . . . 3.0899999999999999 111.012 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.7 -81.47 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.42 1.088 . . . . 1.3700000000000001 110.66 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.52 -28.71 73.61 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.889 -0.484 . . . . 1.6000000000000001 111.889 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 t -61.34 116.16 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.209 1.004 . . . . 2.8900000000000001 110.284 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.66 54.66 1.67 Allowed 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.861 -1.533 . . . . 3.3599999999999999 106.861 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.4 t -160.39 161.48 33.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 120.887 -1.133 . . . . 2.2000000000000002 110.42 155.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.81 109.43 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 127.277 2.231 . . . . 2.8399999999999999 106.779 172.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tt -135.54 63.05 1.61 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.114 -1.069 . . . . 2.4100000000000001 108.114 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -96.12 149.09 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.143 -1.058 . . . . 2.5899999999999999 108.143 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.22 100.0 6.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.113 -1.44 . . . . 1.3700000000000001 107.113 166.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.536 HD21 ' HB ' ' A' ' 19' ' ' VAL . 17.2 mt -64.41 -15.38 60.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.277 0.631 . . . . 2.8900000000000001 112.158 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.4 mmt -72.39 -52.81 14.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.533 0.733 . . . . 5.1100000000000003 110.405 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.33 -34.02 21.93 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.95 0.5 . . . . 1.5 110.974 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.94 62.79 1.28 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.035 1.303 . . . . 1.23 110.899 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -140.14 137.04 34.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.887 -1.523 . . . . 3.6800000000000002 106.887 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.07 96.35 5.99 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 125.044 1.338 . . . . 1.1100000000000001 109.791 173.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -98.65 136.5 38.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.481 -2.044 . . . . 3.6400000000000001 105.481 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.98 177.92 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 N-CA-C 106.079 -1.823 . . . . 2.1099999999999999 106.079 172.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -129.84 99.92 5.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.785 0.434 . . . . 4.0899999999999999 110.386 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -94.47 -177.86 4.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.621 1.968 . . . . 2.6299999999999999 112.857 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -127.67 108.52 20.65 Favored Pre-proline 0 N--CA 1.444 -0.765 0 CA-C-N 114.169 -1.378 . . . . 3.4300000000000002 108.003 169.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.22 -3.01 10.79 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.581 2.187 . . . . 2.1299999999999999 112.764 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.67 -39.6 64.31 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.797 1.18 . . . . 3.5800000000000001 110.708 172.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -110.01 -19.18 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 118.291 0.496 . . . . 3.0 110.335 -166.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 pt -131.7 -176.48 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 107.484 -1.302 . . . . 2.29 107.484 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.64 155.94 59.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 125.418 1.487 . . . . 2.4100000000000001 108.449 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.39 -35.6 60.54 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.309 2.006 . . . . 1.52 110.192 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.94 -37.99 84.27 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 122.064 -0.397 . . . . 2.8199999999999998 111.94 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -67.74 -45.54 74.7 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.964 0.905 . . . . 3.0800000000000001 110.372 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.9 mt -48.5 -56.76 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 106.546 -1.65 . . . . 1.5 106.546 167.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.59 89.31 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.07 -0.514 . . . . 1.52 110.777 -170.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -52.27 -49.78 63.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.81 1.644 . . . . 2.5 109.604 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.74 -50.27 44.9 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.154 0.502 . . . . 3.0299999999999998 109.797 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.552 HD11 HD11 ' A' ' 26' ' ' LEU . 5.9 mm -65.99 -38.9 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 121.919 -0.488 . . . . 2.48 110.958 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -64.11 -46.28 84.91 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.567 -0.531 . . . . 2.04 109.567 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -57.8 -52.43 65.51 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.316 0.646 . . . . 2.6299999999999999 109.817 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.3 mt -58.77 -38.78 79.25 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.27 -0.423 . . . . 2.4500000000000002 111.576 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.79 33.33 0.65 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 123.367 0.508 . . . . 1.3200000000000001 112.59 163.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -133.02 163.64 28.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.733 1.213 . . . . 2.5499999999999998 110.365 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -97.41 128.73 44.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.97 -1.493 . . . . 2.54 106.97 171.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.85 124.33 52.13 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.491 -1.3 . . . . 1.02 107.491 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.806 ' HB3' HE22 ' A' ' 9' ' ' GLN . . . -128.49 138.01 52.06 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.558 -1.275 . . . . 1.29 107.558 168.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -60.64 141.14 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.536 -0.913 . . . . 3.25 108.536 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.6 mtt . . . . . 0 N--CA 1.45 -0.45 0 C-N-CA 124.805 1.242 . . . . 4.75 110.604 176.647 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.7 0 N-CA-C 110.686 -0.965 . . . . 2.2599999999999998 110.686 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.99 101.84 4.13 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.236 1.414 . . . . 2.54 108.66 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.733 HD12 ' N ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -125.87 155.31 35.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 125.55 1.54 . . . . 3.0899999999999999 108.123 -167.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.74 ' OE1' ' HB3' ' A' ' 148' ' ' ALA . 2.6 pp20? -131.38 153.17 49.93 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.121 1.368 . . . . 4.2400000000000002 107.396 174.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.07 162.71 32.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.151 -1.425 . . . . 2.4199999999999999 107.151 170.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.596 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -97.42 133.52 41.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.965 -2.235 . . . . 2.1000000000000001 104.965 170.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.411 ' O ' HD12 ' A' ' 86' ' ' ILE . 1.6 pp -106.16 117.59 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 123.54 0.736 . . . . 1.95 109.652 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.6 m -105.6 136.79 44.54 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.577 -1.268 . . . . 1.6699999999999999 107.577 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.28 -45.24 1.34 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.493 1.044 . . . . 1.4299999999999999 111.151 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -62.26 132.96 54.42 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.39 -0.476 . . . . 2.7200000000000002 110.345 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -156.89 42.01 0.35 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.373 0.669 . . . . 3.9100000000000001 110.303 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.6 t -162.4 144.92 11.1 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 120.711 -1.243 . . . . 2.8399999999999999 110.523 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.49 -40.37 62.29 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.697 0.799 . . . . 3.1800000000000002 110.897 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -54.67 -47.1 74.02 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.897 -0.502 . . . . 2.0 110.364 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.8 m -64.6 -44.76 89.58 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.06 0.544 . . . . 2.1000000000000001 109.596 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.4 t -51.14 -51.17 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 122.589 0.356 . . . . 1.6599999999999999 110.074 171.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -62.28 -37.84 87.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.208 -0.664 . . . . 2.6499999999999999 109.208 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -59.95 -55.02 39.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.183 0.993 . . . . 1.99 110.185 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.8 mt -54.91 -56.4 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.301 -0.629 . . . . 1.5900000000000001 109.301 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.86 -43.32 76.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.19 0.996 . . . . 3.3799999999999999 108.938 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.3 t -53.82 -47.18 71.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.643 0.656 . . . . 1.27 111.069 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -63.96 -42.74 97.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.63 -1.294 . . . . 2.79 111.54 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.423 HD23 ' CB ' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -61.44 -54.89 37.59 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.359 -0.978 . . . . 2.6200000000000001 108.359 176.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.0 p -59.11 -25.03 63.48 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.647 0.61 . . . . 1.8500000000000001 112.647 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -72.52 -16.27 61.78 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.187 0.903 . . . . 4.0 112.357 175.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.5 m -80.55 152.82 28.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.915 0.886 . . . . 1.8300000000000001 109.528 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -72.41 -49.49 33.36 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.197 0.999 . . . . 2.7400000000000002 112.555 -175.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.75 -40.26 7.76 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 121.702 0.612 . . . . 1.1599999999999999 111.71 -167.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.514 HD11 ' HB ' ' A' ' 122' ' ' VAL . 2.4 mm -53.66 136.11 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.06 -0.719 . . . . 2.21 109.06 168.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 38.6 p -123.25 -25.69 4.43 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.33 0.493 . . . . 2.98 112.33 166.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.07 112.51 6.8 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.258 -1.756 . . . . 2.02 106.258 -169.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.423 ' CB ' HD23 ' A' ' 102' ' ' LEU . . . -115.55 157.65 23.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.154 -1.054 . . . . 1.1200000000000001 108.154 163.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 61.8 m -144.72 118.46 9.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.048 -1.464 . . . . 2.0499999999999998 107.048 170.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.92 134.3 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 108.57 -0.9 . . . . 2.9300000000000002 108.57 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.2 88.76 2.9 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.678 0.751 . . . . 1.8200000000000001 109.146 -167.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -54.2 -30.18 48.86 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.315 1.046 . . . . 2.9199999999999999 112.13 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.59 65.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.101 0.96 . . . . 2.0 111.088 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.74 -9.8 15.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.32 1.448 . . . . 2.3500000000000001 110.949 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.3 m 66.58 30.58 8.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.574 1.55 . . . . 1.49 111.713 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -105.74 158.15 16.93 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.292 0.637 . . . . 3.9700000000000002 110.683 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.11 109.4 8.91 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.235 1.814 . . . . 1.26 107.988 174.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.9 mp -98.55 131.06 45.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.722 -1.214 . . . . 2.4900000000000002 107.722 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.514 ' HB ' HD11 ' A' ' 108' ' ' ILE . 19.7 m -132.65 133.82 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.371 1.068 . . . . 2.4399999999999999 108.555 -174.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -117.67 93.75 4.27 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.041 -1.096 . . . . 3.3599999999999999 108.041 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -122.28 168.76 11.65 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.645 1.178 . . . . 1.9099999999999999 112.284 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -98.13 113.47 63.95 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 109.266 -0.642 . . . . 2.6499999999999999 109.266 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.53 67.86 7.71 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.695 2.93 . . . . 1.95 111.474 -172.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -160.49 -46.86 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.159 1.384 . . . . 3.5499999999999998 108.874 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.1 pt -86.66 -28.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 123.692 0.797 . . . . 1.8799999999999999 111.876 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.53 165.04 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.159 -1.052 . . . . 1.5600000000000001 108.159 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.98 162.5 28.94 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 109.874 -1.29 . . . . 1.6200000000000001 109.874 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -62.57 -35.13 72.48 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.425 2.75 . . . . 1.6699999999999999 111.516 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -52.71 -42.06 64.5 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 112.759 0.651 . . . . 5.4699999999999998 112.759 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.57 -39.0 74.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.459 -0.896 . . . . 3.3599999999999999 109.565 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.1 -47.57 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.967 -0.753 . . . . 1.4399999999999999 108.967 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 52.2 mt -55.36 -56.48 11.45 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 124.015 0.926 . . . . 2.0800000000000001 109.573 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -49.89 -50.44 45.92 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 119.461 1.028 . . . . 4.0599999999999996 110.619 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 50.7 mt -54.88 -55.33 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 122.557 0.343 . . . . 2.3599999999999999 110.154 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.7 pp -68.21 -29.59 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.774 -1.204 . . . . 1.3200000000000001 112.951 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.11 -35.86 74.18 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.401 0.546 . . . . 3.0800000000000001 110.657 171.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.62 -37.76 82.49 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.471 -0.566 . . . . 4.7300000000000004 109.471 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.0 mt -72.92 -40.5 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 109.212 -0.662 . . . . 1.6399999999999999 109.212 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.7 33.97 2.95 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.047 1.308 . . . . 1.4199999999999999 110.961 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -99.19 177.4 5.23 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 108.233 -1.025 . . . . 3.0299999999999998 108.233 164.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -141.38 120.88 13.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.099 -1.815 . . . . 4.5199999999999996 106.099 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.0 110.81 22.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.533 1.533 . . . . 1.3700000000000001 108.727 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.7 m -130.35 134.33 47.09 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.477 0.711 . . . . 2.8599999999999999 110.935 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -37.97 127.88 1.25 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.063 2.145 . . . . 4.3200000000000003 110.151 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.74 ' HB3' ' OE1' ' A' ' 83' ' ' GLU . . . -103.93 -12.09 17.06 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 116.445 -1.74 . . . . 3.2999999999999998 113.343 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 . . . . . 0 C--O 1.259 1.597 0 C-N-CA 129.4 3.08 . . . . 6.8499999999999996 114.554 152.267 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 106.471 -1.677 . . . . 2.9900000000000002 106.471 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -95.45 157.89 15.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.586 1.555 . . . . 4.1100000000000003 107.448 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.9 p -140.95 133.79 28.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 122.544 0.337 . . . . 2.98 110.215 168.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -104.01 105.58 15.8 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 125.665 1.586 . . . . 3.0899999999999999 108.371 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.464 HD21 HD12 ' A' ' 46' ' ' ILE . 1.7 pt? -134.63 169.46 17.27 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.472 -0.491 . . . . 2.1699999999999999 110.969 172.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.22 138.95 51.37 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.012 -1.848 . . . . 1.73 106.012 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.8 mm -97.93 134.04 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 106.802 -1.555 . . . . 1.04 106.802 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -104.51 123.29 47.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.533 -1.654 . . . . 3.3399999999999999 106.533 160.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.84 -27.38 3.06 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.367 0.985 . . . . 3.0600000000000001 111.472 -175.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.2 ptt? -57.92 167.67 1.14 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.791 -0.829 . . . . 2.7799999999999998 111.405 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 m 77.11 -8.81 1.63 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.801 1.24 . . . . 9.25 112.016 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.8 m -114.45 136.01 53.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.888 0.875 . . . . 6.4900000000000002 109.645 -173.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 42.33 -106.15 0.08 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.357 1.463 . . . . 6.29 109.894 -174.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 p -158.95 38.84 0.22 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.918 0.866 . . . . 3.1299999999999999 109.308 171.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.66 -42.96 63.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.76 -0.655 . . . . 1.9299999999999999 110.443 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -57.08 -42.01 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 122.252 1.025 . . . . 2.2799999999999998 109.378 171.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.95 -46.07 82.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.863 -1.062 . . . . 2.7999999999999998 111.293 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -60.83 -46.41 90.66 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.267 -0.896 . . . . 2.5800000000000001 110.519 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.0 mt -47.68 -40.29 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 C-N-CA 124.153 0.981 . . . . 1.71 111.637 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -47.31 -60.34 2.57 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.117 0.567 . . . . 5.1500000000000004 111.974 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -37.29 72.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.327 -0.62 . . . . 6.1100000000000003 109.327 -173.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -56.61 -54.85 41.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.186 -0.461 . . . . 1.24 110.066 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mt -58.7 -44.37 90.3 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 118.652 0.66 . . . . 2.1600000000000001 111.137 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.08 -11.26 1.04 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 114.285 1.217 . . . . 1.8 114.285 171.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.11 3.75 11.4 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.955 -1.091 . . . . 3.8100000000000001 111.974 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.73 -65.9 0.66 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.851 1.205 . . . . 2.52 110.515 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.28 -131.36 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.122 0.569 . . . . 1.46 109.951 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.42 -0.94 80.47 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 119.501 1.046 . . . . 1.6899999999999999 113.096 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.91 127.61 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 O-C-N 121.523 -0.986 . . . . 1.6100000000000001 111.298 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.52 54.01 1.12 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.284 0.846 . . . . 2.3799999999999999 113.284 173.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 t -157.15 143.68 18.16 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 107.02 -1.474 . . . . 1.8700000000000001 107.02 165.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.0 92.53 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.04 -1.837 . . . . 2.4500000000000002 106.04 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -116.53 79.78 1.37 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.351 -1.722 . . . . 3.27 106.351 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.9 p -98.73 128.23 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.453 -0.943 . . . . 2.2200000000000002 108.453 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.39 74.98 2.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.957 -1.868 . . . . 1.21 105.957 172.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.86 -29.88 3.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.393 1.077 . . . . 3.1600000000000001 111.87 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.2 ttt -72.65 -36.18 67.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.947 1.299 . . . . 4.0300000000000002 111.135 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.71 -48.02 5.65 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 124.177 0.991 . . . . 1.3200000000000001 109.191 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.23 58.24 0.35 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 125.48 1.514 . . . . 1.1100000000000001 111.599 167.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -142.97 136.91 28.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.12 -1.067 . . . . 3.0899999999999999 108.12 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.64 110.36 22.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.637 1.575 . . . . 1.0 111.597 168.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -99.51 111.36 23.72 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.081 -1.081 . . . . 4.6500000000000004 108.081 167.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.464 HD12 HD21 ' A' ' 8' ' ' LEU . 13.9 mt -109.57 167.04 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.684 0.794 . . . . 2.6200000000000001 109.066 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -123.61 108.23 12.37 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.871 0.868 . . . . 4.0300000000000002 109.107 162.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -113.81 163.4 15.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.73 1.212 . . . . 2.8399999999999999 111.336 168.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -105.71 106.37 56.21 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 127.215 2.206 . . . . 4.6200000000000001 110.075 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.69 2.21 1.77 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.057 2.505 . . . . 1.9199999999999999 114.015 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -83.14 -22.75 33.22 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.128 1.371 . . . . 4.4900000000000002 110.408 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.1 t -123.42 -65.44 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.2 -1.037 . . . . 2.75 108.2 -171.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -87.26 155.14 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.276 -0.638 . . . . 1.46 109.276 174.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -129.27 151.74 78.29 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.692 1.597 . . . . 2.5899999999999999 108.004 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.91 -38.42 79.21 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.841 2.361 . . . . 1.21 112.149 -172.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -59.51 -41.09 89.14 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.328 -0.857 . . . . 2.9199999999999999 111.255 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -61.2 -40.54 94.35 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.307 0.643 . . . . 3.0299999999999998 110.254 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.503 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -54.75 -46.45 74.17 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 N-CA-C 107.746 -1.205 . . . . 1.1000000000000001 107.746 171.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.4 94.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.064 0.459 . . . . 1.21 111.036 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -57.77 -52.89 63.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.468 -0.77 . . . . 2.5299999999999998 110.34 173.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -51.0 -55.5 17.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.429 0.692 . . . . 5.1699999999999999 111.496 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.558 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.5 pp -61.4 -39.87 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 121.065 -1.022 . . . . 4.4299999999999997 111.647 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.58 -33.72 76.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.343 0.52 . . . . 3.0800000000000001 110.816 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.51 -50.3 67.95 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.485 -0.561 . . . . 2.5099999999999998 109.485 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.1 mt -58.65 -35.73 73.0 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.937 -0.305 . . . . 2.04 111.402 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.08 31.19 2.52 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 123.92 0.771 . . . . 1.1799999999999999 111.915 169.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -112.16 164.64 12.95 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.625 1.57 . . . . 2.1000000000000001 109.04 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -102.9 136.05 43.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.02 -1.474 . . . . 2.6000000000000001 107.02 164.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.558 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -130.3 127.04 38.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.216 -1.772 . . . . 0.93999999999999995 106.216 169.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.4 138.98 33.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.009 0.818 . . . . 0.92000000000000004 109.328 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.84 144.46 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 116.138 -0.483 . . . . 2.77 109.734 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.7 mtp . . . . . 0 CA--C 1.532 0.285 0 C-N-CA 124.098 0.959 . . . . 3.9100000000000001 111.23 -175.518 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 107.366 -2.294 . . . . 1.72 107.366 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -102.65 110.06 21.88 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.381 1.472 . . . . 2.6800000000000002 109.046 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.96 138.91 53.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 O-C-N 123.332 0.395 . . . . 2.71 110.67 175.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -110.33 141.36 43.45 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.128 1.371 . . . . 4.4199999999999999 108.326 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.492 HD13 ' N ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -142.79 156.45 44.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.298 -0.63 . . . . 3.29 109.298 174.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.414 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.6 OUTLIER -97.31 121.75 39.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 105.018 -2.216 . . . . 1.5600000000000001 105.018 -177.093 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 pp -100.88 121.07 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.14 -0.689 . . . . 1.5700000000000001 109.14 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.2 p -106.92 142.79 35.98 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.27 0.628 . . . . 2.1499999999999999 109.348 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.74 -26.17 10.31 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.741 1.162 . . . . 1.48 112.742 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.474 ' SD ' HD12 ' A' ' 98' ' ' ILE . 4.0 ttp -67.51 108.62 2.9 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.641 -0.917 . . . . 3.0 112.096 -169.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.7 m -117.86 7.77 12.47 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.044 0.938 . . . . 2.46 111.923 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 23.9 p -163.07 151.21 13.78 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 120.742 -1.224 . . . . 2.9300000000000002 112.08 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.54 72.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.683 0.793 . . . . 2.9399999999999999 111.411 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.2 m -53.29 -40.96 65.14 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.284 -0.885 . . . . 2.6200000000000001 110.785 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.1 m -69.89 -40.93 75.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.615 -0.707 . . . . 1.79 110.04 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.0 t -50.35 -57.21 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 118.636 0.653 . . . . 1.47 109.557 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -58.58 -45.71 88.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.358 0.663 . . . . 4.2000000000000002 110.205 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -61.21 -50.62 72.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.0 0.52 . . . . 1.77 110.84 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.474 HD12 ' SD ' ' A' ' 89' ' ' MET . 41.7 mt -56.27 -47.2 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.089 -0.708 . . . . 1.03 109.089 177.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.28 -49.49 74.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.634 -0.876 . . . . 2.8100000000000001 108.634 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.3 t -52.52 -50.45 62.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.719 0.808 . . . . 1.48 110.159 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -61.31 -42.37 98.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.753 -0.592 . . . . 3.2000000000000002 111.31 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.5 mt -67.18 -56.26 10.68 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.932 -1.136 . . . . 1.8500000000000001 107.932 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.7 p -55.33 -17.78 5.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.484 0.714 . . . . 1.8600000000000001 112.703 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -13.77 62.59 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.502 -0.749 . . . . 5.5300000000000002 112.398 171.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -80.83 153.86 27.45 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.389 1.876 . . . . 1.8500000000000001 109.63 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -67.39 -64.44 0.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.943 0.897 . . . . 3.0299999999999998 111.353 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.32 -32.41 58.08 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 122.253 -0.279 . . . . 1.2 112.921 -172.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.07 112.52 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.733 0.766 . . . . 1.8100000000000001 109.616 -172.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.6 m -99.3 -41.32 7.5 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.561 0.344 . . . . 2.27 110.265 -172.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 123' ' ' LYS . 54.2 p90 -140.15 121.22 14.69 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.468 -0.567 . . . . 2.3900000000000001 109.468 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.18 140.8 37.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.72 -0.844 . . . . 1.0900000000000001 108.72 165.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -132.69 116.98 17.29 Favored 'General case' 0 C--O 1.228 -0.052 0 N-CA-C 108.29 -1.004 . . . . 1.5900000000000001 108.29 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.604 HG12 ' HB1' ' A' ' 120' ' ' ALA . 3.0 m -112.28 135.23 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.591 1.157 . . . . 2.2400000000000002 109.087 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.32 89.55 2.57 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.332 0.969 . . . . 1.1699999999999999 111.211 -173.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -24.51 67.04 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 125.22 1.408 . . . . 3.1099999999999999 113.718 -170.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.81 70.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.654 0.381 . . . . 1.45 110.397 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.83 -13.12 12.02 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.477 1.511 . . . . 1.76 111.317 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.3 m 69.13 15.8 8.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.319 1.847 . . . . 1.3100000000000001 114.326 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -95.16 158.0 15.65 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 120.127 1.33 . . . . 3.25 108.464 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.604 ' HB1' HG12 ' A' ' 113' ' ' VAL . . . -140.53 125.15 17.98 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.225 1.01 . . . . 0.85999999999999999 108.652 168.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.26 114.42 26.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.637 -1.616 . . . . 1.6699999999999999 106.637 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 m -106.75 135.06 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.048 0.84 . . . . 2.2599999999999998 111.687 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HG3' ' CE2' ' A' ' 110' ' ' TYR . 9.2 mmmt -113.01 95.97 5.69 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.13 1.372 . . . . 3.5099999999999998 109.524 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -122.95 174.16 7.35 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.843 0.747 . . . . 2.52 111.362 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -105.19 110.07 63.99 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 108.564 -0.902 . . . . 3.1299999999999999 108.564 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.53 69.01 6.83 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.48 2.787 . . . . 1.97 111.305 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -158.45 -48.53 0.06 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.875 1.27 . . . . 3.21 108.917 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pt -82.83 -28.93 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.406 0.682 . . . . 1.8200000000000001 110.867 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.64 163.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.575 -0.898 . . . . 1.6200000000000001 108.575 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.71 161.5 28.24 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.444 -1.462 . . . . 1.76 109.444 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.52 -37.62 87.9 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.557 2.838 . . . . 1.98 111.713 -172.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -52.21 -36.65 52.7 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.262 0.838 . . . . 7.0700000000000003 113.262 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.43 -46.02 67.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.453 -0.573 . . . . 3.4199999999999999 109.453 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.4 mt -57.46 -45.32 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.631 -0.878 . . . . 1.3899999999999999 108.631 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.7 mt -53.85 -61.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 118.354 -0.831 . . . . 2.3900000000000001 109.055 173.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.15 -49.49 32.17 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.913 1.233 . . . . 5.4299999999999997 111.174 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.5 mt -53.05 -60.11 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.808 -0.812 . . . . 2.1200000000000001 108.808 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.3 pp -65.9 -30.56 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 119.375 -0.93 . . . . 1.3500000000000001 113.279 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.43 -40.53 94.78 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.111 0.869 . . . . 2.5499999999999998 109.758 170.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -64.98 -37.47 87.76 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.079 -0.712 . . . . 2.8399999999999999 109.079 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.35 -43.29 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.075 -0.391 . . . . 1.1499999999999999 109.956 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.61 31.56 4.83 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.57 1.557 . . . . 1.0700000000000001 111.619 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -99.62 174.93 6.01 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.315 1.057 . . . . 2.2000000000000002 108.652 165.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -139.02 119.15 13.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.055 -1.831 . . . . 4.0300000000000002 106.055 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.19 109.42 20.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.129 1.771 . . . . 1.1100000000000001 108.793 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 26.6 m -117.14 113.72 22.66 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.944 0.497 . . . . 1.8 110.274 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -31.34 115.2 0.14 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.391 1.876 . . . . 3.8599999999999999 112.039 169.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.414 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -101.17 15.69 27.93 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.637 1.347 . . . . 3.1600000000000001 114.637 -161.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.085 -1.436 . . . . 5.6399999999999997 112.618 -175.76 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 106.564 -1.643 . . . . 3.04 106.564 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -126.2 149.04 49.3 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.546 1.538 . . . . 4.9500000000000002 106.951 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.1 p -140.53 146.03 37.58 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.829 -0.804 . . . . 3.4100000000000001 108.829 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.15 109.68 19.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.041 -1.466 . . . . 4.6500000000000004 107.041 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.478 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 2.3 pt? -133.69 174.72 10.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.071 0.938 . . . . 2.3700000000000001 111.192 170.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.436 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -136.78 137.75 40.16 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.023 -1.103 . . . . 2.3199999999999998 108.023 176.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 mm -98.67 126.51 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 106.972 -1.492 . . . . 1.3200000000000001 106.972 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -102.48 103.55 13.92 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.064 -1.828 . . . . 4.0199999999999996 106.064 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.23 -89.46 0.1 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.287 -1.525 . . . . 1.26 109.287 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.4 mtt 47.1 73.67 0.18 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.169 1.388 . . . . 2.1099999999999999 113.497 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -57.56 -11.8 2.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.75 1.22 . . . . 2.7000000000000002 113.653 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.5 t 73.97 -66.03 0.32 Allowed 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 126.187 1.795 . . . . 2.9500000000000002 110.878 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -15.4 -74.51 0.01 OUTLIER 'General case' 0 C--N 1.342 0.279 0 C-N-CA 128.368 2.667 . . . . 6.8099999999999996 113.219 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.8 m -153.37 19.26 0.55 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.498 0.719 . . . . 4.0599999999999996 111.07 161.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 31.7 m -70.64 -47.5 59.74 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 121.093 -1.004 . . . . 2.1299999999999999 109.211 -169.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -54.81 -49.83 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.752 -0.462 . . . . 2.9300000000000002 109.752 175.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -55.55 -48.38 74.82 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.175 0.59 . . . . 2.3500000000000001 111.433 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -58.75 -47.92 82.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.615 -0.513 . . . . 3.0899999999999999 109.615 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -46.4 -50.89 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.632 1.173 . . . . 1.8799999999999999 110.051 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -54.51 -54.54 39.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.472 0.578 . . . . 4.3899999999999997 111.168 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -59.9 -43.04 95.04 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.166 -0.47 . . . . 5.0 110.3 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -56.52 -57.44 12.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.267 0.627 . . . . 1.48 109.478 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mp -57.68 -44.99 86.17 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 119.014 -0.517 . . . . 2.23 111.679 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -54.85 -20.68 9.24 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.428 1.013 . . . . 2.0 113.481 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -112.05 15.37 20.65 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.712 1.004 . . . . 3.4300000000000002 113.712 173.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -70.02 -64.54 0.87 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.949 1.25 . . . . 2.77 110.229 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.73 -124.09 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.929 0.492 . . . . 1.4399999999999999 110.713 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.74 -25.62 69.2 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 118.795 0.725 . . . . 1.6399999999999999 111.987 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 46' ' ' ILE . 4.9 p -62.95 125.73 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 O-C-N 122.446 -0.444 . . . . 1.5900000000000001 110.036 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 pp -143.12 50.55 1.41 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.71 0.767 . . . . 3.0699999999999998 109.765 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.8 t -160.64 149.53 16.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.092 -1.077 . . . . 1.99 108.092 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.0 129.7 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.046 -1.094 . . . . 2.6800000000000002 108.046 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -142.52 74.28 1.44 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.104 -1.073 . . . . 2.9399999999999999 108.104 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 m -97.33 159.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 121.372 -0.83 . . . . 2.98 108.995 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.88 90.6 2.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.307 -1.368 . . . . 2.1200000000000001 107.307 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 tp -51.86 -27.44 12.67 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.881 1.672 . . . . 3.4900000000000002 110.358 172.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.3 mtp -59.16 -38.65 80.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.187 0.995 . . . . 3.5099999999999998 111.603 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.3 -31.47 7.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.473 0.709 . . . . 2.7000000000000002 111.449 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.49 61.59 0.96 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.457 1.503 . . . . 2.1899999999999999 110.403 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -142.08 142.7 32.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.429 -1.323 . . . . 3.4199999999999999 107.429 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.08 101.34 7.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.968 0.907 . . . . 1.53 110.43 171.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -102.31 131.05 49.15 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.161 -2.162 . . . . 5.6900000000000004 105.161 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 32' ' ' VAL . 13.7 pt -136.74 171.71 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 120.434 -1.416 . . . . 2.3900000000000001 108.988 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.22 99.77 6.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.422 1.089 . . . . 5.8499999999999996 108.356 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.529 ' HB2' HD12 ' A' ' 53' ' ' ILE . 31.8 p90 -100.05 -179.17 4.07 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.686 1.194 . . . . 3.6400000000000001 110.206 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -128.25 103.3 20.53 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.597 1.159 . . . . 3.98 110.894 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.25 -8.32 18.29 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.796 3.664 . . . . 2.9100000000000001 114.84 -167.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -92.86 -8.94 42.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.352 0.661 . . . . 4.79 111.598 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.5 -47.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 123.934 0.894 . . . . 3.6299999999999999 110.21 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.529 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -116.36 143.25 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 108.08 -1.081 . . . . 2.3300000000000001 108.08 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.89 142.72 26.44 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 124.352 1.061 . . . . 2.8500000000000001 109.143 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -57.39 -40.39 81.96 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.12 2.546 . . . . 1.97 111.505 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.24 -43.37 98.99 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.319 0.648 . . . . 4.9900000000000002 110.371 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -63.05 -40.24 97.12 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.902 0.481 . . . . 3.79 110.103 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.457 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -52.35 -53.4 19.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 N-CA-C 106.915 -1.513 . . . . 1.4199999999999999 106.915 170.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.15 -45.46 79.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.99 -0.55 . . . . 1.4399999999999999 110.599 -172.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.69 -49.94 56.16 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.486 0.715 . . . . 4.0599999999999996 110.485 174.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.44 -48.9 65.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.527 0.679 . . . . 2.2599999999999998 109.858 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -64.01 -39.06 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 122.081 -0.387 . . . . 2.5 111.413 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -65.56 -44.56 86.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.731 -0.47 . . . . 2.0099999999999998 109.731 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.0 -50.51 73.83 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.714 -0.476 . . . . 2.5 109.714 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.7 mt -55.62 -40.58 72.3 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.387 -0.369 . . . . 2.1400000000000001 111.629 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.37 33.46 1.03 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 123.516 0.579 . . . . 1.1699999999999999 112.017 165.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -124.44 162.02 24.79 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.704 1.202 . . . . 1.95 108.86 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.81 130.46 41.37 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.138 -1.43 . . . . 2.5800000000000001 107.138 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.59 111.38 24.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.836 1.254 . . . . 1.1399999999999999 108.117 173.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.436 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -128.31 116.28 19.57 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.621 -0.511 . . . . 1.4199999999999999 109.621 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.478 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.8 t -68.71 155.45 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.187 1.795 . . . . 2.7999999999999998 111.36 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mtt . . . . . 0 CA--C 1.53 0.176 0 C-N-CA 124.176 0.99 . . . . 5.0800000000000001 111.267 173.804 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.672 0 N-CA-C 111.208 -0.757 . . . . 2.6200000000000001 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.543 ' C ' HD13 ' A' ' 82' ' ' ILE . 50.9 t30 -129.65 128.33 42.38 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.359 -1.348 . . . . 2.9900000000000002 107.359 169.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.543 HD13 ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -125.89 154.11 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 107.096 -1.446 . . . . 3.1699999999999999 107.096 175.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.22 141.14 51.55 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 123.477 0.711 . . . . 3.1400000000000001 110.143 169.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.66 149.28 52.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.37 -2.085 . . . . 2.4700000000000002 105.37 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 147' ' ' LEU . 0.4 OUTLIER -100.5 127.92 46.71 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 104.87 -2.27 . . . . 1.6599999999999999 104.87 176.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.01 136.78 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 O-C-N 123.863 0.727 . . . . 1.77 109.065 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.2 m -128.34 115.2 17.9 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.372 1.069 . . . . 1.6599999999999999 109.401 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.38 -38.13 1.72 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.174 1.369 . . . . 1.1200000000000001 111.438 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.6 mtp -45.94 119.55 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.667 1.187 . . . . 3.23 111.763 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.0 m -129.66 17.02 5.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.922 0.889 . . . . 2.8999999999999999 110.676 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 47.5 t -165.56 141.26 5.15 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 120.827 -1.171 . . . . 2.6000000000000001 109.993 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.92 -32.51 66.02 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.709 0.686 . . . . 2.98 111.495 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -53.12 -37.92 62.18 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.756 -0.59 . . . . 1.9099999999999999 110.469 173.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 85.8 m -62.53 -49.74 74.12 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 109.265 -0.643 . . . . 1.77 109.265 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.9 t -49.87 -45.54 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 122.506 0.322 . . . . 1.3799999999999999 110.712 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -48.67 80.73 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.065 -0.346 . . . . 2.8799999999999999 110.065 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -38.88 92.59 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 119.812 -0.755 . . . . 3.48 110.484 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.437 HD11 ' CE2' ' A' ' 143' ' ' PHE . 81.5 mt -64.76 -54.29 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.43 -0.952 . . . . 1.3500000000000001 108.43 -177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -49.46 -49.77 43.99 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 126.337 1.855 . . . . 4.3899999999999997 109.251 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.0 t -50.17 -50.43 49.13 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 119.368 -0.349 . . . . 1.8700000000000001 111.317 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -50.2 68.52 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.03 0.832 . . . . 3.0899999999999999 112.3 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.75 -45.13 87.71 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 120.841 -1.162 . . . . 3.0 110.892 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 87.2 m -61.11 -16.93 49.58 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.707 0.803 . . . . 2.27 111.061 173.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -17.71 64.83 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 118.624 -0.703 . . . . 4.75 111.733 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.9 p -72.66 -176.41 1.95 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 120.159 1.345 . . . . 2.8900000000000001 110.885 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -94.29 -50.35 5.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.541 1.137 . . . . 2.3900000000000001 111.083 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.47 -41.37 30.31 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 122.245 -0.285 . . . . 1.5600000000000001 112.768 -168.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.17 126.34 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.751 -0.833 . . . . 2.6800000000000002 108.751 -173.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.0 m -112.36 -46.32 3.19 Favored 'General case' 0 CA--C 1.522 -0.11 0 N-CA-C 111.824 0.305 . . . . 2.3999999999999999 111.824 -174.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.45 ' CE2' ' HG3' ' A' ' 123' ' ' LYS . 49.5 p90 -136.42 125.15 23.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.718 -1.216 . . . . 2.8700000000000001 107.718 167.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.17 159.99 21.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.784 -1.191 . . . . 0.91000000000000003 107.784 161.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.0 m -142.98 105.12 4.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.794 -1.187 . . . . 1.8500000000000001 107.794 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.1 t -98.36 115.67 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 125.968 1.707 . . . . 2.3599999999999999 107.596 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -119.0 106.37 12.37 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 118.943 0.792 . . . . 1.22 110.484 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 pp -72.59 -29.92 63.92 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.467 1.107 . . . . 2.1899999999999999 112.447 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.52 -43.22 89.1 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.395 0.678 . . . . 1.3999999999999999 110.341 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -28.69 19.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.786 1.234 . . . . 1.76 110.314 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.35 21.91 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.162 1.785 . . . . 2.1299999999999999 111.155 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -99.08 160.82 13.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.607 1.563 . . . . 3.2599999999999998 110.216 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.48 130.13 24.25 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.408 -0.96 . . . . 0.95999999999999996 108.408 166.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -95.54 143.27 26.99 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.24 -1.393 . . . . 1.72 107.24 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.35 128.7 25.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 124.998 1.319 . . . . 1.98 109.027 -173.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HG3' ' CE2' ' A' ' 110' ' ' TYR . 1.8 mmmt -118.54 106.65 12.88 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.006 -0.739 . . . . 3.73 109.006 176.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -125.44 175.8 7.26 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.802 0.841 . . . . 2.79 110.318 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -97.82 113.58 63.86 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 108.009 -1.108 . . . . 3.75 108.009 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.6 67.96 7.11 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.524 2.816 . . . . 2.4500000000000002 111.222 -173.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -162.49 -47.64 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.719 1.208 . . . . 3.9300000000000002 109.026 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 pt -86.39 -32.18 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 122.539 0.335 . . . . 2.2599999999999998 111.524 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.68 163.05 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 107.939 -1.134 . . . . 2.04 107.939 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.21 160.82 28.37 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.456 -1.458 . . . . 1.99 109.456 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.36 -35.78 89.8 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.511 2.807 . . . . 2.04 111.665 -172.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -32.66 69.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 112.39 0.515 . . . . 6.6900000000000004 112.39 -175.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.79 -48.45 68.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.976 -0.75 . . . . 3.6800000000000002 108.976 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 74.9 mt -58.3 -45.18 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.533 -0.914 . . . . 1.5 108.533 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 80.4 mt -52.44 -61.09 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 117.566 -1.207 . . . . 2.29 108.889 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.26 -51.8 17.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.399 1.454 . . . . 5.0700000000000003 110.996 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.0 mm -52.89 -49.92 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.599 0.636 . . . . 2.0899999999999999 110.104 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.288 2.5 pp -70.75 -31.53 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 121.173 -0.954 . . . . 1.4399999999999999 113.31 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.5 -39.76 84.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.74 1.155 . . . . 3.0600000000000001 109.813 169.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -35.41 77.27 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.196 1.398 . . . . 3.1699999999999999 108.867 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 78.1 mt -77.27 -41.81 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 122.542 0.337 . . . . 0.98999999999999999 110.724 172.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.31 30.98 5.45 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.598 1.57 . . . . 1.0600000000000001 111.583 -173.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 98' ' ' ILE . 46.1 m-85 -98.33 175.3 6.1 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.422 1.111 . . . . 1.99 108.251 165.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -135.92 126.36 26.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.191 -2.151 . . . . 3.9100000000000001 105.191 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.6 100.57 7.2 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.648 1.579 . . . . 1.4399999999999999 107.466 -175.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.1 m -146.8 117.2 7.44 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 117.896 -1.049 . . . . 3.0499999999999998 111.408 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.424 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 0.2 OUTLIER -166.99 -102.0 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.217 -0.896 . . . . 6.8099999999999996 109.588 170.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 41.1 40.21 1.04 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.434 1.493 . . . . 6.8600000000000003 111.814 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 . . . . . 0 C--O 1.248 0.99 0 N-CA-C 114.726 1.38 . . . . 7.3499999999999996 114.726 -169.942 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.514 -0.414 0 N-CA-C 109.78 -0.452 . . . . 4.5099999999999998 109.78 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 152.39 19.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 123.891 0.744 . . . . 3.4500000000000002 110.547 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.7 t -119.65 137.45 53.88 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.562 -0.903 . . . . 2.0600000000000001 108.562 168.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -102.33 103.55 14.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.847 1.659 . . . . 3.6699999999999999 108.973 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.565 ' HB3' HG13 ' A' ' 71' ' ' VAL . 1.8 pt? -125.8 176.91 6.6 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.894 0.854 . . . . 2.6099999999999999 111.236 171.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.47 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -139.82 136.45 34.04 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.225 -1.028 . . . . 1.79 108.225 176.331 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 44' ' ' ALA . 29.6 mm -93.69 121.25 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 107.004 -1.48 . . . . 0.79000000000000004 107.004 -169.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.75 102.17 11.75 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.583 -2.377 . . . . 4.0899999999999999 104.583 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.47 -89.27 0.09 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 109.785 -1.326 . . . . 1.1599999999999999 109.785 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.2 mmt 46.98 77.32 0.09 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.079 1.752 . . . . 2.2799999999999998 113.375 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 p -65.62 -58.41 5.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.464 -0.773 . . . . 2.7000000000000002 111.528 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 49.68 0.07 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 119.976 -0.689 . . . . 3.6000000000000001 110.784 -172.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 47.66 36.27 5.37 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.822 0.849 . . . . 5.3099999999999996 111.593 -177.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -129.4 -51.66 1.18 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.698 1.199 . . . . 3.25 109.635 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 23.4 t -68.79 -43.25 76.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 118.434 -1.306 . . . . 2.4199999999999999 109.811 -174.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -38.65 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 122.125 0.965 . . . . 2.2799999999999998 109.399 173.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -65.83 -41.55 91.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.084 -0.962 . . . . 2.4500000000000002 111.26 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.57 -38.17 70.99 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 120.801 -1.187 . . . . 3.1099999999999999 111.667 172.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.0 mt -49.4 -42.79 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.494 1.118 . . . . 1.3999999999999999 109.968 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -41.14 -56.46 2.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.635 0.731 . . . . 4.4400000000000004 112.515 172.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -68.57 -27.51 66.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.873 0.869 . . . . 5.04 110.79 -175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -69.48 -57.4 5.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.436 -0.95 . . . . 1.21 108.436 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.11 -40.6 85.87 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 118.745 0.702 . . . . 2.29 110.261 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -24.56 5.94 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 112.771 0.656 . . . . 2.0699999999999998 112.771 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -127.31 25.43 6.15 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.273 0.629 . . . . 4.0300000000000002 111.734 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -76.77 -58.15 3.44 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.995 -0.742 . . . . 2.8300000000000001 108.995 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -162.56 -131.87 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.015 0.526 . . . . 1.21 109.972 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.49 -2.44 42.69 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.761 0.696 . . . . 1.4299999999999999 113.767 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -80.22 122.38 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.163 0.981 . . . . 1.3300000000000001 109.382 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.1 51.36 2.13 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.774 0.797 . . . . 2.5600000000000001 109.933 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 t -161.6 151.14 16.47 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.246 -1.761 . . . . 1.6399999999999999 106.246 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -140.72 124.35 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.172 -1.788 . . . . 2.54 106.172 166.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.73 87.89 2.55 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.144 0.973 . . . . 4.3300000000000001 110.492 169.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.59 139.92 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.249 -1.019 . . . . 2.2999999999999998 108.249 172.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -109.3 100.97 10.01 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.967 -1.864 . . . . 1.55 105.967 162.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.74 -33.61 70.45 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.258 1.023 . . . . 3.9300000000000002 109.052 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -53.07 62.41 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.56 1.144 . . . . 4.5999999999999996 110.78 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.73 -25.39 22.33 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.347 0.659 . . . . 1.8600000000000001 111.388 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.66 55.68 2.65 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.741 1.162 . . . . 1.46 110.957 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -135.33 139.42 44.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.175 0.988 . . . . 3.29 108.336 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -112.66 105.3 13.45 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 124.682 1.193 . . . . 0.90000000000000002 109.765 167.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.31 144.49 28.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.591 -1.633 . . . . 3.7200000000000002 106.591 163.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.64 172.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.536 -1.283 . . . . 2.0699999999999998 107.536 166.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -115.4 112.32 22.15 Favored 'General case' 0 C--N 1.34 0.178 0 O-C-N 124.054 0.846 . . . . 3.7999999999999998 110.206 167.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.519 ' HB2' HD12 ' A' ' 53' ' ' ILE . 7.8 p90 -105.21 172.33 6.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.598 1.559 . . . . 2.7200000000000002 110.758 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -117.17 106.34 47.37 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.894 1.278 . . . . 3.4199999999999999 109.001 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.15 -12.56 30.36 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 124.609 3.539 . . . . 2.4199999999999999 113.819 -160.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -96.46 0.86 50.97 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.177 0.591 . . . . 3.1800000000000002 111.3 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.0 t -118.85 -49.03 3.73 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 123.979 0.912 . . . . 2.6000000000000001 109.478 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.623 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -121.16 149.97 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.833 1.253 . . . . 1.48 108.344 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.23 140.06 27.54 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 106.564 -1.643 . . . . 2.98 106.564 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -56.69 -38.78 94.91 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.022 2.482 . . . . 1.6599999999999999 112.06 -172.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mp -52.06 -43.83 64.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.681 0.792 . . . . 3.6000000000000001 111.061 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -39.51 94.08 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.137 -0.69 . . . . 3.3500000000000001 109.137 -176.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.623 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -54.55 -52.11 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.493 -1.299 . . . . 1.3200000000000001 107.493 172.317 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.82 -45.53 86.01 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 123.365 0.415 . . . . 1.24 110.263 -173.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.5 -45.99 69.87 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.068 0.547 . . . . 3.3100000000000001 110.944 172.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.37 -46.83 87.58 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.379 0.609 . . . . 2.52 109.863 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mm -58.76 -44.21 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.916 -0.49 . . . . 2.7599999999999998 110.991 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -63.69 -39.77 95.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.348 0.659 . . . . 3.2200000000000002 111.507 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -62.62 -46.69 87.08 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.977 0.511 . . . . 2.1200000000000001 109.702 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 mt -58.21 -36.85 73.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.549 0.34 . . . . 1.8999999999999999 111.742 172.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.88 24.56 3.03 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.268 0.937 . . . . 0.97999999999999998 112.469 167.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 18' ' ' CYS . 2.1 m-30 -115.12 160.91 19.1 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.188 1.395 . . . . 2.3500000000000001 109.118 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -98.03 119.21 36.27 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.321 -0.992 . . . . 4.04 108.321 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.31 91.11 5.06 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.087 1.355 . . . . 1.1499999999999999 107.947 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -98.71 97.5 8.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.596 -1.631 . . . . 1.0700000000000001 106.596 177.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.565 HG13 ' HB3' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -60.81 155.67 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.187 -1.37 . . . . 4.0 110.104 169.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.568 -0.901 . . . . 4.8899999999999997 108.568 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.813 0 CA-C-O 117.674 -1.626 . . . . 2.2200000000000002 109.899 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.442 HD22 ' C ' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -96.45 70.26 2.65 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.534 1.667 . . . . 2.5899999999999999 107.739 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.42 161.25 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.521 -0.918 . . . . 2.8700000000000001 108.521 -178.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.12 148.09 44.06 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.522 0.729 . . . . 2.8700000000000001 109.611 177.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.49 HD13 ' HB1' ' A' ' 145' ' ' ALA . 0.1 OUTLIER -131.02 147.45 52.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.908 1.283 . . . . 2.6800000000000002 108.505 172.332 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 m -98.02 126.31 43.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 105.971 -1.863 . . . . 1.8500000000000001 105.971 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.03 134.69 35.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 109.181 -0.674 . . . . 1.47 109.181 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.5 m -125.74 140.56 52.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.115 -1.439 . . . . 1.78 107.115 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.44 -22.53 5.87 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.912 1.244 . . . . 1.3300000000000001 111.89 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -51.74 139.49 21.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.061 1.134 . . . . 3.8500000000000001 114.061 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.2 t -147.0 11.02 1.04 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.384 0.674 . . . . 3.98 111.902 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.04 144.83 1.03 Allowed 'General case' 0 C--N 1.342 0.277 0 O-C-N 120.455 -1.403 . . . . 3.48 110.084 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.69 -34.0 66.98 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.422 0.689 . . . . 2.5699999999999998 111.782 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.8 m -43.48 -49.01 7.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.753 0.421 . . . . 2.1200000000000001 110.991 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.52 -36.82 83.78 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.825 0.284 . . . . 2.75 111.059 -177.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.83 -56.59 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.636 -0.876 . . . . 1.9399999999999999 108.636 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -59.85 -35.73 75.37 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.801 0.81 . . . . 2.6000000000000001 110.556 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -63.19 -49.41 74.35 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.814 1.646 . . . . 1.6599999999999999 111.252 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 34.5 mt -58.49 -45.3 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.716 -0.846 . . . . 1.1000000000000001 108.716 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -55.32 -48.7 73.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.239 0.616 . . . . 3.3300000000000001 110.194 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.8 t -51.91 -53.43 41.01 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.334 0.97 . . . . 1.3899999999999999 110.889 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.34 -39.68 73.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.321 -0.862 . . . . 2.8100000000000001 112.056 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.4 -60.41 2.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.576 -1.268 . . . . 2.1499999999999999 107.576 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.0 p -54.93 -20.97 10.17 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.855 0.862 . . . . 2.2599999999999998 112.754 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.1 mtt85 -60.73 -34.1 73.91 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.88 0.696 . . . . 5.5999999999999996 112.88 171.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.1 m -57.36 150.23 18.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.604 0.762 . . . . 1.74 111.621 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -68.87 -56.0 9.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.155 0.982 . . . . 2.6899999999999999 112.336 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.89 -28.18 65.32 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.972 -0.451 . . . . 1.0700000000000001 111.972 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.34 122.62 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.718 -0.871 . . . . 1.95 109.426 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.7 m -104.35 -41.25 5.82 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.163 0.185 . . . . 2.0299999999999998 111.225 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.429 ' CZ ' ' HG2' ' A' ' 123' ' ' LYS . 30.3 p90 -138.25 122.39 18.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.017 -0.735 . . . . 2.8300000000000001 109.017 172.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.73 135.28 46.4 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 107.419 -1.326 . . . . 1.05 107.419 163.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.7 t -127.8 121.94 31.44 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.205 0.457 . . . . 2.1699999999999999 110.488 164.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.54 114.37 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.014 1.326 . . . . 2.48 111.111 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -106.81 88.75 2.82 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.708 1.603 . . . . 1.2 110.43 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.58 -33.19 69.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.374 1.87 . . . . 1.98 111.683 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.24 -31.51 53.62 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.379 1.072 . . . . 1.3799999999999999 111.477 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.08 -0.14 12.82 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.01 1.324 . . . . 1.75 110.495 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.0 m 59.85 20.63 9.54 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.039 1.336 . . . . 1.4299999999999999 113.176 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -97.61 150.63 20.94 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.484 0.714 . . . . 3.7400000000000002 110.604 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.02 106.14 7.08 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.663 1.985 . . . . 0.81999999999999995 108.124 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.01 108.93 20.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.469 -2.048 . . . . 2.04 105.469 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.5 p -113.95 127.0 71.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 2.1899999999999999 108.412 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.429 ' HG2' ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -114.87 105.6 13.19 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 123.929 0.892 . . . . 4.8600000000000003 110.044 -176.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -124.01 -177.37 3.74 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.003 0.814 . . . . 1.9399999999999999 111.804 -174.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -105.38 106.81 57.39 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.2 -1.407 . . . . 3.5600000000000001 107.2 178.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.71 66.11 8.82 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.519 2.813 . . . . 1.72 111.088 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -161.51 -48.34 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.484 1.514 . . . . 3.2400000000000002 108.623 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.9 pt -86.28 -32.59 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 123.698 0.799 . . . . 1.54 111.23 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.02 163.68 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.287 0.635 . . . . 1.3300000000000001 109.574 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.39 166.44 26.44 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.452 -1.059 . . . . 1.3400000000000001 110.452 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.19 -37.11 19.31 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.397 2.731 . . . . 1.48 111.156 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -50.05 -39.06 40.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.237 0.615 . . . . 6.3200000000000003 111.471 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.25 -38.99 71.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.506 -0.924 . . . . 4.3499999999999996 108.506 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.15 -49.02 85.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.486 0.714 . . . . 1.03 109.165 172.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 77.1 mt -51.51 -53.04 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.704 -0.85 . . . . 1.8100000000000001 108.704 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -48.79 75.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.364 -0.835 . . . . 3.6400000000000001 111.872 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 49.9 mt -49.92 -56.08 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.894 -0.78 . . . . 2.2999999999999998 108.894 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.256 2.2 pp -67.25 -30.38 49.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 113.194 0.813 . . . . 1.55 113.194 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -60.79 -37.78 83.09 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.511 1.051 . . . . 2.6099999999999999 110.15 170.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -69.33 -31.39 69.82 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.758 -0.46 . . . . 3.8900000000000001 109.758 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.2 mt -66.72 -45.14 88.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.898 -0.501 . . . . 1.3799999999999999 109.765 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.07 31.94 3.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.667 1.603 . . . . 1.2 111.343 -175.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.87 174.46 6.19 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.927 0.864 . . . . 2.4900000000000002 109.068 171.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -125.96 123.26 38.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.622 -1.622 . . . . 3.9500000000000002 106.622 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.49 ' HB1' HD13 ' A' ' 84' ' ' LEU . . . -115.81 100.77 8.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.357 1.463 . . . . 1.23 108.91 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.4 p -98.42 99.25 10.42 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.012 -1.107 . . . . 3.21 108.012 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -47.91 98.9 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.489 1.915 . . . . 4.0 110.811 176.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 48.38 42.7 18.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.951 0.901 . . . . 3.75 112.23 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 116.893 -1.527 . . . . 8.4399999999999995 108.716 -175.267 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 107.032 -1.47 . . . . 3.5899999999999999 107.032 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.41 ' HA ' ' HG3' ' A' ' 47' ' ' LYS . 32.2 ttmt -94.93 151.67 19.0 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 119.645 1.111 . . . . 4.1799999999999997 109.376 176.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.66 133.63 40.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.441 -1.254 . . . . 2.0600000000000001 108.531 167.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -103.67 118.49 36.84 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.657 1.583 . . . . 3.3999999999999999 109.135 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.463 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.8 pt? -141.09 179.93 6.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.567 0.747 . . . . 2.1600000000000001 111.488 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -130.62 146.38 52.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.327 -0.99 . . . . 1.5900000000000001 108.327 173.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 mm -100.95 136.19 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 107.442 -1.318 . . . . 0.98999999999999999 107.442 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -108.98 125.3 51.91 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.157 -1.423 . . . . 3.0899999999999999 107.157 164.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.02 -79.98 0.17 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.507 1.051 . . . . 1.05 110.957 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.9 mtt 45.26 78.73 0.06 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.22 1.808 . . . . 2.0699999999999998 114.685 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -54.29 -60.78 2.88 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.75 0.648 . . . . 2.1699999999999999 112.75 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -169.59 68.27 0.06 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.443 0.565 . . . . 3.1099999999999999 110.321 -174.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 34.37 41.52 0.05 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.304 2.242 . . . . 5.75 115.78 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -160.14 -41.05 0.05 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.192 1.397 . . . . 3.3799999999999999 111.27 -171.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.2 t -70.88 -38.53 73.06 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.673 -1.267 . . . . 1.6899999999999999 111.01 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.605 ' HB ' HD21 ' A' ' 39' ' ' LEU . 95.8 t -59.4 -34.96 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.434 0.635 . . . . 1.9399999999999999 109.397 167.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.27 -40.84 96.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.37 -0.831 . . . . 2.3799999999999999 111.088 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -44.85 83.42 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.752 -1.218 . . . . 2.46 110.451 172.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.544 HG12 HD13 ' A' ' 65' ' ' LEU . 3.3 mt -47.36 -31.24 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 123.249 0.62 . . . . 1.51 111.854 175.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -46.54 -59.22 3.13 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.588 0.631 . . . . 5.25 111.539 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -71.55 -21.43 61.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.424 -0.353 . . . . 4.6900000000000004 111.834 -173.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -67.59 -57.59 6.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.407 -1.331 . . . . 1.1799999999999999 107.407 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.567 HD11 HD11 ' A' ' 62' ' ' ILE . 5.2 mp -63.27 -41.71 99.05 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 118.39 0.541 . . . . 1.97 111.237 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.54 -17.91 9.97 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.582 -0.699 . . . . 2.1299999999999999 112.59 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -123.58 27.48 7.37 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.56 0.744 . . . . 3.7000000000000002 111.406 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -81.2 -61.45 1.95 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.932 0.893 . . . . 2.6899999999999999 110.04 172.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.16 -138.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.138 0.575 . . . . 1.23 109.927 -172.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.22 -18.09 66.76 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 119.068 0.849 . . . . 1.52 112.541 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.38 121.02 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 O-C-N 121.842 -0.799 . . . . 1.5800000000000001 110.862 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 pp -142.16 50.05 1.53 Allowed 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 121.86 0.838 . . . . 2.46 110.336 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -157.92 144.51 17.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.713 -1.588 . . . . 1.6399999999999999 106.713 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.4 t -138.61 112.64 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 104.553 -2.388 . . . . 2.6899999999999999 104.553 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.94 86.77 2.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 122.219 1.009 . . . . 2.6800000000000002 109.128 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 44' ' ' ALA . 19.7 m -97.18 157.1 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.07 -0.968 . . . . 2.3399999999999999 109.11 171.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.38 98.42 5.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.116 -1.809 . . . . 1.3600000000000001 106.116 159.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.605 HD21 ' HB ' ' A' ' 19' ' ' VAL . 4.0 mp -62.33 -20.82 64.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.014 0.37 . . . . 3.6299999999999999 111.242 176.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 40.4 ttm -73.83 -37.03 64.96 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.368 1.067 . . . . 3.04 110.735 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.57 -23.2 14.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.6 0.76 . . . . 1.6899999999999999 111.797 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.17 62.29 1.83 Allowed Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.475 1.036 . . . . 1.29 111.322 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -144.0 140.37 29.55 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.487 -1.301 . . . . 4.0199999999999996 107.487 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.435 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -115.21 108.49 16.67 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.616 1.167 . . . . 1.02 110.104 165.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -104.09 148.7 25.95 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.442 1.019 . . . . 4.0099999999999998 109.082 158.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.5 pt -137.53 177.76 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.187 -1.412 . . . . 2.04 107.187 176.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HG3' ' HA ' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -126.11 110.75 13.87 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 119.137 -0.459 . . . . 3.6299999999999999 110.644 165.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -115.59 -178.43 3.38 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.232 1.813 . . . . 2.73 111.475 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -122.83 106.58 34.22 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 127.675 2.39 . . . . 4.54 110.095 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.19 10.53 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.614 2.876 . . . . 2.1099999999999999 113.358 -173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.32 -19.01 18.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.494 0.718 . . . . 3.52 110.724 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.08 -66.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.115 -1.069 . . . . 2.8100000000000001 108.115 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -94.07 142.26 13.63 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-O 120.859 0.361 . . . . 1.6000000000000001 110.299 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.39 149.06 41.52 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.302 1.441 . . . . 2.6400000000000001 109.939 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.97 -19.97 67.27 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.942 2.428 . . . . 1.4399999999999999 112.546 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -70.59 -60.35 2.31 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.986 -0.746 . . . . 2.9199999999999999 108.986 173.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -59.76 -33.57 71.85 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.1 -0.375 . . . . 3.5600000000000001 111.963 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.559 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -51.87 -47.06 41.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 N-CA-C 107.321 -1.363 . . . . 1.3200000000000001 107.321 171.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.56 -36.65 81.23 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.697 -0.683 . . . . 1.29 110.686 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -59.57 -45.39 91.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.843 0.747 . . . . 2.6000000000000001 109.568 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -52.16 63.47 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.185 -0.672 . . . . 2.3399999999999999 109.185 176.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.567 HD11 HD11 ' A' ' 26' ' ' LEU . 9.8 mm -63.48 -42.77 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 O-C-N 122.007 -0.433 . . . . 2.54 112.123 -176.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -44.45 95.64 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.23 1.012 . . . . 2.29 110.356 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -60.39 -53.94 51.54 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.671 0.788 . . . . 2.1600000000000001 108.899 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.544 HD13 HG12 ' A' ' 22' ' ' ILE . 4.7 mt -50.36 -39.82 47.58 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.648 0.779 . . . . 1.8999999999999999 111.775 174.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.56 37.55 1.07 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.637 -0.985 . . . . 1.0600000000000001 110.637 167.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -130.92 158.79 39.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.41 -1.33 . . . . 2.2200000000000002 107.41 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -99.24 119.58 38.13 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.243 -1.021 . . . . 2.29 108.243 171.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.66 119.72 36.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.417 -1.327 . . . . 0.91000000000000003 107.417 168.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -133.46 124.94 27.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.099 -1.074 . . . . 0.93000000000000005 108.099 174.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 21.8 t -60.78 151.69 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 124.546 1.139 . . . . 2.79 111.261 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.378 0 CA-C-N 115.955 -0.566 . . . . 4.4299999999999997 110.984 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 109.616 -1.393 . . . . 3.0600000000000001 109.616 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -95.79 111.12 23.16 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 107.637 -1.246 . . . . 3.3599999999999999 107.637 164.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.73 161.81 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 125.445 1.716 . . . . 2.9500000000000002 107.136 173.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.84 154.42 21.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.828 1.251 . . . . 3.1699999999999999 108.292 165.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -142.42 151.87 42.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.332 0.653 . . . . 3.1000000000000001 110.518 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 m -99.95 132.1 45.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.831 1.652 . . . . 1.8600000000000001 107.296 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.585 HD13 HD13 ' A' ' 98' ' ' ILE . 8.5 mt -99.1 124.69 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.965 -0.754 . . . . 2.4199999999999999 108.965 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.7 m -110.56 100.98 9.69 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.247 0.619 . . . . 1.5700000000000001 109.342 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.57 -34.35 2.12 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.621 1.105 . . . . 1.24 111.216 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -58.23 141.8 49.58 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.383 0.673 . . . . 2.46 111.811 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 51.8 m -153.57 84.46 1.18 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.858 1.663 . . . . 3.48 106.558 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 63.3 m 51.09 -110.51 0.48 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.017 1.327 . . . . 6.3099999999999996 111.602 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 48.72 -144.11 0.44 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.164 1.385 . . . . 5.25 110.3 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.5 t -89.15 9.4 25.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 118.849 -0.596 . . . . 3.8399999999999999 109.97 164.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.54 -56.93 6.66 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 119.506 1.048 . . . . 3.02 110.082 -166.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.5 t -49.6 -46.41 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.321 1.049 . . . . 1.26 109.92 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -63.82 -36.28 83.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.125 -0.489 . . . . 3.54 109.927 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -63.45 -52.79 59.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.556 0.742 . . . . 1.8500000000000001 109.691 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.585 HD13 HD13 ' A' ' 86' ' ' ILE . 4.0 mt -53.92 -53.99 23.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 109.496 -0.557 . . . . 1.25 109.496 178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -56.95 -45.69 82.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.907 -0.568 . . . . 2.1600000000000001 109.758 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.3 t -54.29 -54.07 45.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.822 0.737 . . . . 1.53 110.857 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -34.54 72.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 121.169 -0.957 . . . . 2.4500000000000002 111.147 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -71.07 -60.63 2.12 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.429 -0.952 . . . . 2.0499999999999998 108.429 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.1 p -56.34 -18.78 11.86 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.06 0.763 . . . . 1.73 113.06 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -61.48 -33.23 73.42 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.767 0.712 . . . . 5.5899999999999999 112.466 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.7 m -62.35 152.4 34.05 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.077 0.951 . . . . 1.6399999999999999 111.387 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -70.64 -52.96 17.8 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.317 1.047 . . . . 2.23 111.502 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.49 -43.04 20.72 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.572 -0.611 . . . . 1.1499999999999999 111.572 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.66 134.64 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.855 -0.794 . . . . 2.0 108.855 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.8 t -128.0 -35.95 2.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.756 0.823 . . . . 2.9700000000000002 110.845 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -110.11 92.0 3.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.951 -1.5 . . . . 3.02 106.951 -173.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.49 135.11 47.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.165 -1.791 . . . . 0.98999999999999999 106.165 160.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 t -140.23 108.75 5.87 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.477 -1.305 . . . . 1.6000000000000001 107.477 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.5 t -101.63 107.55 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.521 1.128 . . . . 2.3300000000000001 109.341 -173.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.97 80.12 2.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.561 1.144 . . . . 1.51 109.818 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 pp -53.56 -26.63 22.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.012 0.925 . . . . 2.2599999999999998 113.042 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.48 -35.23 65.3 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.342 0.657 . . . . 1.7 111.248 176.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -7.61 18.79 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.264 1.425 . . . . 1.8200000000000001 110.78 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.4 m 73.51 3.9 4.66 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.003 1.721 . . . . 1.6000000000000001 112.406 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -98.09 165.33 11.95 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.132 0.973 . . . . 3.1800000000000002 112.0 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -137.51 136.12 37.38 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.66 1.184 . . . . 1.05 108.651 168.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.96 132.18 43.76 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.959 -1.867 . . . . 2.5899999999999999 105.959 171.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.0 t -125.44 142.01 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 105.345 -2.094 . . . . 1.8600000000000001 105.345 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -125.06 99.52 6.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.458 1.103 . . . . 3.4500000000000002 109.255 169.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -109.68 -178.78 3.63 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.645 1.578 . . . . 2.1499999999999999 109.106 173.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -114.41 113.12 45.81 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.201 1.4 . . . . 4.1600000000000001 107.651 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.01 58.72 6.8 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.754 2.303 . . . . 2.1499999999999999 112.479 -164.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -145.77 -49.89 0.23 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.894 1.677 . . . . 4.7400000000000002 108.242 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -80.34 -32.03 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 122.34 -0.225 . . . . 1.6399999999999999 111.205 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.41 162.94 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.942 -1.132 . . . . 1.4099999999999999 107.942 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.23 163.91 27.71 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.628 -1.389 . . . . 1.3700000000000001 109.628 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.72 -41.26 39.85 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.101 2.534 . . . . 1.4399999999999999 110.396 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -40.05 25.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.184 0.809 . . . . 6.21 113.184 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.38 -47.96 79.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.18 -0.674 . . . . 2.71 109.18 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.31 -46.76 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.493 -0.928 . . . . 1.03 108.493 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.2 mt -53.66 -54.24 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 109.121 -0.696 . . . . 1.8200000000000001 109.121 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -54.65 -47.24 73.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.935 0.789 . . . . 3.6800000000000002 111.702 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.2 mm -54.17 -56.47 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.863 -0.421 . . . . 1.9399999999999999 109.863 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 pp -66.57 -30.96 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 120.973 -1.08 . . . . 1.3700000000000001 113.119 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.31 -38.38 73.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.312 0.645 . . . . 3.3900000000000001 109.917 170.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -65.99 -36.49 83.45 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.485 -0.561 . . . . 3.0099999999999998 109.485 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.7 mt -68.38 -40.84 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.395 -0.594 . . . . 1.25 109.395 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.13 33.18 3.52 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.518 1.532 . . . . 1.1699999999999999 111.007 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -101.35 176.67 5.16 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.279 1.039 . . . . 3.0499999999999998 108.364 166.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -134.92 125.67 27.15 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.413 -1.328 . . . . 4.8099999999999996 107.413 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.22 106.15 14.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.983 1.313 . . . . 1.3200000000000001 109.74 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.57 94.75 6.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.848 1.659 . . . . 2.1400000000000001 108.572 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.79 103.76 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.663 1.585 . . . . 4.2199999999999998 110.501 172.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 46.75 43.76 13.33 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.744 0.818 . . . . 4.2300000000000004 112.397 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.158 -0.925 . . . . 10.4 108.531 177.612 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 121.853 0.835 . . . . 3.8500000000000001 109.163 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.7 151.35 19.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.86 -1.904 . . . . 4.2300000000000004 105.86 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.413 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 5.8 t -123.25 141.41 52.01 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 117.837 -1.078 . . . . 1.8999999999999999 108.333 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -123.85 100.53 6.8 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.752 -0.833 . . . . 3.5499999999999998 108.752 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -125.04 168.02 13.93 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.38 1.086 . . . . 3.0299999999999998 110.736 177.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.68 146.16 43.9 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.65 -1.611 . . . . 1.7 106.65 169.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.5 mm -102.37 130.54 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.614 -1.254 . . . . 1.1200000000000001 107.614 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -118.78 117.87 30.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.494 -1.669 . . . . 3.25 106.494 167.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.78 -99.91 0.18 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.127 -1.589 . . . . 1.1200000000000001 109.127 -174.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 58.5 76.25 0.35 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.172 1.789 . . . . 1.6699999999999999 113.288 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -48.96 -58.73 4.41 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.893 0.877 . . . . 2.5899999999999999 112.698 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.56 52.63 0.05 OUTLIER 'General case' 0 C--N 1.346 0.449 0 C-N-CA 119.211 -0.995 . . . . 4.1399999999999997 111.37 -175.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.46 41.12 20.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.97 0.908 . . . . 4.5199999999999996 112.399 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -151.82 -43.19 0.11 Allowed 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.494 1.118 . . . . 2.1600000000000001 110.881 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.36 -46.99 83.96 Favored 'General case' 0 C--O 1.226 -0.167 0 O-C-N 121.052 -1.03 . . . . 2.0099999999999998 109.132 -176.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.18 -36.98 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.967 0.889 . . . . 2.25 109.996 174.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -65.8 -31.19 72.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.921 -0.581 . . . . 1.8999999999999999 112.336 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -38.19 71.82 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.93 -1.106 . . . . 3.0899999999999999 110.171 172.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.573 HG12 HD13 ' A' ' 65' ' ' LEU . 54.0 mt -59.85 -39.96 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.264 1.026 . . . . 1.5800000000000001 110.256 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.9 -58.26 2.47 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.791 0.836 . . . . 5.7300000000000004 112.08 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.53 -39.99 88.9 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.924 0.392 . . . . 4.8799999999999999 110.144 -172.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -54.45 -56.66 16.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.519 -0.764 . . . . 1.47 109.266 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mt -65.67 -36.25 83.12 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 113.313 0.857 . . . . 2.5299999999999998 113.313 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -21.9 3.65 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 118.283 0.492 . . . . 2.8100000000000001 112.165 168.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -123.75 30.88 6.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.152 0.581 . . . . 3.5299999999999998 112.42 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.32 -80.08 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.582 0.628 . . . . 3.54 109.371 167.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.29 -114.28 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.516 0.726 . . . . 1.28 110.469 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.5 -9.58 69.13 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 119.248 0.931 . . . . 1.3300000000000001 112.984 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.8 t -59.22 119.75 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 118.366 1.083 . . . . 2.3500000000000001 109.092 167.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.45 49.6 1.71 Allowed 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.496 0.665 . . . . 2.4300000000000002 110.448 162.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 t -159.66 151.13 19.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.566 -1.272 . . . . 1.6399999999999999 107.566 161.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.01 120.11 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.399 -2.074 . . . . 2.5299999999999998 105.399 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 tt -138.75 89.72 2.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.936 -1.876 . . . . 2.4100000000000001 105.936 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.7 p -106.29 135.63 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.3 -1.0 . . . . 2.3100000000000001 108.3 172.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -104.76 102.69 12.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.247 -1.76 . . . . 1.22 106.247 164.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tp -57.57 -33.7 68.44 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.054 1.342 . . . . 2.9399999999999999 109.182 169.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 62.8 mtt -59.29 -47.67 84.49 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.537 0.735 . . . . 4.0899999999999999 110.901 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.3 -25.86 16.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.915 0.886 . . . . 1.27 111.446 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.4 55.71 2.82 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.615 1.102 . . . . 1.0900000000000001 110.833 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 128.74 27.86 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.04 -1.096 . . . . 2.98 108.04 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.07 117.32 30.24 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 124.518 1.136 . . . . 1.0900000000000001 111.071 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -113.63 142.47 45.96 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.609 0.719 . . . . 3.98 110.641 162.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.5 mt -121.25 168.16 13.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 125.595 1.558 . . . . 3.4500000000000002 106.893 171.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -133.84 105.54 6.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.098 0.559 . . . . 4.1799999999999997 109.568 170.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.465 ' CD2' HD11 ' A' ' 53' ' ' ILE . 5.0 p90 -102.69 -176.22 3.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.8 2.04 . . . . 3.1299999999999999 111.792 174.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -109.35 129.93 23.34 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.252 1.421 . . . . 4.1699999999999999 107.7 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.57 41.49 1.15 Allowed 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.46 2.774 . . . . 4.0300000000000002 112.334 -166.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -163.41 24.42 0.08 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.041 0.936 . . . . 3.4900000000000002 110.392 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.13 -50.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 107.027 -1.471 . . . . 3.2200000000000002 107.027 -174.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.465 HD11 ' CD2' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -126.35 153.01 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.837 -0.801 . . . . 2.6699999999999999 108.837 176.005 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -125.77 158.49 65.12 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 106.373 -1.714 . . . . 3.6899999999999999 106.373 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.44 -27.9 54.39 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.528 1.485 . . . . 1.6399999999999999 110.438 -165.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -56.74 -42.17 78.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.123 0.969 . . . . 3.5600000000000001 111.239 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.6 -52.52 57.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.976 0.807 . . . . 2.8399999999999999 109.856 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.421 HD12 HD11 ' A' ' 53' ' ' ILE . 1.2 mt -47.7 -54.16 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.071 -1.085 . . . . 1.8400000000000001 108.071 168.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.35 -35.05 74.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.158 -0.474 . . . . 1.8999999999999999 111.308 -172.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -58.2 -47.39 83.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.506 1.122 . . . . 3.4199999999999999 109.269 -178.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -54.11 -53.14 57.34 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.747 -0.464 . . . . 2.5 109.747 174.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.409 HG21 ' HB2' ' A' ' 69' ' ' ALA . 11.0 mm -59.07 -48.16 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.04 0.448 . . . . 2.71 110.631 -174.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.3 -45.79 90.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.381 0.673 . . . . 2.71 111.164 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.36 -49.81 76.1 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.504 0.593 . . . . 2.5600000000000001 110.192 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.573 HD13 HG12 ' A' ' 22' ' ' ILE . 2.0 mt -57.97 -28.03 64.0 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.688 0.795 . . . . 1.98 111.793 174.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.43 36.15 3.91 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.11 -1.196 . . . . 1.6899999999999999 110.11 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -120.13 162.07 19.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.187 1.795 . . . . 1.9399999999999999 106.445 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -104.1 124.43 49.06 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.598 -0.89 . . . . 2.7400000000000002 108.598 168.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.409 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -108.35 121.96 45.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.506 -1.294 . . . . 1.28 107.506 162.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.52 156.54 48.72 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.767 -1.198 . . . . 1.4399999999999999 107.767 169.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.28 153.96 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.841 -1.072 . . . . 3.7000000000000002 110.004 -164.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.8 mtp . . . . . 0 C--O 1.226 -0.174 0 C-N-CA 123.719 0.808 . . . . 4.7699999999999996 111.578 172.963 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.288 0 N-CA-C 109.455 -1.458 . . . . 3.25 109.455 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.57 71.79 1.53 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.507 1.523 . . . . 3.5 108.044 -165.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.8 148.3 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.855 -1.535 . . . . 3.4399999999999999 106.855 -173.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -117.76 145.57 44.4 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 123.46 0.704 . . . . 3.79 109.152 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.41 HD13 ' HB1' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -146.94 157.45 43.64 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.128 0.971 . . . . 2.79 109.899 -175.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.46 133.58 41.85 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 106.778 -1.564 . . . . 2.9199999999999999 106.778 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.08 110.76 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.522 -0.918 . . . . 2.2599999999999998 108.522 173.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.0 m -98.93 137.81 36.95 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.946 -1.131 . . . . 1.8899999999999999 107.946 172.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.3 -28.19 14.48 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.487 1.042 . . . . 1.5800000000000001 112.806 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -75.0 122.91 24.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 117.914 0.857 . . . . 2.7599999999999998 110.537 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 m -138.88 44.31 2.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.162 0.985 . . . . 2.8999999999999999 109.748 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 11.0 t -165.73 140.8 4.86 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.268 -0.895 . . . . 3.5499999999999998 112.167 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.66 75.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.027 0.531 . . . . 2.8399999999999999 111.361 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.4 m -53.55 -45.69 69.95 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.439 -0.788 . . . . 2.54 110.036 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.0 m -64.85 -44.97 88.02 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.188 -0.91 . . . . 2.5299999999999998 109.493 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 37.2 t -46.32 -60.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 118.772 0.714 . . . . 1.95 110.749 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -56.7 -45.14 81.99 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.686 0.755 . . . . 4.0099999999999998 110.357 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.72 -50.76 72.57 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.808 0.843 . . . . 2.2400000000000002 111.166 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.2 mt -54.6 -50.53 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.041 -1.096 . . . . 1.3799999999999999 108.041 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.77 -44.32 86.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.697 0.799 . . . . 2.6600000000000001 110.299 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.8 t -56.07 -55.76 28.98 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.829 -0.434 . . . . 2.0600000000000001 109.829 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -43.15 77.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.274 0.63 . . . . 3.5499999999999998 112.572 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.39 -58.91 5.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.756 -0.831 . . . . 2.1099999999999999 108.756 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.8 m -53.09 -23.65 8.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.673 1.189 . . . . 1.7 111.432 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -4.45 8.88 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.028 1.121 . . . . 5.2699999999999996 114.028 174.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.3 m -84.74 149.73 25.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.055 1.742 . . . . 1.8600000000000001 109.646 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -67.0 -53.56 30.15 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.89 0.876 . . . . 3.1699999999999999 112.004 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.94 -21.03 69.12 Favored Glycine 0 CA--C 1.528 0.871 0 O-C-N 122.157 -0.34 . . . . 1.6499999999999999 113.202 -170.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.75 129.54 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 121.138 -1.213 . . . . 2.0699999999999998 109.154 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.9 m -103.98 -51.65 3.11 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 119.403 -0.332 . . . . 2.1099999999999999 111.867 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.462 ' CE2' ' HG3' ' A' ' 123' ' ' LYS . 43.6 p90 -140.0 114.98 9.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.373 0.533 . . . . 2.1499999999999999 110.014 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.49 149.69 23.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.988 -0.745 . . . . 1.4099999999999999 108.988 165.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.9 m -139.34 115.61 10.44 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.347 -1.353 . . . . 2.0299999999999998 107.347 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.16 119.78 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 118.227 0.467 . . . . 2.5800000000000001 110.358 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -118.78 87.98 2.84 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.817 0.818 . . . . 2.2999999999999998 109.612 -168.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.65 -32.1 28.12 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 125.724 1.61 . . . . 3.0099999999999998 112.025 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.62 -36.28 69.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.525 0.73 . . . . 3.0099999999999998 111.158 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.99 -20.08 15.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.96 1.304 . . . . 2.7200000000000002 110.439 177.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 78.79 7.05 2.23 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.656 1.583 . . . . 2.0899999999999999 111.407 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -96.37 148.86 22.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.66 1.584 . . . . 3.8399999999999999 110.057 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.41 119.29 25.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.281 2.232 . . . . 1.6699999999999999 107.605 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.88 122.85 40.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.701 -1.962 . . . . 3.1200000000000001 105.701 174.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.35 133.95 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.4 -0.963 . . . . 2.5800000000000001 108.4 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 110' ' ' TYR . 4.8 mmmt -116.12 110.4 18.8 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.363 1.065 . . . . 3.04 109.272 177.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.25 176.71 7.2 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 118.498 0.59 . . . . 2.7799999999999998 111.933 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -96.73 109.05 46.61 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 107.008 -1.479 . . . . 3.96 107.008 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.36 64.36 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.534 2.823 . . . . 3.7999999999999998 111.07 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.21 -44.88 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.426 1.49 . . . . 4.0599999999999996 109.321 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -90.88 -29.81 4.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 118.003 0.365 . . . . 3.1600000000000001 111.254 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.76 164.81 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.225 1.01 . . . . 2.9700000000000002 108.53 -175.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -149.68 167.05 29.81 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.011 -0.835 . . . . 3.0299999999999998 111.011 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -60.82 -34.38 91.54 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.243 3.295 . . . . 3.0299999999999998 111.953 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -54.17 -37.62 64.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.557 0.743 . . . . 7.6900000000000004 112.062 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.58 -43.46 84.87 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.05 0.452 . . . . 4.3300000000000001 109.834 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 14.1 mm -56.07 -48.7 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.712 0.805 . . . . 2.7200000000000002 109.189 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.9 mt -53.46 -57.89 4.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 123.513 0.725 . . . . 2.8399999999999999 109.382 172.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.0 tttp -49.36 -48.39 46.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 119.264 0.938 . . . . 4.2800000000000002 112.74 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.6 mt -51.46 -52.71 19.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.055 -0.721 . . . . 4.2599999999999998 109.055 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.309 2.2 pp -70.62 -29.15 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 118.892 -1.123 . . . . 1.54 114.021 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -58.11 -45.05 87.93 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.356 0.98 . . . . 3.23 109.019 170.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.88 -37.12 85.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.041 0.536 . . . . 3.7000000000000002 109.558 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.8 mt -66.37 -41.67 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.99 -0.444 . . . . 1.8300000000000001 110.483 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.68 30.75 6.34 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.337 1.446 . . . . 1.4199999999999999 111.8 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -101.16 -179.78 4.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.549 1.175 . . . . 1.98 108.771 163.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -133.79 121.13 21.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.938 -1.504 . . . . 4.3700000000000001 106.938 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.41 ' HB1' HD13 ' A' ' 84' ' ' LEU . . . -103.78 115.38 30.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.177 1.391 . . . . 1.8400000000000001 108.249 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.8 t -135.28 128.32 31.61 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 117.78 -1.105 . . . . 2.8700000000000001 108.606 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 pp -25.42 109.74 0.03 OUTLIER 'General case' 0 C--N 1.341 0.214 0 C-N-CA 127.626 2.37 . . . . 6.1600000000000001 109.705 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.85 -37.62 55.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.745 -0.662 . . . . 5.9100000000000001 110.782 -173.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 C--O 1.245 0.824 0 CA-C-O 116.149 -1.881 . . . . 9.6300000000000008 111.079 -179.877 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.514 -0.413 0 N-CA-C 110.256 -0.276 . . . . 3.0899999999999999 110.256 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.408 ' NZ ' ' O ' ' A' ' 149' ' ' GLN . 2.7 ttpt -93.16 136.45 33.4 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.289 -1.004 . . . . 6.5700000000000003 108.289 -175.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.3 t -125.07 130.25 51.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.029 -1.441 . . . . 2.3900000000000001 110.534 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -102.3 96.28 6.85 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 126.615 1.966 . . . . 5.0300000000000002 111.125 -171.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.489 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.3 pt? -128.46 174.49 9.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.307 1.051 . . . . 2.5899999999999999 112.839 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.6 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -127.09 155.7 42.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.977 -1.49 . . . . 2.02 106.977 169.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 44' ' ' ALA . 31.4 mm -98.72 145.16 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.418 -1.327 . . . . 0.79000000000000004 107.418 171.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -118.86 128.07 54.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.645 -1.613 . . . . 3.1000000000000001 106.645 162.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.86 -54.12 0.48 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.933 0.777 . . . . 1.3200000000000001 112.037 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.0 mtt 11.85 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.946 2.498 . . . . 2.3999999999999999 115.595 -172.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.3 p -62.36 -61.2 2.62 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.697 -0.627 . . . . 3.71 111.104 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.8 t -162.87 48.18 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.984 0.421 . . . . 3.3399999999999999 110.205 -173.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 55.52 22.18 4.94 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.275 1.03 . . . . 6.7199999999999998 113.553 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 m -130.71 -38.96 1.27 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.931 0.892 . . . . 4.1200000000000001 111.732 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 m -64.41 -48.4 75.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 O-C-N 121.427 -0.796 . . . . 2.3599999999999999 109.228 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 81.8 t -55.39 -39.92 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.006 -0.739 . . . . 2.21 109.006 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 t -58.99 -42.06 89.15 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.971 -0.559 . . . . 3.0299999999999998 110.856 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -43.33 69.04 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.251 -1.53 . . . . 3.3399999999999999 111.242 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.3 mt -52.7 -49.61 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.768 1.227 . . . . 1.5600000000000001 109.375 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -55.23 -38.22 68.19 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.241 -0.912 . . . . 4.21 111.946 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -68.07 -31.84 71.76 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.1 -1.0 . . . . 8.5199999999999996 110.366 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -65.82 -49.45 68.18 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.69 -0.856 . . . . 1.6899999999999999 108.69 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -57.04 -37.54 71.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 112.695 0.628 . . . . 1.8600000000000001 112.695 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -54.78 -18.58 4.93 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.219 -0.926 . . . . 2.1299999999999999 112.819 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -116.99 23.86 11.6 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.643 0.777 . . . . 2.9700000000000002 112.271 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -71.98 -69.17 0.41 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.945 0.793 . . . . 2.79 109.632 167.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.2 -118.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.162 0.985 . . . . 1.1399999999999999 109.568 -171.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.19 -23.76 68.3 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.829 -0.544 . . . . 1.5 113.106 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 32' ' ' VAL . 1.2 p -60.1 111.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.914 0.886 . . . . 1.8100000000000001 111.556 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.17 52.32 1.37 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.068 -1.086 . . . . 2.6000000000000001 108.068 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.3 t -162.9 152.88 15.97 Favored 'General case' 0 CA--C 1.521 -0.154 0 O-C-N 119.866 -1.772 . . . . 2.0299999999999998 108.498 156.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.14 74.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 125.365 1.466 . . . . 2.48 108.981 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.88 68.79 1.02 Allowed 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.473 -0.767 . . . . 5.4699999999999998 109.18 -177.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.99 157.42 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.561 -0.903 . . . . 3.0499999999999998 108.561 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.71 103.04 8.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.06 -1.459 . . . . 1.78 107.06 170.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.4 mt -67.31 -15.69 63.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.895 0.878 . . . . 3.54 110.962 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 17.2 ttt -76.25 -47.86 22.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.584 1.154 . . . . 4.6600000000000001 109.885 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.72 -35.83 12.61 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.595 1.158 . . . . 1.72 111.271 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.73 74.85 1.29 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 124.612 1.101 . . . . 1.49 110.627 -174.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -140.58 141.03 35.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.986 -2.227 . . . . 3.0600000000000001 104.986 165.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.414 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -114.87 101.63 9.22 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 124.036 0.835 . . . . 1.1399999999999999 108.82 163.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -96.75 133.87 40.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.2 -1.407 . . . . 4.0899999999999999 107.2 165.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.67 160.33 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.993 -1.854 . . . . 2.9700000000000002 105.993 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -121.11 105.58 10.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 123.264 0.353 . . . . 4.5499999999999998 110.587 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.463 ' HB2' HD12 ' A' ' 53' ' ' ILE . 25.4 p90 -104.13 -177.09 3.27 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 126.81 2.044 . . . . 2.8999999999999999 112.757 174.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -122.15 109.12 33.66 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.809 2.044 . . . . 4.7199999999999998 109.12 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.71 -11.29 23.11 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.756 2.304 . . . . 2.73 114.722 -175.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -95.21 -4.5 45.78 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.885 0.766 . . . . 6.0800000000000001 110.938 -170.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.5 p -134.29 -37.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.585 1.154 . . . . 3.5899999999999999 111.184 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -118.53 153.02 20.71 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 N-CA-C 109.024 -0.732 . . . . 1.97 109.024 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -138.02 152.81 72.73 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.639 1.176 . . . . 3.4300000000000002 109.86 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.57 -37.14 39.09 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.711 2.274 . . . . 1.96 111.757 -170.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.1 -40.95 95.67 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.8 -0.563 . . . . 3.54 112.085 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -61.88 -44.58 96.51 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.264 0.625 . . . . 3.7400000000000002 109.984 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -52.3 -54.97 12.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 N-CA-C 106.986 -1.487 . . . . 1.49 106.986 170.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.01 -45.95 71.65 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.948 -0.569 . . . . 1.6399999999999999 110.255 -172.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -51.06 -51.15 56.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.966 0.906 . . . . 4.9400000000000004 110.022 175.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -45.16 75.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.318 0.58 . . . . 2.7400000000000002 110.183 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 69' ' ' ALA . 7.3 mm -65.82 -37.7 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 O-C-N 121.939 -0.476 . . . . 2.6499999999999999 110.515 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -66.28 -41.07 90.36 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.382 -0.599 . . . . 3.0099999999999998 109.382 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.4 -50.8 72.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.866 0.466 . . . . 3.23 109.998 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.0 mt -57.67 -32.46 67.35 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 111.889 0.329 . . . . 1.95 111.889 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.85 35.11 1.9 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.458 1.028 . . . . 1.6499999999999999 111.445 166.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -132.18 164.05 27.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.054 1.342 . . . . 2.1899999999999999 109.149 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -102.72 124.83 48.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.867 -1.16 . . . . 2.4399999999999999 107.867 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.405 ' HB2' HG13 ' A' ' 62' ' ' ILE . . . -102.97 122.3 44.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.829 -1.175 . . . . 1.28 107.829 166.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.6 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -126.98 118.59 24.79 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.555 -0.906 . . . . 1.26 108.555 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.489 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 7.1 p -69.07 160.3 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 125.169 1.388 . . . . 3.1499999999999999 110.247 171.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 121.3 0.572 . . . . 6.0300000000000002 110.15 168.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.054 0 N-CA-C 112.264 -0.334 . . . . 2.3999999999999999 112.264 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.681 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -142.65 118.14 10.32 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 104.907 -2.257 . . . . 2.6600000000000001 104.907 174.268 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.681 HD13 ' O ' ' A' ' 81' ' ' ASN . 2.3 mm -131.6 165.82 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.657 0.783 . . . . 2.98 109.062 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -131.1 149.03 52.78 Favored 'General case' 0 N--CA 1.438 -1.056 0 O-C-N 124.51 1.131 . . . . 4.6799999999999997 111.551 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.51 151.04 38.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.344 1.027 . . . . 2.5499999999999998 109.221 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.99 132.87 43.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.27 -2.122 . . . . 1.6299999999999999 105.27 174.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.5 pt -98.62 139.46 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.191 -1.04 . . . . 1.8700000000000001 108.191 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.4 m -136.64 140.66 42.93 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.219 -1.4 . . . . 1.9099999999999999 107.219 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.51 -20.62 15.49 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.5 1.048 . . . . 1.1799999999999999 112.669 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.42 148.78 26.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.494 1.147 . . . . 3.2400000000000002 112.073 176.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.6 t -134.89 -9.97 2.34 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.586 1.154 . . . . 3.7799999999999998 112.521 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 35.4 t -160.03 158.35 30.34 Favored 'General case' 0 C--N 1.341 0.237 0 O-C-N 120.952 -1.092 . . . . 2.7200000000000002 108.598 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.33 -37.26 35.88 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.375 1.07 . . . . 2.6299999999999999 112.028 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -45.53 -42.13 10.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.732 0.813 . . . . 1.98 111.721 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 81.5 m -62.51 -53.18 58.57 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 109.134 -0.691 . . . . 1.75 109.134 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -45.33 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.648 -0.657 . . . . 2.0099999999999998 111.65 176.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -62.43 -35.31 78.85 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.696 -0.483 . . . . 3.1800000000000002 109.696 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -61.63 -60.84 3.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.535 1.134 . . . . 2.4399999999999999 109.035 176.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -44.4 -57.12 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 123.733 0.813 . . . . 2.0299999999999998 110.073 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.57 -45.02 93.09 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 120.173 -0.611 . . . . 2.5899999999999999 109.794 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.9 t -53.74 -57.57 10.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.48 0.712 . . . . 2.1099999999999999 110.519 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.538 ' CE ' HG22 ' A' ' 138' ' ' ILE . 10.7 mtpt -55.15 -38.06 67.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.446 0.906 . . . . 6.4100000000000001 113.446 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.1 mt -71.05 -56.7 5.6 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.681 -1.97 . . . . 2.3300000000000001 105.681 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.447 ' HA ' HG21 ' A' ' 108' ' ' ILE . 53.7 m -50.08 -21.51 1.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.86 2.064 . . . . 2.2200000000000002 112.499 176.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -68.22 -24.61 64.95 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.578 0.751 . . . . 4.8799999999999999 112.97 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.4 m -62.42 170.18 2.53 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.141 0.576 . . . . 2.1699999999999999 110.707 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -82.59 -49.91 9.34 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.137 -0.977 . . . . 3.2999999999999998 110.302 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.46 -30.98 66.07 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.444 1.021 . . . . 1.3 112.425 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.447 HG21 ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER -49.77 105.35 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.313 0.645 . . . . 2.7799999999999998 110.843 178.435 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 59.8 m -104.39 -31.31 9.58 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.729 0.412 . . . . 2.29 110.522 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.26 114.07 8.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.345 -1.724 . . . . 2.8599999999999999 106.345 -175.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -117.85 157.33 26.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.076 -1.453 . . . . 1.21 107.076 155.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.0 t -141.98 136.48 30.37 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.904 -1.517 . . . . 1.76 106.904 166.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.2 133.83 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 123.841 0.857 . . . . 2.1000000000000001 110.052 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -132.34 116.06 16.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.681 1.192 . . . . 1.3 110.256 -170.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.4 mt -75.43 -46.82 30.4 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 127.251 2.22 . . . . 2.9199999999999999 110.859 -172.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.59 -35.44 4.01 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.581 1.552 . . . . 1.7 111.705 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.92 -4.37 13.28 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.548 1.939 . . . . 1.8700000000000001 111.281 -177.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 63.6 m 52.73 31.85 11.09 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.054 1.342 . . . . 1.47 112.508 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -108.2 151.0 26.52 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.484 0.713 . . . . 4.7400000000000002 110.509 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.86 116.84 10.47 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.269 1.028 . . . . 0.95999999999999996 108.599 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mp -102.03 128.79 48.33 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 126.607 1.963 . . . . 2.6099999999999999 106.451 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.82 131.75 50.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.309 -0.626 . . . . 2.6600000000000001 109.309 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -113.33 83.94 1.92 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.717 0.807 . . . . 3.8900000000000001 110.651 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -113.97 171.94 7.29 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.65 1.58 . . . . 2.0499999999999998 109.317 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -96.33 117.75 65.93 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 108.93 -0.767 . . . . 3.1299999999999999 108.93 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.7 70.85 6.77 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.287 2.658 . . . . 2.04 111.013 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -164.29 -44.95 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.082 1.353 . . . . 4.1100000000000003 109.709 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 25.7 pt -76.83 -38.73 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 123.377 0.671 . . . . 2.3999999999999999 110.364 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.18 156.09 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.998 1.319 . . . . 2.1200000000000001 108.127 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -121.82 158.66 16.52 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.048 -1.221 . . . . 2.2799999999999998 110.048 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -62.52 -43.39 22.21 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.801 2.334 . . . . 2.02 110.056 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -54.21 -37.68 64.83 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 122.759 0.424 . . . . 5.4199999999999999 111.907 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.79 -44.19 70.6 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.752 -1.203 . . . . 4.8399999999999999 107.752 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.51 -48.99 86.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 108.604 -0.887 . . . . 1.6699999999999999 108.604 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 64.2 mt -50.26 -58.75 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 124.237 1.015 . . . . 2.1800000000000002 108.958 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -53.09 -45.76 68.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.032 -1.043 . . . . 5.2800000000000002 112.488 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.2 mm -56.29 -46.08 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 109.965 -0.383 . . . . 2.8300000000000001 109.965 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.538 HG22 ' CE ' ' A' ' 101' ' ' LYS . 27.4 pt -72.35 -34.77 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 121.112 -0.993 . . . . 1.46 113.109 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -56.05 -36.86 68.51 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.171 0.896 . . . . 2.6400000000000001 109.279 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.25 -25.52 68.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.061 -0.518 . . . . 3.6299999999999999 110.057 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.3 mt -86.89 -39.26 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.155 0.582 . . . . 1.95 109.708 172.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.33 27.42 5.3 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.129 1.347 . . . . 1.73 111.342 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -99.28 170.35 8.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.299 1.049 . . . . 1.9099999999999999 108.954 165.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -135.53 144.87 46.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.835 -1.172 . . . . 5.3600000000000003 107.835 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.4 103.08 7.99 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.136 1.775 . . . . 1.3799999999999999 109.31 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.45 112.66 19.25 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.656 0.782 . . . . 2.1899999999999999 109.932 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -17.71 106.68 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.983 2.513 . . . . 4.3300000000000001 113.191 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.52 -40.22 23.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.94 -0.573 . . . . 3.6499999999999999 110.403 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.408 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 14.9 mt-30 . . . . . 0 C--O 1.256 1.441 0 CA-C-O 115.403 -2.236 . . . . 6.9199999999999999 116.994 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 . . . . . 0 C--O 1.223 -0.32 0 N-CA-C 107.487 -1.301 . . . . 3.9500000000000002 107.487 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -92.37 159.17 15.7 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.506 1.522 . . . . 5.3300000000000001 107.348 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.457 ' SG ' HD21 ' A' ' 8' ' ' LEU . 30.8 p -152.14 145.97 25.13 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 118.426 0.557 . . . . 2.6600000000000001 111.3 166.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.96 102.49 11.49 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.273 1.029 . . . . 4.1799999999999997 109.001 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -106.58 168.83 8.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.069 0.938 . . . . 2.7200000000000002 111.113 172.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.12 156.31 33.9 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.549 -1.278 . . . . 1.6799999999999999 107.549 167.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.3 mm -99.13 141.06 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 107.608 -1.256 . . . . 1.1399999999999999 107.608 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -119.55 121.78 40.14 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.236 -1.765 . . . . 2.8500000000000001 106.236 160.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.57 -83.68 0.15 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.644 1.116 . . . . 1.3200000000000001 110.396 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.5 mmt 54.07 71.58 0.51 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.708 1.603 . . . . 1.9399999999999999 113.6 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -55.26 -61.95 1.99 Allowed 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.616 -0.677 . . . . 2.1499999999999999 112.374 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.0 t -168.59 64.57 0.06 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.757 0.708 . . . . 3.0699999999999998 110.034 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 38.86 44.65 0.86 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.452 1.501 . . . . 5.7000000000000002 112.912 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.5 t -160.81 -41.8 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.054 0.542 . . . . 3.0 110.528 -166.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -61.78 -40.3 94.71 Favored 'General case' 0 CA--C 1.527 0.08 0 O-C-N 120.889 -1.132 . . . . 1.9399999999999999 109.833 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.672 ' HB ' HD21 ' A' ' 39' ' ' LEU . 77.0 t -61.44 -32.48 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 121.871 -0.518 . . . . 1.8 110.456 171.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 m -66.85 -37.56 84.7 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.102 -0.639 . . . . 2.2000000000000002 111.428 176.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.262 0.3 OUTLIER -71.9 -35.14 69.64 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.556 -1.34 . . . . 3.6299999999999999 112.146 171.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 mt -48.15 -51.41 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.712 -0.617 . . . . 2.0800000000000001 110.965 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -34.37 -55.13 0.53 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.083 0.953 . . . . 4.3499999999999996 110.907 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -68.8 -30.46 69.04 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.0 1.32 . . . . 8.1099999999999994 110.285 -170.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -65.48 -57.94 7.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.513 -0.921 . . . . 1.9399999999999999 108.513 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.83 -38.8 79.48 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.568 -0.16 . . . . 2.02 110.568 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -49.57 -26.64 3.68 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.949 0.9 . . . . 2.6499999999999999 112.53 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -123.29 22.55 9.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.176 -0.916 . . . . 4.4000000000000004 112.858 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -61.93 -68.88 0.28 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.433 1.015 . . . . 3.2400000000000002 110.756 165.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.8 -130.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.938 0.495 . . . . 1.1200000000000001 109.828 -163.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.07 -13.26 72.68 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 118.791 0.723 . . . . 1.4099999999999999 112.959 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 46' ' ' ILE . 8.2 p -60.95 127.16 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 118.417 1.108 . . . . 1.3 110.635 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 pp -142.69 51.81 1.43 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.41 0.624 . . . . 2.52 111.032 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 t -156.66 151.61 26.09 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.015 -0.735 . . . . 1.5900000000000001 109.015 164.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.83 69.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.553 1.541 . . . . 2.7400000000000002 108.583 -171.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tt -98.05 74.17 2.26 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.14 -1.059 . . . . 2.2999999999999998 108.14 -173.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.428 HG11 ' CG1' ' A' ' 19' ' ' VAL . 17.7 t -104.81 136.95 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.849 -0.614 . . . . 2.21 109.435 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -113.74 98.84 7.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.56 -0.904 . . . . 1.3400000000000001 108.56 173.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.672 HD21 ' HB ' ' A' ' 19' ' ' VAL . 18.2 mt -60.5 -17.49 45.65 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.585 0.754 . . . . 2.9199999999999999 112.607 173.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 6.1 mtm -70.05 -55.95 8.2 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.137 0.494 . . . . 4.2599999999999998 109.781 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.89 -24.88 22.39 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.398 0.679 . . . . 1.49 111.429 -175.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.93 68.32 1.54 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.185 -1.166 . . . . 1.22 110.185 -174.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.24 139.46 41.02 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.574 -2.009 . . . . 2.8900000000000001 105.574 171.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.91 101.48 9.53 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 124.641 1.213 . . . . 0.88 111.878 169.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -97.97 136.0 38.87 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.799 -1.185 . . . . 5.1399999999999997 107.799 169.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 32' ' ' VAL . 37.2 pt -141.51 168.57 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.88 -0.785 . . . . 1.8700000000000001 108.88 171.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -120.6 97.96 5.81 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 119.072 -0.489 . . . . 3.73 110.151 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -102.27 178.97 4.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 124.611 1.194 . . . . 2.2999999999999998 112.156 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -123.38 104.53 34.42 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 127.96 2.504 . . . . 4.3499999999999996 110.056 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.66 26.95 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 124.336 3.357 . . . . 2.0899999999999999 112.717 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -106.1 -20.83 13.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.959 1.303 . . . . 3.1899999999999999 110.76 165.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 87.9 t -117.6 -72.06 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 N-CA-C 108.246 -1.02 . . . . 2.7400000000000002 108.246 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.47 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -88.12 140.62 15.5 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.079 0 N-CA-C 108.853 -0.795 . . . . 1.5 108.853 176.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -121.38 153.05 58.61 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.358 1.063 . . . . 2.77 108.421 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.46 -39.57 87.95 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.897 2.398 . . . . 1.21 112.739 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.23 -42.55 98.8 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.491 -0.755 . . . . 2.8399999999999999 111.477 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -62.07 -39.99 94.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.027 0.531 . . . . 3.7000000000000002 110.544 175.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.47 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -53.44 -51.04 45.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.359 -1.349 . . . . 1.0900000000000001 107.359 171.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.37 -39.68 70.4 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 119.238 -0.411 . . . . 1.1399999999999999 111.152 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -57.64 -47.82 81.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.101 0.864 . . . . 2.4900000000000002 110.394 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -46.15 82.66 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.053 0.454 . . . . 2.7599999999999998 110.44 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -67.9 -45.39 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.483 -0.761 . . . . 2.5099999999999998 111.23 -175.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -33.38 72.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.852 -0.594 . . . . 2.3500000000000001 110.877 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.96 -50.24 72.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.905 0.775 . . . . 2.1800000000000002 110.225 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.81 -28.73 67.01 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 118.087 -1.445 . . . . 3.7999999999999998 111.195 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.55 31.42 2.16 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.178 -0.769 . . . . 1.1000000000000001 111.178 171.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -109.25 168.36 9.44 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.282 -0.636 . . . . 2.1800000000000002 109.282 169.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -107.64 129.66 54.98 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.794 -0.817 . . . . 2.5699999999999998 108.794 168.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.93 123.27 48.7 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.615 0.766 . . . . 0.79000000000000004 109.074 166.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.81 162.48 31.9 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.891 1.277 . . . . 1.05 107.658 166.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 1.6 m -75.9 151.73 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 108.701 -0.851 . . . . 2.98 108.701 -171.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 108.844 -0.799 . . . . 4.3700000000000001 108.844 171.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.826 0 N-CA-C 111.64 -0.584 . . . . 2.3900000000000001 111.64 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.75 84.47 2.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.619 1.167 . . . . 3.0099999999999998 109.082 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -102.52 157.71 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 108.803 -0.814 . . . . 2.98 108.803 -175.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.49 157.1 44.39 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.555 -0.716 . . . . 3.6299999999999999 111.287 175.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 mt -144.14 155.99 44.15 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.049 0.94 . . . . 2.3300000000000001 109.845 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.623 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -98.11 122.74 41.62 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 106.659 -1.608 . . . . 1.6899999999999999 106.659 177.064 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.3 pt -97.93 111.65 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-O 122.015 0.912 . . . . 2.04 109.321 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 m -103.72 145.06 30.63 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.496 1.118 . . . . 1.8799999999999999 108.702 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.29 -33.84 5.87 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.292 0.948 . . . . 1.1599999999999999 111.436 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.7 151.93 36.96 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.398 0.599 . . . . 2.7599999999999998 110.948 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 t -163.39 33.83 0.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.597 0.359 . . . . 2.9300000000000002 111.103 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.0 p -162.15 145.1 11.61 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.381 -0.824 . . . . 3.3700000000000001 111.658 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.0 -34.92 70.52 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.573 1.149 . . . . 2.7599999999999998 111.334 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 t -54.2 -50.06 67.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.642 0.377 . . . . 2.2799999999999998 110.046 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 55.6 m -68.14 -45.96 72.13 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.961 -0.462 . . . . 1.78 110.125 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.407 ' CG1' HG23 ' A' ' 113' ' ' VAL . 89.4 t -48.75 -57.18 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.937 1.695 . . . . 1.3500000000000001 109.921 172.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -59.0 -43.96 91.58 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.686 -0.634 . . . . 3.46 111.017 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -60.78 -42.88 98.41 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.347 0.659 . . . . 1.7 110.876 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.0 mt -57.28 -50.41 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 108.321 -0.992 . . . . 0.83999999999999997 108.321 174.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -53.51 -43.67 68.48 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.029 -0.51 . . . . 2.6699999999999999 110.425 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.4 t -57.96 -50.4 73.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.544 0.738 . . . . 1.3999999999999999 111.305 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -37.35 78.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.25 -0.906 . . . . 2.5 110.933 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.4 mt -70.59 -51.34 28.91 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.837 -0.801 . . . . 1.8200000000000001 108.837 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.6 p -60.05 -17.07 36.53 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.936 0.717 . . . . 1.8999999999999999 112.936 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -59.82 -33.91 72.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 119.298 -0.961 . . . . 4.5599999999999996 112.338 168.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.8 m -73.34 142.51 47.07 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.706 0.803 . . . . 1.77 111.162 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -66.0 -42.38 89.83 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.361 0.874 . . . . 3.0800000000000001 113.361 -173.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.29 -39.29 27.03 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.127 -1.189 . . . . 1.0700000000000001 110.127 -170.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.33 126.36 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.975 -0.75 . . . . 3.6000000000000001 108.975 168.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.1 t -124.41 -26.3 3.93 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.676 0.791 . . . . 3.3199999999999998 111.585 165.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.62 93.97 3.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.694 -1.965 . . . . 2.3199999999999998 105.694 -172.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.98 151.45 21.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.219 -1.401 . . . . 1.3100000000000001 107.219 158.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.7 t -142.23 110.83 6.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.213 -1.773 . . . . 1.6499999999999999 106.213 167.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.407 HG23 ' CG1' ' A' ' 95' ' ' VAL . 6.4 m -104.89 147.64 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 118.048 0.385 . . . . 2.5899999999999999 110.774 176.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.73 102.31 4.7 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.305 0.574 . . . . 1.6499999999999999 110.395 -174.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 pp -61.94 -19.12 62.4 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.345 0.868 . . . . 2.5499999999999998 113.345 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.14 -40.75 64.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.908 -0.775 . . . . 1.99 108.908 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.1 p -90.14 -25.35 20.74 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.004 0.921 . . . . 3.3700000000000001 110.344 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 p 77.9 9.68 2.27 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 128.257 2.623 . . . . 2.3300000000000001 112.894 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -99.71 151.18 21.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.163 0.982 . . . . 3.3999999999999999 111.767 174.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -117.25 117.48 29.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.855 2.462 . . . . 0.95999999999999996 107.0 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.5 mp -99.83 131.23 45.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.547 -1.279 . . . . 2.8399999999999999 107.547 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 83.0 t -140.78 128.94 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.378 1.071 . . . . 2.04 109.682 -170.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -116.45 93.03 4.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.951 -0.759 . . . . 3.6000000000000001 108.951 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -113.98 169.48 8.97 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.654 1.182 . . . . 1.99 109.777 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.561 ' HB3' HD11 ' A' ' 128' ' ' ILE . 35.6 t0 -105.28 115.6 61.83 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.289 1.036 . . . . 3.6800000000000002 109.708 -179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.86 65.17 7.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.856 3.037 . . . . 1.8899999999999999 112.83 -170.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -143.29 -51.14 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.671 1.588 . . . . 3.4399999999999999 108.219 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 128' ' ' ILE . 0.0 OUTLIER -77.89 -34.48 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 122.96 0.504 . . . . 2.46 111.096 -177.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.5 tp -145.79 168.49 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.078 -0.712 . . . . 1.9099999999999999 109.078 -174.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.96 169.86 31.33 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.181 -1.168 . . . . 1.4099999999999999 110.181 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -61.22 -35.31 85.88 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.278 2.652 . . . . 1.54 110.801 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -51.93 -39.68 59.56 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 112.458 0.54 . . . . 6.9900000000000002 112.458 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.05 -44.45 84.54 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.209 -0.663 . . . . 3.1699999999999999 109.209 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.97 -55.95 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.24 -0.652 . . . . 1.47 109.24 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 pt -54.61 -57.1 7.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-O 118.003 -0.998 . . . . 3.1000000000000001 109.334 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -47.77 -50.59 25.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.125 1.33 . . . . 4.1200000000000001 112.839 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.4 mm -52.91 -54.7 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.423 -0.584 . . . . 1.9399999999999999 109.423 175.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.287 2.6 pp -71.49 -25.0 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 119.077 -1.049 . . . . 1.47 113.538 -176.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -63.86 -32.06 73.45 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.327 1.051 . . . . 3.0299999999999998 110.32 169.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -62.17 -39.24 92.02 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.214 -0.661 . . . . 2.98 109.214 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.2 mt -66.78 -42.01 88.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.409 -0.589 . . . . 1.3999999999999999 109.409 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.91 22.61 5.6 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.874 1.702 . . . . 1.48 111.511 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -99.06 -178.71 4.02 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.52 -1.289 . . . . 2.2400000000000002 107.52 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -140.6 135.65 31.98 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.157 -1.053 . . . . 3.1800000000000002 108.157 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -122.87 96.67 5.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.236 1.014 . . . . 1.54 109.765 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.1 p -123.43 127.21 48.1 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.425 0.69 . . . . 2.4199999999999999 110.918 -173.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.417 HD12 ' OE1' ' A' ' 149' ' ' GLN . 0.4 OUTLIER -14.92 113.13 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.109 2.564 . . . . 4.2000000000000002 115.086 175.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.623 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -107.29 48.61 0.83 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.698 0.999 . . . . 5.0300000000000002 113.698 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.417 ' OE1' HD12 ' A' ' 147' ' ' LEU . 7.0 pm0 . . . . . 0 C--O 1.254 1.319 0 CA-C-O 117.798 -1.096 . . . . 6.7199999999999998 112.366 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 109.393 -0.595 . . . . 3.8199999999999998 109.393 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -110.3 154.75 23.03 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.409 0.684 . . . . 3.8399999999999999 110.58 165.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.9 t -125.78 130.18 50.93 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.142 0.977 . . . . 2.3300000000000001 109.424 170.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.52 106.37 16.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 128.388 2.675 . . . . 3.27 110.027 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 -179.19 5.4 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.458 -0.776 . . . . 3.3300000000000001 110.617 173.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.16 161.58 28.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.49 -1.3 . . . . 2.3599999999999999 107.49 173.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mm -97.16 134.84 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.878 -1.897 . . . . 1.05 105.878 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -117.58 67.83 0.75 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.537 -1.283 . . . . 3.1000000000000001 107.537 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.4 -69.4 0.06 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.152 -0.779 . . . . 1.3799999999999999 111.152 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.08 93.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.521 2.328 . . . . 2.5099999999999998 116.883 176.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.44 -22.7 21.6 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.387 1.075 . . . . 2.3900000000000001 113.589 170.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 89.5 m 75.57 -62.9 0.43 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.938 1.695 . . . . 5.7400000000000002 110.078 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.98 -75.29 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.495 2.318 . . . . 4.3200000000000003 112.925 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.3 p -160.02 14.28 0.13 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.432 0.901 . . . . 2.2200000000000002 113.432 169.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.92 -45.05 64.93 Favored 'General case' 0 N--CA 1.462 0.126 0 O-C-N 121.239 -0.913 . . . . 1.8999999999999999 110.071 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -53.67 -47.13 61.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.418 -0.956 . . . . 1.6200000000000001 108.418 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.02 -41.53 64.79 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.353 0.661 . . . . 1.95 112.073 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -67.41 -49.27 64.53 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.969 -0.382 . . . . 2.7200000000000002 109.969 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.491 HG12 HD13 ' A' ' 65' ' ' LEU . 69.3 mt -48.96 -45.32 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.963 0.905 . . . . 1.4299999999999999 110.586 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -44.62 -57.38 3.68 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.042 0.837 . . . . 4.7000000000000002 111.194 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -61.6 -39.17 90.27 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.154 0.982 . . . . 4.9199999999999999 110.208 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -62.65 -57.38 11.24 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.963 -0.755 . . . . 1.3500000000000001 108.963 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.12 -31.42 72.61 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.036 -0.415 . . . . 3.3500000000000001 111.009 -175.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.572 HE22 HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -45.58 -35.01 3.68 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.445 0.566 . . . . 1.79 112.257 168.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -110.2 24.19 13.33 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.377 0.671 . . . . 3.8900000000000001 112.135 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.34 -72.24 0.17 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.034 0.534 . . . . 3.5499999999999998 109.596 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.38 -120.88 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.418 0.687 . . . . 1.21 109.998 -172.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.17 -11.23 63.67 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.782 0.719 . . . . 1.5900000000000001 113.183 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -75.46 122.56 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.691 -0.888 . . . . 1.5 109.464 173.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.21 49.35 1.93 Allowed 'General case' 0 C--N 1.34 0.164 0 CA-C-O 120.786 0.327 . . . . 2.6800000000000002 110.577 173.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.6 m -150.53 156.11 40.78 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.291 -1.003 . . . . 3.1000000000000001 108.291 165.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.572 HG11 HE22 ' A' ' 27' ' ' GLN . 5.0 p -140.29 117.01 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 107.37 -1.345 . . . . 2.8399999999999999 107.37 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -140.44 79.59 1.71 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 108.172 -1.047 . . . . 2.5499999999999998 108.172 172.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.1 t -99.4 136.58 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.135 -0.939 . . . . 2.27 108.551 169.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.88 96.58 6.25 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.608 -1.256 . . . . 1.52 107.608 167.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.66 -21.04 24.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.906 0.882 . . . . 2.6200000000000001 111.669 175.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -59.0 5.12 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.793 1.237 . . . . 3.02 109.547 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.22 20.3 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.99 0.916 . . . . 1.6799999999999999 111.102 -172.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.71 63.96 1.86 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.154 -1.178 . . . . 1.3400000000000001 110.154 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.77 137.36 41.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.253 -2.128 . . . . 2.5600000000000001 105.253 169.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.85 104.51 11.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.784 1.302 . . . . 1.26 109.61 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -111.74 144.65 40.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.244 0.545 . . . . 4.0300000000000002 109.719 167.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.08 178.78 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 124.444 1.097 . . . . 1.8300000000000001 109.147 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.74 94.92 4.33 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.033 0.933 . . . . 8.8499999999999996 110.213 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.412 ' HB2' HD12 ' A' ' 53' ' ' ILE . 1.9 p90 -99.99 169.51 9.14 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.414 2.285 . . . . 2.8799999999999999 113.476 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.93 97.43 41.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.849 1.66 . . . . 2.8900000000000001 108.858 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -53.22 -21.31 16.72 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.663 3.576 . . . . 3.02 114.817 -171.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -77.98 -25.52 48.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.5 1.52 . . . . 4.5099999999999998 111.285 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 p -121.34 -31.19 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 123.988 0.915 . . . . 3.4199999999999999 112.522 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -128.11 135.32 63.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 123.601 0.76 . . . . 1.8 109.189 179.548 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -120.46 154.83 56.81 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.505 1.122 . . . . 3.1600000000000001 111.84 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.23 -30.19 92.35 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.152 1.901 . . . . 1.8 111.607 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -42.25 94.15 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.797 0.726 . . . . 3.9399999999999999 111.705 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -71.17 -41.08 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.686 0.794 . . . . 3.6299999999999999 110.745 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.8 -42.34 42.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 108.255 -1.017 . . . . 1.54 108.255 170.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.23 86.59 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.519 -0.764 . . . . 1.51 111.172 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -59.93 -52.96 63.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.278 -0.889 . . . . 3.1099999999999999 109.655 171.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -54.86 19.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.94 0.4 . . . . 2.6600000000000001 110.846 -177.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.3 pp -62.05 -44.26 98.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.503 0.557 . . . . 4.1299999999999999 112.503 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.64 -39.35 84.06 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.587 1.085 . . . . 2.1899999999999999 110.226 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.37 -47.75 72.38 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.648 0.779 . . . . 2.5800000000000001 109.636 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.491 HD13 HG12 ' A' ' 22' ' ' ILE . 11.7 mt -53.81 -33.07 54.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.184 0.594 . . . . 1.78 111.452 170.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.58 33.09 2.97 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.262 -1.135 . . . . 1.1799999999999999 110.262 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -124.67 149.56 47.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.763 -1.569 . . . . 1.96 106.763 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.81 129.66 44.2 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.017 -1.475 . . . . 3.2200000000000002 107.017 170.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.552 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -118.77 120.19 36.63 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.63 -1.619 . . . . 0.88 106.63 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.89 128.28 34.28 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.424 -1.262 . . . . 0.94999999999999996 107.923 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.4 t -49.29 151.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.012 1.325 . . . . 3.0099999999999998 108.832 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 110.283 -0.266 . . . . 3.46 110.283 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.688 0 N-CA-C 106.757 -2.537 . . . . 1.9399999999999999 106.757 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -104.23 126.13 51.08 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.719 1.208 . . . . 4.0099999999999998 109.366 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.71 149.72 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 C-N-CA 124.297 1.039 . . . . 2.4900000000000002 108.253 175.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -125.37 146.51 49.56 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.35 1.06 . . . . 3.6699999999999999 110.536 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.46 149.63 39.48 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.269 1.027 . . . . 2.3999999999999999 108.744 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.32 132.2 42.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.404 -1.702 . . . . 2.0299999999999998 106.404 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 pp -106.59 113.39 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 O-C-N 123.909 0.756 . . . . 1.75 110.727 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.5 m -104.43 139.33 39.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.177 0.991 . . . . 1.8700000000000001 108.794 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.1 -27.8 11.3 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.995 1.283 . . . . 1.21 111.984 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 5.3 tmm? -63.8 131.65 48.48 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.845 0.858 . . . . 2.7999999999999998 109.901 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 m -144.77 34.9 1.14 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.588 1.155 . . . . 2.5499999999999998 109.331 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 43.3 t -165.82 129.61 2.2 Favored 'General case' 0 C--N 1.341 0.239 0 O-C-N 120.854 -1.154 . . . . 2.79 111.908 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.43 -35.89 63.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.542 0.737 . . . . 2.73 111.785 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 t -53.73 -46.94 70.99 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.134 0.492 . . . . 2.2400000000000002 110.257 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 35.1 m -62.58 -46.24 89.23 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.112 -0.699 . . . . 2.0899999999999999 109.112 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.5 t -52.79 -53.03 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.098 0.408 . . . . 1.3400000000000001 110.783 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -56.85 -44.88 82.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.158 0.504 . . . . 3.1200000000000001 110.746 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -60.74 -47.68 85.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.891 0.476 . . . . 1.97 110.639 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.3 mt -55.83 -52.64 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.746 -0.835 . . . . 1.04 108.746 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -56.24 -42.06 76.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.837 0.855 . . . . 3.1800000000000002 110.134 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.2 t -57.94 -55.51 33.96 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.923 0.329 . . . . 1.74 110.815 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -50.82 64.7 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.666 -0.646 . . . . 2.5800000000000001 110.999 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.8 mt -55.82 -58.0 9.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 119.22 -0.419 . . . . 1.96 110.051 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.8 m -53.67 -25.17 16.92 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.61 1.164 . . . . 2.2200000000000002 111.549 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -62.39 -28.29 69.67 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.881 -0.512 . . . . 6.5499999999999998 111.348 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.3 m -68.08 118.31 11.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.448 1.499 . . . . 2.2599999999999998 111.225 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -33.05 -55.82 0.39 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.637 1.975 . . . . 2.9199999999999999 114.033 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.55 -29.14 60.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 119.513 -0.604 . . . . 1.72 113.354 -171.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.1 127.94 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.522 -1.288 . . . . 3.1899999999999999 107.522 -174.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 36.9 p -99.16 -51.4 3.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 118.303 0.501 . . . . 3.5099999999999998 110.437 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -131.95 128.66 38.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.322 -0.992 . . . . 2.3999999999999999 108.322 169.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.99 128.26 53.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.879 -1.156 . . . . 1.1899999999999999 107.879 165.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.2 m -115.45 112.32 22.1 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 117.707 -1.14 . . . . 2.6499999999999999 109.498 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 t -114.47 131.55 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 120.325 1.421 . . . . 2.3199999999999998 112.651 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -125.67 106.44 9.73 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.489 1.115 . . . . 1.1100000000000001 111.226 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -22.92 59.5 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 125.172 1.389 . . . . 2.3199999999999998 113.266 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.73 80.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.149 0.5 . . . . 1.46 110.073 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.22 -34.82 10.19 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.243 1.417 . . . . 2.0699999999999998 110.402 177.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.4 m 79.78 38.55 0.11 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.407 1.883 . . . . 1.77 110.875 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.9 144.05 46.64 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 123.539 0.736 . . . . 3.0099999999999998 109.436 173.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.18 120.65 29.28 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.249 2.62 . . . . 1.1000000000000001 107.679 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.8 mp -115.07 104.43 11.87 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.623 1.569 . . . . 2.4100000000000001 110.254 -170.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.3 m -103.82 135.86 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.6 1.16 . . . . 2.3599999999999999 111.114 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.71 104.52 11.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.858 -1.164 . . . . 4.7300000000000004 107.858 174.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -123.25 176.47 6.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.667 1.587 . . . . 2.48 112.258 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -98.7 113.55 64.49 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 108.49 -0.93 . . . . 3.1800000000000002 108.49 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.31 71.52 6.72 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.772 2.981 . . . . 2.0 111.346 -167.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -168.59 -48.43 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.318 1.047 . . . . 4.4800000000000004 109.337 -173.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.6 pt -83.75 -33.05 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.819 0.847 . . . . 1.8999999999999999 110.917 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.92 160.59 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.318 1.047 . . . . 1.6000000000000001 109.144 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.87 169.63 23.81 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.623 1.106 . . . . 1.5800000000000001 110.45 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.97 -40.44 11.93 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.233 2.622 . . . . 1.8799999999999999 111.092 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -51.32 -37.21 46.51 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.359 0.664 . . . . 6.4500000000000002 112.396 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.77 -45.37 78.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.619 -0.882 . . . . 4.2699999999999996 108.619 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 64.2 mt -60.73 -46.65 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 108.644 -0.872 . . . . 1.3300000000000001 108.644 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 77.2 mt -51.2 -58.46 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 118.363 -0.827 . . . . 2.2200000000000002 108.972 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -48.53 -50.25 32.75 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.568 1.076 . . . . 4.5300000000000002 110.606 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.5 mm -55.6 -50.02 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 109.85 -0.426 . . . . 1.8 109.85 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.283 2.5 pp -70.11 -28.52 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 119.197 -1.001 . . . . 1.74 113.615 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -63.71 -42.26 97.98 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.566 1.076 . . . . 2.29 109.896 170.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -60.0 -39.24 85.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.79 0.836 . . . . 3.3599999999999999 109.16 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.2 mt -71.01 -39.0 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 O-C-N 122.259 -0.275 . . . . 1.0700000000000001 110.941 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.03 29.48 8.0 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.499 1.523 . . . . 0.93000000000000005 112.096 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -99.65 177.11 5.25 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.689 1.245 . . . . 2.29 109.443 165.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -130.78 120.14 23.32 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.045 -1.465 . . . . 4.4500000000000002 107.045 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.06 113.31 26.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.502 1.521 . . . . 1.8200000000000001 108.654 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.8 m -123.13 114.23 20.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.101 0.41 . . . . 2.04 111.028 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.6 mt -28.29 114.58 0.08 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 128.222 2.609 . . . . 4.0599999999999996 111.923 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.86 23.9 5.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.442 0.697 . . . . 3.5 112.68 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.456 -1.259 . . . . 5.7300000000000004 110.78 168.687 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--O 1.223 -0.322 0 N-CA-C 109.786 -0.45 . . . . 4.9400000000000004 109.786 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.12 148.9 23.08 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.424 1.09 . . . . 3.9100000000000001 108.356 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.1 t -135.89 134.77 39.12 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.784 -1.191 . . . . 2.8399999999999999 107.784 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -103.65 98.01 7.95 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 124.244 0.965 . . . . 3.9199999999999999 109.02 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 2.6 pt? -121.67 169.73 10.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.957 0.884 . . . . 2.1499999999999999 111.364 172.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.02 142.67 49.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.24 -1.022 . . . . 2.0499999999999998 108.24 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.41 HG12 ' HB2' ' A' ' 44' ' ' ALA . 26.4 mm -98.18 146.92 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.674 -1.232 . . . . 0.84999999999999998 107.674 -178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -128.2 96.74 4.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.565 -1.643 . . . . 3.6699999999999999 106.565 171.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.14 -70.98 0.09 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.952 -1.259 . . . . 1.75 109.952 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 ptm 29.03 70.47 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.48 2.312 . . . . 2.48 116.053 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.69 -14.32 2.17 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.764 1.626 . . . . 2.54 114.16 175.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t 71.66 -63.49 0.42 Allowed 'General case' 0 C--N 1.339 0.128 0 C-N-CA 126.372 1.869 . . . . 2.9399999999999999 111.373 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -16.17 -73.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 128.177 2.591 . . . . 6.5700000000000003 113.224 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -157.5 24.11 0.29 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.856 0.862 . . . . 3.8199999999999998 110.654 159.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.0 m -71.01 -52.98 16.44 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.296 -0.877 . . . . 1.9199999999999999 109.178 -170.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.7 t -50.24 -46.83 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.019 -0.734 . . . . 1.9399999999999999 109.019 173.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 t -54.91 -51.9 64.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.46 0.704 . . . . 3.23 110.875 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -40.53 80.19 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 121.331 -0.856 . . . . 2.7799999999999998 110.386 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mt -55.93 -50.71 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.781 1.232 . . . . 1.49 109.548 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -52.22 -44.44 64.79 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.63 0.65 . . . . 4.1900000000000004 111.27 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -69.22 -40.46 77.94 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.748 -1.22 . . . . 5.8399999999999999 111.588 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -61.7 -53.75 51.84 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 122.116 -0.365 . . . . 1.3400000000000001 110.043 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.54 -39.01 70.03 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.677 0.791 . . . . 3.04 110.361 175.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.17 -23.97 9.66 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.212 0.915 . . . . 1.72 112.902 173.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -106.12 21.13 17.86 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.108 0.963 . . . . 3.6800000000000002 112.491 176.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.417 ' HG3' ' CD2' ' A' ' 61' ' ' PHE . 33.0 tt0 -70.34 -72.64 0.19 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.802 -0.814 . . . . 3.5600000000000001 108.802 177.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.42 -105.08 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.839 1.256 . . . . 1.95 107.859 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.83 25.33 24.05 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.241 -1.31 . . . . 2.3999999999999999 113.352 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.65 ' C ' HD12 ' A' ' 33' ' ' LEU . 8.5 p -96.0 120.74 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 119.373 1.587 . . . . 2.0800000000000001 109.308 168.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 32' ' ' VAL . 3.5 mp -139.54 53.72 1.7 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 108.96 -0.756 . . . . 2.9399999999999999 108.96 -178.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 t -161.64 156.51 23.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.869 -1.9 . . . . 2.8900000000000001 105.869 165.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.29 110.05 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 106.7 -1.593 . . . . 2.71 106.7 175.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -128.98 76.87 1.75 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.822 -1.177 . . . . 3.4500000000000002 107.822 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 t -97.84 127.09 50.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 109.541 -0.54 . . . . 2.4100000000000001 109.541 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.84 88.24 3.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.93 -1.137 . . . . 2.1800000000000002 107.93 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.5 tp -53.33 -22.98 8.14 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.029 1.332 . . . . 3.6899999999999999 110.805 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -35.04 68.77 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.388 0.675 . . . . 5.7300000000000004 111.285 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.49 -39.44 4.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.955 0.902 . . . . 2.6000000000000001 110.926 -172.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.99 63.41 0.81 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 125.916 1.722 . . . . 1.8200000000000001 110.47 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -142.35 136.68 29.89 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.127 -1.805 . . . . 4.0099999999999998 106.127 172.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -117.43 95.02 4.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.434 1.084 . . . . 1.5 109.272 172.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -101.51 137.43 39.84 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.805 -1.554 . . . . 5.7400000000000002 106.805 171.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.484 HD13 ' H ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -133.77 -178.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 107.316 -1.365 . . . . 2.8399999999999999 107.316 177.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.58 106.2 6.88 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.753 -1.203 . . . . 5.9199999999999999 107.753 176.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -117.41 176.23 5.25 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 124.762 1.289 . . . . 3.52 114.459 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -113.37 107.3 53.67 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.895 1.278 . . . . 3.8700000000000001 111.348 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.48 -11.37 31.33 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.991 2.461 . . . . 3.3700000000000001 112.929 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.37 -21.33 64.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 120.203 1.365 . . . . 3.5699999999999998 111.228 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -128.59 -46.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.44 0.696 . . . . 3.8500000000000001 110.403 -169.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.748 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -92.37 147.61 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 121.913 0.863 . . . . 2.6899999999999999 109.43 174.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -128.04 150.07 72.7 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 125.69 1.596 . . . . 3.6600000000000001 108.776 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -58.42 -29.8 89.49 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.261 2.641 . . . . 2.1499999999999999 111.596 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -49.55 77.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.245 1.418 . . . . 2.5499999999999998 109.718 172.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -68.11 -38.55 82.39 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.933 -0.479 . . . . 3.0299999999999998 109.726 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.748 HD12 HD11 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -58.36 -46.25 89.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 107.486 -1.302 . . . . 1.71 107.486 172.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.48 -44.52 95.84 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 122.973 0.509 . . . . 1.3500000000000001 110.397 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -60.1 -51.25 70.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.661 -0.649 . . . . 2.3399999999999999 110.94 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.417 ' CD2' ' HG3' ' A' ' 29' ' ' GLU . 0.6 OUTLIER -55.11 -48.43 73.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.612 0.642 . . . . 3.6899999999999999 112.176 -179.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.567 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.5 pp -67.07 -39.63 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 121.261 -0.9 . . . . 4.3300000000000001 111.658 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.5 -34.9 79.35 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.518 0.599 . . . . 3.4199999999999999 110.511 177.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.18 -52.02 65.48 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.459 -0.571 . . . . 2.8300000000000001 109.459 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.6 mt -58.45 -29.95 66.55 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.828 0.307 . . . . 2.1899999999999999 111.828 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.36 31.54 3.73 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 124.512 1.053 . . . . 1.4299999999999999 111.336 167.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.59 161.48 19.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.63 1.572 . . . . 2.0099999999999998 108.405 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -98.45 134.58 41.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.77 -1.567 . . . . 2.2000000000000002 106.77 163.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.567 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -125.49 127.23 46.14 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.919 -1.882 . . . . 1.0800000000000001 105.919 169.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.48 123.98 23.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.201 -1.037 . . . . 1.1299999999999999 108.201 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.433 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.5 t -71.1 145.26 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.057 -1.09 . . . . 2.98 108.057 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.4 mtt . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 109.04 -0.726 . . . . 4.6200000000000001 109.04 173.336 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.341 0 N-CA-C 109.597 -1.401 . . . . 2.6000000000000001 109.597 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.33 104.63 17.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.594 -1.632 . . . . 2.8399999999999999 106.594 -176.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.504 HD11 ' CE1' ' A' ' 124' ' ' PHE . 0.0 OUTLIER -130.94 157.72 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 106.94 -1.504 . . . . 3.2799999999999998 106.94 172.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -123.06 160.7 25.81 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.947 -1.024 . . . . 3.9100000000000001 110.176 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 pp -143.78 159.92 41.66 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.638 -1.164 . . . . 3.1200000000000001 110.229 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.8 m -109.36 131.67 54.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.374 1.87 . . . . 2.27 107.943 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.53 98.08 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.733 1.613 . . . . 1.76 110.706 -170.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.3 m -95.53 112.52 24.23 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.877 -0.786 . . . . 1.9199999999999999 108.877 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 135.3 -22.98 3.5 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.486 1.041 . . . . 1.3100000000000001 111.921 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.1 ttp -70.74 133.59 46.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.021 -0.693 . . . . 2.7200000000000002 111.719 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.2 m -151.53 39.44 0.65 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.844 0.858 . . . . 3.2200000000000002 110.239 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.5 t -167.96 138.94 2.82 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.963 -1.086 . . . . 2.5 110.71 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.7 67.2 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.474 0.654 . . . . 2.6699999999999999 111.856 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.9 m -53.47 -43.93 68.54 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.256 -0.902 . . . . 2.2000000000000002 110.275 170.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.0 m -64.4 -42.24 96.21 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.888 0.475 . . . . 1.74 109.849 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.763 HG13 HG13 ' A' ' 113' ' ' VAL . 46.7 t -52.23 -55.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.721 0.808 . . . . 1.23 108.826 173.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.7 m170 -61.66 -36.6 81.29 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 109.737 -0.468 . . . . 3.77 109.737 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -59.01 -60.71 3.44 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.959 -0.756 . . . . 2.0099999999999998 108.959 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.6 mt -49.59 -49.2 19.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 C-N-CA 124.472 1.109 . . . . 1.0600000000000001 110.051 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -54.38 -52.93 60.13 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.222 1.009 . . . . 2.4700000000000002 109.786 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.0 m -66.85 -25.16 66.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.431 0.692 . . . . 2.1600000000000001 112.186 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -46.87 49.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 120.865 -1.147 . . . . 3.2999999999999998 111.816 170.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.58 -45.8 64.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.272 0.942 . . . . 3.5299999999999998 108.888 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.0 p -60.43 -12.45 9.52 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.702 0.63 . . . . 2.2799999999999998 112.702 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -53.57 -34.29 57.8 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.634 -0.666 . . . . 4.0099999999999998 111.349 167.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.4 p -78.44 164.88 24.39 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 118.936 0.789 . . . . 2.4100000000000001 110.907 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -82.89 -44.87 14.9 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.887 0.875 . . . . 2.3900000000000001 111.188 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.742 ' HA3' HD11 ' A' ' 128' ' ' ILE . . . -71.01 -36.58 64.47 Favored Glycine 0 C--N 1.335 0.523 0 O-C-N 122.236 -0.29 . . . . 1.6100000000000001 112.606 -170.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -66.21 130.19 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.127 -0.694 . . . . 2.2000000000000002 109.127 -174.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.0 t -109.81 -53.46 2.67 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.422 0.289 . . . . 3.3599999999999999 111.466 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CD2' ' HG3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -131.41 124.88 31.21 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.694 -1.224 . . . . 3.1299999999999999 107.694 175.069 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.39 161.82 15.27 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.525 -0.546 . . . . 0.91000000000000003 109.525 153.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.4 m -139.27 110.24 6.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.696 -1.594 . . . . 1.72 106.696 168.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.763 HG13 HG13 ' A' ' 95' ' ' VAL . 3.3 p -108.68 132.74 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.446 1.099 . . . . 1.8100000000000001 110.115 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.42 119.16 12.45 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.96 0.886 . . . . 1.3200000000000001 111.545 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 115' ' ' LEU . 2.4 pt? -71.36 -31.05 66.87 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.322 1.449 . . . . 2.4900000000000002 112.778 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.99 81.74 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.522 0.677 . . . . 1.6100000000000001 109.947 -176.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.67 -36.65 65.37 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.352 -0.84 . . . . 1.8999999999999999 109.363 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.3 t 85.23 14.78 0.17 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 126.473 1.909 . . . . 2.52 111.462 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.86 164.74 16.2 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.471 0.708 . . . . 4.6399999999999997 111.029 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.74 143.57 47.22 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.04 1.336 . . . . 1.26 108.567 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -99.46 146.02 26.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.535 1.147 . . . . 1.96 108.122 165.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.4 t -134.93 136.67 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 126.349 1.859 . . . . 2.2599999999999998 107.869 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HG3' ' CD2' ' A' ' 110' ' ' TYR . 19.7 mmmt -113.22 109.52 18.9 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.276 1.43 . . . . 3.8799999999999999 108.81 166.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.504 ' CE1' HD11 ' A' ' 82' ' ' ILE . 0.9 OUTLIER -127.51 -176.1 3.65 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.654 1.115 . . . . 2.3599999999999999 111.098 173.769 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -103.0 112.32 65.7 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 108.307 -0.998 . . . . 3.1299999999999999 108.307 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.99 67.65 8.0 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.874 2.383 . . . . 2.4399999999999999 111.962 -166.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -165.25 -43.93 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.227 1.411 . . . . 3.8399999999999999 109.59 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.742 HD11 ' HA3' ' A' ' 107' ' ' GLY . 2.6 pp -79.68 -40.48 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 122.852 0.461 . . . . 2.4500000000000002 110.303 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.672 ' HB ' HD12 ' A' ' 128' ' ' ILE . 1.7 tp -135.42 178.23 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.237 1.015 . . . . 2.3799999999999999 109.398 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.84 -178.81 34.17 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.031 -2.027 . . . . 1.8700000000000001 108.031 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.11 -40.19 34.96 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.12 1.88 . . . . 1.72 110.285 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 -50.94 -40.07 56.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.485 1.114 . . . . 5.5199999999999996 113.511 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.75 -52.66 64.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.56 -0.533 . . . . 4.21 109.56 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.72 -44.79 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.336 -0.987 . . . . 1.6899999999999999 108.336 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.2 mt -51.9 -61.32 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 123.711 0.804 . . . . 1.9399999999999999 109.105 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.68 -46.31 67.2 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.269 0.94 . . . . 4.5199999999999996 110.835 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.5 mm -57.13 -51.68 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 121.974 -0.454 . . . . 2.1200000000000001 109.856 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.13 -27.2 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 120.701 -1.249 . . . . 1.3500000000000001 112.925 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -59.68 -35.39 74.35 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.659 -0.65 . . . . 3.0099999999999998 110.349 170.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.52 -35.56 79.79 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.472 -0.566 . . . . 3.3599999999999999 109.472 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.4 mt -69.85 -45.63 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.681 -0.488 . . . . 1.2 109.681 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.19 31.33 2.26 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.612 1.577 . . . . 0.93999999999999995 111.66 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -99.06 -179.52 4.28 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.92 0.86 . . . . 2.23 109.69 171.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -139.33 105.19 5.16 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 107.774 -1.195 . . . . 4.1299999999999999 107.774 -175.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.88 98.96 9.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.913 1.285 . . . . 1.6000000000000001 109.267 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 51.8 m -101.44 115.91 31.58 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.618 -1.253 . . . . 2.0499999999999998 107.618 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.38 101.28 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.772 1.229 . . . . 4.6799999999999997 109.469 170.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.65 -38.77 77.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.922 -0.581 . . . . 3.96 110.168 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 126.168 1.787 . . . . 7.8300000000000001 112.804 -175.542 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.419 -0.586 . . . . 3.0299999999999998 109.419 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.64 161.59 18.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.708 -1.219 . . . . 4.7800000000000002 107.708 169.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.31 132.72 26.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.492 -0.929 . . . . 2.5499999999999998 108.492 162.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -109.08 93.72 4.66 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.137 1.375 . . . . 3.7599999999999998 109.125 -171.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.441 HD22 ' H ' ' A' ' 8' ' ' LEU 0.279 0.0 OUTLIER -116.65 173.75 6.45 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.472 1.13 . . . . 3.0099999999999998 111.22 177.705 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.38 156.89 42.41 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.804 -1.924 . . . . 1.6000000000000001 105.804 174.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mm -97.87 134.26 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 106.454 -1.684 . . . . 1.1399999999999999 106.454 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -106.5 117.53 34.29 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 105.768 -1.938 . . . . 4.2999999999999998 105.768 158.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.5 -101.49 0.24 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.3 -1.12 . . . . 1.6599999999999999 110.3 -175.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.3 mtt 60.14 89.04 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.886 1.674 . . . . 1.8500000000000001 114.529 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -30.88 71.13 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.467 -0.771 . . . . 2.2400000000000002 111.231 166.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.0 t 78.05 -58.35 0.46 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.141 1.376 . . . . 3.7599999999999998 111.187 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -19.03 -68.46 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.91 2.484 . . . . 5.25 113.139 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.9 m -156.17 24.87 0.36 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.12 0.968 . . . . 2.6600000000000001 110.509 162.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.1 m -70.99 -51.53 25.03 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.283 -0.886 . . . . 1.5600000000000001 109.939 -169.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.4 t -47.68 -50.53 8.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 N-CA-C 109.1 -0.704 . . . . 2.1299999999999999 109.1 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -49.99 -48.85 52.11 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.134 0.574 . . . . 2.2999999999999998 112.54 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -39.13 74.85 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.464 -0.772 . . . . 3.0099999999999998 111.212 178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.3 mt -59.89 -48.84 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.812 1.245 . . . . 1.54 109.063 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.24 -49.73 41.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.458 0.572 . . . . 3.77 110.896 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -63.77 -34.57 78.18 Favored 'General case' 0 N--CA 1.458 -0.029 0 O-C-N 121.596 -0.69 . . . . 5.4400000000000004 111.056 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.97 -51.8 65.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.641 -0.503 . . . . 1.3200000000000001 109.641 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.29 -37.54 75.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.975 0.352 . . . . 2.3599999999999999 111.449 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -23.96 3.02 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.701 -1.25 . . . . 2.8700000000000001 112.078 173.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -126.08 34.86 4.78 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.231 -0.89 . . . . 3.9700000000000002 112.941 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' CG ' HG13 ' A' ' 32' ' ' VAL . 6.3 pt-20 -69.46 -70.54 0.27 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.992 1.269 . . . . 4.6500000000000004 111.96 169.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.29 -132.38 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.524 -0.917 . . . . 1.3600000000000001 108.524 -164.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.83 15.85 29.65 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-O 118.139 -1.367 . . . . 1.6399999999999999 113.112 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.465 HG13 ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -101.26 128.76 53.24 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 119.961 1.88 . . . . 1.6899999999999999 107.241 163.265 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 53.46 1.98 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.904 -1.147 . . . . 3.0499999999999998 107.904 172.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.1 t -156.25 143.85 19.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.307 -1.738 . . . . 1.8700000000000001 106.307 174.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.6 132.19 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.452 -1.684 . . . . 2.21 106.452 174.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tt -139.05 83.68 1.97 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.785 -0.82 . . . . 2.2000000000000002 108.785 172.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.32 139.57 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 107.909 -1.145 . . . . 2.0800000000000001 107.909 171.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.14 99.67 7.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 106.938 -1.504 . . . . 1.4299999999999999 106.938 165.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.02 -27.15 66.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.897 0.879 . . . . 2.6200000000000001 110.679 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 36.6 mtt -63.28 -60.52 3.29 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.517 0.727 . . . . 3.25 110.353 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.24 -29.07 47.98 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.795 -0.639 . . . . 1.7 110.91 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.05 61.18 1.77 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.227 -1.149 . . . . 1.26 110.227 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -134.82 144.08 47.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.539 -1.652 . . . . 3.5099999999999998 106.539 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.427 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -121.57 104.22 9.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.444 1.097 . . . . 1.1100000000000001 108.265 165.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.61 137.93 50.89 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.77 0.714 . . . . 4.4299999999999997 109.478 169.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.48 172.2 16.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 O-C-N 121.919 -0.488 . . . . 2.3599999999999999 110.594 178.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.03 105.33 10.53 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.286 1.034 . . . . 4.4400000000000004 111.012 173.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -106.15 171.48 7.32 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.077 1.751 . . . . 2.8300000000000001 112.916 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.96 112.0 38.63 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.822 1.649 . . . . 3.6099999999999999 107.764 174.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.4 36.38 0.62 Allowed 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.892 3.061 . . . . 2.46 114.286 -155.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -129.27 -15.64 4.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.03 0.932 . . . . 3.9300000000000002 112.398 170.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.1 t -106.06 -35.21 3.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 C-N-CA 124.379 1.072 . . . . 2.8799999999999999 109.43 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.574 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -132.83 150.69 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 105.351 -2.092 . . . . 1.8300000000000001 105.351 179.176 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -135.7 155.25 78.27 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.881 1.272 . . . . 3.29 111.416 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.57 -34.07 88.74 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.024 2.483 . . . . 1.55 112.662 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.38 -56.54 19.91 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.211 0.529 . . . . 2.5099999999999998 110.805 176.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.99 -31.7 69.52 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.77 -0.581 . . . . 4.75 110.964 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.574 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -54.66 -50.68 57.86 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 N-CA-C 107.269 -1.382 . . . . 1.29 107.269 168.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.4 76.15 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.462 -0.335 . . . . 1.25 110.19 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.32 -48.41 79.02 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 119.04 -0.505 . . . . 2.6200000000000001 111.011 175.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.61 -52.23 62.87 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 109.246 -0.65 . . . . 2.5099999999999998 109.246 176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.6 mm -62.84 -44.6 99.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 122.27 -0.269 . . . . 2.9900000000000002 111.059 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.71 -47.7 79.38 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.204 1.001 . . . . 2.02 111.173 173.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.23 -48.83 80.07 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.241 0.473 . . . . 2.3500000000000001 109.876 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.9 mt -58.27 -32.2 68.17 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.906 -0.588 . . . . 2.04 111.3 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.8 25.08 3.45 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 123.976 0.798 . . . . 1.21 111.604 164.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -119.03 158.21 26.27 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.767 -1.568 . . . . 3.04 106.767 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -97.03 128.15 43.7 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.059 -1.089 . . . . 2.4199999999999999 108.059 167.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.38 115.18 27.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.344 -1.354 . . . . 1.3100000000000001 107.344 169.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.43 142.92 39.5 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.559 -1.275 . . . . 1.1499999999999999 107.559 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 t -59.49 153.4 4.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.19 0.596 . . . . 2.6899999999999999 110.003 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 mtm . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 112.77 0.656 . . . . 4.9900000000000002 112.77 171.105 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.45 0 N-CA-C 108.101 -2.0 . . . . 2.2999999999999998 108.101 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -98.69 59.03 1.23 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.605 1.202 . . . . 3.71 109.668 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.3 mm -92.0 139.74 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.185 -1.413 . . . . 2.7400000000000002 107.185 -167.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -106.84 149.38 27.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.218 -1.03 . . . . 2.96 108.218 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.8 mt -144.24 152.44 40.83 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 122.899 0.479 . . . . 2.4500000000000002 110.054 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.01 135.86 38.41 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.878 -1.527 . . . . 2.6299999999999999 106.878 173.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.448 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -97.37 109.0 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 108.289 -1.004 . . . . 2.0899999999999999 108.289 -179.195 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.4 m -96.44 134.16 39.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.283 -1.377 . . . . 1.8799999999999999 107.283 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.25 -15.71 54.05 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.521 1.058 . . . . 1.79 113.002 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -76.56 124.05 27.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.192 1.496 . . . . 3.3900000000000001 110.807 -174.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -129.58 9.83 5.56 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.75 0.82 . . . . 4.8300000000000001 113.1 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 50.2 t -155.23 134.31 12.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.675 1.125 . . . . 3.8500000000000001 111.546 -173.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.8 -38.95 61.89 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.537 0.735 . . . . 2.8100000000000001 112.83 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -49.64 -39.25 35.4 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.295 -0.878 . . . . 2.4700000000000002 111.842 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 74.1 m -61.91 -34.14 75.52 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.986 -0.446 . . . . 2.29 110.597 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.6 t -58.58 -50.78 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.18 -0.674 . . . . 2.1699999999999999 109.18 174.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -60.63 -41.34 94.71 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.78 -0.822 . . . . 2.77 108.78 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -59.07 -52.34 66.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.0 0.92 . . . . 2.2599999999999998 110.11 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.1 mt -56.26 -53.15 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.013 0.925 . . . . 0.97999999999999998 109.867 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.14 -37.77 86.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.685 -0.487 . . . . 2.2200000000000002 109.685 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -59.57 -53.57 56.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.039 -0.356 . . . . 1.46 110.039 171.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.32 -47.42 66.02 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.285 0.634 . . . . 3.6499999999999999 111.372 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.3 -59.47 4.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.125 -0.694 . . . . 1.6799999999999999 109.125 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.6 m -55.3 -19.75 9.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.863 1.265 . . . . 1.78 112.144 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -31.88 63.14 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.324 0.65 . . . . 5.4800000000000004 111.131 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.1 m -70.47 151.08 45.52 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.991 2.117 . . . . 1.98 111.908 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -72.54 -49.08 35.16 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.814 0.446 . . . . 3.9399999999999999 111.964 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.98 -34.77 71.18 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 122.193 -0.317 . . . . 1.72 112.56 -172.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.31 124.12 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 O-C-N 121.881 -0.776 . . . . 2.3300000000000001 110.395 -170.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 59.7 m -99.65 -49.65 4.32 Favored 'General case' 0 CA--C 1.522 -0.114 0 O-C-N 122.978 0.174 . . . . 2.6299999999999999 111.082 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -140.82 124.23 16.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.437 -0.579 . . . . 2.2599999999999998 109.437 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -98.52 153.79 18.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.222 -1.029 . . . . 1.0900000000000001 108.222 161.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.6 t -142.73 109.77 5.57 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.43 -1.322 . . . . 2.7799999999999998 107.43 169.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.5 p -114.15 121.82 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.669 0.788 . . . . 2.2400000000000002 111.188 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -122.72 105.13 9.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.05 0.94 . . . . 2.46 110.072 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.28 -22.94 65.31 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.08 0.771 . . . . 3.1499999999999999 113.08 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.02 -54.51 7.05 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.886 -0.783 . . . . 3.1200000000000001 108.886 -172.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.4 p -69.73 -25.28 63.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.08 0.952 . . . . 4.3600000000000003 109.998 172.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.423 ' O ' HD12 ' A' ' 86' ' ' ILE . 17.2 m 74.02 19.03 3.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.426 1.891 . . . . 2.3900000000000001 111.732 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -113.81 149.17 35.35 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.559 0.744 . . . . 3.46 110.531 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.01 115.87 16.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.723 2.009 . . . . 1.5 108.516 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 mt -100.62 130.54 46.69 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.465 -1.309 . . . . 2.6800000000000002 107.465 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.3 t -131.04 121.19 48.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.65 -0.87 . . . . 2.3300000000000001 108.65 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -100.62 93.77 5.76 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.754 1.221 . . . . 3.1600000000000001 109.624 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -111.18 -179.51 3.75 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.444 0.698 . . . . 2.46 110.338 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -108.4 109.97 61.64 Favored Pre-proline 0 C--O 1.236 0.39 0 N-CA-C 107.502 -1.295 . . . . 3.9399999999999999 107.502 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.27 63.42 8.72 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.29 2.66 . . . . 2.1600000000000001 112.119 -167.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -147.17 -51.5 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.033 1.733 . . . . 4.0499999999999998 108.343 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.15 -35.33 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 110.401 -0.222 . . . . 2.5499999999999998 110.401 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.11 159.52 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 108.17 -1.048 . . . . 1.78 108.17 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.33 164.31 25.93 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.59 -1.404 . . . . 1.77 109.59 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -63.07 -44.18 16.53 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.047 2.498 . . . . 1.9399999999999999 111.03 -172.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -51.06 -40.86 59.3 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 113.614 0.968 . . . . 6.75 113.614 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -63.08 -47.4 83.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.94 -0.763 . . . . 2.75 108.94 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.413 ' O ' HD13 ' A' ' 138' ' ' ILE . 97.5 mt -56.86 -50.18 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.878 -0.786 . . . . 1.1799999999999999 108.878 177.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.7 mt -48.85 -60.67 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-O 118.399 -0.81 . . . . 2.1800000000000002 109.004 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.62 -48.17 39.63 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.221 0.919 . . . . 3.2599999999999998 110.716 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 9.9 mm -54.18 -48.76 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 118.31 -0.852 . . . . 1.8 110.849 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 134' ' ' ILE 0.332 0.0 OUTLIER -72.97 -31.74 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 120.436 1.471 . . . . 2.7999999999999998 114.154 174.152 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.05 -36.56 70.66 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.113 1.324 . . . . 2.3999999999999999 110.246 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -70.43 -24.36 62.89 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.1 0.96 . . . . 4.3600000000000003 110.778 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 30.1 mt -75.36 -43.77 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.481 0.582 . . . . 1.3700000000000001 109.455 166.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.93 31.94 2.36 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.793 1.663 . . . . 1.1399999999999999 111.284 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -114.13 160.73 18.62 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.726 -1.212 . . . . 2.5800000000000001 107.726 165.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -124.46 131.97 53.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.847 -1.168 . . . . 4.2999999999999998 107.847 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.86 105.9 13.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.2 1.0 . . . . 1.3600000000000001 109.533 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.0 m -134.21 117.78 16.88 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 117.616 -1.183 . . . . 2.2400000000000002 111.156 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -5.23 98.93 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.5 2.72 . . . . 5.2800000000000002 114.964 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.09 65.45 1.5 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.932 0.893 . . . . 5.6299999999999999 111.872 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 C--O 1.25 1.101 0 C-N-CA 125.253 1.421 . . . . 7.25 107.729 168.182 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 120.747 0.308 . . . . 3.8500000000000001 110.545 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -92.08 141.76 28.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.558 -0.534 . . . . 3.79 109.558 -176.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.3 p -119.57 154.94 33.14 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.866 -1.161 . . . . 2.7599999999999998 107.866 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -115.9 105.57 12.82 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.71 -1.218 . . . . 3.3199999999999998 107.71 173.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mt -114.32 170.59 8.19 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.173 0.987 . . . . 2.77 109.73 172.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.06 146.61 47.02 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.441 -1.689 . . . . 1.79 106.441 168.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 mm -98.04 142.9 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 107.307 -1.368 . . . . 0.92000000000000004 107.307 172.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -117.2 126.73 53.25 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.217 -1.031 . . . . 3.3799999999999999 108.217 165.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.28 -57.83 0.39 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.559 1.076 . . . . 1.9399999999999999 111.089 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.1 mtt 24.91 73.09 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.119 2.167 . . . . 2.1299999999999999 115.643 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -59.24 -57.54 12.59 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.729 0.64 . . . . 2.5 112.729 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.3 t -166.79 61.81 0.09 Allowed 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.722 0.692 . . . . 3.9100000000000001 112.031 -171.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 38.52 50.31 1.53 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.59 1.556 . . . . 5.04 112.765 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.7 t -167.63 -45.6 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.812 0.845 . . . . 2.5099999999999998 109.223 -168.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.8 t -65.42 -45.51 83.63 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.507 -0.746 . . . . 1.54 109.794 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.2 -22.68 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 121.337 -0.852 . . . . 1.9099999999999999 112.031 170.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -39.49 94.73 Favored 'General case' 0 C--O 1.223 -0.301 0 O-C-N 120.848 -1.157 . . . . 1.8100000000000001 110.537 167.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -36.16 71.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.081 -1.012 . . . . 3.7799999999999998 111.089 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -49.15 -32.9 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.122 0.969 . . . . 1.96 111.787 172.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -55.17 -53.0 61.53 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.523 0.729 . . . . 5.1100000000000003 110.653 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.93 -43.76 67.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.745 -0.661 . . . . 5.3499999999999996 109.679 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -54.52 -52.56 61.61 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.698 -0.482 . . . . 3.2000000000000002 109.698 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.531 HD21 HD11 ' A' ' 62' ' ' ILE . 24.9 mt -66.3 -41.06 90.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.901 -0.571 . . . . 2.4700000000000002 112.111 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -22.84 16.44 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.552 1.069 . . . . 2.0699999999999998 111.957 172.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -116.1 33.48 5.5 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.935 0.494 . . . . 3.1099999999999999 112.269 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.438 ' OE1' HG12 ' A' ' 32' ' ' VAL . 5.4 tm-20 -75.58 -93.76 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.249 -1.389 . . . . 3.8199999999999998 107.249 161.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.51 -101.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.249 1.019 . . . . 1.04 110.325 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.92 -23.27 67.39 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 119.248 0.931 . . . . 1.24 113.437 -176.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.438 HG12 ' OE1' ' A' ' 29' ' ' GLU . 9.4 p -74.82 130.26 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.009 1.404 . . . . 1.52 111.311 -175.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -141.89 54.22 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.828 1.299 . . . . 2.2200000000000002 110.807 173.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.82 143.25 17.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.991 -1.485 . . . . 1.6799999999999999 106.991 169.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.428 ' HA ' HG22 ' A' ' 46' ' ' ILE . 84.9 t -133.92 100.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 106.271 -1.752 . . . . 2.3700000000000001 106.271 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -119.1 78.39 1.28 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.212 -1.033 . . . . 2.4700000000000002 108.212 175.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.96 126.98 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 109.306 -0.627 . . . . 1.8600000000000001 109.306 173.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.94 95.79 7.12 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.997 -1.482 . . . . 1.1000000000000001 106.997 167.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.43 -22.82 63.86 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.362 0.265 . . . . 3.21 110.707 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 10.8 tpt -65.3 -46.85 78.72 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.389 1.075 . . . . 4.1200000000000001 110.56 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.62 -30.34 13.33 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.288 1.035 . . . . 1.29 111.061 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.94 66.58 1.27 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 125.016 1.293 . . . . 1.01 111.003 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -142.05 132.69 25.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.244 -1.762 . . . . 3.0800000000000001 106.244 172.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.24 103.4 12.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 124.368 1.043 . . . . 0.94999999999999996 109.697 168.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -106.72 146.7 30.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.002 -1.11 . . . . 3.46 108.002 166.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.543 ' C ' HD12 ' A' ' 46' ' ' ILE . 1.9 pp -139.62 166.62 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 106.647 -1.612 . . . . 2.7200000000000002 106.647 174.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 107.21 15.5 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.138 1.375 . . . . 4.4800000000000004 108.456 171.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.526 ' CD2' HD11 ' A' ' 53' ' ' ILE . 26.1 p90 -104.52 -178.8 3.76 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.245 1.018 . . . . 2.2000000000000002 112.578 171.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.18 104.06 35.44 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.215 1.406 . . . . 3.9199999999999999 109.335 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.98 -5.07 16.13 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.678 2.252 . . . . 2.2799999999999998 112.991 -172.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -75.98 -15.35 60.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.703 0.683 . . . . 3.6899999999999999 111.72 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.5 p -125.68 -41.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 118.772 0.715 . . . . 2.9100000000000001 109.518 -172.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.526 HD11 ' CD2' ' A' ' 48' ' ' TYR . 2.1 pp -113.3 -177.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 121.315 0.579 . . . . 2.48 111.477 170.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -139.45 155.92 71.77 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 104.575 -2.38 . . . . 3.1099999999999999 104.575 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -59.5 -34.2 97.09 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.739 1.626 . . . . 1.73 110.493 -175.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.79 -43.73 77.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.74 -0.648 . . . . 3.9199999999999999 111.549 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -65.7 -43.45 89.17 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.745 1.157 . . . . 2.6899999999999999 110.818 -174.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.0 mt -51.79 -55.78 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.065 -1.457 . . . . 1.8799999999999999 107.065 169.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.06 -43.59 78.08 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.782 -0.644 . . . . 1.8 111.121 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -54.46 -46.82 73.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.28 1.032 . . . . 2.6400000000000001 110.021 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.54 -48.03 72.48 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.837 -0.431 . . . . 3.4399999999999999 109.837 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.531 HD11 HD21 ' A' ' 26' ' ' LEU . 7.8 mm -60.29 -43.28 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 122.228 -0.295 . . . . 2.9900000000000002 111.182 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -64.48 -44.89 89.58 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.007 -0.368 . . . . 2.2599999999999998 110.007 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.13 -43.94 98.1 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.848 0.859 . . . . 4.6699999999999999 109.961 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.93 -47.63 74.18 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 123.922 0.889 . . . . 3.1000000000000001 108.878 173.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.61 34.12 1.12 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.919 0.771 . . . . 1.72 112.02 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -119.31 165.68 13.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.993 1.317 . . . . 2.3300000000000001 109.199 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -99.95 139.02 36.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.318 -0.993 . . . . 2.1800000000000002 108.318 162.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.9 122.89 38.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.736 -1.95 . . . . 0.94999999999999996 105.736 165.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.02 142.88 46.51 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 108.457 -0.942 . . . . 0.97999999999999998 108.457 174.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 71' ' ' VAL . 0.5 OUTLIER -67.62 136.03 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 124.127 0.971 . . . . 2.8500000000000001 109.482 -177.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 C-N-CA 123.911 0.884 . . . . 4.2699999999999996 109.202 166.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.692 0 N-CA-C 107.936 -2.065 . . . . 2.0299999999999998 107.936 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.26 79.95 5.03 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.569 -1.641 . . . . 3.4900000000000002 106.569 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -121.83 148.71 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 118.514 0.597 . . . . 3.1299999999999999 111.123 178.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -99.05 154.86 17.77 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.779 -0.823 . . . . 2.8199999999999998 108.779 174.133 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 147' ' ' LEU . 1.3 mp -133.71 142.1 47.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.88 -1.155 . . . . 2.9199999999999999 107.88 168.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.0 m -96.05 123.96 39.87 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.016 -1.476 . . . . 2.6000000000000001 107.016 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.67 112.22 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 123.51 0.724 . . . . 1.6200000000000001 110.111 -172.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.4 m -101.04 135.48 42.43 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.741 -0.837 . . . . 1.95 108.741 176.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.88 -30.31 8.17 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.775 1.179 . . . . 1.28 112.283 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 131.26 50.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.535 1.134 . . . . 2.8199999999999998 111.009 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.7 m -148.69 46.23 1.02 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.093 0.957 . . . . 3.0 110.254 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.0 t -169.61 139.86 2.1 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 120.987 -1.07 . . . . 2.6499999999999999 110.857 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.38 -44.77 68.9 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.873 0.469 . . . . 2.4700000000000002 110.638 174.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.1 m -52.45 -39.54 61.2 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.758 0.823 . . . . 2.3500000000000001 112.06 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.4 t -63.41 -55.42 24.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.129 -0.693 . . . . 3.1000000000000001 109.129 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.503 HG13 HG13 ' A' ' 113' ' ' VAL . 6.7 t -46.81 -50.34 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.68 -0.691 . . . . 1.3200000000000001 110.653 172.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -47.16 84.77 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.317 -0.623 . . . . 3.0499999999999998 109.317 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -45.92 91.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.789 -0.448 . . . . 3.5800000000000001 109.789 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.5 mt -58.77 -49.72 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -56.37 -50.0 72.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.115 0.966 . . . . 2.4399999999999999 108.539 177.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 66.9 m -60.42 -36.25 77.71 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.845 0.858 . . . . 2.1299999999999999 112.419 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -66.76 -50.36 62.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.55 -0.719 . . . . 2.73 109.773 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.76 -42.32 70.58 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.023 -0.732 . . . . 2.6400000000000001 109.023 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.6 p -55.8 -16.05 3.99 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.374 0.879 . . . . 2.3399999999999999 113.374 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -27.47 69.2 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.104 0.866 . . . . 4.3799999999999999 111.383 172.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.8 m -60.49 150.7 30.48 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.92 1.688 . . . . 1.49 110.385 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -73.65 -54.73 7.45 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.398 0.679 . . . . 2.2599999999999998 112.114 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.17 -32.84 68.98 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 121.387 0.437 . . . . 1.6799999999999999 112.688 -172.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.96 119.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.817 -0.813 . . . . 2.5099999999999998 109.73 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.7 m -102.79 -49.16 3.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.727 0.411 . . . . 2.29 111.018 -174.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.409 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 36.2 p90 -142.04 117.42 10.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.575 -0.726 . . . . 2.5099999999999998 109.46 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.85 155.19 17.17 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 118.865 -1.134 . . . . 1.4399999999999999 110.721 161.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -140.81 114.46 8.86 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.464 -0.569 . . . . 2.6000000000000001 109.464 160.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.503 HG13 HG13 ' A' ' 95' ' ' VAL . 2.7 p -109.66 140.65 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.727 0.694 . . . . 2.0 112.764 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.23 104.61 6.56 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-O 121.972 0.891 . . . . 1.47 111.857 -171.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.771 HD13 ' H ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -65.9 -20.01 66.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.625 1.57 . . . . 2.9700000000000002 114.061 -177.305 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.71 70.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.18 0.445 . . . . 1.46 110.757 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.22 -18.02 10.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.605 1.562 . . . . 1.8400000000000001 111.164 -173.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.4 m 72.43 17.63 4.7 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 126.713 2.005 . . . . 1.45 112.426 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -101.11 135.74 42.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.862 1.265 . . . . 2.98 110.371 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 83' ' ' GLU . . . -114.09 110.9 20.74 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 126.049 1.74 . . . . 1.3999999999999999 109.094 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.82 125.16 35.64 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 105.892 -1.892 . . . . 2.6699999999999999 105.892 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.3 t -130.98 132.1 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.353 1.061 . . . . 2.3100000000000001 109.463 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -119.71 88.12 2.87 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.466 0.706 . . . . 3.3999999999999999 109.65 -174.293 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -108.64 -179.48 3.88 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.558 1.161 . . . . 2.1899999999999999 111.76 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -107.36 112.78 62.51 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 124.25 1.02 . . . . 4.1299999999999999 108.324 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.79 67.41 8.62 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.162 2.575 . . . . 2.3999999999999999 111.115 -171.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -161.52 -46.75 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.03 1.332 . . . . 3.7799999999999998 109.413 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.5 pt -84.24 -31.25 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 123.021 0.528 . . . . 1.9099999999999999 110.722 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.88 161.7 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 124.446 1.099 . . . . 1.5800000000000001 108.156 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.68 162.06 28.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.672 -1.371 . . . . 1.55 109.672 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -57.18 -36.45 99.11 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.655 2.903 . . . . 1.5700000000000001 111.57 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -49.92 -37.18 30.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.467 0.707 . . . . 6.9000000000000004 112.616 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.15 -44.66 71.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.2 0.524 . . . . 3.2999999999999998 109.639 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.53 -45.87 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.27 -1.011 . . . . 1.0900000000000001 108.27 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.4 mt -53.29 -60.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 118.027 -0.987 . . . . 2.0299999999999998 108.685 175.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -46.26 -53.17 11.18 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 120.18 1.355 . . . . 3.9199999999999999 111.012 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 90.0 mt -51.22 -53.12 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.428 0.558 . . . . 2.4300000000000002 110.068 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.252 2.5 pp -71.08 -28.25 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 114.032 1.123 . . . . 1.6499999999999999 114.032 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -61.63 -42.9 99.54 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.158 0.89 . . . . 3.1099999999999999 109.063 170.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -39.81 87.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.891 0.877 . . . . 4.3600000000000003 108.734 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.503 HG21 ' CE2' ' A' ' 143' ' ' PHE . 74.6 mt -71.22 -41.54 75.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 O-C-N 122.348 -0.22 . . . . 1.6399999999999999 110.957 175.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.13 32.65 6.04 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.291 1.424 . . . . 1.54 111.899 -173.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.503 ' CE2' HG21 ' A' ' 141' ' ' ILE . 27.4 m-85 -101.5 -178.77 3.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.325 1.063 . . . . 2.3799999999999999 109.507 165.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -135.89 114.43 11.79 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 105.798 -1.927 . . . . 5.7000000000000002 105.798 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.07 108.4 19.89 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.05 1.74 . . . . 1.3200000000000001 108.73 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 m -104.65 95.29 5.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.115 -1.439 . . . . 2.2400000000000002 107.115 -174.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -62.15 84.68 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.865 1.666 . . . . 5.3600000000000003 111.262 -177.338 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 47.31 52.94 11.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.722 0.809 . . . . 4.7000000000000002 109.965 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 116.406 -1.759 . . . . 7.6699999999999999 108.683 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 . . . . . 0 CA--C 1.528 0.127 0 N-CA-C 109.335 -0.617 . . . . 3.04 109.335 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -93.61 152.03 19.28 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.315 0.646 . . . . 3.3900000000000001 111.697 177.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 t -140.83 128.05 20.96 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.552 1.141 . . . . 2.1699999999999999 110.282 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -105.63 101.16 10.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.434 1.893 . . . . 3.9399999999999999 110.864 -176.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.638 HD22 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -124.99 173.38 8.71 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.223 0.92 . . . . 2.6899999999999999 111.17 175.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.546 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 3.8 pm0 -124.8 149.03 47.82 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.31 -0.869 . . . . 3.1499999999999999 109.163 165.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -96.11 124.82 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.88 -1.526 . . . . 0.88 106.88 177.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -100.47 111.91 24.21 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.707 -1.96 . . . . 3.25 105.707 173.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.65 -78.0 0.16 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.178 0.894 . . . . 1.25 111.306 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.0 mtm 42.24 79.99 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.477 1.911 . . . . 2.73 114.205 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.7 m -53.14 -55.74 21.78 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.492 -0.755 . . . . 2.1299999999999999 112.232 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t -164.09 56.55 0.16 Allowed 'General case' 0 C--N 1.344 0.343 0 C-N-CA 119.527 -0.869 . . . . 3.04 111.904 -174.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 40.23 44.99 1.68 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.464 1.506 . . . . 5.9900000000000002 112.832 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.4 t -171.91 -43.03 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.413 0.685 . . . . 3.3900000000000001 109.682 -166.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.96 -43.06 99.82 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.998 -1.064 . . . . 1.6899999999999999 110.393 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -51.55 -39.69 23.57 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 O-C-N 122.053 -0.404 . . . . 1.9199999999999999 110.203 170.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 t -60.58 -33.46 72.74 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.359 0.412 . . . . 2.4199999999999999 110.737 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.19 -54.95 10.65 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.037 -1.039 . . . . 2.48 109.895 170.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mp -44.33 -56.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 122.893 0.477 . . . . 2.3399999999999999 110.919 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.61 -35.42 72.42 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.184 -0.947 . . . . 4.5899999999999999 112.594 -176.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -67.48 -34.58 77.45 Favored 'General case' 0 N--CA 1.458 -0.035 0 O-C-N 121.082 -1.012 . . . . 7.1299999999999999 109.779 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -65.41 -48.06 74.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.929 -0.767 . . . . 1.78 108.929 173.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.32 -36.6 68.9 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.704 0.684 . . . . 3.4500000000000002 112.144 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.85 -22.96 6.07 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.822 0.675 . . . . 1.7 112.822 174.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -110.45 21.1 17.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.103 0.961 . . . . 3.52 112.059 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -72.98 -64.82 0.89 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.229 0.612 . . . . 3.5099999999999998 109.705 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.35 -123.9 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.439 1.096 . . . . 1.52 108.064 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.84 -0.23 54.37 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 119.039 0.836 . . . . 1.54 114.594 -173.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -82.11 102.79 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.055 1.427 . . . . 1.6599999999999999 109.275 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -120.56 52.35 1.17 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 122.145 0.974 . . . . 2.4100000000000001 110.688 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.1 m -159.81 143.86 14.6 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.494 -1.298 . . . . 2.9100000000000001 107.494 172.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.88 116.69 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 105.663 -1.977 . . . . 2.4700000000000002 105.663 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pp -139.02 90.39 2.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 119.591 -0.844 . . . . 4.6600000000000001 111.381 166.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -99.5 163.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.426 -0.796 . . . . 2.6699999999999999 109.951 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.58 101.73 6.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.568 -1.271 . . . . 1.3300000000000001 107.568 167.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.75 -17.59 64.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.958 0.903 . . . . 3.3199999999999998 111.325 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 49.4 mtm -68.58 -55.52 11.32 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.87 0.868 . . . . 4.3700000000000001 109.941 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.71 -26.88 24.03 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.047 0.539 . . . . 1.46 111.494 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.88 65.86 1.67 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.313 -1.115 . . . . 1.1200000000000001 110.313 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -141.01 140.9 34.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.909 -1.515 . . . . 3.1099999999999999 106.909 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.638 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -116.74 110.19 18.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.677 1.191 . . . . 0.95999999999999996 110.236 170.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.32 134.06 42.73 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.572 -1.64 . . . . 4.5199999999999996 106.572 168.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.4 HD12 HD21 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -136.51 168.69 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.217 0.917 . . . . 1.77 111.117 167.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.67 109.85 19.26 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 123.911 0.885 . . . . 3.96 110.228 163.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.45 ' HB2' HD12 ' A' ' 53' ' ' ILE . 2.6 p90 -98.63 -176.75 3.46 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 127.96 2.504 . . . . 2.6000000000000001 111.022 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -138.06 108.67 8.25 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.861 1.264 . . . . 3.8100000000000001 109.443 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.59 8.47 1.23 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 124.497 3.465 . . . . 2.4100000000000001 113.997 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -95.82 -13.92 23.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.276 1.398 . . . . 4.0 111.688 167.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.2 m -130.23 -42.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 118.929 0.786 . . . . 2.7799999999999998 112.853 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.45 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -115.21 137.42 48.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 N-CA-C 107.21 -1.404 . . . . 1.8100000000000001 107.21 177.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.5 mm100 -119.67 149.91 49.17 Favored Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 108.219 -1.03 . . . . 3.6299999999999999 108.219 -175.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -61.04 -35.78 85.48 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.449 2.099 . . . . 1.53 111.308 -173.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -58.21 -45.42 87.65 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.839 -0.538 . . . . 3.52 111.439 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -58.48 -44.76 89.47 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.657 0.783 . . . . 3.6200000000000001 110.008 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.28 -56.41 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.04 -1.837 . . . . 1.3 106.04 172.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.51 -44.81 95.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.916 -0.584 . . . . 1.1499999999999999 111.142 -170.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -55.96 -44.27 78.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.747 0.819 . . . . 2.8500000000000001 110.283 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.56 -42.99 95.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.399 -0.593 . . . . 3.1899999999999999 109.399 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mm -60.18 -43.34 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.859 -0.526 . . . . 2.5 110.141 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -63.42 -42.41 98.72 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.549 0.739 . . . . 2.9199999999999999 111.683 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.98 -50.66 72.88 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.582 0.628 . . . . 2.6099999999999999 109.741 175.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.65 -34.65 67.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.515 0.726 . . . . 1.8400000000000001 111.62 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.93 37.63 1.24 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.161 0.886 . . . . 1.3400000000000001 111.093 166.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -133.15 169.46 16.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.773 1.629 . . . . 2.1600000000000001 107.002 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -113.3 129.32 56.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.315 -0.624 . . . . 2.4399999999999999 109.315 169.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.06 120.44 38.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.551 -1.648 . . . . 0.79000000000000004 106.551 168.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.546 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -131.03 133.88 46.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.074 -1.454 . . . . 0.89000000000000001 107.074 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.15 154.36 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.508 -0.923 . . . . 2.4900000000000002 108.508 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.658 0 CA-C-N 114.97 -1.014 . . . . 4.7000000000000002 111.892 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.095 0 N-CA-C 108.345 -1.902 . . . . 2.1600000000000001 108.345 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.4 104.18 14.25 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.196 -1.409 . . . . 2.7599999999999998 107.196 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.02 170.4 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.152 -1.425 . . . . 2.8999999999999999 107.152 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.33 151.06 46.09 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.497 0.719 . . . . 2.6899999999999999 111.948 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.2 mt -136.94 146.16 45.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.901 1.28 . . . . 2.0099999999999998 107.674 -172.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.04 127.9 55.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.392 -1.336 . . . . 1.9099999999999999 107.392 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.768 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -97.26 117.41 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.37 -1.715 . . . . 1.8 106.37 -171.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.2 p -98.72 141.91 30.93 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.013 -1.106 . . . . 2.5099999999999998 108.013 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.52 -17.68 28.52 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 119.348 -0.695 . . . . 2.0099999999999998 113.257 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -79.92 140.46 36.69 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.199 1.5 . . . . 2.2799999999999998 111.023 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 t -155.37 85.91 1.07 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.216 -1.031 . . . . 4.5 108.216 176.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 77.8 m 59.86 -99.2 0.09 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.017 1.327 . . . . 6.4900000000000002 111.386 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 43.37 -148.49 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.508 1.923 . . . . 5.4100000000000001 110.7 -168.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.9 t -79.76 -6.31 57.01 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.346 -0.613 . . . . 3.6000000000000001 109.346 159.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.4 t -59.76 -49.96 75.67 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.39 -0.818 . . . . 3.3100000000000001 109.817 -167.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.7 p -46.48 -61.19 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.375 1.07 . . . . 2.6400000000000001 111.447 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -65.04 -31.01 72.03 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.369 0.668 . . . . 3.8599999999999999 110.579 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.576 HD21 HD13 ' A' ' 141' ' ' ILE . 3.5 t30 -69.08 -48.95 61.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.225 1.01 . . . . 1.6799999999999999 110.333 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.5 mt -58.95 -47.9 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.216 -1.031 . . . . 0.98999999999999999 108.216 175.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -50.69 -54.35 23.89 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.508 -0.553 . . . . 2.5699999999999998 109.508 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.3 t -52.34 -48.06 65.7 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.471 0.708 . . . . 1.6799999999999999 111.093 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -60.59 -39.05 86.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.216 -0.928 . . . . 2.52 111.201 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 25.5 mt -71.25 -61.65 1.69 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.196 -1.038 . . . . 1.6899999999999999 108.196 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 74.0 p -59.31 -19.21 44.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.323 1.049 . . . . 1.72 112.736 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -57.15 -36.24 70.5 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 119.291 -0.385 . . . . 4.3499999999999996 110.7 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 t -75.33 174.84 9.01 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.649 0.738 . . . . 3.02 111.597 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -85.27 -47.72 9.78 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.11 0.964 . . . . 2.2799999999999998 111.428 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.72 -35.56 80.56 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-O 119.974 -0.348 . . . . 1.1899999999999999 112.916 -170.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.67 119.08 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 117.552 0.676 . . . . 2.8900000000000001 109.339 -172.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.8 m -95.72 -47.13 6.32 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 109.658 -0.497 . . . . 2.3900000000000001 109.658 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -142.55 92.54 2.42 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 112.859 0.688 . . . . 3.4700000000000002 112.859 -176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.42 145.13 24.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.665 -1.235 . . . . 0.89000000000000001 107.665 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 m -141.76 109.31 5.64 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.572 -0.899 . . . . 2.3700000000000001 108.572 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.3 p -99.91 124.73 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.918 1.287 . . . . 2.1699999999999999 109.475 -177.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.32 88.27 2.91 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.309 1.443 . . . . 1.49 109.626 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 pp -66.18 -20.84 66.26 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 125.408 1.483 . . . . 2.25 113.295 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.57 97.56 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.382 0.537 . . . . 1.73 109.965 176.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -19.09 20.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.893 1.277 . . . . 1.8200000000000001 110.41 175.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.5 m 65.83 37.18 5.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.167 1.387 . . . . 1.6399999999999999 110.647 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.96 157.45 37.76 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.43 0.559 . . . . 3.0499999999999998 109.499 171.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.42 131.58 26.43 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.128 0.971 . . . . 1.0700000000000001 109.386 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.92 129.68 45.26 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.942 1.697 . . . . 2.23 107.166 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.15 124.45 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.263 1.425 . . . . 2.3900000000000001 110.49 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.65 94.74 5.15 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 107.57 -1.27 . . . . 4.2599999999999998 107.57 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -111.12 -177.71 3.28 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 124.239 0.962 . . . . 1.96 110.397 174.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.86 116.69 60.4 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 108.255 -1.017 . . . . 2.8500000000000001 108.255 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -81.32 68.55 8.16 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.893 2.396 . . . . 1.96 111.135 -167.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -165.86 -44.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.748 1.219 . . . . 3.3300000000000001 109.669 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.8 pt -79.72 -38.23 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 123.109 0.564 . . . . 1.8100000000000001 111.136 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.54 158.28 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 123.576 0.75 . . . . 1.6299999999999999 109.118 175.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -124.07 168.76 16.17 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.861 1.22 . . . . 1.7 110.452 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.0 -41.88 6.96 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.718 2.279 . . . . 1.6100000000000001 110.383 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.48 -39.59 57.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.678 0.791 . . . . 6.6200000000000001 112.487 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.95 -49.58 75.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.667 0.787 . . . . 3.9500000000000002 109.332 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.21 -47.28 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.563 -0.903 . . . . 1.3400000000000001 108.563 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 95.2 mt -52.52 -59.25 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.538 -0.912 . . . . 2.0099999999999998 108.538 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -49.05 -48.86 43.66 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 119.159 0.891 . . . . 4.1299999999999999 112.431 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 mm -51.59 -53.51 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.82 -0.437 . . . . 2.46 109.82 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.315 2.0 pp -70.75 -26.99 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 114.385 1.254 . . . . 1.5 114.385 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.36 -43.5 96.47 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 119.359 0.981 . . . . 2.6499999999999999 109.078 169.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -63.97 -38.29 90.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.18 -0.674 . . . . 3.21 109.18 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.576 HD13 HD21 ' A' ' 97' ' ' ASN . 73.2 mt -64.44 -44.84 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 122.227 -0.296 . . . . 1.1499999999999999 110.257 171.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.38 23.85 5.58 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.536 1.541 . . . . 1.25 112.629 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -100.59 178.78 4.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.268 1.534 . . . . 2.8100000000000001 108.802 164.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -136.93 130.39 31.52 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.146 -1.798 . . . . 4.0499999999999998 106.146 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.98 97.24 5.18 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.717 1.607 . . . . 1.3600000000000001 108.073 -171.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.7 p -143.22 134.17 25.52 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.269 -0.641 . . . . 1.8999999999999999 109.269 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -174.31 -94.35 0.0 OUTLIER 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.138 1.375 . . . . 7.6900000000000004 109.12 170.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 37.47 36.38 0.08 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.445 1.898 . . . . 6.04 113.367 -169.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.224 -1.37 . . . . 6.3200000000000003 110.912 -176.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 106.733 -1.581 . . . . 2.8199999999999998 106.733 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -104.37 154.48 19.78 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.704 0.802 . . . . 4.4199999999999999 110.812 179.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 54.1 t -143.19 140.72 30.87 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.42 0.688 . . . . 2.1800000000000002 110.939 170.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -109.57 92.3 3.99 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.076 2.15 . . . . 3.5499999999999998 109.698 -173.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.521 HD12 ' HB3' ' A' ' 44' ' ' ALA 0.262 1.5 pp -119.07 164.58 15.3 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.068 0.937 . . . . 2.71 112.195 176.45 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.15 154.72 18.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.487 -1.301 . . . . 2.4500000000000002 107.487 166.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.407 HG12 ' HB2' ' A' ' 44' ' ' ALA . 14.4 mm -97.78 145.45 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 106.628 -1.619 . . . . 0.83999999999999997 106.628 160.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -123.77 123.13 39.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.039 -1.837 . . . . 3.3700000000000001 106.039 158.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.04 -81.38 0.19 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 108.792 -1.723 . . . . 1.29 108.792 -172.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 28.43 73.15 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.064 2.146 . . . . 2.3300000000000001 115.335 178.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -16.63 2.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.214 1.406 . . . . 2.3199999999999998 113.781 174.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.8 t 78.25 -48.67 0.47 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.745 1.618 . . . . 3.9500000000000002 112.433 173.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.25 -70.29 0.11 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.448 1.499 . . . . 4.8600000000000003 111.776 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 p -159.96 15.13 0.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.13 0.572 . . . . 2.4900000000000002 112.43 172.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.7 m -70.69 -48.3 55.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.573 -0.705 . . . . 2.2999999999999998 109.385 -168.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.0 t -47.96 -51.69 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.365 -0.976 . . . . 2.0699999999999998 108.365 172.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -59.22 -34.29 72.0 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.906 1.282 . . . . 1.8300000000000001 113.675 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -45.52 58.77 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.233 -0.292 . . . . 3.0099999999999998 110.321 172.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.6 mt -56.23 -47.34 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.895 0.878 . . . . 1.6100000000000001 109.213 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -47.63 -53.45 14.76 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.391 0.676 . . . . 4.4800000000000004 110.837 175.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.0 mtt85 -67.9 -30.21 69.5 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.629 0.771 . . . . 5.7999999999999998 112.378 -175.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -69.07 -55.77 9.76 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.75 -0.833 . . . . 1.3600000000000001 108.75 175.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -61.06 -36.07 78.63 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.067 0.547 . . . . 3.6000000000000001 110.792 -176.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.539 HE22 HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -51.78 -24.61 6.2 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.896 0.702 . . . . 3.3300000000000001 112.896 171.563 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -119.55 30.22 7.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.748 0.819 . . . . 4.0599999999999996 111.537 178.45 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -77.8 -89.27 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 105.686 -1.968 . . . . 3.2999999999999998 105.686 163.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.54 -91.24 0.06 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.489 0.716 . . . . 1.1200000000000001 111.044 177.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.27 -15.75 68.44 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.287 -0.729 . . . . 1.8100000000000001 112.593 -171.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.45 109.71 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 CA-C-N 118.102 0.951 . . . . 2.1699999999999999 109.168 177.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.3 mt -138.59 50.59 1.86 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.89 -0.782 . . . . 3.73 108.89 177.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 t -159.86 152.68 21.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.217 -1.771 . . . . 2.1800000000000002 106.217 159.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.539 HG13 HE22 ' A' ' 27' ' ' GLN . 0.0 OUTLIER -142.17 102.07 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.122 -1.807 . . . . 2.21 106.122 -178.711 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -127.24 74.2 1.49 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.419 -1.697 . . . . 2.9100000000000001 106.419 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.13 123.66 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.427 -0.953 . . . . 2.2599999999999998 108.427 174.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.75 92.65 6.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.692 -1.966 . . . . 1.4099999999999999 105.692 169.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 tp -54.71 -30.04 54.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.24 1.416 . . . . 3.4399999999999999 110.192 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 31.7 mtt -66.51 -54.32 25.24 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.418 0.687 . . . . 3.29 110.421 -178.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.11 -23.59 28.4 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.151 0.58 . . . . 1.4299999999999999 111.484 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.54 63.78 2.28 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.059 1.314 . . . . 1.2 110.9 -176.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.0 pttm -140.98 140.58 34.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.751 -1.203 . . . . 3.1600000000000001 107.751 170.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.521 ' HB3' HD12 ' A' ' 8' ' ' LEU . . . -116.72 104.44 11.36 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 124.435 1.084 . . . . 0.95999999999999996 112.975 173.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -98.01 125.76 43.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.259 -1.385 . . . . 4.3099999999999996 107.259 172.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.0 mt -126.06 163.29 28.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 107.027 -1.471 . . . . 2.7000000000000002 107.027 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -123.98 105.75 9.84 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.435 -0.95 . . . . 4.1600000000000001 108.435 165.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -117.54 159.8 22.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.397 1.479 . . . . 3.0899999999999999 110.027 172.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -98.95 111.15 60.05 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.931 0.893 . . . . 3.7400000000000002 110.297 -179.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.08 -3.84 7.92 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.076 3.184 . . . . 2.1200000000000001 113.623 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -73.25 -44.99 58.43 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 120.07 1.305 . . . . 4.6399999999999997 110.741 169.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -108.59 -30.22 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 122.175 -0.328 . . . . 2.77 111.427 -165.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.402 HD11 ' CG1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -127.51 131.96 69.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 108.655 -0.868 . . . . 1.77 108.655 177.34 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.02 150.7 39.05 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.605 1.562 . . . . 2.6699999999999999 109.773 -177.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -51.94 -52.58 8.65 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.37 2.713 . . . . 1.3600000000000001 112.247 179.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -60.4 -43.76 96.35 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.419 -0.8 . . . . 3.0899999999999999 111.265 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -57.77 -37.62 73.99 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.944 0.498 . . . . 3.9399999999999999 111.101 174.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.402 ' CG1' HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -55.31 -50.11 67.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 107.568 -1.271 . . . . 1.1799999999999999 107.568 171.175 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.84 -43.87 77.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.988 -0.551 . . . . 1.4199999999999999 110.203 -175.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -53.12 -46.84 68.94 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.305 0.502 . . . . 2.7400000000000002 110.75 175.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -48.79 79.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.002 0.43 . . . . 2.52 110.371 177.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -64.53 -44.04 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 121.961 -0.462 . . . . 2.6000000000000001 111.012 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -42.69 98.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.448 1.099 . . . . 2.4700000000000002 110.247 176.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.77 -49.15 77.55 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.39 0.541 . . . . 2.6000000000000001 109.974 177.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 mt -56.24 -37.03 69.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.399 0.279 . . . . 1.95 111.583 174.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.94 26.51 2.75 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.239 0.923 . . . . 1.3500000000000001 112.242 167.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -118.5 167.72 11.33 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.35 1.46 . . . . 2.0299999999999998 107.96 176.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -98.55 143.74 28.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.373 -0.973 . . . . 2.5899999999999999 108.373 163.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.74 135.16 48.13 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.801 0.84 . . . . 1.1399999999999999 108.79 162.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.63 138.72 30.91 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.912 0.885 . . . . 1.26 109.731 171.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 p -87.19 152.84 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 125.613 1.565 . . . . 2.71 109.499 178.245 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.7 mtt . . . . . 0 CA--C 1.533 0.294 0 O-C-N 123.371 0.419 . . . . 3.6600000000000001 111.605 178.275 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.087 0 N-CA-C 112.004 -0.439 . . . . 2.0299999999999998 112.004 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.504 ' C ' HD13 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -142.01 114.44 8.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.067 -1.457 . . . . 2.3700000000000001 107.067 173.647 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.504 HD13 ' C ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER -128.01 160.85 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.405 -1.331 . . . . 2.8799999999999999 107.405 176.825 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.8 153.83 28.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.23 -1.026 . . . . 3.9700000000000002 108.23 169.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 mp -133.01 141.21 48.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.705 0.802 . . . . 2.46 109.027 163.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.4 m -94.74 125.97 39.75 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.356 -1.72 . . . . 2.6099999999999999 106.356 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.8 mt -101.52 123.36 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.241 -0.651 . . . . 3.46 109.241 -174.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.5 m -96.5 124.65 40.56 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.819 -1.178 . . . . 1.77 107.819 172.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 117.22 -34.82 4.41 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.95 1.262 . . . . 1.3400000000000001 112.161 175.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 55.7 ttp -50.44 120.52 4.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.998 0.899 . . . . 2.96 110.98 177.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.4 6.18 1.27 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.526 0.935 . . . . 3.3199999999999998 113.526 -170.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.4 t -156.01 142.21 18.32 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.084 1.311 . . . . 2.7400000000000002 111.243 -178.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.19 64.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.568 1.147 . . . . 3.1299999999999999 112.271 -175.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.24 -49.5 66.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.124 0.97 . . . . 3.1899999999999999 110.739 171.33 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 88.4 m -64.17 -46.56 83.48 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.011 -0.737 . . . . 1.8700000000000001 109.011 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.519 HG13 HG13 ' A' ' 113' ' ' VAL . 91.2 t -47.67 -59.0 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.279 1.032 . . . . 1.55 109.778 175.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -57.68 -44.33 85.73 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 122.997 0.519 . . . . 4.5 111.285 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -62.69 -47.66 82.67 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.836 0.455 . . . . 1.8500000000000001 110.627 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.437 HD11 ' CE2' ' A' ' 143' ' ' PHE . 81.2 mt -57.35 -48.75 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.744 -0.836 . . . . 1.1399999999999999 108.744 177.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -59.74 -46.45 89.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.427 -0.582 . . . . 3.1000000000000001 109.427 178.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.6 t -52.0 -46.64 64.99 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.577 0.626 . . . . 1.28 110.811 174.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -60.18 -50.65 72.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.747 -0.596 . . . . 3.4100000000000001 110.89 177.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.7 mt -58.0 -56.81 17.15 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 118.378 0.536 . . . . 2.1699999999999999 109.587 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 33.3 m -50.04 -19.15 0.66 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.144 1.778 . . . . 1.73 112.912 173.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -67.37 -16.46 64.26 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.058 0.845 . . . . 5.2599999999999998 112.251 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.0 m -72.38 155.0 40.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.169 1.387 . . . . 1.75 110.838 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -74.47 -52.82 10.91 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.962 0.905 . . . . 2.6499999999999999 111.7 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.36 -37.75 80.13 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.786 -0.525 . . . . 1.45 111.786 -172.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.51 136.94 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.706 -0.85 . . . . 1.76 108.706 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.8 m -137.22 -12.92 1.61 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.482 -0.761 . . . . 3.4100000000000001 112.394 171.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.91 118.34 10.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.786 -2.301 . . . . 2.3300000000000001 104.786 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.49 161.04 28.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.314 -1.365 . . . . 1.0800000000000001 107.314 166.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.0 m -141.07 111.96 7.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 118.915 -0.564 . . . . 1.8300000000000001 109.505 161.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.519 HG13 HG13 ' A' ' 95' ' ' VAL . 7.4 p -95.71 134.52 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.641 0.776 . . . . 1.8400000000000001 110.542 171.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.65 108.47 5.67 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.53 1.157 . . . . 1.3700000000000001 110.967 -171.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.71 -41.18 98.13 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.544 1.937 . . . . 4.3300000000000001 112.081 -173.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.22 62.45 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.277 0.631 . . . . 2.3100000000000001 111.094 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 -15.81 15.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.455 1.902 . . . . 2.4399999999999999 110.199 -177.252 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.1 t 71.56 20.27 4.83 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.517 2.327 . . . . 1.8400000000000001 112.145 168.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -131.55 172.82 11.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.271 0.558 . . . . 2.6400000000000001 110.741 177.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . . . -129.06 134.35 48.07 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.739 1.216 . . . . 1.1699999999999999 109.377 170.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.39 123.35 35.65 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 104.484 -2.413 . . . . 1.8700000000000001 104.484 172.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.4 t -124.14 129.39 74.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.372 -1.344 . . . . 1.78 107.372 -176.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.12 88.15 2.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.7 -1.222 . . . . 3.4700000000000002 107.7 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -113.04 164.71 13.13 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.055 0.942 . . . . 2.0299999999999998 111.311 174.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -99.04 116.63 65.11 Favored Pre-proline 0 C--O 1.237 0.423 0 C-N-CA 123.932 0.893 . . . . 3.0099999999999998 109.344 177.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -78.22 68.22 7.97 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.236 2.624 . . . . 2.1099999999999999 111.546 -173.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.54 -47.34 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.245 1.018 . . . . 3.2200000000000002 109.348 173.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -81.59 -30.88 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 122.922 0.489 . . . . 1.76 110.924 -177.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -135.25 163.39 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.91 -0.774 . . . . 1.8 108.91 176.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.49 163.54 28.18 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.488 -1.445 . . . . 1.99 109.488 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.45 -35.67 81.54 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.857 3.038 . . . . 2.3799999999999999 112.565 -170.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -40.62 75.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.92 -0.488 . . . . 7.7800000000000002 111.316 -175.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.92 -38.99 72.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 119.148 -1.021 . . . . 3.8500000000000001 109.969 -177.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 83.4 mt -56.65 -48.68 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.674 -0.862 . . . . 1.6699999999999999 108.674 173.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.9 mt -50.51 -60.33 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 118.111 -0.947 . . . . 2.8199999999999998 108.671 173.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -51.47 -44.71 62.51 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.959 1.254 . . . . 4.5199999999999996 112.469 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.4 mm -56.05 -54.39 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.449 -0.782 . . . . 2.3799999999999999 109.491 176.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.256 2.5 pp -68.18 -25.53 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 120.861 -1.149 . . . . 1.78 113.392 -178.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.34 -39.52 87.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.954 0.797 . . . . 3.5099999999999998 109.932 168.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.77 -40.59 97.76 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.994 -0.743 . . . . 3.8100000000000001 108.994 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.8 mt -66.41 -43.09 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 110.02 -0.363 . . . . 1.0800000000000001 110.02 173.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.01 33.42 4.96 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.647 1.594 . . . . 0.90000000000000002 111.536 -175.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 98' ' ' ILE . 51.2 m-85 -103.81 177.3 4.88 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.403 1.102 . . . . 2.4199999999999999 109.264 166.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -129.79 121.98 27.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.176 -1.787 . . . . 4.04 106.176 172.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.84 113.27 26.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.574 1.15 . . . . 1.46 108.691 179.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.1 m -110.66 98.61 7.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.758 1.623 . . . . 1.9299999999999999 107.991 -173.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.59 98.71 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.186 1.794 . . . . 5.4000000000000004 111.003 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 48.53 45.19 21.12 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.74 0.816 . . . . 4.9800000000000004 111.289 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 . . . . . 0 C--O 1.248 1.006 0 N-CA-C 106.537 -1.653 . . . . 9.8499999999999996 106.537 -175.587 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 107.544 -1.28 . . . . 4.8300000000000001 107.544 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -96.79 142.66 28.53 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.697 0.681 . . . . 4.3200000000000003 111.572 -172.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.0 t -141.1 126.53 18.74 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.077 0.551 . . . . 2.6699999999999999 111.826 172.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -97.43 101.69 13.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.255 2.222 . . . . 3.7200000000000002 108.187 175.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -119.34 167.35 11.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 122.344 1.069 . . . . 3.0899999999999999 108.616 173.991 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.471 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -140.63 136.86 33.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.641 -0.874 . . . . 1.97 108.641 175.204 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.02 138.06 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 105.34 -2.096 . . . . 1.1499999999999999 105.34 -178.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -106.95 125.17 50.65 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.201 -1.037 . . . . 3.5800000000000001 108.201 170.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.23 -88.23 0.28 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.787 1.66 . . . . 1.5 109.494 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.4 mpt? 66.13 144.32 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.502 1.921 . . . . 2.6800000000000002 112.416 -169.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -109.34 -19.08 13.41 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.495 1.118 . . . . 2.3900000000000001 110.702 172.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.4 t 65.73 -65.23 0.18 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.183 1.793 . . . . 2.96 112.001 -170.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.36 -73.25 0.02 OUTLIER 'General case' 0 C--N 1.342 0.264 0 C-N-CA 128.083 2.553 . . . . 5.8499999999999996 113.413 -175.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.63 13.07 0.09 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.006 0.743 . . . . 3.1600000000000001 113.006 166.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.3 m -74.85 -41.57 59.59 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 120.169 -1.582 . . . . 2.25 110.768 -171.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.87 -31.86 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.878 -0.786 . . . . 2.0099999999999998 108.878 176.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -61.06 -52.13 66.24 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.919 -0.488 . . . . 2.21 110.72 170.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -53.15 -45.76 68.55 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.877 -1.139 . . . . 2.96 110.833 175.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -43.88 -38.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.61 1.164 . . . . 1.6200000000000001 111.613 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -52.24 -58.41 6.7 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.268 0.627 . . . . 4.8399999999999999 111.469 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -67.11 -37.58 84.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.655 -0.498 . . . . 4.3200000000000003 109.655 -176.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -55.68 -56.8 16.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.414 -0.587 . . . . 1.3700000000000001 109.414 178.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 mp -61.18 -42.43 98.56 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.822 0.737 . . . . 2.4100000000000001 110.969 177.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -22.25 18.84 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.781 0.719 . . . . 1.8899999999999999 112.537 178.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -113.01 16.53 19.32 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.414 0.894 . . . . 3.1499999999999999 113.414 175.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.41 -69.5 0.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.265 -1.013 . . . . 2.8199999999999998 108.265 165.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.13 -134.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.163 1.385 . . . . 2.2200000000000002 107.951 -176.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.11 35.69 1.28 Allowed Glycine 0 CA--C 1.538 1.499 0 CA-C-N 120.255 1.389 . . . . 2.6000000000000001 114.847 -172.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.89 77.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 125.306 1.443 . . . . 2.77 109.454 175.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.47 51.55 0.77 Allowed 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 108.602 -0.888 . . . . 3.4100000000000001 108.602 -172.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -163.79 126.02 2.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.607 -1.257 . . . . 1.8300000000000001 107.607 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.1 t -128.48 114.52 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.998 -1.482 . . . . 2.8100000000000001 106.998 176.255 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -123.68 79.57 1.71 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.612 -1.255 . . . . 3.6499999999999999 107.612 174.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 t -97.76 128.26 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 109.054 -0.721 . . . . 2.46 109.054 173.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.31 86.81 3.99 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.333 -1.358 . . . . 2.21 107.333 176.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.8 mt -57.25 -5.38 0.29 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.958 1.096 . . . . 3.1000000000000001 113.958 176.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 28.5 mtp -97.66 -42.51 7.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.268 1.427 . . . . 3.9900000000000002 110.468 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.3 -38.12 12.25 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.644 0.778 . . . . 2.3900000000000001 110.879 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.89 60.14 1.04 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 126.216 1.865 . . . . 1.8200000000000001 111.649 173.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -138.19 137.47 37.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 105.412 -2.07 . . . . 3.5800000000000001 105.412 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.5 92.94 4.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.185 0.928 . . . . 1.4099999999999999 110.119 169.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.04 111.63 23.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.112 -2.551 . . . . 6.1900000000000004 104.112 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 pt -117.38 174.94 3.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 O-C-N 120.325 -1.484 . . . . 2.5099999999999998 108.414 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -131.12 108.61 9.87 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.924 -0.399 . . . . 5.5099999999999998 109.924 170.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -117.32 164.78 14.32 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.618 1.567 . . . . 3.0899999999999999 113.288 174.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -99.0 106.12 36.0 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.646 1.978 . . . . 3.8799999999999999 109.978 177.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.05 9.66 0.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.354 2.703 . . . . 3.6099999999999999 113.701 -171.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -97.85 -21.32 16.98 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.535 0.734 . . . . 5.0999999999999996 111.038 173.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.9 t -111.01 -62.45 2.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 N-CA-C 108.34 -0.985 . . . . 3.8599999999999999 108.34 -175.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.498 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -98.96 144.42 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 N-CA-C 109.115 -0.698 . . . . 2.5800000000000001 109.115 176.541 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -113.49 151.78 44.77 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 125.008 1.323 . . . . 3.6600000000000001 108.328 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.26 -39.38 85.21 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.716 2.277 . . . . 2.1099999999999999 111.314 -175.136 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.574 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -72.01 -38.4 69.61 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.461 -0.774 . . . . 3.1600000000000001 112.505 -178.431 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -57.3 -43.65 83.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.998 -0.741 . . . . 3.2599999999999998 108.998 172.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.498 HD12 HD11 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -53.2 -47.56 55.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 108.51 -0.922 . . . . 1.4399999999999999 108.51 168.808 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.49 -38.69 78.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 119.898 -0.721 . . . . 1.1899999999999999 110.266 -171.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -52.65 -50.85 62.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.047 0.939 . . . . 2.8300000000000001 109.971 177.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -48.15 70.54 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.501 -0.555 . . . . 2.4100000000000001 109.501 177.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.5 mm -62.77 -39.85 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 122.164 -0.335 . . . . 2.4300000000000002 111.08 -178.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -67.38 -42.92 82.59 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.813 -0.439 . . . . 1.8400000000000001 109.813 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -60.58 -49.9 75.67 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.029 0.532 . . . . 2.3199999999999998 109.878 176.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.61 -36.42 69.42 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.02 0.528 . . . . 2.0699999999999998 111.032 175.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.24 41.67 0.95 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.127 -0.789 . . . . 1.3400000000000001 111.127 165.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -132.59 162.88 30.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.277 1.031 . . . . 3.0 109.168 -174.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -93.17 124.11 36.91 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 106.914 -1.513 . . . . 2.6899999999999999 106.914 171.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.38 124.63 43.16 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.853 -1.165 . . . . 1.3 107.853 167.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -137.66 113.46 9.71 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.789 -0.819 . . . . 1.1200000000000001 108.789 172.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 4.5 t -72.83 158.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.836 0.855 . . . . 2.6499999999999999 110.171 -178.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.4 mtt . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 113.296 0.85 . . . . 4.2199999999999998 113.296 174.361 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.374 0 N-CA-C 109.592 -1.403 . . . . 2.6000000000000001 109.592 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -115.21 122.92 47.51 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.682 -2.34 . . . . 2.8900000000000001 104.682 175.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.71 158.9 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.553 -1.277 . . . . 3.4199999999999999 107.553 168.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.7 157.32 39.36 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 123.333 0.653 . . . . 3.3300000000000001 109.471 171.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 pp -147.31 161.6 40.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.585 -0.734 . . . . 2.5499999999999998 110.333 172.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.9 126.3 44.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.15 -1.426 . . . . 2.0499999999999998 107.15 173.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.65 127.08 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.57 -0.9 . . . . 1.8100000000000001 108.57 176.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.6 m -118.02 112.08 19.79 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.034 -1.099 . . . . 1.8999999999999999 108.034 176.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.96 -25.76 1.15 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.656 1.122 . . . . 1.5600000000000001 111.386 -172.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.9 tpp -61.25 120.72 10.92 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 121.978 -0.719 . . . . 2.8300000000000001 111.389 -174.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.7 t -130.49 4.92 4.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.29 0.636 . . . . 2.4399999999999999 111.463 176.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.27 153.12 6.41 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 120.654 -1.278 . . . . 3.5 111.682 177.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.89 -32.62 66.06 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.319 0.647 . . . . 3.1099999999999999 111.148 173.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.9 t -51.99 -43.95 63.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.949 0.5 . . . . 2.21 110.525 171.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.5 m -63.91 -53.51 49.22 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 108.41 -0.959 . . . . 1.8899999999999999 108.41 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 82.1 t -43.39 -54.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.194 0.998 . . . . 1.3799999999999999 110.71 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -59.05 -40.0 83.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.685 -0.234 . . . . 4.25 110.958 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -66.89 -46.34 75.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.874 -0.516 . . . . 1.6200000000000001 110.579 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.6 mm -55.65 -50.46 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.616 -0.883 . . . . 1.6200000000000001 108.616 176.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -59.75 -45.54 91.91 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 118.842 -0.599 . . . . 2.1099999999999999 110.057 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.3 m -55.44 -39.87 70.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.826 0.739 . . . . 2.71 111.622 175.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.44 -39.27 81.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.016 -0.428 . . . . 2.98 111.193 175.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.92 -58.25 5.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.338 -0.986 . . . . 1.7 108.338 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.9 p -57.27 -15.39 5.96 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.597 1.159 . . . . 2.0899999999999999 113.13 176.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -35.66 64.26 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.517 -0.739 . . . . 5.5 111.583 167.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.8 m -66.85 144.77 56.08 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.632 1.573 . . . . 1.77 111.1 -175.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -68.17 -47.3 68.35 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.011 0.925 . . . . 2.6899999999999999 111.432 177.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.27 -21.75 74.92 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.62 -0.544 . . . . 1.8899999999999999 113.139 -168.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.2 156.77 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.596 -0.89 . . . . 2.29 108.596 177.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.9 m -140.0 -39.8 0.45 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.39 -0.819 . . . . 3.3999999999999999 112.348 168.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.39 95.02 4.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.94 -1.504 . . . . 2.5899999999999999 106.94 -168.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -96.51 155.32 16.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.984 -1.117 . . . . 0.98999999999999999 107.984 168.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.3 m -140.22 111.27 7.01 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.005 -0.434 . . . . 1.8500000000000001 110.276 159.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.19 133.38 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.749 1.219 . . . . 2.0099999999999998 110.657 -178.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.92 104.92 5.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.594 1.158 . . . . 1.4399999999999999 110.803 -171.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 pp -70.53 -21.6 62.71 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 124.204 1.002 . . . . 2.75 112.649 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.41 91.39 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.398 -0.593 . . . . 1.9399999999999999 109.398 -179.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.07 -34.48 16.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.941 0.897 . . . . 2.3399999999999999 110.049 170.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.96 45.51 0.15 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.312 -0.996 . . . . 2.3599999999999999 108.312 -168.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.06 167.72 20.43 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.852 -0.613 . . . . 4.0700000000000003 111.592 165.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.5 141.83 46.85 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.624 1.169 . . . . 1.1299999999999999 108.695 171.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.53 137.92 36.49 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.127 -1.805 . . . . 2.02 106.127 168.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.16 129.89 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.484 -0.932 . . . . 2.9500000000000002 108.484 -179.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.83 105.57 13.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.079 -1.082 . . . . 3.4300000000000002 108.079 -176.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -137.04 168.75 18.99 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.172 0.92 . . . . 2.48 111.714 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -97.29 115.79 65.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.681 -0.488 . . . . 3.79 109.681 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.36 55.06 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.343 2.696 . . . . 2.4900000000000002 112.552 -166.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -143.76 -51.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.489 1.516 . . . . 3.1600000000000001 108.012 172.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pt -77.38 -31.75 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 122.438 -0.163 . . . . 2.5099999999999998 110.987 -176.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.88 163.54 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.985 -0.746 . . . . 2.1000000000000001 108.985 -178.03 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.75 164.73 31.82 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.256 -1.137 . . . . 2.0499999999999998 110.256 -176.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -61.55 -38.5 62.07 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.575 2.85 . . . . 2.04 111.817 -168.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -31.83 62.95 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 113.086 0.772 . . . . 7.1399999999999997 113.086 -176.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.87 -40.63 65.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 118.498 -1.281 . . . . 3.3100000000000001 110.231 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.3 -48.14 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.543 -0.91 . . . . 1.46 108.543 171.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.18 -60.99 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 108.799 -0.815 . . . . 2.2599999999999998 108.799 174.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.98 -50.23 19.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.14 0.882 . . . . 4.3600000000000003 113.147 178.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.8 -53.57 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 121.933 -0.479 . . . . 2.1299999999999999 109.858 177.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.268 2.5 pp -68.16 -29.24 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.287 -0.883 . . . . 1.54 113.278 -177.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.71 -41.98 78.35 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.158 0.89 . . . . 4.0 109.54 169.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -61.45 -40.26 93.85 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.41 0.684 . . . . 3.7599999999999998 109.295 -179.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.9 mt -68.91 -38.95 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 122.865 0.466 . . . . 1.0800000000000001 110.153 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.16 33.49 6.55 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.975 1.274 . . . . 1.0700000000000001 110.771 -171.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -99.48 175.03 5.98 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 107.914 -1.143 . . . . 3.3700000000000001 107.914 167.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -135.25 121.7 20.53 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.01 -1.478 . . . . 3.8900000000000001 107.01 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.03 100.89 10.18 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.613 1.165 . . . . 1.5 109.56 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.6 m -99.13 104.12 16.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.394 -0.965 . . . . 1.96 108.394 174.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 mt -48.03 107.74 0.14 Allowed 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 125.323 1.449 . . . . 6.1799999999999997 108.346 171.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -84.4 -31.23 24.79 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.606 -0.887 . . . . 4.4699999999999998 108.606 175.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 127.563 2.345 . . . . 8.8399999999999999 112.678 165.462 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 119.885 -0.102 . . . . 3.54 110.734 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -123.84 147.09 47.91 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 124.604 1.161 . . . . 4.8200000000000003 110.292 -179.037 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.17 137.15 51.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.693 -1.225 . . . . 2.4399999999999999 107.693 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -121.64 96.08 4.93 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.786 -1.19 . . . . 4.2800000000000002 107.786 -172.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.2 177.4 4.74 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.711 0.767 . . . . 3.0600000000000001 111.095 -176.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.18 149.42 49.98 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.693 1.597 . . . . 1.5700000000000001 107.19 166.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mm -103.11 126.35 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 106.859 -1.534 . . . . 1.1000000000000001 106.859 175.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -107.24 138.11 44.04 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.158 -1.053 . . . . 3.0499999999999998 108.158 160.328 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 144.84 -88.32 0.17 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.342 1.449 . . . . 1.0700000000000001 109.685 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt 55.86 73.89 0.41 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.263 1.425 . . . . 1.6799999999999999 113.554 171.125 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m -50.12 -59.95 3.42 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.072 0.768 . . . . 2.3100000000000001 113.072 -178.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 t -170.01 63.08 0.05 OUTLIER 'General case' 0 C--N 1.343 0.323 0 CA-C-N 118.522 0.601 . . . . 3.5299999999999998 110.119 -175.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 41.89 47.97 3.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.887 1.275 . . . . 4.9199999999999999 112.898 176.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.01 -40.1 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.451 0.7 . . . . 2.3100000000000001 110.905 -174.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -67.63 -42.59 82.05 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.029 -1.044 . . . . 1.78 109.733 -177.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.38 -32.59 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 O-C-N 121.219 -0.925 . . . . 1.7 109.955 170.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -62.69 -25.8 68.34 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.597 -1.314 . . . . 1.73 112.133 173.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.95 -36.85 70.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.2 -0.937 . . . . 2.7799999999999998 110.42 173.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.407 HG12 HD13 ' A' ' 65' ' ' LEU . 19.9 mt -49.51 -42.76 17.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-O 118.91 -0.567 . . . . 2.4199999999999999 110.496 174.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -46.2 -58.41 3.68 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.377 0.535 . . . . 5.8799999999999999 111.519 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -66.83 -39.93 87.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.981 0.512 . . . . 4.4699999999999998 110.053 -173.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -58.42 -58.24 9.41 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.777 -0.647 . . . . 1.1899999999999999 109.289 178.215 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.77 -39.67 92.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 119.176 -0.44 . . . . 2.5699999999999998 111.058 -177.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.67 -34.71 3.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.67 0.788 . . . . 2.1299999999999999 111.604 172.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -121.7 29.58 7.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.296 0.639 . . . . 3.2200000000000002 111.914 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -72.87 -69.1 0.43 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.888 -0.782 . . . . 3.7999999999999998 108.888 170.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.78 -143.37 0.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.014 0.926 . . . . 1.02 108.805 -167.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.9 -15.07 40.7 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 119.144 0.884 . . . . 1.55 114.039 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.3 79.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.567 1.147 . . . . 1.52 112.351 -177.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.86 52.52 1.68 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.225 1.012 . . . . 2.5800000000000001 109.34 -178.344 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 m -160.48 145.05 14.3 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.305 -0.872 . . . . 2.7799999999999998 109.099 172.422 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.9 t -140.87 112.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.046 -2.205 . . . . 2.79 105.046 171.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -131.57 79.83 1.9 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.496 0.665 . . . . 3.1899999999999999 110.065 175.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 p -98.98 150.75 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 115.81 -0.632 . . . . 2.29 109.624 173.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.17 113.34 15.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.784 -1.191 . . . . 1.48 107.784 163.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 tp -62.67 -32.78 73.91 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.554 1.542 . . . . 3.2799999999999998 109.869 176.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 28.7 mtt -57.62 -55.63 32.37 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.383 0.611 . . . . 3.1000000000000001 110.192 -177.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.28 -21.6 25.67 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.268 -0.878 . . . . 1.9399999999999999 110.928 -177.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.39 53.28 6.84 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 110.27 -1.132 . . . . 1.3700000000000001 110.27 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -128.17 130.65 48.37 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.126 -1.435 . . . . 3.9900000000000002 107.126 178.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.55 107.6 18.52 Favored 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 125.259 1.424 . . . . 1.1699999999999999 109.194 167.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -99.29 131.87 45.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.751 -1.574 . . . . 4.5999999999999996 106.751 166.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.73 163.91 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 119.104 0.865 . . . . 2.27 111.338 161.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.38 106.83 15.43 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.274 2.23 . . . . 8.2100000000000009 107.562 175.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.404 ' HB2' HD12 ' A' ' 53' ' ' ILE . 19.3 p90 -106.76 -179.48 3.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.338 1.055 . . . . 3.0099999999999998 113.14 171.558 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.66 118.88 14.75 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.238 1.415 . . . . 3.25 108.033 175.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.65 -16.43 38.03 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.9 3.067 . . . . 2.8799999999999999 113.069 -165.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -72.44 -11.82 60.84 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.981 0.363 . . . . 3.5600000000000001 111.981 -177.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.08 -46.93 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 123.438 0.695 . . . . 2.8799999999999999 111.227 -170.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.55 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -114.12 152.47 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.141 0.576 . . . . 1.6599999999999999 109.99 174.38 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -127.08 156.96 73.6 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 125.316 1.446 . . . . 2.5899999999999999 109.696 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.19 -9.7 27.01 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.368 2.045 . . . . 1.54 112.276 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mp -73.54 -61.88 1.68 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.59 0.756 . . . . 2.5600000000000001 110.159 172.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -32.41 73.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.481 -0.327 . . . . 5.0499999999999998 111.195 -174.2 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.55 HD12 HD11 ' A' ' 53' ' ' ILE . 1.5 tt -58.79 -51.04 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.66 -1.607 . . . . 1.6200000000000001 106.66 173.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.85 98.1 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.267 -0.424 . . . . 1.21 110.225 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -55.53 -46.41 77.08 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.433 -0.581 . . . . 2.4199999999999999 109.433 174.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.24 -49.81 74.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.128 -0.693 . . . . 2.4900000000000002 109.128 -177.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 69' ' ' ALA . 5.6 mm -55.57 -47.19 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 121.926 -0.484 . . . . 2.7799999999999998 111.505 178.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.47 -47.56 81.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.989 0.516 . . . . 2.4700000000000002 111.331 176.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.67 -49.82 71.67 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.42 0.688 . . . . 2.3799999999999999 110.391 -178.117 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.407 HD13 HG12 ' A' ' 22' ' ' ILE . 4.3 mt -50.34 -43.24 53.99 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.761 1.224 . . . . 2.2599999999999998 110.528 173.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.18 40.36 0.34 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 111.123 -0.791 . . . . 1.4399999999999999 111.123 162.317 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -137.81 160.86 38.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.058 -0.719 . . . . 2.8500000000000001 109.058 -175.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -98.52 117.39 32.83 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.595 -1.261 . . . . 2.77 107.595 170.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.516 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -96.57 111.45 23.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.409 -1.7 . . . . 1.03 106.409 164.05 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.02 154.59 46.49 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 106.708 -1.59 . . . . 0.94999999999999996 106.708 169.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.02 148.59 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 115.446 -0.797 . . . . 3.8599999999999999 109.202 -172.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.4 ptm . . . . . 0 CA--C 1.536 0.412 0 C-N-CA 120.016 -0.673 . . . . 3.79 111.066 177.561 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 124' ' ' PHE . . . . . . . . 0 N--CA 1.444 -0.804 0 N-CA-C 110.688 -0.965 . . . . 2.8799999999999999 110.688 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.439 HD22 ' C ' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -108.0 76.95 1.08 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.925 -1.139 . . . . 3.2599999999999998 107.925 -140.936 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.8 pt -105.92 158.54 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.689 -0.486 . . . . 3.7000000000000002 109.689 177.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -106.76 144.09 33.92 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 124.026 0.829 . . . . 4.4900000000000002 109.989 169.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 mt -131.57 145.46 51.73 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.843 0.857 . . . . 2.4100000000000001 109.126 175.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.52 124.2 44.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.147 0.979 . . . . 2.9300000000000002 108.66 179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.34 110.97 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 O-C-N 123.57 0.544 . . . . 2.0600000000000001 110.124 -176.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.9 p -96.53 164.97 12.38 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.539 -0.912 . . . . 2.7400000000000002 108.539 177.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.5 -33.89 3.17 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 121.914 -0.491 . . . . 1.98 112.262 -178.222 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.69 142.17 50.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 117.991 0.896 . . . . 3.2599999999999998 111.414 178.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 m -155.26 46.74 0.51 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.783 0.833 . . . . 3.2999999999999998 108.782 172.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.7 t -165.36 143.69 6.19 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.263 -0.898 . . . . 3.6299999999999999 111.136 174.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.66 -46.5 81.06 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 109.546 -0.538 . . . . 2.77 109.546 175.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.1 m -50.19 -41.44 49.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.753 0.821 . . . . 2.21 112.006 174.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.59 -50.68 62.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.249 -0.649 . . . . 2.4900000000000002 109.249 -177.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -48.34 -54.77 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.122 0.569 . . . . 1.73 110.506 170.406 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.31 -39.6 83.56 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.842 0.829 . . . . 2.8999999999999999 111.088 -176.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -63.67 -44.33 94.07 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.912 0.885 . . . . 2.2400000000000002 110.499 175.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.6 mt -60.26 -46.88 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.593 -0.521 . . . . 1.02 109.593 176.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -55.8 -45.95 78.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.796 -0.446 . . . . 2.1899999999999999 109.796 174.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.9 m -57.16 -48.19 79.32 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 117.82 0.282 . . . . 1.8799999999999999 111.519 175.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -55.09 -52.36 63.48 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.825 0.739 . . . . 2.8900000000000001 110.565 177.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.4 mt -57.93 -59.41 5.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.004 -0.739 . . . . 1.97 109.004 179.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 59.2 m -51.06 -26.06 5.81 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.772 1.629 . . . . 2.04 112.244 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -64.83 -19.77 66.04 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.77 -0.581 . . . . 4.0499999999999998 112.359 177.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.5 m -68.87 139.12 55.15 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.731 1.212 . . . . 2.2400000000000002 111.116 178.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -54.4 -57.29 11.85 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.836 0.854 . . . . 4.2199999999999998 111.926 177.089 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.44 -36.02 76.77 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 121.237 0.354 . . . . 1.8500000000000001 112.59 -170.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.49 121.24 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 122.007 -0.702 . . . . 2.5099999999999998 109.337 -173.102 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.5 m -97.48 -42.95 7.47 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.857 -0.423 . . . . 2.4199999999999999 109.857 -176.019 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.471 ' CE2' ' HD3' ' A' ' 123' ' ' LYS . 36.7 p90 -144.07 97.41 3.05 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 113.664 0.987 . . . . 1.9399999999999999 113.664 -178.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -94.09 135.87 34.99 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 107.675 -1.231 . . . . 1.1899999999999999 107.675 178.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.3 t -129.1 108.42 10.36 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.91 -0.774 . . . . 2.52 108.91 172.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 120' ' ' ALA . 5.0 p -100.28 131.12 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.106 1.363 . . . . 2.5699999999999998 108.926 -179.366 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -127.25 144.63 51.0 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.799 1.181 . . . . 2.6200000000000001 109.475 179.031 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 pp -104.61 -43.72 5.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 124.415 1.086 . . . . 3.0600000000000001 109.481 -171.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -46.71 -41.85 15.69 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.485 1.114 . . . . 2.7999999999999998 111.71 173.17 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -106.87 1.96 25.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.671 1.188 . . . . 2.6400000000000001 111.819 178.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.5 p 60.55 -6.77 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 127.925 2.49 . . . . 2.27 115.498 177.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -98.43 155.42 17.25 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.814 0.846 . . . . 4.3099999999999996 111.319 -174.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.65 ' HB2' HG23 ' A' ' 113' ' ' VAL . . . -140.68 120.56 13.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.883 0.873 . . . . 1.4099999999999999 110.513 -174.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.8 119.81 34.95 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.287 2.235 . . . . 2.1400000000000001 107.865 -173.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 22.6 t -128.88 122.77 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 116.27 -1.824 . . . . 2.3399999999999999 108.602 -168.332 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.471 ' HD3' ' CE2' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -112.91 97.49 6.57 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.965 1.257 . . . . 5.4000000000000004 110.446 -179.344 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.414 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 50.2 p90 -114.2 -179.46 3.64 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.378 1.049 . . . . 2.6499999999999999 112.374 -178.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -98.37 109.36 52.14 Favored Pre-proline 0 C--O 1.237 0.444 0 N-CA-C 107.454 -1.313 . . . . 3.1899999999999999 107.454 176.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -78.12 69.93 7.32 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.885 2.39 . . . . 3.02 110.747 -171.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -163.31 -46.13 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.935 1.694 . . . . 4.2800000000000002 109.063 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 pt -85.62 -33.1 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 117.693 0.224 . . . . 2.6899999999999999 111.021 -177.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.17 160.06 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.119 -1.067 . . . . 2.3799999999999999 108.119 177.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.82 156.13 24.68 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.228 -1.149 . . . . 2.3500000000000001 110.228 -177.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -59.77 -33.93 96.08 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.74 2.96 . . . . 2.5 111.887 -174.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -54.87 -35.32 63.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.235 -0.29 . . . . 5.2300000000000004 110.934 177.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -70.54 -40.79 73.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.272 -1.01 . . . . 3.3199999999999998 108.272 -174.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 62.1 mt -53.51 -57.86 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.83 -0.804 . . . . 2.2200000000000002 108.83 174.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.8 pt -56.16 -51.09 66.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 118.291 -0.861 . . . . 3.2999999999999998 111.056 178.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -53.94 -47.81 70.89 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.952 1.251 . . . . 3.8900000000000001 111.352 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.6 mm -57.4 -50.57 76.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 121.545 -0.722 . . . . 2.5600000000000001 109.712 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.282 2.7 pp -70.85 -26.17 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 119.113 -1.035 . . . . 1.3899999999999999 113.245 -177.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.09 -37.29 79.5 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.093 0.957 . . . . 4.0199999999999996 110.42 169.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.88 -31.14 72.22 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.794 -0.566 . . . . 4.7000000000000002 110.071 176.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.5 mt -73.36 -39.55 55.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.578 -0.527 . . . . 1.6499999999999999 109.578 170.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.81 26.06 5.44 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.917 1.723 . . . . 1.29 111.454 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -104.28 179.96 4.12 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.14 -1.43 . . . . 2.8599999999999999 107.14 175.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -142.28 130.58 22.24 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.63 -1.248 . . . . 4.0199999999999996 107.63 173.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.91 81.88 1.84 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.133 0.973 . . . . 1.79 109.492 -168.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.8 m -97.75 120.2 37.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.162 -0.681 . . . . 2.1699999999999999 109.162 -170.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -40.06 107.8 0.08 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.381 1.473 . . . . 3.5600000000000001 110.631 164.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.36 43.88 2.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.24 0.83 . . . . 4.9500000000000002 113.24 -175.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 . . . . . 0 C--O 1.252 1.235 0 CA-C-O 117.305 -1.331 . . . . 6.0700000000000003 111.159 167.528 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.12 -0.696 . . . . 3.8399999999999999 109.12 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -96.38 134.33 39.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.764 -1.569 . . . . 5.9699999999999998 106.764 176.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.9 t -116.82 133.45 56.0 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 124.036 0.835 . . . . 2.0099999999999998 109.204 -179.275 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -103.61 103.57 13.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.59 1.156 . . . . 2.9500000000000002 109.756 -170.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.65 172.02 10.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.116 0.96 . . . . 2.7000000000000002 112.516 176.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.14 153.86 43.98 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.251 -1.388 . . . . 1.6399999999999999 107.251 168.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.4 mm -98.94 139.9 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 106.815 -1.55 . . . . 1.1200000000000001 106.815 170.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 mtmm -111.71 112.33 23.95 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.239 -1.763 . . . . 2.98 106.239 159.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.16 -81.95 0.17 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.211 1.386 . . . . 1.29 110.132 -177.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.5 mtm 29.28 77.13 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.958 2.103 . . . . 1.98 114.707 -175.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.4 p -57.19 -43.02 82.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.605 0.762 . . . . 3.2599999999999998 112.153 176.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.7 t 111.13 -42.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.965 2.506 . . . . 3.0099999999999998 110.715 175.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.28 -67.42 0.19 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.41 1.484 . . . . 5.9299999999999997 112.146 -174.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.99 24.24 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.922 0.489 . . . . 3.0 111.384 167.052 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.5 m -70.86 -45.82 63.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 120.974 -1.079 . . . . 1.8300000000000001 109.939 -172.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.5 t -57.04 -49.78 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.08 -1.081 . . . . 1.53 108.08 175.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -54.19 -45.44 72.17 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.895 1.278 . . . . 2.3199999999999998 111.868 -178.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.01 -50.39 68.68 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 121.654 -0.654 . . . . 2.4900000000000002 109.837 174.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mt -49.39 -41.24 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 124.238 1.015 . . . . 1.6000000000000001 110.792 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -47.49 -56.24 7.44 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.514 0.597 . . . . 3.9900000000000002 111.542 176.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -64.45 -46.64 82.29 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.463 -0.569 . . . . 5.0199999999999996 109.463 -177.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -55.07 -55.46 30.74 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 109.207 -0.664 . . . . 1.3999999999999999 109.207 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.48 -43.98 88.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.633 -0.699 . . . . 2.8999999999999999 110.371 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -50.78 -33.85 25.05 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.283 1.401 . . . . 1.8700000000000001 112.474 170.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -95.97 19.02 12.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.927 0.891 . . . . 2.8100000000000001 112.165 -177.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.4 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 5.4 tp10 -72.34 -74.78 0.15 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.911 0.884 . . . . 2.9700000000000002 109.535 174.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -163.26 -117.61 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.861 -0.524 . . . . 1.3500000000000001 111.193 -170.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.18 -31.13 72.29 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.456 -0.658 . . . . 1.75 111.456 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 29' ' ' GLU . 3.5 p -59.01 125.17 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 122.916 0.486 . . . . 1.5900000000000001 111.274 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.08 52.17 1.38 Allowed 'General case' 0 CA--C 1.522 -0.103 0 CA-C-O 122.325 1.059 . . . . 2.7999999999999998 109.705 170.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -156.46 154.73 30.87 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.403 -1.332 . . . . 2.0299999999999998 107.403 169.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -141.02 119.57 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.904 -1.887 . . . . 2.6299999999999999 105.904 176.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tt -131.06 70.34 1.47 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.415 -1.328 . . . . 2.5499999999999998 107.415 176.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.9 t -98.53 130.21 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.294 -1.002 . . . . 1.8700000000000001 108.294 175.181 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.93 97.08 8.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.298 -1.371 . . . . 1.21 107.298 168.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.1 -23.33 54.4 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.059 0.544 . . . . 2.6600000000000001 111.082 175.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 52.0 mtt -75.44 -55.16 5.96 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.672 -0.642 . . . . 3.8700000000000001 110.12 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.58 -22.84 37.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.968 0.507 . . . . 1.29 111.823 -175.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.48 61.78 2.88 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 124.209 0.909 . . . . 1.0700000000000001 111.047 -178.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -140.91 140.17 34.46 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.834 -1.543 . . . . 3.1000000000000001 106.834 172.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.0 99.11 7.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.113 1.365 . . . . 0.85999999999999999 109.855 174.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.22 135.94 37.37 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 104.61 -2.367 . . . . 3.7200000000000002 104.61 166.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 pt -131.12 -179.17 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.324 -1.361 . . . . 1.78 107.324 169.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -132.87 104.85 6.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.215 -0.661 . . . . 4.1900000000000004 109.215 173.358 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.428 ' HB2' HD12 ' A' ' 53' ' ' ILE . 6.6 p90 -119.7 167.18 12.3 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.825 1.65 . . . . 3.0699999999999998 112.553 178.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.48 100.72 19.7 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.745 1.618 . . . . 4.04 109.803 -174.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.55 -11.08 18.51 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.094 2.53 . . . . 2.4100000000000001 114.074 -173.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -85.75 -20.45 29.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.718 0.807 . . . . 5.0800000000000001 112.505 179.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 m -120.34 -39.91 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-O 118.635 -0.698 . . . . 3.4199999999999999 111.554 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -110.18 139.01 35.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 123.282 0.633 . . . . 1.78 109.505 176.985 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.517 ' HB3' HD23 ' A' ' 56' ' ' LEU . 1.1 mp0 -114.92 154.05 47.02 Favored Pre-proline 0 N--CA 1.451 -0.385 0 C-N-CA 125.779 1.632 . . . . 2.6899999999999999 111.026 -178.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.97 -39.01 43.07 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.061 2.507 . . . . 1.3 112.659 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 54' ' ' GLN . 2.3 pt? -64.79 -46.73 80.83 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.148 -0.97 . . . . 2.8100000000000001 111.635 -174.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.11 -33.61 75.83 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.207 0.603 . . . . 4.8099999999999996 112.216 175.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.12 -47.61 43.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 107.756 -1.201 . . . . 1.05 107.756 163.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 56' ' ' LEU . . . -58.47 -48.8 79.57 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.456 -0.793 . . . . 1.1499999999999999 109.597 -173.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -47.5 -49.85 24.84 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.903 0.32 . . . . 3.4100000000000001 110.806 176.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.75 -53.49 54.34 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.376 0.608 . . . . 2.6800000000000002 110.969 -176.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.689 HD13 ' H ' ' A' ' 69' ' ' ALA . 2.2 pp -63.71 -39.81 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 118.774 -0.631 . . . . 4.1699999999999999 111.847 178.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -63.21 -42.36 99.28 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.612 1.097 . . . . 1.9299999999999999 109.201 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.08 -49.44 75.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.498 0.719 . . . . 2.73 109.355 -179.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.1 mt -54.9 -38.66 67.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.397 -0.365 . . . . 1.8100000000000001 111.77 172.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.65 29.71 2.38 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 123.891 0.758 . . . . 1.28 111.601 168.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -116.72 154.16 31.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.34 1.456 . . . . 2.3999999999999999 107.681 173.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -95.72 128.07 42.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.648 -1.612 . . . . 3.0099999999999998 106.648 164.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.689 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -107.33 133.57 51.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.455 -2.054 . . . . 0.93000000000000005 105.455 163.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.05 140.29 41.93 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.498 1.124 . . . . 0.98999999999999999 108.638 171.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.27 147.37 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.221 -1.029 . . . . 2.8799999999999999 108.221 -179.14 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.6 mtp . . . . . 0 N--CA 1.451 -0.375 0 C-N-CA 123.765 0.826 . . . . 3.52 111.033 179.061 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 N-CA-C 107.557 -2.217 . . . . 2.0699999999999998 107.557 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.532 ' C ' HD13 ' A' ' 82' ' ' ILE . 6.2 p-10 -104.0 133.4 49.02 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.691 0.796 . . . . 3.96 109.642 175.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.532 HD13 ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -127.7 158.1 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.963 -1.125 . . . . 3.1200000000000001 107.963 171.647 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.88 144.38 46.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.092 -1.818 . . . . 3.48 106.092 166.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mt -140.85 150.65 43.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.072 -1.825 . . . . 2.54 106.072 168.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -98.25 126.18 43.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.698 -1.223 . . . . 1.8200000000000001 107.698 177.113 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.7 pt -98.47 127.29 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.682 -0.859 . . . . 1.95 108.682 -175.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.7 m -119.42 137.37 53.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.46 -0.941 . . . . 1.6399999999999999 108.46 177.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.22 -45.75 1.16 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.336 1.446 . . . . 1.1200000000000001 111.295 175.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 157.31 27.81 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.1 -0.647 . . . . 3.3300000000000001 111.423 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -168.54 52.07 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.007 0.923 . . . . 3.3500000000000001 109.341 171.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -165.63 137.33 3.98 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 120.882 -1.137 . . . . 2.6200000000000001 109.751 178.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.47 -42.04 31.43 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.868 0.867 . . . . 3.0600000000000001 111.01 175.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -55.3 -49.06 73.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.204 0.602 . . . . 1.8899999999999999 110.792 175.45 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 79.0 m -63.65 -46.75 84.21 Favored 'General case' 0 N--CA 1.458 -0.053 0 O-C-N 121.707 -0.62 . . . . 1.8 109.729 -178.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.81 -49.29 70.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 122.777 0.431 . . . . 1.71 110.708 175.444 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -57.74 -41.76 82.54 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.119 0.568 . . . . 4.6200000000000001 110.707 175.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -63.09 -41.47 99.4 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.672 -0.643 . . . . 1.5900000000000001 110.686 177.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.9 mt -61.35 -52.27 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.576 0.75 . . . . 1.0 109.698 175.069 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.87 -39.09 76.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.501 -0.749 . . . . 2.3399999999999999 109.473 177.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.8 t -60.66 -56.8 16.94 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.626 0.771 . . . . 1.3600000000000001 110.671 176.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -30.72 70.89 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 120.303 1.41 . . . . 4.54 111.343 -175.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 mt -67.5 -59.61 3.23 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 109.233 -0.655 . . . . 1.72 109.233 171.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.7 m -54.96 -19.92 7.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.912 0.885 . . . . 1.8100000000000001 111.777 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.04 -33.04 66.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.831 0.852 . . . . 5.1900000000000004 111.992 173.498 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.3 p -75.45 166.09 24.13 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.927 0.891 . . . . 2.7799999999999998 111.604 -173.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.68 -40.38 34.08 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.243 -0.286 . . . . 3.5 111.572 178.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.55 -35.06 37.78 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 122.833 0.254 . . . . 1.5900000000000001 113.582 -169.002 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.36 133.09 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 O-C-N 121.658 -0.907 . . . . 2.1899999999999999 109.128 -174.075 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.8 p -107.63 -53.44 2.62 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 122.905 0.482 . . . . 2.48 111.816 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.51 126.09 32.11 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.55 -0.907 . . . . 2.0499999999999998 108.55 169.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.57 153.61 18.91 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.025 -1.102 . . . . 1.0700000000000001 108.025 161.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.8 m -144.7 116.92 8.42 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.139 -1.06 . . . . 2.0099999999999998 108.139 166.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 p -118.12 132.33 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.745 0.818 . . . . 1.9199999999999999 110.446 -174.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -129.57 98.66 4.91 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.142 0.977 . . . . 1.48 110.878 -172.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -25.4 66.23 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.686 1.194 . . . . 2.1800000000000002 112.445 -176.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.83 -32.56 53.27 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.114 0.566 . . . . 1.8999999999999999 111.033 173.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.07 -9.14 12.39 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.369 1.468 . . . . 2.2400000000000002 111.166 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.0 m 63.03 31.78 15.82 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.831 1.652 . . . . 1.4199999999999999 112.407 -178.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.3 mmtm -105.35 153.54 21.51 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.613 0.765 . . . . 3.6299999999999999 110.929 176.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.84 113.82 15.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.985 2.114 . . . . 1.0600000000000001 107.19 173.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.06 134.18 38.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.143 -1.429 . . . . 1.8200000000000001 107.143 173.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.4 t -135.33 129.62 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 124.027 0.931 . . . . 2.0 108.578 -174.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -111.96 93.61 4.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.43 1.092 . . . . 3.1299999999999999 109.148 178.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -119.9 175.01 6.1 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.709 0.804 . . . . 2.1699999999999999 111.627 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -97.86 115.75 65.74 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.672 -0.862 . . . . 3.7000000000000002 108.672 174.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -76.45 71.19 6.0 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.444 2.763 . . . . 2.0899999999999999 111.275 -171.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -161.62 -46.01 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.169 1.387 . . . . 4.1299999999999999 109.305 177.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -87.48 -32.33 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 123.256 0.623 . . . . 2.04 111.469 -174.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.92 165.15 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 124.258 1.023 . . . . 1.6000000000000001 108.406 176.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.91 168.37 32.34 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.403 -0.679 . . . . 1.3600000000000001 111.403 -178.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.68 -34.87 49.41 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.839 3.026 . . . . 1.49 112.583 -172.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -44.94 87.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.594 -0.891 . . . . 5.2000000000000002 108.594 177.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.08 -41.68 94.83 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.47 -0.937 . . . . 3.2599999999999998 108.47 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 83.2 mt -55.08 -57.39 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 117.749 -1.12 . . . . 1.21 109.99 176.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . 0.264 18.0 pt -52.45 -56.03 8.51 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 CA-C-N 119.109 0.868 . . . . 2.4700000000000002 109.998 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -48.86 -52.2 25.56 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.135 0.969 . . . . 3.71 111.926 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.69 -33.65 61.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 118.785 -0.626 . . . . 2.5 110.507 -175.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.35 2.6 pp -75.26 -32.33 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 114.891 1.441 . . . . 1.24 114.891 168.331 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.97 -34.21 69.7 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.307 0.958 . . . . 2.2000000000000002 109.634 174.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.86 -35.88 82.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.085 0.469 . . . . 3.7799999999999998 109.929 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 32.7 mm -76.18 -42.66 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.277 -0.638 . . . . 2.3999999999999999 109.277 173.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.5 41.13 1.06 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.1 1.333 . . . . 0.95999999999999996 111.59 178.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -112.54 -180.0 3.82 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.365 -0.976 . . . . 2.3399999999999999 108.365 166.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -133.63 132.96 41.39 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.89 -1.152 . . . . 3.6699999999999999 107.89 171.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.67 95.03 4.68 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 123.981 0.912 . . . . 1.45 109.778 -175.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.7 t -110.01 121.41 45.18 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.255 0.622 . . . . 2.75 109.852 -172.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -38.64 115.97 0.51 Allowed 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 126.37 1.868 . . . . 4.0599999999999996 110.89 171.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.584 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -103.26 30.77 4.68 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.151 1.167 . . . . 3.23 114.151 -178.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.301 0 CA-C-O 116.999 -1.477 . . . . 7.7599999999999998 111.571 177.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.226 -0.136 0 CA-C-O 120.894 0.378 . . . . 3.7999999999999998 110.821 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.1 143.13 29.71 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.991 -0.443 . . . . 3.98 110.912 179.02 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -125.94 131.63 52.25 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.413 1.085 . . . . 2.79 108.109 177.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -113.71 97.25 6.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.69 -1.226 . . . . 4.8899999999999997 107.69 -171.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 44' ' ' ALA 0.252 0.0 OUTLIER -122.36 177.09 5.53 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.829 0.824 . . . . 2.3799999999999999 110.508 -178.13 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.627 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -132.12 147.49 52.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.317 -1.734 . . . . 1.6299999999999999 106.317 174.51 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.4 mm -98.38 132.36 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 106.814 -1.55 . . . . 0.77000000000000002 106.814 177.259 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -111.46 109.14 18.95 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.171 -1.418 . . . . 5.0099999999999998 107.171 170.004 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.94 -83.91 0.09 OUTLIER Glycine 0 CA--C 1.532 1.106 0 N-CA-C 110.159 -1.176 . . . . 1.1499999999999999 110.159 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 47.52 70.46 0.42 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.746 1.618 . . . . 1.95 114.203 179.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.9 m -49.09 -59.33 3.73 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.451 -0.781 . . . . 2.3599999999999999 112.521 170.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 t -168.59 63.66 0.06 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.541 1.064 . . . . 3.1099999999999999 111.212 -175.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.408 ' HA ' HD22 ' A' ' 39' ' ' LEU . . . 31.86 56.82 0.33 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.076 1.75 . . . . 5.8200000000000003 113.411 177.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.1 t -169.17 -49.52 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 122.762 1.268 . . . . 2.8700000000000001 108.39 -167.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 19.7 p -61.87 -40.57 95.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.511 -0.743 . . . . 3.5 110.529 178.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.711 ' HB ' HD21 ' A' ' 39' ' ' LEU . 50.9 t -70.87 -31.25 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.924 -0.769 . . . . 1.95 108.924 173.008 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -58.57 -31.76 68.3 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.487 -0.758 . . . . 1.8899999999999999 111.464 175.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -55.38 -50.05 70.71 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.231 -0.918 . . . . 3.21 109.642 170.092 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.42 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -46.93 -47.24 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 125.546 1.539 . . . . 2.48 110.023 -176.509 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -50.47 -59.02 4.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.449 1.119 . . . . 3.7599999999999998 109.626 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -70.0 -19.31 63.33 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.997 -1.065 . . . . 4.6799999999999997 112.422 -177.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -70.24 -56.0 7.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.939 -0.763 . . . . 1.1499999999999999 108.939 168.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.42 HD12 ' O ' ' A' ' 22' ' ' ILE . 1.2 mp -59.41 -34.87 72.99 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.59 -0.694 . . . . 2.1499999999999999 112.412 179.029 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.71 -20.87 15.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.891 1.223 . . . . 3.2400000000000002 112.022 178.066 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -128.68 36.07 4.28 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.283 0.633 . . . . 4.7999999999999998 110.9 174.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -67.78 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.804 -0.813 . . . . 3.2599999999999998 108.804 167.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.27 -128.73 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.715 0.806 . . . . 1.6599999999999999 108.926 -163.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.12 -20.26 68.88 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.679 0.656 . . . . 2.0899999999999999 112.984 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.44 124.06 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 117.557 0.679 . . . . 2.0499999999999998 110.561 176.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.85 57.53 1.56 Allowed 'General case' 0 C--N 1.339 0.129 0 CA-C-O 121.573 0.701 . . . . 3.1400000000000001 110.343 172.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -155.97 159.63 39.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.863 -1.162 . . . . 1.9299999999999999 107.863 160.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.85 114.8 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.672 0.789 . . . . 2.5699999999999998 109.252 170.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -127.23 74.61 1.52 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.534 -0.913 . . . . 2.71 108.534 176.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.93 142.26 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 N-CA-C 109.378 -0.601 . . . . 2.4900000000000002 109.378 171.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.44 94.46 4.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.772 -1.196 . . . . 1.6899999999999999 107.772 165.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.711 HD21 ' HB ' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -56.08 -18.83 10.79 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.937 0.895 . . . . 3.8500000000000001 112.198 172.69 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.9 ttm -66.07 -44.22 85.09 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.361 1.064 . . . . 4.1200000000000001 110.62 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.77 -29.24 12.74 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.077 0.951 . . . . 1.6499999999999999 111.126 -178.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.39 63.19 1.51 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.111 -1.196 . . . . 1.3100000000000001 110.111 -177.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -140.4 132.11 27.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.008 -2.219 . . . . 3.5 105.008 174.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 8' ' ' LEU . . . -115.69 105.27 12.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.555 1.159 . . . . 1.26 110.011 170.155 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.9 137.51 41.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.712 -1.218 . . . . 5.3300000000000001 107.712 169.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.43 ' CD1' HD11 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -138.46 173.27 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.525 0.602 . . . . 2.1499999999999999 110.227 171.027 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -116.39 102.2 9.32 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.081 1.352 . . . . 5.9500000000000002 110.239 174.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.544 ' HB2' HD12 ' A' ' 53' ' ' ILE . 8.0 p90 -98.6 173.74 6.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.092 1.357 . . . . 3.4300000000000002 113.055 171.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -124.07 100.01 36.97 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.553 1.541 . . . . 3.0800000000000001 108.192 -179.132 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.8 5.36 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.72 1 C-N-CA 125.387 4.058 . . . . 3.1099999999999999 115.35 -166.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.05 -17.23 16.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.533 1.533 . . . . 4.7199999999999998 110.359 -177.073 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.0 p -124.86 -41.23 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.498 1.119 . . . . 4.1600000000000001 110.933 178.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -116.36 143.6 26.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 N-CA-C 108.794 -0.817 . . . . 2.3500000000000001 108.794 179.286 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.37 149.89 50.66 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 124.842 1.257 . . . . 3.4300000000000002 109.402 -176.15 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -57.34 -39.34 90.38 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.951 2.434 . . . . 2.0800000000000001 111.228 -177.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -60.02 -39.94 87.58 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.222 0.609 . . . . 3.5099999999999998 110.995 175.021 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -65.46 -43.33 90.69 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.118 -0.697 . . . . 3.8300000000000001 109.118 178.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.77 -50.52 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.625 -1.25 . . . . 1.3799999999999999 107.625 174.51 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.48 66.72 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.585 -0.734 . . . . 1.47 110.807 -174.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -52.54 -49.75 64.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.728 0.811 . . . . 4.8600000000000003 110.526 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -47.84 80.76 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 122.009 0.909 . . . . 3.2599999999999998 109.298 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mm -59.37 -42.91 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.581 -0.736 . . . . 2.5 111.001 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -67.3 -39.05 85.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.392 0.277 . . . . 2.46 110.43 179.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.01 -54.6 44.1 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.219 1.008 . . . . 3.79 109.847 176.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.63 -46.45 73.91 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.776 -0.193 . . . . 3.9100000000000001 110.829 175.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.72 39.87 0.41 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.429 -1.068 . . . . 1.74 110.429 162.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -129.65 164.96 22.77 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.222 -1.399 . . . . 2.3199999999999998 107.222 178.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -98.51 132.37 44.0 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.872 -1.159 . . . . 2.5 107.872 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.54 116.51 31.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.578 -1.267 . . . . 1.3 107.578 173.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.627 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -130.57 138.8 50.34 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.203 -1.036 . . . . 0.90000000000000002 108.203 173.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -67.01 146.3 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.3 -1.0 . . . . 2.9300000000000002 108.3 178.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.1 mtp . . . . . 0 CA--C 1.535 0.368 0 C-N-CA 119.967 -0.693 . . . . 3.7999999999999998 110.508 -179.754 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.429 0 N-CA-C 109.298 -1.521 . . . . 2.6800000000000002 109.298 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -111.69 145.94 38.39 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 126.011 1.724 . . . . 4.1699999999999999 107.548 166.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.449 ' O ' HD12 ' A' ' 82' ' ' ILE 0.281 1.1 pp -114.95 140.15 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.363 0.528 . . . . 4.4199999999999999 109.762 150.643 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.541 ' OE1' ' HB3' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -107.64 123.34 48.34 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.603 2.361 . . . . 3.5099999999999998 107.205 175.796 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.436 HD13 ' CB ' ' A' ' 145' ' ' ALA . 4.6 pp -120.95 151.72 39.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 123.452 0.47 . . . . 3.6899999999999999 110.188 173.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -94.66 126.76 40.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.582 -2.377 . . . . 2.3199999999999998 104.582 175.516 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 pt -99.03 130.06 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.376 -0.972 . . . . 1.8200000000000001 108.376 176.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.4 m -123.97 141.95 51.59 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.416 -0.957 . . . . 2.1200000000000001 108.416 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.08 -37.36 3.76 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.621 1.105 . . . . 1.4299999999999999 111.361 -178.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.417 ' HB2' ' SG ' ' A' ' 94' ' ' CYS . 0.0 OUTLIER -61.27 159.06 12.93 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.053 0.541 . . . . 2.7799999999999998 111.998 177.861 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.9 t -175.0 48.95 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.019 0.927 . . . . 3.2999999999999998 110.229 170.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 8.5 t -160.39 144.26 13.96 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.958 -1.088 . . . . 2.8799999999999999 111.715 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.22 -10.48 23.65 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.02 0.928 . . . . 3.1299999999999999 113.305 178.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.7 t -79.2 -46.28 18.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.563 0.745 . . . . 2.8399999999999999 109.091 170.009 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 89' ' ' MET . 5.1 t -56.95 -53.64 55.77 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 121.762 -0.586 . . . . 3.4500000000000002 110.264 -177.215 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 p -51.22 -43.32 27.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.553 0.205 . . . . 2.8300000000000001 111.553 175.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -32.51 74.18 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.363 0.665 . . . . 3.1000000000000001 109.985 179.053 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -66.96 -56.9 8.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.804 1.242 . . . . 2.1899999999999999 108.507 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 mp -45.59 -60.38 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 C-N-CA 124.471 1.108 . . . . 1.6100000000000001 110.265 167.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -52.4 -44.4 65.35 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.465 0.575 . . . . 2.8999999999999999 111.772 -178.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.0 t -65.4 -60.26 3.15 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.018 -1.051 . . . . 1.8400000000000001 110.883 178.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -33.46 75.65 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.525 -0.734 . . . . 4.0599999999999996 111.147 -171.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.93 -49.78 48.48 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.249 -0.882 . . . . 3.2400000000000002 109.256 171.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.2 m -57.4 -24.43 55.38 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.164 1.347 . . . . 2.52 111.183 -177.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -57.22 -30.99 65.04 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.099 0.778 . . . . 4.3099999999999996 113.099 172.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.8 m -57.03 153.98 10.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.799 1.24 . . . . 1.8600000000000001 111.868 175.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -73.8 -56.19 5.28 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.826 1.25 . . . . 2.9700000000000002 112.533 -176.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.403 ' HA3' HD11 ' A' ' 128' ' ' ILE . . . -74.45 -34.86 53.45 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 121.88 -0.513 . . . . 1.75 112.016 -171.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.18 132.56 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.184 -0.672 . . . . 2.0 109.184 -175.395 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.5 m -121.1 -38.57 2.8 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 112.965 0.728 . . . . 2.71 112.965 -177.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -142.27 140.41 32.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.884 -1.127 . . . . 2.75 110.235 164.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.86 161.43 18.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.964 -1.016 . . . . 1.54 109.789 160.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -142.44 118.94 10.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.228 -1.767 . . . . 2.23 106.228 165.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 42.9 t -112.57 129.25 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 118.196 0.453 . . . . 2.5499999999999998 110.476 178.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -117.66 126.75 53.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.354 1.062 . . . . 1.3799999999999999 109.189 -177.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mp -90.4 -41.01 11.72 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.794 2.038 . . . . 3.8100000000000001 108.729 -170.399 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -43.77 -44.1 6.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.634 1.574 . . . . 1.4099999999999999 110.324 172.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -100.95 -15.07 17.64 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.729 0.812 . . . . 2.3500000000000001 112.464 174.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.9 m 65.86 30.58 9.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.971 1.708 . . . . 1.77 113.896 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -106.14 149.86 26.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.534 1.533 . . . . 4.5300000000000002 110.3 177.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.92 112.64 15.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.154 0.982 . . . . 1.24 108.897 176.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.61 124.52 39.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.869 -1.53 . . . . 2.5800000000000001 106.869 176.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.5 123.24 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 C-N-CA 125.364 1.466 . . . . 1.8600000000000001 108.844 -178.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -96.37 100.65 12.25 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.221 -1.029 . . . . 3.6899999999999999 108.221 -177.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -126.12 174.13 8.71 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 123.833 0.708 . . . . 2.6899999999999999 109.761 -178.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -104.48 117.56 58.83 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 118.273 -0.87 . . . . 5.2400000000000002 109.471 177.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -73.78 71.36 4.09 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.401 2.734 . . . . 2.9700000000000002 111.882 -174.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -166.52 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.864 1.666 . . . . 3.8599999999999999 110.013 174.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.534 HD12 ' HB ' ' A' ' 129' ' ' ILE . 2.2 pp -87.09 -41.22 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 118.448 0.567 . . . . 3.2200000000000002 111.297 -169.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.534 ' HB ' HD12 ' A' ' 128' ' ' ILE . 0.4 OUTLIER -128.79 170.22 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.447 1.499 . . . . 2.1200000000000001 107.557 174.384 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.36 25.5 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.1 -1.2 . . . . 1.99 110.1 176.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.69 -45.78 23.62 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.021 2.48 . . . . 1.99 110.768 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.4 ttm105 -48.37 -39.45 22.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.679 1.192 . . . . 6.9100000000000001 113.106 -178.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -53.34 58.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.333 -0.617 . . . . 3.96 109.333 173.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.97 -44.55 82.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 109.442 -0.577 . . . . 1.21 109.442 -178.035 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' A' ' 145' ' ' ALA . 86.9 mt -51.89 -56.42 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.165 0.986 . . . . 2.27 108.498 174.06 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -55.17 -43.98 74.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.015 -1.053 . . . . 4.04 112.512 178.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.2 mm -63.92 -34.25 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.704 -0.623 . . . . 2.0499999999999998 110.35 -177.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 145' ' ' ALA . 27.3 pt -74.57 -33.52 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 119.812 1.187 . . . . 1.5800000000000001 113.377 168.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -56.04 -25.98 47.1 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.475 1.034 . . . . 3.0600000000000001 111.47 176.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.74 -34.49 75.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.835 0.454 . . . . 3.8999999999999999 110.029 176.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.3 mt -79.31 -44.4 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.178 -0.675 . . . . 1.79 109.178 172.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.77 36.19 2.64 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 124.314 0.959 . . . . 1.4299999999999999 110.868 -177.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -96.89 168.18 10.64 Favored 'General case' 0 C--N 1.338 0.083 0 N-CA-C 108.23 -1.026 . . . . 2.8100000000000001 108.23 165.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -125.19 123.01 38.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.226 -1.768 . . . . 3.54 106.226 -177.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.436 ' CB ' HD13 ' A' ' 84' ' ' LEU . . . -111.0 107.91 17.47 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.838 1.255 . . . . 2.1099999999999999 108.48 174.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.5 m -108.29 114.95 29.21 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.42 -0.955 . . . . 2.6499999999999999 108.42 168.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -35.75 107.14 0.05 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 126.735 2.014 . . . . 4.2699999999999996 110.122 170.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.632 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -82.93 -36.7 25.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.378 -0.601 . . . . 3.6699999999999999 109.378 -175.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.109 0 C-N-CA 125.668 1.587 . . . . 5.9100000000000001 112.713 -165.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 . . . . . 0 C--O 1.223 -0.329 0 N-CA-C 109.967 -0.383 . . . . 3.6099999999999999 109.967 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -90.75 130.85 36.69 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.097 0.959 . . . . 5.1200000000000001 109.464 -159.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.3 t -138.02 123.33 19.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.971 0.508 . . . . 1.8500000000000001 110.227 177.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -98.64 106.76 19.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.913 1.685 . . . . 2.9100000000000001 107.788 174.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -128.6 171.82 11.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.384 -0.969 . . . . 2.6000000000000001 108.384 179.226 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.453 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -141.21 144.95 35.03 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.314 -0.866 . . . . 1.54 109.352 175.037 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.3 mm -99.16 126.14 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 106.178 -1.786 . . . . 1.55 106.178 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -95.56 99.06 10.98 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.658 -1.608 . . . . 3.6099999999999999 106.658 174.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.65 -94.18 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.623 -1.391 . . . . 1.76 109.623 178.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.0 mtt 58.66 90.66 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.485 1.514 . . . . 2.3900000000000001 113.789 179.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -14.72 33.93 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.083 -1.011 . . . . 2.1099999999999999 113.125 172.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 t 72.88 -59.97 0.55 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 126.239 1.816 . . . . 4.0599999999999996 112.395 -178.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.25 -74.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.993 2.117 . . . . 4.8099999999999996 113.103 -174.385 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.5 p -154.24 15.17 0.46 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.668 0.387 . . . . 2.6699999999999999 111.706 168.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.7 m -69.42 -53.3 20.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.286 -1.376 . . . . 1.8 107.286 -170.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.541 ' HB ' HD11 ' A' ' 39' ' ' LEU . 71.9 t -61.73 -39.83 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 119.554 -0.858 . . . . 1.74 109.759 -175.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.1 t -53.08 -46.65 68.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.893 0.477 . . . . 2.3900000000000001 111.311 173.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -63.07 -49.26 75.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.251 -0.906 . . . . 2.6699999999999999 109.351 176.509 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.541 HG13 HD13 ' A' ' 65' ' ' LEU . 1.3 mp -49.9 -53.53 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.322 0.649 . . . . 2.0499999999999998 109.546 178.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -48.62 -52.71 21.69 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.99 1.316 . . . . 4.5 111.5 175.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -70.24 -24.0 63.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.256 -0.902 . . . . 4.8499999999999996 111.006 -176.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -71.66 -44.81 63.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.305 -0.872 . . . . 1.26 109.933 170.034 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.83 -37.6 79.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.127 0.571 . . . . 1.99 110.947 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -26.97 6.58 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.481 0.549 . . . . 1.8100000000000001 112.481 172.081 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -109.7 19.38 19.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.489 1.116 . . . . 4.6699999999999999 111.381 -177.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -73.76 -67.22 0.62 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.612 -0.884 . . . . 3.23 108.612 174.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.6 -96.55 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.852 1.261 . . . . 1.23 109.443 173.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.38 -5.82 89.58 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.897 -0.502 . . . . 1.3899999999999999 112.658 -176.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.36 114.11 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 118.044 0.922 . . . . 2.5600000000000001 109.682 176.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.68 53.05 1.61 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.539 -1.282 . . . . 3.3900000000000001 107.539 179.109 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -162.73 153.24 16.72 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.804 -1.184 . . . . 1.6499999999999999 107.804 158.334 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.2 94.77 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 125.421 1.488 . . . . 2.52 106.989 172.312 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -116.34 66.31 0.71 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.275 -1.379 . . . . 2.52 107.275 176.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 t -97.47 130.92 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.585 -0.894 . . . . 1.9299999999999999 108.585 175.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.52 96.8 6.98 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.844 -1.169 . . . . 1.1699999999999999 107.844 175.069 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.541 HD11 ' HB ' ' A' ' 19' ' ' VAL . 2.8 mm? -63.58 -12.95 37.11 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.333 0.515 . . . . 3.6000000000000001 111.888 178.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -43.61 13.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.095 0.958 . . . . 5.8399999999999999 111.41 -178.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.71 -36.26 15.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.74 0.816 . . . . 1.24 111.017 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.19 62.28 1.23 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.53 1.538 . . . . 0.97999999999999998 111.101 178.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -143.41 138.8 29.6 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.588 -1.634 . . . . 3.1400000000000001 106.588 177.08 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.37 98.91 8.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 124.443 1.089 . . . . 0.82999999999999996 112.326 171.295 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -94.09 131.42 39.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 105.996 -1.853 . . . . 4.9199999999999999 105.996 169.156 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 pt -133.44 -179.16 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 O-C-N 121.816 -0.552 . . . . 1.71 109.603 170.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 34' ' ' SER . 43.5 mtmt -124.68 119.06 27.91 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.728 -0.669 . . . . 4.1100000000000003 109.768 160.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.559 ' HB2' HD12 ' A' ' 53' ' ' ILE . 11.7 p90 -114.73 154.66 28.1 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.777 1.631 . . . . 2.1600000000000001 110.525 170.222 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.26 111.35 63.47 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.2 0.6 . . . . 3.3999999999999999 109.704 176.626 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.85 -19.75 69.49 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.837 3.025 . . . . 2.0600000000000001 112.845 -171.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -62.94 -24.37 67.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.701 -0.666 . . . . 3.7400000000000002 112.752 177.283 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.87 -43.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 118.944 0.793 . . . . 2.5499999999999998 111.496 -173.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -102.19 147.95 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 108.48 -0.933 . . . . 1.3799999999999999 108.48 176.623 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -126.92 150.96 73.21 Favored Pre-proline 0 N--CA 1.451 -0.379 0 C-N-CA 125.075 1.35 . . . . 2.4700000000000002 109.179 177.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.27 -36.38 94.99 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.629 2.219 . . . . 1.25 111.69 -175.019 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -41.68 99.25 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 121.916 -0.49 . . . . 3.54 110.959 177.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -59.99 -44.45 94.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.101 0.561 . . . . 3.0600000000000001 109.973 177.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.401 HD12 HD11 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -54.03 -48.48 64.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 172.694 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.43 -44.99 95.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.016 -0.538 . . . . 1.1499999999999999 111.004 -176.334 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -53.54 -50.39 65.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.934 -1.104 . . . . 2.8199999999999998 110.169 171.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.62 -53.66 48.69 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.427 0.691 . . . . 2.3599999999999999 109.34 -176.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.7 HG12 ' HB2' ' A' ' 69' ' ' ALA . 1.8 pp -68.74 -33.88 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 119.306 -0.958 . . . . 4.0599999999999996 112.019 -178.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -57.92 -41.45 82.73 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 120.269 1.395 . . . . 2.0099999999999998 108.574 -179.001 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -60.83 -50.92 71.48 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.619 -0.511 . . . . 2.7400000000000002 109.619 177.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.541 HD13 HG13 ' A' ' 22' ' ' ILE . 11.0 mt -54.38 -41.91 69.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.058 0.543 . . . . 2.1299999999999999 111.917 177.261 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.18 43.71 0.32 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.468 0.556 . . . . 1.05 112.123 164.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -134.2 -177.01 4.39 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.081 1.352 . . . . 1.8999999999999999 110.198 179.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -114.08 129.21 56.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.093 0.957 . . . . 2.27 108.898 162.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.7 ' HB2' HG12 ' A' ' 62' ' ' ILE . . . -97.99 129.32 44.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.253 -1.388 . . . . 1.3 107.253 168.267 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.453 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -139.47 118.74 12.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.255 -1.387 . . . . 0.97999999999999998 107.255 173.351 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 23.2 t -56.34 153.58 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.683 -0.858 . . . . 2.6800000000000002 108.683 174.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 111.802 0.297 . . . . 4.1699999999999999 111.802 178.448 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 124' ' ' PHE . . . . . . . . 0 N--CA 1.43 -1.721 0 N-CA-C 109.146 -1.582 . . . . 1.8100000000000001 109.146 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.49 ' HB2' ' CD ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -91.54 116.37 28.81 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.125 -2.546 . . . . 3.5 104.125 176.722 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.03 161.91 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 O-C-N 125.412 1.695 . . . . 3.2999999999999998 110.047 170.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.91 125.2 50.71 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 127.329 2.252 . . . . 3.6400000000000001 110.003 -175.305 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.439 HD12 ' HB1' ' A' ' 145' ' ' ALA . 4.4 mm? -119.62 127.52 53.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.675 1.19 . . . . 2.7999999999999998 108.214 172.812 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.6 m -95.78 122.68 38.82 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.673 -1.603 . . . . 2.1000000000000001 106.673 176.383 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.495 ' H ' HD12 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -102.56 114.0 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.483 1.113 . . . . 1.6299999999999999 109.979 -172.022 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 84.6 m -107.23 124.0 49.11 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.262 0.625 . . . . 1.4399999999999999 110.267 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 127.16 -27.92 4.69 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.262 1.41 . . . . 0.98999999999999999 111.585 177.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 34.8 ttp -71.52 146.24 48.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.88 -0.777 . . . . 2.6600000000000001 111.661 -176.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 t -164.05 41.52 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.616 0.766 . . . . 2.7999999999999998 110.817 174.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -163.29 145.05 9.75 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.192 -0.943 . . . . 2.5899999999999999 111.551 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.75 -42.04 67.78 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.252 1.021 . . . . 2.6099999999999999 111.787 176.087 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -53.46 -48.77 68.56 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.732 -0.605 . . . . 2.1000000000000001 110.12 174.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 96.7 m -64.8 -41.45 95.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.082 0.553 . . . . 1.8200000000000001 110.26 -178.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -52.47 -51.95 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.227 -0.286 . . . . 1.3400000000000001 110.227 169.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.11 -33.22 75.0 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.826 -0.435 . . . . 3.1899999999999999 109.826 -176.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -65.28 -57.15 9.17 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.489 1.116 . . . . 1.8 109.576 178.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.5 mt -56.2 -51.42 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 121.457 -0.777 . . . . 1.05 110.098 177.569 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.82 -45.96 85.38 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.542 -0.742 . . . . 2.4199999999999999 110.101 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.3 t -49.25 -53.72 20.22 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.283 0.947 . . . . 1.9099999999999999 109.76 172.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -31.36 72.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.809 -0.557 . . . . 3.1200000000000001 111.067 -172.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.6 mt -72.23 -61.39 1.81 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.536 -0.913 . . . . 1.97 108.536 174.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 60.9 p -54.41 -19.66 6.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.601 1.161 . . . . 2.1400000000000001 113.099 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -57.53 -33.42 68.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.697 0.68 . . . . 4.3700000000000001 112.03 171.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.7 m -62.38 132.04 51.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.599 1.56 . . . . 1.8300000000000001 111.069 -176.112 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.04 -53.89 46.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.319 0.648 . . . . 4.8300000000000001 112.473 177.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.444 ' HA3' HD11 ' A' ' 128' ' ' ILE . . . -78.87 -16.95 78.17 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.837 -0.424 . . . . 1.46 113.394 -169.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.51 HD11 HG13 ' A' ' 122' ' ' VAL . 4.2 tt -68.86 133.84 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 118.387 1.094 . . . . 2.0 109.171 -176.195 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.9 m -104.32 -51.62 3.08 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 121.929 0.092 . . . . 2.5 110.859 -177.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -141.49 116.44 9.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.091 -0.707 . . . . 2.5899999999999999 109.091 176.448 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.12 143.27 32.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.049 -0.723 . . . . 1.0800000000000001 109.049 163.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.0 m -135.89 119.58 17.18 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.126 -1.064 . . . . 1.46 108.126 174.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.5 p -117.53 131.91 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.572 1.149 . . . . 2.2000000000000002 110.601 -177.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -128.59 86.67 2.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.027 0.931 . . . . 1.3799999999999999 110.298 -172.204 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -53.93 -26.56 26.01 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.997 1.319 . . . . 2.5099999999999998 113.012 179.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.81 -34.83 65.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.417 0.687 . . . . 1.6599999999999999 110.967 176.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.74 -10.04 11.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.821 1.649 . . . . 1.9399999999999999 111.393 -178.293 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.431 ' O ' HD12 ' A' ' 86' ' ' ILE . 8.7 m 69.46 22.39 6.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.836 2.054 . . . . 1.48 112.318 178.446 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -102.43 156.06 17.85 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 125.291 1.437 . . . . 4.6299999999999999 111.343 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.06 115.82 7.74 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.089 1.355 . . . . 0.83999999999999997 110.462 174.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 121' ' ' LEU . 3.9 mm? -92.03 126.42 37.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.219 -1.4 . . . . 2.4100000000000001 107.219 170.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.51 HG13 HD11 ' A' ' 108' ' ' ILE . 2.3 t -114.3 131.4 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.928 1.691 . . . . 1.8 107.409 176.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.49 ' CD ' ' HB2' ' A' ' 81' ' ' ASN . 2.1 mmmt -115.07 95.9 5.43 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.038 1.335 . . . . 3.0499999999999998 110.023 178.45 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.413 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -118.48 -176.77 3.15 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.494 1.118 . . . . 2.0899999999999999 111.22 -177.133 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -106.77 111.31 63.89 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.097 -1.075 . . . . 3.1400000000000001 108.097 175.044 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.21 68.3 7.93 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.916 2.411 . . . . 1.77 111.626 -167.339 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -162.57 -42.95 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.471 1.508 . . . . 3.0 109.729 174.481 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.514 HD12 ' HB ' ' A' ' 129' ' ' ILE . 2.0 pp -79.39 -35.98 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.296 0.57 . . . . 2.0699999999999998 110.168 -175.265 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.514 ' HB ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -131.6 166.02 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.601 1.56 . . . . 1.3200000000000001 108.955 179.165 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.41 168.44 29.08 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.066 -1.614 . . . . 1.3 109.066 178.076 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.35 -44.59 36.92 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.42 2.746 . . . . 1.3899999999999999 111.851 -172.278 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -46.08 -42.27 13.32 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.183 1.179 . . . . 6.1600000000000001 114.183 -177.204 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.51 -47.48 83.75 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.512 -0.475 . . . . 3.25 109.72 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 85.1 mt -58.59 -45.86 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.929 -0.767 . . . . 1.1100000000000001 108.929 178.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 83.6 mt -51.93 -59.47 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.541 -0.911 . . . . 2.0499999999999998 108.541 174.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -46.24 66.78 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.874 0.761 . . . . 4.1699999999999999 111.245 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.2 mm -54.66 -50.66 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 121.413 -0.804 . . . . 1.9099999999999999 110.119 177.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.261 2.5 pp -71.14 -26.12 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.01 -1.056 . . . . 1.47 113.653 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.82 -38.77 76.17 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.762 0.71 . . . . 3.2200000000000002 109.848 168.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -59.84 -40.73 89.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.57 0.7 . . . . 3.1800000000000002 109.182 -179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 51.2 mt -70.63 -42.01 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.361 0.664 . . . . 1.01 109.827 175.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.1 34.19 5.21 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.434 1.493 . . . . 0.91000000000000003 111.187 -175.535 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -99.88 176.14 5.54 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.098 0.949 . . . . 2.3700000000000001 110.019 168.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -129.86 111.42 12.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.704 -1.591 . . . . 4.3399999999999999 106.704 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.439 ' HB1' HD12 ' A' ' 84' ' ' LEU . . . -104.0 103.03 12.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.682 1.193 . . . . 1.1200000000000001 107.982 178.845 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.8 m -109.66 110.33 21.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.664 1.586 . . . . 1.95 107.144 -174.233 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.45 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.405 1.482 . . . . 3.9700000000000002 111.384 -178.224 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 50.31 33.35 7.33 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.325 0.861 . . . . 3.7000000000000002 113.325 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.331 -1.318 . . . . 8.9700000000000006 109.826 -166.699 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 121.533 0.682 . . . . 3.4300000000000002 110.327 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -92.83 123.12 35.86 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.617 1.167 . . . . 5.9299999999999997 109.896 -171.043 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 t -108.99 124.29 50.47 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.188 -1.042 . . . . 2.3799999999999999 108.188 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -102.47 103.66 14.05 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.187 1.395 . . . . 3.1099999999999999 107.48 -178.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.1 pt? -130.63 173.99 10.35 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.926 0.869 . . . . 2.79 111.036 176.087 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.558 HE21 ' HB3' ' A' ' 70' ' ' ALA . 3.3 pt20 -122.44 150.29 42.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.032 -0.986 . . . . 2.2000000000000002 108.757 173.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 44' ' ' ALA . 39.2 mm -99.32 113.73 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 106.51 -1.663 . . . . 1.3700000000000001 106.51 173.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -99.47 93.46 5.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.587 -1.264 . . . . 3.0099999999999998 107.587 175.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.18 -77.29 0.08 OUTLIER Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.637 -0.985 . . . . 1.28 110.637 178.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.0 mmt 54.31 88.27 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.291 1.836 . . . . 2.1299999999999999 113.79 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 m -55.85 -64.39 0.87 Allowed 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.259 -0.901 . . . . 2.5499999999999998 112.477 177.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.7 t -169.7 56.19 0.04 OUTLIER 'General case' 0 C--N 1.345 0.397 0 CA-C-N 118.46 0.573 . . . . 3.3300000000000001 109.945 -176.172 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 41.47 49.09 3.49 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.769 1.227 . . . . 5.6100000000000003 112.707 178.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.4 t -164.18 -45.13 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.304 0.642 . . . . 2.8100000000000001 110.264 -172.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.5 t -66.44 -36.82 83.75 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 120.743 -1.223 . . . . 1.8300000000000001 110.277 -178.37 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.8 t -63.58 -30.63 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.657 0.741 . . . . 1.75 110.012 173.423 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -66.33 -31.03 71.57 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.54 -0.725 . . . . 1.95 110.884 175.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.74 -48.82 65.38 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.096 -1.003 . . . . 2.9900000000000002 110.232 169.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mt -38.52 -44.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.598 0.759 . . . . 1.49 112.163 171.022 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -42.81 -57.8 2.63 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.536 0.734 . . . . 5.1500000000000004 112.509 178.412 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -67.23 -40.25 86.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.225 -0.287 . . . . 5.4800000000000004 110.225 -177.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -56.09 -53.53 55.89 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.767 -0.827 . . . . 1.22 108.767 -177.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.16 -43.83 97.96 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 119.493 -0.289 . . . . 3.0 111.279 177.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -22.21 24.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.872 0.76 . . . . 2.0 112.967 176.635 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -115.53 33.65 5.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.433 0.693 . . . . 3.1200000000000001 111.549 175.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -84.73 -88.81 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.704 -1.591 . . . . 3.3399999999999999 106.704 168.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -143.74 -126.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.908 1.283 . . . . 1.3500000000000001 109.837 178.147 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.49 32.85 1.38 Allowed Glycine 0 CA--C 1.532 1.139 0 O-C-N 120.7 -1.25 . . . . 2.1899999999999999 113.709 -171.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.19 117.99 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 106.936 -1.505 . . . . 1.55 106.936 174.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.05 53.38 1.57 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.211 1.005 . . . . 3.2999999999999998 109.718 -178.547 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.5 m -161.84 132.08 4.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.146 -1.427 . . . . 2.1200000000000001 107.146 171.586 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.75 117.04 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.414 -1.328 . . . . 2.8399999999999999 107.414 176.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 tt -124.87 78.03 1.66 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.332 -0.988 . . . . 2.5800000000000001 108.332 -179.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 t -99.98 137.1 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.182 -0.673 . . . . 2.04 109.182 173.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.93 98.39 7.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.543 -0.91 . . . . 1.1200000000000001 108.543 169.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.94 -8.66 7.57 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.205 1.002 . . . . 3.04 112.865 175.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.3 mtt -80.34 -48.63 12.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.113 0.965 . . . . 4.1500000000000004 110.011 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.59 -27.3 17.44 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.793 0.837 . . . . 1.24 111.805 -175.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 61.67 2.25 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.764 -0.934 . . . . 1.1599999999999999 110.764 -177.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -140.0 139.08 35.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.38 -1.711 . . . . 2.7200000000000002 106.38 173.141 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -111.21 105.1 13.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.439 1.087 . . . . 1.1799999999999999 109.91 165.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -97.63 133.68 41.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.538 -2.023 . . . . 3.6699999999999999 105.538 164.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 pt -129.94 167.05 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.54 -1.281 . . . . 2.0899999999999999 107.54 169.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.37 105.12 10.59 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 124.393 1.077 . . . . 5.3300000000000001 108.794 172.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.631 ' HB2' HD12 ' A' ' 53' ' ' ILE . 12.9 p90 -104.66 -179.51 3.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.255 1.822 . . . . 2.8500000000000001 111.46 175.79 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.4 108.18 17.54 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.342 1.057 . . . . 3.8300000000000001 111.316 175.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.43 -7.97 22.36 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.242 2.628 . . . . 2.1099999999999999 113.586 -168.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.41 -16.37 57.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.222 0.919 . . . . 3.1699999999999999 111.393 173.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.9 t -124.73 -47.89 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 118.476 0.58 . . . . 2.5 110.23 -172.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.631 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -116.85 146.79 20.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.014 0.925 . . . . 1.6100000000000001 109.029 -173.425 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -123.48 154.88 66.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 124.213 1.005 . . . . 2.96 113.178 179.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.87 -38.19 81.14 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.547 2.165 . . . . 1.55 111.243 174.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 3.1 mp -54.44 -60.54 3.2 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.391 -0.818 . . . . 2.9500000000000002 111.494 178.475 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -57.13 -35.29 69.3 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.325 -0.859 . . . . 3.8599999999999999 112.734 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.502 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -55.28 -41.45 61.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.94 -0.763 . . . . 1.25 108.94 171.947 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 56' ' ' LEU . . . -59.51 -38.59 81.34 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.076 -0.511 . . . . 1.6200000000000001 111.341 -179.619 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -63.48 -51.15 66.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.197 -0.939 . . . . 3.02 109.98 175.025 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.22 -52.22 59.62 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.376 0.608 . . . . 2.25 111.424 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.547 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.3 pp -65.46 -37.82 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.283 -0.886 . . . . 4.21 112.308 -179.567 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.93 -31.88 71.94 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.04 0.837 . . . . 2.9399999999999999 110.683 177.232 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.57 -52.45 63.38 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 109.252 -0.647 . . . . 3.5299999999999998 109.252 174.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -55.0 -42.71 72.85 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.673 0.249 . . . . 3.5099999999999998 111.673 172.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.28 48.39 0.43 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.293 0.949 . . . . 1.3 111.129 171.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -135.04 162.92 31.08 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.509 1.124 . . . . 2.3399999999999999 109.675 -176.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -100.27 122.99 43.95 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.892 1.277 . . . . 2.96 107.623 167.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.547 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -104.16 82.67 1.98 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.512 1.525 . . . . 0.87 108.824 172.154 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB3' HE21 ' A' ' 9' ' ' GLN . . . -96.66 101.82 13.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.611 -1.177 . . . . 1.6699999999999999 108.985 -176.697 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -70.36 158.28 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.438 1.495 . . . . 3.4500000000000002 112.08 176.649 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.38 0 CA-C-N 114.853 -1.067 . . . . 6.4900000000000002 111.287 167.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.889 0 N-CA-C 110.487 -1.045 . . . . 2.8700000000000001 110.487 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.487 ' CG ' ' HE3' ' A' ' 123' ' ' LYS . 21.0 t30 -106.01 131.83 52.83 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 117.599 0.7 . . . . 3.6600000000000001 109.909 153.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -141.54 169.0 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 130.776 3.63 . . . . 3.1299999999999999 105.627 175.937 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -117.06 119.79 36.35 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.953 1.701 . . . . 4.1399999999999997 110.07 179.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.2 mt -113.63 137.62 51.34 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.316 0.646 . . . . 2.2999999999999998 109.444 -179.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 m -100.48 131.11 46.57 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 108.171 -1.048 . . . . 1.6799999999999999 108.171 173.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.518 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.5 OUTLIER -95.53 122.62 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.748 1.619 . . . . 1.8999999999999999 107.762 175.64 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 63.8 m -112.22 134.59 53.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.922 -1.14 . . . . 1.76 107.922 175.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 112.14 -36.3 4.22 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.495 1.045 . . . . 1.72 111.557 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.512 ' HE3' HD13 ' A' ' 86' ' ' ILE . 2.9 tmm? -57.32 129.47 41.92 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.183 0.593 . . . . 2.23 111.204 -178.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -157.03 91.96 1.23 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.072 -1.455 . . . . 3.25 107.072 169.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 63.3 m 84.2 -134.18 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.593 1.957 . . . . 4.9000000000000004 111.087 178.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 60.07 -6.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.059 1.744 . . . . 6.8899999999999997 114.581 -170.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.46 29.42 11.09 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.408 -0.807 . . . . 4.0700000000000003 110.186 -158.225 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -33.43 69.29 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 123.079 1.418 . . . . 2.3100000000000001 111.358 -171.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.4 t -52.53 -43.42 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.862 1.665 . . . . 1.6799999999999999 110.561 174.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -58.01 -47.81 81.93 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.462 1.125 . . . . 2.6800000000000002 108.526 -176.053 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.251 1.2 p-10 -70.99 -38.35 72.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.84 -1.073 . . . . 3.3199999999999998 112.003 179.076 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.5 mt -57.14 -54.11 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.815 1.188 . . . . 0.95999999999999996 109.906 173.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -52.83 -49.95 64.68 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 108.717 -0.845 . . . . 2.8999999999999999 108.717 176.391 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.2 t -52.4 -51.67 57.84 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 122.021 -0.424 . . . . 1.5 111.945 177.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -61.56 -40.07 93.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.174 -0.954 . . . . 2.5800000000000001 111.414 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.8 mt -63.58 -60.81 2.86 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.534 0.607 . . . . 1.99 110.145 175.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.6 m -54.33 -20.18 6.76 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.315 1.446 . . . . 1.8600000000000001 112.321 177.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.5 mtp-105 -61.8 -28.82 69.73 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.802 0.667 . . . . 4.6900000000000004 112.802 172.811 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.1 p -69.53 166.19 19.42 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 119.828 1.194 . . . . 2.2999999999999998 110.892 -179.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.75 -39.61 30.66 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.071 -0.393 . . . . 3.5099999999999998 111.346 176.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.33 -50.46 7.43 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 112.256 -0.338 . . . . 1.1599999999999999 112.256 -170.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.68 144.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.851 -1.166 . . . . 3.27 107.851 176.309 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.0 m -142.51 -44.9 0.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.473 0.709 . . . . 3.27 109.845 171.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -100.51 103.36 14.69 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.016 -1.846 . . . . 2.2999999999999998 106.016 176.63 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.04 149.01 41.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.501 -1.296 . . . . 0.97999999999999998 107.501 165.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.9 m -142.87 135.71 27.97 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.213 -1.032 . . . . 1.9299999999999999 108.213 162.779 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.41 118.68 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.53 1.532 . . . . 2.4300000000000002 106.939 -177.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.06 105.51 10.7 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.902 1.281 . . . . 1.3200000000000001 110.3 -171.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pp -74.05 -39.07 63.77 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 125.851 1.66 . . . . 2.04 111.878 -172.076 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.71 -40.39 62.94 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.194 0.998 . . . . 1.4099999999999999 110.901 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.07 -12.51 24.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.779 1.232 . . . . 1.8799999999999999 111.08 175.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.2 m 54.1 43.52 30.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.883 1.273 . . . . 1.55 111.925 -176.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -128.22 163.43 24.73 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 117.618 0.19 . . . . 3.3300000000000001 110.734 166.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.96 136.9 32.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.281 1.432 . . . . 1.01 108.702 173.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -117.81 136.36 53.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.201 1.4 . . . . 2.46 107.583 171.916 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.4 m -134.3 136.11 53.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 116.805 -1.569 . . . . 2.1000000000000001 107.327 -177.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.487 ' HE3' ' CG ' ' A' ' 81' ' ' ASN . 4.1 mtpt -115.25 105.13 12.52 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 120.456 1.48 . . . . 3.3599999999999999 108.453 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -115.15 179.81 3.85 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.289 1.435 . . . . 2.75 110.894 175.218 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -100.51 117.37 63.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 125.089 1.355 . . . . 3.0299999999999998 108.355 173.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -82.52 57.9 6.29 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.663 2.242 . . . . 1.95 112.351 -168.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -147.38 -49.57 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.482 1.513 . . . . 3.8599999999999999 108.661 174.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pt -77.28 -33.25 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 122.382 -0.199 . . . . 1.6200000000000001 111.05 -176.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.24 165.7 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.289 1.036 . . . . 1.4299999999999999 108.373 -177.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.23 165.65 33.88 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.273 -1.131 . . . . 1.3799999999999999 110.273 -175.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.71 -35.73 78.39 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.698 2.932 . . . . 1.5700000000000001 112.637 -170.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 10.2 mtt-85 -50.99 -40.53 58.23 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.897 0.702 . . . . 6.1299999999999999 112.897 178.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.46 -46.8 84.57 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.306 0.574 . . . . 3.3900000000000001 109.645 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.68 -45.01 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.504 0.721 . . . . 1.0600000000000001 109.574 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.7 mt -55.98 -58.64 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 108.704 -0.85 . . . . 2.0299999999999998 108.704 175.023 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -49.28 -49.59 42.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.747 1.158 . . . . 3.6000000000000001 112.851 177.153 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 52.0 mt -48.68 -56.21 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.612 -0.514 . . . . 2.4399999999999999 109.612 176.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.253 2.2 pp -70.84 -26.68 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 113.509 0.929 . . . . 1.52 113.509 -178.294 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.37 -38.58 80.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.311 0.959 . . . . 2.5 109.683 168.642 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -66.08 -39.85 90.38 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.444 -0.576 . . . . 3.23 109.444 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.1 mt -62.23 -38.84 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.873 -0.417 . . . . 1.26 109.873 169.319 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.72 29.24 9.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.762 1.649 . . . . 0.97999999999999998 110.825 -177.096 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -100.31 178.99 4.6 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 117.982 0.891 . . . . 2.3100000000000001 108.99 175.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -127.88 104.51 7.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.609 -1.256 . . . . 4.1600000000000001 107.609 -178.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.68 103.84 15.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.136 -1.431 . . . . 1.28 107.136 174.205 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.4 t -97.12 -179.19 4.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.236 -1.394 . . . . 2.2599999999999998 107.236 169.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.5 117.94 22.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.278 -1.749 . . . . 4.0 106.278 171.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.56 90.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.862 -0.421 . . . . 3.3500000000000001 109.862 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 C--O 1.249 1.048 0 C-N-CA 127.192 2.197 . . . . 6.3799999999999999 111.22 -178.473 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.121 0 N-CA-C 108.589 -0.893 . . . . 7.4199999999999999 108.589 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.19 153.88 17.85 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.198 -1.408 . . . . 5.8499999999999996 107.198 166.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 117.97 21.68 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.509 -1.293 . . . . 3.6499999999999999 107.509 178.01 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -99.89 102.67 14.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.277 1.831 . . . . 5.4000000000000004 109.849 -176.061 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 44' ' ' ALA 0.277 0.0 OUTLIER -130.3 159.86 35.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.185 0.993 . . . . 2.46 111.572 176.223 . . . . . . . . 4 4 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -113.63 152.05 30.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.001 -1.0 . . . . 2.1800000000000002 108.375 173.273 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mm -99.95 137.89 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 106.437 -1.69 . . . . 1.0700000000000001 106.437 175.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -119.38 98.55 6.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.27 -1.011 . . . . 3.79 108.27 169.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.45 -94.65 0.13 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 109.119 -1.592 . . . . 1.8100000000000001 109.119 177.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 mtp 67.86 90.48 0.09 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.012 1.725 . . . . 2.3300000000000001 113.503 173.366 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -57.4 -28.55 63.34 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.973 0.731 . . . . 3.0099999999999998 112.973 175.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 t 78.38 -48.5 0.46 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.009 1.324 . . . . 4.9900000000000002 112.068 177.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -36.15 -70.01 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.802 1.641 . . . . 4.4100000000000001 112.063 -179.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.3 p -161.49 18.99 0.11 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.254 0.465 . . . . 2.6800000000000002 112.254 172.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 27.1 m -70.23 -52.12 25.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.329 -0.989 . . . . 2.5299999999999998 108.329 -170.292 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.53 -39.27 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 109.702 -0.481 . . . . 2.9300000000000002 109.702 177.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -61.95 -37.51 85.0 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.933 0.893 . . . . 2.1000000000000001 113.344 177.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -41.29 64.0 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.732 -1.23 . . . . 2.8599999999999999 110.866 171.201 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.441 HG12 HD13 ' A' ' 65' ' ' LEU . 88.0 mt -60.29 -48.62 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.258 1.023 . . . . 1.8799999999999999 110.18 -174.354 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HB2' HG11 ' A' ' 35' ' ' VAL . 1.8 pp20? -51.52 -45.62 63.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.632 0.73 . . . . 4.3399999999999999 111.079 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -64.6 -43.59 93.31 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 124.654 1.182 . . . . 6.5099999999999998 110.343 -179.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.91 -52.27 64.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.129 -0.487 . . . . 1.95 109.825 173.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -29.39 66.48 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.016 0.747 . . . . 1.98 113.016 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -55.0 -22.07 14.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.907 1.23 . . . . 3.4100000000000001 111.666 174.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -123.93 33.68 5.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.638 0.775 . . . . 4.21 110.182 178.182 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -64.26 0.89 Allowed 'General case' 0 C--N 1.343 0.314 0 N-CA-C 108.796 -0.816 . . . . 2.5299999999999998 108.796 174.776 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.05 -133.85 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.833 1.253 . . . . 1.53 108.112 -172.114 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.66 -16.96 74.49 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.556 1.071 . . . . 1.9399999999999999 113.009 -178.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 p -60.35 122.4 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 121.949 -0.736 . . . . 2.04 110.279 177.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.55 50.55 2.15 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 121.209 0.528 . . . . 4.1200000000000001 111.119 177.239 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.7 m -155.44 153.73 30.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.299 -1.371 . . . . 3.7999999999999998 107.299 167.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 23' ' ' GLU . 11.4 p -143.33 132.06 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 104.815 -2.291 . . . . 3.1699999999999999 104.815 161.57 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 36' ' ' LEU . 2.2 tm? -141.35 83.73 1.88 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.007 -1.108 . . . . 2.6000000000000001 108.007 174.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.0 p -98.8 147.16 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.27 -1.011 . . . . 2.1000000000000001 108.27 174.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.52 103.87 9.81 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.322 -1.362 . . . . 1.9199999999999999 107.322 167.188 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -27.54 66.4 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.608 0.763 . . . . 2.6099999999999999 110.817 175.376 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 46.3 mtt -66.26 -58.8 4.58 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.944 0.898 . . . . 3.3300000000000001 110.209 -178.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.75 -25.35 38.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.938 0.495 . . . . 2.0800000000000001 111.414 -178.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.69 57.94 2.79 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.508 1.052 . . . . 1.4199999999999999 110.878 179.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -140.31 147.1 39.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.865 -1.064 . . . . 3.21 108.693 179.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.504 ' HB3' HD22 ' A' ' 8' ' ' LEU . . . -124.63 101.17 6.99 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.145 1.378 . . . . 1.73 112.192 177.013 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -99.57 122.62 42.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.004 -1.06 . . . . 4.7699999999999996 108.375 172.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.06 -179.5 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.742 1.155 . . . . 2.6200000000000001 111.179 171.708 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -134.72 90.28 2.63 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.021 0.928 . . . . 7.6900000000000004 112.561 -174.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.7 179.93 4.81 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.506 1.122 . . . . 3.77 113.974 -176.469 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -126.16 98.74 32.36 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 128.03 2.532 . . . . 4.8700000000000001 108.283 176.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.62 27.89 0.38 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.917 3.078 . . . . 3.6899999999999999 113.555 -170.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -108.15 -16.21 14.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.888 1.675 . . . . 4.6500000000000004 110.669 165.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.1 t -116.66 -60.9 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.762 1.225 . . . . 3.25 108.067 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.65 124.99 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.646 0.778 . . . . 2.3500000000000001 110.297 -177.509 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -101.62 172.08 4.76 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.09 1.756 . . . . 3.0 110.956 -177.645 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -75.45 -15.24 19.89 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.622 1.548 . . . . 2.7599999999999998 112.259 -178.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.257 0.5 OUTLIER -73.08 -60.0 2.44 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.442 -0.786 . . . . 4.5599999999999996 110.396 175.601 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -57.45 -32.37 66.86 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.284 -0.885 . . . . 2.77 112.281 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.3 tt -55.98 -45.34 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.878 -1.156 . . . . 1.6699999999999999 107.878 175.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.87 73.56 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.364 -0.835 . . . . 1.9399999999999999 110.42 -178.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.91 -44.9 94.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 119.459 1.027 . . . . 2.4300000000000002 110.073 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -55.62 -52.69 62.95 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 109.195 -0.669 . . . . 2.3399999999999999 109.195 175.326 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 mm -63.15 -41.86 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 120.246 -0.582 . . . . 2.73 111.839 -174.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -46.25 89.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.4 1.08 . . . . 2.8999999999999999 110.421 175.037 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.19 -50.28 74.29 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.154 0.582 . . . . 3.98 109.829 178.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.441 HD13 HG12 ' A' ' 22' ' ' ILE . 29.1 mt -55.62 -36.43 66.97 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.311 0.644 . . . . 2.2000000000000002 110.882 175.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.16 28.75 2.98 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 124.082 0.849 . . . . 1.95 111.149 165.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -117.53 157.02 27.05 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.995 -1.483 . . . . 3.1200000000000001 106.995 177.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -96.5 116.36 28.94 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.797 -1.186 . . . . 3.1000000000000001 107.797 169.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.87 123.92 43.45 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 108.096 -1.076 . . . . 1.6699999999999999 108.096 166.412 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -126.92 132.14 50.95 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.28 -1.007 . . . . 1.8400000000000001 108.28 170.158 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.485 ' HA ' ' HB3' ' A' ' 8' ' ' LEU . 2.2 t -89.46 160.04 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 124.619 1.168 . . . . 4.25 108.336 -177.236 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.8 mmt . . . . . 0 CA--C 1.534 0.341 0 O-C-N 123.935 0.772 . . . . 5.4400000000000004 110.472 168.303 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.733 0 N-CA-C 109.714 -1.354 . . . . 2.79 109.714 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.34 113.4 24.98 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 104.469 -2.419 . . . . 3.23 104.469 159.532 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.405 HG13 ' CD1' ' A' ' 124' ' ' PHE . 1.4 pp -98.3 158.76 3.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.072 -1.825 . . . . 3.5699999999999998 106.072 158.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.48 155.69 38.5 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.122 -1.807 . . . . 3.9100000000000001 106.122 174.166 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.526 HD13 ' HB1' ' A' ' 145' ' ' ALA . 4.2 pp -147.79 163.52 36.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.637 -0.221 . . . . 3.3199999999999998 111.18 168.283 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 m -98.89 126.49 44.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.602 1.961 . . . . 1.96 107.261 171.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.02 125.5 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.856 -0.794 . . . . 1.6200000000000001 108.856 176.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.5 t -108.03 163.31 13.26 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.326 -0.62 . . . . 3.6499999999999999 109.326 170.703 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.34 -39.27 2.94 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.846 1.213 . . . . 1.4199999999999999 112.583 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -58.92 132.73 54.87 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.879 0.871 . . . . 2.5 110.953 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 m -148.01 40.94 0.99 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.904 1.281 . . . . 2.75 109.861 176.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -169.19 136.83 1.86 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.88 -1.137 . . . . 2.7799999999999998 111.1 177.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.13 64.94 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.576 -0.703 . . . . 2.8999999999999999 112.118 177.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.6 t -56.45 -42.08 77.54 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.638 -0.664 . . . . 2.4300000000000002 110.365 173.589 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 84.5 m -63.24 -44.4 95.31 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.75 -0.833 . . . . 1.75 108.75 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.6 t -53.87 -58.86 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.522 0.729 . . . . 1.6299999999999999 110.543 175.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -57.11 -41.88 79.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.678 0.752 . . . . 4.4199999999999999 111.316 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -59.77 -55.09 38.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.821 0.848 . . . . 1.95 110.338 177.779 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.8 mt -47.39 -50.63 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 125.657 1.583 . . . . 0.82999999999999996 109.234 174.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -56.53 -47.25 79.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.217 1.007 . . . . 3.7599999999999998 109.947 177.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.9 m -58.15 -44.21 87.75 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.999 -1.063 . . . . 2.5699999999999998 111.384 174.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.629 ' HG3' HD11 ' A' ' 141' ' ' ILE . 14.3 mmmt -64.28 -50.19 68.87 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.444 -0.785 . . . . 2.96 110.265 -177.101 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.71 -47.23 79.08 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.36 -0.607 . . . . 2.4900000000000002 109.36 -179.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.8 m -58.38 -21.21 49.35 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.034 0.934 . . . . 2.6299999999999999 112.584 176.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -64.96 -19.17 65.83 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.4 -0.813 . . . . 5.2699999999999996 112.71 172.342 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.3 m -71.22 150.72 45.02 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.681 1.193 . . . . 1.8700000000000001 110.431 178.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -69.3 -48.94 60.13 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.869 0.868 . . . . 3.0899999999999999 111.887 179.188 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.43 -28.56 61.44 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 122.287 -0.258 . . . . 2.4300000000000002 112.939 -166.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.51 142.18 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.368 -0.975 . . . . 2.0 108.368 178.437 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 22.4 p -124.21 -39.12 2.37 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.891 0.7 . . . . 3.3100000000000001 112.891 173.434 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.34 125.26 18.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.246 -1.39 . . . . 3.1200000000000001 107.246 -178.582 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.88 168.16 12.63 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.376 0.67 . . . . 1.6699999999999999 110.308 165.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.4 m -143.87 128.09 17.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.625 -0.88 . . . . 1.76 108.625 160.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 52.1 t -107.32 126.61 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.822 0.849 . . . . 2.5899999999999999 110.223 178.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.76 101.09 6.46 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.075 1.75 . . . . 1.6100000000000001 110.128 -168.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.14 -31.8 62.89 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 126.146 1.778 . . . . 2.0899999999999999 111.979 -174.253 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.6 -34.18 61.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.783 0.433 . . . . 1.6000000000000001 110.981 175.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.83 -4.67 19.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.108 1.363 . . . . 2.29 111.218 176.608 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.5 m 59.71 28.8 18.31 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.659 1.183 . . . . 1.6200000000000001 113.128 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -124.37 165.16 18.2 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.028 0.831 . . . . 2.9700000000000002 112.973 176.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.45 127.28 43.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.573 2.349 . . . . 1.4099999999999999 107.588 179.382 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.02 123.47 48.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.002 -1.851 . . . . 2.6099999999999999 106.002 175.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.1 t -130.32 123.38 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.163 -1.051 . . . . 1.8899999999999999 108.163 -170.016 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 96.93 9.73 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.099 -1.445 . . . . 4.2599999999999998 107.099 176.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.405 ' CD1' HG13 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -107.9 -177.87 3.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.449 1.5 . . . . 3.4300000000000002 111.019 178.309 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -127.2 112.83 21.53 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.059 0.943 . . . . 5.1799999999999997 108.917 175.736 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.43 50.23 3.44 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.577 3.518 . . . . 2.8100000000000001 113.523 -171.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -141.59 -52.19 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.484 1.513 . . . . 5.8499999999999996 107.495 171.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 pt -80.29 -31.69 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 119.399 -0.334 . . . . 2.5 111.302 -177.262 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.67 164.67 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 110.156 -0.313 . . . . 2.0600000000000001 110.156 -177.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.99 150.24 20.11 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.912 -0.938 . . . . 1.7 111.64 -167.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -57.22 -36.62 99.08 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.966 2.444 . . . . 1.75 110.535 178.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -34.75 67.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.119 -0.491 . . . . 6.3200000000000003 111.474 179.136 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -69.99 -44.04 70.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.761 -0.829 . . . . 3.29 108.761 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.424 ' O ' HD13 ' A' ' 138' ' ' ILE . 17.1 mm -52.42 -54.97 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.414 -0.958 . . . . 2.23 108.414 178.16 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.699 HG22 ' HB3' ' A' ' 145' ' ' ALA . 9.4 pt -59.2 -57.01 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 117.885 -1.055 . . . . 2.8999999999999999 109.879 179.04 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -44.46 -46.59 9.72 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.0 0.818 . . . . 4.7300000000000004 112.401 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.4 mm -51.07 -60.24 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 118.836 -0.602 . . . . 1.77 110.019 173.047 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.518 HG22 HD12 ' A' ' 141' ' ' ILE 0.29 0.0 OUTLIER -70.4 -26.93 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 117.628 -1.629 . . . . 2.77 113.909 -176.273 . . . . . . . . 4 4 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.48 -34.84 78.65 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.783 -0.573 . . . . 2.6800000000000002 110.538 172.128 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -66.6 -36.13 81.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.884 -0.784 . . . . 2.8399999999999999 108.884 176.288 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.629 HD11 ' HG3' ' A' ' 101' ' ' LYS . 38.2 mt -65.37 -44.28 94.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 119.84 -0.744 . . . . 1.6100000000000001 109.691 174.557 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.98 27.86 3.33 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.694 1.14 . . . . 1.4399999999999999 112.032 -177.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -98.5 -178.18 3.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.863 -1.532 . . . . 2.6600000000000001 106.863 158.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -139.36 130.69 26.85 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.741 -1.207 . . . . 3.8300000000000001 107.741 174.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.699 ' HB3' HG22 ' A' ' 135' ' ' ILE . . . -105.64 117.48 34.13 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.936 -0.765 . . . . 2.0800000000000001 108.936 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.2 t -109.04 115.55 30.29 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.361 -1.348 . . . . 2.2599999999999998 107.361 174.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.47 115.58 4.0 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.764 -1.198 . . . . 5.25 107.764 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.28 -34.83 20.26 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 123.61 0.569 . . . . 4.0 110.538 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 C--O 1.262 1.735 0 C-N-CA 128.131 2.572 . . . . 5.8600000000000003 115.633 175.396 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.513 -0.461 0 CA-C-O 121.717 0.77 . . . . 3.27 111.822 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.5 152.52 20.9 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.445 -1.252 . . . . 3.6699999999999999 108.899 -178.123 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.615 ' SG ' HD11 ' A' ' 8' ' ' LEU . 21.9 p -143.2 138.55 29.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 123.608 0.567 . . . . 2.4900000000000002 109.629 167.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.493 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -100.41 109.13 21.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.613 1.565 . . . . 4.25 109.379 177.659 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.615 HD11 ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -124.37 166.91 15.12 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.786 0.803 . . . . 2.9900000000000002 109.279 172.197 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.3 136.24 54.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.807 -1.553 . . . . 1.77 106.807 176.037 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.6 mm -98.2 136.02 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.593 -1.262 . . . . 0.81000000000000005 107.593 -177.36 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -114.0 136.51 52.83 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.061 -1.089 . . . . 2.8399999999999999 108.061 168.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.9 -80.6 0.27 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.04 1.781 . . . . 1.1200000000000001 109.962 -174.03 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.2 mmm 56.91 56.45 5.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.957 2.103 . . . . 2.1600000000000001 114.521 170.193 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -43.51 -63.95 0.74 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.774 1.398 . . . . 2.21 114.774 -173.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.3 t -167.9 59.47 0.07 Allowed 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.066 0.848 . . . . 3.3300000000000001 109.621 -176.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 42.86 48.75 5.04 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.476 1.111 . . . . 5.2199999999999998 111.994 -179.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.0 t -161.74 -40.21 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.005 0.522 . . . . 2.5699999999999998 111.364 -172.307 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.39 -43.5 81.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 118.731 -1.188 . . . . 1.47 109.357 -178.487 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.5 t -55.33 -40.61 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.486 -0.931 . . . . 1.8999999999999999 108.486 173.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -60.19 -37.4 80.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.002 0.43 . . . . 1.95 111.982 177.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -45.45 80.85 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.36 -0.838 . . . . 3.0899999999999999 110.047 173.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.49 -47.75 70.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.245 1.018 . . . . 1.3600000000000001 110.198 176.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -50.02 -49.18 51.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.888 0.875 . . . . 4.2599999999999998 111.478 175.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -64.71 -38.23 90.3 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 122.114 -0.366 . . . . 4.8499999999999996 110.346 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -61.19 -53.05 61.87 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.934 -0.395 . . . . 1.24 109.934 176.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.73 -37.26 75.78 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 118.22 0.464 . . . . 2.0600000000000001 111.381 -179.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.58 -19.05 5.19 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.206 0.817 . . . . 1.8100000000000001 113.206 174.41 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -118.36 20.9 12.92 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.325 0.65 . . . . 3.1099999999999999 112.499 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -68.16 -62.56 1.34 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.094 0.861 . . . . 2.5299999999999998 109.866 173.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.91 -128.47 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.384 1.474 . . . . 1.1799999999999999 108.038 -168.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.84 14.56 3.53 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 119.487 1.04 . . . . 1.3300000000000001 115.043 -173.409 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.09 122.26 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.593 1.157 . . . . 1.51 108.133 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.87 53.29 1.38 Allowed 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.448 0.642 . . . . 2.4399999999999999 110.566 179.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 t -160.05 147.13 16.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.555 -1.276 . . . . 1.6499999999999999 107.555 170.627 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.82 116.0 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 106.608 -1.627 . . . . 2.4700000000000002 106.608 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 tt -131.67 72.41 1.5 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.851 -1.166 . . . . 2.3399999999999999 107.851 177.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 p -97.27 153.11 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.64 -0.874 . . . . 2.2599999999999998 108.64 172.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.02 100.26 6.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.577 -1.268 . . . . 1.1899999999999999 107.577 163.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.2 mt -58.05 -19.12 29.19 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.207 1.003 . . . . 2.8900000000000001 111.762 172.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -49.81 64.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.852 0.861 . . . . 4.7999999999999998 109.696 178.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.88 -31.85 13.5 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.121 0.968 . . . . 1.1899999999999999 111.749 -174.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.22 55.3 1.98 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.511 1.053 . . . . 0.93000000000000005 111.307 -178.423 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.95 131.64 31.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 117.835 -1.079 . . . . 3.1499999999999999 108.491 177.097 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.406 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -108.49 105.13 14.65 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 125.333 1.453 . . . . 0.93999999999999995 110.563 170.536 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.5 130.36 45.75 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 106.639 -1.615 . . . . 4.5899999999999999 106.639 165.146 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.2 pt -133.04 169.6 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-N 119.292 0.951 . . . . 1.9099999999999999 109.897 170.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.7 105.99 12.6 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 124.699 1.199 . . . . 4.0099999999999998 111.124 172.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -98.27 -176.34 3.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.928 2.091 . . . . 2.5800000000000001 112.188 170.422 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -127.64 111.64 20.77 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.781 1.633 . . . . 3.2400000000000002 110.151 167.745 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.87 20.13 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.391 3.394 . . . . 2.1200000000000001 113.885 -173.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -99.27 -39.37 8.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.616 1.166 . . . . 3.8599999999999999 110.323 169.061 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.3 m -109.74 -34.13 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 118.743 0.701 . . . . 2.7200000000000002 111.26 -176.278 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.475 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -120.98 130.9 74.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 109.618 -0.512 . . . . 1.6399999999999999 109.618 176.818 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -110.47 149.18 39.87 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 124.195 0.998 . . . . 3.46 109.878 -179.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -54.34 -40.66 81.83 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.408 2.739 . . . . 1.6200000000000001 112.419 -178.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mp -57.54 -49.1 77.44 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.783 -0.573 . . . . 3.9399999999999999 111.013 177.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -60.3 -40.34 90.13 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.183 0.516 . . . . 3.0499999999999998 110.293 179.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.475 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -54.15 -50.65 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.67 -1.233 . . . . 1.05 107.67 173.181 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.08 -41.63 83.86 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.942 -0.572 . . . . 1.24 110.855 -174.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -56.33 -46.03 80.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.173 0.589 . . . . 2.3199999999999998 110.469 175.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.13 -51.59 63.78 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.621 -0.511 . . . . 2.71 109.621 176.03 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 mm -58.17 -45.88 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.784 0.326 . . . . 2.4700000000000002 111.26 -179.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -61.58 -43.06 99.55 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.122 -0.466 . . . . 3.4700000000000002 111.783 178.004 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.45 -49.02 78.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.6 0.636 . . . . 2.3100000000000001 110.067 176.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -59.63 -27.12 66.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.111 0.564 . . . . 2.1000000000000001 111.754 175.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.0 40.16 2.35 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.596 -1.002 . . . . 1.1499999999999999 110.596 165.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -131.93 170.74 14.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.419 1.488 . . . . 1.8799999999999999 108.029 178.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -115.01 121.46 43.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.351 -0.981 . . . . 3.8300000000000001 108.351 169.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.03 117.7 34.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.381 -1.711 . . . . 0.94999999999999996 106.381 163.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.78 144.18 45.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 105.979 -1.86 . . . . 0.91000000000000003 105.979 166.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.1 t -71.46 152.17 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.474 -1.306 . . . . 2.4100000000000001 107.474 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.8 ptm . . . . . 0 N--CA 1.447 -0.578 0 CA-C-N 116.193 -0.458 . . . . 3.7799999999999998 110.404 174.313 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.078 0 N-CA-C 110.519 -1.032 . . . . 2.0899999999999999 110.519 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -143.31 95.43 2.75 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 119.803 1.802 . . . . 2.79 110.911 172.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.33 145.52 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 C-N-CA 126.095 1.758 . . . . 4.71 108.169 178.637 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.426 ' HB2' HD12 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -109.4 148.25 31.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.071 1.348 . . . . 3.4399999999999999 110.629 173.173 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -140.89 161.4 37.92 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.296 1.038 . . . . 2.4100000000000001 109.069 -178.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.09 138.57 35.19 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 120.181 1.355 . . . . 2.1899999999999999 109.069 172.235 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.501 HD13 HD13 ' A' ' 98' ' ' ILE . 6.2 mt -94.98 117.14 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.731 -1.211 . . . . 2.6699999999999999 107.731 176.572 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 21.4 m -98.46 124.63 43.28 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.252 -1.388 . . . . 1.4099999999999999 107.252 171.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.82 -43.75 1.51 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.116 1.341 . . . . 1.02 111.337 175.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.88 121.65 8.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.726 0.81 . . . . 2.4199999999999999 110.938 174.523 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -166.09 26.33 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.842 0.857 . . . . 2.9100000000000001 111.074 166.07 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 31.1 p -172.47 168.21 5.46 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.296 -0.878 . . . . 5.4699999999999998 110.026 -167.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 58.99 6.9 0.72 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.983 2.113 . . . . 7.2300000000000004 113.574 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.5 m 38.11 47.47 0.96 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.336 0.589 . . . . 4.4299999999999997 110.734 -154.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.6 p -55.15 -21.99 15.39 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.711 1.204 . . . . 2.3900000000000001 112.417 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.523 HG13 ' CG2' ' A' ' 113' ' ' VAL . 7.2 t -30.0 -55.9 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.029 1.332 . . . . 1.47 111.327 157.036 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -58.85 -40.23 83.66 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.189 0.596 . . . . 3.6600000000000001 111.067 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.672 HD21 HD13 ' A' ' 141' ' ' ILE . 3.1 t30 -64.87 -46.65 80.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.866 -0.521 . . . . 2.0800000000000001 110.008 177.026 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.501 HD13 HD13 ' A' ' 86' ' ' ILE . 96.9 mt -59.97 -52.51 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.143 0.577 . . . . 0.94999999999999996 110.029 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -55.73 -43.62 76.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.568 1.947 . . . . 2.4399999999999999 108.966 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.5 t -59.74 -51.35 70.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.792 -0.567 . . . . 1.8999999999999999 110.064 174.329 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -53.87 -53.85 46.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.85 0.75 . . . . 2.52 110.705 -178.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.48 -48.52 74.91 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.545 -0.462 . . . . 2.7599999999999998 110.318 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.5 m -63.27 -19.44 64.57 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.369 1.068 . . . . 1.79 112.235 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.5 mtt-85 -63.28 -21.59 66.34 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.373 -0.823 . . . . 4.8700000000000001 111.52 170.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.36 169.53 17.12 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.557 1.071 . . . . 3.04 110.422 -177.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -80.12 -47.53 14.64 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.164 0.586 . . . . 2.2599999999999998 111.656 -175.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.72 -37.57 66.96 Favored Glycine 0 CA--C 1.524 0.606 0 O-C-N 122.139 -0.351 . . . . 1.0900000000000001 113.006 -168.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.74 123.49 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 122.111 -0.64 . . . . 2.1000000000000001 109.432 -173.501 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.7 m -101.56 -51.78 3.38 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 122.477 0.311 . . . . 1.97 111.497 -178.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CE1' ' HG3' ' A' ' 123' ' ' LYS . 27.4 p90 -140.55 111.34 6.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.049 -0.722 . . . . 2.2999999999999998 109.049 -177.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.15 155.05 16.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.889 -0.782 . . . . 1.0900000000000001 108.889 166.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.8 p -143.73 92.97 2.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.787 -1.19 . . . . 1.8700000000000001 107.787 169.07 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.523 ' CG2' HG13 ' A' ' 95' ' ' VAL . 2.4 m -96.52 140.02 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.241 -1.022 . . . . 2.3300000000000001 108.241 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.37 108.15 8.02 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.851 0.86 . . . . 1.4199999999999999 109.54 -168.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.38 -27.78 65.61 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.154 0.798 . . . . 2.25 113.154 -171.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.61 71.52 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.138 0.975 . . . . 1.74 110.05 -176.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.3 -28.33 13.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.702 2.001 . . . . 1.77 109.334 175.864 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.2 m 71.92 40.55 0.73 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.13 1.772 . . . . 2.2200000000000002 110.429 -174.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -101.21 163.31 12.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 123.839 0.712 . . . . 5.8200000000000003 110.818 172.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.82 108.17 5.54 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.104 2.161 . . . . 0.95999999999999996 109.105 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 83' ' ' GLU . 2.8 mp -96.68 131.0 43.8 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.697 -1.223 . . . . 2.1299999999999999 107.697 178.299 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.477 HG11 ' CD1' ' A' ' 134' ' ' ILE . 69.9 t -131.36 113.65 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.452 1.101 . . . . 1.77 108.538 -173.363 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HG3' ' CE1' ' A' ' 110' ' ' TYR . 0.7 OUTLIER -99.84 92.53 5.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 117.78 -1.105 . . . . 4.2699999999999996 110.351 176.375 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -109.82 -177.15 3.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.682 0.674 . . . . 2.2799999999999998 110.817 176.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -108.24 115.95 57.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.789 -1.189 . . . . 3.0499999999999998 107.789 173.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.47 68.94 8.16 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.042 2.495 . . . . 2.1200000000000001 111.841 -162.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -161.67 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.79 1.236 . . . . 3.0 109.613 175.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.4 pt -80.25 -39.2 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 123.964 0.906 . . . . 1.6899999999999999 110.811 -174.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.93 170.71 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.906 0.882 . . . . 1.55 108.657 178.81 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.05 159.46 28.03 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.443 -1.063 . . . . 1.8 110.443 178.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.34 -32.17 72.59 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.32 2.68 . . . . 2.52 110.719 -175.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -51.53 -37.42 49.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.508 1.123 . . . . 8.0399999999999991 111.016 175.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.34 -45.22 66.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.607 -1.257 . . . . 2.7799999999999998 107.607 -176.138 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.477 ' CD1' HG11 ' A' ' 122' ' ' VAL . 88.6 mt -60.73 -52.66 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 118.542 -0.742 . . . . 1.4399999999999999 109.213 -177.714 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.72 HG22 ' HB3' ' A' ' 145' ' ' ALA . 17.3 pt -50.55 -57.09 2.85 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 108.617 -0.883 . . . . 3.9199999999999999 108.617 175.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -54.39 -44.11 72.02 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.461 0.911 . . . . 5.9500000000000002 113.461 -177.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.3 mm -55.65 -50.23 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.468 -0.568 . . . . 1.97 109.468 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.478 ' HA ' HD12 ' A' ' 141' ' ' ILE . 25.3 pt -71.06 -28.14 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.907 -1.121 . . . . 2.1499999999999999 112.725 -179.226 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -59.05 -30.97 68.43 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.225 0.921 . . . . 3.5499999999999998 110.293 173.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.08 -42.74 95.25 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.579 -0.526 . . . . 2.5800000000000001 109.579 174.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.672 HD13 HD21 ' A' ' 97' ' ' ASN . 25.4 mt -71.91 -33.17 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.273 0.629 . . . . 1.22 109.845 178.263 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.53 22.05 7.97 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.347 1.451 . . . . 1.21 111.249 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.472 ' CD2' HD11 ' A' ' 98' ' ' ILE . 9.8 m-85 -105.8 157.13 17.67 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.143 0.971 . . . . 1.9299999999999999 108.866 167.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -126.18 138.28 53.64 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 107.713 -1.218 . . . . 3.4399999999999999 107.713 -179.334 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.72 ' HB3' HG22 ' A' ' 135' ' ' ILE . . . -111.06 110.5 21.07 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.622 1.169 . . . . 1.6100000000000001 108.342 178.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 68.2 m -141.47 122.89 14.96 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.022 -1.466 . . . . 2.0699999999999998 110.483 176.56 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 0.05 103.33 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.936 2.894 . . . . 5.7300000000000004 114.633 174.718 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.03 -35.61 66.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.668 -0.682 . . . . 5.8700000000000001 111.333 177.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.012 -1.471 . . . . 8.7699999999999996 113.828 -177.85 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.225 -0.221 0 CA-C-O 121.272 0.558 . . . . 2.7999999999999998 109.782 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -95.27 137.6 34.11 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.623 -1.251 . . . . 3.3999999999999999 107.623 -170.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 16.7 t -125.03 145.28 49.98 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 123.89 0.876 . . . . 2.04 109.004 176.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -121.05 91.2 3.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.749 1.62 . . . . 3.6099999999999999 108.976 -172.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.548 HD12 ' HB3' ' A' ' 44' ' ' ALA . 3.1 pp -124.29 167.59 14.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.046 0.45 . . . . 3.0099999999999998 110.834 178.8 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.44 168.92 8.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.917 -1.142 . . . . 3.7999999999999998 107.917 163.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.9 mm -102.04 122.28 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 105.064 -2.199 . . . . 1.1599999999999999 105.064 164.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.47 99.41 11.07 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 104.837 -2.282 . . . . 3.79 104.837 178.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.81 -59.75 0.38 Allowed Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.418 -0.657 . . . . 1.1000000000000001 112.193 178.019 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.6 mtp 21.68 84.91 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.332 2.653 . . . . 1.8700000000000001 114.399 -178.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 p -57.03 -56.49 21.08 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.911 -0.566 . . . . 2.8700000000000001 112.36 -175.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.9 m 135.23 -60.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 129.013 2.925 . . . . 3.8399999999999999 108.434 -179.361 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.89 -69.51 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.506 1.923 . . . . 5.2000000000000002 112.644 -165.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 p -163.98 28.07 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 122.477 1.132 . . . . 2.52 109.945 163.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.5 t -75.06 -41.14 59.61 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.477 -0.783 . . . . 1.71 110.346 -168.069 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.58 -43.87 66.62 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 N-CA-C 108.566 -0.901 . . . . 2.8799999999999999 108.566 170.172 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -44.85 80.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.203 -0.453 . . . . 1.9299999999999999 110.326 179.391 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.427 HD22 ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -65.25 -37.26 86.67 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 121.976 -0.453 . . . . 3.3599999999999999 111.138 176.867 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.63 -46.12 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 123.808 0.843 . . . . 2.7999999999999998 110.161 175.168 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -57.74 -49.57 76.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.757 0.313 . . . . 4.25 110.791 -179.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -33.4 75.84 Favored 'General case' 0 CA--C 1.521 -0.149 0 O-C-N 121.726 -0.609 . . . . 5.9500000000000002 110.978 -179.18 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.427 ' ND2' HD22 ' A' ' 21' ' ' ASN . 3.2 m-80 -67.24 -60.33 2.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.127 -0.694 . . . . 1.5700000000000001 109.127 178.274 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.557 HD21 HD11 ' A' ' 62' ' ' ILE . 10.2 mt -53.73 -50.49 65.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 119.005 -0.522 . . . . 2.5499999999999998 111.828 179.636 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.29 -18.25 60.8 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.788 1.176 . . . . 2.9700000000000002 113.261 -176.335 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm -95.38 0.05 53.09 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.501 1.297 . . . . 4.1399999999999997 114.501 171.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.12 -60.26 3.12 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 120.244 1.384 . . . . 3.0800000000000001 110.59 175.182 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.41 -97.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.917 1.687 . . . . 1.1499999999999999 109.4 175.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.9 -0.64 82.38 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 121.873 -0.517 . . . . 1.2 113.773 -171.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.71 114.83 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 CA-C-N 118.652 1.226 . . . . 1.3999999999999999 109.251 178.293 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mp -131.12 52.04 2.09 Favored 'General case' 0 C--N 1.338 0.086 0 N-CA-C 108.982 -0.748 . . . . 3.1800000000000002 108.982 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.8 t -159.56 120.17 3.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.332 -1.359 . . . . 1.6699999999999999 107.332 171.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.5 m -107.76 122.38 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.624 1.17 . . . . 2.5 108.597 173.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tt -137.93 82.35 1.91 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.921 -0.712 . . . . 2.3500000000000001 109.693 172.516 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 t -102.58 127.16 56.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 116.231 -0.441 . . . . 1.8400000000000001 110.839 173.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.51 97.75 9.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.367 -1.346 . . . . 1.0600000000000001 107.367 168.428 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.95 -26.29 62.08 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.097 0.559 . . . . 2.8399999999999999 110.835 173.151 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.7 mtt -68.03 -57.97 5.26 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.204 1.001 . . . . 3.25 110.324 -178.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.98 -25.23 30.19 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.069 0.548 . . . . 1.25 111.56 -177.019 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.81 61.16 2.32 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 124.771 1.177 . . . . 0.96999999999999997 110.798 -178.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -142.17 131.75 23.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.142 -1.429 . . . . 2.6600000000000001 107.142 174.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.548 ' HB3' HD12 ' A' ' 8' ' ' LEU . . . -110.45 102.25 10.88 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 124.631 1.207 . . . . 0.87 110.688 171.129 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.41 138.84 39.6 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.831 -1.174 . . . . 4.1699999999999999 107.831 168.563 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.24 166.55 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.392 -1.336 . . . . 2.0099999999999998 107.392 -177.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -124.49 90.46 3.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.576 0.751 . . . . 3.7000000000000002 109.765 -172.362 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.456 ' HB2' HD12 ' A' ' 53' ' ' ILE . 9.7 p90 -95.3 -177.99 4.29 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.648 1.979 . . . . 2.23 112.155 -176.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.78 94.85 24.14 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.724 1.61 . . . . 2.9700000000000002 108.946 -176.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -55.81 -22.63 38.14 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.253 2.635 . . . . 2.1499999999999999 113.828 -174.146 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -64.13 -32.34 73.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.448 1.099 . . . . 3.5600000000000001 112.37 177.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.75 -26.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 113.536 0.939 . . . . 2.6200000000000001 113.536 -175.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -123.44 133.22 69.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 N-CA-C 108.436 -0.95 . . . . 1.4199999999999999 108.436 174.065 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -107.2 154.26 40.59 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.603 1.161 . . . . 3.1600000000000001 110.088 175.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -60.5 -35.72 89.27 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.587 2.191 . . . . 1.3300000000000001 111.261 -178.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 pp -60.89 -43.57 98.3 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.567 -0.708 . . . . 3.7000000000000002 112.152 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.02 -40.65 78.54 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.298 0.639 . . . . 3.7000000000000002 109.418 177.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.431 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -49.92 -51.68 15.82 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 106.883 -1.525 . . . . 1.1200000000000001 106.883 173.09 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.47 -42.34 82.39 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.476 -0.784 . . . . 1.23 109.715 -175.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.35 -48.56 71.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.607 0.763 . . . . 3.5299999999999998 110.021 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -44.09 92.34 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.296 0.57 . . . . 2.46 109.604 179.699 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.557 HD11 HD21 ' A' ' 26' ' ' LEU . 8.9 mm -62.6 -44.46 99.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 O-C-N 121.817 -0.552 . . . . 2.75 110.994 179.155 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -63.62 -45.26 91.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.627 -0.508 . . . . 2.3399999999999999 109.627 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.29 -50.4 71.5 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.773 0.829 . . . . 2.21 110.194 177.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.42 ' C ' HD12 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -65.73 -36.19 82.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 121.193 -0.203 . . . . 3.4399999999999999 110.469 -175.952 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 129.43 26.5 0.88 Allowed Glycine 0 C--N 1.34 0.799 0 CA-C-O 119.792 -0.449 . . . . 1.6299999999999999 112.988 164.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -118.66 177.94 4.65 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.015 0.926 . . . . 1.99 110.985 173.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.54 142.13 41.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.856 -1.535 . . . . 2.3300000000000001 106.856 160.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.4 131.95 55.75 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.095 -1.076 . . . . 1.0700000000000001 108.095 163.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.4 124.87 26.41 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.71 -0.478 . . . . 1.04 109.71 174.227 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.02 148.42 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.844 1.658 . . . . 2.5600000000000001 109.266 172.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.5 mtp . . . . . 0 CA--C 1.532 0.268 0 O-C-N 123.856 0.722 . . . . 3.6899999999999999 110.986 -177.944 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 106.935 -2.466 . . . . 1.5900000000000001 106.935 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.45 133.08 43.33 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.405 1.482 . . . . 2.4700000000000002 107.634 169.387 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.59 HD13 ' H ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -142.22 161.22 19.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 129.387 3.075 . . . . 3.25 104.977 166.342 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.64 153.34 32.48 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.182 -1.784 . . . . 3.48 106.182 167.016 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mp -127.17 147.01 50.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.745 0.653 . . . . 2.2000000000000002 110.077 162.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.3 m -92.97 117.3 29.9 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.909 -1.515 . . . . 2.2599999999999998 106.909 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.437 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.6 OUTLIER -96.41 104.24 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 123.768 0.827 . . . . 1.6299999999999999 109.415 -174.563 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.3 m -96.9 136.14 37.88 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.522 -1.288 . . . . 1.3999999999999999 107.522 175.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.22 -33.31 4.58 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.701 1.143 . . . . 1.0900000000000001 112.124 177.705 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.7 ptp -64.05 160.72 17.45 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.372 0.586 . . . . 2.27 112.54 -177.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 t -172.41 40.03 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.167 0.987 . . . . 2.6299999999999999 110.394 168.524 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -164.76 133.7 3.54 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.04 -1.038 . . . . 2.6800000000000002 111.711 -176.443 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.55 81.72 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.071 0.548 . . . . 2.6600000000000001 111.174 177.366 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.8 t -56.46 -47.64 78.74 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.228 -0.92 . . . . 2.23 109.825 174.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.4 m -60.25 -43.95 95.67 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.874 -0.516 . . . . 2.1299999999999999 110.366 177.455 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.65 -50.62 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 O-C-N 122.332 -0.23 . . . . 1.78 111.286 177.072 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -59.19 -39.24 81.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.075 0.95 . . . . 3.6800000000000002 109.673 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -62.56 -50.6 70.68 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.626 0.37 . . . . 1.99 110.128 176.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.415 HD11 ' CE2' ' A' ' 143' ' ' PHE . 51.0 mt -55.99 -55.95 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.842 -0.429 . . . . 1.3300000000000001 109.842 177.517 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.52 -42.45 67.42 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.716 0.807 . . . . 3.0 110.86 177.795 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 p -62.69 -52.05 64.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.536 1.062 . . . . 1.75 110.843 177.212 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -63.6 -39.45 94.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.133 0.879 . . . . 5.5800000000000001 111.286 -174.235 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.89 -46.25 65.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.241 -0.885 . . . . 2.5800000000000001 109.24 177.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 95.9 m -55.84 -26.03 44.78 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.206 0.912 . . . . 1.7 111.563 176.004 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -61.65 -20.45 63.41 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.376 0.88 . . . . 4.3499999999999996 113.376 174.075 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.9 m -66.3 150.79 48.31 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.154 1.382 . . . . 1.77 110.909 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -68.34 -50.82 50.61 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.05 0.94 . . . . 2.3599999999999999 111.756 177.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.99 -26.67 61.76 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 123.52 0.581 . . . . 1.23 113.569 -169.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.45 140.35 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.467 -0.938 . . . . 2.8500000000000001 108.467 -177.21 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 24.8 p -115.49 -64.0 1.38 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 122.621 0.369 . . . . 2.9199999999999999 111.006 -175.05 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.404 ' CZ ' ' HG3' ' A' ' 123' ' ' LYS . 42.0 p90 -135.57 119.01 16.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.171 -1.048 . . . . 2.9100000000000001 108.171 174.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.62 161.02 14.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.728 -0.471 . . . . 0.80000000000000004 109.728 164.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.8 t -142.81 111.61 6.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.698 -1.223 . . . . 2.2000000000000002 107.698 168.169 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 68.9 t -98.93 123.17 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.912 1.285 . . . . 2.3100000000000001 109.458 -177.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -130.11 113.42 14.48 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.041 0.837 . . . . 1.28 112.644 -172.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 pp -77.88 -37.98 46.88 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 124.126 0.971 . . . . 2.4900000000000002 112.853 -171.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.67 70.13 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.344 0.592 . . . . 1.4299999999999999 110.86 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -35.69 16.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.779 1.232 . . . . 1.71 109.633 177.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.1 m 90.18 17.53 0.04 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.321 1.848 . . . . 1.8200000000000001 111.463 175.77 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -125.64 160.42 29.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.626 0.648 . . . . 3.02 110.446 175.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -130.74 125.82 34.83 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.127 1.371 . . . . 0.82999999999999996 108.24 179.146 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -92.55 129.19 38.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.423 -2.065 . . . . 1.71 105.423 177.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.72 139.06 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.312 -0.996 . . . . 1.8300000000000001 108.312 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 13.0 mmmm -114.76 96.93 5.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.61 0.764 . . . . 3.8300000000000001 109.602 173.067 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.66 -179.77 3.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.202 0.456 . . . . 2.2799999999999998 110.744 176.827 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -110.08 110.74 58.57 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 108.562 -0.903 . . . . 3.3999999999999999 108.562 175.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.57 63.12 8.69 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.506 2.804 . . . . 1.8700000000000001 113.049 -164.302 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -148.03 -50.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.873 1.669 . . . . 4.1799999999999997 108.184 172.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.37 -32.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 123.468 0.707 . . . . 1.8700000000000001 111.33 -173.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.85 163.63 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.9 -1.148 . . . . 1.54 107.9 172.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.93 154.87 26.17 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.361 -1.095 . . . . 1.3700000000000001 110.361 -179.407 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -60.44 -33.08 94.41 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.383 2.722 . . . . 1.4099999999999999 111.71 -175.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -57.28 -38.36 73.83 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.585 0.354 . . . . 5.3799999999999999 110.784 178.122 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -67.23 -45.2 77.49 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.081 -1.081 . . . . 2.8500000000000001 108.081 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.78 -56.53 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 118.355 -0.831 . . . . 1.3600000000000001 109.266 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 pt -53.5 -54.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 118.55 0.614 . . . . 2.46 110.559 176.49 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -56.24 -45.47 79.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 119.789 1.177 . . . . 5.0700000000000003 112.869 -175.384 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.6 mm -69.05 -40.13 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 121.366 -0.834 . . . . 3.6200000000000001 110.072 -178.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.86 -29.72 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 120.12 -1.612 . . . . 1.4299999999999999 112.195 176.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -59.36 -29.59 67.78 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.674 -0.642 . . . . 3.96 111.107 170.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.61 -38.69 92.06 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.963 -0.755 . . . . 4.7300000000000004 108.963 176.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.7 mt -70.77 -37.44 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.494 -0.558 . . . . 1.4099999999999999 109.494 172.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.46 28.62 5.38 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.054 1.311 . . . . 1.0800000000000001 111.02 178.298 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.415 ' CE2' HD11 ' A' ' 98' ' ' ILE . 3.7 m-85 -99.57 -178.91 4.03 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.828 -1.545 . . . . 2.1200000000000001 106.828 172.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -141.54 128.34 20.46 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.537 -1.283 . . . . 4.75 107.537 177.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.84 94.62 4.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.656 0.782 . . . . 1.1299999999999999 109.794 -172.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.6 t -98.61 96.83 8.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.799 1.24 . . . . 2.0699999999999998 107.745 -168.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.55 101.25 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.041 1.737 . . . . 4.2999999999999998 111.875 179.477 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 55.95 35.91 26.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.621 0.769 . . . . 4.2400000000000002 111.895 178.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 108.847 -0.797 . . . . 8.5999999999999996 108.847 -176.377 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 105.74 -1.948 . . . . 3.8199999999999998 105.74 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -97.02 165.78 11.91 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.626 0.771 . . . . 3.3399999999999999 109.682 173.598 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.57 126.57 17.29 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 119.067 -0.492 . . . . 1.9299999999999999 110.635 164.812 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -99.19 104.69 16.67 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.718 1.607 . . . . 2.7599999999999998 109.537 178.121 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.435 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -127.9 172.34 10.97 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.219 0.533 . . . . 2.3900000000000001 109.677 172.413 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.578 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -121.49 138.55 54.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.286 -1.375 . . . . 1.7 107.286 173.212 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.8 mm -100.17 129.88 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.527 -1.286 . . . . 1.05 107.527 177.209 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -108.89 120.71 43.32 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.666 -1.235 . . . . 2.6299999999999999 107.666 172.762 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.77 -56.28 0.33 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.258 0.932 . . . . 1.6699999999999999 112.095 177.467 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.3 mtt 25.54 77.14 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.078 2.151 . . . . 2.4700000000000002 115.522 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m -55.26 -54.68 40.44 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.719 -0.613 . . . . 2.4100000000000001 112.489 178.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.3 41.4 0.1 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.013 0.435 . . . . 4.21 111.355 -169.075 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 51.33 31.14 6.7 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.349 1.459 . . . . 5.0899999999999999 113.911 177.888 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -154.11 -42.79 0.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.424 1.489 . . . . 2.9399999999999999 110.905 -172.305 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.42 -46.91 88.31 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.622 -0.674 . . . . 1.6200000000000001 110.588 -177.716 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.04 -43.36 36.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 123.086 0.554 . . . . 2.1000000000000001 109.902 171.964 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -61.04 -47.92 84.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.479 -0.563 . . . . 2.5099999999999998 109.479 -179.062 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -46.93 88.32 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 122.178 -0.326 . . . . 2.7200000000000002 110.454 178.347 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.9 mt -50.1 -55.06 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.415 1.086 . . . . 2.0499999999999998 110.292 175.648 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' CD ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -66.79 -32.71 74.17 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.491 1.139 . . . . 6.29 110.563 -176.811 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -32.47 73.84 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 119.634 -1.917 . . . . 4.1699999999999999 111.603 172.086 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -66.32 -38.33 87.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.21 -0.663 . . . . 1.6799999999999999 109.21 171.883 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.12 -39.54 78.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.327 0.512 . . . . 2.0299999999999998 110.086 173.235 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.415 ' N ' HE21 ' A' ' 27' ' ' GLN . 0.0 OUTLIER -53.55 -20.61 5.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.135 1.161 . . . . 3.4199999999999999 114.135 173.27 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -107.88 9.67 28.73 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.612 0.765 . . . . 3.1800000000000002 112.647 179.029 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -67.22 -67.94 0.42 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.664 0.785 . . . . 2.3700000000000001 110.443 178.393 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -167.59 -101.68 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.061 0.944 . . . . 1.49 109.136 177.431 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.57 23.71 6.29 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.5 -0.75 . . . . 1.3600000000000001 113.22 -175.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.2 t -95.44 113.17 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.751 1.221 . . . . 2.3599999999999999 109.271 178.553 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 mp -139.6 54.04 1.69 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.225 0.466 . . . . 2.8100000000000001 111.172 177.272 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 m -157.08 152.65 26.7 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.047 -1.094 . . . . 1.6899999999999999 108.047 155.097 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.453 HG23 ' CD ' ' A' ' 23' ' ' GLU . 2.1 p -141.03 96.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.636 1.174 . . . . 2.73 107.979 179.779 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.71 80.75 1.99 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 108.223 -1.028 . . . . 3.0299999999999998 108.223 -177.494 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.6 t -99.53 129.35 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.206 -0.665 . . . . 1.97 109.206 174.53 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.44 81.8 3.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.37 -1.715 . . . . 1.2 106.37 170.353 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.83 -16.61 4.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.767 0.827 . . . . 3.4399999999999999 111.609 176.374 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 6.3 tpt -67.51 -38.8 84.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.401 2.28 . . . . 3.8300000000000001 110.774 176.739 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.87 -36.2 4.23 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.851 1.26 . . . . 1.5 111.624 -168.45 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.85 58.7 0.98 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.11 1.338 . . . . 1.1000000000000001 111.36 179.518 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -141.71 133.35 26.99 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.631 -1.248 . . . . 2.6800000000000002 107.631 170.701 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.78 120.28 41.01 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 0.92000000000000004 110.709 170.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.46 ' OE2' ' NZ ' ' A' ' 47' ' ' LYS . 30.0 tt0 -109.84 115.12 29.24 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.843 0.857 . . . . 4.0999999999999996 108.874 166.49 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.6 mt -107.92 168.07 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 125.39 1.476 . . . . 2.52 108.872 170.707 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.46 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -126.59 108.2 10.91 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.103 0.961 . . . . 4.5899999999999999 109.168 162.263 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.472 ' HB2' HD12 ' A' ' 53' ' ' ILE . 12.6 p90 -104.04 177.99 4.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.805 2.042 . . . . 2.1899999999999999 111.114 174.401 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -121.38 114.3 31.84 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.194 1.397 . . . . 3.2200000000000002 109.866 171.267 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.13 -22.44 69.89 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.069 2.513 . . . . 2.04 113.553 179.044 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -35.41 80.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.421 1.009 . . . . 3.4500000000000002 111.188 -179.99 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -116.32 -31.58 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-N 118.591 0.632 . . . . 2.5099999999999998 111.61 -171.136 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.472 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -126.73 132.46 70.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 123.752 0.821 . . . . 1.46 109.178 178.408 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -107.46 151.58 41.0 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.195 1.398 . . . . 2.6600000000000001 111.149 179.443 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -59.79 -34.55 95.79 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.636 2.224 . . . . 1.3100000000000001 111.981 -179.848 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.6 -53.19 60.89 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.466 -0.771 . . . . 3.1499999999999999 110.643 179.818 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.45 -36.17 82.85 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.965 -0.459 . . . . 4.3600000000000003 110.929 178.874 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.462 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -53.07 -49.97 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.028 -1.471 . . . . 1.0900000000000001 107.028 171.632 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.92 90.93 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.386 -0.37 . . . . 1.1299999999999999 111.236 -177.262 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -56.7 -43.96 81.05 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.852 -0.53 . . . . 2.46 109.726 175.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.64 -49.87 69.53 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 110.123 -0.325 . . . . 2.3100000000000001 110.123 176.099 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -63.28 -48.2 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.294 0.569 . . . . 2.3999999999999999 111.251 -176.781 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -40.92 96.86 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.935 -0.575 . . . . 2.0499999999999998 110.483 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.32 -50.92 65.9 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.469 0.577 . . . . 2.5 110.305 177.049 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.5 mt -54.17 -33.77 58.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.914 0.486 . . . . 2.1000000000000001 111.112 174.799 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.09 37.24 1.54 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.56 -1.016 . . . . 1.2 110.56 164.369 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -129.77 170.07 14.33 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.798 -1.186 . . . . 2.4399999999999999 107.798 -179.753 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -111.06 122.74 48.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.082 -0.71 . . . . 2.5899999999999999 109.082 170.331 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.84 122.27 43.15 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.443 -1.317 . . . . 0.83999999999999997 107.443 163.49 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -121.9 144.49 48.82 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.794 -1.558 . . . . 0.92000000000000004 106.794 167.235 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.43 ' HA ' ' HB3' ' A' ' 8' ' ' LEU . 2.9 t -75.49 156.89 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 108.032 -1.099 . . . . 2.4900000000000002 108.032 -179.424 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.8 ptm . . . . . 0 N--CA 1.438 -1.038 0 C-N-CA 119.238 -0.985 . . . . 4.0999999999999996 111.025 174.486 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 109.761 -1.336 . . . . 2.0699999999999998 109.761 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.486 ' HB2' ' CD ' ' A' ' 123' ' ' LYS . 1.2 p-10 -145.79 96.08 2.75 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 114.879 1.437 . . . . 3.6400000000000001 114.879 -178.553 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.33 143.77 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 106.589 -1.634 . . . . 3.98 106.589 -174.268 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -104.87 150.2 25.04 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.115 -1.809 . . . . 3.5699999999999998 106.115 172.966 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mp -135.91 154.82 51.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.32 -0.992 . . . . 2.2599999999999998 108.32 167.631 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -95.38 125.87 40.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.835 -1.913 . . . . 1.5 105.835 173.752 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 pt -98.37 139.28 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.757 -1.201 . . . . 1.77 107.757 178.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.3 m -125.22 140.21 53.05 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.634 0.773 . . . . 1.5600000000000001 109.252 174.65 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.93 -21.66 12.14 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.622 1.582 . . . . 1.1899999999999999 113.334 171.8 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.66 130.85 1.35 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.087 0.955 . . . . 3.5600000000000001 112.523 168.603 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.8 m -130.54 2.73 4.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.209 0.604 . . . . 3.8799999999999999 111.114 -178.02 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.2 p 178.74 154.83 0.41 Allowed 'General case' 0 C--N 1.341 0.231 0 O-C-N 121.165 -0.959 . . . . 3.25 109.181 -174.637 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.91 -27.66 65.45 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.579 0.752 . . . . 2.6299999999999999 112.724 -178.354 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 m -51.65 -41.43 61.34 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.343 -0.848 . . . . 2.0 111.141 169.815 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 90.8 m -65.54 -45.72 82.33 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.599 -0.519 . . . . 1.75 109.599 -179.602 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.7 t -53.28 -54.73 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.562 1.145 . . . . 1.4199999999999999 109.924 175.444 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -57.26 -45.37 84.05 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.966 0.507 . . . . 3.8199999999999998 110.168 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -61.98 -45.79 92.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.144 -0.348 . . . . 1.6200000000000001 110.968 179.077 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.7 mt -56.27 -49.63 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.93 -0.767 . . . . 0.88 108.93 176.583 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -58.57 -47.69 83.41 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.354 -0.61 . . . . 2.2799999999999998 109.354 178.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.5 t -50.83 -50.06 57.44 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.92 0.488 . . . . 1.3200000000000001 110.07 174.703 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.494 ' HG2' HD11 ' A' ' 141' ' ' ILE . 13.2 mptt -61.53 -37.93 85.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.551 -0.718 . . . . 2.7599999999999998 111.838 -178.99 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.6 mt -70.19 -60.91 2.0 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.78 -1.192 . . . . 1.8200000000000001 107.78 178.202 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.4 p -54.86 -20.67 9.28 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.206 1.402 . . . . 2.0099999999999998 113.147 -179.069 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -59.26 -25.67 64.27 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.456 0.539 . . . . 3.8199999999999998 112.456 171.279 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 39.1 m -66.68 154.28 41.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.352 1.461 . . . . 1.48 111.337 -178.559 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -72.87 -54.23 9.29 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.293 1.037 . . . . 2.3199999999999998 111.869 179.295 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.34 -36.2 63.34 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 121.401 0.445 . . . . 1.1299999999999999 112.37 -172.605 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.76 126.52 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 121.774 -0.839 . . . . 2.23 109.81 -173.309 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.0 m -98.8 -51.25 3.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.553 0.341 . . . . 2.0499999999999998 110.963 179.168 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.423 ' CZ ' ' HG3' ' A' ' 123' ' ' LYS . 36.2 p90 -140.9 111.6 6.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.325 -0.369 . . . . 2.1299999999999999 110.082 -178.749 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -96.6 153.69 17.71 Favored 'General case' 0 C--O 1.227 -0.082 0 N-CA-C 108.373 -0.973 . . . . 0.81999999999999995 108.373 167.014 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -142.83 125.51 15.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 107.041 -1.466 . . . . 2.1099999999999999 107.041 169.202 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 p -123.88 128.22 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.348 1.059 . . . . 1.96 109.734 -172.501 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.88 106.36 6.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.74 0.781 . . . . 1.0900000000000001 111.112 -168.791 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -69.29 -19.24 63.9 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 124.304 1.042 . . . . 2.2599999999999998 113.328 179.155 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.01 94.5 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.786 -0.449 . . . . 1.3799999999999999 109.786 176.004 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.06 -28.99 17.59 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.124 0.97 . . . . 1.8300000000000001 110.189 175.338 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.41 34.34 0.37 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.24 1.416 . . . . 1.55 111.319 -175.261 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -138.6 166.74 23.55 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.923 -0.485 . . . . 3.52 111.064 175.217 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -136.66 135.53 38.33 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.819 1.648 . . . . 0.81999999999999995 108.733 -178.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.01 134.55 40.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.717 -1.586 . . . . 1.77 106.717 174.323 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.4 127.99 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.032 0.533 . . . . 2.1099999999999999 110.001 -178.853 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.486 ' CD ' ' HB2' ' A' ' 81' ' ' ASN . 12.6 mmtp -116.06 87.44 2.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.615 0.766 . . . . 3.5299999999999998 109.425 -172.783 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -119.63 170.39 9.23 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.456 1.098 . . . . 2.6099999999999999 111.738 -178.255 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -96.99 114.02 63.96 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 108.182 -1.044 . . . . 3.3700000000000001 108.182 -179.053 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.72 67.95 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.137 2.558 . . . . 1.6299999999999999 110.997 -172.917 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -160.46 -47.65 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.831 1.252 . . . . 3.1800000000000002 109.125 176.886 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -85.79 -30.31 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 122.928 0.491 . . . . 1.5700000000000001 111.561 -173.145 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.74 162.04 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.155 -1.054 . . . . 1.4199999999999999 108.155 171.477 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -133.77 163.16 24.49 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.167 -1.573 . . . . 1.7 109.167 178.786 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -63.39 -35.86 58.98 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.92 2.413 . . . . 1.98 111.852 -175.968 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.17 -40.41 73.88 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.149 0.431 . . . . 4.9000000000000004 111.606 -174.071 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -51.1 71.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.647 -0.871 . . . . 3.3199999999999998 108.647 178.992 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.436 ' O ' HD13 ' A' ' 138' ' ' ILE . 53.6 mt -58.82 -50.25 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.532 -0.914 . . . . 1.3300000000000001 108.532 -179.589 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 78.4 mt -46.08 -58.74 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 118.432 -0.794 . . . . 2.3199999999999998 109.193 172.812 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -49.62 -49.86 45.21 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.697 1.135 . . . . 3.8399999999999999 112.15 177.24 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.4 mm -51.08 -55.55 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 118.206 0.457 . . . . 1.96 110.576 177.184 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.436 HD13 ' O ' ' A' ' 134' ' ' ILE 0.295 0.0 OUTLIER -68.68 -32.51 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 118.339 -1.345 . . . . 2.8100000000000001 113.311 -179.705 . . . . . . . . 4 4 . 1 . 031 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.46 -40.28 90.66 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.368 1.44 . . . . 2.2200000000000002 110.666 173.838 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -63.33 -36.92 85.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.339 0.656 . . . . 3.4399999999999999 109.818 177.1 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.494 HD11 ' HG2' ' A' ' 101' ' ' LYS . 80.6 mt -69.22 -39.7 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 120.171 -0.611 . . . . 0.93000000000000005 110.935 172.475 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.8 30.73 6.64 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.386 1.47 . . . . 0.82999999999999996 111.64 -171.597 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.442 ' CE2' HG21 ' A' ' 141' ' ' ILE . 23.1 m-85 -108.27 166.16 10.96 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.009 0.904 . . . . 1.9299999999999999 108.907 164.088 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -129.53 130.03 45.25 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 106.704 -1.591 . . . . 3.8700000000000001 106.704 -178.942 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.09 103.18 10.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.407 1.483 . . . . 1.1499999999999999 109.144 -175.685 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.5 t -121.25 120.34 34.86 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 123.314 0.646 . . . . 2.4399999999999999 110.539 -177.482 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -37.1 119.59 0.69 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.581 1.552 . . . . 3.6699999999999999 111.248 170.94 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.415 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -119.78 61.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.83 1.652 . . . . 3.54 109.464 175.717 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.252 1.217 0 O-C-N 125.737 1.898 . . . . 6.25 109.545 162.866 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 106.784 -1.562 . . . . 9.2300000000000004 106.784 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.34 89.51 3.25 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 107.421 -1.325 . . . . 4.3200000000000003 107.421 167.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.24 124.19 8.29 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.083 1.855 . . . . 2.8799999999999999 110.393 -174.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -110.35 135.49 51.0 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.592 -0.892 . . . . 2.96 108.592 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -91.73 140.73 29.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.665 -0.865 . . . . 3.52 108.665 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.5 t -119.6 132.24 55.67 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.048 -1.093 . . . . 2.4399999999999999 108.048 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -106.01 102.69 12.1 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.674 1.189 . . . . 2.7000000000000002 108.533 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.5 pt? -130.36 171.9 12.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.401 0.62 . . . . 2.5899999999999999 111.713 174.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.468 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -122.05 153.33 38.77 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.451 -1.315 . . . . 1.8700000000000001 107.451 172.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.9 mm -97.64 148.05 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 106.541 -1.652 . . . . 1.24 106.541 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -126.43 132.93 51.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.419 -1.697 . . . . 3.0600000000000001 106.419 159.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.16 -94.45 0.2 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 108.062 -2.015 . . . . 1.29 108.062 -168.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.2 mtt 50.92 75.01 0.2 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.176 1.39 . . . . 1.9299999999999999 112.552 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -37.87 37.79 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.565 -0.731 . . . . 2.1699999999999999 111.758 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.1 t 133.6 -74.66 0.0 OUTLIER 'General case' 0 C--N 1.347 0.471 0 C-N-CA 127.104 2.162 . . . . 3.1200000000000001 109.471 162.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.23 -44.0 89.64 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.053 0.76 . . . . 5.5099999999999998 113.053 -160.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 m -153.56 0.47 0.24 Allowed 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 114.689 1.366 . . . . 2.9500000000000002 114.689 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.26 -42.44 68.79 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.985 1.266 . . . . 1.7 110.227 -174.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -53.58 -46.35 60.42 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 108.703 -0.851 . . . . 2.0 108.703 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -60.64 -41.59 95.22 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.387 0.613 . . . . 2.75 111.545 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -61.42 -52.32 65.06 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.625 -0.672 . . . . 2.3599999999999999 109.81 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.6 mt -47.66 -50.4 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.331 1.052 . . . . 1.8400000000000001 110.822 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -49.8 -49.13 49.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.117 0.567 . . . . 4.75 112.055 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -65.25 -40.0 93.44 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.918 -0.489 . . . . 8.6899999999999995 110.214 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -59.4 -53.5 57.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.662 -0.496 . . . . 1.7 109.662 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.49 -41.83 86.19 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.969 -0.457 . . . . 2.4399999999999999 111.748 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -54.58 -19.49 6.06 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.977 0.732 . . . . 2.0699999999999998 112.977 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -110.54 3.04 19.13 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 117.865 -1.064 . . . . 3.25 113.069 175.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -60.37 -68.03 0.34 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 120.359 1.436 . . . . 2.98 110.97 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -168.96 -117.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.306 0.642 . . . . 1.3700000000000001 109.987 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.47 -8.53 76.08 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.557 -0.58 . . . . 1.6000000000000001 113.341 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.48 122.16 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 118.628 1.214 . . . . 1.3899999999999999 110.231 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.54 51.93 1.34 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.435 0.636 . . . . 3.1499999999999999 111.613 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -160.72 132.58 5.89 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.595 -1.631 . . . . 2.0600000000000001 106.595 161.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.9 m -118.36 132.57 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.771 -1.937 . . . . 2.5099999999999998 105.771 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -140.0 74.88 1.48 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.052 -1.462 . . . . 2.6200000000000001 107.052 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -97.39 127.88 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.432 -0.951 . . . . 2.0899999999999999 108.432 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.78 93.49 5.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.301 -1.74 . . . . 1.3500000000000001 106.301 166.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.46 -28.13 65.03 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.28 0.632 . . . . 3.3900000000000001 110.499 176.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 40.9 mtt -59.39 -64.35 0.97 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.448 1.099 . . . . 3.3599999999999999 110.425 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.0 -26.83 54.33 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.391 -0.822 . . . . 1.4299999999999999 110.552 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.63 61.23 1.8 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 125.009 1.29 . . . . 1.1499999999999999 110.545 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -138.52 144.39 39.93 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.412 -1.329 . . . . 5.8600000000000003 107.412 175.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.38 102.08 9.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.283 1.433 . . . . 1.24 109.35 167.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -96.17 134.67 38.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.301 -2.111 . . . . 4.7599999999999998 105.301 165.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 pt -140.1 171.27 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.634 -1.247 . . . . 1.78 107.634 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -120.47 108.17 13.77 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.658 0.663 . . . . 4.46 111.952 167.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.537 ' HB2' HD12 ' A' ' 53' ' ' ILE . 8.2 p90 -97.52 -179.67 4.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.684 2.393 . . . . 2.3799999999999999 111.907 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -134.97 98.86 12.74 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.065 1.346 . . . . 4.9199999999999999 109.322 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.68 -26.87 75.58 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.754 2.969 . . . . 1.8500000000000001 113.185 -162.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -75.04 -10.5 59.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.939 0.495 . . . . 3.6000000000000001 111.753 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.3 -49.37 2.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 124.102 0.961 . . . . 3.0800000000000001 109.954 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -115.59 147.5 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.71 1.204 . . . . 2.3199999999999998 107.958 179.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -124.17 151.89 66.48 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.484 1.114 . . . . 2.8300000000000001 108.869 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.4 -34.87 97.44 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.747 2.298 . . . . 1.6399999999999999 112.127 -172.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -71.28 -35.07 71.2 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.567 0.58 . . . . 3.3700000000000001 112.567 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -58.02 -48.33 80.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.407 0.683 . . . . 3.1600000000000001 109.22 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -52.47 -53.28 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 106.931 -1.507 . . . . 1.3899999999999999 106.931 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.33 73.78 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.008 -0.542 . . . . 1.1100000000000001 109.964 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -45.79 74.84 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.3 0.64 . . . . 2.6600000000000001 110.645 176.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -47.51 81.57 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.387 0.613 . . . . 2.2799999999999998 110.119 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 69' ' ' ALA . 6.2 mm -67.36 -41.84 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.548 -0.72 . . . . 2.6400000000000001 111.008 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -44.86 95.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.94 1.296 . . . . 2.1600000000000001 109.443 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.04 -51.62 68.88 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.067 0.547 . . . . 2.1699999999999999 109.842 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.3 mt -58.94 -31.1 68.37 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.567 -0.288 . . . . 3.3199999999999998 111.767 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.89 27.63 2.93 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.145 0.879 . . . . 1.0900000000000001 111.923 163.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -119.31 167.35 11.97 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.102 1.361 . . . . 2.2400000000000002 108.274 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -96.82 132.74 42.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.183 -1.414 . . . . 2.52 107.183 164.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.404 ' HB2' HG13 ' A' ' 62' ' ' ILE . . . -108.09 119.37 39.28 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.162 -1.792 . . . . 0.81999999999999995 106.162 163.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.468 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -129.53 122.44 29.23 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.063 -1.088 . . . . 1.1299999999999999 108.063 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.431 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.9 t -56.89 144.05 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 109.551 -0.537 . . . . 2.3500000000000001 109.551 171.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.6 mtp -53.99 -46.78 71.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.361 -0.836 . . . . 3.6899999999999999 109.245 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.407 ' H ' HG12 ' A' ' 71' ' ' VAL . 2.1 tt0 166.45 -43.78 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 131.255 3.822 . . . . 4.1900000000000004 102.441 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.91 63.61 7.65 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 124.621 2.153 . . . . 7.54 111.616 -165.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -40.24 -21.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 1 C-N-CA 132.493 4.317 . . . . 4.3499999999999996 115.47 168.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -172.84 -97.31 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.6 0.76 . . . . 3.9300000000000002 110.34 162.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.89 58.57 0.88 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.204 -1.958 . . . . 3.7799999999999998 108.204 -168.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.9 -116.91 0.09 Allowed 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 117.401 -1.285 . . . . 5.21 111.704 -156.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -107.84 115.0 29.34 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 121.752 2.069 . . . . 5.1100000000000003 109.335 -175.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.12 -49.24 4.19 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.392 -1.883 . . . . 2.0499999999999998 108.392 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.83 82.53 3.03 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 127.469 2.308 . . . . 4.5 107.572 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.41 172.63 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.665 0.745 . . . . 2.9399999999999999 109.005 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -142.34 157.39 44.86 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 124.26 1.024 . . . . 4.5599999999999996 108.402 170.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.6 mt -143.0 147.39 35.05 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.581 1.152 . . . . 2.3300000000000001 109.138 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.64 119.34 34.94 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.72 -1.585 . . . . 1.78 106.72 165.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.24 116.0 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.712 1.205 . . . . 1.98 108.165 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.7 m -106.58 147.49 29.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.149 1.38 . . . . 2.46 107.986 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.4 -40.29 2.48 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.635 1.112 . . . . 1.2 111.279 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -58.96 141.67 53.13 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.458 0.703 . . . . 2.5699999999999998 110.648 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.8 t -159.94 37.68 0.18 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.092 0.557 . . . . 3.2000000000000002 111.328 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 51.8 t -162.71 142.06 9.07 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.257 -0.902 . . . . 2.7200000000000002 110.732 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.78 -45.31 49.55 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.878 0.871 . . . . 2.7599999999999998 111.441 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 m -56.21 -39.74 72.96 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.816 -0.553 . . . . 2.4300000000000002 111.649 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 78.7 m -64.97 -46.81 79.96 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.838 -0.801 . . . . 1.8500000000000001 108.838 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.1 t -50.91 -55.06 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.167 0.587 . . . . 1.3600000000000001 110.593 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -59.38 -42.47 91.74 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.865 0.84 . . . . 3.6899999999999999 109.581 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.59 -49.36 75.53 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.136 1.374 . . . . 1.8799999999999999 110.906 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -54.75 -50.08 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.233 0.613 . . . . 1.4099999999999999 109.677 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.86 -41.39 99.36 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.195 0.598 . . . . 2.3799999999999999 109.507 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.7 t -56.15 -52.88 62.78 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.116 0.566 . . . . 1.3500000000000001 110.475 171.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -51.98 -45.8 64.61 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.639 -0.663 . . . . 2.6899999999999999 110.77 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.23 -60.19 3.26 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.732 -1.21 . . . . 1.9299999999999999 107.732 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -52.92 -23.2 6.68 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.822 0.701 . . . . 2.2599999999999998 112.429 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -64.89 -25.53 67.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 120.36 -0.536 . . . . 4.3600000000000003 112.305 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 m -69.69 135.09 49.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.195 1.798 . . . . 1.79 110.384 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.9 p-10 -52.38 -51.22 60.14 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.139 0.975 . . . . 2.1800000000000002 113.565 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.29 -36.96 43.4 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 122.094 -0.379 . . . . 1.25 113.277 -170.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.38 121.57 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 O-C-N 121.753 -0.851 . . . . 1.78 109.307 -168.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.7 m -102.64 -40.11 6.77 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.665 0.386 . . . . 2.2599999999999998 111.141 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -141.74 127.69 19.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.291 0.496 . . . . 2.1800000000000002 110.378 164.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -98.45 155.61 17.17 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.707 -1.22 . . . . 0.98999999999999999 107.707 162.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.0 m -144.36 106.17 4.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 118.048 -0.977 . . . . 2.1400000000000001 108.687 165.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 120' ' ' ALA . 11.1 p -98.76 126.66 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.216 0.916 . . . . 2.3500000000000001 112.496 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.87 101.59 7.15 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.844 1.257 . . . . 1.21 109.947 -172.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 pp -75.49 -29.2 59.47 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.367 1.467 . . . . 2.2000000000000002 113.062 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.32 85.55 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 121.716 0.77 . . . . 1.72 109.171 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.8 -30.9 18.65 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.27 1.828 . . . . 2.4700000000000002 109.138 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 74.1 m 64.76 50.48 2.03 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.974 1.709 . . . . 2.0699999999999998 110.261 -176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -139.71 166.15 25.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.618 -0.719 . . . . 2.8100000000000001 110.816 158.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.408 ' HB2' HG23 ' A' ' 113' ' ' VAL . . . -130.38 132.7 45.91 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.073 2.149 . . . . 0.96999999999999997 107.917 -176.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.49 138.56 34.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.711 -1.218 . . . . 2.0099999999999998 107.711 172.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.1 t -131.42 128.64 61.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.624 1.17 . . . . 2.27 108.811 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -121.67 94.36 4.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.106 0.963 . . . . 3.4300000000000002 109.123 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -128.4 -177.94 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.719 0.691 . . . . 2.6200000000000001 111.528 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -99.65 115.3 65.73 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.0 0.92 . . . . 3.3799999999999999 109.476 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.28 69.52 7.56 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.256 2.637 . . . . 1.8200000000000001 112.084 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -163.56 -44.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.694 1.198 . . . . 3.9900000000000002 109.928 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pt -81.69 -30.71 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 122.275 -0.266 . . . . 1.71 111.318 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.01 171.38 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.76 -1.57 . . . . 1.6299999999999999 106.76 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.11 160.98 28.76 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.789 -0.924 . . . . 1.9099999999999999 110.789 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.85 -36.59 90.31 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.93 3.086 . . . . 1.9199999999999999 112.231 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -35.64 74.74 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 123.01 0.524 . . . . 6.4699999999999998 110.177 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.36 -43.19 82.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.175 0.898 . . . . 3.2999999999999998 109.622 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 68.7 mt -57.96 -48.14 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.447 -0.575 . . . . 1.3400000000000001 109.447 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 60.1 mt -51.41 -60.8 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 108.82 -0.807 . . . . 2.1499999999999999 108.82 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -44.44 -52.7 7.59 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.633 1.173 . . . . 4.5800000000000001 112.378 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.4 mm -51.99 -53.64 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 109.253 -0.647 . . . . 2.2799999999999998 109.253 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.272 2.3 pp -70.34 -26.83 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 114.034 1.124 . . . . 1.3300000000000001 114.034 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -62.74 -38.16 89.4 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.321 0.964 . . . . 3.3500000000000001 109.418 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -63.88 -35.87 82.08 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.609 0.764 . . . . 5.0599999999999996 109.017 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 47.7 mt -68.38 -49.3 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 110.052 -0.351 . . . . 1.3 110.052 170.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.91 30.53 2.31 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.943 1.735 . . . . 1.1200000000000001 112.488 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -102.06 179.06 4.43 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.944 1.372 . . . . 2.1000000000000001 109.757 166.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -132.94 118.03 18.38 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 108.007 -1.108 . . . . 4.4100000000000001 108.007 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.07 100.06 9.57 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.554 1.142 . . . . 1.2 109.755 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.6 m -109.37 112.73 25.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.189 0.995 . . . . 2.3100000000000001 108.587 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -33.07 105.81 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 126.447 1.899 . . . . 4.4299999999999997 110.101 168.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.93 -34.76 71.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.345 -0.843 . . . . 3.3700000000000001 110.314 -171.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.249 1.044 0 C-N-CA 128.156 2.582 . . . . 5.8200000000000003 114.604 169.187 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 108.201 -1.037 . . . . 9.2300000000000004 108.201 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.41 125.61 91.83 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.659 1.583 . . . . 4.3200000000000003 111.797 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.24 110.92 2.8 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 121.39 1.394 . . . . 2.8799999999999999 110.742 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.89 146.35 51.73 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.193 1.797 . . . . 2.96 106.478 175.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -103.23 154.53 19.24 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.747 -1.205 . . . . 3.52 107.747 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.616 ' SG ' HD21 ' A' ' 8' ' ' LEU . 12.6 p -142.32 130.34 21.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.316 0.488 . . . . 2.4399999999999999 112.316 169.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -98.27 103.69 15.66 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.126 2.17 . . . . 2.7000000000000002 110.271 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.616 HD21 ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -122.39 176.64 5.77 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.744 0.783 . . . . 2.5899999999999999 110.199 171.329 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.87 151.51 43.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.259 -1.386 . . . . 1.8700000000000001 107.259 168.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 44' ' ' ALA . 20.5 mm -95.85 148.04 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.538 -1.653 . . . . 1.24 106.538 171.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -121.64 106.43 11.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.46 -1.311 . . . . 3.0600000000000001 107.46 163.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.8 -93.65 0.12 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.746 -1.342 . . . . 1.29 109.746 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 mtt 54.25 80.66 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.137 1.375 . . . . 1.9299999999999999 113.808 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.14 -20.47 17.78 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.847 0.859 . . . . 2.1699999999999999 112.671 170.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.4 t 74.79 -79.5 0.04 OUTLIER 'General case' 0 C--N 1.342 0.255 0 N-CA-C 107.642 -1.244 . . . . 3.1200000000000001 107.642 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 4.83 -87.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 128.418 2.687 . . . . 5.5099999999999998 112.813 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.1 m -138.22 22.49 2.78 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.292 0.637 . . . . 2.9500000000000002 109.982 160.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.5 m -69.69 -53.49 18.31 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 119.342 -0.943 . . . . 1.7 109.125 -168.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.5 t -50.03 -39.65 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.348 0.594 . . . . 2.0 110.381 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.12 -46.83 87.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.491 0.663 . . . . 2.75 111.221 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -64.57 -46.52 82.39 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.836 -1.165 . . . . 2.3599999999999999 110.804 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -46.57 -53.7 2.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 C-N-CA 124.868 1.267 . . . . 1.8400000000000001 108.842 175.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -45.68 -56.26 5.45 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.393 0.616 . . . . 4.75 110.858 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -24.33 61.48 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.151 0.98 . . . . 8.6899999999999995 110.874 -173.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -69.98 -57.35 5.11 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.683 -0.858 . . . . 1.7 108.683 173.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.03 -42.03 89.22 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 118.522 0.601 . . . . 2.4399999999999999 110.562 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -22.51 19.93 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.513 0.56 . . . . 2.0699999999999998 112.513 177.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -124.28 32.16 5.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.944 0.898 . . . . 3.25 111.229 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -74.18 -76.84 0.12 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.021 -1.103 . . . . 2.98 108.021 165.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.74 -118.69 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.276 0.63 . . . . 1.3700000000000001 110.0 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.82 -13.03 80.89 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 119.522 1.056 . . . . 1.6000000000000001 113.049 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.08 125.86 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 117.61 0.705 . . . . 1.3899999999999999 112.215 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.91 57.01 1.41 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.701 1.2 . . . . 3.1499999999999999 108.093 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.5 t -160.32 154.4 23.12 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 120.535 -1.353 . . . . 2.0600000000000001 108.141 149.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.4 t -132.94 106.74 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.681 -1.229 . . . . 2.5099999999999998 107.681 167.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 tt -124.25 73.79 1.26 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.509 -1.293 . . . . 2.6200000000000001 107.509 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' A' ' 44' ' ' ALA . 58.6 t -102.75 128.0 55.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 109.003 -0.74 . . . . 2.0899999999999999 109.003 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.94 98.07 9.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.654 -1.239 . . . . 1.3500000000000001 107.654 170.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 tp -61.67 -26.83 68.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.267 1.027 . . . . 3.3900000000000001 110.258 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -50.75 43.42 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.784 -0.573 . . . . 3.3599999999999999 110.108 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.5 -7.22 26.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.545 0.738 . . . . 1.4299999999999999 112.555 -169.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.38 66.98 2.13 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.181 -1.168 . . . . 1.1499999999999999 110.181 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 131.16 20.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.106 -1.232 . . . . 5.8600000000000003 108.839 171.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.507 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -110.06 90.2 3.24 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.992 2.117 . . . . 1.24 110.521 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -102.95 130.08 49.91 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.254 -1.388 . . . . 4.7599999999999998 107.254 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 pt -140.13 -179.6 2.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 O-C-N 121.236 -0.915 . . . . 1.78 108.585 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -132.67 104.71 6.78 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.27 0.628 . . . . 4.46 110.007 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -106.27 172.55 6.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.83 1.252 . . . . 2.3799999999999999 113.265 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -114.56 101.49 54.32 Favored Pre-proline 0 N--CA 1.444 -0.75 0 C-N-CA 129.212 3.005 . . . . 4.9199999999999999 109.627 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.11 8.91 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.749 1.633 . . . . 1.8500000000000001 113.978 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -91.05 -26.83 18.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.533 1.133 . . . . 3.6000000000000001 112.039 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.69 -63.35 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 105.566 -2.012 . . . . 3.0800000000000001 105.566 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.46 170.07 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 120.242 -0.583 . . . . 2.3199999999999998 110.35 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.86 159.54 68.26 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 124.742 1.217 . . . . 2.8300000000000001 108.416 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.24 -40.78 30.64 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.46 2.107 . . . . 1.6399999999999999 111.256 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -58.22 -40.71 82.36 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.993 -0.442 . . . . 3.3700000000000001 111.184 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -61.16 -44.94 96.53 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.893 0.877 . . . . 3.1600000000000001 110.656 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -49.66 -57.92 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.368 0 N-CA-C 106.212 -1.773 . . . . 1.3899999999999999 106.212 170.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -58.03 -43.51 86.84 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.473 -0.785 . . . . 1.1100000000000001 110.165 -170.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -50.1 65.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.569 1.548 . . . . 2.6600000000000001 110.049 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.06 -45.83 86.4 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.574 0.702 . . . . 2.2799999999999998 109.707 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.534 HG21 ' HB2' ' A' ' 69' ' ' ALA . 5.6 mm -61.59 -44.03 97.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 116.291 -0.413 . . . . 2.6400000000000001 110.373 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -64.96 -40.86 95.65 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.234 -0.916 . . . . 2.1600000000000001 110.012 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -61.1 -50.44 73.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.935 0.894 . . . . 2.1699999999999999 109.932 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.38 -35.18 80.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.3 -0.56 . . . . 3.3199999999999998 110.781 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.29 23.4 1.75 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 123.386 0.517 . . . . 1.0900000000000001 112.708 163.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.425 ' O ' HG22 ' A' ' 62' ' ' ILE . 2.5 m-30 -112.79 158.71 19.79 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.889 0.845 . . . . 2.2400000000000002 109.68 174.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -95.43 133.35 39.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.045 -1.465 . . . . 2.52 107.045 167.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.534 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -123.06 125.31 44.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.111 0.964 . . . . 0.81999999999999995 108.531 169.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.19 134.88 44.66 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.408 -0.59 . . . . 1.1299999999999999 109.408 171.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 2.3 t -53.15 151.8 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.315 1.046 . . . . 2.3500000000000001 110.726 175.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.0 mtp -74.9 -3.76 33.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.649 -0.705 . . . . 3.6899999999999999 111.946 173.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 98.51 7.37 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 129.111 2.964 . . . . 4.1900000000000004 110.666 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -156.5 65.16 0.54 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 123.428 1.585 . . . . 7.54 108.45 -166.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -24.79 -63.28 0.06 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 112.429 -2.168 . . . . 4.3499999999999996 113.927 173.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -179.58 -71.24 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 119.255 0.934 . . . . 3.9300000000000002 111.365 -167.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.58 83.78 1.61 Allowed Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 109.355 -1.498 . . . . 3.7799999999999998 109.355 -175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.0 t -135.34 -105.41 0.22 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 118.734 -0.651 . . . . 5.21 112.648 -177.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -114.67 142.18 46.83 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.004 -1.48 . . . . 5.1100000000000003 107.004 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.26 -43.72 2.54 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.642 -0.983 . . . . 2.0499999999999998 110.642 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.465 ' C ' HD13 ' A' ' 82' ' ' ILE . 31.9 p-10 -129.39 119.34 23.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.917 0.887 . . . . 4.5 111.283 169.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.547 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -112.27 157.02 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.547 -1.279 . . . . 2.9399999999999999 107.547 172.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.94 141.54 32.96 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.813 0.845 . . . . 4.5599999999999996 109.632 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.6 mt -141.47 143.77 34.03 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 109.099 -0.704 . . . . 2.3300000000000001 109.099 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.57 130.63 43.72 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 107.726 -1.212 . . . . 1.78 107.726 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 pp -111.4 99.88 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.331 1.052 . . . . 1.98 110.671 -169.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.1 p -97.31 129.51 44.58 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.875 -0.787 . . . . 2.46 108.875 -175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.86 -26.98 6.98 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.349 0.976 . . . . 1.2 111.326 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.487 ' SD ' HD13 ' A' ' 98' ' ' ILE . 3.0 mtm -63.11 149.03 46.21 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.125 -0.632 . . . . 2.5699999999999998 112.211 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -169.82 41.92 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.939 1.295 . . . . 3.2000000000000002 109.287 172.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -166.04 140.63 4.54 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 121.107 -0.996 . . . . 2.7200000000000002 112.895 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.08 -42.62 81.02 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.447 0.699 . . . . 2.7599999999999998 110.751 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.3 m -50.48 -45.14 56.15 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.228 0.611 . . . . 2.4300000000000002 110.807 173.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 75.5 m -64.39 -50.94 65.68 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.017 -0.735 . . . . 1.8500000000000001 109.017 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 78.7 t -48.32 -51.77 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.08 0.552 . . . . 1.3600000000000001 110.664 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -59.17 -34.71 72.42 Favored 'General case' 0 C--O 1.227 -0.086 0 CA-C-O 120.722 0.296 . . . . 3.6899999999999999 110.335 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -63.4 -58.86 5.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.86 0.864 . . . . 1.8799999999999999 109.393 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.487 HD13 ' SD ' ' A' ' 89' ' ' MET . 3.2 mp -52.94 -52.22 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.366 -0.605 . . . . 1.4099999999999999 109.366 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.28 -49.76 73.32 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.175 -0.676 . . . . 2.3799999999999999 109.175 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 t -53.73 -46.77 70.94 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 122.047 -0.408 . . . . 1.3500000000000001 110.529 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -65.18 -38.11 89.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.124 0.57 . . . . 2.6899999999999999 111.791 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.497 HD22 HG11 ' A' ' 122' ' ' VAL . 47.7 mt -70.91 -62.64 1.32 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.373 -0.973 . . . . 1.9299999999999999 108.373 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.4 m -50.29 -24.36 2.88 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.633 2.373 . . . . 2.2599999999999998 112.692 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -32.12 62.58 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.288 0.477 . . . . 4.3600000000000003 112.288 172.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.2 m -59.42 144.54 46.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.573 1.149 . . . . 1.79 111.118 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -66.8 -47.97 70.43 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.968 0.907 . . . . 2.1800000000000002 111.552 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.74 -30.21 66.45 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 123.527 0.584 . . . . 1.25 113.293 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.9 tt -69.61 130.26 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 122.117 -0.637 . . . . 1.78 110.277 -167.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 37.7 m -99.64 -49.77 4.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.753 -0.203 . . . . 2.2599999999999998 110.824 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -141.31 122.65 14.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.274 -0.639 . . . . 2.1800000000000002 109.274 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.88 156.12 16.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.265 -1.013 . . . . 0.98999999999999999 108.265 161.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.5 t -141.05 122.25 14.77 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 107.276 -1.379 . . . . 2.1400000000000001 107.276 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.59 117.2 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.691 1.196 . . . . 2.3500000000000001 108.825 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.26 97.72 5.18 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.131 0.967 . . . . 1.21 111.525 -171.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 pp -59.72 -22.07 61.53 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.412 0.893 . . . . 2.2000000000000002 113.412 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.53 -38.28 49.12 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.454 0.645 . . . . 1.72 109.471 -176.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.5 p -88.79 -20.08 25.17 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 125.011 1.324 . . . . 2.4700000000000002 109.353 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.5 m 73.25 21.48 3.05 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.885 2.074 . . . . 2.0699999999999998 111.096 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -130.24 157.3 42.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.899 0.857 . . . . 2.8100000000000001 112.083 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.27 122.47 29.7 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.061 2.145 . . . . 0.96999999999999997 107.366 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mp -99.87 137.86 37.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.542 1.537 . . . . 2.0099999999999998 107.451 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.497 HG11 HD22 ' A' ' 102' ' ' LEU . 3.5 m -136.73 122.63 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.825 1.25 . . . . 2.27 109.346 -169.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -111.37 87.94 2.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.665 -0.683 . . . . 3.4300000000000002 109.615 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -117.55 173.33 6.78 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.858 0.863 . . . . 2.6200000000000001 110.657 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -98.49 112.61 62.78 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 108.397 -0.964 . . . . 3.3799999999999999 108.397 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.02 73.65 4.81 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.39 2.726 . . . . 1.8200000000000001 111.991 -165.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -162.1 -43.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.228 1.411 . . . . 3.9900000000000002 110.153 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 pt -83.77 -31.77 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 123.762 0.825 . . . . 1.71 111.281 -170.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.68 158.96 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.337 -0.986 . . . . 1.6299999999999999 108.337 171.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -126.71 159.93 20.99 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.099 1.333 . . . . 1.9099999999999999 109.958 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.7 -36.17 42.77 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.125 2.55 . . . . 1.9199999999999999 111.356 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.17 -40.71 74.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.748 1.219 . . . . 6.4699999999999998 110.869 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -66.05 -43.91 86.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.671 -0.492 . . . . 3.2999999999999998 109.671 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.45 -47.68 89.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.645 -0.872 . . . . 1.3400000000000001 108.645 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.7 mt -53.05 -56.19 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 123.825 0.85 . . . . 2.1499999999999999 109.529 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -48.34 64.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.366 0.985 . . . . 4.5800000000000001 110.824 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.0 mm -54.74 -52.99 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 122.047 -0.408 . . . . 2.2799999999999998 110.065 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.257 2.5 pp -70.52 -27.85 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.764 -1.21 . . . . 1.3300000000000001 113.419 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.29 -32.85 73.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.36 0.527 . . . . 3.3500000000000001 110.646 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -57.31 -42.94 82.78 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.844 -0.798 . . . . 5.0599999999999996 108.844 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.8 mt -73.8 -40.57 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.771 -0.65 . . . . 1.3 109.517 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.38 37.0 3.41 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.007 1.289 . . . . 1.1200000000000001 110.92 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.459 ' CD2' HD11 ' A' ' 98' ' ' ILE . 30.5 m-85 -99.49 178.1 4.97 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.262 -1.014 . . . . 2.1000000000000001 108.262 160.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -140.63 125.87 18.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 107.027 -1.471 . . . . 4.4100000000000001 107.027 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.59 106.45 14.88 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.498 1.519 . . . . 1.2 108.722 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.9 t -123.6 136.27 54.42 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 118.423 0.556 . . . . 2.3100000000000001 110.496 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp -32.24 119.91 0.29 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.808 2.043 . . . . 4.4299999999999997 113.27 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.56 49.03 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.085 0.954 . . . . 3.3700000000000001 111.211 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.332 0 CA-C-O 116.042 -1.932 . . . . 5.8200000000000003 107.356 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 109.11 -0.7 . . . . 7.6799999999999997 109.11 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.79 98.79 0.04 OUTLIER Pre-proline 0 C--O 1.219 -0.515 0 C-N-CA 125.184 1.393 . . . . 3.9700000000000002 109.311 -166.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.39 141.5 22.85 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.547 2.165 . . . . 2.8900000000000001 110.754 -170.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -116.32 141.56 48.0 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.418 -0.956 . . . . 4.0 108.418 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -90.64 157.08 17.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.99 -1.855 . . . . 3.98 105.99 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.495 ' SG ' HD11 ' A' ' 8' ' ' LEU . 0.5 OUTLIER -135.22 121.92 20.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.695 -1.594 . . . . 2.29 106.695 177.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.43 ' C ' HD13 ' A' ' 8' ' ' LEU . 62.8 m-85 -102.3 90.59 3.95 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.313 1.845 . . . . 3.71 109.05 -173.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.592 HD12 ' HB ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -117.68 171.26 8.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.576 0.703 . . . . 2.77 111.204 178.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.456 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -116.48 143.03 46.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.394 -0.965 . . . . 1.8200000000000001 108.394 166.203 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.417 HG12 ' HB2' ' A' ' 44' ' ' ALA . 42.3 mm -99.44 139.29 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 107.276 -1.379 . . . . 1.04 107.276 175.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -125.97 123.01 37.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.074 -1.454 . . . . 2.9700000000000002 107.074 168.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.58 -69.66 0.25 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.224 1.392 . . . . 1.74 110.442 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.9 mmt 37.09 71.2 0.15 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.758 2.023 . . . . 2.71 114.254 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -52.56 -60.52 3.15 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.469 -0.769 . . . . 2.73 113.064 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 t -165.87 48.67 0.08 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 119.518 -0.873 . . . . 3.7799999999999998 111.816 -172.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.05 51.91 15.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.454 1.102 . . . . 5.6699999999999999 112.243 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.3 m -175.18 -36.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.039 1.335 . . . . 3.3900000000000001 110.96 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.71 -42.86 77.12 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 120.965 -1.084 . . . . 2.02 110.536 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.0 -43.98 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.348 -0.612 . . . . 1.8500000000000001 109.348 168.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -62.07 -30.78 71.23 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.459 0.647 . . . . 2.2599999999999998 111.861 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -71.47 -46.45 59.87 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 120.98 -1.075 . . . . 3.52 110.706 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.513 HG12 HD13 ' A' ' 65' ' ' LEU . 50.8 mt -49.28 -45.98 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.397 0.679 . . . . 1.5 110.823 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -45.19 -48.07 12.48 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.444 0.565 . . . . 4.1699999999999999 112.216 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.0 mtm105 -66.02 -34.09 77.29 Favored 'General case' 0 C--N 1.339 0.115 0 O-C-N 121.754 -0.591 . . . . 5.6200000000000001 110.753 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -63.7 -54.55 33.7 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.241 -1.022 . . . . 1.1599999999999999 108.241 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mp -60.19 -36.44 77.63 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 111.953 0.353 . . . . 1.97 111.953 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -19.45 6.34 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.178 -0.951 . . . . 1.78 113.128 173.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -118.77 21.31 12.54 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.656 -0.688 . . . . 3.6800000000000002 112.519 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -66.69 -68.36 0.38 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.355 0.98 . . . . 3.0899999999999999 109.292 168.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.57 -125.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.419 0.687 . . . . 1.29 109.161 -167.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.0 -10.07 61.07 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 121.85 -0.531 . . . . 1.51 113.389 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -74.95 120.59 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 118.739 1.269 . . . . 1.96 110.38 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.86 53.07 1.09 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.068 0.396 . . . . 2.7400000000000002 112.068 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.487 ' HB3' ' CB ' ' A' ' 47' ' ' LYS . 29.1 t -158.16 137.0 11.34 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 106.731 -1.581 . . . . 2.0299999999999998 106.731 171.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.25 101.79 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.607 -1.627 . . . . 2.6299999999999999 106.607 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -129.3 76.39 1.72 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.158 -1.793 . . . . 2.3500000000000001 106.158 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.21 141.55 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.945 -1.131 . . . . 2.0899999999999999 107.945 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -112.85 101.82 9.87 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.263 -1.754 . . . . 1.27 106.263 164.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 tp -55.65 -33.0 63.67 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.488 1.115 . . . . 3.46 109.037 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -48.97 77.29 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.545 0.738 . . . . 5.6699999999999999 110.571 -174.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.05 -30.48 16.74 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.499 0.72 . . . . 1.54 110.875 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.35 57.69 1.74 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.984 1.278 . . . . 1.1699999999999999 110.603 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -140.05 144.56 36.94 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.131 0.966 . . . . 3.2400000000000002 108.856 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.417 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -112.49 116.24 29.95 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.151 0.98 . . . . 1.1000000000000001 111.398 164.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -97.78 123.79 41.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.716 -1.216 . . . . 4.3300000000000001 107.716 157.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mt -114.01 164.87 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 108.136 -1.061 . . . . 3.0 108.136 167.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.487 ' CB ' ' HB3' ' A' ' 34' ' ' SER . 10.3 ttmt -124.65 108.93 12.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.739 1.215 . . . . 3.8799999999999999 110.194 166.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -116.83 177.26 4.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.1 2.16 . . . . 2.7400000000000002 112.634 175.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.42 107.63 23.81 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.641 1.576 . . . . 3.1899999999999999 107.559 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.93 6.81 2.28 Favored 'Trans proline' 0 N--CA 1.455 -0.753 1 C-N-CA 125.512 4.142 . . . . 2.4700000000000002 113.605 -168.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -86.73 -22.16 26.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.46 0.704 . . . . 3.8300000000000001 111.207 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.73 -56.01 3.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-N 118.566 0.621 . . . . 3.2200000000000002 109.876 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.31 142.77 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.549 -1.278 . . . . 1.8799999999999999 107.549 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.26 150.79 54.78 Favored Pre-proline 0 N--CA 1.453 -0.293 0 C-N-CA 124.798 1.239 . . . . 2.5800000000000001 109.583 -174.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.18 -44.27 35.46 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.758 2.305 . . . . 1.51 111.627 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -63.97 -39.72 94.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.372 -0.83 . . . . 3.3599999999999999 111.488 178.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -58.47 -43.69 89.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.005 0.522 . . . . 4.2199999999999998 110.352 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.57 -42.39 29.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 N-CA-C 108.727 -0.842 . . . . 1.5900000000000001 108.727 173.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 56' ' ' LEU . . . -57.32 -38.59 74.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.12 0.486 . . . . 1.72 111.152 -176.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -63.88 -51.48 64.38 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.491 -0.755 . . . . 3.0099999999999998 110.109 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -54.26 -51.91 63.05 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.91 0.323 . . . . 3.52 111.695 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.621 HD13 ' H ' ' A' ' 69' ' ' ALA . 2.4 pp -61.25 -42.73 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.649 -0.657 . . . . 4.5700000000000003 111.741 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.404 ' NE2' HD11 ' A' ' 62' ' ' ILE . 0.9 OUTLIER -65.41 -35.15 80.06 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.663 -0.648 . . . . 2.4900000000000002 110.758 178.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -64.27 -50.75 66.69 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.174 0.59 . . . . 2.5899999999999999 109.901 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.513 HD13 HG12 ' A' ' 22' ' ' ILE . 15.3 mt -55.08 -35.38 64.5 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.163 0.585 . . . . 1.9299999999999999 111.129 173.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.4 39.88 1.44 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.558 1.075 . . . . 1.45 110.589 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -135.43 156.97 48.04 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.528 1.531 . . . . 2.3300000000000001 107.596 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -104.94 129.75 53.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.695 -1.224 . . . . 3.6299999999999999 107.695 171.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.621 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -123.62 112.32 17.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.392 -1.707 . . . . 1.0900000000000001 106.392 171.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -117.53 129.45 55.8 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.356 1.035 . . . . 0.94999999999999996 108.916 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.592 ' HB ' HD12 ' A' ' 8' ' ' LEU . 7.1 p -81.8 154.29 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.788 0.835 . . . . 2.73 109.153 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.0 mtt -51.23 -56.26 13.82 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.19 -0.459 . . . . 3.5099999999999998 110.525 170.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' H ' HG22 ' A' ' 71' ' ' VAL . 2.4 tt0 -170.7 54.72 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.551 0.532 . . . . 4.8499999999999996 111.136 -171.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.483 ' HA ' HG21 ' A' ' 71' ' ' VAL . 0.2 OUTLIER 11.23 64.93 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 128.447 2.699 . . . . 9.8399999999999999 114.053 -170.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.493 ' CE1' ' HB2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -103.86 -47.38 4.22 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 112.628 -2.078 . . . . 7.2300000000000004 110.074 -166.228 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 93.79 -103.49 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.835 2.054 . . . . 3.6099999999999999 112.139 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 82' ' ' ILE . . . 100.49 84.02 1.77 Allowed Glycine 0 C--N 1.335 0.502 0 CA-C-N 119.377 0.99 . . . . 3.5800000000000001 114.671 175.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 t -162.74 -61.11 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.915 -0.402 . . . . 5.2599999999999998 109.915 154.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -142.75 123.35 14.09 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.364 -1.347 . . . . 5.7999999999999998 107.364 -163.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.41 -61.76 4.67 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 107.913 -2.075 . . . . 2.3500000000000001 107.913 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.05 110.94 23.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.225 0.61 . . . . 2.2799999999999998 109.489 175.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.485 ' C ' HD12 ' A' ' 82' ' ' ILE . 1.5 pp -129.67 174.96 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.799 0.84 . . . . 3.6000000000000001 110.874 164.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' HB2' ' CE1' ' A' ' 75' ' ' TYR . 0.9 OUTLIER -111.3 150.93 28.97 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 128.041 2.536 . . . . 4.4100000000000001 109.401 174.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.2 mt -142.34 139.58 31.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.563 0.745 . . . . 2.4700000000000002 110.03 172.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.1 t -97.1 124.45 41.12 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.33 0.968 . . . . 1.99 109.51 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -95.9 106.51 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.185 -0.672 . . . . 1.6699999999999999 109.185 -171.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.9 m -98.83 133.74 42.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.903 -1.147 . . . . 1.46 107.903 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.62 -44.96 1.32 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.918 1.247 . . . . 0.96999999999999997 112.013 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.52 150.82 41.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.662 0.731 . . . . 2.6200000000000001 111.349 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -162.5 44.65 0.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.543 0.687 . . . . 2.9199999999999999 110.057 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 48.9 t -161.99 136.67 6.98 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.826 -1.171 . . . . 2.8799999999999999 110.721 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.6 -39.15 49.23 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.055 0.942 . . . . 2.8799999999999999 111.352 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 m -56.23 -44.2 79.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.611 -0.681 . . . . 2.0699999999999998 111.394 174.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 64.1 m -68.58 -49.98 55.25 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.222 -0.659 . . . . 1.8500000000000001 109.222 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 113' ' ' VAL . 78.8 t -43.49 -60.4 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.775 1.23 . . . . 1.27 109.792 170.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -59.13 -43.31 91.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.239 1.016 . . . . 3.5699999999999998 111.105 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -62.48 -47.68 82.92 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.578 0.751 . . . . 1.8899999999999999 110.673 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.7 mt -56.02 -49.42 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.388 -0.967 . . . . 0.95999999999999996 108.388 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.57 -45.11 92.8 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.679 -0.489 . . . . 2.5800000000000001 109.679 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.1 m -57.02 -48.82 77.59 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.358 0.663 . . . . 2.0699999999999998 110.736 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -60.01 -38.64 83.24 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.723 0.809 . . . . 3.73 111.493 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.436 HD21 HG23 ' A' ' 134' ' ' ILE . 42.6 mt -67.81 -60.5 2.48 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.693 -1.225 . . . . 1.6699999999999999 107.693 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.6 p -55.74 -17.37 5.86 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.278 0.631 . . . . 1.6799999999999999 112.64 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -60.99 -24.49 66.18 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.615 -0.678 . . . . 5.6600000000000001 112.412 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.1 m -73.86 166.13 23.89 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.407 1.483 . . . . 1.53 111.505 -167.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -76.57 -58.32 3.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.65 1.18 . . . . 3.2799999999999998 111.722 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.69 -45.73 8.35 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.362 -1.095 . . . . 1.73 110.362 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 122' ' ' VAL . 0.4 OUTLIER -60.44 131.29 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.485 -0.561 . . . . 2.46 109.485 175.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.2 t -131.53 -39.21 1.14 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.217 1.007 . . . . 2.8300000000000001 110.875 172.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.06 112.18 17.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.704 -1.591 . . . . 2.4300000000000002 106.704 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.75 166.69 16.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.672 -0.862 . . . . 1.3300000000000001 108.672 163.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 m -142.59 138.34 30.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.69 -1.226 . . . . 1.8100000000000001 107.69 163.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 95' ' ' VAL . 7.1 p -129.66 105.12 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.207 1.003 . . . . 1.9299999999999999 108.616 -171.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -112.61 102.47 10.54 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.12 0.968 . . . . 1.1299999999999999 110.573 -168.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -29.7 68.95 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.079 1.352 . . . . 2.6299999999999999 113.638 -173.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.32 -44.75 95.77 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.797 0.839 . . . . 1.5700000000000001 109.964 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.74 -25.63 26.32 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.519 1.127 . . . . 1.6799999999999999 109.623 170.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.2 m 73.97 24.31 2.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.127 1.771 . . . . 1.4199999999999999 111.509 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -116.06 150.33 37.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.459 1.027 . . . . 3.0899999999999999 110.425 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.14 107.57 4.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.82 1.248 . . . . 0.98999999999999999 112.595 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.82 141.5 28.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.245 1.021 . . . . 2.7000000000000002 110.794 173.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.616 ' HB ' HD11 ' A' ' 108' ' ' ILE . 11.8 m -133.94 135.3 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 126.029 1.732 . . . . 2.54 106.475 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.15 104.21 14.11 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 108.292 -1.003 . . . . 3.46 108.292 171.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -113.43 -179.55 3.67 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.782 0.833 . . . . 2.9300000000000002 111.199 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.79 114.32 37.62 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.165 1.386 . . . . 3.73 108.587 171.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.96 57.83 6.69 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.677 2.918 . . . . 2.3799999999999999 112.511 -169.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -147.11 -52.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.634 1.573 . . . . 4.5899999999999999 107.539 172.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 pt -83.94 -25.71 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 123.178 0.591 . . . . 1.8899999999999999 112.27 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -147.03 169.73 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.075 -0.713 . . . . 1.51 109.075 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.57 165.75 30.09 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 111.145 -0.782 . . . . 1.4099999999999999 111.145 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.18 -32.99 41.51 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.535 2.823 . . . . 1.5800000000000001 111.505 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.414 ' HA ' HG12 ' A' ' 135' ' ' ILE . 19.1 ptt180 -52.37 -39.62 61.02 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.369 0.604 . . . . 6.6100000000000003 111.188 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -72.26 -38.28 68.9 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.355 -0.98 . . . . 4.4199999999999999 108.355 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.436 HG23 HD21 ' A' ' 102' ' ' LEU . 81.3 mt -58.03 -54.14 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.648 -0.501 . . . . 1.21 109.648 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 132' ' ' ARG . 22.2 pt -56.25 -55.01 21.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.404 -0.591 . . . . 3.1000000000000001 109.404 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -47.52 -46.28 27.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 119.117 0.871 . . . . 4.04 112.931 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 mm -59.07 -42.7 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 O-C-N 121.735 -0.603 . . . . 1.71 111.682 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.3 pt -76.93 -28.99 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 113.785 1.032 . . . . 1.9099999999999999 113.785 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.38 -28.33 65.06 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.363 -0.836 . . . . 3.0600000000000001 110.301 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -60.77 -41.0 94.66 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.638 -0.504 . . . . 5.4900000000000002 109.638 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 27.7 mt -70.79 -40.95 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.887 -0.782 . . . . 1.28 108.887 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.62 31.61 3.39 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.393 1.473 . . . . 1.02 110.729 -176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -108.9 166.82 10.53 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 108.782 -0.822 . . . . 2.1299999999999999 108.782 169.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -137.59 133.72 34.74 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 106.985 -1.487 . . . . 3.46 106.985 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.45 92.66 3.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.981 1.712 . . . . 1.54 109.239 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.3 p -146.87 105.47 3.82 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 117.021 -1.466 . . . . 2.1099999999999999 112.581 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.3 -70.56 0.09 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 121.361 1.891 . . . . 8.0700000000000003 114.031 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HA ' ' CB ' ' A' ' 83' ' ' GLU 0.361 . . 40.68 80.09 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.334 2.254 . . . . 5.1600000000000001 116.891 -163.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.917 0 C-N-CA 128.643 2.777 . . . . 7.0599999999999996 103.875 172.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 118.771 -0.633 . . . . 15.619999999999999 109.338 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.61 154.19 38.03 Favored Pre-proline 0 N--CA 1.452 -0.37 0 O-C-N 124.54 1.15 . . . . 7.4400000000000004 108.081 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -90.73 29.79 0.38 Allowed 'Trans proline' 0 CA--C 1.514 -0.497 0 N-CA-C 117.37 2.027 . . . . 4.2199999999999998 117.37 -158.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -106.33 109.38 21.29 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 111.648 -2.524 . . . . 4.2800000000000002 107.84 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.84 154.36 18.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.274 -1.33 . . . . 4.3399999999999999 107.75 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.6 t -141.71 132.25 25.39 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.674 0.67 . . . . 2.3300000000000001 109.507 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -107.83 87.35 2.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.983 1.313 . . . . 2.8599999999999999 108.983 -162.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.19 177.69 4.55 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.51 0.671 . . . . 2.7200000000000002 110.59 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.86 151.79 49.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.74 -1.578 . . . . 2.4700000000000002 106.74 172.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.1 mm -99.3 120.57 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.296 -1.372 . . . . 0.70999999999999996 107.296 171.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -101.47 87.44 3.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.677 -1.972 . . . . 4.5 105.677 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.12 -87.71 0.08 OUTLIER Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.117 -1.193 . . . . 1.3100000000000001 110.117 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.2 ptp 41.51 69.72 0.33 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.263 1.825 . . . . 1.96 115.636 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -53.33 -13.32 0.53 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.822 1.416 . . . . 2.54 114.822 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.8 t 74.58 -61.76 0.48 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.397 1.879 . . . . 3.0 111.217 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.15 -72.69 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.741 2.416 . . . . 5.9500000000000002 113.043 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.6 p -157.51 10.88 0.2 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 113.027 0.751 . . . . 4.3399999999999999 113.027 166.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -50.64 30.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.423 -1.325 . . . . 2.2400000000000002 107.423 -169.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 p -49.72 -48.71 20.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 109.783 -0.451 . . . . 3.0499999999999998 109.783 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 m -54.77 -46.98 74.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.667 0.787 . . . . 2.4900000000000002 112.552 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -63.82 -45.49 89.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.978 -1.076 . . . . 2.8799999999999999 110.122 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.431 HG13 HD13 ' A' ' 65' ' ' LEU . 1.2 mp -55.83 -45.02 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.314 1.046 . . . . 2.2200000000000002 109.291 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -56.08 -50.52 70.77 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.209 1.403 . . . . 5.3099999999999996 110.779 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -61.4 -39.53 91.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.084 0.554 . . . . 4.9699999999999998 109.979 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -63.4 -51.58 65.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.554 -0.536 . . . . 1.53 109.554 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -57.26 9.25 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.487 1.115 . . . . 2.8100000000000001 111.783 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.8 -18.67 34.24 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.946 1.091 . . . . 2.5699999999999998 113.946 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -102.79 5.64 38.86 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.039 1.336 . . . . 3.2000000000000002 114.136 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -57.33 -64.68 0.81 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 121.169 1.804 . . . . 3.77 111.611 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -168.47 -133.99 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.434 -1.691 . . . . 1.3700000000000001 106.434 -169.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.78 33.13 1.23 Allowed Glycine 0 CA--C 1.534 1.221 0 CA-C-N 119.929 1.241 . . . . 1.6399999999999999 113.61 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.41 124.22 60.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 N-CA-C 105.559 -2.015 . . . . 1.5900000000000001 105.559 165.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 49.65 1.68 Allowed 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.073 -0.714 . . . . 2.6200000000000001 109.073 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.3 t -161.88 148.41 13.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.559 -1.275 . . . . 2.29 107.559 173.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.25 120.59 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.964 -1.865 . . . . 2.8799999999999999 105.964 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.41 71.46 1.47 Allowed 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.262 -1.014 . . . . 2.6000000000000001 108.262 168.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.3 m -98.14 160.89 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.511 0.672 . . . . 2.3700000000000001 110.49 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.24 99.65 5.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.426 -1.694 . . . . 1.4299999999999999 106.426 170.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.7 -27.35 64.77 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.239 1.415 . . . . 3.6000000000000001 109.869 171.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -69.14 -43.15 74.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.838 0.855 . . . . 4.5499999999999998 111.688 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.43 -37.96 9.39 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.234 1.014 . . . . 1.5600000000000001 110.104 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.4 62.94 0.83 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 126.082 1.801 . . . . 1.0800000000000001 111.011 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -143.04 144.37 32.25 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.834 -1.172 . . . . 2.7999999999999998 107.834 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.23 105.83 12.18 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.959 1.304 . . . . 1.0600000000000001 111.174 171.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.66 136.39 38.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 105.64 -1.985 . . . . 4.3099999999999996 105.64 166.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.9 pt -136.34 174.13 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.039 -1.097 . . . . 1.8200000000000001 108.039 169.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -134.64 111.48 10.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.967 1.307 . . . . 4.9400000000000004 109.488 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -124.38 177.31 5.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.86 1.664 . . . . 3.3100000000000001 113.526 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -113.43 106.0 54.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.343 1.457 . . . . 4.0199999999999996 111.128 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.47 -10.78 29.88 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.69 2.26 . . . . 2.9199999999999999 114.296 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -65.89 -18.38 65.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.859 0.754 . . . . 4.1299999999999999 112.397 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.87 -45.85 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 123.287 0.635 . . . . 2.9500000000000002 110.281 -170.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.452 HD11 ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -94.66 153.59 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 109.255 -0.646 . . . . 2.1499999999999999 109.255 175.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -130.62 150.08 75.35 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.911 1.685 . . . . 2.8199999999999998 108.952 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -62.29 -39.27 48.52 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.075 2.516 . . . . 1.96 111.998 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.43 -46.98 87.8 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.495 -0.753 . . . . 4.6699999999999999 109.91 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -59.79 -37.28 78.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.972 0.509 . . . . 3.0499999999999998 111.128 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.452 ' CD1' HD11 ' A' ' 53' ' ' ILE . 1.5 mt -54.16 -56.36 10.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 107.202 -1.407 . . . . 1.6699999999999999 107.202 169.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.1 -44.48 74.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.104 -0.498 . . . . 1.6000000000000001 111.002 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -48.67 -52.2 24.52 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.134 0.974 . . . . 4.5999999999999996 110.301 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -49.08 73.52 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.087 0.47 . . . . 2.3700000000000001 109.811 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -62.4 -37.16 78.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 122.099 -0.376 . . . . 2.7000000000000002 110.928 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -65.81 -45.17 83.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.629 -0.508 . . . . 1.98 109.629 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -59.02 -50.07 75.5 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.89 -0.411 . . . . 2.46 109.89 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.431 HD13 HG13 ' A' ' 22' ' ' ILE . 21.0 mt -53.49 -45.12 69.52 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.31 0.644 . . . . 2.52 111.241 176.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.87 30.63 0.87 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.807 0.718 . . . . 1.29 112.363 166.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -129.95 163.79 25.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.401 1.48 . . . . 2.1400000000000001 108.951 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -99.84 122.6 43.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.63 -1.248 . . . . 2.29 107.63 170.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.04 122.54 45.47 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.727 -1.583 . . . . 1.0900000000000001 106.727 165.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.27 141.62 50.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.772 -1.196 . . . . 1.05 107.772 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.515 HG21 ' HB3' ' A' ' 75' ' ' TYR . 4.3 p -67.97 149.09 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.107 -0.701 . . . . 3.0 109.107 -176.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.2 mtt -55.38 -43.73 75.42 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.99 -0.374 . . . . 4.5700000000000003 109.99 173.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 174.84 -58.85 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 127.964 2.506 . . . . 4.1200000000000001 105.589 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.2 90.23 5.42 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.596 1.959 . . . . 7.96 109.092 -165.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.515 ' HB3' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -68.7 28.58 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.763 1.394 . . . . 5.54 114.763 175.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.409 ' HB1' ' H ' ' A' ' 77' ' ' GLY . . . 57.57 -154.75 0.34 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.107 1.363 . . . . 3.2999999999999998 113.125 174.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.409 ' H ' ' HB1' ' A' ' 76' ' ' ALA . . . -102.96 91.33 0.84 Allowed Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 125.727 1.632 . . . . 4.1799999999999997 109.427 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.5 m -77.9 64.54 3.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.628 1.214 . . . . 6.6399999999999997 110.136 162.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 t70 66.25 -70.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 127.811 2.444 . . . . 4.9800000000000004 113.733 165.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 124' ' ' PHE . . . -91.49 -23.92 27.53 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 109.715 -1.354 . . . . 2.0699999999999998 109.715 171.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -93.1 102.86 15.19 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.574 -2.009 . . . . 2.7200000000000002 105.574 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.51 143.04 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 108.111 -1.07 . . . . 2.9500000000000002 108.111 175.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -95.92 146.91 24.21 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.349 -1.723 . . . . 4.4100000000000001 106.349 170.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.3 mt -137.73 158.96 43.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.172 -1.788 . . . . 2.29 106.172 166.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.75 123.43 42.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.333 -1.729 . . . . 1.6399999999999999 106.333 170.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.3 pt -97.82 140.18 18.47 Favored 'Isoleucine or valine' 0 C--N 1.336 0.009 0 N-CA-C 108.465 -0.939 . . . . 1.8899999999999999 108.465 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.4 m -129.03 138.18 51.75 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.814 0.845 . . . . 1.6599999999999999 109.42 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.51 -35.32 2.7 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 126.032 1.777 . . . . 1.1799999999999999 112.146 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -30.48 103.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.964 1.706 . . . . 3.5600000000000001 114.565 172.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.5 m -100.6 -4.81 27.77 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.268 0.627 . . . . 3.5099999999999998 111.063 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.66 165.52 14.33 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 120.646 -1.284 . . . . 3.3399999999999999 110.25 177.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.06 -36.79 61.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.54 0.336 . . . . 2.8700000000000001 110.712 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.3 t -48.46 -45.9 37.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.37 0.668 . . . . 2.0800000000000001 111.364 173.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 64.2 m -59.77 -53.78 53.98 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 108.759 -0.83 . . . . 2.0299999999999998 108.759 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.436 HG21 HD22 ' A' ' 115' ' ' LEU . 58.7 t -52.41 -43.6 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.389 0.676 . . . . 1.55 111.027 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -65.21 -42.31 93.61 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.362 -0.977 . . . . 2.5600000000000001 108.362 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -42.01 97.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.022 -0.362 . . . . 3.8500000000000001 110.022 176.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.28 -53.66 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.683 -0.858 . . . . 1.0700000000000001 108.683 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -54.97 -45.19 74.95 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.644 1.178 . . . . 3.2400000000000002 108.834 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -53.75 -52.85 58.84 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.927 -0.483 . . . . 1.3300000000000001 111.612 172.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' HG2' HD11 ' A' ' 141' ' ' ILE . 4.1 mptp? -60.36 -35.2 75.12 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 120.823 -1.173 . . . . 2.4300000000000002 111.716 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.49 -59.07 3.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.194 -1.039 . . . . 1.8 108.194 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.8 p -57.05 -19.03 16.65 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.077 0.951 . . . . 1.8799999999999999 112.637 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.93 -31.84 67.2 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.048 -0.407 . . . . 3.7999999999999998 111.499 171.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 17.4 m -65.45 142.64 58.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.569 1.547 . . . . 1.6100000000000001 110.923 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -64.83 -48.1 75.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.459 1.103 . . . . 2.5800000000000001 111.697 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.19 -32.85 57.8 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.97 -0.35 . . . . 1.3600000000000001 112.741 -171.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.48 134.61 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 117.899 0.85 . . . . 2.27 109.039 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.8 t -107.71 -49.82 3.17 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.08 0.4 . . . . 3.2599999999999998 112.08 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -136.65 121.64 18.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.482 -0.933 . . . . 2.0 108.482 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.43 133.15 44.16 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.009 -0.737 . . . . 0.93999999999999995 109.009 166.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.5 m -113.4 102.73 10.6 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 107.901 -1.148 . . . . 2.21 107.901 168.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -108.43 140.33 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.233 -0.654 . . . . 2.7599999999999998 109.233 175.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.37 95.58 3.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.165 0.983 . . . . 1.52 110.599 -169.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.436 HD22 HG21 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -60.72 -33.02 72.26 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.993 1.317 . . . . 2.2799999999999998 112.685 -174.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.78 -33.74 17.36 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.071 0.948 . . . . 1.77 111.308 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.66 -5.93 12.16 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.743 1.617 . . . . 2.0800000000000001 111.426 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.0 m 63.41 27.87 15.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.056 1.742 . . . . 1.45 111.989 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -99.02 158.08 15.9 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.348 0.659 . . . . 3.7599999999999998 110.642 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -139.13 101.62 4.32 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.506 1.922 . . . . 1.1499999999999999 108.455 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.79 103.62 15.26 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.185 0.994 . . . . 1.8700000000000001 108.319 -176.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.6 m -102.12 127.56 55.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 C-N-CA 124.612 1.165 . . . . 2.0800000000000001 109.688 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.36 103.75 14.2 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.457 1.103 . . . . 3.9100000000000001 108.619 172.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.415 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 13.9 p90 -121.51 -174.67 2.91 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.149 1.379 . . . . 2.6899999999999999 110.257 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -111.59 111.9 54.32 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 119.153 0.888 . . . . 3.21 109.424 176.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.35 72.18 6.65 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.973 2.449 . . . . 2.2000000000000002 111.937 -164.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.33 -43.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.206 1.402 . . . . 3.73 109.669 172.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.1 pt -85.73 -31.81 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 124.149 0.98 . . . . 1.8300000000000001 110.827 -174.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.29 161.67 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.791 1.236 . . . . 1.5800000000000001 108.296 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.02 162.95 29.33 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.969 -1.252 . . . . 1.53 109.969 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -59.89 -34.38 95.41 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.602 2.868 . . . . 1.53 111.375 -173.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -36.3 69.01 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 122.991 0.517 . . . . 4.7199999999999998 111.337 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -69.9 -45.7 67.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.617 -0.882 . . . . 3.2200000000000002 108.617 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.8 -49.38 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.29 -1.004 . . . . 1.22 108.29 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.5 mt -49.66 -59.99 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 118.369 -0.824 . . . . 1.9399999999999999 109.05 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -49.65 -50.89 41.45 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.891 1.223 . . . . 3.6000000000000001 112.713 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.62 -52.31 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.737 -0.602 . . . . 1.95 110.864 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.455 ' HA ' HD12 ' A' ' 141' ' ' ILE 0.259 2.4 pp -70.43 -26.11 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 120.777 -1.202 . . . . 1.29 113.716 -177.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -60.77 -39.45 88.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.575 0.625 . . . . 2.6099999999999999 110.224 169.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.11 -40.37 81.02 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.999 -0.741 . . . . 3.4300000000000002 108.999 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.457 HD11 ' HG2' ' A' ' 101' ' ' LYS . 48.7 mt -72.73 -42.16 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.095 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.37 35.12 4.53 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.997 1.284 . . . . 1.02 111.383 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 141' ' ' ILE . 58.2 m-85 -97.35 176.01 6.05 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.286 -1.005 . . . . 2.02 108.286 163.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -133.42 131.05 39.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.071 -1.455 . . . . 3.3999999999999999 107.071 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.87 99.0 6.37 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.647 1.579 . . . . 1.3 109.551 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 58.4 m -111.49 114.85 28.23 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.886 0.875 . . . . 1.76 110.701 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -35.88 113.06 0.19 Allowed 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 127.793 2.437 . . . . 3.8100000000000001 111.216 169.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -103.14 68.45 0.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.706 0.765 . . . . 3.6800000000000002 110.85 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.291 1.436 . . . . 6.9299999999999997 110.32 171.972 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 106.086 -1.82 . . . . 8.5199999999999996 106.086 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.82 100.11 25.81 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 119.981 1.264 . . . . 4.6500000000000004 109.121 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -69.49 134.51 28.74 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.246 1.964 . . . . 3.52 110.473 -174.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.53 141.88 35.25 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.376 0.67 . . . . 4.5499999999999998 110.911 -177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -96.51 140.15 31.57 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.578 -0.701 . . . . 4.3499999999999996 109.677 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.9 t -119.39 136.19 54.4 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.338 1.055 . . . . 2.25 110.115 174.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -106.99 90.06 3.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.401 1.881 . . . . 4.6799999999999997 111.075 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 71' ' ' VAL 0.271 0.3 OUTLIER -118.13 167.39 11.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.249 1.023 . . . . 2.8100000000000001 113.087 176.408 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.69 161.05 20.31 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.594 -1.632 . . . . 2.9399999999999999 106.594 165.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.0 mm -100.16 136.81 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 105.552 -2.018 . . . . 1.03 105.552 167.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -121.85 78.01 1.42 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.06 -1.459 . . . . 5.2699999999999996 107.06 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.96 -76.73 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.737 -0.945 . . . . 1.3799999999999999 110.737 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mpt? 57.98 89.18 0.05 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.664 1.586 . . . . 1.8600000000000001 112.715 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.9 m -59.18 -60.72 3.41 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.583 -0.698 . . . . 2.4500000000000002 110.961 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.5 t -167.72 88.18 0.27 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.689 -1.226 . . . . 3.3599999999999999 107.689 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 1.94 65.87 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 129.189 2.996 . . . . 5.8399999999999999 115.476 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t 173.61 -43.89 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 125.218 1.407 . . . . 3.3799999999999999 108.537 -168.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 t -66.42 -40.76 89.73 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.833 -1.167 . . . . 2.0299999999999998 111.32 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.9 -32.02 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 121.799 -0.563 . . . . 1.8 110.464 167.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 t -69.51 -27.2 64.98 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.039 -0.413 . . . . 3.1600000000000001 111.253 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.59 -47.75 74.65 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.598 -1.314 . . . . 2.8599999999999999 109.599 171.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.2 mt -42.74 -37.99 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 121.354 -0.841 . . . . 1.3799999999999999 112.966 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -47.71 -55.37 9.66 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.719 0.691 . . . . 3.7000000000000002 112.821 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -64.52 -36.01 82.82 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.48 -0.762 . . . . 6.3799999999999999 109.858 -172.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -61.7 -54.22 45.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.94 -1.133 . . . . 1.3400000000000001 107.94 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -54.97 -44.58 74.52 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 112.173 0.434 . . . . 2.1299999999999999 112.173 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.82 -21.1 3.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.907 0.776 . . . . 1.9299999999999999 112.814 175.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 5.05 13.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 117.843 -1.075 . . . . 5.3099999999999996 112.61 177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -64.12 -58.42 6.7 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.678 1.126 . . . . 2.77 110.735 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.5 -135.84 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 O-C-N 122.002 -0.436 . . . . 1.3300000000000001 110.48 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.79 -15.09 47.1 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.929 1.252 . . . . 1.49 113.465 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.28 125.34 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 117.981 0.891 . . . . 1.72 111.755 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 mt -141.53 44.32 1.74 Allowed 'General case' 0 C--N 1.342 0.257 0 CA-C-O 119.286 -0.387 . . . . 3.5 111.074 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -158.13 149.1 20.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.451 -0.574 . . . . 2.7599999999999998 109.451 169.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.98 70.26 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 124.902 1.281 . . . . 2.7000000000000002 109.275 -170.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.304 0.7 OUTLIER -102.32 78.93 1.79 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 119.234 -0.986 . . . . 5.0300000000000002 110.26 -177.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p -96.91 145.76 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.002 -0.999 . . . . 2.5099999999999998 108.81 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.59 99.78 6.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.963 -1.495 . . . . 1.4399999999999999 106.963 163.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.6 mt -56.88 -26.65 59.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.007 0.923 . . . . 2.8799999999999999 111.441 172.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.1 ttt -56.55 -57.59 11.7 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.226 1.01 . . . . 4.0999999999999996 110.197 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.29 -27.57 22.81 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.798 0.839 . . . . 1.4099999999999999 110.898 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.89 57.59 2.25 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.552 1.072 . . . . 1.1599999999999999 110.567 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.34 132.18 35.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.178 -1.045 . . . . 3.6899999999999999 108.178 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.9 102.62 11.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.584 2.354 . . . . 0.94999999999999996 109.273 171.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -96.95 137.91 35.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.326 -1.731 . . . . 3.3700000000000001 106.326 164.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.3 pt -143.49 171.61 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.178 -1.045 . . . . 1.8200000000000001 108.178 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -125.74 105.48 9.01 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.828 0.851 . . . . 5.3399999999999999 109.971 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -97.53 169.79 9.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.052 2.541 . . . . 2.6800000000000002 113.007 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -117.26 100.7 53.11 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 106.096 -1.816 . . . . 2.8900000000000001 106.096 171.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.75 -29.62 43.05 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.535 3.49 . . . . 2.8700000000000001 114.704 -170.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -65.65 -18.82 65.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.7 1.6 . . . . 4.5999999999999996 112.469 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.3 m -126.8 -38.22 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.343 0.657 . . . . 3.1200000000000001 111.46 -175.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.93 149.88 17.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-N 118.887 0.767 . . . . 1.8700000000000001 109.268 173.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -129.6 150.34 75.42 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 124.634 1.173 . . . . 3.48 109.287 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -56.22 -37.24 97.0 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.114 2.542 . . . . 1.78 111.263 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.6 mp -54.64 -41.71 70.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.26 0.624 . . . . 3.0800000000000001 111.344 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -69.49 -40.97 76.73 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.546 -0.721 . . . . 3.7000000000000002 109.564 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -45.22 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.06 -1.089 . . . . 1.47 108.06 172.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.53 -42.97 93.51 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.904 -0.589 . . . . 1.6599999999999999 110.804 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -59.4 -51.63 69.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 121.773 -0.58 . . . . 3.1099999999999999 110.19 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -56.06 15.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.208 0.528 . . . . 2.2200000000000002 111.137 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.526 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.4 pp -62.12 -40.23 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 121.187 -0.946 . . . . 4.1900000000000004 112.559 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.59 -32.6 74.27 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.492 -0.755 . . . . 2.5499999999999998 110.85 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.31 -51.29 61.63 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.503 0.592 . . . . 2.6499999999999999 109.648 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.07 -38.63 68.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.416 -0.514 . . . . 3.6899999999999999 111.808 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.77 45.47 0.65 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.676 -0.97 . . . . 1.53 110.676 171.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -131.95 157.09 44.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.72 1.208 . . . . 2.6200000000000001 108.035 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -99.82 129.71 45.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.944 -1.502 . . . . 2.5299999999999998 106.944 166.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.526 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -121.38 124.71 45.2 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.222 -1.399 . . . . 1.24 107.222 173.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.53 119.98 27.23 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.155 0.909 . . . . 0.97999999999999998 109.946 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 2.2 p -68.33 141.31 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 125.065 1.346 . . . . 2.73 108.737 166.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.2 ptm -40.55 -52.03 2.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 124.486 1.117 . . . . 5.7599999999999998 111.357 -172.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -160.31 41.34 0.18 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.796 1.238 . . . . 3.9300000000000002 109.068 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.407 ' HA ' ' CG2' ' A' ' 71' ' ' VAL . 1.9 m-20 29.03 51.92 0.07 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.171 1.788 . . . . 10.1 111.95 -164.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -70.45 -70.44 0.3 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.657 -1.979 . . . . 6.1500000000000004 105.657 -174.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 73.54 120.08 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.783 2.833 . . . . 4.2000000000000002 109.352 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.416 ' HA3' ' CZ ' ' A' ' 75' ' ' TYR . . . -145.14 104.29 0.31 Allowed Glycine 0 C--N 1.336 0.57 0 CA-C-N 118.393 0.542 . . . . 3.6400000000000001 111.938 -160.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 t -169.99 -56.47 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.811 -0.811 . . . . 4.8899999999999997 108.811 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -153.5 147.12 25.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 104.968 -2.234 . . . . 5.25 104.968 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.11 -59.48 4.48 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 108.107 -1.997 . . . . 1.8400000000000001 108.107 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.614 ' C ' HD13 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -118.46 107.02 13.3 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.275 1.43 . . . . 2.3700000000000001 108.467 -166.101 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.614 HD13 ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -127.6 148.02 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 120.336 1.425 . . . . 2.73 112.455 -178.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 1.0 OUTLIER -109.11 124.0 50.08 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.15 1.78 . . . . 4.4699999999999998 112.621 -175.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.7 mt -128.76 138.83 52.32 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.315 1.046 . . . . 2.3599999999999999 109.418 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.6 OUTLIER -102.96 124.1 47.83 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.808 -1.182 . . . . 2.2799999999999998 107.808 -177.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.37 105.49 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.713 1.205 . . . . 1.76 109.715 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.8 p -101.77 126.26 48.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.575 -0.898 . . . . 2.2599999999999998 108.575 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.64 -34.3 3.66 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.128 0.87 . . . . 1.3600000000000001 111.034 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -63.36 130.94 46.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.083 0.553 . . . . 2.8799999999999999 109.808 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 p -137.54 22.58 2.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.965 1.306 . . . . 3.7200000000000002 110.693 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 5.3 t -157.25 141.19 16.1 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 121.298 -0.876 . . . . 2.9500000000000002 111.881 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.6 -35.13 79.93 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.214 0.606 . . . . 2.6099999999999999 111.456 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 p -53.4 -47.3 69.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.504 -0.554 . . . . 2.1800000000000002 109.504 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 59.7 m -59.26 -49.76 76.6 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 119.22 -0.419 . . . . 2.5 110.129 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.4 t -49.36 -50.15 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 118.237 0.471 . . . . 1.6100000000000001 110.544 175.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -60.63 -40.81 93.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.768 -0.456 . . . . 4.6600000000000001 109.768 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -42.47 96.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.865 -0.522 . . . . 2.6600000000000001 110.253 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.8 mt -61.42 -51.47 72.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.111 -1.07 . . . . 1.3 108.111 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -55.67 -45.88 77.64 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.676 1.19 . . . . 2.23 109.61 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.8 t -54.95 -54.82 37.88 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.687 -0.633 . . . . 1.8200000000000001 110.637 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -51.2 -61.32 2.3 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.194 0.452 . . . . 2.71 110.261 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.85 -39.32 91.45 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.768 -0.373 . . . . 2.23 110.415 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 96.3 m -59.73 -19.24 48.82 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.54 0.609 . . . . 1.8400000000000001 112.1 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -66.49 -27.02 67.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 119.166 -1.014 . . . . 4.4699999999999998 111.919 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 81.3 m -63.54 126.58 27.98 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.631 0.773 . . . . 2.1899999999999999 111.597 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -38.51 -59.63 0.89 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.651 1.98 . . . . 3.3999999999999999 113.845 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.22 -28.36 68.29 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.231 0.469 . . . . 1.6699999999999999 113.319 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.78 118.8 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 O-C-N 121.359 -1.083 . . . . 1.75 109.475 -168.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.2 m -102.92 -44.86 5.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.857 0.318 . . . . 2.71 111.857 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -142.12 128.8 20.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.406 -0.961 . . . . 1.99 108.406 166.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.75 162.52 12.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.87 -0.332 . . . . 0.87 110.375 161.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m -145.0 113.05 6.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.45 -0.945 . . . . 1.73 108.45 162.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 p -110.03 128.93 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.75 0.705 . . . . 1.8899999999999999 110.962 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -125.04 90.4 3.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.145 0.978 . . . . 1.53 110.951 -166.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.09 -32.5 55.01 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.287 1.435 . . . . 2.6099999999999999 112.964 -174.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.71 -32.12 65.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.259 0.624 . . . . 2.0 111.154 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.53 -14.45 11.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.145 1.378 . . . . 1.9299999999999999 111.202 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.4 m 65.99 28.29 10.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.101 1.361 . . . . 1.8899999999999999 111.951 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.458 ' HD3' ' HB1' ' A' ' 148' ' ' ALA . 44.3 mmtt -96.75 152.84 18.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.312 1.445 . . . . 2.8700000000000001 109.703 173.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.26 106.36 4.35 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.521 1.128 . . . . 0.98999999999999999 109.383 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.3 mp -95.43 130.19 42.32 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.633 -1.247 . . . . 2.8500000000000001 107.633 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.1 t -128.28 123.9 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.031 0.932 . . . . 1.9099999999999999 108.75 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -105.55 92.06 4.03 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.918 0.887 . . . . 2.9900000000000002 109.136 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -115.35 173.7 6.38 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.761 0.709 . . . . 2.54 111.098 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -100.26 112.68 64.65 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 108.886 -0.783 . . . . 2.7400000000000002 108.886 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.72 70.03 7.11 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.649 2.899 . . . . 1.99 111.217 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -165.05 -47.95 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.523 1.529 . . . . 3.04 108.836 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.6 pt -84.85 -37.48 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.121 0.969 . . . . 2.1699999999999999 111.103 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.7 tp -136.86 169.3 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.304 0.642 . . . . 2.0800000000000001 109.458 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.25 170.77 32.17 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.64 -1.784 . . . . 1.75 108.64 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -58.41 -35.65 98.44 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.27 2.646 . . . . 1.8 111.285 -171.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.9 ptm85 -56.63 -30.55 63.41 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.18 0.807 . . . . 5.4000000000000004 113.18 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.36 -50.03 67.11 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.231 -1.026 . . . . 3.3700000000000001 108.231 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 42.5 mt -63.32 -44.17 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.512 -1.222 . . . . 1.1000000000000001 108.123 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.54 -57.2 5.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 118.476 -0.773 . . . . 1.8700000000000001 109.366 172.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -49.58 -51.14 39.15 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.302 1.41 . . . . 3.46 112.36 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.6 mm -54.16 -53.72 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.019 0.528 . . . . 1.8100000000000001 110.377 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 pp -70.36 -29.72 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 120.967 -1.083 . . . . 1.4399999999999999 113.108 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -59.04 -41.79 88.71 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 119.143 0.883 . . . . 2.7999999999999998 109.309 168.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -64.82 -37.92 89.23 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.483 -0.562 . . . . 2.9900000000000002 109.483 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.7 mt -62.83 -44.96 99.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 122.006 -0.434 . . . . 1.0900000000000001 110.437 170.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.19 28.21 5.02 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.381 1.467 . . . . 1.03 111.941 -174.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -101.67 -179.81 4.12 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.42 1.11 . . . . 2.2400000000000002 108.929 164.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -139.1 126.55 21.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.635 -1.617 . . . . 3.8799999999999999 106.635 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.62 91.16 3.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.315 1.846 . . . . 1.21 108.373 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 68.3 m -102.82 131.45 49.69 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.092 -0.707 . . . . 2.27 109.092 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 mt -41.25 109.87 0.14 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.26 1.824 . . . . 3.77 111.37 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.663 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -90.09 -20.93 22.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.742 -0.663 . . . . 4.0099999999999998 110.741 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.403 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.375 0 C-N-CA 125.91 1.684 . . . . 6.3499999999999996 112.062 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.3 mtm . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 106.439 -1.689 . . . . 7.2599999999999998 106.439 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.48 112.98 15.85 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-O 117.024 -1.465 . . . . 4.25 107.904 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -87.68 148.57 7.29 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.903 2.402 . . . . 3.0299999999999998 109.621 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -114.36 164.19 14.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.41 -1.329 . . . . 3.9300000000000002 107.41 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.56 147.95 41.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.444 -0.947 . . . . 4.9000000000000004 108.444 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.4 p -141.18 140.38 34.02 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.871 -0.788 . . . . 3.0899999999999999 108.871 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -120.72 103.52 9.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.693 -1.966 . . . . 3.04 105.693 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.581 HD12 ' HB1' ' A' ' 69' ' ' ALA . 2.1 pt? -132.66 160.37 36.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.136 -1.061 . . . . 2.2200000000000002 108.136 175.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.495 HE22 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -101.41 171.83 7.34 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.545 -0.909 . . . . 3.4700000000000002 108.545 173.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.2 mm -99.84 126.74 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.098 -1.815 . . . . 0.98999999999999999 106.098 162.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -102.36 95.86 6.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.348 -2.093 . . . . 3.6800000000000002 105.348 166.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.38 -77.26 0.11 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.14 0.876 . . . . 1.28 110.961 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 mtp 35.53 76.22 0.05 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.933 2.093 . . . . 2.1200000000000001 114.831 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 p -41.04 -54.0 2.89 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.669 0.787 . . . . 2.8399999999999999 112.448 171.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t 119.13 -62.95 0.0 OUTLIER 'General case' 0 C--N 1.342 0.266 0 C-N-CA 129.355 3.062 . . . . 2.8500000000000001 107.659 -174.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -22.51 -77.5 0.01 OUTLIER 'General case' 0 C--N 1.344 0.341 0 C-N-CA 127.659 2.384 . . . . 5.8099999999999996 113.148 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 t -161.82 21.9 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.487 0.661 . . . . 2.8500000000000001 110.945 165.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -71.89 -41.28 68.17 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 120.91 -1.119 . . . . 2.1499999999999999 110.256 -163.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.68 -46.89 79.64 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.684 -0.858 . . . . 1.46 108.684 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 t -55.79 -48.63 75.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.294 0.569 . . . . 2.3900000000000001 110.285 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.25 -49.3 74.67 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.827 -0.434 . . . . 2.5600000000000001 109.827 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.6 mt -56.06 -49.93 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.886 0.874 . . . . 1.9199999999999999 109.509 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.479 ' CD ' HG21 ' A' ' 37' ' ' VAL . 82.5 mm-40 -61.94 -39.08 90.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.892 0.877 . . . . 7.0300000000000002 112.393 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -44.38 93.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.105 -0.702 . . . . 5.0199999999999996 109.105 175.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -61.69 -37.12 82.95 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.883 -0.51 . . . . 1.47 110.031 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.79 -52.72 33.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.93 0.892 . . . . 2.0600000000000001 110.958 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.474 HE22 HG11 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -56.67 -26.53 56.63 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.784 1.175 . . . . 2.5 112.608 176.179 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -74.22 0.63 13.5 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 116.782 -1.58 . . . . 2.96 115.125 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -48.67 -84.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 121.044 1.747 . . . . 3.0099999999999998 112.581 174.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.84 -90.91 0.0 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.686 0.795 . . . . 2.3300000000000001 110.095 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.15 -26.18 74.21 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.369 -0.692 . . . . 1.6200000000000001 111.369 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.424 ' CG1' ' HA ' ' A' ' 27' ' ' GLN . 1.1 t -61.06 128.6 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.069 -0.715 . . . . 2.2400000000000002 109.069 172.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.19 53.5 1.08 Allowed 'General case' 0 C--N 1.337 0.053 0 C-N-CA 121.099 -0.241 . . . . 3.0299999999999998 111.207 163.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.1 t -158.1 139.22 13.28 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 120.926 -1.109 . . . . 1.8999999999999999 110.549 167.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.474 HG11 HE22 ' A' ' 27' ' ' GLN . 1.6 p -126.53 107.89 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 125.94 1.696 . . . . 2.8900000000000001 107.432 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -126.22 72.24 1.3 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.503 -1.666 . . . . 2.4300000000000002 106.503 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.538 HG22 ' HA ' ' A' ' 44' ' ' ALA . 44.4 t -103.55 141.09 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.843 -0.799 . . . . 1.8899999999999999 108.843 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.25 95.75 5.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.551 -0.907 . . . . 1.4299999999999999 108.551 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.97 -18.19 4.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.022 0.529 . . . . 3.0499999999999998 112.309 169.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.8 mtt -69.13 -50.54 46.97 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.3 0.64 . . . . 3.6099999999999999 110.116 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.08 -30.69 12.89 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.715 0.806 . . . . 1.48 111.435 -172.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.38 64.08 1.4 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.837 1.208 . . . . 1.2 110.479 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -141.0 138.5 33.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.384 -1.709 . . . . 2.9300000000000002 106.384 171.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.538 ' HA ' HG22 ' A' ' 37' ' ' VAL . . . -117.09 92.74 3.94 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 124.868 1.355 . . . . 1.27 112.301 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.92 119.59 35.67 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.996 -1.113 . . . . 4.6699999999999999 107.996 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.99 163.35 20.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 126.379 1.872 . . . . 2.6000000000000001 108.858 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -122.34 106.08 10.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.588 0.755 . . . . 3.9100000000000001 110.083 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.513 ' HB2' HD12 ' A' ' 53' ' ' ILE . 18.6 p90 -100.11 173.36 6.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.075 1.75 . . . . 2.3799999999999999 113.272 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -122.85 102.86 37.66 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.239 1.815 . . . . 4.0599999999999996 109.27 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -45.8 -36.02 14.38 Favored 'Trans proline' 0 C--N 1.355 0.913 1 C-N-CA 126.076 4.517 . . . . 2.2999999999999998 113.743 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.39 -29.11 68.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.224 1.409 . . . . 3.3599999999999999 111.69 -170.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.89 -32.45 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.684 0.794 . . . . 2.79 112.261 -174.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.513 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -120.56 146.2 25.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 107.947 -1.131 . . . . 1.6000000000000001 107.947 173.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -124.27 146.51 51.97 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.149 1.38 . . . . 2.4399999999999999 109.394 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.72 -38.5 49.29 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.313 2.676 . . . . 1.6899999999999999 112.057 -171.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -57.58 -45.62 85.01 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.879 -0.513 . . . . 3.2599999999999998 111.005 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -61.05 -43.18 99.28 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.002 0.921 . . . . 3.3900000000000001 109.904 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.401 ' CD1' HD11 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -52.37 -53.2 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.251 -1.388 . . . . 1.1200000000000001 107.251 171.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.17 85.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 110.019 -0.363 . . . . 1.47 110.019 -173.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -55.89 -42.55 76.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.292 0.637 . . . . 2.7599999999999998 110.86 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.2 -43.25 87.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.394 0.543 . . . . 2.79 110.129 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 69' ' ' ALA . 6.1 mm -65.4 -44.03 94.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.671 -0.643 . . . . 2.5699999999999998 110.607 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -58.46 -41.96 86.34 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.288 0.635 . . . . 3.3799999999999999 111.279 174.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -63.76 -48.73 75.78 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.174 0.59 . . . . 2.9100000000000001 109.984 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.8 mt -56.22 -35.51 67.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.645 0.378 . . . . 2.0800000000000001 111.323 173.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.82 25.57 3.6 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.216 0.912 . . . . 1.3400000000000001 112.077 168.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -115.48 168.79 9.68 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.055 1.742 . . . . 2.0899999999999999 108.643 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -104.06 142.55 34.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.801 -1.185 . . . . 2.3999999999999999 107.801 165.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.581 ' HB1' HD12 ' A' ' 8' ' ' LEU . . . -123.81 112.38 17.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.78 -1.563 . . . . 0.95999999999999996 106.78 175.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB3' HE22 ' A' ' 9' ' ' GLN . . . -126.85 129.33 48.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.656 -0.868 . . . . 0.93000000000000005 108.656 175.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.7 p -47.69 145.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 125.484 1.513 . . . . 2.8599999999999999 109.702 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -55.2 -40.03 70.29 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.751 -0.659 . . . . 4.9500000000000002 110.273 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 168.11 -43.87 0.0 OUTLIER 'General case' 0 C--O 1.235 0.333 0 C-N-CA 130.697 3.599 . . . . 6.3700000000000001 106.231 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.48 95.65 4.53 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.494 1.518 . . . . 7.6500000000000004 107.441 -176.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.545 ' CE1' HD11 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -40.2 -58.44 1.48 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.131 1.372 . . . . 5.5999999999999996 112.656 178.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 133.79 167.83 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 130.8 3.64 . . . . 4.1200000000000001 105.811 -175.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' A' ' 82' ' ' ILE . . . -75.71 83.55 0.91 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.923 -1.132 . . . . 2.96 112.395 173.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.3 m -75.15 61.84 1.16 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.132 1.773 . . . . 5.4400000000000004 111.043 168.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.3 t70 54.88 109.2 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 128.526 2.73 . . . . 4.3099999999999996 115.958 159.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.58 -47.23 3.73 Favored Glycine 0 C--N 1.341 0.857 0 N-CA-C 107.17 -2.372 . . . . 1.6399999999999999 107.17 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.15 96.49 10.61 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 105.477 -2.046 . . . . 2.4900000000000002 105.477 172.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.611 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 5.6 pt -123.06 145.69 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 O-C-N 123.211 0.319 . . . . 2.96 110.213 173.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.401 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.0 OUTLIER -96.98 157.35 15.94 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.491 -1.67 . . . . 3.54 106.491 178.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.63 HD13 ' HB1' ' A' ' 145' ' ' ALA . 4.6 pp -147.51 161.72 40.52 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.091 -0.707 . . . . 2.9700000000000002 109.091 161.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.6 m -99.73 127.86 45.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.624 1.17 . . . . 1.8300000000000001 108.815 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 pp -99.57 127.61 52.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 C-N-CA 123.079 0.552 . . . . 1.5900000000000001 110.311 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.5 m -106.45 142.6 35.84 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.722 0.809 . . . . 1.3600000000000001 109.188 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.65 -24.26 17.78 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.653 1.121 . . . . 0.94999999999999996 113.061 172.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.2 ttm -66.28 143.6 57.11 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.063 0.931 . . . . 2.6000000000000001 111.274 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.6 t -162.0 37.18 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.925 0.49 . . . . 2.5800000000000001 110.593 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.1 t -164.62 138.35 5.1 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.605 -1.31 . . . . 2.8199999999999998 111.509 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.27 -40.17 81.15 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.243 0.617 . . . . 2.6200000000000001 110.895 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -43.23 70.44 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.494 -0.753 . . . . 2.4399999999999999 109.612 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 91.2 m -67.76 -42.38 81.84 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.157 -0.449 . . . . 2.0600000000000001 110.796 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.95 -50.35 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 118.864 0.756 . . . . 2.0600000000000001 110.509 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -59.23 -37.0 76.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.766 -0.457 . . . . 3.3999999999999999 109.766 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -65.25 -49.11 70.9 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.275 -0.266 . . . . 1.7 110.663 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.07 -48.27 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 109.438 -0.579 . . . . 0.92000000000000004 109.438 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -58.63 -49.3 78.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.443 -0.947 . . . . 2.46 108.443 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.1 t -52.45 -46.38 66.42 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.1 0.56 . . . . 1.3799999999999999 110.122 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.454 ' HG2' HD11 ' A' ' 141' ' ' ILE . 13.7 mptt -63.33 -41.47 98.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.284 0.634 . . . . 2.96 111.723 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.6 mt -67.34 -58.59 4.51 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.538 -1.282 . . . . 1.78 107.538 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.3 p -57.05 -18.74 15.43 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.133 0.973 . . . . 1.8500000000000001 112.749 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.16 -34.45 66.17 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.943 -0.473 . . . . 6.0 111.65 170.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.5 m -67.44 149.22 50.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.407 1.883 . . . . 1.6399999999999999 111.458 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -64.47 -52.68 56.71 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.347 1.059 . . . . 2.4700000000000002 111.891 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.21 -27.41 59.94 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 122.175 -0.328 . . . . 1.1000000000000001 113.074 -168.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.52 132.02 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 117.647 0.723 . . . . 1.96 109.538 -173.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 49.6 m -103.03 -58.21 1.91 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.249 0.619 . . . . 1.96 111.19 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -134.69 113.7 11.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.2 -0.667 . . . . 2.6899999999999999 109.2 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.24 149.88 21.54 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 108.102 -1.073 . . . . 0.83999999999999997 108.102 165.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.7 t -143.03 109.01 5.18 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 108.19 -1.041 . . . . 1.9399999999999999 108.19 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.44 138.99 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.322 1.449 . . . . 2.1000000000000001 110.686 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.21 93.64 2.85 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.74 1.216 . . . . 1.1799999999999999 110.665 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 pp -60.11 -17.62 41.38 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.538 1.135 . . . . 2.2799999999999998 113.83 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.71 86.75 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.458 0.572 . . . . 1.48 109.574 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.82 -39.91 10.02 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.505 1.122 . . . . 2.0899999999999999 108.905 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.1 m 88.94 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 127.568 2.347 . . . . 1.3 110.539 -169.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.0 157.95 17.41 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.365 -0.606 . . . . 4.0899999999999999 109.365 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.57 144.26 34.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.812 -1.09 . . . . 1.1100000000000001 109.944 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.545 HD11 ' CE1' ' A' ' 75' ' ' TYR . 4.3 mm? -94.79 143.31 26.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.462 -0.94 . . . . 2.8999999999999999 108.462 163.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.74 124.16 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.634 -1.987 . . . . 1.72 105.634 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -108.64 92.44 4.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.086 -1.079 . . . . 3.1400000000000001 108.086 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -113.33 -178.56 3.41 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 124.014 0.926 . . . . 2.1299999999999999 108.83 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -113.99 110.75 48.5 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 108.322 -0.992 . . . . 2.98 108.322 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.32 68.47 8.27 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.924 2.416 . . . . 1.74 112.229 -166.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.34 -44.92 0.07 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.617 1.567 . . . . 3.3100000000000001 109.206 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.6 pt -86.67 -30.73 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 123.365 0.666 . . . . 1.6599999999999999 111.559 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.2 162.63 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.426 -0.953 . . . . 1.4399999999999999 108.426 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.79 167.84 31.64 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.837 -0.905 . . . . 1.4399999999999999 110.837 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.12 -39.01 62.81 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.811 3.008 . . . . 1.49 112.334 -169.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.76 -39.43 52.33 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.471 0.545 . . . . 6.0599999999999996 112.471 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.51 -45.0 81.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.602 -0.518 . . . . 3.3700000000000001 109.602 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 88.3 mt -58.67 -49.29 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.815 -0.809 . . . . 1.1499999999999999 108.815 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.2 mt -49.57 -59.31 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 N-CA-C 108.445 -0.946 . . . . 2.1299999999999999 108.445 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -50.07 -47.55 53.5 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.105 -0.997 . . . . 5.0199999999999996 111.365 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 82.4 mt -55.54 -50.12 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.447 -0.783 . . . . 2.6899999999999999 109.646 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 145' ' ' ALA . 12.7 pt -70.37 -30.14 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 118.108 -0.949 . . . . 1.26 112.861 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.77 -42.48 79.47 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.829 1.195 . . . . 3.02 109.068 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.71 -34.32 76.91 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.758 1.223 . . . . 3.4500000000000002 109.232 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.454 HD11 ' HG2' ' A' ' 101' ' ' LYS . 75.9 mt -75.39 -41.21 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.264 0.626 . . . . 1.04 111.376 172.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.55 30.44 6.19 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.847 1.689 . . . . 0.91000000000000003 112.433 -172.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -105.31 171.58 7.25 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.727 1.263 . . . . 2.1699999999999999 110.304 167.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -129.04 117.63 21.22 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 106.655 -1.609 . . . . 4.4000000000000004 106.655 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.63 ' HB1' HD13 ' A' ' 84' ' ' LEU . . . -106.06 102.54 11.95 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 125.292 1.437 . . . . 1.0900000000000001 108.616 174.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.0 p -98.85 112.7 24.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.092 -1.447 . . . . 2.52 107.092 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 83' ' ' GLU . 1.2 mt -49.78 105.86 0.1 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.523 -1.288 . . . . 5.6900000000000004 107.523 166.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.67 -38.48 33.53 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.333 -0.617 . . . . 3.8100000000000001 109.333 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 126.72 2.008 . . . . 6.9100000000000001 113.167 -179.848 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.586 ' SD ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 107.312 -1.366 . . . . 11.1 107.312 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.75 123.34 79.1 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 119.968 1.258 . . . . 4.3799999999999999 108.94 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.51 111.48 3.26 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 N-CA-C 109.165 -1.129 . . . . 3.5800000000000001 109.165 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.79 158.47 44.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.449 -1.686 . . . . 3.29 106.449 170.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -123.09 152.13 41.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.331 1.052 . . . . 3.5099999999999998 109.585 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.5 t -140.87 127.98 20.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.774 -0.825 . . . . 2.0699999999999998 108.774 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -101.01 98.73 9.15 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.986 1.715 . . . . 3.73 109.082 -171.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.476 ' CB ' ' HA ' ' A' ' 71' ' ' VAL 0.273 1.4 pt? -125.44 176.55 6.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.943 0.877 . . . . 2.1600000000000001 112.383 176.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.601 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -136.36 147.11 47.21 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.186 -1.412 . . . . 1.79 107.186 176.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.1 mm -99.05 140.07 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 106.264 -1.754 . . . . 0.83999999999999997 106.264 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -115.41 76.69 1.02 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.293 -1.003 . . . . 3.1299999999999999 108.293 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.25 -69.96 0.04 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.952 -1.259 . . . . 1.23 109.952 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 31.38 72.1 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.734 2.013 . . . . 2.54 115.646 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -53.08 -16.62 1.18 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.557 1.543 . . . . 2.4100000000000001 114.053 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.2 t 74.79 -56.68 0.63 Allowed 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 126.28 1.832 . . . . 3.3599999999999999 111.767 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -23.15 -75.44 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 127.523 2.329 . . . . 5.6900000000000004 112.917 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.8 m -154.66 17.44 0.45 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.83 0.852 . . . . 3.0499999999999998 111.541 162.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.83 -51.83 36.48 Favored 'General case' 0 C--O 1.224 -0.242 0 O-C-N 121.051 -1.031 . . . . 1.8500000000000001 109.618 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -51.67 -47.86 37.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 CA-C-N 118.458 0.572 . . . . 1.48 109.689 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -56.95 -49.66 75.0 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.545 0.688 . . . . 2.8700000000000001 110.609 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -59.1 -51.7 68.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.612 -0.68 . . . . 2.6400000000000001 109.677 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 67' ' ' PHE . 2.8 mt -51.32 -47.57 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.334 1.454 . . . . 1.45 110.859 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -55.38 -53.19 59.26 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.877 0.762 . . . . 4.0599999999999996 110.482 174.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -65.58 -31.55 72.66 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.395 -0.815 . . . . 4.4699999999999998 111.438 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -68.66 -51.29 43.61 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.255 1.022 . . . . 1.1899999999999999 109.697 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.33 -40.35 67.93 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.084 0.954 . . . . 1.9299999999999999 110.663 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.67 -19.72 2.58 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.66 0.615 . . . . 2.7000000000000002 112.66 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -126.63 24.06 6.68 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.216 1.406 . . . . 3.8799999999999999 111.831 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.38 -82.57 0.05 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.091 -1.078 . . . . 3.2000000000000002 108.091 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.44 -132.74 0.08 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.074 0.95 . . . . 1.28 109.19 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.38 33.17 1.35 Allowed Glycine 0 CA--C 1.531 1.06 0 O-C-N 120.909 -1.12 . . . . 1.3100000000000001 113.816 -174.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.412 ' C ' HD12 ' A' ' 33' ' ' LEU . 14.3 p -104.31 118.79 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.682 1.593 . . . . 1.5700000000000001 108.923 170.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.586 HD13 ' SD ' ' A' ' 1' ' ' MET . 4.1 mp -134.24 53.38 2.0 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.406 -0.961 . . . . 3.3199999999999998 108.406 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.66 149.42 14.88 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.419 -1.326 . . . . 2.0899999999999999 107.419 173.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.92 100.84 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 106.404 -1.702 . . . . 2.8300000000000001 106.404 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.72 71.89 1.05 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.046 -1.094 . . . . 3.2400000000000002 108.046 176.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.77 133.6 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.432 -0.951 . . . . 1.8400000000000001 108.432 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.36 83.06 1.71 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.033 -1.099 . . . . 1.28 108.033 173.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.49 -24.03 1.87 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.466 1.506 . . . . 2.8799999999999999 112.267 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -70.16 -40.06 74.96 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.806 1.242 . . . . 4.75 111.785 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.24 -31.89 11.49 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.513 1.125 . . . . 1.3799999999999999 110.991 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.79 61.17 1.71 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 125.072 1.32 . . . . 1.0 110.565 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -141.23 136.83 32.1 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.181 -1.414 . . . . 3.6600000000000001 107.181 171.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.34 102.15 10.82 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.283 1.433 . . . . 1.05 109.683 170.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -98.67 135.88 39.54 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.777 -1.934 . . . . 4.2800000000000002 105.777 166.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.45 HD12 HD21 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -135.09 174.34 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.978 -1.119 . . . . 2.29 107.978 168.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.74 103.44 6.83 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.753 0.821 . . . . 5.5499999999999998 108.797 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -117.6 167.83 10.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.103 1.361 . . . . 3.3100000000000001 113.755 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -99.26 106.32 38.16 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 127.202 2.201 . . . . 3.1699999999999999 110.452 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.01 -4.44 13.53 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.103 1.869 . . . . 2.7000000000000002 114.35 -172.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -88.62 -20.84 24.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.926 0.785 . . . . 4.46 110.907 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.97 -30.48 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.505 1.122 . . . . 2.7999999999999998 110.091 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.45 HD11 ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -115.98 155.96 17.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.666 0.746 . . . . 1.74 109.257 173.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -132.31 154.27 81.54 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.416 2.286 . . . . 2.9399999999999999 108.379 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.28 -40.13 34.03 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.634 2.223 . . . . 1.54 112.194 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -63.76 -40.27 96.3 Favored 'General case' 0 C--O 1.225 -0.227 0 O-C-N 121.763 -0.586 . . . . 2.8199999999999998 110.868 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -58.36 -45.83 87.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.943 0.897 . . . . 2.9500000000000002 110.334 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.45 ' CD1' HD11 ' A' ' 53' ' ' ILE . 1.9 mt -53.98 -56.06 11.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.851 -1.537 . . . . 1.3200000000000001 106.851 172.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.95 -41.32 70.95 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.787 -0.642 . . . . 1.4399999999999999 110.578 -173.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -53.84 -50.18 66.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.23 1.412 . . . . 2.77 109.387 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -48.46 72.12 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.379 0.609 . . . . 2.21 109.777 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.7 mm -63.22 -40.33 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.129 -0.357 . . . . 2.6699999999999999 110.564 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -64.9 -42.19 94.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.735 -0.469 . . . . 1.96 109.735 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -60.46 -47.89 84.15 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.138 0.575 . . . . 2.98 109.562 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.18 -33.52 71.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.209 0.604 . . . . 2.04 111.629 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.9 27.72 3.92 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.172 0.892 . . . . 1.3899999999999999 111.632 168.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.44 ' CD2' HD13 ' A' ' 22' ' ' ILE . 2.6 m-30 -118.91 162.3 18.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.994 1.717 . . . . 2.1800000000000002 108.694 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -98.31 129.19 45.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.931 1.293 . . . . 3.6899999999999999 107.973 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.4 110.61 21.8 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.984 1.314 . . . . 1.1699999999999999 108.507 174.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -126.93 122.92 35.96 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.122 0.419 . . . . 1.21 109.977 175.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.476 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.4 t -58.38 148.23 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 123.24 0.616 . . . . 3.1400000000000001 110.931 172.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 39.8 mtt -58.63 -36.11 73.56 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 119.076 -0.488 . . . . 4.96 111.449 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 128.95 -25.94 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.565 1 C-N-CA 134.237 5.015 . . . . 5.1600000000000001 110.42 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -40.71 -30.04 0.11 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 129.618 3.167 . . . . 8.3000000000000007 112.19 166.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.403 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.3 OUTLIER 81.11 -88.9 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.924 1.29 . . . . 6.1200000000000001 110.318 169.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 75' ' ' TYR . . . 159.15 -64.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.875 1.67 . . . . 2.9900000000000002 111.389 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.62 -42.79 1.26 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.763 -0.935 . . . . 5.1500000000000004 110.763 -162.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.4 m 18.2 45.22 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.89 2.876 . . . . 6.8499999999999996 115.777 -173.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 t70 41.42 105.6 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 129.724 3.21 . . . . 5.2599999999999998 114.353 -171.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.96 -30.67 9.35 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.038 -1.225 . . . . 1.8500000000000001 110.038 -174.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.32 73.09 2.13 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.847 1.259 . . . . 2.8100000000000001 109.139 -167.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.28 155.68 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.584 -0.895 . . . . 2.6200000000000001 108.584 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.84 140.69 50.41 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.636 1.174 . . . . 2.7599999999999998 107.998 173.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 mp -130.68 149.53 52.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.844 -0.799 . . . . 2.1400000000000001 108.844 171.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.63 130.77 44.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.311 1.044 . . . . 1.6499999999999999 108.614 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.8 mt -99.92 115.28 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.635 -0.506 . . . . 2.9399999999999999 109.635 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.8 p -107.84 89.13 2.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.926 1.29 . . . . 2.46 109.543 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.6 -45.8 0.57 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.798 -0.921 . . . . 1.1000000000000001 110.798 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -56.41 136.64 53.73 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 110.221 -0.289 . . . . 2.1000000000000001 110.221 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -158.2 34.71 0.24 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.103 0.561 . . . . 2.8799999999999999 110.891 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 34.0 t -158.91 144.23 16.22 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.548 -0.72 . . . . 2.6099999999999999 110.617 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.15 -39.12 42.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.153 0.981 . . . . 2.6299999999999999 111.995 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.2 p -53.6 -46.27 70.34 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.906 -0.497 . . . . 3.46 110.74 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 65.6 m -67.98 -45.96 72.68 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.909 -0.774 . . . . 1.8200000000000001 108.909 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.425 HG21 HD12 ' A' ' 115' ' ' LEU . 61.1 t -51.91 -49.58 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.042 0.937 . . . . 1.6299999999999999 109.591 175.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -64.38 -37.66 88.29 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.776 -0.824 . . . . 3.27 108.776 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -59.87 -52.61 64.71 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.63 0.772 . . . . 2.1200000000000001 110.347 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.1 mt -54.17 -54.13 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.654 0.782 . . . . 1.0600000000000001 109.045 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.6 -45.17 85.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.806 -0.442 . . . . 3.1299999999999999 109.806 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.8 t -54.69 -49.31 70.98 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.507 0.723 . . . . 1.8200000000000001 110.583 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -34.8 78.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.412 -0.805 . . . . 2.5699999999999998 111.274 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.3 mt -71.57 -58.16 3.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.778 -0.823 . . . . 1.8 108.778 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.5 p -56.21 -22.73 31.13 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 111.915 0.339 . . . . 2.3799999999999999 111.915 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.31 -27.09 69.09 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.457 0.91 . . . . 4.79 113.457 174.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.1 p -69.4 172.71 6.73 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 119.822 1.192 . . . . 2.6299999999999999 111.246 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -88.62 -47.21 8.45 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.222 -0.899 . . . . 3.98 110.278 173.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.47 -34.09 51.06 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.471 -0.627 . . . . 1.1899999999999999 113.587 -170.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.97 135.17 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 119.145 1.472 . . . . 2.3399999999999999 109.251 -176.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -105.27 -44.67 4.68 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 122.407 0.283 . . . . 2.8100000000000001 111.624 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.431 ' CZ ' ' HG3' ' A' ' 123' ' ' LYS . 27.2 p90 -139.7 122.75 16.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.67 -1.604 . . . . 2.0899999999999999 106.67 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.85 143.82 45.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.564 -0.854 . . . . 1.4299999999999999 109.795 164.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.6 m -133.56 119.99 20.19 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.037 -1.468 . . . . 1.9299999999999999 107.037 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 p -122.55 133.55 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 123.631 0.772 . . . . 1.8999999999999999 109.079 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -127.92 99.98 5.73 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.961 0.886 . . . . 1.3400000000000001 109.216 -171.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.591 HD13 ' H ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -55.62 -21.43 17.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.756 1.622 . . . . 3.0899999999999999 113.743 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.406 ' N ' HD22 ' A' ' 115' ' ' LEU . . . -73.76 -41.36 62.57 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.933 -0.765 . . . . 1.4299999999999999 108.933 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.2 p -88.11 -15.28 36.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.711 1.204 . . . . 3.27 111.191 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.8 t 65.11 25.64 12.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.869 1.268 . . . . 1.98 110.778 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.56 149.28 50.22 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.412 0.685 . . . . 2.77 110.941 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -125.15 115.64 20.78 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.68 2.392 . . . . 0.93000000000000005 108.199 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.42 116.55 29.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.003 -1.48 . . . . 2.1899999999999999 107.003 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.3 m -111.58 140.12 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.025 0.93 . . . . 2.0699999999999998 109.799 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.431 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 2.2 mmtp -123.19 95.89 4.78 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-O 118.511 -0.757 . . . . 3.6800000000000002 110.063 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -121.52 178.52 4.78 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.706 1.002 . . . . 2.0800000000000001 113.706 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -104.64 110.42 64.33 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.233 1.013 . . . . 3.48 108.687 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.9 62.51 6.59 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.609 2.873 . . . . 1.71 112.788 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -148.25 -52.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.123 1.769 . . . . 2.9700000000000002 107.72 172.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -86.98 -32.67 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.442 0.697 . . . . 1.8100000000000001 111.413 -172.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.78 165.82 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.429 -1.693 . . . . 1.6599999999999999 106.429 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.94 164.46 31.32 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 109.852 -1.299 . . . . 1.79 109.852 -176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.23 -40.86 46.69 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.032 2.488 . . . . 1.9299999999999999 110.2 -171.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -48.35 -38.47 19.32 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 113.47 0.915 . . . . 7.79 113.47 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.1 -44.92 75.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.681 -0.859 . . . . 3.4399999999999999 108.681 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.13 -47.59 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.383 -0.969 . . . . 1.5600000000000001 108.383 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.9 mt -54.12 -60.69 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.004 -0.739 . . . . 2.1299999999999999 109.004 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -51.61 -45.74 63.34 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 119.59 1.086 . . . . 3.6200000000000001 111.055 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.6 mt -54.17 -53.49 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 121.664 -0.647 . . . . 2.3300000000000001 110.076 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.253 2.1 pp -67.83 -30.83 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 121.109 -0.994 . . . . 1.24 112.891 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -55.89 -39.94 72.3 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.798 0.726 . . . . 2.98 110.107 170.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -63.06 -35.86 81.65 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.756 -0.461 . . . . 2.6499999999999999 109.756 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.5 mt -68.26 -44.33 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.562 -0.533 . . . . 0.95999999999999996 109.562 172.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.35 32.6 2.51 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.273 1.416 . . . . 0.85999999999999999 111.182 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -99.28 178.41 4.91 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.116 0.958 . . . . 2.4399999999999999 108.891 165.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -141.05 124.38 16.59 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.57 -1.641 . . . . 3.7200000000000002 106.57 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.97 94.78 4.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.307 1.443 . . . . 1.1799999999999999 108.706 -174.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.3 m -103.0 117.66 35.08 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.997 0.919 . . . . 1.6699999999999999 110.456 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 mp -45.73 117.89 1.62 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.786 1.634 . . . . 4.29 110.108 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -109.57 13.44 23.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.37 0.668 . . . . 3.4399999999999999 112.303 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? . . . . . 0 C--O 1.25 1.129 0 C-N-CA 125.486 1.514 . . . . 7.3899999999999997 109.811 161.214 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmt . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 106.744 -1.576 . . . . 7.5700000000000003 106.744 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.39 112.21 7.24 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 118.693 0.679 . . . . 3.6299999999999999 109.28 -167.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.05 108.66 2.68 Favored 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.294 1.329 . . . . 2.77 110.283 -171.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -118.05 158.64 24.62 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.291 -1.744 . . . . 2.98 106.291 170.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.51 166.51 10.49 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 107.758 -1.201 . . . . 4.0 107.758 166.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.97 120.25 11.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.579 1.081 . . . . 3.5600000000000001 108.933 170.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -98.2 90.23 4.77 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.556 0.742 . . . . 2.8799999999999999 110.267 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.56 165.72 15.97 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.704 0.764 . . . . 2.6699999999999999 111.04 175.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.806 HE22 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -120.14 156.32 31.3 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.303 -0.999 . . . . 1.9399999999999999 108.303 174.379 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.1 144.44 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 107.677 -1.231 . . . . 0.98999999999999999 107.677 172.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -116.54 125.07 51.36 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.678 -1.231 . . . . 4.9100000000000001 107.678 162.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 147.86 -81.14 0.2 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.188 1.375 . . . . 1.3999999999999999 109.998 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.9 mtt 57.92 66.64 1.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.825 1.25 . . . . 2.0499999999999998 113.013 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -46.52 -54.71 8.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.862 1.265 . . . . 2.5699999999999998 113.303 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.2 p -167.83 44.48 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.516 0.598 . . . . 5.5 111.323 -170.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.67 35.44 8.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.274 1.029 . . . . 4.7999999999999998 112.681 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 m -152.24 -43.26 0.11 Allowed 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.385 1.474 . . . . 2.46 110.555 -173.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.55 -46.15 87.45 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.347 -0.845 . . . . 2.1600000000000001 109.937 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.536 ' HB ' HD21 ' A' ' 39' ' ' LEU . 54.3 t -52.69 -39.64 31.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 O-C-N 122.184 -0.322 . . . . 1.96 110.437 171.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -59.7 -42.73 93.63 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.085 0.469 . . . . 2.29 110.868 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -66.19 -47.6 73.39 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.31 -0.869 . . . . 2.6299999999999999 109.631 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.41 -46.98 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 122.211 -0.306 . . . . 2.25 110.418 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -57.6 -41.15 80.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.292 1.037 . . . . 6.96 112.39 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -46.48 89.07 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.355 -0.98 . . . . 5.5700000000000003 108.355 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -58.0 -45.16 87.27 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.072 -0.49 . . . . 1.5900000000000001 110.557 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.552 HD11 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -52.2 -58.56 6.24 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.533 0.733 . . . . 2.6000000000000001 111.424 172.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -19.99 65.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.812 1.187 . . . . 2.3199999999999998 112.921 -175.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -90.39 -0.92 57.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.713 1.375 . . . . 4.5599999999999996 114.713 168.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -53.1 -70.63 0.09 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.848 1.658 . . . . 3.0899999999999999 111.012 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.7 -81.47 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.42 1.088 . . . . 1.3700000000000001 110.66 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.52 -28.71 73.61 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.889 -0.484 . . . . 1.6000000000000001 111.889 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 t -61.34 116.16 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.209 1.004 . . . . 2.8900000000000001 110.284 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.66 54.66 1.67 Allowed 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.861 -1.533 . . . . 3.3599999999999999 106.861 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.4 t -160.39 161.48 33.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 120.887 -1.133 . . . . 2.2000000000000002 110.42 155.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.81 109.43 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 127.277 2.231 . . . . 2.8399999999999999 106.779 172.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tt -135.54 63.05 1.61 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.114 -1.069 . . . . 2.4100000000000001 108.114 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -96.12 149.09 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.143 -1.058 . . . . 2.5899999999999999 108.143 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.22 100.0 6.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.113 -1.44 . . . . 1.3700000000000001 107.113 166.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.536 HD21 ' HB ' ' A' ' 19' ' ' VAL . 17.2 mt -64.41 -15.38 60.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.277 0.631 . . . . 2.8900000000000001 112.158 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.4 mmt -72.39 -52.81 14.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.533 0.733 . . . . 5.1100000000000003 110.405 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.33 -34.02 21.93 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.95 0.5 . . . . 1.5 110.974 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.94 62.79 1.28 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.035 1.303 . . . . 1.23 110.899 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -140.14 137.04 34.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.887 -1.523 . . . . 3.6800000000000002 106.887 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.07 96.35 5.99 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 125.044 1.338 . . . . 1.1100000000000001 109.791 173.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -98.65 136.5 38.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.481 -2.044 . . . . 3.6400000000000001 105.481 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.98 177.92 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 N-CA-C 106.079 -1.823 . . . . 2.1099999999999999 106.079 172.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -129.84 99.92 5.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.785 0.434 . . . . 4.0899999999999999 110.386 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -94.47 -177.86 4.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.621 1.968 . . . . 2.6299999999999999 112.857 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -127.67 108.52 20.65 Favored Pre-proline 0 N--CA 1.444 -0.765 0 CA-C-N 114.169 -1.378 . . . . 3.4300000000000002 108.003 169.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.22 -3.01 10.79 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.581 2.187 . . . . 2.1299999999999999 112.764 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.67 -39.6 64.31 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.797 1.18 . . . . 3.5800000000000001 110.708 172.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -110.01 -19.18 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 118.291 0.496 . . . . 3.0 110.335 -166.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 pt -131.7 -176.48 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 107.484 -1.302 . . . . 2.29 107.484 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.64 155.94 59.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 125.418 1.487 . . . . 2.4100000000000001 108.449 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.39 -35.6 60.54 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.309 2.006 . . . . 1.52 110.192 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.94 -37.99 84.27 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 122.064 -0.397 . . . . 2.8199999999999998 111.94 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -67.74 -45.54 74.7 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.964 0.905 . . . . 3.0800000000000001 110.372 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.9 mt -48.5 -56.76 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 106.546 -1.65 . . . . 1.5 106.546 167.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.59 89.31 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.07 -0.514 . . . . 1.52 110.777 -170.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -52.27 -49.78 63.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.81 1.644 . . . . 2.5 109.604 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.74 -50.27 44.9 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.154 0.502 . . . . 3.0299999999999998 109.797 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.552 HD11 HD11 ' A' ' 26' ' ' LEU . 5.9 mm -65.99 -38.9 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 121.919 -0.488 . . . . 2.48 110.958 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -64.11 -46.28 84.91 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.567 -0.531 . . . . 2.04 109.567 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -57.8 -52.43 65.51 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.316 0.646 . . . . 2.6299999999999999 109.817 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.3 mt -58.77 -38.78 79.25 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.27 -0.423 . . . . 2.4500000000000002 111.576 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.79 33.33 0.65 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 123.367 0.508 . . . . 1.3200000000000001 112.59 163.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -133.02 163.64 28.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.733 1.213 . . . . 2.5499999999999998 110.365 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -97.41 128.73 44.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.97 -1.493 . . . . 2.54 106.97 171.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.85 124.33 52.13 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.491 -1.3 . . . . 1.02 107.491 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.806 ' HB3' HE22 ' A' ' 9' ' ' GLN . . . -128.49 138.01 52.06 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.558 -1.275 . . . . 1.29 107.558 168.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -60.64 141.14 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.536 -0.913 . . . . 3.25 108.536 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.6 mtt -42.84 -55.14 3.81 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.805 1.242 . . . . 4.75 110.604 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -164.82 -52.23 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.727 2.011 . . . . 6.2699999999999996 107.303 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -83.25 -89.5 0.09 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.633 -0.698 . . . . 7.6299999999999999 112.867 -168.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.4 ' CE2' HD23 ' A' ' 121' ' ' LEU . 0.0 OUTLIER 152.72 -105.96 0.0 OUTLIER 'General case' 0 C--N 1.345 0.409 0 C-N-CA 128.478 2.711 . . . . 4.2999999999999998 111.965 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -119.97 -61.85 1.55 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.25 2.22 . . . . 3.2200000000000002 111.712 -167.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 82' ' ' ILE . . . 63.47 85.29 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 125.591 1.567 . . . . 3.1299999999999999 113.391 171.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.7 t -162.39 -81.75 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.235 1.017 . . . . 5.5999999999999996 113.132 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -113.87 126.77 55.55 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.541 1.137 . . . . 4.6399999999999997 109.114 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.76 -35.4 2.5 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.686 -0.965 . . . . 2.2599999999999998 110.686 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.99 101.84 4.13 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.236 1.414 . . . . 2.54 108.66 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.733 HD12 ' N ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -125.87 155.31 35.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 125.55 1.54 . . . . 3.0899999999999999 108.123 -167.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.74 ' OE1' ' HB3' ' A' ' 148' ' ' ALA . 2.6 pp20? -131.38 153.17 49.93 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.121 1.368 . . . . 4.2400000000000002 107.396 174.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.07 162.71 32.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.151 -1.425 . . . . 2.4199999999999999 107.151 170.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.596 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -97.42 133.52 41.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.965 -2.235 . . . . 2.1000000000000001 104.965 170.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.411 ' O ' HD12 ' A' ' 86' ' ' ILE . 1.6 pp -106.16 117.59 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 123.54 0.736 . . . . 1.95 109.652 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.6 m -105.6 136.79 44.54 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.577 -1.268 . . . . 1.6699999999999999 107.577 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.28 -45.24 1.34 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.493 1.044 . . . . 1.4299999999999999 111.151 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -62.26 132.96 54.42 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.39 -0.476 . . . . 2.7200000000000002 110.345 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -156.89 42.01 0.35 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.373 0.669 . . . . 3.9100000000000001 110.303 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.6 t -162.4 144.92 11.1 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 120.711 -1.243 . . . . 2.8399999999999999 110.523 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.49 -40.37 62.29 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.697 0.799 . . . . 3.1800000000000002 110.897 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -54.67 -47.1 74.02 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.897 -0.502 . . . . 2.0 110.364 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.8 m -64.6 -44.76 89.58 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.06 0.544 . . . . 2.1000000000000001 109.596 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.4 t -51.14 -51.17 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 122.589 0.356 . . . . 1.6599999999999999 110.074 171.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -62.28 -37.84 87.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.208 -0.664 . . . . 2.6499999999999999 109.208 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -59.95 -55.02 39.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.183 0.993 . . . . 1.99 110.185 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.8 mt -54.91 -56.4 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.301 -0.629 . . . . 1.5900000000000001 109.301 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.86 -43.32 76.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.19 0.996 . . . . 3.3799999999999999 108.938 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.3 t -53.82 -47.18 71.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.643 0.656 . . . . 1.27 111.069 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -63.96 -42.74 97.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.63 -1.294 . . . . 2.79 111.54 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.423 HD23 ' CB ' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -61.44 -54.89 37.59 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.359 -0.978 . . . . 2.6200000000000001 108.359 176.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.0 p -59.11 -25.03 63.48 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.647 0.61 . . . . 1.8500000000000001 112.647 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -72.52 -16.27 61.78 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.187 0.903 . . . . 4.0 112.357 175.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.5 m -80.55 152.82 28.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.915 0.886 . . . . 1.8300000000000001 109.528 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -72.41 -49.49 33.36 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.197 0.999 . . . . 2.7400000000000002 112.555 -175.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.75 -40.26 7.76 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 121.702 0.612 . . . . 1.1599999999999999 111.71 -167.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.514 HD11 ' HB ' ' A' ' 122' ' ' VAL . 2.4 mm -53.66 136.11 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.06 -0.719 . . . . 2.21 109.06 168.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 38.6 p -123.25 -25.69 4.43 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.33 0.493 . . . . 2.98 112.33 166.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.07 112.51 6.8 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.258 -1.756 . . . . 2.02 106.258 -169.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.423 ' CB ' HD23 ' A' ' 102' ' ' LEU . . . -115.55 157.65 23.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.154 -1.054 . . . . 1.1200000000000001 108.154 163.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 61.8 m -144.72 118.46 9.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.048 -1.464 . . . . 2.0499999999999998 107.048 170.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.92 134.3 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 108.57 -0.9 . . . . 2.9300000000000002 108.57 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.2 88.76 2.9 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.678 0.751 . . . . 1.8200000000000001 109.146 -167.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -54.2 -30.18 48.86 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.315 1.046 . . . . 2.9199999999999999 112.13 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.59 65.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.101 0.96 . . . . 2.0 111.088 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.74 -9.8 15.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.32 1.448 . . . . 2.3500000000000001 110.949 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.3 m 66.58 30.58 8.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.574 1.55 . . . . 1.49 111.713 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -105.74 158.15 16.93 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.292 0.637 . . . . 3.9700000000000002 110.683 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.11 109.4 8.91 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.235 1.814 . . . . 1.26 107.988 174.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.4 HD23 ' CE2' ' A' ' 75' ' ' TYR . 8.9 mp -98.55 131.06 45.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.722 -1.214 . . . . 2.4900000000000002 107.722 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.514 ' HB ' HD11 ' A' ' 108' ' ' ILE . 19.7 m -132.65 133.82 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.371 1.068 . . . . 2.4399999999999999 108.555 -174.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -117.67 93.75 4.27 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.041 -1.096 . . . . 3.3599999999999999 108.041 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -122.28 168.76 11.65 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.645 1.178 . . . . 1.9099999999999999 112.284 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -98.13 113.47 63.95 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 109.266 -0.642 . . . . 2.6499999999999999 109.266 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.53 67.86 7.71 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.695 2.93 . . . . 1.95 111.474 -172.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -160.49 -46.86 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.159 1.384 . . . . 3.5499999999999998 108.874 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.1 pt -86.66 -28.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 123.692 0.797 . . . . 1.8799999999999999 111.876 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.53 165.04 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.159 -1.052 . . . . 1.5600000000000001 108.159 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.98 162.5 28.94 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 109.874 -1.29 . . . . 1.6200000000000001 109.874 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -62.57 -35.13 72.48 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.425 2.75 . . . . 1.6699999999999999 111.516 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -52.71 -42.06 64.5 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 112.759 0.651 . . . . 5.4699999999999998 112.759 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.57 -39.0 74.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.459 -0.896 . . . . 3.3599999999999999 109.565 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.1 -47.57 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.967 -0.753 . . . . 1.4399999999999999 108.967 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 52.2 mt -55.36 -56.48 11.45 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 124.015 0.926 . . . . 2.0800000000000001 109.573 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -49.89 -50.44 45.92 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 119.461 1.028 . . . . 4.0599999999999996 110.619 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 50.7 mt -54.88 -55.33 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 122.557 0.343 . . . . 2.3599999999999999 110.154 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.7 pp -68.21 -29.59 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.774 -1.204 . . . . 1.3200000000000001 112.951 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.11 -35.86 74.18 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.401 0.546 . . . . 3.0800000000000001 110.657 171.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.62 -37.76 82.49 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.471 -0.566 . . . . 4.7300000000000004 109.471 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.0 mt -72.92 -40.5 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 109.212 -0.662 . . . . 1.6399999999999999 109.212 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.7 33.97 2.95 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.047 1.308 . . . . 1.4199999999999999 110.961 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -99.19 177.4 5.23 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 108.233 -1.025 . . . . 3.0299999999999998 108.233 164.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -141.38 120.88 13.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.099 -1.815 . . . . 4.5199999999999996 106.099 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.0 110.81 22.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.533 1.533 . . . . 1.3700000000000001 108.727 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.7 m -130.35 134.33 47.09 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.477 0.711 . . . . 2.8599999999999999 110.935 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -37.97 127.88 1.25 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.063 2.145 . . . . 4.3200000000000003 110.151 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.74 ' HB3' ' OE1' ' A' ' 83' ' ' GLU . . . -103.93 -12.09 17.06 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 116.445 -1.74 . . . . 3.2999999999999998 113.343 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 . . . . . 0 C--O 1.259 1.597 0 C-N-CA 129.4 3.08 . . . . 6.8499999999999996 114.554 152.267 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 mtm . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 105.225 -2.139 . . . . 9.5899999999999999 105.225 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -53.49 113.79 5.3 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 119.189 0.904 . . . . 4.2000000000000002 111.405 -168.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.54 97.74 1.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.502 1.468 . . . . 2.7400000000000002 111.361 -171.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -123.53 141.16 52.27 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 126.965 2.106 . . . . 2.9900000000000002 106.471 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -95.45 157.89 15.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.586 1.555 . . . . 4.1100000000000003 107.448 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.9 p -140.95 133.79 28.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 122.544 0.337 . . . . 2.98 110.215 168.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -104.01 105.58 15.8 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 125.665 1.586 . . . . 3.0899999999999999 108.371 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.464 HD21 HD12 ' A' ' 46' ' ' ILE . 1.7 pt? -134.63 169.46 17.27 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.472 -0.491 . . . . 2.1699999999999999 110.969 172.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.22 138.95 51.37 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.012 -1.848 . . . . 1.73 106.012 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.8 mm -97.93 134.04 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 106.802 -1.555 . . . . 1.04 106.802 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -104.51 123.29 47.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.533 -1.654 . . . . 3.3399999999999999 106.533 160.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.84 -27.38 3.06 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.367 0.985 . . . . 3.0600000000000001 111.472 -175.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.2 ptt? -57.92 167.67 1.14 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.791 -0.829 . . . . 2.7799999999999998 111.405 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 m 77.11 -8.81 1.63 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.801 1.24 . . . . 9.25 112.016 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.8 m -114.45 136.01 53.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.888 0.875 . . . . 6.4900000000000002 109.645 -173.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 42.33 -106.15 0.08 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.357 1.463 . . . . 6.29 109.894 -174.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 p -158.95 38.84 0.22 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.918 0.866 . . . . 3.1299999999999999 109.308 171.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.66 -42.96 63.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.76 -0.655 . . . . 1.9299999999999999 110.443 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -57.08 -42.01 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 122.252 1.025 . . . . 2.2799999999999998 109.378 171.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.95 -46.07 82.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.863 -1.062 . . . . 2.7999999999999998 111.293 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -60.83 -46.41 90.66 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.267 -0.896 . . . . 2.5800000000000001 110.519 174.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.0 mt -47.68 -40.29 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 C-N-CA 124.153 0.981 . . . . 1.71 111.637 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -47.31 -60.34 2.57 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.117 0.567 . . . . 5.1500000000000004 111.974 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -37.29 72.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.327 -0.62 . . . . 6.1100000000000003 109.327 -173.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -56.61 -54.85 41.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.186 -0.461 . . . . 1.24 110.066 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mt -58.7 -44.37 90.3 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 118.652 0.66 . . . . 2.1600000000000001 111.137 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.08 -11.26 1.04 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 114.285 1.217 . . . . 1.8 114.285 171.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.11 3.75 11.4 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.955 -1.091 . . . . 3.8100000000000001 111.974 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.73 -65.9 0.66 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.851 1.205 . . . . 2.52 110.515 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.28 -131.36 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.122 0.569 . . . . 1.46 109.951 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.42 -0.94 80.47 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 119.501 1.046 . . . . 1.6899999999999999 113.096 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.91 127.61 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 O-C-N 121.523 -0.986 . . . . 1.6100000000000001 111.298 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.52 54.01 1.12 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.284 0.846 . . . . 2.3799999999999999 113.284 173.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 t -157.15 143.68 18.16 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 107.02 -1.474 . . . . 1.8700000000000001 107.02 165.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.0 92.53 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.04 -1.837 . . . . 2.4500000000000002 106.04 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -116.53 79.78 1.37 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.351 -1.722 . . . . 3.27 106.351 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.9 p -98.73 128.23 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.453 -0.943 . . . . 2.2200000000000002 108.453 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.39 74.98 2.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.957 -1.868 . . . . 1.21 105.957 172.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.86 -29.88 3.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.393 1.077 . . . . 3.1600000000000001 111.87 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.2 ttt -72.65 -36.18 67.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.947 1.299 . . . . 4.0300000000000002 111.135 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.71 -48.02 5.65 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 124.177 0.991 . . . . 1.3200000000000001 109.191 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.23 58.24 0.35 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 125.48 1.514 . . . . 1.1100000000000001 111.599 167.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -142.97 136.91 28.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.12 -1.067 . . . . 3.0899999999999999 108.12 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.64 110.36 22.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.637 1.575 . . . . 1.0 111.597 168.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -99.51 111.36 23.72 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.081 -1.081 . . . . 4.6500000000000004 108.081 167.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.464 HD12 HD21 ' A' ' 8' ' ' LEU . 13.9 mt -109.57 167.04 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.684 0.794 . . . . 2.6200000000000001 109.066 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -123.61 108.23 12.37 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.871 0.868 . . . . 4.0300000000000002 109.107 162.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -113.81 163.4 15.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.73 1.212 . . . . 2.8399999999999999 111.336 168.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -105.71 106.37 56.21 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 127.215 2.206 . . . . 4.6200000000000001 110.075 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.69 2.21 1.77 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.057 2.505 . . . . 1.9199999999999999 114.015 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -83.14 -22.75 33.22 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.128 1.371 . . . . 4.4900000000000002 110.408 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.1 t -123.42 -65.44 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.2 -1.037 . . . . 2.75 108.2 -171.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -87.26 155.14 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.276 -0.638 . . . . 1.46 109.276 174.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -129.27 151.74 78.29 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.692 1.597 . . . . 2.5899999999999999 108.004 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.91 -38.42 79.21 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.841 2.361 . . . . 1.21 112.149 -172.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -59.51 -41.09 89.14 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.328 -0.857 . . . . 2.9199999999999999 111.255 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -61.2 -40.54 94.35 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.307 0.643 . . . . 3.0299999999999998 110.254 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.503 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -54.75 -46.45 74.17 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 N-CA-C 107.746 -1.205 . . . . 1.1000000000000001 107.746 171.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.4 94.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.064 0.459 . . . . 1.21 111.036 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -57.77 -52.89 63.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.468 -0.77 . . . . 2.5299999999999998 110.34 173.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -51.0 -55.5 17.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.429 0.692 . . . . 5.1699999999999999 111.496 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.558 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.5 pp -61.4 -39.87 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 121.065 -1.022 . . . . 4.4299999999999997 111.647 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.58 -33.72 76.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.343 0.52 . . . . 3.0800000000000001 110.816 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.51 -50.3 67.95 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.485 -0.561 . . . . 2.5099999999999998 109.485 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.1 mt -58.65 -35.73 73.0 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.937 -0.305 . . . . 2.04 111.402 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.08 31.19 2.52 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 123.92 0.771 . . . . 1.1799999999999999 111.915 169.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -112.16 164.64 12.95 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.625 1.57 . . . . 2.1000000000000001 109.04 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -102.9 136.05 43.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.02 -1.474 . . . . 2.6000000000000001 107.02 164.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.558 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -130.3 127.04 38.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.216 -1.772 . . . . 0.93999999999999995 106.216 169.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.4 138.98 33.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.009 0.818 . . . . 0.92000000000000004 109.328 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.84 144.46 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 116.138 -0.483 . . . . 2.77 109.734 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.7 mtp -49.31 -42.93 42.85 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.098 0.959 . . . . 3.9100000000000001 111.23 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -170.3 -57.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 127.245 2.218 . . . . 5.9199999999999999 105.177 170.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -79.78 -92.49 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 130.256 3.423 . . . . 6.8399999999999999 112.871 -168.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 76' ' ' ALA . 21.9 p90 157.48 -58.48 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 130.265 3.426 . . . . 4.3899999999999997 110.996 -171.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.413 ' N ' ' CD1' ' A' ' 75' ' ' TYR . . . 167.14 -82.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.935 1.694 . . . . 3.5299999999999998 115.134 -168.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.78 94.26 1.06 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.777 -0.929 . . . . 3.4900000000000002 110.777 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 t -136.64 -66.2 0.54 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 119.383 -0.341 . . . . 5.46 111.201 168.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -147.91 136.84 22.0 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.937 -1.135 . . . . 4.8899999999999997 107.937 -171.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.0 -64.14 4.28 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 107.366 -2.294 . . . . 1.72 107.366 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -102.65 110.06 21.88 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.381 1.472 . . . . 2.6800000000000002 109.046 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.96 138.91 53.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 O-C-N 123.332 0.395 . . . . 2.71 110.67 175.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -110.33 141.36 43.45 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.128 1.371 . . . . 4.4199999999999999 108.326 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.492 HD13 ' N ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -142.79 156.45 44.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.298 -0.63 . . . . 3.29 109.298 174.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.414 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.6 OUTLIER -97.31 121.75 39.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 105.018 -2.216 . . . . 1.5600000000000001 105.018 -177.093 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 pp -100.88 121.07 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.14 -0.689 . . . . 1.5700000000000001 109.14 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.2 p -106.92 142.79 35.98 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.27 0.628 . . . . 2.1499999999999999 109.348 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.74 -26.17 10.31 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.741 1.162 . . . . 1.48 112.742 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.474 ' SD ' HD12 ' A' ' 98' ' ' ILE . 4.0 ttp -67.51 108.62 2.9 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.641 -0.917 . . . . 3.0 112.096 -169.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.7 m -117.86 7.77 12.47 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.044 0.938 . . . . 2.46 111.923 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 23.9 p -163.07 151.21 13.78 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 120.742 -1.224 . . . . 2.9300000000000002 112.08 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.54 72.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.683 0.793 . . . . 2.9399999999999999 111.411 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.2 m -53.29 -40.96 65.14 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.284 -0.885 . . . . 2.6200000000000001 110.785 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.1 m -69.89 -40.93 75.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.615 -0.707 . . . . 1.79 110.04 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.0 t -50.35 -57.21 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 118.636 0.653 . . . . 1.47 109.557 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -58.58 -45.71 88.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.358 0.663 . . . . 4.2000000000000002 110.205 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -61.21 -50.62 72.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.0 0.52 . . . . 1.77 110.84 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.474 HD12 ' SD ' ' A' ' 89' ' ' MET . 41.7 mt -56.27 -47.2 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.089 -0.708 . . . . 1.03 109.089 177.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.28 -49.49 74.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.634 -0.876 . . . . 2.8100000000000001 108.634 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.3 t -52.52 -50.45 62.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.719 0.808 . . . . 1.48 110.159 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -61.31 -42.37 98.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.753 -0.592 . . . . 3.2000000000000002 111.31 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.5 mt -67.18 -56.26 10.68 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.932 -1.136 . . . . 1.8500000000000001 107.932 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.7 p -55.33 -17.78 5.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.484 0.714 . . . . 1.8600000000000001 112.703 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -13.77 62.59 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.502 -0.749 . . . . 5.5300000000000002 112.398 171.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -80.83 153.86 27.45 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.389 1.876 . . . . 1.8500000000000001 109.63 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -67.39 -64.44 0.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.943 0.897 . . . . 3.0299999999999998 111.353 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.32 -32.41 58.08 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 122.253 -0.279 . . . . 1.2 112.921 -172.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.07 112.52 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.733 0.766 . . . . 1.8100000000000001 109.616 -172.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.6 m -99.3 -41.32 7.5 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.561 0.344 . . . . 2.27 110.265 -172.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 123' ' ' LYS . 54.2 p90 -140.15 121.22 14.69 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.468 -0.567 . . . . 2.3900000000000001 109.468 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.18 140.8 37.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.72 -0.844 . . . . 1.0900000000000001 108.72 165.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -132.69 116.98 17.29 Favored 'General case' 0 C--O 1.228 -0.052 0 N-CA-C 108.29 -1.004 . . . . 1.5900000000000001 108.29 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.604 HG12 ' HB1' ' A' ' 120' ' ' ALA . 3.0 m -112.28 135.23 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.591 1.157 . . . . 2.2400000000000002 109.087 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.32 89.55 2.57 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.332 0.969 . . . . 1.1699999999999999 111.211 -173.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -24.51 67.04 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 125.22 1.408 . . . . 3.1099999999999999 113.718 -170.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.81 70.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.654 0.381 . . . . 1.45 110.397 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.83 -13.12 12.02 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.477 1.511 . . . . 1.76 111.317 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.3 m 69.13 15.8 8.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.319 1.847 . . . . 1.3100000000000001 114.326 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -95.16 158.0 15.65 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 120.127 1.33 . . . . 3.25 108.464 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.604 ' HB1' HG12 ' A' ' 113' ' ' VAL . . . -140.53 125.15 17.98 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.225 1.01 . . . . 0.85999999999999999 108.652 168.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.26 114.42 26.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.637 -1.616 . . . . 1.6699999999999999 106.637 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.7 m -106.75 135.06 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.048 0.84 . . . . 2.2599999999999998 111.687 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HG3' ' CE2' ' A' ' 110' ' ' TYR . 9.2 mmmt -113.01 95.97 5.69 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.13 1.372 . . . . 3.5099999999999998 109.524 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -122.95 174.16 7.35 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.843 0.747 . . . . 2.52 111.362 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -105.19 110.07 63.99 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 108.564 -0.902 . . . . 3.1299999999999999 108.564 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.53 69.01 6.83 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.48 2.787 . . . . 1.97 111.305 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -158.45 -48.53 0.06 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.875 1.27 . . . . 3.21 108.917 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pt -82.83 -28.93 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.406 0.682 . . . . 1.8200000000000001 110.867 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.64 163.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.575 -0.898 . . . . 1.6200000000000001 108.575 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.71 161.5 28.24 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.444 -1.462 . . . . 1.76 109.444 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.52 -37.62 87.9 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.557 2.838 . . . . 1.98 111.713 -172.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -52.21 -36.65 52.7 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.262 0.838 . . . . 7.0700000000000003 113.262 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -69.43 -46.02 67.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.453 -0.573 . . . . 3.4199999999999999 109.453 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.4 mt -57.46 -45.32 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.631 -0.878 . . . . 1.3899999999999999 108.631 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.7 mt -53.85 -61.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 118.354 -0.831 . . . . 2.3900000000000001 109.055 173.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.15 -49.49 32.17 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.913 1.233 . . . . 5.4299999999999997 111.174 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.5 mt -53.05 -60.11 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.808 -0.812 . . . . 2.1200000000000001 108.808 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.3 pp -65.9 -30.56 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 119.375 -0.93 . . . . 1.3500000000000001 113.279 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.43 -40.53 94.78 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.111 0.869 . . . . 2.5499999999999998 109.758 170.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -64.98 -37.47 87.76 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.079 -0.712 . . . . 2.8399999999999999 109.079 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.35 -43.29 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.075 -0.391 . . . . 1.1499999999999999 109.956 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.61 31.56 4.83 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.57 1.557 . . . . 1.0700000000000001 111.619 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -99.62 174.93 6.01 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.315 1.057 . . . . 2.2000000000000002 108.652 165.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -139.02 119.15 13.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.055 -1.831 . . . . 4.0300000000000002 106.055 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.19 109.42 20.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.129 1.771 . . . . 1.1100000000000001 108.793 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 26.6 m -117.14 113.72 22.66 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.944 0.497 . . . . 1.8 110.274 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -31.34 115.2 0.14 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.391 1.876 . . . . 3.8599999999999999 112.039 169.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.414 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -101.17 15.69 27.93 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.637 1.347 . . . . 3.1600000000000001 114.637 -161.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.085 -1.436 . . . . 5.6399999999999997 112.618 -175.76 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.08 -1.082 . . . . 7.5099999999999998 108.08 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.76 110.94 10.24 Favored Pre-proline 0 CA--C 1.533 0.304 0 O-C-N 123.858 0.724 . . . . 4.4800000000000004 109.529 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.62 114.79 4.11 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 N-CA-C 108.173 -1.51 . . . . 4.3700000000000001 108.173 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.75 158.87 15.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.564 -1.643 . . . . 3.04 106.564 166.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -126.2 149.04 49.3 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.546 1.538 . . . . 4.9500000000000002 106.951 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.1 p -140.53 146.03 37.58 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.829 -0.804 . . . . 3.4100000000000001 108.829 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.15 109.68 19.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.041 -1.466 . . . . 4.6500000000000004 107.041 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.478 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 2.3 pt? -133.69 174.72 10.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.071 0.938 . . . . 2.3700000000000001 111.192 170.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.436 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -136.78 137.75 40.16 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.023 -1.103 . . . . 2.3199999999999998 108.023 176.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 mm -98.67 126.51 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 106.972 -1.492 . . . . 1.3200000000000001 106.972 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -102.48 103.55 13.92 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.064 -1.828 . . . . 4.0199999999999996 106.064 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.23 -89.46 0.1 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.287 -1.525 . . . . 1.26 109.287 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.4 mtt 47.1 73.67 0.18 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.169 1.388 . . . . 2.1099999999999999 113.497 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -57.56 -11.8 2.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.75 1.22 . . . . 2.7000000000000002 113.653 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.5 t 73.97 -66.03 0.32 Allowed 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 126.187 1.795 . . . . 2.9500000000000002 110.878 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -15.4 -74.51 0.01 OUTLIER 'General case' 0 C--N 1.342 0.279 0 C-N-CA 128.368 2.667 . . . . 6.8099999999999996 113.219 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.8 m -153.37 19.26 0.55 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.498 0.719 . . . . 4.0599999999999996 111.07 161.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 31.7 m -70.64 -47.5 59.74 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 121.093 -1.004 . . . . 2.1299999999999999 109.211 -169.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -54.81 -49.83 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.752 -0.462 . . . . 2.9300000000000002 109.752 175.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -55.55 -48.38 74.82 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.175 0.59 . . . . 2.3500000000000001 111.433 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -58.75 -47.92 82.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.615 -0.513 . . . . 3.0899999999999999 109.615 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -46.4 -50.89 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.632 1.173 . . . . 1.8799999999999999 110.051 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -54.51 -54.54 39.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.472 0.578 . . . . 4.3899999999999997 111.168 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -59.9 -43.04 95.04 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.166 -0.47 . . . . 5.0 110.3 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -56.52 -57.44 12.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.267 0.627 . . . . 1.48 109.478 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mp -57.68 -44.99 86.17 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 119.014 -0.517 . . . . 2.23 111.679 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -54.85 -20.68 9.24 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.428 1.013 . . . . 2.0 113.481 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -112.05 15.37 20.65 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.712 1.004 . . . . 3.4300000000000002 113.712 173.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -70.02 -64.54 0.87 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.949 1.25 . . . . 2.77 110.229 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.73 -124.09 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.929 0.492 . . . . 1.4399999999999999 110.713 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.74 -25.62 69.2 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 118.795 0.725 . . . . 1.6399999999999999 111.987 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 46' ' ' ILE . 4.9 p -62.95 125.73 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 O-C-N 122.446 -0.444 . . . . 1.5900000000000001 110.036 177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 pp -143.12 50.55 1.41 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.71 0.767 . . . . 3.0699999999999998 109.765 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.8 t -160.64 149.53 16.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.092 -1.077 . . . . 1.99 108.092 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.0 129.7 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.046 -1.094 . . . . 2.6800000000000002 108.046 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -142.52 74.28 1.44 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.104 -1.073 . . . . 2.9399999999999999 108.104 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 m -97.33 159.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 121.372 -0.83 . . . . 2.98 108.995 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.88 90.6 2.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.307 -1.368 . . . . 2.1200000000000001 107.307 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 tp -51.86 -27.44 12.67 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.881 1.672 . . . . 3.4900000000000002 110.358 172.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.3 mtp -59.16 -38.65 80.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.187 0.995 . . . . 3.5099999999999998 111.603 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.3 -31.47 7.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.473 0.709 . . . . 2.7000000000000002 111.449 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.49 61.59 0.96 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.457 1.503 . . . . 2.1899999999999999 110.403 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -142.08 142.7 32.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.429 -1.323 . . . . 3.4199999999999999 107.429 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.08 101.34 7.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.968 0.907 . . . . 1.53 110.43 171.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -102.31 131.05 49.15 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.161 -2.162 . . . . 5.6900000000000004 105.161 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 32' ' ' VAL . 13.7 pt -136.74 171.71 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 120.434 -1.416 . . . . 2.3900000000000001 108.988 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.22 99.77 6.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.422 1.089 . . . . 5.8499999999999996 108.356 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.529 ' HB2' HD12 ' A' ' 53' ' ' ILE . 31.8 p90 -100.05 -179.17 4.07 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.686 1.194 . . . . 3.6400000000000001 110.206 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -128.25 103.3 20.53 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.597 1.159 . . . . 3.98 110.894 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.25 -8.32 18.29 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.796 3.664 . . . . 2.9100000000000001 114.84 -167.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -92.86 -8.94 42.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.352 0.661 . . . . 4.79 111.598 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.5 -47.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 123.934 0.894 . . . . 3.6299999999999999 110.21 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.529 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -116.36 143.25 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 108.08 -1.081 . . . . 2.3300000000000001 108.08 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.89 142.72 26.44 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 124.352 1.061 . . . . 2.8500000000000001 109.143 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -57.39 -40.39 81.96 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.12 2.546 . . . . 1.97 111.505 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.24 -43.37 98.99 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.319 0.648 . . . . 4.9900000000000002 110.371 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -63.05 -40.24 97.12 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.902 0.481 . . . . 3.79 110.103 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.457 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -52.35 -53.4 19.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 N-CA-C 106.915 -1.513 . . . . 1.4199999999999999 106.915 170.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.15 -45.46 79.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.99 -0.55 . . . . 1.4399999999999999 110.599 -172.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.69 -49.94 56.16 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.486 0.715 . . . . 4.0599999999999996 110.485 174.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.44 -48.9 65.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.527 0.679 . . . . 2.2599999999999998 109.858 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -64.01 -39.06 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 122.081 -0.387 . . . . 2.5 111.413 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -65.56 -44.56 86.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.731 -0.47 . . . . 2.0099999999999998 109.731 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.0 -50.51 73.83 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.714 -0.476 . . . . 2.5 109.714 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.7 mt -55.62 -40.58 72.3 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.387 -0.369 . . . . 2.1400000000000001 111.629 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.37 33.46 1.03 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 123.516 0.579 . . . . 1.1699999999999999 112.017 165.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -124.44 162.02 24.79 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.704 1.202 . . . . 1.95 108.86 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.81 130.46 41.37 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.138 -1.43 . . . . 2.5800000000000001 107.138 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.59 111.38 24.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.836 1.254 . . . . 1.1399999999999999 108.117 173.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.436 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -128.31 116.28 19.57 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.621 -0.511 . . . . 1.4199999999999999 109.621 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.478 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.8 t -68.71 155.45 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.187 1.795 . . . . 2.7999999999999998 111.36 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mtt -87.91 19.92 3.33 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.176 0.99 . . . . 5.0800000000000001 111.267 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 80.93 -36.86 0.13 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.597 1.559 . . . . 3.8799999999999999 109.718 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.63 67.21 0.06 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.043 1.737 . . . . 8.6099999999999994 110.758 163.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.429 ' CE2' ' ND2' ' A' ' 81' ' ' ASN . 38.5 p90 -68.24 -25.81 65.37 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 127.771 2.428 . . . . 4.1100000000000003 114.447 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 142.76 -150.25 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 129.121 2.968 . . . . 2.9399999999999999 105.628 -168.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.19 97.95 0.81 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 108.135 -1.986 . . . . 3.0800000000000001 108.135 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 t -160.37 -56.02 0.06 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.486 0.643 . . . . 5.7000000000000002 110.996 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.32 134.76 45.62 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.447 -0.946 . . . . 4.7000000000000002 108.447 -176.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.05 -46.42 2.69 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.208 -0.757 . . . . 2.6200000000000001 111.208 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.543 ' C ' HD13 ' A' ' 82' ' ' ILE . 50.9 t30 -129.65 128.33 42.38 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.359 -1.348 . . . . 2.9900000000000002 107.359 169.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.543 HD13 ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -125.89 154.11 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 107.096 -1.446 . . . . 3.1699999999999999 107.096 175.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.22 141.14 51.55 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 123.477 0.711 . . . . 3.1400000000000001 110.143 169.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.66 149.28 52.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.37 -2.085 . . . . 2.4700000000000002 105.37 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 147' ' ' LEU . 0.4 OUTLIER -100.5 127.92 46.71 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 104.87 -2.27 . . . . 1.6599999999999999 104.87 176.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.01 136.78 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 O-C-N 123.863 0.727 . . . . 1.77 109.065 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.2 m -128.34 115.2 17.9 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.372 1.069 . . . . 1.6599999999999999 109.401 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.38 -38.13 1.72 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.174 1.369 . . . . 1.1200000000000001 111.438 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.6 mtp -45.94 119.55 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.667 1.187 . . . . 3.23 111.763 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.0 m -129.66 17.02 5.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.922 0.889 . . . . 2.8999999999999999 110.676 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 47.5 t -165.56 141.26 5.15 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 120.827 -1.171 . . . . 2.6000000000000001 109.993 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.92 -32.51 66.02 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.709 0.686 . . . . 2.98 111.495 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 t -53.12 -37.92 62.18 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.756 -0.59 . . . . 1.9099999999999999 110.469 173.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 85.8 m -62.53 -49.74 74.12 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 109.265 -0.643 . . . . 1.77 109.265 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.9 t -49.87 -45.54 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 122.506 0.322 . . . . 1.3799999999999999 110.712 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -48.67 80.73 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.065 -0.346 . . . . 2.8799999999999999 110.065 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -38.88 92.59 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 119.812 -0.755 . . . . 3.48 110.484 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.437 HD11 ' CE2' ' A' ' 143' ' ' PHE . 81.5 mt -64.76 -54.29 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.43 -0.952 . . . . 1.3500000000000001 108.43 -177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -49.46 -49.77 43.99 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 126.337 1.855 . . . . 4.3899999999999997 109.251 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.0 t -50.17 -50.43 49.13 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 119.368 -0.349 . . . . 1.8700000000000001 111.317 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -50.2 68.52 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.03 0.832 . . . . 3.0899999999999999 112.3 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.75 -45.13 87.71 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 120.841 -1.162 . . . . 3.0 110.892 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 87.2 m -61.11 -16.93 49.58 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.707 0.803 . . . . 2.27 111.061 173.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -17.71 64.83 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 118.624 -0.703 . . . . 4.75 111.733 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.9 p -72.66 -176.41 1.95 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 120.159 1.345 . . . . 2.8900000000000001 110.885 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -94.29 -50.35 5.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.541 1.137 . . . . 2.3900000000000001 111.083 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.47 -41.37 30.31 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 122.245 -0.285 . . . . 1.5600000000000001 112.768 -168.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.17 126.34 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.751 -0.833 . . . . 2.6800000000000002 108.751 -173.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.0 m -112.36 -46.32 3.19 Favored 'General case' 0 CA--C 1.522 -0.11 0 N-CA-C 111.824 0.305 . . . . 2.3999999999999999 111.824 -174.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.45 ' CE2' ' HG3' ' A' ' 123' ' ' LYS . 49.5 p90 -136.42 125.15 23.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.718 -1.216 . . . . 2.8700000000000001 107.718 167.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -116.17 159.99 21.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.784 -1.191 . . . . 0.91000000000000003 107.784 161.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.0 m -142.98 105.12 4.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.794 -1.187 . . . . 1.8500000000000001 107.794 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.1 t -98.36 115.67 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 125.968 1.707 . . . . 2.3599999999999999 107.596 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -119.0 106.37 12.37 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 118.943 0.792 . . . . 1.22 110.484 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 pp -72.59 -29.92 63.92 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.467 1.107 . . . . 2.1899999999999999 112.447 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.52 -43.22 89.1 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.395 0.678 . . . . 1.3999999999999999 110.341 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -28.69 19.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.786 1.234 . . . . 1.76 110.314 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.35 21.91 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.162 1.785 . . . . 2.1299999999999999 111.155 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -99.08 160.82 13.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.607 1.563 . . . . 3.2599999999999998 110.216 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.48 130.13 24.25 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.408 -0.96 . . . . 0.95999999999999996 108.408 166.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -95.54 143.27 26.99 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.24 -1.393 . . . . 1.72 107.24 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.35 128.7 25.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 124.998 1.319 . . . . 1.98 109.027 -173.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HG3' ' CE2' ' A' ' 110' ' ' TYR . 1.8 mmmt -118.54 106.65 12.88 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.006 -0.739 . . . . 3.73 109.006 176.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -125.44 175.8 7.26 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.802 0.841 . . . . 2.79 110.318 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -97.82 113.58 63.86 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 108.009 -1.108 . . . . 3.75 108.009 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.6 67.96 7.11 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.524 2.816 . . . . 2.4500000000000002 111.222 -173.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -162.49 -47.64 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.719 1.208 . . . . 3.9300000000000002 109.026 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 pt -86.39 -32.18 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 122.539 0.335 . . . . 2.2599999999999998 111.524 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.68 163.05 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 107.939 -1.134 . . . . 2.04 107.939 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.21 160.82 28.37 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.456 -1.458 . . . . 1.99 109.456 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.36 -35.78 89.8 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.511 2.807 . . . . 2.04 111.665 -172.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -32.66 69.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 112.39 0.515 . . . . 6.6900000000000004 112.39 -175.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -66.79 -48.45 68.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.976 -0.75 . . . . 3.6800000000000002 108.976 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 74.9 mt -58.3 -45.18 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.533 -0.914 . . . . 1.5 108.533 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 80.4 mt -52.44 -61.09 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 117.566 -1.207 . . . . 2.29 108.889 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.26 -51.8 17.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.399 1.454 . . . . 5.0700000000000003 110.996 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.0 mm -52.89 -49.92 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.599 0.636 . . . . 2.0899999999999999 110.104 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.288 2.5 pp -70.75 -31.53 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 121.173 -0.954 . . . . 1.4399999999999999 113.31 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.5 -39.76 84.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.74 1.155 . . . . 3.0600000000000001 109.813 169.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -35.41 77.27 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.196 1.398 . . . . 3.1699999999999999 108.867 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 78.1 mt -77.27 -41.81 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 122.542 0.337 . . . . 0.98999999999999999 110.724 172.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.31 30.98 5.45 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.598 1.57 . . . . 1.0600000000000001 111.583 -173.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 98' ' ' ILE . 46.1 m-85 -98.33 175.3 6.1 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.422 1.111 . . . . 1.99 108.251 165.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -135.92 126.36 26.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.191 -2.151 . . . . 3.9100000000000001 105.191 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.6 100.57 7.2 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.648 1.579 . . . . 1.4399999999999999 107.466 -175.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.1 m -146.8 117.2 7.44 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 117.896 -1.049 . . . . 3.0499999999999998 111.408 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.424 ' HB2' ' HB ' ' A' ' 85' ' ' THR . 0.2 OUTLIER -166.99 -102.0 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.217 -0.896 . . . . 6.8099999999999996 109.588 170.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 41.1 40.21 1.04 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.434 1.493 . . . . 6.8600000000000003 111.814 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 . . . . . 0 C--O 1.248 0.99 0 N-CA-C 114.726 1.38 . . . . 7.3499999999999996 114.726 -169.942 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 107.146 -1.427 . . . . 7.9299999999999997 107.146 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.33 111.71 47.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 117.361 -1.304 . . . . 4.5199999999999996 108.429 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -84.05 151.2 12.47 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.291 2.661 . . . . 3.2000000000000002 109.734 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.03 142.48 32.89 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 123.264 0.625 . . . . 4.5099999999999998 109.78 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 152.39 19.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 123.891 0.744 . . . . 3.4500000000000002 110.547 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.7 t -119.65 137.45 53.88 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.562 -0.903 . . . . 2.0600000000000001 108.562 168.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -102.33 103.55 14.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.847 1.659 . . . . 3.6699999999999999 108.973 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.565 ' HB3' HG13 ' A' ' 71' ' ' VAL . 1.8 pt? -125.8 176.91 6.6 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.894 0.854 . . . . 2.6099999999999999 111.236 171.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.47 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -139.82 136.45 34.04 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.225 -1.028 . . . . 1.79 108.225 176.331 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 44' ' ' ALA . 29.6 mm -93.69 121.25 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 107.004 -1.48 . . . . 0.79000000000000004 107.004 -169.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.75 102.17 11.75 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.583 -2.377 . . . . 4.0899999999999999 104.583 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.47 -89.27 0.09 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 109.785 -1.326 . . . . 1.1599999999999999 109.785 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.2 mmt 46.98 77.32 0.09 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.079 1.752 . . . . 2.2799999999999998 113.375 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 p -65.62 -58.41 5.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.464 -0.773 . . . . 2.7000000000000002 111.528 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 49.68 0.07 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 119.976 -0.689 . . . . 3.6000000000000001 110.784 -172.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 47.66 36.27 5.37 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.822 0.849 . . . . 5.3099999999999996 111.593 -177.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -129.4 -51.66 1.18 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.698 1.199 . . . . 3.25 109.635 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 23.4 t -68.79 -43.25 76.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 118.434 -1.306 . . . . 2.4199999999999999 109.811 -174.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -38.65 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 122.125 0.965 . . . . 2.2799999999999998 109.399 173.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -65.83 -41.55 91.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.084 -0.962 . . . . 2.4500000000000002 111.26 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.57 -38.17 70.99 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 120.801 -1.187 . . . . 3.1099999999999999 111.667 172.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.0 mt -49.4 -42.79 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.494 1.118 . . . . 1.3999999999999999 109.968 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -41.14 -56.46 2.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.635 0.731 . . . . 4.4400000000000004 112.515 172.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -68.57 -27.51 66.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.873 0.869 . . . . 5.04 110.79 -175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -69.48 -57.4 5.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.436 -0.95 . . . . 1.21 108.436 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.11 -40.6 85.87 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 118.745 0.702 . . . . 2.29 110.261 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -24.56 5.94 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 112.771 0.656 . . . . 2.0699999999999998 112.771 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -127.31 25.43 6.15 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.273 0.629 . . . . 4.0300000000000002 111.734 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -76.77 -58.15 3.44 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.995 -0.742 . . . . 2.8300000000000001 108.995 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -162.56 -131.87 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.015 0.526 . . . . 1.21 109.972 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.49 -2.44 42.69 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.761 0.696 . . . . 1.4299999999999999 113.767 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -80.22 122.38 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.163 0.981 . . . . 1.3300000000000001 109.382 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.1 51.36 2.13 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.774 0.797 . . . . 2.5600000000000001 109.933 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 t -161.6 151.14 16.47 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.246 -1.761 . . . . 1.6399999999999999 106.246 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -140.72 124.35 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.172 -1.788 . . . . 2.54 106.172 166.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.73 87.89 2.55 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.144 0.973 . . . . 4.3300000000000001 110.492 169.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.59 139.92 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.249 -1.019 . . . . 2.2999999999999998 108.249 172.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -109.3 100.97 10.01 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.967 -1.864 . . . . 1.55 105.967 162.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.74 -33.61 70.45 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.258 1.023 . . . . 3.9300000000000002 109.052 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -53.07 62.41 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.56 1.144 . . . . 4.5999999999999996 110.78 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.73 -25.39 22.33 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.347 0.659 . . . . 1.8600000000000001 111.388 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.66 55.68 2.65 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.741 1.162 . . . . 1.46 110.957 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -135.33 139.42 44.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.175 0.988 . . . . 3.29 108.336 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -112.66 105.3 13.45 Favored 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 124.682 1.193 . . . . 0.90000000000000002 109.765 167.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.31 144.49 28.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.591 -1.633 . . . . 3.7200000000000002 106.591 163.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.64 172.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.536 -1.283 . . . . 2.0699999999999998 107.536 166.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -115.4 112.32 22.15 Favored 'General case' 0 C--N 1.34 0.178 0 O-C-N 124.054 0.846 . . . . 3.7999999999999998 110.206 167.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.519 ' HB2' HD12 ' A' ' 53' ' ' ILE . 7.8 p90 -105.21 172.33 6.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.598 1.559 . . . . 2.7200000000000002 110.758 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -117.17 106.34 47.37 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.894 1.278 . . . . 3.4199999999999999 109.001 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.15 -12.56 30.36 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 124.609 3.539 . . . . 2.4199999999999999 113.819 -160.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -96.46 0.86 50.97 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.177 0.591 . . . . 3.1800000000000002 111.3 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.0 t -118.85 -49.03 3.73 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 123.979 0.912 . . . . 2.6000000000000001 109.478 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.623 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -121.16 149.97 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.833 1.253 . . . . 1.48 108.344 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.23 140.06 27.54 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 106.564 -1.643 . . . . 2.98 106.564 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -56.69 -38.78 94.91 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.022 2.482 . . . . 1.6599999999999999 112.06 -172.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mp -52.06 -43.83 64.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.681 0.792 . . . . 3.6000000000000001 111.061 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -39.51 94.08 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.137 -0.69 . . . . 3.3500000000000001 109.137 -176.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.623 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -54.55 -52.11 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.493 -1.299 . . . . 1.3200000000000001 107.493 172.317 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.82 -45.53 86.01 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 123.365 0.415 . . . . 1.24 110.263 -173.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.5 -45.99 69.87 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.068 0.547 . . . . 3.3100000000000001 110.944 172.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.37 -46.83 87.58 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.379 0.609 . . . . 2.52 109.863 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mm -58.76 -44.21 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.916 -0.49 . . . . 2.7599999999999998 110.991 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -63.69 -39.77 95.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.348 0.659 . . . . 3.2200000000000002 111.507 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -62.62 -46.69 87.08 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.977 0.511 . . . . 2.1200000000000001 109.702 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 mt -58.21 -36.85 73.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.549 0.34 . . . . 1.8999999999999999 111.742 172.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.88 24.56 3.03 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.268 0.937 . . . . 0.97999999999999998 112.469 167.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 18' ' ' CYS . 2.1 m-30 -115.12 160.91 19.1 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.188 1.395 . . . . 2.3500000000000001 109.118 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -98.03 119.21 36.27 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.321 -0.992 . . . . 4.04 108.321 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.31 91.11 5.06 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.087 1.355 . . . . 1.1499999999999999 107.947 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -98.71 97.5 8.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.596 -1.631 . . . . 1.0700000000000001 106.596 177.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.565 HG13 ' HB3' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -60.81 155.67 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.187 -1.37 . . . . 4.0 110.104 169.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.24 -50.18 73.69 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.568 -0.901 . . . . 4.8899999999999997 108.568 168.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -171.37 21.58 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.21 0.819 . . . . 8.1500000000000004 113.21 175.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 64.03 -16.33 0.07 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.592 1.701 . . . . 10.74 115.592 -172.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.452 ' CZ ' ' HG2' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -52.71 -49.79 64.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.314 1.446 . . . . 5.9199999999999999 109.018 -168.23 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 67.81 -116.61 0.19 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.337 1.055 . . . . 3.7400000000000002 111.33 161.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.85 -48.52 0.17 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 107.986 -2.046 . . . . 4.8099999999999996 107.986 169.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 32.08 44.93 0.04 OUTLIER 'General case' 0 C--N 1.345 0.389 0 C-N-CA 127.86 2.464 . . . . 7.9400000000000004 114.909 163.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 53.48 86.26 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.14 2.176 . . . . 6.7300000000000004 112.903 162.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.46 3.85 88.91 Favored Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 126.412 1.958 . . . . 2.2200000000000002 109.899 -170.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.442 HD22 ' C ' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -96.45 70.26 2.65 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.534 1.667 . . . . 2.5899999999999999 107.739 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.42 161.25 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.521 -0.918 . . . . 2.8700000000000001 108.521 -178.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.452 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -120.12 148.09 44.06 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.522 0.729 . . . . 2.8700000000000001 109.611 177.152 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.49 HD13 ' HB1' ' A' ' 145' ' ' ALA . 0.1 OUTLIER -131.02 147.45 52.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.908 1.283 . . . . 2.6800000000000002 108.505 172.332 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 m -98.02 126.31 43.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 105.971 -1.863 . . . . 1.8500000000000001 105.971 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.03 134.69 35.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 109.181 -0.674 . . . . 1.47 109.181 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.5 m -125.74 140.56 52.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.115 -1.439 . . . . 1.78 107.115 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.44 -22.53 5.87 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.912 1.244 . . . . 1.3300000000000001 111.89 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -51.74 139.49 21.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.061 1.134 . . . . 3.8500000000000001 114.061 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.2 t -147.0 11.02 1.04 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.384 0.674 . . . . 3.98 111.902 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.04 144.83 1.03 Allowed 'General case' 0 C--N 1.342 0.277 0 O-C-N 120.455 -1.403 . . . . 3.48 110.084 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.69 -34.0 66.98 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.422 0.689 . . . . 2.5699999999999998 111.782 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.8 m -43.48 -49.01 7.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.753 0.421 . . . . 2.1200000000000001 110.991 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.52 -36.82 83.78 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.825 0.284 . . . . 2.75 111.059 -177.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.83 -56.59 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.636 -0.876 . . . . 1.9399999999999999 108.636 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -59.85 -35.73 75.37 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.801 0.81 . . . . 2.6000000000000001 110.556 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -63.19 -49.41 74.35 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.814 1.646 . . . . 1.6599999999999999 111.252 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 34.5 mt -58.49 -45.3 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.716 -0.846 . . . . 1.1000000000000001 108.716 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -55.32 -48.7 73.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.239 0.616 . . . . 3.3300000000000001 110.194 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.8 t -51.91 -53.43 41.01 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.334 0.97 . . . . 1.3899999999999999 110.889 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.34 -39.68 73.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.321 -0.862 . . . . 2.8100000000000001 112.056 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.4 -60.41 2.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.576 -1.268 . . . . 2.1499999999999999 107.576 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.0 p -54.93 -20.97 10.17 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.855 0.862 . . . . 2.2599999999999998 112.754 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.1 mtt85 -60.73 -34.1 73.91 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.88 0.696 . . . . 5.5999999999999996 112.88 171.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.1 m -57.36 150.23 18.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.604 0.762 . . . . 1.74 111.621 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -68.87 -56.0 9.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.155 0.982 . . . . 2.6899999999999999 112.336 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.89 -28.18 65.32 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.972 -0.451 . . . . 1.0700000000000001 111.972 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.34 122.62 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.718 -0.871 . . . . 1.95 109.426 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.7 m -104.35 -41.25 5.82 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.163 0.185 . . . . 2.0299999999999998 111.225 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.429 ' CZ ' ' HG2' ' A' ' 123' ' ' LYS . 30.3 p90 -138.25 122.39 18.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.017 -0.735 . . . . 2.8300000000000001 109.017 172.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.73 135.28 46.4 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 107.419 -1.326 . . . . 1.05 107.419 163.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.7 t -127.8 121.94 31.44 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.205 0.457 . . . . 2.1699999999999999 110.488 164.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.54 114.37 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.014 1.326 . . . . 2.48 111.111 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -106.81 88.75 2.82 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.708 1.603 . . . . 1.2 110.43 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.58 -33.19 69.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.374 1.87 . . . . 1.98 111.683 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.24 -31.51 53.62 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.379 1.072 . . . . 1.3799999999999999 111.477 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.08 -0.14 12.82 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.01 1.324 . . . . 1.75 110.495 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.0 m 59.85 20.63 9.54 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.039 1.336 . . . . 1.4299999999999999 113.176 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -97.61 150.63 20.94 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.484 0.714 . . . . 3.7400000000000002 110.604 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.02 106.14 7.08 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.663 1.985 . . . . 0.81999999999999995 108.124 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.01 108.93 20.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.469 -2.048 . . . . 2.04 105.469 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.5 p -113.95 127.0 71.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 2.1899999999999999 108.412 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.429 ' HG2' ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -114.87 105.6 13.19 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 123.929 0.892 . . . . 4.8600000000000003 110.044 -176.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -124.01 -177.37 3.74 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.003 0.814 . . . . 1.9399999999999999 111.804 -174.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -105.38 106.81 57.39 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.2 -1.407 . . . . 3.5600000000000001 107.2 178.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.71 66.11 8.82 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.519 2.813 . . . . 1.72 111.088 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -161.51 -48.34 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.484 1.514 . . . . 3.2400000000000002 108.623 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.9 pt -86.28 -32.59 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 123.698 0.799 . . . . 1.54 111.23 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.02 163.68 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.287 0.635 . . . . 1.3300000000000001 109.574 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.39 166.44 26.44 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.452 -1.059 . . . . 1.3400000000000001 110.452 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.19 -37.11 19.31 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.397 2.731 . . . . 1.48 111.156 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -50.05 -39.06 40.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.237 0.615 . . . . 6.3200000000000003 111.471 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.25 -38.99 71.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.506 -0.924 . . . . 4.3499999999999996 108.506 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.15 -49.02 85.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.486 0.714 . . . . 1.03 109.165 172.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 77.1 mt -51.51 -53.04 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.704 -0.85 . . . . 1.8100000000000001 108.704 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -48.79 75.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.364 -0.835 . . . . 3.6400000000000001 111.872 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 49.9 mt -49.92 -56.08 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.894 -0.78 . . . . 2.2999999999999998 108.894 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.256 2.2 pp -67.25 -30.38 49.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 113.194 0.813 . . . . 1.55 113.194 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -60.79 -37.78 83.09 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.511 1.051 . . . . 2.6099999999999999 110.15 170.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -69.33 -31.39 69.82 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.758 -0.46 . . . . 3.8900000000000001 109.758 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.2 mt -66.72 -45.14 88.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.898 -0.501 . . . . 1.3799999999999999 109.765 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.07 31.94 3.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.667 1.603 . . . . 1.2 111.343 -175.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.87 174.46 6.19 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.927 0.864 . . . . 2.4900000000000002 109.068 171.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -125.96 123.26 38.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.622 -1.622 . . . . 3.9500000000000002 106.622 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.49 ' HB1' HD13 ' A' ' 84' ' ' LEU . . . -115.81 100.77 8.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.357 1.463 . . . . 1.23 108.91 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.4 p -98.42 99.25 10.42 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.012 -1.107 . . . . 3.21 108.012 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -47.91 98.9 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.489 1.915 . . . . 4.0 110.811 176.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 48.38 42.7 18.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.951 0.901 . . . . 3.75 112.23 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 116.893 -1.527 . . . . 8.4399999999999995 108.716 -175.267 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 106.856 -1.535 . . . . 8.3599999999999994 106.856 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.92 110.28 44.16 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.059 0.944 . . . . 3.77 108.843 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.51 134.36 11.1 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.424 2.75 . . . . 2.71 109.903 -178.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.62 135.65 51.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.032 -1.47 . . . . 3.5899999999999999 107.032 -169.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.41 ' HA ' ' HG3' ' A' ' 47' ' ' LYS . 32.2 ttmt -94.93 151.67 19.0 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 119.645 1.111 . . . . 4.1799999999999997 109.376 176.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.66 133.63 40.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.441 -1.254 . . . . 2.0600000000000001 108.531 167.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -103.67 118.49 36.84 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.657 1.583 . . . . 3.3999999999999999 109.135 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.463 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.8 pt? -141.09 179.93 6.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.567 0.747 . . . . 2.1600000000000001 111.488 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -130.62 146.38 52.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.327 -0.99 . . . . 1.5900000000000001 108.327 173.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 mm -100.95 136.19 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 107.442 -1.318 . . . . 0.98999999999999999 107.442 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -108.98 125.3 51.91 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.157 -1.423 . . . . 3.0899999999999999 107.157 164.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.02 -79.98 0.17 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.507 1.051 . . . . 1.05 110.957 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.9 mtt 45.26 78.73 0.06 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.22 1.808 . . . . 2.0699999999999998 114.685 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -54.29 -60.78 2.88 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.75 0.648 . . . . 2.1699999999999999 112.75 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -169.59 68.27 0.06 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.443 0.565 . . . . 3.1099999999999999 110.321 -174.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 34.37 41.52 0.05 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.304 2.242 . . . . 5.75 115.78 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -160.14 -41.05 0.05 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.192 1.397 . . . . 3.3799999999999999 111.27 -171.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.2 t -70.88 -38.53 73.06 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.673 -1.267 . . . . 1.6899999999999999 111.01 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.605 ' HB ' HD21 ' A' ' 39' ' ' LEU . 95.8 t -59.4 -34.96 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.434 0.635 . . . . 1.9399999999999999 109.397 167.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.27 -40.84 96.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.37 -0.831 . . . . 2.3799999999999999 111.088 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -44.85 83.42 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.752 -1.218 . . . . 2.46 110.451 172.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.544 HG12 HD13 ' A' ' 65' ' ' LEU . 3.3 mt -47.36 -31.24 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 123.249 0.62 . . . . 1.51 111.854 175.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -46.54 -59.22 3.13 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.588 0.631 . . . . 5.25 111.539 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -71.55 -21.43 61.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.424 -0.353 . . . . 4.6900000000000004 111.834 -173.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -67.59 -57.59 6.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.407 -1.331 . . . . 1.1799999999999999 107.407 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.567 HD11 HD11 ' A' ' 62' ' ' ILE . 5.2 mp -63.27 -41.71 99.05 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 118.39 0.541 . . . . 1.97 111.237 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.54 -17.91 9.97 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.582 -0.699 . . . . 2.1299999999999999 112.59 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -123.58 27.48 7.37 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.56 0.744 . . . . 3.7000000000000002 111.406 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -81.2 -61.45 1.95 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.932 0.893 . . . . 2.6899999999999999 110.04 172.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.16 -138.03 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.138 0.575 . . . . 1.23 109.927 -172.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.22 -18.09 66.76 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 119.068 0.849 . . . . 1.52 112.541 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.38 121.02 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 O-C-N 121.842 -0.799 . . . . 1.5800000000000001 110.862 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 pp -142.16 50.05 1.53 Allowed 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 121.86 0.838 . . . . 2.46 110.336 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -157.92 144.51 17.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.713 -1.588 . . . . 1.6399999999999999 106.713 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.4 t -138.61 112.64 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 104.553 -2.388 . . . . 2.6899999999999999 104.553 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.94 86.77 2.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 122.219 1.009 . . . . 2.6800000000000002 109.128 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 44' ' ' ALA . 19.7 m -97.18 157.1 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.07 -0.968 . . . . 2.3399999999999999 109.11 171.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.38 98.42 5.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.116 -1.809 . . . . 1.3600000000000001 106.116 159.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.605 HD21 ' HB ' ' A' ' 19' ' ' VAL . 4.0 mp -62.33 -20.82 64.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.014 0.37 . . . . 3.6299999999999999 111.242 176.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 40.4 ttm -73.83 -37.03 64.96 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.368 1.067 . . . . 3.04 110.735 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.57 -23.2 14.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.6 0.76 . . . . 1.6899999999999999 111.797 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.17 62.29 1.83 Allowed Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.475 1.036 . . . . 1.29 111.322 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -144.0 140.37 29.55 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.487 -1.301 . . . . 4.0199999999999996 107.487 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.435 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -115.21 108.49 16.67 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.616 1.167 . . . . 1.02 110.104 165.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -104.09 148.7 25.95 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.442 1.019 . . . . 4.0099999999999998 109.082 158.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.5 pt -137.53 177.76 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.187 -1.412 . . . . 2.04 107.187 176.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HG3' ' HA ' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -126.11 110.75 13.87 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 119.137 -0.459 . . . . 3.6299999999999999 110.644 165.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -115.59 -178.43 3.38 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.232 1.813 . . . . 2.73 111.475 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -122.83 106.58 34.22 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 127.675 2.39 . . . . 4.54 110.095 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.19 10.53 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.614 2.876 . . . . 2.1099999999999999 113.358 -173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.32 -19.01 18.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.494 0.718 . . . . 3.52 110.724 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.08 -66.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.115 -1.069 . . . . 2.8100000000000001 108.115 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -94.07 142.26 13.63 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-O 120.859 0.361 . . . . 1.6000000000000001 110.299 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.39 149.06 41.52 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.302 1.441 . . . . 2.6400000000000001 109.939 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.97 -19.97 67.27 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.942 2.428 . . . . 1.4399999999999999 112.546 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -70.59 -60.35 2.31 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.986 -0.746 . . . . 2.9199999999999999 108.986 173.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -59.76 -33.57 71.85 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.1 -0.375 . . . . 3.5600000000000001 111.963 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.559 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -51.87 -47.06 41.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 N-CA-C 107.321 -1.363 . . . . 1.3200000000000001 107.321 171.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.56 -36.65 81.23 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.697 -0.683 . . . . 1.29 110.686 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -59.57 -45.39 91.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.843 0.747 . . . . 2.6000000000000001 109.568 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -52.16 63.47 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.185 -0.672 . . . . 2.3399999999999999 109.185 176.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.567 HD11 HD11 ' A' ' 26' ' ' LEU . 9.8 mm -63.48 -42.77 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 O-C-N 122.007 -0.433 . . . . 2.54 112.123 -176.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -44.45 95.64 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.23 1.012 . . . . 2.29 110.356 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -60.39 -53.94 51.54 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.671 0.788 . . . . 2.1600000000000001 108.899 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.544 HD13 HG12 ' A' ' 22' ' ' ILE . 4.7 mt -50.36 -39.82 47.58 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.648 0.779 . . . . 1.8999999999999999 111.775 174.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.56 37.55 1.07 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.637 -0.985 . . . . 1.0600000000000001 110.637 167.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -130.92 158.79 39.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.41 -1.33 . . . . 2.2200000000000002 107.41 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -99.24 119.58 38.13 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.243 -1.021 . . . . 2.29 108.243 171.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.66 119.72 36.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.417 -1.327 . . . . 0.91000000000000003 107.417 168.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -133.46 124.94 27.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.099 -1.074 . . . . 0.93000000000000005 108.099 174.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 21.8 t -60.78 151.69 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 124.546 1.139 . . . . 2.79 111.261 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -25.55 65.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.955 -0.566 . . . . 4.4299999999999997 110.984 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.421 ' H ' HG12 ' A' ' 71' ' ' VAL . 28.5 tt0 123.59 -55.91 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.579 1 C-N-CA 134.097 4.959 . . . . 4.6900000000000004 103.97 175.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.62 61.73 6.67 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.865 0.691 . . . . 7.7800000000000002 112.865 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -43.55 -58.06 2.82 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.773 0.657 . . . . 5.5 112.773 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 47.08 -158.39 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.776 1.631 . . . . 4.7699999999999996 113.486 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 57.02 27.63 57.37 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 126.592 2.044 . . . . 3.7400000000000002 112.8 167.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.7 m -82.05 -59.08 2.69 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.054 -1.091 . . . . 5.5199999999999996 108.054 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.401 ' HB3' ' H ' ' A' ' 80' ' ' GLY . 8.0 t0 -176.77 -88.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 120.475 -0.49 . . . . 4.8899999999999997 110.59 -163.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 79' ' ' ASP . . . -98.19 5.7 61.25 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 109.616 -1.393 . . . . 3.0600000000000001 109.616 159.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -95.79 111.12 23.16 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 107.637 -1.246 . . . . 3.3599999999999999 107.637 164.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.73 161.81 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 125.445 1.716 . . . . 2.9500000000000002 107.136 173.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.84 154.42 21.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.828 1.251 . . . . 3.1699999999999999 108.292 165.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -142.42 151.87 42.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.332 0.653 . . . . 3.1000000000000001 110.518 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 m -99.95 132.1 45.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.831 1.652 . . . . 1.8600000000000001 107.296 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.585 HD13 HD13 ' A' ' 98' ' ' ILE . 8.5 mt -99.1 124.69 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.965 -0.754 . . . . 2.4199999999999999 108.965 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.7 m -110.56 100.98 9.69 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.247 0.619 . . . . 1.5700000000000001 109.342 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.57 -34.35 2.12 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.621 1.105 . . . . 1.24 111.216 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -58.23 141.8 49.58 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.383 0.673 . . . . 2.46 111.811 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 51.8 m -153.57 84.46 1.18 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.858 1.663 . . . . 3.48 106.558 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 63.3 m 51.09 -110.51 0.48 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.017 1.327 . . . . 6.3099999999999996 111.602 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 48.72 -144.11 0.44 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.164 1.385 . . . . 5.25 110.3 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.5 t -89.15 9.4 25.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 118.849 -0.596 . . . . 3.8399999999999999 109.97 164.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.54 -56.93 6.66 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 119.506 1.048 . . . . 3.02 110.082 -166.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.5 t -49.6 -46.41 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.321 1.049 . . . . 1.26 109.92 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -63.82 -36.28 83.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.125 -0.489 . . . . 3.54 109.927 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -63.45 -52.79 59.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.556 0.742 . . . . 1.8500000000000001 109.691 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.585 HD13 HD13 ' A' ' 86' ' ' ILE . 4.0 mt -53.92 -53.99 23.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 109.496 -0.557 . . . . 1.25 109.496 178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -56.95 -45.69 82.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.907 -0.568 . . . . 2.1600000000000001 109.758 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.3 t -54.29 -54.07 45.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.822 0.737 . . . . 1.53 110.857 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -34.54 72.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 121.169 -0.957 . . . . 2.4500000000000002 111.147 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -71.07 -60.63 2.12 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.429 -0.952 . . . . 2.0499999999999998 108.429 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.1 p -56.34 -18.78 11.86 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.06 0.763 . . . . 1.73 113.06 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -61.48 -33.23 73.42 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.767 0.712 . . . . 5.5899999999999999 112.466 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.7 m -62.35 152.4 34.05 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.077 0.951 . . . . 1.6399999999999999 111.387 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -70.64 -52.96 17.8 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.317 1.047 . . . . 2.23 111.502 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.49 -43.04 20.72 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.572 -0.611 . . . . 1.1499999999999999 111.572 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.66 134.64 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.855 -0.794 . . . . 2.0 108.855 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.8 t -128.0 -35.95 2.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.756 0.823 . . . . 2.9700000000000002 110.845 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -110.11 92.0 3.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.951 -1.5 . . . . 3.02 106.951 -173.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.49 135.11 47.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.165 -1.791 . . . . 0.98999999999999999 106.165 160.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 t -140.23 108.75 5.87 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.477 -1.305 . . . . 1.6000000000000001 107.477 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.5 t -101.63 107.55 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.521 1.128 . . . . 2.3300000000000001 109.341 -173.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.97 80.12 2.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.561 1.144 . . . . 1.51 109.818 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 pp -53.56 -26.63 22.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.012 0.925 . . . . 2.2599999999999998 113.042 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.48 -35.23 65.3 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.342 0.657 . . . . 1.7 111.248 176.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -7.61 18.79 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.264 1.425 . . . . 1.8200000000000001 110.78 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.4 m 73.51 3.9 4.66 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.003 1.721 . . . . 1.6000000000000001 112.406 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -98.09 165.33 11.95 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.132 0.973 . . . . 3.1800000000000002 112.0 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -137.51 136.12 37.38 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.66 1.184 . . . . 1.05 108.651 168.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.96 132.18 43.76 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.959 -1.867 . . . . 2.5899999999999999 105.959 171.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.0 t -125.44 142.01 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 105.345 -2.094 . . . . 1.8600000000000001 105.345 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -125.06 99.52 6.15 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.458 1.103 . . . . 3.4500000000000002 109.255 169.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -109.68 -178.78 3.63 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.645 1.578 . . . . 2.1499999999999999 109.106 173.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -114.41 113.12 45.81 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.201 1.4 . . . . 4.1600000000000001 107.651 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.01 58.72 6.8 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.754 2.303 . . . . 2.1499999999999999 112.479 -164.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -145.77 -49.89 0.23 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.894 1.677 . . . . 4.7400000000000002 108.242 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -80.34 -32.03 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 122.34 -0.225 . . . . 1.6399999999999999 111.205 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.41 162.94 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.942 -1.132 . . . . 1.4099999999999999 107.942 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.23 163.91 27.71 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.628 -1.389 . . . . 1.3700000000000001 109.628 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.72 -41.26 39.85 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.101 2.534 . . . . 1.4399999999999999 110.396 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -40.05 25.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.184 0.809 . . . . 6.21 113.184 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.38 -47.96 79.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.18 -0.674 . . . . 2.71 109.18 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.31 -46.76 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.493 -0.928 . . . . 1.03 108.493 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.2 mt -53.66 -54.24 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 109.121 -0.696 . . . . 1.8200000000000001 109.121 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -54.65 -47.24 73.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.935 0.789 . . . . 3.6800000000000002 111.702 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.2 mm -54.17 -56.47 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.863 -0.421 . . . . 1.9399999999999999 109.863 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 pp -66.57 -30.96 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 120.973 -1.08 . . . . 1.3700000000000001 113.119 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.31 -38.38 73.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.312 0.645 . . . . 3.3900000000000001 109.917 170.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -65.99 -36.49 83.45 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.485 -0.561 . . . . 3.0099999999999998 109.485 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.7 mt -68.38 -40.84 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.395 -0.594 . . . . 1.25 109.395 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.13 33.18 3.52 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.518 1.532 . . . . 1.1699999999999999 111.007 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -101.35 176.67 5.16 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.279 1.039 . . . . 3.0499999999999998 108.364 166.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -134.92 125.67 27.15 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.413 -1.328 . . . . 4.8099999999999996 107.413 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.22 106.15 14.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.983 1.313 . . . . 1.3200000000000001 109.74 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.57 94.75 6.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.848 1.659 . . . . 2.1400000000000001 108.572 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.79 103.76 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.663 1.585 . . . . 4.2199999999999998 110.501 172.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 46.75 43.76 13.33 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.744 0.818 . . . . 4.2300000000000004 112.397 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.158 -0.925 . . . . 10.4 108.531 177.612 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.291 -1.374 . . . . 9.6400000000000006 107.291 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.58 97.91 7.3 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 119.319 0.963 . . . . 5.1699999999999999 108.698 -172.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.33 130.24 11.8 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.266 1.977 . . . . 3.3999999999999999 109.107 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.49 131.84 53.87 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.853 0.835 . . . . 3.8500000000000001 109.163 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.7 151.35 19.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.86 -1.904 . . . . 4.2300000000000004 105.86 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.413 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 5.8 t -123.25 141.41 52.01 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 117.837 -1.078 . . . . 1.8999999999999999 108.333 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -123.85 100.53 6.8 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.752 -0.833 . . . . 3.5499999999999998 108.752 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -125.04 168.02 13.93 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.38 1.086 . . . . 3.0299999999999998 110.736 177.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.68 146.16 43.9 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.65 -1.611 . . . . 1.7 106.65 169.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.5 mm -102.37 130.54 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.614 -1.254 . . . . 1.1200000000000001 107.614 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -118.78 117.87 30.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.494 -1.669 . . . . 3.25 106.494 167.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.78 -99.91 0.18 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.127 -1.589 . . . . 1.1200000000000001 109.127 -174.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 58.5 76.25 0.35 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.172 1.789 . . . . 1.6699999999999999 113.288 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -48.96 -58.73 4.41 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.893 0.877 . . . . 2.5899999999999999 112.698 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.56 52.63 0.05 OUTLIER 'General case' 0 C--N 1.346 0.449 0 C-N-CA 119.211 -0.995 . . . . 4.1399999999999997 111.37 -175.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 49.46 41.12 20.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.97 0.908 . . . . 4.5199999999999996 112.399 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -151.82 -43.19 0.11 Allowed 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.494 1.118 . . . . 2.1600000000000001 110.881 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.36 -46.99 83.96 Favored 'General case' 0 C--O 1.226 -0.167 0 O-C-N 121.052 -1.03 . . . . 2.0099999999999998 109.132 -176.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.18 -36.98 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.967 0.889 . . . . 2.25 109.996 174.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -65.8 -31.19 72.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.921 -0.581 . . . . 1.8999999999999999 112.336 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -38.19 71.82 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.93 -1.106 . . . . 3.0899999999999999 110.171 172.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.573 HG12 HD13 ' A' ' 65' ' ' LEU . 54.0 mt -59.85 -39.96 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.264 1.026 . . . . 1.5800000000000001 110.256 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.9 -58.26 2.47 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.791 0.836 . . . . 5.7300000000000004 112.08 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.53 -39.99 88.9 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.924 0.392 . . . . 4.8799999999999999 110.144 -172.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -54.45 -56.66 16.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.519 -0.764 . . . . 1.47 109.266 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mt -65.67 -36.25 83.12 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 113.313 0.857 . . . . 2.5299999999999998 113.313 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -21.9 3.65 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 118.283 0.492 . . . . 2.8100000000000001 112.165 168.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -123.75 30.88 6.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.152 0.581 . . . . 3.5299999999999998 112.42 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.32 -80.08 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.582 0.628 . . . . 3.54 109.371 167.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.29 -114.28 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.516 0.726 . . . . 1.28 110.469 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.5 -9.58 69.13 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 119.248 0.931 . . . . 1.3300000000000001 112.984 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.8 t -59.22 119.75 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 118.366 1.083 . . . . 2.3500000000000001 109.092 167.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.45 49.6 1.71 Allowed 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 121.496 0.665 . . . . 2.4300000000000002 110.448 162.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 t -159.66 151.13 19.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.566 -1.272 . . . . 1.6399999999999999 107.566 161.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.01 120.11 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.399 -2.074 . . . . 2.5299999999999998 105.399 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 tt -138.75 89.72 2.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.936 -1.876 . . . . 2.4100000000000001 105.936 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.7 p -106.29 135.63 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.3 -1.0 . . . . 2.3100000000000001 108.3 172.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -104.76 102.69 12.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.247 -1.76 . . . . 1.22 106.247 164.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 tp -57.57 -33.7 68.44 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.054 1.342 . . . . 2.9399999999999999 109.182 169.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 62.8 mtt -59.29 -47.67 84.49 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.537 0.735 . . . . 4.0899999999999999 110.901 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.3 -25.86 16.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.915 0.886 . . . . 1.27 111.446 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.4 55.71 2.82 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.615 1.102 . . . . 1.0900000000000001 110.833 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 128.74 27.86 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.04 -1.096 . . . . 2.98 108.04 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.07 117.32 30.24 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 124.518 1.136 . . . . 1.0900000000000001 111.071 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -113.63 142.47 45.96 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.609 0.719 . . . . 3.98 110.641 162.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.5 mt -121.25 168.16 13.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 125.595 1.558 . . . . 3.4500000000000002 106.893 171.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -133.84 105.54 6.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.098 0.559 . . . . 4.1799999999999997 109.568 170.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.465 ' CD2' HD11 ' A' ' 53' ' ' ILE . 5.0 p90 -102.69 -176.22 3.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.8 2.04 . . . . 3.1299999999999999 111.792 174.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -109.35 129.93 23.34 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 125.252 1.421 . . . . 4.1699999999999999 107.7 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.57 41.49 1.15 Allowed 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.46 2.774 . . . . 4.0300000000000002 112.334 -166.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -163.41 24.42 0.08 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.041 0.936 . . . . 3.4900000000000002 110.392 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.13 -50.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 107.027 -1.471 . . . . 3.2200000000000002 107.027 -174.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.465 HD11 ' CD2' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -126.35 153.01 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.837 -0.801 . . . . 2.6699999999999999 108.837 176.005 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -125.77 158.49 65.12 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 106.373 -1.714 . . . . 3.6899999999999999 106.373 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.44 -27.9 54.39 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.528 1.485 . . . . 1.6399999999999999 110.438 -165.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -56.74 -42.17 78.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.123 0.969 . . . . 3.5600000000000001 111.239 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.6 -52.52 57.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.976 0.807 . . . . 2.8399999999999999 109.856 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.421 HD12 HD11 ' A' ' 53' ' ' ILE . 1.2 mt -47.7 -54.16 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.071 -1.085 . . . . 1.8400000000000001 108.071 168.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.35 -35.05 74.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.158 -0.474 . . . . 1.8999999999999999 111.308 -172.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -58.2 -47.39 83.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.506 1.122 . . . . 3.4199999999999999 109.269 -178.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -54.11 -53.14 57.34 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.747 -0.464 . . . . 2.5 109.747 174.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.409 HG21 ' HB2' ' A' ' 69' ' ' ALA . 11.0 mm -59.07 -48.16 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.04 0.448 . . . . 2.71 110.631 -174.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.3 -45.79 90.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.381 0.673 . . . . 2.71 111.164 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.36 -49.81 76.1 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.504 0.593 . . . . 2.5600000000000001 110.192 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.573 HD13 HG12 ' A' ' 22' ' ' ILE . 2.0 mt -57.97 -28.03 64.0 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.688 0.795 . . . . 1.98 111.793 174.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.43 36.15 3.91 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.11 -1.196 . . . . 1.6899999999999999 110.11 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -120.13 162.07 19.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.187 1.795 . . . . 1.9399999999999999 106.445 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -104.1 124.43 49.06 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.598 -0.89 . . . . 2.7400000000000002 108.598 168.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.409 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -108.35 121.96 45.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.506 -1.294 . . . . 1.28 107.506 162.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.52 156.54 48.72 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.767 -1.198 . . . . 1.4399999999999999 107.767 169.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.28 153.96 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.841 -1.072 . . . . 3.7000000000000002 110.004 -164.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.8 mtp -83.18 38.81 0.62 Allowed 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.719 0.808 . . . . 4.7699999999999996 111.578 172.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 66.55 -49.09 0.45 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.37 2.668 . . . . 4.6699999999999999 112.776 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -29.95 -40.06 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.97 2.508 . . . . 8.1199999999999992 114.572 164.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.44 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER 82.86 -64.17 0.11 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.304 1.441 . . . . 7.3200000000000003 111.896 173.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 75' ' ' TYR . . . 124.4 -89.14 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.328 2.251 . . . . 3.1200000000000001 114.249 175.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.413 ' HA2' ' H ' ' A' ' 81' ' ' ASN . . . 166.31 -130.38 2.13 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.751 -0.94 . . . . 7.2199999999999998 110.751 -148.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.51 -29.58 0.18 Allowed 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.039 -1.271 . . . . 8.4499999999999993 114.113 -175.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -150.5 53.98 0.9 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.3 1.44 . . . . 10.83 108.248 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 47.28 47.96 21.19 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 125.927 1.727 . . . . 3.25 109.455 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.413 ' H ' ' HA2' ' A' ' 77' ' ' GLY . 0.2 OUTLIER -100.57 71.79 1.53 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.507 1.523 . . . . 3.5 108.044 -165.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.8 148.3 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.855 -1.535 . . . . 3.4399999999999999 106.855 -173.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -117.76 145.57 44.4 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 123.46 0.704 . . . . 3.79 109.152 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.41 HD13 ' HB1' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -146.94 157.45 43.64 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.128 0.971 . . . . 2.79 109.899 -175.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.46 133.58 41.85 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 106.778 -1.564 . . . . 2.9199999999999999 106.778 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.08 110.76 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.522 -0.918 . . . . 2.2599999999999998 108.522 173.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.0 m -98.93 137.81 36.95 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.946 -1.131 . . . . 1.8899999999999999 107.946 172.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.3 -28.19 14.48 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.487 1.042 . . . . 1.5800000000000001 112.806 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -75.0 122.91 24.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 117.914 0.857 . . . . 2.7599999999999998 110.537 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 m -138.88 44.31 2.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.162 0.985 . . . . 2.8999999999999999 109.748 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 11.0 t -165.73 140.8 4.86 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.268 -0.895 . . . . 3.5499999999999998 112.167 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.66 75.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.027 0.531 . . . . 2.8399999999999999 111.361 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.4 m -53.55 -45.69 69.95 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.439 -0.788 . . . . 2.54 110.036 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.0 m -64.85 -44.97 88.02 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.188 -0.91 . . . . 2.5299999999999998 109.493 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 37.2 t -46.32 -60.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 118.772 0.714 . . . . 1.95 110.749 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -56.7 -45.14 81.99 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.686 0.755 . . . . 4.0099999999999998 110.357 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.72 -50.76 72.57 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.808 0.843 . . . . 2.2400000000000002 111.166 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.2 mt -54.6 -50.53 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.041 -1.096 . . . . 1.3799999999999999 108.041 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.77 -44.32 86.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.697 0.799 . . . . 2.6600000000000001 110.299 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.8 t -56.07 -55.76 28.98 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.829 -0.434 . . . . 2.0600000000000001 109.829 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -43.15 77.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.274 0.63 . . . . 3.5499999999999998 112.572 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.39 -58.91 5.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.756 -0.831 . . . . 2.1099999999999999 108.756 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.8 m -53.09 -23.65 8.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.673 1.189 . . . . 1.7 111.432 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -4.45 8.88 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.028 1.121 . . . . 5.2699999999999996 114.028 174.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.3 m -84.74 149.73 25.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.055 1.742 . . . . 1.8600000000000001 109.646 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -67.0 -53.56 30.15 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.89 0.876 . . . . 3.1699999999999999 112.004 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.94 -21.03 69.12 Favored Glycine 0 CA--C 1.528 0.871 0 O-C-N 122.157 -0.34 . . . . 1.6499999999999999 113.202 -170.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.75 129.54 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 121.138 -1.213 . . . . 2.0699999999999998 109.154 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.9 m -103.98 -51.65 3.11 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 119.403 -0.332 . . . . 2.1099999999999999 111.867 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.462 ' CE2' ' HG3' ' A' ' 123' ' ' LYS . 43.6 p90 -140.0 114.98 9.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.373 0.533 . . . . 2.1499999999999999 110.014 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -100.49 149.69 23.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.988 -0.745 . . . . 1.4099999999999999 108.988 165.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.9 m -139.34 115.61 10.44 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.347 -1.353 . . . . 2.0299999999999998 107.347 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.16 119.78 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 118.227 0.467 . . . . 2.5800000000000001 110.358 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -118.78 87.98 2.84 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.817 0.818 . . . . 2.2999999999999998 109.612 -168.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.65 -32.1 28.12 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 125.724 1.61 . . . . 3.0099999999999998 112.025 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.62 -36.28 69.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.525 0.73 . . . . 3.0099999999999998 111.158 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.99 -20.08 15.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.96 1.304 . . . . 2.7200000000000002 110.439 177.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 78.79 7.05 2.23 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.656 1.583 . . . . 2.0899999999999999 111.407 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -96.37 148.86 22.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.66 1.584 . . . . 3.8399999999999999 110.057 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.41 119.29 25.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.281 2.232 . . . . 1.6699999999999999 107.605 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.88 122.85 40.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.701 -1.962 . . . . 3.1200000000000001 105.701 174.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.35 133.95 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.4 -0.963 . . . . 2.5800000000000001 108.4 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 110' ' ' TYR . 4.8 mmmt -116.12 110.4 18.8 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.363 1.065 . . . . 3.04 109.272 177.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -127.25 176.71 7.2 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 118.498 0.59 . . . . 2.7799999999999998 111.933 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -96.73 109.05 46.61 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 107.008 -1.479 . . . . 3.96 107.008 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.36 64.36 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.534 2.823 . . . . 3.7999999999999998 111.07 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.21 -44.88 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.426 1.49 . . . . 4.0599999999999996 109.321 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -90.88 -29.81 4.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 118.003 0.365 . . . . 3.1600000000000001 111.254 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.76 164.81 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.225 1.01 . . . . 2.9700000000000002 108.53 -175.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -149.68 167.05 29.81 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.011 -0.835 . . . . 3.0299999999999998 111.011 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -60.82 -34.38 91.54 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.243 3.295 . . . . 3.0299999999999998 111.953 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -54.17 -37.62 64.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.557 0.743 . . . . 7.6900000000000004 112.062 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.58 -43.46 84.87 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.05 0.452 . . . . 4.3300000000000001 109.834 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 14.1 mm -56.07 -48.7 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.712 0.805 . . . . 2.7200000000000002 109.189 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.9 mt -53.46 -57.89 4.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 123.513 0.725 . . . . 2.8399999999999999 109.382 172.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.0 tttp -49.36 -48.39 46.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 119.264 0.938 . . . . 4.2800000000000002 112.74 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.6 mt -51.46 -52.71 19.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.055 -0.721 . . . . 4.2599999999999998 109.055 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.309 2.2 pp -70.62 -29.15 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 118.892 -1.123 . . . . 1.54 114.021 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -58.11 -45.05 87.93 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.356 0.98 . . . . 3.23 109.019 170.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.88 -37.12 85.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.041 0.536 . . . . 3.7000000000000002 109.558 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.8 mt -66.37 -41.67 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.99 -0.444 . . . . 1.8300000000000001 110.483 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.68 30.75 6.34 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.337 1.446 . . . . 1.4199999999999999 111.8 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -101.16 -179.78 4.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.549 1.175 . . . . 1.98 108.771 163.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -133.79 121.13 21.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.938 -1.504 . . . . 4.3700000000000001 106.938 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.41 ' HB1' HD13 ' A' ' 84' ' ' LEU . . . -103.78 115.38 30.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.177 1.391 . . . . 1.8400000000000001 108.249 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.8 t -135.28 128.32 31.61 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 117.78 -1.105 . . . . 2.8700000000000001 108.606 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 pp -25.42 109.74 0.03 OUTLIER 'General case' 0 C--N 1.341 0.214 0 C-N-CA 127.626 2.37 . . . . 6.1600000000000001 109.705 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.85 -37.62 55.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.745 -0.662 . . . . 5.9100000000000001 110.782 -173.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 C--O 1.245 0.824 0 CA-C-O 116.149 -1.881 . . . . 9.6300000000000008 111.079 -179.877 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mmt . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 105.473 -2.047 . . . . 8.8599999999999994 105.473 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.93 108.66 1.98 Allowed Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 125.084 1.354 . . . . 4.5099999999999998 109.867 -167.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -80.18 111.58 2.68 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 121.355 1.37 . . . . 3.3599999999999999 111.713 -166.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -132.63 128.06 36.28 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 124.384 1.074 . . . . 3.0899999999999999 110.256 -172.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.408 ' NZ ' ' O ' ' A' ' 149' ' ' GLN . 2.7 ttpt -93.16 136.45 33.4 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.289 -1.004 . . . . 6.5700000000000003 108.289 -175.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.3 t -125.07 130.25 51.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.029 -1.441 . . . . 2.3900000000000001 110.534 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -102.3 96.28 6.85 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 126.615 1.966 . . . . 5.0300000000000002 111.125 -171.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.489 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 1.3 pt? -128.46 174.49 9.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.307 1.051 . . . . 2.5899999999999999 112.839 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.6 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -127.09 155.7 42.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.977 -1.49 . . . . 2.02 106.977 169.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 44' ' ' ALA . 31.4 mm -98.72 145.16 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.418 -1.327 . . . . 0.79000000000000004 107.418 171.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -118.86 128.07 54.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.645 -1.613 . . . . 3.1000000000000001 106.645 162.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.86 -54.12 0.48 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.933 0.777 . . . . 1.3200000000000001 112.037 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.0 mtt 11.85 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.946 2.498 . . . . 2.3999999999999999 115.595 -172.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.3 p -62.36 -61.2 2.62 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.697 -0.627 . . . . 3.71 111.104 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.8 t -162.87 48.18 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.984 0.421 . . . . 3.3399999999999999 110.205 -173.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 55.52 22.18 4.94 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.275 1.03 . . . . 6.7199999999999998 113.553 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 m -130.71 -38.96 1.27 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.931 0.892 . . . . 4.1200000000000001 111.732 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 m -64.41 -48.4 75.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 O-C-N 121.427 -0.796 . . . . 2.3599999999999999 109.228 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 81.8 t -55.39 -39.92 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.006 -0.739 . . . . 2.21 109.006 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 t -58.99 -42.06 89.15 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.971 -0.559 . . . . 3.0299999999999998 110.856 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -43.33 69.04 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.251 -1.53 . . . . 3.3399999999999999 111.242 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.3 mt -52.7 -49.61 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.768 1.227 . . . . 1.5600000000000001 109.375 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -55.23 -38.22 68.19 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.241 -0.912 . . . . 4.21 111.946 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -68.07 -31.84 71.76 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.1 -1.0 . . . . 8.5199999999999996 110.366 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -65.82 -49.45 68.18 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.69 -0.856 . . . . 1.6899999999999999 108.69 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -57.04 -37.54 71.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 112.695 0.628 . . . . 1.8600000000000001 112.695 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -54.78 -18.58 4.93 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.219 -0.926 . . . . 2.1299999999999999 112.819 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -116.99 23.86 11.6 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.643 0.777 . . . . 2.9700000000000002 112.271 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -71.98 -69.17 0.41 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.945 0.793 . . . . 2.79 109.632 167.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.2 -118.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.162 0.985 . . . . 1.1399999999999999 109.568 -171.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.19 -23.76 68.3 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 121.829 -0.544 . . . . 1.5 113.106 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 32' ' ' VAL . 1.2 p -60.1 111.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.914 0.886 . . . . 1.8100000000000001 111.556 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.17 52.32 1.37 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.068 -1.086 . . . . 2.6000000000000001 108.068 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.3 t -162.9 152.88 15.97 Favored 'General case' 0 CA--C 1.521 -0.154 0 O-C-N 119.866 -1.772 . . . . 2.0299999999999998 108.498 156.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.14 74.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 125.365 1.466 . . . . 2.48 108.981 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.88 68.79 1.02 Allowed 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.473 -0.767 . . . . 5.4699999999999998 109.18 -177.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.99 157.42 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.561 -0.903 . . . . 3.0499999999999998 108.561 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.71 103.04 8.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.06 -1.459 . . . . 1.78 107.06 170.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.4 mt -67.31 -15.69 63.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.895 0.878 . . . . 3.54 110.962 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 17.2 ttt -76.25 -47.86 22.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.584 1.154 . . . . 4.6600000000000001 109.885 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.72 -35.83 12.61 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.595 1.158 . . . . 1.72 111.271 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.73 74.85 1.29 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 124.612 1.101 . . . . 1.49 110.627 -174.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -140.58 141.03 35.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.986 -2.227 . . . . 3.0600000000000001 104.986 165.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.414 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -114.87 101.63 9.22 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 124.036 0.835 . . . . 1.1399999999999999 108.82 163.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -96.75 133.87 40.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.2 -1.407 . . . . 4.0899999999999999 107.2 165.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.67 160.33 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.993 -1.854 . . . . 2.9700000000000002 105.993 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -121.11 105.58 10.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 123.264 0.353 . . . . 4.5499999999999998 110.587 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.463 ' HB2' HD12 ' A' ' 53' ' ' ILE . 25.4 p90 -104.13 -177.09 3.27 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 126.81 2.044 . . . . 2.8999999999999999 112.757 174.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -122.15 109.12 33.66 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.809 2.044 . . . . 4.7199999999999998 109.12 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.71 -11.29 23.11 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.756 2.304 . . . . 2.73 114.722 -175.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -95.21 -4.5 45.78 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.885 0.766 . . . . 6.0800000000000001 110.938 -170.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.5 p -134.29 -37.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.585 1.154 . . . . 3.5899999999999999 111.184 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -118.53 153.02 20.71 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 N-CA-C 109.024 -0.732 . . . . 1.97 109.024 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -138.02 152.81 72.73 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.639 1.176 . . . . 3.4300000000000002 109.86 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.57 -37.14 39.09 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.711 2.274 . . . . 1.96 111.757 -170.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.1 -40.95 95.67 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.8 -0.563 . . . . 3.54 112.085 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -61.88 -44.58 96.51 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.264 0.625 . . . . 3.7400000000000002 109.984 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -52.3 -54.97 12.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 N-CA-C 106.986 -1.487 . . . . 1.49 106.986 170.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.01 -45.95 71.65 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.948 -0.569 . . . . 1.6399999999999999 110.255 -172.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -51.06 -51.15 56.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.966 0.906 . . . . 4.9400000000000004 110.022 175.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -45.16 75.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.318 0.58 . . . . 2.7400000000000002 110.183 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 69' ' ' ALA . 7.3 mm -65.82 -37.7 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 O-C-N 121.939 -0.476 . . . . 2.6499999999999999 110.515 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -66.28 -41.07 90.36 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.382 -0.599 . . . . 3.0099999999999998 109.382 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -60.4 -50.8 72.14 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.866 0.466 . . . . 3.23 109.998 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.0 mt -57.67 -32.46 67.35 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 111.889 0.329 . . . . 1.95 111.889 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.85 35.11 1.9 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.458 1.028 . . . . 1.6499999999999999 111.445 166.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -132.18 164.05 27.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.054 1.342 . . . . 2.1899999999999999 109.149 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -102.72 124.83 48.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.867 -1.16 . . . . 2.4399999999999999 107.867 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.405 ' HB2' HG13 ' A' ' 62' ' ' ILE . . . -102.97 122.3 44.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.829 -1.175 . . . . 1.28 107.829 166.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.6 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -126.98 118.59 24.79 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.555 -0.906 . . . . 1.26 108.555 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.591 HG21 ' HA ' ' A' ' 74' ' ' ASP . 7.1 p -69.07 160.3 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 125.169 1.388 . . . . 3.1499999999999999 110.247 171.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -51.76 68.46 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.3 0.572 . . . . 6.0300000000000002 110.15 168.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.45 106.06 0.23 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 100.886 -3.746 . . . . 7.3499999999999996 100.886 -173.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.591 ' HA ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -67.94 126.43 29.43 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 119.64 1.109 . . . . 11.359999999999999 108.389 -166.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.421 ' CD2' ' HG3' ' A' ' 83' ' ' GLU 0.259 2.9 p90 -143.43 -72.58 0.29 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 112.682 -2.054 . . . . 5.9400000000000004 112.868 -176.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 101.72 125.67 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 127.893 2.477 . . . . 5.04 108.786 -172.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -130.33 109.83 0.96 Allowed Glycine 0 C--N 1.334 0.421 0 CA-C-O 118.19 -1.339 . . . . 3.02 110.834 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.2 t -173.77 -56.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.4 1.1 . . . . 4.9699999999999998 111.055 170.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -155.24 141.64 18.65 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 127.147 2.179 . . . . 5.1500000000000004 105.16 -175.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.44 -30.65 1.43 Allowed Glycine 0 CA--C 1.531 1.054 0 O-C-N 120.268 -1.52 . . . . 2.3999999999999999 112.264 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.681 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -142.65 118.14 10.32 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 104.907 -2.257 . . . . 2.6600000000000001 104.907 174.268 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.681 HD13 ' O ' ' A' ' 81' ' ' ASN . 2.3 mm -131.6 165.82 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.657 0.783 . . . . 2.98 109.062 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.421 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 3.0 mt-10 -131.1 149.03 52.78 Favored 'General case' 0 N--CA 1.438 -1.056 0 O-C-N 124.51 1.131 . . . . 4.6799999999999997 111.551 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.51 151.04 38.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.344 1.027 . . . . 2.5499999999999998 109.221 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.99 132.87 43.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.27 -2.122 . . . . 1.6299999999999999 105.27 174.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.5 pt -98.62 139.46 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.191 -1.04 . . . . 1.8700000000000001 108.191 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.4 m -136.64 140.66 42.93 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.219 -1.4 . . . . 1.9099999999999999 107.219 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.51 -20.62 15.49 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.5 1.048 . . . . 1.1799999999999999 112.669 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.42 148.78 26.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.494 1.147 . . . . 3.2400000000000002 112.073 176.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.6 t -134.89 -9.97 2.34 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.586 1.154 . . . . 3.7799999999999998 112.521 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 35.4 t -160.03 158.35 30.34 Favored 'General case' 0 C--N 1.341 0.237 0 O-C-N 120.952 -1.092 . . . . 2.7200000000000002 108.598 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.33 -37.26 35.88 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.375 1.07 . . . . 2.6299999999999999 112.028 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -45.53 -42.13 10.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.732 0.813 . . . . 1.98 111.721 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 81.5 m -62.51 -53.18 58.57 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 109.134 -0.691 . . . . 1.75 109.134 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -45.33 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.648 -0.657 . . . . 2.0099999999999998 111.65 176.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -62.43 -35.31 78.85 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.696 -0.483 . . . . 3.1800000000000002 109.696 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -61.63 -60.84 3.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.535 1.134 . . . . 2.4399999999999999 109.035 176.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -44.4 -57.12 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 123.733 0.813 . . . . 2.0299999999999998 110.073 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.57 -45.02 93.09 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 120.173 -0.611 . . . . 2.5899999999999999 109.794 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.9 t -53.74 -57.57 10.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.48 0.712 . . . . 2.1099999999999999 110.519 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.538 ' CE ' HG22 ' A' ' 138' ' ' ILE . 10.7 mtpt -55.15 -38.06 67.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.446 0.906 . . . . 6.4100000000000001 113.446 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.1 mt -71.05 -56.7 5.6 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.681 -1.97 . . . . 2.3300000000000001 105.681 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.447 ' HA ' HG21 ' A' ' 108' ' ' ILE . 53.7 m -50.08 -21.51 1.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.86 2.064 . . . . 2.2200000000000002 112.499 176.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -68.22 -24.61 64.95 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.578 0.751 . . . . 4.8799999999999999 112.97 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.4 m -62.42 170.18 2.53 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.141 0.576 . . . . 2.1699999999999999 110.707 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -82.59 -49.91 9.34 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.137 -0.977 . . . . 3.2999999999999998 110.302 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.46 -30.98 66.07 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.444 1.021 . . . . 1.3 112.425 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.447 HG21 ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER -49.77 105.35 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.313 0.645 . . . . 2.7799999999999998 110.843 178.435 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 59.8 m -104.39 -31.31 9.58 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.729 0.412 . . . . 2.29 110.522 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.26 114.07 8.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.345 -1.724 . . . . 2.8599999999999999 106.345 -175.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -117.85 157.33 26.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.076 -1.453 . . . . 1.21 107.076 155.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.0 t -141.98 136.48 30.37 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.904 -1.517 . . . . 1.76 106.904 166.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.2 133.83 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 123.841 0.857 . . . . 2.1000000000000001 110.052 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -132.34 116.06 16.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.681 1.192 . . . . 1.3 110.256 -170.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.4 mt -75.43 -46.82 30.4 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 127.251 2.22 . . . . 2.9199999999999999 110.859 -172.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.59 -35.44 4.01 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.581 1.552 . . . . 1.7 111.705 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.92 -4.37 13.28 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.548 1.939 . . . . 1.8700000000000001 111.281 -177.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 63.6 m 52.73 31.85 11.09 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.054 1.342 . . . . 1.47 112.508 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -108.2 151.0 26.52 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.484 0.713 . . . . 4.7400000000000002 110.509 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.86 116.84 10.47 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.269 1.028 . . . . 0.95999999999999996 108.599 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mp -102.03 128.79 48.33 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 126.607 1.963 . . . . 2.6099999999999999 106.451 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.82 131.75 50.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.309 -0.626 . . . . 2.6600000000000001 109.309 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -113.33 83.94 1.92 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.717 0.807 . . . . 3.8900000000000001 110.651 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -113.97 171.94 7.29 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.65 1.58 . . . . 2.0499999999999998 109.317 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -96.33 117.75 65.93 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 108.93 -0.767 . . . . 3.1299999999999999 108.93 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.7 70.85 6.77 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.287 2.658 . . . . 2.04 111.013 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -164.29 -44.95 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.082 1.353 . . . . 4.1100000000000003 109.709 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 25.7 pt -76.83 -38.73 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 123.377 0.671 . . . . 2.3999999999999999 110.364 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.18 156.09 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.998 1.319 . . . . 2.1200000000000001 108.127 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -121.82 158.66 16.52 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.048 -1.221 . . . . 2.2799999999999998 110.048 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -62.52 -43.39 22.21 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.801 2.334 . . . . 2.02 110.056 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -54.21 -37.68 64.83 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 122.759 0.424 . . . . 5.4199999999999999 111.907 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.79 -44.19 70.6 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.752 -1.203 . . . . 4.8399999999999999 107.752 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.51 -48.99 86.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 108.604 -0.887 . . . . 1.6699999999999999 108.604 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 64.2 mt -50.26 -58.75 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 C-N-CA 124.237 1.015 . . . . 2.1800000000000002 108.958 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -53.09 -45.76 68.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.032 -1.043 . . . . 5.2800000000000002 112.488 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.2 mm -56.29 -46.08 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 109.965 -0.383 . . . . 2.8300000000000001 109.965 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.538 HG22 ' CE ' ' A' ' 101' ' ' LYS . 27.4 pt -72.35 -34.77 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 121.112 -0.993 . . . . 1.46 113.109 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -56.05 -36.86 68.51 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.171 0.896 . . . . 2.6400000000000001 109.279 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.25 -25.52 68.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.061 -0.518 . . . . 3.6299999999999999 110.057 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.3 mt -86.89 -39.26 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.155 0.582 . . . . 1.95 109.708 172.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.33 27.42 5.3 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.129 1.347 . . . . 1.73 111.342 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -99.28 170.35 8.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.299 1.049 . . . . 1.9099999999999999 108.954 165.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -135.53 144.87 46.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.835 -1.172 . . . . 5.3600000000000003 107.835 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.4 103.08 7.99 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.136 1.775 . . . . 1.3799999999999999 109.31 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.45 112.66 19.25 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.656 0.782 . . . . 2.1899999999999999 109.932 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -17.71 106.68 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.983 2.513 . . . . 4.3300000000000001 113.191 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.52 -40.22 23.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.94 -0.573 . . . . 3.6499999999999999 110.403 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.408 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 14.9 mt-30 . . . . . 0 C--O 1.256 1.441 0 CA-C-O 115.403 -2.236 . . . . 6.9199999999999999 116.994 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 106.48 -1.674 . . . . 8.3000000000000007 106.48 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.34 119.34 6.51 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.502 -2.036 . . . . 3.8199999999999998 105.502 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -91.1 147.2 3.66 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.42 2.747 . . . . 2.9100000000000001 110.443 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 79' ' ' ASP . 23.9 mp0 -127.89 154.46 45.48 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 107.487 -1.301 . . . . 3.9500000000000002 107.487 -176.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -92.37 159.17 15.7 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.506 1.522 . . . . 5.3300000000000001 107.348 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.457 ' SG ' HD21 ' A' ' 8' ' ' LEU . 30.8 p -152.14 145.97 25.13 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 118.426 0.557 . . . . 2.6600000000000001 111.3 166.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.96 102.49 11.49 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.273 1.029 . . . . 4.1799999999999997 109.001 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -106.58 168.83 8.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.069 0.938 . . . . 2.7200000000000002 111.113 172.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.12 156.31 33.9 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.549 -1.278 . . . . 1.6799999999999999 107.549 167.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.3 mm -99.13 141.06 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 107.608 -1.256 . . . . 1.1399999999999999 107.608 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -119.55 121.78 40.14 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.236 -1.765 . . . . 2.8500000000000001 106.236 160.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.57 -83.68 0.15 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.644 1.116 . . . . 1.3200000000000001 110.396 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.5 mmt 54.07 71.58 0.51 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.708 1.603 . . . . 1.9399999999999999 113.6 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -55.26 -61.95 1.99 Allowed 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.616 -0.677 . . . . 2.1499999999999999 112.374 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.0 t -168.59 64.57 0.06 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.757 0.708 . . . . 3.0699999999999998 110.034 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 38.86 44.65 0.86 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.452 1.501 . . . . 5.7000000000000002 112.912 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.5 t -160.81 -41.8 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.054 0.542 . . . . 3.0 110.528 -166.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -61.78 -40.3 94.71 Favored 'General case' 0 CA--C 1.527 0.08 0 O-C-N 120.889 -1.132 . . . . 1.9399999999999999 109.833 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.672 ' HB ' HD21 ' A' ' 39' ' ' LEU . 77.0 t -61.44 -32.48 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 121.871 -0.518 . . . . 1.8 110.456 171.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 m -66.85 -37.56 84.7 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.102 -0.639 . . . . 2.2000000000000002 111.428 176.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.262 0.3 OUTLIER -71.9 -35.14 69.64 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.556 -1.34 . . . . 3.6299999999999999 112.146 171.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 mt -48.15 -51.41 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.712 -0.617 . . . . 2.0800000000000001 110.965 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -34.37 -55.13 0.53 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.083 0.953 . . . . 4.3499999999999996 110.907 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -68.8 -30.46 69.04 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.0 1.32 . . . . 8.1099999999999994 110.285 -170.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -65.48 -57.94 7.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.513 -0.921 . . . . 1.9399999999999999 108.513 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.83 -38.8 79.48 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.568 -0.16 . . . . 2.02 110.568 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -49.57 -26.64 3.68 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.949 0.9 . . . . 2.6499999999999999 112.53 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -123.29 22.55 9.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.176 -0.916 . . . . 4.4000000000000004 112.858 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -61.93 -68.88 0.28 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.433 1.015 . . . . 3.2400000000000002 110.756 165.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.8 -130.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.938 0.495 . . . . 1.1200000000000001 109.828 -163.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.07 -13.26 72.68 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 118.791 0.723 . . . . 1.4099999999999999 112.959 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 46' ' ' ILE . 8.2 p -60.95 127.16 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 118.417 1.108 . . . . 1.3 110.635 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 pp -142.69 51.81 1.43 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.41 0.624 . . . . 2.52 111.032 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 t -156.66 151.61 26.09 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.015 -0.735 . . . . 1.5900000000000001 109.015 164.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.83 69.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 125.553 1.541 . . . . 2.7400000000000002 108.583 -171.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tt -98.05 74.17 2.26 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.14 -1.059 . . . . 2.2999999999999998 108.14 -173.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.428 HG11 ' CG1' ' A' ' 19' ' ' VAL . 17.7 t -104.81 136.95 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.849 -0.614 . . . . 2.21 109.435 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -113.74 98.84 7.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.56 -0.904 . . . . 1.3400000000000001 108.56 173.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.672 HD21 ' HB ' ' A' ' 19' ' ' VAL . 18.2 mt -60.5 -17.49 45.65 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.585 0.754 . . . . 2.9199999999999999 112.607 173.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 6.1 mtm -70.05 -55.95 8.2 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.137 0.494 . . . . 4.2599999999999998 109.781 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.89 -24.88 22.39 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.398 0.679 . . . . 1.49 111.429 -175.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.93 68.32 1.54 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.185 -1.166 . . . . 1.22 110.185 -174.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.24 139.46 41.02 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.574 -2.009 . . . . 2.8900000000000001 105.574 171.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.91 101.48 9.53 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 124.641 1.213 . . . . 0.88 111.878 169.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -97.97 136.0 38.87 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.799 -1.185 . . . . 5.1399999999999997 107.799 169.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 32' ' ' VAL . 37.2 pt -141.51 168.57 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.88 -0.785 . . . . 1.8700000000000001 108.88 171.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -120.6 97.96 5.81 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 119.072 -0.489 . . . . 3.73 110.151 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -102.27 178.97 4.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 124.611 1.194 . . . . 2.2999999999999998 112.156 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -123.38 104.53 34.42 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 127.96 2.504 . . . . 4.3499999999999996 110.056 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.66 26.95 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 124.336 3.357 . . . . 2.0899999999999999 112.717 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -106.1 -20.83 13.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.959 1.303 . . . . 3.1899999999999999 110.76 165.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 87.9 t -117.6 -72.06 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 N-CA-C 108.246 -1.02 . . . . 2.7400000000000002 108.246 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.47 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -88.12 140.62 15.5 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.079 0 N-CA-C 108.853 -0.795 . . . . 1.5 108.853 176.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -121.38 153.05 58.61 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.358 1.063 . . . . 2.77 108.421 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.46 -39.57 87.95 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.897 2.398 . . . . 1.21 112.739 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.23 -42.55 98.8 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.491 -0.755 . . . . 2.8399999999999999 111.477 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -62.07 -39.99 94.29 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.027 0.531 . . . . 3.7000000000000002 110.544 175.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.47 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -53.44 -51.04 45.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.359 -1.349 . . . . 1.0900000000000001 107.359 171.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.37 -39.68 70.4 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 119.238 -0.411 . . . . 1.1399999999999999 111.152 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -57.64 -47.82 81.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.101 0.864 . . . . 2.4900000000000002 110.394 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -46.15 82.66 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.053 0.454 . . . . 2.7599999999999998 110.44 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -67.9 -45.39 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.483 -0.761 . . . . 2.5099999999999998 111.23 -175.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -33.38 72.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.852 -0.594 . . . . 2.3500000000000001 110.877 174.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.96 -50.24 72.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.905 0.775 . . . . 2.1800000000000002 110.225 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.81 -28.73 67.01 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 118.087 -1.445 . . . . 3.7999999999999998 111.195 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.55 31.42 2.16 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.178 -0.769 . . . . 1.1000000000000001 111.178 171.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -109.25 168.36 9.44 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.282 -0.636 . . . . 2.1800000000000002 109.282 169.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -107.64 129.66 54.98 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.794 -0.817 . . . . 2.5699999999999998 108.794 168.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.93 123.27 48.7 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.615 0.766 . . . . 0.79000000000000004 109.074 166.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.81 162.48 31.9 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.891 1.277 . . . . 1.05 107.658 166.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 1.6 m -75.9 151.73 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 108.701 -0.851 . . . . 2.98 108.701 -171.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -51.15 62.1 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.844 -0.799 . . . . 4.3700000000000001 108.844 171.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 179.64 -50.15 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.037 1.735 . . . . 5.4900000000000002 111.223 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -32.45 -57.56 0.34 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.999 2.52 . . . . 7.6299999999999999 116.725 169.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.425 ' CE2' HD23 ' A' ' 121' ' ' LEU 0.301 0.5 OUTLIER 66.61 -42.9 0.41 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.989 2.516 . . . . 4.0 114.289 -172.461 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.02 -53.38 0.03 OUTLIER 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.823 1.192 . . . . 3.4900000000000002 113.536 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 43.2 54.15 5.46 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.309 0.957 . . . . 3.0600000000000001 115.08 172.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.1 t -142.06 -56.45 0.46 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.898 1.349 . . . . 4.5800000000000001 113.099 -173.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.411 ' HB3' HE21 ' A' ' 4' ' ' GLN . 8.5 t70 -161.02 135.87 7.47 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 106.979 -1.489 . . . . 4.4100000000000001 106.979 -171.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.18 -37.96 2.0 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 120.036 1.289 . . . . 2.3900000000000001 111.64 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.42 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -137.75 84.47 2.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.619 1.167 . . . . 3.0099999999999998 109.082 -179.423 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -102.52 157.71 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 108.803 -0.814 . . . . 2.98 108.803 -175.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.49 157.1 44.39 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.555 -0.716 . . . . 3.6299999999999999 111.287 175.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 mt -144.14 155.99 44.15 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.049 0.94 . . . . 2.3300000000000001 109.845 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.623 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -98.11 122.74 41.62 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 106.659 -1.608 . . . . 1.6899999999999999 106.659 177.064 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.3 pt -97.93 111.65 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-O 122.015 0.912 . . . . 2.04 109.321 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 m -103.72 145.06 30.63 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.496 1.118 . . . . 1.8799999999999999 108.702 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.29 -33.84 5.87 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.292 0.948 . . . . 1.1599999999999999 111.436 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.7 151.93 36.96 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.398 0.599 . . . . 2.7599999999999998 110.948 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 t -163.39 33.83 0.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.597 0.359 . . . . 2.9300000000000002 111.103 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.0 p -162.15 145.1 11.61 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.381 -0.824 . . . . 3.3700000000000001 111.658 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.0 -34.92 70.52 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.573 1.149 . . . . 2.7599999999999998 111.334 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 t -54.2 -50.06 67.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.642 0.377 . . . . 2.2799999999999998 110.046 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 55.6 m -68.14 -45.96 72.13 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.961 -0.462 . . . . 1.78 110.125 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.407 ' CG1' HG23 ' A' ' 113' ' ' VAL . 89.4 t -48.75 -57.18 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.937 1.695 . . . . 1.3500000000000001 109.921 172.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -59.0 -43.96 91.58 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.686 -0.634 . . . . 3.46 111.017 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -60.78 -42.88 98.41 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.347 0.659 . . . . 1.7 110.876 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.0 mt -57.28 -50.41 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 108.321 -0.992 . . . . 0.83999999999999997 108.321 174.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -53.51 -43.67 68.48 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.029 -0.51 . . . . 2.6699999999999999 110.425 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.4 t -57.96 -50.4 73.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.544 0.738 . . . . 1.3999999999999999 111.305 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -37.35 78.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.25 -0.906 . . . . 2.5 110.933 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.4 mt -70.59 -51.34 28.91 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.837 -0.801 . . . . 1.8200000000000001 108.837 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.6 p -60.05 -17.07 36.53 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.936 0.717 . . . . 1.8999999999999999 112.936 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -59.82 -33.91 72.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 119.298 -0.961 . . . . 4.5599999999999996 112.338 168.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.8 m -73.34 142.51 47.07 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.706 0.803 . . . . 1.77 111.162 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -66.0 -42.38 89.83 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.361 0.874 . . . . 3.0800000000000001 113.361 -173.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.29 -39.29 27.03 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.127 -1.189 . . . . 1.0700000000000001 110.127 -170.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.33 126.36 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.975 -0.75 . . . . 3.6000000000000001 108.975 168.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.1 t -124.41 -26.3 3.93 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.676 0.791 . . . . 3.3199999999999998 111.585 165.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.62 93.97 3.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.694 -1.965 . . . . 2.3199999999999998 105.694 -172.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.98 151.45 21.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.219 -1.401 . . . . 1.3100000000000001 107.219 158.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.7 t -142.23 110.83 6.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.213 -1.773 . . . . 1.6499999999999999 106.213 167.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.407 HG23 ' CG1' ' A' ' 95' ' ' VAL . 6.4 m -104.89 147.64 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 118.048 0.385 . . . . 2.5899999999999999 110.774 176.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.73 102.31 4.7 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.305 0.574 . . . . 1.6499999999999999 110.395 -174.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 pp -61.94 -19.12 62.4 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.345 0.868 . . . . 2.5499999999999998 113.345 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.14 -40.75 64.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.908 -0.775 . . . . 1.99 108.908 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.1 p -90.14 -25.35 20.74 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.004 0.921 . . . . 3.3700000000000001 110.344 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 p 77.9 9.68 2.27 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 128.257 2.623 . . . . 2.3300000000000001 112.894 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -99.71 151.18 21.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.163 0.982 . . . . 3.3999999999999999 111.767 174.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -117.25 117.48 29.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.855 2.462 . . . . 0.95999999999999996 107.0 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.425 HD23 ' CE2' ' A' ' 75' ' ' TYR . 5.5 mp -99.83 131.23 45.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.547 -1.279 . . . . 2.8399999999999999 107.547 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 83.0 t -140.78 128.94 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.378 1.071 . . . . 2.04 109.682 -170.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -116.45 93.03 4.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.951 -0.759 . . . . 3.6000000000000001 108.951 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -113.98 169.48 8.97 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.654 1.182 . . . . 1.99 109.777 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.561 ' HB3' HD11 ' A' ' 128' ' ' ILE . 35.6 t0 -105.28 115.6 61.83 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.289 1.036 . . . . 3.6800000000000002 109.708 -179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.86 65.17 7.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.856 3.037 . . . . 1.8899999999999999 112.83 -170.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -143.29 -51.14 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.671 1.588 . . . . 3.4399999999999999 108.219 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 128' ' ' ILE . 0.0 OUTLIER -77.89 -34.48 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 122.96 0.504 . . . . 2.46 111.096 -177.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.5 tp -145.79 168.49 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.078 -0.712 . . . . 1.9099999999999999 109.078 -174.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.96 169.86 31.33 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.181 -1.168 . . . . 1.4099999999999999 110.181 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -61.22 -35.31 85.88 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.278 2.652 . . . . 1.54 110.801 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -51.93 -39.68 59.56 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 112.458 0.54 . . . . 6.9900000000000002 112.458 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.05 -44.45 84.54 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.209 -0.663 . . . . 3.1699999999999999 109.209 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.97 -55.95 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.24 -0.652 . . . . 1.47 109.24 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 pt -54.61 -57.1 7.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-O 118.003 -0.998 . . . . 3.1000000000000001 109.334 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -47.77 -50.59 25.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.125 1.33 . . . . 4.1200000000000001 112.839 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.4 mm -52.91 -54.7 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.423 -0.584 . . . . 1.9399999999999999 109.423 175.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.287 2.6 pp -71.49 -25.0 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 119.077 -1.049 . . . . 1.47 113.538 -176.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -63.86 -32.06 73.45 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.327 1.051 . . . . 3.0299999999999998 110.32 169.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -62.17 -39.24 92.02 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.214 -0.661 . . . . 2.98 109.214 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.2 mt -66.78 -42.01 88.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.409 -0.589 . . . . 1.3999999999999999 109.409 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.91 22.61 5.6 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.874 1.702 . . . . 1.48 111.511 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -99.06 -178.71 4.02 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.52 -1.289 . . . . 2.2400000000000002 107.52 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -140.6 135.65 31.98 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.157 -1.053 . . . . 3.1800000000000002 108.157 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -122.87 96.67 5.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.236 1.014 . . . . 1.54 109.765 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.1 p -123.43 127.21 48.1 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.425 0.69 . . . . 2.4199999999999999 110.918 -173.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.417 HD12 ' OE1' ' A' ' 149' ' ' GLN . 0.4 OUTLIER -14.92 113.13 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.109 2.564 . . . . 4.2000000000000002 115.086 175.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.623 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -107.29 48.61 0.83 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.698 0.999 . . . . 5.0300000000000002 113.698 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.417 ' OE1' HD12 ' A' ' 147' ' ' LEU . 7.0 pm0 . . . . . 0 C--O 1.254 1.319 0 CA-C-O 117.798 -1.096 . . . . 6.7199999999999998 112.366 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 105.932 -1.877 . . . . 12.859999999999999 105.932 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.282 . . 98.66 -33.86 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 118.402 2.742 . . . . 5.75 118.402 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.448 ' CB ' ' HE3' ' A' ' 47' ' ' LYS . 72.6 Cg_endo -80.36 125.47 5.74 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 CA-C-N 122.751 2.018 . . . . 4.75 109.549 171.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -124.85 -176.97 3.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.754 0.821 . . . . 3.8199999999999998 109.393 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -110.3 154.75 23.03 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.409 0.684 . . . . 3.8399999999999999 110.58 165.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.9 t -125.78 130.18 50.93 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.142 0.977 . . . . 2.3300000000000001 109.424 170.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.52 106.37 16.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 128.388 2.675 . . . . 3.27 110.027 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 -179.19 5.4 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.458 -0.776 . . . . 3.3300000000000001 110.617 173.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.16 161.58 28.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.49 -1.3 . . . . 2.3599999999999999 107.49 173.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mm -97.16 134.84 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 105.878 -1.897 . . . . 1.05 105.878 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -117.58 67.83 0.75 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.537 -1.283 . . . . 3.1000000000000001 107.537 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.4 -69.4 0.06 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.152 -0.779 . . . . 1.3799999999999999 111.152 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.08 93.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.521 2.328 . . . . 2.5099999999999998 116.883 176.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.44 -22.7 21.6 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.387 1.075 . . . . 2.3900000000000001 113.589 170.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 89.5 m 75.57 -62.9 0.43 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.938 1.695 . . . . 5.7400000000000002 110.078 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.98 -75.29 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.495 2.318 . . . . 4.3200000000000003 112.925 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.3 p -160.02 14.28 0.13 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.432 0.901 . . . . 2.2200000000000002 113.432 169.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.92 -45.05 64.93 Favored 'General case' 0 N--CA 1.462 0.126 0 O-C-N 121.239 -0.913 . . . . 1.8999999999999999 110.071 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -53.67 -47.13 61.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.418 -0.956 . . . . 1.6200000000000001 108.418 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.02 -41.53 64.79 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.353 0.661 . . . . 1.95 112.073 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -67.41 -49.27 64.53 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.969 -0.382 . . . . 2.7200000000000002 109.969 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.491 HG12 HD13 ' A' ' 65' ' ' LEU . 69.3 mt -48.96 -45.32 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.963 0.905 . . . . 1.4299999999999999 110.586 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -44.62 -57.38 3.68 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.042 0.837 . . . . 4.7000000000000002 111.194 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -61.6 -39.17 90.27 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.154 0.982 . . . . 4.9199999999999999 110.208 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -62.65 -57.38 11.24 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.963 -0.755 . . . . 1.3500000000000001 108.963 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.12 -31.42 72.61 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.036 -0.415 . . . . 3.3500000000000001 111.009 -175.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.572 HE22 HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -45.58 -35.01 3.68 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.445 0.566 . . . . 1.79 112.257 168.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -110.2 24.19 13.33 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.377 0.671 . . . . 3.8900000000000001 112.135 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.34 -72.24 0.17 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.034 0.534 . . . . 3.5499999999999998 109.596 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.38 -120.88 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.418 0.687 . . . . 1.21 109.998 -172.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.17 -11.23 63.67 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.782 0.719 . . . . 1.5900000000000001 113.183 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -75.46 122.56 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.691 -0.888 . . . . 1.5 109.464 173.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.21 49.35 1.93 Allowed 'General case' 0 C--N 1.34 0.164 0 CA-C-O 120.786 0.327 . . . . 2.6800000000000002 110.577 173.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.6 m -150.53 156.11 40.78 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.291 -1.003 . . . . 3.1000000000000001 108.291 165.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.572 HG11 HE22 ' A' ' 27' ' ' GLN . 5.0 p -140.29 117.01 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 107.37 -1.345 . . . . 2.8399999999999999 107.37 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -140.44 79.59 1.71 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 108.172 -1.047 . . . . 2.5499999999999998 108.172 172.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.1 t -99.4 136.58 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.135 -0.939 . . . . 2.27 108.551 169.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.88 96.58 6.25 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.608 -1.256 . . . . 1.52 107.608 167.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.66 -21.04 24.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.906 0.882 . . . . 2.6200000000000001 111.669 175.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -59.0 5.12 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.793 1.237 . . . . 3.02 109.547 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.22 20.3 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.99 0.916 . . . . 1.6799999999999999 111.102 -172.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.71 63.96 1.86 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.154 -1.178 . . . . 1.3400000000000001 110.154 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.77 137.36 41.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.253 -2.128 . . . . 2.5600000000000001 105.253 169.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.85 104.51 11.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.784 1.302 . . . . 1.26 109.61 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -111.74 144.65 40.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.244 0.545 . . . . 4.0300000000000002 109.719 167.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.08 178.78 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 124.444 1.097 . . . . 1.8300000000000001 109.147 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.448 ' HE3' ' CB ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -124.74 94.92 4.33 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.033 0.933 . . . . 8.8499999999999996 110.213 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.412 ' HB2' HD12 ' A' ' 53' ' ' ILE . 1.9 p90 -99.99 169.51 9.14 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.414 2.285 . . . . 2.8799999999999999 113.476 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.93 97.43 41.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.849 1.66 . . . . 2.8900000000000001 108.858 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -53.22 -21.31 16.72 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.663 3.576 . . . . 3.02 114.817 -171.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -77.98 -25.52 48.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.5 1.52 . . . . 4.5099999999999998 111.285 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 p -121.34 -31.19 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 123.988 0.915 . . . . 3.4199999999999999 112.522 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -128.11 135.32 63.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 123.601 0.76 . . . . 1.8 109.189 179.548 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -120.46 154.83 56.81 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.505 1.122 . . . . 3.1600000000000001 111.84 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.23 -30.19 92.35 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.152 1.901 . . . . 1.8 111.607 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -42.25 94.15 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.797 0.726 . . . . 3.9399999999999999 111.705 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -71.17 -41.08 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.686 0.794 . . . . 3.6299999999999999 110.745 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.8 -42.34 42.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 108.255 -1.017 . . . . 1.54 108.255 170.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.23 86.59 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.519 -0.764 . . . . 1.51 111.172 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -59.93 -52.96 63.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 121.278 -0.889 . . . . 3.1099999999999999 109.655 171.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -54.86 19.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.94 0.4 . . . . 2.6600000000000001 110.846 -177.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.3 pp -62.05 -44.26 98.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.503 0.557 . . . . 4.1299999999999999 112.503 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.64 -39.35 84.06 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.587 1.085 . . . . 2.1899999999999999 110.226 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.37 -47.75 72.38 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.648 0.779 . . . . 2.5800000000000001 109.636 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.491 HD13 HG12 ' A' ' 22' ' ' ILE . 11.7 mt -53.81 -33.07 54.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.184 0.594 . . . . 1.78 111.452 170.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.58 33.09 2.97 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.262 -1.135 . . . . 1.1799999999999999 110.262 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -124.67 149.56 47.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.763 -1.569 . . . . 1.96 106.763 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.81 129.66 44.2 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.017 -1.475 . . . . 3.2200000000000002 107.017 170.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.552 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -118.77 120.19 36.63 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.63 -1.619 . . . . 0.88 106.63 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.89 128.28 34.28 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.424 -1.262 . . . . 0.94999999999999996 107.923 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.4 t -49.29 151.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.012 1.325 . . . . 3.0099999999999998 108.832 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.31 -44.15 79.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.283 -0.266 . . . . 3.46 110.283 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.15 -65.04 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 105.227 -2.138 . . . . 4.1299999999999999 105.227 175.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.57 ' HA ' HD21 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -60.68 -85.89 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.07 -1.423 . . . . 6.1699999999999999 112.609 176.226 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.703 ' CE2' HD23 ' A' ' 121' ' ' LEU . 0.1 OUTLIER 155.29 -30.2 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 115.502 -2.189 . . . . 4.6399999999999997 114.671 -153.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 75' ' ' TYR . . . 130.05 -58.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 122.237 2.289 . . . . 3.5299999999999998 112.692 -170.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.65 89.14 0.15 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.277 -0.729 . . . . 3.6800000000000002 111.277 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.0 t -138.48 -98.84 0.18 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 117.236 0.518 . . . . 4.9800000000000004 111.937 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.35 152.1 21.48 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.832 -1.914 . . . . 5.4100000000000001 105.832 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.31 -71.78 2.86 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 106.757 -2.537 . . . . 1.9399999999999999 106.757 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -104.23 126.13 51.08 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.719 1.208 . . . . 4.0099999999999998 109.366 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.71 149.72 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 C-N-CA 124.297 1.039 . . . . 2.4900000000000002 108.253 175.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -125.37 146.51 49.56 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.35 1.06 . . . . 3.6699999999999999 110.536 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.46 149.63 39.48 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.269 1.027 . . . . 2.3999999999999999 108.744 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.32 132.2 42.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.404 -1.702 . . . . 2.0299999999999998 106.404 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 pp -106.59 113.39 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 O-C-N 123.909 0.756 . . . . 1.75 110.727 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.5 m -104.43 139.33 39.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.177 0.991 . . . . 1.8700000000000001 108.794 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.1 -27.8 11.3 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.995 1.283 . . . . 1.21 111.984 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 5.3 tmm? -63.8 131.65 48.48 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.845 0.858 . . . . 2.7999999999999998 109.901 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 m -144.77 34.9 1.14 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.588 1.155 . . . . 2.5499999999999998 109.331 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 43.3 t -165.82 129.61 2.2 Favored 'General case' 0 C--N 1.341 0.239 0 O-C-N 120.854 -1.154 . . . . 2.79 111.908 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.43 -35.89 63.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.542 0.737 . . . . 2.73 111.785 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 t -53.73 -46.94 70.99 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.134 0.492 . . . . 2.2400000000000002 110.257 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 35.1 m -62.58 -46.24 89.23 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.112 -0.699 . . . . 2.0899999999999999 109.112 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.5 t -52.79 -53.03 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.098 0.408 . . . . 1.3400000000000001 110.783 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -56.85 -44.88 82.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.158 0.504 . . . . 3.1200000000000001 110.746 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -60.74 -47.68 85.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.891 0.476 . . . . 1.97 110.639 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.3 mt -55.83 -52.64 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.746 -0.835 . . . . 1.04 108.746 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -56.24 -42.06 76.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.837 0.855 . . . . 3.1800000000000002 110.134 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.2 t -57.94 -55.51 33.96 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.923 0.329 . . . . 1.74 110.815 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -50.82 64.7 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.666 -0.646 . . . . 2.5800000000000001 110.999 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.8 mt -55.82 -58.0 9.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 119.22 -0.419 . . . . 1.96 110.051 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.8 m -53.67 -25.17 16.92 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.61 1.164 . . . . 2.2200000000000002 111.549 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -62.39 -28.29 69.67 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.881 -0.512 . . . . 6.5499999999999998 111.348 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.3 m -68.08 118.31 11.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.448 1.499 . . . . 2.2599999999999998 111.225 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -33.05 -55.82 0.39 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.637 1.975 . . . . 2.9199999999999999 114.033 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.55 -29.14 60.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 119.513 -0.604 . . . . 1.72 113.354 -171.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.1 127.94 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.522 -1.288 . . . . 3.1899999999999999 107.522 -174.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 36.9 p -99.16 -51.4 3.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 118.303 0.501 . . . . 3.5099999999999998 110.437 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -131.95 128.66 38.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.322 -0.992 . . . . 2.3999999999999999 108.322 169.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.99 128.26 53.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.879 -1.156 . . . . 1.1899999999999999 107.879 165.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.2 m -115.45 112.32 22.1 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 117.707 -1.14 . . . . 2.6499999999999999 109.498 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 t -114.47 131.55 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 120.325 1.421 . . . . 2.3199999999999998 112.651 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -125.67 106.44 9.73 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.489 1.115 . . . . 1.1100000000000001 111.226 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -22.92 59.5 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 125.172 1.389 . . . . 2.3199999999999998 113.266 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.73 80.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.149 0.5 . . . . 1.46 110.073 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.22 -34.82 10.19 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.243 1.417 . . . . 2.0699999999999998 110.402 177.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.4 m 79.78 38.55 0.11 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.407 1.883 . . . . 1.77 110.875 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.9 144.05 46.64 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 123.539 0.736 . . . . 3.0099999999999998 109.436 173.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.18 120.65 29.28 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.249 2.62 . . . . 1.1000000000000001 107.679 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.703 HD23 ' CE2' ' A' ' 75' ' ' TYR . 9.8 mp -115.07 104.43 11.87 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.623 1.569 . . . . 2.4100000000000001 110.254 -170.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.3 m -103.82 135.86 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.6 1.16 . . . . 2.3599999999999999 111.114 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.71 104.52 11.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.858 -1.164 . . . . 4.7300000000000004 107.858 174.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -123.25 176.47 6.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.667 1.587 . . . . 2.48 112.258 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -98.7 113.55 64.49 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 108.49 -0.93 . . . . 3.1800000000000002 108.49 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.31 71.52 6.72 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.772 2.981 . . . . 2.0 111.346 -167.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -168.59 -48.43 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.318 1.047 . . . . 4.4800000000000004 109.337 -173.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.6 pt -83.75 -33.05 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.819 0.847 . . . . 1.8999999999999999 110.917 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.92 160.59 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.318 1.047 . . . . 1.6000000000000001 109.144 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.87 169.63 23.81 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.623 1.106 . . . . 1.5800000000000001 110.45 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.97 -40.44 11.93 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.233 2.622 . . . . 1.8799999999999999 111.092 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -51.32 -37.21 46.51 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.359 0.664 . . . . 6.4500000000000002 112.396 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.77 -45.37 78.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.619 -0.882 . . . . 4.2699999999999996 108.619 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 64.2 mt -60.73 -46.65 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 108.644 -0.872 . . . . 1.3300000000000001 108.644 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 77.2 mt -51.2 -58.46 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 118.363 -0.827 . . . . 2.2200000000000002 108.972 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -48.53 -50.25 32.75 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.568 1.076 . . . . 4.5300000000000002 110.606 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.5 mm -55.6 -50.02 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 109.85 -0.426 . . . . 1.8 109.85 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.283 2.5 pp -70.11 -28.52 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 119.197 -1.001 . . . . 1.74 113.615 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -63.71 -42.26 97.98 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.566 1.076 . . . . 2.29 109.896 170.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -60.0 -39.24 85.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.79 0.836 . . . . 3.3599999999999999 109.16 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.2 mt -71.01 -39.0 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 O-C-N 122.259 -0.275 . . . . 1.0700000000000001 110.941 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.03 29.48 8.0 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.499 1.523 . . . . 0.93000000000000005 112.096 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -99.65 177.11 5.25 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.689 1.245 . . . . 2.29 109.443 165.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -130.78 120.14 23.32 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.045 -1.465 . . . . 4.4500000000000002 107.045 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.06 113.31 26.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.502 1.521 . . . . 1.8200000000000001 108.654 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.8 m -123.13 114.23 20.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.101 0.41 . . . . 2.04 111.028 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.6 mt -28.29 114.58 0.08 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 128.222 2.609 . . . . 4.0599999999999996 111.923 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.86 23.9 5.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.442 0.697 . . . . 3.5 112.68 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.456 -1.259 . . . . 5.7300000000000004 110.78 168.687 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 106.233 -1.766 . . . . 12.82 106.233 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.24 132.87 95.4 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-N 119.663 1.12 . . . . 4.6100000000000003 108.128 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.91 77.91 3.16 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 CA-C-O 123.523 1.384 . . . . 4.5800000000000001 113.197 -162.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -111.11 123.81 50.94 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 112.519 -2.128 . . . . 4.9400000000000004 109.786 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.12 148.9 23.08 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.424 1.09 . . . . 3.9100000000000001 108.356 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.1 t -135.89 134.77 39.12 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.784 -1.191 . . . . 2.8399999999999999 107.784 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -103.65 98.01 7.95 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 124.244 0.965 . . . . 3.9199999999999999 109.02 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 71' ' ' VAL . 2.6 pt? -121.67 169.73 10.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.957 0.884 . . . . 2.1499999999999999 111.364 172.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.02 142.67 49.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.24 -1.022 . . . . 2.0499999999999998 108.24 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.41 HG12 ' HB2' ' A' ' 44' ' ' ALA . 26.4 mm -98.18 146.92 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.674 -1.232 . . . . 0.84999999999999998 107.674 -178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -128.2 96.74 4.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.565 -1.643 . . . . 3.6699999999999999 106.565 171.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.14 -70.98 0.09 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.952 -1.259 . . . . 1.75 109.952 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 ptm 29.03 70.47 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.48 2.312 . . . . 2.48 116.053 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.69 -14.32 2.17 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.764 1.626 . . . . 2.54 114.16 175.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t 71.66 -63.49 0.42 Allowed 'General case' 0 C--N 1.339 0.128 0 C-N-CA 126.372 1.869 . . . . 2.9399999999999999 111.373 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -16.17 -73.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 128.177 2.591 . . . . 6.5700000000000003 113.224 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -157.5 24.11 0.29 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.856 0.862 . . . . 3.8199999999999998 110.654 159.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.0 m -71.01 -52.98 16.44 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.296 -0.877 . . . . 1.9199999999999999 109.178 -170.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.7 t -50.24 -46.83 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.019 -0.734 . . . . 1.9399999999999999 109.019 173.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 t -54.91 -51.9 64.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.46 0.704 . . . . 3.23 110.875 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -40.53 80.19 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 121.331 -0.856 . . . . 2.7799999999999998 110.386 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mt -55.93 -50.71 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.781 1.232 . . . . 1.49 109.548 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -52.22 -44.44 64.79 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.63 0.65 . . . . 4.1900000000000004 111.27 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -69.22 -40.46 77.94 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.748 -1.22 . . . . 5.8399999999999999 111.588 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -61.7 -53.75 51.84 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 122.116 -0.365 . . . . 1.3400000000000001 110.043 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.54 -39.01 70.03 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.677 0.791 . . . . 3.04 110.361 175.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.17 -23.97 9.66 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.212 0.915 . . . . 1.72 112.902 173.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -106.12 21.13 17.86 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.108 0.963 . . . . 3.6800000000000002 112.491 176.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.417 ' HG3' ' CD2' ' A' ' 61' ' ' PHE . 33.0 tt0 -70.34 -72.64 0.19 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.802 -0.814 . . . . 3.5600000000000001 108.802 177.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.42 -105.08 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.839 1.256 . . . . 1.95 107.859 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.83 25.33 24.05 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.241 -1.31 . . . . 2.3999999999999999 113.352 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.65 ' C ' HD12 ' A' ' 33' ' ' LEU . 8.5 p -96.0 120.74 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 119.373 1.587 . . . . 2.0800000000000001 109.308 168.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 32' ' ' VAL . 3.5 mp -139.54 53.72 1.7 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 108.96 -0.756 . . . . 2.9399999999999999 108.96 -178.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 t -161.64 156.51 23.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.869 -1.9 . . . . 2.8900000000000001 105.869 165.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.29 110.05 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 106.7 -1.593 . . . . 2.71 106.7 175.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -128.98 76.87 1.75 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.822 -1.177 . . . . 3.4500000000000002 107.822 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 t -97.84 127.09 50.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 109.541 -0.54 . . . . 2.4100000000000001 109.541 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.84 88.24 3.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.93 -1.137 . . . . 2.1800000000000002 107.93 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.5 tp -53.33 -22.98 8.14 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.029 1.332 . . . . 3.6899999999999999 110.805 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -35.04 68.77 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.388 0.675 . . . . 5.7300000000000004 111.285 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.49 -39.44 4.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.955 0.902 . . . . 2.6000000000000001 110.926 -172.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.99 63.41 0.81 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 125.916 1.722 . . . . 1.8200000000000001 110.47 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -142.35 136.68 29.89 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.127 -1.805 . . . . 4.0099999999999998 106.127 172.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -117.43 95.02 4.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.434 1.084 . . . . 1.5 109.272 172.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -101.51 137.43 39.84 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.805 -1.554 . . . . 5.7400000000000002 106.805 171.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.484 HD13 ' H ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -133.77 -178.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 107.316 -1.365 . . . . 2.8399999999999999 107.316 177.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.58 106.2 6.88 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.753 -1.203 . . . . 5.9199999999999999 107.753 176.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -117.41 176.23 5.25 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 124.762 1.289 . . . . 3.52 114.459 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -113.37 107.3 53.67 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.895 1.278 . . . . 3.8700000000000001 111.348 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.48 -11.37 31.33 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.991 2.461 . . . . 3.3700000000000001 112.929 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.37 -21.33 64.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 120.203 1.365 . . . . 3.5699999999999998 111.228 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -128.59 -46.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.44 0.696 . . . . 3.8500000000000001 110.403 -169.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.748 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -92.37 147.61 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 121.913 0.863 . . . . 2.6899999999999999 109.43 174.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -128.04 150.07 72.7 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 125.69 1.596 . . . . 3.6600000000000001 108.776 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -58.42 -29.8 89.49 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.261 2.641 . . . . 2.1499999999999999 111.596 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -49.55 77.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.245 1.418 . . . . 2.5499999999999998 109.718 172.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -68.11 -38.55 82.39 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.933 -0.479 . . . . 3.0299999999999998 109.726 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.748 HD12 HD11 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -58.36 -46.25 89.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 107.486 -1.302 . . . . 1.71 107.486 172.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.48 -44.52 95.84 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 122.973 0.509 . . . . 1.3500000000000001 110.397 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -60.1 -51.25 70.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.661 -0.649 . . . . 2.3399999999999999 110.94 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.417 ' CD2' ' HG3' ' A' ' 29' ' ' GLU . 0.6 OUTLIER -55.11 -48.43 73.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.612 0.642 . . . . 3.6899999999999999 112.176 -179.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.567 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.5 pp -67.07 -39.63 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 121.261 -0.9 . . . . 4.3300000000000001 111.658 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.5 -34.9 79.35 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.518 0.599 . . . . 3.4199999999999999 110.511 177.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.18 -52.02 65.48 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.459 -0.571 . . . . 2.8300000000000001 109.459 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.6 mt -58.45 -29.95 66.55 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.828 0.307 . . . . 2.1899999999999999 111.828 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.36 31.54 3.73 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 124.512 1.053 . . . . 1.4299999999999999 111.336 167.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.59 161.48 19.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.63 1.572 . . . . 2.0099999999999998 108.405 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -98.45 134.58 41.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.77 -1.567 . . . . 2.2000000000000002 106.77 163.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.567 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -125.49 127.23 46.14 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.919 -1.882 . . . . 1.0800000000000001 105.919 169.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.48 123.98 23.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.201 -1.037 . . . . 1.1299999999999999 108.201 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.433 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 2.5 t -71.1 145.26 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.057 -1.09 . . . . 2.98 108.057 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.4 mtt -56.38 -48.39 76.96 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.04 -0.726 . . . . 4.6200000000000001 109.04 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 158.38 -34.19 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.829 1 C-N-CA 133.542 4.737 . . . . 6.4000000000000004 108.191 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -64.97 71.44 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.302 1.841 . . . . 8.5 111.247 174.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -73.72 -20.88 60.39 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.87 1.668 . . . . 4.3099999999999996 114.056 -176.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 133.3 -150.83 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 128.854 2.862 . . . . 3.1499999999999999 108.874 -172.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 150.56 94.58 0.12 Allowed Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 109.021 -1.632 . . . . 3.1899999999999999 109.021 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.1 t -163.62 -25.63 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 115.963 1.838 . . . . 5.6900000000000004 115.963 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -80.9 -136.95 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.55 1.068 . . . . 6.6299999999999999 108.354 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.19 -21.24 68.0 Favored Glycine 0 N--CA 1.436 -1.341 0 O-C-N 120.179 -1.576 . . . . 2.6000000000000001 109.597 152.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.33 104.63 17.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.594 -1.632 . . . . 2.8399999999999999 106.594 -176.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.504 HD11 ' CE1' ' A' ' 124' ' ' PHE . 0.0 OUTLIER -130.94 157.72 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 106.94 -1.504 . . . . 3.2799999999999998 106.94 172.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -123.06 160.7 25.81 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.947 -1.024 . . . . 3.9100000000000001 110.176 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 pp -143.78 159.92 41.66 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.638 -1.164 . . . . 3.1200000000000001 110.229 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.8 m -109.36 131.67 54.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.374 1.87 . . . . 2.27 107.943 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.53 98.08 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.733 1.613 . . . . 1.76 110.706 -170.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.3 m -95.53 112.52 24.23 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.877 -0.786 . . . . 1.9199999999999999 108.877 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 135.3 -22.98 3.5 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.486 1.041 . . . . 1.3100000000000001 111.921 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.1 ttp -70.74 133.59 46.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.021 -0.693 . . . . 2.7200000000000002 111.719 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.2 m -151.53 39.44 0.65 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.844 0.858 . . . . 3.2200000000000002 110.239 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.5 t -167.96 138.94 2.82 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.963 -1.086 . . . . 2.5 110.71 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.7 67.2 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.474 0.654 . . . . 2.6699999999999999 111.856 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.9 m -53.47 -43.93 68.54 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.256 -0.902 . . . . 2.2000000000000002 110.275 170.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.0 m -64.4 -42.24 96.21 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.888 0.475 . . . . 1.74 109.849 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.763 HG13 HG13 ' A' ' 113' ' ' VAL . 46.7 t -52.23 -55.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.721 0.808 . . . . 1.23 108.826 173.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.7 m170 -61.66 -36.6 81.29 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 109.737 -0.468 . . . . 3.77 109.737 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -59.01 -60.71 3.44 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.959 -0.756 . . . . 2.0099999999999998 108.959 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.6 mt -49.59 -49.2 19.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 C-N-CA 124.472 1.109 . . . . 1.0600000000000001 110.051 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -54.38 -52.93 60.13 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.222 1.009 . . . . 2.4700000000000002 109.786 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.0 m -66.85 -25.16 66.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.431 0.692 . . . . 2.1600000000000001 112.186 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -46.87 49.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 120.865 -1.147 . . . . 3.2999999999999998 111.816 170.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.58 -45.8 64.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.272 0.942 . . . . 3.5299999999999998 108.888 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.0 p -60.43 -12.45 9.52 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.702 0.63 . . . . 2.2799999999999998 112.702 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -53.57 -34.29 57.8 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.634 -0.666 . . . . 4.0099999999999998 111.349 167.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.4 p -78.44 164.88 24.39 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 118.936 0.789 . . . . 2.4100000000000001 110.907 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -82.89 -44.87 14.9 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.887 0.875 . . . . 2.3900000000000001 111.188 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.742 ' HA3' HD11 ' A' ' 128' ' ' ILE . . . -71.01 -36.58 64.47 Favored Glycine 0 C--N 1.335 0.523 0 O-C-N 122.236 -0.29 . . . . 1.6100000000000001 112.606 -170.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -66.21 130.19 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.127 -0.694 . . . . 2.2000000000000002 109.127 -174.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.0 t -109.81 -53.46 2.67 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.422 0.289 . . . . 3.3599999999999999 111.466 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CD2' ' HG3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -131.41 124.88 31.21 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.694 -1.224 . . . . 3.1299999999999999 107.694 175.069 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.39 161.82 15.27 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.525 -0.546 . . . . 0.91000000000000003 109.525 153.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.4 m -139.27 110.24 6.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.696 -1.594 . . . . 1.72 106.696 168.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.763 HG13 HG13 ' A' ' 95' ' ' VAL . 3.3 p -108.68 132.74 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.446 1.099 . . . . 1.8100000000000001 110.115 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.42 119.16 12.45 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.96 0.886 . . . . 1.3200000000000001 111.545 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 115' ' ' LEU . 2.4 pt? -71.36 -31.05 66.87 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.322 1.449 . . . . 2.4900000000000002 112.778 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.99 81.74 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.522 0.677 . . . . 1.6100000000000001 109.947 -176.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.67 -36.65 65.37 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.352 -0.84 . . . . 1.8999999999999999 109.363 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.3 t 85.23 14.78 0.17 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 126.473 1.909 . . . . 2.52 111.462 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.86 164.74 16.2 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.471 0.708 . . . . 4.6399999999999997 111.029 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.74 143.57 47.22 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.04 1.336 . . . . 1.26 108.567 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -99.46 146.02 26.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.535 1.147 . . . . 1.96 108.122 165.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.4 t -134.93 136.67 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 126.349 1.859 . . . . 2.2599999999999998 107.869 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HG3' ' CD2' ' A' ' 110' ' ' TYR . 19.7 mmmt -113.22 109.52 18.9 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.276 1.43 . . . . 3.8799999999999999 108.81 166.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.504 ' CE1' HD11 ' A' ' 82' ' ' ILE . 0.9 OUTLIER -127.51 -176.1 3.65 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.654 1.115 . . . . 2.3599999999999999 111.098 173.769 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -103.0 112.32 65.7 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 108.307 -0.998 . . . . 3.1299999999999999 108.307 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.99 67.65 8.0 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.874 2.383 . . . . 2.4399999999999999 111.962 -166.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -165.25 -43.93 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.227 1.411 . . . . 3.8399999999999999 109.59 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.742 HD11 ' HA3' ' A' ' 107' ' ' GLY . 2.6 pp -79.68 -40.48 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 122.852 0.461 . . . . 2.4500000000000002 110.303 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.672 ' HB ' HD12 ' A' ' 128' ' ' ILE . 1.7 tp -135.42 178.23 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.237 1.015 . . . . 2.3799999999999999 109.398 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.84 -178.81 34.17 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.031 -2.027 . . . . 1.8700000000000001 108.031 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.11 -40.19 34.96 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.12 1.88 . . . . 1.72 110.285 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 -50.94 -40.07 56.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.485 1.114 . . . . 5.5199999999999996 113.511 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.75 -52.66 64.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.56 -0.533 . . . . 4.21 109.56 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.72 -44.79 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.336 -0.987 . . . . 1.6899999999999999 108.336 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 90.2 mt -51.9 -61.32 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 123.711 0.804 . . . . 1.9399999999999999 109.105 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.68 -46.31 67.2 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.269 0.94 . . . . 4.5199999999999996 110.835 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.5 mm -57.13 -51.68 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 121.974 -0.454 . . . . 2.1200000000000001 109.856 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.13 -27.2 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 120.701 -1.249 . . . . 1.3500000000000001 112.925 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -59.68 -35.39 74.35 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.659 -0.65 . . . . 3.0099999999999998 110.349 170.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.52 -35.56 79.79 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.472 -0.566 . . . . 3.3599999999999999 109.472 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.4 mt -69.85 -45.63 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.681 -0.488 . . . . 1.2 109.681 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.19 31.33 2.26 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.612 1.577 . . . . 0.93999999999999995 111.66 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -99.06 -179.52 4.28 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.92 0.86 . . . . 2.23 109.69 171.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -139.33 105.19 5.16 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 107.774 -1.195 . . . . 4.1299999999999999 107.774 -175.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.88 98.96 9.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.913 1.285 . . . . 1.6000000000000001 109.267 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 51.8 m -101.44 115.91 31.58 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.618 -1.253 . . . . 2.0499999999999998 107.618 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.38 101.28 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.772 1.229 . . . . 4.6799999999999997 109.469 170.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.65 -38.77 77.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.922 -0.581 . . . . 3.96 110.168 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 126.168 1.787 . . . . 7.8300000000000001 112.804 -175.542 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mmt . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 117.019 -1.467 . . . . 9.6199999999999992 107.702 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.429 ' CB ' HE22 ' A' ' 4' ' ' GLN . . . -136.03 102.84 9.95 Favored Pre-proline 0 N--CA 1.454 -0.225 0 CA-C-N 119.824 1.193 . . . . 3.8700000000000001 107.9 -171.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -82.67 110.81 1.94 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.109 1.872 . . . . 2.8799999999999999 110.105 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.429 HE22 ' CB ' ' A' ' 2' ' ' ALA . 2.8 mp0 -99.37 172.35 7.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.448 -0.796 . . . . 3.0299999999999998 109.419 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.64 161.59 18.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.708 -1.219 . . . . 4.7800000000000002 107.708 169.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.31 132.72 26.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.492 -0.929 . . . . 2.5499999999999998 108.492 162.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -109.08 93.72 4.66 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.137 1.375 . . . . 3.7599999999999998 109.125 -171.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.441 HD22 ' H ' ' A' ' 8' ' ' LEU 0.279 0.0 OUTLIER -116.65 173.75 6.45 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.472 1.13 . . . . 3.0099999999999998 111.22 177.705 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.38 156.89 42.41 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.804 -1.924 . . . . 1.6000000000000001 105.804 174.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mm -97.87 134.26 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 106.454 -1.684 . . . . 1.1399999999999999 106.454 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -106.5 117.53 34.29 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 105.768 -1.938 . . . . 4.2999999999999998 105.768 158.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.5 -101.49 0.24 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.3 -1.12 . . . . 1.6599999999999999 110.3 -175.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.3 mtt 60.14 89.04 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.886 1.674 . . . . 1.8500000000000001 114.529 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -30.88 71.13 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.467 -0.771 . . . . 2.2400000000000002 111.231 166.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.0 t 78.05 -58.35 0.46 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.141 1.376 . . . . 3.7599999999999998 111.187 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -19.03 -68.46 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.91 2.484 . . . . 5.25 113.139 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.9 m -156.17 24.87 0.36 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.12 0.968 . . . . 2.6600000000000001 110.509 162.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.1 m -70.99 -51.53 25.03 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.283 -0.886 . . . . 1.5600000000000001 109.939 -169.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.4 t -47.68 -50.53 8.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 N-CA-C 109.1 -0.704 . . . . 2.1299999999999999 109.1 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -49.99 -48.85 52.11 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.134 0.574 . . . . 2.2999999999999998 112.54 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -39.13 74.85 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.464 -0.772 . . . . 3.0099999999999998 111.212 178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.3 mt -59.89 -48.84 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.812 1.245 . . . . 1.54 109.063 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.24 -49.73 41.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.458 0.572 . . . . 3.77 110.896 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -63.77 -34.57 78.18 Favored 'General case' 0 N--CA 1.458 -0.029 0 O-C-N 121.596 -0.69 . . . . 5.4400000000000004 111.056 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.97 -51.8 65.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.641 -0.503 . . . . 1.3200000000000001 109.641 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.29 -37.54 75.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.975 0.352 . . . . 2.3599999999999999 111.449 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -23.96 3.02 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.701 -1.25 . . . . 2.8700000000000001 112.078 173.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -126.08 34.86 4.78 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.231 -0.89 . . . . 3.9700000000000002 112.941 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' CG ' HG13 ' A' ' 32' ' ' VAL . 6.3 pt-20 -69.46 -70.54 0.27 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.992 1.269 . . . . 4.6500000000000004 111.96 169.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.29 -132.38 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.524 -0.917 . . . . 1.3600000000000001 108.524 -164.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.83 15.85 29.65 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-O 118.139 -1.367 . . . . 1.6399999999999999 113.112 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.465 HG13 ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -101.26 128.76 53.24 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 119.961 1.88 . . . . 1.6899999999999999 107.241 163.265 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 53.46 1.98 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.904 -1.147 . . . . 3.0499999999999998 107.904 172.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.1 t -156.25 143.85 19.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.307 -1.738 . . . . 1.8700000000000001 106.307 174.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.6 132.19 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.452 -1.684 . . . . 2.21 106.452 174.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tt -139.05 83.68 1.97 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.785 -0.82 . . . . 2.2000000000000002 108.785 172.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.32 139.57 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 107.909 -1.145 . . . . 2.0800000000000001 107.909 171.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.14 99.67 7.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 106.938 -1.504 . . . . 1.4299999999999999 106.938 165.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.02 -27.15 66.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.897 0.879 . . . . 2.6200000000000001 110.679 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 36.6 mtt -63.28 -60.52 3.29 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.517 0.727 . . . . 3.25 110.353 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.24 -29.07 47.98 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.795 -0.639 . . . . 1.7 110.91 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.05 61.18 1.77 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.227 -1.149 . . . . 1.26 110.227 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -134.82 144.08 47.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.539 -1.652 . . . . 3.5099999999999998 106.539 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.427 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -121.57 104.22 9.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.444 1.097 . . . . 1.1100000000000001 108.265 165.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.61 137.93 50.89 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.77 0.714 . . . . 4.4299999999999997 109.478 169.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.48 172.2 16.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 O-C-N 121.919 -0.488 . . . . 2.3599999999999999 110.594 178.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.03 105.33 10.53 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.286 1.034 . . . . 4.4400000000000004 111.012 173.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -106.15 171.48 7.32 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.077 1.751 . . . . 2.8300000000000001 112.916 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.96 112.0 38.63 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.822 1.649 . . . . 3.6099999999999999 107.764 174.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.4 36.38 0.62 Allowed 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.892 3.061 . . . . 2.46 114.286 -155.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -129.27 -15.64 4.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.03 0.932 . . . . 3.9300000000000002 112.398 170.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.1 t -106.06 -35.21 3.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 C-N-CA 124.379 1.072 . . . . 2.8799999999999999 109.43 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.574 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -132.83 150.69 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 105.351 -2.092 . . . . 1.8300000000000001 105.351 179.176 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -135.7 155.25 78.27 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.881 1.272 . . . . 3.29 111.416 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.57 -34.07 88.74 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.024 2.483 . . . . 1.55 112.662 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.38 -56.54 19.91 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.211 0.529 . . . . 2.5099999999999998 110.805 176.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.99 -31.7 69.52 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.77 -0.581 . . . . 4.75 110.964 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.574 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -54.66 -50.68 57.86 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 N-CA-C 107.269 -1.382 . . . . 1.29 107.269 168.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.4 76.15 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.462 -0.335 . . . . 1.25 110.19 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.32 -48.41 79.02 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 119.04 -0.505 . . . . 2.6200000000000001 111.011 175.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.61 -52.23 62.87 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 109.246 -0.65 . . . . 2.5099999999999998 109.246 176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.6 mm -62.84 -44.6 99.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 122.27 -0.269 . . . . 2.9900000000000002 111.059 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.71 -47.7 79.38 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.204 1.001 . . . . 2.02 111.173 173.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.23 -48.83 80.07 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.241 0.473 . . . . 2.3500000000000001 109.876 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.9 mt -58.27 -32.2 68.17 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.906 -0.588 . . . . 2.04 111.3 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.8 25.08 3.45 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 123.976 0.798 . . . . 1.21 111.604 164.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -119.03 158.21 26.27 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.767 -1.568 . . . . 3.04 106.767 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -97.03 128.15 43.7 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.059 -1.089 . . . . 2.4199999999999999 108.059 167.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.38 115.18 27.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.344 -1.354 . . . . 1.3100000000000001 107.344 169.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.43 142.92 39.5 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.559 -1.275 . . . . 1.1499999999999999 107.559 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 t -59.49 153.4 4.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.19 0.596 . . . . 2.6899999999999999 110.003 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 mtm -66.79 -7.39 21.02 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.77 0.656 . . . . 4.9900000000000002 112.77 171.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 82.72 -22.73 0.23 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.837 2.455 . . . . 4.5800000000000001 110.699 -171.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -41.23 -50.2 3.61 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 127.111 2.164 . . . . 8.9100000000000001 111.646 164.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.4 t80 70.37 -35.25 0.32 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.876 1.67 . . . . 5.4500000000000002 113.001 -176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 78.79 -46.52 0.4 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 127.719 2.408 . . . . 4.5 113.622 164.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 79' ' ' ASP . . . 99.37 72.77 1.05 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 108.165 -1.974 . . . . 2.7200000000000002 108.165 -166.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.79 44.15 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.136 1.774 . . . . 6.1900000000000004 111.285 159.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 77' ' ' GLY . 11.3 t0 47.65 114.31 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 130.947 3.699 . . . . 4.8799999999999999 115.566 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.46 -43.96 1.74 Allowed Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 108.101 -2.0 . . . . 2.2999999999999998 108.101 -167.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -98.69 59.03 1.23 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.605 1.202 . . . . 3.71 109.668 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.3 mm -92.0 139.74 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.185 -1.413 . . . . 2.7400000000000002 107.185 -167.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -106.84 149.38 27.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.218 -1.03 . . . . 2.96 108.218 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.8 mt -144.24 152.44 40.83 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 122.899 0.479 . . . . 2.4500000000000002 110.054 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.01 135.86 38.41 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.878 -1.527 . . . . 2.6299999999999999 106.878 173.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.448 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -97.37 109.0 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 108.289 -1.004 . . . . 2.0899999999999999 108.289 -179.195 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.4 m -96.44 134.16 39.96 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.283 -1.377 . . . . 1.8799999999999999 107.283 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.25 -15.71 54.05 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.521 1.058 . . . . 1.79 113.002 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -76.56 124.05 27.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.192 1.496 . . . . 3.3900000000000001 110.807 -174.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -129.58 9.83 5.56 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.75 0.82 . . . . 4.8300000000000001 113.1 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 50.2 t -155.23 134.31 12.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.675 1.125 . . . . 3.8500000000000001 111.546 -173.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.8 -38.95 61.89 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.537 0.735 . . . . 2.8100000000000001 112.83 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -49.64 -39.25 35.4 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.295 -0.878 . . . . 2.4700000000000002 111.842 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 74.1 m -61.91 -34.14 75.52 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.986 -0.446 . . . . 2.29 110.597 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.6 t -58.58 -50.78 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.18 -0.674 . . . . 2.1699999999999999 109.18 174.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -60.63 -41.34 94.71 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.78 -0.822 . . . . 2.77 108.78 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -59.07 -52.34 66.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.0 0.92 . . . . 2.2599999999999998 110.11 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.1 mt -56.26 -53.15 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.013 0.925 . . . . 0.97999999999999998 109.867 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.14 -37.77 86.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.685 -0.487 . . . . 2.2200000000000002 109.685 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -59.57 -53.57 56.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.039 -0.356 . . . . 1.46 110.039 171.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.32 -47.42 66.02 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.285 0.634 . . . . 3.6499999999999999 111.372 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.3 -59.47 4.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.125 -0.694 . . . . 1.6799999999999999 109.125 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.6 m -55.3 -19.75 9.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.863 1.265 . . . . 1.78 112.144 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -31.88 63.14 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.324 0.65 . . . . 5.4800000000000004 111.131 172.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.1 m -70.47 151.08 45.52 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.991 2.117 . . . . 1.98 111.908 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -72.54 -49.08 35.16 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.814 0.446 . . . . 3.9399999999999999 111.964 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.98 -34.77 71.18 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 122.193 -0.317 . . . . 1.72 112.56 -172.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.31 124.12 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 O-C-N 121.881 -0.776 . . . . 2.3300000000000001 110.395 -170.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 59.7 m -99.65 -49.65 4.32 Favored 'General case' 0 CA--C 1.522 -0.114 0 O-C-N 122.978 0.174 . . . . 2.6299999999999999 111.082 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -140.82 124.23 16.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.437 -0.579 . . . . 2.2599999999999998 109.437 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -98.52 153.79 18.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.222 -1.029 . . . . 1.0900000000000001 108.222 161.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.6 t -142.73 109.77 5.57 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.43 -1.322 . . . . 2.7799999999999998 107.43 169.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.5 p -114.15 121.82 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.669 0.788 . . . . 2.2400000000000002 111.188 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -122.72 105.13 9.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.05 0.94 . . . . 2.46 110.072 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.28 -22.94 65.31 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.08 0.771 . . . . 3.1499999999999999 113.08 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.02 -54.51 7.05 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.886 -0.783 . . . . 3.1200000000000001 108.886 -172.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.4 p -69.73 -25.28 63.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.08 0.952 . . . . 4.3600000000000003 109.998 172.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.423 ' O ' HD12 ' A' ' 86' ' ' ILE . 17.2 m 74.02 19.03 3.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.426 1.891 . . . . 2.3900000000000001 111.732 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -113.81 149.17 35.35 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.559 0.744 . . . . 3.46 110.531 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.01 115.87 16.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.723 2.009 . . . . 1.5 108.516 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 mt -100.62 130.54 46.69 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.465 -1.309 . . . . 2.6800000000000002 107.465 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.3 t -131.04 121.19 48.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.65 -0.87 . . . . 2.3300000000000001 108.65 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -100.62 93.77 5.76 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.754 1.221 . . . . 3.1600000000000001 109.624 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -111.18 -179.51 3.75 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.444 0.698 . . . . 2.46 110.338 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -108.4 109.97 61.64 Favored Pre-proline 0 C--O 1.236 0.39 0 N-CA-C 107.502 -1.295 . . . . 3.9399999999999999 107.502 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.27 63.42 8.72 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.29 2.66 . . . . 2.1600000000000001 112.119 -167.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -147.17 -51.5 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.033 1.733 . . . . 4.0499999999999998 108.343 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.15 -35.33 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 110.401 -0.222 . . . . 2.5499999999999998 110.401 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.11 159.52 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 108.17 -1.048 . . . . 1.78 108.17 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.33 164.31 25.93 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.59 -1.404 . . . . 1.77 109.59 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -63.07 -44.18 16.53 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.047 2.498 . . . . 1.9399999999999999 111.03 -172.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -51.06 -40.86 59.3 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 113.614 0.968 . . . . 6.75 113.614 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -63.08 -47.4 83.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.94 -0.763 . . . . 2.75 108.94 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.413 ' O ' HD13 ' A' ' 138' ' ' ILE . 97.5 mt -56.86 -50.18 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.878 -0.786 . . . . 1.1799999999999999 108.878 177.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.7 mt -48.85 -60.67 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-O 118.399 -0.81 . . . . 2.1800000000000002 109.004 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.62 -48.17 39.63 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.221 0.919 . . . . 3.2599999999999998 110.716 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 9.9 mm -54.18 -48.76 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 118.31 -0.852 . . . . 1.8 110.849 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 134' ' ' ILE 0.332 0.0 OUTLIER -72.97 -31.74 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 120.436 1.471 . . . . 2.7999999999999998 114.154 174.152 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.05 -36.56 70.66 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.113 1.324 . . . . 2.3999999999999999 110.246 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -70.43 -24.36 62.89 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.1 0.96 . . . . 4.3600000000000003 110.778 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 30.1 mt -75.36 -43.77 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.481 0.582 . . . . 1.3700000000000001 109.455 166.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.93 31.94 2.36 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.793 1.663 . . . . 1.1399999999999999 111.284 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -114.13 160.73 18.62 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.726 -1.212 . . . . 2.5800000000000001 107.726 165.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -124.46 131.97 53.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.847 -1.168 . . . . 4.2999999999999998 107.847 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.86 105.9 13.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.2 1.0 . . . . 1.3600000000000001 109.533 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.0 m -134.21 117.78 16.88 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 117.616 -1.183 . . . . 2.2400000000000002 111.156 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -5.23 98.93 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.5 2.72 . . . . 5.2800000000000002 114.964 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.09 65.45 1.5 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.932 0.893 . . . . 5.6299999999999999 111.872 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 C--O 1.25 1.101 0 C-N-CA 125.253 1.421 . . . . 7.25 107.729 168.182 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mtm . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 117.495 -1.241 . . . . 16.469999999999999 113.327 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.429 ' HA ' ' NE2' ' A' ' 4' ' ' GLN . . . -88.5 -27.1 0.34 Allowed Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 117.688 2.477 . . . . 6.0300000000000002 117.688 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.52 112.18 3.13 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 122.672 1.99 . . . . 3.4399999999999999 109.552 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.429 ' NE2' ' HA ' ' A' ' 2' ' ' ALA . 4.8 mm-40 -106.94 126.15 51.94 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.436 0.694 . . . . 3.8500000000000001 110.545 -168.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -92.08 141.76 28.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.558 -0.534 . . . . 3.79 109.558 -176.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.3 p -119.57 154.94 33.14 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.866 -1.161 . . . . 2.7599999999999998 107.866 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -115.9 105.57 12.82 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.71 -1.218 . . . . 3.3199999999999998 107.71 173.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mt -114.32 170.59 8.19 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.173 0.987 . . . . 2.77 109.73 172.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.06 146.61 47.02 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.441 -1.689 . . . . 1.79 106.441 168.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 mm -98.04 142.9 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 107.307 -1.368 . . . . 0.92000000000000004 107.307 172.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -117.2 126.73 53.25 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.217 -1.031 . . . . 3.3799999999999999 108.217 165.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.28 -57.83 0.39 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.559 1.076 . . . . 1.9399999999999999 111.089 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.1 mtt 24.91 73.09 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.119 2.167 . . . . 2.1299999999999999 115.643 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -59.24 -57.54 12.59 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.729 0.64 . . . . 2.5 112.729 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.3 t -166.79 61.81 0.09 Allowed 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.722 0.692 . . . . 3.9100000000000001 112.031 -171.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 38.52 50.31 1.53 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.59 1.556 . . . . 5.04 112.765 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.7 t -167.63 -45.6 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.812 0.845 . . . . 2.5099999999999998 109.223 -168.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.8 t -65.42 -45.51 83.63 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.507 -0.746 . . . . 1.54 109.794 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.2 -22.68 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 121.337 -0.852 . . . . 1.9099999999999999 112.031 170.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -39.49 94.73 Favored 'General case' 0 C--O 1.223 -0.301 0 O-C-N 120.848 -1.157 . . . . 1.8100000000000001 110.537 167.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -36.16 71.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.081 -1.012 . . . . 3.7799999999999998 111.089 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -49.15 -32.9 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.122 0.969 . . . . 1.96 111.787 172.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -55.17 -53.0 61.53 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.523 0.729 . . . . 5.1100000000000003 110.653 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.93 -43.76 67.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.745 -0.661 . . . . 5.3499999999999996 109.679 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -54.52 -52.56 61.61 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.698 -0.482 . . . . 3.2000000000000002 109.698 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.531 HD21 HD11 ' A' ' 62' ' ' ILE . 24.9 mt -66.3 -41.06 90.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.901 -0.571 . . . . 2.4700000000000002 112.111 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -22.84 16.44 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.552 1.069 . . . . 2.0699999999999998 111.957 172.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -116.1 33.48 5.5 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.935 0.494 . . . . 3.1099999999999999 112.269 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.438 ' OE1' HG12 ' A' ' 32' ' ' VAL . 5.4 tm-20 -75.58 -93.76 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.249 -1.389 . . . . 3.8199999999999998 107.249 161.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.51 -101.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.249 1.019 . . . . 1.04 110.325 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.92 -23.27 67.39 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 119.248 0.931 . . . . 1.24 113.437 -176.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.438 HG12 ' OE1' ' A' ' 29' ' ' GLU . 9.4 p -74.82 130.26 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.009 1.404 . . . . 1.52 111.311 -175.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -141.89 54.22 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.828 1.299 . . . . 2.2200000000000002 110.807 173.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.82 143.25 17.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.991 -1.485 . . . . 1.6799999999999999 106.991 169.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.428 ' HA ' HG22 ' A' ' 46' ' ' ILE . 84.9 t -133.92 100.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 106.271 -1.752 . . . . 2.3700000000000001 106.271 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -119.1 78.39 1.28 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.212 -1.033 . . . . 2.4700000000000002 108.212 175.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.96 126.98 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 109.306 -0.627 . . . . 1.8600000000000001 109.306 173.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.94 95.79 7.12 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.997 -1.482 . . . . 1.1000000000000001 106.997 167.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.43 -22.82 63.86 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.362 0.265 . . . . 3.21 110.707 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 10.8 tpt -65.3 -46.85 78.72 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.389 1.075 . . . . 4.1200000000000001 110.56 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.62 -30.34 13.33 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.288 1.035 . . . . 1.29 111.061 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.94 66.58 1.27 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 125.016 1.293 . . . . 1.01 111.003 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -142.05 132.69 25.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.244 -1.762 . . . . 3.0800000000000001 106.244 172.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.24 103.4 12.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 124.368 1.043 . . . . 0.94999999999999996 109.697 168.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -106.72 146.7 30.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.002 -1.11 . . . . 3.46 108.002 166.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.543 ' C ' HD12 ' A' ' 46' ' ' ILE . 1.9 pp -139.62 166.62 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 106.647 -1.612 . . . . 2.7200000000000002 106.647 174.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 107.21 15.5 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.138 1.375 . . . . 4.4800000000000004 108.456 171.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.526 ' CD2' HD11 ' A' ' 53' ' ' ILE . 26.1 p90 -104.52 -178.8 3.76 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.245 1.018 . . . . 2.2000000000000002 112.578 171.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.18 104.06 35.44 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.215 1.406 . . . . 3.9199999999999999 109.335 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.98 -5.07 16.13 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.678 2.252 . . . . 2.2799999999999998 112.991 -172.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -75.98 -15.35 60.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.703 0.683 . . . . 3.6899999999999999 111.72 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.5 p -125.68 -41.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 118.772 0.715 . . . . 2.9100000000000001 109.518 -172.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.526 HD11 ' CD2' ' A' ' 48' ' ' TYR . 2.1 pp -113.3 -177.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 121.315 0.579 . . . . 2.48 111.477 170.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -139.45 155.92 71.77 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 104.575 -2.38 . . . . 3.1099999999999999 104.575 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -59.5 -34.2 97.09 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.739 1.626 . . . . 1.73 110.493 -175.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.79 -43.73 77.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.74 -0.648 . . . . 3.9199999999999999 111.549 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -65.7 -43.45 89.17 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.745 1.157 . . . . 2.6899999999999999 110.818 -174.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.0 mt -51.79 -55.78 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.065 -1.457 . . . . 1.8799999999999999 107.065 169.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.06 -43.59 78.08 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.782 -0.644 . . . . 1.8 111.121 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -54.46 -46.82 73.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.28 1.032 . . . . 2.6400000000000001 110.021 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.54 -48.03 72.48 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.837 -0.431 . . . . 3.4399999999999999 109.837 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.531 HD11 HD21 ' A' ' 26' ' ' LEU . 7.8 mm -60.29 -43.28 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 122.228 -0.295 . . . . 2.9900000000000002 111.182 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -64.48 -44.89 89.58 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.007 -0.368 . . . . 2.2599999999999998 110.007 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.13 -43.94 98.1 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.848 0.859 . . . . 4.6699999999999999 109.961 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.93 -47.63 74.18 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 123.922 0.889 . . . . 3.1000000000000001 108.878 173.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.61 34.12 1.12 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.919 0.771 . . . . 1.72 112.02 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -119.31 165.68 13.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.993 1.317 . . . . 2.3300000000000001 109.199 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -99.95 139.02 36.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.318 -0.993 . . . . 2.1800000000000002 108.318 162.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.9 122.89 38.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.736 -1.95 . . . . 0.94999999999999996 105.736 165.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.02 142.88 46.51 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 108.457 -0.942 . . . . 0.97999999999999998 108.457 174.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 71' ' ' VAL . 0.5 OUTLIER -67.62 136.03 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 124.127 0.971 . . . . 2.8500000000000001 109.482 -177.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -55.02 28.44 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.911 0.884 . . . . 4.2699999999999996 109.202 166.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -177.36 -54.89 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.632 1.973 . . . . 5.2300000000000004 108.244 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.89 79.5 0.21 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.588 1.155 . . . . 7.5800000000000001 111.02 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.428 ' CE2' ' ND2' ' A' ' 81' ' ' ASN . 46.3 p90 -63.07 -26.79 69.0 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.031 1.732 . . . . 3.9700000000000002 111.827 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 132.8 84.76 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 128.764 2.825 . . . . 3.6899999999999999 111.733 170.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -98.04 89.65 0.99 Allowed Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.537 -0.839 . . . . 3.29 111.023 -174.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.8 t -158.68 18.24 0.2 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 114.462 1.282 . . . . 5.2599999999999998 114.462 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.89 68.96 0.52 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.205 0.526 . . . . 4.4100000000000001 110.943 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.97 -52.4 4.4 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 107.936 -2.065 . . . . 2.0299999999999998 107.936 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.428 ' ND2' ' CE2' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -92.26 79.95 5.03 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.569 -1.641 . . . . 3.4900000000000002 106.569 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -121.83 148.71 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 118.514 0.597 . . . . 3.1299999999999999 111.123 178.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -99.05 154.86 17.77 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.779 -0.823 . . . . 2.8199999999999998 108.779 174.133 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 147' ' ' LEU . 1.3 mp -133.71 142.1 47.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.88 -1.155 . . . . 2.9199999999999999 107.88 168.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.0 m -96.05 123.96 39.87 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.016 -1.476 . . . . 2.6000000000000001 107.016 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.67 112.22 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 123.51 0.724 . . . . 1.6200000000000001 110.111 -172.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.4 m -101.04 135.48 42.43 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.741 -0.837 . . . . 1.95 108.741 176.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.88 -30.31 8.17 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.775 1.179 . . . . 1.28 112.283 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 131.26 50.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.535 1.134 . . . . 2.8199999999999998 111.009 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.7 m -148.69 46.23 1.02 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.093 0.957 . . . . 3.0 110.254 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.0 t -169.61 139.86 2.1 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 120.987 -1.07 . . . . 2.6499999999999999 110.857 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.38 -44.77 68.9 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.873 0.469 . . . . 2.4700000000000002 110.638 174.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.1 m -52.45 -39.54 61.2 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.758 0.823 . . . . 2.3500000000000001 112.06 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.4 t -63.41 -55.42 24.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.129 -0.693 . . . . 3.1000000000000001 109.129 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.503 HG13 HG13 ' A' ' 113' ' ' VAL . 6.7 t -46.81 -50.34 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.68 -0.691 . . . . 1.3200000000000001 110.653 172.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -47.16 84.77 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.317 -0.623 . . . . 3.0499999999999998 109.317 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -45.92 91.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.789 -0.448 . . . . 3.5800000000000001 109.789 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.5 mt -58.77 -49.72 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -56.37 -50.0 72.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.115 0.966 . . . . 2.4399999999999999 108.539 177.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 66.9 m -60.42 -36.25 77.71 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.845 0.858 . . . . 2.1299999999999999 112.419 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -66.76 -50.36 62.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.55 -0.719 . . . . 2.73 109.773 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.76 -42.32 70.58 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.023 -0.732 . . . . 2.6400000000000001 109.023 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.6 p -55.8 -16.05 3.99 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.374 0.879 . . . . 2.3399999999999999 113.374 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -27.47 69.2 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.104 0.866 . . . . 4.3799999999999999 111.383 172.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.8 m -60.49 150.7 30.48 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.92 1.688 . . . . 1.49 110.385 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -73.65 -54.73 7.45 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.398 0.679 . . . . 2.2599999999999998 112.114 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.17 -32.84 68.98 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 121.387 0.437 . . . . 1.6799999999999999 112.688 -172.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.96 119.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.817 -0.813 . . . . 2.5099999999999998 109.73 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.7 m -102.79 -49.16 3.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.727 0.411 . . . . 2.29 111.018 -174.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.409 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 36.2 p90 -142.04 117.42 10.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.575 -0.726 . . . . 2.5099999999999998 109.46 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.85 155.19 17.17 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 118.865 -1.134 . . . . 1.4399999999999999 110.721 161.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -140.81 114.46 8.86 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.464 -0.569 . . . . 2.6000000000000001 109.464 160.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.503 HG13 HG13 ' A' ' 95' ' ' VAL . 2.7 p -109.66 140.65 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.727 0.694 . . . . 2.0 112.764 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.23 104.61 6.56 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-O 121.972 0.891 . . . . 1.47 111.857 -171.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.771 HD13 ' H ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -65.9 -20.01 66.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.625 1.57 . . . . 2.9700000000000002 114.061 -177.305 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.71 70.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.18 0.445 . . . . 1.46 110.757 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.22 -18.02 10.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.605 1.562 . . . . 1.8400000000000001 111.164 -173.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.4 m 72.43 17.63 4.7 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 126.713 2.005 . . . . 1.45 112.426 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -101.11 135.74 42.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.862 1.265 . . . . 2.98 110.371 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 83' ' ' GLU . . . -114.09 110.9 20.74 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 126.049 1.74 . . . . 1.3999999999999999 109.094 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.82 125.16 35.64 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 105.892 -1.892 . . . . 2.6699999999999999 105.892 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.3 t -130.98 132.1 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.353 1.061 . . . . 2.3100000000000001 109.463 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -119.71 88.12 2.87 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.466 0.706 . . . . 3.3999999999999999 109.65 -174.293 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -108.64 -179.48 3.88 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.558 1.161 . . . . 2.1899999999999999 111.76 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -107.36 112.78 62.51 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 124.25 1.02 . . . . 4.1299999999999999 108.324 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.79 67.41 8.62 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.162 2.575 . . . . 2.3999999999999999 111.115 -171.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -161.52 -46.75 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.03 1.332 . . . . 3.7799999999999998 109.413 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.5 pt -84.24 -31.25 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 123.021 0.528 . . . . 1.9099999999999999 110.722 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.88 161.7 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 124.446 1.099 . . . . 1.5800000000000001 108.156 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.68 162.06 28.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.672 -1.371 . . . . 1.55 109.672 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -57.18 -36.45 99.11 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.655 2.903 . . . . 1.5700000000000001 111.57 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -49.92 -37.18 30.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.467 0.707 . . . . 6.9000000000000004 112.616 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.15 -44.66 71.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.2 0.524 . . . . 3.2999999999999998 109.639 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.53 -45.87 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.27 -1.011 . . . . 1.0900000000000001 108.27 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.4 mt -53.29 -60.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 118.027 -0.987 . . . . 2.0299999999999998 108.685 175.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -46.26 -53.17 11.18 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 120.18 1.355 . . . . 3.9199999999999999 111.012 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 90.0 mt -51.22 -53.12 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.428 0.558 . . . . 2.4300000000000002 110.068 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.252 2.5 pp -71.08 -28.25 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 114.032 1.123 . . . . 1.6499999999999999 114.032 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -61.63 -42.9 99.54 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.158 0.89 . . . . 3.1099999999999999 109.063 170.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -39.81 87.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.891 0.877 . . . . 4.3600000000000003 108.734 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.503 HG21 ' CE2' ' A' ' 143' ' ' PHE . 74.6 mt -71.22 -41.54 75.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 O-C-N 122.348 -0.22 . . . . 1.6399999999999999 110.957 175.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.13 32.65 6.04 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.291 1.424 . . . . 1.54 111.899 -173.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.503 ' CE2' HG21 ' A' ' 141' ' ' ILE . 27.4 m-85 -101.5 -178.77 3.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.325 1.063 . . . . 2.3799999999999999 109.507 165.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -135.89 114.43 11.79 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 105.798 -1.927 . . . . 5.7000000000000002 105.798 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.07 108.4 19.89 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.05 1.74 . . . . 1.3200000000000001 108.73 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 m -104.65 95.29 5.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.115 -1.439 . . . . 2.2400000000000002 107.115 -174.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -62.15 84.68 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.865 1.666 . . . . 5.3600000000000003 111.262 -177.338 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 47.31 52.94 11.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.722 0.809 . . . . 4.7000000000000002 109.965 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 116.406 -1.759 . . . . 7.6699999999999999 108.683 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ttt . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 118.188 -0.91 . . . . 13.41 109.269 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 161.02 -44.42 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 127.268 2.227 . . . . 4.6799999999999997 114.896 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.6 122.87 9.31 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 121.74 1.657 . . . . 4.0099999999999998 108.618 168.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -125.61 154.2 42.62 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.703 1.201 . . . . 3.04 109.335 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -93.61 152.03 19.28 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.315 0.646 . . . . 3.3900000000000001 111.697 177.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 t -140.83 128.05 20.96 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.552 1.141 . . . . 2.1699999999999999 110.282 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -105.63 101.16 10.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.434 1.893 . . . . 3.9399999999999999 110.864 -176.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.638 HD22 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -124.99 173.38 8.71 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.223 0.92 . . . . 2.6899999999999999 111.17 175.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.546 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 3.8 pm0 -124.8 149.03 47.82 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 121.31 -0.869 . . . . 3.1499999999999999 109.163 165.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -96.11 124.82 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.88 -1.526 . . . . 0.88 106.88 177.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -100.47 111.91 24.21 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.707 -1.96 . . . . 3.25 105.707 173.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.65 -78.0 0.16 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.178 0.894 . . . . 1.25 111.306 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.0 mtm 42.24 79.99 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.477 1.911 . . . . 2.73 114.205 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.7 m -53.14 -55.74 21.78 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.492 -0.755 . . . . 2.1299999999999999 112.232 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t -164.09 56.55 0.16 Allowed 'General case' 0 C--N 1.344 0.343 0 C-N-CA 119.527 -0.869 . . . . 3.04 111.904 -174.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 40.23 44.99 1.68 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.464 1.506 . . . . 5.9900000000000002 112.832 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.4 t -171.91 -43.03 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.413 0.685 . . . . 3.3900000000000001 109.682 -166.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.96 -43.06 99.82 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.998 -1.064 . . . . 1.6899999999999999 110.393 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -51.55 -39.69 23.57 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 O-C-N 122.053 -0.404 . . . . 1.9199999999999999 110.203 170.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 t -60.58 -33.46 72.74 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.359 0.412 . . . . 2.4199999999999999 110.737 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.19 -54.95 10.65 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.037 -1.039 . . . . 2.48 109.895 170.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mp -44.33 -56.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 122.893 0.477 . . . . 2.3399999999999999 110.919 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.61 -35.42 72.42 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.184 -0.947 . . . . 4.5899999999999999 112.594 -176.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -67.48 -34.58 77.45 Favored 'General case' 0 N--CA 1.458 -0.035 0 O-C-N 121.082 -1.012 . . . . 7.1299999999999999 109.779 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -65.41 -48.06 74.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.929 -0.767 . . . . 1.78 108.929 173.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.32 -36.6 68.9 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.704 0.684 . . . . 3.4500000000000002 112.144 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.85 -22.96 6.07 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.822 0.675 . . . . 1.7 112.822 174.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -110.45 21.1 17.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.103 0.961 . . . . 3.52 112.059 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -72.98 -64.82 0.89 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.229 0.612 . . . . 3.5099999999999998 109.705 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.35 -123.9 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.439 1.096 . . . . 1.52 108.064 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.84 -0.23 54.37 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 119.039 0.836 . . . . 1.54 114.594 -173.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -82.11 102.79 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.055 1.427 . . . . 1.6599999999999999 109.275 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -120.56 52.35 1.17 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 122.145 0.974 . . . . 2.4100000000000001 110.688 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.1 m -159.81 143.86 14.6 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.494 -1.298 . . . . 2.9100000000000001 107.494 172.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.88 116.69 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 105.663 -1.977 . . . . 2.4700000000000002 105.663 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pp -139.02 90.39 2.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 119.591 -0.844 . . . . 4.6600000000000001 111.381 166.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -99.5 163.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.426 -0.796 . . . . 2.6699999999999999 109.951 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.58 101.73 6.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.568 -1.271 . . . . 1.3300000000000001 107.568 167.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.75 -17.59 64.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.958 0.903 . . . . 3.3199999999999998 111.325 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 49.4 mtm -68.58 -55.52 11.32 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.87 0.868 . . . . 4.3700000000000001 109.941 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.71 -26.88 24.03 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.047 0.539 . . . . 1.46 111.494 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.88 65.86 1.67 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.313 -1.115 . . . . 1.1200000000000001 110.313 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -141.01 140.9 34.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.909 -1.515 . . . . 3.1099999999999999 106.909 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.638 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -116.74 110.19 18.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.677 1.191 . . . . 0.95999999999999996 110.236 170.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.32 134.06 42.73 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.572 -1.64 . . . . 4.5199999999999996 106.572 168.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.4 HD12 HD21 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -136.51 168.69 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.217 0.917 . . . . 1.77 111.117 167.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.67 109.85 19.26 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 123.911 0.885 . . . . 3.96 110.228 163.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.45 ' HB2' HD12 ' A' ' 53' ' ' ILE . 2.6 p90 -98.63 -176.75 3.46 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 127.96 2.504 . . . . 2.6000000000000001 111.022 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -138.06 108.67 8.25 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.861 1.264 . . . . 3.8100000000000001 109.443 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.59 8.47 1.23 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 124.497 3.465 . . . . 2.4100000000000001 113.997 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -95.82 -13.92 23.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.276 1.398 . . . . 4.0 111.688 167.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.2 m -130.23 -42.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 118.929 0.786 . . . . 2.7799999999999998 112.853 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.45 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -115.21 137.42 48.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 N-CA-C 107.21 -1.404 . . . . 1.8100000000000001 107.21 177.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.5 mm100 -119.67 149.91 49.17 Favored Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 108.219 -1.03 . . . . 3.6299999999999999 108.219 -175.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -61.04 -35.78 85.48 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.449 2.099 . . . . 1.53 111.308 -173.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -58.21 -45.42 87.65 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.839 -0.538 . . . . 3.52 111.439 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -58.48 -44.76 89.47 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.657 0.783 . . . . 3.6200000000000001 110.008 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.28 -56.41 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.04 -1.837 . . . . 1.3 106.04 172.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.51 -44.81 95.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.916 -0.584 . . . . 1.1499999999999999 111.142 -170.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -55.96 -44.27 78.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.747 0.819 . . . . 2.8500000000000001 110.283 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.56 -42.99 95.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.399 -0.593 . . . . 3.1899999999999999 109.399 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mm -60.18 -43.34 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.859 -0.526 . . . . 2.5 110.141 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -63.42 -42.41 98.72 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.549 0.739 . . . . 2.9199999999999999 111.683 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.98 -50.66 72.88 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.582 0.628 . . . . 2.6099999999999999 109.741 175.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.65 -34.65 67.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.515 0.726 . . . . 1.8400000000000001 111.62 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.93 37.63 1.24 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.161 0.886 . . . . 1.3400000000000001 111.093 166.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -133.15 169.46 16.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.773 1.629 . . . . 2.1600000000000001 107.002 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -113.3 129.32 56.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.315 -0.624 . . . . 2.4399999999999999 109.315 169.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.06 120.44 38.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.551 -1.648 . . . . 0.79000000000000004 106.551 168.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.546 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -131.03 133.88 46.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.074 -1.454 . . . . 0.89000000000000001 107.074 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.15 154.36 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.508 -0.923 . . . . 2.4900000000000002 108.508 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -5.33 39.01 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.97 -1.014 . . . . 4.7000000000000002 111.892 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 94.16 7.75 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 129.282 3.033 . . . . 4.2999999999999998 111.302 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -76.15 0.46 Allowed 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 125.93 1.692 . . . . 7.1500000000000004 107.946 168.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.11 -44.73 0.05 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 115.325 1.602 . . . . 5.5700000000000003 115.325 -160.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.29 100.83 12.55 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.387 1.475 . . . . 4.9500000000000002 113.9 -157.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.45 63.46 0.21 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.777 -0.929 . . . . 3.3599999999999999 110.777 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.81 -67.29 0.27 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.943 -0.551 . . . . 4.7000000000000002 112.076 -175.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -173.88 120.51 0.29 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.546 -1.279 . . . . 4.9699999999999998 107.546 -168.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.99 -55.0 4.9 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 108.345 -1.902 . . . . 2.1600000000000001 108.345 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.4 104.18 14.25 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.196 -1.409 . . . . 2.7599999999999998 107.196 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.02 170.4 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.152 -1.425 . . . . 2.8999999999999999 107.152 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.33 151.06 46.09 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.497 0.719 . . . . 2.6899999999999999 111.948 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.2 mt -136.94 146.16 45.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.901 1.28 . . . . 2.0099999999999998 107.674 -172.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.04 127.9 55.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.392 -1.336 . . . . 1.9099999999999999 107.392 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.768 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -97.26 117.41 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.37 -1.715 . . . . 1.8 106.37 -171.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.2 p -98.72 141.91 30.93 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.013 -1.106 . . . . 2.5099999999999998 108.013 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.52 -17.68 28.52 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 119.348 -0.695 . . . . 2.0099999999999998 113.257 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -79.92 140.46 36.69 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.199 1.5 . . . . 2.2799999999999998 111.023 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 t -155.37 85.91 1.07 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.216 -1.031 . . . . 4.5 108.216 176.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 77.8 m 59.86 -99.2 0.09 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.017 1.327 . . . . 6.4900000000000002 111.386 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 43.37 -148.49 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.508 1.923 . . . . 5.4100000000000001 110.7 -168.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.9 t -79.76 -6.31 57.01 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.346 -0.613 . . . . 3.6000000000000001 109.346 159.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.4 t -59.76 -49.96 75.67 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.39 -0.818 . . . . 3.3100000000000001 109.817 -167.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.7 p -46.48 -61.19 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.375 1.07 . . . . 2.6400000000000001 111.447 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -65.04 -31.01 72.03 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.369 0.668 . . . . 3.8599999999999999 110.579 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.576 HD21 HD13 ' A' ' 141' ' ' ILE . 3.5 t30 -69.08 -48.95 61.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.225 1.01 . . . . 1.6799999999999999 110.333 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.5 mt -58.95 -47.9 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.216 -1.031 . . . . 0.98999999999999999 108.216 175.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -50.69 -54.35 23.89 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.508 -0.553 . . . . 2.5699999999999998 109.508 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.3 t -52.34 -48.06 65.7 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.471 0.708 . . . . 1.6799999999999999 111.093 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -60.59 -39.05 86.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.216 -0.928 . . . . 2.52 111.201 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 25.5 mt -71.25 -61.65 1.69 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.196 -1.038 . . . . 1.6899999999999999 108.196 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 74.0 p -59.31 -19.21 44.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.323 1.049 . . . . 1.72 112.736 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -57.15 -36.24 70.5 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 119.291 -0.385 . . . . 4.3499999999999996 110.7 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 t -75.33 174.84 9.01 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.649 0.738 . . . . 3.02 111.597 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -85.27 -47.72 9.78 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.11 0.964 . . . . 2.2799999999999998 111.428 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.72 -35.56 80.56 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-O 119.974 -0.348 . . . . 1.1899999999999999 112.916 -170.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.67 119.08 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 117.552 0.676 . . . . 2.8900000000000001 109.339 -172.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.8 m -95.72 -47.13 6.32 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 109.658 -0.497 . . . . 2.3900000000000001 109.658 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -142.55 92.54 2.42 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 112.859 0.688 . . . . 3.4700000000000002 112.859 -176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.42 145.13 24.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.665 -1.235 . . . . 0.89000000000000001 107.665 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 m -141.76 109.31 5.64 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.572 -0.899 . . . . 2.3700000000000001 108.572 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.3 p -99.91 124.73 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.918 1.287 . . . . 2.1699999999999999 109.475 -177.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.32 88.27 2.91 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.309 1.443 . . . . 1.49 109.626 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 pp -66.18 -20.84 66.26 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 125.408 1.483 . . . . 2.25 113.295 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.57 97.56 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.382 0.537 . . . . 1.73 109.965 176.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -19.09 20.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.893 1.277 . . . . 1.8200000000000001 110.41 175.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.5 m 65.83 37.18 5.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.167 1.387 . . . . 1.6399999999999999 110.647 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.96 157.45 37.76 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.43 0.559 . . . . 3.0499999999999998 109.499 171.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.42 131.58 26.43 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.128 0.971 . . . . 1.0700000000000001 109.386 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.92 129.68 45.26 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.942 1.697 . . . . 2.23 107.166 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.15 124.45 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.263 1.425 . . . . 2.3900000000000001 110.49 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.65 94.74 5.15 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 107.57 -1.27 . . . . 4.2599999999999998 107.57 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -111.12 -177.71 3.28 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 124.239 0.962 . . . . 1.96 110.397 174.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.86 116.69 60.4 Favored Pre-proline 0 C--O 1.237 0.429 0 N-CA-C 108.255 -1.017 . . . . 2.8500000000000001 108.255 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -81.32 68.55 8.16 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.893 2.396 . . . . 1.96 111.135 -167.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -165.86 -44.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.748 1.219 . . . . 3.3300000000000001 109.669 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.8 pt -79.72 -38.23 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 123.109 0.564 . . . . 1.8100000000000001 111.136 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.54 158.28 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 123.576 0.75 . . . . 1.6299999999999999 109.118 175.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -124.07 168.76 16.17 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.861 1.22 . . . . 1.7 110.452 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.0 -41.88 6.96 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.718 2.279 . . . . 1.6100000000000001 110.383 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.48 -39.59 57.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.678 0.791 . . . . 6.6200000000000001 112.487 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.95 -49.58 75.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.667 0.787 . . . . 3.9500000000000002 109.332 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.21 -47.28 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.563 -0.903 . . . . 1.3400000000000001 108.563 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 95.2 mt -52.52 -59.25 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.538 -0.912 . . . . 2.0099999999999998 108.538 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -49.05 -48.86 43.66 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 119.159 0.891 . . . . 4.1299999999999999 112.431 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 mm -51.59 -53.51 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.82 -0.437 . . . . 2.46 109.82 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.315 2.0 pp -70.75 -26.99 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 114.385 1.254 . . . . 1.5 114.385 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.36 -43.5 96.47 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 119.359 0.981 . . . . 2.6499999999999999 109.078 169.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -63.97 -38.29 90.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.18 -0.674 . . . . 3.21 109.18 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.576 HD13 HD21 ' A' ' 97' ' ' ASN . 73.2 mt -64.44 -44.84 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 122.227 -0.296 . . . . 1.1499999999999999 110.257 171.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.38 23.85 5.58 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.536 1.541 . . . . 1.25 112.629 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -100.59 178.78 4.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.268 1.534 . . . . 2.8100000000000001 108.802 164.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -136.93 130.39 31.52 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.146 -1.798 . . . . 4.0499999999999998 106.146 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.98 97.24 5.18 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.717 1.607 . . . . 1.3600000000000001 108.073 -171.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.7 p -143.22 134.17 25.52 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.269 -0.641 . . . . 1.8999999999999999 109.269 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -174.31 -94.35 0.0 OUTLIER 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.138 1.375 . . . . 7.6900000000000004 109.12 170.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 37.47 36.38 0.08 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.445 1.898 . . . . 6.04 113.367 -169.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.224 -1.37 . . . . 6.3200000000000003 110.912 -176.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 107.845 -1.169 . . . . 9.5500000000000007 107.845 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.03 123.03 87.97 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.824 0.738 . . . . 4.4199999999999999 109.376 -174.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.11 107.37 2.47 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.84 1.694 . . . . 2.79 111.025 -172.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -125.92 146.24 49.93 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.762 1.625 . . . . 2.8199999999999998 106.733 176.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -104.37 154.48 19.78 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.704 0.802 . . . . 4.4199999999999999 110.812 179.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 54.1 t -143.19 140.72 30.87 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.42 0.688 . . . . 2.1800000000000002 110.939 170.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -109.57 92.3 3.99 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.076 2.15 . . . . 3.5499999999999998 109.698 -173.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.521 HD12 ' HB3' ' A' ' 44' ' ' ALA 0.262 1.5 pp -119.07 164.58 15.3 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.068 0.937 . . . . 2.71 112.195 176.45 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.15 154.72 18.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.487 -1.301 . . . . 2.4500000000000002 107.487 166.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.407 HG12 ' HB2' ' A' ' 44' ' ' ALA . 14.4 mm -97.78 145.45 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 106.628 -1.619 . . . . 0.83999999999999997 106.628 160.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -123.77 123.13 39.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.039 -1.837 . . . . 3.3700000000000001 106.039 158.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.04 -81.38 0.19 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 108.792 -1.723 . . . . 1.29 108.792 -172.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 28.43 73.15 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.064 2.146 . . . . 2.3300000000000001 115.335 178.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -16.63 2.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.214 1.406 . . . . 2.3199999999999998 113.781 174.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.8 t 78.25 -48.67 0.47 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.745 1.618 . . . . 3.9500000000000002 112.433 173.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.25 -70.29 0.11 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.448 1.499 . . . . 4.8600000000000003 111.776 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 p -159.96 15.13 0.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.13 0.572 . . . . 2.4900000000000002 112.43 172.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.7 m -70.69 -48.3 55.41 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.573 -0.705 . . . . 2.2999999999999998 109.385 -168.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.0 t -47.96 -51.69 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.365 -0.976 . . . . 2.0699999999999998 108.365 172.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -59.22 -34.29 72.0 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.906 1.282 . . . . 1.8300000000000001 113.675 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -45.52 58.77 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.233 -0.292 . . . . 3.0099999999999998 110.321 172.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.6 mt -56.23 -47.34 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.895 0.878 . . . . 1.6100000000000001 109.213 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -47.63 -53.45 14.76 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.391 0.676 . . . . 4.4800000000000004 110.837 175.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.0 mtt85 -67.9 -30.21 69.5 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.629 0.771 . . . . 5.7999999999999998 112.378 -175.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -69.07 -55.77 9.76 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.75 -0.833 . . . . 1.3600000000000001 108.75 175.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -61.06 -36.07 78.63 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.067 0.547 . . . . 3.6000000000000001 110.792 -176.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.539 HE22 HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -51.78 -24.61 6.2 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.896 0.702 . . . . 3.3300000000000001 112.896 171.563 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -119.55 30.22 7.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.748 0.819 . . . . 4.0599999999999996 111.537 178.45 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -77.8 -89.27 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 105.686 -1.968 . . . . 3.2999999999999998 105.686 163.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.54 -91.24 0.06 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.489 0.716 . . . . 1.1200000000000001 111.044 177.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.27 -15.75 68.44 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-O 119.287 -0.729 . . . . 1.8100000000000001 112.593 -171.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.45 109.71 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 CA-C-N 118.102 0.951 . . . . 2.1699999999999999 109.168 177.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.3 mt -138.59 50.59 1.86 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.89 -0.782 . . . . 3.73 108.89 177.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 t -159.86 152.68 21.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.217 -1.771 . . . . 2.1800000000000002 106.217 159.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.539 HG13 HE22 ' A' ' 27' ' ' GLN . 0.0 OUTLIER -142.17 102.07 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.122 -1.807 . . . . 2.21 106.122 -178.711 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -127.24 74.2 1.49 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.419 -1.697 . . . . 2.9100000000000001 106.419 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.13 123.66 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.427 -0.953 . . . . 2.2599999999999998 108.427 174.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.75 92.65 6.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.692 -1.966 . . . . 1.4099999999999999 105.692 169.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 tp -54.71 -30.04 54.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.24 1.416 . . . . 3.4399999999999999 110.192 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 31.7 mtt -66.51 -54.32 25.24 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.418 0.687 . . . . 3.29 110.421 -178.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.11 -23.59 28.4 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.151 0.58 . . . . 1.4299999999999999 111.484 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.54 63.78 2.28 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.059 1.314 . . . . 1.2 110.9 -176.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.0 pttm -140.98 140.58 34.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.751 -1.203 . . . . 3.1600000000000001 107.751 170.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.521 ' HB3' HD12 ' A' ' 8' ' ' LEU . . . -116.72 104.44 11.36 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 124.435 1.084 . . . . 0.95999999999999996 112.975 173.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -98.01 125.76 43.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.259 -1.385 . . . . 4.3099999999999996 107.259 172.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.0 mt -126.06 163.29 28.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 107.027 -1.471 . . . . 2.7000000000000002 107.027 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -123.98 105.75 9.84 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.435 -0.95 . . . . 4.1600000000000001 108.435 165.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -117.54 159.8 22.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.397 1.479 . . . . 3.0899999999999999 110.027 172.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -98.95 111.15 60.05 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.931 0.893 . . . . 3.7400000000000002 110.297 -179.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.08 -3.84 7.92 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.076 3.184 . . . . 2.1200000000000001 113.623 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -73.25 -44.99 58.43 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 120.07 1.305 . . . . 4.6399999999999997 110.741 169.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -108.59 -30.22 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 122.175 -0.328 . . . . 2.77 111.427 -165.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.402 HD11 ' CG1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -127.51 131.96 69.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 108.655 -0.868 . . . . 1.77 108.655 177.34 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.02 150.7 39.05 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.605 1.562 . . . . 2.6699999999999999 109.773 -177.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -51.94 -52.58 8.65 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.37 2.713 . . . . 1.3600000000000001 112.247 179.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -60.4 -43.76 96.35 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.419 -0.8 . . . . 3.0899999999999999 111.265 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -57.77 -37.62 73.99 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.944 0.498 . . . . 3.9399999999999999 111.101 174.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.402 ' CG1' HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -55.31 -50.11 67.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 107.568 -1.271 . . . . 1.1799999999999999 107.568 171.175 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.84 -43.87 77.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.988 -0.551 . . . . 1.4199999999999999 110.203 -175.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -53.12 -46.84 68.94 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.305 0.502 . . . . 2.7400000000000002 110.75 175.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -48.79 79.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.002 0.43 . . . . 2.52 110.371 177.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -64.53 -44.04 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 121.961 -0.462 . . . . 2.6000000000000001 111.012 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -42.69 98.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.448 1.099 . . . . 2.4700000000000002 110.247 176.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.77 -49.15 77.55 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.39 0.541 . . . . 2.6000000000000001 109.974 177.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 mt -56.24 -37.03 69.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.399 0.279 . . . . 1.95 111.583 174.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.94 26.51 2.75 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.239 0.923 . . . . 1.3500000000000001 112.242 167.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -118.5 167.72 11.33 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.35 1.46 . . . . 2.0299999999999998 107.96 176.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -98.55 143.74 28.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.373 -0.973 . . . . 2.5899999999999999 108.373 163.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.74 135.16 48.13 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.801 0.84 . . . . 1.1399999999999999 108.79 162.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.63 138.72 30.91 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.912 0.885 . . . . 1.26 109.731 171.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 p -87.19 152.84 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 125.613 1.565 . . . . 2.71 109.499 178.245 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.7 mtt -51.26 -53.25 37.29 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 123.371 0.419 . . . . 3.6600000000000001 111.605 178.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -166.77 70.96 0.11 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.512 -0.922 . . . . 4.9800000000000004 108.512 -172.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -21.86 101.16 0.02 OUTLIER 'General case' 0 C--N 1.341 0.203 0 C-N-CA 126.663 1.985 . . . . 10.43 114.704 -162.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.476 ' CZ ' ' HA3' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -136.26 -67.58 0.51 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.611 -1.631 . . . . 6.5800000000000001 107.559 -161.056 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 99.41 -85.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.494 2.317 . . . . 3.7400000000000002 109.853 176.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.476 ' HA3' ' CZ ' ' A' ' 75' ' ' TYR . . . 107.6 69.2 0.68 Allowed Glycine 0 C--N 1.336 0.537 0 N-CA-C 115.885 1.114 . . . . 2.8700000000000001 115.885 163.121 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.88 -73.58 0.16 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 118.953 -1.099 . . . . 4.25 113.616 -173.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -150.4 144.88 25.73 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 103.961 -2.607 . . . . 4.96 103.961 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.83 -32.37 1.47 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.441 1.018 . . . . 2.0299999999999998 112.004 -178.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.504 ' C ' HD13 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -142.01 114.44 8.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.067 -1.457 . . . . 2.3700000000000001 107.067 173.647 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.504 HD13 ' C ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER -128.01 160.85 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.405 -1.331 . . . . 2.8799999999999999 107.405 176.825 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.413 ' HG2' ' CZ ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -113.8 153.83 28.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.23 -1.026 . . . . 3.9700000000000002 108.23 169.51 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 mp -133.01 141.21 48.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.705 0.802 . . . . 2.46 109.027 163.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.4 m -94.74 125.97 39.75 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.356 -1.72 . . . . 2.6099999999999999 106.356 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.8 mt -101.52 123.36 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.241 -0.651 . . . . 3.46 109.241 -174.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.5 m -96.5 124.65 40.56 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.819 -1.178 . . . . 1.77 107.819 172.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 117.22 -34.82 4.41 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.95 1.262 . . . . 1.3400000000000001 112.161 175.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 55.7 ttp -50.44 120.52 4.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.998 0.899 . . . . 2.96 110.98 177.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.4 6.18 1.27 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.526 0.935 . . . . 3.3199999999999998 113.526 -170.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.4 t -156.01 142.21 18.32 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.084 1.311 . . . . 2.7400000000000002 111.243 -178.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.19 64.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.568 1.147 . . . . 3.1299999999999999 112.271 -175.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.24 -49.5 66.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.124 0.97 . . . . 3.1899999999999999 110.739 171.33 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 88.4 m -64.17 -46.56 83.48 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.011 -0.737 . . . . 1.8700000000000001 109.011 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.519 HG13 HG13 ' A' ' 113' ' ' VAL . 91.2 t -47.67 -59.0 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.279 1.032 . . . . 1.55 109.778 175.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -57.68 -44.33 85.73 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 122.997 0.519 . . . . 4.5 111.285 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -62.69 -47.66 82.67 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.836 0.455 . . . . 1.8500000000000001 110.627 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.437 HD11 ' CE2' ' A' ' 143' ' ' PHE . 81.2 mt -57.35 -48.75 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.744 -0.836 . . . . 1.1399999999999999 108.744 177.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -59.74 -46.45 89.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.427 -0.582 . . . . 3.1000000000000001 109.427 178.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.6 t -52.0 -46.64 64.99 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.577 0.626 . . . . 1.28 110.811 174.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -60.18 -50.65 72.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.747 -0.596 . . . . 3.4100000000000001 110.89 177.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.7 mt -58.0 -56.81 17.15 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 118.378 0.536 . . . . 2.1699999999999999 109.587 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 33.3 m -50.04 -19.15 0.66 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.144 1.778 . . . . 1.73 112.912 173.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -67.37 -16.46 64.26 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.058 0.845 . . . . 5.2599999999999998 112.251 175.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.0 m -72.38 155.0 40.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.169 1.387 . . . . 1.75 110.838 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -74.47 -52.82 10.91 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.962 0.905 . . . . 2.6499999999999999 111.7 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.36 -37.75 80.13 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.786 -0.525 . . . . 1.45 111.786 -172.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.51 136.94 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.706 -0.85 . . . . 1.76 108.706 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.8 m -137.22 -12.92 1.61 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.482 -0.761 . . . . 3.4100000000000001 112.394 171.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -141.91 118.34 10.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.786 -2.301 . . . . 2.3300000000000001 104.786 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.49 161.04 28.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.314 -1.365 . . . . 1.0800000000000001 107.314 166.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.0 m -141.07 111.96 7.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 118.915 -0.564 . . . . 1.8300000000000001 109.505 161.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.519 HG13 HG13 ' A' ' 95' ' ' VAL . 7.4 p -95.71 134.52 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.641 0.776 . . . . 1.8400000000000001 110.542 171.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.65 108.47 5.67 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.53 1.157 . . . . 1.3700000000000001 110.967 -171.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.71 -41.18 98.13 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.544 1.937 . . . . 4.3300000000000001 112.081 -173.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.22 62.45 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.277 0.631 . . . . 2.3100000000000001 111.094 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.88 -15.81 15.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.455 1.902 . . . . 2.4399999999999999 110.199 -177.252 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.1 t 71.56 20.27 4.83 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.517 2.327 . . . . 1.8400000000000001 112.145 168.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -131.55 172.82 11.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.271 0.558 . . . . 2.6400000000000001 110.741 177.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . . . -129.06 134.35 48.07 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.739 1.216 . . . . 1.1699999999999999 109.377 170.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.39 123.35 35.65 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 104.484 -2.413 . . . . 1.8700000000000001 104.484 172.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.4 t -124.14 129.39 74.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.372 -1.344 . . . . 1.78 107.372 -176.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.12 88.15 2.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.7 -1.222 . . . . 3.4700000000000002 107.7 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -113.04 164.71 13.13 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.055 0.942 . . . . 2.0299999999999998 111.311 174.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -99.04 116.63 65.11 Favored Pre-proline 0 C--O 1.237 0.423 0 C-N-CA 123.932 0.893 . . . . 3.0099999999999998 109.344 177.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -78.22 68.22 7.97 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.236 2.624 . . . . 2.1099999999999999 111.546 -173.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.54 -47.34 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.245 1.018 . . . . 3.2200000000000002 109.348 173.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -81.59 -30.88 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 122.922 0.489 . . . . 1.76 110.924 -177.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -135.25 163.39 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.91 -0.774 . . . . 1.8 108.91 176.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.49 163.54 28.18 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.488 -1.445 . . . . 1.99 109.488 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.45 -35.67 81.54 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.857 3.038 . . . . 2.3799999999999999 112.565 -170.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -40.62 75.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.92 -0.488 . . . . 7.7800000000000002 111.316 -175.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.92 -38.99 72.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 119.148 -1.021 . . . . 3.8500000000000001 109.969 -177.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 83.4 mt -56.65 -48.68 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.674 -0.862 . . . . 1.6699999999999999 108.674 173.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.9 mt -50.51 -60.33 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 118.111 -0.947 . . . . 2.8199999999999998 108.671 173.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -51.47 -44.71 62.51 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.959 1.254 . . . . 4.5199999999999996 112.469 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.4 mm -56.05 -54.39 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.449 -0.782 . . . . 2.3799999999999999 109.491 176.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.256 2.5 pp -68.18 -25.53 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 120.861 -1.149 . . . . 1.78 113.392 -178.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.34 -39.52 87.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.954 0.797 . . . . 3.5099999999999998 109.932 168.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.77 -40.59 97.76 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.994 -0.743 . . . . 3.8100000000000001 108.994 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.8 mt -66.41 -43.09 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 110.02 -0.363 . . . . 1.0800000000000001 110.02 173.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.01 33.42 4.96 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.647 1.594 . . . . 0.90000000000000002 111.536 -175.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 98' ' ' ILE . 51.2 m-85 -103.81 177.3 4.88 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.403 1.102 . . . . 2.4199999999999999 109.264 166.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -129.79 121.98 27.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.176 -1.787 . . . . 4.04 106.176 172.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.84 113.27 26.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.574 1.15 . . . . 1.46 108.691 179.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.1 m -110.66 98.61 7.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.758 1.623 . . . . 1.9299999999999999 107.991 -173.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.59 98.71 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.186 1.794 . . . . 5.4000000000000004 111.003 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 48.53 45.19 21.12 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.74 0.816 . . . . 4.9800000000000004 111.289 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 . . . . . 0 C--O 1.248 1.006 0 N-CA-C 106.537 -1.653 . . . . 9.8499999999999996 106.537 -175.587 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 mtm . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 107.081 -1.451 . . . . 10.73 107.081 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.52 71.04 25.85 Favored Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 124.349 1.031 . . . . 6.6600000000000001 109.508 -178.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.35 149.37 75.26 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.449 1.432 . . . . 5.6500000000000004 108.998 174.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -98.96 175.59 5.88 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.916 1.286 . . . . 4.8300000000000001 107.544 176.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -96.79 142.66 28.53 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.697 0.681 . . . . 4.3200000000000003 111.572 -172.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.0 t -141.1 126.53 18.74 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.077 0.551 . . . . 2.6699999999999999 111.826 172.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -97.43 101.69 13.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.255 2.222 . . . . 3.7200000000000002 108.187 175.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -119.34 167.35 11.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 122.344 1.069 . . . . 3.0899999999999999 108.616 173.991 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.471 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -140.63 136.86 33.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.641 -0.874 . . . . 1.97 108.641 175.204 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.02 138.06 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 105.34 -2.096 . . . . 1.1499999999999999 105.34 -178.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -106.95 125.17 50.65 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.201 -1.037 . . . . 3.5800000000000001 108.201 170.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.23 -88.23 0.28 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.787 1.66 . . . . 1.5 109.494 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.4 mpt? 66.13 144.32 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.502 1.921 . . . . 2.6800000000000002 112.416 -169.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -109.34 -19.08 13.41 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.495 1.118 . . . . 2.3900000000000001 110.702 172.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.4 t 65.73 -65.23 0.18 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.183 1.793 . . . . 2.96 112.001 -170.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.36 -73.25 0.02 OUTLIER 'General case' 0 C--N 1.342 0.264 0 C-N-CA 128.083 2.553 . . . . 5.8499999999999996 113.413 -175.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.63 13.07 0.09 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.006 0.743 . . . . 3.1600000000000001 113.006 166.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.3 m -74.85 -41.57 59.59 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 120.169 -1.582 . . . . 2.25 110.768 -171.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.87 -31.86 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.878 -0.786 . . . . 2.0099999999999998 108.878 176.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -61.06 -52.13 66.24 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.919 -0.488 . . . . 2.21 110.72 170.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -53.15 -45.76 68.55 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.877 -1.139 . . . . 2.96 110.833 175.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -43.88 -38.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.61 1.164 . . . . 1.6200000000000001 111.613 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -52.24 -58.41 6.7 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.268 0.627 . . . . 4.8399999999999999 111.469 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -67.11 -37.58 84.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.655 -0.498 . . . . 4.3200000000000003 109.655 -176.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -55.68 -56.8 16.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.414 -0.587 . . . . 1.3700000000000001 109.414 178.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 mp -61.18 -42.43 98.56 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.822 0.737 . . . . 2.4100000000000001 110.969 177.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -22.25 18.84 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.781 0.719 . . . . 1.8899999999999999 112.537 178.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -113.01 16.53 19.32 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.414 0.894 . . . . 3.1499999999999999 113.414 175.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.41 -69.5 0.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.265 -1.013 . . . . 2.8199999999999998 108.265 165.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -170.13 -134.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.163 1.385 . . . . 2.2200000000000002 107.951 -176.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.11 35.69 1.28 Allowed Glycine 0 CA--C 1.538 1.499 0 CA-C-N 120.255 1.389 . . . . 2.6000000000000001 114.847 -172.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.89 77.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 125.306 1.443 . . . . 2.77 109.454 175.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.47 51.55 0.77 Allowed 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 108.602 -0.888 . . . . 3.4100000000000001 108.602 -172.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -163.79 126.02 2.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.607 -1.257 . . . . 1.8300000000000001 107.607 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.1 t -128.48 114.52 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.998 -1.482 . . . . 2.8100000000000001 106.998 176.255 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -123.68 79.57 1.71 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.612 -1.255 . . . . 3.6499999999999999 107.612 174.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 t -97.76 128.26 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 109.054 -0.721 . . . . 2.46 109.054 173.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.31 86.81 3.99 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.333 -1.358 . . . . 2.21 107.333 176.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.8 mt -57.25 -5.38 0.29 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.958 1.096 . . . . 3.1000000000000001 113.958 176.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 28.5 mtp -97.66 -42.51 7.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.268 1.427 . . . . 3.9900000000000002 110.468 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.3 -38.12 12.25 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.644 0.778 . . . . 2.3900000000000001 110.879 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.89 60.14 1.04 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 126.216 1.865 . . . . 1.8200000000000001 111.649 173.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -138.19 137.47 37.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 105.412 -2.07 . . . . 3.5800000000000001 105.412 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.5 92.94 4.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.185 0.928 . . . . 1.4099999999999999 110.119 169.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.04 111.63 23.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.112 -2.551 . . . . 6.1900000000000004 104.112 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 pt -117.38 174.94 3.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 O-C-N 120.325 -1.484 . . . . 2.5099999999999998 108.414 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -131.12 108.61 9.87 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.924 -0.399 . . . . 5.5099999999999998 109.924 170.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -117.32 164.78 14.32 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.618 1.567 . . . . 3.0899999999999999 113.288 174.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -99.0 106.12 36.0 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.646 1.978 . . . . 3.8799999999999999 109.978 177.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.05 9.66 0.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.354 2.703 . . . . 3.6099999999999999 113.701 -171.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -97.85 -21.32 16.98 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.535 0.734 . . . . 5.0999999999999996 111.038 173.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.9 t -111.01 -62.45 2.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 N-CA-C 108.34 -0.985 . . . . 3.8599999999999999 108.34 -175.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.498 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -98.96 144.42 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 N-CA-C 109.115 -0.698 . . . . 2.5800000000000001 109.115 176.541 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -113.49 151.78 44.77 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 125.008 1.323 . . . . 3.6600000000000001 108.328 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.26 -39.38 85.21 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.716 2.277 . . . . 2.1099999999999999 111.314 -175.136 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.574 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -72.01 -38.4 69.61 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.461 -0.774 . . . . 3.1600000000000001 112.505 -178.431 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -57.3 -43.65 83.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.998 -0.741 . . . . 3.2599999999999998 108.998 172.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.498 HD12 HD11 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -53.2 -47.56 55.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 108.51 -0.922 . . . . 1.4399999999999999 108.51 168.808 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.49 -38.69 78.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 119.898 -0.721 . . . . 1.1899999999999999 110.266 -171.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -52.65 -50.85 62.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.047 0.939 . . . . 2.8300000000000001 109.971 177.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -48.15 70.54 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.501 -0.555 . . . . 2.4100000000000001 109.501 177.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.5 mm -62.77 -39.85 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 122.164 -0.335 . . . . 2.4300000000000002 111.08 -178.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -67.38 -42.92 82.59 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.813 -0.439 . . . . 1.8400000000000001 109.813 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -60.58 -49.9 75.67 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.029 0.532 . . . . 2.3199999999999998 109.878 176.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.61 -36.42 69.42 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.02 0.528 . . . . 2.0699999999999998 111.032 175.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.24 41.67 0.95 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.127 -0.789 . . . . 1.3400000000000001 111.127 165.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -132.59 162.88 30.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.277 1.031 . . . . 3.0 109.168 -174.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -93.17 124.11 36.91 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 106.914 -1.513 . . . . 2.6899999999999999 106.914 171.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.38 124.63 43.16 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.853 -1.165 . . . . 1.3 107.853 167.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -137.66 113.46 9.71 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.789 -0.819 . . . . 1.1200000000000001 108.789 172.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 4.5 t -72.83 158.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.836 0.855 . . . . 2.6499999999999999 110.171 -178.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.4 mtt -77.53 -4.75 47.24 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.296 0.85 . . . . 4.2199999999999998 113.296 174.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 81.67 18.56 0.4 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.594 1.957 . . . . 5.1200000000000001 111.732 -177.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -83.13 -37.09 24.22 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.266 -0.896 . . . . 7.46 108.71 165.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.497 ' CE1' ' ND2' ' A' ' 81' ' ' ASN 0.336 14.9 p90 54.69 -63.69 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 129.958 3.303 . . . . 4.21 113.958 -179.489 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 148.99 82.56 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 129.023 2.929 . . . . 4.1399999999999997 111.517 175.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.93 104.96 3.18 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 110.172 -1.171 . . . . 3.1400000000000001 110.172 -175.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.71 -47.62 0.09 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.535 0.569 . . . . 4.2000000000000002 112.535 -170.235 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -134.55 109.18 8.52 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.029 -1.471 . . . . 4.4800000000000004 107.029 -165.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.81 -51.17 4.52 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 109.592 -1.403 . . . . 2.6000000000000001 109.592 176.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.497 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 21.4 t-20 -115.21 122.92 47.51 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.682 -2.34 . . . . 2.8900000000000001 104.682 175.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.71 158.9 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.553 -1.277 . . . . 3.4199999999999999 107.553 168.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.7 157.32 39.36 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 123.333 0.653 . . . . 3.3300000000000001 109.471 171.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 pp -147.31 161.6 40.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.585 -0.734 . . . . 2.5499999999999998 110.333 172.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.9 126.3 44.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.15 -1.426 . . . . 2.0499999999999998 107.15 173.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.65 127.08 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.57 -0.9 . . . . 1.8100000000000001 108.57 176.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.6 m -118.02 112.08 19.79 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.034 -1.099 . . . . 1.8999999999999999 108.034 176.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.96 -25.76 1.15 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.656 1.122 . . . . 1.5600000000000001 111.386 -172.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.9 tpp -61.25 120.72 10.92 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 121.978 -0.719 . . . . 2.8300000000000001 111.389 -174.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.7 t -130.49 4.92 4.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.29 0.636 . . . . 2.4399999999999999 111.463 176.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.27 153.12 6.41 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 120.654 -1.278 . . . . 3.5 111.682 177.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.89 -32.62 66.06 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.319 0.647 . . . . 3.1099999999999999 111.148 173.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.9 t -51.99 -43.95 63.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.949 0.5 . . . . 2.21 110.525 171.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.5 m -63.91 -53.51 49.22 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 108.41 -0.959 . . . . 1.8899999999999999 108.41 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 82.1 t -43.39 -54.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.194 0.998 . . . . 1.3799999999999999 110.71 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -59.05 -40.0 83.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.685 -0.234 . . . . 4.25 110.958 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -66.89 -46.34 75.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.874 -0.516 . . . . 1.6200000000000001 110.579 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.6 mm -55.65 -50.46 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.616 -0.883 . . . . 1.6200000000000001 108.616 176.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -59.75 -45.54 91.91 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 118.842 -0.599 . . . . 2.1099999999999999 110.057 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.3 m -55.44 -39.87 70.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.826 0.739 . . . . 2.71 111.622 175.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.44 -39.27 81.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.016 -0.428 . . . . 2.98 111.193 175.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.92 -58.25 5.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.338 -0.986 . . . . 1.7 108.338 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.9 p -57.27 -15.39 5.96 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.597 1.159 . . . . 2.0899999999999999 113.13 176.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -35.66 64.26 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.517 -0.739 . . . . 5.5 111.583 167.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.8 m -66.85 144.77 56.08 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.632 1.573 . . . . 1.77 111.1 -175.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -68.17 -47.3 68.35 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.011 0.925 . . . . 2.6899999999999999 111.432 177.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.27 -21.75 74.92 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.62 -0.544 . . . . 1.8899999999999999 113.139 -168.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.2 156.77 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.596 -0.89 . . . . 2.29 108.596 177.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.9 m -140.0 -39.8 0.45 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.39 -0.819 . . . . 3.3999999999999999 112.348 168.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.39 95.02 4.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.94 -1.504 . . . . 2.5899999999999999 106.94 -168.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -96.51 155.32 16.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.984 -1.117 . . . . 0.98999999999999999 107.984 168.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.3 m -140.22 111.27 7.01 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.005 -0.434 . . . . 1.8500000000000001 110.276 159.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.19 133.38 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.749 1.219 . . . . 2.0099999999999998 110.657 -178.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.92 104.92 5.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.594 1.158 . . . . 1.4399999999999999 110.803 -171.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 pp -70.53 -21.6 62.71 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 124.204 1.002 . . . . 2.75 112.649 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.41 91.39 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.398 -0.593 . . . . 1.9399999999999999 109.398 -179.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.07 -34.48 16.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.941 0.897 . . . . 2.3399999999999999 110.049 170.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.96 45.51 0.15 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.312 -0.996 . . . . 2.3599999999999999 108.312 -168.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.06 167.72 20.43 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.852 -0.613 . . . . 4.0700000000000003 111.592 165.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.5 141.83 46.85 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.624 1.169 . . . . 1.1299999999999999 108.695 171.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.448 HD12 ' CE2' ' A' ' 75' ' ' TYR . 2.2 mm? -98.53 137.92 36.49 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.127 -1.805 . . . . 2.02 106.127 168.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.16 129.89 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.484 -0.932 . . . . 2.9500000000000002 108.484 -179.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.83 105.57 13.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.079 -1.082 . . . . 3.4300000000000002 108.079 -176.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -137.04 168.75 18.99 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.172 0.92 . . . . 2.48 111.714 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -97.29 115.79 65.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.681 -0.488 . . . . 3.79 109.681 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -82.36 55.06 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.343 2.696 . . . . 2.4900000000000002 112.552 -166.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -143.76 -51.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.489 1.516 . . . . 3.1600000000000001 108.012 172.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pt -77.38 -31.75 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 122.438 -0.163 . . . . 2.5099999999999998 110.987 -176.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.88 163.54 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.985 -0.746 . . . . 2.1000000000000001 108.985 -178.03 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.75 164.73 31.82 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.256 -1.137 . . . . 2.0499999999999998 110.256 -176.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -61.55 -38.5 62.07 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.575 2.85 . . . . 2.04 111.817 -168.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -31.83 62.95 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 113.086 0.772 . . . . 7.1399999999999997 113.086 -176.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.87 -40.63 65.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 118.498 -1.281 . . . . 3.3100000000000001 110.231 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.3 -48.14 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.543 -0.91 . . . . 1.46 108.543 171.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.18 -60.99 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 108.799 -0.815 . . . . 2.2599999999999998 108.799 174.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.98 -50.23 19.45 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.14 0.882 . . . . 4.3600000000000003 113.147 178.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.8 -53.57 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 121.933 -0.479 . . . . 2.1299999999999999 109.858 177.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.268 2.5 pp -68.16 -29.24 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.287 -0.883 . . . . 1.54 113.278 -177.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.71 -41.98 78.35 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.158 0.89 . . . . 4.0 109.54 169.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -61.45 -40.26 93.85 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.41 0.684 . . . . 3.7599999999999998 109.295 -179.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.9 mt -68.91 -38.95 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 122.865 0.466 . . . . 1.0800000000000001 110.153 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.16 33.49 6.55 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.975 1.274 . . . . 1.0700000000000001 110.771 -171.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -99.48 175.03 5.98 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 107.914 -1.143 . . . . 3.3700000000000001 107.914 167.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -135.25 121.7 20.53 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.01 -1.478 . . . . 3.8900000000000001 107.01 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.03 100.89 10.18 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.613 1.165 . . . . 1.5 109.56 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.6 m -99.13 104.12 16.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.394 -0.965 . . . . 1.96 108.394 174.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 mt -48.03 107.74 0.14 Allowed 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 125.323 1.449 . . . . 6.1799999999999997 108.346 171.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -84.4 -31.23 24.79 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.606 -0.887 . . . . 4.4699999999999998 108.606 175.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 127.563 2.345 . . . . 8.8399999999999999 112.678 165.462 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 117.63 -1.176 . . . . 9.4900000000000002 107.829 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.23 99.56 40.23 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 124.162 0.985 . . . . 5.0599999999999996 109.07 -171.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.64 143.83 30.88 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.571 2.847 . . . . 3.73 110.232 -175.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -133.68 154.44 50.93 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.75 0.42 . . . . 3.54 110.734 -171.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -123.84 147.09 47.91 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 124.604 1.161 . . . . 4.8200000000000003 110.292 -179.037 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.17 137.15 51.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.693 -1.225 . . . . 2.4399999999999999 107.693 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -121.64 96.08 4.93 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.786 -1.19 . . . . 4.2800000000000002 107.786 -172.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.2 177.4 4.74 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.711 0.767 . . . . 3.0600000000000001 111.095 -176.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.18 149.42 49.98 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.693 1.597 . . . . 1.5700000000000001 107.19 166.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mm -103.11 126.35 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 106.859 -1.534 . . . . 1.1000000000000001 106.859 175.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -107.24 138.11 44.04 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.158 -1.053 . . . . 3.0499999999999998 108.158 160.328 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 144.84 -88.32 0.17 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.342 1.449 . . . . 1.0700000000000001 109.685 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt 55.86 73.89 0.41 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.263 1.425 . . . . 1.6799999999999999 113.554 171.125 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m -50.12 -59.95 3.42 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.072 0.768 . . . . 2.3100000000000001 113.072 -178.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 t -170.01 63.08 0.05 OUTLIER 'General case' 0 C--N 1.343 0.323 0 CA-C-N 118.522 0.601 . . . . 3.5299999999999998 110.119 -175.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 41.89 47.97 3.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.887 1.275 . . . . 4.9199999999999999 112.898 176.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.01 -40.1 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.451 0.7 . . . . 2.3100000000000001 110.905 -174.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -67.63 -42.59 82.05 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.029 -1.044 . . . . 1.78 109.733 -177.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.38 -32.59 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 O-C-N 121.219 -0.925 . . . . 1.7 109.955 170.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -62.69 -25.8 68.34 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.597 -1.314 . . . . 1.73 112.133 173.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.95 -36.85 70.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.2 -0.937 . . . . 2.7799999999999998 110.42 173.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.407 HG12 HD13 ' A' ' 65' ' ' LEU . 19.9 mt -49.51 -42.76 17.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-O 118.91 -0.567 . . . . 2.4199999999999999 110.496 174.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -46.2 -58.41 3.68 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.377 0.535 . . . . 5.8799999999999999 111.519 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -66.83 -39.93 87.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.981 0.512 . . . . 4.4699999999999998 110.053 -173.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -58.42 -58.24 9.41 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.777 -0.647 . . . . 1.1899999999999999 109.289 178.215 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.77 -39.67 92.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 119.176 -0.44 . . . . 2.5699999999999998 111.058 -177.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.67 -34.71 3.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.67 0.788 . . . . 2.1299999999999999 111.604 172.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -121.7 29.58 7.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.296 0.639 . . . . 3.2200000000000002 111.914 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -72.87 -69.1 0.43 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.888 -0.782 . . . . 3.7999999999999998 108.888 170.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.78 -143.37 0.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.014 0.926 . . . . 1.02 108.805 -167.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.9 -15.07 40.7 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 119.144 0.884 . . . . 1.55 114.039 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.3 79.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.567 1.147 . . . . 1.52 112.351 -177.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.86 52.52 1.68 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.225 1.012 . . . . 2.5800000000000001 109.34 -178.344 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.1 m -160.48 145.05 14.3 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.305 -0.872 . . . . 2.7799999999999998 109.099 172.422 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.9 t -140.87 112.41 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.046 -2.205 . . . . 2.79 105.046 171.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -131.57 79.83 1.9 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.496 0.665 . . . . 3.1899999999999999 110.065 175.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 p -98.98 150.75 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 115.81 -0.632 . . . . 2.29 109.624 173.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.17 113.34 15.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.784 -1.191 . . . . 1.48 107.784 163.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 tp -62.67 -32.78 73.91 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.554 1.542 . . . . 3.2799999999999998 109.869 176.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 28.7 mtt -57.62 -55.63 32.37 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.383 0.611 . . . . 3.1000000000000001 110.192 -177.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.28 -21.6 25.67 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.268 -0.878 . . . . 1.9399999999999999 110.928 -177.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.39 53.28 6.84 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 110.27 -1.132 . . . . 1.3700000000000001 110.27 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -128.17 130.65 48.37 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.126 -1.435 . . . . 3.9900000000000002 107.126 178.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.55 107.6 18.52 Favored 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 125.259 1.424 . . . . 1.1699999999999999 109.194 167.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -99.29 131.87 45.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.751 -1.574 . . . . 4.5999999999999996 106.751 166.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.73 163.91 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 119.104 0.865 . . . . 2.27 111.338 161.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.38 106.83 15.43 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.274 2.23 . . . . 8.2100000000000009 107.562 175.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.404 ' HB2' HD12 ' A' ' 53' ' ' ILE . 19.3 p90 -106.76 -179.48 3.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.338 1.055 . . . . 3.0099999999999998 113.14 171.558 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.66 118.88 14.75 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.238 1.415 . . . . 3.25 108.033 175.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.65 -16.43 38.03 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.9 3.067 . . . . 2.8799999999999999 113.069 -165.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -72.44 -11.82 60.84 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.981 0.363 . . . . 3.5600000000000001 111.981 -177.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.08 -46.93 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 123.438 0.695 . . . . 2.8799999999999999 111.227 -170.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.55 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -114.12 152.47 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.141 0.576 . . . . 1.6599999999999999 109.99 174.38 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -127.08 156.96 73.6 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 125.316 1.446 . . . . 2.5899999999999999 109.696 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.19 -9.7 27.01 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.368 2.045 . . . . 1.54 112.276 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mp -73.54 -61.88 1.68 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.59 0.756 . . . . 2.5600000000000001 110.159 172.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -32.41 73.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.481 -0.327 . . . . 5.0499999999999998 111.195 -174.2 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.55 HD12 HD11 ' A' ' 53' ' ' ILE . 1.5 tt -58.79 -51.04 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.66 -1.607 . . . . 1.6200000000000001 106.66 173.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.85 98.1 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.267 -0.424 . . . . 1.21 110.225 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -55.53 -46.41 77.08 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.433 -0.581 . . . . 2.4199999999999999 109.433 174.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -62.24 -49.81 74.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.128 -0.693 . . . . 2.4900000000000002 109.128 -177.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 69' ' ' ALA . 5.6 mm -55.57 -47.19 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 121.926 -0.484 . . . . 2.7799999999999998 111.505 178.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.47 -47.56 81.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.989 0.516 . . . . 2.4700000000000002 111.331 176.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.67 -49.82 71.67 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.42 0.688 . . . . 2.3799999999999999 110.391 -178.117 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.407 HD13 HG12 ' A' ' 22' ' ' ILE . 4.3 mt -50.34 -43.24 53.99 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.761 1.224 . . . . 2.2599999999999998 110.528 173.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.18 40.36 0.34 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 111.123 -0.791 . . . . 1.4399999999999999 111.123 162.317 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -137.81 160.86 38.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.058 -0.719 . . . . 2.8500000000000001 109.058 -175.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -98.52 117.39 32.83 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.595 -1.261 . . . . 2.77 107.595 170.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.516 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -96.57 111.45 23.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.409 -1.7 . . . . 1.03 106.409 164.05 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.02 154.59 46.49 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 106.708 -1.59 . . . . 0.94999999999999996 106.708 169.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -67.02 148.59 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 115.446 -0.797 . . . . 3.8599999999999999 109.202 -172.67 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.4 ptm -62.06 -39.41 92.3 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.016 -0.673 . . . . 3.79 111.066 177.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 176.86 -41.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 129.246 3.019 . . . . 6.4000000000000004 108.351 168.529 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -81.53 -47.2 13.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.659 1.183 . . . . 7.1500000000000004 113.299 -168.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.409 ' HB3' HG21 ' A' ' 71' ' ' VAL . 1.7 p90 53.55 10.4 0.22 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.756 2.423 . . . . 5.8600000000000003 114.451 -168.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.453 ' HB1' ' HA ' ' A' ' 82' ' ' ILE . . . -73.29 157.54 36.85 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 120.595 -1.316 . . . . 4.9800000000000004 113.942 -154.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.21 16.79 80.24 Favored Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 113.14 -1.845 . . . . 4.3300000000000001 110.34 177.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 t -57.67 -34.74 69.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.745 1.218 . . . . 8.3900000000000006 109.083 177.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 p30 167.66 80.75 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.286 0.847 . . . . 10.140000000000001 113.286 -170.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 124' ' ' PHE . . . 76.52 -10.51 16.92 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.688 -0.965 . . . . 2.8799999999999999 110.688 -167.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.439 HD22 ' C ' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -108.0 76.95 1.08 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.925 -1.139 . . . . 3.2599999999999998 107.925 -140.936 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.453 ' HA ' ' HB1' ' A' ' 76' ' ' ALA . 8.8 pt -105.92 158.54 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.689 -0.486 . . . . 3.7000000000000002 109.689 177.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -106.76 144.09 33.92 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 124.026 0.829 . . . . 4.4900000000000002 109.989 169.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 mt -131.57 145.46 51.73 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.843 0.857 . . . . 2.4100000000000001 109.126 175.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.52 124.2 44.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.147 0.979 . . . . 2.9300000000000002 108.66 179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.34 110.97 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 O-C-N 123.57 0.544 . . . . 2.0600000000000001 110.124 -176.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.9 p -96.53 164.97 12.38 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.539 -0.912 . . . . 2.7400000000000002 108.539 177.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.5 -33.89 3.17 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 121.914 -0.491 . . . . 1.98 112.262 -178.222 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.69 142.17 50.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 117.991 0.896 . . . . 3.2599999999999998 111.414 178.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 m -155.26 46.74 0.51 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.783 0.833 . . . . 3.2999999999999998 108.782 172.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.7 t -165.36 143.69 6.19 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.263 -0.898 . . . . 3.6299999999999999 111.136 174.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.66 -46.5 81.06 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 109.546 -0.538 . . . . 2.77 109.546 175.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.1 m -50.19 -41.44 49.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.753 0.821 . . . . 2.21 112.006 174.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.59 -50.68 62.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.249 -0.649 . . . . 2.4900000000000002 109.249 -177.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -48.34 -54.77 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.122 0.569 . . . . 1.73 110.506 170.406 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.31 -39.6 83.56 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.842 0.829 . . . . 2.8999999999999999 111.088 -176.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -63.67 -44.33 94.07 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.912 0.885 . . . . 2.2400000000000002 110.499 175.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.6 mt -60.26 -46.88 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.593 -0.521 . . . . 1.02 109.593 176.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -55.8 -45.95 78.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.796 -0.446 . . . . 2.1899999999999999 109.796 174.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.9 m -57.16 -48.19 79.32 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 117.82 0.282 . . . . 1.8799999999999999 111.519 175.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -55.09 -52.36 63.48 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.825 0.739 . . . . 2.8900000000000001 110.565 177.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.4 mt -57.93 -59.41 5.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.004 -0.739 . . . . 1.97 109.004 179.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 59.2 m -51.06 -26.06 5.81 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.772 1.629 . . . . 2.04 112.244 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -64.83 -19.77 66.04 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.77 -0.581 . . . . 4.0499999999999998 112.359 177.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.5 m -68.87 139.12 55.15 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.731 1.212 . . . . 2.2400000000000002 111.116 178.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -54.4 -57.29 11.85 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.836 0.854 . . . . 4.2199999999999998 111.926 177.089 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.44 -36.02 76.77 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 121.237 0.354 . . . . 1.8500000000000001 112.59 -170.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.49 121.24 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 122.007 -0.702 . . . . 2.5099999999999998 109.337 -173.102 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.5 m -97.48 -42.95 7.47 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.857 -0.423 . . . . 2.4199999999999999 109.857 -176.019 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.471 ' CE2' ' HD3' ' A' ' 123' ' ' LYS . 36.7 p90 -144.07 97.41 3.05 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 113.664 0.987 . . . . 1.9399999999999999 113.664 -178.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -94.09 135.87 34.99 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 107.675 -1.231 . . . . 1.1899999999999999 107.675 178.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.3 t -129.1 108.42 10.36 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.91 -0.774 . . . . 2.52 108.91 172.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 120' ' ' ALA . 5.0 p -100.28 131.12 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.106 1.363 . . . . 2.5699999999999998 108.926 -179.366 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -127.25 144.63 51.0 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.799 1.181 . . . . 2.6200000000000001 109.475 179.031 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 pp -104.61 -43.72 5.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 124.415 1.086 . . . . 3.0600000000000001 109.481 -171.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -46.71 -41.85 15.69 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.485 1.114 . . . . 2.7999999999999998 111.71 173.17 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -106.87 1.96 25.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.671 1.188 . . . . 2.6400000000000001 111.819 178.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.5 p 60.55 -6.77 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 127.925 2.49 . . . . 2.27 115.498 177.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -98.43 155.42 17.25 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.814 0.846 . . . . 4.3099999999999996 111.319 -174.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.65 ' HB2' HG23 ' A' ' 113' ' ' VAL . . . -140.68 120.56 13.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.883 0.873 . . . . 1.4099999999999999 110.513 -174.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.8 119.81 34.95 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.287 2.235 . . . . 2.1400000000000001 107.865 -173.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 22.6 t -128.88 122.77 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 116.27 -1.824 . . . . 2.3399999999999999 108.602 -168.332 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.471 ' HD3' ' CE2' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -112.91 97.49 6.57 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.965 1.257 . . . . 5.4000000000000004 110.446 -179.344 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.414 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 50.2 p90 -114.2 -179.46 3.64 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.378 1.049 . . . . 2.6499999999999999 112.374 -178.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -98.37 109.36 52.14 Favored Pre-proline 0 C--O 1.237 0.444 0 N-CA-C 107.454 -1.313 . . . . 3.1899999999999999 107.454 176.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -78.12 69.93 7.32 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.885 2.39 . . . . 3.02 110.747 -171.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -163.31 -46.13 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.935 1.694 . . . . 4.2800000000000002 109.063 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 pt -85.62 -33.1 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 117.693 0.224 . . . . 2.6899999999999999 111.021 -177.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.17 160.06 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.119 -1.067 . . . . 2.3799999999999999 108.119 177.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.82 156.13 24.68 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.228 -1.149 . . . . 2.3500000000000001 110.228 -177.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -59.77 -33.93 96.08 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.74 2.96 . . . . 2.5 111.887 -174.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -54.87 -35.32 63.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.235 -0.29 . . . . 5.2300000000000004 110.934 177.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -70.54 -40.79 73.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.272 -1.01 . . . . 3.3199999999999998 108.272 -174.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 62.1 mt -53.51 -57.86 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.83 -0.804 . . . . 2.2200000000000002 108.83 174.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.8 pt -56.16 -51.09 66.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 118.291 -0.861 . . . . 3.2999999999999998 111.056 178.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -53.94 -47.81 70.89 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.952 1.251 . . . . 3.8900000000000001 111.352 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.6 mm -57.4 -50.57 76.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 121.545 -0.722 . . . . 2.5600000000000001 109.712 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.282 2.7 pp -70.85 -26.17 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 119.113 -1.035 . . . . 1.3899999999999999 113.245 -177.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.09 -37.29 79.5 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.093 0.957 . . . . 4.0199999999999996 110.42 169.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.88 -31.14 72.22 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.794 -0.566 . . . . 4.7000000000000002 110.071 176.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.5 mt -73.36 -39.55 55.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.578 -0.527 . . . . 1.6499999999999999 109.578 170.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.81 26.06 5.44 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.917 1.723 . . . . 1.29 111.454 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -104.28 179.96 4.12 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.14 -1.43 . . . . 2.8599999999999999 107.14 175.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -142.28 130.58 22.24 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.63 -1.248 . . . . 4.0199999999999996 107.63 173.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.91 81.88 1.84 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.133 0.973 . . . . 1.79 109.492 -168.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.8 m -97.75 120.2 37.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.162 -0.681 . . . . 2.1699999999999999 109.162 -170.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -40.06 107.8 0.08 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.381 1.473 . . . . 3.5600000000000001 110.631 164.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.36 43.88 2.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.24 0.83 . . . . 4.9500000000000002 113.24 -175.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 . . . . . 0 C--O 1.252 1.235 0 CA-C-O 117.305 -1.331 . . . . 6.0700000000000003 111.159 167.528 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.467 0.411 0 N-CA-C 106.368 -1.716 . . . . 8.75 106.368 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.88 116.14 10.54 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 127.072 2.149 . . . . 4.21 111.246 -169.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -84.01 81.81 2.07 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 CA-C-O 123.485 1.369 . . . . 3.5099999999999998 113.7 -162.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -113.66 122.34 46.87 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 111.603 -2.544 . . . . 3.8399999999999999 109.12 176.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -96.38 134.33 39.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.764 -1.569 . . . . 5.9699999999999998 106.764 176.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 41.9 t -116.82 133.45 56.0 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 124.036 0.835 . . . . 2.0099999999999998 109.204 -179.275 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -103.61 103.57 13.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.59 1.156 . . . . 2.9500000000000002 109.756 -170.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.65 172.02 10.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.116 0.96 . . . . 2.7000000000000002 112.516 176.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.14 153.86 43.98 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.251 -1.388 . . . . 1.6399999999999999 107.251 168.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.4 mm -98.94 139.9 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 106.815 -1.55 . . . . 1.1200000000000001 106.815 170.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 mtmm -111.71 112.33 23.95 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.239 -1.763 . . . . 2.98 106.239 159.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.16 -81.95 0.17 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.211 1.386 . . . . 1.29 110.132 -177.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.5 mtm 29.28 77.13 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.958 2.103 . . . . 1.98 114.707 -175.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.4 p -57.19 -43.02 82.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.605 0.762 . . . . 3.2599999999999998 112.153 176.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.7 t 111.13 -42.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.965 2.506 . . . . 3.0099999999999998 110.715 175.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.28 -67.42 0.19 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.41 1.484 . . . . 5.9299999999999997 112.146 -174.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.99 24.24 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.922 0.489 . . . . 3.0 111.384 167.052 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.5 m -70.86 -45.82 63.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 120.974 -1.079 . . . . 1.8300000000000001 109.939 -172.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.5 t -57.04 -49.78 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.08 -1.081 . . . . 1.53 108.08 175.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -54.19 -45.44 72.17 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.895 1.278 . . . . 2.3199999999999998 111.868 -178.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.01 -50.39 68.68 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 121.654 -0.654 . . . . 2.4900000000000002 109.837 174.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mt -49.39 -41.24 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 124.238 1.015 . . . . 1.6000000000000001 110.792 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -47.49 -56.24 7.44 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.514 0.597 . . . . 3.9900000000000002 111.542 176.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -64.45 -46.64 82.29 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.463 -0.569 . . . . 5.0199999999999996 109.463 -177.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -55.07 -55.46 30.74 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 109.207 -0.664 . . . . 1.3999999999999999 109.207 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.48 -43.98 88.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.633 -0.699 . . . . 2.8999999999999999 110.371 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -50.78 -33.85 25.05 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.283 1.401 . . . . 1.8700000000000001 112.474 170.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -95.97 19.02 12.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.927 0.891 . . . . 2.8100000000000001 112.165 -177.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.4 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 5.4 tp10 -72.34 -74.78 0.15 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.911 0.884 . . . . 2.9700000000000002 109.535 174.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -163.26 -117.61 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.861 -0.524 . . . . 1.3500000000000001 111.193 -170.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.18 -31.13 72.29 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.456 -0.658 . . . . 1.75 111.456 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 29' ' ' GLU . 3.5 p -59.01 125.17 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 122.916 0.486 . . . . 1.5900000000000001 111.274 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.08 52.17 1.38 Allowed 'General case' 0 CA--C 1.522 -0.103 0 CA-C-O 122.325 1.059 . . . . 2.7999999999999998 109.705 170.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -156.46 154.73 30.87 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.403 -1.332 . . . . 2.0299999999999998 107.403 169.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -141.02 119.57 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.904 -1.887 . . . . 2.6299999999999999 105.904 176.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tt -131.06 70.34 1.47 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.415 -1.328 . . . . 2.5499999999999998 107.415 176.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.9 t -98.53 130.21 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.294 -1.002 . . . . 1.8700000000000001 108.294 175.181 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.93 97.08 8.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.298 -1.371 . . . . 1.21 107.298 168.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.1 -23.33 54.4 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.059 0.544 . . . . 2.6600000000000001 111.082 175.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 52.0 mtt -75.44 -55.16 5.96 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.672 -0.642 . . . . 3.8700000000000001 110.12 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.58 -22.84 37.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.968 0.507 . . . . 1.29 111.823 -175.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.48 61.78 2.88 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 124.209 0.909 . . . . 1.0700000000000001 111.047 -178.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -140.91 140.17 34.46 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.834 -1.543 . . . . 3.1000000000000001 106.834 172.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.0 99.11 7.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.113 1.365 . . . . 0.85999999999999999 109.855 174.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.22 135.94 37.37 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 104.61 -2.367 . . . . 3.7200000000000002 104.61 166.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 pt -131.12 -179.17 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.324 -1.361 . . . . 1.78 107.324 169.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -132.87 104.85 6.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.215 -0.661 . . . . 4.1900000000000004 109.215 173.358 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.428 ' HB2' HD12 ' A' ' 53' ' ' ILE . 6.6 p90 -119.7 167.18 12.3 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.825 1.65 . . . . 3.0699999999999998 112.553 178.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.48 100.72 19.7 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.745 1.618 . . . . 4.04 109.803 -174.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.55 -11.08 18.51 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.094 2.53 . . . . 2.4100000000000001 114.074 -173.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -85.75 -20.45 29.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.718 0.807 . . . . 5.0800000000000001 112.505 179.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 m -120.34 -39.91 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-O 118.635 -0.698 . . . . 3.4199999999999999 111.554 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -110.18 139.01 35.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 123.282 0.633 . . . . 1.78 109.505 176.985 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.517 ' HB3' HD23 ' A' ' 56' ' ' LEU . 1.1 mp0 -114.92 154.05 47.02 Favored Pre-proline 0 N--CA 1.451 -0.385 0 C-N-CA 125.779 1.632 . . . . 2.6899999999999999 111.026 -178.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.97 -39.01 43.07 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.061 2.507 . . . . 1.3 112.659 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 54' ' ' GLN . 2.3 pt? -64.79 -46.73 80.83 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.148 -0.97 . . . . 2.8100000000000001 111.635 -174.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.11 -33.61 75.83 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.207 0.603 . . . . 4.8099999999999996 112.216 175.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.12 -47.61 43.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 107.756 -1.201 . . . . 1.05 107.756 163.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 56' ' ' LEU . . . -58.47 -48.8 79.57 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.456 -0.793 . . . . 1.1499999999999999 109.597 -173.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -47.5 -49.85 24.84 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.903 0.32 . . . . 3.4100000000000001 110.806 176.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.75 -53.49 54.34 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.376 0.608 . . . . 2.6800000000000002 110.969 -176.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.689 HD13 ' H ' ' A' ' 69' ' ' ALA . 2.2 pp -63.71 -39.81 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 118.774 -0.631 . . . . 4.1699999999999999 111.847 178.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -63.21 -42.36 99.28 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.612 1.097 . . . . 1.9299999999999999 109.201 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.08 -49.44 75.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.498 0.719 . . . . 2.73 109.355 -179.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.1 mt -54.9 -38.66 67.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.397 -0.365 . . . . 1.8100000000000001 111.77 172.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.65 29.71 2.38 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 123.891 0.758 . . . . 1.28 111.601 168.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -116.72 154.16 31.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.34 1.456 . . . . 2.3999999999999999 107.681 173.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -95.72 128.07 42.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.648 -1.612 . . . . 3.0099999999999998 106.648 164.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.689 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -107.33 133.57 51.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.455 -2.054 . . . . 0.93000000000000005 105.455 163.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.05 140.29 41.93 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.498 1.124 . . . . 0.98999999999999999 108.638 171.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.27 147.37 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.221 -1.029 . . . . 2.8799999999999999 108.221 -179.14 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.6 mtp -50.11 -50.06 49.72 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.765 0.826 . . . . 3.52 111.033 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.02 -64.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.357 -1.72 . . . . 4.0499999999999998 106.357 178.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -68.06 -91.08 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.618 1.167 . . . . 7.3899999999999997 111.999 -174.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 148.36 -119.88 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 128.943 2.897 . . . . 4.3499999999999996 107.684 -169.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.85 -77.31 0.6 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.059 1.343 . . . . 3.2799999999999998 110.087 168.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.25 84.3 1.02 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.744 -0.942 . . . . 3.0600000000000001 110.744 176.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.8 t -155.02 -68.47 0.13 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.002 0.521 . . . . 5.5199999999999996 112.203 174.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -103.17 119.16 38.35 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.744 1.217 . . . . 4.4000000000000004 108.103 -172.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.25 -62.6 4.55 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.557 -2.217 . . . . 2.0699999999999998 107.557 178.134 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.532 ' C ' HD13 ' A' ' 82' ' ' ILE . 6.2 p-10 -104.0 133.4 49.02 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.691 0.796 . . . . 3.96 109.642 175.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.532 HD13 ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -127.7 158.1 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.963 -1.125 . . . . 3.1200000000000001 107.963 171.647 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.88 144.38 46.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.092 -1.818 . . . . 3.48 106.092 166.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mt -140.85 150.65 43.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.072 -1.825 . . . . 2.54 106.072 168.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -98.25 126.18 43.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.698 -1.223 . . . . 1.8200000000000001 107.698 177.113 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.7 pt -98.47 127.29 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.682 -0.859 . . . . 1.95 108.682 -175.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.7 m -119.42 137.37 53.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.46 -0.941 . . . . 1.6399999999999999 108.46 177.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.22 -45.75 1.16 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.336 1.446 . . . . 1.1200000000000001 111.295 175.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 157.31 27.81 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.1 -0.647 . . . . 3.3300000000000001 111.423 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -168.54 52.07 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.007 0.923 . . . . 3.3500000000000001 109.341 171.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -165.63 137.33 3.98 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 120.882 -1.137 . . . . 2.6200000000000001 109.751 178.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.47 -42.04 31.43 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.868 0.867 . . . . 3.0600000000000001 111.01 175.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -55.3 -49.06 73.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.204 0.602 . . . . 1.8899999999999999 110.792 175.45 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 79.0 m -63.65 -46.75 84.21 Favored 'General case' 0 N--CA 1.458 -0.053 0 O-C-N 121.707 -0.62 . . . . 1.8 109.729 -178.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.81 -49.29 70.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 122.777 0.431 . . . . 1.71 110.708 175.444 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -57.74 -41.76 82.54 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.119 0.568 . . . . 4.6200000000000001 110.707 175.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -63.09 -41.47 99.4 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.672 -0.643 . . . . 1.5900000000000001 110.686 177.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.9 mt -61.35 -52.27 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.576 0.75 . . . . 1.0 109.698 175.069 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.87 -39.09 76.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.501 -0.749 . . . . 2.3399999999999999 109.473 177.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.8 t -60.66 -56.8 16.94 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.626 0.771 . . . . 1.3600000000000001 110.671 176.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -30.72 70.89 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 120.303 1.41 . . . . 4.54 111.343 -175.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 mt -67.5 -59.61 3.23 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 109.233 -0.655 . . . . 1.72 109.233 171.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.7 m -54.96 -19.92 7.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.912 0.885 . . . . 1.8100000000000001 111.777 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.04 -33.04 66.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.831 0.852 . . . . 5.1900000000000004 111.992 173.498 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.3 p -75.45 166.09 24.13 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.927 0.891 . . . . 2.7799999999999998 111.604 -173.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.68 -40.38 34.08 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.243 -0.286 . . . . 3.5 111.572 178.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.55 -35.06 37.78 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 122.833 0.254 . . . . 1.5900000000000001 113.582 -169.002 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.36 133.09 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 O-C-N 121.658 -0.907 . . . . 2.1899999999999999 109.128 -174.075 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.8 p -107.63 -53.44 2.62 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 122.905 0.482 . . . . 2.48 111.816 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.51 126.09 32.11 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.55 -0.907 . . . . 2.0499999999999998 108.55 169.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -99.57 153.61 18.91 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.025 -1.102 . . . . 1.0700000000000001 108.025 161.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.8 m -144.7 116.92 8.42 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.139 -1.06 . . . . 2.0099999999999998 108.139 166.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 p -118.12 132.33 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.745 0.818 . . . . 1.9199999999999999 110.446 -174.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -129.57 98.66 4.91 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.142 0.977 . . . . 1.48 110.878 -172.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -25.4 66.23 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.686 1.194 . . . . 2.1800000000000002 112.445 -176.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.83 -32.56 53.27 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.114 0.566 . . . . 1.8999999999999999 111.033 173.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.07 -9.14 12.39 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.369 1.468 . . . . 2.2400000000000002 111.166 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.0 m 63.03 31.78 15.82 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.831 1.652 . . . . 1.4199999999999999 112.407 -178.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.3 mmtm -105.35 153.54 21.51 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.613 0.765 . . . . 3.6299999999999999 110.929 176.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.84 113.82 15.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.985 2.114 . . . . 1.0600000000000001 107.19 173.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.06 134.18 38.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.143 -1.429 . . . . 1.8200000000000001 107.143 173.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.4 t -135.33 129.62 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 124.027 0.931 . . . . 2.0 108.578 -174.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -111.96 93.61 4.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.43 1.092 . . . . 3.1299999999999999 109.148 178.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -119.9 175.01 6.1 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.709 0.804 . . . . 2.1699999999999999 111.627 179.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -97.86 115.75 65.74 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.672 -0.862 . . . . 3.7000000000000002 108.672 174.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -76.45 71.19 6.0 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.444 2.763 . . . . 2.0899999999999999 111.275 -171.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -161.62 -46.01 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.169 1.387 . . . . 4.1299999999999999 109.305 177.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -87.48 -32.33 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 123.256 0.623 . . . . 2.04 111.469 -174.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.92 165.15 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 124.258 1.023 . . . . 1.6000000000000001 108.406 176.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.91 168.37 32.34 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.403 -0.679 . . . . 1.3600000000000001 111.403 -178.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.68 -34.87 49.41 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.839 3.026 . . . . 1.49 112.583 -172.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -44.94 87.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.594 -0.891 . . . . 5.2000000000000002 108.594 177.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.08 -41.68 94.83 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.47 -0.937 . . . . 3.2599999999999998 108.47 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 83.2 mt -55.08 -57.39 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 117.749 -1.12 . . . . 1.21 109.99 176.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . 0.264 18.0 pt -52.45 -56.03 8.51 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 CA-C-N 119.109 0.868 . . . . 2.4700000000000002 109.998 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -48.86 -52.2 25.56 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.135 0.969 . . . . 3.71 111.926 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.69 -33.65 61.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 118.785 -0.626 . . . . 2.5 110.507 -175.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.35 2.6 pp -75.26 -32.33 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 114.891 1.441 . . . . 1.24 114.891 168.331 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.97 -34.21 69.7 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.307 0.958 . . . . 2.2000000000000002 109.634 174.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.86 -35.88 82.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.085 0.469 . . . . 3.7799999999999998 109.929 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 32.7 mm -76.18 -42.66 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.277 -0.638 . . . . 2.3999999999999999 109.277 173.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.5 41.13 1.06 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.1 1.333 . . . . 0.95999999999999996 111.59 178.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -112.54 -180.0 3.82 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.365 -0.976 . . . . 2.3399999999999999 108.365 166.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -133.63 132.96 41.39 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.89 -1.152 . . . . 3.6699999999999999 107.89 171.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.67 95.03 4.68 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 123.981 0.912 . . . . 1.45 109.778 -175.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.7 t -110.01 121.41 45.18 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.255 0.622 . . . . 2.75 109.852 -172.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -38.64 115.97 0.51 Allowed 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 126.37 1.868 . . . . 4.0599999999999996 110.89 171.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.584 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -103.26 30.77 4.68 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.151 1.167 . . . . 3.23 114.151 -178.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.301 0 CA-C-O 116.999 -1.477 . . . . 7.7599999999999998 111.571 177.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 mtt . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 108.705 -0.85 . . . . 10.539999999999999 108.705 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.6 89.89 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.102 0.961 . . . . 5.5999999999999996 111.757 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.66 125.85 14.48 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.745 1.63 . . . . 4.5999999999999996 110.539 -175.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.48 137.91 39.18 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.132 0.573 . . . . 3.7999999999999998 110.821 -176.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.1 143.13 29.71 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.991 -0.443 . . . . 3.98 110.912 179.02 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -125.94 131.63 52.25 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.413 1.085 . . . . 2.79 108.109 177.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -113.71 97.25 6.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.69 -1.226 . . . . 4.8899999999999997 107.69 -171.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 44' ' ' ALA 0.252 0.0 OUTLIER -122.36 177.09 5.53 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.829 0.824 . . . . 2.3799999999999999 110.508 -178.13 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.627 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -132.12 147.49 52.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.317 -1.734 . . . . 1.6299999999999999 106.317 174.51 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.4 mm -98.38 132.36 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 106.814 -1.55 . . . . 0.77000000000000002 106.814 177.259 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -111.46 109.14 18.95 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.171 -1.418 . . . . 5.0099999999999998 107.171 170.004 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.94 -83.91 0.09 OUTLIER Glycine 0 CA--C 1.532 1.106 0 N-CA-C 110.159 -1.176 . . . . 1.1499999999999999 110.159 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 47.52 70.46 0.42 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.746 1.618 . . . . 1.95 114.203 179.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.9 m -49.09 -59.33 3.73 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.451 -0.781 . . . . 2.3599999999999999 112.521 170.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 t -168.59 63.66 0.06 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.541 1.064 . . . . 3.1099999999999999 111.212 -175.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.408 ' HA ' HD22 ' A' ' 39' ' ' LEU . . . 31.86 56.82 0.33 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.076 1.75 . . . . 5.8200000000000003 113.411 177.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.1 t -169.17 -49.52 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 122.762 1.268 . . . . 2.8700000000000001 108.39 -167.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 19.7 p -61.87 -40.57 95.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.511 -0.743 . . . . 3.5 110.529 178.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.711 ' HB ' HD21 ' A' ' 39' ' ' LEU . 50.9 t -70.87 -31.25 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.924 -0.769 . . . . 1.95 108.924 173.008 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -58.57 -31.76 68.3 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.487 -0.758 . . . . 1.8899999999999999 111.464 175.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -55.38 -50.05 70.71 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.231 -0.918 . . . . 3.21 109.642 170.092 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.42 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -46.93 -47.24 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 125.546 1.539 . . . . 2.48 110.023 -176.509 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -50.47 -59.02 4.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.449 1.119 . . . . 3.7599999999999998 109.626 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -70.0 -19.31 63.33 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.997 -1.065 . . . . 4.6799999999999997 112.422 -177.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -70.24 -56.0 7.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.939 -0.763 . . . . 1.1499999999999999 108.939 168.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.42 HD12 ' O ' ' A' ' 22' ' ' ILE . 1.2 mp -59.41 -34.87 72.99 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.59 -0.694 . . . . 2.1499999999999999 112.412 179.029 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.71 -20.87 15.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.891 1.223 . . . . 3.2400000000000002 112.022 178.066 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -128.68 36.07 4.28 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.283 0.633 . . . . 4.7999999999999998 110.9 174.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -67.78 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.804 -0.813 . . . . 3.2599999999999998 108.804 167.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.27 -128.73 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.715 0.806 . . . . 1.6599999999999999 108.926 -163.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.12 -20.26 68.88 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.679 0.656 . . . . 2.0899999999999999 112.984 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.44 124.06 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 117.557 0.679 . . . . 2.0499999999999998 110.561 176.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.85 57.53 1.56 Allowed 'General case' 0 C--N 1.339 0.129 0 CA-C-O 121.573 0.701 . . . . 3.1400000000000001 110.343 172.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.8 t -155.97 159.63 39.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.863 -1.162 . . . . 1.9299999999999999 107.863 160.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.85 114.8 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.672 0.789 . . . . 2.5699999999999998 109.252 170.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tt -127.23 74.61 1.52 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.534 -0.913 . . . . 2.71 108.534 176.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.93 142.26 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 N-CA-C 109.378 -0.601 . . . . 2.4900000000000002 109.378 171.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.44 94.46 4.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.772 -1.196 . . . . 1.6899999999999999 107.772 165.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.711 HD21 ' HB ' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -56.08 -18.83 10.79 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.937 0.895 . . . . 3.8500000000000001 112.198 172.69 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.9 ttm -66.07 -44.22 85.09 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.361 1.064 . . . . 4.1200000000000001 110.62 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.77 -29.24 12.74 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.077 0.951 . . . . 1.6499999999999999 111.126 -178.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.39 63.19 1.51 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.111 -1.196 . . . . 1.3100000000000001 110.111 -177.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -140.4 132.11 27.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.008 -2.219 . . . . 3.5 105.008 174.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 8' ' ' LEU . . . -115.69 105.27 12.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.555 1.159 . . . . 1.26 110.011 170.155 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.9 137.51 41.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.712 -1.218 . . . . 5.3300000000000001 107.712 169.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.43 ' CD1' HD11 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -138.46 173.27 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.525 0.602 . . . . 2.1499999999999999 110.227 171.027 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -116.39 102.2 9.32 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.081 1.352 . . . . 5.9500000000000002 110.239 174.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.544 ' HB2' HD12 ' A' ' 53' ' ' ILE . 8.0 p90 -98.6 173.74 6.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.092 1.357 . . . . 3.4300000000000002 113.055 171.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -124.07 100.01 36.97 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.553 1.541 . . . . 3.0800000000000001 108.192 -179.132 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.8 5.36 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.72 1 C-N-CA 125.387 4.058 . . . . 3.1099999999999999 115.35 -166.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.05 -17.23 16.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.533 1.533 . . . . 4.7199999999999998 110.359 -177.073 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.0 p -124.86 -41.23 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.498 1.119 . . . . 4.1600000000000001 110.933 178.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -116.36 143.6 26.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 N-CA-C 108.794 -0.817 . . . . 2.3500000000000001 108.794 179.286 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.37 149.89 50.66 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 124.842 1.257 . . . . 3.4300000000000002 109.402 -176.15 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -57.34 -39.34 90.38 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.951 2.434 . . . . 2.0800000000000001 111.228 -177.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -60.02 -39.94 87.58 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.222 0.609 . . . . 3.5099999999999998 110.995 175.021 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -65.46 -43.33 90.69 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.118 -0.697 . . . . 3.8300000000000001 109.118 178.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.77 -50.52 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.625 -1.25 . . . . 1.3799999999999999 107.625 174.51 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.48 66.72 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.585 -0.734 . . . . 1.47 110.807 -174.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -52.54 -49.75 64.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.728 0.811 . . . . 4.8600000000000003 110.526 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -47.84 80.76 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 122.009 0.909 . . . . 3.2599999999999998 109.298 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mm -59.37 -42.91 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.581 -0.736 . . . . 2.5 111.001 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -67.3 -39.05 85.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.392 0.277 . . . . 2.46 110.43 179.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.01 -54.6 44.1 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.219 1.008 . . . . 3.79 109.847 176.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.63 -46.45 73.91 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.776 -0.193 . . . . 3.9100000000000001 110.829 175.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 125.72 39.87 0.41 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.429 -1.068 . . . . 1.74 110.429 162.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -129.65 164.96 22.77 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.222 -1.399 . . . . 2.3199999999999998 107.222 178.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -98.51 132.37 44.0 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.872 -1.159 . . . . 2.5 107.872 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.54 116.51 31.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.578 -1.267 . . . . 1.3 107.578 173.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.627 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -130.57 138.8 50.34 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.203 -1.036 . . . . 0.90000000000000002 108.203 173.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -67.01 146.3 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.3 -1.0 . . . . 2.9300000000000002 108.3 178.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.1 mtp -57.94 -46.68 84.67 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.967 -0.693 . . . . 3.7999999999999998 110.508 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 167.71 94.84 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 128.652 2.781 . . . . 5.1500000000000004 105.46 -179.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 48.5 41.86 17.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 123.356 1.551 . . . . 8.3599999999999994 114.697 172.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . 0.29 0.6 OUTLIER 59.99 -88.35 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.85 1.66 . . . . 5.1399999999999997 113.714 170.03 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 142.69 158.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.989 2.515 . . . . 5.6900000000000004 111.47 -173.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.43 ' HA3' ' H ' ' A' ' 83' ' ' GLU . . . -71.23 70.83 0.8 Allowed Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 123.822 0.725 . . . . 4.3600000000000003 114.414 171.167 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.8 t -86.87 -58.97 2.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.792 -0.818 . . . . 5.4299999999999997 108.792 174.05 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -163.09 129.07 3.26 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 106.817 -1.549 . . . . 7.3399999999999999 106.817 -162.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.61 -38.89 3.01 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 122.039 2.2 . . . . 2.6800000000000002 109.298 170.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -111.69 145.94 38.39 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 126.011 1.724 . . . . 4.1699999999999999 107.548 166.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.449 ' O ' HD12 ' A' ' 82' ' ' ILE 0.281 1.1 pp -114.95 140.15 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.363 0.528 . . . . 4.4199999999999999 109.762 150.643 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.541 ' OE1' ' HB3' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -107.64 123.34 48.34 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.603 2.361 . . . . 3.5099999999999998 107.205 175.796 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.436 HD13 ' CB ' ' A' ' 145' ' ' ALA . 4.6 pp -120.95 151.72 39.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 123.452 0.47 . . . . 3.6899999999999999 110.188 173.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -94.66 126.76 40.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.582 -2.377 . . . . 2.3199999999999998 104.582 175.516 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 pt -99.03 130.06 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.376 -0.972 . . . . 1.8200000000000001 108.376 176.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.4 m -123.97 141.95 51.59 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.416 -0.957 . . . . 2.1200000000000001 108.416 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.08 -37.36 3.76 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.621 1.105 . . . . 1.4299999999999999 111.361 -178.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.417 ' HB2' ' SG ' ' A' ' 94' ' ' CYS . 0.0 OUTLIER -61.27 159.06 12.93 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.053 0.541 . . . . 2.7799999999999998 111.998 177.861 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.9 t -175.0 48.95 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.019 0.927 . . . . 3.2999999999999998 110.229 170.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 8.5 t -160.39 144.26 13.96 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.958 -1.088 . . . . 2.8799999999999999 111.715 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.22 -10.48 23.65 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.02 0.928 . . . . 3.1299999999999999 113.305 178.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.7 t -79.2 -46.28 18.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.563 0.745 . . . . 2.8399999999999999 109.091 170.009 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 89' ' ' MET . 5.1 t -56.95 -53.64 55.77 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 121.762 -0.586 . . . . 3.4500000000000002 110.264 -177.215 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 p -51.22 -43.32 27.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.553 0.205 . . . . 2.8300000000000001 111.553 175.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -32.51 74.18 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 123.363 0.665 . . . . 3.1000000000000001 109.985 179.053 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -66.96 -56.9 8.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.804 1.242 . . . . 2.1899999999999999 108.507 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 mp -45.59 -60.38 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 C-N-CA 124.471 1.108 . . . . 1.6100000000000001 110.265 167.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -52.4 -44.4 65.35 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.465 0.575 . . . . 2.8999999999999999 111.772 -178.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.0 t -65.4 -60.26 3.15 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.018 -1.051 . . . . 1.8400000000000001 110.883 178.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -33.46 75.65 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.525 -0.734 . . . . 4.0599999999999996 111.147 -171.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.93 -49.78 48.48 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.249 -0.882 . . . . 3.2400000000000002 109.256 171.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.2 m -57.4 -24.43 55.38 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.164 1.347 . . . . 2.52 111.183 -177.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -57.22 -30.99 65.04 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.099 0.778 . . . . 4.3099999999999996 113.099 172.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.8 m -57.03 153.98 10.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.799 1.24 . . . . 1.8600000000000001 111.868 175.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -73.8 -56.19 5.28 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.826 1.25 . . . . 2.9700000000000002 112.533 -176.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.403 ' HA3' HD11 ' A' ' 128' ' ' ILE . . . -74.45 -34.86 53.45 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 121.88 -0.513 . . . . 1.75 112.016 -171.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.18 132.56 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.184 -0.672 . . . . 2.0 109.184 -175.395 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.5 m -121.1 -38.57 2.8 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 112.965 0.728 . . . . 2.71 112.965 -177.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -142.27 140.41 32.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.884 -1.127 . . . . 2.75 110.235 164.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -114.86 161.43 18.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.964 -1.016 . . . . 1.54 109.789 160.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -142.44 118.94 10.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.228 -1.767 . . . . 2.23 106.228 165.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 42.9 t -112.57 129.25 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 118.196 0.453 . . . . 2.5499999999999998 110.476 178.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -117.66 126.75 53.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.354 1.062 . . . . 1.3799999999999999 109.189 -177.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mp -90.4 -41.01 11.72 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.794 2.038 . . . . 3.8100000000000001 108.729 -170.399 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -43.77 -44.1 6.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.634 1.574 . . . . 1.4099999999999999 110.324 172.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -100.95 -15.07 17.64 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.729 0.812 . . . . 2.3500000000000001 112.464 174.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.9 m 65.86 30.58 9.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.971 1.708 . . . . 1.77 113.896 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -106.14 149.86 26.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.534 1.533 . . . . 4.5300000000000002 110.3 177.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.92 112.64 15.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.154 0.982 . . . . 1.24 108.897 176.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.61 124.52 39.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.869 -1.53 . . . . 2.5800000000000001 106.869 176.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.5 123.24 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 C-N-CA 125.364 1.466 . . . . 1.8600000000000001 108.844 -178.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -96.37 100.65 12.25 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.221 -1.029 . . . . 3.6899999999999999 108.221 -177.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -126.12 174.13 8.71 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 123.833 0.708 . . . . 2.6899999999999999 109.761 -178.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -104.48 117.56 58.83 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 118.273 -0.87 . . . . 5.2400000000000002 109.471 177.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -73.78 71.36 4.09 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.401 2.734 . . . . 2.9700000000000002 111.882 -174.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -166.52 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.864 1.666 . . . . 3.8599999999999999 110.013 174.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.534 HD12 ' HB ' ' A' ' 129' ' ' ILE . 2.2 pp -87.09 -41.22 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 118.448 0.567 . . . . 3.2200000000000002 111.297 -169.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.534 ' HB ' HD12 ' A' ' 128' ' ' ILE . 0.4 OUTLIER -128.79 170.22 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.447 1.499 . . . . 2.1200000000000001 107.557 174.384 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.36 25.5 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.1 -1.2 . . . . 1.99 110.1 176.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.69 -45.78 23.62 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.021 2.48 . . . . 1.99 110.768 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.4 ttm105 -48.37 -39.45 22.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.679 1.192 . . . . 6.9100000000000001 113.106 -178.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -53.34 58.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.333 -0.617 . . . . 3.96 109.333 173.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.97 -44.55 82.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 109.442 -0.577 . . . . 1.21 109.442 -178.035 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' A' ' 145' ' ' ALA . 86.9 mt -51.89 -56.42 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.165 0.986 . . . . 2.27 108.498 174.06 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -55.17 -43.98 74.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.015 -1.053 . . . . 4.04 112.512 178.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.2 mm -63.92 -34.25 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.704 -0.623 . . . . 2.0499999999999998 110.35 -177.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 145' ' ' ALA . 27.3 pt -74.57 -33.52 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 119.812 1.187 . . . . 1.5800000000000001 113.377 168.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -56.04 -25.98 47.1 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.475 1.034 . . . . 3.0600000000000001 111.47 176.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.74 -34.49 75.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.835 0.454 . . . . 3.8999999999999999 110.029 176.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.3 mt -79.31 -44.4 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.178 -0.675 . . . . 1.79 109.178 172.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.77 36.19 2.64 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 124.314 0.959 . . . . 1.4299999999999999 110.868 -177.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -96.89 168.18 10.64 Favored 'General case' 0 C--N 1.338 0.083 0 N-CA-C 108.23 -1.026 . . . . 2.8100000000000001 108.23 165.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -125.19 123.01 38.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.226 -1.768 . . . . 3.54 106.226 -177.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.436 ' CB ' HD13 ' A' ' 84' ' ' LEU . . . -111.0 107.91 17.47 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.838 1.255 . . . . 2.1099999999999999 108.48 174.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.5 m -108.29 114.95 29.21 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.42 -0.955 . . . . 2.6499999999999999 108.42 168.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -35.75 107.14 0.05 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 126.735 2.014 . . . . 4.2699999999999996 110.122 170.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.632 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -82.93 -36.7 25.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.378 -0.601 . . . . 3.6699999999999999 109.378 -175.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.109 0 C-N-CA 125.668 1.587 . . . . 5.9100000000000001 112.713 -165.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 106.421 -1.696 . . . . 9.7200000000000006 106.421 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.51 42.04 0.72 Allowed Pre-proline 0 C--O 1.222 -0.368 0 CA-C-O 117.874 -1.06 . . . . 5.4900000000000002 112.05 -173.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -67.99 157.42 61.86 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.757 2.305 . . . . 5.4800000000000004 112.911 -160.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -111.83 160.45 17.34 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.092 1.757 . . . . 3.6099999999999999 109.967 -167.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -90.75 130.85 36.69 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.097 0.959 . . . . 5.1200000000000001 109.464 -159.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.3 t -138.02 123.33 19.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.971 0.508 . . . . 1.8500000000000001 110.227 177.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -98.64 106.76 19.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.913 1.685 . . . . 2.9100000000000001 107.788 174.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -128.6 171.82 11.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.384 -0.969 . . . . 2.6000000000000001 108.384 179.226 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.453 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -141.21 144.95 35.03 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.314 -0.866 . . . . 1.54 109.352 175.037 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.3 mm -99.16 126.14 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 106.178 -1.786 . . . . 1.55 106.178 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -95.56 99.06 10.98 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.658 -1.608 . . . . 3.6099999999999999 106.658 174.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.65 -94.18 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.623 -1.391 . . . . 1.76 109.623 178.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.0 mtt 58.66 90.66 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.485 1.514 . . . . 2.3900000000000001 113.789 179.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -14.72 33.93 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.083 -1.011 . . . . 2.1099999999999999 113.125 172.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 t 72.88 -59.97 0.55 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 126.239 1.816 . . . . 4.0599999999999996 112.395 -178.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.25 -74.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.993 2.117 . . . . 4.8099999999999996 113.103 -174.385 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.5 p -154.24 15.17 0.46 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.668 0.387 . . . . 2.6699999999999999 111.706 168.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.7 m -69.42 -53.3 20.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.286 -1.376 . . . . 1.8 107.286 -170.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.541 ' HB ' HD11 ' A' ' 39' ' ' LEU . 71.9 t -61.73 -39.83 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 119.554 -0.858 . . . . 1.74 109.759 -175.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.1 t -53.08 -46.65 68.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.893 0.477 . . . . 2.3900000000000001 111.311 173.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -63.07 -49.26 75.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.251 -0.906 . . . . 2.6699999999999999 109.351 176.509 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.541 HG13 HD13 ' A' ' 65' ' ' LEU . 1.3 mp -49.9 -53.53 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.322 0.649 . . . . 2.0499999999999998 109.546 178.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -48.62 -52.71 21.69 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.99 1.316 . . . . 4.5 111.5 175.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -70.24 -24.0 63.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.256 -0.902 . . . . 4.8499999999999996 111.006 -176.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -71.66 -44.81 63.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.305 -0.872 . . . . 1.26 109.933 170.034 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.83 -37.6 79.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.127 0.571 . . . . 1.99 110.947 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -26.97 6.58 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.481 0.549 . . . . 1.8100000000000001 112.481 172.081 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -109.7 19.38 19.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.489 1.116 . . . . 4.6699999999999999 111.381 -177.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -73.76 -67.22 0.62 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.612 -0.884 . . . . 3.23 108.612 174.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.6 -96.55 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.852 1.261 . . . . 1.23 109.443 173.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.38 -5.82 89.58 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.897 -0.502 . . . . 1.3899999999999999 112.658 -176.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.2 t -66.36 114.11 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 118.044 0.922 . . . . 2.5600000000000001 109.682 176.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.68 53.05 1.61 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.539 -1.282 . . . . 3.3900000000000001 107.539 179.109 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -162.73 153.24 16.72 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.804 -1.184 . . . . 1.6499999999999999 107.804 158.334 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.2 94.77 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 125.421 1.488 . . . . 2.52 106.989 172.312 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -116.34 66.31 0.71 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.275 -1.379 . . . . 2.52 107.275 176.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 t -97.47 130.92 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.585 -0.894 . . . . 1.9299999999999999 108.585 175.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.52 96.8 6.98 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.844 -1.169 . . . . 1.1699999999999999 107.844 175.069 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.541 HD11 ' HB ' ' A' ' 19' ' ' VAL . 2.8 mm? -63.58 -12.95 37.11 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.333 0.515 . . . . 3.6000000000000001 111.888 178.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -43.61 13.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.095 0.958 . . . . 5.8399999999999999 111.41 -178.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.71 -36.26 15.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.74 0.816 . . . . 1.24 111.017 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.19 62.28 1.23 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.53 1.538 . . . . 0.97999999999999998 111.101 178.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -143.41 138.8 29.6 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.588 -1.634 . . . . 3.1400000000000001 106.588 177.08 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.37 98.91 8.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 124.443 1.089 . . . . 0.82999999999999996 112.326 171.295 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -94.09 131.42 39.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 105.996 -1.853 . . . . 4.9199999999999999 105.996 169.156 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 pt -133.44 -179.16 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 O-C-N 121.816 -0.552 . . . . 1.71 109.603 170.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 34' ' ' SER . 43.5 mtmt -124.68 119.06 27.91 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.728 -0.669 . . . . 4.1100000000000003 109.768 160.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.559 ' HB2' HD12 ' A' ' 53' ' ' ILE . 11.7 p90 -114.73 154.66 28.1 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.777 1.631 . . . . 2.1600000000000001 110.525 170.222 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.26 111.35 63.47 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.2 0.6 . . . . 3.3999999999999999 109.704 176.626 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.85 -19.75 69.49 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.837 3.025 . . . . 2.0600000000000001 112.845 -171.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -62.94 -24.37 67.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.701 -0.666 . . . . 3.7400000000000002 112.752 177.283 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.87 -43.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 118.944 0.793 . . . . 2.5499999999999998 111.496 -173.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -102.19 147.95 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 108.48 -0.933 . . . . 1.3799999999999999 108.48 176.623 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -126.92 150.96 73.21 Favored Pre-proline 0 N--CA 1.451 -0.379 0 C-N-CA 125.075 1.35 . . . . 2.4700000000000002 109.179 177.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.27 -36.38 94.99 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.629 2.219 . . . . 1.25 111.69 -175.019 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -41.68 99.25 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 121.916 -0.49 . . . . 3.54 110.959 177.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -59.99 -44.45 94.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.101 0.561 . . . . 3.0600000000000001 109.973 177.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.401 HD12 HD11 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -54.03 -48.48 64.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 172.694 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.43 -44.99 95.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.016 -0.538 . . . . 1.1499999999999999 111.004 -176.334 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -53.54 -50.39 65.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.934 -1.104 . . . . 2.8199999999999998 110.169 171.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.62 -53.66 48.69 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.427 0.691 . . . . 2.3599999999999999 109.34 -176.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.7 HG12 ' HB2' ' A' ' 69' ' ' ALA . 1.8 pp -68.74 -33.88 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 119.306 -0.958 . . . . 4.0599999999999996 112.019 -178.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -57.92 -41.45 82.73 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 120.269 1.395 . . . . 2.0099999999999998 108.574 -179.001 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -60.83 -50.92 71.48 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.619 -0.511 . . . . 2.7400000000000002 109.619 177.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.541 HD13 HG13 ' A' ' 22' ' ' ILE . 11.0 mt -54.38 -41.91 69.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.058 0.543 . . . . 2.1299999999999999 111.917 177.261 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.18 43.71 0.32 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.468 0.556 . . . . 1.05 112.123 164.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -134.2 -177.01 4.39 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.081 1.352 . . . . 1.8999999999999999 110.198 179.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -114.08 129.21 56.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.093 0.957 . . . . 2.27 108.898 162.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.7 ' HB2' HG12 ' A' ' 62' ' ' ILE . . . -97.99 129.32 44.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.253 -1.388 . . . . 1.3 107.253 168.267 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.453 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -139.47 118.74 12.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.255 -1.387 . . . . 0.97999999999999998 107.255 173.351 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 23.2 t -56.34 153.58 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.683 -0.858 . . . . 2.6800000000000002 108.683 174.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -15.21 47.11 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.802 0.297 . . . . 4.1699999999999999 111.802 178.448 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 112.98 -48.1 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.364 1 C-N-CA 132.558 4.343 . . . . 4.9299999999999997 106.484 174.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -91.53 77.5 5.71 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.322 1.049 . . . . 7.4800000000000004 110.792 169.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.431 ' CE1' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -46.54 -52.74 12.78 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.224 1.01 . . . . 5.3700000000000001 113.146 -178.0 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 139.51 159.68 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 128.791 2.837 . . . . 3.8900000000000001 109.726 -179.001 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 82' ' ' ILE . . . -49.73 89.57 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.704 -0.68 . . . . 2.8599999999999999 113.634 144.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.5 -51.54 8.67 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 109.031 -0.729 . . . . 4.9400000000000004 109.031 163.435 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -158.43 -102.34 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.675 0.39 . . . . 4.7000000000000002 111.229 -171.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 124' ' ' PHE . . . -72.32 -28.39 68.05 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 125.711 1.624 . . . . 1.8100000000000001 109.146 173.545 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.49 ' HB2' ' CD ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -91.54 116.37 28.81 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.125 -2.546 . . . . 3.5 104.125 176.722 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.472 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -142.03 161.91 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 O-C-N 125.412 1.695 . . . . 3.2999999999999998 110.047 170.977 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.91 125.2 50.71 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 127.329 2.252 . . . . 3.6400000000000001 110.003 -175.305 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.439 HD12 ' HB1' ' A' ' 145' ' ' ALA . 4.4 mm? -119.62 127.52 53.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.675 1.19 . . . . 2.7999999999999998 108.214 172.812 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.6 m -95.78 122.68 38.82 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.673 -1.603 . . . . 2.1000000000000001 106.673 176.383 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.495 ' H ' HD12 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -102.56 114.0 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.483 1.113 . . . . 1.6299999999999999 109.979 -172.022 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 84.6 m -107.23 124.0 49.11 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.262 0.625 . . . . 1.4399999999999999 110.267 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 127.16 -27.92 4.69 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.262 1.41 . . . . 0.98999999999999999 111.585 177.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 34.8 ttp -71.52 146.24 48.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.88 -0.777 . . . . 2.6600000000000001 111.661 -176.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 t -164.05 41.52 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.616 0.766 . . . . 2.7999999999999998 110.817 174.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -163.29 145.05 9.75 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.192 -0.943 . . . . 2.5899999999999999 111.551 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.75 -42.04 67.78 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.252 1.021 . . . . 2.6099999999999999 111.787 176.087 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -53.46 -48.77 68.56 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.732 -0.605 . . . . 2.1000000000000001 110.12 174.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 96.7 m -64.8 -41.45 95.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.082 0.553 . . . . 1.8200000000000001 110.26 -178.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.5 t -52.47 -51.95 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.227 -0.286 . . . . 1.3400000000000001 110.227 169.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.11 -33.22 75.0 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.826 -0.435 . . . . 3.1899999999999999 109.826 -176.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -65.28 -57.15 9.17 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.489 1.116 . . . . 1.8 109.576 178.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.5 mt -56.2 -51.42 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 121.457 -0.777 . . . . 1.05 110.098 177.569 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.82 -45.96 85.38 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.542 -0.742 . . . . 2.4199999999999999 110.101 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.3 t -49.25 -53.72 20.22 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.283 0.947 . . . . 1.9099999999999999 109.76 172.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -31.36 72.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.809 -0.557 . . . . 3.1200000000000001 111.067 -172.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.6 mt -72.23 -61.39 1.81 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.536 -0.913 . . . . 1.97 108.536 174.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 60.9 p -54.41 -19.66 6.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.601 1.161 . . . . 2.1400000000000001 113.099 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -57.53 -33.42 68.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.697 0.68 . . . . 4.3700000000000001 112.03 171.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.7 m -62.38 132.04 51.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.599 1.56 . . . . 1.8300000000000001 111.069 -176.112 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.04 -53.89 46.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.319 0.648 . . . . 4.8300000000000001 112.473 177.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.444 ' HA3' HD11 ' A' ' 128' ' ' ILE . . . -78.87 -16.95 78.17 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.837 -0.424 . . . . 1.46 113.394 -169.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.51 HD11 HG13 ' A' ' 122' ' ' VAL . 4.2 tt -68.86 133.84 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 118.387 1.094 . . . . 2.0 109.171 -176.195 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.9 m -104.32 -51.62 3.08 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 121.929 0.092 . . . . 2.5 110.859 -177.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -141.49 116.44 9.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.091 -0.707 . . . . 2.5899999999999999 109.091 176.448 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.12 143.27 32.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.049 -0.723 . . . . 1.0800000000000001 109.049 163.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.0 m -135.89 119.58 17.18 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.126 -1.064 . . . . 1.46 108.126 174.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.5 p -117.53 131.91 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.572 1.149 . . . . 2.2000000000000002 110.601 -177.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -128.59 86.67 2.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.027 0.931 . . . . 1.3799999999999999 110.298 -172.204 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -53.93 -26.56 26.01 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.997 1.319 . . . . 2.5099999999999998 113.012 179.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.81 -34.83 65.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.417 0.687 . . . . 1.6599999999999999 110.967 176.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.74 -10.04 11.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.821 1.649 . . . . 1.9399999999999999 111.393 -178.293 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.431 ' O ' HD12 ' A' ' 86' ' ' ILE . 8.7 m 69.46 22.39 6.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.836 2.054 . . . . 1.48 112.318 178.446 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -102.43 156.06 17.85 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 125.291 1.437 . . . . 4.6299999999999999 111.343 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.06 115.82 7.74 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.089 1.355 . . . . 0.83999999999999997 110.462 174.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 121' ' ' LEU . 3.9 mm? -92.03 126.42 37.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.219 -1.4 . . . . 2.4100000000000001 107.219 170.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.51 HG13 HD11 ' A' ' 108' ' ' ILE . 2.3 t -114.3 131.4 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.928 1.691 . . . . 1.8 107.409 176.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.49 ' CD ' ' HB2' ' A' ' 81' ' ' ASN . 2.1 mmmt -115.07 95.9 5.43 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.038 1.335 . . . . 3.0499999999999998 110.023 178.45 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.413 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -118.48 -176.77 3.15 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.494 1.118 . . . . 2.0899999999999999 111.22 -177.133 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -106.77 111.31 63.89 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 108.097 -1.075 . . . . 3.1400000000000001 108.097 175.044 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.21 68.3 7.93 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.916 2.411 . . . . 1.77 111.626 -167.339 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -162.57 -42.95 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.471 1.508 . . . . 3.0 109.729 174.481 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.514 HD12 ' HB ' ' A' ' 129' ' ' ILE . 2.0 pp -79.39 -35.98 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.296 0.57 . . . . 2.0699999999999998 110.168 -175.265 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.514 ' HB ' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -131.6 166.02 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.601 1.56 . . . . 1.3200000000000001 108.955 179.165 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.41 168.44 29.08 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.066 -1.614 . . . . 1.3 109.066 178.076 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.35 -44.59 36.92 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.42 2.746 . . . . 1.3899999999999999 111.851 -172.278 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -46.08 -42.27 13.32 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.183 1.179 . . . . 6.1600000000000001 114.183 -177.204 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.51 -47.48 83.75 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.512 -0.475 . . . . 3.25 109.72 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 85.1 mt -58.59 -45.86 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.929 -0.767 . . . . 1.1100000000000001 108.929 178.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 83.6 mt -51.93 -59.47 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.541 -0.911 . . . . 2.0499999999999998 108.541 174.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -46.24 66.78 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.874 0.761 . . . . 4.1699999999999999 111.245 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.2 mm -54.66 -50.66 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 121.413 -0.804 . . . . 1.9099999999999999 110.119 177.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.261 2.5 pp -71.14 -26.12 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.01 -1.056 . . . . 1.47 113.653 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.82 -38.77 76.17 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.762 0.71 . . . . 3.2200000000000002 109.848 168.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -59.84 -40.73 89.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.57 0.7 . . . . 3.1800000000000002 109.182 -179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 51.2 mt -70.63 -42.01 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.361 0.664 . . . . 1.01 109.827 175.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.1 34.19 5.21 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.434 1.493 . . . . 0.91000000000000003 111.187 -175.535 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -99.88 176.14 5.54 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.098 0.949 . . . . 2.3700000000000001 110.019 168.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -129.86 111.42 12.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.704 -1.591 . . . . 4.3399999999999999 106.704 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.439 ' HB1' HD12 ' A' ' 84' ' ' LEU . . . -104.0 103.03 12.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.682 1.193 . . . . 1.1200000000000001 107.982 178.845 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.8 m -109.66 110.33 21.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.664 1.586 . . . . 1.95 107.144 -174.233 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.45 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.405 1.482 . . . . 3.9700000000000002 111.384 -178.224 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 50.31 33.35 7.33 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.325 0.861 . . . . 3.7000000000000002 113.325 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 117.331 -1.318 . . . . 8.9700000000000006 109.826 -166.699 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 mtt . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 108.011 -1.107 . . . . 8.1500000000000004 108.011 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.35 114.17 65.54 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 117.274 -1.346 . . . . 5.7199999999999998 107.471 175.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -93.61 148.21 2.25 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.774 2.983 . . . . 3.9399999999999999 110.423 177.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -106.08 129.4 54.18 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.367 -0.833 . . . . 3.4300000000000002 110.327 -168.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -92.83 123.12 35.86 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.617 1.167 . . . . 5.9299999999999997 109.896 -171.043 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 t -108.99 124.29 50.47 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.188 -1.042 . . . . 2.3799999999999999 108.188 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -102.47 103.66 14.05 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.187 1.395 . . . . 3.1099999999999999 107.48 -178.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.1 pt? -130.63 173.99 10.35 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.926 0.869 . . . . 2.79 111.036 176.087 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.558 HE21 ' HB3' ' A' ' 70' ' ' ALA . 3.3 pt20 -122.44 150.29 42.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.032 -0.986 . . . . 2.2000000000000002 108.757 173.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 44' ' ' ALA . 39.2 mm -99.32 113.73 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 106.51 -1.663 . . . . 1.3700000000000001 106.51 173.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -99.47 93.46 5.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.587 -1.264 . . . . 3.0099999999999998 107.587 175.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.18 -77.29 0.08 OUTLIER Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.637 -0.985 . . . . 1.28 110.637 178.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.0 mmt 54.31 88.27 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.291 1.836 . . . . 2.1299999999999999 113.79 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 m -55.85 -64.39 0.87 Allowed 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.259 -0.901 . . . . 2.5499999999999998 112.477 177.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.7 t -169.7 56.19 0.04 OUTLIER 'General case' 0 C--N 1.345 0.397 0 CA-C-N 118.46 0.573 . . . . 3.3300000000000001 109.945 -176.172 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 41.47 49.09 3.49 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.769 1.227 . . . . 5.6100000000000003 112.707 178.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.4 t -164.18 -45.13 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.304 0.642 . . . . 2.8100000000000001 110.264 -172.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.5 t -66.44 -36.82 83.75 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 120.743 -1.223 . . . . 1.8300000000000001 110.277 -178.37 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.8 t -63.58 -30.63 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.657 0.741 . . . . 1.75 110.012 173.423 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -66.33 -31.03 71.57 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.54 -0.725 . . . . 1.95 110.884 175.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.74 -48.82 65.38 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.096 -1.003 . . . . 2.9900000000000002 110.232 169.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mt -38.52 -44.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.598 0.759 . . . . 1.49 112.163 171.022 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -42.81 -57.8 2.63 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.536 0.734 . . . . 5.1500000000000004 112.509 178.412 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -67.23 -40.25 86.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.225 -0.287 . . . . 5.4800000000000004 110.225 -177.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -56.09 -53.53 55.89 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.767 -0.827 . . . . 1.22 108.767 -177.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.16 -43.83 97.96 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 119.493 -0.289 . . . . 3.0 111.279 177.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -22.21 24.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.872 0.76 . . . . 2.0 112.967 176.635 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -115.53 33.65 5.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.433 0.693 . . . . 3.1200000000000001 111.549 175.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -84.73 -88.81 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.704 -1.591 . . . . 3.3399999999999999 106.704 168.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -143.74 -126.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.908 1.283 . . . . 1.3500000000000001 109.837 178.147 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.49 32.85 1.38 Allowed Glycine 0 CA--C 1.532 1.139 0 O-C-N 120.7 -1.25 . . . . 2.1899999999999999 113.709 -171.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.19 117.99 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 106.936 -1.505 . . . . 1.55 106.936 174.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.05 53.38 1.57 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.211 1.005 . . . . 3.2999999999999998 109.718 -178.547 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.5 m -161.84 132.08 4.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.146 -1.427 . . . . 2.1200000000000001 107.146 171.586 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.75 117.04 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.414 -1.328 . . . . 2.8399999999999999 107.414 176.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 tt -124.87 78.03 1.66 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.332 -0.988 . . . . 2.5800000000000001 108.332 -179.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 t -99.98 137.1 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.182 -0.673 . . . . 2.04 109.182 173.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.93 98.39 7.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.543 -0.91 . . . . 1.1200000000000001 108.543 169.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.94 -8.66 7.57 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.205 1.002 . . . . 3.04 112.865 175.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.3 mtt -80.34 -48.63 12.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.113 0.965 . . . . 4.1500000000000004 110.011 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.59 -27.3 17.44 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.793 0.837 . . . . 1.24 111.805 -175.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 61.67 2.25 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.764 -0.934 . . . . 1.1599999999999999 110.764 -177.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -140.0 139.08 35.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.38 -1.711 . . . . 2.7200000000000002 106.38 173.141 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -111.21 105.1 13.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.439 1.087 . . . . 1.1799999999999999 109.91 165.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -97.63 133.68 41.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.538 -2.023 . . . . 3.6699999999999999 105.538 164.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 pt -129.94 167.05 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.54 -1.281 . . . . 2.0899999999999999 107.54 169.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.37 105.12 10.59 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 124.393 1.077 . . . . 5.3300000000000001 108.794 172.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.631 ' HB2' HD12 ' A' ' 53' ' ' ILE . 12.9 p90 -104.66 -179.51 3.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.255 1.822 . . . . 2.8500000000000001 111.46 175.79 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.4 108.18 17.54 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.342 1.057 . . . . 3.8300000000000001 111.316 175.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.43 -7.97 22.36 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.242 2.628 . . . . 2.1099999999999999 113.586 -168.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.41 -16.37 57.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.222 0.919 . . . . 3.1699999999999999 111.393 173.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.9 t -124.73 -47.89 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 118.476 0.58 . . . . 2.5 110.23 -172.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.631 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -116.85 146.79 20.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.014 0.925 . . . . 1.6100000000000001 109.029 -173.425 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -123.48 154.88 66.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 124.213 1.005 . . . . 2.96 113.178 179.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.87 -38.19 81.14 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.547 2.165 . . . . 1.55 111.243 174.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 3.1 mp -54.44 -60.54 3.2 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.391 -0.818 . . . . 2.9500000000000002 111.494 178.475 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -57.13 -35.29 69.3 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.325 -0.859 . . . . 3.8599999999999999 112.734 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.502 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -55.28 -41.45 61.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.94 -0.763 . . . . 1.25 108.94 171.947 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 56' ' ' LEU . . . -59.51 -38.59 81.34 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.076 -0.511 . . . . 1.6200000000000001 111.341 -179.619 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -63.48 -51.15 66.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.197 -0.939 . . . . 3.02 109.98 175.025 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.22 -52.22 59.62 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.376 0.608 . . . . 2.25 111.424 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.547 HD13 ' N ' ' A' ' 69' ' ' ALA . 2.3 pp -65.46 -37.82 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.283 -0.886 . . . . 4.21 112.308 -179.567 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.93 -31.88 71.94 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.04 0.837 . . . . 2.9399999999999999 110.683 177.232 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.57 -52.45 63.38 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 109.252 -0.647 . . . . 3.5299999999999998 109.252 174.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -55.0 -42.71 72.85 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.673 0.249 . . . . 3.5099999999999998 111.673 172.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.28 48.39 0.43 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.293 0.949 . . . . 1.3 111.129 171.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -135.04 162.92 31.08 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.509 1.124 . . . . 2.3399999999999999 109.675 -176.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -100.27 122.99 43.95 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.892 1.277 . . . . 2.96 107.623 167.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.547 ' N ' HD13 ' A' ' 62' ' ' ILE . . . -104.16 82.67 1.98 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.512 1.525 . . . . 0.87 108.824 172.154 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB3' HE21 ' A' ' 9' ' ' GLN . . . -96.66 101.82 13.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.611 -1.177 . . . . 1.6699999999999999 108.985 -176.697 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -70.36 158.28 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.438 1.495 . . . . 3.4500000000000002 112.08 176.649 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -56.01 -50.58 70.47 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.853 -1.067 . . . . 6.4900000000000002 111.287 167.246 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.86 61.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.008 1.323 . . . . 7.2599999999999998 108.537 -175.394 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -17.11 71.56 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 130.107 3.363 . . . . 10.550000000000001 117.005 -173.536 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 83' ' ' GLU . 5.3 p90 -95.89 -56.2 2.74 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.51 -1.223 . . . . 6.1500000000000004 113.533 -167.411 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . 0.252 . . 125.56 -108.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 130.374 3.47 . . . . 4.6500000000000004 110.255 177.359 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 82' ' ' ILE . . . 99.17 79.68 1.47 Allowed Glycine 0 C--N 1.336 0.548 0 CA-C-N 119.981 1.264 . . . . 2.79 114.41 167.465 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.4 t 178.22 -28.88 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.766 2.026 . . . . 5.2800000000000002 111.113 168.46 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -78.71 -139.8 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.009 -0.737 . . . . 4.9699999999999998 109.009 177.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.84 9.39 59.91 Favored Glycine 0 N--CA 1.443 -0.889 0 O-C-N 120.332 -1.48 . . . . 2.8700000000000001 110.487 166.555 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.487 ' CG ' ' HE3' ' A' ' 123' ' ' LYS . 21.0 t30 -106.01 131.83 52.83 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 117.599 0.7 . . . . 3.6600000000000001 109.909 153.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -141.54 169.0 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 130.776 3.63 . . . . 3.1299999999999999 105.627 175.937 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.466 ' HB2' ' CE2' ' A' ' 75' ' ' TYR . 2.0 tt0 -117.06 119.79 36.35 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.953 1.701 . . . . 4.1399999999999997 110.07 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.2 mt -113.63 137.62 51.34 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.316 0.646 . . . . 2.2999999999999998 109.444 -179.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 m -100.48 131.11 46.57 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 108.171 -1.048 . . . . 1.6799999999999999 108.171 173.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.518 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.5 OUTLIER -95.53 122.62 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.748 1.619 . . . . 1.8999999999999999 107.762 175.64 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 63.8 m -112.22 134.59 53.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.922 -1.14 . . . . 1.76 107.922 175.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 112.14 -36.3 4.22 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.495 1.045 . . . . 1.72 111.557 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.512 ' HE3' HD13 ' A' ' 86' ' ' ILE . 2.9 tmm? -57.32 129.47 41.92 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.183 0.593 . . . . 2.23 111.204 -178.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -157.03 91.96 1.23 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.072 -1.455 . . . . 3.25 107.072 169.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 63.3 m 84.2 -134.18 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.593 1.957 . . . . 4.9000000000000004 111.087 178.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 60.07 -6.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.059 1.744 . . . . 6.8899999999999997 114.581 -170.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.46 29.42 11.09 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.408 -0.807 . . . . 4.0700000000000003 110.186 -158.225 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -33.43 69.29 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 123.079 1.418 . . . . 2.3100000000000001 111.358 -171.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.4 t -52.53 -43.42 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.862 1.665 . . . . 1.6799999999999999 110.561 174.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -58.01 -47.81 81.93 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.462 1.125 . . . . 2.6800000000000002 108.526 -176.053 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.251 1.2 p-10 -70.99 -38.35 72.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.84 -1.073 . . . . 3.3199999999999998 112.003 179.076 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.5 mt -57.14 -54.11 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.815 1.188 . . . . 0.95999999999999996 109.906 173.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -52.83 -49.95 64.68 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 108.717 -0.845 . . . . 2.8999999999999999 108.717 176.391 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.2 t -52.4 -51.67 57.84 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 122.021 -0.424 . . . . 1.5 111.945 177.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -61.56 -40.07 93.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.174 -0.954 . . . . 2.5800000000000001 111.414 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.8 mt -63.58 -60.81 2.86 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.534 0.607 . . . . 1.99 110.145 175.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.6 m -54.33 -20.18 6.76 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.315 1.446 . . . . 1.8600000000000001 112.321 177.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.5 mtp-105 -61.8 -28.82 69.73 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.802 0.667 . . . . 4.6900000000000004 112.802 172.811 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.1 p -69.53 166.19 19.42 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 119.828 1.194 . . . . 2.2999999999999998 110.892 -179.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.75 -39.61 30.66 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.071 -0.393 . . . . 3.5099999999999998 111.346 176.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.33 -50.46 7.43 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 112.256 -0.338 . . . . 1.1599999999999999 112.256 -170.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.68 144.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.851 -1.166 . . . . 3.27 107.851 176.309 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.0 m -142.51 -44.9 0.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.473 0.709 . . . . 3.27 109.845 171.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -100.51 103.36 14.69 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.016 -1.846 . . . . 2.2999999999999998 106.016 176.63 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.04 149.01 41.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.501 -1.296 . . . . 0.97999999999999998 107.501 165.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.9 m -142.87 135.71 27.97 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.213 -1.032 . . . . 1.9299999999999999 108.213 162.779 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.41 118.68 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.53 1.532 . . . . 2.4300000000000002 106.939 -177.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.06 105.51 10.7 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.902 1.281 . . . . 1.3200000000000001 110.3 -171.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pp -74.05 -39.07 63.77 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 125.851 1.66 . . . . 2.04 111.878 -172.076 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.71 -40.39 62.94 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.194 0.998 . . . . 1.4099999999999999 110.901 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.07 -12.51 24.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.779 1.232 . . . . 1.8799999999999999 111.08 175.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.2 m 54.1 43.52 30.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.883 1.273 . . . . 1.55 111.925 -176.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -128.22 163.43 24.73 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 117.618 0.19 . . . . 3.3300000000000001 110.734 166.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.96 136.9 32.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.281 1.432 . . . . 1.01 108.702 173.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -117.81 136.36 53.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.201 1.4 . . . . 2.46 107.583 171.916 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.4 m -134.3 136.11 53.48 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 116.805 -1.569 . . . . 2.1000000000000001 107.327 -177.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.487 ' HE3' ' CG ' ' A' ' 81' ' ' ASN . 4.1 mtpt -115.25 105.13 12.52 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 120.456 1.48 . . . . 3.3599999999999999 108.453 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -115.15 179.81 3.85 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.289 1.435 . . . . 2.75 110.894 175.218 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -100.51 117.37 63.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 125.089 1.355 . . . . 3.0299999999999998 108.355 173.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -82.52 57.9 6.29 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.663 2.242 . . . . 1.95 112.351 -168.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -147.38 -49.57 0.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.482 1.513 . . . . 3.8599999999999999 108.661 174.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pt -77.28 -33.25 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 O-C-N 122.382 -0.199 . . . . 1.6200000000000001 111.05 -176.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.24 165.7 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.289 1.036 . . . . 1.4299999999999999 108.373 -177.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.23 165.65 33.88 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.273 -1.131 . . . . 1.3799999999999999 110.273 -175.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.71 -35.73 78.39 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.698 2.932 . . . . 1.5700000000000001 112.637 -170.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 10.2 mtt-85 -50.99 -40.53 58.23 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.897 0.702 . . . . 6.1299999999999999 112.897 178.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.46 -46.8 84.57 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.306 0.574 . . . . 3.3900000000000001 109.645 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.68 -45.01 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.504 0.721 . . . . 1.0600000000000001 109.574 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.7 mt -55.98 -58.64 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 108.704 -0.85 . . . . 2.0299999999999998 108.704 175.023 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -49.28 -49.59 42.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.747 1.158 . . . . 3.6000000000000001 112.851 177.153 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 52.0 mt -48.68 -56.21 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.612 -0.514 . . . . 2.4399999999999999 109.612 176.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . 0.253 2.2 pp -70.84 -26.68 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 113.509 0.929 . . . . 1.52 113.509 -178.294 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.37 -38.58 80.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.311 0.959 . . . . 2.5 109.683 168.642 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -66.08 -39.85 90.38 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.444 -0.576 . . . . 3.23 109.444 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.1 mt -62.23 -38.84 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.873 -0.417 . . . . 1.26 109.873 169.319 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.72 29.24 9.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.762 1.649 . . . . 0.97999999999999998 110.825 -177.096 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -100.31 178.99 4.6 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 117.982 0.891 . . . . 2.3100000000000001 108.99 175.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -127.88 104.51 7.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.609 -1.256 . . . . 4.1600000000000001 107.609 -178.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.68 103.84 15.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.136 -1.431 . . . . 1.28 107.136 174.205 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.4 t -97.12 -179.19 4.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.236 -1.394 . . . . 2.2599999999999998 107.236 169.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.5 117.94 22.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.278 -1.749 . . . . 4.0 106.278 171.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.56 90.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.862 -0.421 . . . . 3.3500000000000001 109.862 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 C--O 1.249 1.048 0 C-N-CA 127.192 2.197 . . . . 6.3799999999999999 111.22 -178.473 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 mmt . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 107.22 -1.4 . . . . 11.84 107.22 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.12 87.65 39.71 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.187 0.995 . . . . 7.1200000000000001 111.097 -166.142 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.04 155.55 67.62 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 121.953 1.769 . . . . 5.9500000000000002 109.809 172.25 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.53 158.93 43.29 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.082 0.953 . . . . 7.4199999999999999 108.589 172.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.19 153.88 17.85 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.198 -1.408 . . . . 5.8499999999999996 107.198 166.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.13 117.97 21.68 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.509 -1.293 . . . . 3.6499999999999999 107.509 178.01 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -99.89 102.67 14.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.277 1.831 . . . . 5.4000000000000004 109.849 -176.061 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 44' ' ' ALA 0.277 0.0 OUTLIER -130.3 159.86 35.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.185 0.993 . . . . 2.46 111.572 176.223 . . . . . . . . 4 4 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -113.63 152.05 30.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.001 -1.0 . . . . 2.1800000000000002 108.375 173.273 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.7 mm -99.95 137.89 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 106.437 -1.69 . . . . 1.0700000000000001 106.437 175.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -119.38 98.55 6.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.27 -1.011 . . . . 3.79 108.27 169.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.45 -94.65 0.13 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 109.119 -1.592 . . . . 1.8100000000000001 109.119 177.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 mtp 67.86 90.48 0.09 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.012 1.725 . . . . 2.3300000000000001 113.503 173.366 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -57.4 -28.55 63.34 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.973 0.731 . . . . 3.0099999999999998 112.973 175.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 t 78.38 -48.5 0.46 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.009 1.324 . . . . 4.9900000000000002 112.068 177.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -36.15 -70.01 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.802 1.641 . . . . 4.4100000000000001 112.063 -179.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.3 p -161.49 18.99 0.11 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.254 0.465 . . . . 2.6800000000000002 112.254 172.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 27.1 m -70.23 -52.12 25.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.329 -0.989 . . . . 2.5299999999999998 108.329 -170.292 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.53 -39.27 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 109.702 -0.481 . . . . 2.9300000000000002 109.702 177.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -61.95 -37.51 85.0 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.933 0.893 . . . . 2.1000000000000001 113.344 177.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -41.29 64.0 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.732 -1.23 . . . . 2.8599999999999999 110.866 171.201 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.441 HG12 HD13 ' A' ' 65' ' ' LEU . 88.0 mt -60.29 -48.62 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.258 1.023 . . . . 1.8799999999999999 110.18 -174.354 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HB2' HG11 ' A' ' 35' ' ' VAL . 1.8 pp20? -51.52 -45.62 63.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.632 0.73 . . . . 4.3399999999999999 111.079 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -64.6 -43.59 93.31 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 124.654 1.182 . . . . 6.5099999999999998 110.343 -179.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.91 -52.27 64.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.129 -0.487 . . . . 1.95 109.825 173.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -29.39 66.48 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.016 0.747 . . . . 1.98 113.016 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -55.0 -22.07 14.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.907 1.23 . . . . 3.4100000000000001 111.666 174.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -123.93 33.68 5.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.638 0.775 . . . . 4.21 110.182 178.182 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -64.26 0.89 Allowed 'General case' 0 C--N 1.343 0.314 0 N-CA-C 108.796 -0.816 . . . . 2.5299999999999998 108.796 174.776 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.05 -133.85 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.833 1.253 . . . . 1.53 108.112 -172.114 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.66 -16.96 74.49 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.556 1.071 . . . . 1.9399999999999999 113.009 -178.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 p -60.35 122.4 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 121.949 -0.736 . . . . 2.04 110.279 177.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.55 50.55 2.15 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 121.209 0.528 . . . . 4.1200000000000001 111.119 177.239 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.7 m -155.44 153.73 30.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.299 -1.371 . . . . 3.7999999999999998 107.299 167.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 23' ' ' GLU . 11.4 p -143.33 132.06 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 104.815 -2.291 . . . . 3.1699999999999999 104.815 161.57 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 36' ' ' LEU . 2.2 tm? -141.35 83.73 1.88 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.007 -1.108 . . . . 2.6000000000000001 108.007 174.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.0 p -98.8 147.16 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.27 -1.011 . . . . 2.1000000000000001 108.27 174.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.52 103.87 9.81 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.322 -1.362 . . . . 1.9199999999999999 107.322 167.188 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -27.54 66.4 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.608 0.763 . . . . 2.6099999999999999 110.817 175.376 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 46.3 mtt -66.26 -58.8 4.58 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.944 0.898 . . . . 3.3300000000000001 110.209 -178.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.75 -25.35 38.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.938 0.495 . . . . 2.0800000000000001 111.414 -178.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.69 57.94 2.79 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.508 1.052 . . . . 1.4199999999999999 110.878 179.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -140.31 147.1 39.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.865 -1.064 . . . . 3.21 108.693 179.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.504 ' HB3' HD22 ' A' ' 8' ' ' LEU . . . -124.63 101.17 6.99 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.145 1.378 . . . . 1.73 112.192 177.013 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -99.57 122.62 42.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.004 -1.06 . . . . 4.7699999999999996 108.375 172.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.06 -179.5 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.742 1.155 . . . . 2.6200000000000001 111.179 171.708 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -134.72 90.28 2.63 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.021 0.928 . . . . 7.6900000000000004 112.561 -174.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.7 179.93 4.81 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.506 1.122 . . . . 3.77 113.974 -176.469 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -126.16 98.74 32.36 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 128.03 2.532 . . . . 4.8700000000000001 108.283 176.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.62 27.89 0.38 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.917 3.078 . . . . 3.6899999999999999 113.555 -170.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -108.15 -16.21 14.32 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.888 1.675 . . . . 4.6500000000000004 110.669 165.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.1 t -116.66 -60.9 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.762 1.225 . . . . 3.25 108.067 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.65 124.99 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.646 0.778 . . . . 2.3500000000000001 110.297 -177.509 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -101.62 172.08 4.76 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.09 1.756 . . . . 3.0 110.956 -177.645 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -75.45 -15.24 19.89 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.622 1.548 . . . . 2.7599999999999998 112.259 -178.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.257 0.5 OUTLIER -73.08 -60.0 2.44 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.442 -0.786 . . . . 4.5599999999999996 110.396 175.601 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -57.45 -32.37 66.86 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.284 -0.885 . . . . 2.77 112.281 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.3 tt -55.98 -45.34 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.878 -1.156 . . . . 1.6699999999999999 107.878 175.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.87 73.56 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.364 -0.835 . . . . 1.9399999999999999 110.42 -178.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.91 -44.9 94.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 119.459 1.027 . . . . 2.4300000000000002 110.073 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -55.62 -52.69 62.95 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 109.195 -0.669 . . . . 2.3399999999999999 109.195 175.326 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 mm -63.15 -41.86 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 120.246 -0.582 . . . . 2.73 111.839 -174.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -46.25 89.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.4 1.08 . . . . 2.8999999999999999 110.421 175.037 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.19 -50.28 74.29 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.154 0.582 . . . . 3.98 109.829 178.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.441 HD13 HG12 ' A' ' 22' ' ' ILE . 29.1 mt -55.62 -36.43 66.97 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.311 0.644 . . . . 2.2000000000000002 110.882 175.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.16 28.75 2.98 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 124.082 0.849 . . . . 1.95 111.149 165.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -117.53 157.02 27.05 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.995 -1.483 . . . . 3.1200000000000001 106.995 177.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -96.5 116.36 28.94 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.797 -1.186 . . . . 3.1000000000000001 107.797 169.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.87 123.92 43.45 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 108.096 -1.076 . . . . 1.6699999999999999 108.096 166.412 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -126.92 132.14 50.95 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.28 -1.007 . . . . 1.8400000000000001 108.28 170.158 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.485 ' HA ' ' HB3' ' A' ' 8' ' ' LEU . 2.2 t -89.46 160.04 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 124.619 1.168 . . . . 4.25 108.336 -177.236 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.8 mmt -49.95 -64.56 0.77 Allowed 'General case' 0 CA--C 1.534 0.341 0 O-C-N 123.935 0.772 . . . . 5.4400000000000004 110.472 168.303 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 154.64 65.31 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 130.322 3.449 . . . . 8.3100000000000005 106.061 -173.407 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 36.34 50.84 0.78 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.289 1.436 . . . . 10.98 111.803 -173.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -63.46 -59.53 4.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 112.932 -1.94 . . . . 8.4600000000000009 109.868 -178.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB3' ' CG ' ' A' ' 81' ' ' ASN . . . 55.17 -101.7 0.13 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 128.371 2.668 . . . . 3.3900000000000001 112.519 175.325 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.83 89.9 0.2 Allowed Glycine 0 CA--C 1.536 1.379 0 C-N-CA 123.998 0.809 . . . . 4.1900000000000004 113.235 -178.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.2 t 179.65 -80.14 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.027 2.131 . . . . 5.5800000000000001 108.092 171.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.05 132.04 53.41 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 105.13 -2.174 . . . . 6.9900000000000002 105.13 179.804 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.83 -59.07 4.99 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 122.434 2.379 . . . . 2.79 109.714 160.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.412 ' CG ' ' HB3' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -96.34 113.4 24.98 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 104.469 -2.419 . . . . 3.23 104.469 159.532 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.405 HG13 ' CD1' ' A' ' 124' ' ' PHE . 1.4 pp -98.3 158.76 3.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.072 -1.825 . . . . 3.5699999999999998 106.072 158.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.48 155.69 38.5 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.122 -1.807 . . . . 3.9100000000000001 106.122 174.166 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.526 HD13 ' HB1' ' A' ' 145' ' ' ALA . 4.2 pp -147.79 163.52 36.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.637 -0.221 . . . . 3.3199999999999998 111.18 168.283 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 m -98.89 126.49 44.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.602 1.961 . . . . 1.96 107.261 171.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.02 125.5 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.856 -0.794 . . . . 1.6200000000000001 108.856 176.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.5 t -108.03 163.31 13.26 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.326 -0.62 . . . . 3.6499999999999999 109.326 170.703 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.34 -39.27 2.94 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.846 1.213 . . . . 1.4199999999999999 112.583 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -58.92 132.73 54.87 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.879 0.871 . . . . 2.5 110.953 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 m -148.01 40.94 0.99 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.904 1.281 . . . . 2.75 109.861 176.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -169.19 136.83 1.86 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.88 -1.137 . . . . 2.7799999999999998 111.1 177.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.13 64.94 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.576 -0.703 . . . . 2.8999999999999999 112.118 177.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.6 t -56.45 -42.08 77.54 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.638 -0.664 . . . . 2.4300000000000002 110.365 173.589 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 84.5 m -63.24 -44.4 95.31 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.75 -0.833 . . . . 1.75 108.75 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.6 t -53.87 -58.86 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.522 0.729 . . . . 1.6299999999999999 110.543 175.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -57.11 -41.88 79.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.678 0.752 . . . . 4.4199999999999999 111.316 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -59.77 -55.09 38.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.821 0.848 . . . . 1.95 110.338 177.779 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.8 mt -47.39 -50.63 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 125.657 1.583 . . . . 0.82999999999999996 109.234 174.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -56.53 -47.25 79.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.217 1.007 . . . . 3.7599999999999998 109.947 177.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.9 m -58.15 -44.21 87.75 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.999 -1.063 . . . . 2.5699999999999998 111.384 174.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.629 ' HG3' HD11 ' A' ' 141' ' ' ILE . 14.3 mmmt -64.28 -50.19 68.87 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.444 -0.785 . . . . 2.96 110.265 -177.101 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.71 -47.23 79.08 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.36 -0.607 . . . . 2.4900000000000002 109.36 -179.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.8 m -58.38 -21.21 49.35 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.034 0.934 . . . . 2.6299999999999999 112.584 176.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -64.96 -19.17 65.83 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.4 -0.813 . . . . 5.2699999999999996 112.71 172.342 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.3 m -71.22 150.72 45.02 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.681 1.193 . . . . 1.8700000000000001 110.431 178.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -69.3 -48.94 60.13 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.869 0.868 . . . . 3.0899999999999999 111.887 179.188 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.43 -28.56 61.44 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 122.287 -0.258 . . . . 2.4300000000000002 112.939 -166.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.51 142.18 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.368 -0.975 . . . . 2.0 108.368 178.437 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 22.4 p -124.21 -39.12 2.37 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.891 0.7 . . . . 3.3100000000000001 112.891 173.434 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.34 125.26 18.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.246 -1.39 . . . . 3.1200000000000001 107.246 -178.582 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.88 168.16 12.63 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.376 0.67 . . . . 1.6699999999999999 110.308 165.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.4 m -143.87 128.09 17.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.625 -0.88 . . . . 1.76 108.625 160.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 52.1 t -107.32 126.61 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.822 0.849 . . . . 2.5899999999999999 110.223 178.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -126.76 101.09 6.46 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.075 1.75 . . . . 1.6100000000000001 110.128 -168.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.14 -31.8 62.89 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 126.146 1.778 . . . . 2.0899999999999999 111.979 -174.253 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.6 -34.18 61.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.783 0.433 . . . . 1.6000000000000001 110.981 175.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.83 -4.67 19.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.108 1.363 . . . . 2.29 111.218 176.608 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.5 m 59.71 28.8 18.31 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.659 1.183 . . . . 1.6200000000000001 113.128 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -124.37 165.16 18.2 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.028 0.831 . . . . 2.9700000000000002 112.973 176.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.45 127.28 43.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.573 2.349 . . . . 1.4099999999999999 107.588 179.382 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.02 123.47 48.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.002 -1.851 . . . . 2.6099999999999999 106.002 175.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.1 t -130.32 123.38 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.163 -1.051 . . . . 1.8899999999999999 108.163 -170.016 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 96.93 9.73 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.099 -1.445 . . . . 4.2599999999999998 107.099 176.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.405 ' CD1' HG13 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -107.9 -177.87 3.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.449 1.5 . . . . 3.4300000000000002 111.019 178.309 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -127.2 112.83 21.53 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.059 0.943 . . . . 5.1799999999999997 108.917 175.736 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.43 50.23 3.44 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.577 3.518 . . . . 2.8100000000000001 113.523 -171.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -141.59 -52.19 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.484 1.513 . . . . 5.8499999999999996 107.495 171.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 pt -80.29 -31.69 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 119.399 -0.334 . . . . 2.5 111.302 -177.262 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.67 164.67 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 110.156 -0.313 . . . . 2.0600000000000001 110.156 -177.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.99 150.24 20.11 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.912 -0.938 . . . . 1.7 111.64 -167.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -57.22 -36.62 99.08 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.966 2.444 . . . . 1.75 110.535 178.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -34.75 67.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.119 -0.491 . . . . 6.3200000000000003 111.474 179.136 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -69.99 -44.04 70.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.761 -0.829 . . . . 3.29 108.761 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.424 ' O ' HD13 ' A' ' 138' ' ' ILE . 17.1 mm -52.42 -54.97 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.414 -0.958 . . . . 2.23 108.414 178.16 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.699 HG22 ' HB3' ' A' ' 145' ' ' ALA . 9.4 pt -59.2 -57.01 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 117.885 -1.055 . . . . 2.8999999999999999 109.879 179.04 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -44.46 -46.59 9.72 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.0 0.818 . . . . 4.7300000000000004 112.401 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.4 mm -51.07 -60.24 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 118.836 -0.602 . . . . 1.77 110.019 173.047 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.518 HG22 HD12 ' A' ' 141' ' ' ILE 0.29 0.0 OUTLIER -70.4 -26.93 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 117.628 -1.629 . . . . 2.77 113.909 -176.273 . . . . . . . . 4 4 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.48 -34.84 78.65 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.783 -0.573 . . . . 2.6800000000000002 110.538 172.128 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -66.6 -36.13 81.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.884 -0.784 . . . . 2.8399999999999999 108.884 176.288 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.629 HD11 ' HG3' ' A' ' 101' ' ' LYS . 38.2 mt -65.37 -44.28 94.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 119.84 -0.744 . . . . 1.6100000000000001 109.691 174.557 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.98 27.86 3.33 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.694 1.14 . . . . 1.4399999999999999 112.032 -177.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -98.5 -178.18 3.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.863 -1.532 . . . . 2.6600000000000001 106.863 158.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -139.36 130.69 26.85 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.741 -1.207 . . . . 3.8300000000000001 107.741 174.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.699 ' HB3' HG22 ' A' ' 135' ' ' ILE . . . -105.64 117.48 34.13 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.936 -0.765 . . . . 2.0800000000000001 108.936 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.2 t -109.04 115.55 30.29 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.361 -1.348 . . . . 2.2599999999999998 107.361 174.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.47 115.58 4.0 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.764 -1.198 . . . . 5.25 107.764 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.28 -34.83 20.26 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 123.61 0.569 . . . . 4.0 110.538 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 C--O 1.262 1.735 0 C-N-CA 128.131 2.572 . . . . 5.8600000000000003 115.633 175.396 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtt . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 117.384 -1.293 . . . . 7.8099999999999996 107.571 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.69 107.25 1.86 Allowed Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 119.2 0.909 . . . . 3.4300000000000002 109.788 -170.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.03 110.68 2.94 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.672 1.581 . . . . 2.7799999999999998 111.616 -163.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.44 119.92 21.27 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.35 -0.841 . . . . 3.27 111.822 -165.524 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.5 152.52 20.9 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.445 -1.252 . . . . 3.6699999999999999 108.899 -178.123 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.615 ' SG ' HD11 ' A' ' 8' ' ' LEU . 21.9 p -143.2 138.55 29.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 123.608 0.567 . . . . 2.4900000000000002 109.629 167.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.493 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -100.41 109.13 21.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.613 1.565 . . . . 4.25 109.379 177.659 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.615 HD11 ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -124.37 166.91 15.12 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.786 0.803 . . . . 2.9900000000000002 109.279 172.197 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.3 136.24 54.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.807 -1.553 . . . . 1.77 106.807 176.037 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.6 mm -98.2 136.02 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.593 -1.262 . . . . 0.81000000000000005 107.593 -177.36 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -114.0 136.51 52.83 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.061 -1.089 . . . . 2.8399999999999999 108.061 168.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.9 -80.6 0.27 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.04 1.781 . . . . 1.1200000000000001 109.962 -174.03 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.2 mmm 56.91 56.45 5.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.957 2.103 . . . . 2.1600000000000001 114.521 170.193 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -43.51 -63.95 0.74 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.774 1.398 . . . . 2.21 114.774 -173.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.3 t -167.9 59.47 0.07 Allowed 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.066 0.848 . . . . 3.3300000000000001 109.621 -176.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 42.86 48.75 5.04 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.476 1.111 . . . . 5.2199999999999998 111.994 -179.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.0 t -161.74 -40.21 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.005 0.522 . . . . 2.5699999999999998 111.364 -172.307 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.39 -43.5 81.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 118.731 -1.188 . . . . 1.47 109.357 -178.487 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.5 t -55.33 -40.61 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.486 -0.931 . . . . 1.8999999999999999 108.486 173.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -60.19 -37.4 80.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.002 0.43 . . . . 1.95 111.982 177.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -45.45 80.85 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.36 -0.838 . . . . 3.0899999999999999 110.047 173.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.49 -47.75 70.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.245 1.018 . . . . 1.3600000000000001 110.198 176.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -50.02 -49.18 51.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.888 0.875 . . . . 4.2599999999999998 111.478 175.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -64.71 -38.23 90.3 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 122.114 -0.366 . . . . 4.8499999999999996 110.346 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -61.19 -53.05 61.87 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.934 -0.395 . . . . 1.24 109.934 176.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.73 -37.26 75.78 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 118.22 0.464 . . . . 2.0600000000000001 111.381 -179.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.58 -19.05 5.19 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.206 0.817 . . . . 1.8100000000000001 113.206 174.41 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -118.36 20.9 12.92 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.325 0.65 . . . . 3.1099999999999999 112.499 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -68.16 -62.56 1.34 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.094 0.861 . . . . 2.5299999999999998 109.866 173.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.91 -128.47 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.384 1.474 . . . . 1.1799999999999999 108.038 -168.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.84 14.56 3.53 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 119.487 1.04 . . . . 1.3300000000000001 115.043 -173.409 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.09 122.26 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.593 1.157 . . . . 1.51 108.133 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.87 53.29 1.38 Allowed 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.448 0.642 . . . . 2.4399999999999999 110.566 179.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 t -160.05 147.13 16.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.555 -1.276 . . . . 1.6499999999999999 107.555 170.627 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.82 116.0 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 106.608 -1.627 . . . . 2.4700000000000002 106.608 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 tt -131.67 72.41 1.5 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.851 -1.166 . . . . 2.3399999999999999 107.851 177.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 p -97.27 153.11 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.64 -0.874 . . . . 2.2599999999999998 108.64 172.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.02 100.26 6.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.577 -1.268 . . . . 1.1899999999999999 107.577 163.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.2 mt -58.05 -19.12 29.19 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.207 1.003 . . . . 2.8900000000000001 111.762 172.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -49.81 64.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.852 0.861 . . . . 4.7999999999999998 109.696 178.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.88 -31.85 13.5 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.121 0.968 . . . . 1.1899999999999999 111.749 -174.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.22 55.3 1.98 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.511 1.053 . . . . 0.93000000000000005 111.307 -178.423 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.95 131.64 31.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 117.835 -1.079 . . . . 3.1499999999999999 108.491 177.097 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.406 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -108.49 105.13 14.65 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 125.333 1.453 . . . . 0.93999999999999995 110.563 170.536 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.5 130.36 45.75 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 106.639 -1.615 . . . . 4.5899999999999999 106.639 165.146 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.2 pt -133.04 169.6 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-N 119.292 0.951 . . . . 1.9099999999999999 109.897 170.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.7 105.99 12.6 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 124.699 1.199 . . . . 4.0099999999999998 111.124 172.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -98.27 -176.34 3.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.928 2.091 . . . . 2.5800000000000001 112.188 170.422 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -127.64 111.64 20.77 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.781 1.633 . . . . 3.2400000000000002 110.151 167.745 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.87 20.13 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.391 3.394 . . . . 2.1200000000000001 113.885 -173.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -99.27 -39.37 8.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.616 1.166 . . . . 3.8599999999999999 110.323 169.061 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.3 m -109.74 -34.13 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 118.743 0.701 . . . . 2.7200000000000002 111.26 -176.278 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.475 HD11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -120.98 130.9 74.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 109.618 -0.512 . . . . 1.6399999999999999 109.618 176.818 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -110.47 149.18 39.87 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 124.195 0.998 . . . . 3.46 109.878 -179.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -54.34 -40.66 81.83 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.408 2.739 . . . . 1.6200000000000001 112.419 -178.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mp -57.54 -49.1 77.44 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.783 -0.573 . . . . 3.9399999999999999 111.013 177.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -60.3 -40.34 90.13 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.183 0.516 . . . . 3.0499999999999998 110.293 179.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.475 HD12 HD11 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -54.15 -50.65 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.67 -1.233 . . . . 1.05 107.67 173.181 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.08 -41.63 83.86 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.942 -0.572 . . . . 1.24 110.855 -174.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -56.33 -46.03 80.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.173 0.589 . . . . 2.3199999999999998 110.469 175.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.13 -51.59 63.78 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.621 -0.511 . . . . 2.71 109.621 176.03 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 mm -58.17 -45.88 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.784 0.326 . . . . 2.4700000000000002 111.26 -179.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -61.58 -43.06 99.55 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.122 -0.466 . . . . 3.4700000000000002 111.783 178.004 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.45 -49.02 78.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.6 0.636 . . . . 2.3100000000000001 110.067 176.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -59.63 -27.12 66.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.111 0.564 . . . . 2.1000000000000001 111.754 175.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.0 40.16 2.35 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.596 -1.002 . . . . 1.1499999999999999 110.596 165.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -131.93 170.74 14.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.419 1.488 . . . . 1.8799999999999999 108.029 178.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -115.01 121.46 43.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.351 -0.981 . . . . 3.8300000000000001 108.351 169.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.03 117.7 34.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.381 -1.711 . . . . 0.94999999999999996 106.381 163.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.78 144.18 45.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 105.979 -1.86 . . . . 0.91000000000000003 105.979 166.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.625 HG12 ' H ' ' A' ' 73' ' ' GLU . 45.1 t -71.46 152.17 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.474 -1.306 . . . . 2.4100000000000001 107.474 -178.188 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.8 ptm -58.55 -28.81 65.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.193 -0.458 . . . . 3.7799999999999998 110.404 174.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.625 ' H ' HG12 ' A' ' 71' ' ' VAL 0.289 14.1 tt0 123.47 -8.85 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.801 1 C-N-CA 132.304 4.242 . . . . 4.4000000000000004 110.43 175.979 . . . . . . . . 4 3 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -73.61 -55.14 6.68 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 125.361 1.464 . . . . 7.2699999999999996 111.491 171.462 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.513 ' HB3' HG11 ' A' ' 71' ' ' VAL 0.274 0.4 OUTLIER 60.12 -28.54 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.791 1.774 . . . . 4.2400000000000002 115.791 -164.431 . . . . . . . . 4 4 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 106.83 -135.93 0.0 OUTLIER 'General case' 0 C--N 1.345 0.403 0 C-N-CA 129.372 3.069 . . . . 3.5699999999999998 111.625 170.763 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.88 77.87 0.34 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 127.691 2.567 . . . . 3.4700000000000002 108.149 169.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.66 76.66 0.29 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.928 0.891 . . . . 6.5 109.302 174.359 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 2.95 99.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 129.396 3.079 . . . . 4.1299999999999999 114.183 -173.685 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.37 -1.23 66.66 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.519 -1.032 . . . . 2.0899999999999999 110.519 -168.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.458 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 15.0 t30 -143.31 95.43 2.75 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 119.803 1.802 . . . . 2.79 110.911 172.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.33 145.52 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 C-N-CA 126.095 1.758 . . . . 4.71 108.169 178.637 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 74' ' ' ASP . 0.3 OUTLIER -109.4 148.25 31.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.071 1.348 . . . . 3.4399999999999999 110.629 173.173 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -140.89 161.4 37.92 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.296 1.038 . . . . 2.4100000000000001 109.069 -178.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.09 138.57 35.19 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 120.181 1.355 . . . . 2.1899999999999999 109.069 172.235 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.501 HD13 HD13 ' A' ' 98' ' ' ILE . 6.2 mt -94.98 117.14 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.731 -1.211 . . . . 2.6699999999999999 107.731 176.572 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 21.4 m -98.46 124.63 43.28 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.252 -1.388 . . . . 1.4099999999999999 107.252 171.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.82 -43.75 1.51 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.116 1.341 . . . . 1.02 111.337 175.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.88 121.65 8.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.726 0.81 . . . . 2.4199999999999999 110.938 174.523 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -166.09 26.33 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.842 0.857 . . . . 2.9100000000000001 111.074 166.07 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 31.1 p -172.47 168.21 5.46 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.296 -0.878 . . . . 5.4699999999999998 110.026 -167.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 58.99 6.9 0.72 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.983 2.113 . . . . 7.2300000000000004 113.574 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.5 m 38.11 47.47 0.96 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.336 0.589 . . . . 4.4299999999999997 110.734 -154.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.6 p -55.15 -21.99 15.39 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.711 1.204 . . . . 2.3900000000000001 112.417 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.523 HG13 ' CG2' ' A' ' 113' ' ' VAL . 7.2 t -30.0 -55.9 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.029 1.332 . . . . 1.47 111.327 157.036 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -58.85 -40.23 83.66 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.189 0.596 . . . . 3.6600000000000001 111.067 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.672 HD21 HD13 ' A' ' 141' ' ' ILE . 3.1 t30 -64.87 -46.65 80.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.866 -0.521 . . . . 2.0800000000000001 110.008 177.026 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.501 HD13 HD13 ' A' ' 86' ' ' ILE . 96.9 mt -59.97 -52.51 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.143 0.577 . . . . 0.94999999999999996 110.029 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -55.73 -43.62 76.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.568 1.947 . . . . 2.4399999999999999 108.966 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.5 t -59.74 -51.35 70.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.792 -0.567 . . . . 1.8999999999999999 110.064 174.329 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -53.87 -53.85 46.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.85 0.75 . . . . 2.52 110.705 -178.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.48 -48.52 74.91 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.545 -0.462 . . . . 2.7599999999999998 110.318 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.5 m -63.27 -19.44 64.57 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.369 1.068 . . . . 1.79 112.235 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.5 mtt-85 -63.28 -21.59 66.34 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.373 -0.823 . . . . 4.8700000000000001 111.52 170.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.36 169.53 17.12 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.557 1.071 . . . . 3.04 110.422 -177.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -80.12 -47.53 14.64 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.164 0.586 . . . . 2.2599999999999998 111.656 -175.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.72 -37.57 66.96 Favored Glycine 0 CA--C 1.524 0.606 0 O-C-N 122.139 -0.351 . . . . 1.0900000000000001 113.006 -168.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.74 123.49 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 122.111 -0.64 . . . . 2.1000000000000001 109.432 -173.501 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.7 m -101.56 -51.78 3.38 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 122.477 0.311 . . . . 1.97 111.497 -178.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CE1' ' HG3' ' A' ' 123' ' ' LYS . 27.4 p90 -140.55 111.34 6.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.049 -0.722 . . . . 2.2999999999999998 109.049 -177.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -97.15 155.05 16.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.889 -0.782 . . . . 1.0900000000000001 108.889 166.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.8 p -143.73 92.97 2.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.787 -1.19 . . . . 1.8700000000000001 107.787 169.07 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.523 ' CG2' HG13 ' A' ' 95' ' ' VAL . 2.4 m -96.52 140.02 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.241 -1.022 . . . . 2.3300000000000001 108.241 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.37 108.15 8.02 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.851 0.86 . . . . 1.4199999999999999 109.54 -168.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.38 -27.78 65.61 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.154 0.798 . . . . 2.25 113.154 -171.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.61 71.52 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.138 0.975 . . . . 1.74 110.05 -176.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.3 -28.33 13.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.702 2.001 . . . . 1.77 109.334 175.864 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.2 m 71.92 40.55 0.73 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.13 1.772 . . . . 2.2200000000000002 110.429 -174.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -101.21 163.31 12.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 123.839 0.712 . . . . 5.8200000000000003 110.818 172.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.82 108.17 5.54 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.104 2.161 . . . . 0.95999999999999996 109.105 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 83' ' ' GLU . 2.8 mp -96.68 131.0 43.8 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.697 -1.223 . . . . 2.1299999999999999 107.697 178.299 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.477 HG11 ' CD1' ' A' ' 134' ' ' ILE . 69.9 t -131.36 113.65 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.452 1.101 . . . . 1.77 108.538 -173.363 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HG3' ' CE1' ' A' ' 110' ' ' TYR . 0.7 OUTLIER -99.84 92.53 5.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 117.78 -1.105 . . . . 4.2699999999999996 110.351 176.375 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -109.82 -177.15 3.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.682 0.674 . . . . 2.2799999999999998 110.817 176.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -108.24 115.95 57.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.789 -1.189 . . . . 3.0499999999999998 107.789 173.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.47 68.94 8.16 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.042 2.495 . . . . 2.1200000000000001 111.841 -162.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -161.67 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.79 1.236 . . . . 3.0 109.613 175.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.4 pt -80.25 -39.2 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 123.964 0.906 . . . . 1.6899999999999999 110.811 -174.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.93 170.71 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.906 0.882 . . . . 1.55 108.657 178.81 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.05 159.46 28.03 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.443 -1.063 . . . . 1.8 110.443 178.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.34 -32.17 72.59 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.32 2.68 . . . . 2.52 110.719 -175.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -51.53 -37.42 49.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.508 1.123 . . . . 8.0399999999999991 111.016 175.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.34 -45.22 66.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.607 -1.257 . . . . 2.7799999999999998 107.607 -176.138 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.477 ' CD1' HG11 ' A' ' 122' ' ' VAL . 88.6 mt -60.73 -52.66 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 118.542 -0.742 . . . . 1.4399999999999999 109.213 -177.714 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.72 HG22 ' HB3' ' A' ' 145' ' ' ALA . 17.3 pt -50.55 -57.09 2.85 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 108.617 -0.883 . . . . 3.9199999999999999 108.617 175.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -54.39 -44.11 72.02 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.461 0.911 . . . . 5.9500000000000002 113.461 -177.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.3 mm -55.65 -50.23 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.468 -0.568 . . . . 1.97 109.468 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.478 ' HA ' HD12 ' A' ' 141' ' ' ILE . 25.3 pt -71.06 -28.14 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.907 -1.121 . . . . 2.1499999999999999 112.725 -179.226 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -59.05 -30.97 68.43 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.225 0.921 . . . . 3.5499999999999998 110.293 173.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.08 -42.74 95.25 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.579 -0.526 . . . . 2.5800000000000001 109.579 174.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.672 HD13 HD21 ' A' ' 97' ' ' ASN . 25.4 mt -71.91 -33.17 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.273 0.629 . . . . 1.22 109.845 178.263 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.53 22.05 7.97 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.347 1.451 . . . . 1.21 111.249 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.472 ' CD2' HD11 ' A' ' 98' ' ' ILE . 9.8 m-85 -105.8 157.13 17.67 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.143 0.971 . . . . 1.9299999999999999 108.866 167.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -126.18 138.28 53.64 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 107.713 -1.218 . . . . 3.4399999999999999 107.713 -179.334 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.72 ' HB3' HG22 ' A' ' 135' ' ' ILE . . . -111.06 110.5 21.07 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.622 1.169 . . . . 1.6100000000000001 108.342 178.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 68.2 m -141.47 122.89 14.96 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.022 -1.466 . . . . 2.0699999999999998 110.483 176.56 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 0.05 103.33 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.936 2.894 . . . . 5.7300000000000004 114.633 174.718 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.03 -35.61 66.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.668 -0.682 . . . . 5.8700000000000001 111.333 177.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.012 -1.471 . . . . 8.7699999999999996 113.828 -177.85 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mtt . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 105.874 -1.898 . . . . 8.3200000000000003 105.874 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.02 103.99 8.47 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 120.692 1.587 . . . . 3.71 110.25 -171.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.56 110.44 2.42 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.762 1.641 . . . . 2.6099999999999999 112.015 -167.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -117.52 132.73 56.49 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.329 1.452 . . . . 2.7999999999999998 109.782 -176.118 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -95.27 137.6 34.11 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.623 -1.251 . . . . 3.3999999999999999 107.623 -170.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 16.7 t -125.03 145.28 49.98 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 123.89 0.876 . . . . 2.04 109.004 176.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -121.05 91.2 3.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.749 1.62 . . . . 3.6099999999999999 108.976 -172.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.548 HD12 ' HB3' ' A' ' 44' ' ' ALA . 3.1 pp -124.29 167.59 14.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.046 0.45 . . . . 3.0099999999999998 110.834 178.8 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.44 168.92 8.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.917 -1.142 . . . . 3.7999999999999998 107.917 163.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.9 mm -102.04 122.28 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 105.064 -2.199 . . . . 1.1599999999999999 105.064 164.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.47 99.41 11.07 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 104.837 -2.282 . . . . 3.79 104.837 178.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.81 -59.75 0.38 Allowed Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.418 -0.657 . . . . 1.1000000000000001 112.193 178.019 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.6 mtp 21.68 84.91 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.332 2.653 . . . . 1.8700000000000001 114.399 -178.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 p -57.03 -56.49 21.08 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.911 -0.566 . . . . 2.8700000000000001 112.36 -175.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.9 m 135.23 -60.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 129.013 2.925 . . . . 3.8399999999999999 108.434 -179.361 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.89 -69.51 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.506 1.923 . . . . 5.2000000000000002 112.644 -165.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 p -163.98 28.07 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 122.477 1.132 . . . . 2.52 109.945 163.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.5 t -75.06 -41.14 59.61 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.477 -0.783 . . . . 1.71 110.346 -168.069 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.58 -43.87 66.62 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 N-CA-C 108.566 -0.901 . . . . 2.8799999999999999 108.566 170.172 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -44.85 80.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.203 -0.453 . . . . 1.9299999999999999 110.326 179.391 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.427 HD22 ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -65.25 -37.26 86.67 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 121.976 -0.453 . . . . 3.3599999999999999 111.138 176.867 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.63 -46.12 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 123.808 0.843 . . . . 2.7999999999999998 110.161 175.168 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -57.74 -49.57 76.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.757 0.313 . . . . 4.25 110.791 -179.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -33.4 75.84 Favored 'General case' 0 CA--C 1.521 -0.149 0 O-C-N 121.726 -0.609 . . . . 5.9500000000000002 110.978 -179.18 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.427 ' ND2' HD22 ' A' ' 21' ' ' ASN . 3.2 m-80 -67.24 -60.33 2.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.127 -0.694 . . . . 1.5700000000000001 109.127 178.274 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.557 HD21 HD11 ' A' ' 62' ' ' ILE . 10.2 mt -53.73 -50.49 65.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 119.005 -0.522 . . . . 2.5499999999999998 111.828 179.636 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.29 -18.25 60.8 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.788 1.176 . . . . 2.9700000000000002 113.261 -176.335 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm -95.38 0.05 53.09 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.501 1.297 . . . . 4.1399999999999997 114.501 171.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.12 -60.26 3.12 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 120.244 1.384 . . . . 3.0800000000000001 110.59 175.182 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.41 -97.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.917 1.687 . . . . 1.1499999999999999 109.4 175.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.9 -0.64 82.38 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 121.873 -0.517 . . . . 1.2 113.773 -171.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.71 114.83 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 CA-C-N 118.652 1.226 . . . . 1.3999999999999999 109.251 178.293 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mp -131.12 52.04 2.09 Favored 'General case' 0 C--N 1.338 0.086 0 N-CA-C 108.982 -0.748 . . . . 3.1800000000000002 108.982 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.8 t -159.56 120.17 3.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.332 -1.359 . . . . 1.6699999999999999 107.332 171.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.5 m -107.76 122.38 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.624 1.17 . . . . 2.5 108.597 173.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tt -137.93 82.35 1.91 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.921 -0.712 . . . . 2.3500000000000001 109.693 172.516 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 t -102.58 127.16 56.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 116.231 -0.441 . . . . 1.8400000000000001 110.839 173.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.51 97.75 9.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.367 -1.346 . . . . 1.0600000000000001 107.367 168.428 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.95 -26.29 62.08 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.097 0.559 . . . . 2.8399999999999999 110.835 173.151 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.7 mtt -68.03 -57.97 5.26 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.204 1.001 . . . . 3.25 110.324 -178.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.98 -25.23 30.19 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.069 0.548 . . . . 1.25 111.56 -177.019 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.81 61.16 2.32 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 124.771 1.177 . . . . 0.96999999999999997 110.798 -178.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -142.17 131.75 23.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.142 -1.429 . . . . 2.6600000000000001 107.142 174.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.548 ' HB3' HD12 ' A' ' 8' ' ' LEU . . . -110.45 102.25 10.88 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 124.631 1.207 . . . . 0.87 110.688 171.129 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.41 138.84 39.6 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.831 -1.174 . . . . 4.1699999999999999 107.831 168.563 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.24 166.55 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.392 -1.336 . . . . 2.0099999999999998 107.392 -177.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -124.49 90.46 3.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.576 0.751 . . . . 3.7000000000000002 109.765 -172.362 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.456 ' HB2' HD12 ' A' ' 53' ' ' ILE . 9.7 p90 -95.3 -177.99 4.29 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.648 1.979 . . . . 2.23 112.155 -176.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.78 94.85 24.14 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.724 1.61 . . . . 2.9700000000000002 108.946 -176.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -55.81 -22.63 38.14 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.253 2.635 . . . . 2.1499999999999999 113.828 -174.146 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -64.13 -32.34 73.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.448 1.099 . . . . 3.5600000000000001 112.37 177.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -124.75 -26.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 113.536 0.939 . . . . 2.6200000000000001 113.536 -175.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -123.44 133.22 69.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 N-CA-C 108.436 -0.95 . . . . 1.4199999999999999 108.436 174.065 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -107.2 154.26 40.59 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.603 1.161 . . . . 3.1600000000000001 110.088 175.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -60.5 -35.72 89.27 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.587 2.191 . . . . 1.3300000000000001 111.261 -178.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 pp -60.89 -43.57 98.3 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.567 -0.708 . . . . 3.7000000000000002 112.152 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.02 -40.65 78.54 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.298 0.639 . . . . 3.7000000000000002 109.418 177.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.431 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -49.92 -51.68 15.82 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 106.883 -1.525 . . . . 1.1200000000000001 106.883 173.09 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.47 -42.34 82.39 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.476 -0.784 . . . . 1.23 109.715 -175.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.35 -48.56 71.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.607 0.763 . . . . 3.5299999999999998 110.021 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -44.09 92.34 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.296 0.57 . . . . 2.46 109.604 179.699 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.557 HD11 HD21 ' A' ' 26' ' ' LEU . 8.9 mm -62.6 -44.46 99.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 O-C-N 121.817 -0.552 . . . . 2.75 110.994 179.155 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -63.62 -45.26 91.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.627 -0.508 . . . . 2.3399999999999999 109.627 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.29 -50.4 71.5 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.773 0.829 . . . . 2.21 110.194 177.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.42 ' C ' HD12 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -65.73 -36.19 82.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 121.193 -0.203 . . . . 3.4399999999999999 110.469 -175.952 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 129.43 26.5 0.88 Allowed Glycine 0 C--N 1.34 0.799 0 CA-C-O 119.792 -0.449 . . . . 1.6299999999999999 112.988 164.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -118.66 177.94 4.65 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.015 0.926 . . . . 1.99 110.985 173.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.54 142.13 41.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.856 -1.535 . . . . 2.3300000000000001 106.856 160.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.4 131.95 55.75 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.095 -1.076 . . . . 1.0700000000000001 108.095 163.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.4 124.87 26.41 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.71 -0.478 . . . . 1.04 109.71 174.227 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.02 148.42 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.844 1.658 . . . . 2.5600000000000001 109.266 172.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.5 mtp -46.47 -52.96 12.11 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.856 0.722 . . . . 3.6899999999999999 110.986 -177.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -165.87 108.44 0.77 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 100.938 -3.727 . . . . 5.0099999999999998 100.938 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.37 122.34 9.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.978 1.263 . . . . 10.380000000000001 112.311 -165.358 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.451 ' CZ ' ' HA3' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -152.72 -74.48 0.13 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.28 -1.782 . . . . 6.2199999999999998 108.402 -160.165 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 94.48 -89.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 126.993 2.117 . . . . 3.8300000000000001 109.034 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.451 ' HA3' ' CZ ' ' A' ' 75' ' ' TYR . . . 81.93 87.39 0.69 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 114.618 0.607 . . . . 2.8399999999999999 114.618 172.317 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.6 t -163.0 -42.66 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 119.062 -0.494 . . . . 4.8099999999999996 111.559 164.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -146.84 136.19 22.76 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.071 -1.455 . . . . 4.4100000000000001 107.071 176.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.2 -62.29 4.6 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 106.935 -2.466 . . . . 1.5900000000000001 106.935 176.658 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.45 133.08 43.33 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.405 1.482 . . . . 2.4700000000000002 107.634 169.387 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.59 HD13 ' H ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -142.22 161.22 19.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 129.387 3.075 . . . . 3.25 104.977 166.342 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.409 ' HB3' ' CE1' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -116.64 153.34 32.48 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.182 -1.784 . . . . 3.48 106.182 167.016 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mp -127.17 147.01 50.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.745 0.653 . . . . 2.2000000000000002 110.077 162.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.3 m -92.97 117.3 29.9 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.909 -1.515 . . . . 2.2599999999999998 106.909 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.437 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.6 OUTLIER -96.41 104.24 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 123.768 0.827 . . . . 1.6299999999999999 109.415 -174.563 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.3 m -96.9 136.14 37.88 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.522 -1.288 . . . . 1.3999999999999999 107.522 175.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.22 -33.31 4.58 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.701 1.143 . . . . 1.0900000000000001 112.124 177.705 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.7 ptp -64.05 160.72 17.45 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.372 0.586 . . . . 2.27 112.54 -177.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 t -172.41 40.03 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.167 0.987 . . . . 2.6299999999999999 110.394 168.524 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -164.76 133.7 3.54 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.04 -1.038 . . . . 2.6800000000000002 111.711 -176.443 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.55 81.72 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.071 0.548 . . . . 2.6600000000000001 111.174 177.366 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.8 t -56.46 -47.64 78.74 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.228 -0.92 . . . . 2.23 109.825 174.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 87.4 m -60.25 -43.95 95.67 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.874 -0.516 . . . . 2.1299999999999999 110.366 177.455 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.65 -50.62 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 O-C-N 122.332 -0.23 . . . . 1.78 111.286 177.072 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -59.19 -39.24 81.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.075 0.95 . . . . 3.6800000000000002 109.673 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -62.56 -50.6 70.68 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.626 0.37 . . . . 1.99 110.128 176.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.415 HD11 ' CE2' ' A' ' 143' ' ' PHE . 51.0 mt -55.99 -55.95 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.842 -0.429 . . . . 1.3300000000000001 109.842 177.517 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.52 -42.45 67.42 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.716 0.807 . . . . 3.0 110.86 177.795 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 p -62.69 -52.05 64.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.536 1.062 . . . . 1.75 110.843 177.212 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -63.6 -39.45 94.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.133 0.879 . . . . 5.5800000000000001 111.286 -174.235 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.89 -46.25 65.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.241 -0.885 . . . . 2.5800000000000001 109.24 177.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 95.9 m -55.84 -26.03 44.78 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.206 0.912 . . . . 1.7 111.563 176.004 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -61.65 -20.45 63.41 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.376 0.88 . . . . 4.3499999999999996 113.376 174.075 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.9 m -66.3 150.79 48.31 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.154 1.382 . . . . 1.77 110.909 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -68.34 -50.82 50.61 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.05 0.94 . . . . 2.3599999999999999 111.756 177.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.99 -26.67 61.76 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 123.52 0.581 . . . . 1.23 113.569 -169.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.45 140.35 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.467 -0.938 . . . . 2.8500000000000001 108.467 -177.21 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 24.8 p -115.49 -64.0 1.38 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 122.621 0.369 . . . . 2.9199999999999999 111.006 -175.05 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.404 ' CZ ' ' HG3' ' A' ' 123' ' ' LYS . 42.0 p90 -135.57 119.01 16.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.171 -1.048 . . . . 2.9100000000000001 108.171 174.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -105.62 161.02 14.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.728 -0.471 . . . . 0.80000000000000004 109.728 164.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.8 t -142.81 111.61 6.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.698 -1.223 . . . . 2.2000000000000002 107.698 168.169 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 68.9 t -98.93 123.17 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.912 1.285 . . . . 2.3100000000000001 109.458 -177.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -130.11 113.42 14.48 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.041 0.837 . . . . 1.28 112.644 -172.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 pp -77.88 -37.98 46.88 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 124.126 0.971 . . . . 2.4900000000000002 112.853 -171.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.67 70.13 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.344 0.592 . . . . 1.4299999999999999 110.86 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -35.69 16.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.779 1.232 . . . . 1.71 109.633 177.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.1 m 90.18 17.53 0.04 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.321 1.848 . . . . 1.8200000000000001 111.463 175.77 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -125.64 160.42 29.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.626 0.648 . . . . 3.02 110.446 175.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -130.74 125.82 34.83 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.127 1.371 . . . . 0.82999999999999996 108.24 179.146 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -92.55 129.19 38.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.423 -2.065 . . . . 1.71 105.423 177.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.72 139.06 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.312 -0.996 . . . . 1.8300000000000001 108.312 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 110' ' ' TYR . 13.0 mmmm -114.76 96.93 5.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.61 0.764 . . . . 3.8300000000000001 109.602 173.067 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.66 -179.77 3.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.202 0.456 . . . . 2.2799999999999998 110.744 176.827 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -110.08 110.74 58.57 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 108.562 -0.903 . . . . 3.3999999999999999 108.562 175.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.57 63.12 8.69 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.506 2.804 . . . . 1.8700000000000001 113.049 -164.302 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -148.03 -50.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.873 1.669 . . . . 4.1799999999999997 108.184 172.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.37 -32.03 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 123.468 0.707 . . . . 1.8700000000000001 111.33 -173.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.85 163.63 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.9 -1.148 . . . . 1.54 107.9 172.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.93 154.87 26.17 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.361 -1.095 . . . . 1.3700000000000001 110.361 -179.407 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -60.44 -33.08 94.41 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.383 2.722 . . . . 1.4099999999999999 111.71 -175.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -57.28 -38.36 73.83 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.585 0.354 . . . . 5.3799999999999999 110.784 178.122 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -67.23 -45.2 77.49 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.081 -1.081 . . . . 2.8500000000000001 108.081 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 56.1 mt -53.78 -56.53 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 118.355 -0.831 . . . . 1.3600000000000001 109.266 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 pt -53.5 -54.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 118.55 0.614 . . . . 2.46 110.559 176.49 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -56.24 -45.47 79.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 119.789 1.177 . . . . 5.0700000000000003 112.869 -175.384 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.6 mm -69.05 -40.13 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 121.366 -0.834 . . . . 3.6200000000000001 110.072 -178.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.86 -29.72 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 120.12 -1.612 . . . . 1.4299999999999999 112.195 176.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -59.36 -29.59 67.78 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.674 -0.642 . . . . 3.96 111.107 170.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.61 -38.69 92.06 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.963 -0.755 . . . . 4.7300000000000004 108.963 176.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.7 mt -70.77 -37.44 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.494 -0.558 . . . . 1.4099999999999999 109.494 172.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.46 28.62 5.38 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.054 1.311 . . . . 1.0800000000000001 111.02 178.298 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.415 ' CE2' HD11 ' A' ' 98' ' ' ILE . 3.7 m-85 -99.57 -178.91 4.03 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.828 -1.545 . . . . 2.1200000000000001 106.828 172.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -141.54 128.34 20.46 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.537 -1.283 . . . . 4.75 107.537 177.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.84 94.62 4.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.656 0.782 . . . . 1.1299999999999999 109.794 -172.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.6 t -98.61 96.83 8.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.799 1.24 . . . . 2.0699999999999998 107.745 -168.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.55 101.25 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.041 1.737 . . . . 4.2999999999999998 111.875 179.477 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 55.95 35.91 26.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.621 0.769 . . . . 4.2400000000000002 111.895 178.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 108.847 -0.797 . . . . 8.5999999999999996 108.847 -176.377 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 mmt . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 116.634 -1.651 . . . . 8.5 106.623 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.56 153.15 66.08 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.793 1.237 . . . . 3.9300000000000002 110.257 -176.343 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -92.75 115.72 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.843 2.362 . . . . 2.7999999999999998 112.22 -179.221 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -140.55 146.54 38.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.74 -1.948 . . . . 3.8199999999999998 105.74 169.293 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -97.02 165.78 11.91 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.626 0.771 . . . . 3.3399999999999999 109.682 173.598 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.57 126.57 17.29 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 119.067 -0.492 . . . . 1.9299999999999999 110.635 164.812 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -99.19 104.69 16.67 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.718 1.607 . . . . 2.7599999999999998 109.537 178.121 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.435 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -127.9 172.34 10.97 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.219 0.533 . . . . 2.3900000000000001 109.677 172.413 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.578 ' NE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -121.49 138.55 54.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.286 -1.375 . . . . 1.7 107.286 173.212 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.8 mm -100.17 129.88 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.527 -1.286 . . . . 1.05 107.527 177.209 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -108.89 120.71 43.32 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.666 -1.235 . . . . 2.6299999999999999 107.666 172.762 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.77 -56.28 0.33 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.258 0.932 . . . . 1.6699999999999999 112.095 177.467 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.3 mtt 25.54 77.14 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.078 2.151 . . . . 2.4700000000000002 115.522 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m -55.26 -54.68 40.44 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.719 -0.613 . . . . 2.4100000000000001 112.489 178.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.3 41.4 0.1 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.013 0.435 . . . . 4.21 111.355 -169.075 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 51.33 31.14 6.7 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.349 1.459 . . . . 5.0899999999999999 113.911 177.888 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -154.11 -42.79 0.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.424 1.489 . . . . 2.9399999999999999 110.905 -172.305 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.42 -46.91 88.31 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.622 -0.674 . . . . 1.6200000000000001 110.588 -177.716 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.04 -43.36 36.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 123.086 0.554 . . . . 2.1000000000000001 109.902 171.964 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -61.04 -47.92 84.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.479 -0.563 . . . . 2.5099999999999998 109.479 -179.062 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -46.93 88.32 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 122.178 -0.326 . . . . 2.7200000000000002 110.454 178.347 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.9 mt -50.1 -55.06 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.415 1.086 . . . . 2.0499999999999998 110.292 175.648 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' CD ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -66.79 -32.71 74.17 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.491 1.139 . . . . 6.29 110.563 -176.811 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -32.47 73.84 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 119.634 -1.917 . . . . 4.1699999999999999 111.603 172.086 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -66.32 -38.33 87.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.21 -0.663 . . . . 1.6799999999999999 109.21 171.883 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.12 -39.54 78.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.327 0.512 . . . . 2.0299999999999998 110.086 173.235 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.415 ' N ' HE21 ' A' ' 27' ' ' GLN . 0.0 OUTLIER -53.55 -20.61 5.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.135 1.161 . . . . 3.4199999999999999 114.135 173.27 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -107.88 9.67 28.73 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.612 0.765 . . . . 3.1800000000000002 112.647 179.029 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -67.22 -67.94 0.42 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.664 0.785 . . . . 2.3700000000000001 110.443 178.393 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -167.59 -101.68 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.061 0.944 . . . . 1.49 109.136 177.431 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.57 23.71 6.29 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.5 -0.75 . . . . 1.3600000000000001 113.22 -175.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.2 t -95.44 113.17 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.751 1.221 . . . . 2.3599999999999999 109.271 178.553 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 mp -139.6 54.04 1.69 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.225 0.466 . . . . 2.8100000000000001 111.172 177.272 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 m -157.08 152.65 26.7 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.047 -1.094 . . . . 1.6899999999999999 108.047 155.097 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.453 HG23 ' CD ' ' A' ' 23' ' ' GLU . 2.1 p -141.03 96.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.636 1.174 . . . . 2.73 107.979 179.779 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.71 80.75 1.99 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 108.223 -1.028 . . . . 3.0299999999999998 108.223 -177.494 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.6 t -99.53 129.35 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.206 -0.665 . . . . 1.97 109.206 174.53 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.44 81.8 3.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.37 -1.715 . . . . 1.2 106.37 170.353 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.83 -16.61 4.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.767 0.827 . . . . 3.4399999999999999 111.609 176.374 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 6.3 tpt -67.51 -38.8 84.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.401 2.28 . . . . 3.8300000000000001 110.774 176.739 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.87 -36.2 4.23 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.851 1.26 . . . . 1.5 111.624 -168.45 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.85 58.7 0.98 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.11 1.338 . . . . 1.1000000000000001 111.36 179.518 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -141.71 133.35 26.99 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.631 -1.248 . . . . 2.6800000000000002 107.631 170.701 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.78 120.28 41.01 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 0.92000000000000004 110.709 170.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.46 ' OE2' ' NZ ' ' A' ' 47' ' ' LYS . 30.0 tt0 -109.84 115.12 29.24 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.843 0.857 . . . . 4.0999999999999996 108.874 166.49 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.6 mt -107.92 168.07 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 125.39 1.476 . . . . 2.52 108.872 170.707 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.46 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -126.59 108.2 10.91 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.103 0.961 . . . . 4.5899999999999999 109.168 162.263 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.472 ' HB2' HD12 ' A' ' 53' ' ' ILE . 12.6 p90 -104.04 177.99 4.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.805 2.042 . . . . 2.1899999999999999 111.114 174.401 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -121.38 114.3 31.84 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.194 1.397 . . . . 3.2200000000000002 109.866 171.267 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.13 -22.44 69.89 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.069 2.513 . . . . 2.04 113.553 179.044 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -35.41 80.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.421 1.009 . . . . 3.4500000000000002 111.188 -179.99 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -116.32 -31.58 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-N 118.591 0.632 . . . . 2.5099999999999998 111.61 -171.136 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.472 HD12 ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -126.73 132.46 70.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 123.752 0.821 . . . . 1.46 109.178 178.408 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -107.46 151.58 41.0 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.195 1.398 . . . . 2.6600000000000001 111.149 179.443 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -59.79 -34.55 95.79 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.636 2.224 . . . . 1.3100000000000001 111.981 -179.848 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.6 -53.19 60.89 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.466 -0.771 . . . . 3.1499999999999999 110.643 179.818 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.45 -36.17 82.85 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.965 -0.459 . . . . 4.3600000000000003 110.929 178.874 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.462 HD12 HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -53.07 -49.97 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.028 -1.471 . . . . 1.0900000000000001 107.028 171.632 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.92 90.93 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.386 -0.37 . . . . 1.1299999999999999 111.236 -177.262 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -56.7 -43.96 81.05 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.852 -0.53 . . . . 2.46 109.726 175.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.64 -49.87 69.53 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 110.123 -0.325 . . . . 2.3100000000000001 110.123 176.099 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mm -63.28 -48.2 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.294 0.569 . . . . 2.3999999999999999 111.251 -176.781 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -40.92 96.86 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.935 -0.575 . . . . 2.0499999999999998 110.483 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.32 -50.92 65.9 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.469 0.577 . . . . 2.5 110.305 177.049 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.5 mt -54.17 -33.77 58.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.914 0.486 . . . . 2.1000000000000001 111.112 174.799 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.09 37.24 1.54 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.56 -1.016 . . . . 1.2 110.56 164.369 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -129.77 170.07 14.33 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.798 -1.186 . . . . 2.4399999999999999 107.798 -179.753 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -111.06 122.74 48.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.082 -0.71 . . . . 2.5899999999999999 109.082 170.331 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.84 122.27 43.15 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.443 -1.317 . . . . 0.83999999999999997 107.443 163.49 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . . . -121.9 144.49 48.82 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.794 -1.558 . . . . 0.92000000000000004 106.794 167.235 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.43 ' HA ' ' HB3' ' A' ' 8' ' ' LEU . 2.9 t -75.49 156.89 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 108.032 -1.099 . . . . 2.4900000000000002 108.032 -179.424 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.8 ptm -63.9 -48.38 76.86 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 119.238 -0.985 . . . . 4.0999999999999996 111.025 174.486 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 161.34 -57.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 129.974 3.31 . . . . 4.04 107.682 177.821 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.04 -29.78 68.75 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 125.367 1.467 . . . . 7.2599999999999998 113.116 -172.318 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.496 ' CE1' ' ND2' ' A' ' 81' ' ' ASN 0.324 2.2 p90 65.49 -56.34 0.33 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 128.321 2.648 . . . . 4.0300000000000002 113.339 -173.573 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -165.76 -71.25 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 120.411 1.46 . . . . 3.3100000000000001 113.217 -172.771 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.457 ' HA2' ' H ' ' A' ' 83' ' ' GLU . . . 95.21 67.1 0.99 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.253 -1.539 . . . . 3.2999999999999998 109.253 -178.541 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.3 t -156.42 -153.08 0.41 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.064 1.432 . . . . 4.5099999999999998 112.692 -172.886 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.84 126.3 29.61 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.405 1.482 . . . . 4.8099999999999996 108.398 -157.692 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.59 -36.56 3.23 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 109.761 -1.336 . . . . 2.0699999999999998 109.761 -173.173 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.496 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 1.2 p-10 -145.79 96.08 2.75 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 114.879 1.437 . . . . 3.6400000000000001 114.879 -178.553 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.33 143.77 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 106.589 -1.634 . . . . 3.98 106.589 -174.268 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' H ' ' HA2' ' A' ' 77' ' ' GLY . 1.2 pp20? -104.87 150.2 25.04 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.115 -1.809 . . . . 3.5699999999999998 106.115 172.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mp -135.91 154.82 51.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.32 -0.992 . . . . 2.2599999999999998 108.32 167.631 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 0.5 OUTLIER -95.38 125.87 40.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.835 -1.913 . . . . 1.5 105.835 173.752 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 pt -98.37 139.28 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.757 -1.201 . . . . 1.77 107.757 178.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.3 m -125.22 140.21 53.05 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.634 0.773 . . . . 1.5600000000000001 109.252 174.65 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.93 -21.66 12.14 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.622 1.582 . . . . 1.1899999999999999 113.334 171.8 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.66 130.85 1.35 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.087 0.955 . . . . 3.5600000000000001 112.523 168.603 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.8 m -130.54 2.73 4.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.209 0.604 . . . . 3.8799999999999999 111.114 -178.02 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.2 p 178.74 154.83 0.41 Allowed 'General case' 0 C--N 1.341 0.231 0 O-C-N 121.165 -0.959 . . . . 3.25 109.181 -174.637 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.91 -27.66 65.45 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.579 0.752 . . . . 2.6299999999999999 112.724 -178.354 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 m -51.65 -41.43 61.34 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.343 -0.848 . . . . 2.0 111.141 169.815 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 90.8 m -65.54 -45.72 82.33 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.599 -0.519 . . . . 1.75 109.599 -179.602 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.7 t -53.28 -54.73 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.562 1.145 . . . . 1.4199999999999999 109.924 175.444 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -57.26 -45.37 84.05 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.966 0.507 . . . . 3.8199999999999998 110.168 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -61.98 -45.79 92.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.144 -0.348 . . . . 1.6200000000000001 110.968 179.077 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.7 mt -56.27 -49.63 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.93 -0.767 . . . . 0.88 108.93 176.583 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -58.57 -47.69 83.41 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.354 -0.61 . . . . 2.2799999999999998 109.354 178.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.5 t -50.83 -50.06 57.44 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.92 0.488 . . . . 1.3200000000000001 110.07 174.703 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.494 ' HG2' HD11 ' A' ' 141' ' ' ILE . 13.2 mptt -61.53 -37.93 85.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.551 -0.718 . . . . 2.7599999999999998 111.838 -178.99 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.6 mt -70.19 -60.91 2.0 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.78 -1.192 . . . . 1.8200000000000001 107.78 178.202 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.4 p -54.86 -20.67 9.28 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.206 1.402 . . . . 2.0099999999999998 113.147 -179.069 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -59.26 -25.67 64.27 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.456 0.539 . . . . 3.8199999999999998 112.456 171.279 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 39.1 m -66.68 154.28 41.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.352 1.461 . . . . 1.48 111.337 -178.559 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -72.87 -54.23 9.29 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.293 1.037 . . . . 2.3199999999999998 111.869 179.295 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.34 -36.2 63.34 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 121.401 0.445 . . . . 1.1299999999999999 112.37 -172.605 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.76 126.52 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 121.774 -0.839 . . . . 2.23 109.81 -173.309 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.0 m -98.8 -51.25 3.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.553 0.341 . . . . 2.0499999999999998 110.963 179.168 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.423 ' CZ ' ' HG3' ' A' ' 123' ' ' LYS . 36.2 p90 -140.9 111.6 6.97 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.325 -0.369 . . . . 2.1299999999999999 110.082 -178.749 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -96.6 153.69 17.71 Favored 'General case' 0 C--O 1.227 -0.082 0 N-CA-C 108.373 -0.973 . . . . 0.81999999999999995 108.373 167.014 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -142.83 125.51 15.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 107.041 -1.466 . . . . 2.1099999999999999 107.041 169.202 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 p -123.88 128.22 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.348 1.059 . . . . 1.96 109.734 -172.501 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.88 106.36 6.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.74 0.781 . . . . 1.0900000000000001 111.112 -168.791 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -69.29 -19.24 63.9 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 124.304 1.042 . . . . 2.2599999999999998 113.328 179.155 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.01 94.5 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.786 -0.449 . . . . 1.3799999999999999 109.786 176.004 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.06 -28.99 17.59 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.124 0.97 . . . . 1.8300000000000001 110.189 175.338 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.41 34.34 0.37 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.24 1.416 . . . . 1.55 111.319 -175.261 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -138.6 166.74 23.55 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.923 -0.485 . . . . 3.52 111.064 175.217 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -136.66 135.53 38.33 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.819 1.648 . . . . 0.81999999999999995 108.733 -178.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.441 ' HG ' ' HE2' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -98.01 134.55 40.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.717 -1.586 . . . . 1.77 106.717 174.323 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.4 127.99 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.032 0.533 . . . . 2.1099999999999999 110.001 -178.853 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.486 ' CD ' ' HB2' ' A' ' 81' ' ' ASN . 12.6 mmtp -116.06 87.44 2.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.615 0.766 . . . . 3.5299999999999998 109.425 -172.783 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -119.63 170.39 9.23 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.456 1.098 . . . . 2.6099999999999999 111.738 -178.255 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -96.99 114.02 63.96 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 108.182 -1.044 . . . . 3.3700000000000001 108.182 -179.053 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.72 67.95 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.137 2.558 . . . . 1.6299999999999999 110.997 -172.917 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -160.46 -47.65 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.831 1.252 . . . . 3.1800000000000002 109.125 176.886 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -85.79 -30.31 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 122.928 0.491 . . . . 1.5700000000000001 111.561 -173.145 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.74 162.04 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.155 -1.054 . . . . 1.4199999999999999 108.155 171.477 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -133.77 163.16 24.49 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.167 -1.573 . . . . 1.7 109.167 178.786 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -63.39 -35.86 58.98 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.92 2.413 . . . . 1.98 111.852 -175.968 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.17 -40.41 73.88 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.149 0.431 . . . . 4.9000000000000004 111.606 -174.071 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -51.1 71.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.647 -0.871 . . . . 3.3199999999999998 108.647 178.992 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.436 ' O ' HD13 ' A' ' 138' ' ' ILE . 53.6 mt -58.82 -50.25 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.532 -0.914 . . . . 1.3300000000000001 108.532 -179.589 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 78.4 mt -46.08 -58.74 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 118.432 -0.794 . . . . 2.3199999999999998 109.193 172.812 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -49.62 -49.86 45.21 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.697 1.135 . . . . 3.8399999999999999 112.15 177.24 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.4 mm -51.08 -55.55 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 118.206 0.457 . . . . 1.96 110.576 177.184 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.436 HD13 ' O ' ' A' ' 134' ' ' ILE 0.295 0.0 OUTLIER -68.68 -32.51 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 118.339 -1.345 . . . . 2.8100000000000001 113.311 -179.705 . . . . . . . . 4 4 . 1 . 031 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.46 -40.28 90.66 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.368 1.44 . . . . 2.2200000000000002 110.666 173.838 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -63.33 -36.92 85.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.339 0.656 . . . . 3.4399999999999999 109.818 177.1 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.494 HD11 ' HG2' ' A' ' 101' ' ' LYS . 80.6 mt -69.22 -39.7 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 120.171 -0.611 . . . . 0.93000000000000005 110.935 172.475 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.8 30.73 6.64 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.386 1.47 . . . . 0.82999999999999996 111.64 -171.597 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.442 ' CE2' HG21 ' A' ' 141' ' ' ILE . 23.1 m-85 -108.27 166.16 10.96 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.009 0.904 . . . . 1.9299999999999999 108.907 164.088 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -129.53 130.03 45.25 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 106.704 -1.591 . . . . 3.8700000000000001 106.704 -178.942 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.09 103.18 10.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.407 1.483 . . . . 1.1499999999999999 109.144 -175.685 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.5 t -121.25 120.34 34.86 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 123.314 0.646 . . . . 2.4399999999999999 110.539 -177.482 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -37.1 119.59 0.69 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.581 1.552 . . . . 3.6699999999999999 111.248 170.94 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.415 ' HB2' ' HB ' ' A' ' 85' ' ' THR . . . -119.78 61.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.83 1.652 . . . . 3.54 109.464 175.717 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.252 1.217 0 O-C-N 125.737 1.898 . . . . 6.25 109.545 162.866 . . . . . . . . 0 0 . 1 stop_ save_